PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Song, W; Hwang, Y; Youngblood, VM; Cook, RS; Balko, JM; Chen, J; Brantley-Sieders, DM				Song, W.; Hwang, Y.; Youngblood, V. M.; Cook, R. S.; Balko, J. M.; Chen, J.; Brantley-Sieders, D. M.			Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASE; METASTATIC PROGRESSION; MAMMARY ADENOCARCINOMA; TUMOR ANGIOGENESIS; SIGNALING AXIS; T-ANTIGEN; MYC; DISEASE; MICE; GENE	Basal-like/triple-negative breast cancers (TNBCs) are among the most aggressive forms of breast cancer, and disproportionally affects young premenopausal women and women of African descent. Patients with TNBC suffer a poor prognosis due in part to a lack of molecularly targeted therapies, which represents a critical barrier for effective treatment. Here, we identify EphA2 receptor tyrosine kinase as a clinically relevant target for TNBC. EphA2 expression is enriched in the basal-like molecular subtype in human breast cancers. Loss of EphA2 function in both human and genetically engineered mouse models of TNBC reduced tumor growth in culture and in vivo. Mechanistically, targeting EphA2 impaired cell cycle progression through S-phase via downregulation of c-Myc and stabilization of the cyclin-dependent kinase inhibitor p27/KIP1. A small molecule kinase inhibitor of EphA2 effectively suppressed tumor cell growth in vivo, including TNBC patient-derived xenografts. Thus, our data identify EphA2 as a novel molecular target for TNBC.	[Song, W.; Hwang, Y.; Chen, J.; Brantley-Sieders, D. M.] Vanderbilt Univ, Sch Med, Dept Med, T-3107A MCN,1161 21st Ave South, Nashville, TN 37232 USA; [Youngblood, V. M.; Cook, R. S.; Balko, J. M.; Chen, J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Cook, R. S.; Balko, J. M.; Chen, J.; Brantley-Sieders, D. M.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Chen, J.] Vanderbilt Univ, Sch Med, Dept Cellular & Dev Biol, Nashville, TN 37212 USA; [Chen, J.] Vet Affairs Med Ctr, Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Chen, J; Brantley-Sieders, DM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, T-3107A MCN,1161 21st Ave South, Nashville, TN 37232 USA.; Chen, J (corresponding author), Vanderbilt Univ, Sch Med, T-3107A MCN,1161 21st Ave South, Nashville, TN 37232 USA.	jin.chen@vanderbilt.edu; dana.brantley@vanderbilt.edu		Hwang, Yoonha/0000-0001-7420-4477; Chen, Jin/0000-0002-5557-2079	NIH/NCI [R01 CA148934, R01 CA177681, R01 CA95004]; CTSA (via Vanderbilt Institute of Clinical and Translational Research (VICTR)) from the National Center for Advancing Translational Sciences [UL1TR000445, VR10608]; US Department of Veterans Affairs VA Merit Award [5I01BX000134]; NCI Cancer Center Support Grant [P30 CA068485]; NATIONAL CANCER INSTITUTE [R01CA095004, R01CA177681, P30CA068485, R01CA148934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000134] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA (via Vanderbilt Institute of Clinical and Translational Research (VICTR)) from the National Center for Advancing Translational Sciences; US Department of Veterans Affairs VA Merit Award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr Bojana Jovanovic (Dana-Farber Cancer Institute) and Dr Tammy Sobolik (Vanderbilt University) for helpful discussions on the research. This work was supported by NIH/NCI Grants R01 CA148934 (DMB-S); R01 CA177681, and R01 CA95004 (JC). Acquisition of PDX models from the Huntsman Cancer Institute was supported by CTSA award UL1TR000445 (via Vanderbilt Institute of Clinical and Translational Research (VICTR) Grant VR10608 (DMB-S)) from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. JC is also supported by US Department of Veterans Affairs VA Merit Award (5I01BX000134). This work was also supported in part by the NCI Cancer Center Support Grant # P30 CA068485 utilizing the Translational Pathology Shared Resources.	Amato KR, 2016, CANCER RES, V76, P305, DOI 10.1158/0008-5472.CAN-15-0717; Arnato KR, 2014, J CLIN INVEST, V124, P2037, DOI 10.1172/JCI72522; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Brantley-Sieders DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024426; Brantley-Sieders DM, 2011, CANCER RES, V71, P976, DOI 10.1158/0008-5472.CAN-10-3396; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Caldon CE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-2; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Choi Y, 2009, BIOORG MED CHEM LETT, V19, P4467, DOI 10.1016/j.bmcl.2009.05.029; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dillon JL, 2016, BREAST, V29, P202, DOI 10.1016/j.breast.2016.06.018; Fosu-Mensah N, 2015, FUTURE MED CHEM, V7, P2019, DOI 10.4155/fmc.15.129; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; Guo ZM, 2015, INT J PHARMACEUT, V493, P380, DOI 10.1016/j.ijpharm.2015.05.051; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haibe-Kains B., GENEFU R PACKAGE REL; Hartl M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00132; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Hutcheson J, 2015, CELL CYCLE, V14, P3812, DOI 10.1080/15384101.2015.1010922; Knudsen ES, 2015, CELL CYCLE, V14, P109, DOI 10.4161/15384101.2014.967118; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Larsen AB, 2007, MOL CANCER RES, V5, P283, DOI 10.1158/1541-7786.MCR-06-0321; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lehmann BD, 2015, BREAST, V24, pS36, DOI 10.1016/j.breast.2015.07.009; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; MAROULAKOU IG, 1994, P NATL ACAD SCI USA, V91, P11236, DOI 10.1073/pnas.91.23.11236; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moccia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128364; Murria R, 2015, AM J CANCER RES, V5, P2330; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Sullivan CS, 2000, MOL CELL BIOL, V20, P6233, DOI 10.1128/MCB.20.17.6233-6243.2000; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tsouko E, 2015, CARCINOGENESIS, V36, P1051, DOI 10.1093/carcin/bgv087; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Weisman PS, 2016, MODERN PATHOL, V29, P476, DOI 10.1038/modpathol.2016.39; Young CD, 2015, MOL CELL PROTEOMICS, V14, P1959, DOI 10.1074/mcp.M115.049783; Youngblood VM, 2016, CANCER RES, V76, P1825, DOI 10.1158/0008-5472.CAN-15-0847; Zardavas D, 2015, NAT REV CLIN ONCOL, V12, P381, DOI 10.1038/nrclinonc.2015.73	47	54	55	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5620	5630		10.1038/onc.2017.170	http://dx.doi.org/10.1038/onc.2017.170			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581527	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000412293600006
J	Szczepny, A; Rogers, S; Jayasekara, WSN; Park, K; McCloy, RA; Cochrane, CR; Ganju, V; Cooper, WA; Sage, J; Peacock, CD; Cain, JE; Burgess, A; Watkins, DN				Szczepny, A.; Rogers, S.; Jayasekara, W. S. N.; Park, K.; McCloy, R. A.; Cochrane, C. R.; Ganju, V.; Cooper, W. A.; Sage, J.; Peacock, C. D.; Cain, J. E.; Burgess, A.; Watkins, D. N.			The role of canonical and non-canonical Hedgehog signaling in tumor progression in a mouse model of small cell lung cancer	ONCOGENE			English	Article							CHROMOSOMAL INSTABILITY; CYCLE PROGRESSION; SONIC HEDGEHOG; TUMORIGENESIS; CARCINOMAS; ANEUPLOIDY; RECEPTOR; PATHWAY	Hedgehog (Hh) signaling regulates cell fate and self-renewal in development and cancer. Canonical Hh signaling is mediated by Hh ligand binding to the receptor Patched (Ptch), which in turn activates Gli-mediated transcription through Smoothened (Smo), the molecular target of the Hh pathway inhibitors used as cancer therapeutics. Small cell lung cancer (SCLC) is a common, aggressive malignancy with universally poor prognosis. Although preclinical studies have shown that Hh inhibitors block the self-renewal capacity of SCLC cells, the lack of activating pathway mutations have cast doubt over the significance of these observations. In particular, the existence of autocrine, ligand-dependent Hh signaling in SCLC has been disputed. In a conditional Tp53;Rb1 mutant mouse model of SCLC, we now demonstrate a requirement for the Hh ligand Sonic Hedgehog (Shh) for the progression of SCLC. Conversely, we show that conditional Shh overexpression activates canonical Hh signaling in SCLC cells, and markedly accelerates tumor progression. When compared to mouse SCLC tumors expressing an activating, ligand-independent Smo mutant, tumors overexpressing Shh exhibited marked chromosomal instability and Smoothened-independent upregulation of Cyclin B1, a putative non-canonical arm of the Hh pathway. In turn, we show that overexpression of Cyclin B1 induces chromosomal instability in mouse embryonic fibroblasts lacking both Tp53 and Rb1. These results provide strong support for an autocrine, ligand-dependent model of Hh signaling in SCLC pathogenesis, and reveal a novel role for non-canonical Hh signaling through the induction of chromosomal instability.	[Szczepny, A.; Jayasekara, W. S. N.; Cochrane, C. R.; Ganju, V.; Cain, J. E.] Hudson Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Rogers, S.; McCloy, R. A.; Burgess, A.; Watkins, D. N.] Garvan Inst Med Res, Kinghorn Canc Ctr, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Rogers, S.; Burgess, A.; Watkins, D. N.] UNSW Fac Med, St Vincents Clin Sch, Sydney, NSW, Australia; [Park, K.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Cochrane, C. R.; Ganju, V.] Monash Univ, Sch Clin Sci, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Ganju, V.] Monash Hlth, Dept Med Oncol, Clayton, Vic, Australia; [Cooper, W. A.] Royal Prince Alfred Hosp, Dept Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia; [Sage, J.] Stanford Univ, Dept Pediat, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Sage, J.] Stanford Univ, Dept Genet, Stanford Canc Inst, Sch Med, Stanford, CA 94305 USA; [Peacock, C. D.] Cleveland Clin, Dept Translat Hematol Oncol Res, Cleveland, OH 44106 USA; [Watkins, D. N.] St Vincents Hosp, Dept Thorac Med, Sydney, NSW, Australia	Hudson Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Virginia; Monash University; University of Sydney; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Cleveland Clinic Foundation; St Vincents Hospital Sydney	Burgess, A; Watkins, DN (corresponding author), Garvan Inst Med Res, Kinghorn Canc Ctr, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	a.burgess@garvan.org.au; n.watkins@garvan.org.au	Burgess, Andrew/C-7952-2009; Burgess, Andrew/H-3339-2019	Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; Rogers, Samuel/0000-0002-5345-5741; Cochrane, Catherine/0000-0001-9683-8905; Park, Kwon-Sik/0000-0003-3346-9086; McCloy, Rachael/0000-0001-7791-4044	National Health and Medical Research Council of Australia [GNT1048669]; Victorian Cancer Agency [TS10-01]; Petre Foundation; Victorian Government's Operational Infrastructure Support Program; National Institutes of Health (NCI) [CA201513]; Cancer Institute of NSW Fellowship [10/FRL/3-02]; Patricia Helen Guest Fellowship; NATIONAL CANCER INSTITUTE [R01CA201513] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; Petre Foundation; Victorian Government's Operational Infrastructure Support Program; National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Institute of NSW Fellowship; Patricia Helen Guest Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia (GNT1048669), The Victorian Cancer Agency (TS10-01), The Petre Foundation, the Victorian Government's Operational Infrastructure Support Program, and the National Institutes of Health (NCI CA201513). Also, Cancer Institute of NSW Fellowship (10/FRL/3-02) and the Patricia Helen Guest Fellowship was awarded to JS and AB, respectively.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Badea TC, 2003, J NEUROSCI, V23, P2314; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Casimiro MC, 2015, ONCOTARGET, V6, P8525, DOI 10.18632/oncotarget.3267; Cui M, 2014, MOL CANCER RES, V12, P654, DOI 10.1158/1541-7786.MCR-13-0554; de Carcer G, 2014, NAT CELL BIOL, V16, P504, DOI 10.1038/ncb2978; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fombonne J, 2012, P NATL ACAD SCI USA, V109, P10510, DOI 10.1073/pnas.1200094109; Gazdar AF, 2016, J THORAC ONCOL, V11, P287, DOI 10.1016/j.jtho.2015.10.009; Gazdar AF, 2015, J THORAC ONCOL, V10, P553, DOI 10.1097/JTO.0000000000000459; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Heng HH, 2013, CANCER METAST REV, V32, P325, DOI 10.1007/s10555-013-9427-7; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Marini KD, 2011, GROWTH FACTORS, V29, P221, DOI 10.3109/08977194.2011.610756; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Nagy Andras, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4706; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; O'Toole SA, 2011, CANCER RES, V71, P4002, DOI 10.1158/0008-5472.CAN-10-3738; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Robles-Oteiza C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9783; Rogers S, 2016, J CELL SCI, V129, P1340, DOI 10.1242/jcs.179754; ROOS G, 1993, LAB INVEST, V68, P204; Shaukat Z, 2015, ONCOGENE, V34, P4044, DOI 10.1038/onc.2014.344; Sheltzer JM, 2013, CANCER RES, V73, P6401, DOI 10.1158/0008-5472.CAN-13-0749; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stevens JB, 2013, CANCER METAST REV, V32, P391, DOI 10.1007/s10555-013-9428-6; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Wu N, 2016, ONCOTARGET, V7, P57514, DOI 10.18632/oncotarget.11583; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	40	38	38	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5544	5550		10.1038/onc.2017.173	http://dx.doi.org/10.1038/onc.2017.173			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28581526	hybrid, Green Accepted			2022-12-26	WOS:000411960500010
J	Berkowitz, BA; Lenning, J; Khetarpal, N; Tran, C; Wu, JY; Berri, AM; Dernay, K; Haacke, EM; Shafie-Khorassani, F; Podolsky, RH; Gant, JC; Maimaiti, S; Thibault, O; Murphy, GG; Bennett, BM; Roberts, R				Berkowitz, Bruce A.; Lenning, Jacob; Khetarpal, Nikita; Tran, Catherine; Wu, Johnny Y.; Berri, Ali M.; Dernay, Kristin; Haacke, E. Mark; Shafie-Khorassani, Fatema; Podolsky, Robert H.; Gant, John C.; Maimaiti, Shaniya; Thibault, Olivier; Murphy, Geoffrey G.; Bennett, Brian M.; Roberts, Robin			In vivo imaging of prodromal hippocampus CA1 subfield oxidative stress in models of Alzheimer disease and Angelman syndrome	FASEB JOURNAL			English	Article						reactive oxygen species; MRI; dorsoventral CA1; neurodegenerative disease; neurodevelopment disorders	TRANSGENIC MOUSE MODEL; FREE-RADICAL PRODUCTION; MANGANESE-ENHANCED MRI; MILD COGNITIVE IMPAIRMENT; LIPID-PEROXIDATION; MEMORY DEFICITS; HYDROGEN-PEROXIDE; PYRAMIDAL NEURONS; XANTHINE-OXIDASE; CALCIUM-CHANNEL	Hippocampus oxidative stress is considered pathogenic in neurodegenerative diseases, such as Alzheimer disease (AD), and in neurodevelopmental disorders, such as Angelman syndrome (AS). Yet clinical benefits of antioxidant treatment for these diseases remain unclear because conventional imaging methods are unable to guide management of therapies in specific hippocampus subfields in vivo that underlie abnormal behavior. Excessive production of paramagnetic free radicals in nonhippocampus brain tissue can be measured in vivo as a greater-than-normal 1/T-1 that is quenchable with antioxidant as measured by quench-assisted (Quest) MRI. Here, we further test this approach in phantoms, and we present proof-of-concept data in models of AD-like and AS hippocampus oxidative stress that also exhibit impaired spatial learning and memory. AD-like models showed an abnormal gradient along the CA1 dorsal-ventral axis of excessive free radical production as measured by Quest MRI, and redox-sensitive calcium dysregulation as measured by manganese-enhanced MRI and electrophysiology. In the AS model, abnormally high free radical levels were observed in dorsal and ventral CA1. Quest MRI is a promising in vivo paradigm for bridging brain sub-field oxidative stress and behavior in animal models and in human patients to better manage antioxidant therapy in devastating neurodegenerative and neurodevelopmental diseases.	[Berkowitz, Bruce A.; Lenning, Jacob; Khetarpal, Nikita; Tran, Catherine; Wu, Johnny Y.; Berri, Ali M.; Dernay, Kristin; Roberts, Robin] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA; [Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Shafie-Khorassani, Fatema; Podolsky, Robert H.] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Detroit, MI USA; [Gant, John C.; Maimaiti, Shaniya; Thibault, Olivier] Univ Kentucky, Med Ctr, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Murphy, Geoffrey G.] Univ Michigan, Sch Med, Mol Behav Neurosci Inst, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Bennett, Brian M.] Queens Univ, Ctr Neurosci Studies, Dept Biomed & Mol Sci, Fac Hlth Sci, Kingston, ON, Canada	Wayne State University; Wayne State University; Wayne State University; Wayne State University; University of Kentucky; University of Michigan System; University of Michigan; Queens University - Canada	Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield, Detroit, MI 48201 USA.	baberko@med.wayne.edu	Lenning, Jacob/GXG-7868-2022; Thibault, Olivier/AAY-7614-2020; Podolsky, Robert/GRY-0740-2022	Thibault, Olivier/0000-0002-3548-3466; Shafie Khorassani, Fatema/0000-0001-7445-322X	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) [R21EY021619, R01EY026584]; NIH/National Institute on Aging [R01 AG033649, R01 AG028488]; Alzheimer's Society Research Program; Canadian Vascular Network; University of Michigan Protein Folding Disease Initiative; NIH/NEI Core Grant [P30 EY04068]; Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA); NATIONAL EYE INSTITUTE [R21EY021619, R01EY026584, P30EY004068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG058171, R01AG028488, R01AG052934, R01AG033649] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Society Research Program; Canadian Vascular Network; University of Michigan Protein Folding Disease Initiative; NIH/NEI Core Grant; Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part, by the U.S. National Institutes of Health (NIH)/National Eye Institute (NEI) (Grants R21EY021619 and R01EY026584 to B.A.B.), NIH/National Institute on Aging (Grants R01 AG033649 to O.T. and R01 AG028488 to G.G.M.), Alzheimer's Society Research Program (B.M.B.), the Canadian Vascular Network (B.M.B.), University of Michigan Protein Folding Disease Initiative (G.G.M.), NIH/NEI Core Grant P30 EY04068, and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute, Detroit, MI, USA).	Arimon M, 2015, NEUROBIOL DIS, V84, P109, DOI 10.1016/j.nbd.2015.06.013; ASHTON D, 1989, BRAIN RES, V487, P368, DOI 10.1016/0006-8993(89)90842-1; Bakalova R, 2015, ACS CHEM NEUROSCI, V6, P1922, DOI 10.1021/acschemneuro.5b00220; Beeman SC, 2016, MAGN RESON MED, V75, P2442, DOI 10.1002/mrm.25821; BENNETT HF, 1987, MAGNET RESON MED, V4, P93, DOI 10.1002/mrm.1910040202; BERKOWITZ BA, 2015, INVEST OPHTH VIS SCI, V56; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Berkowitz BA, 2016, PROG RETIN EYE RES, V51, P90, DOI 10.1016/j.preteyeres.2015.09.001; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P7931, DOI 10.1167/iovs.15-18420; Berkowitz BA, 2012, MOL VIS, V18, P372; Bissig D, 2014, NEUROBIOL AGING, V35, P1453, DOI 10.1016/j.neurobiolaging.2013.12.019; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Blalock EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010405; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Chen LJ, 2014, NEUROBIOL AGING, V35, P2552, DOI 10.1016/j.neurobiolaging.2014.05.007; Crystal GJ, 2012, ACTA ANAESTH SCAND, V56, P39, DOI 10.1111/j.1399-6576.2011.02583.x; D'Souza Y, 2011, BRIT J PHARMACOL, V164, P632, DOI 10.1111/j.1476-5381.2011.01448.x; D'Souza Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0117-y; de Carvalho JER, 2014, SURV OPHTHALMOL, V59, P393, DOI 10.1016/j.survophthal.2013.09.005; Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Durak I, 1999, CAN J ANAESTH, V46, P797, DOI 10.1007/BF03013919; Ekanger LA, 2015, METALLOMICS, V7, P405, DOI 10.1039/c4mt00289j; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; FREEMAN R, 1971, J CHEM PHYS, V54, P3367, DOI 10.1063/1.1675352; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Furman R, 2016, ACS CHEM NEUROSCI, V7, P367, DOI 10.1021/acschemneuro.5b00316; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gomes MB, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-80; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Grivas I, 2003, BRAIN RES, V971, P245, DOI 10.1016/S0006-8993(03)02475-2; Haacke E. M., 1999, J MAGN RESON; Han BH, 2015, P NATL ACAD SCI USA, V112, pE881, DOI 10.1073/pnas.1414930112; Hardas SS, 2013, REDOX BIOL, V1, P80, DOI 10.1016/j.redox.2013.01.002; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Hsu JJ, 2009, MAGN RESON MED, V62, P1202, DOI 10.1002/mrm.22111; Hu Q, 2011, STROKE, V42, P1750, DOI 10.1161/STROKEAHA.110.603142; Hyodo F, 2008, J PHARM PHARMACOL, V60, P1049, DOI 10.1211/jpp.60.8.0011; Hyodo F, 2008, J CEREBR BLOOD F MET, V28, P1165, DOI 10.1038/jcbfm.2008.5; Hyodo F, 2008, J MAGN RESON, V190, P105, DOI 10.1016/j.jmr.2007.10.013; Ilangovan G, 2004, METHOD ENZYMOL, V381, P747; Kanamaru T, 2015, NEUROSCI LETT, V587, P126, DOI 10.1016/j.neulet.2014.12.033; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Kudo M, 2001, ANESTHESIOLOGY, V94, P303, DOI 10.1097/00000542-200102000-00021; KUPPUSAMY P, 1989, J BIOL CHEM, V264, P9880; Lin BW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003154; Malik R, 2016, HIPPOCAMPUS, V26, P341, DOI 10.1002/hipo.22526; Mason RP, 2016, REDOX BIOL, V8, P422, DOI 10.1016/j.redox.2016.04.003; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; Matsumura A, 2015, FREE RADICAL BIO MED, V85, P165, DOI 10.1016/j.freeradbiomed.2015.04.013; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Modi KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130398; MOSER E, 1993, J NEUROSCI, V13, P3916; Muralidharan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19067; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nunomura A, 2012, J NEUROPATH EXP NEUR, V71, P233, DOI 10.1097/NEN.0b013e318248e614; Pancani T, 2013, NEUROBIOL AGING, V34, P1977, DOI 10.1016/j.neurobiolaging.2013.02.019; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Prunty MC, 2015, INVEST OPHTH VIS SCI, V56, P5862, DOI 10.1167/iovs.15-16810; Rayner CL, 2016, NEUROCHEM INT, V92, P1, DOI 10.1016/j.neuint.2015.11.003; Rocha TLA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/264971; Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015; Sarracanie M, 2014, MAGN RESON MED, V71, P735, DOI 10.1002/mrm.24705; Schallner N, 2014, ANESTH ANALG, V119, P1429, DOI 10.1213/ANE.0000000000000488; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Stinnett G., 2015, ISMRM M; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221; Tamagnini F, 2015, HIPPOCAMPUS, V25, P786, DOI 10.1002/hipo.22403; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thibault O, 2012, BBA-MOL BASIS DIS, V1822, P546, DOI 10.1016/j.bbadis.2012.01.004; Towner RA, 2012, DIABETES, V61, P2405, DOI 10.2337/db11-1540; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vlcek K, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00089; Wang Q, 2014, DIS MODEL MECH, V7, P1385, DOI 10.1242/dmm.018218; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Yang L, 2013, J PHYSIOL SCI, V63, P419, DOI 10.1007/s12576-013-0279-2; Yiu AP, 2011, NEUROPSYCHOPHARMACOL, V36, P2169, DOI 10.1038/npp.2011.107; Zhelev Z, 2013, ACS CHEM NEUROSCI, V4, P1439, DOI 10.1021/cn400159h	83	25	25	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4179	4186		10.1096/fj.201700229R	http://dx.doi.org/10.1096/fj.201700229R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592637	Green Published, Green Submitted			2022-12-26	WOS:000408713300039
J	Chrysochou, C; Green, D; Ritchie, J; Buckley, DL; Kalra, PA				Chrysochou, Constantina; Green, Darren; Ritchie, James; Buckley, David L.; Kalra, Philip A.			Kidney volume to GFR ratio predicts functional improvement after revascularization in atheromatous renal artery stenosis	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ATHEROSCLEROTIC RENOVASCULAR DISEASE; MEDICAL THERAPY	Background Randomized controlled trials (RCT) have shown no overall benefit of renal revascularization in atherosclerotic renovascular disease (ARVD). However, 25% of patients demonstrate improvement in renal function. We used the ratio of magnetic resonance parenchymal volume (PV) to isotopic single kidney glomerular filtration rate (isoSKGFR) ratio as our method to prospectively identify "improvers" before revascularization Methods Patients with renal artery stenosis who were due revascularization were recruited alongside non-ARVD hypertensive CKD controls. Using the controls, 95% CI were calculated for expected PV: isoSK-GFR at given renal volumes. For ARVD patients, "improvers" were defined as having both >15% and >1 ml/min increase in isoSK-GFR at 4 months after revascularization. Sensitivity and specificity of PV: isoSK-GFR for predicting improvers was calculated. Results 30 patients (mean age 68 +/- 8 years), underwent revascularization, of whom 10 patients had intervention for bilateral RAS. Stented kidneys which manifested >15% improvement in function had larger PV: isoSK-GFR compared to controls (19 +/- 16 vs. 6 +/- 4 ml/ml/min, p = 0.002). The sensitivity and specificity of this equation in predicting a positive renal functional outcome were 64% and 88% respectively. Use of PV: isoSK-GFR increased prediction of functional improvement (area under curve 0.93). Of note, non-RAS contralateral kidneys which improved (n = 5) also demonstrated larger PV: isoSK-GFR (15.2 +/- 16.2 ml/ml/min, p = 0.006). Conclusion This study offers early indicators that the ratio of PV: isoSK-GFR may help identify patients with kidneys suitable for renal revascularization which could improve patient selection for a procedure associated with risks. Calculation of the PV: isoSK-GFR ratio is easy, does not require MRI contrast agent.	[Chrysochou, Constantina; Green, Darren; Ritchie, James; Kalra, Philip A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Buckley, David L.] Univ Leeds, LIGHT Labs, Div Biomed Imaging, Leeds, W Yorkshire, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Leeds	Kalra, PA (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal NHS Fdn Trust, Salford, Lancs, England.	Philip.kalra@srft.nhs.uk	Buckley, David/L-8343-2017	Buckley, David/0000-0001-6659-8365; Kalra, Philip/0000-0001-7652-1572; Ritchie, James/0000-0002-7864-3597; Green, Darren/0000-0002-9370-8176	Kidney Research UK [RP24/1/2006]	Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by Kidney Research UK, grant reference number RP24/1/2006 (http://www.kidneyresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker J, 1999, RADIOLOGY, V211, P623, DOI 10.1148/radiology.211.3.r99jn19623; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; Buller CE, 2004, J AM COLL CARDIOL, V43, P1606, DOI 10.1016/j.jacc.2003.11.050; Chade AR, 2002, CIRCULATION, V106, P1165, DOI 10.1161/01.CIR.0000027105.02327.48; Cheung CM, 2010, NEPHROL DIAL TRANSPL, V25, P1133, DOI 10.1093/ndt/gfp623; Cheung CM, 2002, J AM SOC NEPHROL, V13, P149, DOI 10.1681/ASN.V131149; Chrysochou C, 2012, NEPHROL DIAL TRANSPL, V27, P1013, DOI 10.1093/ndt/gfr392; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Fleming JS, 2004, NUCL MED COMMUN, V25, P759, DOI 10.1097/01.mnm.0000136715.71820.4a; Herrmann S. M., 2016, CLIN J AM SOC NEPHRO; Kalra PA, 2010, CATHETER CARDIO INTE, V75, P1, DOI 10.1002/ccd.22290; Kalra PA, 2010, KIDNEY INT, V77, P37, DOI 10.1038/ki.2009.406; Lim SW, 2013, AM J PHYSIOL-RENAL, V305, pF672, DOI 10.1152/ajprenal.00007.2013; REHLING M, 1985, EUR J NUCL MED, V11, P1, DOI 10.1007/BF00440952; REHLING M, 1986, SCAND J UROL NEPHROL, V20, P57, DOI 10.3109/00365598609024481; Ritchie J, 2015, NEPHROLOGY; Ritchie J, 2014, CURR OPIN NEPHROL HY, V23, P525, DOI 10.1097/MNH.0000000000000059; Ritchie J, 2014, AM J KIDNEY DIS, V63, P186, DOI 10.1053/j.ajkd.2013.07.020; Tanemoto M, 2010, HYPERTENS RES; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; Wright JR, 2001, NEPHROL DIAL TRANSPL, V16, P765, DOI 10.1093/ndt/16.4.765	21	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177178	10.1371/journal.pone.0177178	http://dx.doi.org/10.1371/journal.pone.0177178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594847	Green Published, gold			2022-12-26	WOS:000402923200008
J	Devaraj, S; Patel, PC				Devaraj, Srikant; Patel, Pankaj C.			Taxicab tipping and sunlight	PLOS ONE			English	Article							WEATHER CONDITIONS; MOOD MAINTENANCE; HELPING-BEHAVIOR; POSITIVE MOOD; SOCIAL NORMS; RESTAURANT; SENTIMENT; EXPOSURE; SUNSHINE; BELIEFS	Does the level of sunlight affect the tipping percentage in taxicab rides in New York City? We examined this question using data on 13.82 million cab rides from January to October in 2009 in New York City combined with data on hourly levels of solar radiation. We found a small but statistically significant positive relationship between sunlight and tipping, with an estimated tipping increase of 0.5 to 0.7 percentage points when transitioning from a dark sky to full sunshine. The findings are robust to two-way clustering of standard errors based on hour-of-the-day and day-of-the-year and controlling for day-of-the-year, month-of-theyear, cab driver fixed effects, weather conditions, and ride characteristics. The NYC cab ride context is suitable for testing the association between sunlight and tipping due to the largely random assignment of riders to drivers, direct exposure to sunlight, and low confounding from variation in service experiences.	[Devaraj, Srikant] Ball State Univ, Miller Coll Business, Ctr Business & Econ Res, Muncie, IN 47306 USA; [Patel, Pankaj C.] Villanova Univ, Villanova Sch Business, Villanova, PA 19085 USA	Ball State University; Villanova University	Patel, PC (corresponding author), Villanova Univ, Villanova Sch Business, Villanova, PA 19085 USA.	pankaj.patel@villanova.edu	Devaraj, Srikant/T-1709-2018	Devaraj, Srikant/0000-0002-5652-3682				Augustine AA, 2011, EMOTION, V11, P403, DOI 10.1037/a0021777; Ayres I, 2005, YALE LAW J, V114, P1613; Azar O. H., 2003, INT J SOC ECON, V30, P1084; Azar OH, 2011, J ECON PSYCHOL, V32, P515, DOI 10.1016/j.joep.2011.03.018; Azar OH, 2004, J ECON BEHAV ORGAN, V54, P49, DOI 10.1016/j.jebo.2003.06.001; Batson CD., 2003, ALTRUISM PROSOCIAL B; Benabou R, 2006, AM ECON REV, V96, P1652, DOI 10.1257/aer.96.5.1652; Bodvarsson OB, 2002, SOC SCI J, V39, P471, DOI 10.1016/S0362-3319(02)00199-4; BOUBEKRI M, 1991, ENVIRON BEHAV, V23, P474, DOI 10.1177/0013916591234004; Brown GW, 2005, J BUS, V78, P405, DOI 10.1086/427633; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Busse MR, 2015, Q J ECON, V130, P371, DOI 10.1093/qje/qju033; Camerer C, 1997, Q J ECON, V112, P407, DOI 10.1162/003355397555244; CARLSON M, 1988, J PERS SOC PSYCHOL, V55, P211, DOI 10.1037/0022-3514.55.2.211; Carlson M, 1988, POSITIVE MOOD HELPIN; Chou Y. K., 2002, SINGAP ECON REV, V47, P17, DOI DOI 10.1142/S0217590802000389; Cialdini RB, 2007, PSYCHOMETRIKA, V72, P263, DOI 10.1007/s11336-006-1560-6; Conlin M, 2003, J ECON BEHAV ORGAN, V52, P297, DOI 10.1016/S0167-2681(03)00030-1; Conlin M, 2007, AM ECON REV, V97, P1217, DOI 10.1257/aer.97.4.1217; Correia S, 2015, STAT SOFTWARE COMPON; CRUSCO AH, 1984, PERS SOC PSYCHOL B, V10, P512, DOI 10.1177/0146167284104003; CUNNINGHAM MR, 1979, J PERS SOC PSYCHOL, V37, P1947, DOI 10.1037/0022-3514.37.11.1947; De Silva DG, 2012, J ECON BEHAV ORGAN, V82, P167, DOI 10.1016/j.jebo.2012.01.007; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; FEINBERG RA, 1986, J CONSUM RES, V13, P348, DOI 10.1086/209074; Flynn SM, 2012, J APPL SOC PSYCHOL, V42, P702, DOI 10.1111/j.1559-1816.2011.00813.x; Forgas JP, 2009, J EXP SOC PSYCHOL, V45, P254, DOI 10.1016/j.jesp.2008.08.014; GARDNER MP, 1985, J CONSUM RES, V12, P281, DOI 10.1086/208516; GARRITY K, 1990, J APPL SOC PSYCHOL, V20, P168, DOI 10.1111/j.1559-1816.1990.tb00405.x; GEORGE JM, 1991, J APPL PSYCHOL, V76, P299, DOI 10.1037/0021-9010.76.2.299; Haggag K, 2014, AM ECON J-APPL ECON, V6, P1, DOI 10.1257/app.6.3.1; Handley IM, 2004, J EXP SOC PSYCHOL, V40, P106, DOI 10.1016/S0022-1031(03)00086-6; Hirshleifer D, 2003, J FINANC, V58, P1009, DOI 10.1111/1540-6261.00556; Ho TH, 2017, P NATL ACAD SCI USA, V114, P3074, DOI 10.1073/pnas.1612551114; Hockberger PE, 2002, PHOTOCHEM PHOTOBIOL, V76, P561, DOI 10.1562/0031-8655(2002)076<0561:AHOUPF>2.0.CO;2; ISEN AM, 1987, ADV EXP SOC PSYCHOL, V20, P203, DOI 10.1016/s0065-2601(08)60415-3; Jacob C, 2013, INT J HOSP MANAG, V32, P299, DOI 10.1016/j.ijhm.2012.03.003; Jacob C, 2010, INT J HOSP MANAG, V29, P761, DOI 10.1016/j.ijhm.2010.02.004; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Kamstra MJ, 2003, AM ECON REV, V93, P324, DOI 10.1257/000282803321455322; Kent ST, 2013, ANN NEUROL, V73, P32, DOI 10.1002/ana.23737; Keysers C., 2011, EMPATHIC BRAIN DISCO; Kliger D, 2014, QUANT FINANC, V14, P629, DOI 10.1080/14697688.2012.745646; Lee JJ, 2014, J APPL PSYCHOL, V99, P504, DOI 10.1037/a0035559; Lynn M., 2006, TIPPING RESTAURANTS; Lynn M, 2015, J ECON PSYCHOL, V46, P74, DOI 10.1016/j.joep.2014.12.002; Lynn M, 2009, INT J HOSP MANAG, V28, P432, DOI 10.1016/j.ijhm.2008.10.009; Lynn Michael., 2000, J SOCIO-ECON, V29, P203, DOI [DOI 10.1016/S1053-5357(00)00062-7, 10.1016/S1053-5357(00)00062-7]; MANUCIA GK, 1984, J PERS SOC PSYCHOL, V46, P357, DOI 10.1037/0022-3514.46.2.357; NYC Taxicab Factbook, 2006, NEW YORK CIT TAX FAC; NYC Taxicab Factbook, 2014, NYC TAX LIM COMM; Rind B, 1996, J APPL SOC PSYCHOL, V26, P137, DOI 10.1111/j.1559-1816.1996.tb01842.x; Rind B, 2001, J APPL SOC PSYCHOL, V31, P2160, DOI 10.1111/j.1559-1816.2001.tb00168.x; Schotter A., 1979, EC TIPPING GRATUITIE; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Sheahan M, 2003, DEVIANT BEHAV, V24, P449, DOI 10.1080/713840244; Simonsohn U, 2007, J BEHAV DECIS MAKING, V20, P143, DOI 10.1002/bdm.545; Simonsohn U, 2010, ECON J, V120, P270, DOI 10.1111/j.1468-0297.2009.02296.x; Vuchelen J, 2004, J ECON PSYCHOL, V25, P493, DOI 10.1016/S0167-4870(03)00031-X; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039	62	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179193	10.1371/journal.pone.0179193	http://dx.doi.org/10.1371/journal.pone.0179193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594917	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200098
J	Eudes, A; Dutta, T; Deng, K; Jacquet, N; Sinha, A; Benites, VT; Baidoo, EEK; Richel, A; Sattler, SE; Northen, TR; Singh, S; Simmons, BA; Loque, D				Eudes, Aymerick; Dutta, Tanmoy; Deng, Kai; Jacquet, Nicolas; Sinha, Anagh; Benites, Veronica T.; Baidoo, Edward E. K.; Richel, Aurore; Sattler, Scott E.; Northen, Trent R.; Singh, Seema; Simmons, Blake A.; Loque, Dominique			SbCOMT (Bmr12) is involved in the biosynthesis of tricin-lignin in sorghum	PLOS ONE			English	Article							ACID-O-METHYLTRANSFERASE; MONOCOT LIGNIFICATION; REDUCES RECALCITRANCE; NMR-SPECTROSCOPY; DOWN-REGULATION; ORYZA-SATIVA; MAIZE; RICE; GENES; SACCHARIFICATION	Lignin in plant biomass represents a target for engineering strategies towards the development of a sustainable bioeconomy. In addition to the conventional lignin monomers, namely p-coumaryl, coniferyl and sinapyl alcohols, tricin has been shown to be part of the native lignin polymer in certain monocot species. Because tricin is considered to initiate the polymerization of lignin chains, elucidating its biosynthesis and mechanism of export to the cell wall constitute novel challenges for the engineering of bioenergy crops. Late steps of tricin biosynthesis require two methylation reactions involving the pathway intermediate selgin. It has recently been demonstrated in rice and maize that caffeate O-methyltransferase (COMT) involved in the synthesis syringyl (S) lignin units derived from sinapyl alcohol also participates in the synthesis of tricin in planta. In this work, we validate in sorghum (Sorghum bicolor L.) that the O-methyltransferase responsible for the production of S lignin units (SbCOMT / Bmr12) is also involved in the synthesis of lignin-linked tricin. In particular, we show that biomass from the sorghum bmr12 mutant contains lower level of tricin incorporated into lignin, and that SbCOMT can methylate the tricin precursors luteolin and selgin. Our genetic and biochemical data point toward a general mechanism whereby COMT is involved in the synthesis of both tricin and S lignin units.	[Eudes, Aymerick; Dutta, Tanmoy; Deng, Kai; Jacquet, Nicolas; Sinha, Anagh; Benites, Veronica T.; Baidoo, Edward E. K.; Northen, Trent R.; Singh, Seema; Simmons, Blake A.; Loque, Dominique] Joint BioEnergy Inst, EmeryStn East, Emeryville, CA 94608 USA; [Eudes, Aymerick; Sinha, Anagh; Northen, Trent R.; Loque, Dominique] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Dutta, Tanmoy; Singh, Seema] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA; [Deng, Kai] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA USA; [Jacquet, Nicolas; Richel, Aurore] Univ Liege, Lab Biol & Ind Chem, Gembloux Agrobio Tech, Gembloux, Belgium; [Sinha, Anagh] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Benites, Veronica T.; Baidoo, Edward E. K.; Simmons, Blake A.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA USA; [Sattler, Scott E.] USDA ARS, Wheat Sorghum & Forage Res Unit, Lincoln, NE USA; [Northen, Trent R.] Joint Genome Inst, Walnut Creek, CA USA; [Loque, Dominique] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Loque, Dominique] Univ Lyon 1, INSA Lyon, CNRS, UMR5240,Microbiol Adaptat & Pathogenie, Villeurbanne, France	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; University of Liege; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Agriculture (USDA); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Eudes, A; Loque, D (corresponding author), Joint BioEnergy Inst, EmeryStn East, Emeryville, CA 94608 USA.; Eudes, A; Loque, D (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.; Loque, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Loque, D (corresponding author), Univ Lyon 1, INSA Lyon, CNRS, UMR5240,Microbiol Adaptat & Pathogenie, Villeurbanne, France.	ageudes@lbl.gov; dloque@lbl.gov	Simmons, Blake/N-6022-2016; Eudes, Aymerick/AAH-4909-2021	Simmons, Blake/0000-0002-1332-1810; Eudes, Aymerick/0000-0002-1387-6111; Richel, Aurore/0000-0002-4352-6542; Sattler, Scott/0000-0002-6814-4073; Dutta, Tanmoy/0000-0002-7597-9028	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy.	Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bout S, 2003, MOL GENET GENOMICS, V269, P205, DOI 10.1007/s00438-003-0824-4; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; Eloy NB, 2017, PLANT PHYSIOL, V173, P998, DOI 10.1104/pp.16.01108; Eudes A, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-62; Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x; Feng JP, 2006, CHINESE J CHEM, V24, P215, DOI 10.1002/cjoc.200690041; Fornale S, 2017, PLANT CELL PHYSIOL, V58, P240, DOI 10.1093/pcp/pcw198; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Green AR, 2014, PLANT PHYSIOL, V165, P1440, DOI 10.1104/pp.114.241729; Guo D, 2011, PLANT CELL, V13, P73; HARTWIG UA, 1990, PLANT PHYSIOL, V92, P116, DOI 10.1104/pp.92.1.116; Heikkinen S, 2003, J AM CHEM SOC, V125, P4362, DOI 10.1021/ja029035k; Ho-Yue-Kuang S, 2016, J EXP BOT, V67, P227, DOI 10.1093/jxb/erv446; Huber TD, 2016, ACS CHEM BIOL, V11, P2484, DOI 10.1021/acschembio.6b00348; Jouanin L, 2000, PLANT PHYSIOL, V123, P1363, DOI 10.1104/pp.123.4.1363; Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x; Kim BG, 2006, PHYTOCHEMISTRY, V67, P387, DOI 10.1016/j.phytochem.2005.11.022; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Koshiba T, 2013, PLANT BIOTECHNOL-NAR, V30, P157, DOI 10.5511/plantbiotechnology.13.0219a; Lam PY, 2015, PLANT PHYSIOL, V168, P1527, DOI 10.1104/pp.15.00566; Lan W, 2016, PLANT J, V88, P1046, DOI 10.1111/tpj.13315; Lan W, 2016, PLANT PHYSIOL, V171, P810, DOI 10.1104/pp.16.02012; Lan W, 2015, PLANT PHYSIOL, V167, P1284, DOI 10.1104/pp.114.253757; Lin FQ, 2006, J PESTIC SCI, V31, P47, DOI 10.1584/jpestics.31.47; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Matsuta T, 2011, IN VIVO, V25, P757; Osakabe K, 1999, P NATL ACAD SCI USA, V96, P8955, DOI 10.1073/pnas.96.16.8955; Palmer NA, 2008, PLANTA, V229, P115, DOI 10.1007/s00425-008-0814-1; Piquemal J, 2002, PLANT PHYSIOL, V130, P1675, DOI 10.1104/pp.012237; Sattler SE, 2010, J AGR FOOD CHEM, V58, P3611, DOI 10.1021/jf903784j; Tu Y, 2010, PLANT CELL, V22, P3357, DOI 10.1105/tpc.109.072827; Vanholme R, 2010, PLANT J, V64, P885, DOI 10.1111/j.1365-313X.2010.04353.x; Yelle DJ, 2008, MAGN RESON CHEM, V46, P508, DOI 10.1002/mrc.2201; Zhou JM, 2008, PHARM BIOL, V46, P26, DOI 10.1080/13880200701729745; Zhou JM, 2006, NAT PROD COMMUN, V1, P981; Zhou JM, 2006, BBA-GEN SUBJECTS, V1760, P1115, DOI 10.1016/j.bbagen.2006.02.008; Zhou JM, 2009, PLANT PHYSIOL BIOCH, V47, P322, DOI 10.1016/j.plaphy.2008.11.011	38	41	41	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178160	10.1371/journal.pone.0178160	http://dx.doi.org/10.1371/journal.pone.0178160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594846	Green Published, gold			2022-12-26	WOS:000402923200018
J	Ukai, H; Kawahara, A; Hirayama, K; Case, MJ; Aino, S; Miyabe, M; Wakita, K; Oogi, R; Kasayuki, M; Kawashima, S; Sugimoto, S; Chikamatsu, K; Nitta, N; Koga, T; Shigemoto, R; Takai, T; Ito, I				Ukai, Hikari; Kawahara, Aiko; Hirayama, Keiko; Case, Matthew Julian; Aino, Shotaro; Miyabe, Masahiro; Wakita, Ken; Oogi, Ryohei; Kasayuki, Michiyo; Kawashima, Shihomi; Sugimoto, Shunichi; Chikamatsu, Kanako; Nitta, Noritaka; Koga, Tsuneyuki; Shigemoto, Ryuichi; Takai, Toshiyuki; Ito, Isao			PirB regulates asymmetries in hippocampal circuitry	PLOS ONE			English	Article							MHC CLASS-I; BETA-2-MICROGLOBULIN DEFICIENT MICE; IMMUNOGLOBULIN-LIKE RECEPTORS; SYNAPTIC PLASTICITY; VISUAL-CORTEX; ANTIGEN PRESENTATION; BRAIN-DEVELOPMENT; MUTANT MICE; NODAL FLOW; T-CELLS	Left - right asymmetry is a fundamental feature of higher-order brain structure; however, the molecular basis of brain asymmetry remains unclear. We recently identified structural and functional asymmetries in mouse hippocampal circuitry that result from the asymmetrical distribution of two distinct populations of pyramidal cell synapses that differ in the density of the NMDA receptor subunit GluRe2 (also known as NR2B, GRIN2B or GluN2B). By examining the synaptic distribution of epsilon 2 subunits, we previously found that beta 2-microglobulin-deficient mice, which lack cell surface expression of the vast majority of major histocompatibility complex class I (MHCI) proteins, do not exhibit circuit asymmetry. In the present study, we conducted electrophysiological and anatomical analyses on the hippocampal circuitry of mice with a knockout of the paired immunoglobulin-like receptor B (PirB), an MHCI receptor. As in beta 2-microglobulin-deficient mice, the PirB-deficient hippocampus lacked circuit asymmetries. This finding that MHCI loss-of-function mice and PirB knockout mice have identical phenotypes suggests that MHCI signals that produce hippocampal asymmetries are transduced through PirB. Our results provide evidence for a critical role of the MHCI/PirB signaling system in the generation of asymmetries in hippocampal circuitry.	[Ukai, Hikari; Kawahara, Aiko; Hirayama, Keiko; Aino, Shotaro; Miyabe, Masahiro; Wakita, Ken; Oogi, Ryohei; Kasayuki, Michiyo; Kawashima, Shihomi; Sugimoto, Shunichi; Chikamatsu, Kanako; Nitta, Noritaka; Koga, Tsuneyuki; Ito, Isao] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan; [Case, Matthew Julian; Shigemoto, Ryuichi] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Shigemoto, Ryuichi] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi, Japan	Kyushu University; Institute of Science & Technology - Austria; Tohoku University	Ito, I (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan.	isitoscb@kyushu-u.org	Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444	Ministry of Education, Culture, Sports, Science and Technology of Japan [25280051]; Kakihara Science Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kakihara Science Technology Foundation	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 25280051) to II, and a grant from the Kakihara Science Technology Foundation to II.	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Delekate A, 2011, P NATL ACAD SCI USA, V108, P2569, DOI 10.1073/pnas.1013322108; Djurisic M, 2013, P NATL ACAD SCI USA, V110, P20771, DOI 10.1073/pnas.1321092110; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Glynn MW, 2011, NAT NEUROSCI, V14, P442, DOI 10.1038/nn.2764; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Goto K, 2017, NEUROBIOL LEARN MEM, V139, P50, DOI 10.1016/j.nlm.2016.12.020; Goto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015468; Hayami K, 1997, J BIOL CHEM, V272, P7320, DOI 10.1074/jbc.272.11.7320; Hummel K. P., 1959, Journal of Heredity, V50, P9; Kawahara A, 2013, J PHYSIOL-LONDON, V591, P4777, DOI 10.1113/jphysiol.2013.252122; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lindahl KF, 1997, IMMUNOGENETICS, V46, P53, DOI 10.1007/s002510050242; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mutel V, 1998, J NEUROCHEM, V70, P2147; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; NEEFJES JJ, 1993, CURR OPIN IMMUNOL, V5, P27, DOI 10.1016/0952-7915(93)90077-6; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Philpot BD, 2007, NEURON; Raiker SJ, 2010, J NEUROSCI, V30, P12432, DOI 10.1523/JNEUROSCI.0895-10.2010; Ribic A, 2010, CELL MOL NEUROBIOL, V30, P827, DOI 10.1007/s10571-010-9510-3; Richard M, 2005, EUR J NEUROSCI, V22, P2145, DOI 10.1111/j.1460-9568.2005.04418.x; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Spiliotis ET, 2002, MOL BIOL CELL, V13, P1566, DOI 10.1091/mbc.01-07-0322; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Syken J, 2006, SCIENCE, V313, P1795, DOI 10.1126/science.1128232; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	54	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179377	10.1371/journal.pone.0179377	http://dx.doi.org/10.1371/journal.pone.0179377			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594961	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200125
J	Chang, YP; Chen, YM; Lai, CH; Lin, CY; Fang, WF; Huang, CH; Li, SH; Chen, HC; Wang, CC; Lin, MC				Chang, Yu-Ping; Chen, Yu-Mu; Lai, Chien-Hao; Lin, Chiung-Yu; Fang, Wen-Feng; Huang, Cherng-Hua; Li, Shau-Hsuan; Chen, Hung-Chen; Wang, Chin-Chou; Lin, Meng-Chih			The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; COOPERATIVE-ONCOLOGY-GROUP; PROGNOSTIC-FACTORS; SURVIVAL; 1ST-LINE; ADENOCARCINOMA; GEFITINIB; CHEMOTHERAPY; CRITERIA; SITE	Liver metastasis has been found to affect outcome in prostate cancer and colorectal cancer, but its role in lung cancer is unclear. The current study aimed to evaluate the impact of de novo liver metastasis (DLM) on stage IV non-small cell lung cancer (NSCLC) outcomes and to examine whether tyrosine kinase inhibitors (TKI) reverse poor prognosis in patients with DLM and epidermal growth factor receptor (EGFR)-mutant NSCLC. Among 1392 newly diagnosed NSCLC patients, 490 patients with stage IV disease treated between November 2010 and March 2014 at Kaohsiung Chang Gung Memorial Hospital were included. Patients were divided into two groups according to DLM status. There were 75 patients in the DLM group and 415 patients in the non-DLM group. The DLM group included more patients with bone metastasis, fewer patients with a lymphocyte-to-monocyte ratio (LMR) > 3.1, and fewer patients with pleural metastasis. In the DLM group, Eastern Cooperative Oncology Group performance status 3-4 and LMR. 3.1 were associated with poor outcome. In patients without DLM, overall survival (OS) was longer in patients with EGFR-mutant NSCLC than in those without (20.2 vs. 7.3 months, p < 0.001). Among DLM patients, OS was similar between the EGFR-mutant and wild-type EGFR tumor subgroups (11.9 vs. 7.7 months, p = 0.155). We found that DLM was a significant poor prognostic factor in the EGFR-mutant patients treated with EGFR-TKIs, whereas DLM did not affect the prognosis of EGFR-wildtype patients.	[Chang, Yu-Ping; Chen, Yu-Mu; Lai, Chien-Hao; Lin, Chiung-Yu; Fang, Wen-Feng; Chen, Hung-Chen; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Med Ctr,Dept Internal Med,Div Pulm & Critical Car, Kaohsiung, Taiwan; [Fang, Wen-Feng; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan; [Huang, Cherng-Hua; Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Internal Med,Div Hematol O, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University	Wang, CC (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Med Ctr,Dept Internal Med,Div Pulm & Critical Car, Kaohsiung, Taiwan.; Wang, CC (corresponding author), Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan.	ccwang5202@yahoo.com.tw	Fang, Wen-Feng/AAT-6296-2021	Fang, Wen-Feng/0000-0003-0350-9059; chen, hong cheng/0000-0001-9713-3835; Chang, Yu-Ping/0000-0002-2535-5954	Chang Gung Memorial Hospital [CMRPG8E1661, CMRPG8F1351, CMRPG8F1491]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The work was supported by grants from the Chang Gung Memorial Hospital Grant (CMRPG8E1661, CMRPG8F1351, CMRPG8F1491 to Chin-Chou Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINS MS, 1991, CHEST, V100, P826, DOI 10.1378/chest.100.3.826; Chen YM, 2016, LUNG CANCER, V98, P99, DOI 10.1016/j.lungcan.2016.05.020; Chen YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149722; Chen YM, 2016, LUNG CANCER, V93, P47, DOI 10.1016/j.lungcan.2016.01.001; Chen YM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002239; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fiala O, 2016, NEOPLASMA, V63, P471, DOI 10.4149/318_151001N512; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Hsu F, 2016, LUNG CANCER, V96, P101, DOI 10.1016/j.lungcan.2016.04.004; Hwang M, 2014, EUR J CANCER, V50, P1747, DOI 10.1016/j.ejca.2014.03.277; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Niu FY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2169-5; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Paralkar VR, 2008, CLIN LUNG CANCER, V9, P116, DOI 10.3816/CLC.2008.n.018; Pond GR, 2014, EUR UROL, V65, P3, DOI 10.1016/j.eururo.2013.09.024; Quint LE, 1996, ANN THORAC SURG, V62, P246, DOI 10.1016/0003-4975(96)00220-2; Robinson P.J., 2002, CANC IMAGING, V2, P1; Tang C, 2016, ACTA ONCOL, V55, P1022, DOI 10.3109/0284186X.2016.1154602; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Wu KL, 2015, LUNG CANCER, V88, P187, DOI 10.1016/j.lungcan.2015.02.012; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8	28	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178676	10.1371/journal.pone.0178676	http://dx.doi.org/10.1371/journal.pone.0178676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591157	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700042
J	Ersdal, HL; Singhal, N; Msemo, G; Ashish, KC; Data, S; Moyo, NT; Evans, CL; Smith, J; Perlman, JM; Niermeyer, S				Ersdal, Hege L.; Singhal, Nalini; Msemo, Georgina; Ashish, K. C.; Data, Santorino; Moyo, Nester T.; Evans, Cherrie L.; Smith, Jeffrey; Perlman, Jeffrey M.; Niermeyer, Susan		Utstein Consensus Process How	Successful implementation of Helping Babies Survive and Helping Mothers Survive programs-An Utstein formula for newborn and maternal survival	PLOS ONE			English	Article							BIRTH; MORTALITY; STILLBIRTH; RETENTION; SKILLS; CARE	Globally, the burden of deaths and illness is still unacceptably high at the day of birth. Annually, approximately 300.000 women die related to childbirth, 2.7 million babies die within their first month of life, and 2.6 million babies are stillborn. Many of these fatalities could be avoided by basic, but prompt care, if birth attendants around the world had the necessary skills and competencies to manage life-threatening complications around the time of birth. Thus, the innovative Helping Babies Survive (HBS) and Helping Mothers Survive (HMS) programs emerged to meet the need for more practical, low-cost, and low-tech simulation-based training. This paper provides users of HBS and HMS programs a 10-point list of key implementation steps to create sustained impact, leading to increased survival of mothers and babies. The list evolved through an Utstein consensus process, involving a broad spectrum of international experts within the field, and can be used as a means to guide processes in low-resourced countries. Successful implementation of HBS and HMS training programs require country-led commitment, readiness, and follow-up to create local accountability and ownership. Each country has to identify its own gaps and define realistic service delivery standards and patient outcome goals depending on available financial resources for dissemination and sustainment.	[Ersdal, Hege L.] Stavanger Univ Hosp, Dept Anaesthesiol & Intens Care, Stavanger, Norway; [Singhal, Nalini] Univ Calgary, Div Neonatol, Calgary, AB, Canada; [Msemo, Georgina] Minist Hlth & Social Serv, Reprod & Child Hlth Serv, Dar Es Salaam, Tanzania; [Ashish, K. C.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Ashish, K. C.] UNICEF, Hlth Sect, Kathmandu, Nepal; [Data, Santorino] Mbarara Univ Sci & Technol, Pediat & Child Hlth, Mbarara, Uganda; [Moyo, Nester T.] Int Confederat Midwives, Harare, Zimbabwe; [Evans, Cherrie L.; Smith, Jeffrey] Johns Hopkins Univ, Jhpiego, Baltimore, MD USA; [Perlman, Jeffrey M.] Weill Cornell Med Coll, Div Newborn Med, New York, NY USA; [Niermeyer, Susan] Univ Colorado, Sch Med, Sect Neonatol, Aurora, CO USA	Stavanger University Hospital; University of Calgary; Uppsala University; Mbarara University of Science & Technology; Jhpiego; Johns Hopkins University; Cornell University; University of Colorado System; University of Colorado Anschutz Medical Campus	Ersdal, HL (corresponding author), Stavanger Univ Hosp, Dept Anaesthesiol & Intens Care, Stavanger, Norway.	hege.ersdal@safer.net	KC, Ashish/AAH-3360-2021; KC, Ashish/ABC-6651-2021	KC, Ashish/0000-0002-0541-4486; 	Laerdal Foundation	Laerdal Foundation	The Utstein consensus meeting was sponsored by the Laerdal Foundation. The authors received no specific funding for this work. The funding source had no role in data analysis, data interpretation, writing of the report, or in the decision to submit the paper for publication.	Ashish KC, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0117; Bellad RM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0997-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Cancedda C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001840; Chamberlain DA, 2003, RESUSCITATION, V59, P11, DOI 10.1016/j.resuscitation.2003.08.011; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Eisenberg M, 2016, IMPROVING SURVIVAL O; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Evans CL, 2014, INT J GYNECOL OBSTET, V126, P286, DOI 10.1016/j.ijgo.2014.02.021; Goudar SS, 2013, PEDIATRICS, V131, pE344, DOI 10.1542/peds.2012-2112; Hoban R, 2013, J TROP PEDIATRICS, V59, P180, DOI 10.1093/tropej/fms077; Kak LP, 2015, HELPING BABIES BREAT; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Mduma E, 2015, RESUSCITATION, V93, P1, DOI 10.1016/j.resuscitation.2015.04.019; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Musafili A, 2013, ACTA PAEDIATR, V102, pe34, DOI 10.1111/apa.12034; Nathan LM, 2016, INT J GYNECOL OBSTET, V134, P350, DOI 10.1016/j.ijgo.2016.01.021; Nelissen E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0612-2; Nelissen E, 2014, ACTA OBSTET GYN SCAN, V93, P287, DOI 10.1111/aogs.12321; Open Working Group, 2014, OUTC DOC OP WORK GRO; Perkins GD, 2014, RESUSCITATION; Perlman J, 2016, J PEDIAT INTENSIVE C; Seto TL, 2015, PERSPECT MED EDUC, V4, P225, DOI 10.1007/s40037-015-0214-8; Singhal N, 2012, RESUSCITATION, V83, P90, DOI 10.1016/j.resuscitation.2011.07.010; Soreide E, 2013, RESUSCITATION, V84, P1487, DOI 10.1016/j.resuscitation.2013.07.020; Thukral A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0382-z; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	29	32	32	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178073	10.1371/journal.pone.0178073	http://dx.doi.org/10.1371/journal.pone.0178073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591145	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700019
J	Valasek, MA; Thung, I; Gollapalle, E; Hodkoff, AA; Kelly, KJ; Baumgartner, JM; Vavinskaya, V; Lin, GY; Tipps, AP; Hosseini, MV; Lowy, AM				Valasek, Mark A.; Thung, Irene; Gollapalle, Esha; Hodkoff, Alexey A.; Kelly, Kaitlyn J.; Baumgartner, Joel M.; Vavinskaya, Vera; Lin, Grace Y.; Tipps, Ann P.; Hosseini, Mojgan V.; Lowy, Andrew M.			Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care	PLOS ONE			English	Article							MUCINOUS EPITHELIAL NEOPLASMS; PSEUDOMYXOMA PERITONEI; CLINICOPATHOLOGICAL ANALYSIS; TUMORS; CLASSIFICATION; ENDOMETRIOSIS; INVOLVEMENT; METAPLASIA; SECONDARY; TERATOMAS	Context Low-grade appendiceal mucinous neoplasm (LAMN) and appendiceal adenocarcinoma are known to cause the majority of pseudomyxoma peritonei (PMP, i.e. mucinous ascites); however, recognition and proper classification of these neoplasms can be difficult despite established diagnostic criteria. Objective To determine the pathological diagnostic concordance for appendix neoplasia and related lesions during patient referral to an academic medical center specialized in treating patients with PMP. Design The anatomic pathology laboratory information system was searched to identify cases over a two-year period containing appendix specimens with mucinous neoplasia evaluated by an outside pathology group and by in-house slide review at a single large academic medical center during patient referral. Results 161 cases containing appendix specimens were identified over this period. Forty-six of 161 cases (28.6%) contained appendiceal primary neoplasia or lesions. Of these, the originating pathologist diagnosed 23 cases (50%) as adenocarcinoma and 23 cases (50%) as LAMN; however, the reference pathologist diagnosed 29 cases (63.0%) as LAMN, 13 cases (28.3%) as adenocarcinoma, and 4 cases (8.7%) as ruptured simple mucocele. Importantly, for cases in which the originating pathologist rendered a diagnosis of adenocarcinoma, the reference pathologist rendered a diagnosis of adenocarcinoma (56.5%, 13 of 23), LAMN 39.1%, 9 of 23), or simple mucocele (4.3%, 1 of 23). The overall diagnostic concordance rate for these major classifications was 71.7% (33 of 46) with an unweighted observed kappa value of 0.48 (95% CI, 0.27-0.69), consistent with moderate interobserver agreement. All of the observed discordance (28.3%) for major classifications could be attributed to over-interpretation. In addition, the majority of LAMN cases (65.5%) had potential diagnostic deficiencies including over-interpretation as adenocarcinoma and lacking or discordant risk stratification (i. e. documentation of extra-appendiceal neoplastic epithelium). Conclusions Appendiceal mucinous lesions remain a difficult area for appropriate pathological classification with substantial discordance due to over-interpretation in this study. The findings highlight the critical need for recognition and application of diagnostic criteria regarding these tumors. Recently published consensus guidelines and a checklist provided herein may help facilitate improvement of diagnostic concordance and thereby reduce over-interpretation and potential overtreatment. Further studies	[Valasek, Mark A.; Thung, Irene; Gollapalle, Esha; Hodkoff, Alexey A.; Vavinskaya, Vera; Lin, Grace Y.; Tipps, Ann P.; Hosseini, Mojgan V.] Univ Calif San Diego, Med Ctr, Dept Pathol, Div Anat Pathol, San Diego, CA 92103 USA; [Kelly, Kaitlyn J.; Baumgartner, Joel M.; Lowy, Andrew M.] Univ Calif San Diego, Moores Canc Ctr, Div Surg Oncol, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Valasek, MA (corresponding author), Univ Calif San Diego, Med Ctr, Dept Pathol, Div Anat Pathol, San Diego, CA 92103 USA.	mvalasek@ucsd.edu						Arnason T, 2015, ARCH PATHOL LAB MED, V139, P518, DOI 10.5858/arpa.2014-0246-OA; CARR NJ, 1995, CANCER-AM CANCER SOC, V75, P757, DOI 10.1002/1097-0142(19950201)75:3<757::AID-CNCR2820750303>3.0.CO;2-F; Carr NJ, 2010, WHO CLASSIFICATION T, P122; Carr NJ, 2016, AM J SURG PATHOL, V40, P14, DOI 10.1097/PAS.0000000000000535; Carr NJ, 2012, J CLIN PATHOL, V65, P919, DOI 10.1136/jclinpath-2012-200843; Charfi S, 2014, INT J COLORECTAL DIS, V29, P1009, DOI 10.1007/s00384-014-1934-7; Connor SJ, 1998, DIS COLON RECTUM, V41, P75, DOI 10.1007/BF02236899; Davison JM, 2014, MODERN PATHOL, V27, P1521, DOI 10.1038/modpathol.2014.37; Dhage-Ivatury S, 2006, J AM COLL SURGEONS, V202, P680, DOI 10.1016/j.jamcollsurg.2005.12.003; Edge S, 2010, AJCC CANC STAGING HD, P161; ELMORE JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI DOI 10.1001/JAMA.2015.1405; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; LYSS AP, 1988, SEMIN ONCOL, V15, P129; McDonald JR, 2012, BRIT J SURG, V99, P987, DOI 10.1002/bjs.8739; McKenne JK, 2008, AM J SURG PATHOL, V32, P645, DOI 10.1097/PAS.0b013e31815b486d; McVeigh G, 2015, INT J GYNECOL PATHOL, V34, P232, DOI 10.1097/PGP.0000000000000149; Misdraji J, 2003, AM J SURG PATHOL, V27, P1089, DOI 10.1097/00000478-200308000-00006; Misdraji J, 2015, MODERN PATHOL, V28, pS67, DOI 10.1038/modpathol.2014.129; Misdraji J, 2014, AM J SURG PATHOL, V38, P698, DOI 10.1097/PAS.0000000000000167; Misdraji J, 2010, ARCH PATHOL LAB MED, V134, P864, DOI 10.1043/1543-2165-134.6.864; Mitchell A, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-39; Nakhleh RE, 2010, ARCH PATHOL LAB MED, V134, P740, DOI 10.1043/1543-2165-134.5.740; Pai RK, 2009, AM J SURG PATHOL, V33, P1425, DOI 10.1097/PAS.0b013e3181af6067; Pai RK, 2014, HUM PATHOL, V45, P227, DOI 10.1016/j.humpath.2013.10.021; Pai RK, 2005, ADV ANAT PATHOL, V12, P291, DOI 10.1097/01.pap.0000194625.05137.51; Sirintrapun SJ, 2014, HUM PATHOL, V45, P1597, DOI 10.1016/j.humpath.2014.03.007; Tang LH, 2008, AM J SURG PATHOL, V32, P1429, DOI 10.1097/PAS.0b013e31817f1816; Tirumani H, 2013, CANCER IMAGING, V13, P14, DOI 10.1102/1470-7330.2013.0003; Vang R, 2007, AM J SURG PATHOL, V31, P854, DOI 10.1097/PAS.0b013e31802efb45; Vavinskaya V., 2016, CASE REP OBSTET GYNE, V2016, P6841989; Werth R., 1884, ARCH GYNECOL OBSTET, V84, P100; Yantiss RK, 2007, AM J SURG PATHOL, V31, P1742, DOI 10.1097/PAS.0b013e31806bee6d; Yantiss RK, 2009, AM J SURG PATHOL, V33, P248, DOI 10.1097/PAS.0b013e31817ec31e; Zih FSW, 2014, ANN SURG ONCOL, V21, P225, DOI 10.1245/s10434-013-3283-0	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179216	10.1371/journal.pone.0179216	http://dx.doi.org/10.1371/journal.pone.0179216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591173	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700094
J	Stanga, PE; Pastor-Idoate, S; Zambrano, I; Carlin, P; McLeod, D				Stanga, Paulo Eduardo; Pastor-Idoate, Salvador; Zambrano, Isaac; Carlin, Paul; McLeod, David			Performance analysis of a new hypersonic vitrector system	PLOS ONE			English	Article							25-GAUGE; 23-GAUGE; 20-GAUGE; DYNAMICS	Purpose To evaluate porcine vitreous flow and water flow rates in a new prototype hypersonic vitrectomy system compared to currently available pneumatic guillotine vitrectors (GVs) systems. Methods Two vitrectors were tested, a prototype, ultrasound-powered, hypersonic vitrector (HV) and a GV. Porcine vitreous was obtained within 12 to 24 h of sacrifice and kept at 4 degrees C. A vial of vitreous or water was placed on a precision balance and its weight measured before and after the use of each vitrector. Test parameters included changes in aspiration levels, vitrector gauge, cut rates for GVs,% ultrasound (US) power for HVs, and port size for HVs. Data was analysed using linear regression and t-tests. Results There was no difference in the total average mean water flow between the 25-gauge GV and the 25-gauge HV (t-test: P = 0.363); however, 25-gauge GV was superior (t-test: P < 0.001) in vitreous flow. The 23-gauge GV was only more efficient in water and vitreous removal than 23-gauge HV needle-1 (Port 0.0055) (t-test: P < 0.001). For HV, wall thickness and gauge had no effect on flow rates. Water and vitreous flows showed a direct correlation with increasing aspiration levels and% US power (p<0.05). Conclusions The HV produced consistent water and vitreous flow rates across the range of US power and aspiration levels tested. Hypersonic vitrectomy may be a promising new alternative to the currently available guillotine-based technologies.	[Stanga, Paulo Eduardo; Pastor-Idoate, Salvador; Zambrano, Isaac; Carlin, Paul; McLeod, David] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Manchester, Lancs, England; [Stanga, Paulo Eduardo; Pastor-Idoate, Salvador] Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England; [Stanga, Paulo Eduardo; Pastor-Idoate, Salvador] NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England; [Stanga, Paulo Eduardo; McLeod, David] Univ Manchester, Ctr Ophthalmol & Vis Sci, Inst Human Dev, Manchester, Lancs, England; [Zambrano, Isaac] Manchester Royal Eye Hosp, Eye Bank, Manchester, Lancs, England; [Carlin, Paul] Manchester Royal Eye Hosp, Operating Theatre Serv, Manchester, Lancs, England	Manchester Royal Eye Hospital; University of Manchester; Manchester Royal Eye Hospital; University of Manchester; Manchester Royal Eye Hospital; Manchester Royal Eye Hospital	Stanga, PE (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Royal Eye Hosp, Manchester, Lancs, England.; Stanga, PE (corresponding author), Manchester Royal Eye Hosp, Manchester Vis Regenerat MVR Lab, Manchester, Lancs, England.; Stanga, PE (corresponding author), NIHR Wellcome Trust Manchester CRF, Manchester, Lancs, England.; Stanga, PE (corresponding author), Univ Manchester, Ctr Ophthalmol & Vis Sci, Inst Human Dev, Manchester, Lancs, England.	retinaspecialist@btinternet.com	PASTOR-IDOATE, SALVADOR/G-2548-2016	PASTOR-IDOATE, SALVADOR/0000-0002-6463-4227	Bausch Lomb	Bausch Lomb	The authors received the following financial support: Paulo Stanga: Bausch & Lomb: Consultancy, Equipment, Research Funding, Lecture Fees, Travel expenses, Patent; Salvador Pastor-Idoate: Bausch & Lomb: Research Funding; Isaac Zambrano: none; Paul Carlin: none; David McLeod: none. The sponsor or funding organization had no role in the design or conduct of this research.	Charles S, 2004, RETINA-J RET VIT DIS, V24, P435, DOI 10.1097/00006982-200406000-00015; DeBoer C, 2008, RETINA-J RET VIT DIS, V28, P1061, DOI 10.1097/IAE.0b013e3181840b64; Diniz B, 2013, OPHTHALMOLOGICA, V229, P15, DOI 10.1159/000343073; Dugel PU, 2012, RETINA-J RET VIT DIS, V32, P1761, DOI 10.1097/IAE.0b013e3182456f4d; Fabian ID, 2011, BRIT J OPHTHALMOL, V95, P318, DOI 10.1136/bjo.2009.176495; Fang SY, 2008, GRAEF ARCH CLIN EXP, V246, P61, DOI 10.1007/s00417-007-0672-8; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1814, DOI 10.1016/S0161-6420(02)01119-3; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Hubschman JP, 2009, RETINA-J RET VIT DIS, V29, P1289, DOI 10.1097/IAE.0b013e3181acd3a9; Ibarra MS, 2005, AM J OPHTHALMOL, V139, P831, DOI 10.1016/j.ajo.2004.12.002; Jackson T, 2000, AM J OPHTHALMOL, V129, P116, DOI 10.1016/S0002-9394(99)00377-3; LEITGEB N, 1979, A GRAEF ARCH KLIN EX, V209, P263, DOI 10.1007/BF00419061; Lima LH, 2010, RETINA-J RET VIT DIS, V30, P1515, DOI 10.1097/IAE.0b013e3181ea48f9; Magalhaes O, 2008, RETINA-J RET VIT DIS, V28, P236, DOI 10.1097/IAE.0b013e318158e9e0; Matsuoka N, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20101223-03; Oshima Y, 2010, OPHTHALMOLOGY, V117, P93, DOI 10.1016/j.ophtha.2009.06.043; Ribeiro RM, 2013, RETINA-J RET VIT DIS, V33, P928, DOI 10.1097/IAE.0b013e31826f069e; Rizzo S, 2011, RETINA-J RET VIT DIS, V31, P2007, DOI 10.1097/IAE.0b013e318213623a; Rossi T, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.4.1; Rossi T, 2014, RETINA-J RET VIT DIS, V34, P558, DOI 10.1097/IAE.0b013e3182a0e628; Sharif-Kashani P, 2013, RETINA-J RET VIT DIS, V33, P166, DOI 10.1097/IAE.0b013e31825db758; Thompson JT, 2011, SURV OPHTHALMOL, V56, P162, DOI 10.1016/j.survophthal.2010.08.003	22	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178462	10.1371/journal.pone.0178462	http://dx.doi.org/10.1371/journal.pone.0178462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586375	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700012
J	Sliwczynski, A; Brzozowska, M; Jacyna, A; Iltchev, P; Iwanczuk, T; Wierzba, W; Marczak, M; Orlewska, K; Szymanski, P; Orlewska, E				Sliwczynski, Andrzej; Brzozowska, Melania; Jacyna, Andrzej; Iltchev, Petre; Iwanczuk, Tymoteusz; Wierzba, Waldemar; Marczak, Michal; Orlewska, Katarzyna; Szymanski, Piotr; Orlewska, Ewa			Drug-class-specific changes in the volume and cost of antidiabetic medications in Poland between 2012 and 2015	PLOS ONE			English	Article							PATIENT-CENTERED APPROACH; TYPE-2 DIABETES-MELLITUS; GLYCEMIC CONTROL; HYPERGLYCEMIA; MANAGEMENT; THERAPIES; PATTERNS	Aim to investigate the drug-class-specific changes in the volume and cost of antidiabetic medications in Poland in 2012-2015. Methods This retrospective analysis was conducted based on the National Health Fund database covering an entire Polish population. The volume of antidiabetic medications is reported according to ATC/DDD methodology, costs-in current international dollars, based on purchasing power parity. Results During a 4-year observational period the number of patients, consumption of antidiabetic drugs and costs increased by 17%, 21% and 20%, respectively. Biguanides are the basic diabetes medication with a 39% market share. The insulin market is still dominated by human insuiins, new antidiabetics (incretins, thiazoiidinediones) are practically absent. Insulins had the largest share in diabetes medications expenditures (67% in 2015). The increase in antidiabetic medications costs over the analysed period of time was mainly caused by the increased use of insulin analogues. Conclusions The observed tendencies correspond to the evidence-based HTA recommendations. The reimbursement status, the ratio of cost to clinical outcomes and data on the long-term safety have a deciding impact on how a drug is used.	[Sliwczynski, Andrzej; Brzozowska, Melania; Marczak, Michal] Med Univ Lodz, Div Qual Serv Procedures & Med Stand, Lodz, Poland; [Sliwczynski, Andrzej; Brzozowska, Melania; Jacyna, Andrzej] Natl Hlth Fund, Warsaw, Poland; [Iltchev, Petre] Med Univ Lodz, Hlth Care Policy Dept, Lodz, Poland; [Iwanczuk, Tymoteusz] Agcy Hlth Technol Assessment & Tariff Syst, Warsaw, Poland; [Wierzba, Waldemar] Univ Humanities & Econ, Lodz, Poland; [Orlewska, Katarzyna] Med Univ Warsaw, Warsaw, Poland; [Szymanski, Piotr] Inst Cardiol, Warsaw, Poland; [Orlewska, Ewa] Jan Kochanowski Univ Humanities & Sci, Kielce, Poland	Medical University Lodz; Medical University Lodz; Medical University of Warsaw; Institute of Cardiology - Poland; Jan Kochanowski University	Orlewska, E (corresponding author), Jan Kochanowski Univ Humanities & Sci, Kielce, Poland.	eorl@ujk.edu.pl	Wierzba, Waldemar/AGX-5728-2022; Śliwczyński, Andrzej/AAT-5246-2021; Śliwczynski, Andrzej/ABD-1910-2022; Sliwczynski, Andrzej/F-1825-2014; Iltchev, Petre/G-2946-2014	Wierzba, Waldemar/0000-0002-8134-2955; marczak, michal/0000-0001-6262-0529; Szymanski, Piotr/0000-0001-9486-7892; Sliwczynski, Andrzej/0000-0002-0239-1637; Iltchev, Petre/0000-0002-6060-3247				Colhoun HM, 2012, DIABETOLOGIA, V55, P2929, DOI 10.1007/s00125-012-2668-0; Consoli A, 2013, DIABETES OBES METAB, V15, P967, DOI 10.1111/dom.12101; Currie CJ, 2010, DIABETIC MED, V27, P744, DOI 10.1111/j.1464-5491.2009.02849.x; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Guidoni CM, 2012, ARQ BRAS ENDOCRINOL, V56, P120, DOI 10.1590/S0004-27302012000200005; Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ko SH, 2016, MEDICINE, V95; Mata-Cases M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012463; Mor A, 2015, DIABETIC MED, V32, P1546, DOI 10.1111/dme.12819; Muller N, 2015, DIABETIC MED, V32, P951, DOI 10.1111/dme.12747; Orlando V, 2016, CURR DIABETES REV, V12, P100, DOI 10.2174/1573399811666150701120408; Pavlov R, 2016, INT J FAM MED; Shalini S, 2010, INT J PHARM SCI NANO, V31, P803; Sharma M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010210; Thomsen RW, 2015, DIABETOLOGIA, V58, P2247, DOI 10.1007/s00125-015-3698-1; WHO Collaborating Centre for Drug Statistics Methodology WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services., 2003, INT DRUG UTIL RES WH; Yurgin N, 2007, CLIN THER, V29, P316, DOI 10.1016/j.clinthera.2007.02.012; Zaharan NL, 2014, IRISH J MED SCI, V183, P311, DOI 10.1007/s11845-013-1011-1	22	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178764	10.1371/journal.pone.0178764	http://dx.doi.org/10.1371/journal.pone.0178764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582404	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600037
J	Valenzuela, I; Trebicki, P; Powell, KS; Vereijssen, J; Norng, S; Yen, AL				Valenzuela, Isabel; Trebicki, Piotr; Powell, Kevin S.; Vereijssen, Jessica; Norng, Sorn; Yen, Alan L.			Acizzia solanicola (Hemiptera: Psyllidae) probing behaviour on two Solanum spp. and implications for possible pathogen spread	PLOS ONE			English	Article							ELECTRICAL PENETRATION GRAPHS; FEEDING-BEHAVIOR; DIAPHORINA-CITRI; STYLET PENETRATION; WAVE-FORM; POTATO DISEASE; ZEBRA CHIP; PHLOEM; APHIDS; HOST	Piercing-sucking insects are vectors of plant pathogens, and an understanding of their feeding behaviour is crucial for studies on insect population dynamics and pathogen spread. This study examines probing behaviour of the eggplant psyllid, Acizzia solanicola (Hemiptera: Psyllidae), using the electrical penetration graph (EPG) technique, on two widespread and common hosts: eggplant (Solanum melongena) and tobacco bush (S. mauritianum). Six EPG waveforms were observed: waveform NP (non-probing phase), waveform C (pathway phase), G (feeding activities in xylem tissues), D (first contact with phloem tissues), E1 (salivation in the sieve elements) and E2 (ingestion from phloem tissues). Results showed that A. solanicola is predominantly a phloem feeder and time spent in salivation and ingestion phases (E1 and E2) differed between hosts. Feeding was enhanced on eggplant compared to tobacco bush which showed some degree of resistance, as evidenced by shorter periods of phloem ingestion, a higher propensity to return to the pathway phase once in the sieve elements and higher number of salivation events on tobacco bush. We discuss how prolonged phloem feeding could indicate the potential for A. solanicola to become an important pest of eggplant and potential pathogen vector.	[Valenzuela, Isabel; Yen, Alan L.] Ctr AgriBiosci, AgriBio, Agr Victoria, Bundoora, Vic, Australia; [Trebicki, Piotr] Horsham Ctr, Agr Victoria, Horsham, Vic, Australia; [Powell, Kevin S.] Rutherglen Ctr, Agr Victoria, Rutherglen, Vic, Australia; [Vereijssen, Jessica] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Norng, Sorn] Parkville Ctr, Agr Victoria, Parkville, Vic, Australia; [Yen, Alan L.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia	La Trobe University; New Zealand Institute for Plant & Food Research Ltd; La Trobe University	Valenzuela, I (corresponding author), Ctr AgriBiosci, AgriBio, Agr Victoria, Bundoora, Vic, Australia.	Isabel.valenzuela-gonzalez@ecodev.vic.gov.au	Trebicki, Piotr/AAY-7023-2020; Dohmen-Vereijssen, Jessica/E-8239-2012	Trebicki, Piotr/0000-0002-7075-6650; Dohmen-Vereijssen, Jessica/0000-0002-2095-6312; Powell, Kevin/0000-0002-7152-3517	Plant Biosecurity Cooperative Research Centre (PB-CRC) [CRC2079]	Plant Biosecurity Cooperative Research Centre (PB-CRC)	The authors thank the Plant Biosecurity Cooperative Research Centre (PB-CRC) for financial support to this research (grant CRC2079: understanding the role of alternative host plants in tomato potato psyllid and Liberibacter life cycle and ecology) and for the research position awarded to the first author.	[Anonymous], 2005, PLANT RESISTANCE ART; [Anonymous], 2013, UNPUB; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Backus EA, 2005, ANN ENTOMOL SOC AM, V98, P787, DOI 10.1603/0013-8746(2005)098[0787:SPBAHC]2.0.CO;2; BACKUS EA, 1988, J INSECT PHYSIOL, V34, P151, DOI 10.1016/0022-1910(88)90045-5; Biosecurity Australia, 2009, PEST RISK A IN PRESS; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; CAMPBELL PL, 1994, PLANT GROWTH REGUL, V14, P97, DOI 10.1007/BF00025209; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Civolani S, 2011, J INSECT PHYSIOL, V57, P1407, DOI 10.1016/j.jinsphys.2011.07.008; Davidson MM, 2008, 2231 CROP FOOD RES; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; HAL. Horticulture Australia Limited, 2014, EGGPL STRAT AGR REV, P1; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Hollis D, 2004, AUSTR PSYLLOIDEA JUM; IPPC, 2017, DET BACT COCK TOM PO; Jiang YX, 2000, ANN ENTOMOL SOC AM, V93, P573, DOI 10.1603/0013-8746(2000)093[0573:CBWHAF]2.0.CO;2; Kent D, 2010, AUST J ENTOMOL, V49, P73, DOI 10.1111/j.1440-6055.2009.00739.x; Khan SA, 2015, J ECON ENTOMOL, V108, P2465, DOI 10.1093/jee/tov183; KIMMINS FM, 1985, ENTOMOL EXP APPL, V39, P135, DOI 10.1007/BF00414500; Leroux V, 2008, J ECON ENTOMOL, V101, P584, DOI 10.1603/0022-0493(2008)101[584:WSRTAA]2.0.CO;2; Liu BM, 2012, INT J BIOL SCI, V8, P697, DOI 10.7150/ijbs.4108; Luo XZ, 2015, FLA ENTOMOL, V98, P186, DOI 10.1653/024.098.0132; Marchetti E, 2009, B INSECTOL, V62, P203; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; Miao J, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu085; MORAN V C, 1968, Journal of the Entomological Society of Southern Africa, V31, P391; Morgan F.D., 1984, P1; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2010, SOUTHWEST ENTOMOL, V35, P471, DOI 10.3958/059.035.0335; Mustafa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138946; Palacios I, 2002, J GEN VIROL, V83, P3163, DOI 10.1099/0022-1317-83-12-3163; Payne R. W, 2016, GUIDE GENSTAT RELE 2; Pearson CC, 2014, ANN ENTOMOL SOC AM, V107, P650, DOI 10.1603/AN13178; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; PURCELL AH, 1982, ANNU REV PHYTOPATHOL, V20, P397, DOI 10.1146/annurev.py.20.090182.002145; Sandanayaka WRM, 2014, ENTOMOL EXP APPL, V151, P170, DOI 10.1111/eea.12179; Sarkar D, 2008, USE R, P1; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Serikawa RH, 2012, J ECON ENTOMOL, V105, P1492, DOI 10.1603/EC11211; SPILLER NJ, 1990, ENTOMOL EXP APPL, V55, P101, DOI 10.1007/BF00352570; Sulc K., 1909, ACTA SOC ENTOMOL BOH, V6, P102; Taylor GS, 2013, ZOOTAXA, V3613, P257, DOI 10.11646/zootaxa.3613.3.4; Tholt G, 2015, ENTOMOL EXP APPL, V155, P123, DOI 10.1111/eea.12290; Thomas J., 2017, PBCRC2146; Thompson S., 2013, New Disease Reports, V27, P6, DOI 10.5197/j.2044-0588.2013.027.006; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088; Trebicki P, 2012, ARTHROPOD-PLANT INTE, V6, P405, DOI 10.1007/s11829-012-9192-5; van Helden Maarten, 2000, P144; VSN International, GENSTAT WINDOWS, V19th ed.; Walker G.P., 2000, P14; Youn Y, 2011, FLA ENTOMOL, V94, P1084, DOI 10.1653/024.094.0456; Zhang ZF, 2015, ENTOMOL EXP APPL, V156, P14, DOI 10.1111/eea.12307; Zhu LC, 2011, J ECON ENTOMOL, V104, P2068, DOI 10.1603/EC11203	58	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178609	10.1371/journal.pone.0178609	http://dx.doi.org/10.1371/journal.pone.0178609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575085	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300073
J	Muller, EM; Leporacci, NM; Macartney, KJ; Shea, AG; Crane, RE; Hall, ER; Ritchie, KB				Muller, Erinn M.; Leporacci, Nicole M.; Macartney, Keir J.; Shea, Alessandra G.; Crane, Rachel E.; Hall, Emily R.; Ritchie, Kim B.			Low pH reduces the virulence of black band disease on Orbicella faveolata	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CYANOBACTERIUM SYNECHOCOCCUS SP; OCEAN ACIDIFICATION; PHORMIDIUM-CORALLYTICUM; ELEMENTAL RATIOS; CLIMATE-CHANGE; CORALS; DYNAMICS; GROWTH; TEMPERATURE	Black band is a deadly coral disease found worldwide, which may become more virulent as oceanic conditions continue to change. To determine the effects of climate change and ocean acidification on black band disease virulence, Orbicella faveolata corals with black band were exposed to different temperature and pH conditions. Results showed a significant decrease in disease progression under low pH (7.7) conditions. Low pH also altered the relative abundance of the bacterial community of the black band disease consortium. Here, there was a significant decrease in Roseofilum, the cyanobacterium that typically dominates the black band mat. These results indicate that as oceanic pH decreases so may the virulence of a worldwide coral disease.	[Muller, Erinn M.; Hall, Emily R.; Ritchie, Kim B.] Mote Marine Lab, Sarasota, FL 34236 USA; [Leporacci, Nicole M.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Macartney, Keir J.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Shea, Alessandra G.] Univ Hawaii, Dept Geog, Honolulu, HI 96822 USA; [Crane, Rachel E.] Unity Coll, Unity, ME USA; [Ritchie, Kim B.] Univ South Carolina, Beaufort, SC USA	Mote Marine Laboratory & Aquarium; University of Rhode Island; University System Of New Hampshire; University of New Hampshire; University of Hawaii System	Muller, EM (corresponding author), Mote Marine Lab, Sarasota, FL 34236 USA.	emuller@mote.org		Muller, Erinn/0000-0002-2695-2064	Florida Protect Our Reef License Plate Grant [POR-2011-20, POR-2012-11, POR-2013-3]; Mote Postdoctoral Fellowship; Dart Foundation; National Science Foundation Research Experience for Undergraduates [NSF OCE 1156580]	Florida Protect Our Reef License Plate Grant; Mote Postdoctoral Fellowship; Dart Foundation; National Science Foundation Research Experience for Undergraduates(National Science Foundation (NSF))	This study was supported by the Florida Protect Our Reef License Plate Grant POR-2011-20, POR-2012-11, and POR-2013-3; a Mote Postdoctoral Fellowship for EMM; Dart Foundation supported KBR; and a National Science Foundation Research Experience for Undergraduates (NSF OCE 1156580), which supported KJM.	[Anonymous], 2011, R LANG ENV STAT COMP, V55, P275; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arotsker L, 2016, DIS AQUAT ORGAN, V118, P77, DOI 10.3354/dao02952; Arotsker L, 2015, DIS AQUAT ORGAN, V116, P47, DOI 10.3354/dao02911; Arotsker L, 2009, FEMS MICROBIOL ECOL, V70, P515, DOI 10.1111/j.1574-6941.2009.00770.x; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Casamatta D, 2012, PHYCOLOGIA, V51, P489, DOI 10.2216/11-10.1; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Gantar M, 2009, MICROB ECOL, V58, P856, DOI 10.1007/s00248-009-9540-x; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Giraldez-Ruiz N, 1997, NEW PHYTOL, V137, P599, DOI 10.1046/j.1469-8137.1997.00864.x; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Hall ER, 2012, P 12 INT COR REEF S, V34236, P9; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hassenr C, 2016, QUANTIFICATION EFFEC, P1; Hassenruck C, 2015, ENV MICROBIOL REP, V7, P516, DOI 10.1111/1758-2229.12282; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; IPCC, 2013, IPCC FIFTH ASSESSMEN; Jokiel PL, 2011, B MAR SCI, V87, P639, DOI 10.5343/bms.2010.1107; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Kay M, ARTOOL ALIGNED RANK; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; KUTA KG, 1997, P 8 INT COR REEF S, V1, P575; Lomas MW, 2012, AQUAT MICROB ECOL, V66, P211, DOI 10.3354/ame01576; Low-Decarie E, 2014, TRENDS ECOL EVOL, V29, P223, DOI 10.1016/j.tree.2014.02.006; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Muller EM, 2011, J EXP MAR BIOL ECOL, V397, P52, DOI 10.1016/j.jembe.2010.11.002; Mydlarz LD, 2009, DIS AQUAT ORGAN, V87, P67, DOI 10.3354/dao02088; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Oksanen J, 2013, VEGAN COMMUNITY ECOL, P254; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Richardson LL, 2007, FEMS MICROBIOL LETT, V272, P182, DOI 10.1111/j.1574-6968.2007.00751.x; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2003, FEMS MICROBIOL ECOL, V43, P287, DOI 10.1016/S0168-6496(03)00025-4; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Russell BD, PHIL T R SOC B, V368AD; Sato Y, 2011, CORAL REEFS, V30, P753, DOI 10.1007/s00338-011-0751-5; Sato Y, 2013, ENVIRON MICROBIOL, V15, P2994, DOI 10.1111/1462-2920.12256; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; Shi DL, 2012, P NATL ACAD SCI USA, V109, pE3094, DOI 10.1073/pnas.1216012109; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Traving SJ, 2014, FEMS MICROBIOL ECOL, V87, P133, DOI 10.1111/1574-6941.12199; Williams GJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3069; Witt V, 2011, ENVIRON MICROBIOL, V13, P2976, DOI 10.1111/j.1462-2920.2011.02571.x; Wobbrock J., 2011, P ACM C HUM FACT COM, P143, DOI DOI 10.1145/1978942.1978963	59	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178869	10.1371/journal.pone.0178869	http://dx.doi.org/10.1371/journal.pone.0178869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570712	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800128
J	Kim, HJ; Lee, JJ; Cho, JH; Jeong, J; Park, AY; Kang, W; Lee, KJ				Kim, Hee-Jung; Lee, Jae-Jin; Cho, Jin-Hwan; Jeong, Jaeho; Park, A. Young; Kang, Wonmo; Lee, Kong-Joo			Heterogeneous nuclear ribonucleoprotein K inhibits heat shock-induced transcriptional activity of heat shock factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); heat shock protein (HSP); mass spectrometry (MS); post-translational modification (PTM); proteomics; redox regulation; hnRNP K	HNRNP-K; ARGININE METHYLATION; C-SRC; DNA; ACTIVATION; BINDING; PROTEIN; PHOSPHORYLATION; STRESS; IDENTIFICATION	When cells are exposed to heat shock and various other stresses, heat shock factor 1 (HSF1) is activated, and the heat shock response (HSR) is elicited. To better understand the molecular regulation of the HSR, we used 2D-PAGE-based proteome analysis to screen for heat shock-induced post-translationally modified cellular proteins. Our analysis revealed that two protein spots typically present on 2D-PAGE gels and containing heterogeneous nuclear ribonucleoprotein K (hnRNP K) with trioxidized Cys(132) disappeared after the heat shock treatment and reappeared during recovery, but the total amount of hnRNP K protein remained unchanged. We next tested whether hnRNP K plays a role in HSR by regulating HSF1 and found that hnRNP K inhibits HSF1 activity, resulting in reduced expression of hsp70 and hsp27 mRNAs. hnRNP K also reduced binding affinity of HSF1 to the heat shock element by directly interacting with HSF1 but did not affect HSF1 phosphorylation-dependent activation or nuclear localization. hnRNP K lost its ability to induce these effects when its Cys(132) was substituted with Ser, Asp, or Glu. These findings suggest that hnRNP K inhibits transcriptional activity of HSF1 by inhibiting its binding to heat shock element and that the oxidation status of Cys(132) in hnRNP K is critical for this inhibition.	[Kim, Hee-Jung; Lee, Jae-Jin; Cho, Jin-Hwan; Jeong, Jaeho; Park, A. Young; Kang, Wonmo; Lee, Kong-Joo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea	Ewha Womans University	Lee, KJ (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Seoul 120750, South Korea.	kjl@ewha.ac.kr			Global Research Lab Program Grant of the National Research Foundation of Korea [2012K1A1A2045441]; Basic Science Research Program Grant of the National Research Foundation of Korea [2016R1A6 A3A11934127]; Brain Research Program Grant of the National Research Foundation of Korea [2015M3C7A1028373]	Global Research Lab Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Brain Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Global Research Lab Program Grant 2012K1A1A2045441, Basic Science Research Program Grant 2016R1A6 A3A11934127, and Brain Research Program Grant 2015M3C7A1028373 of the National Research Foundation of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Barboro P, 2014, CANCER LETT, V352, P152, DOI 10.1016/j.canlet.2014.06.019; Chen YB, 2008, FEBS LETT, V582, P1761, DOI 10.1016/j.febslet.2008.04.051; Choi HS, 2008, MOL CELL PROTEOMICS, V7, P1517, DOI 10.1074/mcp.M800052-MCP200; Da Silva N, 2002, BLOOD, V100, P3536, DOI 10.1182/blood.V100.10.3536; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Habelhah H, 2001, J BIOL CHEM, V276, P18090, DOI 10.1074/jbc.M011396200; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020252; Kim HJ, 2002, MOL CELL BIOCHEM, V229, P139, DOI 10.1023/A:1017941131744; Kim JA, 2015, CARCINOGENESIS, V36, P696, DOI 10.1093/carcin/bgv045; Kim MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073340; Kim S, 2006, NUCLEIC ACIDS RES, V34, pW258, DOI 10.1093/nar/gkl245; Kimura Y, 2010, PROTEOMICS, V10, P3884, DOI 10.1002/pmic.201000349; Lau JS, 2000, J CELL BIOCHEM, V79, P395, DOI 10.1002/1097-4644(20001201)79:3<395::AID-JCB50>3.0.CO;2-M; LEE KJ, 1988, J CELL PHYSIOL, V136, P411, DOI 10.1002/jcp.1041360304; Lee SW, 2012, EMBO J, V31, P4441, DOI 10.1038/emboj.2012.293; Leopoldino AM, 2007, GENOME, V50, P451, DOI 10.1139/G07-016; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Moumen A, 2013, CELL CYCLE, V12, P698, DOI 10.4161/cc.23592; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Satyal SH, 1998, GENE DEV, V12, P1962, DOI 10.1101/gad.12.13.1962; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sullivan EK, 2001, MOL CELL BIOL, V21, P5826, DOI 10.1128/MCB.21.17.5826-5837.2001; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Yamamoto K, 2016, GENES CELLS, V21, P1006, DOI 10.1111/gtc.12400; Yang JH, 2014, NUCLEIC ACIDS RES, V42, P9908, DOI 10.1093/nar/gku705	43	8	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12801	12812		10.1074/jbc.M117.774992	http://dx.doi.org/10.1074/jbc.M117.774992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28592492	Green Published, hybrid			2022-12-26	WOS:000407220100012
J	Ponzio, G; Rezzonico, R; Bourget, I; Allan, R; Nottet, N; Popa, A; Magnone, V; Rios, G; Mari, B; Barbry, P				Ponzio, Gilles; Rezzonico, Roger; Bourget, Isabelle; Allan, Richard; Nottet, Nicolas; Popa, Alexandra; Magnone, Virginie; Rios, Geraldine; Mari, Bernard; Barbry, Pascal			A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; long noncoding RNA (long ncRNA; lncRNA); microarray; RNA; skin	ALPHA-B-CRYSTALLIN; PLASMINOGEN-ACTIVATOR INHIBITOR-2; SPECIFICITY PHOSPHATASE 5; CORNIFIED ENVELOPE; CANCER; GROWTH; EXPRESSION; MIGRATION; IDENTIFICATION; TRANSFORMATION	Keratinocyte-derived cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer. Although some of the early events involved in this pathology have been identified, the subsequent steps leading to tumor development are poorly defined. We demonstrate here that the development of mouse tumors induced by the concomitant application of a carcinogen and a tumor promoter (7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA), respectively) is associated with the up-regulation of a previously uncharacterized long noncoding RNA (lncRNA), termed AK144841. We found that AK144841 expression was absent from normal skin and was specifically stimulated in tumors and highly tumorigenic cells. We also found that AK144841 exists in two variants, one consisting of a large 2-kb transcript composed of four exons and one consisting of a 1.8-kb transcript lacking the second exon. Gain- and loss-of-function studies indicated that AK144841 mainly inhibited gene expression, specifically down-regulating the expression of genes of the late cornified envelope-1 (Lce1) family involved in epidermal terminal differentiation and of anticancer genes such as Cgref1, Brsk1, Basp1, Dusp5, Btg2, Anpep, Dhrs9, Stfa2, Tpm1, SerpinB2, Cpa4, Crct1, Cryab, Il24, Csf2, and Rgs16. Interestingly, the lack of the second exon significantly decreased AK144841's inhibitory effect on gene expression. We also noted that high AK144841 expression correlated with a low expression of the aforementioned genes and with the tumorigenic potential of cell lines. These findings suggest that AK144841 could contribute to the dedifferentiation program of tumor-forming keratinocytes and to molecular cascades leading to tumor development.	[Ponzio, Gilles; Rezzonico, Roger; Allan, Richard; Nottet, Nicolas; Popa, Alexandra; Magnone, Virginie; Rios, Geraldine; Mari, Bernard; Barbry, Pascal] Univ Cote Azur, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Bourget, Isabelle] Univ Cote Azur, CNRS, INSERM, Inst Res Canc & Aging, F-06000 Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Ponzio, G (corresponding author), IPMC CNRS, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	ponzio@ipmc.cnrs.fr	Mari, Bernard/Q-5832-2019; Mari, Bernard P/GVS-3100-2022; Mari, Bernard P/F-8960-2013; REZZONICO, Roger/N-9626-2016; Mari, Bernard P/D-7445-2015; Barbry, Pascal/O-5021-2016	Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; REZZONICO, Roger/0000-0002-8460-1641; Mari, Bernard P/0000-0002-0422-9182; Popa, Alexandra Mariela/0000-0001-7156-272X; Barbry, Pascal/0000-0001-9632-6483; Rios Munera, Geraldine/0000-0002-2993-1859; Nottet, Nicolas/0000-0002-8699-6747	CNRS; INSERM; French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" FRANCE GENOMIQUE [ANR-10-INBS-09-03, ANR-10-INBS-09-02]; Canceropole Provence Alpes Cote d'Azur (PACA); la Ligue contre le cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE(French National Research Agency (ANR)); French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" FRANCE GENOMIQUE(French National Research Agency (ANR)); Canceropole Provence Alpes Cote d'Azur (PACA); la Ligue contre le cancer(Ligue nationale contre le cancer)	This work was supported by the CNRS, INSERM, the French Government (Agence Nationale de la Recherche (ANR)) through the "Investments for the Future" LABEX SIGNALIFE (Grant ANR-11-LABX-0028-01) and FRANCE GENOMIQUE (Grants ANR-10-INBS-09-03 and ANR-10-INBS-09-02), Canceropole Provence Alpes Cote d'Azur (PACA), and la Ligue contre le cancer. The authors declare that they have no conflicts of interest with the contents of this article.	Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Bharadwaj S, 2002, CANCER LETT, V183, P205, DOI 10.1016/S0304-3835(02)00119-2; Cai C, 2015, INT J CLIN EXP MED, V8, P4186; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 2015, CELL DEATH DIFFER, V22, P12, DOI 10.1038/cdd.2014.113; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carper Miranda B, 2014, Genes Cancer, V5, P420; Cheng H, 2015, PROTEIN CELL, V6, P746, DOI 10.1007/s13238-015-0188-7; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Daley GQ, 2008, COLD SH Q B, V73, P171, DOI 10.1101/sqb.2008.73.041; Deng WW, 2015, INT J BIOCHEM CELL B, V65, P32, DOI 10.1016/j.biocel.2015.05.019; Deng ZZ, 2014, NEOPLASIA, V16, P656, DOI 10.1016/j.neo.2014.07.008; Dranoff G, 2003, ONCOGENE, V22, P3188, DOI 10.1038/sj.onc.1206459; Durinck S, 2011, CANCER DISCOV, V1, P137, DOI 10.1158/2159-8290.CD-11-0028; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; Emmert Steffen, 2014, Adv Exp Med Biol, V810, P234; Fatima Roshan, 2015, Mol Cell Ther, V3, P5, DOI 10.1186/s40591-015-0042-6; Gastaldi C, 2014, CARCINOGENESIS, V35, P1110, DOI 10.1093/carcin/bgt490; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Gupta R, 2016, J INVEST DERMATOL, V136, P603, DOI 10.1016/j.jid.2015.12.009; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hu L, 2016, TUMOR BIOL, V37, P837, DOI 10.1007/s13277-015-3880-6; Huang HM, 2014, J NANOMATER, V2014, DOI 10.1155/2014/180765; Huang Z, 2012, ONCOGENE, V31, P3709, DOI 10.1038/onc.2011.529; Huang ZQ, 2014, MOL CARCINOGEN, V53, P777, DOI 10.1002/mc.22033; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jackson B, 2005, J INVEST DERMATOL, V124, P1062, DOI 10.1111/j.0022-202X.2005.23699.x; Jiang YJ, 2014, J STEROID BIOCHEM, V144, P87, DOI 10.1016/j.jsbmb.2013.11.018; Johnsson P, 2014, BBA-GEN SUBJECTS, V1840, P1063, DOI 10.1016/j.bbagen.2013.10.035; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Kretz M, 2012, GENE DEV, V26, P338, DOI 10.1101/gad.182121.111; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liang XB, 2015, INT J ONCOL, V47, P1829, DOI 10.3892/ijo.2015.3177; Lim SK, 2012, CLIN EXP METASTAS, V29, P901, DOI 10.1007/s10585-012-9479-z; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Lung HL, 2008, INT J CANCER, V122, P1288, DOI 10.1002/ijc.23259; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Madden SL, 1996, CANCER RES, V56, P5384; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Mao BJ, 2015, INT J ONCOL, V46, P459, DOI 10.3892/ijo.2014.2765; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; MUELLER BM, 1995, P NATL ACAD SCI USA, V92, P205, DOI 10.1073/pnas.92.1.205; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Panneerselvam J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122439; Piipponen M, 2016, J INVEST DERMATOL, V136, P1701, DOI 10.1016/j.jid.2016.03.028; Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rentoft M, 2011, INT J ONCOL, V38, P61, DOI 10.3892/ijo_00000824; REZZONICO R, 1995, ONCOGENE, V11, P1069; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Sand M, 2016, TUMOR BIOL, V37, P10595, DOI 10.1007/s13277-016-4927-z; Shin SH, 2013, AM J PATHOL, V182, P1275, DOI 10.1016/j.ajpath.2013.01.004; Smith R, 2007, WORLD J SURG, V31, P493, DOI 10.1007/s00268-006-0289-9; Sorensen KD, 2013, BRIT J CANCER, V108, P420, DOI 10.1038/bjc.2012.549; Strojan P, 2007, INT J RADIAT ONCOL, V68, P1335, DOI 10.1016/j.ijrobp.2007.02.004; Takashi M, 1998, UROL RES, V26, P395, DOI 10.1007/s002400050075; Urdinguio RG, 2013, CANCER RES, V73, P395, DOI 10.1158/0008-5472.CAN-12-0806; Wang SH, 2014, INT J CLIN EXP PATHO, V7, P7131; Wang ZZ, 2016, EXP DERMATOL, V25, P131, DOI 10.1111/exd.12900; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yoshino H, 1998, BRIT J CANCER, V78, P833, DOI 10.1038/bjc.1998.588; Zare M, 2012, MOL CARCINOGEN, V51, P796, DOI 10.1002/mc.20847; Zhang L, 2010, MOL BIOL REP, V37, P2579, DOI 10.1007/s11033-009-9777-y	67	26	26	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12483	12495		10.1074/jbc.M117.776260	http://dx.doi.org/10.1074/jbc.M117.776260			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28596382	hybrid, Green Published			2022-12-26	WOS:000406636900013
J	Nenasheva, T; Nikolaev, A; Diykanov, D; Sukhanova, A; Tcyganov, E; Panteleev, A; Bocharova, I; Serdyuk, Y; Nezlin, L; Radaeva, T; Adrianov, N; Rubtsov, Y; Lyadova, I				Nenasheva, Tatiana; Nikolaev, Alexander; Diykanov, Daniar; Sukhanova, Anna; Tcyganov, Evgenii; Panteleev, Alexander; Bocharova, Irina; Serdyuk, Yana; Nezlin, Leonid; Radaeva, Tatiana; Adrianov, Nikolai; Rubtsov, Yuri; Lyadova, Irina			The introduction of mesenchymal stromal cells induces different immunological responses in the lungs of healthy and M. tuberculosis infected mice	PLOS ONE			English	Article							STEM-CELLS; T-CELLS; INHIBIT; IMMUNOMODULATION; MECHANISMS; RESISTANT; TRANSPLANTATION; INFUSION; IMMUNITY; INJURY	Mesenchymal stromal cells (MSC) have strong immunomodulatory properties and therefore can be used to control inflammation and tissue damage. It was suggested recently that MSC injections can be used to treat multi-drug resistant tuberculosis (TB). However, MSC trafficking and immunomodulatory effects of MSC injections during Mycobacterium tuberculosis (Mtb) infection have not been studied. To address this issue we have analyzed MSC distribution in tissues and local immunological effects of MSC injections in Mtb infected and uninfected mice. After intravenous injection, MSC accumulated preferentially in the lungs where they were located as cell aggregates in the alveolar walls. Immunological analysis of MSC effects included detection of activated, IFN-gamma and IL-4 producing CD4(+) lymphocytes, the frequency analysis of dendritic cells (CD11c + F4/80) and macrophages (CD11c -F4/80 +) located in the lungs, the expression of IA/IE and CD11b molecules by these cells, and evaluation of 23 cytokines/chemokines in lung lysates. In the lungs of uninfected mice, MSC transfer markedly increased the percentage of IFN-gamma(+) CD4(+) lymphocytes and dendritic cells, elevated levels of IA/IE expression by dendritic cells and macrophages, augmented local production of type 2 cytokines (IL-4, IL-5, IL-10) and chemokines (CCL2, CCL3, CCL4, CCL5, CXCL1), and downregulated type 1 and hematopoietic cytokines (IL-12p70, IFN-gamma, IL-3, IL-6, GM-CSF). Compared to uninfected mice, Mtb infected mice had statistically higher "background" frequency of activated CD69(+) and IFN-gamma(+) CD4(+) lymphocytes and dendritic cells, and higher levels of cytokines in the lungs. The injections of MSC to Mtb infected mice did not show statistically significant effects on CD4(+) lymphocytes, dendritic cells and macrophages, only slightly shifted cytokine profile, and did not change pathogen load or slow down TB progression. Lung section analysis showed that in Mtb infected mice, MSC could not be found in the proximity of the inflammatory foci. Thus, in healthy recipients, MSC administration dramatically changed T-cell function and cytokine/chemokine milieu in the lungs, most likely, due to capillary blockade. But, during Mtb infection, i.e., in the highly-inflammatory conditions, MSC did not affect T-cell function and the level of inflammation. The findings emphasize the importance of the evaluation of MSC effects locally at the site of their predominant post-injection localization and question MSC usefulness as anti-TB treatment.	[Nenasheva, Tatiana; Nikolaev, Alexander; Sukhanova, Anna; Tcyganov, Evgenii; Panteleev, Alexander; Bocharova, Irina; Serdyuk, Yana; Nezlin, Leonid; Radaeva, Tatiana; Lyadova, Irina] Cent TB Res Inst, Moscow, Russia; [Diykanov, Daniar; Rubtsov, Yuri] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Dept Biochem & Mol Med, Moscow, Russia; [Nezlin, Leonid] Russian Acad Sci, Koltzov Inst Dev Biol, Moscow, Russia; [Adrianov, Nikolai] Pirogov Russian Natl Res Med Univ, Moscow, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Pirogov Russian National Research Medical University	Lyadova, I (corresponding author), Cent TB Res Inst, Moscow, Russia.	ivlyadova@mail.ru	Rubtsov, Yury P/A-8227-2014; Nenasheva, Tatiana/AAM-8556-2020; Lyadova, Irina V/T-7806-2017; Serdyuk, Yana/AAH-6487-2021; Nikolaev, Alexander/H-4111-2014; Nikolaev, Alexander/S-6926-2019	Rubtsov, Yury P/0000-0001-9175-3013; Nenasheva, Tatiana/0000-0002-1669-5244; Lyadova, Irina V/0000-0003-3147-5386; Nikolaev, Alexander/0000-0002-1738-1511; Nikolaev, Alexander/0000-0002-1738-1511; Serdyuk, Yana/0000-0003-1573-7614	Government of the Ministry of Education and Science of the Russian Federation [14.610.21.0001, RFMEFI61014X0001]; Russian Science Foundation [14-15-00439, 15-15-00136]	Government of the Ministry of Education and Science of the Russian Federation; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Government Contract No 14.610.21.0001 of the Ministry of Education and Science of the Russian Federation RFMEFI61014X0001 (TN), and partially by the Russian Science Foundation, grant # No 14-15-00439 (YR) and grant # 15-15-00136 (IL).	Benvenuto F, 2007, STEM CELLS, V25, P1753, DOI 10.1634/stemcells.2007-0068; Bloom BR, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.MCHD-0006-2015; Choi EW, 2014, CELL TRANSPLANT, V23, P873, DOI 10.3727/096368913X664586; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Gholamrezanezhad A, 2011, NUCL MED BIOL, V38, P961, DOI 10.1016/j.nucmedbio.2011.03.008; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; Hackstein H, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0288-1; Haddad R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/216806; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Lyadova I, 1998, INFECT IMMUN, V66, P4981, DOI 10.1128/IAI.66.10.4981-4988.1998; Lyadova IV, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/854507; Lyadova I, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P19; Lyadova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010469; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Lyadova V I, 2016, J IMMUNOL RES, V2016, P1; Madrigal M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0260-8; Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560; Mei SHJ, 2007, PLOS MED, V4, P1525, DOI 10.1371/journal.pmed.0040269; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nagaya R, 2014, EXP THER MED, V7, P17, DOI 10.3892/etm.2013.1382; Najar M, 2016, CYTOTHERAPY, V18, P160, DOI 10.1016/j.jcyt.2015.10.011; Nystedt J, 2013, STEM CELLS, V31, P317, DOI 10.1002/stem.1271; Parida SK, 2015, INT J INFECT DIS, V32, P32, DOI 10.1016/j.ijid.2015.01.016; Rubtsov YP, 2012, ACTA NATURAE, V4, P23, DOI 10.32607/20758251-2012-4-1-23-31; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Skrahin Aliaksandr, 2016, J Clin Tuberc Other Mycobact Dis, V4, P21; Skrahin A, 2014, LANCET RESP MED, V2, P108, DOI 10.1016/S2213-2600(13)70234-0; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Tatara R, 2011, CYTOTHERAPY, V13, P686, DOI 10.3109/14653249.2010.542456; Tsiganov EN, 2014, J IMMUNOL, V192, P4718, DOI 10.4049/jimmunol.1301365; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762	48	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178983	10.1371/journal.pone.0178983	http://dx.doi.org/10.1371/journal.pone.0178983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594940	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200073
J	Vilaseca, A; Campillo, N; Torres, M; Musquera, M; Gozal, D; Montserrat, JM; Alcaraz, A; Touijer, KA; Farre, R; Almendros, I				Vilaseca, Antoni; Campillo, Noelia; Torres, Marta; Musquera, Mireia; Gozal, David; Montserrat, Josep M.; Alcaraz, Antonio; Touijer, Karim A.; Farre, Ramon; Almendros, Isaac			Intermittent hypoxia increases kidney tumor vascularization in a murine model of sleep apnea	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; MOUSE MODEL; CANCER; MACROPHAGES; EXPRESSION; OBESITY; COHORT; ANGIOGENESIS; PROGRESSION	We investigate the effects of intermittent hypoxia (IH), a characteristic feature of obstructive sleep apnea (OSA), on renal cancer progression in an animal and cell model. An in vivo mouse model (Balb/c, n = 50) of kidney cancer was used to assess the effect of IH on tumor growth, metastatic capacity, angiogenesis and tumor immune response. An in vitro model tested the effect of IH on RENCA cells, macrophages and endothelial cells. Tumor growth, metastatic capacity, circulating vascular endothelial growth factor (VEGF) and content of endothelial cells, tumor associated macrophages and their phenotype were assessed in the tumor. In vitro, VEGF cell expression was quantified. Although IH did not boost tumor growth, it significantly increased endothelial cells (p = 0.001) and circulating VEGF (p<0.001) in the in vivo model. Macrophages exposed to IH in vitro increased VEGF expression, whereas RENCA cells and endothelial cells did not. These findings are in keeping with previous clinical data suggesting that OSA has no effect on kidney cancer size and that the association observed between OSA and higher Fuhrman grade of renal cell carcinoma may be mediated though a proangiogenic process, with a key role of macrophages.	[Vilaseca, Antoni; Campillo, Noelia; Farre, Ramon; Almendros, Isaac] Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain; [Vilaseca, Antoni; Musquera, Mireia; Alcaraz, Antonio] Hosp Clin Barcelona, Dept Urol, Barcelona, Spain; [Campillo, Noelia] Inst Bioengn Catalonia, Barcelona, Spain; [Torres, Marta; Montserrat, Josep M.; Farre, Ramon; Almendros, Isaac] Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain; [Torres, Marta; Montserrat, Josep M.] Hosp Clin Barcelona, Lab Son, Serv Pneumol, Barcelona, Spain; [Gozal, David] Univ Chicago, Pritzker Sch Med, Dept Pediat, Div Biol Sci, Chicago, IL 60637 USA; [Montserrat, Josep M.; Farre, Ramon; Almendros, Isaac] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Touijer, Karim A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10021 USA	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Chicago; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Memorial Sloan Kettering Cancer Center	Almendros, I (corresponding author), Univ Barcelona, Fac Med & Ciencies Salut, Unitat Biofis & Bioengn, Barcelona, Spain.; Almendros, I (corresponding author), Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain.; Almendros, I (corresponding author), Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	isaac.almendros@ub.edu	Farre, Ramon/L-2664-2017; Gozal, David/M-9492-2017; Gozal, David/ABH-3805-2020; Almendros, Isaac/A-8251-2016	Farre, Ramon/0000-0002-9084-7824; Almendros, Isaac/0000-0002-1998-9379; Alcaraz Asensio, Antonio/0000-0003-2612-5250; Campillo, Noelia/0000-0001-9712-3784; Vilaseca, Antoni/0000-0003-0160-620X; Musquera Felip, Mireia/0000-0002-5915-9935	Spanish Ministry of Economy and Competitiveness (Institute de Salud Carlos III) [PI14-00004]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2010 BP_A2 00002]; SEPAR [086/2014]	Spanish Ministry of Economy and Competitiveness (Institute de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); SEPAR	RF is supported by the Spanish Ministry of Economy and Competitiveness (Institute de Salud Carlos III; PI14-00004 (http://www.isciii.es/ ISCII/es/general/index.shtml), IA is supported by Agencia de Gestio d'Ajuts Universitaris i de Recerca (2010 BP_A2 00002; http://agaur.gencat.cat/ca/ inici/) and SEPAR (086/2014; http:// sepamontenidos.es/site/?q=node/584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendros I, 2012, EUR RESPIR J, V39, P215, DOI 10.1183/09031936.00185110; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Almendros I, 2013, RESP PHYSIOL NEUROBI, V186, P303, DOI 10.1016/j.resp.2013.03.001; Almendros I, 2012, SLEEP MED, V13, P1254, DOI 10.1016/j.sleep.2012.08.012; [Anonymous], 2015, ACTA PHARMA CEUTICA, V5, P378; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campillo N, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00319; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Choi H, PLOS ONE, V10; Duffy A.M., 2000, MADAME CURIE BIOSCIE; Fukata S, 2005, CANCER-AM CANCER SOC, V103, P931, DOI 10.1002/cncr.20887; Gozal D, 2002, SLEEP, V25, P59, DOI 10.1093/sleep/25.1.59; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Gudas LJ, 2014, J MOL MED, V92, P825, DOI 10.1007/s00109-014-1180-z; Hakim F, 2014, CANCER RES, V74, P1329, DOI 10.1158/0008-5472.CAN-13-3014; Jacobsen J, 2000, J UROLOGY, V163, P343, DOI 10.1016/S0022-5347(05)68049-4; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karam JA, 2011, EUR UROL, V59, P619, DOI 10.1016/j.eururo.2010.11.043; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Patard JJ, 2006, EUR UROL, V49, P633, DOI 10.1016/j.eururo.2006.01.016; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Riazalhosseini Y, 2016, NAT REV NEPHROL, V12, P655, DOI 10.1038/nrneph.2016.133; Salumbides BC, 2009, CURR PROTOC PHARM, P13; Schulz R, 2002, AM J RESP CRIT CARE, V165, P67, DOI 10.1164/ajrccm.165.1.2101062; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Toth K, 2014, APPL IMMUNOHISTO M M, V22, P642, DOI 10.1097/PAI.0000000000000012; Verduzco D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120958; Vilaseca A, 2016, WORLD J UROL; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537; Zhu Y, 2013, J UROLOGY, V189, P447, DOI 10.1016/j.juro.2012.09.030	33	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179444	10.1371/journal.pone.0179444	http://dx.doi.org/10.1371/journal.pone.0179444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594929	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200127
J	Peniche, AG; Bonilla, DL; Palma, GI; Melby, PC; Travi, BL; Osorio, EY				Peniche, Alex G.; Bonilla, Diana L.; Palma, Gloria I.; Melby, Peter C.; Travi, Bruno L.; Yaneth Osorio, E.			A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis	PLOS ONE			English	Article							APOPTOTIC CELL CLEARANCE; SERINE PROTEASES; INFLAMMATORY RESPONSE; TYROSINE-PHOSPHATASE; VIANNIA BRAZILIENSIS; IMMUNE-RESPONSE; MAJOR INFECTION; SKIN; MECHANISMS; RESISTANT	We evaluated the importance of neutrophils in the development of chronic lesions caused by L. Viannia spp. using the hamster as experimental model of American Cutaneous Leishmaniasis (ACL). Neutrophils infiltrated the lesion within the first six hours post-infection. Inhibition of this early infiltration using a polyclonal antibody or cyclophosphamide was associated with transient parasite control but the protective effect vanished when lesions became clinically apparent. At lesion onset (approximately 10 days p.i.), there was an increased proportion of both uninfected and infected macrophages, and subsequently a second wave of neutrophils infiltrated the lesion (after 19 days p.i.) This second neutrophil infiltration was associated with lesion necrosis and ulceration (R-2 = 0.75) and maximum parasite burden. Intradermal delivery of N-formylmethionyl-leucyl-phenylalanine (fMLP), aimed to increase neutrophil infiltration, resulted in larger lesions with marked necrosis and higher parasite burden than in mock treated groups (p<0.001 each). In contrast, reduced neutrophil infiltration via cyclophosphamide-mediated depletion led to more benign lesions and lower parasite loads compared to controls (p<0.001 each). Neutrophils of the second wave expressed significantly lower GM-CSF, reactive oxygen species and nitric oxide than those of the first wave, suggesting that they had less efficient anti-leishmania activity. However, there was increased inflammatory cytokines and expression of neutrophil proteases (myeloperoxidase, cathepsin G and elastase) in lesions during the second wave of neutrophil infiltration compared with the levels reached during the first wave (6h p.i.). his suggests that augmented neutrophil proteases and inflammatory cytokines during the secondary wave of neutrophils could contribute to skin inflammation, ulceration and necrosis in ACL. The overall results indicate that neutrophils were unable to clear the infection in this model, and that the second wave of neutrophils played an important role in the severity of ACL.	[Peniche, Alex G.; Bonilla, Diana L.; Travi, Bruno L.; Yaneth Osorio, E.] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Valle Del Cauca, Colombia; [Peniche, Alex G.; Melby, Peter C.; Travi, Bruno L.; Yaneth Osorio, E.] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA; [Peniche, Alex G.; Palma, Gloria I.] Univ Valle, Dept Microbiol, Cali, Valle Del Cauca, Colombia; [Melby, Peter C.; Travi, Bruno L.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Universidad del Valle; University of Texas System; University of Texas Medical Branch Galveston	Osorio, EY (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Valle Del Cauca, Colombia.; Osorio, EY (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.	ejosorio@utmb.edu	Osorio, Elvia Janeth/AAF-4469-2020	Osorio, Elvia Janeth/0000-0001-8014-6330; Peniche, Alex/0000-0001-8112-4694; Palma, Gloria I./0000-0003-1541-7223	Colciencias, Administrative Department of Science, Technology and Innovation, Colombia [22290412603, 478-2002]	Colciencias, Administrative Department of Science, Technology and Innovation, Colombia	This study was supported by Colciencias, Administrative Department of Science, Technology and Innovation, Colombia, http://www.coluencias.gov.co, project ID# 22290412603, contract 478-2002.	AKINTONWA DAA, 1984, BIOCHEM MED METAB B, V32, P151, DOI 10.1016/0006-2944(84)90069-3; Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bank U, 2001, J LEUKOCYTE BIOL, V69, P197; BEIL WJ, 1992, J LEUKOCYTE BIOL, V52, P135, DOI 10.1002/jlb.52.2.135; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P119; CHANG KP, 1981, AM J TROP MED HYG, V30, P322, DOI 10.4269/ajtmh.1981.30.322; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2005, PARASITOL INT, V54, P109, DOI 10.1016/j.parint.2005.02.001; COHEN AM, 1988, INFECT IMMUN, V56, P2861, DOI 10.1128/IAI.56.11.2861-2865.1988; CRABTREE JE, 1984, PARASITOLOGY, V89, P59, DOI 10.1017/S003118200000113X; Culpitt SV, 2002, AM J RESP CRIT CARE, V165, P1371, DOI 10.1164/rccm.2105106; Daboul M. W., 2010, Eastern Mediterranean Health Journal, V16, P1055; de Souza Carmo EV, 2010, PLOS ONE, V5; Eidsmo L, 2007, AM J PATHOL, V170, P227, DOI 10.2353/ajpath.2007.060068; ESTERRE P, 1992, VIRCHOWS ARCH A, V421, P239, DOI 10.1007/BF01611181; Faria DR, 2009, PARASITE IMMUNOL, V31, P432, DOI 10.1111/j.1365-3024.2009.01125.x; Fernandez-Figueroa EA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001533; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Freitas-Teixeira PM, 2012, SCAND J IMMUNOL, V76, P421, DOI 10.1111/j.1365-3083.2012.02748.x; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Gueirard P, 2008, CELL MICROBIOL, V10, P100, DOI 10.1111/j.1462-5822.2007.01018.x; Guimaraes-Costa AB, 2014, INFECT IMMUN, V82, P1732, DOI 10.1128/IAI.01232-13; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hamerschlak Nelson, 2005, Sao Paulo Med. J., V123, P247, DOI 10.1590/S1516-31802005000500009; HERRMANN RG, 1967, ARCH INT PHARMACOD T, V168, P467; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; Hurt M, 2001, INFECT IMMUN, V69, P2988, DOI 10.1128/IAI.69.5.2988-2995.2001; Kasahara S, 2016, J INFECT DIS, V213, P1289, DOI 10.1093/infdis/jiw054; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Lainson R., 2010, TOPLEY WILSONS MICRO, DOI 10.1002/9780470688618; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; MELBY PC, 1994, INFECT IMMUN, V62, P837, DOI 10.1128/IAI.62.3.837-842.1994; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Muller K, 2001, MED MICROBIOL IMMUN, V190, P73; MURLAS C, 1985, J APPL PHYSIOL, V58, P1630, DOI 10.1152/jappl.1985.58.5.1630; Navas A, 2014, INFECT IMMUN, V82, P2872, DOI 10.1128/IAI.01133-13; Novais FO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006196; Novais FO, 2009, J IMMUNOL, V183, P8088, DOI 10.4049/jimmunol.0803720; Osorio Y, 2003, PARASITE IMMUNOL, V25, P139, DOI 10.1046/j.1365-3024.2003.00615.x; Palma GI, 1997, AM J DERMATOPATH, V19, P585, DOI 10.1097/00000372-199712000-00006; PEARSON RD, 1981, J IMMUNOL, V127, P1438; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Pillay J, 2013, CELL MOL LIFE SCI, V70, P3813, DOI 10.1007/s00018-013-1286-4; Qu CK, 2000, CELL RES, V10, P279, DOI 10.1038/sj.cr.7290055; Ribeiro-Gomes FL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.351; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Ribeiro-Gomes FL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00059; Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536; Rocha FJS, 2007, INFECT IMMUN, V75, P3823, DOI 10.1128/IAI.01335-06; Rousseau D, 2001, BMC Microbiol, V1, P17, DOI 10.1186/1471-2180-1-17; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Salei N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171850; Santos CDS, 2013, J INVEST DERMATOL, V133, P1533, DOI 10.1038/jid.2013.4; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495; Tacchini-Cottier F, 2000, J IMMUNOL, V165, P2628, DOI 10.4049/jimmunol.165.5.2628; Tacchini-Cottier F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00032; Taekema-Roelvink MEJ, 2001, J AM SOC NEPHROL, V12, P932, DOI 10.1681/ASN.V125932; Tasew G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000844; Tavares N, 2016, J IMMUNOL, V196, P1865, DOI 10.4049/jimmunol.1502224; Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10; Travi BL, 2002, INFECT IMMUN, V70, P2288, DOI 10.1128/IAI.70.5.2288-2296.2002; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; WEIGLE KA, 1993, J INFECT DIS, V168, P699, DOI 10.1093/infdis/168.3.699; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	72	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179084	10.1371/journal.pone.0179084	http://dx.doi.org/10.1371/journal.pone.0179084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591228	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700084
J	Sieben, A; Schumann, J; Seyfried, A				Sieben, Anna; Schumann, Jette; Seyfried, Armin			Collective phenomena in crowds-Where pedestrian dynamics need social psychology	PLOS ONE			English	Article							LANE FORMATION; EVACUATION; BEHAVIOR; IDENTIFICATION; SIMULATION; DENSITY; DRIVEN; FIELD; FLOW	This article is on collective phenomena in pedestrian dynamics during the assembling and dispersal of gatherings. To date pedestrian dynamics have been primarily studied in the natural and engineering sciences. Pedestrians are analyzed and modeled as driven particles revealing self-organizing phenomena and complex transport characteristics. However, pedestrians in crowds also behave as living beings according to stimulus-response mechanisms or act as human subjects on the basis of social norms, social identities or strategies. To show where pedestrian dynamics need social psychology in addition to the natural sciences we propose the application of three categories-phenomena, behavior and action. They permit a clear discrimination between situations in which minimal models from the natural sciences are appropriate and those in which sociological and psychological concepts are needed. To demonstrate the necessity of this framework, an experiment in which a large group of people (n = 270) enters a concert hall through two different spatial barrier structures is analyzed. These two structures correspond to everyday situations such as boarding trains and access to immigration desks. Methods from the natural and social sciences are applied. Firstly, physical measurements show the influence of the spatial structure on the dynamics of the entrance procedure. Density, waiting time and speed of progress show large variations. Secondly, a questionnaire study (n = 60) reveals how people perceive and evaluate these entrance situations. Markedly different expectations, social norms and strategies are associated with the two spatial structures. The results from the questionnaire study do not always conform to objective physical measures, indicating the limitations of models which are based on objective physical measures alone and which neglect subjective perspectives.	[Sieben, Anna] Ruhr Univ Bochum, Chair Social Theory & Social Psychol, Bochum, Germany; [Schumann, Jette; Seyfried, Armin] Forschungszentrum Julich, Julich Supercomp Ctr, Julich, Germany; [Seyfried, Armin] Univ Wuppertal, Sch Architecture & Civil Engn, Wuppertal, Germany	Ruhr University Bochum; Helmholtz Association; Research Center Julich; University of Wuppertal	Seyfried, A (corresponding author), Forschungszentrum Julich, Julich Supercomp Ctr, Julich, Germany.; Seyfried, A (corresponding author), Univ Wuppertal, Sch Architecture & Civil Engn, Wuppertal, Germany.	a.seyfried@fz-juelich.de	Seyfried, Armin/T-4868-2017	Seyfried, Armin/0000-0001-8888-0978; Schumann, Jette/0000-0003-3668-999X	German Federal Ministry of Education and Research [13N12045]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The experiments were part of the project "Basigo Bausteine fur die Sicherheit von Grossveranstaltungen". The project was funded by the German Federal Ministry of Education and Research under grant number: 13N12045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Maik Boltes for his valuable support in extracting the trajectories. The empirical data analyzed in the first section were part of the BaSiGo project. Armin Seyfried would like to thank the team responsible for the planning and execution of the experiment, in particular Martin Hoube. The project "Basigo-Bausteine fur die Sicherheit von Grossveranstaltungen" was funded by the German Federal Ministry of Education and Research under grant number: 13N12045.	Ali S., 2013, MODELING SIMULATION; Alnabulsi H, 2014, P NATL ACAD SCI USA, V111, P9091, DOI 10.1073/pnas.1404953111; [Anonymous], 1981, THESIS; Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Blue V.J., 1999, TRANSP RES REC, V1678, p135?141; Bode N.W.F., 2011, THESIS; Bode NWF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121227; Boltes M, 2013, NEUROCOMPUTING, V100, P127, DOI 10.1016/j.neucom.2012.01.036; Bruner J.S, 1990, ACT OF MEANING; Buchmueller S., 2007, PARAMETERS PEDESTRIA; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Chraibi M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046111; Chraibi Mohcine., 2015, TRAFFIC GRANULAR FLO; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Dietrich F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062801; Drury J., 2009, INT J MASS EMERGENCI, V27, P66; Dzubiella J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021402; Frey BS, 2010, P NATL ACAD SCI USA, V107, P4862, DOI 10.1073/pnas.0911303107; Fukui M, 1999, J PHYS SOC JPN, V68, P2861, DOI 10.1143/JPSJ.68.2861; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/313; Heliovaara S, 2012, SAFETY SCI, V50, P221, DOI 10.1016/j.ssci.2011.08.020; Hemelrijk CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126913; Hirai K., 1975, Proceedings of the 1975 International Conference on Cybernetics and Society, P409; Hofinger G, 2014, TRANSP RES PROC, V2, P603, DOI 10.1016/j.trpro.2014.09.101; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Koster G, 2015, TRAFFIC GRANULAR FLO; Lachapelle A., 2011, MEAN FIELD GAME APPR; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Lewin K., 1975, FIELD THEORY SOCIAL; MCPHAIL C., 2003, HDB SYMBOLIC INTERAC, P721; McPhail C, 2006, SYMB INTERACT, V29, P433, DOI 10.1525/si.2006.29.4.433; Meyer-Konig T, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P297; MINTZ A, 1951, J ABNORM SOC PSYCH, V46, P150, DOI 10.1037/h0063293; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Muir HC, 1996, INT J AVIAT PSYCHOL, V6, P57, DOI 10.1207/s15327108ijap0601_4; Narang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117856; Pastor JM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062817; Predtechenskii V.M., 1978, PLANNING FOOT TRAFFI; Reynolds CW., 1999, GAM DEV C, P763; Schadschneider A., 2011, ENCY COMPLEXITY SYST, P517, DOI [DOI 10.1007/978-0-387-30440-3_187, 10.1007/978-1-4419-7695-6_29, 10.1007/978-0-387-30440-3_187]; Schafer C, 2014, TRANSP RES PROC, V2, P636, DOI 10.1016/j.trpro.2014.09.106; Schneider D., 2001, BRANDSCHUTZ DTSCH FE, V1, P13; Schreckenberg M., 1998, TRAFFIC GRANULAR FLO; Schweingruber D, 2005, TEACH SOCIOL, V33, P136, DOI 10.1177/0092055X0503300202; Schweingruber D, 1999, SOCIOL METHOD RES, V27, P451, DOI 10.1177/0049124199027004001; Sime J. D., 1980, FIRES HUMAN BEHAV; Sime JD, 1995, SAFETY SCI, V21, P1, DOI 10.1016/0925-7535(96)81011-3; Steffen B, 2010, PHYSICA A, V389, P1902, DOI 10.1016/j.physa.2009.12.015; Straub J., 1999, INTERPRETATION KRITI; Sutterlin KR, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.085003; Templeton A, 2015, REV GEN PSYCHOL, V19, P215, DOI 10.1037/gpr0000032; To K, 2001, PHYS REV LETT, V86, P71, DOI 10.1103/PhysRevLett.86.71; Torrens PM, 2012, ANN ASSOC AM GEOGR, V102, P35, DOI 10.1080/00045608.2011.595658; Trans Res Board, 2000, HIGHWAY CAPACITY MAN; Van den Berg J, 2008, C P IEEE INT C ROB A; von Kruchten C, 2017, PHYSICA A, V475, P129, DOI 10.1016/j.physa.2017.02.004; von Sivers I, 2016, SAFETY SCI, V89, P288, DOI 10.1016/j.ssci.2016.07.001; von Sivers I, 2015, TRANSPORT RES B-METH, V74, P104, DOI 10.1016/j.trb.2015.01.009; Wagoum AUK, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160896; Weber Max., 1985, WIRTSCHAFT GESELLSCH; Weidmann U., 2014, PEDESTRIAN EVACUATIO; Yanagisawa D, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036110; Zhang J, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02002; Zheng XP, 2011, COMPUT MATH APPL, V62, P4627, DOI 10.1016/j.camwa.2011.10.048; Zuriguel I, 2014, PAP PHYS-LA PLATA, V6, DOI 10.4279/PIP.060014; Zuriguel I, 2014, SCI REP-UK, V4, DOI 10.1038/srep07324	72	61	61	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177328	10.1371/journal.pone.0177328	http://dx.doi.org/10.1371/journal.pone.0177328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591142	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700007
J	Bruneau, M; Colombel, A; Mirallie, S; Freour, T; Hardouin, JB; Barriere, P; Grall-Bronnec, M				Bruneau, Melanie; Colombel, Agnes; Mirallie, Sophie; Freour, Thomas; Hardouin, Jean-Benoit; Barriere, Paul; Grall-Bronnec, Marie			Desire for a child and eating disorders in women seeking infertility treatment	PLOS ONE			English	Article							QUALITY-OF-LIFE; SCOFF QUESTIONNAIRE; PSYCHOSOCIAL CHARACTERISTICS; ANOREXIA-NERVOSA; FRENCH VERSION; SCREENING TOOL; PREVALENCE; VALIDATION; IVF; COUPLES	Objectives The purpose of this study was to evaluate the prevalence of EDs in women seeking treatment for infertility, and to better characterize their clinical profile. Study design Sixty participants completed self-report measures that assessed EDs, desire for a child, body preoccupations, quality of life, anxiety and depression. Results Ten patients (17%) met criteria for a past or current ED. We showed a significant association between greater body dissatisfaction and a more ambivalent desire for a child. Furthermore, an ED was associated with (i) a lower quality of life, and (ii) more anxiety disorders. Conclusion Screening for a history of ED in infertile women is recommended to plan for adapted care regarding infertility but also regarding ED and psychiatric comorbidities. Therefore, the assessment has to take into account the desire for a child and the body satisfaction, that are essential parts of the ED process on the one hand and infertility process on the other. This could help with the infertility treatment and the prevention of negative maternal and fetal outcomes.	[Bruneau, Melanie; Grall-Bronnec, Marie] CHU Nantes, Dept Addictol & Psychiat, Nantes, France; [Bruneau, Melanie; Hardouin, Jean-Benoit; Grall-Bronnec, Marie] Univ Nantes, EA 4275, SPHERE bioStat Pharmacoepidemiol & Human Sci Res, Fac Med, Nantes, France; [Bruneau, Melanie; Hardouin, Jean-Benoit; Grall-Bronnec, Marie] Univ Nantes, EA 4275, SPHERE bioStat Pharmacoepidemiol & Human Sci Res, Fac Pharmaceut Sci, Nantes, France; [Colombel, Agnes; Mirallie, Sophie; Freour, Thomas; Barriere, Paul] CHU Nantes, Dept Reprod Med, Nantes, France; [Hardouin, Jean-Benoit] CHU Nantes, Unit Methodol & Biostat, Nantes, France	Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Grall-Bronnec, M (corresponding author), CHU Nantes, Dept Addictol & Psychiat, Nantes, France.; Grall-Bronnec, M (corresponding author), Univ Nantes, EA 4275, SPHERE bioStat Pharmacoepidemiol & Human Sci Res, Fac Med, Nantes, France.; Grall-Bronnec, M (corresponding author), Univ Nantes, EA 4275, SPHERE bioStat Pharmacoepidemiol & Human Sci Res, Fac Pharmaceut Sci, Nantes, France.	marie.bronnec@chu-nantes.fr		grall-bronnec, marie/0000-0003-0722-7243; Hardouin, Jean-Benoit/0000-0001-8664-623X				Ackerman KE, 2013, CLIN ENDOCRINOL, V78, P114, DOI 10.1111/j.1365-2265.2012.04458.x; Aschenbrenner VK, 2005, Z PSYCHOSOM MED PSYC, V51, P230, DOI 10.13109/zptm.2005.51.3.230; Assens M, 2015, ACTA OBSTET GYN SCAN, V94, P1254, DOI 10.1111/aogs.12727; Attia E, 2009, INT J EAT DISORDER, V42, P581, DOI 10.1002/eat.20720; Baird DT, 2006, HUM REPROD UPDATE, V12, P193, DOI 10.1093/humupd/dmk003; Boivin J, 2011, HUM REPROD, V26, P2084, DOI 10.1093/humrep/der171; BRINCH M, 1988, ACTA PSYCHIAT SCAND, V77, P611, DOI 10.1111/j.1600-0447.1988.tb05175.x; Castellini G, 2012, J SEX MED, V9, P2590, DOI 10.1111/j.1743-6109.2012.02888.x; COOPER PJ, 1987, INT J EAT DISORDER, V6, P485, DOI 10.1002/1098-108X(198707)6:4<485::AID-EAT2260060405>3.0.CO;2-O; Dalle Grave R, 2008, BEHAV RES THER, V46, P1290, DOI 10.1016/j.brat.2008.08.007; De Souza MJ, 2004, J CLIN ENDOCR METAB, V89, P3536, DOI 10.1210/jc.2003-032007; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; Fassino S, 2002, HUM REPROD, V17, P2986, DOI 10.1093/humrep/17.11.2986; Freizinger M, 2010, FERTIL STERIL, V93, P72, DOI 10.1016/j.fertnstert.2008.09.055; Garcia FD, 2010, WORLD J BIOL PSYCHIA, V11, P888, DOI 10.3109/15622975.2010.483251; Hoek HW, 2003, INT J EAT DISORDER, V34, P383, DOI 10.1002/eat.10222; Holzle C, 2001, FRAGEBOGEN ZUM KINDE, P110; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Jenkins PE, 2011, CLIN PSYCHOL REV, V31, P113, DOI 10.1016/j.cpr.2010.08.003; Katz MG, 2000, BRIT J OBSTET GYNAEC, V107, P707, DOI 10.1111/j.1471-0528.2000.tb13329.x; Kouba S, 2005, OBSTET GYNECOL, V105, P255, DOI 10.1097/01.AOG.0000148265.90984.c3; Lamas C, 2014, EMC PSYCHIAT, V11, P1; Luck AJ, 2002, BRIT MED J, V325, P755, DOI 10.1136/bmj.325.7367.755; Mehler PS, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0040-8; Morgan JF, 1999, BRIT MED J, V319, P1467, DOI 10.1136/bmj.319.7223.1467; Perry L, 2002, INT J EAT DISORDER, V32, P466, DOI 10.1002/eat.10093; Ragni G, 2005, HUM REPROD, V20, P1286, DOI 10.1093/humrep/deh788; Rashidi B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-186; Resch M, 1999, J PSYCHOSOM OBST GYN, V20, P152, DOI 10.3109/01674829909075589; Rodino IS, 2016, AUST NZ J OBSTET GYN, V56, P82, DOI 10.1111/ajo.12407; Rodino IS, 2016, REPROD BIOMED ONLINE, V32, P104, DOI 10.1016/j.rbmo.2015.10.002; Rousseau A, 2005, ENCEPHALE, V31, P162; Sbaragli C, 2008, FERTIL STERIL, V90, P2107, DOI 10.1016/j.fertnstert.2007.10.045; STEWART DE, 1990, AM J OBSTET GYNECOL, V163, P1196, DOI 10.1016/0002-9378(90)90688-4; Stoleru S, 1996, J PSYCHOSOM OBST GYN, V17, P103, DOI 10.3109/01674829609025670; Verhaak CM, 2007, HUM REPROD UPDATE, V13, P27, DOI 10.1093/humupd/dml040; Wischmann T, 2009, HUM REPROD, V24, P378, DOI 10.1093/humrep/den401; Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178848	10.1371/journal.pone.0178848	http://dx.doi.org/10.1371/journal.pone.0178848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586392	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700032
J	Kumari, A; Singh, KP; Mandal, A; Paswan, RK; Sinha, P; Das, P; Ali, V; Bimal, S; Lal, CS				Kumari, Anjali; Singh, Krishn Pratap; Mandal, Abhishek; Paswan, Ranjeet Kumar; Sinha, Preeti; Das, Pradeep; Ali, Vahab; Bimal, Sanjiva; Lal, Chandra Shekhar			Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani	PLOS ONE			English	Article							FLUORESCENT-PROBE; APOPTOSIS; PROMASTIGOTES; PROLIFERATION; HOMEOSTASIS; MODULATION; RESISTANCE; INHIBITION; MECHANISM; CATALYSIS	Leishmaniasis caused by Leishmania parasite is a global threat to public health and one of the most neglected tropical diseases. Therefore, the discovery of novel drug targets and effective drug is a major challenge and an important goal. Leishmania is an obligate intracellular parasite that alternates between sand fly and human host. To survive and establish infections, Leishmania parasites scavenge and internalize nutrients from the host. Nevertheless, host cells presents mechanism like nutrient restriction to inhibit microbial growth and control infection. Zinc is crucial for cellular growth and disruption in its homeostasis hinders growth and survival in many cells. However, little is known about the role of zinc in Leishmania growth and survival. In this study, the effect of zinc on the growth and survival of L. donovani was analyzed by both Zinc-depletion and Zinc-supplementation using Zinc-specific chelator N, N, N', N'-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) and Zinc Sulfate (ZnSO4). Treatment of parasites with TPEN rather than ZnSO4 had significantly affected the growth in a dose-and time-dependent manner. The pre-treatment of promastigotes with TPEN resulted into reduced host-parasite interaction as indicated by decreased association index. Zn depletion resulted into flux in intracellular labile Zn pool and increased in ROS generation correlated with decreased intracellular total thiol and retention of plasma membrane integrity without phosphatidylserine exposure in TPEN treated promastigotes. We also observed that TPEN-induced Zn depletion resulted into collapse of mitochondrial membrane potential which is associated with increase in cytosolic calcium and cytochrome-c. DNA fragmentation analysis showed increased DNA fragments in Zn-depleted cells. In summary, intracellular Zn depletion in the L. donovani promastigotes led to ROS-mediated caspase-independent mitochondrial dysfunction resulting into apoptosis-like cell death. Therefore, cellular zinc homeostasis in Leishmania can be explored for new drug targets and chemotherapeutics to control Leishmanial growth and disease progression.	[Kumari, Anjali; Paswan, Ranjeet Kumar; Sinha, Preeti; Lal, Chandra Shekhar] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Biochem, Patna, Bihar, India; [Singh, Krishn Pratap; Ali, Vahab] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Biochem, Lab Mol Biochem & Cell Biol, Patna, Bihar, India; [Mandal, Abhishek; Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Mol Biol, Patna, Bihar, India; [Bimal, Sanjiva] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Immunol, Patna, Bihar, India	Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI)	Lal, CS (corresponding author), Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Div Biochem, Patna, Bihar, India.	drcslal@gmail.com	Mandal, Abhishek/Y-5333-2019	Lal, Chandra Shekhar/0000-0002-8172-0362	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, India [INT-87-BAS]	Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, India	This work was supported by an intramural grant (INT-87-BAS) from the Indian Council of Medical Research (ICMR), Ministry of Health and Family Welfare, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; [Anonymous], [No title captured]; Bafghi AF, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.11192; Bangs JD, 2001, MOL BIOCHEM PARASIT, V114, P111, DOI 10.1016/S0166-6851(01)00244-4; Barczyk K, 2005, INT J CANCER, V116, P167, DOI 10.1002/ijc.21037; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; BROUCKAERT G, 2005, APOPTOTIC PATHWAYS T; Carvalho S, 2015, MOL MICROBIOL, V96, P581, DOI 10.1111/mmi.12957; Chimienti F, 2003, CURR DRUG TARGETS, V4, P323, DOI 10.2174/1389450033491082; Clegg MS, 2005, IUBMB LIFE, V57, P661, DOI 10.1080/15216540500264554; COYLE P, 1994, BIOCHEM J, V303, P781, DOI 10.1042/bj3030781; Cuevas IC, 2003, INFECT IMMUN, V71, P5739, DOI 10.1128/IAI.71.10.5739-5749.2003; Desjardins M, 1998, RES IMMUNOL, V149, P689, DOI 10.1016/S0923-2494(99)80040-6; Devergnas S, 2004, BIOCHEM PHARMACOL, V68, P699, DOI 10.1016/j.bcp.2004.05.024; Duffy JY, 2001, APOPTOSIS, V6, P161, DOI 10.1023/A:1011380508902; Equbal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097600; Foucher AL, 2013, ANTIMICROBIAL AGENTS, V57; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Ghavami S, 2004, J LEUKOCYTE BIOL, V76, P169, DOI 10.1189/jlb.0903435; Ghavami S, 2005, MED SCI MONITOR, V11, pRA337; Haase H, 2008, J IMMUNOL, V181, P6491, DOI 10.4049/jimmunol.181.9.6491; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Islamuddin M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00626; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Krzemieniecki K, 2006, CENT EUR J BIOL, V1, P167, DOI 10.2478/s11535-006-0014-6; Li YM, 2009, CELL BIOCHEM FUNCT, V27, P417, DOI 10.1002/cbf.1598; Lima AKC, 2009, PARASITOLOGY, V136, P1179, DOI 10.1017/S0031182009990540; Maddika S, 2005, J CELL SCI, V118, P4485, DOI 10.1242/jcs.02580; Mandal A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004373; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Maret W, 2009, BIOMETALS, V22, P149, DOI 10.1007/s10534-008-9186-z; MARTIN SJ, 1991, CLIN EXP IMMUNOL, V83, P338; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Mesquita-Rodrigues C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002481; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Paski SC, 2001, J NUTR BIOCHEM, V12, P655, DOI 10.1016/S0955-2863(01)00188-7; PRASAD AS, 1974, J LAB CLIN MED, V83, P634; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Sandstead HH, 2003, J TRACE ELEM EXP MED, V16, P165, DOI 10.1002/jtra.10042; Santos ALS, 2012, CURRENT MED CHEM, V19; Sardar AH, 2013, EXP PARASITOL, V135, P715, DOI 10.1016/j.exppara.2013.10.011; Seay MB, 1996, INFECT IMMUN, V64, P5129, DOI 10.1128/IAI.64.12.5129-5137.1996; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Silva MS, 2008, BIOCHEMISTRY-US, V47, P195, DOI 10.1021/bi700989m; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5; TREVES S, 1994, EXP CELL RES, V211, P339, DOI 10.1006/excr.1994.1096; Trincao J, 2006, ACTA CRYSTALLOGR F, V62, P805, DOI 10.1107/S1744309106027539; Truong-Tran AQ, 2000, J NUTR, V130, p1459S, DOI 10.1093/jn/130.5.1459S; Vicentefranqueira R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00160; WHO, 2010, WHO TECH REP SER, V949, P1; Zalewski P D, 1994, Chem Biol, V1, P153, DOI 10.1016/1074-5521(94)90005-1; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	61	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178800	10.1371/journal.pone.0178800	http://dx.doi.org/10.1371/journal.pone.0178800			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586364	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700026
J	Wu, YL; Guan, YY; Zhuang, Z; Wang, WM; Liu, YA				Wu, Yongle; Guan, Yangyang; Zhuang, Zheng; Wang, Weimin; Liu, Yuanan			A novel tri-band T-junction impedance-transforming power divider with independent power division ratios	PLOS ONE			English	Article							DESIGN	In this paper, a novel L network (LN) is presented, which is composed of a frequency-selected section (FSS) and a middle stub (MS). Based on the proposed LN, a tri-band T-junction power divider (TTPD) with impedance transformation and independent power division ratios is designed. Moreover, the closed-form design theory of the TTPD is derived based on the transmission line theory and circuit theory. Finally, a microstrip prototype of the TTPD is simulated, fabricated, and measured. The design is for three arbitrarily chosen frequencies, 1 GHz, 1.6 GHz, and 2.35 GHz with the independent power division ratios of 0.5, 0.7, and 0.9. The measured results show that the fabricated prototype is consistent with the simulation, which demonstrates the effectiveness of this proposed design.	[Wu, Yongle; Guan, Yangyang; Zhuang, Zheng; Wang, Weimin; Liu, Yuanan] Beijing Univ Posts & Telecommun, Sch Elect Engn, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Wu, YL (corresponding author), Beijing Univ Posts & Telecommun, Sch Elect Engn, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing, Peoples R China.	ywu@bupt.edu.cn		Wu, Yongle/0000-0002-3269-7143; GUAN, YANGYANG/0000-0002-8215-135X	National Key Basic Research Program of China (973 Program) [2014CB339900]; National Natural Science Foundations of China [61422103, 61671084, 61327806]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Key Basic Research Program of China (973 Program) (No.2014CB339900), and National Natural Science Foundations of China (No.61422103 and No.61671084).; This work was supported in part by National Natural Science Foundations of China (No.61327806, No.61422103, and No.61671084), and National Key Basic Research Program of China (973 Program) (No.2014CB339900).	Chongheawchamnan M, 2006, IEEE MICROW WIREL CO, V16, P452, DOI 10.1109/LMWC.2006.879488; Chu QX, 2011, IEEE T MICROW THEORY, V59, P2221, DOI 10.1109/TMTT.2011.2160195; Gao NJ, 2014, IEEE MICROW WIREL CO, V24, P81, DOI 10.1109/LMWC.2013.2290226; Gomez-Garcia R, 2015, IEEE T CIRCUITS-I, V62, P1518, DOI 10.1109/TCSI.2015.2418838; Guan YY, 2017, IET MICROW ANTENNA P, V11, P294, DOI 10.1049/iet-map.2016.0071; Mezaal YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164916; Mezaal YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152615; Mezaal YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115412; Pozar D.M., 2006, MICROWAVE ENG; Ren X, 2015, IEEE MICROW WIREL CO, V25, P82, DOI 10.1109/LMWC.2014.2372481; Tang CW, 2016, IEEE T MICROW THEORY, V64, P486, DOI 10.1109/TMTT.2015.2506627; Wu YL, 2010, IEEE T MICROW THEORY, V58, P3832, DOI 10.1109/TMTT.2010.2086712; Wu YL, 2009, IEEE MICROW WIREL CO, V19, P792, DOI 10.1109/LMWC.2009.2034034; Zhang TY, 2015, IEEE MICROW WIREL CO, V25, P94, DOI 10.1109/LMWC.2014.2382681	14	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178956	10.1371/journal.pone.0178956	http://dx.doi.org/10.1371/journal.pone.0178956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586372	gold, Green Submitted, Green Published			2022-12-26	WOS:000402875700039
J	Beggs, CB; Shepherd, SJ; Emmonds, S; Jones, B				Beggs, Clive B.; Shepherd, Simon J.; Emmonds, Stacey; Jones, Ben			A novel application of PageRank and user preference algorithms for assessing the relative performance of track athletes in competition	PLOS ONE			English	Article								Ranking enables coaches, sporting authorities, and pundits to determine the relative performance of individual athletes and teams in comparison to their peers. While ranking is relatively straightforward in sports that employ traditional leagues, it is more difficult in sports where competition is fragmented (e.g. athletics, boxing, etc.), with not all competitors competing against each other. In such situations, complex points systems are often employed to rank athletes. However, these systems have the inherent weakness that they frequently rely on subjective assessments in order to gauge the calibre of the competitors involved. Here we show how two Internet derived algorithms, the PageRank (PR) and user preference (UP) algorithms, when utilised with a simple 'who beat who' matrix, can be used to accurately rank track athletes, avoiding the need for subjective assessment. We applied the PR and UP algorithms to the 2015 IAAF Diamond League men's 100m competition and compared their performance with the Keener, Colley and Massey ranking algorithms. The top five places computed by the PR and UP algorithms, and the Diamond League '2016' points system were all identical, with the Kendall's tau distance between the PR standings and '2016' points system standings being just 15, indicating that only 5.9% of pairs differed in their order between these two lists. By comparison, the UP and '2016' standings displayed a less strong relationship, with a tau distance of 95, indicating that 37.6% of the pairs differed in their order. When compared with the standings produced using the Keener, Colley and Massey algorithms, the PR standings appeared to be closest to the Keener standings (tau distance = 67, 26.5% pair order disagreement), whereas the UP standings were more similar to the Colley and Massey standings, with the tau distances between these ranking lists being only 48 (19.0% pair order disagreement) and 59 (23.3% pair order disagreement) respectively. In particular, the UP algorithm ranked 'one-off victors more highly than the PR algorithm, suggesting that the UP algorithm captures alternative characteristics to the PR algorithm, which may more suitable for predicting future performance in say knockout tournaments, rather than for use in competitions such as the Diamond League. As such, these Internet derived algorithms appear to have considerable potential for objectively assessing the relative performance of track athletes, without the need for complicated points equivalence tables. Importantly, because both algorithms utilise a 'who beat who' model, they automatically adjust for the strength of the competition, thus avoiding the need for subjective decision making.	[Beggs, Clive B.; Emmonds, Stacey; Jones, Ben] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Carnegie Fac, Leeds, W Yorkshire, England; [Shepherd, Simon J.] Univ Bradford, Med Biophys Lab, Bradford, W Yorkshire, England	Leeds Beckett University; University of Bradford	Beggs, CB (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Carnegie Fac, Leeds, W Yorkshire, England.	c.beggs@leedsbeckett.ac.uk		Jones, Ben/0000-0002-4274-6236				Albers PCH, 2001, ANIM BEHAV, V61, P489, DOI 10.1006/anbe.2000.1571; [Anonymous], 2015, 2015 DIAMOND LEAGUE; [Anonymous], 2016, RULES ALL ATHLETICS; [Anonymous], 1997, WORLD FOOTBALL ELO R; [Anonymous], 2015, HOW IT WORKS IAAF DI; [Anonymous], 2016, DIAMOND RACE RULES P; ATP, 2016, ATP WORLD RANK STRUC; Balreira EC, J QUANTITATIVE ANAL, V10, P183; Brandt M, 2015, GRAPH BASED APPROACH; Bressan M, 2010, J DISCRET ALGORITHMS, V8, P199, DOI 10.1016/j.jda.2009.11.001; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brin S, 2012, COMPUT NETW, V56, P3825, DOI 10.1016/j.comnet.2012.10.007; Chartier TP, 2014, IMAGE B INT LINEAR A, V52; Colley W, 2002, COLLEYS BIAS FREE CO; Govan A.Y, 2008, RANKING THEORY APPL; Govan AY, 2006, AA MARK ANN M; KEENER JP, 1993, SIAM REV, V35, P80, DOI 10.1137/1035004; Langville AN, 2012, WHOS SCI RATING RA; Lazova V, 2015, ARXIV 150301331; Massey K, 1997, STAT MODELS APPL RAT; Meyer CD, 2000, 8 PERRON FROBENIUS T; OWG, 2016, OFF WORLD GOLF RANK; Paine N., 2017, NFL ELO RATINGS ARE; Pena JL, 2012, NETWORK THEORY ANAL; Premiership_Rugby, 2016, LEAG RULES2016; RFL, 2016, RUGBY FOOFB LEAG SEC; Robinson J., 2016, UNDERSTANDING PREMIE; Spiriev B, 2014, IAAF SCORING TABLES; Till K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155047; Till K, 2016, J SPORT SCI, V34, P1240, DOI 10.1080/02640414.2015.1105380; Zack L, 2012, J MATH, V5, P463	31	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178458	10.1371/journal.pone.0178458	http://dx.doi.org/10.1371/journal.pone.0178458			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575009	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000402624300054
J	Li, X; Tian, B; Zhou, JF; Chen, YK; Li, XD; Zhu, WF; Yan, L; Jing, T; Guo, JF; Tao, C; Gao, RB; Wang, DY; Shu, YL				Li, Xin; Tian, Bai; Zhou Jianfang; Chen Yongkun; Li Xiaodan; Zhu Wenfei; Yan, Li; Jing, Tang; Guo Junfeng; Tao, Chen; Gao Rongbao; Wang Dayan; Shu, Yuelong			A comprehensive retrospective study of the seroprevalence of H9N2 avian influenza viruses in occupationally exposed populations in China	PLOS ONE			English	Article							HUMAN INFECTION; POULTRY WORKERS; MAINLAND CHINA; H7N9 VIRUS; HONG-KONG; EVOLUTION; H5N1	The H9N2 avian influenza virus circulates worldwide, predominantly in poultry. Its increasing infectivity and adaptation in poultry and mammals have enhanced the possibility of human infection. However, H9N2 human cases are difficult to detect due to their mild clinical symptoms. Serological study is valuable for risk assessment. A total of 15,700 serum samples were collected from occupationally exposed populations in 22 provinces of China and tested using hemagglutination inhibition (HI) and microneutralization (MN) assays. The sera positive rate of A/Guangzhou/333/99 (G9) was significantly higher than that of A/quail/Hong Kong/G1/97 (G1) (p<0.0001). The seroprevalences of H9N2 were significantly higher in live poultry market workers, large-scale poultry farmers and backyard farmers than in poultry slaughtering factory workers and wild bird habitant workers. The seroprevalences of N Guangzhou/333/99 (G9) (3.42%) and A/quail/Hong Kong/G1/97 (G1) (1.37%) in Southern China were significantly higher than those in Northern China (p<0.001). The seroprevalence was highest in the elderly, followed by adults and then youths. Our results indicate that sub clinical human infection with H9N2 avian influenza virus is widely distributed in China. Longer poultry exposure might contribute to the higher seroprevalence in the elderly group. The higher seroprevalence observed in Southern China than in Northern China might be caused by a higher poultry density.	[Li, Xin; Tian, Bai; Zhou Jianfang; Chen Yongkun; Li Xiaodan; Zhu Wenfei; Yan, Li; Jing, Tang; Guo Junfeng; Tao, Chen; Gao Rongbao; Wang Dayan; Shu, Yuelong] Minist Hlth, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Shu, YL (corresponding author), Minist Hlth, Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol, Beijing, Peoples R China.	yshu@cnic.org.cn	Gao, Rongbao/GXM-4237-2022		China National Mega-Projects for Infectious Diseases [2014ZX10004002]	China National Mega-Projects for Infectious Diseases	This study was supported by China National Mega-Projects for Infectious Diseases (2014ZX10004002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFL VIR RES; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen BL, 1994, J VET MED, P223; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen Y, 2011, CLIN MICROBIOL INFEC, V17, P1347, DOI 10.1111/j.1469-0691.2011.03538.x; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gohrbandt S, 2011, J GEN VIROL, V92, P1843, DOI 10.1099/vir.0.031591-0; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; HOMME PJ, 1970, AVIAN DIS, V14, P285, DOI 10.2307/1588473; Huang R, 2013, EUR J CLIN MICROBIOL, V32, P1347, DOI 10.1007/s10096-013-1888-7; Jiang WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052671; Jin Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1110; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wang Q, 2014, ZOONOSES PUBLIC HLTH; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Wu P, 2014, EMERG INFECT DIS, V20, P1891, DOI 10.3201/eid2011.140556; Yang ZF, 2015, NEW ENGL J MED, V373, P487, DOI 10.1056/NEJMc1502983; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu Q, 2013, EMERG INFECT DIS, V19, P313, DOI 10.3201/eid1902.120251; Zhang K, 2013, VIRUS RES, V175, P52, DOI 10.1016/j.virusres.2013.04.004	29	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178328	10.1371/journal.pone.0178328	http://dx.doi.org/10.1371/journal.pone.0178328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575073	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300041
J	Perez-Alea, M; McGrail, K; Sanchez-Redondo, S; Ferrer, B; Fournet, G; Cortes, J; Munoz, E; Hernandez-Losa, J; Tenbaum, S; Martin, G; Costello, R; Ceylan, I; Garcia-Patos, V; Recio, JA				Perez-Alea, M.; McGrail, K.; Sanchez-Redondo, S.; Ferrer, B.; Fournet, G.; Cortes, J.; Munoz, E.; Hernandez-Losa, J.; Tenbaum, S.; Martin, G.; Costello, R.; Ceylan, I.; Garcia-Patos, V.; Recio, J. A.			ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment	ONCOGENE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; STEM-CELLS; LIPID-PEROXIDATION; HUMAN PROSTATE; HL-60 CELLS; CANCER; INHIBITORS; METASTASIS; MARKER; GROWTH	Despite the promising targeted and immune-based interventions in melanoma treatment, long-lasting responses are limited. Melanoma cells present an aberrant redox state that leads to the production of toxic aldehydes that must be converted into less reactive molecules. Targeting the detoxification machinery constitutes a novel therapeutic avenue for melanoma. Here, using 56 cell lines representing nine different tumor types, we demonstrate that melanoma cells exhibit a strong correlation between reactive oxygen species amounts and aldehyde dehydrogenase 1 (ALDH1) activity. We found that ALDH1A3 is upregulated by epigenetic mechanisms in melanoma cells compared with normal melanocytes. Furthermore, it is highly expressed in a large percentage of human nevi and melanomas during melanocyte transformation, which is consistent with the data from the TCGA, CCLE and protein atlas databases. Melanoma treatment with the novel irreversible isoform-specific ALDH1 inhibitor [4-dimethylamino-4-methyl-pent-2-ynthioic acid-S methylester] di-methyl-ampal-thio-ester (DIMATE) or depletion of ALDH1A1 and/or ALDH1A3, promoted the accumulation of apoptogenic aldehydes leading to apoptosis and tumor growth inhibition in immunocompetent, immunosuppressed and patient-derived xenograft mouse models. Interestingly, DIMATE also targeted the slow cycling label-retaining tumor cell population containing the tumorigenic and chemoresistant cells. Our findings suggest that aldehyde detoxification is relevant metabolic mechanism in melanoma cells, which can be used as a novel approach for melanoma treatment.	[Perez-Alea, M.; McGrail, K.; Sanchez-Redondo, S.; Ferrer, B.; Garcia-Patos, V.; Recio, J. A.] Barcelona UAB, VHIR Vall dHebron Hosp, Vall dHebron Res Inst, Biomed Res Melanoma Anim Models, Barcelona, Spain; [Perez-Alea, M.; McGrail, K.; Sanchez-Redondo, S.; Ferrer, B.; Garcia-Patos, V.; Recio, J. A.] Barcelona UAB, VHIR Vall dHebron Hosp, Vall dHebron Res Inst, Canc Lab,Oncol Program, Barcelona, Spain; [Ferrer, B.; Hernandez-Losa, J.] Barcelona UAB, Vall dHebron Hosp, Anat Pathol Dept, Barcelona, Spain; [Fournet, G.] Univ Claude Bernard Lyon1, UMR CNRS 5246, Inst Chim & Biochim Mol & Supramol, Villeurbanne, France; [Cortes, J.] Ramon y Cajal Univ Hosp, Madrid, Spain; [Cortes, J.; Munoz, E.] Barcelona UAB, Vall dHebron Hosp, Vall dHebron Inst Oncol VHIO, Clin Oncol Program, Barcelona, Spain; [Tenbaum, S.] Vall dHebron Inst Oncol, Stem Cells & Canc Lab, Barcelona, Spain; [Martin, G.; Ceylan, I.] Adv BioDesign, Parc Technol Lyon,Woodstock Batiment Cedre 1, St Priest, France; [Costello, R.] Ctr Hosp Univ La Conception, Serv Hematol & Therapie Cellulaire, Marseille, France; [Garcia-Patos, V.] Barcelona UAB, Vall dHebron Hosp, Dermatol Dept, Barcelona, Spain; [Sanchez-Redondo, S.] CNIO, Microenvironm & Metastasis Grp, Madrid 28029, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Hospital Universitario Ramon y Cajal; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Vall d'Hebron Institut d'Oncologia (VHIO); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hospital Universitari Vall d'Hebron; Centro Nacional de Investigaciones Oncologicas (CNIO)	Recio, JA (corresponding author), Inst Recerca Vall dHebron VHIR, Biomed Res Melanoma Anim Models & Canc Lab, Lab 203 Ed Collserola, Barcelona 08035, Spain.	juan.recio@vhir.org	Miquel, Josep Maria/AAG-3508-2019; Varela, Pedro Fuentes/AAD-4607-2020; Javier, Hernandez Losa/C-1173-2008	Varela, Pedro Fuentes/0000-0001-8471-0197; Javier, Hernandez Losa/0000-0003-1526-3201; Mc Grail Fernandez, Kimberley/0000-0001-7227-7306; PEREZ, Mileidys/0000-0002-8739-8087; Cortes, Javier/0000-0001-7623-1583; Recio, Juan Angel/0000-0002-7320-3832; Garcia-Patos Briones, Vicente/0000-0003-1654-6035	Advanced BioDesign; Spanish Health Ministry (Fondo de Investigaciones Sanitarias-FIS) [PI1400375-Fondos FEDER, AECC-GCB15152978SOEN]; Marie Curie Actions [IEF_METABOSET-627869]	Advanced BioDesign; Spanish Health Ministry (Fondo de Investigaciones Sanitarias-FIS); Marie Curie Actions(European Commission)	Dr G Quash is gratefully acknowledged for critical reading of the manuscript and his contributions. We also thank Dr HG Palmer for his generous contribution. This work was supported by funds from Advanced BioDesign (MPA), the Spanish Health Ministry (Fondo de Investigaciones Sanitarias-FIS) PI1400375-Fondos FEDER, AECC-GCB15152978SOEN, Marie Curie Actions (IEF_METABOSET-627869) supported MPA.	Alnouti Y, 2008, TOXICOL SCI, V101, P51, DOI 10.1093/toxsci/kfm280; Andreu-Perez P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-265; BARRERA G, 1991, EXP CELL RES, V197, P148, DOI 10.1016/0014-4827(91)90416-R; BLACKWELL LF, 1983, BIOCHEMISTRY-US, V22, P3784, DOI 10.1021/bi00285a011; Boonyaratanakornkit JB, 2010, J INVEST DERMATOL, V130, P2799, DOI 10.1038/jid.2010.237; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Charafe-Jauffret E, 2013, CANCER RES, V73, P7290, DOI 10.1158/0008-5472.CAN-12-4704; Chen Y, 2009, OCUL SURF, V7, P176, DOI 10.1016/S1542-0124(12)70185-4; Cheung AMS, 2007, LEUKEMIA, V21, P1423, DOI 10.1038/sj.leu.2404721; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Delyon J, 2013, ANN ONCOL, V24, P1697, DOI 10.1093/annonc/mdt027; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Fournet G, 2013, CURR MED CHEM, V20, P527; Grammatico P, 1998, EXP DERMATOL, V7, P205, DOI 10.1111/j.1600-0625.1998.tb00325.x; Hill BG, 2009, CIRC RES, V105, P1044, DOI 10.1161/CIRCRESAHA.109.209791; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jackson Brian, 2011, Human Genomics, V5, P283; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Koppaka V, 2012, PHARMACOL REV, V64, P520, DOI 10.1124/pr.111.005538; Li X, 2012, J THORAC ONCOL, V7, P1235, DOI 10.1097/JTO.0b013e318257cc6d; Lopez-Fauqued M, 2010, INT J CANCER, V126, P1549, DOI 10.1002/ijc.24926; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Marcato P, 2015, MOL ONCOL, V9, P17, DOI 10.1016/j.molonc.2014.07.010; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI 10.1517/17425255.4.6.697 ; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Monneuse O, 2005, J GASTROINTEST SURG, V9, P769, DOI 10.1016/j.gassur.2005.02.006; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Moreb JS, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-87; Pizzimenti S, 2002, FREE RADICAL BIO MED, V32, P233, DOI 10.1016/S0891-5849(01)00798-5; Pizzimenti S, 1999, FREE RADICAL BIO MED, V26, P1578, DOI 10.1016/S0891-5849(99)00022-2; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Quash G, 2002, BIOCHEM PHARMACOL, V64, P1279, DOI 10.1016/S0006-2952(02)01294-7; Quash G, 2008, EUR J MED CHEM, V43, P906, DOI 10.1016/j.ejmech.2007.06.004; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Roch AM, 1996, BIOCHEM J, V313, P973, DOI 10.1042/bj3130973; Rodriguez-Torres M, 2016, CLIN EXP METASTAS, V33, P97, DOI 10.1007/s10585-015-9755-9; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sovic A, 2001, ANTICANCER RES, V21, P1997; SUMMERFIELD FW, 1984, CHEM-BIOL INTERACT, V50, P87, DOI 10.1016/0009-2797(84)90134-0; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Townsend AJ, 2001, CHEM-BIOL INTERACT, V130, P261, DOI 10.1016/S0009-2797(00)00270-2; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Venza M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/481782; Wittgen HGM, 2007, MELANOMA RES, V17, P400, DOI 10.1097/CMR.0b013e3282f1d312; Wonisch W, 1998, FREE RADICAL BIO MED, V25, P682, DOI 10.1016/S0891-5849(98)00110-5; YOSHIDA A, 1992, ENZYME, V46, P239, DOI 10.1159/000468794; Yue LL, 2015, MELANOMA RES, V25, P138, DOI 10.1097/CMR.0000000000000144	57	30	32	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5695	5708		10.1038/onc.2017.160	http://dx.doi.org/10.1038/onc.2017.160			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28581514				2022-12-26	WOS:000412843900004
J	Fattahi, F; Kalbitz, M; Malan, EA; Abe, E; Jajou, L; Huber-Lang, MS; Bosmann, M; Russell, MW; Zetoune, FS; Ward, PA				Fattahi, Fatemeh; Kalbitz, Miriam; Malan, Elizabeth A.; Abe, Elizabeth; Jajou, Lawrence; Huber-Lang, Markus S.; Bosmann, Markus; Russell, Mark W.; Zetoune, Firas S.; Ward, Peter A.			Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction	FASEB JOURNAL			English	Article						CLP; cardiomyocyte; C5a receptor	MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; PROTEIN-KINASE; EXTRACELLULAR HISTONES; NLRP3 INFLAMMASOME; SEPTIC SHOCK; C5A; HEART; CARDIOPROTECTION; LOCALIZATION; INHIBITION	Polymicrobial sepsis in mice causes myocardial dysfunction after generation of the complement anaphylatoxin, complement component 5a (C5a). C5a interacts with its receptors on cardiomyocytes (CMs), resulting in redox imbalance and cardiac dysfunction that can be functionally measured and quantitated using Doppler echocardiography. In this report we have evaluated activation of MAPKs and Akt in CMs exposed to C5a in vitro and after cecal ligation and puncture (CLP) in vivo. In both cases, C5a in vitro caused activation (phosphorylation) of MAPKs and Akt in CMs, which required availability of both C5a receptors. Using immunofluorescence technology, activation of MAPKs and Akt occurred in left ventricular (LV) CMs, requiring both C5a receptors, C5aR1 and -2. Use of a water-soluble p38 inhibitor curtailed activation in vivo of MAPKs and Akt in LVCMs as well as the appearance of cytokines and histones in plasma from CLP mice. When mouse macrophages were exposed in vitro to LPS, activation of MAPKs and Akt also occurred. The copresence of the p38 inhibitor blocked these activation responses. Finally, the presence of the p38 inhibitor in CLP mice reduced the development of cardiac dysfunction. These data suggest that polymicrobial sepsis causes cardiac dysfunction that appears to be linked to activation of MAPKs and Akt in heart.	[Fattahi, Fatemeh; Malan, Elizabeth A.; Abe, Elizabeth; Jajou, Lawrence; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB I,Box 5602, Ann Arbor, MI 48109 USA; [Russell, Mark W.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Kalbitz, Miriam; Huber-Lang, Markus S.] Univ Hosp Ulm, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Ulm, Germany; [Bosmann, Markus] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulm University; Johannes Gutenberg University of Mainz	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB I,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Bosmann, Markus/0000-0003-2773-1033	U.S. National Institutes of Health (NIH) National Cancer Institute; O'Brien Renal Center; UM Medical School; Endowment for the Basic Sciences (EBS); UM Department of Cell and Developmental Biology; NIH [GM-29507, GM-61656]; Deutsche Forschungsgemeinschaft [KA 3740, BO 3482/3-1]; Federal Ministry of Education and Research [01EO1003, HU823/302]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); O'Brien Renal Center; UM Medical School; Endowment for the Basic Sciences (EBS); UM Department of Cell and Developmental Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the Microscopy and Image Analysis Laboratory (MIL), University of Michigan (UM) Medical School, a multiuser imaging facility supported by a grant from the U.S. National Institutes of Health (NIH) National Cancer Institute; the O'Brien Renal Center, the UM Medical School, the Endowment for the Basic Sciences (EBS), and the UM Department of Cell and Developmental Biology; Kimber Converso-Baran, research sonographer and echocardiographic specialist, for excellent services provided; and Sue Scott, Melissa Rennells, and Michelle Possley (all from UM) for excellent assistance in the preparation of the manuscript. This study was supported by NIH, General Medicine Grants GM-29507 and GM-61656 (to P.A.W.), the Deutsche Forschungsgemeinschaft Fellowship Project KA 3740 (to M.K.); Deutsche Forschungsgemeinschaft Grant BO 3482/3-1 (to M.B.), Federal Ministry of Education and Research Grant 01EO1003 (to M.B.) and HU823/302 (to M.S.H.-L.). F.F. and M.K. are cofirst authors. The authors declare no conflicts of interest.	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S; Behr TM, 2001, CIRCULATION, V104, P1292, DOI 10.1161/hc3601.094275; Bell JR, 2008, CLIN EXP PHARMACOL P, V35, P126, DOI 10.1111/j.1440-1681.2007.04794.x; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Cain BS, 1999, CRIT CARE MED, V27, P1309, DOI 10.1097/00003246-199907000-00018; Cattin ME, 2013, CURR OPIN CARDIOL, V28, P297, DOI 10.1097/HCO.0b013e32835f0c79; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Chen YP, 2017, EUR J PHARMACOL, V796, P90, DOI 10.1016/j.ejphar.2016.11.053; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; Court NW, 2002, J MOL CELL CARDIOL, V34, P413, DOI 10.1006/jmcc.2001.1523; Du JF, 2016, AM J PHYSIOL-CELL PH, V310, pC270, DOI 10.1152/ajpcell.00194.2015; Fattahi F, 2017, J INNATE IMMUN, V9, P300, DOI 10.1159/000452951; Fattahi F, 2017, MOL IMMUNOL, V84, P57, DOI 10.1016/j.molimm.2016.11.012; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Haudek SB, 2001, AM J PHYSIOL-HEART C, V280, pH962, DOI 10.1152/ajpheart.2001.280.3.H962; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hsu WC, 2014, CELL SIGNAL, V26, P1409, DOI 10.1016/j.cellsig.2014.02.021; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang MS, 2001, FASEB J, V15, P568; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kalbitz M, 2016, FASEB J, V30, P3997, DOI 10.1096/fj.201600728R; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Kato K, 2003, AM J PHYSIOL-HEART C, V285, pH1506, DOI 10.1152/ajpheart.00270.2003; Klintman D, 2005, ANN SURG, V242, P830, DOI 10.1097/01.sla.0000189132.86878.f7; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lim NR, 2013, BIOCHEM J, V456, P149, DOI 10.1042/BJ20121538; Liu XR, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/7013032; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Pinsetta FR, 2014, J BIOMOL STRUCT DYN, V32, P1047, DOI 10.1080/07391102.2013.803441; Riedemann NC, 2003, FASEB J, V17, P370, DOI 10.1096/fj.03-0708fje; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Romero-Bermejo FJ, 2011, CURR CARDIOL REV, V7, P163, DOI 10.2174/157340311798220494; Rubinfeld H, 1999, J BIOL CHEM, V274, P30349, DOI 10.1074/jbc.274.43.30349; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Song LN, 2014, APOPTOSIS, V19, P567, DOI 10.1007/s10495-013-0946-z; Sun LL, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0420-2; Toledo-Pereyra LH, 2004, J INVEST SURG, V17, P303, DOI 10.1080/08941930490884706; Trunzer K, 2013, J CLIN ONCOL, V31, P1767, DOI 10.1200/JCO.2012.44.7888; Ward PA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/427607; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Zetoune FS, 2007, FASEB J, V21, pA1150; ZHENG CF, 1994, J BIOL CHEM, V269, P19947	58	35	37	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4129	4139		10.1096/fj.201700140R	http://dx.doi.org/10.1096/fj.201700140R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572445	Green Published, Green Submitted			2022-12-26	WOS:000408713300035
J	Xu, ER; Blythe, EE; Fischer, G; Hyvonen, M				Xu, Emma-Ruoqi; Blythe, Emily E.; Fischer, Gerhard; Hyvoenen, Marko			Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); collagen; crystal structure; extracellular matrix protein; protein-protein interaction; signaling; CCN proteins; vWC domain	MODULATES BMP; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR REGULATION; AMINO PROPEPTIDE; IIA PROCOLLAGEN; FAMILY; GROWTH; CHORDIN; TISSUE; EXPRESSION	Bone morphogenetic proteins (BMPs) are secreted growth factors that promote differentiation processes in embryogenesis and tissue development. Regulation of BMP signaling involves binding to a variety of extracellular proteins, among which are many von Willebrand factor C (vWC) domain-containing proteins. Although the crystal structure of the complex of crossveinless-2 (CV-2) vWC1 and BMP-2 previously revealed one mode of the vWC/BMP-binding mechanism, other vWC domains may bind to BMP differently. Here, using X-ray crystallography, we present for the first time structures of the vWC domains of two proteins thought to interact with BMP-2: collagen IIA and matricellular protein CCN3. We found that these two vWC domains share a similar N-terminal fold that differs greatly from that in CV-2 vWC, which comprises its BMP-2-binding site. We analyzed the ability of these vWC domains to directly bind to BMP-2 and detected an interaction only between the collagen IIa vWC and BMP-2. Guided by the collagen IIa vWC domain crystal structure and conservation of surface residues among orthologous domains, we mapped the BMP-binding epitope on the subdomain 1 of the vWC domain. This binding site is different from that previously observed in the complex between CV-2 vWC and BMP-2, revealing an alternative mode of interaction between vWC domains and BMPs.	[Xu, Emma-Ruoqi; Blythe, Emily E.; Fischer, Gerhard; Hyvoenen, Marko] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Xu, Emma-Ruoqi] DESY, EMBL, Notkestr 85, D-22607 Hamburg, Germany; [Blythe, Emily E.] CALTECH, 1200 E Calif Blvd,MC 114-96, Pasadena, CA 91125 USA	University of Cambridge; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); California Institute of Technology	Hyvonen, M (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	mh256@cam.ac.uk	Fischer, Gerhard/B-2900-2011; Hyvonen, Marko/A-1501-2015	Fischer, Gerhard/0000-0001-9861-1528; Hyvonen, Marko/0000-0001-8683-4070; Xu, Emma-Ruoqi/0000-0001-7300-3868; Blythe, Emily/0000-0001-6363-2644	Cambridge Overseas Trust; China Scholarship Council	Cambridge Overseas Trust; China Scholarship Council(China Scholarship Council)	This work was supported by Cambridge Overseas Trust and China Scholarship Council through a postgraduate scholarship (to E.-R.X.). The authors declare that they have no conflicts of interest with the contents of this article.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G., 2016, BUSTER VERSION 2 11; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chang CC, 2014, WORLD J GASTROENTERO, V20, P6826, DOI 10.3748/wjg.v20.i22.6826; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui L, 2014, TUMOR BIOL, V35, P3195, DOI 10.1007/s13277-013-1418-3; El Kader TA, 2013, J CELL COMMUN SIGNAL, V7, P11, DOI 10.1007/s12079-012-0180-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiebig JE, 2013, MOLECULES, V18, P11658, DOI 10.3390/molecules181011658; Fujisawa T, 2009, BIOCHEM BIOPH RES CO, V385, P215, DOI 10.1016/j.bbrc.2009.05.041; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Janune D, 2011, FEBS LETT, V585, P3033, DOI 10.1016/j.febslet.2011.08.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Kisonaite M, 2016, BIOCHEM J, V473, P1593, DOI 10.1042/BCJ20160254; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larrain J, 2000, DEVELOPMENT, V127, P821; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; Manson SR, 2015, J UROLOGY, V193, P1860, DOI 10.1016/j.juro.2014.10.117; McCallum L, 2006, BLOOD, V108, P1716, DOI 10.1182/blood-2006-04-016113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Moura J, 2013, ARCH DERMATOL RES, V305, P557, DOI 10.1007/s00403-013-1381-2; Nakamura Y, 2007, J CLIN INVEST, V117, P3075, DOI 10.1172/JCI32001; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nolan K, 2016, CELL REP, V16, P2077, DOI 10.1016/j.celrep.2016.07.046; Nolan K, 2013, STRUCTURE, V21, P1417, DOI 10.1016/j.str.2013.06.005; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Oganesian A, 1997, J HISTOCHEM CYTOCHEM, V45, P1469, DOI 10.1177/002215549704501104; Ohgawara T, 2011, J CELL COMMUN SIGNAL, V5, P291, DOI 10.1007/s12079-011-0133-3; Ono M, 2011, J BONE MINER RES, V26, P193, DOI 10.1002/jbmr.205; Ouellet V, 2012, J CELL COMMUN SIGNAL, V6, P73, DOI 10.1007/s12079-012-0161-7; Pal A, 2012, CANCER RES, V72, P4818, DOI 10.1158/0008-5472.CAN-12-0154; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Reddi AH, 2003, ANN RHEUM DIS, V62, P73; RYAN MC, 1990, J BIOL CHEM, V265, P10334; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; SANDELL LJ, 1994, DEV DYNAM, V199, P129, DOI 10.1002/aja.1001990206; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simic P, 2005, CYTOKINE GROWTH F R, V16, P299, DOI 10.1016/j.cytogfr.2005.02.010; Tobin JF, 2006, DRUG DISCOV TODAY, V11, P405, DOI 10.1016/j.drudis.2006.03.016; Troilo H, 2014, P NATL ACAD SCI USA, V111, P13063, DOI 10.1073/pnas.1404166111; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	66	18	18	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12516	12527		10.1074/jbc.M117.788992	http://dx.doi.org/10.1074/jbc.M117.788992			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584056	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000406636900016
J	Sun, Y; Chen, C; Gao, J; Abbas, MN; Kausar, S; Qian, C; Wang, L; Wei, GQ; Zhu, BJ; Liu, CL				Sun, Yu; Chen, Chen; Gao, Jin; Abbas, Muhammad Nadeem; Kausar, Saima; Qian, Cen; Wang, Lei; Wei, Guoqing; Zhu, Bao-Jian; Liu, Chao-Liang			Comparative mitochondrial genome analysis of Daphnis nerii and other lepidopteran insects reveals conserved mitochondrial genome organization and phylogenetic relationships	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; COMPLETE MITOGENOME; SILKWORM MOTH; EVOLUTION; VARIABILITY; GEOMETRIDAE; SPHINGIDAE; SILKMOTH; PROGRAM	In the present study, the complete sequence of the mitochondrial genome (mitogenome) of Daphnis nerii (Lepidoptera: Sphingidae) is described. The mitogenome (15,247 bp) of D. nerii encodes13 protein-coding genes (PCGs), 22 transfer RNA genes (tRNAs), two ribosomal RNA genes (rRNAs) and an adenine (A) + thymine (T)-rich region. Its gene complement and order is similar to that of other sequenced lepidopterans. The 12 PCGs initiated by ATN codons except for cytochrome c oxidase subunit 1 (cox1) gene that is seemingly initiated by the CGA codon as documented in other insect mitogenomes. Four of the 13 PCGs have the incomplete termination codon T, while the remainder terminated with the canonical stop codon. This mitogenome has six major intergenic spacers, with the exception of A+T-rich region, spanning at least 10 bp. The A+T-rich region is 351 bp long, and contains some conserved regions, including 'ATAGA' motif followed by a 17 bp poly-T stretch, a microsatellite-like element (AT)(9) and also a poly-A element. Phylogenetic analyses based on 13 PCGs using maximum likelihood (ML) and Bayesian inference (BI) revealed that D. nerii resides in the Sphingidae family.	[Sun, Yu; Chen, Chen; Gao, Jin; Abbas, Muhammad Nadeem; Kausar, Saima; Qian, Cen; Wang, Lei; Wei, Guoqing; Zhu, Bao-Jian; Liu, Chao-Liang] Anhui Agr Univ, Coll Life Sci, Hefei, Peoples R China	Anhui Agricultural University	Zhu, BJ; Liu, CL (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei, Peoples R China.	zhubaojian@ahau.edu.cn; clliu@ahau.edu.cn	Zhu, Baojian/ABG-4522-2021		modern Argoindustry Technology Research System [CARS-22 SYZ10]; Biology Key Subjects of Anhui Province; National Natural Science Foundation of China [31301715, 31472147, 31402018]; Sericulture Biotechnology Innovation Team [2013xkdt-05]; Biochemistry and Molecular Biology [xk2013042]; Graduate Student Innovation Fund of Anhui Agricultural University [2015-34]	modern Argoindustry Technology Research System; Biology Key Subjects of Anhui Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sericulture Biotechnology Innovation Team; Biochemistry and Molecular Biology; Graduate Student Innovation Fund of Anhui Agricultural University	The modern Argoindustry Technology Research System (CARS-22 SYZ10), the Biology Key Subjects of Anhui Province, the National Natural Science Foundation of China (31301715), the Sericulture Biotechnology Innovation Team (2013xkdt-05), the National Natural Science Foundation of China (31472147), the Ph.D. Programs in Biochemistry and Molecular Biology (xk2013042), the National Natural Science Foundation of China (31402018), and the Graduate Student Innovation Fund of Anhui Agricultural University (2015-34).	Babbucci M, 2014, GENOME BIOL EVOL, V6, P3326, DOI 10.1093/gbe/evu265; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chen S, 2015, MINER PETROL, V109, P577, DOI 10.1007/s00710-015-0383-5; Dai LS, 2016, MITOCHONDRIAL DNA A, V27, P1512, DOI 10.3109/19401736.2014.953116; Dai LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132951; Dong Y, 2016, MITOCHONDRIAL DNA A, V27, P403, DOI 10.3109/19401736.2014.898278; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; He SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129355; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; Kim MJ, 2013, MITOCHONDR DNA, V24, P622, DOI 10.3109/19401736.2013.772155; Kim SR, 2009, MOL BIOL REP, V36, P1871, DOI 10.1007/s11033-008-9393-2; Lee ES, 2006, GENE, V373, P52, DOI 10.1016/j.gene.2006.01.003; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; Li WW, 2011, DNA CELL BIOL, V30, P3, DOI 10.1089/dna.2010.1058; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu QN, 2013, GENOMICS, V101, P64, DOI 10.1016/j.ygeno.2012.10.002; Liu QN, 2012, GENE, V505, P291, DOI 10.1016/j.gene.2012.06.003; Liu SX, 2014, GENE, V547, P136, DOI 10.1016/j.gene.2014.06.044; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu Cheng, 2002, Journal of Agricultural Biotechnology, V10, P163; Lu HF, 2013, PLOS ONE, V8; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; Lutz-Bonengel S, 2004, INT J LEGAL MED, V118, P274, DOI 10.1007/s00414-004-0457-0; Moore Aubrey, 2008, Proceedings of the Hawaiian Entomological Society, V40, P67; Park JS, 2016, MITOCHONDRIAL DNA A, V27, P2093, DOI 10.3109/19401736.2014.982572; Park JS, 2014, MITOCHONDR DNA, V25, P275, DOI 10.3109/19401736.2013.800504; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wei SJ, 2013, DNA CELL BIOL, V32, P173, DOI 10.1089/dna.2012.1942; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu LW, 2010, ENTOMOL NEWS, V121, P267; Wu QL, 2015, MITOCHONDR DNA, V26, P139, DOI 10.3109/19401736.2013.815175; Wu QL, 2013, MITOCHONDR DNA, V24, P214, DOI 10.3109/19401736.2012.748044; Wu YP, 2012, DNA CELL BIOL, V31, P1508, DOI 10.1089/dna.2012.1642; Wu YP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7201; Xu Y, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005185; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031; Yi JQ, 2016, MITOCHONDRIAL DNA A, V27, P109, DOI 10.3109/19401736.2013.873926; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zhu BJ, 2013, GENE, V527, P283, DOI 10.1016/j.gene.2013.06.035	52	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178773	10.1371/journal.pone.0178773	http://dx.doi.org/10.1371/journal.pone.0178773			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598968	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000009
J	Nakade, Y; Sakamoto, K; Yamauchi, T; Inoue, T; Kobayashi, Y; Yamamoto, T; Ishii, N; Ohashi, T; Sumida, Y; Ito, K; Nakao, H; Fukuzawa, Y; Umezawa, K; Yoneda, M				Nakade, Yukiomi; Sakamoto, Kazumasa; Yamauchi, Taeko; Inoue, Tadahisa; Kobayashi, Yuji; Yamamoto, Takaya; Ishii, Norimitsu; Ohashi, Tomohiko; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Umezawa, Kazuo; Yoneda, Masashi			Conophylline inhibits non-alcoholic steatohepatitis in mice	PLOS ONE			English	Article							CHOLINE-DEFICIENT DIET; PEROXISOMAL BETA-OXIDATION; FATTY LIVER-DISEASE; METABOLIC SYNDROME; HEPATIC STEATOSIS; ADIPOSE-TISSUE; STELLATE CELLS; KUPFFER CELLS; DB/DB MICE; RAT-LIVER	Conophylline (CnP), a vinca alkaloid extracted from the leaves of the tropical plant Ervatamia microphylla, attenuates hepatic fibrosis in mice. However, little is known about whether CnP inhibits steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis (NASH) in mice. A methionine-choline-deficient (MCD) diet was administered to male db/db mice as a NASH model, and CnP (1 mu g/kg/d) was co-administered. Eight weeks after the commencement of the MCD diet, hepatic steatosis, inflammation, and fibrosis, and hepatic fat metabolism-, inflammation-, and fibrosis-related markers were examined. Feeding on an MCD for 8 weeks induced hepatic steatosis, inflammation, and fibrosis. CnP significantly attenuated the MCD-induced increases in hepatic steatosis, as well as hepatic inflammation and fibrosis. The MCD diet increased hepatic transforming growth factor-beta (TGF-beta) mRNA levels, which are correlated with hepatic steatosis, inflammation, and fibrosis. The diet also attenuated acyl-coenzyme A oxidase 1 (ACOX1) and carnitine palmitoyltransferase 1 (CPT1) mRNA levels, which are involved in beta-oxidation. The putative mechanism of the CnP effect involves reduced hepatic TGF-beta mRNA levels, and increased mRNA levels of hepatic peroxisome proliferator-activated receptor (PPAR) a and its target genes ACOX1 and CPT1. The results of this study indicate that CnP inhibits steatohepatitis, possibly through the inhibition of hepatic TGF-beta mRNA levels, and induces an increase in PPAR alpha mRNA levels, resulting in the attenuation of hepatic steatosis, inflammation, and fibrosis in mice. CnP might accordingly be a suitable therapeutic option for NASH.	[Nakade, Yukiomi; Sakamoto, Kazumasa; Yamauchi, Taeko; Inoue, Tadahisa; Kobayashi, Yuji; Yamamoto, Takaya; Ishii, Norimitsu; Ohashi, Tomohiko; Sumida, Yoshio; Ito, Kiyoaki; Nakao, Haruhisa; Fukuzawa, Yoshitaka; Yoneda, Masashi] Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan; [Umezawa, Kazuo] Aichi Med Univ, Dept Mol Target Med Screening, Nagakute, Aichi, Japan	Aichi Medical University; Aichi Medical University	Nakade, Y (corresponding author), Aichi Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Nagakute, Aichi, Japan.	ynakade@aichi-med-u.ac.jp	Sumida, Yoshio/AAL-6723-2020; Inoue, Tadahisa/AFK-7576-2022	Inoue, Tadahisa/0000-0003-0718-9099	Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) [2011-2015 (S1101027)]	Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT)	This work was supported in part by the Program for the Strategic Research Foundation at Private Universities 2011-2015 (S1101027) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) (http://www. mext.go.jp/a_menu/koutou/shinkou/07021403/ 002/002/1218299.htm).	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Almeda-Valdes P, 2009, ANN HEPATOL, V8, pS18, DOI 10.1016/S1665-2681(19)31822-8; Atsumi S, 2003, CELL MOL LIFE SCI, V60, P2516, DOI 10.1007/s00018-003-3299-x; BARTER PJ, 1973, METABOLISM, V22, P779, DOI 10.1016/0026-0495(73)90048-6; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; BRANDES R, 1990, BIOCHIM BIOPHYS ACTA, V1034, P53, DOI 10.1016/0304-4165(90)90152-M; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Fox ES, 1997, J IMMUNOL, V158, P5418; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; Fujita K, 2009, HEPATOLOGY, V50, P772, DOI 10.1002/hep.23094; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Jha P, 2014, BBA-MOL BASIS DIS, V1842, P959, DOI 10.1016/j.bbadis.2014.02.012; Kawaguchi K, 2004, BIOCHEM BIOPH RES CO, V315, P187, DOI 10.1016/J.BBRC.2004.01.038; Kubo N, 2014, LIVER INT, V34, P1057, DOI 10.1111/liv.12328; Kudo H, 2009, LIVER INT, V29, P988, DOI 10.1111/j.1478-3231.2009.02006.x; Kuroda M, 2013, FEBS LETT, V587, P3656, DOI 10.1016/j.febslet.2013.09.017; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Luo YW, 2016, AM J PHYSIOL-ENDOC M, V310, pE418, DOI 10.1152/ajpendo.00319.2015; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Mukai K, 2016, J IMMUNOL, V196, P395, DOI 10.4049/jimmunol.1402709; Nagasawa T, 2006, EUR J PHARMACOL, V536, P182, DOI 10.1016/j.ejphar.2006.02.028; Namikawa C, 2004, J HEPATOL, V40, P781, DOI 10.1016/j.jhep.2004.01.028; Ogata T, 2004, DIABETES, V53, P2596, DOI 10.2337/diabetes.53.10.2596; Okada Y, 2013, LIVER INT, V33, P301, DOI 10.1111/liv.12033; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; Rao MS, 2001, SEMIN LIVER DIS, V21, P43, DOI 10.1055/s-2001-12928; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Saito R, 2012, ENDOCRINOLOGY, V153, P621, DOI 10.1210/en.2011-1767; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; Tanaka N, 2014, BBA-MOL CELL BIOL L, V1841, P1596, DOI 10.1016/j.bbalip.2014.08.015; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; UMEZAWA K, 1994, ANTICANCER RES, V14, P2413; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698	41	15	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178436	10.1371/journal.pone.0178436	http://dx.doi.org/10.1371/journal.pone.0178436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594915	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200032
J	Szczurek, P; Mosiichuk, N; Wolinski, J; Yatsenko, T; Grujic, D; Lozinska, L; Pieszka, M; Swiech, E; Pierzynowski, SG; Goncharova, K				Szczurek, Paulina; Mosiichuk, Nadia; Wolinski, Jaroslaw; Yatsenko, Tetiana; Grujic, Danica; Lozinska, Liudmyla; Pieszka, Marek; Swiech, Ewa; Pierzynowski, Stefan Grzegorz; Goncharova, Kateryna			Oral uricase eliminates blood uric acid in the hyperuricemic pig model	PLOS ONE			English	Article							DISEASE; URATE; GOUT; NEPHROPATHY; TRANSPORTER; MECHANISM; EXCRETION; OXIDASE; ABCG2; RAT	An elevated level of serum uric acid-hyperuricemia, is strongly associated with the development of gout and chronic kidney disease (CKD) which is often accompanied by a significantly reduced glomerular filtration rate (GFR). In the present study, we investigated the extra-renal elimination of uric acid via the intestine in a healthy pig model and the effect of oral uricase therapy on plasma uric acid concentrations in pigs with induced hyperuricemia and CKD. The experiment was conducted on eleven, ten-week-old pigs (n = 11). The porcine model of CKD was developed by performing 9/10 nephrectomy surgery on eight pigs. A stable model of hyperuricemia was established in only five of the eight nephrectomized pigs by frequent injections of uric acid (UA) into the jugular vein. All pigs (three healthy pigs and five CKD pigs) were operated for implantation of jugular vein catheters and the three healthy pigs also had portal vein catheters inserted. Blood uric acid concentrations were measured spectrophotometrically, using the Uric Acid Assay Kit (BioAssay Systems, Hayward, USA). The piglets with CKD received orally administered uricase (treatment) and served as their own controls (without uricase supplementation). Oral uricase therapy significantly decreased plasma uric acid concentrations in pigs with CKD, whereas hyperuricemia was observed in the pigs whilst not being treated with uricase. Urinary uric acid excretion was similar during both the treatment and control periods during the first 8 h and 24 h after UA infusions in the CKD pigs. To demonstrate the elimination of UA via the intestine, the healthy pigs were infused with UA into the jugular vein. The blood collected from the jugular vein represents circulating UA concentrations and the blood collected from the portal vein represents the concentration of UA leaving the intestine. The final (after 2 h) concentration of UA was significantly lower in blood collected from the portal vein compared to that collected from the jugular vein (3.34 vs. 2.43 mg/dL, respectively, p = 0.024). The latter allows us to suggest that UA is eliminated from the blood via the gut tissue.	[Szczurek, Paulina; Mosiichuk, Nadia; Yatsenko, Tetiana; Lozinska, Liudmyla; Pierzynowski, Stefan Grzegorz; Goncharova, Kateryna] Lund Univ, Dept Biol, Lund, Sweden; [Szczurek, Paulina; Pieszka, Marek] Natl Res Inst Anim Prod, Dept Anim Nutr & Feed Sci, Balice, Poland; [Mosiichuk, Nadia; Lozinska, Liudmyla] Vasyl Stefanyk Precarpathian Natl Univ, Dept Biochem & Biotechnol, Ivano Frankivsk, Ukraine; [Wolinski, Jaroslaw] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Endocrinol, Jablonna, Poland; [Grujic, Danica] Allena Pharmaceut, Newton, MA USA; [Swiech, Ewa] Polish Acad Sci, Kielanowski Inst Anim Physiol & Nutr, Dept Monogastr Nutr, Jablonna, Poland; [Pierzynowski, Stefan Grzegorz; Goncharova, Kateryna] Anara AB, Malmo, Sweden; [Pierzynowski, Stefan Grzegorz] Inst Rural Hlth, Lublin, Poland	Lund University; National Research Institute of Animal Production; Ministry of Education & Science of Ukraine; Vasyl Stefanyk Precarpathian National University; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Polish Academy of Sciences; Kielanowski Institute of Animal Physiology & Nutrition of the Polish Academy of Sciences; Institute of Rural Health in Lublin, Poland	Pierzynowski, SG; Goncharova, K (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.; Pierzynowski, SG; Goncharova, K (corresponding author), Anara AB, Malmo, Sweden.; Pierzynowski, SG (corresponding author), Inst Rural Hlth, Lublin, Poland.	Stefan.Pierzynowski@biol.lu.se; katerina.goncharova@biol.lu.se	Pierzynowski, Stefan Grzegorz/AAU-6107-2021; Woliński, Jarosław/AAH-3109-2021; Szczurek, Paulina/AAH-2474-2019; Yatsenko, Tetiana A./ABB-1853-2021	Pierzynowski, Stefan Grzegorz/0000-0002-0308-3214; Woliński, Jarosław/0000-0001-8645-1045; Yatsenko, Tetiana A./0000-0001-8601-1939; Mosiichuk, Nadiia/0000-0002-5362-1164; Szczurek, Paulina/0000-0001-9008-3505; Swiech, Ewa/0000-0002-8752-1161	Allena Pharmaceuticals, Inc., Newton, USA; Anara AB, Malmo, Sweden	Allena Pharmaceuticals, Inc., Newton, USA; Anara AB, Malmo, Sweden	The present study was supported by Allena Pharmaceuticals, Inc., Newton, USA and Anara AB, Malmo, Sweden. The funders provided support in the form of salaries for authors DG, as well as SGP and KG, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dziechciaz M, 2013, ANN AGR ENV MED, P35; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Garay RP, 2012, JOINT BONE SPINE, V79, P237, DOI 10.1016/j.jbspin.2012.01.004; Garg JP, 2005, ARTHRITIS RHEUM-US, V52, P290, DOI 10.1002/art.20781; Grassi D, 2013, CURR PHARM DESIGN, V19, P2432, DOI 10.2174/1381612811319130011; Gustafsson D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-164; HATCH M, 1994, CLIN SCI, V86, P511, DOI 10.1042/cs0860511; Hosomi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030456; Hyndman D, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0587-7; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Johnson RJ, 2011, SEMIN NEPHROL, V31, P394, DOI 10.1016/j.semnephrol.2011.08.002; Johnson RJ, 2013, NEPHROL DIAL TRANSPL; Koguchi T., 2004, Current topics in biotechnology, Volume 1, P1; Mandel NS, 2004, J UROLOGY, V171, P1301, DOI 10.1097/01.ju.0000110101.41653.bb; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; OGRYZLO METRO A., 1965, ARTHRITIS RHEUM, V8, P799, DOI 10.1002/art.1780080443; Prasad Sah Om Shankar, 2015, Nephrourol Mon, V7, pe27233, DOI 10.5812/numonthly.7(3)2015.27233; Pui Ching-Hon, 2002, Expert Opin Pharmacother, V3, P433, DOI 10.1517/14656566.3.4.433; Roddy E, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-13; Smith EUR, 2010, BEST PRACT RES CL RH, V24, P811, DOI 10.1016/j.berh.2010.10.004; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; SORENSEN LEIF B., 1965, ARTHRITIS RHEUM, V8, P694, DOI 10.1002/art.1780080429; STAVRIC B, 1969, P SOC EXP BIOL MED, V130, P512; Swieboda P, 2013, ANN AGR ENV MED, P2; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Tan QY, 2012, INT J NANOMED, V7, P3929, DOI 10.2147/IJN.S33835; Trifilio S, 2006, BONE MARROW TRANSPL, V37, P997, DOI 10.1038/sj.bmt.1705379; Wellek S, 2012, DTSCH ARZTEBL INT, V109, P276, DOI 10.3238/arztebl.2012.0276; Whelton A, 2010, AM J THER, V17, P402, DOI 10.1097/MJT.0b013e3181df8ad2; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Yang HC, 2010, TODAY DIS MODELS, V7, P13; Yano H, 2014, CLIN EXP NEPHROL, V18, P50, DOI 10.1007/s10157-013-0806-8	33	20	22	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179195	10.1371/journal.pone.0179195	http://dx.doi.org/10.1371/journal.pone.0179195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594873	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200099
J	Zhang, PP; Ma, G; Wang, CY; Lu, HF; Li, SS; Xie, YX; Ma, DY; Zhu, YJ; Guo, TC				Zhang, Panpan; Ma, Geng; Wang, Chenyang; Lu, Hongfang; Li, Shasha; Xie, Yingxin; Ma, Dongyun; Zhu, Yunji; Guo, Tiancai			Effect of irrigation and nitrogen application on grain amino acid composition and protein quality in winter wheat	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; WATER-USE EFFICIENCY; BREAD WHEAT; AGRONOMIC CHARACTERISTICS; YIELD; MANAGEMENT; FERTILIZATION; ACCUMULATION; TILLAGE; REMOBILIZATION	Water management and nitrogen application are critical factors in wheat grain yield and protein quality. This study aimed to evaluate the effect of irrigation and nitrogen application on the grain yield, protein content and amino acid composition of winter wheat. Field experiments were conducted in a split-plot design with three replications in high-yielding land on the North China Plain in 2012/2013, 2013/2014 and 2014/2015. Three irrigation treatments were examined in main plots: no irrigation, irrigation at jointing, and irrigation at jointing plus anthesis, while subplots were assigned to nitrogen treatment at four different rates: 0, 180, 240, 300 kg N ha(-1), respectively. The results indicated that irrigation at jointing and at jointing plus anthesis improved grain yield by an average of 12.79 and 18.65% across three cropping seasons, respectively, compared with no irrigation. However, different irrigation treatments had no significant effect on grain protein content in any cropping season. Compared with no N treatment, 180, 240, and 300 kg N ha(-1) N application significantly increased grain yield, by 58.66, 61.26 and 63.42% respectively, averaged over three cropping seasons. Grain protein and the total, essential and non-essential amino acid content significantly increased with increasing nitrogen application. Irrigation significantly improved the essential amino acid index (EAAI) and protein-digestibility-corrected amino acid score (PDCAAS) compared with no irrigation; however, N application decreased them by an average of 7.68 and 11.18% across three cropping seasons, respectively. EAAI and PDCAAS were positively correlated, however, they were highly negatively correlated with yield and grain protein content.	[Zhang, Panpan; Ma, Geng; Wang, Chenyang; Lu, Hongfang; Li, Shasha; Xie, Yingxin; Ma, Dongyun; Zhu, Yunji; Guo, Tiancai] Henan Agr Univ, Agron Coll, Zhengzhou, Henan, Peoples R China; [Wang, Chenyang; Lu, Hongfang; Xie, Yingxin; Ma, Dongyun; Zhu, Yunji; Guo, Tiancai] Henan Agr Univ, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Wang, CY (corresponding author), Henan Agr Univ, Agron Coll, Zhengzhou, Henan, Peoples R China.; Wang, CY (corresponding author), Henan Agr Univ, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China.	xmzxwang@163.com			National Key Technology Support Program of China [2015BAD26B01, 2013BAD07B07]	National Key Technology Support Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology Support Program of China (2015BAD26B01 and 2013BAD07B07).	Anderson WK, 2010, FIELD CROP RES, V116, P14, DOI 10.1016/j.fcr.2009.11.016; Bandyopadhyay KK, 2010, IRRIGATION SCI, V28, P285, DOI 10.1007/s00271-009-0190-z; BYERS M, 1979, J SCI FOOD AGR, V30, P251, DOI 10.1002/jsfa.2740300308; Chen CC, 2011, AGRON J, V103, P786, DOI 10.2134/agronj2010.0424; Conesa DP, 2002, ARCH LATINOAM NUTR, V52, P193; Coventry DR, 2011, FIELD CROP RES, V123, P80, DOI 10.1016/j.fcr.2011.05.004; Dai ZM, 2016, PLANT SOIL ENVIRON, V62, P53, DOI 10.17221/728/2015-PSE; Ercoli L, 2013, EUR J AGRON, V44, P38, DOI 10.1016/j.eja.2012.08.005; FAO/WHO Expert Consultation, 1991, FAO WHO EXP CONS, P5; Fuertes-Mendizabal T, 2013, J SCI FOOD AGR, V93, P2162, DOI 10.1002/jsfa.6022; Gao Y, 2014, FIELD CROP RES, V167, P19, DOI 10.1016/j.fcr.2014.07.003; Geesing D, 2014, J PLANT NUTR SOIL SC, V177, P509, DOI 10.1002/jpln.201300215; Grahmann K, 2014, FIELD CROP RES, V164, P166, DOI 10.1016/j.fcr.2014.05.002; Gursoy S, 2010, FIELD CROP RES, V119, P260, DOI 10.1016/j.fcr.2010.07.016; Howarth JR, 2008, J EXP BOT, V59, P3675, DOI 10.1093/jxb/ern218; Jalilian J, 2012, FIELD CROP RES, V127, P26, DOI 10.1016/j.fcr.2011.11.001; Jia DY, 2012, CROP SCI, V52, P1816, DOI 10.2135/cropsci2011.08.0444; Jood S, 1995, PLANT FOOD HUM NUTR, V48, P159, DOI 10.1007/BF01088312; Konvalina P, 2011, J FOOD AGRIC ENVIRON, V9, P193; Kooch Y, 2017, CATENA, V150, P223, DOI 10.1016/j.catena.2016.11.023; Li P, 2011, AGRON J, V103, P1619, DOI 10.2134/agronj2011.0013; Makowski D, 2014, AGRON SUSTAIN DEV, V34, P293, DOI 10.1007/s13593-013-0179-0; Marino S, 2011, EUR J AGRON, V34, P172, DOI 10.1016/j.eja.2010.10.006; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Massoudifar O, 2014, ARCH AGRON SOIL SCI, V60, P925, DOI 10.1080/03650340.2013.856004; Michaelsen KF, 2009, FOOD NUTR BULL, V30, pS343, DOI 10.1177/15648265090303S303; Millward DJ, 2012, BRIT J NUTR, V108, pS31, DOI 10.1017/S0007114512002462; Nakano H, 2009, PLANT PROD SCI, V12, P109, DOI 10.1626/pps.12.109; Penas E, 2013, POL J FOOD NUTR SCI, V63, P5, DOI 10.2478/v10222-012-0067-3; Pleijel H, 1999, AGR ECOSYST ENVIRON, V72, P265, DOI 10.1016/S0167-8809(98)00185-6; Qiu GY, 2008, AGR FOREST METEOROL, V148, P1848, DOI 10.1016/j.agrformet.2008.06.010; Rajala A, 2009, FIELD CROP RES, V114, P263, DOI 10.1016/j.fcr.2009.08.007; Ram H, 2013, AGR WATER MANAGE, V128, P92, DOI 10.1016/j.agwat.2013.06.011; Rezaei M, 2010, J FOOD AGRIC ENVIRON, V8, P535; Rodriguez-Felix F, 2014, PAK J BOT, V46, P221; Schaafsma G, 2012, BRIT J NUTR, V108, pS333, DOI 10.1017/S0007114512002541; Sepaskhah AR, 2008, PLANT PROD SCI, V11, P250, DOI 10.1626/pps.11.250; Shao YH, 2016, EUR J AGRON, V81, P37, DOI 10.1016/j.eja.2016.08.014; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shi RL, 2010, J CEREAL SCI, V51, P165, DOI 10.1016/j.jcs.2009.11.008; Sissons M, 2014, CROP PASTURE SCI, V65, P411, DOI 10.1071/CP13431; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x; Tome D, 2012, BRIT J NUTR, V108, pS222, DOI 10.1017/S0007114512002565; Tosti G, 2010, EUR J AGRON, V33, P157, DOI 10.1016/j.eja.2010.05.001; Wan YF, 2014, ANN BOT-LONDON, V113, P607, DOI 10.1093/aob/mct291; Wang ChenYang, 2004, Acta Agronomica Sinica, V30, P1031; Wang YZ, 2013, FIELD CROP RES, V144, P236, DOI 10.1016/j.fcr.2013.01.021; Waraich EA, 2010, J PLANT NUTR, V33, P640, DOI 10.1080/01904160903575881; WHO, 2007, WHO TECH REP SER, V935, P1; Wu XR, 2003, PLANT BIOTECHNOL J, V1, P187, DOI 10.1046/j.1467-7652.2003.00017.x; Xu ZZ, 2013, J SCI FOOD AGR, V93, P2339, DOI 10.1002/jsfa.6098; Zeleke KT, 2016, AGR WATER MANAGE, V166, P139, DOI 10.1016/j.agwat.2015.12.016; [张林生 Zhang Linsheng], 2002, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V22, P646; Zhang MW, 2016, CROP SCI, V56, P1277, DOI 10.2135/cropsci2015.08.0504; Zhang M, 2014, J PROTEOME RES, V13, P4281, DOI 10.1021/pr500400t; Zhang Y. D., 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1155/2016/1317232	56	43	44	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e01784940	10.1371/journal.pone.0178494	http://dx.doi.org/10.1371/journal.pone.0178494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594830	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200035
J	Henderson, J; Redshaw, M				Henderson, Jane; Redshaw, Maggie			Parents' experience of perinatal post-mortem following stillbirth: A mixed methods study	PLOS ONE			English	Article							CONSENT PROCESS; MATERNITY CARE; AUTOPSY RATES; ATTITUDES; VIEWS; WOMEN	Objectives To analyse quantitative and qualitative data, to describe the experience of parents in relation to post-mortem following stillbirth, looking at offer and uptake of post-mortem, information-giving, the type of post-mortem carried out, receiving the results and any sociodemographic differences in care practices in relation to post-mortem. Design Secondary analysis of a postal survey which included both open and closed questions allowing for a mixed methods study design. Population Random sample of women who experienced a stillbirth in 2013. Methods A sample of women who experienced a stillbirth in 2013 were selected by staff at the Office for National Statistics and sent a letter and information leaflet about the study followed by a postal questionnaire. The questionnaire included questions about pregnancy, labour and birth, the postnatal period, the time at which the baby died, and also asked about the postmortem process. Results Completed questionnaires were received from 477 women. Overall, 95% of women were asked for consent to a post-mortem, almost half prior to birth, and half by a consultant. The majority of women received written information and felt sufficiently informed, and agreed to a full post-mortem. A third of women had to wait longer than 12 weeks for the post-mortem result and this was the most common theme in the free text comments. Women also commented on the manner of being asked for consent, and wrote about issues related to communication and support. There were significant differences between sociodemographic groups in many of these factors. Conclusions The inconsistencies in offer and consent to post-mortem following stillbirth suggest inequality in this area. The amount of time that many parents have to wait for post-mortem results is unacceptable and should be prioritised for improvement.	[Henderson, Jane; Redshaw, Maggie] Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England	University of Oxford	Redshaw, M (corresponding author), Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England.	maggie.redshaw@npeu.ox.ac.uk			Policy Research Programme in the Department of Health; Policy Research Programme at the UK Department of Health funds a programme of work at the NPEU	Policy Research Programme in the Department of Health; Policy Research Programme at the UK Department of Health funds a programme of work at the NPEU	The Policy Research Programme at the UK Department of Health funds a programme of work (2011-2017) at the NPEU, of which the research described was a part. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breeze ACG, 2012, BIRTH-ISS PERINAT C, V39, P57, DOI 10.1111/j.1523-536X.2011.00513.x; Chichester Melanie, 2005, AWHONN Lifelines, V9, P312, DOI 10.1177/1091592305280875; Desilets V, 2011, J OBSTET GYNAECOL CA, V33, P1047, DOI 10.1016/S1701-2163(16)35055-1; Golafshani N., 2003, QUAL REP, V8, P597; Heazell AEP, 2012, BJOG-INT J OBSTET GY, V119, P987, DOI 10.1111/j.1471-0528.2012.03357.x; Henderson J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-196; Holste C, 2011, ACTA OBSTET GYN SCAN, V90, P1287, DOI 10.1111/j.1600-0412.2011.01202.x; Horey D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009932.pub2; Jones F, 2016, ARCH DIS CHILD FETAL; Khong TY, 2006, J PAEDIATR CHILD H, V42, P366, DOI 10.1111/j.1440-1754.2006.00874.x; Khong TY, 1997, BIRTH-ISS PERINAT C, V24, P55, DOI 10.1111/j.1523-536X.1997.tb00337.x; Lewis Judith A, 2003, MCN Am J Matern Child Nurs, V28, P306, DOI 10.1097/00005721-200309000-00008; Lindquist A, 2015, BJOG-INT J OBSTET GY, V122, P1610, DOI 10.1111/1471-0528.13059; Manktelow BN, 2016, MBRRACE UK PERINATAL; Manning DJ, 2000, J MED ETHICS, V26, P249, DOI 10.1136/jme.26.4.249; Meaney S, 2015, HEALTH EXPECT, V18, P3160, DOI 10.1111/hex.12305; NHS England, 2013, 2013 14 NHS STAND CO; O'Connell O, 2016, WOMEN BIRTH; Rankin J, 2002, BRIT MED J, V324, P816, DOI 10.1136/bmj.324.7341.816; Redshaw M., 2010, DELIVERED CARE NATL; Redshaw M., 2015, SAFELY DELIVERED NAT; Redshaw M, 2014, LISTENING PARENTS ST; Tsitsikas DA, 2011, J CLIN PATHOL, V64, P412, DOI 10.1136/jcp.2010.086645	23	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178475	10.1371/journal.pone.0178475	http://dx.doi.org/10.1371/journal.pone.0178475			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586361	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700014
J	Nadugala, MN; Jeewandara, C; Malavige, GN; Premaratne, PH; Goonasekara, CL				Nadugala, Mahesha N.; Jeewandara, Chandima; Malavige, Gathsaurie N.; Premaratne, Prasad H.; Goonasekara, Charitha L.			Natural antibody responses to the capsid protein in sera of Dengue infected patients from Sri Lanka	PLOS ONE			English	Article							VIRUS; IDENTIFICATION	This study aims to characterize the antigenicity of the Capsid (C) protein and the human antibody responses to C protein from the four dengue virus (DENV) serotypes. Parker hydrophilicity prediction, Emini surface accessibility prediction and Karplus & Schulz flexibility predictions were used to bioinformatically characterize antigenicity. The human antibody response to C protein was assessed by ELISA using immune sera and an array of overlapping DENV2 C peptides. DENV2 C protein peptides P1 (located on C protein at 2-18 a.a), P11 (79-95 a.a) and P12 (86-101 a.a) were recognized by most individuals exposed to infections with only one of the 4 DENV serotypes as well as people exposed to infections with two serotypes. These conserved peptide epitopes are located on the amino (1-40 a.a) and carboxy (70-100 a.a) terminal regions of C protein, which were predicted to be antigenic using different bioinformatic tools. DENV2 C peptide P6 (39-56 a.a) was recognized by all individuals exposed to DENV2 infections, some individuals exposed to DENV4 infections and none of the individuals exposed to DENV1 or 3 infections. Thus, unlike C peptides P1, P11 and P12, which contain epitopes, recognized by DENV serotype cross-reactive antibodies, DENV2 peptide P6 contains an epitope that is preferentially recognized by antibodies in people exposed to this serotype compared to other serotypes. We discuss our results in the context of the known structure of C protein and recent work on the human B-cell response to DENV infection.	[Nadugala, Mahesha N.; Premaratne, Prasad H.; Goonasekara, Charitha L.] Gen Sir John Kotelawala Def Univ, Fac Med, Ratmalana, Sri Lanka; [Jeewandara, Chandima; Malavige, Gathsaurie N.] Univ Sri Jayawardanapura, Ctr Dengue Res, Gangodawila, Sri Lanka	General Sir John Kotelawala Defence University; University Sri Jayewardenepura	Premaratne, PH; Goonasekara, CL (corresponding author), Gen Sir John Kotelawala Def Univ, Fac Med, Ratmalana, Sri Lanka.	prasadpremaratne@yahoo.com; charithalg@kdu.ac.lk	Premaratne, Prasad/AAO-1937-2021; Malavige, Gathsaurie Neelika/J-5483-2015		National Science Foundation of Sri Lanka [RG/2014/BT/03]	National Science Foundation of Sri Lanka	This research was financially supported by the National Science Foundation of Sri Lanka (Grant No. RG/2014/BT/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of National Science Foundation http://www.nsf.ac.lk/. PI of the research project is Dr Charitha Goonasekara.	AnandaRao R, 2005, VIRUS RES, V112, P60, DOI 10.1016/j.virusres.2005.03.022; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Honda ER, 2012, J VIROL METHODS, V186, P55, DOI 10.1016/j.jviromet.2012.08.006; Jeewandara C, 2015, PLOS NEGL TROP DIS, V9; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Malavige GN, 2012, CLIN EXP IMMUNOL, V168, P215, DOI 10.1111/j.1365-2249.2012.04566.x; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nadugala Mahesha N., 2016, Advances in Bioinformatics, V2016, P1373157, DOI 10.1155/2016/1373157; Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Puttikhunt C, 2009, ARCH VIROL, V154, P1211, DOI 10.1007/s00705-009-0426-5; Vazquez Y, 2009, MABS, P157; WHO, 2016, IMM VACC BIOL; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990	18	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178009	10.1371/journal.pone.0178009	http://dx.doi.org/10.1371/journal.pone.0178009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582388	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600008
J	Pozo, RA; Coulson, T; McCulloch, G; Stronza, AL; Songhurst, AC				Pozo, Rocio A.; Coulson, Tim; McCulloch, Graham; Stronza, Amanda L.; Songhurst, Anna C.			Determining baselines for human-elephant conflict: A matter of time	PLOS ONE			English	Article							AFRICAN ELEPHANTS; CONSERVATION; WILDLIFE; MANAGEMENT	Elephant crop raiding is one of the most relevant forms of human-elephant conflict (HEC) in Africa. Northern Botswana holds the largest population of African elephants in the world, and in the eastern Okavango Panhandle, 16,000 people share and compete for resources with more than 11,000 elephants. Hence, it is not surprising this area represents a HEC 'hot-spot' in the region. Crop-raiding impacts lead to negative perceptions of elephants by local communities, which can strongly undermine conservation efforts. Therefore, assessing trends in conflict levels is essential to developing successful management strategies. In this context, we investigated the trend in the number of reported raiding incidents as one of the indicators of the level of HEC, and assessed its relationship to trends in human and elephant population size, as well as land-use in the study area. For each of these factors, we considered data spanning historical (since the 1970s) and contemporary (2008-2015) time frames, with the aim of comparing subsequent inferences on the drivers of crop raiding and predictions for the future. We find that the level of reported crop raiding by elephants in the eastern Panhandle appears to have decreased since 2008, which seems to be related to the reduction in agricultural land allocated to people in recent years, more than with human and elephant population size. We show that inferences regarding the drivers of HEC and predictions for the future are dependent on the time span of the data used. Although our study represents a first step in developing a HEC baseline in the eastern Panhandle, it highlights the need for additional multi-scale analyses that consider progress in conservation conflict to better understand and predict drivers of HEC in the region.	[Pozo, Rocio A.; Coulson, Tim; McCulloch, Graham; Songhurst, Anna C.] Univ Oxford, Dept Zool, Oxford, England; [Pozo, Rocio A.; McCulloch, Graham; Stronza, Amanda L.; Songhurst, Anna C.] Ecoexist Project, Maun, Botswana; [Stronza, Amanda L.] Texas A&M Univ, Appl Biodivers Sci Program, College Stn, TX USA	University of Oxford; Texas A&M University System; Texas A&M University College Station	Pozo, RA (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Pozo, RA (corresponding author), Ecoexist Project, Maun, Botswana.	rocio.pozo@zoo.ox.ac.uk	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003	Ecoexist Project Fellowship (Botswana); National Commission for Scientific and Technological Research's International Doctorate program (Chile); Kellogg College; Department of Zoology, University of Oxford (United Kingdom)	Ecoexist Project Fellowship (Botswana); National Commission for Scientific and Technological Research's International Doctorate program (Chile); Kellogg College; Department of Zoology, University of Oxford (United Kingdom)	This project was funded by grants from the Ecoexist Project Fellowship (Botswana), and the National Commission for Scientific and Technological Research's International Doctorate program (Chile). In addition, financial support was granted by Kellogg College as well as the Department of Zoology, University of Oxford (United Kingdom). All grants were awarded to RAP. The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Akaike H, 1973, B N PETR P 2 INT S I, P267; Alagona P.S., 2012, ENV PHILOS, V9, P49, DOI 10.5840/envirophil2012914; Barnes RFW, 1995, PACHYDERM, V19, P33; Blanc JJ, 2007, OCCASIONAL PAPER SER, P33; Bull JW, 2014, CONSERV BIOL, V28, P799, DOI 10.1111/cobi.12243; Chase MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2354; CSO, 2011, GOV BOTSW; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; DWNP, 2013, ORYX; DWNP, 2010, ART COMP; Galanti V, 2006, MAMM BIOL, V71, P99, DOI 10.1016/j.mambio.2005.10.001; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Hillman-Smith A. K. K, 1995, PACHYDERM, V19, P39; Hoare R, 2000, ORYX, V34, P34, DOI 10.1017/S0030605300030878; Hoare R. E., 1999, DATA COLLECTION PROT; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; Hoare RE, 1999, J APPL ECOL, V36, P689, DOI 10.1046/j.1365-2664.1999.00437.x; IUCN, 1999, TRAIN PACK EN EL DAM; JOLLY G M, 1969, East African Agricultural and Forestry Journal, V34, P46; Lahm S., 1996, PACHYDERM, V21, P69; Lee P. C., 2006, International Zoo Yearbook, V40, P9, DOI 10.1111/j.1748-1090.2006.00009.x; Lukasik Victoria M., 2011, Human Dimensions of Wildlife, V16, P114, DOI 10.1080/10871209.2011.544014; McDonald-Madden E, 2009, SCIENCE, V323, P43, DOI 10.1126/science.1164342; Mosojane S, 2004, THESIS; Naughton-Treves L, 1998, CONSERV BIOL, V12, P156, DOI 10.1046/j.1523-1739.1998.96346.x; Naughton-Treves Lisa, 2001, P369; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nyhus P.J., 2003, CONSERV PRACT, V4, P37, DOI DOI 10.1111/J.1526-4629.2003.TB00061.X; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Osborn FV, 2005, CONSERV BIOL SER, V9, P72; PARRY D, 1992, ENVIRON CONSERV, V19, P245, DOI 10.1017/S0376892900031040; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; R Core Team, 2014, R FDN STAT COMP; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Roodt V, 1998, LAHM SHELL FIELD G 1; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Songhurst A, 2015, ORYX, V49, P1; Songhurst A, 2015, WETL ECOL MANAG, p[23, 1]; Songhurst A., 2012, THESIS; Songhurst A, 2014, ECOL EVOL, V4, P582, DOI 10.1002/ece3.837; Stem C, 2005, CONSERV BIOL, V19, P295, DOI 10.1111/j.1523-1739.2005.00594.x; STRUM SC, 1994, REV ECOL-TERRE VIE, V49, P295; SUKUMAR R, 1991, BIOL CONSERV, V55, P93, DOI 10.1016/0006-3207(91)90007-V; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; van Aarde RJ, 2007, BIOL CONSERV, V134, P289, DOI 10.1016/j.biocon.2006.08.027; Von Gerhardt K, 2014, ORYX, V48, P436, DOI 10.1017/S003060531200138X	49	24	25	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178840	10.1371/journal.pone.0178840	http://dx.doi.org/10.1371/journal.pone.0178840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582425	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600046
J	Ustero, PA; Kay, AW; Ngo, K; Golin, R; Tsabedze, B; Mzileni, B; Glickman, J; Xaba, MW; Mavimbela, G; Mandalakas, AM				Ustero, Piluca Alonzo; Kay, Alexander W.; Ngo, Katherine; Golin, Rachel; Tsabedze, Bhekisisa; Mzileni, Bulisile; Glickman, Jessica; Xaba, Mildred Wisile; Mavimbela, Gcinile; Mandalakas, Anna Maria			School and household tuberculosis contact investigations in Swaziland: Active TB case finding in a high HIV/TB burden setting	PLOS ONE			English	Article							CHILD CONTACTS; TRANSMISSION; INFECTION; ADOLESCENTS	Background Investigation of household contacts exposed to infectious tuberculosis (TB) is widely recommended by international guidelines to identify secondary cases of TB and limit spread. There is little data to guide the use of contact investigations outside of the household, despite strong evidence that most TB infections occur outside of the home in TB high burden settings. In older adolescents, the majority of infections are estimated to occur in school. Therefore, as part of a project to increase active case finding in Swaziland, we performed school contact investigations following the identification of a student with infectious TB. Methods The Butimba Project identified 7 adolescent TB index cases (age 10-20) with microbiologically confirmed disease attending 6 different schools between June 2014 and March 2015. In addition to household contact investigations, Butimba Project staff worked with the Swaziland School Health Programme (SHP) to perform school contact investigations. At 6 school TB screening events, between May and October 2015, selected students underwent voluntary TB screening and those with positive symptom screens provided sputum for TB testing. Results Among 2015 student contacts tested, 177 (9%) screened positive for TB symptoms, 132 (75%) produced a sputum sample, of which zero tested positive for TB. Household contact investigations of the same index cases yielded 40 contacts; 24 (60%) screened positive for symptoms; 19 produced a sputum sample, of which one case was confirmed positive for TB. The odds ratio of developing TB following household vs. school contact exposure was significantly lower (OR 0.0, 95% CI 0.0 to 0.18, P = 0.02) after exposure in school. Conclusion School-based contact investigations require further research to establish best practices in TB high burden settings. In this case, a symptom-based screening approach did not identify additional cases of tuberculosis. In comparison, household contact investigations yielded a higher percentage of contacts with positive TB screens and an additional tuberculosis case.	[Ustero, Piluca Alonzo; Kay, Alexander W.; Ngo, Katherine; Golin, Rachel; Tsabedze, Bhekisisa; Mzileni, Bulisile; Glickman, Jessica; Mandalakas, Anna Maria] Texas Childrens Hosp, Baylor Coll Med, Global TB Program, Sect Global & Immigrant Hlth,Dept Pediat, Houston, TX 77030 USA; [Tsabedze, Bhekisisa; Mzileni, Bulisile] Childrens Fdn Swaziland, Baylor Coll Med, Mbabane, Swaziland; [Xaba, Mildred Wisile] Swaziland Natl Sch Hlth Program, Mbabane, Swaziland; [Mavimbela, Gcinile] Swaziland Natl TB Control Program, Mbabane, Swaziland	Baylor College of Medicine; Baylor College of Medicine	Mandalakas, AM (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Global TB Program, Sect Global & Immigrant Hlth,Dept Pediat, Houston, TX 77030 USA.	anna.mandalakas@bcm.edu			TB REACH Initiative (Global Affairs Canada); Baylor College of Medicine's Children's Foundation Swaziland; Stop TB Partnership; Global Affairs Canada	TB REACH Initiative (Global Affairs Canada); Baylor College of Medicine's Children's Foundation Swaziland; Stop TB Partnership; Global Affairs Canada(CGIAR)	This project was supported by the TB REACH Initiative of the Stop TB Partnership (through a grant from Global Affairs Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The primary grant recipient was the Baylor College of Medicine's Children's Foundation Swaziland (Program Director PAU). Mott MacDonald was contracted by the Stop TB Partnership to provide independent monitoring and evaluation of TB REACH projects. It contributed professional services and opinion independently of the funder (principally Global Affairs Canada), Stop TB Partnership and the grantee.	Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; [Anonymous], 2016, 2015 SWAZILAND ANN N, P1; [Anonymous], 2012, SWAZILAND NATL GUIDE, P1; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Hill PC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001105; Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645; Mahomed H, 2013, TUBERCULOSIS, V93, P357, DOI 10.1016/j.tube.2013.02.007; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933; Mandalakas AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169769; Middelkoop K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-221; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; National Tuberculosis Controllers Association, 2005, MMWR RECOMM REP, P54; Picco P., 2017, PEDIATR INFECT DIS J, P1; Roberts JR, 2012, PEDIATR INFECT DIS J, V31, P82, DOI 10.1097/INF.0b013e31823378c9; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Steppacher A, 2014, PEDIATR INFECT DIS J, V33, P325, DOI 10.1097/INF.0000000000000091; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; WHO, 2016, END TB STRAT GLOB ST; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2013, SYST SCREEN ACT TUB	23	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178873	10.1371/journal.pone.0178873	http://dx.doi.org/10.1371/journal.pone.0178873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582435	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600048
J	Rasnitsyn, A; Doucette, L; Seifi, M; Footz, T; Raymond, V; Walter, MA				Rasnitsyn, Alexandra; Doucette, Lance; Seifi, Morteza; Footz, Tim; Raymond, Vincent; Walter, Michael A.			FOXC1 modulates MYOC secretion through regulation of the exocytic proteins RAB3GAP1, RAB3GAP2 and SNAP25	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; AXENFELD-RIEGER-SYNDROME; ANTERIOR SEGMENT DYSGENESIS; TRANSCRIPTION FACTOR GENE; OPEN-ANGLE GLAUCOMA; MOLECULAR-GENETICS; MUTATIONS; ENDOCYTOSIS; SNAP-25; STRESS	The neurodegenerative disease glaucoma is one of the leading causes of blindness in the world. Glaucoma is characterized by progressive visual field loss caused by retinal ganglion cell (RGC) death. Both surgical glaucoma treatments and medications are available, however, they only halt glaucoma progression and are unable to reverse damage. Furthermore, many patients do not respond well to treatments. It is therefore important to better understand the mechanisms involved in glaucoma pathogenesis. Patients with Axenfeld-Rieger syndrome (ARS) offer important insight into glaucoma progression. ARS patients are at 50% risk of developing early onset glaucoma and respond poorly to treatments, even when surgical treatments are combined with medications. Mutations in the transcription factor FOXC1 cause ARS. Alterations in FOXC1 levels cause ocular malformations and disrupt stress response in ocular tissues, thereby contributing to glaucoma progression. In this study, using biochemical and molecular techniques, we show that FOXC1 regulates the expression of RAB3GAP1, RAB3GAP2 and SNAP25, three genes with central roles in both exocytosis and endocytosis, responsible for extracellular trafficking. FOXC1 positively regulates RAB3GAP1 and RAB3GAP2, while either increase or decrease in FOXC1 levels beyond its normal range results in decreased SNAP25. In addition, we found that FOXC1 regulation of RAB3GAP1, RAB3GAP2 and SNAP25 affects secretion of Myocilin (MYOC), a protein associated with juvenile onset glaucoma and steroid-induced glaucoma. The present work reveals that FOXC1 is an important regulator of exocytosis and establishes a new link between FOXC1 and MYOC-associated glaucoma.	[Rasnitsyn, Alexandra; Doucette, Lance; Seifi, Morteza; Footz, Tim; Walter, Michael A.] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; [Raymond, Vincent] CHU Laval, Quebec City, PQ, Canada	University of Alberta; Laval University	Walter, MA (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.	mwalter@ualberta.ca	Doucette, Lance P./I-9794-2019	Doucette, Lance P./0000-0002-8495-9723	Canadian Institutes of Health Research [G118160216]; Alberta Innovates [201500029] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/); Grant no. G118160216, to M.A.W.; The authors also would like to thank May Yu for technical assistance and the members of the Walter Laboratory for critical reading of the manuscript and for helpful comments. This work was supported by the Canadian Institute for Health Research (M.A. Walter, [grant number G118160216]).	Aldinger KA, 2009, NAT GENET, V41, P1037, DOI 10.1038/ng.422; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Alward WLM, 2000, AM J OPHTHALMOL, V130, P107, DOI 10.1016/S0002-9394(00)00525-0; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2008, HUM MOL GENET, V17, P490, DOI 10.1093/hmg/ddm326; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; CAIRNS JE, 1968, AM J OPHTHALMOL, V66, P673, DOI 10.1016/0002-9394(68)91288-9; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Clabecq A, 2000, J BIOL CHEM, V275, P31786, DOI 10.1074/jbc.M003705200; Daniel B, 2014, FEBS LETT, V588, P2379, DOI 10.1016/j.febslet.2014.05.041; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Digiuni Maurizio, 2012, Expert Opin Pharmacother, V13, P723, DOI 10.1517/14656566.2012.662219; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2002, HUM MOL GENET, V11, P1185, DOI 10.1093/hmg/11.10.1185; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Heraud C, 2008, NEUROPEPTIDES, V42, P611, DOI 10.1016/j.npep.2008.05.005; Huang CC, 2011, TRAFFIC, V12, P1356, DOI 10.1111/j.1600-0854.2011.01237.x; Itakura T, 2015, MOL VIS, V21, P1071; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; Kaur K, 2005, CLIN GENET, V67, P335, DOI 10.1111/j.1399-0004.2005.00411.x; Khan AO, 2011, CURR OPIN OPHTHALMOL, V22, P347, DOI 10.1097/ICU.0b013e32834922d2; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Lehmann OJ, 2002, INVEST OPHTH VIS SCI, V43, P1843; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Luna C, 2009, INVEST OPHTH VIS SCI, V50, P5805, DOI 10.1167/iovs.09-3796; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Ohya T, 1998, J BIOL CHEM, V273, P613, DOI 10.1074/jbc.273.1.613; Okayama M, 2007, FEBS LETT, V581, P4583, DOI 10.1016/j.febslet.2007.08.046; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; PARTRIDGE CA, 1989, INVEST OPHTH VIS SCI, V30, P1843; PIERROU S, 1995, ANAL BIOCHEM, V229, P99, DOI 10.1006/abio.1995.1384; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Raymond V, 1997, AM J HUM GENET, V60, P272; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Spang N, 2014, AUTOPHAGY, V10, P2297, DOI 10.4161/15548627.2014.994359; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Taylor P., 2015, RES TREATMENT PRINTI, P37, DOI [10.1080/19443994.2014.891463, DOI 10.1080/10580530.2015.1018770, DOI 10.1080/19443994.2014.891463]; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Walter MA, 2003, INVEST OPHTH VIS SCI, V44, P1402, DOI 10.1167/iovs.02-0618; Xu JH, 2013, CELL REP, V3, P1414, DOI 10.1016/j.celrep.2013.03.010; Yang YZ, 2000, J BIOL CHEM, V275, P29482, DOI 10.1074/jbc.M003237200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	58	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178518	10.1371/journal.pone.0178518	http://dx.doi.org/10.1371/journal.pone.0178518			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575017	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300060
J	Rorabaugh, BR; Seeley, SL; Stoops, TS; D'Souza, MS				Rorabaugh, Boyd R.; Seeley, Sarah L.; Stoops, Thorne S.; D'Souza, Manoranjan S.			Repeated exposure to methamphetamine induces sex-dependent hypersensitivity to ischemic injury in the adult rat heart	PLOS ONE			English	Article							EPSILON GENE REPRESSION; PERMEABILITY TRANSITION PORE; MYOCARDIAL-INFARCTION; REPERFUSION INJURY; DOPAMINE TRANSPORTER; GENDER-DIFFERENCES; SUSCEPTIBILITY; PHARMACOKINETICS; CARDIOMYOCYTES; SENSITIVITY	Background We previously reported that adult female, but not male rats that were prenatally exposed to methamphetamine exhibit myocardial hypersensitivity to ischemic injury. However, it is unknown whether hypersensitivity to ischemic injury develops when rats are exposed to methamphetamine during adulthood. The goal of this study was to determine whether meth amphetamine exposure during adulthood sensitizes the heart to ischemic injury. Methods Adult male and female rats received daily injections of methamphetamine (5 mg/kg) or saline for 10 days. Their hearts were isolated on day 11 and subjected to a 20 min ischemic insult on a Langendorff isolated heart apparatus. Cardiac contractile function was measured by an intraventricular balloon, and infarct size was measured by triphenyltetrazolium chloride staining. Results Hearts from methamphetamine-treated females exhibited significantly larger infarcts and suppressed postischemic recovery of contractile function compared to hearts from saline treated females. In contrast, methamphetamine had no effect on infarct size or contractile recovery in male hearts. Subsequent experiments demonstrated that hypersensitivity to ischemic injury persisted in female hearts following a 1 month period of abstinence from methamphetamine. Myocardial protein kinase C-epsilon expression, Akt phosphorylation, and ERK phosphorylation were unaffected by adult exposure to methamphetamine. Conclusions Exposure of adult rats to methamphetamine sex-dependently increases the extent of myocardial injury following an ischemic insult. These data suggest that women who have a heart attack might be at risk of more extensive myocardial injury if they have a recent history of methamphetamine abuse.	[Rorabaugh, Boyd R.; Seeley, Sarah L.; Stoops, Thorne S.; D'Souza, Manoranjan S.] Ohio Northern Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, Ada, OH 45810 USA	Ohio Northern University	Rorabaugh, BR (corresponding author), Ohio Northern Univ, Dept Pharmaceut & Biomed Sci, Coll Pharm, Ada, OH 45810 USA.	b-rorabaugh@onu.edu	D'Souza, Manoranjan/AAT-8783-2020; Seeley, Sarah/AFV-6015-2022		Bower and Bennet Endowed Research Award from Ohio Northern University	Bower and Bennet Endowed Research Award from Ohio Northern University	This work was supported by a Bower and Bennet Endowed Research Award from Ohio Northern University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RM, 2007, CARDIOVASC RES, V73, P153, DOI 10.1016/j.cardiores.2006.10.013; Bosch PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139829; Brown DA, 2005, J PHYSIOL-LONDON, V564, P619, DOI 10.1113/jphysiol.2004.081323; Center for Behavioral Health Statistics and Quality, 2015, 2015 NAT SURV DRUG U; Chen Jack P, 2007, J Invasive Cardiol, V19, pE89; Chen M, 2011, DRUG DISCOV TODAY, V16, P1007, DOI 10.1016/j.drudis.2011.09.008; Chen R, 2016, TOXICOL APPL PHARM, V295, P1, DOI 10.1016/j.taap.2016.01.017; Clemens KJ, 2007, DRUG ALCOHOL DEPEN, V86, P183, DOI 10.1016/j.drugalcdep.2006.06.004; Cohen MV, 1999, AM J PHYSIOL-HEART C, V277, pH1754, DOI 10.1152/ajpheart.1999.277.5.H1754; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Farnsworth TL, 1997, AM J HEALTH-SYST PH, V54, P586, DOI 10.1093/ajhp/54.5.586; FURST SR, 1990, NEW ENGL J MED, V323, P1147; Giv MJ, 2017, CARDIOVASC TOXICOL, V17, P13, DOI 10.1007/s12012-016-9385-8; Haning W, 2007, ADDICTION, V102, P70, DOI 10.1111/j.1360-0443.2006.01776.x; Hausenloy DJ, 2005, AM J PHYSIOL-HEART C, V288, pH971, DOI 10.1152/ajpheart.00374.2004; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; Huang MC, 2016, J CLIN PSYCHIAT, V77, P1396, DOI 10.4088/JCP.15m09872; Janetsian SS, 2015, BEHAV PHARMACOL, V26, P786, DOI 10.1097/FBP.0000000000000158; Janetsian SS, 2015, PSYCHOPHARMACOLOGY, V232, P2083, DOI 10.1007/s00213-014-3840-7; Johnson MS, 2006, AM J PHYSIOL-HEART C, V290, pH2644, DOI 10.1152/ajpheart.01291.2005; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lawrence J, 2011, CARDIOVASC RES, V89, P89, DOI 10.1093/cvr/cvq270; Leung KP, 2014, MOL MED REP, V10, P2306, DOI 10.3892/mmr.2014.2572; Lochner A, 2003, BASIC RES CARDIOL, V98, P337, DOI 10.1007/s00395-003-0427-6; Lord KC, 2010, CARDIOVASC RES, V87, P111, DOI 10.1093/cvr/cvq043; Ma Y, 2009, BRIT J PHARMACOL, V157, P705, DOI 10.1111/j.1476-5381.2009.00212.x; Mashayekhi V, 2014, N-S ARCH PHARMACOL, V387, P47, DOI 10.1007/s00210-013-0919-3; McKetin R, 2006, DRUG ALCOHOL DEPEN, V85, P198, DOI 10.1016/j.drugalcdep.2006.04.007; Meyer K, 2009, J MOL CELL CARDIOL, V47, P504, DOI 10.1016/j.yjmcc.2009.06.004; Milerova M, 2016, MOL CELL BIOCHEM, V412, P147, DOI 10.1007/s11010-015-2619-4; Milesi-Halle A, 2005, TOXICOL APPL PHARM, V209, P203, DOI 10.1016/j.taap.2005.04.007; Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015; Morio KA, 2008, J AM DENT ASSOC, V139, P171, DOI 10.14219/jada.archive.2008.0133; Neeki MM, 2016, AM J CARDIOL, V118, P585, DOI 10.1016/j.amjcard.2016.05.057; North A, 2013, SYNAPSE, V67, P245, DOI 10.1002/syn.21635; Ohia-Nwoko O, 2017, BEHAV BRAIN RES, V327, P94, DOI 10.1016/j.bbr.2017.03.030; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Rambousek L, 2014, DRUG ALCOHOL DEPEN, V139, P138, DOI 10.1016/j.drugalcdep.2014.03.023; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Rorabaugh BR, 2017, J PHARMACOL EXP THER, V360, P409, DOI 10.1124/jpet.116.238345; Rorabaugh BR, 2016, AM J PHYSIOL-HEART C, V310, pH516, DOI 10.1152/ajpheart.00642.2015; Roth ME, 2004, PSYCHOPHARMACOLOGY, V172, P443, DOI 10.1007/s00213-003-1670-0; Ruda-Kucerova J, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00091; Schindler CW, 2002, EUR J PHARMACOL, V442, P231, DOI 10.1016/S0014-2999(02)01550-9; Schultz JE, 1998, AM J PHYSIOL-HEART C, V275, pH495, DOI 10.1152/ajpheart.1998.275.2.H495; Shao Q, 2016, AM J PHYSIOL-HEART C, V310, pH505, DOI 10.1152/ajpheart.00681.2015; Shen WW, 2014, J ADDICT MED, V8, P183, DOI 10.1097/ADM.0000000000000021; Sirova J, 2016, NEUROCHEM RES, V41, P1911, DOI 10.1007/s11064-016-1902-4; Slamberova R, 2007, DEV PSYCHOBIOL, V49, P312, DOI 10.1002/dev.20203; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Wang Y, 2010, CIRC J, V74, P634, DOI 10.1253/circj.CJ-09-0223; Watts DJ, 2006, AM J EMERG MED, V24, P132, DOI 10.1016/j.ajem.2005.08.005; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Zhang HT, 2009, BIOL REPROD, V80, P440, DOI 10.1095/biolreprod.108.072983; Zuloaga DG., 2016, METAB BRAIN DIS	56	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0179129	10.1371/journal.pone.0179129	http://dx.doi.org/10.1371/journal.pone.0179129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575091	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300148
J	Scheuerl, T; Stelzer, CP				Scheuerl, Thomas; Stelzer, Claus-Peter			Sex initiates adaptive evolution by recombination between beneficial loci	PLOS ONE			English	Article							DELETERIOUS MUTATIONS; MONOGONONT ROTIFERS; YEAST POPULATIONS; SPEEDS ADAPTATION; SELECTION; LINKAGE; REPRODUCTION; DIAPAUSE; DYNAMICS	Current theory proposes that sex can increase genetic variation and produce high fitness genotypes if genetic associations between alleles at different loci are non-random. In case beneficial and deleterious alleles at different loci are in linkage disequilibrium, sex may i) recombine beneficial alleles of different loci, ii) liberate beneficial alleles from genetic backgrounds of low fitness, or iii) recombine deleterious mutations for more effective elimination. In our study, we found that the first mechanism dominated the initial phase of adaptive evolution in Brachionus calyciflorus rotifers during a natural selection experiment. We used populations that had been locally adapted to two environments previously, creating a linkage disequilibrium between beneficial and deleterious alleles at different loci in a combined environment. We observed the highest fitness increase when several beneficial alleles of different loci could be recombined, while the other mechanisms were ineffective. Our study thus provides evidence for the hypothesis that sex can speed up adaptation by recombination between beneficial alleles of different loci, in particular during early stages of adaptive evolution in our system. We also suggest that the benefits of sex might change over time and state of adaptive progress.	[Scheuerl, Thomas; Stelzer, Claus-Peter] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Scheuerl, Thomas] Imperial Coll London, Silwood Pk Campus, London, England; [Scheuerl, Thomas] Univ Helsinki, Dept Food & Environm Sci Microbiol & Biotechnol, Helsinki, Finland	University of Innsbruck; Imperial College London; University of Helsinki	Scheuerl, T (corresponding author), Univ Innsbruck, Res Inst Limnol, Mondsee, Austria.; Scheuerl, T (corresponding author), Imperial Coll London, Silwood Pk Campus, London, England.; Scheuerl, T (corresponding author), Univ Helsinki, Dept Food & Environm Sci Microbiol & Biotechnol, Helsinki, Finland.	t.scheuerl@imperial.ac.uk	Stelzer, Claus-Peter/F-3789-2018; Scheuerl, Thomas/AAC-6358-2020	Stelzer, Claus-Peter/0000-0002-6682-0904; Scheuerl, Thomas/0000-0001-5216-5630	Austrian Science Funds (FWF) [P20735, P26256]	Austrian Science Funds (FWF)(Austrian Science Fund (FWF))	Financial support was provided by Austrian Science Funds (FWF) Grants: P20735 and P26256 to C.P.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 2009, COLD SH Q B, V74, P187, DOI 10.1101/sqb.2009.74.030; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Cutter AD, 2013, NAT REV GENET, V14, P262, DOI 10.1038/nrg3425; de Visser JAGM, 2007, NAT REV GENET, V8, P139, DOI 10.1038/nrg1985; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FELSENSTEIN J, 1965, GENETICS, V52, P349; Fisher RA, 1930, GENETICAL THEORY NAT; Freeman S, 2006, EVOLUTIONARY ANAL; Gray JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-43; Hartfield M, 2012, INTEGR ZOOL, V7, P192, DOI 10.1111/j.1749-4877.2012.00284.x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Logan M, 2020, BIOSTATISTICAL DESIG, DOI DOI 10.1002/9781444319620; McDonald MJ, 2016, NATURE, V531, P233, DOI 10.1038/nature17143; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; PECK JR, 1994, GENETICS, V137, P597; R Development Core Team, 2010, R PROJECT STAT COMPU; Rice WR, 2001, SCIENCE, V294, P555, DOI 10.1126/science.1061380; Scheuerl T, 2013, ECOL EVOL, V3, P4253, DOI 10.1002/ece3.781; Scheuerl T, 2011, J HERED, V102, P409, DOI 10.1093/jhered/esr036; Schroder T, 2005, HYDROBIOLOGIA, V546, P291, DOI 10.1007/s10750-005-4235-x; Schroder T, 2004, FUNCT ECOL, V18, P458, DOI 10.1111/j.0269-8463.2004.00854.x; SMITH JM, 1978, EVOLUTION SEX; Weismann A., 1889, ESSAYS HEREDITY KIND; Woods S., 2012, GAMS GCV AIC REMOL S; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312; Zuur Alain F., 2009, P1	37	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177895	10.1371/journal.pone.0177895	http://dx.doi.org/10.1371/journal.pone.0177895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575015	Green Published, gold			2022-12-26	WOS:000402624300020
J	Talaga, S; Leroy, C; Guidez, A; Dusfour, I; Girod, R; Dejean, A; Murienne, J				Talaga, Stanislas; Leroy, Celine; Guidez, Amandine; Dusfour, Isabelle; Girod, Romain; Dejean, Alain; Murienne, Jerome			DNA reference libraries of French Guianese mosquitoes for barcoding and metabarcoding	PLOS ONE			English	Article							DIPTERA-CULICIDAE; BIODIVERSITY ASSESSMENT; SUBGENUS PEYTONULUS; SABETHINI DIPTERA; SPECIES DIPTERA; TAXONOMY; IDENTIFICATION; ECUADOR; TOOL	The mosquito family (Diptera: Culicidae) constitutes the most medically important group of arthropods because certain species are vectors of human pathogens. In some parts of the world, the diversity is so high that the accurate delimitation and/or identification of species is challenging. A DNA-basedidentification system for all animals has been proposed, the socalled DNA barcoding approach. In this study, our objectives were (i) to establish DNA barcode libraries for the mosquitoes of French Guiana based on the COI and the 16S markers, (ii) to compare distance-based and tree-based methods of species delimitation to traditional taxonomy, and (iii) to evaluate the accuracy of each marker in identifying specimens. A total of 266 specimens belonging to 75 morphologically identified species or morphospecies were analyzed allowing us to delimit 86 DNA clusters with only 21 of them already present in the BOLD database. We thus provide a substantial contribution to the global mosquito barcoding initiative. Our results confirm that DNA barcodes can be successfully used to delimit and identify mosquito species with only a few cases where the marker could not distinguish closely related species. Our results also validate the presence of new species identified based on morphology, plus potential cases of cryptic species. We found that both COI and 16S markers performed very well, with successful identifications at the species level of up to 98% for COI and 97% for 16S when compared to traditional taxonomy. This shows great potential for the use of metabarcoding for vector monitoring and eco-epidemiological studies.	[Talaga, Stanislas; Guidez, Amandine; Dusfour, Isabelle; Girod, Romain] Unite Entomol Med, Inst Pasteur Guyane, Cayenne, France; [Talaga, Stanislas; Dejean, Alain] Univ Antilles, Univ Guyane, INRA, AgroParisTech,Cirad,CNRS,UMR EcoFoG, Kourou, France; [Leroy, Celine] IRD, UMR AMAP, Blvd Lironde, Montpellier, France; [Dejean, Alain] Univ Toulouse Paul Sabatier, CNRS, INP ENSAT, UMR Ecolab, Toulouse, France; [Murienne, Jerome] Univ Toulouse Paul Sabatier, CNRS, UMR EDB, ENFA, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS)	Talaga, S (corresponding author), Unite Entomol Med, Inst Pasteur Guyane, Cayenne, France.; Talaga, S (corresponding author), Univ Antilles, Univ Guyane, INRA, AgroParisTech,Cirad,CNRS,UMR EcoFoG, Kourou, France.	stantalaga@free.fr	Murienne, Jerome/J-9015-2019; Leroy, Celine/I-4857-2016	Murienne, Jerome/0000-0003-1474-7829; Talaga, Stanislas/0000-0003-1591-4115; Dusfour, Isabelle/0000-0002-5265-8432; Leroy, Celine/0000-0003-4859-8040; Amandine, Guidez/0000-0003-2821-6447	Investissement d'Avenir [CEBA: ANR-10-LABX-25-01, TULIP: ANR-10-LABX-41, ANR-11-IDEX-0002-02]; Universite Antilles-Guyane	Investissement d'Avenir(French National Research Agency (ANR)); Universite Antilles-Guyane	This study was funded by Investissement d'Avenir grants managed by the French Agence Nationale de la Recherche (CEBA: ANR-10-LABX-25-01; TULIP: ANR-10-LABX-41, ANR-11-IDEX-0002-02). ST was funded by a PhD fellowship from the Universite Antilles-Guyane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the Parc Amazonien de Guyane (PAG) and the Reserve Naturelle de La Trinite for logistical support during field studies, as well as all of the contributors who helped to collect samples (R. Carinci, O. Dezerald, M. Minot and H. Rodriguez). We also aknowledge Arthur Kocher for his help with the assignation statistics and Andrea Yockey-Dejean for proofreading the manuscript. This study was funded by Investissement d'Avenir grants managed by the French Agence Nationale de la Recherche (CEBA: ANR-10-LABX-25-01; TULIP: ANR-10-LABX-41, ANR-11-IDEX-0002-02). ST was funded by a PhD fellowship from the Universite Antilles-Guyane.	Arregui G, 2015, B MALARIOL SALUD AMB, V55, P132; Ashfaq M, 2016, PLOS ONE, V9; Azari-Hamidian S, 2010, J NAT HIST, V44, P913, DOI 10.1080/00222930903437358; Belkin J.N., 1962, MOSQUITOES S PACIFIC, V2; Belkin J.N., 1962, MOSQUITOES S PACIFIC, V1; Belkin JN., 1970, CONTRIB AM ENTOMOL I, V6, P1; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; BRAM R. A., 1967, Proceedings of the United States National Museum, V120, P1; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chan A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0569-4; Chippaux JP, 1983, FACTEURS BIOTIQUES I; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Dusfour I, 2012, MEM I OSWALDO CRUZ, V107, P429, DOI 10.1590/S0074-02762012000300021; Foley DH, 2008, ECOL ENTOMOL, V33, P12, DOI 10.1111/j.1365-2311.2007.00927.x; Foley DH, 2007, J MED ENTOMOL, V44, P554, DOI 10.1603/0022-2585(2007)44[554:IIGMBF]2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouque F, 2001, TROP MED INT HEALTH, V6, P76, DOI 10.1046/j.1365-3156.2001.00672.x; Gaffigan T., 1997, COLLECTING REARING M, P1; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Hall CR, 1999, MEM I OSWALDO CRUZ, V94, P329, DOI 10.1590/S0074-02761999000300009; HARBACH R E, 1991, Mosquito Systematics, V23, P1; Harbach RE, 2007, ZOOTAXA, P591; HARBACH RE, 1995, MEM I OSWALDO CRUZ, V90, P583, DOI 10.1590/S0074-02761995000500007; HARBACH RE, 1995, ENTOMOL SCAND, V26, P87; Harbach RE, 2002, P ENTOMOL SOC WASH, V104, P363; Harbach RE, 1998, CONTRIB AM ENTOMOL I, V24, P1; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kocher A, 2016, MOL ECOL RESOUR; Kumar NP, 2007, J MED ENTOMOL, V44, P1, DOI 10.1603/0022-2585(2007)44[1:DBCDSO]2.0.CO;2; Lane J., 1942, ARQ ZOOL ESTADO SAO PAULO, V3, P473; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Linton Yvonne-Marie, 2013, Mem Inst Oswaldo Cruz, V108 Suppl 1, P100, DOI 10.1590/0074-0276130440; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Motta MA, 2000, MEM I OSWALDO CRUZ, V95, P649, DOI 10.1590/S0074-02762000000500011; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rozo-Lopez P, 2015, ZOOKEYS, P39, DOI 10.3897/zookeys.513.9561; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Talaga S, 2016, EVOL ECOL, V30, P1133, DOI 10.1007/s10682-016-9862-3; Talaga S, 2015, ZOOKEYS, P107, DOI 10.3897/zookeys.532.6176; Talaga S, 2015, J MED ENTOMOL, V52, P770, DOI 10.1093/jme/tjv109; Tanaka Kazuo, 2003, Japanese Journal of Systematic Entomology, V9, P159; Torres-Gutierrez C, 2016, ACTA TROP, V164, P137, DOI 10.1016/j.actatropica.2016.09.007; Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780; Versteirt V, 2015, MOL ECOL RESOUR, V15, P449, DOI 10.1111/1755-0998.12318; Wang G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039700, 10.1371/journal.pone.0051764, 10.1371/journal.pone.0047051]; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; ZAVORTINK T J, 1979, Contributions of the American Entomological Institute, V17, P1; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	60	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0176993	10.1371/journal.pone.0176993	http://dx.doi.org/10.1371/journal.pone.0176993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575090	Green Published, gold			2022-12-26	WOS:000402624300010
J	Ahlbrecht, CA; Ruellas, ACD; Paniagua, B; Schilling, JA; McNamara, JA; Cevidanes, LHS				Ahlbrecht, Carly A.; de Oliveira Ruellas, Antonio Carlos; Paniagua, Beatriz; Schilling, Juan A.; McNamara, James A., Jr.; Cevidanes, Lucia Helena Soares			Three-dimensional characterization of root morphology for maxillary incisors	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ORTHODONTIC TREATMENT; CONE-BEAM; STRESS-DISTRIBUTION; RISK-FACTORS; RESORPTION; TEETH; RADIOGRAPHY; RELIABILITY; RESOLUTION	The aim of this study was to test the reproducibility of three-dimensional (3D) surface models of maxillary incisors and to propose a characterization of root morphology. The sample was comprised of pre-treatment cone-beam computed tomography (CBCT) images of fifty-five patients. The CBCTs were used to construct 3D surface models of the maxillary incisors. The reproducibility of surface models was tested by repeated construction of them by two observers. A 3D surface model that corresponded to the average of all lateral and all central incisors was generated. 3D surface distances and vector differences were calculated for each individual tooth and the average of the teeth considered. The corresponding points on the 3D surface mesh for each subgroup were compared statistically to those of the neutral subgroup using shape analysis MANCOVA and Hotelling's t-statistic (p < 0.05). Repeated construction of surface models demonstrated adequate inter-rater reproducibility. The distribution of 3D models into root morphology subgroups was: blunt (11% and 26% of the central and lateral incisors, respectively), conical (15% of the central incisors), long (27% and 20% of the central and lateral incisors, respectively), and short (15% and 4% of the central and lateral incisors, respectively). Compared to the neutral average, statistically significant differences in root morphology were found for blunt, long, conical, and short central incisors and for blunt, long, and short lateral incisors. We can conclude that 3D surface models construction for upper incisors is reproducible. 3D shape analysis using CBCT images allows a phenotypic characterization of incisor root morphology.	[Ahlbrecht, Carly A.; de Oliveira Ruellas, Antonio Carlos; Schilling, Juan A.; McNamara, James A., Jr.; Cevidanes, Lucia Helena Soares] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [de Oliveira Ruellas, Antonio Carlos] Univ Fed Rio de Janeiro, Dept Orthodont & Pediat Dent, Rio De Janeiro, RJ, Brazil; [Paniagua, Beatriz] Univ North Carolina Chapel Hill, Dept Psychiat, Chapel Hill, NC USA	University of Michigan System; University of Michigan; Universidade Federal do Rio de Janeiro; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ruellas, ACD (corresponding author), Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA.; Ruellas, ACD (corresponding author), Univ Fed Rio de Janeiro, Dept Orthodont & Pediat Dent, Rio De Janeiro, RJ, Brazil.	antonioruellas@yahoo.com.br; luciacev@umich.edu			National Institutes of Health [R01 DE024450]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by the National Institutes of Health [www.nih.gov]: R01 DE024450 (LHSC received the funding).	Al-Qawasmi RA, 2003, J DENT RES, V82, P356, DOI 10.1177/154405910308200506; Cevidanes LHS, 2010, ORAL SURG ORAL MED O, V110, P110, DOI 10.1016/j.tripleo.2010.01.008; Cevidanes LHS, 2005, DENTOMAXILLOFAC RAD, V34, P369, DOI 10.1259/dmfr/17102411; Cevidanes Lucia H, 2009, Craniofac Growth Ser, V46, P147; Donaldson M, 2001, DENT TRAUMATOL, V17, P205; Dudic A, 2009, AM J ORTHOD DENTOFAC, V135, P434, DOI 10.1016/j.ajodo.2008.10.014; Elhaddaoui R, 2016, INT ORTHOD, V14, P48, DOI 10.1016/j.ortho.2015.12.015; Gunst V, 2013, INT ENDOD J, V46, P877, DOI 10.1111/iej.12073; Harris E F, 1993, Quintessence Int, V24, P417; HARRIS EF, 1992, AM J ORTHOD DENTOFAC, V101, P112, DOI 10.1016/0889-5406(92)70002-R; Harris EF, 1997, AM J ORTHOD DENTOFAC, V111, P301, DOI 10.1016/S0889-5406(97)70189-6; Hartsfield JK, 2009, ORTHOD CRANIOFAC RES, V12, P236, DOI 10.1111/j.1601-6343.2009.01458.x; Hartsfield JK, 2004, CRIT REV ORAL BIOL M, V15, P115, DOI 10.1177/154411130401500205; Kamble RH, 2012, ANGLE ORTHOD, V82, P799, DOI 10.2319/083111-560.1; Kapila S, 2011, DENTOMAXILLOFAC RAD, V40, P24, DOI 10.1259/dmfr/12615645; Killiany D M, 1999, Semin Orthod, V5, P128, DOI 10.1016/S1073-8746(99)80032-2; KJAER I, 1995, EUR J ORTHODONT, V17, P25, DOI 10.1093/ejo/17.1.25; Lee YJ, 2016, AM J ORTHOD DENTOFAC, V149, P84, DOI 10.1016/j.ajodo.2015.06.027; LEVANDER E, 1988, EUR J ORTHODONT, V10, P30, DOI 10.1093/ejo/10.1.30; Lund H, 2010, ANGLE ORTHOD, V80, P466, DOI 10.2319/072909-427.1; Marques L, 2012, ORTHODONTICS BASIC A; Marques LS, 2011, AM J ORTHOD DENTOFAC, V139, pS166, DOI 10.1016/j.ajodo.2009.05.032; Marques LS, 2010, AM J ORTHOD DENTOFAC, V137, P384, DOI 10.1016/j.ajodo.2008.04.024; MASSLER M, 1954, AM J ORTHOD DENTOFAC, V40, P619, DOI 10.1016/0002-9416(54)90070-6; Massler M., 1954, J DENT CHILD, V21, P158; MIRABELLA AD, 1995, AM J ORTHOD DENTOFAC, V108, P48, DOI 10.1016/S0889-5406(95)70065-X; Moyers R, 1976, MONOGRAPH U MICHIGAN, V5, P371; NEWMAN WG, 1975, AM J ORTHOD DENTOFAC, V67, P522, DOI 10.1016/0002-9416(75)90298-5; Oyama K, 2007, EUR J ORTHODONT, V29, P113, DOI 10.1093/ejo/cjl043; Paniagua B, 2009, INSIGHT J; Picanço Gracemia Vasconcelos, 2013, Dental Press J. Orthod., V18, P110; Ponder SN, 2013, AM J ORTHOD DENTOFAC, V143, P77, DOI 10.1016/j.ajodo.2012.08.023; REITAN K., 1957, AMER JOUR ORTHODONT, V43, P32, DOI 10.1016/0002-9416(57)90114-8; Sameshima GT, 2001, AM J ORTHOD DENTOFAC, V119, P505, DOI 10.1067/mod.2001.113409; Sherrard JF, 2010, AM J ORTHOD DENTOFAC, V137, pS100, DOI 10.1016/j.ajodo.2009.03.040; Taithongchai R, 1996, AM J ORTHOD DENTOFAC, V110, P296, DOI 10.1016/S0889-5406(96)80014-X; Tymofiyeva O, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120271; Tymofiyeva O, 2013, J ORAL MAXIL SURG, V71, P1159, DOI 10.1016/j.joms.2013.02.014; Wang Y, 2013, ORTHOD CRANIOFAC RES, V16, P169, DOI 10.1111/ocr.12016; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	40	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178728	10.1371/journal.pone.0178728	http://dx.doi.org/10.1371/journal.pone.0178728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594852	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200046
J	Bian, XM; Chi, L; Gao, B; Tu, PC; Ru, HY; Lu, K				Bian, Xiaoming; Chi, Liang; Gao, Bei; Tu, Pengcheng; Ru, Hongyu; Lu, Kun			The artificial sweetener acesulfame potassium affects the gut microbiome and body weight gain in CD-1 mice	PLOS ONE			English	Article							NONNUTRITIVE SWEETENERS; ARSENIC EXPOSURE; GLUCOSE; CONSUMPTION; RECEPTOR; BACTERIA; OBESITY; INFLAMMATION; FERMENTATION; POPULATION	Artificial sweeteners have been widely used in the modern diet, and their observed effects on human health have been inconsistent, with both beneficial and adverse outcomes reported. Obesity and type 2 diabetes have dramatically increased in the U.S. and other countries over the last two decades. Numerous studies have indicated an important role of the gut microbiome in body weight control and glucose metabolism and regulation. Interestingly, the artificial sweetener saccharin could alter gut microbiota and induce glucose intolerance, raising questions about the contribution of artificial sweeteners to the global epidemic of obesity and diabetes. Acesulfame-potassium (Ace-K), a FDA-approved artificial sweetener, is commonly used, but its toxicity data reported to date are considered inadequate. In particular, the functional impact of Ace-K on the gut microbiome is largely unknown. In this study, we explored the effects of Ace-K on the gut microbiome and the changes in fecal metabolic profiles using 16S rRNA sequencing and gas chromatography-mass spectrometry (GC-MS) metabolomics. We found that Ace-K consumption perturbed the gut microbiome of CD-1 mice after a 4-week treatment. The observed body weight gain, shifts in the gut bacterial community composition, enrichment of functional bacterial genes related to energy metabolism, and fecal metabolomic changes were highly gender-specific, with differential effects observed for males and females. In particular, ace-K increased body weight gain of male but not female mice. Collectively, our results may provide a novel understanding of the interaction between artificial sweeteners and the gut microbiome, as well as the potential role of this interaction in the development of obesity and the associated chronic inflammation.	[Bian, Xiaoming; Gao, Bei] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Chi, Liang; Tu, Pengcheng; Lu, Kun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA; [Ru, Hongyu] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University System of Georgia; University of Georgia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; North Carolina State University	Lu, K (corresponding author), Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA.	kunlu@unc.edu		Gao, Bei/0000-0002-3321-2339	University of Georgia; University of North Carolina; NIH/NIEHS [R01ES024950]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES024950] Funding Source: NIH RePORTER	University of Georgia; University of North Carolina; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The University of Georgia, University of North Carolina and NIH/NIEHS (R01ES024950) provided partial financial support for this work.	Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P1415, DOI 10.1080/15287390802328630; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Bandyopadhyay A, 2008, DRUG CHEM TOXICOL, V31, P447, DOI [10.1080/01480540802390270, 10.1080/01480540802390270 ]; Ben David Y, 2015, ENVIRON MICROBIOL, V17, P3407, DOI 10.1111/1462-2920.12868; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027; Bunyavanich S., 2016, J ALLERGY CLIN IMMUN; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chi L, 2016, CHEM RES TOXICOL; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Comstock LE, 2009, CELL HOST MICROBE, V5, P522, DOI 10.1016/j.chom.2009.05.010; Cong WN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070257; Cong XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152751; Crittenden R, 2002, J SCI FOOD AGR, V82, P781, DOI 10.1002/jsfa.1095; Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Eeckhaut V, 2010, INT J SYST EVOL MICR, V60, P1108, DOI 10.1099/ijs.0.015289-0; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Frankenfeld CL, 2015, ANN EPIDEMIOL, V25, P736, DOI 10.1016/j.annepidem.2015.06.083; GarciaAlcaraz JL, 2016, MANAGE IND ENG, P1, DOI [10.1007/978-3-319-25919-2, 10.1007/s11036-016-0730-8]; Gardner C, 2012, DIABETES CARE, V35, P1798, DOI 10.2337/dc12-9002; Genc Yeliz, 2008, Ann Clin Microbiol Antimicrob, V7, P17, DOI 10.1186/1476-0711-7-17; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hiippala K, 2016, FRONTIERS MICROBIOLO, P7; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Karstadt M, 2010, INT J OCCUP ENV HEAL, V16, P89; Kritchevsky D., 1986, DIETARY FIBER, P131, DOI DOI 10.1007/978-1-4613-2111-8_10; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lindberg AL, 2008, ENVIRON RES, V106, P110, DOI 10.1016/j.envres.2007.08.011; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Morgan P, 1996, REV MED MICROBIOL, V7, P221, DOI DOI 10.1097/00013542-199610000-00004; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e; PFEFFER M, 1985, Z ERNAHRUNGSWISS, V24, P231, DOI 10.1007/BF02023668; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Rahman M, 2006, ENVIRON HEALTH PERSP, V114, P1847, DOI 10.1289/ehp.9207; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Sanz Y, 2008, INTERDISCIPLINARY PE, V2008; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheflin AM, 2016, MOL NUTR FOOD RES; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Taguchi H, 2002, J MED MICROBIOL, V51, P336, DOI 10.1099/0022-1317-51-4-336; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang YD, 2011, HEPATOLOGY, V54, P1421, DOI 10.1002/hep.24525; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	59	102	105	4	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178426	10.1371/journal.pone.0178426	http://dx.doi.org/10.1371/journal.pone.0178426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594855	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200031
J	Mateen, S; Moin, S; Shahzad, S; Khan, AQ				Mateen, Somaiya; Moin, Shagufta; Shahzad, Sumayya; Khan, Abdul Qayyum			Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species	PLOS ONE			English	Article							LIPID-PEROXIDATION; OXIDATIVE STRESS; DISEASE-ACTIVITY; SERUM; CELLS; PATHOGENESIS; NECROSIS; IL-17; INTERLEUKIN-6; ALPHA	Background Rheumatoid arthritis (RA) is an autoimmune inflammatory disorder. Reactive oxygen species (ROS) and pro-inflammatory cytokines have been believed to be involved in the etiopathogenesis of the disease. The aim of the study was to determine the correlation of inflammatory cytokines with 25-hydroxy vitamin D and ROS. Methods 100 RA patients and 50 healthy age and sex matched individuals were included in the study. Patients were further divided on the basis of presence or absence of rheumatoid factor and disease severity. Serum 25-hydroxy vitamin D levels were monitored by chemiluminescent immunoassay. 10% hematocrit was used to detect the level of ROS by spectro fluorometer. The levels of inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, IL-10 and IL-17) were determined in plasma by ELISA. Results The level of 25-hydroxy vitamin D was found to be decreased in RA patients in comparison to the control group. However the level of ROS and inflammatory cytokines were found to be elevated in RA patients in comparison with the healthy controls, with the increase being more pronounced in seropositive and RA patients having high disease severity. Inflammatory cytokines showed negative correlation with 25-hydroxy vitamin D and positive correlation with ROS. Conclusion This study for the first time shows the association of inflammatory cytokines with 25-hydroxy vitamin D and ROS in RA patients. The results suggest that 25-hydroxy vitamin D being an immune modulator is decreased in the serum of RA patients. Further ROS and cytokines play an important role in the pathogenesis of RA and are responsible for increasing the severity of disease.	[Mateen, Somaiya; Moin, Shagufta; Shahzad, Sumayya] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India; [Khan, Abdul Qayyum] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Orthopaed Surg, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Moin, S (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Fac Med, Dept Biochem, Aligarh, Uttar Pradesh, India.	moinshagufta2@gmail.com						Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Al-Saadany HM, 2016, EGYPT RHEUMATOL, V38, P1, DOI 10.1016/j.ejr.2015.01.001; Arendt W, 2001, LECT NOTES PURE APPL, V215, P1; Azzeh F. S., 2012, Pakistan Journal of Nutrition, V11, P293; Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; Benedetti G, 2014, EUR J IMMUNOL, V44, P339, DOI 10.1002/eji.201344184; Berridge MJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0434; Brzustewicz E, 2015, CYTOKINE, V76, P527, DOI 10.1016/j.cyto.2015.08.260; Chizzolini C, 2009, ARTHRITIS RES THER, V11, P1; CICUTTINI FM, 1995, RHEUMATOL INT, V14, P201, DOI 10.1007/BF00262298; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; Dayer J-M, 2009, RHEUMATOLOGY; DING L, 1993, J IMMUNOL, V151, P1224; Edrees AF, 2005, CLIN EXP RHEUMATOL, V23, P469; Fatima N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161548; Filippin LI, 2008, CLIN EXP IMMUNOL, V152, P415, DOI 10.1111/j.1365-2249.2008.03634.x; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Isomaki P, 1997, ANN MED, V29, P499, DOI 10.3109/07853899709007474; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Keller A, 2004, FREE RADICAL RES, V38, P1257, DOI 10.1080/10715760400022145; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lin JF, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9213034; MANICOURT DH, 1993, ARTHRITIS RHEUM, V36, P490, DOI 10.1002/art.1780360409; Mateen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152925; Mateen S, 2016, CLIN CHIM ACTA, V455, P161, DOI 10.1016/j.cca.2016.02.010; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nozawa K, 2014, WORLD J ORTHOP, V5, P653, DOI 10.5312/wjo.v5.i5.653; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029; Shah D, 2011, IMMUNOBIOLOGY, V216, P1010, DOI 10.1016/j.imbio.2011.04.001; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Surh Y.J., 2005, OXIDATIVE STRESS INF; van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100; van Roon JAG, 2001, ARTHRITIS RHEUM-US, V44, P3, DOI 10.1002/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U; Vasanthi P., 2007, APLAR J RHEUMATOL, V10, P270, DOI [DOI 10.1111/J.1479-8077.2007.00305.X, 10.1111/j.1479-8077.2007.00305.x]; Veselinovic M, 2014, MOL CELL BIOCHEM, V391, P225, DOI 10.1007/s11010-014-2006-6; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhang C, 2008, CYTOKINE, V42, P345, DOI 10.1016/j.cyto.2008.03.006	44	68	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178879	10.1371/journal.pone.0178879	http://dx.doi.org/10.1371/journal.pone.0178879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594861	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200062
J	Paras-Bravo, P; Paz-Zulueta, M; Alonso-Blanco, MC; Salvadores-Fuentes, P; Alconero-Camarero, AR; Santibanez, M				Paras-Bravo, Paula; Paz-Zulueta, Maria; Cristina Alonso-Blanco, Maria; Salvadores-Fuentes, Paloma; Rosa Alconero-Camarero, Ana; Santibanez, Miguel			Association among presence of cancer pain, inadequate pain control, and psychotropic drug use	PLOS ONE			English	Article							MANAGEMENT; CARE; PREVALENCE; PHARMACOTHERAPY; DEPRESSION; DISORDERS; DIAGNOSIS; DISTRESS; GENDER	Introduction Pain is a common symptom in cancer patients, and its control and management are complex. Despite the high concomitant use of psychotropic drugs among such patients, the association among pain, inadequate pain control, and psychotropic drug use has not been fully determined. This study examined the prevalence of cancer pain and inadequate pain control and the association with psychotropic drug use. Materials and methods In this cross-sectional study, we investigated 402 medical records obtained by simple random sampling of oncology patients at a hospital in northern Spain from July 2012 to July 2014. Adjusted odds ratios (ORs) were estimated together with their 95% confidence intervals (95% Cls) by unconditional logistic regression for each type of psychotropic drug (anxiolytics, hypnotics, and antidepressants). Results The mean patient age was 61.17 (standard deviation +/- 13.14) years; 57.5% were women, 42.5% men. Pain was present in 18.4% of patients and inadequate pain control in 54.2%. We found a statistically significant association between the presence of cancer pain and anxiolytic use (adjusted OR, 3.15; 95% Cl, 1.49-6.68) and hypnotic use (adjusted OR, 5.19; 95% Cl, 1.77-15.25). Inadequate pain control was associated to a greater extent with the use of those drugs: adjusted OR for anxiolytic use, 4.74 (95% Cl, 1.91-11.80); adjusted OR for hypnotic use, 6.09 (95% Cl, 1.74-21.32). By contrast, no association was found between pain and antidepressant use (adjusted OR, 0.99). Conclusion The presence of pain and (to a greater extent) poor pain control were associated with increased use of certain psychotropic drugs, such as anxiolytics and hypnotics. There appeared to be no association between pain and antidepressant use.	[Paras-Bravo, Paula; Paz-Zulueta, Maria; Rosa Alconero-Camarero, Ana; Santibanez, Miguel] Univ Cantabria, Dept Nursing, Santander, Spain; [Cristina Alonso-Blanco, Maria] Univ Rey Juan Carlos, Dept Nursing, Madrid, Spain; [Salvadores-Fuentes, Paloma] Univ Rey Juan Carlos, Div Phys Therapy, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid, Spain	Universidad de Cantabria; Universidad Rey Juan Carlos; Universidad Rey Juan Carlos	Paz-Zulueta, M (corresponding author), Univ Cantabria, Dept Nursing, Santander, Spain.	maria.paz@unican.es	Parás-Bravo, Paula/AAC-7250-2020; Santibanez, Miguel/L-3323-2017	Parás-Bravo, Paula/0000-0001-7745-3006; Santibanez, Miguel/0000-0003-2634-615X; Alonso-Blanco, Maria Cristina/0000-0002-6809-6534	Social Work Caja Cantabria	Social Work Caja Cantabria	This study won 16th edition National Nursing Research Award Valdecilla that funded the Social Work Caja Cantabria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research team thanks all the staff at the Medical Day Hospital of the Marques de Valdecilla University Hospital for their collaboration; without them, this study would not have been possible. We are also grateful for the support of Social Work Caja Cantabria, which funded the 16th National Nursing Research Award Valdecilla for this project.	Almakadma Yasin S, 2013, Saudi J Anaesth, V7, P291, DOI 10.4103/1658-354X.115362; Aloisi AM, 2016, EUR J PHYS REHAB MED, V52, P730; American Cancer Society, 2015, MAN CANC PAIN OTH ME; Barry Declan T, 2016, J Opioid Manag, V12, P259, DOI 10.5055/jom.2016.0341; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Choi M, 2014, INT J NURS PRACT, V20, P60, DOI 10.1111/ijn.12122; Cipta AM, 2015, J COMMUNITY SUPPORT, V13, P347, DOI 10.12788/jcso.0173; Cohen E, 2008, CANCER NURS, V31, pE1, DOI 10.1097/01.NCC.0000305693.67131.7d; Davis MP, 2005, LANCET ONCOL, V6, P696, DOI 10.1016/S1470-2045(05)70317-X; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Desplenter F, 2012, BRIT J CANCER, V107, P1644, DOI 10.1038/bjc.2012.364; Dong ST, 2014, J PAIN SYMPTOM MANAG, V48, P411, DOI 10.1016/j.jpainsymman.2013.10.027; Doran DM, 2011, DORAN DM NURSING OUT; Drapeau A, 2012, TECH, P155; Effendy C, 2015, PAIN PRACT, V15, P441, DOI 10.1111/papr.12203; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Fischer DJ, 2010, SUPPORT CARE CANCER, V18, P801, DOI 10.1007/s00520-009-0712-5; George Mathew, 2015, Asian Pac J Cancer Prev, V16, P6711; Goudas LC, 2005, CANCER INVEST, V23, P182, DOI 10.1081/CNV-200050482; Grassi L, 2014, INT REV PSYCHIATR, V26, P44, DOI 10.3109/09540261.2013.842542; Greco MT, 2014, J CLIN ONCOL 2014, V32, P54; Induru RR, 2011, CLEV CLIN J MED, V78, P449, DOI 10.3949/ccjm.78a.10054; International Association for the Study of Pain The IASP Taxonomy, 2012, CLASSIFICATION CHRON; Kierner KA, 2016, SUPPORT CARE CANCER, V24, P2067, DOI 10.1007/s00520-015-3007-z; Kwon JH, 2014, J CLIN ONCOL, V32, P1727, DOI 10.1200/JCO.2013.52.4827; Li YX, 2013, CANCER NURS, V36, P326, DOI 10.1097/NCC.0b013e318268f95b; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mehnert A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-70; Mellar D, 2009, OPIOIDS CANC PAIN; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; National Cancer Institute, 2015, SIDE EFFECTS; Ng CG, 2011, J AFFECT DISORDERS, V131, P1, DOI 10.1016/j.jad.2010.07.034; Ovayolu O, 2015, SUPPORT CARE CANCER, V23, P1857, DOI 10.1007/s00520-014-2540-5; PDQ Supportive and Palliative Care Editorial Board, 2002, CANC PAIN PDQPDQ CAN; Petkova M, 2010, PROCD SOC BEHV, V5, P421, DOI 10.1016/j.sbspro.2010.07.116; Portenoy RK, 2011, LANCET, V377, P2236, DOI 10.1016/S0140-6736(11)60236-5; Ripamonti CI, 2012, ANN ONCOL, V23, P139, DOI 10.1093/annonc/mds233; Saturno PJ, 2015, EUR J PAIN, V19, P28, DOI 10.1002/ejp.516; Schug SA, 2015, EXPERT OPIN PHARMACO, V16, P5, DOI 10.1517/14656566.2015.980723; Shaheen PE, 2010, J PAIN SYMPTOM MANAG, V39, P702, DOI 10.1016/j.jpainsymman.2009.09.009; Singer S, 2010, ANN ONCOL, V21, P925, DOI 10.1093/annonc/mdp515; Stanton AL, 2013, J CONSULT CLIN PSYCH, V81, P318, DOI 10.1037/a0028833; Swartzman S., 2016, PSYCHOONCOLOGY; Syrowatka A, 2016, J NATL COMPR CANC NE, V14, P1412, DOI 10.6004/jnccn.2016.0151; Wengstrom Y, 2014, EUR J ONCOL NURS, V18, P127, DOI 10.1016/j.ejon.2013.11.009; World Health Organization, 1986, CANC PAIN REL PALL C; World Health Organization, 2005, 58 CANC PREV CONTR W	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178742	10.1371/journal.pone.0178742	http://dx.doi.org/10.1371/journal.pone.0178742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594871	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200047
J	Thomas, N; Lucas, R; Bunting, P; Hardy, A; Rosenqvist, A; Simard, M				Thomas, Nathan; Lucas, Richard; Bunting, Peter; Hardy, Andrew; Rosenqvist, Ake; Simard, Marc			Distribution and drivers of global mangrove forest change, 1996-2010	PLOS ONE			English	Article							AQUACULTURE DEVELOPMENT; SHRIMP AQUACULTURE; ALOS PALSAR; SHORELINES; ECOSYSTEMS; BIOMASS; WORLDS; COVER; SAR; MAP	For the period 1996-2010, we provide the first indication of the drivers behind mangrove land cover and land use change across the (pan-) tropics using time-series Japanese Earth Resources Satellite (JERS-1) Synthetic Aperture Radar (SAR) and Advanced Land Observing Satellite (ALOS) Phased Array-type L-band SAR (PALSAR) data. Multi-temporal radar mosaics were manually interpreted for evidence of loss and gain in forest extent and its associated driver. Mangrove loss as a consequence of human activities was observed across their entire range. Between 1996-2010 12% of the 1168 1 degrees x1 degrees radar mosaic tiles examined contained evidence of mangrove loss, as a consequence of anthropogenic degradation, with this increasing to 38% when combined with evidence of anthropogenic activity prior to 1996. The greatest proportion of loss was observed in Southeast Asia, whereby approximately 50% of the tiles in the region contained evidence of mangrove loss, corresponding to 18.4% of the global mangrove forest tiles. Southeast Asia contained the greatest proportion (33.8%) of global mangrove forest. The primary driver of anthropogenic mangrove loss was found to be the conversion of mangrove to aquaculture/agriculture, although substantial advance of mangroves was also evident in many regions.	[Thomas, Nathan; Simard, Marc] CALTECH, Jet Prop Lab, MS 300-356A, Pasadena, CA 91109 USA; [Lucas, Richard] Univ New South Wales, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Bunting, Peter; Hardy, Andrew] Aberystwyth Univ, Dept Geog & Earth Sci, Aberystwyth, Dyfed, Wales; [Rosenqvist, Ake] Solo Earth Observat soloEO, Tokyo, Japan	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of New South Wales Sydney; Aberystwyth University	Thomas, N (corresponding author), CALTECH, Jet Prop Lab, MS 300-356A, Pasadena, CA 91109 USA.	nathan.m.thomas@jpl.nasa.gov	Bunting, Pete/M-5839-2019; Bunting, Peter J/GVT-0875-2022	Bunting, Pete/0000-0002-7435-0148; Bunting, Peter J/0000-0002-7435-0148; Hardy, Andy/0000-0002-7928-8873; Lucas, Richard/0000-0003-3010-3302; Thomas, Nathan/0000-0002-7808-6444	NERC [NE/P014127/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahmed M, 2002, FOOD POLICY, V27, P125, DOI 10.1016/S0306-9192(02)00007-6; [Anonymous], 1997, WORLD MANGROVE ATLAS; Bandaranayake WM, 1998, MANGROVES SALT MARSH, V2, P133, DOI 10.1023/A:1009988607044; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Dewalt BR, 1996, WORLD DEV, V24, P1193, DOI 10.1016/0305-750X(96)00033-2; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1365-2699.1999.00126.x; FAO, 2007, FIR MAN GLOB ASS 200; Fromard F, 1998, OECOLOGIA, V115, P39, DOI 10.1007/s004420050489; Fromard F, 2004, MAR GEOL, V208, P265, DOI 10.1016/j.margeo.2004.04.018; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Hamilton SE, 2016, GLOBAL ECOL BIOGEOGR, V25, P729, DOI 10.1111/geb.12449; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hogarth P. J., 1999, The Biology of Mangroves and Seagrasses; Japanese Aerospace Exploration Agency, 2016, JAXA GLOB 25M RES PA; Komiyama A, 2008, AQUAT BOT, V89, P128, DOI 10.1016/j.aquabot.2007.12.006; Lucas R, 2014, MAR FRESHWATER RES, V65, P589, DOI 10.1071/MF13177; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; Nascimento WR, 2013, ESTUAR COAST SHELF S, V117, P83, DOI 10.1016/j.ecss.2012.10.005; Ohimain B. L., 2003, P 8 INT MIN WAT ASS, P503; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paez-Osuna F, 2001, ENVIRON MANAGE, V28, P131, DOI 10.1007/s002670010212; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Putz FE, 1986, TREE GROWTH DYNAMICS; Rahman AF, 2013, REMOTE SENS ENVIRON, V130, P96, DOI 10.1016/j.rse.2012.11.014; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Rivera-Ferre M, 2009, J AGR ENVIRON ETHIC, V22, P301, DOI 10.1007/s10806-009-9148-7; Ronnback P, 1999, ECOL ECON, V29, P235, DOI 10.1016/S0921-8009(99)00016-6; Rosenqvist A, 2014, REMOTE SENS ENVIRON, V155, P3, DOI 10.1016/j.rse.2014.04.011; Rosenqvist A, 2000, INT J REMOTE SENS, V21, P1375, DOI 10.1080/014311600210227; Rosenqvist A, 2007, IEEE T GEOSCI REMOTE, V45, P3307, DOI 10.1109/TGRS.2007.901027; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; TEAS H J, 1977, Environmental Conservation, V4, P51; Thomas N, 2015, WETL ECOL MANAG, V23, P3, DOI 10.1007/s11273-014-9370-6; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tong PHS, 2004, INT J REMOTE SENS, V25, P4795, DOI 10.1080/01431160412331270858; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; UNFAO, 2014, STAT WORLD FISH AQ 2, V24; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Wilkie ML, 2003, 63 FAO FOR RES DIV	44	241	249	17	136	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179302	10.1371/journal.pone.0179302	http://dx.doi.org/10.1371/journal.pone.0179302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594908	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200116
J	Zhu, JWJ; Chaudhury, MF; Durso, LM; Sagel, A; Skoda, SR; Jelvez-Serra, NS; Santanab, EG				Zhu, Junwei J.; Chaudhury, Muhammad F.; Durso, Lisa M.; Sagel, Agustin; Skoda, Steven R.; Jelvez-Serra, Nadia S.; Santanab, Euzebio Goulart			Semiochemicals released from five bacteria identified from animal wounds infested by primary screwworms and their effects on fly behavioral activity	PLOS ONE			English	Article							NEW-WORLD SCREWWORM; FLIES DIPTERA-CALLIPHORIDAE; INCUBATED BOVINE BLOOD; COCHLIOMYIA-HOMINIVORAX; VOLATILES; COMMUNICATION; FERMENTATION; OLFACTOMETER; OVIPOSITION; COMPONENTS	Background The Primary screwworm, Cochliomyia hominivorax (Coquerel), is a serious pest feeding on living flesh of any warm-blooded animal, including humans. It was eradicated from the United States in the early 1980s using the sterile male technique. However, it was recently detected in populations of wild deer and pets in the Florida Keys of the US. For monitoring purposes, screwworm flies are normally trapped using attractant bait with liver. However, there has been little effort to develop an efficient monitoring system for detection of screwworm flies using a specific synthetic attractant blend. Several studies have shown that odors from animal wound fluids attract screwworm adults, particularly gravid females. Bacteria associated with animal wounds have been identified that act as a major source for this attraction. To understand what volatiles attract screwworms we inoculated bovine blood with previously identified bacteria. We identified volatile chemicals released from the inoculated blood and other selected media over time and assessed the effect of those chemicals on behavioral activity of adult screwworm flies. Methodology/Principal findings A total of 7 volatile compounds were collected from bacteria incubated in either broth or blood using solid-phase microextraction, and their chemical structures were identified by their characteristic mass spectrum fragments and confirmed by retention times in comparison to those of synthetic standards via gas chromatograph combined mass spectrometry analyses. Five major volatiles including dimethyl disulfide, dimethyl trisulfide, phenol, p-cresol and indole were detected from a mixture of 5 bacteria incubated in blood. The ratios of volatiles released differed among different incubation media, time and individual bacteria. A synthetic mixture containing the five compounds was demonstrated to be attractive to adult screwworm flies both in laboratory assays and field trapping trials. Conclusions/Significance The results obtained from this study may assist in developing an efficient trapping system using the identified attractant blend to detect the infestation of primary screwworms. This is also the first study to explore the complex systems in volatile release profiles from 5 bacteria isolated from screwworm-infested animal wounds that are incubated with different media and incubation time, as well as individual and multi-species bacterial communities.	[Zhu, Junwei J.; Durso, Lisa M.] UNL, ARS, USDA, Agroecosyst Management Res Unit, East Campus, Lincoln, NE 68583 USA; [Chaudhury, Muhammad F.] UNL, EC, ARS, USDA,Screwworm Res Unit, Lincoln, NE USA; [Sagel, Agustin] ARS, USDA, Screwworm Res Unit, Pacora, Panama; [Skoda, Steven R.] ARS, USDA, Screwworm Res Unit, Knipling Bushland US Livestock Insects Res Lab, Kerrville, TX USA; [Jelvez-Serra, Nadia S.; Santanab, Euzebio Goulart] Univ Fed Alagoas, Inst Quim & Biotecnol, Maceio, Alagoas, Brazil	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universidade Federal de Alagoas	Zhu, JWJ (corresponding author), UNL, ARS, USDA, Agroecosyst Management Res Unit, East Campus, Lincoln, NE 68583 USA.	jerry.zhu@ars.usda.gov	Melo, Nadia/GRF-3999-2022	Melo, Nadia/0000-0002-1303-4934; Zhu, Junwei/0000-0001-9846-9656				ADAMS TS, 1979, J MED ENTOMOL, V15, P124, DOI 10.1093/jmedent/15.2.124; Anderson GS, 2004, CAN VET J, V45, P993; Bartelt RJ, 1997, ANAL CHEM, V69, P364, DOI 10.1021/ac960820n; Bishopp FC, 1916, USDA FARMERS B; Bishopp FC, 1937, USDA FARMERS B, V1916; Boatright SA, 2010, J MED ENTOMOL, V47, P917, DOI 10.1603/ME09206; Broce A.B., 1985, P83; Bromel M., 1983, ENDOCYTOBIOLOGY, V2, P791; Chaudhury MF, 2014, J MED ENTOMOL, V51, P591, DOI 10.1603/ME13193; Chaudhury MF, 2010, J MED ENTOMOL, V47, P349, DOI 10.1603/ME09235; Chaudhury MF, 2002, J MED ENTOMOL, V39, P130, DOI 10.1603/0022-2585-39.1.130; Cork A, 2007, MED VET ENTOMOL, V21, P85, DOI 10.1111/j.1365-2915.2006.00661.x; CORK A, 1994, MED VET ENTOMOL, V8, P151, DOI 10.1111/j.1365-2915.1994.tb00155.x; DeMilo AB, 1996, J AGR FOOD CHEM, V44, P607, DOI 10.1021/jf950525o; DEVANEY JA, 1973, J MED ENTOMOL, V10, P591, DOI 10.1093/jmedent/10.6.591; Dickschat JS, 2005, CHEM BIODIVERS, V2, P318, DOI 10.1002/cbdv.200590014; EDDY GW, 1975, J MED ENTOMOL, V12, P379, DOI 10.1093/jmedent/12.3.379; Fernandes FF, 2004, J MED ENTOMOL, V41, P545, DOI 10.1603/0022-2585-41.4.545; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; GUILLOT F S, 1977, Southwestern Entomologist, V2, P49; GUILLOT FS, 1977, ANN ENTOMOL SOC AM, V70, P588, DOI 10.1093/aesa/70.4.588; Jones C. M., 1976, J ECON ENTOMOL, V48, P459; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Laake EW, 1936, USDA TECHNICAL B; LEE CJ, 1995, J AGR FOOD CHEM, V43, P1348, DOI 10.1021/jf00053a041; Mackley JW, 1984, MISCELLANEOUS PUBLIC, V62, P49; Marsili R., 2001, SOLID PHASE MICROEXT; Mastrangelo Thiago, 2012, Insects, V3, P930, DOI 10.3390/insects3040930; PARKER FD, 1992, J ECON ENTOMOL, V85, P1740, DOI 10.1093/jee/85.5.1740; Robacker David C., 2007, IOBC-WPRS Bulletin, V30, P9; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Scholler C, 1997, CHEMOSPHERE, V35, P1487, DOI 10.1016/S0045-6535(97)00209-9; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Scutti S., 2016, FLORIDA USING OVERWH; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Spradbery J.P., 2002, MANUAL DIAGNOSIS SCR; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; TAYLOR BF, 1989, ACS SYM SER, V393, P202; THOMAS DB, 1989, ANN ENTOMOL SOC AM, V82, P526, DOI 10.1093/aesa/82.4.526; Wheatley RE, 2002, ANTON LEEUW INT J G, V81, P357, DOI 10.1023/A:1020592802234; Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x	41	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179090	10.1371/journal.pone.0179090	http://dx.doi.org/10.1371/journal.pone.0179090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594888	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200085
J	Chung, MC; Yu, TM; Shu, KH; Wu, MJ; Chang, CH; Muo, CH; Chung, CJ				Chung, Mu-Chi; Yu, Tung-Min; Shu, Kuo-Hsiung; Wu, Ming-Ju; Chang, Chao-Hsiang; Muo, Chih-Hsin; Chung, Chi-Jung			Hyponatremia and increased risk of dementia: A population-based retrospective cohort study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BRAIN; COMPLICATIONS; PATHOBIOLOGY; PATHOGENESIS; INFLAMMATION; ANGIOTENSIN; PATHOLOGY; HYPOXIA	Hyponatremia is the most common electrolyte disorder and also a predictor of mild cognition impairment. However, the association between hyponatremia and dementia in long follow up periods is rarely investigated. A retrospective cohort study was performed using the claims data of all insured residents who were covered by Taiwan's universal health insurance from 2000 to 2011. A total of 4900 hyponatremia patients and 19545 matched comparisons were recruited for the analysis. The incidences of hyponatremia and dementia were diagnosed with clinical protocol and defined using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Cox proportional hazard regression and Kaplan-Meier curves were used for the analyses. Independent of adjusting factors, hyponatremia patients had 2.36-fold higher chances of suffering dementia, including Alzheimer's disease (AD) and non-AD dementia, than the comparisons. Severe hyponatremia patients had higher risks of suffering dementia than the non-severe hyponatremia patients (adjusted hazard ratio: 4.29 (95% CI: 3.47-5.31) versus 2.08 (95% CI: 1.83-2.37)). A dose response relationship was observed between hyponatremia and dementia. Those hyponatremia patients with baseline or incident stroke had significantly higher chances of suffering dementia compared with those patients without hyponatremia and stroke. Stroke is a significant modifier of the relationship between hyponatremia and dementia. Cerebrovascular disease after incident hyponatremia must be prevented to reduce the incidence of dementia.	[Chung, Mu-Chi; Yu, Tung-Min; Shu, Kuo-Hsiung; Wu, Ming-Ju] Taichung Vet Gen Hosp, Dept Med, Div Nephrol, Taichung, Taiwan; [Wu, Ming-Ju] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Dept Urol, Taichung, Taiwan; [Chang, Chao-Hsiang] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Muo, Chih-Hsin] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chung, CJ (corresponding author), China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan.; Chung, CJ (corresponding author), China Med Univ & Hosp, Dept Med Res, Taichung, Taiwan.	cjchung1010@gmail.com		, Mu Chi/0000-0001-5283-2886	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital [DMR-105-081]; Academia Sinica Taiwan Biobank Stroke Biosignature [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation in Taichung, Taiwan; Taiwan Brain Disease Foundation in Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds in Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation in Taichung, Taiwan; Taiwan Brain Disease Foundation in Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds in Japan	This study is supported by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), the China Medical University Hospital (DMR-105-081), the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), the NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), the Tseng-Lien Lin Foundation in Taichung, Taiwan, the Taiwan Brain Disease Foundation in Taipei, Taiwan, and the Katsuzo and Kiyo Aoshima Memorial Funds in Japan. These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia V, 2015, J HEPATOL, V62, P75, DOI 10.1016/j.jhep.2014.07.033; AYUS JC, 1995, CHEST, V107, P517, DOI 10.1378/chest.107.2.517; Barsony J, 2011, J BIOL CHEM, V286, P10864, DOI 10.1074/jbc.M110.155002; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Combs S, 2014, AM J KIDNEY DIS, V63, P294, DOI 10.1053/j.ajkd.2013.09.017; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; Dzau VJ, 2001, HYPERTENSION, V37, P1047, DOI 10.1161/01.HYP.37.4.1047; Foster GE, 2009, J PHYSIOL-LONDON, V587, P3287, DOI 10.1113/jphysiol.2009.171553; Fraser CL, 1997, AM J MED, V102, P67, DOI 10.1016/S0002-9343(96)00274-4; Fujisawa H, 2015, J AM SOC NEPHROL; Gankam-Kengne F, 2013, KIDNEY INT, V83, P700, DOI 10.1038/ki.2012.459; Gibbs ME, 2013, NEUROSCIENCE, V230, P62, DOI 10.1016/j.neuroscience.2012.10.070; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Grote K, 2004, NEPHROL DIAL TRANSPL, V19, P770, DOI 10.1093/ndt/gfh030; Hsu PF, 2013, DIABETES CARE, V36, P894, DOI 10.2337/dc12-0916; Hurd MD, 2013, NEW ENGL J MED, V369, P489, DOI 10.1056/NEJMc1305541; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017; Kim HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129480; Kokko JP, 2006, KIDNEY INT, V69, P1291, DOI 10.1038/sj.ki.5000252; Launer LJ, 2008, NEUROBIOL AGING, V29, P1587, DOI 10.1016/j.neurobiolaging.2007.03.008; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Mandai S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-276; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Park Se Jin, 2013, Korean J Pediatr, V56, P519, DOI 10.3345/kjp.2013.56.12.519; Pasantes-Morales H, 2006, CONTRIB NEPHROL, V152, P221, DOI 10.1159/000096326; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pentimone F, 1992, Minerva Psichiatr, V33, P165; Raz L, 2015, J CEREB BLOOD FLOW M; Renneboog B, 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.09.026, 10.1016/j.amjmed.2005.09.026]; Rodrigues B, 2014, J STROKE CEREBROVASC, V23, P850, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.011; Ryan S, 2009, THORAX, V64, P631, DOI 10.1136/thx.2008.105577; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Wannamethee SG, 2016, NUTR METAB CARDIOVAS, V26, P12, DOI 10.1016/j.numecd.2015.07.008; Wortmann M, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt143; Xu R, 2015, CLIN J AM SOC NEPHRO, V10, P1806, DOI 10.2215/CJN.02240215	39	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178977	10.1371/journal.pone.0178977	http://dx.doi.org/10.1371/journal.pone.0178977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591195	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700066
J	Gat, I; Tang, K; Quach, K; Kuznyetsov, V; Antes, R; Filice, M; Zohni, K; Librach, C				Gat, Itai; Tang, Katelynn; Quach, Kevin; Kuznyetsov, Valeriy; Antes, Ran; Filice, Melissa; Zohni, Khaled; Librach, Clifford			Sperm DNA fragmentation index does not correlate with blastocyst aneuploidy or morphological grading	PLOS ONE			English	Article							CHROMATIN-STRUCTURE ASSAY; IN-VITRO FERTILIZATION; DEOXYRIBONUCLEIC-ACID FRAGMENTATION; PATERNAL AGE; PREGNANCY LOSS; INJECTION; DAMAGE; MISCARRIAGE; PARAMETERS; REPRODUCTION	High DNA fragmentation index (DFI) may be associated with poor outcome after IVF. Our aim was to determine whether DFI impacts blastocyst quality or clinical outcome. This retrospective study included 134 couples who underwent 177 IVF-ICSI and pre-implantation genetic screening (PGS) cycles during January 1st, 2014-March 31st, 2016 and had documented previous DFI. Group 1 (DFI>30%) encompassed 25 couples who underwent 36 cycles; Group 2 (DFI 15-30%) included 45 couples and 57 cycles; group 3 (DFI<15%) included 64 couples and 83 cycles. Male partners within group 1 were older (45.1 compared to 40.6 and 38.3 years, respectively, p<0.05), had higher BMI (32.4 compared to 26.6 and 25.8 respectively, p<0.05) and lower sperm count and motility (46*10(/ml)(6) and 35.5%, respectively) compared to groups 2 (61.8*10(/ml)(6) and 46.6%, respectively) and 3 (75.8*10(/ml)(6) and 55.1%, respectively, p<0.05). Female parameters including ovarian reserve and response and embryo development were similar. Total numbers of biopsied blastocysts were 116, 175 and 259 in groups 1, 2 and 3, respectively. PGS for 24 chromosomes revealed comparable euploidy rate of 46-50.4%, with a similar morphological classification. No significant differences were found regarding pregnancy rates or pregnancy loss. It seems that DFI doesn't correlate with blastocyst aneuploidy or morphological grading.	[Gat, Itai; Tang, Katelynn; Quach, Kevin; Kuznyetsov, Valeriy; Antes, Ran; Filice, Melissa; Zohni, Khaled; Librach, Clifford] CReATe Fertil Ctr, Toronto, ON, Canada; [Gat, Itai] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Gat, Itai] Sheba Med Ctr, Pinchas Borenstein Talpiot Med Leadership Program, Ramat Gan, Israel; [Librach, Clifford] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Librach, Clifford] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Librach, Clifford] Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Librach, C (corresponding author), CReATe Fertil Ctr, Toronto, ON, Canada.; Librach, C (corresponding author), Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.; Librach, C (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Librach, C (corresponding author), Womens Coll Hosp, Dept Gynecol, Toronto, ON, Canada.	drlibrach@createivf.com						Agarwal A, 2016, CURR OPIN OBSTET GYN, V28, P164, DOI 10.1097/GCO.0000000000000271; Ahmadi A, 1999, J EXP ZOOL, V284, P696, DOI 10.1002/(SICI)1097-010X(19991101)284:6&lt;696::AID-JEZ11&gt;3.0.CO;2-E; Avendano C, 2009, FERTIL STERIL, V91, P1077, DOI 10.1016/j.fertnstert.2008.01.015; Balakier H, 2016, FERTIL STERIL; Bareh GM, 2016, FERTIL STERIL, V105, P329, DOI 10.1016/j.fertnstert.2015.10.033; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Begueria R, 2014, HUM REPROD, V29, P2114, DOI 10.1093/humrep/deu189; Belloc S, 2014, FERTIL STERIL, V101, P1588, DOI 10.1016/j.fertnstert.2014.02.006; Benchaib M, 2007, FERTIL STERIL, V87, P93, DOI 10.1016/j.fertnstert.2006.05.057; Boe-Hansen GB, 2005, J ANDROL, V26, P360, DOI 10.2164/jandrol.04056; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bronet F, 2012, HUM REPROD, V27, P1922, DOI 10.1093/humrep/des148; Bungum M, 2007, HUM REPROD, V22, P174, DOI 10.1093/humrep/del326; Cimadomo D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7193075; Cissen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165125; Cohen-Bacrie P, 2009, FERTIL STERIL, V91, P1801, DOI 10.1016/j.fertnstert.2008.01.086; Collins JA, 2008, FERTIL STERIL, V89, P823, DOI 10.1016/j.fertnstert.2007.04.055; Dar S, 2013, FERTIL STERIL, V100, P75, DOI 10.1016/j.fertnstert.2013.03.011; Das M, 2013, J ASSIST REPROD GEN, V30, P843, DOI 10.1007/s10815-013-0015-0; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; DOR J, 1992, FERTIL STERIL, V58, P986; EVENSON DP, 1980, SCIENCE, V210, P1131, DOI 10.1126/science.7444440; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fonseka KGL, 2011, CYTOGENET GENOME RES, V133, P280, DOI 10.1159/000322816; Gianaroli L, 2005, J HISTOCHEM CYTOCHEM, V53, P261, DOI 10.1369/jhc.4B6434.2005; Gleicher N, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0318-3; Greco E, 2015, NEW ENGL J MED, V373, P2089, DOI 10.1056/NEJMc1500421; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Heitmann RJ, 2013, J ASSIST REPROD GEN, V30, P563, DOI 10.1007/s10815-013-9932-1; Holubcova Z, 2015, SCIENCE, V348, P1143, DOI 10.1126/science.aaa9529; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; Katz-Jaffe MG, 2013, FERTIL STERIL, V100, P262, DOI 10.1016/j.fertnstert.2013.03.021; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Kolte AM, 2015, HUM REPROD, V30, P495, DOI 10.1093/humrep/deu299; Kumar Shiv Basant, 2015, Asian Pac J Cancer Prev, V16, P6967; Kushnir VA, 2016, FERTIL STERIL, V106, P75, DOI 10.1016/j.fertnstert.2016.02.026; Lazer T, 2014, INT J REPROD MED, V2014; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Lu Jin-Chun, 2010, Zhonghua Nan Ke Xue, V16, P867; MacLennan M, 2015, SEMIN CELL DEV BIOL, V45, P68, DOI 10.1016/j.semcdb.2015.10.005; Ni K, 2016, ANDROLOGY; Ni WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094956; Orvieto R, 2017, J ASSIST REPROD GENE; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Rathke C, 2014, BBA-GENE REGUL MECH, V1839, P155, DOI 10.1016/j.bbagrm.2013.08.004; Robinson L, 2012, HUM REPROD, V27, P2908, DOI 10.1093/humrep/des261; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; Seli E, 2004, FERTIL STERIL, V82, P378, DOI 10.1016/j.fertnstert.2003.12.039; Simon L, 2016, ASIAN J ANDROL; Virro MR, 2004, FERTIL STERIL, V81, P1289, DOI 10.1016/j.fertnstert.2003.09.063; Wdowiak A, 2015, REPROD BIOL, V15, P94, DOI 10.1016/j.repbio.2015.03.003; Zhao J, 2014, FERTIL STERIL, V102, P998, DOI 10.1016/j.fertnstert.2014.06.033; Zini A, 2011, J ASSIST REPROD GEN, V28, P391, DOI 10.1007/s10815-011-9544-6; Zini A, 2011, SYST BIOL REPROD MED, V57, P78, DOI 10.3109/19396368.2010.515704; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321	56	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179002	10.1371/journal.pone.0179002	http://dx.doi.org/10.1371/journal.pone.0179002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591199	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700070
J	Sanchez-Vaznaugh, EV; Rosas, LG; Fernandez-Pena, JR; Baek, J; Egerter, S; Sanchez, BN				Sanchez-Vaznaugh, Emma V.; Rosas, Lisa Goldman; Fernandez-Pena, Jose Ramon; Baek, Jonggyu; Egerter, Susan; Sanchez, Brisa N.			Physical education policy compliance and Latino children's fitness: Does the association vary by school neighborhood socioeconomic advantage?	PLOS ONE			English	Article							ELEMENTARY-SCHOOLS; AEROBIC FITNESS; STATE LAWS; OBESITY; CHILDHOOD; IMPLEMENTATION; ADOLESCENTS; AMERICAN; HEALTH; IMPACT	Objectives To investigate the contribution of school neighborhood socioeconomic advantage to the association between school-district physical education policy compliance in California public schools and Latino students' physical fitness. Methods Cross-sectional Fitnessgram data for public-school students were linked with school-and district-level information, district-level physical education policy compliance from 2004-2005 and 2005-2006, and 2000 United States Census data. Multilevel logistic regression models examined whether income and education levels in school neighborhoods moderated the effects of district-level physical education policy compliance on Latino fifth-graders' fitness levels. Results Physical education compliance data were available for 48 California school districts, which included 64,073 Latino fifth-graders. Fewer than half (23, or 46%) of these districts were found to be in compliance, and only 16% of Latino fifth-graders attended schools in compliant districts. Overall, there was a positive association between district compliance with physical education policy and fitness (OR, 95%CI: 1.38, 1.07, 1.78) adjusted for covariates. There was no significant interaction between school neighborhood socioeconomic advantage and physical education policy compliance (p>.05): there was a positive pattern in the association between school district compliance with physical education policy and student fitness levels across levels of socioeconomic advantage, though the association was not always significant. Conclusions Across neighborhoods with varying levels of socioeconomic advantage, increasing physical education policy compliance in elementary schools may be an effective strategy for improving fitness among Latino children.	[Sanchez-Vaznaugh, Emma V.; Fernandez-Pena, Jose Ramon] San Francisco State Univ, Dept Hlth Educ, San Francisco, CA 94132 USA; [Sanchez-Vaznaugh, Emma V.; Fernandez-Pena, Jose Ramon] San Francisco State Univ, Hlth Equity Inst, San Francisco, CA 94132 USA; [Sanchez-Vaznaugh, Emma V.; Fernandez-Pena, Jose Ramon] Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA; [Sanchez-Vaznaugh, Emma V.; Egerter, Susan] Univ Calif San Francisco, Sch Med, Ctr Social Dispar Hlth, Family Community Med, San Francisco, CA 94143 USA; [Rosas, Lisa Goldman] Stanford Prevent Res Ctr, Program Prevent Outcomes & Practices, Palo Alto, CA USA; [Baek, Jonggyu] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Sanchez, Brisa N.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	California State University System; San Francisco State University; California State University System; San Francisco State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sanchez-Vaznaugh, EV (corresponding author), San Francisco State Univ, Dept Hlth Educ, San Francisco, CA 94132 USA.; Sanchez-Vaznaugh, EV (corresponding author), San Francisco State Univ, Hlth Equity Inst, San Francisco, CA 94132 USA.; Sanchez-Vaznaugh, EV (corresponding author), Univ Calif San Francisco, Ctr Social Dispar Hlth, San Francisco, CA 94143 USA.; Sanchez-Vaznaugh, EV (corresponding author), Univ Calif San Francisco, Sch Med, Ctr Social Dispar Hlth, Family Community Med, San Francisco, CA 94143 USA.	emmav@sfsu.edu			Robert Wood Johnson Foundation Salud America Network [65047]; National Heart and Lung Blood Institute [K01HL115471]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL115471] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Salud America Network; National Heart and Lung Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge research support by grants from The Robert Wood Johnson Foundation Salud America Network to Prevent Obesity Among Latino Children (grant # 65047; http://www.rwjf.org/en/library/programs-and-initiatives/S/salud-america the-rwjf-researc-network-to-prevert-obesity-amon.html), as well as the National Heart and Lung Blood Institute (grant # K01HL115471; http://www.nhIbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	AAHPERD, 2014, NAT STAND GRAD LEV O; [Anonymous], 2008, FITNESSGRAM ACTIVITY; Barroso CS, 2009, J ADOLESCENT HEALTH, V45, pS82, DOI 10.1016/j.jadohealth.2009.06.017; Bassett DR, 2013, AM J PREV MED, V44, P108, DOI 10.1016/j.amepre.2012.10.017; California Center for Public Health Advocacy, 2006, DISTR COMPL SUMM CAL; California Department of Education, 2006, PHYS ED MOD CONT STA; California Department of Education, 1999, ED COD SECT 51210 EL; Carlson JA, 2013, J SCHOOL HEALTH, V83, P150, DOI 10.1111/josh.12010; Castillo JC, 2015, AM J PREV MED, V49, P753, DOI 10.1016/j.amepre.2015.04.015; Chriqui JF, 2013, CURR OBES REP, V2, P200, DOI 10.1007/s13679-013-0063-x; Christodoulos AD, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/270515; Eisenmann JC, 2007, ACTA PAEDIATR, V96, P1723, DOI 10.1111/j.1651-2227.2007.00534.x; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Gortmaker SL, 2011, MED SCI SPORTS EXERC; Institute of Medicine, 2013, ED STUD BOD TAK PHYS; Institute of Medicine, 2012, ACCELERATING PROGR O; Labarthe DR, 2016, CIRCULATION, V133, pE615, DOI 10.1161/CIR.0000000000000410; Lafleur M, 2013, ANN BEHAV MED; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Masse LC, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-71; Mellerson J, 2010, HEALTH PLACE, V16, P613, DOI 10.1016/j.healthplace.2009.12.013; Meyer U, 2013, SCAND J MED SCI SPOR, V23, P600, DOI 10.1111/j.1600-0838.2011.01425.x; Meyers D, 2013, CALIFORNIAS DIMINISH; Monnat SM, 2014, PREV MED, V69, pS5, DOI 10.1016/j.ypmed.2014.09.006; O'Malley PM, 2009, J ADOLESCENT HEALTH, V45, pS71, DOI 10.1016/j.jadohealth.2009.04.008; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez AG, 2011, HEALTH EDUC BEHAV, V38, P251, DOI 10.1177/1090198110372333; Richmond TK, 2006, PEDIATRICS, V117, P2158, DOI 10.1542/peds.2005-1920; Sanchez-Vaznaugh EV, 2012, AM J PREV MED, V42, P452, DOI 10.1016/j.amepre.2012.01.008; Shaibi GQ, 2006, ETHNIC DIS, V16, P120; Slater SJ, 2012, ARCH PEDIAT ADOL MED, V166, P311, DOI 10.1001/archpediatrics.2011.1133; Taber DR, 2013, JAMA PEDIATR, V167, P513, DOI 10.1001/jamapediatrics.2013.399; Taylor W, 2011, RES SYNTHESIS; Taylor WC, 1999, MED SCI SPORT EXER, V31, P118, DOI 10.1097/00005768-199901000-00019; Thompson HR, 2015, J SCHOOL HEALTH, V85, P604, DOI 10.1111/josh.12286; Twisk JWR, 2000, MED SCI SPORT EXER, V32, P1455, DOI 10.1097/00005768-200008000-00014; UCLA center to eliminate health disparities and Samuels and associates, 2007, FAIL FITN PHYS ACT P	39	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178980	10.1371/journal.pone.0178980	http://dx.doi.org/10.1371/journal.pone.0178980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591139	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700067
J	Widmar, NJO; Dominick, SR; Tyner, WE; Ruple, A				Widmar, Nicole J. Olynk; Dominick, S. R.; Tyner, Wallace E.; Ruple, Audrey			When is genetic modification socially acceptable? When used to advance human health through avenues other than food	PLOS ONE			English	Article							ZIKA VIRUS-INFECTION; VACCINE DEVELOPMENT; DISEASE	Given the potential for genetic modification (GM) to impact human health, via food and health mechanisms, a greater understanding of the social acceptance of GM is necessary to facilitate improved health outcomes. This analysis sought to quantify U.S. residents' acceptance of GM across five potential uses (grain production, fruit or vegetable production, livestock production, human medicine, and human health, i.e. disease vector control) and provides an in-depth analysis of a timely case study-the Zika virus (ZIKV). The two categories with the highest levels of acceptance for GM use were human medicine (62% acceptance) and human health (68% acceptance); the proportions agreeing with the use of GM for these two categories were statistically different from all other categories. Acceptance of GM in food uses revealed 44% of the sample accepted the use of GM in livestock production while grain production and fruit and vegetable production showed similar levels of agreement with 49% and 48% of responses, respectively. Two variables were significant in all five models predicting GM acceptance; namely, being male and GM awareness. Being male was significant and positive for all models; respondents who reported being male were more likely (than those who reported female) to agree with all five of the uses of GM studied. Those who were reportedly aware of GM mosquito technology were also more likely to agree with all uses of GM technology investigated. The potential relationship between awareness of GM technology uses and acceptance of other uses could help inform rates of acceptance of new technologies by various population segments.	[Widmar, Nicole J. Olynk; Dominick, S. R.; Tyner, Wallace E.] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Ruple, Audrey] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dominick, SR (corresponding author), Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA.	sdominic@purdue.edu		Ruple, Audrey/0000-0002-5223-0217	Discretionary internal university funds	Discretionary internal university funds	Discretionary internal university funds were used to fund this research.	Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934; Bar-Yam Y., 2014, PRECAUTION GMOS ALGO; Baum C.F., 2006, INTRO MODERN ECONOME; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Chiang F.-S. F., 2005, PUBLIC COMMUNICATION; Costa-Font J., APPL EC LETT, V12, P859; Dawkins R., 1998, DO REAL DANGERS GENE; Fernandez-Cornejo J., 2014, GENETICALLY ENG CROP, P60; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; Frewer L. J., 1995, Agriculture and Human Values, V12, P48, DOI 10.1007/BF02218074; Giuseppina Migliore, 2015, BRIT FOOD J, V117, P1637; Goeddel David V., 1979, P NATL ACAD SCI USA, V76, P106; Larimer Sarah, 2016, WASHINGTON POST; Lusk JL, 2005, J AGR RESOUR ECON, V30, P28; Mahaffey H., 2016, Journal of Environmental Protection, V7, P1522, DOI 10.4236/jep.2016.711127; Marshall JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-128; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Rozansky, 2016, MICHEAL MOST FLORIDA; Servick K., 2016, SCIENCE, DOI [10.1126/science.aal0350, DOI 10.1126/SCIENCE.AAL0350]; Shoichet Catherine E., 2016, CNN; Singer PA, 2000, NAT BIOTECHNOL, V18, P1225, DOI 10.1038/82256; Snipes Robin L., EMPLOYEE RESPONSIBIL, V11, P81; SPAETE RR, 1991, TRANSPLANT P, V23, P90; StataCorp, 2015, STAT STAT SOFTW REL; U.S. Census Bureau, 2010, DP 1 PROF GEN POP HO; Widmar N. J. O., 2017, PREVENTATIVE MED REP; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178227	10.1371/journal.pone.0178227	http://dx.doi.org/10.1371/journal.pone.0178227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591218	gold, Green Submitted, Green Published			2022-12-26	WOS:000402880700024
J	Gong, B; Deng, Y; Yang, YY; He, Y; Sun, XL; Ge, LY; Zhang, KW; Yang, WZ				Gong, Bing; Deng, Yi; Yang, Yuanyi; He, Yong; Sun, Xiaolong; Ge, Li-Ya; Zhang, Kewei; Yang, Weizhong			Stabilization of lead in incineration fly ash by moderate thermal treatment with sodium hydroxide addition	PLOS ONE			English	Article							SOLID-WASTE INCINERATOR; HEAVY-METALS; BOTTOM ASH; RESIDUES; MANAGEMENT; CARBONATION; EXTRACTION; CHINA	Municipal solid waste (MSW) incineration fly ash (IFA) can be potentially reused as a substitute for some raw materials, but treatment for detoxification is indispensable owing to high contents of heavy metals in fly ash. In the present work, due to excessive leaching concentration of lead (Pb), a moderate thermal treatment with sodium hydroxide (NaOH) addition was employed to stabilize Pb in IFA. The moderate thermal treatment was performed under relatively low temperature ranging from 300 to 500 degrees C and at retention time from 1 to 3 h with NaOH addition in a range of 1 to 9%. Leaching results showed that leaching concentrations of Pb in IFA leachates decreased below the standard for hazardous waste identification (5 mg/L) in China under all treatment scenarios. With the increase of temperature, retention time and the amount of NaOH, the concentration of Pb were further suppressed in IFA leachates. Especially, at 500 degrees C for 3 h with 9% NaOH addition, the concentration of Pb dropped to 0.18 mg/L, which was below the standard for sanitary landfill (0.25 mg/L) in China. In thermal process, needle-like crystallites melted to form granules and clumps with compacter structure and less pores. After the thermal treatment, water-soluble and exchangeable fractions of Pb significantly decreased. Therefore, the thermal treatment coupled with NaOH could be applied to realize the environmentally sound management of MSW IFA.	[Gong, Bing; Deng, Yi; Zhang, Kewei; Yang, Weizhong] Sichuan Univ, Sch Mat Sci & Engn, Chengdu, Peoples R China; [Gong, Bing; Deng, Yi; Zhang, Kewei; Yang, Weizhong] Sichuan Univ, Sch Chem Engn, Chengdu, Peoples R China; [Yang, Yuanyi] Sichuan Coll Architectural Technol, Dept Mat Engn, Deyang, Peoples R China; [He, Yong] CECEP Chengdu Renewable Energy Co Ltd, Chengdu, Peoples R China; [Sun, Xiaolong; Ge, Li-Ya] Zerowaste Asia Co Ltd, Singapore, Singapore	Sichuan University; Sichuan University	Yang, WZ (corresponding author), Sichuan Univ, Sch Mat Sci & Engn, Chengdu, Peoples R China.; Yang, WZ (corresponding author), Sichuan Univ, Sch Chem Engn, Chengdu, Peoples R China.	ywz@scu.edu.cn	Yang, Wei/HIA-0360-2022; zhang, ke/AAH-8217-2019; Ge, Li/T-3955-2018	Ge, Li/0000-0002-1824-8034; yuanyi, Yang/0000-0001-9386-5027	International Science and Technology Co-operation and Exchange Program of Sichuan [2015HH0066-1]; Chengdu Science and Technology Project [2014-HM01-00081-SF, 2015-HM01-00451-SF]; CECEP Chengdu Renewable Energy Co., Ltd.; Zerowaste Asia Co., Ltd	International Science and Technology Co-operation and Exchange Program of Sichuan; Chengdu Science and Technology Project; CECEP Chengdu Renewable Energy Co., Ltd.; Zerowaste Asia Co., Ltd	This work was funded by the International Science and Technology Co-operation and Exchange Program of Sichuan (No. 2015HH0066-1), and Chengdu Science and Technology Project (2014-HM01-00081-SF, 2015-HM01-00451-SF). CECEP Chengdu Renewable Energy Co., Ltd. and Zerowaste Asia Co., Ltd provided support in the form of salaries for authors YH, XLS and LYG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Astrup T, 2007, WASTE MANAGE, V27, P1452, DOI 10.1016/j.wasman.2007.03.017; Bausach M, 2004, THERMOCHIM ACTA, V421, P217, DOI 10.1016/j.tca.2004.04.011; Chi M, 2015, CONSTR BUILD MATER, V99, P128, DOI 10.1016/j.conbuildmat.2015.09.029; Chou JD, 2009, J HAZARD MATER, V162, P1000, DOI 10.1016/j.jhazmat.2008.05.155; Ecke H, 2003, J ENVIRON ENG-ASCE, V129, P435, DOI 10.1061/(ASCE)0733-9372(2003)129:5(435); EPA C, 2007, SOL WAST EXTR PROC L, V300; Ferreira C, 2003, J HAZARD MATER, V96, P201, DOI 10.1016/S0304-3894(02)00201-7; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Hu HY, 2013, CHEMOSPHERE, V93, P590, DOI 10.1016/j.chemosphere.2013.05.077; Hu YY, 2015, J HAZARD MATER, V299, P149, DOI 10.1016/j.jhazmat.2015.06.002; Jiang JG, 2009, J HAZARD MATER, V161, P1046, DOI 10.1016/j.jhazmat.2008.04.051; Jin YQ, 2013, ENERG FUEL, V27, P394, DOI 10.1021/ef3015525; Katsuura H, 1996, WASTE MANAGE, V16, P491, DOI 10.1016/S0956-053X(96)00091-8; Le Forestier L, 1998, ENVIRON SCI TECHNOL, V32, P2250, DOI 10.1021/es980100t; Lin CF, 2006, WASTE MANAGE, V26, P970, DOI 10.1016/j.wasman.2005.09.014; Lindberg D, 2015, WASTE MANAGE, V37, P82, DOI 10.1016/j.wasman.2014.12.009; Liu YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128719; Lombardi L, 2015, WASTE MANAGE, V37, P26, DOI 10.1016/j.wasman.2014.11.010; Ma J, 2016, WASTE MANAGE, V56, P3, DOI 10.1016/j.wasman.2016.06.041; Margallo M, 2015, CLEAN TECHNOL ENVIR, V17, P1333, DOI 10.1007/s10098-015-0961-6; Nurmesniemi H, 2008, WASTE MANAGE RES, V26, P389, DOI 10.1177/0734242X07079051; Polettini A, 2004, CHEMOSPHERE, V56, P901, DOI 10.1016/j.chemosphere.2004.05.004; Quina MJ, 2008, WASTE MANAGE, V28, P2097, DOI 10.1016/j.wasman.2007.08.030; Quina MJ, 2014, APPL CLAY SCI, V102, P71, DOI 10.1016/j.clay.2014.10.016; Quina MJ, 2009, WASTE MANAGE, V29, P2483, DOI 10.1016/j.wasman.2009.05.012; Sabbas T, 2003, WASTE MANAGE, V23, P61, DOI 10.1016/S0956-053X(02)00161-7; Sakai S, 1996, WASTE MANAGE, V16, P341, DOI 10.1016/S0956-053X(96)00106-7; Sakai S, 2000, WASTE MANAGE, V20, P249, DOI 10.1016/S0956-053X(99)00315-3; Song H, 2004, FUEL, V83, P1307, DOI 10.1016/j.fuel.2003.12.011; Todorovic M, 2006, WASTE MANAGE, V26, P430, DOI 10.1016/j.wasman.2005.11.011; Wang Q, 2009, FUEL, V88, P955, DOI 10.1016/j.fuel.2008.12.011; Wey MY, 2006, J HAZARD MATER, V137, P981, DOI 10.1016/j.jhazmat.2006.03.024; Wu MH, 2014, FUEL PROCESS TECHNOL, V125, P67, DOI 10.1016/j.fuproc.2014.03.027; Yliniemi J, 2015, WASTE MANAGE, V43, P273, DOI 10.1016/j.wasman.2015.05.019; Yu J, 2015, WASTE MANAGE, V46, P287, DOI 10.1016/j.wasman.2015.08.005; Zhang HY, 2007, J HAZARD MATER, V141, P106, DOI 10.1016/j.jhazmat.2006.06.100; Zheng L, 2010, CHEMOSPHERE, V79, P665, DOI 10.1016/j.chemosphere.2010.02.018; Zhu FF, 2009, WASTE MANAGE, V29, P259, DOI 10.1016/j.wasman.2008.03.008	38	6	6	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178816	10.1371/journal.pone.0178816	http://dx.doi.org/10.1371/journal.pone.0178816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586368	gold, Green Submitted, Green Published			2022-12-26	WOS:000402875700027
J	Li, D; He, W; Chen, BD; Lv, PX				Li, Duo; He, Wei; Chen, Budong; Lv, Pingxin			Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ADULTS	Background Multidrug-resistant tuberculosis has emerged as a global threat. The aim of this work was to compare the CT findings of primary multidrug-resistant tuberculosis and drug-sensitive tuberculosis in non-AIDS adults. Material and methods From January 2012 to February 2016, 89 patients with primary multidrug-resistant tuberculosis were retrospectively reviewed, and 89 consecutive drug sensitive TB patients with no history of anti-tuberculous chemotherapy from January 2014 to November 2014 were enrolled as control group. All patients were seronegative for HIV. The patients' demographic data and the locations, frequency and patterns of lung lesions on chest CT were compared. Results Gender and frequency of diabetes were similar between the two groups. The mean age of primary multidrug-resistant tuberculosis patients was younger than that of drug-sensitive tuberculosis (39.0 vs 47.5, P = 0.005). Lung cavitary nodules or masses were more frequently observed and also showed greater extent in primary multidrug-resistant tuberculosis compared with drug-sensitive tuberculosis. The extent of bronchiectasis was significantly greater in primary multidrug-resistant tuberculosis than in drug-sensitive tuberculosis. Calcification, large nodules and calcified lymph nodes were more frequent in drug-sensitive tuberculosis. Conclusion Characteristic chest CT findings may help differentiate between primary multi-drug resistant tuberculosis and drug-sensitive tuberculosis in patients without HIV infection.	[Li, Duo; He, Wei; Chen, Budong; Lv, Pingxin] Capital Med Univ, Beijing Chest Hosp, Dept Radiol, Beijing, Peoples R China	Capital Medical University	Lv, PX (corresponding author), Capital Med Univ, Beijing Chest Hosp, Dept Radiol, Beijing, Peoples R China.	lpx1209@163.com						CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cha J, 2009, KOREAN J RADIOL, V10, P207, DOI 10.3348/kjr.2009.10.3.207; Chuchottaworn C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139986; Chung MJ, 2006, EUR RADIOL, V16, P1934, DOI 10.1007/s00330-006-0174-9; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Fishman JE, 1998, J THORAC IMAG, V13, P65, DOI 10.1097/00005382-199801000-00015; Global Tuberculosis Programme, 2015, GLOB TUB REP; IM JG, 1995, CRIT REV DIAGN IMAG, V36, P227; Kim HC, 2004, J COMPUT ASSIST TOMO, V28, P366, DOI 10.1097/00004728-200405000-00011; Kim W, 2016, ACTA RADIOL, V57, P197, DOI 10.1177/0284185115575196; Ko JM, 2015, EUR J RADIOL, V84, P2339, DOI 10.1016/j.ejrad.2015.07.032; Lee ES, 2010, J COMPUT ASSIST TOMO, V34, P559, DOI 10.1097/RCT.0b013e3181d472bc; Lee Jin Hwa, 2001, Korean Journal of Internal Medicine, V16, P173; Lee JY, 2000, J COMPUT ASSIST TOMO, V24, P691, DOI 10.1097/00004728-200009000-00005; Mi FL, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24022; Organization WH, 1998, LAB SERV TUBERCULO 3; Organization WH, 1998, MICR 2; Song QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152507; Yeom JA, 2009, J COMPUT ASSIST TOMO, V33, P956, DOI 10.1097/RCT.0b013e31819877ab; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	20	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0176354	10.1371/journal.pone.0176354	http://dx.doi.org/10.1371/journal.pone.0176354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586348	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700002
J	Wang, Q; Bao, WF; Yang, F; Xu, B; Yang, YZ				Wang, Qian; Bao, Wei-Fang; Yang, Fan; Xu, Bin; Yang, Yi-Zhong			The specific host plant DNA detection suggests a potential migration of Apolygus lucorum from cotton to mungbean fields	PLOS ONE			English	Article							GUT-CONTENT-ANALYSIS; TRNL UAA INTRON; HEMIPTERA-MIRIDAE; HESPERUS HEMIPTERA; ARTHROPOD PREDATORS; BT COTTON; MEYER-DUR; IDENTIFICATION; INSECT; PREY	The polyphagous mirid bug Apolygus lucorum (Heteroptera: Miridae) has more than 200 species of host plants and is an insect pest of important agricultural crops, including cotton (Gossypium hirsutum) and mungbean (Vigna radiata). Previous field trials have shown that A. lucorum adults prefer mungbean to cotton plants, indicating the considerable potential of mungbean as a trap crop in cotton fields. However, direct evidence supporting the migration of A. lucorum adults from cotton to mungbean is lacking. We developed a DNA-based polymerase chain reaction (PCR) approach to reveal the movement of A. lucorum between neighboring mungbean and cotton fields. Two pairs of PCR primers specific to cotton or mungbean were designed to target the trnL-trnF region of chloroplast DNA. Significant differences in the detectability half-life (DS50) were observed between these two host plants, and the mean for cotton (8.26 h) was approximately two times longer than that of mungbean (4.38 h), requiring weighted mean calculations to compare the detectability of plant DNA in the guts of field-collected bugs. In field trials, cotton DNA was detected in the guts of the adult A. lucorum individuals collected in mungbean plots, and the cotton DNA detection rate decreased successively from 5 to 15 m away from the mungbean-cotton midline. In addition to the specific detection of cotton-and mungbean-fed bugs, both cotton and mungbean DNA were simultaneously detected within the guts of single individuals caught from mungbean fields. This study successfully established a tool for molecular gut-content analyses and clearly demonstrated the movement of A. lucorum adults from cotton to neighboring mungbean fields, providing new insights into understanding the feeding characteristics and landscape-level ecology of A. lucorum under natural conditions.	[Wang, Qian; Xu, Bin; Yang, Yi-Zhong] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Wang, Qian; Bao, Wei-Fang; Yang, Fan; Xu, Bin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Yangzhou University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Yang, YZ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	yzyang@yzu.edu.cn			Key Project for Breeding Genetically Modified Organisms [2016ZX08012-004]	Key Project for Breeding Genetically Modified Organisms	This research was supported a grant from the Key Project for Breeding Genetically Modified Organisms (2016ZX08012-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported a grant from the Key Project for Breeding Genetically Modified Organisms (2016ZX08012-004). We greatly thank the anonymous reviewers for their valuable comments. This manuscript has been edited by the native English-speaking experts of American Journal Experts.	Backus EA, 2007, ANN ENTOMOL SOC AM, V100, P296, DOI 10.1603/0013-8746(2007)100[296:LHHMFO]2.0.CO;2; Borsch T, 2003, J EVOLUTION BIOL, V16, P558, DOI 10.1046/j.1420-9101.2003.00577.x; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cooper WR, 2016, ENVIRON ENTOMOL, V45, P938, DOI 10.1093/ee/nvw060; Cooper WR, 2013, J ENTOMOL SCI, V48, P261; Cooper WR, 2013, ANN ENTOMOL SOC AM, V106, P86, DOI 10.1603/AN12096; Gagnon AE, 2011, MOL ECOL RESOUR, V11, P1022, DOI 10.1111/j.1755-0998.2011.03047.x; Geng HH, 2012, THESIS; Geng HH, 2012, APPL ENTOMOL ZOOL, V47, P191, DOI 10.1007/s13355-012-0107-9; Greenstone MH, 2007, B ENTOMOL RES, V97, P201, DOI 10.1017/S000748530700497X; Greenstone MH, 2012, MOL ECOL RESOUR, V12, P464, DOI 10.1111/j.1755-0998.2012.03112.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harwood JD, 2005, EUR J ENTOMOL, V102, P335, DOI 10.14411/eje.2005.051; Hereward JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044435; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Jones VP, 2006, ENVIRON ENTOMOL, V35, P827, DOI 10.1603/0046-225X-35.4.827; Junnila A, 2010, ACTA TROP, V115, P227, DOI 10.1016/j.actatropica.2010.04.002; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI [10.1089/152791600459894, DOI 10.1089/152791600459894]; Li JH, 2017, PEST MANAG SCI, V73, P628, DOI 10.1002/ps.4346; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Lu Y.Q., 2008, THESIS; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Lu YH, 2012, J ECON ENTOMOL, V105, P1603, DOI 10.1603/EC12003; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Matheson CD, 2007, ORG DIVERS EVOL, V7, P294, DOI 10.1016/j.ode.2006.09.002; Miller Michael A., 2006, Russian Entomological Journal, V15, P427; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pumarino L, 2011, B ENTOMOL RES, V101, P271, DOI 10.1017/S0007485310000465; Remen C, 2010, SOIL BIOL BIOCHEM, V42, P1952, DOI 10.1016/j.soilbio.2010.07.007; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Scarratt SL, 2008, BIOL CONTROL, V46, P107, DOI 10.1016/j.biocontrol.2008.03.016; Spaniolas S, 2010, FOOD CHEM, V122, P850, DOI 10.1016/j.foodchem.2010.02.039; Staudacher K, 2011, SOIL BIOL BIOCHEM, V43, P346, DOI 10.1016/j.soilbio.2010.10.022; Stephens AEA, 2008, AUST J ENTOMOL, V47, P131, DOI 10.1111/j.1440-6055.2008.00639.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VELASCO LRI, 1993, ENVIRON ENTOMOL, V22, P326, DOI 10.1093/ee/22.2.326; Wallinger C, 2015, B ENTOMOL RES, V105, P728, DOI 10.1017/S000748531500067X; Wallinger C, 2014, MOL ECOL, V23, P3826, DOI 10.1111/mec.12579; Wallinger C, 2013, MOL ECOL RESOUR, V13, P75, DOI 10.1111/1755-0998.12032; Wallinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029473; Wanner H, 2006, BIOL CONTROL, V39, P240, DOI 10.1016/j.biocontrol.2006.06.001; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x; Zhao H.X., 2011, THESIS	57	24	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0177789	10.1371/journal.pone.0177789	http://dx.doi.org/10.1371/journal.pone.0177789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586352	Green Submitted, Green Published, gold			2022-12-26	WOS:000402875700007
J	Zheng, H; Schnabel, A; Yahiaoui-Doktor, M; Meissner, W; Van Aken, H; Zahn, P; Pogatzki-Zahn, E				Zheng, Hua; Schnabel, Alexander; Yahiaoui-Doktor, Maryam; Meissner, Winfried; Van Aken, Hugo; Zahn, Peter; Pogatzki-Zahn, Esther			Age and preoperative pain are major confounders for sex differences in postoperative pain outcome: A prospective database analysis	PLOS ONE			English	Article							RISK-FACTORS; SURGERY; ANALGESIA; GENDER; PREDICTORS; MANAGEMENT; WOMEN; QUESTIONNAIRE; REQUIREMENTS; HYSTERECTOMY	Objectives Current literature is in disagreement regarding female sex as a risk factor for pain after surgery. We hypothesized, that sex differences exist but that they are influenced by certain factors. Here, we investigated the influence of sex for different clinically relevant postoperative pain ( POP) outcome parameters and evaluated the role of assumed confounders for sex differences. Methods From 1372 screened patients undergoing orthopedic surgery at the university hospital of Muenster between March 2010 and June 2011, 890 patients were included. The validated International Pain Outcomes questionnaire was used to assess the role of sex for several aspects of POP including pain severity, physical and emotional functional interference as well as the patient's perceptions of the care they received on the first day after surgery. Assessed confounders were age, preoperative chronic pain, anesthetic technique employed and surgical procedure. All statistical analyses were performed with SPSS Statistics Software 22. Results Linear regression analysis demonstrated that sex was a statistically significant risk factor for "worst pain since surgery". Additionally, significant sex differences in "time spent in severe pain", "feeling anxious due to pain", "feeling helpless due to pain" and "opioid consumption since surgery" could be identified. An univariate general linear model showed that "age" and "preoperative pain" were significant confounders for sex differences. Further descriptive subgroup analysis revealed consistent sex differences for several POP outcome variables especially in patients older than 50 years or patients with preoperative chronic pain. However, sex differences disappeared in younger patients and in patients without preoperative pain. Discussion Our data confirmed that sex differences exist in pain intensity and frequency, pain interference with feelings and opioid consumption during the first 24 hours postoperatively. However, sex differences were significantly influenced by the factors "age" and "preoperative pain". These findings may in part explain why clinical studies get different results related to sex differences and renders specific awareness in older women and female patients with preoperative chronic pain.	[Zheng, Hua] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan, Peoples R China; [Zheng, Hua; Schnabel, Alexander; Van Aken, Hugo; Pogatzki-Zahn, Esther] Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Schnabel, Alexander] Univ Hosp Wuerzburg, Dept Anesthesiol & Intens Care, Wurzburg, Germany; [Yahiaoui-Doktor, Maryam] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Meissner, Winfried] Jena Univ Hosp, Dept Anesthesiol & Intens Care, Jena, Germany; [Zahn, Peter] Ruhr Univ Bochum, Berufsgenossenschaftl Univ Klinikum Bergmannsheil, Dept Anesthesiol & Intens Care Med Palliat Care M, Bochum, Germany	Huazhong University of Science & Technology; University of Munster; University of Wurzburg; Leipzig University; Friedrich Schiller University of Jena; Ruhr University Bochum	Pogatzki-Zahn, E (corresponding author), Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany.	pogatzki@anit.uni-muenster.de	Yahiaoui-Doktor, Maryam/I-5859-2019; Zahn, Peter/AAB-9377-2021	Yahiaoui-Doktor, Maryam/0000-0002-3321-1598; Pogatzki-Zahn, Esther/0000-0003-0981-3940	FP7-g rant program [42977]	FP7-g rant program	The present study was supported by the FP7-grant program (project 42977) to EP-Z and WM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubrun F, 2005, ANESTHESIOLOGY, V103, P156, DOI 10.1097/00000542-200507000-00023; Bartley EJ, 2015, PAIN MED, V16, P99, DOI 10.1111/pme.12591; Brandsborg B, 2007, ANESTHESIOLOGY, V106, P1003, DOI 10.1097/01.anes.0000265161.39932.e8; Cepeda MS, 2003, ANESTH ANALG, V97, P1464, DOI 10.1213/01.ANE.0000080153.36643.83; Chia YY, 2002, CAN J ANAESTH, V49, P249, DOI 10.1007/BF03020523; Chou R, 2016, J PAIN, V17, P131, DOI 10.1016/j.jpain.2015.12.008; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Craft RM, 2003, CLIN J PAIN, V19, P175, DOI 10.1097/00002508-200305000-00005; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Gerbershagen HJ, 2014, ANESTHESIOLOGY, V120, P1237, DOI 10.1097/ALN.0000000000000108; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Gleichgerrcht E, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00243; Gramke HF, 2009, CLIN J PAIN, V25, P455, DOI 10.1097/AJP.0b013e31819a6e34; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Kalkman CJ, 2003, PAIN, V105, P415, DOI 10.1016/S0304-3959(03)00252-5; Niesters M, 2010, PAIN, V151, P61, DOI 10.1016/j.pain.2010.06.012; Ochroch EA, 2002, ANESTHESIOLOGY, V97, P1234, DOI 10.1097/00000542-200211000-00029; Perttunen K, 1999, ACTA ANAESTH SCAND, V43, P563; Peters ML, 2007, ANN SURG, V245, P487, DOI 10.1097/01.sla.0000245495.79781.65; Pinto PR, 2012, J PAIN, V13, P1045, DOI 10.1016/j.jpain.2012.07.014; Rosseland LA, 2004, PAIN, V112, P248, DOI 10.1016/j.pain.2004.08.028; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; Schnabel A, 2012, PAIN, V153, P238, DOI 10.1016/j.pain.2011.10.022; Sommer M, 2010, CLIN J PAIN, V26, P87, DOI 10.1097/AJP.0b013e3181b43d68; Tighe PJ, 2014, PAIN MED, V15, P1390, DOI 10.1111/pme.12498; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Zaslansky R, 2015, EUR J PAIN, V19, P490, DOI 10.1002/ejp.571; Zaslansky R, 2012, EUR J PAIN, V16, P430, DOI 10.1002/j.1532-2149.2011.00024.x	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178659	10.1371/journal.pone.0178659	http://dx.doi.org/10.1371/journal.pone.0178659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586373	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700021
J	Guardia-Olmos, J; Gallardo-Moreno, GB; Gudayol-Ferre, E; Pero-Cebollero, M; Gonzalez-Garrido, AA				Guardia-Olmos, Joan; Gallardo-Moreno, Geisa B.; Gudayol-Ferre, Esteve; Pero-Cebollero, Maribel; Gonzalez-Garrido, Andres A.			Effect of verbal task complexity in a working memory paradigm in patients with type 1 diabetes. A fMRI study	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; COGNITIVE PERFORMANCE; SEVERE HYPOGLYCEMIA; YOUNG-CHILDREN; BRAIN ACTIVATION; METAANALYSIS; ADULTS; VOLUME; DISEASE; CORTEX	Type 1 diabetes (T1D) is commonly diagnosed in childhood and adolescence, and the developing brain has to cope with its deleterious effects. Although brain adaptation to the disease may not result in evident cognitive dysfunction, the effects of T1D on neurodevelopment could alter the pattern of BOLD fMRI activation. The aim of this study was to explore the neural BOLD activation pattern in patients with T1D versus that of healthy matched controls while performing two visuospatial working memory tasks, which included a pair of assignments administered through a block design. In the first task (condition A), the subjects were shown a trial sequence of 3 or 4 white squares positioned pseudorandomly around a fixation point on a black background. After a fixed delay, a second corresponding sequence of 3 or 4 red squares was shown that either resembled (direct, 50%) or differed from (50%) the previous stimulation order. The subjects were required to press one button if the two spatial sequences were identical or a second button if they were not. In condition B, the participants had to determine whether the second sequence of red squares appeared in inverse order (inverse, 50%) or not (50%) and respond by pressing a button. If the latter sequence followed an order distinct from the inverse sequence, the subjects were instructed to press a different button. Sixteen patients with normal IQ and without diabetes complications and 16 healthy control subjects participated in the study. In the behavioral analysis, there were no significant differences between the groups in the pure visuo-spatial task, but the patients with diabetes exhibited poorer performance in the task with verbal stimuli (p <.001). However, fMRI analyses revealed that the patients with T1D showed significantly increased activation in the prefrontal inferior cortex, subcortical regions and the cerebellum (in general p <.001). These different activation patterns could be due to adaptive compensation mechanisms that are devoted to improving efficiency while solving more complex cognitive tasks.	[Guardia-Olmos, Joan; Pero-Cebollero, Maribel] Univ Barcelona, Inst Complex Syst UBICS, Inst Neurociencies, Fac Psicol, Passeig Vall dHebron 171, Barcelona, Spain; [Gallardo-Moreno, Geisa B.; Gonzalez-Garrido, Andres A.] Univ Guadalajara, Inst Neurociencias, Francisco Quevedo 180, Guadalajara, Jalisco, Mexico; [Gudayol-Ferre, Esteve] Univ Michoacana, Fac Psicol, Morelia, Michoacan, Mexico	University of Barcelona; Universidad de Guadalajara; Universidad Michoacana de San Nicolas de Hidalgo	Guardia-Olmos, J (corresponding author), Univ Barcelona, Inst Complex Syst UBICS, Inst Neurociencies, Fac Psicol, Passeig Vall dHebron 171, Barcelona, Spain.	jguardia@ub.edu	González-Garrido, Andrés A./T-3044-2019; Guàrdia Olmos, Joan/K-6306-2017; Gallardo-Moreno, Geisa B/K-3070-2017; Peró-Cebollero, Maribel/K-2987-2017	González-Garrido, Andrés A./0000-0003-4594-5270; Guàrdia Olmos, Joan/0000-0002-4275-9184; Gallardo-Moreno, Geisa B/0000-0001-5457-354X; Peró-Cebollero, Maribel/0000-0002-8793-5284	Ministerio de Economia y Competitividad [SI2013-41400-P o]	Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by SI2013-41400-P o Ministerio de Economia y Competitividad. Secretaria de Estado de Investigacion, Desarrollo e Innovacion.	Allen KV, 2015, DIABETES CARE, V38, P1108, DOI 10.2337/dc14-1657; Antenor-Dorsey JAV, 2013, DIABETES, V62, P581, DOI 10.2337/db12-0696; Gonzalez-Garrido AA, 2015, NEUROSCI LETT, V585, P43, DOI 10.1016/j.neulet.2014.11.014; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Asvold BO, 2010, DIABETES CARE, V33, P1945, DOI 10.2337/dc10-0621; Aye T, 2012, DIABETES CARE, V35, P2167, DOI 10.2337/dc12-0017; Baier B, 2014, ANN NEUROL, V76, P754, DOI 10.1002/ana.24272; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barnea-Goraly N, 2014, DIABETES CARE, V37, P332, DOI 10.2337/dc13-1388; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biessels GJ, 2014, DIABETES, V63, P62, DOI 10.2337/db13-1466; Blasetti A, 2011, J CHILD NEUROL, V26, P1383, DOI 10.1177/0883073811406730; Bolo NR, 2015, J NEUROSCI, V35, P11012, DOI 10.1523/JNEUROSCI.0319-15.2015; Bolo NR, 2011, DIABETES, V60, P3256, DOI 10.2337/db11-0506; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Brismar T, 2007, PSYCHONEUROENDOCRINO, V32, P1041, DOI 10.1016/j.psyneuen.2007.08.002; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Carreiras M, 2014, TRENDS COGN SCI, V18, P90, DOI 10.1016/j.tics.2013.11.005; Cato MA, 2014, J INT NEUROPSYCH SOC, V20, P238, DOI 10.1017/S1355617713001434; Chen YC, 2014, DIABETES CARE, V37, P1689, DOI 10.2337/dc13-2127; Cognition Musen G., 2008, CURRENT DIABETES REP, V8, P132; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cooray GK, 2011, CLIN NEUROPHYSIOL, V122, P1943, DOI 10.1016/j.clinph.2011.03.007; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; de Ven KCCV, 2013, J CLIN INVEST, V123, P623, DOI 10.1172/JCI62742; Ferguson SC, 2005, DIABETES CARE, V28, P1431, DOI 10.2337/diacare.28.6.1431; Gallardo-Moreno GB, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/703512; Graveling AJ, 2013, DIABETES CARE, V36, P3240, DOI 10.2337/dc13-0194; Hannonen R, 2003, DEV MED CHILD NEUROL, V45, P262, DOI 10.1017/S0012162203000501; Hershey T, 2010, DIABETES, V59, P236, DOI 10.2337/db09-1117; Instituto Nacional de Estadistica y Geografia, 2010, CENS POBL VIV 2010 P; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Koshino H, 2015, J GEN PSYCHOL, V142, P135, DOI 10.1080/00221309.2015.1036830; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Ly TT, 2011, DIABETES CARE, V34, P2192, DOI 10.2337/dc11-0697; Lyoo IK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071304; Lyoo IK, 2009, ARCH GEN PSYCHIAT, V66, P878, DOI 10.1001/archgenpsychiatry.2009.86; Marzelli MJ, 2014, DIABETES, V63, P343, DOI 10.2337/db13-0179; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moheet A, 2015, ANN NY ACAD SCI, V1353, P60, DOI 10.1111/nyas.12807; Morey CC, 2004, PSYCHON B REV, V11, P296, DOI 10.3758/BF03196573; Naguib JM, 2009, J PEDIATR PSYCHOL, V34, P271, DOI 10.1093/jpepsy/jsn074; Northam EA, 2009, DIABETES CARE, V32, P445, DOI 10.2337/dc08-1657; Ohmann S, 2010, PSYCHOL MED, V40, P95, DOI 10.1017/S0033291709005777; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perantie DC, 2007, DIABETES CARE, V30, P2331, DOI 10.2337/dc07-0351; Perantie DC, 2011, DIABETES, V60, P3006, DOI 10.2337/db11-0589; Postle BR, 2005, MEM COGNITION, V33, P203, DOI 10.3758/BF03195309; Rosenthal JM, 2001, DIABETES, V50, P1618, DOI 10.2337/diabetes.50.7.1618; Rottschy C, 2012, NEUROIMAGE, V60, P830, DOI 10.1016/j.neuroimage.2011.11.050; Saggar M, 2016, DIABETES; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; SMYTH MM, 1994, MEM COGNITION, V22, P1, DOI 10.3758/BF03202756; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Tonoli C, 2014, J DIABETES, V6, P499, DOI 10.1111/1753-0407.12193; Tsapkini K, 2011, BRAIN, V134, P3094, DOI 10.1093/brain/awr050; Tupola S, 2004, EUR J PEDIATR, V163, P335, DOI 10.1007/s00431-004-1434-9; van Duinkerken E, 2012, DIABETOLOGIA, V55, P1218, DOI 10.1007/s00125-012-2488-2; van Duinkerken E, 2012, DIABETES, V61, P1814, DOI 10.2337/db11-1358; Wessels AM, 2007, DIABETOLOGIA, V50, P1763, DOI 10.1007/s00125-007-0714-0; Wessels AM, 2006, DIABETES, V55, P334, DOI 10.2337/diabetes.55.02.06.db05-0680	66	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178172	10.1371/journal.pone.0178172	http://dx.doi.org/10.1371/journal.pone.0178172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582399	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600014
J	Sabharwal, T; Sathasivan, K; Mehdy, MC				Sabharwal, Tanya; Sathasivan, Kanagasabapathi; Mehdy, Mona C.			Defense related decadienal elicits membrane lipid remodeling in the diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							COPEPOD CALANUS-HELGOLANDICUS; CHEMICAL DEFENSE; SKELETONEMA-MARINOI; FLOW-CYTOMETRY; NILE RED; IN-VIVO; GROWTH; MICROALGAE; ALGAE; ALDEHYDES	Diatoms rapidly release extracellular oxylipins (oxygenated lipids) including polyunsaturated aldehydes in response to herbivory and other stresses. Oxylipins have several defense-related activities including inhibition of reproduction in herbivores and signaling to distant diatoms. Physiological changes in diatoms exposed to varying levels of oxylipins are only beginning to be understood. In this study, Phaeodactylum tricornutum cultures were treated with sublethal concentrations of the polyunsaturated aldehyde trans, trans-2,4-decadienal (DD) to assess effects on lipid composition and membrane permeability. In cells treated with DD for 3 hr, all measured saturated and unsaturated fatty acids significantly decreased (0.46-0.69 fold of levels in solvent control cells) except for 18: 2 (decreased but not significantly). The decrease was greater in the polyunsaturated fatty acid pool than the saturated and monounsaturated fatty acid pool. Analysis of lipid classes revealed increased abundances of phosphatidylethanolamine and phosphatidylcholine at 3 and 6 hr. Concomitantly, these and other membrane lipids exhibited increased saturated and monounsaturated acyl chains content relative to polyunsaturated acyl chains compared to control cells. Evidence of decreased plasma membrane permeability in DD treated cells was obtained, based on reduced uptake of two of three dyes relative to control cells. Additionally, cells pre-conditioned with a sublethal DD dose for 3 hr then treated with a lethal DD dose for 2 hr exhibited greater membrane integrity than solvent pre-conditioned control cells that were similarly treated. Taken together, the data are supportive of the hypothesis that membrane remodeling induced by sublethal DD is a key element in the development of cellular resistance in diatoms to varying and potentially toxic levels of polyunsaturated aldehydes in environments impacted by herbivory or other stresses.	[Sabharwal, Tanya; Sathasivan, Kanagasabapathi; Mehdy, Mona C.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mehdy, MC (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	mmehdy@austin.utexas.edu		Mehdy, Mona/0000-0003-2093-9747	Defense Advanced Research Projects Agency [4400163119]; University of Texas at Austin (Faculty Research Grant); National Science Foundation [EPS 0236913, MCB 1413036, DBI 0521587, DBI1228622]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20GM103418]; Kansas State University; DARPA grant [4400163119]; University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Texas at Austin (Faculty Research Grant); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; DARPA grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); University of Texas at Austin; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Defense Advanced Research Projects Agency (Grant 4400163119 to KS; http://www.darpa.mil/) and the University of Texas at Austin (Faculty Research Grant to MCM; https://www.utexas.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to UT Health Science Center Mass Spectrometry Core Laboratory at San Antonio, TX where fatty acid methyl ester (FAME) samples were analyzed. The lipid class analyses described in this work were performed at the Kansas Lipidomics Research Center Analytical Laboratory, Manhattan, KS. Instrument acquisition and lipidomics method development was supported by National Science Foundation (EPS 0236913, MCB 1413036, DBI 0521587, DBI1228622), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20GM103418), and Kansas State University.; Authors thank Dr. Susan Weintraub (UT Heath Science Center, San Antonio, TX), Dr. Ruth Welti (Kansas State University, Manhattan, KS) and Dr. Schonna Manning (University of Texas at Austin, TX) for their helpful discussions and suggestions while conducting lipid experiments and analyzing lipid data. Authors also thank several facilities at UT Austin, TX such as UTEX culture collection for providing media for growth of diatom cultures and Greenhouse facilities where cultures were grown and UT core facility where flow cytometry instruments were used. This work was partially supported by funding from DARPA grant #4400163119 and University of Texas at Austin.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Barbosa M, 2016, MAR DRUGS, V14, DOI 10.3390/md14010023; Barofsky A, 2007, ORG LETT, V9, P1017, DOI 10.1021/ol063051v; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brugnano C, 2016, J EXP MAR BIOL ECOL, V476, P41, DOI 10.1016/j.jembe.2015.11.015; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Carotenuto Y, 2014, HARMFUL ALGAE, V31, P153, DOI 10.1016/j.hal.2013.11.002; Carotenuto Y, 2012, J EXP MAR BIOL ECOL, V418, P46, DOI 10.1016/j.jembe.2012.03.014; Casotti R, 2005, J PHYCOL, V41, P7, DOI 10.1111/j.1529-8817.2005.04052.x; Clay AT, 2013, BIOCHEMISTRY-US, V52, P343, DOI 10.1021/bi301532c; Domergue F, 2003, PLANT PHYSIOL, V131, P1648, DOI 10.1104/pp.102.018317; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; Gallina AA, 2014, MAR DRUGS, V12, P4165, DOI 10.3390/md12074165; Garrison HS, 2014, HYDROBIOLOGIA, V738, P155, DOI 10.1007/s10750-014-1927-0; Gerwick WH, 2013, MICROB ECOL, V65, P800, DOI 10.1007/s00248-012-0169-9; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; Grobbelaar JU, 2010, PHOTOSYNTH RES, V106, P135, DOI 10.1007/s11120-010-9573-5; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Hyka P, 2013, BIOTECHNOL ADV, V31, P2, DOI 10.1016/j.biotechadv.2012.04.007; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Iwabuchi K, 2010, PLANT PHYSIOL, V152, P1309, DOI 10.1104/pp.109.149526; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; Lauritano C, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00068; Lauritano C, 2015, MAR GENOM, V24, P89, DOI 10.1016/j.margen.2015.01.007; Leflaive J, 2011, MICROB ECOL, V61, P363, DOI 10.1007/s00248-010-9755-x; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Li JH, 2016, ALCOHOL, V56, P21, DOI 10.1016/j.alcohol.2016.10.004; Li ZG, 2013, LAB CHIP, V13, P1144, DOI 10.1039/c3lc41252k; Malitsky S, 2016, NEW PHYTOL, V210, P88, DOI 10.1111/nph.13852; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matias-Peralta HM, 2012, AQUACULTURE, V344, P168, DOI 10.1016/j.aquaculture.2012.02.026; Michalec FG, 2013, HARMFUL ALGAE, V30, P56, DOI 10.1016/j.hal.2013.09.002; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Pohnert G, 2002, MAR ECOL PROG SER, V245, P33, DOI 10.3354/meps245033; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; Pohnert G, 2002, PLANT PHYSIOL, V129, P103, DOI 10.1104/pp.010974; Pradeep V, 2015, INT J MOL SCI, V16, P20674, DOI 10.3390/ijms160920674; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Rampen SW, 2010, LIMNOL OCEANOGR, V55, P91, DOI 10.4319/lo.2010.55.1.0091; Reynolds JE, 1996, CYTOMETRY, V25, P349, DOI 10.1002/(SICI)1097-0320(19961201)25:4<349::AID-CYTO6>3.3.CO;2-X; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Rioboo C, 2009, AQUAT TOXICOL, V94, P229, DOI 10.1016/j.aquatox.2009.07.009; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Singhal SS, 2015, TOXICOL APPL PHARM, V289, P361, DOI 10.1016/j.taap.2015.10.006; Taylor RL, 2012, MAR BIOTECHNOL, V14, P774, DOI 10.1007/s10126-012-9441-8; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; Trombetta D, 2002, LETT APPL MICROBIOL, V35, P285, DOI 10.1046/j.1472-765X.2002.01190.x; van Creveld SG, 2015, ISME J, V9, P385, DOI 10.1038/ismej.2014.136; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Vazdar M, 2012, J PHYS CHEM B, V116, P6411, DOI 10.1021/jp3044219; Vu HS, 2014, PLANT J, V80, P728, DOI 10.1111/tpj.12659; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Wichard T, 2006, J AM CHEM SOC, V128, P7114, DOI 10.1021/ja057942u; Wu SC, 2014, J APPL PHYCOL, V26, P1659, DOI 10.1007/s10811-013-0223-0; Zhang CY, 2014, MAR GENOM, V16, P63, DOI 10.1016/j.margen.2013.10.003; Zheng JW, 2016, ALGAL RES, V17, P132, DOI 10.1016/j.algal.2016.04.019; Zhou YH, 2008, LIPIDS, V43, P525, DOI 10.1007/s11745-008-3186-1	69	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178761	10.1371/journal.pone.0178761	http://dx.doi.org/10.1371/journal.pone.0178761			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582415	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600036
J	Chuang, TW; Chaves, LF; Chen, PJ				Chuang, Ting-Wu; Chaves, Luis Fernando; Chen, Po-Jiang			Effects of local and regional climatic fluctuations on dengue outbreaks in southern Taiwan	PLOS ONE			English	Article							INDIAN-OCEAN DIPOLE; EARLY WARNING SYSTEMS; VECTOR-BORNE DISEASE; AEDES-AEGYPTI; EL-NINO; METEOROLOGICAL FACTORS; VIRUS TRANSMISSION; FEVER INCIDENCE; TIME-SERIES; TEMPERATURE	Background Southern Taiwan has been a hotspot for dengue fever transmission since 1998. During 2014 and 2015, Taiwan experienced unprecedented dengue outbreaks and the causes are poorly understood. This study aims to investigate the influence of regional and local climate conditions on the incidence of dengue fever in Taiwan, as well as to develop a climatebased model for future forecasting. Methodology/Principle findings Historical time-series data on dengue outbreaks in southern Taiwan from 1998 to 2015 were investigated. Local climate variables were analyzed using a distributed lag non-linear model (DLNM), and the model of best fit was used to predict dengue incidence between 2013 and 2015. The cross-wavelet coherence approach was used to evaluate the regional El Nino Southern Oscillation (ENSO) and Indian Ocean Dipole (IOD) effects on dengue incidence and local climate variables. The DLNM results highlighted the important non-linear and lag effects of minimum temperature and precipitation. Minimum temperature above 23 degrees C or below 17 degrees C can increase dengue incidence rate with lag effects of 10 to 15 weeks. Moderate to high precipitation can increase dengue incidence rates with a lag of 10 or 20 weeks. The model of best fit successfully predicted dengue transmission between 2013 and 2015. The prediction accuracy ranged from 0.7 to 0.9, depending on the number of weeks ahead of the prediction. ENSO and IOD were associated with nonstationary inter-annual patterns of dengue transmission. IOD had a greater impact on the seasonality of local climate conditions. Conclusions/Significance Our findings suggest that dengue transmission can be affected by regional and local climatic fluctuations in southern Taiwan. The climate-based model developed in this study can provide important information for dengue early warning systems in Taiwan. Local climate conditions might be influenced by ENSO and IOD, to result in unusual dengue outbreaks.	[Chuang, Ting-Wu; Chen, Po-Jiang] Taipei Med Univ, Coll Med, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan; [Chaves, Luis Fernando] Univ Costa Rica, Ctr Invest Enfermedades Trop, San Pedro, Costa Rica; [Chaves, Luis Fernando] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica	Taipei Medical University; Universidad Costa Rica; Universidad Nacional Costa Rica	Chuang, TW (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Mol Parasitol & Trop Dis, Taipei, Taiwan.	chtingwu@tmu.edu.tw	Chaves, Luis Fernando/F-3448-2010	Chaves, Luis Fernando/0000-0002-5301-2764; Chuang, Ting-Wu/0000-0001-8359-8172	Ministry of Science and Technology, Taiwan [MOST104-2119M -038-002]; University System of Taipei Joint Research Program [NTPU-TMU-103-01]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); University System of Taipei Joint Research Program	This study was funded by the Ministry of Science and Technology, Taiwan (MOST104-2119M -038-002) and the University System of Taipei Joint Research Program (NTPU-TMU-103-01).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2014, CLIMATE CHANGE N AM; Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681; Atique S, 2016, ASIAN PAC J TROP MED, V9, P932, DOI 10.1016/j.apjtm.2016.07.033; Banu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16105; Betancourt-Cravioto M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003009; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043; Chang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep35028; Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Chaves LF, 2014, ACTA TROP, V129, P15, DOI 10.1016/j.actatropica.2013.02.025; Chaves LF, 2012, J INFECT DIS, V205, P1885, DOI 10.1093/infdis/jis289; Chaves LF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000033; Chen MJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040659, 10.1371/journal.pone.0034651]; Chen SC, 2012, SCI TOTAL ENVIRON, V431, P385, DOI 10.1016/j.scitotenv.2012.05.012; Chen SC, 2010, SCI TOTAL ENVIRON, V408, P4069, DOI 10.1016/j.scitotenv.2010.05.021; Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018; Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Earnest A, 2012, EPIDEMIOL INFECT, V140, P1244, DOI 10.1017/S095026881100183X; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Guo Cui, 2015, Malar J, V14, P116, DOI 10.1186/s12936-015-0630-6; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; Hashizume M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-98; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Kaplan M, 1995, UNDERSTANDING NONLIN; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285; Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Ninphanomchai S, 2014, INT J ENV RES PUB HE, V11, P10694, DOI 10.3390/ijerph111010694; Phung D, 2016, TROP MED INT HEALTH, V21, P1324, DOI 10.1111/tmi.12754; Ruiz D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-206; Ruiz D, 2014, AM J TROP MED HYG, V91, P27, DOI 10.4269/ajtmh.13-0363; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Sharmin S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003901; Shi Y, 2016, ENVIRON HEALTH PERSP, V124, P1369, DOI 10.1289/ehp.1509981; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sriprom M, 2010, SCI TOTAL ENVIRON, V408, P5521, DOI 10.1016/j.scitotenv.2010.08.024; Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8; Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003; Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; Vu Ha Hai, 2014, Trop Med Health, V42, P25, DOI 10.2149/tmh.2013-24; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Xiang JJ, 2017, ENVIRON RES, V153, P17, DOI 10.1016/j.envres.2016.11.009; Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114	67	38	40	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178698	10.1371/journal.pone.0178698	http://dx.doi.org/10.1371/journal.pone.0178698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575035	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300098
J	Gallagher, KE; Howard, N; Kabakama, S; Mounier-Jack, S; Griffiths, UK; Feletto, M; Burchett, HED; LaMontagne, DS; Watson-Jones, D				Gallagher, Katherine E.; Howard, Natasha; Kabakama, Severin; Mounier-Jack, Sandra; Griffiths, Ulla K.; Feletto, Marta; Burchett, Helen E. D.; LaMontagne, D. Scott; Watson-Jones, Deborah			Lessons learnt from human papillomavirus (HPV) vaccination in 45 low-and middle income countries	PLOS ONE			English	Article							CERVICAL-CANCER PREVENTION; YOUNG ADOLESCENT GIRLS; VIRUS VACCINATION; DEMONSTRATION PROJECT; HIGH COVERAGE; SCHOOL GIRLS; HEALTH; PROGRAMS; DELIVERY; UGANDA	Objective To synthesise lessons learnt and determinants of success from human papillomavirus (HPV) vaccine demonstration projects and national programmes in low- and middle-income countries (LAMICs). Methods Interviews were conducted with 56 key informants. A systematic literature review identified 2936 abstracts from five databases; after screening 61 full texts were included. Unpublished literature, including evaluation reports, was solicited from country representatives; 188 documents were received. A data extraction tool and interview topic guide outlining key areas of inquiry were informed by World Health Organization guidelines for new vaccine introduction. Results were synthesised thematically. Results Data were analysed from 12 national programmes and 66 demonstration projects in 46 countries. Among demonstration projects, 30 were supported by the GARDASIL Access Program, 20 by Gavi, four by PATH and 12 by other means. School-based vaccine delivery supplemented with health facility-based delivery for out-of-school girls attained high coverage. There were limited data on facility-only strategies and little evaluation of strategies to reach out-of-school girls. Early engagement of teachers as partners in social mobilisation, consent, vaccination day coordination, follow-up of non-completers and adverse events was considered invaluable. Micro-planning using school/facility registers most effectively enumerated target populations; other estimates proved inaccurate, leading to vaccine under-or over-estimation. Refresher training on adverse events and safe injection procedures was usually necessary. Conclusion Considerable experience in HPV vaccine delivery in LAMICs is available. Lessons are generally consistent across countries and dissemination of these could improve HPV vaccine introduction.	[Gallagher, Katherine E.; Watson-Jones, Deborah] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Gallagher, Katherine E.; Kabakama, Severin; Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Howard, Natasha; Mounier-Jack, Sandra; Griffiths, Ulla K.; Burchett, Helen E. D.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Feletto, Marta; LaMontagne, D. Scott] Ctr Vaccine Innovat & Access, PATH, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	Gallagher, KE (corresponding author), London Sch Hyg & Trop Med, Clin Res Dept, London, England.; Gallagher, KE (corresponding author), Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania.	katherine.gallagher@lshtm.ac.uk		Gallagher, Katherine/0000-0002-5604-7647; Kabakama, Severin/0000-0003-0011-9434; Burchett, Helen/0000-0002-8380-2476; Howard, Natasha/0000-0003-4174-7349	Bill & Melinda Gates Foundation [OPP1115326]; Medical Research Council [1363247] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Bill & Melinda Gates Foundation [grant OPP1115326]. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca K, 2008, REV MED CHILE, V136, P1485; Abuelo CE, 2014, J COMMUN HEALTH, V39, P409, DOI 10.1007/s10900-013-9786-6; Adams M, 2007, VACCINE, V25, P3007, DOI 10.1016/j.vaccine.2007.01.016; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P237; [Anonymous], 2009, B WORLD HEALTH ORGAN, V84, P118; Aujo JC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-155; Ayissi CA, 2012, J COMMUN HEALTH, V37, P1127, DOI 10.1007/s10900-012-9554-z; Baker ML, 2015, REV PANAM SALUD PUBL, V38, P163; Baker ML, 2015, PARENTAL PERCEPTIONS, V25, P10; Banura C, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-24; Bartolini RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048017; Binagwaho A, 2013, B WORLD HEALTH ORGAN, V91, P697, DOI 10.2471/BLT.12.116087; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Botha MH, 2015, SAMJ S AFR MED J, V105, P40, DOI [10.7196/SAMJ.8419, 10.7196/samj.8419]; Botha MH, 2014, INT J GYNECOL CANCER, V24, P821; Cervical Cancer Action, 2015, CERV CANC ACT PROGR; Cover JK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-629; Dorji T, 2015, VACCINE, V33, P3726, DOI 10.1016/j.vaccine.2015.05.078; Dreyer G, 2015, SAMJ S AFR MED J, V105, P912, DOI [10.7196/SAMJ.2015.v105i11.9814, 10.7196/SAMJ.2015.V105I11.9814]; Fregnani JHTG, 2013, PLOS ONE, V8; Galagan SR, 2013, VACCINE, V31, P3072, DOI 10.1016/j.vaccine.2013.04.056; Gavi Alliance, 2014, GUID HUM PAP HPV V S; Grover S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00239; Hanson CM, 2015, VACCINES-BASEL, V3, P408, DOI 10.3390/vaccines3020408; Hasahya OT, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.29336; Herrero R, 2015, LANCET ONCOL, V16, pE206, DOI 10.1016/S1470-2045(14)70481-4; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jain KM, 2013, SEX HEALTH, V10, P57, DOI 10.1071/SH11161; Jauregui B, 2011, VACCINE, V29, P1099, DOI 10.1016/j.vaccine.2010.11.075; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kabakama S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3517-8; Katagwa VN, 2014, EUR J CANCER PREV, V23, P294, DOI 10.1097/CEJ.0000000000000021; Katahoire AR, 2013, INT J CHILD ADOLESC, V6, P211; Katz IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072094; Kury C. M. H., 2013, Trials in Vaccinology, V2, P19, DOI 10.1016/j.trivac.2013.08.001; Ladner J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-670; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Levin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101114; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; Levinson KL, 2013, INT J GYNECOL CANCER, V23, P141, DOI 10.1097/IGC.0b013e318275b007; Limpaphayom KK, 2014, J CLIN ONCOLOGY, V1; Manga S, 2014, INT J GYNECOL CANCER, V24, P819; Masika MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135563; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moodley I, 2013, SAMJ S AFR MED J, V103, P318, DOI 10.7196/SAMJ.6414; Mugisha E, 2015, AFR HEALTH SCI, V15, P33, DOI 10.4314/ahs.v15i1.5; Muhammad H, 2015, BIOMED RES-INDIA, V26, P65; Nakkazi E, 2011, NAT MED, V17, P272, DOI 10.1038/nm0311-272a; Ngabo F, 2015, VACCINE, V33, P7357, DOI 10.1016/j.vaccine.2015.10.022; Ogembo JG, 2014, VACCINE, V32, P4399, DOI 10.1016/j.vaccine.2014.06.064; Ott JJ, 2011, J PUBLIC HEALTH-UK, V33, P223, DOI 10.1093/pubmed/fdq076; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; PATH, 2015, CERV CANC LIB HPV VA; Paul P, 2012, ASIAN PAC J CANCER P, V13, P2587, DOI 10.7314/APJCP.2012.13.6.2587; Penny M, 2011, VACCINE, V29, P5022, DOI 10.1016/j.vaccine.2011.04.078; Peters LM, 2010, J CANCER EDUC, V25, P153, DOI 10.1007/s13187-009-0018-9; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; Raesima MM, 2015, MMWR-MORBID MORTAL W, V64, P1147, DOI 10.15585/mmwr.mm6440a5; Ramogola-Masire D., 2015, INTERNATIONAL JOURNA, V131, pE18; Sankaranarayanan R, 2015, INT J GYNECOL OBSTET, V131, pS33, DOI 10.1016/j.ijgo.2015.02.014; Sathyanarayana T, 2015, SEX TRANSM INFECT, V91, pA61, DOI 10.1136/sextrans-2015-052270.166; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Singh Y, 2010, ASIAN PAC J CANCER P, V11, P615; Snyman LC, 2015, SAMJ S AFR MED J, V105, P115, DOI [10.7196/SAMJ.8418, 10.7196/samj.8418]; Strategic Advisory Group of Experts (SAGE) on Immunization W, 2014, EV BAS REC HUM PAP V; Tathiah N, 2015, SAMJ S AFR MED J, V105, DOI [10.7196/SAMJ.2015.v105i11.10135, 10.7196/SAMJ.2015.V105I11.10135]; Torres-Rueda S, 2016, SEX REPROD HEALTHC, V7, P46, DOI 10.1016/j.srhc.2015.11.006; Tsu VD, 2014, JAIDS-J ACQ IMM DEF, V66, pS209, DOI 10.1097/QAI.0000000000000175; Turiho AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137094; Turiho AK, 2014, AFR J REPROD HEALTH, V18, P45; UNESCO Institute of Statistics, 2015, ED ENR LEV ED PRIM; Vallejos-Sologuren C, 2010, ANN ONCOL, V21, P41; Vermandere H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109353; Wamai RG, 2013, INT J NURS STUD, V50, P1399, DOI 10.1016/j.ijnurstu.2012.12.020; Wamai RG, 2012, J COMMUN HEALTH, V37, P917, DOI 10.1007/s10900-012-9540-5; Watson-Jones D, 2014, 29 INT PAP C HPV 201; Watson-Jones D, 2013, DEL UPT ACC HPV VACC; Watson-Jones D, 2012, J INFECT DIS; Watson-Jones D, 2016, HEALTH POLICY PLANN, V31, P691, DOI 10.1093/heapol/czv119; Watson-Jones D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045231; World Health Organization, 2013, HPV VACC COMM SPEC C; World Health Organization, 2014, PRINC CONS ADD VACC; World Health Organization (WHO), 2014, HUM PAP VACC WHO POS; Yothasamut J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S5	88	59	59	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177773	10.1371/journal.pone.0177773	http://dx.doi.org/10.1371/journal.pone.0177773			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575074	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000402624300017
J	Tugaeva, KV; Tsvetkov, PO; Sluchanko, NN				Tugaeva, Kristina V.; Tsvetkov, Philipp O.; Sluchanko, Nikolai N.			Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 1 4-3-3/phospho-Tau interaction	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; STRUCTURAL BASIS; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION SITES; RECOMBINANT TAU; BINDING; HSP20; 14-3-3-PROTEINS; DIMERIZATION; AGGREGATION	Abundant regulatory 14-3-3 proteins have an extremely wide interactome and coordinate multiple cellular events via interaction with specifically phosphorylated partner proteins. Notwithstanding the key role of 14-3-3/phosphotarget interactions in many physiological and pathological processes, they are dramatically underexplored. Here, we focused on the 14-3-3 interaction with human Tau protein associated with the development of several neurodegenerative disorders, including Alzheimer's and Parkinson's diseases. Among many known phosphorylation sites within Tau, protein kinase A (PKA) phosphorylates several key residues of Tau and induces its tight interaction with 14-3-3 proteins. However, the stoichiometry and mechanism of 14-3-3 interaction with phosphorylated Tau (pTau) are not clearly elucidated. In this work, we describe a simple bacterial co-expression system aimed to facilitate biochemical and structural studies on the 14-3-3/pTau interaction. We show that dual co-expression of human fetal Tau with PKA in Escherichia coli results in multisite Tau phosphorylation including also naturally occurring sites which were not previously considered in the context of 14-3-3 binding. Tau protein co-expressed with PKA displays tight functional interaction with 14-3-3 isoforms of a different type. Upon triple co-expression with 14-3-3 and PKA, Tau protein could be co-purified with 14-3-3 and demonstrates complex which is similar to that formed in vitro between individual 14-3-3 and pTau obtained from dual co expression. Although used in this study for the specific case of the previously known 14-3-3/pTau interaction, our co-expression system may be useful to study of other selected 14-3-3/phosphotarget interactions and for validations of 14-3-3 complexes identified by other methods.	[Tugaeva, Kristina V.; Sluchanko, Nikolai N.] Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, AN Bach Inst Biochem, Moscow, Russia; [Tugaeva, Kristina V.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow, Russia; [Tsvetkov, Philipp O.] Aix Marseille Univ, INSERM, UMR S CRO2 911, Fac Pharm, Marseille, France; [Tsvetkov, Philipp O.] RAMS, Inst Gen Pathol & Pathophysiol, Moscow, Russia; [Sluchanko, Nikolai N.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biophys, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Lomonosov Moscow State University	Sluchanko, NN (corresponding author), Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, AN Bach Inst Biochem, Moscow, Russia.; Sluchanko, NN (corresponding author), Moscow MV Lomonosov State Univ, Sch Biol, Dept Biophys, Moscow, Russia.	nikolai.sluchanko@mail.ru	Sluchanko, Nikolai/R-4110-2016; Tugaeva, KRistina KT/K-3278-2018	Sluchanko, Nikolai/0000-0002-8608-1416; 	Russian Science Foundation [16-14-10055]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was partially supported by a Russian Science Foundation grant 16-14-10055. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Beall A, 1999, J BIOL CHEM, V274, P11344, DOI 10.1074/jbc.274.16.11344; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; Chernik IS, 2007, MOL CELL BIOCHEM, V295, P9, DOI 10.1007/s11010-006-9266-8; Denison FC, 2014, ARCH BIOCHEM BIOPHYS, V541, P1, DOI 10.1016/j.abb.2013.10.025; Flynn CR, 2007, PROTEIN EXPRES PURIF, V52, P50, DOI 10.1016/j.pep.2006.08.015; Gu YM, 2006, FEBS LETT, V580, P305, DOI 10.1016/j.febslet.2005.12.024; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jansen S, 2017, J BIOL CHEM, V292, P6715, DOI 10.1074/jbc.M116.771097; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Karikari TK, 2017, PROTEIN EXPRES PURIF, V130, P44, DOI 10.1016/j.pep.2016.09.009; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kosmidis S, 2010, J NEUROSCI, V30, P464, DOI 10.1523/JNEUROSCI.1490-09.2010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layfield R, 1996, NEUROSCI LETT, V209, P57, DOI 10.1016/0304-3940(96)12598-2; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Papanikolopoulou K, 2010, BIOCHEM SOC T, V38, P981, DOI 10.1042/BST0380981; Petrvalska O, 2016, J BIOL CHEM, V291, P20753, DOI 10.1074/jbc.M116.724310; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rezabkova L, 2012, BIOPHYS J, V103, P1960, DOI 10.1016/j.bpj.2012.09.021; Rodriguez-Martin T, 2013, NEUROBIOL AGING, V34, P2146, DOI 10.1016/j.neurobiolaging.2013.03.015; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Sadik G, 2009, BIOCHEM BIOPH RES CO, V383, P37, DOI 10.1016/j.bbrc.2009.03.107; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; SCHAUB MC, 1969, BIOCHEM J, V115, P993, DOI 10.1042/bj1150993; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Shelkovnikova T A, 2012, Mol Biol (Mosk), V46, P402; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Sluchanko N. N., 2016, FEBS J; Sluchanko NN, 2008, ARCH BIOCHEM BIOPHYS, V477, P305, DOI 10.1016/j.abb.2008.05.020; Sluchanko NN, 2017, STRUCTURE, V25, P305, DOI 10.1016/j.str.2016.12.005; Sluchanko NN, 2016, PROTEIN EXPRES PURIF, V119, P27, DOI 10.1016/j.pep.2015.11.002; Sluchanko NN, 2015, BBA-PROTEINS PROTEOM, V1854, P492, DOI 10.1016/j.bbapap.2015.02.017; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sluchanko NN, 2011, J ALZHEIMERS DIS, V27, P467, DOI 10.3233/JAD-2011-110692; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sluchanko NN, 2009, FEBS LETT, V583, P2739, DOI 10.1016/j.febslet.2009.07.043; Sluchanko NN, 2009, BIOCHEM BIOPH RES CO, V379, P990, DOI 10.1016/j.bbrc.2008.12.164; Stevers LM, 2016, P NATL ACAD SCI USA, V113, pE1152, DOI 10.1073/pnas.1516631113; Tsvetkov PO, 2012, BIOCHIMIE, V94, P916, DOI 10.1016/j.biochi.2011.09.011; Uhart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055703; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	62	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178933	10.1371/journal.pone.0178933	http://dx.doi.org/10.1371/journal.pone.0178933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575131	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300132
J	Wu, WL; Hu, ZZ; Wang, F; Gu, H; Jiang, XQ; Xu, JJ; Zhan, X; Zheng, DT; Zhang, ZD				Wu, Weiling; Hu, Zhenzhen; Wang, Feng; Gu, Hao; Jiang, Xiuqin; Xu, Jinjin; Zhan, Xi; Zheng, Datong; Zhang, Zhengdong			Mxi1-0 regulates the growth of human umbilical vein endothelial cells through extracellular signal-regulated kinase 1/2 (ERK1/2) and interleukin-8 (IL-8)-dependent pathways	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; IL-8 EXPRESSION; CANCER CELLS; PROLIFERATION; ACTIVATION; PROMOTES; MXI1-SR-ALPHA; MIGRATION; INVASION; ISOFORM	Mxi1 plays an important role in the regulation of cell proliferation. Mxi1-0, a Mxi1 isoform, has a different N-terminal amino acid sequence, intracellular location and expression profile from Mxi1. However, the precise role of Mxi1-0 in cell proliferation and the molecular mechanism underlying its function remain poorly understood. Here, we showed that Mxi1-0 suppression decreased the proliferation of human umbilical vein endothelial cells (HUVECs) along with cell accumulation in the G2/M phase. Mxi1-0 suppression also significantly decreased the expression and secretion of interleukin (IL-8). Neutralizing IL-8 in conditioned medium (CM) from Mxi1-0-overexpressed HUVECs significantly eliminated CM-induced proliferation of HUVECs. In addition, Mxi1-0 suppression significantly decreased the activity of MAP kinase ERK1/2. Treatment of HUVECs with U0126, an ERK1/2 signaling inhibitor, attenuated autocrine production of IL-8 induced by Mxi1-0 overexpression. On the other hand, Mxi1-0 overexpression-induced IL-8 increased the level of phosphorylated ERK1/2 in HUVECs, and such increasing was diminished in cells incubated with CM, which neutralized with anti-IL-8 antibody. Taken together, our results suggest that Mxi1-0 regulates the growth of HUVECs via the IL-8 and ERK1/2 pathways, which apparently reciprocally activate each other.	[Wu, Weiling; Wang, Feng; Zheng, Datong] Nanjing Med Univ, Hosp 2, Childrens Hlth Ctr, Nanjing, Jiangsu, Peoples R China; [Hu, Zhenzhen; Jiang, Xiuqin; Xu, Jinjin; Zheng, Datong] Nanjing Med Univ, Hosp 2, Clin Mol Diagnost Lab, Nanjing, Jiangsu, Peoples R China; [Gu, Hao; Zheng, Datong] Nanjing Med Univ, Clin Sch 2, Nanjing, Jiangsu, Peoples R China; [Zhan, Xi] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhang, Zhengdong] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; University System of Maryland; University of Maryland Baltimore; Nanjing Medical University	Zheng, DT (corresponding author), Nanjing Med Univ, Hosp 2, Childrens Hlth Ctr, Nanjing, Jiangsu, Peoples R China.; Zheng, DT (corresponding author), Nanjing Med Univ, Hosp 2, Clin Mol Diagnost Lab, Nanjing, Jiangsu, Peoples R China.; Zheng, DT (corresponding author), Nanjing Med Univ, Clin Sch 2, Nanjing, Jiangsu, Peoples R China.	dtzheng@njmu.edu.cn	zhang, zheng/HCH-9684-2022	Hu, Zhenzhen/0000-0002-9892-6068	State Key Laboratory of Reproductive Medicine, Nanjing Medical University [SKLRM-KF-1202]; National Natural Science Foundation of China [81301822]; Nanjing Medical University [2012NJMU088]; Medical Science and technology development Foundation; Nanjing Department of Health [YKK13177]	State Key Laboratory of Reproductive Medicine, Nanjing Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University; Medical Science and technology development Foundation; Nanjing Department of Health	This work was supported by research grants from State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM-KF-1202) to Weiling Wu, the National Natural Science Foundation of China (81301822) and the Research Program funded by Nanjing Medical University (2012NJMU088) to Zhenzhen Hu, Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (YKK13177) to Datong Zheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MB, 2013, NEOPLASIA, V15, P1363, DOI 10.1593/neo.11606; Bertoli C, 2013, CURR BIOL, V23, P1629, DOI 10.1016/j.cub.2013.06.063; Bhattacharyya S, 2011, AM J PHYSIOL-LUNG C, V300, pL81, DOI 10.1152/ajplung.00051.2010; Chu JR, 2010, CANCER LETT, V297, P207, DOI 10.1016/j.canlet.2010.05.013; Desai S, 2013, CELL SIGNAL, V25, P1780, DOI 10.1016/j.cellsig.2013.05.025; Dugast-Darzacq C, 2004, ONCOGENE, V23, P8887, DOI 10.1038/sj.onc.1208107; Dugast-Darzacq C, 2007, FEBS J, V274, P4643, DOI 10.1111/j.1742-4658.2007.05992.x; Engstrom LD, 2004, NEOPLASIA, V6, P660, DOI 10.1593/neo.04244; Fan XY, 2016, INFLAMMATION, V39, P47, DOI 10.1007/s10753-015-0221-2; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Hartman ZC, 2013, CANCER RES, V73, P3470, DOI 10.1158/0008-5472.CAN-12-4524-T; Hu ZZ, 2017, CELL SIGNAL, V31, P79, DOI 10.1016/j.cellsig.2017.01.007; Hu ZZ, 2013, EXP CELL RES, V319, P1932, DOI 10.1016/j.yexcr.2013.05.028; Hu ZZ, 2012, MOL CELL BIOCHEM, V369, P157, DOI 10.1007/s11010-012-1378-8; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khan NM, 2017, FREE RADICAL BIO MED, V106, P288, DOI 10.1016/j.freeradbiomed.2017.02.041; Ko JY, 2011, BIOCHEM BIOPH RES CO, V415, P36, DOI 10.1016/j.bbrc.2011.10.005; Lee CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090278; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Meissner M, 2010, J BIOL CHEM, V285, P33797, DOI 10.1074/jbc.M110.137943; Montalbano AM, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9063842; Ngo HKC, 2016, MOL CARCINOGEN, V55, P2236, DOI 10.1002/mc.22464; Parsels LA, 2016, CELL CYCLE, V15, P730, DOI 10.1080/15384101.2016.1148841; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Sun L, 2007, J CELL PHYSIOL, V213, P98, DOI 10.1002/jcp.21090; Sun Q, 2014, CANCER LETT, V354, P245, DOI 10.1016/j.canlet.2014.08.021; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Velpula KK, 2012, STEM CELLS DEV, V21, P1779, DOI 10.1089/scd.2011.0424; Wang JC, 2015, ONCOTARGET, V6, P42825, DOI 10.18632/oncotarget.5739; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24058; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Yang DF, 2011, MOL IMMUNOL, V48, P1784, DOI 10.1016/j.molimm.2011.05.003; Yoo KH, 2007, BIOCHEM BIOPH RES CO, V356, P85, DOI 10.1016/j.bbrc.2007.02.103; Zarogoulidis P, 2014, CANCER INVEST, V32, P197, DOI 10.3109/07357907.2014.898156; Zhao Y, 2013, CANCER SCI, V104, P1062, DOI 10.1111/cas.12182; Zheng DT, 2014, ONCOL REP, V32, P411, DOI 10.3892/or.2014.3170; Zhou J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003179	39	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178831	10.1371/journal.pone.0178831	http://dx.doi.org/10.1371/journal.pone.0178831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575053	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300123
J	Mina, JG; Thye, JK; Alqaisi, AQI; Bird, LE; Dods, RH; Groftehauge, MK; Mosely, JA; Pratt, S; Shams-Eldin, H; Schwarz, RT; Pohl, E; Denny, PW				Mina, John G.; Thye, Julie K.; Alqaisi, Amjed Q. I.; Bird, Louise E.; Dods, Robert H.; Groftehauge, Morten K.; Mosely, Jackie A.; Pratt, Steven; Shams-Eldin, Hosam; Schwarz, Ralph T.; Pohl, Ehmke; Denny, Paul W.			Functional and phylogenetic evidence of a bacterial origin for the first enzyme in sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PALMITOYLTRANSFERASE; APICOMPLEXAN PARASITE; DE-NOVO; SOLUTION SCATTERING; TOXOPLASMA; SACCHAROMYCES; PROTEIN; TRAFFICKING; APICOPLAST; SEQUENCE	Toxoplasma gondii is an obligate, intracellular eukaryotic apicomplexan protozoan parasite that can cause fetal damage and abortion in both animals and humans. Sphingolipids are essential and ubiquitous components of eukaryotic membranes that are both synthesized and scavenged by the Apicomplexa. Here we report the identification, isolation, and analyses of the Toxoplasma serine palmitoyltransferase, an enzyme catalyzing the first and rate-limiting step in sphingolipid biosynthesis: the condensation of serine and palmitoyl-CoA. In all eukaryotes analyzed to date, serine palmitoyltransferase is a highly conserved heterodimeric enzyme complex. However, biochemical and structural analyses demonstrated the apicomplexan orthologue to be a functional, homodimeric serine palmitoyltransferase localized to the endoplasmic reticulum. Furthermore, phylogenetic studies indicated that it was evolutionarily related to the prokaryotic serine palmitoyltransferase, identified in the Sphingomonadaceae as a soluble homodimeric enzyme. Therefore this enzyme, conserved throughout the Apicomplexa, is likely to have been obtained via lateral gene transfer from a prokaryote.	[Mina, John G.; Alqaisi, Amjed Q. I.; Pratt, Steven; Pohl, Ehmke; Denny, Paul W.] Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England; [Thye, Julie K.; Dods, Robert H.; Groftehauge, Morten K.; Mosely, Jackie A.; Pohl, Ehmke] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Alqaisi, Amjed Q. I.] Univ Baghdad, Coll Sci, Dept Biol, Baghdad 10071, Iraq; [Bird, Louise E.] Rutherford Appleton Lab, Oxford Prot Prod Facil UK, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Shams-Eldin, Hosam; Schwarz, Ralph T.] Philipps Univ Marburg, Zentrum Hyg & Infekt Biol, Inst Virol, D-35043 Marburg, Germany	Durham University; Durham University; University of Baghdad; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Philipps University Marburg	Denny, PW (corresponding author), Univ Durham, Dept Biosci, Stockton Rd, Durham DH1 3LE, England.	p.w.denny@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Al-Qaisi, Amjed/ABC-2892-2020; Mosely, Jackie/GRS-3914-2022; Mina, John/AAG-2675-2021; Mina, John/N-8622-2014; Denny, Paul/B-8431-2013; Mina, John/AID-6303-2022	Pohl, Ehmke/0000-0002-9949-4471; Mina, John/0000-0003-0429-1370; Denny, Paul/0000-0002-5051-1613; Mina, John/0000-0003-0429-1370; Alqaisi, Amjed/0000-0002-4759-1085; Groftehauge, Morten/0000-0002-1823-3713; Bird, Louise/0000-0002-9846-5716	Oxford Protein Purification Facility; Biotechnology and Biological Sciences Research Council [BB/D52396X/1, BB/M024156/1] Funding Source: researchfish; Medical Research Council [MR/K018779/1] Funding Source: researchfish; BBSRC [BB/D52396X/1, BB/M024156/1] Funding Source: UKRI; MRC [MR/K018779/1] Funding Source: UKRI	Oxford Protein Purification Facility; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Department of Chemistry Mass Spectrometry Service for analytical support. Also, thanks to Martin Walsh from the Diamond Light Source; Christopher Barnes, Ian Edwards, Tim Hawkins, Joanne Robson, Catherine Bruce, and Emily Cardew from the Department of Biosciences; and Robek Pal from the Department of Chemistry for technical input, support, and many helpful discussions. We gratefully acknowledge the provision of beam time and excellent support by the BL21 staff at the Diamond Light Source. Materials were kindly provided by Prof. Dominique Soldati-Favre (Geneva), Dr. Kristin Hagar (Notre Dame), and Prof. Keith Gull (Oxford). This work was also supported by Grant-in-Aid from Oxford Protein Purification Facility.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Antolinos AD, 2015, ACTA CRYSTALLOGR D, V71, P76, DOI 10.1107/S1399004714019609; Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7; Basham M, 2015, J SYNCHROTRON RADIAT, V22, P853, DOI 10.1107/S1600577515002283; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bird LE, 2011, METHODS, V55, P29, DOI 10.1016/j.ymeth.2011.08.002; CHOWDHURY MNH, 1986, J MED, V17, P373; Coppens I, 2014, INT J PARASITOL, V44, P109, DOI 10.1016/j.ijpara.2013.09.003; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Denny P, 1998, PROTIST, V149, P51, DOI 10.1016/S1434-4610(98)70009-4; Denny PW, 2006, J BIOL CHEM, V281, P28200, DOI 10.1074/jbc.M600796200; Denny PW, 2004, MOL MICROBIOL, V53, P725, DOI 10.1111/j.1365-2958.2004.04208.x; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Funato K, 2002, BIOCHEMISTRY-US, V41, P15105, DOI 10.1021/bi026616d; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gerold P, 2001, MOL BIOCHEM PARASIT, V112, P29, DOI 10.1016/S0166-6851(00)00336-4; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hager KM, 1999, J CELL SCI, V112, P2631; Haldar K, 2002, CELL MICROBIOL, V4, P383, DOI 10.1046/j.1462-5822.2002.00204.x; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; Ikushiro H, 2009, J BIOCHEM, V146, P549, DOI 10.1093/jb/mvp100; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAUER SA, 1995, P NATL ACAD SCI USA, V92, P9181, DOI 10.1073/pnas.92.20.9181; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Perry DK, 2002, BBA-MOL CELL BIOL L, V1585, P146, DOI 10.1016/S1388-1981(02)00335-9; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pfluger SL, 2005, EUKARYOT CELL, V4, P432, DOI 10.1128/EC.4.2.432-442.2005; Pratt S, 2013, MOL BIOCHEM PARASIT, V187, P43, DOI 10.1016/j.molbiopara.2012.11.007; Prieschl EE, 2000, IMMUNOL TODAY, V21, P555, DOI 10.1016/S0167-5699(00)01725-4; Pszenny V, 2016, J BIOL CHEM, V291, P3725, DOI 10.1074/jbc.M115.671974; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shams-Eldin H, 2002, MOL BIOCHEM PARASIT, V120, P73, DOI 10.1016/S0166-6851(01)00434-0; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tuukkanen AT, 2016, IUCRJ, V3, P440, DOI 10.1107/S2052252516016018; van Dooren GG, 2013, ANNU REV MICROBIOL, V67, P271, DOI 10.1146/annurev-micro-092412-155741; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Young SA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/248135; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zeitvogel F, 2016, J MICROSC-OXFORD, V261, P148, DOI 10.1111/jmi.12187; Zeitvogel F., 2016, J OPEN RES SOFTWARE, V4, pe5, DOI DOI 10.5334/J0RS.89; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	62	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12208	12219		10.1074/jbc.M117.792374	http://dx.doi.org/10.1074/jbc.M117.792374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578314	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000406053300018
J	Shindou, H; Koso, H; Sasaki, J; Nakanishi, H; Sagara, H; Nakagawa, KM; Takahashi, Y; Hishikawa, D; Iizuka-Hishikawa, Y; Tokumasu, F; Noguchi, H; Watanabe, S; Sasaki, T; Shimizu, T				Shindou, Hideo; Koso, Hideto; Sasaki, Junko; Nakanishi, Hiroki; Sagara, Hiroshi; Nakagawa, Koh M.; Takahashi, Yoshikazu; Hishikawa, Daisuke; Iizuka-Hishikawa, Yoshiko; Tokumasu, Fuyuki; Noguchi, Hiroshi; Watanabe, Sumiko; Sasaki, Takehiko; Shimizu, Takao			Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; FORCE-FIELD; LYSOPHOSPHOLIPID ACYLTRANSFERASES; RHESUS-MONKEYS; OUTER SEGMENTS; ACYL-COA; RHODOPSIN; CHARMM; MICE; PHOSPHATIDYLCHOLINE	Docosahexaenoic acid (DHA) has essential roles in photoreceptor cells in the retina and is therefore crucial to healthy vision. Although the influence of dietary DHA on visual acuity is well known and the retina has an abundance of DHA-containing phospholipids (PL-DHA), the mechanisms associated with DHA's effects on visual function are unknown. We previously identified lysophosphatidic acid acyltransferase 3 (LPAAT3) as a PL-DHA biosynthetic enzyme. Here, using comprehensive phospholipid analyses and imaging mass spectroscopy, we found that LPAAT3 is expressed in the inner segment of photoreceptor cells and that PL-DHA disappears from the outer segment in the LPAAT3-knock-out mice. Dynamic light-scattering analysis of liposomes and molecular dynamics simulations revealed that the physical characteristics of DHA reduced membrane-bending rigidity. Following loss of PL-DHA, LPAAT3-knock-out mice exhibited abnormalities in the retinal layers, such as incomplete elongation of the outer segment and decreased thickness of the outer nuclear layers and impaired visual function, as well as disordered disc morphology in photoreceptor cells. Our results indicate that PL-DHA contributes to visual function by maintaining the disc shape in photoreceptor cells and that this is a function of DHA in the retina. This study thus provides the reason why DHA is required for visual acuity and may help inform approaches for overcoming retinal disorders associated with DHA deficiency or dysfunction.	[Shindou, Hideo; Takahashi, Yoshikazu; Hishikawa, Daisuke; Iizuka-Hishikawa, Yoshiko; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo 1628655, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Tokumasu, Fuyuki; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Shindou, Hideo; Sasaki, Takehiko] Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Koso, Hideto; Watanabe, Sumiko] Univ Tokyo, Inst Med Sci, Div Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan; [Sagara, Hiroshi] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Nakanishi, Hiroki; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Biosignal Res Ctr, Akita 0108502, Japan; [Nakanishi, Hiroki; Sasaki, Takehiko] Akita Lipid Technol LLC, Akita 0100825, Japan; [Nakagawa, Koh M.; Noguchi, Hiroshi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; Akita University; Akita University; University of Tokyo	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	hshindou-tky@umin.net	Tokumasu, Fuyuki/GQP-4413-2022; Sagara, Hiroshi/GRX-7740-2022; Noguchi, Hiroshi/E-6052-2017; Shimizu, Takao/AAV-7052-2021	Tokumasu, Fuyuki/0000-0003-2790-1071; Sagara, Hiroshi/0000-0001-8456-8362; Noguchi, Hiroshi/0000-0003-1735-7586; Nakanishi, Hiroki/0000-0002-5108-1598; Sasaki, Takehiko/0000-0003-1837-3748; KOSO, HIDETO/0000-0002-8986-7617	JSPS KAKENHI [26460380, 26253006, 15H05899, 15K14947, 24229003]; Takeda Science Foundation; JST-CREST [16gm0710002h0104, gm0710002h0303]; AMED-CREST [16gm0710002h0104, gm0710002h0303]; Grants-in-Aid for Scientific Research [15H05897, 17K19375] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED-CREST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grants 26460380 (to H.S.), 26253006 (to T. Sasaki), 15H05899 (to T. Sasaki), 15K14947 (to T. Sasaki), and 24229003 (to T. Shimizu); the Takeda Science Foundation (to T. Shimizu); JST-CREST Grant 16gm0710002h0104 (to H.S.) and Grant gm0710002h0303 (to T. Sasaki); and AMED-CREST Grant 16gm0710002h0104 (to H.S.) and Grant gm0710002h0303 (to T. Sasaki). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Allen M. P., 1989, COMPUTER SIMULATION, P182; Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Barelli H, 2016, CURR OPIN CELL BIOL, V41, P25, DOI 10.1016/j.ceb.2016.03.012; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; BENOLKEN RM, 1973, SCIENCE, V182, P1253, DOI 10.1126/science.182.4118.1253; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Feller SE, 2005, CURR OPIN STRUC BIOL, V15, P416, DOI 10.1016/j.sbi.2005.07.002; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Imae R, 2012, J LIPID RES, V53, P335, DOI 10.1194/jlr.M018655; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jeffrey BG, 2009, INVEST OPHTH VIS SCI, V50, P4360, DOI 10.1167/iovs.09-3640; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kielkowska Anna, 2014, Advances in Biological Regulation, V54, P131, DOI 10.1016/j.jbior.2013.09.001; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Koso H, 2016, GLIA, V64, P2005, DOI 10.1002/glia.23038; Kurabe Nobuya, 2016, World J Gastrointest Pathophysiol, V7, P235, DOI 10.4291/wjgp.v7.i2.235; LATIES AM, 1976, EXP EYE RES, V23, P139, DOI 10.1016/0014-4835(76)90197-4; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lim JB, 2012, J PHYS CHEM B, V116, P203, DOI 10.1021/jp207925m; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; NEURINGER M, 1984, J CLIN INVEST, V73, P272, DOI 10.1172/JCI111202; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Pall S., 2014, SOLVING SOFTWARE CHA, P3; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Quazi F, 2014, P NATL ACAD SCI USA, V111, P5024, DOI 10.1073/pnas.1400780111; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Suh M, 2000, PEDIATR RES, V48, P524, DOI 10.1203/00006450-200010000-00017; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; Takizawa Y, 2011, AUDIOL NEURO-OTOL, V16, P315, DOI 10.1159/000322308; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Wong BH, 2016, J BIOL CHEM, V291, P10501, DOI 10.1074/jbc.M116.721340; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200; Zhigaltsev IV, 2016, J LIPOSOME RES, V26, P96, DOI 10.3109/08982104.2015.1025411	55	78	79	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12054	12064		10.1074/jbc.M117.790568	http://dx.doi.org/10.1074/jbc.M117.790568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578316	hybrid, Green Published			2022-12-26	WOS:000406053300005
J	Dicken, ML; Hussey, NE; Christiansen, HM; Smale, MJ; Nkabi, N; Cliff, G; Wintner, SP				Dicken, Matthew L.; Hussey, Nigel E.; Christiansen, Heather M.; Smale, Malcolm J.; Nkabi, Nomfundo; Cliff, Geremy; Wintner, Sabine P.			Diet and trophic ecology of the tiger shark (Galeocerdo cuvier) from South African waters	PLOS ONE			English	Article							FRENCH FRIGATE SHOALS; PROTECTIVE GILL NETS; WHALES MEGAPTERA-NOVAEANGLIAE; STABLE-ISOTOPE ANALYSIS; APEX PREDATORY SHARKS; RAY MANTA-ALFREDI; MOVEMENT PATTERNS; WESTERN-AUSTRALIA; HABITAT USE; CARCHARHINUS-BRACHYURUS	Knowledge of the diet and trophic ecology of apex predators is key for the implementation of effective ecosystem as well as species-based management initiatives. Using a combination of stomach content data and stable isotope analysis (delta N-15 and delta C-13) the current study provides information on size-based and sex-specific variations in diet, trophic position (TP) and foraging habitat of tiger sharks (Galeocerdo cuvier) caught in the KwaZulu-Natal Sharks Board bather protection program. This study presents the longest time-series and most detailed analysis of stomach content data for G. cuvier worldwide. Prey identified from 628 non-empty stomachs revealed a size-based shift in diet. Reptiles, birds, mysticetes, and large shark species increased in dietary importance with G. cuvier size, concomitant with a decrease in smaller prey such as batoids and teleosts. Seasonal and decadal shifts in diet driven primarily by changes in the importance of elasmobranchs and mammal (cetacean) prey were recorded for medium sized (150-220 cm) G. cuvier. Both stomach content and stable isotope analysis indicated that G. cuvier is a generalist feeder at the population level. Size-based delta C-13 profiles indicated a movement to offshore foraging habitats by larger G. cuvier. Calculated TP varied by method ranging from 4.0 to 5.0 (TPSCA for stomach contents) and from 3.6 to 4.5 (TPscaled and TPadditive for delta N-15). Large (> 220 cm) G. cuvier did not feed at discrete trophic levels, but rather throughout the food web. These data provide key information on the ecological role of G. cuvier to improve the accuracy of regional food web modelling. This will enable a better understanding of the ecological impacts related to changes in the abundance of this predator.	[Dicken, Matthew L.; Nkabi, Nomfundo; Cliff, Geremy; Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa; [Dicken, Matthew L.] Univ Ft Hare, Dept Zool & Entomol, Alice, South Africa; [Hussey, Nigel E.; Christiansen, Heather M.] Univ Windsor, Biol Sci, Windsor, ON, Canada; [Smale, Malcolm J.] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa; [Smale, Malcolm J.] Port Elizabeth Museum, Port Elizabeth, South Africa; [Cliff, Geremy; Wintner, Sabine P.] Univ KwaZulu Natal, Biomed Resource Unit, Durban, South Africa	University of Fort Hare; University of Windsor; Nelson Mandela University; University of Kwazulu Natal	Dicken, ML (corresponding author), KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa.; Dicken, ML (corresponding author), Univ Ft Hare, Dept Zool & Entomol, Alice, South Africa.	matt@shark.co.za	Dicken, Matt/Z-1385-2019	Cliff, Geremy/0000-0003-1790-6055; Dicken, Matt/0000-0001-9779-2347; Smale, Malcolm/0000-0002-1135-8687				Bass AJ, 1975, INVEST REP OCEANOGR, V38, P100; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Best PB, 1998, MAR ECOL PROG SER, V162, P287, DOI 10.3354/meps162287; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bornatowski H, 2012, J MAR BIOL ASSOC UK, V92, P1767, DOI 10.1017/S0025315412001154; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Capon S.J, 2015, SCI TOTAL ENV; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2002, SOUTHEAST NAT, V1, P307, DOI 10.1656/1528-7092(2002)001[0307:AOOJTS]2.0.CO;2; CLAPHAM PJ, 2002, ENCY MARINE MAMMALS, P1328; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clarke M.R, 1986, HDB IDENTIFICATION C; CLIFF G, 1992, S AFR J MARINE SCI, V12, P663; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cliff G, 2011, MAR FRESHWATER RES, V62, P700, DOI 10.1071/MF10182; Compagno L. J. V., 1984, FAO Fisheries Synopsis, P251; Compagno L.J.V., 1989, GUIDE SHARKS RAYS SO; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Couturier LIE, 2014, CORAL REEFS, V33, P329, DOI 10.1007/s00338-014-1126-5; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; da Silva C, 2015, AFR J MAR SCI, V37, P233, DOI 10.2989/1814232X.2015.1044471; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dicken ML, 2016, AFR J MAR SCI, V38, P285, DOI 10.2989/1814232X.2016.1198276; Dicken ML, 2015, MAR FRESHWATER RES, V66, P1211, DOI 10.1071/MF14317; Dudley SFJ, 2006, MAR FRESHWATER RES, V57, P225, DOI 10.1071/MF05156; Dudley SFJ, 2005, AFR J MAR SCI, V27, P107, DOI 10.2989/18142320509504072; Dudley SFJ, 1998, MAR FRESHWATER RES, V49, P653, DOI 10.1071/MF98026; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estrada JA, 2005, MAR BIOL, V147, P37, DOI 10.1007/s00227-004-1541-1; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Findlay KP, 2011, AFR J MAR SCI, V33, P375, DOI 10.2989/1814232X.2011.637345; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; Fitzpatrick B, 2006, B MAR SCI, V78, P397; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Fu AL, 2016, J MORPHOL, V277, P556, DOI 10.1002/jmor.20515; Grubbs RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep20970; Hammerschlag N, 2015, ECOLOGY, V96, P2117, DOI 10.1890/14-2113.1; Hammerschlag N, 2013, FUNCT ECOL, V27, P1273, DOI 10.1111/1365-2435.12157; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2003, J THEOR BIOL, V223, P79, DOI 10.1016/S0022-5193(03)00073-0; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, ENVIRON BIOL FISH, V61, P25, DOI 10.1023/A:1011021210685; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Holmes BJ, 2014, MAR BIOL, V161, P2645, DOI 10.1007/s00227-014-2536-1; Holmes BJ, 2012, FISH RES, V129, P38, DOI 10.1016/j.fishres.2012.06.005; Hughes GR, 1974, INVEST REP OCEANOGR, V35, P144; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Hussey N.E., 2015, FOOD WEBS, V4, P1, DOI [10.1016/j.fooweb.2015.04.002, DOI 10.1016/J.FOOWEB.2015.04.002]; Hussey NE, 2014, ECOL LETT, V17, P768, DOI 10.1111/ele.12270; Hussey NE, 2014, ECOL LETT, V17, P239, DOI 10.1111/ele.12226; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Huveneers C, 2007, ICES J MAR SCI, V64, P1272, DOI 10.1093/icesjms/fsm111; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Ineich I, 2002, SERPENTS MARINS NOUV; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Li YK, 2016, RAPID COMMUN MASS SP, V30, P1, DOI 10.1002/rcm.7396; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Mac Nally R, 2014, AUSTRAL ECOL, V39, P898, DOI 10.1111/aec.12162; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Malcolm H., 2001, REV BIOL STATUS WHIT; Marquez MR., 1990, FAO FISHERIES SYNOPS, V11, P1; Marshall AD, 2010, AFR J MAR SCI, V32, P573, DOI 10.2989/1814232X.2010.538152; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; Matich P, 2010, CAN J FISH AQUAT SCI, V67, P877, DOI 10.1139/F10-037; Mazzuca L., 1998, Pacific Science, V52, P1; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Naessig PJ, 2004, WILDLIFE RES, V31, P163, DOI 10.1071/WR03086; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Platell ME, 2001, J EXP MAR BIOL ECOL, V261, P31, DOI 10.1016/S0022-0981(01)00257-X; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; RANCUREL P, 1982, Tethys, V10, P195; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Sherwood GD, 2005, ESTUAR COAST SHELF S, V63, P537, DOI 10.1016/j.ecss.2004.12.010; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Smale M. J., 1995, ICHTHYOLOGICAL MONOG, V1, P1, DOI DOI 10.5962/BHL.TITLE.141860; SMALE MJ, 1991, S AFR J MARINE SCI, V11, P31, DOI 10.2989/025776191784287808; Smale MJ, 1998, S AFR J MARINE SCI, V20, P241; SMALE MJ, 1993, S AFR J MARINE SCI, V13, P269, DOI 10.2989/025776193784287338; SOUSA MI, 1997, TRADE SHARKS SHARK P, P67; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TRICAS TC, 1981, COPEIA, P904, DOI 10.2307/1444199; Trystram C, 2016, CAN J FISH AQUAT SCI; Vander Zanden HB, 2013, MAR ECOL PROG SER, V476, P237, DOI 10.3354/meps10185; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Vander Zanden MJ, CAN J FISH AQUAT SCI; Vaudo JJ, 2014, ECOL EVOL, V4, P1768, DOI 10.1002/ece3.1053; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; Wetherbee BM, 2004, CRC MAR BIOL SER, P225; White WT, 2004, MAR BIOL, V144, P439, DOI 10.1007/s00227-003-1218-1; Wilson SG, 2001, B MAR SCI, V68, P361; Wintner SP, 2000, MAR FRESHWATER RES, V51, P43, DOI 10.1071/MF99077; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	114	42	42	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177897	10.1371/journal.pone.0177897	http://dx.doi.org/10.1371/journal.pone.0177897			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594833	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200014
J	Feng, W; Lei, HM; Si, JR; Zhang, T				Feng, Wei; Lei, Huimin; Si, Jiarui; Zhang, Tao			Study of structural stability and damaging effect on membrane for four A beta 42 dimers	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BILAYER; PARAMETERS	Increasing evidence shows that A beta oligomers are key pathogenic molecules in Alzheimer's disease. Among A beta oligomers, dimer is the smallest aggregate and toxic unit. Therefore, understanding its structural and dynamic properties is quite useful to prevent the formation and toxicity of the A beta oligomers. In this study, we performed molecular dynamic simulations on four A beta 42 dimers, 2NCb, CNNC, NCNC and NCCN, within the hydrated DPPC membrane. Four A beta 42 dimers differ in the arrangements of two A beta 42 peptides. This study aims to investigate the impact of aggregation pattern of two A beta peptides on the structural stability of the A beta 42 dimer and its disruption to the biological membrane. The MD results demonstrate that the NCCN, CNNC and NCNC have the larger structural fluctuation at the N-terminus of A beta 42 peptide, where the beta-strand structure converts into the coil structure. The loss of the N-terminal beta-strand further impairs the aggregate ability of A beta 42 dimer. In addition, inserting A beta 42 dimer into the membrane can considerably decrease the average APL of DPPC membrane. Moreover this decrease effect is largely dependent on the distance to the location of A beta 42 dimer and its secondary structure forms. Based on the results, the 2NCb is considered as a stable dimeric unit for aggregating the larger A beta 42 oligomer, and has a potent ability to disrupt the membrane.	[Feng, Wei; Lei, Huimin; Zhang, Tao] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Lei, Huimin] Tianjin Med Univ, Sch Continuat Educ, Tianjin, Peoples R China; [Si, Jiarui] Tianjin Med Univ, Sch Basic Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Zhang, T (corresponding author), Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China.	zhangtao@tijmu.edu.cn			National Natural Science Foundation of China [31300597]; China Postdoctoral Science Foundation [2013M530878]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China 31300597 (http://www.nsfc.gov.cn/) and China Postdoctoral Science Foundation 2013M530878 (http://www.chinapostdoctor.org.cn/WebSite/program/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Charles D, 2009, BIOPHYS J, V96, P785; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DOULIEZ JP, 1995, BIOPHYS J, V68, P1727, DOI 10.1016/S0006-3495(95)80350-4; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lemkul JA, 2013, BIOCHEMISTRY-US, V52, P4971, DOI 10.1021/bi400562x; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; SEELIG J, 1974, BIOCHEMISTRY-US, V13, P1585, DOI 10.1021/bi00705a005; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171	18	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179147	10.1371/journal.pone.0179147	http://dx.doi.org/10.1371/journal.pone.0179147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594887	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200090
J	Ko, HH; Chien, WC; Lin, YH; Chung, CH; Cheng, SJ				Ko, Hui-Hsin; Chien, Wu-Chien; Lin, Yen-Hung; Chung, Chi-Hsiang; Cheng, Shih-Jung			Examining the correlation between diabetes and odontogenic infection: A nationwide, retrospective, matched-cohort study in Taiwan	PLOS ONE			English	Article							DEEP NECK INFECTION; MELLITUS; MANAGEMENT; ABSCESS; AGE	More than 90% of head and neck infections are caused by pathological changes originating in the teeth. When odontogenic infections are not properly treated, infections may spread to distant spaces and cause more serious infections in fascial spaces, ultimately leading to deep neck infections. Clinical experience has indicated that patients with diabetes mellitus (DM) may be more susceptible to facial cellulitis and deep neck infections caused by odontogenic infections. This study used the Taiwan National Health Insurance Database (NHIRD) to analyze and examine the correlation between DM and odontogenic infections in patients. To this end, this study analyzed 1 million NHIRD individual datasets from 2005, of which 964,182 individuals had medical treatment records. The insurance database also recorded related factors such as age, sex, duration of hospital stays, season, and whether patients were low income. We also analyzed the correlation between urbanization and the studied diseases. The results indicated that the correlation between facial cellulitis and DM patients was confirmed; facial cellulitis was most likely to occur 2 years after the initial DM diagnosis, with a risk occurrence 1.409 times greater than that of the control group. Facial cellulitis is more likely to occur in patients originating from poorer socioeconomic backgrounds, and female DM patients are more likely to experience this condition. These conclusions may facilitate the establishment of clinical guidelines for preventative education and treatment. Oral prevention and health education for high-risk patients, as well as early-stage surgical intervention and antibiotic usage in early-stage odontogenic infections, can prevent disease progression, improve patient recovery rates, and reduce the use and waste of medical resources.	[Ko, Hui-Hsin; Lin, Yen-Hung; Cheng, Shih-Jung] Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei, Taiwan; [Ko, Hui-Hsin; Cheng, Shih-Jung] Natl Taiwan Univ Hosp, Coll Med, Dept Dent, Taipei, Taiwan; [Ko, Hui-Hsin] Natl Taiwan Univ Hosp, Dept Dent, Hsin Chu Branch, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lin, Yen-Hung] Linkou Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Taoyuan, Taiwan; [Cheng, Shih-Jung] Natl Taiwan Univ, Sch Dent, Taipei, Taiwan; [Cheng, Shih-Jung] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Defense Medical Center; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University	Cheng, SJ (corresponding author), Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei, Taiwan.; Cheng, SJ (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Dept Dent, Taipei, Taiwan.; Cheng, SJ (corresponding author), Natl Taiwan Univ, Sch Dent, Taipei, Taiwan.; Cheng, SJ (corresponding author), Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei, Taiwan.	sjcheng56@ntu.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	LIN, YEN-HUNG/0000-0001-8153-1441; Cheng, Shih-Jung/0000-0003-4674-4892				Agarwal Mukesh M., 2007, Archives of Gynecology and Obstetrics, V276, P237, DOI 10.1007/s00404-007-0334-4; [Anonymous], GLOB HLTH EST DEATHS; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Bai YL, 2009, J CLIN NURS, V18, P3308, DOI 10.1111/j.1365-2702.2009.02992.x; Bartold P M, 1998, J N Z Soc Periodontol, P7; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; BRIDGEMAN A, 1995, AUST DENT J, V40, P281, DOI 10.1111/j.1834-7819.1995.tb04814.x; Bross-Soriano D, 2004, OTOLARYNG HEAD NECK, V130, P712, DOI 10.1016/j.otohns.2003.09.036; CARDOSO AS, 1971, J DENT RES, V50, P934, DOI 10.1177/00220345710500042501; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Chen MK, 1998, J OTOLARYNGOL, V27, P141; Cheng NC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1144-0; Daniel R, 2012, J PHARM BIOALLIED SC, V4, pS280, DOI 10.4103/0975-7406.100251; Fragiskos D., 2007, ORAL SURG, P205; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; GILBERT HS, 1978, METABOLISM, V27, P889, DOI 10.1016/0026-0495(78)90132-4; Herrera D, 2000, J CLIN PERIODONTOL, V27, P387, DOI 10.1034/j.1600-051x.2000.027006387.x; Hill Jacqueline, 2013, Perm J, V17, P67, DOI 10.7812/TPP/12-099; Huang TT, 2005, OTOLARYNG HEAD NECK, V132, P943, DOI 10.1016/j.otohns.2005.01.035; Huang TT, 2004, HEAD NECK-J SCI SPEC, V26, P854, DOI 10.1002/hed.20014; JONES RL, 1981, AM J MED, V70, P339, DOI 10.1016/0002-9343(81)90771-3; KANTER Y, 1975, DIABETES, V24, P724, DOI 10.2337/diabetes.24.8.724; Lalla RV, 2001, J AM DENT ASSOC, V132, P1425, DOI 10.14219/jada.archive.2001.0059; Lin HT, 2006, J LARYNGOL OTOL, V120, P650, DOI 10.1017/S0022215106001149; Liu PY, 1999, CHINESE MED J-PEKING, V112, P612; Lynch J, 2013, DIABETES CARE, V36, P1735, DOI 10.2337/dc12-2420; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matteo Monami, 2006, DIABETES-METAB RES, V1, P3; MORENKOVA SA, 1987, ACTA DIABETOL LAT, V24, P119, DOI 10.1007/BF02742850; Nagasawa T, 2010, INTERNAL MED, V49, P881, DOI 10.2169/internalmedicine.49.3351; National Health Insurance Administration (NHIA), NAT HLTH INS ANN REP; Newman HN, 1996, J DENT RES, V75, P1912, DOI 10.1177/00220345960750120101; Nordfeldt S, 2000, J PEDIATR ENDOCR MET, V13, P529; Ouyang CM, 2015, ASIA PAC J CLIN NUTR, V24, P430, DOI 10.6133/apjcn.2015.24.3.02; Parhiscar A, 2001, ANN OTO RHINOL LARYN, V110, P1051, DOI 10.1177/000348940111001111; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Sakura H, 2010, DIABETES RES CLIN PR, V88, P65, DOI 10.1016/j.diabres.2009.12.011; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simpson TC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub2; Tai TY, 2000, DIABETES RES CLIN PR, V50, pS1, DOI 10.1016/S0168-8227(00)00172-8; Tien KJ, 2016, J FORMOS MED ASSOC, V115, P343, DOI 10.1016/j.jfma.2015.03.010; Weinstock RS, 2013, DIABETES CARE, V36, P1758, DOI 10.2337/dc12-2388; Wu JC, 2012, J NEUROTRAUM, V29, P889, DOI 10.1089/neu.2011.1777; Yonetsu K, 1998, AM J NEURORADIOL, V19, P123	46	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178941	10.1371/journal.pone.0178941	http://dx.doi.org/10.1371/journal.pone.0178941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594848	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200069
J	Medin, AC; Hansen, BH; Astrup, H; Ekelund, U; Andersen, LF				Medin, Anine Christine; Hansen, Bjorge Herman; Astrup, Helene; Ekelund, Ulf; Andersen, Lene Frost			Validation of energy intake from a web-based food recall for children and adolescents	PLOS ONE			English	Article							DOUBLY-LABELED WATER; BASAL METABOLIC-RATE; DIETARY ASSESSMENT; ELEMENTARY-SCHOOLS; LUNCH OBSERVATIONS; PHYSICAL-ACTIVITY; GOLDBERG CUTOFF; EXPENDITURE; DIARY; VALIDITY	The purpose of this study was to validate estimated energy intake from a web-based food recall, designed for children and adolescents. We directly compared energy intake to estimates of total energy expenditure, calculated from accelerometer outputs, combined with data on weight and sex or resting energy expenditure prediction equations. Children (8-9 years) and adolescents (12-14 years) were recruited through schools in Norway in 2013 (N = 253). Results showed that more than one third (36-37%) were identified as under-reporters of energy. In contrast, only 2-4% were defined as over-reporters of energy. The mean energy intake was under-reported with -1.83 MJ/day for the entire study sample. Increased underestimation was observed for overweight and obese participants, the oldest age group (12-14 years), boys, those with parents/legal guardians with low educational level and those living in non-traditional families. In conclusion, energy intake from the web-based food recall is significantly underestimated compared with total energy expenditure, and should be used with caution in young people.	[Medin, Anine Christine; Astrup, Helene; Andersen, Lene Frost] Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Hansen, Bjorge Herman; Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	University of Oslo; Norwegian School of Sport Sciences	Medin, AC (corresponding author), Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.	a.c.medin@medisin.uio.no	Andersen, Lene/ABC-1337-2021; Ekelund, Ulf/AAE-8471-2019	Ekelund, Ulf/0000-0003-2115-9267; Medin, Anine Christine/0000-0003-4154-6264	Institute of Basic Medical Sciences, University of Oslo; Throne Hoist Nutrition Research Foundation	Institute of Basic Medical Sciences, University of Oslo; Throne Hoist Nutrition Research Foundation	This study was funded by the Institute of Basic Medical Sciences, University of Oslo (to LFA), with supplementary funds from the Throne Hoist Nutrition Research Foundation (to LFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActiGraph, WHAT IS DIFF MET ALG; Adamson AJ, 2014, J HUM NUTR DIET, V27, P1, DOI 10.1111/jhn.12206; Andersen LF, 2005, PUBLIC HEALTH NUTR, V8, P1315, DOI 10.1079/PHN2005751; Biltoft-Jensen A, 2014, J HUM NUTR DIET, V27, P43, DOI 10.1111/j.1365-277X.2012.01257.x; Biltoft-Jensen A, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.21434; Biltoft-Jensen A, 2013, BRIT J NUTR, V110, P186, DOI 10.1017/S0007114512004746; Biltoft-Jensen A, 2009, BRIT J NUTR, V102, P1838, DOI 10.1017/S0007114509991292; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 2000, EUR J CLIN NUTR, V54, P386, DOI 10.1038/sj.ejcn.1600970; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; Corella D, 2015, NUTR HOSP, V31, P177, DOI 10.3305/nh.2015.31.sup3.8765; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Gemming L, 2015, J ACAD NUTR DIET, V115, P64, DOI 10.1016/j.jand.2014.09.015; GERSOVITZ M, 1978, J AM DIET ASSOC, V73, P48; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Illner AK, 2012, INT J EPIDEMIOL, V41, P1187, DOI 10.1093/ije/dys105; Lillegaard ITL, 2007, EUR J CLIN NUTR, V61, P61, DOI 10.1038/sj.ejcn.1602487; Lillegaard ITL, 2005, BRIT J NUTR, V94, P998, DOI 10.1079/BJN20051587; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Mangunkusumo RT, 2006, J SCHOOL HEALTH, V76, P80, DOI 10.1111/j.1746-1561.2006.00072.x; Mannes AE, 2014, J PERS SOC PSYCHOL, V107, P276, DOI 10.1037/a0036677; Medin AC, 2016, PUBLIC HEALTH NUTR, V19, P3265, DOI 10.1017/S1368980016001622; Medin AC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.5031; Rangan AM, 2011, NUTRIENTS, V3, P186, DOI 10.3390/nu3020186; Rhee JJ, 2015, AM J EPIDEMIOL, V181, P225, DOI 10.1093/aje/kwu308; Richter SL, 2012, J ACAD NUTR DIET, V112, P1603, DOI 10.1016/j.jand.2012.07.010; Rosenbaum M, 1996, AM J PHYSIOL-REG I, V270, pR496, DOI 10.1152/ajpregu.1996.270.3.R496; Rothausen BW, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.12221; Schap TE, 2014, J HUM NUTR DIET, V27, P82, DOI 10.1111/jhn.12071; Serra-Majem L, 2009, BRIT J NUTR, V102, pS3, DOI 10.1017/S0007114509993114; Svensson A, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/247389; The Norwegian Directorate of Health, 2012, PHYS ACT 6 9 15 YEAR; Thompson FE, 2013, NUTR PREVENTION TREA, P5, DOI DOI 10.1016/B978-0-12-391884-0.00001-9; Thompson FE, 2010, J AM DIET ASSOC, V110, P48, DOI 10.1016/j.jada.2009.10.008; Trijsburg L, 2015, BRIT J NUTR, V114, P1304, DOI 10.1017/S0007114515002871; Wells JCK, 2009, AM J CLIN NUTR, V89, P491, DOI 10.3945/ajcn.2008.26629	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178921	10.1371/journal.pone.0178921	http://dx.doi.org/10.1371/journal.pone.0178921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594899	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200066
J	Peplonska, B; Bukowska, A; Wieczorek, E; Przybek, M; Zienolddiny, S; Reszka, E				Peplonska, Beata; Bukowska, Agnieszka; Wieczorek, Edyta; Przybek, Monika; Zienolddiny, Shanbeh; Reszka, Edyta			Rotating night work, lifestyle factors, obesity and promoter methylation in BRCA1 and BRCA2 genes among nurses and midwives	PLOS ONE			English	Article							BREAST-CANCER RISK; BODY-MASS INDEX; CIGARETTE-SMOKE CONDENSATE; TUMOR-SUPPRESSOR GENES; CORONARY-HEART-DISEASE; LONG-TERM SHIFTWORK; DNA METHYLATION; PHYSICAL-ACTIVITY; ABERRANT METHYLATION; HORMONE-LEVELS	Some recent evidence suggests that environmental and lifestyle factors may modify DNA methylation. We hypothesized that rotating night work and several modifiable factors may be associated with the methylation of the promoter regions within two tumor suppressor and DNA repair genes: BRCA1 and BRCA2. The methylation status of BRCA1 and BRCA2 was determined via qMSP reactions using DNA samples derived from blood leucocytes of 347 nurses and midwives working rotating nights and 363 working during the days. The subjects were classified into unmethylated vs methylated BRCA1 and BRCA2 when the methylation index was 0% or >0%, respectively. The adjusted odds ratios with 95% confidence intervals were calculated for night work status, smoking, obesity, physical activity and alcohol drinking. Current night shift work or night work history was not associated with methylation status of the promoter sites within BRCA1 and BRCA2 genes. We observed weak associations between smoking and the methylation status of BRCA1 with OR = 1.50 (95% CI: 0.98-2.29) for current smoking, OR = 1.83, 95CI: 1.08-3.13 for smoking longer than 31 years, and 0.1>p>0.05 for trends for the number of cigarettes per day, smoking duration and pack-years. In conclusion, no links between night shift work and methylation of the promoter region within the BRCA1, and BRCA2 genes were observed in this exploratory analysis. The findings of our study weakly support the hypothesis that smoking may contribute to epigenetic events.	[Peplonska, Beata; Bukowska, Agnieszka] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Wieczorek, Edyta; Przybek, Monika; Reszka, Edyta] Nofer Inst Occupat Med, Dept Mol Genet & Epigenet, Lodz, Poland; [Zienolddiny, Shanbeh] Natl Inst Occupat Hlth, Oslo, Norway	Nofer Institute of Occupational Medicine; Nofer Institute of Occupational Medicine	Peplonska, B (corresponding author), Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland.	beatap@imp.lodz.pl	Peplonska, Beata/AAO-1265-2020; Reszka, Edyta/F-6008-2010; Lesicka, Monika/G-7673-2015; Wieczorek, Edyta/F-7057-2010	Peplonska, Beata/0000-0003-3915-2872; Reszka, Edyta/0000-0003-2153-4864; Lesicka, Monika/0000-0003-2095-8681; Wieczorek, Edyta/0000-0002-4390-2042; Zienolddiny, Shan/0000-0001-9747-9625; Bukowska-Damska, Agnieszka/0000-0002-3223-6750	Norway Grants, under the Polish-Norwegian Research Programme [PNRF-243-AI-1/07, Pol-Nor/196940/22/2013-clockshift]	Norway Grants, under the Polish-Norwegian Research Programme	This project was supported by the Norway Grants, under the Polish-Norwegian Research Programme (Grant no. PNRF-243-AI-1/07 and Pol-Nor/196940/22/2013-clockshift) (BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani R, 2013, ASIA PAC J CLIN NUTR, V22, P505, DOI 10.6133/apjcn.2013.22.4.11; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Bhatti P, 2015, CHRONOBIOL INT, V32, P103, DOI 10.3109/07420528.2014.956362; Bollati V, 2010, CHRONOBIOL INT, V27, P1093, DOI 10.3109/07420528.2010.490065; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Bryan AD, 2013, ANN BEHAV MED, V45, P89, DOI 10.1007/s12160-012-9411-4; Bushnell PT, 2010, IND HEALTH, V48, P395, DOI 10.2486/indhealth.MSSW-03; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Cordina-Duverger E, 2016, CHRONOBIOL INT, V33, P783, DOI 10.3109/07420528.2016.1167709; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cuozzo C, 2007, PLOS GENET, V3, P1144, DOI 10.1371/journal.pgen.0030110; Davis S, 2012, CANCER EPIDEM BIOMAR, V21, P609, DOI 10.1158/1055-9965.EPI-11-1128; de Assis MAA, 2003, APPETITE, V40, P175, DOI 10.1016/S0195-6663(02)00133-2; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Fritschi L, 2011, MED HYPOTHESES, V77, P430, DOI 10.1016/j.mehy.2011.06.002; Fu DY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000637; Gao X, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0148-3; Gaudet MM, 2016, INT J EPIDEMIOL; Geliebter A, 2000, NUTRITION, V16, P27, DOI 10.1016/S0899-9007(99)00228-2; Ha K, 2011, HUM MOL GENET, V20, P126, DOI 10.1093/hmg/ddq451; Hansen AM, 2006, CHRONOBIOL INT, V23, P1203, DOI 10.1080/07420520601100955; Hansen J, 2012, EUR J CANCER, V48, P1722, DOI 10.1016/j.ejca.2011.07.005; Hardy TM, 2011, EPIGENOMICS-UK, V3, P503, DOI [10.2217/epi.11.71, 10.2217/EPI.11.71]; Harlid S, 2014, ENVIRON HEALTH PERSP, V122, P673, DOI 10.1289/ehp.1307480; Hoffman AE, 2010, CANCER PREV RES, V3, P539, DOI 10.1158/1940-6207.CAPR-09-0127; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Ijaz S, 2013, SCAND J WORK ENV HEA, V39, P431, DOI 10.5271/sjweh.3371; Jacobs DI, 2013, ENVIRON MOL MUTAGEN, V54, P141, DOI 10.1002/em.21752; James FR, 2015, EUR J CANCER, V51, P705, DOI 10.1016/j.ejca.2015.01.057; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kivimaki M, 2001, WORK STRESS, V15, P3, DOI 10.1080/02678370118685; Knutsson A, 1998, SCAND J SOC MED, V26, P183, DOI 10.1177/14034948980260030801; Kochan DZ, 2016, CELL CYCLE, V15, P613, DOI 10.1080/15384101.2015.1131526; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; Liu R, 2015, CANCER CAUSE CONTROL, V26, P171, DOI 10.1007/s10552-014-0494-z; McCullough LE, 2015, INT J CANC CLIN RES, V2, P13, DOI DOI 10.23937/2378-3419/2/1/1013); Morikawa Y, 2007, SCAND J WORK ENV HEA, V33, P45, DOI 10.5271/sjweh.1063; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Nakamura K, 1997, OCCUP MED-OXFORD, V47, P142, DOI 10.1093/occmed/47.3.142; Naushad SM, 2014, MOL CELL BIOCHEM, V392, P273, DOI 10.1007/s11010-014-2037-z; Oesterreich S, 1999, ENDOCR-RELAT CANCER, V6, P405, DOI 10.1677/erc.0.0060405; Opperhuizen AL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00050; Ottini L, 2015, MUTAT RES-GEN TOX EN, V779, P57, DOI 10.1016/j.mrgentox.2015.01.006; Papantoniou K, 2016, EUR J EPIDEMIOL, V31, P867, DOI 10.1007/s10654-015-0073-y; Peplonska B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133761; Peplonska B, 2014, CHRONOBIOL INT, V31, P1152, DOI 10.3109/07420528.2014.957296; Peplonska B, 2012, OCCUP ENVIRON MED, V69, P339, DOI 10.1136/oemed-2011-100273; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Reynolds P, 2013, J MAMMARY GLAND BIOL, V18, P15, DOI 10.1007/s10911-012-9269-x; Rice JC, 1998, ONCOGENE, V17, P1807, DOI 10.1038/sj.onc.1202086; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Saksvik-Lehouillier I, 2013, J ADV NURS, V69, P1136, DOI 10.1111/j.1365-2648.2012.06105.x; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2006, EPIDEMIOLOGY, V17, P108, DOI 10.1097/01.ede.0000190539.03500.c1; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Sharma G, 2007, LIFE SCI, V80, P1873, DOI 10.1016/j.lfs.2007.02.026; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Shi FQ, 2013, ENVIRON MOL MUTAGEN, V54, P406, DOI 10.1002/em.21790; Shield KD, 2016, ALCOHOL CLIN EXP RES, V40, P1166, DOI 10.1111/acer.13071; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; Stewart B, 2014, WORLD CANC REPORT 20; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Sturgeon SR, 2014, ANTICANCER RES, V34, P2985; Sun YV, 2013, HUM GENET, V132, P1027, DOI 10.1007/s00439-013-1311-6; Szwiec M, 2015, CLIN GENET, V87, P288, DOI 10.1111/cge.12360; SZYF M, 1991, BIOCHEM CELL BIOL, V69, P764, DOI 10.1139/o91-117; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tang QQ, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0282-6; Trinkoff AM, 1998, AM J IND MED, V34, P266, DOI 10.1002/(SICI)1097-0274(199809)34:3<266::AID-AJIM9>3.3.CO;2-#; Tsaprouni LG, 2014, EPIGENETICS-US, V9, P1382, DOI 10.4161/15592294.2014.969637; van Amelsvoort LGMP, 1999, INT J OBESITY, V23, P973, DOI 10.1038/sj.ijo.0801028; van Amelsvoort LGPM, 2004, J OCCUP ENVIRON MED, V46, P699, DOI 10.1097/01.jom.0000131794.83723.45; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Voisin S, 2015, ACTA PHYSIOL, V213, P39, DOI 10.1111/apha.12414; Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283; Wang XS, 2012, SCAND J WORK ENV HEA, V38, P590, DOI 10.5271/sjweh.3313; White AJ, 2016, ENVIRON RES, V145, P93, DOI 10.1016/j.envres.2015.11.033; Wong EM, 2011, CANCER PREV RES, V4, P23, DOI 10.1158/1940-6207.CAPR-10-0212; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882; Zhang FF, 2011, EPIGENETICS-US, V6, P293, DOI 10.4161/epi.6.3.14378; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P834, DOI 10.1097/JOM.0b013e31824e1058; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P525, DOI 10.1097/JOM.0b013e31824e1073; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	90	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178792	10.1371/journal.pone.0178792	http://dx.doi.org/10.1371/journal.pone.0178792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594926	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200051
J	Uebel-von Sandersleben, H; Albrecht, B; Rothenberger, A; Fillmer-Heise, A; Roessner, V; Sergeant, J; Tannock, R; Banaschewski, T				Uebel-von Sandersleben, Henrik; Albrecht, Bjorn; Rothenberger, Aribert; Fillmer-Heise, Anke; Roessner, Veit; Sergeant, Joseph; Tannock, Rosemary; Banaschewski, Tobias			Revisiting the co-existence of Attention-Deficit/Hyperactivity Disorder and Chronic Tic Disorder in childhood-The case of colour discrimination, sustained attention and interference control	PLOS ONE			English	Article							MUNSELL 100-HUE TEST; EXECUTIVE FUNCTIONS; DIFFICULTIES QUESTIONNAIRE; STROOP INTERFERENCE; TOURETTE-SYNDROME; CHILDREN; ADHD; HYPERACTIVITY; INHIBITION; DEFICIT	Objective Attention Deficit / Hyperactivity Disorder (ADHD) and Chronic Tic Disorder (CTD) are two common and frequently co-existing disorders, probably following an additive model. But this is not yet clear for the basic sensory function of colour processing sensitive to dopaminergic functioning in the retina and higher cognitive functions like attention and interference control. The latter two reflect important aspects for psychoeducation and behavioural treatment approaches. Methods Colour discrimination using the Farnsworth-Munsell 100-hue Test, sustained attention during the Frankfurt Attention Inventory (FAIR), and interference liability during Colour- and Counting-Stroop-Tests were assessed to further clarify the cognitive profile of the co-existence of ADHD and CTD. Altogether 69 children were classified into four groups: ADHD (N = 14), CTD (N = 20), ADHD+CTD (N = 20) and healthy Controls (N = 15) and compared in cognitive functioning in a 2x2-factorial statistical model. Results Difficulties with colour discrimination were associated with both ADHD and CTD factors following an additive model, but in ADHD these difficulties tended to be more pronounced on the blue-yellow axis. Attention problems were characteristic for ADHD but not CTD. Interference load was significant in both Colour-and Counting-Stroop-Tests and unrelated to colour discrimination. Compared to Controls, interference load in the Colour-Stroop was higher in pure ADHD and in pure CTD, but not in ADHD+CTD, following a sub-additive model. In contrast, interference load in the Counting-Stroop did not reveal ADHD or CTD effects. Conclusion The co-existence of ADHD and CTD is characterized by additive as well as sub-additive performance impairments, suggesting that their co-existence may show simple additive characteristics of both disorders or a more complex interaction, depending on demand. The equivocal findings on interference control may indicate limited validity of the Stroop-Paradigm for clinical assessments.	[Uebel-von Sandersleben, Henrik; Albrecht, Bjorn; Rothenberger, Aribert; Fillmer-Heise, Anke] Univ Med Ctr Gottingen, Child & Adolescent Psychiat, Gottingen, Germany; [Roessner, Veit] Tech Univ Dresden, Dept Child & Adolescent Psychiat, Dresden, Germany; [Sergeant, Joseph] Vrije Univ, Fac Psychol, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Tannock, Rosemary] Hosp Sick Children, Toronto, ON, Canada; [Banaschewski, Tobias] Cent Inst Mental Hlth Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany	University of Gottingen; Technische Universitat Dresden; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Central Institute of Mental Health	Uebel-von Sandersleben, H (corresponding author), Univ Med Ctr Gottingen, Child & Adolescent Psychiat, Gottingen, Germany.	huebel@gwdg.de	Banaschewski, Tobias/ABE-5985-2020; Roessner, Veit/AAQ-8760-2020; Albrecht, Björn/B-5270-2013	Banaschewski, Tobias/0000-0003-4595-1144; Albrecht, Björn/0000-0001-7936-2044; Roessner, Veit/0000-0002-1873-7081	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.; We thank the children and their families for participation, and Dr. Sinje Ruppert for her assistance with the data collection. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Achenbach T, 2007, J CHILD PSY IN PRESS; Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Albrecht B, 2015, CURR DEV DISORD REP; APA, 1994, DIAGN STAT MAN MENT; Banaschewski T, 2007, J CHILD PSYCHOL PSYC, V48, P415, DOI 10.1111/j.1469-7610.2006.01681.x; Banaschewski T, 2006, J CHILD PSYCHOL PSYC, V47, P568, DOI 10.1111/j.1469-7610.2005.01540.x; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Baumler G., 1985, FARBE WORT INTERFERE; BIRCH J, 1989, OPHTHAL PHYSL OPT, V9, P156, DOI 10.1111/j.1475-1313.1989.tb00836.x; Bruehl B, 2000, FREMDBEURTEILUNGSBOG, V9, P116; Cohen DJ, 1985, TOURETTE SYNDROME OT; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cranwell MB, 2015, INVEST OPHTH VIS SCI, V56, P3171, DOI 10.1167/iovs.14-16094; Dain Stephen J, 2004, Clin Exp Optom, V87, P276; Doyle AE, 2006, J CLIN PSYCHIAT, V67, P21; FLOWERS JH, 1979, MEM COGNITION, V7, P86, DOI 10.3758/BF03197589; Ganos C, 2014, MOVEMENT DISORD, V29, P1532, DOI 10.1002/mds.25944; Gaze C, 2006, J CHILD NEUROL, V21, P657, DOI 10.1177/08830738060210081301; Gillberg C, 2004, EUR CHILD ADOLES PSY, V13, P80, DOI 10.1007/s00787-004-1008-4; Golden CJ., 1978, AGE, DOI DOI 10.4135/9781412952644.N441; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greimel E, 2011, J ABNORM CHILD PSYCH, V39, P819, DOI 10.1007/s10802-011-9493-7; Horn W, 1983, LEISTUNGSPRU; Kim Soyeon, 2015, J Optom, V8, P116, DOI 10.1016/j.optom.2014.10.002; Kim S, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-39; Kim Soyeon, 2014, J Optom, V7, P22, DOI 10.1016/j.optom.2013.07.001; Lansbergen MM, 2007, NEUROPSYCHOLOGY, V21, P251, DOI 10.1037/0894-4105.21.2.251; Lavoie Marc E, 2007, Cogn Neuropsychiatry, V12, P165, DOI 10.1080/13546800600826371; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Manassis K, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-4; Marsh R, 2007, AM J PSYCHIAT, V164, P955, DOI 10.1176/appi.ajp.164.6.955; Moore AM, 2015, J EXP CHILD PSYCHOL, V135, P1, DOI 10.1016/j.jecp.2015.02.003; Moosbrugger H, 1996, FRANKFURTER AUFMERKS; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; Oh H, 2005, Z KINDER JUG-PSYCH, V33, P181, DOI 10.1024/1422-4917.33.3.181; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Roessner V, 2008, J NEURAL TRANSM, V115, P235, DOI 10.1007/s00702-007-0817-2; Roessner V, 2007, EUR CHILD ADOLES PSY, V16, P36, DOI 10.1007/s00787-007-1005-5; Roessner V, 2007, J ABNORM CHILD PSYCH, V35, P79, DOI 10.1007/s10802-006-9086-z; Roessner V, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-29; Rothenberger A, 2004, EUR CHILD ADOLES PSY, V13, P1, DOI 10.1007/s00787-004-2001-7; Rothenberger A., 2022, TOURETTE SYNDROME, V2nd ed., P26, DOI DOI 10.1093/MED/9780199796267.003.0002; Rothenberger A, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-007-1001-9; Schuerholz LJ, 1998, J CHILD NEUROL, V13, P277, DOI 10.1177/088307389801300607; Schwartz K, 2008, PSYCHOL MED, V38, P1607, DOI 10.1017/S003329170700267X; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Shapiro Arthur K., 1988, GILLES TOURETTE SYND, VSecond; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sukhodolsky DG, 2007, EUR CHILD ADOLES PSY, V16, P51, DOI 10.1007/s00787-007-1007-3; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; Yordanova J, 1997, BIOL PSYCHIAT, V41, P585, DOI 10.1016/S0006-3223(96)00096-0; Yordanova J, 1996, INT J PSYCHOPHYSIOL, V21, P121, DOI 10.1016/0167-8760(95)00045-3; Zahiruddin Kowser, 2010, Korean J Ophthalmol, V24, P159, DOI 10.3341/kjo.2010.24.3.159	53	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178866	10.1371/journal.pone.0178866	http://dx.doi.org/10.1371/journal.pone.0178866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594866	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200058
J	Chiu, NC; Su, CW; Liu, CA; Huang, YH; Chiou, YY				Chiu, Nai-Chi; Su, Chien-Wei; Liu, Chien-An; Huang, Yi-Hsiang; Chiou, Yi-You			Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infections	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; HYPERVASCULAR HEPATOCELLULAR-CARCINOMA; HYPOVASCULAR HYPOINTENSE NODULES; ENHANCED MR-IMAGES; HEPATOBILIARY PHASE; RISK-FACTORS; INFECTION; TAIWAN; SUPERINFECTION; PROGRESSION	With the widespread use of gadoxetic acid-enhanced magnetic resonance imaging, liver nodules appearing as hypovascular in the arterial phase and hypointense in the hepatobiliary phase, defined as hypovascular hypointense nodules, are increasingly detected in patients with cirrhosis and are considered precursor nodules. We sought to evaluate the interval to vascularization development in hepatitis C virus/hepatitis B virus co-infectedassociated precursor nodules (BC-HHN group) compared with that in hepatitis C virus mono-infected-associated precursor nodules (C-HHN group) in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging. The interval to vascularization development was estimated by the Kaplan-Meier method and compared using the Cox proportional hazards model. The mean intervals to vascularization development in the BC-HHN and C-HHN groups were 272.9 +/- 31.1 and 603.8 +/- 47.6 days, respectively (p<0.001). The cumulative vascularization development incidence at 6, 12, and 18 months was 44.9%, 73.5%, and 91.8%, respectively, in the BC-HHN group and 16.9%, 39.0%, and 55.8%, respectively, in the C-HHN group (p<0.001). The multivariate analysis showed that the presence of hepatitis B virus co-infection (hazard ratio: 1.819; 95% confidence interval: 1.222-2.707; p = 0.003) and male sex (hazard ratio: 1.753; 95% confidence interval: 1.029-2.985; p = 0.039) were predictors of vascularization development. More than half of the hypovascular hypointense nodules showed high-signal changes on T2-weighted imaging, and almost half of them showed restricted diffusion on diffusion-weighted images, but these did not predict vascularization development. In a hepatitis C virus-and hepatitis B virus-endemic area, such as Taiwan, precursor nodules in the BC-HHN group tended to have shorter intervals to vascularization development, especially in male patients.	[Chiu, Nai-Chi; Liu, Chien-An; Chiou, Yi-You] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chiu, Nai-Chi; Su, Chien-Wei; Liu, Chien-An; Huang, Yi-Hsiang; Chiou, Yi-You] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Su, Chien-Wei; Huang, Yi-Hsiang] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chiou, YY (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.; Chiou, YY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	yychiou@vghtpe.gov.tw	Su, Chien-Wei/C-1521-2012; Su, Chien-Wei/AHC-8307-2022	Su, Chien-Wei/0000-0003-3889-7004; Su, Chien-Wei/0000-0003-3889-7004; Huang, Yi-Hsiang/0000-0001-5241-5425; Chiu, Nai-Chi/0000-0001-6543-9063				Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen CL, 2015, J HEPATOL, V63, P354, DOI 10.1016/j.jhep.2015.03.013; Chen CJ, 2000, J GASTROEN HEPATOL, V15, pE3, DOI 10.1046/j.1440-1746.2000.02124.x; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; CHEN DS, 1991, GASTROENTEROL JPN, V26, P164; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; Haradome H, 2011, J MAGN RESON IMAGING, V34, P69, DOI 10.1002/jmri.22588; Hayashi M, 2002, RADIOLOGY, V225, P143, DOI 10.1148/radiol.2251011298; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Kim YS, 2016, EUR RADIOL, V26, P3728, DOI 10.1007/s00330-015-4146-9; Kim YK, 2012, RADIOLOGY, V265, P104, DOI 10.1148/radiol.12112649; Kitao A, 2009, RADIOLOGY, V252, P605, DOI 10.1148/radiol.2522081414; Kobayashi S, 2012, EUR J RADIOL, V81, P3002, DOI 10.1016/j.ejrad.2012.03.029; Kumada T, 2011, AM J ROENTGENOL, V197, P58, DOI 10.2214/AJR.10.5390; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liu CJ, 2009, HEPATOL INT, V3, P517, DOI 10.1007/s12072-009-9147-9; Liu CJ, 2003, LIVER INT, V23, P148, DOI 10.1034/j.1600-0676.2003.00820.x; Motosugi U, 2011, J MAGN RESON IMAGING, V34, P88, DOI 10.1002/jmri.22630; Sagnelli E, 2002, HEPATOLOGY, V36, P1285, DOI 10.1053/jhep.2002.36509; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178841	10.1371/journal.pone.0178841	http://dx.doi.org/10.1371/journal.pone.0178841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591226	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700052
J	Sun, D; Zhou, X; Yu, HL; He, XX; Guo, WX; Xiong, WC; Zhu, XJ				Sun, Dong; Zhou, Xue; Yu, Hua-Li; He, Xiao-Xiao; Guo, Wei-Xiang; Xiong, Wen-Cheng; Zhu, Xiao-Juan			Regulation of neural stem cell proliferation and differentiation by Kinesin family member 2a	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; INTERMEDIATE PROGENITORS; CORTICAL NEUROGENESIS; MICROTUBULE DYNAMICS; BETA-CATENIN; KIF2A; PATHWAY; PHOSPHORYLATION	In the developing neocortex, cells in the ventricular/subventricular zone are largely multipotent neural stem cells and neural progenitor cells. These cells undergo self-renewal at the early stage of embryonic development to amplify the progenitor pool and subsequently differentiate into neurons. It is thus of considerable interest to investigate mechanisms controlling the switch from neural stem cells or neural progenitor cells to neurons. Here, we present evidence that Kif2a, a member of the Kinesin-13 family, plays a role in regulating the proliferation and differentiation of neural stem cells or neural progenitor cells at embryonic day 13.5. Silencing Kif2a by use of in utero electroporation of Kif2a shRNA reduced neural stem cells proliferation or self-renewal but increased neuronal differentiation. We further found that knockdown of Kif2a decreased the protein level of beta-catenin, which is a critical molecule for neocortical neurogenesis. Together, these results reveal an important function of Kif2a in embryonic neocortical neurogenesis.	[Sun, Dong; Zhou, Xue; Yu, Hua-Li; He, Xiao-Xiao; Zhu, Xiao-Juan] Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Jilin, Peoples R China; [Sun, Dong; Yu, Hua-Li; Xiong, Wen-Cheng] Augusta Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Sun, Dong; Yu, Hua-Li; Xiong, Wen-Cheng] Augusta Univ, Dept Neurol, Augusta, GA 30912 USA; [Guo, Wei-Xiang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol & Dev Biol, Beijing, Peoples R China	Northeast Normal University - China; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhu, XJ (corresponding author), Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Jilin, Peoples R China.; Xiong, WC (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA.; Xiong, WC (corresponding author), Augusta Univ, Dept Neurol, Augusta, GA 30912 USA.	wxiong@augusta.edu; zhuxj720@nenu.edu.cn	Sun, Dong/AAN-3325-2021	Zhu, Xiao-Juan/0000-0001-8386-8064	Program of International S and T Cooperation [2015DFA31580]; National Natural Science Foundation of China [31401192, 31271486]; Jilin Provincial Key Laboratory of Neural Plasticity [20160622020JC]; China scholarship council [201506620038]	Program of International S and T Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Key Laboratory of Neural Plasticity; China scholarship council(China Scholarship Council)	This work was supported by the Program of International S and T Cooperation (2015DFA31580), the National Natural Science Foundation of China (31401192, 31271486), the Jilin Provincial Key Laboratory of Neural Plasticity (20160622020JC) and China scholarship council (201506620038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Bradley A, 1990, CURR OPIN CELL BIOL, V2, P1013, DOI 10.1016/0955-0674(90)90150-D; Brouhard GJ, 2014, J CELL BIOL, V207, P323, DOI 10.1083/jcb.201407095; Cavallin M, 2017, NEUROGENETICS, V18, P73, DOI 10.1007/s10048-016-0499-8; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Eagleson G, 2015, MOL BIOL CELL, V26, P924, DOI 10.1091/mbc.E13-12-0721; Fang WQ, 2013, NEURON, V79, P665, DOI 10.1016/j.neuron.2013.06.017; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Ge XC, 2010, NEURON, V65, P191, DOI 10.1016/j.neuron.2010.01.011; Guo WX, 2012, NAT PROTOC, V7, P2005, DOI 10.1038/nprot.2012.123; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Ju XD, 2014, CEREB CORTEX, V24, P1259, DOI 10.1093/cercor/bhs407; Li HD, 2003, GLIA, V44, P37, DOI 10.1002/glia.10267; Lyu J, 2013, CELL REP, V5, P593, DOI 10.1016/j.celrep.2013.09.034; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Miyamoto T, 2015, CELL REP; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Noda Y, 2012, P NATL ACAD SCI USA, V109, P1725, DOI 10.1073/pnas.1107808109; Ogawa T, 2015, CELL REP, V12, P1774, DOI 10.1016/j.celrep.2015.08.018; Pandey A, 2015, J NEUROCHEM, V133, P640, DOI 10.1111/jnc.13089; Rosner H, 2001, BBA-MOL CELL RES, V1540, P166, DOI 10.1016/S0167-4889(01)00129-X; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tian GL, 2016, MOL GENET GENOM MED, V4, P599, DOI 10.1002/mgg3.236; Wang KT, 2014, MOL MED REP, V9, P273, DOI 10.3892/mmr.2013.1804; Watanabe T, 2015, J CELL BIOL, V210, P737, DOI 10.1083/jcb.201412075; Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988; Zhang FY, 2016, NEUROSCI BULL, V32, P205, DOI 10.1007/s12264-016-0032-y; Zhang X, 2016, MOL MED REP, V13, P1781, DOI 10.3892/mmr.2015.4700	38	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179047	10.1371/journal.pone.0179047	http://dx.doi.org/10.1371/journal.pone.0179047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591194	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700080
J	Uchiyama, T; Okajima, F; Mogi, C; Tobo, A; Tomono, S; Sato, K				Uchiyama, Tsuyoshi; Okajima, Fumikazu; Mogi, Chihiro; Tobo, Ayaka; Tomono, Shoichi; Sato, Koichi			Alamandine reduces leptin expression through the c-Src/p38 MAP kinase pathway in adipose tissue	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ANGIOTENSIN-II; NITRIC-OXIDE; RECEPTOR; SYSTEM; IDENTIFICATION; HYPERTENSION; VASOPRESSIN; ACTIVATION; BLOCKADE	Objective Obesity is associated with an increased risk of diabetes mellitus, hypertension, and renal dysfunction. Angiotensin 1-7 and alamandine are heptameric renin angiotensin system peptide hormones. Further, alamandine levels increase with renal dysfunction. In the cardiovascular system, angiotensin 1-7 and alamandine produce similar improvements and counterbalance angiotensin II in regulating vascular function. We aimed to determine whether the effect of alamandine on leptin expression and secretion in adipocytes was similar to that of angiotensin 1-7. Approach and results We studied isolated peri-renal visceral adipose tissue and peri-renal isolated visceral adipocytes from male Wistar rats. Angiotensin II from 0.01 to 10nM had no effect on leptin expression. Angiotensin 1-7 (1 nM) increased leptin secretion and expression, whereas alamandine (1 nM) decreased leptin secretion and expression in adipose tissue and isolated adipocytes and reduced blood leptin levels in vivo. These effects were mediated by Gq, c-Src, p38 mitogen- activated protein, and I.B activation. Additionally, alamandine induced nitric oxide expression via inducible nitric oxidase synthase and plasminogen activator inhibitor 1 expression in adipose tissue and isolated adipocytes. Conclusions Angiotensin 1-7 and alamandine produced opposing effects on leptin expression and secretion in adipose tissue. This result suggests that the action of Mas (angiotensin 1-7 receptor) and Mas-related G-protein coupled receptor D in adipocytes exhibited opposing actions similar to angiotensin II type 1 and type 2 receptors.	[Uchiyama, Tsuyoshi; Mogi, Chihiro; Tobo, Ayaka; Sato, Koichi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma, Japan; [Okajima, Fumikazu] Aomori Univ, Fac Pharmaceut Sci, Aomori, Japan; [Tomono, Shoichi] Gunma Univ, Sch Hlth Sci, Maebashi, Gunma, Japan	Gunma University; Gunma University	Uchiyama, T (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Signal Transduct, Maebashi, Gunma, Japan.	uchiyat@gunma-u.ac.jp		Sato, Koichi/0000-0001-7694-4014	JSPS KAKENHI [24659125]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a JSPS KAKENHI Grant-in-Aid for Exploratory Research (24659125). The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2013, J HUM HYPERTENS, V27, P617, DOI 10.1038/jhh.2013.24; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Bader M, 2014, PHARMACOL REV, V66, P1080, DOI 10.1124/pr.113.008136; Benter IF, 2007, AM J PHYSIOL-HEART C, V292, pH666, DOI 10.1152/ajpheart.00372.2006; Benter IF, 2006, AM J PHYSIOL-HEART C, V290, pH684, DOI 10.1152/ajpheart.00632.2005; Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101; De Mello WC, 2000, HYPERTENSION, V35, P1183, DOI 10.1161/01.HYP.35.6.1183; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Evans BA, 1999, FEBS LETT, V444, P149, DOI 10.1016/S0014-5793(99)00049-6; Fernandez-Formoso G, 2015, LIFE SCI, V140, P4, DOI 10.1016/j.lfs.2015.02.008; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Hrenak J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071098; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Jeon MJ, 2012, EXP MOL MED, V44, P562, DOI 10.3858/emm.2012.44.9.064; Karnik SS, 2015, PHARMACOL REV, V67, P754, DOI 10.1124/pr.114.010454; Lautner RQ, 2013, CIRC RES, V112, P1104, DOI 10.1161/CIRCRESAHA.113.301077; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; Murugan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145413; Niu XL, 2014, J CARDIOVASC PHARM, V64, P536, DOI 10.1097/FJC.0000000000000151; Andrade JMO, 2014, PEPTIDES, V60, P56, DOI 10.1016/j.peptides.2014.07.023; Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Qaradakhi T, 2016, PHARMACOL RES, V111, P820, DOI 10.1016/j.phrs.2016.07.025; RABIN M, 1987, ONCOGENE RES, V1, P169; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; SCHIAVONE MT, 1988, P NATL ACAD SCI USA, V85, P4095, DOI 10.1073/pnas.85.11.4095; Schuchard J, 2015, BRIT J PHARMACOL, V172, P3764, DOI 10.1111/bph.13172; Shek EW, 1998, HYPERTENSION, V31, P409, DOI 10.1161/01.HYP.31.1.409; Shinohara T, 2004, J BIOL CHEM, V279, P23559, DOI 10.1074/jbc.M314240200; Tada Y, 2015, J STROKE CEREBROVASC, V24, P1487, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.015; Tetzner A, 2016, HYPERTENSION, V68, P185, DOI 10.1161/HYPERTENSIONAHA.116.07572; Uchida Y, 1997, EUR J PHARMACOL, V335, P235, DOI 10.1016/S0014-2999(97)01181-3; Uchiyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139638; Vecchione C, 2002, DIABETES, V51, P168, DOI 10.2337/diabetes.51.1.168; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yang R, 2011, HYPERTENSION, V57, P956, DOI 10.1161/HYPERTENSIONAHA.110.161836; Zeng R, 2014, ARQ BRAS ENDOCRINOL, V58, P817, DOI 10.1590/0004-2730000003390; Zhang L, 2005, MOL BRAIN RES, V133, P187, DOI 10.1016/j.molbrainres.2004.10.007	40	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178769	10.1371/journal.pone.0178769	http://dx.doi.org/10.1371/journal.pone.0178769			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591164	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700047
J	Zhu, RM; Lin, W; Zhang, W; Ren, JT; Su, Y; He, JR; Lin, Y; Su, FX; Xie, XM; Tang, LY; Ren, ZF				Zhu, Rui-Mei; Lin, Wei; Zhang, Wei; Ren, Jun-Ting; Su, Yi; He, Jian-Rong; Lin, Ying; Su, Feng-Xi; Xie, Xiao-Ming; Tang, Lu-Ying; Ren, Ze-Fang			Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival	PLOS ONE			English	Article							OXIDATIVE STRESS; MELLITUS; HSP60; INFLAMMATION; METAANALYSIS; COHORT; HEAT-SHOCK-PROTEIN-60; POPULATION; EXPRESSION; DIAGNOSIS	The contribution of diabetes to breast cancer remains uncertain among Chinese females, which may result from different genetic factors. We evaluated the associations of diabetes, combined with the polymorphisms in the genes of fat mass and obesity-associated gene (FTO), interleukin 6 (IL-6), and heat shock protein 60 (HSPD1), with breast cancer risk and survival in a Chinese Han population. The information on the history of diabetes was collected from 1551 incident breast cancer cases and 1605 age-frequency matched controls in Guangzhou, China. In total, 1168 cases were followed up. Diabetes was associated with both an increased risk of breast cancer [OR (95% CI): 1.67 (1.11, 2.52)] and a poor overall survival and progression free survival for breast cancer patients [HRs (95% CIs): 2.66 (1.10, 6.44) and 2.46 (1.29, 4.70), respectively]. IL-6 rs1800796 and HSPD1 rs2605039 had interactions with diabetes on breast cancer risk. Among women with CC genotype of IL-6 rs1800796 or GG genotype of HSPD1 rs2605039, diabetic individuals had a remarkably increased risk of breast cancer compared to non-diabetic women with ORs and 95% CIs of 2.53 (1.45, 4.41) and 6.40 (2.29, 17.87), respectively. GT/TT genotypes of HSPD1 rs2605039 was also associated with a better progression free survival for breast cancer patients [HR (95% CI): 0.70 (0.49, 0.99)]. Our results suggest that the contribution of diabetes to breast cancer risk might be modified by IL-6 rs1800796 and HSPD1 rs2605039. Diabetes and HSPD1 rs2605039 might also influence breast cancer prognosis.	[Zhu, Rui-Mei; Lin, Wei; Zhang, Wei; Ren, Jun-Ting; Su, Yi; Ren, Ze-Fang] Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Hlth Risk Ass, Sch Publ Hlth, Dept Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Su, Yi] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [He, Jian-Rong] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Lin, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Su, Feng-Xi] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Xie, Xiao-Ming] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Tang, Lu-Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ren, ZF (corresponding author), Sun Yat Sen Univ, Guangzhou Key Lab Environm Pollut & Hlth Risk Ass, Sch Publ Hlth, Dept Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Tang, LY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.	tangly@mail.sysu.edu.cn; renzef@mail.sysu.edu.cn		He, Jianrong/0000-0003-3837-5126	National Natural Science Foundation of China [81273147]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number: 81273147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank all the study participants and the nursing, secretary, and administrative staffs in the Breast Departments of the First Affiliated Hospital, the Second Affiliated Hospital, and the Cancer Center of Sun Yat-Sen University. This work was supported by the National Natural Science Foundation of China (grant number: 81273147).	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Bi YF, 2014, J DIABETES, V6, P147, DOI 10.1111/1753-0407.12108; Boyle P, 2012, BRIT J CANCER, V107, P1608, DOI 10.1038/bjc.2012.414; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Cabiscol E, 2002, J BIOL CHEM, V277, P44531, DOI 10.1074/jbc.M206525200; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chlebowski RT, 2012, J CLIN ONCOL, V30, P2844, DOI 10.1200/JCO.2011.39.7505; Choi SW, 2008, FREE RADICAL BIO MED, V44, P1217, DOI 10.1016/j.freeradbiomed.2007.12.005; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Fan SH, 2016, SCIENCE, V354, P54, DOI 10.1126/science.aaf5098; Ferroni P, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/183928; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Godsland IF, 2010, CLIN SCI, V118, P315, DOI 10.1042/CS20090399; Goldberg JE, 2010, CURR DRUG TARGETS, V11, P1133; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu W, 2008, CRIT CARE MED, V36, P1437, DOI 10.1097/CCM.0b013e31816a0adb; He JR, 2011, CANCER LETT, V309, P128, DOI 10.1016/j.canlet.2011.05.012; He MA, 2008, CELL STRESS CHAPERON, V13, P231, DOI 10.1007/s12192-008-0025-5; Janghorbani M, 2012, HORM CANCER-US, V3, P137, DOI 10.1007/s12672-012-0112-z; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Leone A, 2014, CANCER TREAT RES, V159, P355, DOI 10.1007/978-3-642-38007-5_21; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Lin CC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-381; Lin W, 2017, MOL CARCINOGEN, V56, P300, DOI 10.1002/mc.22493; Lopez R, 2013, OBES REV, V14, P679, DOI 10.1111/obr.12030; Ma FJ, 2014, ONCOTARGETS THER, V7, P2147, DOI 10.2147/OTT.S71095; Marker T, 2012, DIABETES, V61, P615, DOI 10.2337/db10-1574; Nechuta S, 2013, BREAST CANCER RES TR, V139, P227, DOI 10.1007/s10549-013-2521-2; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Pace A, 2013, CURR PHARM DESIGN, V19, P2757, DOI 10.2174/1381612811319150011; Qureshi SA, 2016, NUTRITION; Ren ZF, 2010, CANCER EPIDEMIOL, V34, P419, DOI 10.1016/j.canep.2010.04.011; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Sasazuki S, 2013, CANCER SCI, V104, P1499, DOI 10.1111/cas.12241; Song QK, 2014, ASIAN PAC J CANCER P, V15, P10021, DOI 10.7314/APJCP.2014.15.22.10021; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037275; Tseng CH, 2009, DIABETOLOGIA, V52, P240, DOI 10.1007/s00125-008-1204-8; Victor VM, 2011, CURR PHARM DESIGN, V17, P3947, DOI 10.2174/138161211798764915; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Wang H, 2009, DIABETES METAB, V35, P378, DOI 10.1016/j.diabet.2009.03.006; Wisastra R, 2014, CANCERS, V6, P1500, DOI 10.3390/cancers6031500; Wojciechowska J, 2016, EXP CLIN ENDOCR DIAB, V124, P263, DOI 10.1055/s-0042-100910; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yu ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037784; Zhang PH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-567	49	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178850	10.1371/journal.pone.0178850	http://dx.doi.org/10.1371/journal.pone.0178850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591216	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700053
J	Liyew, EF; Yalew, AW; Afework, MF; Essen, B				Liyew, Ewnetu Firdawek; Yalew, Alemayehu Worku; Afework, Mesganaw Fantahun; Essen, Birgitta			Incidence and causes of maternal near-miss in selected hospitals of Addis Ababa, Ethiopia	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; MORBIDITY; DEATH; MORTALITY; WOMEN; DETERMINANTS; TANZANIA; BOLIVIA; QUALITY	Background Because maternal mortality is a rare event, it is important to study maternal near-miss as a complement to evaluate and improve the quality of obstetric care. Thus, the study was conducted with the aim of assessing the incidence and causes of maternal near-miss. Methods A facility-based cross-sectional study was conducted in five selected public hospitals of Addis Ababa, Ethiopia from May 1, 2015 to April 30, 2016. All maternal near-miss cases admitted to the selected hospitals during the study period were prospectively recruited. World Health Organization criteria were used to identify maternal near-miss cases. The number of maternal near-miss cases over one year per 1000 live births occurring during the same year was calculated to determine the incidence of maternal near-miss. Underlying and contributing causes of maternal near-miss were documented from each participant's record. Results During the one-year period, there were a total of 238 maternal near-miss cases and 29,697 live births in all participating hospitals, which provides a maternal near-miss incidence ratio of 8.01 per 1000 live births. The underlying causes of the majority of maternal near-miss cases were hypertensive disorders and obstetric hemorrhage. Anemia was the major contributing cause reported for maternal near-miss. Most of the maternal near-miss cases occurred before the women's arrival at the participating hospitals. Conclusion The study demonstrated a lower maternal near-miss incidence ratio compared to previous country-level studies. The majority of the near-miss cases occurred before the women's arrival at the participating hospitals, which underscores the importance of improving pre-hospital barriers. Efforts made toward improvement in the management of life-threatening obstetric complications could reduce the occurrence of maternal near-miss problems that occur during hospitalization.	[Liyew, Ewnetu Firdawek] Arba Minch Univ, Coll Med & Hlth Sci, Dept Nursing, Arba Minch, Ethiopia; [Yalew, Alemayehu Worku] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Afework, Mesganaw Fantahun] Addis Ababa Univ, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Addis Ababa, Ethiopia; [Essen, Birgitta] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth, Uppsala, Sweden	Arba Minch University; Addis Ababa University; Addis Ababa University; Uppsala University	Liyew, EF (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Nursing, Arba Minch, Ethiopia.	ewnetuliyew@gmail.com			African Doctoral Dissertation Research Fellowship (ADDRF) award; International Development Research Centre (IDRC) [107508-001]; Addis Ababa university; Arba Minch university	African Doctoral Dissertation Research Fellowship (ADDRF) award; International Development Research Centre (IDRC); Addis Ababa university; Arba Minch university	This research was partially funded by an African Doctoral Dissertation Research Fellowship (ADDRF) award offered by the African Population and Health Research Center (APHRC) in partnership with the International Development Research Centre (IDRC) (Grant Number: 107508-001). It was also partially funded by Addis Ababa and Arba Minch universities. The funders have no role in the design of the study, collection, analysis and interpretation of the data. The finding and conclusion of the study reflect the view of the authors only.	Adeoye IA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-93; Ali AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-48; Almerie Y, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-65; Amaral E, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-9; [Anonymous], 2012, ETHIOPIAN J REPROD H; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chhabra P, 2008, TROP DOCT, V38, P201, DOI 10.1258/td.2007.070327; Chu SY, 2008, AM J OBSTET GYNECOL, V199, pE18, DOI [10.1016/j.ajog.2008.02.038, 10.1016/j.ajog.2007.12.020]; David E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0401-3; Donati S, 2012, ACTA OBSTET GYN SCAN, V91, P452, DOI 10.1111/j.1600-0412.2012.01352.x; Elias N, 2014, FDRE MOH Q HLTH B, V6, P14; Ethiopia Central Statistical Agency ICFI, 2012, 2011 ETH DEM HLTH SU; Fekadu M, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.29; Gebrehiwot Y, 2014, INT J GYNECOL OBSTET, V127, pS29, DOI 10.1016/j.ijgo.2014.08.003; Ghazal-Aswad S, 2013, MATERN CHILD HLTH J, V17, P399, DOI 10.1007/s10995-012-0984-0; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Jayaratnam S, 2011, AUST NZ J OBSTET GYN, V51, P421, DOI 10.1111/j.1479-828X.2011.01330.x; Kiruja J, 2017, SEX REPROD HEALTHC, V12, P30, DOI 10.1016/j.srhc.2017.02.003; Litorp H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-244; Lynch C M, 2008, Ir Med J, V101, P134; Mohammadi S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1239-2; Murphy CM, 2009, EUR J OBSTET GYN R B, V143, P34, DOI 10.1016/j.ejogrb.2008.11.008; Mustafa R, 2009, JCPSP-J COLL PHYSICI, V19, P781, DOI 12.2009/JCPSP.781785; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Moraes APP, 2011, SAO PAULO MED J, V129, P146, DOI 10.1590/S1516-31802011000300005; Roost M, 2009, BJOG-INT J OBSTET GY, V116, P1210, DOI 10.1111/j.1471-0528.2009.02209.x; Roost M, 2010, ACTA OBSTET GYN SCAN, V89, P335, DOI 10.3109/00016340903511050; Rulisa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0619-8; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Siddiqui SA, 2012, J PAK MED ASSOC, V62, P226; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P58, DOI 10.1016/j.ijgo.2013.06.003; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; Wahlberg A, 2013, BJOG-INT J OBSTET GY, V120, P1605, DOI 10.1111/1471-0528.12326; WHO, 2011, INT STAT CLASS DIS R; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Wilson Ronee E, 2007, Int J Fertil Womens Med, V52, P121; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2012, WHO APPL ICD 10 DEAT; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG; Zanconato G, 2012, J MATERN-FETAL NEO M, V25, P1025, DOI 10.3109/14767058.2011.614655; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	45	31	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179013	10.1371/journal.pone.0179013	http://dx.doi.org/10.1371/journal.pone.0179013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586355	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700042
J	Mahedy, L; Hammerton, G; Teyhan, A; Edwards, AC; Kendler, KS; Moore, SC; Hickman, M; Macleod, J; Heron, J				Mahedy, Liam; Hammerton, Gemma; Teyhan, Alison; Edwards, Alexis C.; Kendler, Kenneth S.; Moore, Simon C.; Hickman, Matthew; Macleod, John; Heron, Jon			Parental alcohol use and risk of behavioral and emotional problems in offspring	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; DIFFICULTIES QUESTIONNAIRE; GENDER-DIFFERENCES; PRENATAL EXPOSURE; CONDUCT PROBLEMS; SUBSTANCE-ABUSE; BINGE PATTERN; CHILDREN; PREGNANCY; CONSUMPTION	Objective The majority of studies that have examined parental alcohol use and offspring outcomes have either focused on exposure in the antenatal period or from clinical populations. This study sought to examine proximal and distal associations between parental alcohol use and offspring conduct problems and depressive symptoms in a population birth cohort. Methods We used prospective data from a large UK based population cohort (ALSPAC) to investigate the association between parental alcohol use, measured in units, (assessed at ages 4 and 12 years) with childhood conduct trajectories, (assessed on six occasions from 4 to 13.5 years, n = 6,927), and adolescent depressive symptoms (assessed on four occasions from similar to 13 to similar to 18 years, n = 5,539). Heavy drinking was defined as >= 21 units per week in mothers and partners who drank 4+ units daily. Results We found little evidence to support a dose response association between parental alcohol use and offspring outcomes. For example, we found insufficient evidence to support an association between maternal alcohol use at age 4 years and childhood conduct problems (childhood limited: OR = 1.00, 95% CI =.99, 1.01; adolescent onset: OR = 0.99, 95% CI =.98, 1.00; and early-onset persistent: OR = 0.99, 95% CI =.98, 1.00) per 1-unit change in maternal alcohol use compared to those with low levels of conduct problems. We also found insufficient evidence to support an association between maternal alcohol use at age 4 years and adolescent depressive symptoms (intercept: b =.001, 95% CI = -.01,.01, and slope: b =.003, 95% CI = -.03,.03) per 1-unit change in maternal alcohol use. Results remained consistent across amount of alcohol consumed (i.e., number of alcohol units or heavy alcohol use), parent (maternal self-reports or maternal reports of partner's alcohol use), and timing of alcohol use (assessed at age 4 or age 12 years). Conclusions There is no support for an association between parental alcohol use during childhood and conduct and emotional problems during childhood or adolescence.	[Mahedy, Liam; Hammerton, Gemma; Teyhan, Alison; Hickman, Matthew; Macleod, John; Heron, Jon] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Edwards, Alexis C.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Edwards, Alexis C.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Moore, Simon C.] Cardiff Univ, Sch Dent, Coll Biomed & Life Sci, Cardiff, S Glam, Wales	University of Bristol; Virginia Commonwealth University; Virginia Commonwealth University; Cardiff University	Mahedy, L (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	liam.mahedy@bristol.ac.uk	Heron, Jon/D-5884-2011; Hickman, Matthew/Y-2400-2019; Kendler, Kenneth/AAF-2876-2019	Heron, Jon/0000-0001-6199-5644; Hickman, Matthew/0000-0001-9864-459X; Edwards, Alexis/0000-0002-4006-9710; Teyhan, Alison/0000-0002-4965-3139; Hammerton, Gemma/0000-0002-7781-3857; Mahedy, Liam/0000-0001-5417-6595; Moore, Simon/0000-0001-5495-4705	UK Medical Research Council; Wellcome Trust [092731]; University of Bristol; The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; Cancer Research UK [MR/KO232331/1]; Economic and Social Research Council; Medical Research Council; Welsh Government; Wellcome Trust; UK Clinical Research Collaboration; NIHR School of Public Health Research; National Institutes of Health [K01AA021399, R01AA018333]; MRC; Alcohol Research UK [MR/L022206/1]; ESRC [ES/L015471/1]; British Heart Foundation; Economic and Social Research Council [ES/L015471/1] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MR/K006525/1, G0802736, MR/L022206/1, G9815508, G0800612] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10023] Funding Source: researchfish; MRC [G0800612, MR/L022206/1, G0802736, MR/K006525/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); UKCRC Public Health Research Centre of Excellence; Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; NIHR School of Public Health Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alcohol Research UK; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council and Wellcome Trust (Grant Ref: 092731) and the University of Bristol provide core support for ALSPAC. The work was undertaken with the support of The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research Centre of Excellence. Joint funding (MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. We also acknowledge funding from the NIHR School of Public Health Research. The National Institutes of Health provided additional support (K01AA021399 to A.C.E; and R01AA018333 to K.S.K). The MRC and Alcohol Research UK (MR/L022206/1) supports J.H., L.M. and G.H.S.C.M and L.M. is also supported by the ESRC (ES/L015471/1).	Alati R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074844; Alvik A, 2006, ALCOHOL CLIN EXP RES, V30, P510, DOI 10.1111/j.1530-0277.2006.00055.x; Angold A, 1995, INT J METHOD PSYCH, V5, P237; [Anonymous], UK CHIEF MED OFF LOW; Asparouhov T., 2013, AUXILIARY VARIABLES, P1; Bailey BN, 2004, AM J OBSTET GYNECOL, V191, P1037, DOI 10.1016/j.ajog.2004.05.048; Barker ED, 2009, AM J PSYCHIAT, V166, P900, DOI 10.1176/appi.ajp.2009.08121770; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Buvik K, 2015, ADDICTION, V110, P602, DOI [10.1111/add.12843, 10.1111/add.13097]; Chassin L, 1999, J ABNORM PSYCHOL, V108, P106, DOI 10.1037/0021-843X.108.1.106; Christoffersen MN, 2003, J SUBST ABUSE TREAT, V25, P107, DOI 10.1016/S0740-5472(03)00116-8; Clark S.L., 2009, RELATING LATENT CLAS; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; D'Onofrio BM, 2007, ARCH GEN PSYCHIAT, V64, P1296, DOI 10.1001/archpsyc.64.11.1296; Edwards AC, 2014, EUR CHILD ADOLES PSY, V23, P1219, DOI 10.1007/s00787-014-0600-5; Edwards EP, 2006, J ABNORM CHILD PSYCH, V34, P409, DOI 10.1007/s10802-006-9021-3; Eiden RD, 2007, DEV PSYCHOL, V43, P1187, DOI 10.1037/0012-1649.43.5.1187; Feingold A, 2014, PSYCHOL ADDICT BEHAV, V28, P257, DOI 10.1037/a0031487; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gage SH, 2014, PSYCHOL MED, V44, P3435, DOI 10.1017/S0033291714000531; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Heron J, 2015, LONGITUD LIFE COURSE, V6, P420, DOI 10.14301/llcs.v6i4.322; Hussong AM, 2008, J ABNORM CHILD PSYCH, V36, P335, DOI 10.1007/s10802-007-9181-9; Hussong AM, 1998, J ABNORM CHILD PSYCH, V26, P453, DOI 10.1023/A:1022699701996; Hussong AM, 2010, J ABNORM CHILD PSYCH, V38, P367, DOI 10.1007/s10802-009-9374-5; Keller PS, 2008, DEV PSYCHOPATHOL, V20, P195, DOI 10.1017/S0954579408000096; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kendler KS, 2013, ALCOHOL CLIN EXP RES, V37, P2118, DOI 10.1111/acer.12196; Knudsen AK, 2015, EUR CHILD ADOLES PSY, V24, P1269, DOI 10.1007/s00787-015-0677-5; Kretschmer T, 2014, EUR CHILD ADOLES PSY, V23, P539, DOI 10.1007/s00787-013-0488-5; Larkby CA, 2012, EXTERNAL CONTROL ORG, V50, P1; Lewis SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049407; Malone SM, 2010, J CHILD PSYCHOL PSYC, V51, P1067, DOI 10.1111/j.1469-7610.2010.02219.x; Manning V, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-377; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Moffitt T.E., 2006, DEV PSYCHOPATHOL, V3, P570, DOI DOI 10.1002/9780470939406.CH15; Moffitt TE, 1996, DEV PSYCHOPATHOL, V8; Moffitt TE, 2008, J CHILD PSYCHOL PSYC, V49, P3, DOI 10.1111/j.1469-7610.2007.01823.x; Murray J, 2016, J CHILD PSYCHOL PSYC, V57, P575, DOI 10.1111/jcpp.12486; Muthen LK, 2016, USERS GUIDE; Niccols A, 2012, CHILD ABUSE NEGLECT, V36, P308, DOI 10.1016/j.chiabu.2011.10.007; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; O'Leary CM, 2012, DRUG ALCOHOL REV, V31, P170, DOI 10.1111/j.1465-3362.2011.00331.x; O'Leary CM, 2010, PEDIATRICS, V126, pE843, DOI 10.1542/peds.2010-0256; Robinson M, 2010, BJOG-INT J OBSTET GY, V117, P1139, DOI 10.1111/j.1471-0528.2010.02596.x; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; Sayal K, 2014, EUR CHILD ADOLES PSY, V23, P891, DOI 10.1007/s00787-014-0599-7; Sayal K, 2009, PEDIATRICS, V123, pE289, DOI 10.1542/peds.2008-1861; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; Sterne JAC, 2009, BMJ-BRIT MED J, V29, P338; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stringaris A, 2014, BRIT J PSYCHIAT, V205, P17, DOI 10.1192/bjp.bp.113.134221; Vermunt JK, 2010, POLIT ANAL, V18, P450, DOI 10.1093/pan/mpq025; Warnick EM, 2008, CHILD ADOL MENT H-UK, V13, P140, DOI 10.1111/j.1475-3588.2007.00461.x; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; Zuccolo L, 2013, INT J EPIDEMIOL, V42, P1358, DOI 10.1093/ije/dyt172	59	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178862	10.1371/journal.pone.0178862	http://dx.doi.org/10.1371/journal.pone.0178862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586358	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700034
J	Nyine, M; Uwimana, B; Swennen, R; Batte, M; Brown, A; Christelova, P; Hribova, E; Lorenzen, J; Dolezel, J				Nyine, Moses; Uwimana, Brigitte; Swennen, Rony; Batte, Michael; Brown, Allan; Christelova, Pavla; Hribova, Eva; Lorenzen, Jim; Dolezel, Jaroslav			Trait variation and genetic diversity in a banana genomic selection training population	PLOS ONE			English	Article							PLANTAIN MUSA; AAB GROUP; IMPROVEMENT; PREDICTION; HYBRIDS; GROWTH; YIELD	Banana (Musa spp.) is an important crop in the African Great Lakes region in terms of income and food security, with the highest per capita consumption worldwide. Pests, diseases and climate change hamper sustainable production of bananas. New breeding tools with increased crossbreeding efficiency are being investigated to breed for resistant, high yielding hybrids of East African Highland banana (EAHB). These include genomic selection (GS), which will benefit breeding through increased genetic gain per unit time. Understanding trait variation and the correlation among economically important traits is an essential first step in the development and selection of suitable GS models for banana. In this study, we tested the hypothesis that trait variations in bananas are not affected by cross combination, cycle, field management and their interaction with genotype. A training population created using EAHB breeding material and its progeny was phenotyped in two contrasting conditions. A high level of correlation among vegetative and yield related traits was observed. Therefore, genomic selection models could be developed for traits that are easily measured. It is likely that the predictive ability of traits that are difficult to phenotype will be similar to less difficult traits they are highly correlated with. Genotype response to cycle and field management practices varied greatly with respect to traits. Yield related traits accounted for 31-35% of principal component variation under low and high input field management conditions. Resistance to Black Sigatoka was stable across cycles but varied under different field management depending on the genotype. The best cross combination was 1201K-1xSH3217 based on selection response (R) of hybrids. Genotyping using simple sequence repeat (SSR) markers revealed that the training population was genetically diverse, reflecting a complex pedigree background, which was mostly influenced by the male parents.	[Nyine, Moses] Palacky Univ, Fac Sci, Olomouc, Czech Republic; [Nyine, Moses; Uwimana, Brigitte; Swennen, Rony; Batte, Michael; Lorenzen, Jim] Int Inst Trop Agr, Kampala, Uganda; [Nyine, Moses; Christelova, Pavla; Hribova, Eva; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic; [Swennen, Rony] Katholieke Univ Leuven, Div Crop Biotech, Lab Trop Crop Improvement, Leuven, Belgium; [Swennen, Rony] Biovers Int, Leuven, Belgium; [Swennen, Rony; Brown, Allan] Int Inst Trop Agr, Arusha, Tanzania; [Lorenzen, Jim] Bill & Melinda Gates Fdn, Seattle, WA USA	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; KU Leuven; Alliance; Bioversity International; Bill & Melinda Gates Foundation	Uwimana, B (corresponding author), Int Inst Trop Agr, Kampala, Uganda.; Dolezel, J (corresponding author), Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic.	B.Uwimana@cgiar.org; dolezel@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008	Dolezel, Jaroslav/0000-0002-6263-0492; Nyine, Moses/0000-0002-8409-7588; Hribova, Eva/0000-0002-6868-4344	CGIAR Fund; CGIAR Research Program on Roots, Tubers and Bananas; Bill & Melinda Gates Foundation (BMGF) [0PP1093845]; Ministry of Education, Youth and Sports of the Czech Republic [L01204]	CGIAR Fund(CGIAR); CGIAR Research Program on Roots, Tubers and Bananas(CGIAR); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by several donors through their contributions to the CGIAR Fund (http://www.cgiar.org/who-we-are/cgiar-fund/fund-donors-2/), and in particular to the CGIAR Research Program on Roots, Tubers and Bananas. Additional funding was provided by the Bill & Melinda Gates Foundation (BMGF) (Investment ID: 0PP1093845) to the IITA banana breeding program. The genotyping work at the Institute of Experimental Botany was supported by the Ministry of Education, Youth and Sports of the Czech Republic (grant L01204 from the National Program of Sustainability I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnall A, 2014, J CLASSIF, V31, P154, DOI 10.1007/s00357-013-9135-6; Barendregt A, 2009, TIDAL FRESHWATER WET, P1; Beaulieu J, 2014, HEREDITY, V113, P343, DOI 10.1038/hdy.2014.36; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Craenen K, 1998, BLACK SIGATOKA DIS B, P41; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; De Oliveira EJ, 2012, EUPHYTICA; Dens KR, 2008, J HORTIC SCI BIOTECH, V83, P113, DOI 10.1080/14620316.2008.11512355; Desta ZA, 2014, TRENDS PLANT SCI, V19, P592, DOI 10.1016/j.tplants.2014.05.006; DOLEZEL J, 1991, PHYTOCHEM ANALYSIS, V2, P143, DOI 10.1002/pca.2800020402; Dolezel J., 1997, Infomusa, V6, P6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gold CS, 2004, ANN APPL BIOL, V145, P263, DOI 10.1111/j.1744-7348.2004.tb00382.x; Karamura D, 2016, ACTA HORTIC, V1114, P67, DOI 10.17660/ActaHortic.2016.1111.9; Karamura D., 1998, THESIS, P1; Karamura D.A., 2012, BANANA CULTIVAR NAME, P1; Kitavi M, 2016, THEOR APPL GENET, V129, P547, DOI 10.1007/s00122-015-2647-1; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Lorenzen J, 2009, ACTA HORTIC, V828, P305; Lorenzen J, 2010, ACTA HORTIC, V879, P595; Martin G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2579-4; Meuwissen THE, 2001, GENETICS, V157, P1819; MOBAMBO KN, 1994, INT J PEST MANAGE, V40, P75, DOI 10.1080/09670879409371858; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Onogi A, 2016, THEOR APPL GENET, V129, P805, DOI 10.1007/s00122-016-2667-5; ORTIZ R, 1994, J AM SOC HORTIC SCI, V119, P1050, DOI 10.21273/JASHS.119.5.1050; Ortiz R, 2014, BIOTECHNOL ADV, V32, P158, DOI 10.1016/j.biotechadv.2013.09.010; Osuji JO, 1997, SCI HORTIC-AMSTERDAM, V71, P197, DOI 10.1016/S0304-4238(97)00101-5; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Piepho HP, 2007, GENETICS, V177, P1881, DOI 10.1534/genetics.107.074229; Pillay M, 2001, THEOR APPL GENET, V102, P965, DOI 10.1007/s001220000500; Pillay M., 2012, GENETICS GENOMICS BR, P116; Pillay M, 2011, BANANA BREEDING: PROGRESS AND CHALLENGES, P53, DOI 10.1201/b10514-5; Rowe P., 1993, Infomusa, V2, P9; ROWE PR, 1990, FUSARIUM WILT OF BANANA, P115; Simmonds N. W, 1986, FAO TECHNICAL PAPERS, P17; Ssali RT, 2010, ACTA HORTIC, V879, P585, DOI 10.17660/ActaHortic.2010.879.65; Ssebuliba R, 2006, FIELD CROP RES, V95, P250, DOI 10.1016/j.fcr.2005.03.004; Tenkouano A, 1998, EUPHYTICA, V104, P151, DOI 10.1023/A:1018638120145; Togashi K, 2011, J ANIM SCI, V89, P2972, DOI 10.2527/jas.2009-2606; Tushemereirwe W, 2015, PERFORMANCE NARITA H; Tushemereirwe W, 1996, THESIS; van Asten PJA, 2011, AGR WATER MANAGE, V98, P541, DOI 10.1016/j.agwat.2010.10.005; VUYLSTEKE DR, 1993, EUPHYTICA, V65, P33, DOI 10.1007/BF00022197; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x	53	22	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178734	10.1371/journal.pone.0178734	http://dx.doi.org/10.1371/journal.pone.0178734			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586365	Green Submitted, Green Published, gold			2022-12-26	WOS:000402875700025
J	Boza, V; Brejova, B; Vinar, T				Boza, Vladimir; Brejova, Brona; Vinar, Tomas			DeepNano: Deep recurrent neural networks for base calling in MinION nanopore reads	PLOS ONE			English	Article							TIME	The MinION device by Oxford Nanopore produces very long reads (reads over 100 kBp were reported); however it suffers from high sequencing error rate. We present an open-source DNA base caller based on deep recurrent neural networks and show that the accuracy of base calling is much dependent on the underlying software and can be improved by considering modern machine learning methods. By employing carefully crafted recurrent neural networks, our tool significantly improves base calling accuracy on data from R7.3 version of the platform compared to the default base caller supplied by the manufacturer. On R9 version, we achieve results comparable to Nanonet base caller provided by Oxford Nanopore. Availability of an open source tool with high base calling accuracy will be useful for development of new applications of the MinION device, including infectious disease detection and custom target enrichment during sequencing.	[Boza, Vladimir; Brejova, Brona; Vinar, Tomas] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia	Comenius University Bratislava	Vinar, T (corresponding author), Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia.	tomas.vinar@fmph.uniba.sk	Vinar, Tomas/I-3695-2014; Brejova, Brona/I-3718-2014	Vinar, Tomas/0000-0003-3898-3447; Brejova, Brona/0000-0002-9483-1766	VEGA [1/0684/16, 1/0719/14]; Slovak Research and Development Agency [APVV-14-0253]	VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); Slovak Research and Development Agency(Slovak Research and Development Agency)	This research was funded by VEGA grants 1/0684/16 (BB) and 1/0719/14 (TV), and a grant from the Slovak Research and Development Agency APVV-14-0253.	Bergstra J., 2010, P 9 PYTH SCI C, P3, DOI DOI 10.25080/MAJORA-92BF1922-003; Chung J., 2020, ARXIV; David M, 2017, BIOINFORMATICS, V33, P49, DOI 10.1093/bioinformatics/btw569; GILES CL, 1994, IEEE T NEURAL NETWOR, V5, P153, DOI 10.1109/TNN.1994.8753425; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; Graves A, 2012, STUD COMPUT INTELL, V385, P37; Hinton G., 2015, DISTILLING KNOWLEDGE; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Judge K, 2015, J ANTIMICROB CHEMOTH, V70, P2775, DOI 10.1093/jac/dkv206; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]; Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Mohammed O., 2013, J BIOMED SCI ENG, V6, P165, DOI DOI 10.4236/JBISE.2013.62020; Norris AL, 2016, CANCER BIOL THER, V17, P246, DOI 10.1080/15384047.2016.1139236; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2; Schuster M, 1997, IEEE T SIGNAL PROCES, V45, P2673, DOI 10.1109/78.650093; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Sovic I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11307; Sutskever I., 2014, ADV NEURAL INFORM PR, DOI DOI 10.1007/S10107-014-0839-0; Sutskever I., 2013, P 30 INT C MACH LEAR, V28, P1139, DOI DOI 10.1007/S00287-015-0911-Z; Szalay T, 2015, NAT BIOTECHNOL, V33, P1087, DOI 10.1038/nbt.3360; Tibbetts C., 1994, AUTOMATED DNA SEQUEN, P219	29	104	112	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178751	10.1371/journal.pone.0178751	http://dx.doi.org/10.1371/journal.pone.0178751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582401	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600034
J	Svard, J; Mugusi, S; Mloka, D; Neogi, U; Meini, G; Mugusi, F; Incardona, F; Zazzi, M; Sonnerborg, A				Svard, Jenny; Mugusi, Sabina; Mloka, Doreen; Neogi, Ujjwal; Meini, Genny; Mugusi, Ferdinand; Incardona, Francesca; Zazzi, Maurizio; Sonnerborg, Anders			Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy	PLOS ONE			English	Article							VIROLOGICAL FAILURE; VIRAL LOAD; AFRICA; CHILDREN; PERFORMANCE; ADULTS; SWITCH	Introduction Antiretroviral therapy (ART) has been successfully introduced in low-middle income countries. However an increasing rate of ART failure with resistant virus is reported. We therefore described the pattern of drug resistance mutations at antiretroviral treatment (ART) failure in a real-life Tanzanian setting using the remote genotyping procedure and thereafter predicted future treatment options using rule-based algorithm and the EuResist bioinformatics predictive engine. According to national guidelines, the default first-line regimen is tenofovir + lamivudine + efavirenz, but variations including nevirapine, stavudine or emtricitabine can be considered. If failure on first-line ART occurs, a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) and boosted lopinavir or atazanavir is recommended. Materials and methods Plasma was obtained from subjects with first (n = 174) or second-line (n = 99) treatment failure, as defined by clinical or immunological criteria, as well as from a control group of ART naive subjects (n = 17) in Dar es Salaam, Tanzania. Amplification of the pol region was performed locally and the amplified DNA fragment was sent to Sweden for sequencing (split genotyping procedure). The therapeutic options after failure were assessed by the genotypic sensitivity score and the EuResist predictive engine. Viral load was quantified in a subset of subjects with second-line failure (n = 52). Results The HIV-1 pol region was successfully amplified from 55/174 (32%) and 28/99 (28%) subjects with first- or second-line failure, respectively, and 14/17 (82%) ART-naive individuals. HIV-1 pol sequence was obtained in 82 of these 97 cases (84.5%). Undetectable or very low (<2.6 log(10) copies/10(-3) L) viral load explained 19 out of 25 (76%) amplification failures in subjects at second-line ART failure. At first and second line failure, extensive accumulation of NRTI (88% and 73%, respectively) and NNRTI (93% and 73%, respectively) DRMs but a limited number of PI DRMs (11% at second line failure) was observed. First line failure subjects displayed a high degree of cross-resistance to second-generation NNRTIs etravirine (ETR; 51% intermediate and 9% resistant) and rilpivirine (RPV; 12% intermediate and 58% resistant), and to abacavir (ABC; 49% resistant) which is reserved for second line therapy in Tanzania. The predicted probability of success with the best salvage regimen at second-line failure decreased from 93.9% to 78.7% when restricting access to the NRTIs, NNRTIs and PIs currently available in Tanzania compared to when including all approved drugs. Discussion The split genotyping procedure is potential tool to analyse drug resistance in Tanzania but the sensitivity should be evaluated further. The lack of viral load monitoring likely results in a high false positive rate of treatment failures, unnecessary therapy switches and massive accumulation of NRTI and NNRTI mutations. The introduction of regular virological monitoring should be prioritized and integrated with drug resistance studies in resource limited settings.	[Svard, Jenny; Neogi, Ujjwal; Sonnerborg, Anders] Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Mugusi, Sabina] Muhimbili Univ Hlth & Allied Sci, Dept Clin Pharmacol, Sch Med, Dar Es Salaam, Tanzania; [Mloka, Doreen] Muhimbili Univ Hlth & Allied Sci, Dept Pharmaceut Microbiol, Dar Es Salaam, Tanzania; [Meini, Genny; Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Incardona, Francesca] EuResist Network GEIE, Rome, Italy; [Sonnerborg, Anders] Karolinska Inst, Karolinska Univ Hosp, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; University of Siena; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska University Hospital	Svard, J (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.	jenny.s.svard@gmail.com	Zazzi, Maurizio/K-3422-2018; Neogi, Ujjwal/ABF-1172-2021; Sönnerborg, Anders/W-2011-2019; Neogi, Ujjwal/E-4274-2012	Zazzi, Maurizio/0000-0002-0344-6281; Neogi, Ujjwal/0000-0002-0844-3338; Sönnerborg, Anders/0000-0001-8928-3374; mloka, doreen/0000-0002-7300-1958	European and Developing Countries Clinical Trial Partnership (EDCTP) [JP.2009.10800.002]; Swedish Research Council [2012-476]; Swedish Civil Contingencies Agency [2010-7873]	European and Developing Countries Clinical Trial Partnership (EDCTP); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Civil Contingencies Agency	The study was supported by European and Developing Countries Clinical Trial Partnership (EDCTP, grant number JP.2009.10800.002), Swedish Research Council (grant number 2012-476) and the Swedish Civil Contingencies Agency (grant number 2010-7873).	[Anonymous], 2017, EURESIST TRAINING TO; Dow DE, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0567-3; Emmett SD, 2010, JAIDS-J ACQ IMM DEF, V54, P368, DOI 10.1097/QAI.0b013e3181cf4882; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Mgelea EM, 2014, SAMJ S AFR MED J, V104, P696, DOI [10.7196/samj.7807, 10.7196/SAMJ.7807]; Paton NI, 2014, NEW ENGL J MED, V371, P234, DOI 10.1056/NEJMoa1311274; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Rhee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145772; Rosen-Zvi M, 2008, BIOINFORMATICS, V24, pI399, DOI 10.1093/bioinformatics/btn141; Salazar-Vizcaya L, 2014, AIDS, V28, P2451, DOI 10.1097/QAD.0000000000000446; Schoffelen AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058526; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; UNAIDS, 2016, PREV GAP REP; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Vercauteren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061436; Zazzi MM G., 2011, 6 EDCTP FORUM STRENG	22	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178942	10.1371/journal.pone.0178942	http://dx.doi.org/10.1371/journal.pone.0178942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582463	gold, Green Published			2022-12-26	WOS:000402837600060
J	Huang, W; Ren, CH; Li, HM; Huo, D; Wang, YH; Jiang, X; Tian, YS; Luo, P; Chen, T; Hu, CQ				Huang, Wen; Ren, Chunhua; Li, Hongmei; Huo, Da; Wang, Yanhong; Jiang, Xiao; Tian, Yushun; Luo, Peng; Chen, Ting; Hu, Chaoqun			Transcriptomic analyses on muscle tissues of Litopenaeus vannamei provide the first profile insight into the response to low temperature stress	PLOS ONE			English	Article							PACIFIC WHITE SHRIMP; DIFFERENTIAL GENE-EXPRESSION; RNA-SEQ ANALYSIS; COLD; ACCLIMATION; ANNOTATION; KINASES	The Pacific white shrimp (Litopenaeus vannamei) is an important cultured crustacean species worldwide. However, little is known about the molecular mechanism of this species involved in the response to cold stress. In this study, four separate RNA-Seq libraries of L. vannamei were generated from 13 degrees C stress and control temperature. Total 29,662 of Unigenes and overall of 19,619 annotated genes were obtained. Three comparisons were carried out among the four libraries, in which 72 of the top 20% of differentially-expressed genes were obtained, 15 GO and 5 KEGG temperature-sensitive pathways were fished out. Catalytic activity (GO: 0003824) and Metabolic pathways (ko01100) were the most annotated GO and KEGG pathways in response to cold stress, respectively. In addition, Calcium, MAPK cascade, Transcription factor and Serine/threonine-protein kinase signal pathway were picked out and clustered. Serine/threonine-protein kinase signal pathway might play more important roles in cold adaptation, while other three signal pathway were not widely transcribed. Our results had summarized the differentially-expressed genes and suggested the major important signaling pathways and related genes. These findings provide the first profile insight into the molecular basis of L. vannamei response to cold stress.	[Huang, Wen; Ren, Chunhua; Li, Hongmei; Huo, Da; Wang, Yanhong; Jiang, Xiao; Tian, Yushun; Luo, Peng; Chen, Ting; Hu, Chaoqun] Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Huang, Wen; Ren, Chunhua; Wang, Yanhong; Jiang, Xiao; Luo, Peng; Chen, Ting; Hu, Chaoqun] Chinese Acad Sci, Key Lab Appl Marine Biol Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Huang, Wen; Ren, Chunhua; Wang, Yanhong; Jiang, Xiao; Luo, Peng; Chen, Ting; Hu, Chaoqun] Chinese Acad Sci, Chinese Acad Sci LAMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Huang, Wen; Ren, Chunhua; Chen, Ting; Hu, Chaoqun] South China Sea Bio Resource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China; [Li, Hongmei; Huo, Da; Tian, Yushun] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, T; Hu, CQ (corresponding author), Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.; Chen, T; Hu, CQ (corresponding author), Chinese Acad Sci, Key Lab Appl Marine Biol Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Chen, T; Hu, CQ (corresponding author), Chinese Acad Sci, Chinese Acad Sci LAMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.; Chen, T; Hu, CQ (corresponding author), South China Sea Bio Resource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China.	chan1010@scsio.ac.cn; hucq@scsio.ac.cn	huang, wen/GXW-0661-2022	TIAN, Yushun/0000-0003-3641-227X; Chen, Ting/0000-0002-5777-909X	National Natural Science Foundation 375 of China [31602135, 31402287]; Guangdong Province Program [20138091300020, 20148030301064, 2015B020231007, 2016A020210062, 2016A030310112]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [A201601A03]; National High Technology Research & Development Program of China (863 Program) [2012AA10A404-4]; Science and Technology Service Network Initiative of the Chinese Academy of Sciences [KFJ-SW-STS-146]	National Natural Science Foundation 375 of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Program; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province; National High Technology Research & Development Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Service Network Initiative of the Chinese Academy of Sciences	This work was supported by grants the National Natural Science Foundation 375 of China (31602135 and 31402287), the Guangdong Province Program (20138091300020, 20148030301064, 2015B020231007, 2016A020210062 and 2016A030310112), the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (A201601A03), the National High Technology Research & Development Program of China (863 Program) (2012AA10A404-4), and the Science and Technology Service Network Initiative of the Chinese Academy of Sciences (KFJ-SW-STS-146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131503; Chen T, 2016, FISH SHELLFISH IMMUN, V54, P197, DOI 10.1016/j.fsi.2016.04.008; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Fan LF, 2013, J PROTEOMICS, V80, P196, DOI 10.1016/j.jprot.2012.12.017; FAO. Fisheries and Aquaculture Department, 2012, FISH AQ DEP STAT WOR, P37; Gao WH, 2012, AQUACULTURE, V364, P186, DOI 10.1016/j.aquaculture.2012.08.024; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; Hu DX, 2015, MAR GENOM, V24, P297, DOI 10.1016/j.margen.2015.07.003; Ju Z, 2002, MOL GENET GENOMICS, V268, P87, DOI 10.1007/s00438-002-0727-9; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Kim SK, 2014, AQUAC RES, V45, P362, DOI 10.1111/are.12319; Kumlu M, 2010, J THERM BIOL, V35, P302, DOI 10.1016/j.jtherbio.2010.06.008; Li B, 2014, AQUACULT INT, V22, P761, DOI 10.1007/s10499-013-9704-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1560-y; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Long Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037209; Lu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164396; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nie HT, 2016, FISH SHELLFISH IMMUN, V55, P358, DOI 10.1016/j.fsi.2016.06.008; Qiu J, 2011, COMP BIOCHEM PHYS C, V154, P36, DOI 10.1016/j.cbpc.2011.02.007; Quispe RL, 2016, FISH SHELLFISH IMMUN, V58, P103, DOI 10.1016/j.fsi.2016.09.024; Ren LP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-844; Smith S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-375; Teets NM, 2008, AM J PHYSIOL-REG I, V294, pR1938, DOI 10.1152/ajpregu.00459.2007; Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110; Vinagre C, 2014, J THERM BIOL, V41, P38, DOI 10.1016/j.jtherbio.2014.02.005; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102492; Wang XD, 2015, J SHELLFISH RES, V34, P1037, DOI 10.2983/035.034.0330; Yang CG, 2015, GENE, V564, P134, DOI 10.1016/j.gene.2015.01.038; Yin F, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1550-1; Zhao Q, 2015, FISH SHELLFISH IMMUN, V42, P400, DOI 10.1016/j.fsi.2014.11.020; Zhou J, 2010, J THERM BIOL, V35, P284, DOI 10.1016/j.jtherbio.2010.06.004	47	30	33	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178604	10.1371/journal.pone.0178604	http://dx.doi.org/10.1371/journal.pone.0178604			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575089	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300071
J	Mason, C; Weber, J; Atasoy, S; Sabariego, C; Cieza, A				Mason, Catherine; Weber, Joerg; Atasoy, Seryan; Sabariego, Carla; Cieza, Alarcos			Development of indicators for monitoring Community-Based Rehabilitation	PLOS ONE			English	Article							PROGRAMS	Background Community-Based Rehabilitation (CBR) is a multi-sectoral approach working to equalize opportunities and include people with disability in all aspects of community life. Reliable and internationally comparable data needed to monitor and evaluate CBR are scarce, partially due to the absence of standardized indicators. The objective of this manuscript is to describe the collaborative development process which led to the World Health Organization's (WHO) recently launched set of standardized CBR outcome indicators. Methods The WHO's CBR Guidelines recognize CBR as a comprehensive and multi-sectoral strategy, and were therefore used as the starting point for the development of the indicators, in a consensus process involving WHO and International Disability and Development Consortium. Pilot implementations in Guatemala, Egypt and China using a specifically developed mobile phone application to collect data, and an online expert survey were completed to assess validity and feasibility of the indicators and their corresponding questions. Results The indicator set includes 13 Base Indicators which are broad enough to capture the situation of people with disability in settings where CBR is carried out, independently of the specific CBR activities carried out in a community; and 27 Supplementary Indicators that provide more specific coverage and can be selected based on the specific goals of a CBR program. Conclusion The indicators were suitable to assess differences in health, education, social life, livelihood and empowerment between people with disability and other community members. This comparability provides valuable information to CBR managers, donors and government agencies, to guide decision making, support advocacy and improve accountability. The CBR indicators will support WHO and its member states in their efforts towards strengthening CBR, by generating evidence on its effectiveness.	[Mason, Catherine; Atasoy, Seryan; Sabariego, Carla] Ludwig Maximilians Univ Munchen, Publ Hlth & Hlth Serv Res, Dept Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Weber, Joerg] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [Cieza, Alarcos] WHO, Disabil & Rehabil Unit, Geneva, Switzerland	University of Munich; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Mason, C (corresponding author), Ludwig Maximilians Univ Munchen, Publ Hlth & Hlth Serv Res, Dept Med Informat Biometry & Epidemiol IBE, Munich, Germany.	catherine.mason@med.uni-muenchen.de		Mason, Catherine/0000-0002-6859-4373	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Adeoye A, 2011, DISABIL REHABIL, V33, P1110, DOI 10.3109/09638288.2010.521613; [Anonymous], 1996, WORKSH COMM BAS REH; Chung EYH, 2011, DISABIL REHABIL, V33, P1668, DOI 10.3109/09638288.2010.541545; Cornielje H, 2000, LEPROSY REV, V71, P472; Cornielje H, 2008, LEPROSY REV, V79, P36; CRPD, 2006, CONV RIGHTS PERS DIS; Finkenflugel H, 2008, DISABIL REHABIL, V30, P348, DOI 10.1080/09638280701257288; GALLUP, 2013, POLL SOC SER CONS HA; Gibson L., 2015, CAMPBELL SYSTEMATIC, V15; Grandisson M, 2014, DISABIL REHABIL, V36, P265, DOI 10.3109/09638288.2013.785602; International Labour Organization United Nations Educational Scientific and Cultural Organization and the World Health Organization, 2004, CBR STRAT REH EQ OPP; Kendall E, 2000, DISABIL REHABIL, V22, P435, DOI 10.1080/09638280050045901; Kuipers P, 2004, Rural Remote Health, V4, P291; Kuipers P, 2003, J REHABIL, V69, P4; Lukersmith S, 2013, DISABIL REHABIL, V35, P1941, DOI 10.3109/09638288.2013.770078; Madden R.H., 2015, DISABIL CBR INC DEV, V26, P26, DOI [10.5463/dcid.v26i4.472, DOI 10.5463/DCID.V26I4.472]; Meadows D, 1998, EARTHSCAN READER SUS, P364; Organisation for Economic Co-operation and Development, 2004, GLOS KEY TERMS EV RE; Robb A, 2012, TECHN M DEV CBR M E; Sharma M., 2007, ASIA PAC DISABIL REH, V18, P46; Thomas M, 2011, PSYCHOL DEV SOC, V23, P277, DOI 10.1177/097133361102300206; Weltgesundheitsorganisation, 2015, WHO GLOB DIS ACT PLA; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2015, CAPT DIFF WE MAK COM; Wirz S, 2002, INT J REHABIL RES, V25, P163, DOI 10.1097/00004356-200209000-00001; World Health Organization, 2012, WHO QUAL LIF BREF WH; World Health Organization, 2010, COMM BAS REH CBR GUI	27	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178418	10.1371/journal.pone.0178418	http://dx.doi.org/10.1371/journal.pone.0178418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575102	gold, Green Published			2022-12-26	WOS:000402624300050
J	Terveer, EM; Nijhuis, RHT; Crobach, MJT; Knetsch, CW; Veldkamp, KE; Gooskens, J; Kuijper, EJ; Claas, ECJ				Terveer, Elisabeth M.; Nijhuis, Roel H. T.; Crobach, Monique J. T.; Knetsch, Cornelis W.; Veldkamp, Karin E.; Gooskens, Jairo; Kuijper, Ed J.; Claas, Eric C. J.			Prevalence of colistin resistance gene (mcr-1) containing Enterobacteriaceae in feces of patients attending a tertiary care hospital and detection of a mcr-1 containing, colistin susceptible E-coli	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; DECONTAMINATION; DISSEMINATION; SWITZERLAND; TRACT	The emergence of the plasmid-mediated mcrcolistin resistance gene in the community poses a potential threat for treatment of patients, especially when hospitalized. The aim of this study was to determine the prevalence of all currently known mcr mediated colistin resistance gene in fecal samples of patients attending a tertiary care hospital. From November 2014 until July 2015, fecal samples of patients attending the Leiden University Medical Center were collected and screened for presence of mcr using real-time PCR. Two of 576 patients were positive for mcr-1, resulting in a prevalence of 0.35%, whereas no mcr-2 was found. One of these samples was culture negative, the second sample contained a b/aCMY-2 and mcr-1 containing E.coli. This strain belonged to Sequence Type 359 and serotype 0177:H21. The mcr-1 containing E.coli was phenotypically susceptible to colistin with a MIC of >= 0.25mg/I, due to a 1329bp transposon IS1OR inserted into the mcr-1 gene as identified by WGS. This prevalence study shows that mcr-1 is present in low levels patients out of the community attending a hospital. Furthermore the study underlines the importance of phenotypical confirmation of molecular detection of a mcr-1 gene.	[Terveer, Elisabeth M.; Nijhuis, Roel H. T.; Crobach, Monique J. T.; Knetsch, Cornelis W.; Veldkamp, Karin E.; Gooskens, Jairo; Kuijper, Ed J.; Claas, Eric C. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Knetsch, Cornelis W.] DDL Diagnost Lab, Rijswijk, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; DDL Diagnostic Laboratory	Terveer, EM (corresponding author), Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands.	e.m.terveer@lumc.nl	Kuijper, ed/AAB-7853-2022	Kuijper, ed/0000-0001-5726-2405; Nijhuis, Roel/0000-0003-4203-3858; Knetsch, Wilco/0000-0001-8569-3456; Gooskens, Jairo/0000-0002-8381-7870	Netherlands Organization for Health Research and Development, ZonMW [50-52200-98-035]	Netherlands Organization for Health Research and Development, ZonMW(Netherlands Organization for Health Research and Development)	The sample collection of this study was supported by the Netherlands Organization for Health Research and Development, ZonMW (50-52200-98-035), https://www.zonmw.nl/en/.	Arcilla MS, 2016, LANCET INFECT DIS, V16, P147, DOI 10.1016/S1473-3099(15)00541-1; Bergmans DCJJ, 2001, AM J RESP CRIT CARE, V164, P382, DOI 10.1164/ajrccm.164.3.2005003; Catry B, 2015, INT J ANTIMICROB AG, V46, P297, DOI 10.1016/j.ijantimicag.2015.06.005; Doumith M, 2016, J ANTIMICROB CHEMOTH, V71, P2300, DOI 10.1093/jac/dkw093; Du H, 2016, LANCET INFECT DIS; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Falgenhauer L, 2016, LANCET INFECT DIS; Grayson ML, 2010, KUCERS USE ANTIBIOTI; Haenni M, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00007-4; Hasman H, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.49.30085; Huizinga P, 2016, EURO SURVEILLANCE B, V21; Li A, 2016, ANTIMICROBIAL AGENTS; Liassine N, 2016, INT J INFECT DIS, V51, P4, DOI 10.1016/j.ijid.2016.08.008; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Malhotra-Kumar S, 2016, LANCET INFECT DIS; MATSUTANI S, 1991, J BACTERIOL, V173, P7802, DOI 10.1128/jb.173.24.7802-7809.1991; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Nijhuis RH, 2016, J ANTIMICROBIAL CHEM; Oostdijk EAN, 2014, JAMA-J AM MED ASSOC, V312, P1429, DOI 10.1001/jama.2014.7247; Poirel L, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00006-2; Prim N, 2016, EURO SURVEILLANCE B, V21; Skov RL, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.9.30155; Terveer EM, 2016, 26 EUR C CLIN MICR I; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P979, DOI 10.15585/mmwr.mm6536e3; von Wintersdorff CJH, 2016, J ANTIMICROB CHEMOTH, V71, P3416, DOI 10.1093/jac/dkw328; Wang Y, 2017, LANCET INFECT DIS; Webb HE, 2016, LANCET INFECT DIS, V16, P144, DOI 10.1016/S1473-3099(15)00538-1; Wick RR, 2016, J ANTIMICROBIAL CHEM; Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280; Yao X, 2016, LANCET INFECT DIS; Zeng KJ, 2016, ANTIMICROBIAL AGENTS; Zurfluh K, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0186-z; Zurfuh K, 2016, ANTIMICROB AGENTS CH, V60, P2594, DOI 10.1128/AAC.00066-16	36	43	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178598	10.1371/journal.pone.0178598	http://dx.doi.org/10.1371/journal.pone.0178598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575076	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300069
J	Zheng, Z; Du, XD; Xiong, XW; Jiao, Y; Deng, YW; Wang, QH; Huang, RL				Zheng, Zhe; Du, Xiaodong; Xiong, Xinwei; Jiao, Yu; Deng, Yuewen; Wang, Qingheng; Huang, Ronglian			PmRunt regulated by Pm-miR-183 participates in nacre formation possibly through promoting the expression of collagen VI-like and Nacrein in pearl oyster Pinctada martensii	PLOS ONE			English	Article							SCALLOP CHLAMYS-FARRERI; TRANSCRIPTION FACTORS; CHONDROCYTE DIFFERENTIATION; STRUCTURAL BASIS; DOWN-REGULATION; CBF-BETA; GENE; SHELL; BIOMINERALIZATION; RUNT	Heterodimeric PEBP2/CBFs are key regulators in diverse biological processes, such as haematopoietic stem-cell generation, bone formation and cancers. In this work, we cloned runt-like transcriptional factor (designated as PmRunt) and CBF beta (designated as PmCBF) gene, which comprise the heterodimeric transcriptional factor in Pinctada martensii. PmRunt was identified with an open reading frame that encodes 545 amino acids and has typical Runt domain. Phylogenetic analysis results speculated that runt-like transcriptional factors (RDs) in vertebrates and invertebrates are separated into two branches. In molluscs, PmRunt and other RDs are clustered in one of these branches. Direct interaction between PmRunt and PmCBF was evidenced by yeast two-hybrid assay results. Gene repression by RNA interference decreased the expression level of PmRunt, and subsequent observation of the inner surface of the nacre by scanning electron microscopy demonstrated disordered growth. The luciferase activities of reporters that contain promoter regions of Collagen VI-like (PmColVI) and PmNacrein were enhanced by PmRunt. Meanwhile, Pm-miR-183 apparently inhibited the relative luciferase activity of reporters containing the 3'-UTR of PmRunt. The expression level of PmRunt was repressed after Pm-miR-183 was overexpressed in the mantle tissue. Therefore, we proposed that PmRunt could be targeted by Pm-miR-183 and regulate the transcription of PmColVI and PmNacrein by increasing their transcriptional activity, thereby governing nacre formation.	[Zheng, Zhe; Du, Xiaodong; Xiong, Xinwei; Jiao, Yu; Deng, Yuewen; Wang, Qingheng; Huang, Ronglian] Guangdong Ocean Univ, Fishery Coll, Zhanjiang, Peoples R China; [Du, Xiaodong] Guangdong Ocean Univ, Ctr Pearl Aquaculture & Proc, Guangdong Technol Res, Zhanjiang, Peoples R China	Guangdong Ocean University; Guangdong Ocean University	Du, XD; Huang, RL (corresponding author), Guangdong Ocean Univ, Fishery Coll, Zhanjiang, Peoples R China.; Du, XD (corresponding author), Guangdong Ocean Univ, Ctr Pearl Aquaculture & Proc, Guangdong Technol Res, Zhanjiang, Peoples R China.	gdhddxd@hotmail.com; hrl8849@163.com		Xinwei (xiong xin wei), Xiong/0000-0002-1780-4270	National Natural Science Foundation of China [31272635, 31372526]; Natural Foundation of Guangdong Ocean University [1212318]; Excellent Young Scientist Foundation of Guangdong Ocean University [201402]; Guangdong Ocean University [201601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Foundation of Guangdong Ocean University; Excellent Young Scientist Foundation of Guangdong Ocean University; Guangdong Ocean University	The studies were financially supported by grants of the National Natural Science Foundation of China (31272635, 31372526), Natural Foundation of Guangdong Ocean University (1212318), Excellent Young Scientist Foundation of Guangdong Ocean University (201402), Excellent Doctoral Dissertation Breeding Project of Guangdong Ocean University (201601).; The studies were financially supported by grants of the National Natural Science Foundation of China (31272635, 31372526), Natural Foundation of Guangdong Ocean University (1212318), Excellent Young Scientist Foundation of Guangdong Ocean University (201402), Excellent Doctoral Dissertation Breeding Project of Guangdong Ocean University (201601).	Arivalagan J, 2017, MOL BIOL EVOL, V34, P66, DOI 10.1093/molbev/msw219; BAILEY AJ, 1993, CONNECT TISSUE RES, V29, P119, DOI 10.3109/03008209309014239; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Duncan EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-558; Fisher S, 2012, CURR OPIN GENET DEV, V22, P390, DOI 10.1016/j.gde.2012.04.007; Ge TT, 2014, CELL PHYSIOL BIOCHEM, V34, P2209, DOI 10.1159/000369664; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jiao Y, 2015, INT J MOL SCI, V16, P21442, DOI 10.3390/ijms160921442; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Jing G, 2007, ENVIRON TOXICOL PHAR, V24, P122, DOI 10.1016/j.etap.2007.04.002; Kalev-Zylinska ML, 2003, DEV DYNAM, V228, P323, DOI 10.1002/dvdy.10388; Ke K, 2015, BONE, V81, P237, DOI 10.1016/j.bone.2015.07.006; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Li SG, 2016, FISH SHELLFISH IMMUN, V51, P263, DOI 10.1016/j.fsi.2016.02.027; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liang Jinlian, 2016, Jiyinzuxue Yu Yingyong Shengwuxue, V35, P811; Luo YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9301; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Remy H, 2003, BMC EVOL BIOL, V3, P1; Robertson Anthony J, 2009, BMC Res Notes, V2, P59, DOI 10.1186/1756-0500-2-59; Shrivastava T, 2014, LEUKEMIA, V28, P2040, DOI 10.1038/leu.2014.111; Song Xiaolei, 2016, THESIS; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Stricker S, 2003, DEV COMP IMMUNOL, V27, P673, DOI 10.1016/S0145-305X(03)00037-5; Sullivan JC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-228; Sun J., 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119313; Tian RR, 2015, INT J MOL SCI, V16, P29436, DOI 10.3390/ijms161226182; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Xu F, 2014, PLOS ONE, V9; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Yan F, 2014, BIOCHEM BIOPH RES CO, V450, P300, DOI 10.1016/j.bbrc.2014.05.118; Yue F, 2016, DEV COMP IMMUNOL, V61, P88, DOI 10.1016/j.dci.2016.03.021; Yue F, 2014, DEV COMP IMMUNOL, V44, P291, DOI 10.1016/j.dci.2014.01.008; Zhang Y, 2013, FEBS LETT, V587, P3069, DOI 10.1016/j.febslet.2013.06.058; Zhao HE, 2012, INT J MOL MED, V30, P1013, DOI 10.3892/ijmm.2012.1111; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zheng Z, 2016, SAUDI J BIOL SCI, V23, P372, DOI 10.1016/j.sjbs.2015.04.001; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023; Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105	49	13	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178561	10.1371/journal.pone.0178561	http://dx.doi.org/10.1371/journal.pone.0178561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570710	Green Published, Green Submitted, gold			2022-12-26	WOS:000402611800077
J	Dang, BB; Chhabra, S; Pennington, MW; Norton, RS; Kent, SBH				Dang, Bobo; Chhabra, Sandeep; Pennington, Michael W.; Norton, Raymond S.; Kent, Stephen B. H.			Reinvestigation of the biological activity of d-allo-ShK protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide chemical synthesis; protein chemistry; protein folding; protein sequence; protein synthesis; Kv1; 3 blocking activity; ShK; allo-Thr; allo-Ile; chemical protein synthesis	NATIVE CHEMICAL LIGATION; X-RAY-STRUCTURE; TOXIN; PEPTIDE; CHANNELS	ShK toxin from the sea anemone Stichodactyla helianthus is a 35-residue protein that binds to the Kv1.3 ion channel with high affinity. Recently we determined the X-ray structure of ShK toxin by racemic crystallography, in the course of which we discovered that d-ShK has a near-background IC50 value approximate to 50,000 times lower than that of the l-ShK toxin. This lack of activity was at odds with previously reported results for an ShK diastereomer designated d-allo-ShK, for which significant biological activity had been observed in a similar receptor-blocking assay. As reported, d-allo-ShK was made up of d-amino acids, but with retention of the natural stereochemistry of the chiral side chains of the Ile and Thr residues, i.e. containing d-allo-Ile and d-allo-Thr along with d-amino acids and glycine. To understand its apparent biological activity, we set out to chemically synthesize d-allo-ShK and determine its X-ray structure by racemic crystallography. Using validated allo-Thr and allo-Ile, both l-allo-ShK and d-allo-ShK polypeptide chains were prepared by total chemical synthesis. Neither the l-allo-ShK nor the d-allo-ShK polypeptides folded, whereas both l-ShK and d-ShK folded smoothly under the same conditions. Re-examination of NMR spectra of the previously reported d-allo-ShK protein revealed that diagnostic Thr and Ile signals were the same as for authentic d-ShK. On the basis of these results, we conclude that the previously reported d-allo-ShK was in fact d-ShK, the true enantiomer of natural l-ShK toxin, and that the apparent biological activity may have arisen from inadvertent contamination with trace amounts of l-ShK toxin.	[Dang, Bobo; Kent, Stephen B. H.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Pennington, Michael W.] Peptides Int Inc, Louisville, KY 40299 USA; [Chhabra, Sandeep; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia	University of Chicago; Monash University	Dang, BB (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.	bbdang@uchicago.edu	chhabra, sandeep/R-9942-2017; Chhabra, Sandeep/T-5468-2018	Chhabra, Sandeep/0000-0002-5225-1333; pennington, michael/0000-0001-5446-3447; Norton, Raymond/0000-0001-8893-0584	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a fellowship from the National Health and Medical Research Council of Australia (to R. S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Avital-Shmilovici M, 2013, J AM CHEM SOC, V135, P3173, DOI 10.1021/ja311408y; Beeton C, 2008, J BIOL CHEM, V283, P988, DOI 10.1074/jbc.M706008200; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Bunker RD, 2015, P NATL ACAD SCI USA, V112, P4310, DOI 10.1073/pnas.1422387112; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; CORNISHBOWDEN A, 1984, BIOCHEM J, V219, P345; Currier JR, 2008, CLIN VACCINE IMMUNOL, V15, P267, DOI 10.1128/CVI.00284-07; Dang BB, 2017, ANGEW CHEM INT EDIT, V56, P3324, DOI 10.1002/anie.201612398; Dang BB, 2013, J AM CHEM SOC, V135, P11911, DOI 10.1021/ja4046795; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; de Graaf MT, 2008, CYTOM PART A, V73A, P1079, DOI 10.1002/cyto.a.20636; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Hackeng TM, 1999, P NATL ACAD SCI USA, V96, P10068, DOI 10.1073/pnas.96.18.10068; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; MITCHELL AR, 1978, J ORG CHEM, V43, P2845, DOI 10.1021/jo00408a022; PENNINGTON MW, 1995, INT J PEPT PROT RES, V46, P354; Pohl Jan, 1995, Letters in Peptide Science, V1, P291, DOI 10.1007/BF00119770; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Yeates TO, 2012, ANNU REV BIOPHYS, V41, P41, DOI [10.1146/annurev-biophys-050511-102333, 10.1146/annurev-biophys-050511-4023]; ZAWADZKE LE, 1993, PROTEINS, V16, P301, DOI 10.1002/prot.340160308	23	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12599	12605		10.1074/jbc.M117.793943	http://dx.doi.org/10.1074/jbc.M117.793943			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28596383	Green Published, hybrid			2022-12-26	WOS:000406636900024
J	Costa, FB; da Costa, AP; Moraes, J; Martins, TF; Soares, HS; Ramirez, DG; Dias, RA; Labruna, MB				Costa, Francisco B.; da Costa, Andrea P.; Moraes-Filho, Jonas; Martins, Thiago F.; Soares, Herbert S.; Ramirez, Diego G.; Dias, Ricardo A.; Labruna, Marcelo B.			Rickettsia amblyommatis infecting ticks and exposure of domestic dogs to Rickettsia spp. in an Amazon-Cerrado transition region of northeastern Brazil	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; SPOTTED-FEVER; SAO-PAULO; ACARI IXODIDAE; RURAL DOGS; CANINE INFECTION; BORNE DISEASES; PARVUM TICKS; MINAS-GERAIS; ENDEMIC AREA	This study was performed in Maranhao state, a transition area two Brazilian biomes, Amazon and Cerrado. During 2011-2013, 1,560 domestic dogs were sampled for collection of serum blood samples and ticks in eight counties (3 within the Amazon and 5 within the Cerrado). A total of 959 ticks were collected on 150 dogs (9.6%). Rhipicephalus sanguineus sensu lato (s.l.) was the most abundant tick (68% of all collected specimens), followed by Amblyomma cajennense sensu lato (s.l.) (12.9%), Amblyomma parvum (9.2%), and Amblyomma ovale (5.2%). Other less abundant species (<1%) were Amblyomma oblongoguttatum, Rhipicephalus microplus, Haemaphysalis juxtakochi, and Amblyomma rotundatum. Females of A. cajennense s.l. ticks were morphologically identified as A. cajennense sensu stricto (s.s.) or A. sculptum. Molecular analyses of 779 canine ticks revealed three Rickettsia species: Rickettsia amblyommatis in 1% (1/100) A. cajennense s.l., 'Candidatus Rickettsia andeanae' in 20.7% (12/58) A. parvum, Rickettsia bellii in 6.8% (3/44) A. ovale and 100% (1/1) A. rotundatum ticks. An additional collection of A. sculptum from horses in a Cerrado area, and A. cajennense s.s. from pigs in an Amazon area revealed R. amblyommatis infecting only the A. cajennense s.s. ticks. Serological analysis of the 1,560 canine blood samples revealed 12.6% canine seroreactivity to Rickettsia spp., with the highest specific seroreactivity rate (10.2%) for R. amblyommatis. Endpoint titers to R. amblyommatis were significantly higher than those for the other Rickettsia antigens, suggesting that most of the seroreactive dogs were exposed to R. amblyommatis-infected ticks. Highest canine seroreactivity rates per locality (13.1-30.8%) were found in Amazon biome, where A. cajennense s.s. predominated. Lowest seroreactivity rates (1.9-6.5%) were found in Cerrado localities that were further from the Amazon, where A. sculptum predominated. Multivariate analyses revealed that canine seroreactivity to Rickettsia spp. or R. amblyommatis was statistically associated with rural dogs, exposed to Amblyomma ticks.	[Costa, Francisco B.; Moraes-Filho, Jonas; Martins, Thiago F.; Soares, Herbert S.; Ramirez, Diego G.; Dias, Ricardo A.; Labruna, Marcelo B.] Univ Sao Paulo, Fac Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil; [Costa, Francisco B.; da Costa, Andrea P.] Univ Estadual Maranhao, Fac Vet Med, Prevent Vet Med, Sao Luis, MA, Brazil; [Moraes-Filho, Jonas] Univ Santo Amaro, Med & Bem Estar Anim, Ave Prof Eneas de Siqueira Neto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual do Maranhao; Universidade de Santo Amaro (UNISA)	Costa, FB; Labruna, MB (corresponding author), Univ Sao Paulo, Fac Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil.; Costa, FB (corresponding author), Univ Estadual Maranhao, Fac Vet Med, Prevent Vet Med, Sao Luis, MA, Brazil.	franc.borges@usp.br; labruna@usp.br	Labruna, Marcelo B/B-6241-2013; Soares, Herbert/AAR-8828-2021; Costa, Andrea Pereira da Pereira/AAX-6081-2021; Dias, Ricardo A/D-5977-2013; Martins, Thiago/H-9971-2014	Labruna, Marcelo B/0000-0002-9675-3132; Costa, Andrea Pereira da Pereira/0000-0002-8197-9868; 	Sao Paulo Research Foundation (FAPESP) [2010/52395-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work received financial support by the Sao Paulo Research Foundation (FAPESP grant # 2010/52395-0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Tatiana Ueno and Amalia Barbieri for their help in performing tick hemolymph tests. This work received financial support by the Sao Paulo Research Foundation (FAPESP grant # 2010/52395-0).	Apperson CS, 2008, VECTOR-BORNE ZOONOT, V8, P597, DOI 10.1089/vbz.2007.0271; Araes-Santos AI, 2015, VECTOR-BORNE ZOONOT, V15, P645, DOI 10.1089/vbz.2015.1786; Barreto MC, 2008, REV INST MED TROP SP, V50, P297, DOI 10.1590/S0036-46652008000500009; Barrett A, 2014, VECTOR-BORNE ZOONOT, V14, P20, DOI 10.1089/vbz.2013.1325; Barros-Batesti DM, 2006, CARRAPATOS IMPORTANC; Burgdorfer W., 1970, HEMOLYMPH TEST TECHN, V19, P1010; Costa AP, 2013, J MED ENTOMOL, V50, P674, DOI 10.1603/ME12243; Costa LM, 2012, REV BRAS PARASITOL V, V21, P237, DOI 10.1590/S1984-29612012000300011; da Costa AP, 2015, REV BRAS PARASITOL V, V24, P28, DOI 10.1590/S1984-29612015008; Dantas-Torres F, 2009, REV BRAS PARASITOL V, V18, P75, DOI 10.4322/rbpv.01803014; Delisle J, 2016, AM J TROP MED HYG, V94, P1212, DOI 10.4269/ajtmh.15-0372; Grasperge BJ, 2014, J MED ENTOMOL, V51, P855, DOI 10.1603/ME13248; Minervino AHH, 2015, VECTOR-BORNE ZOONOT, V15, P412, DOI 10.1089/vbz.2014.1737; Horta MC, 2007, MEM I OSWALDO CRUZ, V102, P793, DOI 10.1590/S0074-02762007000700003; Horta MC, 2015, MICROBES INFECT, V17, P856, DOI 10.1016/j.micinf.2015.08.010; Horta MC, 2004, AM J TROP MED HYG, V71, P93, DOI 10.4269/ajtmh.2004.71.93; Szabo MPJ, 2007, EXP APPL ACAROL, V43, P73, DOI 10.1007/s10493-007-9096-8; Karpathy SE, 2016, INT J SYST EVOL MICR, V66, P5236, DOI 10.1099/ijsem.0.001502; Krawczak FS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-7; Labruna MB, 2007, APPL ENVIRON MICROB, V73, P869, DOI 10.1128/AEM.02249-06; Labruna Marcelo B., 2005, Systematic and Applied Acarology, V10, P17; Labruna Marcelo B, 2017, Vet Parasitol Reg Stud Reports, V8, P82, DOI 10.1016/j.vprsr.2017.02.007; Labruna MB, 2014, J CLIN MICROBIOL, V52, P3788, DOI 10.1128/JCM.01914-14; Labruna MB, 2000, J MED ENTOMOL, V37, P774, DOI 10.1603/0022-2585-37.5.774; Labruna MB, 2004, J MED ENTOMOL, V41, P1073, DOI 10.1603/0022-2585-41.6.1073; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Labruna MB, 2001, CLIN VET, V30, P24; Martins TF, 2009, REV BRAS PARASITOL V; Martins TF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1460-2; Martins TF, 2010, TICKS TICK-BORNE DIS, V1, P75, DOI 10.1016/j.ttbdis.2010.03.002; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nava S, 2014, TICKS TICK-BORNE DIS, V5, P252, DOI 10.1016/j.ttbdis.2013.11.004; Nieri-Bastos FA, 2014, MEM I OSWALDO CRUZ, V109, P259, DOI 10.1590/0074-0276140283; Ogrzewalska M, 2012, PARASITOLOGY, V139, P1283, DOI 10.1017/S0031182012000546; Pacheco RC, 2007, EXP APPL ACAROL, V43, P63, DOI 10.1007/s10493-007-9099-5; Pacheco RC, 2009, REV SOC BRAS MED TRO, V42, P351, DOI 10.1590/S0037-86822009000300023; Paddock CD, 2017, APPL ENVIRON MICROB; Pinter A, 2008, CAD SAUDE PUBLICA, V24, P247, DOI 10.1590/S0102-311X2008000200003; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Piranda EM, 2008, MEM I OSWALDO CRUZ, V103, P696, DOI 10.1590/S0074-02762008000700012; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sabatini GS, 2010, J MED ENTOMOL, V47, P913, DOI 10.1603/ME10073; Saito TB, 2008, AM J TROP MED HYG, V79, P102, DOI 10.4269/ajtmh.2008.79.102; Sangioni LA, 2005, EMERG INFECT DIS, V11, P265, DOI 10.3201/eid1102.040656; Saraiva DG, 2013, VECTOR-BORNE ZOONOT, V13, P615, DOI 10.1089/vbz.2012.1223; Silveira I, 2007, EMERG INFECT DIS, V13, P1111, DOI 10.3201/eid1307.061397; Soares HS, 2015, EXP APPL ACAROL, V65, P125, DOI 10.1007/s10493-014-9851-6; Soares HS, 2014, REV BRAS PARASITOL V, V23, P473, DOI [10.1590/s1984-29612014093, 10.1590/S1984-29612014093]; Szabo MPJ, 2013, PARASITOLOGY, V140, P719, DOI 10.1017/S0031182012002065; Szabo MPJ, 2010, TRANSBOUND EMERG DIS, V57, P72, DOI 10.1111/j.1865-1682.2010.01111.x; Szabo MPJ, 2001, ASS DOMESTIC DOGS FR, V25, P909; Weck B, 2016, EMERG INFECT DIS, V22, P2014, DOI 10.3201/eid2211.160859	53	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179163	10.1371/journal.pone.0179163	http://dx.doi.org/10.1371/journal.pone.0179163			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594882	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200094
J	Konig, F; Schubert, T; Langst, G				Konig, Fabian; Schubert, Thomas; Langst, Gernot			The monoclonal S9.6 antibody exhibits highly variable binding affinities towards different Rloop sequences	PLOS ONE			English	Article							SOLUTION HYBRIDIZATION ASSAY; TRANSCRIPTIONAL PAUSE SITES; R-LOOP FORMATION; RIBOSOMAL-RNA; STRANDED-RNA; DNA-RNA; HYBRIDS; IMMUNODETECTION; INSTABILITY; TERMINATION	The monoclonal antibody S9.6 is a widely-used tool to purify, analyse and quantify R-loop structures in cells. A previous study using the surface plasmon resonance technology and a single-chain variable fragment (scFv) of S9.6 showed high affinity (0.6 nM) for DNA-RNA and also a high affinity (2.7 nM) for RNA-RNA hybrids. We used the microscale thermo-phoresis method allowing surface independent interaction studies and electromobility shift assays to evaluate additional RNA-DNA hybrid sequences and to quantify the binding affinities of the S9.6 antibody with respect to distinct sequences and their GC-content. Our results confirm high affinity binding to previously analysed sequences, but reveals that binding affinities are highly sequence specific. Our study presents R-loop sequences that independent of GC-content and in different sequence variations exhibit either no binding, binding affinities in the micromolar range and as well high affinity binding in the nanomolar range. Our study questions the usefulness of the S9.6 antibody in the quantitative analysis of R-loop sequences in vivo.	[Konig, Fabian; Schubert, Thomas; Langst, Gernot] Univ Regensburg, BCR, Biochem 3, Univ Str, Regensburg, Germany; [Schubert, Thomas] 2Bind GmbH, Regensburg, Germany	University of Regensburg	Langst, G (corresponding author), Univ Regensburg, BCR, Biochem 3, Univ Str, Regensburg, Germany.	gernot.laengst@vkl.uni-regensburg.de	Längst, Gernot/G-5287-2015	Längst, Gernot/0000-0002-8232-1179; Konig, Fabian/0000-0002-0288-1644	DFG [SFB960]	DFG(German Research Foundation (DFG))	This work was funded by the DFG in the framework of the SFB960. The 2bind GmbH, Regensburg, Germany is a provider for biophysical analytical services. 2bind contributed to this study in data collection using MicroScale Thermophoresis (MST).	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Breitsprecher D, 2016, METHODS MOL BIOL, V1380, P99, DOI 10.1007/978-1-4939-3197-2_8; CASEBOLT DB, 1992, J CLIN MICROBIOL, V30, P608, DOI 10.1128/JCM.30.3.608-612.1992; Chedin F, 2016, TRENDS GENET, V32, P828, DOI 10.1016/j.tig.2016.10.002; DROLET M, 1994, J BIOL CHEM, V269, P2068; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Dutrow N, 2008, NAT GENET, V40, P977, DOI 10.1038/ng.196; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Estep P, 2013, MABS-AUSTIN, V5, P270, DOI 10.4161/mabs.23049; FRIED MG, 1994, NUCLEIC ACIDS RES, V22, P5054, DOI 10.1093/nar/22.23.5054; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Hatchi E, 2015, MOL CELL, V57, P636, DOI 10.1016/j.molcel.2015.01.011; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; KINNEY JS, 1989, J CLIN MICROBIOL, V27, P6, DOI 10.1128/JCM.27.1.6-12.1989; MILLER CA, 1988, J CLIN MICROBIOL, V26, P1271, DOI 10.1128/JCM.26.7.1271-1276.1988; Myszka DG, 1997, BIOPHYS CHEM, V64, P127, DOI 10.1016/S0301-4622(96)02230-2; Phillips DD, 2013, J MOL RECOGNIT, V26, P376, DOI 10.1002/jmr.2284; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Qavi AJ, 2011, ANAL CHEM, V83, P5949, DOI 10.1021/ac201340s; Richard P, 2016, J MOL BIOL; ROBERTS RW, 1992, SCIENCE, V258, P1463, DOI 10.1126/science.1279808; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Sipova H, 2010, ANAL CHEM, V82, P10110, DOI 10.1021/ac102131s; Skourti-Stathaki K, 2014, NATURE, V516, P436, DOI 10.1038/nature13787; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Szekvolgyi L, 2007, P NATL ACAD SCI USA, V104, P14964, DOI 10.1073/pnas.0702269104; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; Xu BJ, 1996, EMBO J, V15, P3135, DOI 10.1002/j.1460-2075.1996.tb00676.x; YEHLE CO, 1987, MOL CELL PROBE, V1, P177, DOI 10.1016/0890-8508(87)90026-0; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zhang Zheng Z, 2015, BMC Res Notes, V8, P127, DOI 10.1186/s13104-015-1092-1	38	34	34	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178875	10.1371/journal.pone.0178875	http://dx.doi.org/10.1371/journal.pone.0178875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594954	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200060
J	Liu, HK; Guo, DS; Ruzi, A; Chen, Y; Pan, TC; Yang, F; Li, JL; Xu, KC; Zhou, TC; Qin, DJ; Li, YX				Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Li, Jialiang; Xu, Kecheng; Zhou, Tiancheng; Qin, Dajiang; Li, Yin-xiong			Testosterone improves the differentiation efficiency of insulin-producing cells from human induced pluripotent stem cells	PLOS ONE			English	Article							BETA-CELLS; GENERATION; RAT; MEN; STREPTOZOTOCIN; NEUROGENIN3; REGULATOR; PANCREAS; TYPE-1; URINE	Human induced pluripotent stem cells (hiPSCs) may provide potential resource for regenerative medicine research, including generation of insulin-producing cells for diabetes research and insulin production. Testosterone (T) is an androgen hormone which promotes protein synthesis and improves the management of type 2 diabetes in clinical studies. Concurrently, co-existed hyperandrogenism and hyperinsulinism is frequently observed in polycystic ovary syndrome, congenital adrenal hyperplasia and some of Wermer's syndrome. However, the relationship among androgens, insulin and the differentiation of pancreatic beta cells is still not fully clear. Here we find that T improves the differentiation efficiency of insulin- producing cells from hiPSCs. The addition of T into routine differentiation formula for pancreatic beta cells increases the differentiation efficiency from 12% to 35%. The administration of T promotes the expression of key genes associated with beta cells differentiation including NGN3, NEUROD1 and INS. This finding benefits the ongoing process to optimize the differentiation protocol of pancreatic beta cells from hiPSCs, and provides some degree of understanding the clinical management of T for type 2 diabetes.	[Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Haikun] Anhui Univ, Sch Life Sci, Hefei, Peoples R China; [Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Zhou, Tiancheng; Qin, Dajiang; Li, Yin-xiong] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Zhou, Tiancheng; Qin, Dajiang; Li, Yin-xiong] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangdong Prov Key Lab Biocomp, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China; [Liu, Haikun; Guo, Dongsheng; Ruzi, Aynisahan; Chen, Yan; Pan, Tingcai; Yang, Fan; Li, Yin-xiong] Chinese Acad Sci, Guangdong Prov Key Lab Biocomp, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China; [Guo, Dongsheng; Ruzi, Aynisahan; Pan, Tingcai; Li, Yin-xiong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Jialiang; Xu, Kecheng] Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Anhui University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, YX (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.; Li, YX (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China.; Li, YX (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China.; Li, YX (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Biocomp, Guangzhou Inst Biomed, Guangzhou, Guangdong, Peoples R China.; Li, YX (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Biocomp, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China.; Li, YX (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	li_yinxiong@gibh.ac.cn	Guo, Dongsheng/AAB-1143-2022	Guo, Dongsheng/0000-0002-9702-7327	Thousand Talents Program [ODCCC2268]; Ministry of Science and Technology 973 Program [2015CB964700]; Guangdong Province Science and Technology Plan [20146020225004, 20156020230007, 20166030301007]; Haizhu District Science and Technology Plan [2011-ZD-02, 2014-CG-05]	Thousand Talents Program; Ministry of Science and Technology 973 Program(National Basic Research Program of China); Guangdong Province Science and Technology Plan; Haizhu District Science and Technology Plan	This work was financially supported by Thousand Talents Program (ODCCC2268, Yinxiong Li), the Ministry of Science and Technology 973 Program (2015CB964700) and the Guangdong Province Science and Technology Plan (20146020225004,20156020230007, 20166030301007), Haizhu District Science and Technology Plan (2011-ZD-02, 2014-CG-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia GR, 2001, FERTIL STERIL, V76, P517, DOI 10.1016/S0015-0282(01)01975-6; Barrett K.E., 2012, GANONGS REV MED PHYS; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Gianatti EJ, 2014, DIABETES CARE, V37, P2098, DOI 10.2337/dc13-2845; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Li JL, 2013, PANCREAS, V42, P353, DOI 10.1097/MPA.0b013e318258f233; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; Morimoto S, 2005, J ENDOCRINOL, V187, P217, DOI 10.1677/joe.1.06357; Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442; Navarro G, 2016, CELL METAB, V23, P837, DOI 10.1016/j.cmet.2016.03.015; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Palomar-Morales M, 2010, PANCREAS, V39, P193, DOI 10.1097/MPA.0b013e3181c156d9; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Sekine K, 2012, TRANSPL P, V44, P1127, DOI 10.1016/j.transproceed.2012.03.001; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	30	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179353	10.1371/journal.pone.0179353	http://dx.doi.org/10.1371/journal.pone.0179353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594910	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200122
J	Guinea, J; Escribano, P; Vena, A; Munoz, P; Martinez-Jimenez, MD; Padilla, B; Bouza, E				Guinea, Jesus; Escribano, Pilar; Vena, Antonio; Munoz, Patricia; del Carmen Martinez-Jimenez, Maria; Padilla, Belen; Bouza, Emilio			Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates	PLOS ONE			English	Article							LICHTHEIMIA-HONGKONGENSIS; FUNGAL-INFECTIONS; ZYGOMYCOSIS; DIAGNOSIS; IDENTIFICATION; WORKLOAD; DISEASES	We studied 19 cases of proven/probable mucormycosis diagnosed from 2007 to 2015 in our hospital and assessed the microbiological characteristics of the isolates. We recorded the incidence of mucormycosis and clinical and microbiological data of infected patients. Isolates were identified to molecular level and tested for their antifungal susceptibility to azoles, amphotericin B, and liposomal amphotericin B according to the CLSI M-38 A2 procedure. The incidence of mucormycosis in cases/100,000 hospital admissions during 2007-2015 increased significantly with respect to that reported in 1988-2006 (3.3 vs. 1.2; P< 0.05). Patients mainly had hematological malignancies (52.6%) and/or trauma/surgical wounds (52.6%) and had received antifungal agents before the diagnosis of mucormycosis in 68% of cases. Diagnosis was by isolation (n = 17/19) and/or direct staining (n = 17/18) of Mucorales fungi in clinical samples. Identification was by panfungal PCR in patients with negative results in culture and in direct staining. The microorganisms identified were Lichtheimia spp. (42%), Rhizopus spp. (21%), Cunninghamella bertholletiae (16%), and others (21%). Liposomal amphotericin B was always more active than the other drugs against all the microorganisms except C. bertholletiae. All patients received antifungal treatment with 1 or more antifungal agents, mainly liposomal amphotericin B (17/19). Mortality was 47.4%, although this was significantly lower in the 11 patients in whom debridement was performed (18% vs. 87.5%) (P = 0.015). The incidence of mucormycosis has risen in recent years. The proportion of cases with soft tissue involvement was high, and Lichtheimia was the most frequently involved species. The highest antifungal activity was observed with liposomal amphotericin B.	[Guinea, Jesus; Escribano, Pilar; Vena, Antonio; Munoz, Patricia; del Carmen Martinez-Jimenez, Maria; Padilla, Belen; Bouza, Emilio] Univ Complutense Madrid, Hosp Gen, Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Guinea, Jesus; Escribano, Pilar; Vena, Antonio; Munoz, Patricia; del Carmen Martinez-Jimenez, Maria; Padilla, Belen; Bouza, Emilio] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Guinea, Jesus; Munoz, Patricia; Padilla, Belen; Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Guinea, Jesus; Munoz, Patricia; Bouza, Emilio] Univ Complutense Madrid, Sch Med, Med Dept, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid	Guinea, J; Escribano, P (corresponding author), Univ Complutense Madrid, Hosp Gen, Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain.; Guinea, J; Escribano, P (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Guinea, J (corresponding author), CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain.; Guinea, J (corresponding author), Univ Complutense Madrid, Sch Med, Med Dept, Madrid, Spain.	jguineaortega@yahoo.es; pilar.escribano.martos@gmail.com	Vena, Antonio/AAD-3688-2021; Bouza, Emilio/D-8661-2014; Escribano, Pilar/M-2387-2014; Guinea, Jesus/G-3083-2014; Muñoz, Patricia/E-9431-2017	Vena, Antonio/0000-0002-0697-3992; Bouza, Emilio/0000-0001-6967-9267; Escribano, Pilar/0000-0001-6254-4570; Guinea, Jesus/0000-0002-7901-8355; Muñoz, Patricia/0000-0001-5706-5583	Gilead; CM-SANTANDER [GR3/2014]; FIS, Instituto de Salud Carlos III; Plan Nacional de I+D+I) [MSI15/00115 FIS]; Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; European Regional Development Fund (FEDER) [CPI15/00115, CPII15/00006]; FIS [FI12/00265]	Gilead(Gilead Sciences); CM-SANTANDER; FIS, Instituto de Salud Carlos III; Plan Nacional de I+D+I); Spanish Network for Research in Infectious Diseases; European Regional Development Fund (FEDER)(European Commission); FIS(Instituto de Salud Carlos III)	This study was supported by a research grant from Gilead and by grants ref. CM-SANTANDER (GR3/2014; group 920200) and MSI15/00115 FIS (FIS, Instituto de Salud Carlos III; Plan Nacional de I+D+I 2013-2016) and by the Spanish Network for Research in Infectious Diseases (REIPI RD12/0015). The study was cofunded by the European Regional Development Fund (FEDER) A way of making Europe. PE (CPI15/00115) and JG (CPII15/00006) hold a Miguel Servet contract; LJMZ (FI12/00265) is supported by FIS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2010, J CLIN MICROBIOL, V48, P2154, DOI 10.1128/JCM.01744-09; Alastruey-Izquierdo A, 2009, ANTIMICROB AGENTS CH, V53, P1686, DOI 10.1128/AAC.01467-08; Ambrosioni J, 2010, INT J INFECT DIS, V14, pE100, DOI 10.1016/j.ijid.2009.11.024; Balajee SA, 2007, MED MYCOL, V45, P475, DOI 10.1080/13693780701449425; Bialek R, 2013, PATHOLOGE, V34, P511, DOI 10.1007/s00292-013-1831-9; Bitar D, 2009, EMERG INFECT DIS, V15, P1395, DOI 10.3201/eid1509.090334; Clinical and Laboratory Standards Institute, 2008, M38A2 CLIN LAB STAND; Cornely OA, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12371; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Garcia-Hermoso D, 2009, J CLIN MICROBIOL, V47, P3862, DOI 10.1128/JCM.02094-08; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Hammond SP, 2011, J CLIN MICROBIOL, V49, P2151, DOI 10.1128/JCM.00256-11; Honda A, 1998, MYCOPATHOLOGIA, V144, P141, DOI 10.1023/A:1007095831301; Kennedy KJ, 2016, CLIN MICROBIOL INFEC, V22, P775, DOI 10.1016/j.cmi.2016.01.005; Kontoyiannis DP, 2011, BLOOD, V118, P1216, DOI 10.1182/blood-2011-03-316430; Kontoyiannis DP, 2005, J INFECT DIS, V191, P1350, DOI 10.1086/428780; Lanternier F, 2012, CLIN INFECT DIS, V54, pS35, DOI 10.1093/cid/cir880; Petrikkos G, 2014, CLIN MICROBIOL INFEC, V20, P67, DOI 10.1111/1469-0691.12563; Reichenberger F, 1998, AM J RESP CRIT CARE, V158, P885, DOI 10.1164/ajrccm.158.3.9801056; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Ruping MJGT, 2010, J ANTIMICROB CHEMOTH, V65, P296, DOI 10.1093/jac/dkp430; Saegeman V, 2010, EMERG INFECT DIS, V16, P1456, DOI 10.3201/eid1609.100276; Skiada A, 2011, CLIN MICROBIOL INFEC, V17, P1859, DOI 10.1111/j.1469-0691.2010.03456.x; Skiada Anna, 2013, Skinmed, V11, P155; Torres-Narbona M, 2008, MED MYCOL, V46, P225, DOI 10.1080/13693780701796973; Torres-Narbona M, 2007, J CLIN MICROBIOL, V45, P2051, DOI 10.1128/JCM.02473-06; Trifilio SM, 2007, BONE MARROW TRANSPL, V39, P425, DOI [10.1038/sj.bmt.1705614, 10.1038/SJ.BMT.1705614]; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Woo PCY, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.11; Woo PCY, 2010, DIAGN MICR INFEC DIS, V66, P274, DOI 10.1016/j.diagmicrobio.2009.10.009; Yeo SF, 2002, CLIN MICROBIOL REV, V15, P465, DOI 10.1128/CMR.15.3.465-484.2002	32	77	82	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179136	10.1371/journal.pone.0179136	http://dx.doi.org/10.1371/journal.pone.0179136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591186	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700091
J	Akinyi, B; Odhiambo, C; Otieno, F; Inzaule, S; Oswago, S; Kerubo, E; Ndivo, R; Zeh, C				Akinyi, Brenda; Odhiambo, Collins; Otieno, Fredrick; Inzaule, Seth; Oswago, Simon; Kerubo, Emily; Ndivo, Richard; Zeh, Clement			Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western Kenya	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; RISK-FACTORS; UGANDA; RAKAI; MEN; WOMEN	Background Herpes simplex virus type 2 (HSV-2) infections are associated with increased risk of HIV transmission. We determined HSV-2 prevalence, incidence and associated risk factors, incidence among persons with indeterminate results, and prevalence of HSV-2/HIV co-infection among young adults (18-34 years) and adolescents (16-17 years) enrolled in an HIV incidence cohort study in western Kenya. Methods Participants (n = 1106; 846 adults) were screened and those HIV-1 negative were enrolled and followed-up quarterly for one year. HSV-2 was assessed using the Kalon enzyme immunoassay. HSV-2 incidence was calculated separately among HSV-2 seronegative participants and those indeterminate at baseline. Logistic regression was used to estimate the odds of HSV-2 infection and Poisson regression was used to assess HSV-2 incidence and associated factors. Results Overall, HSV-2 prevalence was 26.6% [95% confidence interval (CI): 23.9-29.4] and was higher in adults (31.5% [95% CI: 28.3-34.9]) than adolescents (10.7% [95% CI: 7.1-15.3]). Factors associated with prevalent HSV-2 included female gender, increasing age, HIV infection, history of sexually transmitted infection, low level of education, multiple sexual partners, and being married, divorced, separated or widowed. Overall HSV-2 incidence was 4.0 per 100 person-years (/100PY) 95% CI: 2.7-6.1 and was higher in adults (4.5/100PY) and females (5.1/100PY). In multivariable analysis only marital status was associated with HSV-2 incidence. Among 45 participants with indeterminate HSV-2 results at baseline, 22 sero-converted, resulting in an incidence rate of 53.2 /100PY [95% CI: 35.1-80.9]. Inclusion of indeterminate results almost doubled the overall incidence rate to 7.8 /100 PY [95% CI: 5.9-10.5]. Prevalence of HIV/ HSV-2 co-infection was higher in female adults than female adolescents (17.1 [95% CI: 13.6-21.0] versus 3.4 [95% CI: 1.1-7.8]). Conclusion The high incidence rate among persons with indeterminate results underscores the public health concerns for HSV-2 spread and underreporting of the HSV-2 burden. Careful consideration is needed when interpreting HSV-2 serology results in these settings.	[Akinyi, Brenda; Odhiambo, Collins; Otieno, Fredrick; Inzaule, Seth; Oswago, Simon; Kerubo, Emily; Ndivo, Richard] Kenya Med Res Inst KEMRI, Ctr Global Hlth Res, Kisumu, Kenya; [Zeh, Clement] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Kisumu, Kenya	Kenya Medical Research Institute	Zeh, C (corresponding author), Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent, Kisumu, Kenya.	cbz2@cdc.gov		odhiambo, collins/0000-0002-5534-8720; Otieno, Fredrick Odhiambo/0000-0003-0823-412X	Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, USA; Kenya Medical Research Institute (KEMRI)	Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, USA; Kenya Medical Research Institute (KEMRI)	This study was funded by the Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, USA through a collaborating agreement with the Kenya Medical Research Institute (KEMRI). KEMRI and CDC staff participated in the design, data collection, analysis, interpretation of the data, writing the report, and the decision to submit the paper for publication.; The authors are grateful to the study participants, the Kisumu Cohort Study (KICoS) team, and the Kenya Medical Research Institute's (KEMRI) HIV Research Branch collaborating with the US Centers for Disease Control and Prevention (CDC) for making the study possible. We also thank the Division of HIV/AIDS Prevention, CDC, Atlanta, Georgia, USA for funding. KEMRI and CDC staff participated in the design, data collection, analysis, interpretation of the data, writing the report, and the decision to submit the paper for publication. This paper is published with the permission of the Director of KEMRI.	Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cachay ER, 2007, J INFECT DIS, V195, P1270, DOI 10.1086/513568; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chege W, 2012, J INFECT DEV COUNTR, V6, P870, DOI 10.3855/jidc.2636; Johnson KE, 2009, AIDS, V23, P1807, DOI 10.1097/QAD.0b013e32832efdf1; Kaiser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017842; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; National AIDS and STI Control Program (NASCOP), 2009, KEN AIDS IND SURV 20; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; Oluoch Tom, 2011, Open AIDS J, V5, P125, DOI 10.2174/1874613601105010125; Paz-Bailey G, 2007, SEX TRANSM INFECT, V83, P16, DOI 10.1136/sti.2006.020966; Philip SS, 2008, CLIN INFECT DIS, V47, pE79, DOI 10.1086/592696; Tobian AAR, 2009, AIDS, V23, P1589, DOI 10.1097/QAD.0b013e32832d4042; Tobian AAR, 2009, J INFECT DIS, V199, P945, DOI 10.1086/597074; Vandenhoudt HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054953; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; World Health Organization, 2001, HERP SIMPL VIR TYP 2	20	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178907	10.1371/journal.pone.0178907	http://dx.doi.org/10.1371/journal.pone.0178907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586396	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700035
J	Liu, Q; Hu, SY; He, Y; Zhang, JS; Zeng, XN; Gong, FT; Liang, LN				Liu, Qi; Hu, Shouyu; He, Yi; Zhang, Jiashu; Zeng, Xiaona; Gong, Fengtao; Liang, Li'na			The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats	PLOS ONE			English	Article							FIBROSIS; PATHWAY; RISK	Acute kidney injury (AKI) is a common clinical condition that confers a risk of progression of chronic kidney disease and a high risk of death. The purpose of the current study is to investigate the anti-apoptotic and anti-fibrotic effects of Zhen-Wu-Tang (ZWT) on cisplatin (CIS)-induced renal injury and elucidate the involvement of nuclear factor (erythroid-derived 2)like 2 (Nrf2), the PI3K/Akt signaling pathway, transforming growth factor (TGF)-beta and the Wnt/beta-catenin signaling pathway in the positive effects of Zhen-Wu-Tang on the kidneys. Wistar rats were randomly assigned into six groups of 6 rats each as follows: normal control 1; normal control 2; CIS 1 and CIS 2, which received single intraperitoneal injections of CIS (6 mg/kg); CIS+ZWT 4 and CIS+ZWT 10, which received ZWT (1 ml/100 g/day, ig) starting days after the CIS injection for 4 and 10 days, respectively. Hematoxylin-eosin (H&E) staining was performed to identify the amelioration of histopathological changes in the kidneys and apoptosis of the renal proximal tubular cells. Picrosirius red staining was used to evaluate renal fibrosis after ZWT treatment. The relationship between ZWT and the upregulation of Nrf2, phosphorylation of Akt, and the downregulation of TGF-beta and WNT/beta-catenin were determined by Western blotting. At the end of the experiment, serum was isolated from the orbital blood of rats, and blood urea nitrogen (BUN) and creatinine (Cr) levels were measured. The results showed that ZWT restored the histological alterations, aberrant collagen deposition in the kidneys and the BUN and Cr levels that were increased by CIS. Treatment with ZWT reduced the expression levels of TGF-beta and Wnt and increased the expression levels of Nrf2, PI3K and Akt in the CIS-exposed kidney tissues. Furthermore, ZWT downregulated apoptosis and fibrosis by modulating the expression levels of caspase-3, Bax and alpha-smooth muscle actin (alpha-SMA). In conclusion, this study provides evidence for the anti-fibrotic and anti-apoptotic roles of ZWT in CIS-induced experimental kidney injury.	[Liu, Qi; Zhang, Jiashu; Zeng, Xiaona; Gong, Fengtao] Dalian Med Univ, Coll Pharm, Dalian, Liaoning, Peoples R China; [Hu, Shouyu] Dalian Med Univ, Affiliated Hosp 2, Dept Neurol, Dalian, Liaoning, Peoples R China; [He, Yi] Dalian Med Univ, Affiliated Hosp 2, Dept Urol, Dalian, Liaoning, Peoples R China; [Liang, Li'na] Dalian Med Univ, Coll Inst Integrat Med, Dalian, Liaoning, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Liang, LN (corresponding author), Dalian Med Univ, Coll Inst Integrat Med, Dalian, Liaoning, Peoples R China.	lianglina304@163.com			Youth fund of national natural science fund [81302893]	Youth fund of national natural science fund	Support was provided by the Youth fund of national natural science fund (grant number: 81302893) [Receiver: LLN]. This work is technical supported from the Collegue of pharmacy and College (Institute) of Integrative Medicine of Dalian Meduical University, Dalian, Liaoning, China.	Alfiya Akhmetshina, 2011, NATURE COMMUNICATION, V3, P735; Apoznanski W, 2013, INT UROL NEPHROL, V45, P607, DOI 10.1007/s11255-013-0454-7; Atilano-Roque A, 2016, TOXICOL REP, V3, P153, DOI 10.1016/j.toxrep.2016.01.006; Bijkerk R, 2016, KIDNEY INT; Cai Y, 2010, J ETHNOPHARMACOL, V131, P88, DOI 10.1016/j.jep.2010.06.004; Nguyen CN, 2013, PHYTOTHER RES, V27, P1810, DOI 10.1002/ptr.4931; Conroy Andrea L., 2016, OPEN FORUM INFECT DI, V3; Demeng Chen, 2012, DEVELOPMENT, V139, P1522; Dhanapriya J, 2016, CLIN KIDNEY J, V9, P201, DOI 10.1093/ckj/sfw004; Erik Johansson, 2016, EXP CELL RES; Fabre V, 2011, J INFECT DIS, V203, P707, DOI 10.1093/infdis/jiq099; Ievgeniia Burlaka, 2016, KIDNEY INT; Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014; Lee J, 2015, APOPTOSIS, V20, P740, DOI 10.1007/s10495-015-1112-6; Liu Q, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0062-3; Parr SK, 2016, ADV CHRONIC KIDNEY D, V23, P186, DOI 10.1053/j.ackd.2016.01.014; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Seo MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166913; Shen N, 2013, KIDNEY INT, V84, P64, DOI 10.1038/ki.2013.82; Tan HL, 2016, BLOOD PURIFICAT, V41, P144, DOI 10.1159/000441269; Tilyek A, 2016, J ETHNOPHARMACOL, V178, P297, DOI 10.1016/j.jep.2015.10.003; Trujillo KA, 2011, INT J CANCER, V129, P1310, DOI 10.1002/ijc.25788; Wang B, 2014, KIDNEY INT, V85, P352, DOI 10.1038/ki.2013.372; Wu JJ, 2014, EXP CELL RES, V328, P351, DOI 10.1016/j.yexcr.2014.08.030; Wu JB, 2016, INT IMMUNOPHARMACOL, V33, P33, DOI 10.1016/j.intimp.2016.01.008; Zerr P, 2016, ANN RHEUM DIS, V75, P226, DOI 10.1136/annrheumdis-2014-205740; Zhou ZM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162873	27	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179137	10.1371/journal.pone.0179137	http://dx.doi.org/10.1371/journal.pone.0179137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586398	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700048
J	Bhatt, NB; Pandya, DN; Xu, JD; Tatum, D; Magda, D; Wadas, TJ				Bhatt, Nikunj B.; Pandya, Darpan N.; Xu, Jide; Tatum, David; Magda, Darren; Wadas, Thaddeus J.			Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89	PLOS ONE			English	Article							CIRCULARLY-POLARIZED LUMINESCENCE; MOLECULAR-ORBITAL METHODS; HYDROXAMATE LIGANDS; ANTENNA LIGANDS; IMMUNO-PET; BASIS-SETS; ZR-89; COMPLEXATION; DESIGN; MODEL	The development of bifunctional chelators (BFCs) for zirconium-89 immuno-PET applications is an area of active research. Herein we report the synthesis and evaluation of octadentate hydroxyisophthalamide ligands (1 and 2) as zirconium-89 chelators. While both radiometal complexes could be prepared quantitatively and with excellent specific activity, preparation of Zr-89-1 required elevated temperature and an increased reaction time. Zr-89-1 was more stable than Zr-89-2 when challenged in vitro by excess DTPA or serum proteins and in vivo during acute biodistribution studies. Differences in radiometal complex stability arise from structural changes between the two ligand systems, and suggest further ligandoptimization is necessary to enhance Zr-89 chelation.	[Bhatt, Nikunj B.; Pandya, Darpan N.; Wadas, Thaddeus J.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Xu, Jide; Tatum, David; Magda, Darren] Lumiphore Inc, Berkeley, CA 94710 USA	Wake Forest University	Wadas, TJ (corresponding author), Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA.; Magda, D (corresponding author), Lumiphore Inc, Berkeley, CA 94710 USA.	dmagda@lumiphore.com; twadas@wakehealth.edu	Bhatt, Nikunj/AAQ-2588-2021; Pandya, Darpan/S-3967-2016	Pandya, Darpan/0000-0001-6288-5172; Tatum, David/0000-0002-9020-7878; Wadas, Thad/0000-0002-9913-0336	NSF SBIR [IIP-1215462]; Wake Forest University Health Sciences; Washington University School of Medicine; Department of Energy Officeof Science, Nuclear Physics Isotope Program [DESC0008657]; Wake Forest Clinical and Translational Science Institute [UL1TR001420]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001420] Funding Source: NIH RePORTER	NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Wake Forest University Health Sciences; Washington University School of Medicine; Department of Energy Officeof Science, Nuclear Physics Isotope Program(United States Department of Energy (DOE)); Wake Forest Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported in part by NSF SBIR grant No. IIP-1215462 to Lumiphore, Inc. and Wake Forest University Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 89Zr was provided y Zevacor,Inc. and Washington University School of Medicine with support from Department of Energy Officeof Science, Nuclear Physics Isotope Program (DESC0008657). We also acknowledge the editorial assistance of Karen Klein, MA, in the Wake Forest Clinical and Translational Science Institute (UL1TR001420;PI:McClain).	Abou DS, 2011, NUCL MED BIOL, V38, P675, DOI 10.1016/j.nucmedbio.2010.12.011; ANDRAE D, 1990, THEOR CHIM ACTA, V77, P123, DOI 10.1007/BF01114537; Boros E, 2016, CHEMPLUSCHEM, V81, P274, DOI 10.1002/cplu.201600003; Cohen SM, 1999, INORG CHEM, V38, P4522, DOI 10.1021/ic990411k; Daumann LJ, 2016, J INORG BIOCHEM, V162, P263, DOI 10.1016/j.jinorgbio.2016.01.006; Deri MA, 2014, J MED CHEM, V57, P4849, DOI 10.1021/jm500389b; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Guerard F, 2013, CHEM COMMUN, V49, P1002, DOI 10.1039/c2cc37549d; Guerard F, 2014, CHEM-EUR J, V20, P5584, DOI 10.1002/chem.201304115; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Holland JP, 2014, DALTON T, V43, P9872, DOI 10.1039/c4dt00733f; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Jacobson O, 2011, MOL IMAGING BIOL, V13, P1224, DOI 10.1007/s11307-010-0458-y; Law GL, 2012, J AM CHEM SOC, V134, P15545, DOI 10.1021/ja306354n; Liu ZD, 2002, J MED CHEM, V45, P631, DOI 10.1021/jm010817i; Liu ZD, 2002, MED RES REV, V22, P26, DOI 10.1002/med.1027; Ma MT, 2015, DALTON T, V44, P4884, DOI 10.1039/c4dt02978j; Martin JML, 2001, J CHEM PHYS, V114, P3408, DOI 10.1063/1.1337864; MEIJS WE, 1994, APPL RADIAT ISOTOPES, V45, P1143, DOI 10.1016/0969-8043(94)90029-9; Moore EG, 2009, ACCOUNTS CHEM RES, V42, P542, DOI 10.1021/ar800211j; MUSTAFA MG, 1988, PHYS REV C, V38, P1624, DOI 10.1103/PhysRevC.38.1624; Pandya DN, 2017, CHEM SCI, V8, P2309, DOI 10.1039/c6sc04128k; Pandya DN, 2015, CHEM COMMUN, V51, P2301, DOI 10.1039/c4cc09256b; Patra M, 2014, CHEM COMMUN, V50, P11523, DOI 10.1039/c4cc05558f; Perez-Medina C, 2014, J NUCL MED, V55, P1706, DOI 10.2967/jnumed.114.141861; PETERSSON GA, 1988, J CHEM PHYS, V89, P2193, DOI 10.1063/1.460448; Price EW, 2014, DALTON T, V43, P119, DOI 10.1039/c3dt51940f; Price EW, 2014, CHEM SOC REV, V43, P260, DOI 10.1039/c3cs60304k; Rudd SE, 2016, CHEM COMMUN, V52, P11889, DOI 10.1039/c6cc05961a; Samuel APS, 2008, INORG CHEM, V47, P7535, DOI 10.1021/ic800328g; Samuel APS, 2010, EUR J INORG CHEM, P3343, DOI 10.1002/ejic.201000309; Samuel APS, 2009, INORG CHEM, V48, P687, DOI 10.1021/ic801904s; Scalmani G., 2016, GAUSSIAN 09; Seitz M, 2009, INORG CHEM, V48, P8469, DOI 10.1021/ic901079s; Tinianow JN, 2016, THERANOSTICS, V6, P511, DOI 10.7150/thno.14261; Verel I, 2003, J NUCL MED, V44, P1271; Wadas TJ, 2010, MAGN RESON MED, V64, P1274, DOI 10.1002/mrm.22553; Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Xu JD, 2011, J AM CHEM SOC, V133, P19900, DOI 10.1021/ja2079898	41	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178767	10.1371/journal.pone.0178767	http://dx.doi.org/10.1371/journal.pone.0178767			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575044	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300112
J	Calvino, FR; Kornprobst, M; Schermann, G; Birkle, F; Wild, K; Fischer, T; Hurt, E; Ahmed, YL; Sinning, I				Calvino, Fabiola R.; Kornprobst, Markus; Schermann, Geza; Birkle, Fabienne; Wild, Klemens; Fischer, Tamas; Hurt, Ed; Ahmed, Yasar Luqman; Sinning, Irmgard			Structural basis for 5 '-ETS recognition by Utp4 at the early stages of ribosome biogenesis	PLOS ONE			English	Article							U3 SNORNA; RNA; RIBONUCLEOPROTEIN; TRANSCRIPTION	Eukaryotic ribosome biogenesis begins with the co-transcriptional assembly of the 90S pre ribosome. The 'U three protein' (UTP) complexes and snoRNP particles arrange around the nascent pre-ribosomal RNA chaperoning its folding and further maturation. The earliest event in this hierarchical process is the binding of the UTP-A complex to the 5'-end of the pre-ribosomal RNA (5'-ETS). This oligomeric complex predominantly consists of (3-propeller and alpha-solenoidal proteins. Here we present the structure of the Utp4 subunit from the thermophilic fungus Chaetomium thermophilum at 2.15 A resolution and analyze its function by UV RNA-crosslinking (CRAC) and in context of a recent cryo-EM structure of the 90S pre ribosome. Utp4 consists of two orthogonal and highly basic (3-propellers that perfectly fit the EM-data. The Utp4 structure highlights an unusual Velcro-closure of its C-terminal (3-propeller as relevant for protein integrity and potentially Utp8 recognition in the context of the pre ribosome. We provide a first model of the 5'-ETS RNA from the internally hidden 5'-end up to the region that hybridizes to the 3'-hinge sequence of U3 snoRNA and validate a specific Utp4/5'-ETS interaction by CRAC analysis.	[Calvino, Fabiola R.; Kornprobst, Markus; Schermann, Geza; Birkle, Fabienne; Wild, Klemens; Fischer, Tamas; Hurt, Ed; Ahmed, Yasar Luqman; Sinning, Irmgard] Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, Heidelberg, Germany; [Fischer, Tamas] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia	Ruprecht Karls University Heidelberg; Australian National University; John Curtin School of Medical Research	Ahmed, YL; Sinning, I (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, Heidelberg, Germany.	yasar.ahmed@bzh.uni-heidelberg.de; irmi.sinning@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Fischer, Tamas/A-7729-2016	Ed Hurt, Dr./0000-0002-4535-8255; Birkle, Fabienne/0000-0003-0238-8865; Fischer, Tamas/0000-0002-7996-4042	Deutsche Forschungsgemeinschaft (DFG) [SFB638, HU363/15-1]; Cluster of Excellence: CellNetworks (EcTOP1); Kekule Fellowship (VCI); DFG [Leibniz Programme]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence: CellNetworks (EcTOP1); Kekule Fellowship (VCI); DFG [Leibniz Programme](German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) (SFB638, Z4 to I.S. and HU363/15-1 to E.H. and the Leibniz programme to I.S.); Cluster of Excellence: CellNetworks (EcTOP1 to I.S. and E.H.); Funding for open access charge: DFG [Leibniz Programme]. M.K. was funded by a Kekule Fellowship (VCI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bassler J, 2017, PROTEIN SCI, V26, P327, DOI 10.1002/pro.3085; Chaker-Margot M, 2017, SCIENCE, V355, DOI 10.1126/science.aal1880; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hunziker M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12090; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Poll G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114898; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Webb S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r8; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178752	10.1371/journal.pone.0178752	http://dx.doi.org/10.1371/journal.pone.0178752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575120	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300106
J	Leshinsky, J; McLachlan, A; Foster, DJR; Norris, R; Barrs, VR				Leshinsky, Jana; McLachlan, Andrew; Foster, David J. R.; Norris, Ross; Barrs, Vanessa R.			Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats	PLOS ONE			English	Article							EXPERIMENTAL PULMONARY ASPERGILLOSIS; PERSISTENTLY NEUTROPENIC RABBITS; ANTIFUNGAL AGENT; INVASIVE ASPERGILLOSIS; DOSE PHARMACOKINETICS; NEOSARTORYA-UDAGAWAE; DEPENDENT ACTIVITY; FUNGAL-INFECTIONS; AMPHOTERICIN-B; MURINE MODEL	Cats are the most common mammal to develop invasive fungal rhinosinusitis caused by cryptic species in Aspergillus section Fumigati that are resistant to azoles but susceptible to caspofungin. In this study nonlinear mixed-effects pharmacokinetic modeling and simulation was used to investigate caspofungin pharmacokinetics and explore dosing regimens in cats using caspofungin minimum effective concentrations (MECs). Plasma concentrations in healthy cats were determined using HPLC-MS/MS after administration of a single and seven consecutive daily intravenous doses of 1 mg/kg caspofungin. In the final pharmacokinetic model an optimum maximum concentration (C-max): MEC ratio of 10-20 was used to guide caspofungin efficacy. Simulations were performed for dosing regimens (doses 0.25-2 mg/kg and 6-72 h dosing intervals) with and without inclusion of a loading dose. Using a 1 mg/kg dose Cmax first dose was 14.8 mu g/mL, Cmax at steady state was 19.8 mu g/mL, Cmin was 5 mu g/mL and Cmax: MEC was > 20 in 42.6% of cats after multiple doses. An optimal Cmax: MEC ratio was achieved in caspofungin simulations using 0.75 mg/kg q 24 h or 1 mg/kg q 72h. However, at 1 mg/kg q 72h, C-min was < MEC (< 1 mu g/mL) in over 95% of the population. Using a loading dose of 1 mg/kg and a daily dose of 0.75 mg/kg thereafter, the Cmax: MEC was optimal and Cmin was > 2.5 aeg/mL for 98% of the population. Based on the modeling data this dosing regimen is likely to achieve target therapeutic concentrations, meet the proposed Cmax: MEC window and provide consistent exposure between doses.	[Leshinsky, Jana; Barrs, Vanessa R.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia; [McLachlan, Andrew] Univ Sydney, Fac Pharm & Educ & Res Ageing, Camperdown, NSW, Australia; [McLachlan, Andrew] Concord Hosp, Concord, NSW, Australia; [Foster, David J. R.] Univ South Australia, Australian Ctr Pharmacometr, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Norris, Ross] St Vincents Hosp, SydPath, Clin Pharmacol Div, Darlinghurst, NSW, Australia; [Norris, Ross] Univ New South Wales, Clin Sch, Darlinghurst, NSW, Australia; [Norris, Ross] Griffith Univ, Sch Pharm, Gold Coast, Qld, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital; University of South Australia; St Vincents Hospital Sydney; University of New South Wales Sydney; Griffith University	Barrs, VR (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia.	vanessa.barrs@sydney.edu.au		Barrs, Vanessa/0000-0001-6761-8022; Foster, David/0000-0002-7345-4084	Australian Companion Animal Health Foundation [009/2015]	Australian Companion Animal Health Foundation	This study was funded by the Australian Companion Animal Health Foundation 009/2015. The funder had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B., 2012, GRIDEXTRA FUNCTIONS, P1; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balani SK, 2000, DRUG METAB DISPOS, V28, P1274; Barrs VR, 2012, VET J, V191, P58, DOI 10.1016/j.tvjl.2011.02.009; Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871; Beal S.L., 1989, NONMEM 7 3 0 USERS G; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; Cleary JD, 2003, PHARMACOTHERAPY, V23, P966, DOI 10.1592/phco.23.8.966.32875; Dean HR, 1924, J PATHOL BACTERIOL, V27, P51, DOI 10.1002/path.1700270106; Espinel-Ingroff A, 2011, ANTIMICROB AGENTS CH, V55, P2855, DOI 10.1128/AAC.01730-10; Genovese A, 2010, CHEM IMMUNOL ALLERGY, V95, P98, DOI 10.1159/000315945; Greenberger PA, 2007, ANN ALLERG ASTHMA IM, V98, P252, DOI 10.1016/S1081-1206(10)60714-4; Groll AH, 2001, ANTIMICROB AGENTS CH, V45, P596, DOI 10.1128/AAC.45.2.596-600.2001; Groll AH, 2001, ANTIMICROB AGENTS CH, V45, P2845, DOI 10.1128/AAC.45.10.2845-2855.2001; Groll AH, 2001, EXPERT OPIN INV DRUG, V10, P1545, DOI 10.1517/13543784.10.8.1545; Hajdu R, 1997, ANTIMICROB AGENTS CH, V41, P2339, DOI 10.1128/AAC.41.11.2339; Harrell FE., 2021, HMISC HARRELL MISCEL; Hojsgaard S, 2014, DOBY GROUPWISE STAT, V4, P5; Kauffman CA, 2008, SEMINARS RESP CRITIC; LAUTT WW, 1987, AM J PHYSIOL, V252, pG472, DOI 10.1152/ajpgi.1987.252.4.G472; Lewis RE, 2008, J ANTIMICROB CHEMOTH, V61, P1140, DOI 10.1093/jac/dkn069; Litster A, 2006, AUST VET J, V84, P151, DOI 10.1111/j.1751-0813.2006.tb12768.x; Lynch J, 2004, PHARMACOTHERAPY, V24, P1408, DOI 10.1592/phco.24.14.1408.43148; McCormack PL, 2005, DRUGS, V65, P2049, DOI 10.2165/00003495-200565140-00009; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; Mistry GC, 2007, J CLIN PHARMACOL, V47, P951, DOI 10.1177/0091270007303764; Mora-Duarte J, 2002, NEW ENGL J MED, V347, P2020, DOI 10.1056/NEJMoa021585; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Perlin DS, 2010, ECHINOCANDINS ASPERG, P263; Petraitiene R, 2002, ANTIMICROB AGENTS CH, V46, P12, DOI 10.1128/AAC.46.1.12-23.2002; Petraitis V, 1998, ANTIMICROB AGENTS CH, V42, P2898, DOI 10.1128/AAC.42.11.2898; Posteraro B, 2011, J CLIN MICROBIOL, V49, P2357, DOI 10.1128/JCM.00134-11; Quantz JE, 2009, J VET EMERG CRIT CAR, V19, P536, DOI 10.1111/j.1476-4431.2009.00474.x; RICHARDSON PDI, 1978, BRIT J PHARMACOL, V64, P581, DOI 10.1111/j.1476-5381.1978.tb17320.x; Sandhu P, 2004, ANTIMICROB AGENTS CH, V48, P1272, DOI 10.1128/AAC.48.4.1272-1280.2004; Schloerke B, 2014, GGALLY EXTENSION TO; Shmuel DL, 2013, J VET EMERG CRIT CAR, V23, P377, DOI 10.1111/vec.12066; Stone JA, 2004, ANTIMICROB AGENTS CH, V48, P815, DOI 10.1128/AAC.48.3.815-823.2004; Stone JA, 2002, ANTIMICROB AGENTS CH, V46, P739, DOI 10.1128/AAC.46.3.739-745.2002; Sugui JA, 2014, J CLIN MICROBIOL, V52, P3707, DOI 10.1128/JCM.01704-14; Team RC, 2015, R LANG ENV STAT COMP; Trepanier LA, 1998, PHARMACOGENETICS, V8, P169, DOI 10.1097/00008571-199804000-00009; Vinh DC, 2009, CLIN INFECT DIS, V49, P102, DOI 10.1086/599345; Wickham H., 2012, STRINGR MAKE IT EASI, P2; Wickham H., 2016, EASILY TIDY DATA WIT; Wickham H., 2014, SCALES SCALE FUNCTIO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Wiederhold NP, 2004, J INFECT DIS, V190, P1464, DOI 10.1086/424465; Wiederhold NP, 2003, EXPERT OPIN INV DRUG, V12, P1313, DOI 10.1517/13543784.12.8.1313; Yamato Y, 2002, JPN J CHEMOTHER S1, V50, P74	52	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178783	10.1371/journal.pone.0178783	http://dx.doi.org/10.1371/journal.pone.0178783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575121	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300114
J	Pannu, PK; Piers, LS; Soares, MJ; Zhao, Y; Ansari, Z				Pannu, Poonam K.; Piers, Leonard S.; Soares, Mario J.; Zhao, Yun; Ansari, Zahid			Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; METABOLIC SYNDROME; INSULIN-RESISTANCE; D SUPPLEMENTATION; GLYCEMIC CONTROL; CALCIUM INTAKE; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; NATIONAL-HEALTH; NEW-ZEALAND	A growing body of evidence suggests a protective role of vitamin D on the risk of type 2 diabetes mellitus (T2DM). We investigated this relationship in a population sample from one Australian state. The data of 3,393 Australian adults aged 18-75 years who participated in the 2009-2010 Victorian Health Monitor survey was analyzed. Socio-demographic information, biomedical variables, and dietary intakes were collected and fasting blood samples were analyzed for 25, hydroxycholecalciferol (250HD), HbA1c, fasting plasma glucose (FPG), and lipid profiles. Logistic regression analyses were used to evaluate the association between tertiles of serum 250HD and categories of FPG (<5.6 mmol/L vs. 5.6-6.9 mmol/L), and HbA1c (<5.7% vs. 5.7-6.4%). After adjusting for social, dietary, biomedical and metabolic syndrome (MetS) components (waist circumference, HDL cholesterol, triglycerides, and blood pressure), every 10 nmol/L increment in serum 250HD significantly reduced the adjusted odds ratio (AOR) of a higher FPG [AOR 0.91, (0.86, 0.97); p = 0.002] and a higher HbA1c [AOR 0.94, (0.90, 0.98); p = 0.009]. Analysis by tertiles of 250HD indicated that after adjustment for socio-demographic and dietary variables, those with high 250HD (65-204 nmol/L) had reduced odds of a higher FPG [AOR 0.60, (0.43, 0.83); p = 0.008] as well as higher HbA1c [AOR 0.67, (0.53, 0.85); p = 0.005] compared to the lowest 250HD (10-44 nmol/L) tertile. On final adjustment for other components of MetS, those in the highest tertile of 250HD had significantly reduced odds of higher FPG [AOR 0.61, (0.44, 0.84); p = 0.011] and of higher HbA1c [AOR 0.74, (0.58, 0.93); p = 0.041] vs. low 250HD tertile. Overall, the data support a direct, protective effect of higher 250HD on FPG and HbA1c; two criteria for assessment of risk of T2DM.	[Pannu, Poonam K.; Soares, Mario J.] Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Publ Hlth, Food Nutr & Hlth, Perth, WA, Australia; [Piers, Leonard S.; Ansari, Zahid] Product & Analyt Div, Hlth Intelligence Unit, Syst Intelligence & Analyt Branch, Hlth Strategy Prod & Analyt Div,Dept Hlth, Melbourne, Vic, Australia; [Zhao, Yun] Curtin Univ, Sch Publ Hlth, Occupat & Environm, Fac Hlth Sci, Perth, WA, Australia	Curtin University; Curtin University	Soares, MJ (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Sch Publ Hlth, Food Nutr & Hlth, Perth, WA, Australia.	m.soares@curtin.edu.au	Soares, Mario J/P-3519-2019	Soares, Mario J/0000-0001-6071-0272				Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Armstrong T, 2000, PHYS ACTIVITY PATTER; ARNAUD J, 1993, HUM GENET, V92, P183; Attard SM, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2015.16; Bikle DD, 2010, TRENDS ENDOCRIN MET, V21, P375, DOI 10.1016/j.tem.2010.01.003; Bonora E, 2004, DIABETIC MED, V21, P52, DOI 10.1046/j.1464-5491.2003.01068.x; Boucher BJ, 2012, DERM-ENDOCRINOL, V4, P212, DOI 10.4161/derm.20012; Boucher BJ, 1998, BRIT J NUTR, V79, P315, DOI 10.1079/BJN19980055; Calton EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141770; Cavalier E, 2011, DIABETES METAB, V37, P265, DOI 10.1016/j.diabet.2011.01.001; Cespedes EM, 2016, AM J EPIDEMIOL, V183, P622, DOI 10.1093/aje/kwv241; Chon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089721; Dalan R, 2014, IJC METAB ENDOCR, V4, P4, DOI 10.1016/j.ijcme.2014.06.003; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Department of Health, 2012, VICT HLTH MON FOOD N; Department of Health, 2012, VICT HLTH MON; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; Durazo-Arvizu RA, 2010, J NUTR, V140, P595, DOI 10.3945/jn.109.116681; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Fu L, 2009, CLIN BIOCHEM, V42, P1174, DOI 10.1016/j.clinbiochem.2009.03.008; Gagnon C, 2012, J CLIN ENDOCR METAB, V97, P1953, DOI 10.1210/jc.2011-3187; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Gikas A, 2009, PRIM CARE DIABETES, V3, P111, DOI 10.1016/j.pcd.2009.05.004; Goldberg G. R., 1998, Scandinavian Journal of Nutrition/Naringsforskning, V42, P6; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Heaney RP, 2008, CLIN J AM SOC NEPHRO, V3, P1535, DOI 10.2215/CJN.01160308; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hutchinson MS, 2011, SCAND J CLIN LAB INV, V71, P399, DOI 10.3109/00365513.2011.575235; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jamka M, 2015, SCI REP, V176, pR1; Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643; Kim C, 2010, DIABETES CARE, V33, P780, DOI 10.2337/dc09-0836; Kositsawat J, 2010, DIABETES CARE, V33, P1236, DOI 10.2337/dc09-2150; Krishnan S, 2009, AM J EPIDEMIOL, V169, P428, DOI 10.1093/aje/kwn344; Krul-Poel YHM, 2017, EUR J ENDOCRINOL, V176, pR1, DOI [10.1530/eje-16-0391, 10.1530/EJE-16-0391]; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Li L, 2013, ARCH MED RES, V44, P235, DOI 10.1016/j.arcmed.2013.02.002; Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021; Lorenzo C, 2003, DIABETES CARE, V26, P3153, DOI 10.2337/diacare.26.11.3153; Manickam B, 2013, ENDOCR PRACT, V19, P73, DOI 10.4158/EP12168.OR; Markwick A, 2015, SOC SCI MED, V128, P178, DOI 10.1016/j.socscimed.2015.01.014; Martinez-Hernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123313; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; Milner R D, 1967, Diabetologia, V3, P47, DOI 10.1007/BF01269910; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Mitri J, 2011, AM J CLIN NUTR, V94, P486, DOI 10.3945/ajcn.111.011684; Nagpal J, 2009, DIABETIC MED, V26, P19, DOI 10.1111/j.1464-5491.2008.02636.x; Need AG, 2005, CLIN ENDOCRINOL, V62, P738, DOI 10.1111/j.1365-2265.2005.02288.x; Nichols GA, 2010, DIABETES RES CLIN PR, V90, P115, DOI 10.1016/j.diabres.2010.06.011; NORMAN AW, 1990, AM J CLIN NUTR, V51, P290, DOI 10.1093/ajcn/51.2.290; Nowson CA, 2012, MED J AUSTRALIA, V196, P686, DOI 10.5694/mja11.10301; Pannu P. K., 2016, PUBLIC HEALTH NUTR, P1; Pannu Poonam K, 2016, Adv Food Nutr Res, V77, P57, DOI 10.1016/bs.afnr.2015.11.001; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pink B, 2013, SOCIO EC INDEXES ARE; Pittas AG, 2006, DIABETES CARE, V29, P650, DOI 10.2337/diacare.29.03.06.dc05-1961; Poolsup N, 2016, DIABETIC MED, V33, P290, DOI 10.1111/dme.12893; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Salazar MR, 2016, DIABETES VASC DIS RE, V13, P157, DOI 10.1177/1479164115610057; Scott RA, 2013, DIABETOLOGIA, V56, P60, DOI 10.1007/s00125-012-2715-x; Shamshirgaran SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1223; Soares MJ, 2017, TRENDS FOOD SCI TECH, V62, P79, DOI 10.1016/j.tifs.2017.01.009; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tseng CL, 2005, AM J EPIDEMIOL, V161, P565, DOI 10.1093/aje/kwi071; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Vitezova A, 2015, EUR J ENDOCRINOL, V172, P327, DOI 10.1530/EJE-14-0580; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang LX, 2014, PUBLIC HEALTH NUTR, V17, P1858, DOI 10.1017/S1368980013002000; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412; Zoppini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082733	81	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178825	10.1371/journal.pone.0178825	http://dx.doi.org/10.1371/journal.pone.0178825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575036	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300122
J	Sarker, S; Menanteau-Ledouble, S; Kotob, MH; El-Matbouli, M				Sarker, Subhodeep; Menanteau-Ledouble, Simon; Kotob, Mohamed H.; El-Matbouli, Mansour			A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo	PLOS ONE			English	Article							MYXOBOLUS-CEREBRALIS; ACTINOSPOREAN STAGE; CAUSATIVE AGENT; TUBIFEX; RESISTANCE; INFECTION; SUSCEPTIBILITY; INTERFERENCE; POPULATIONS; MYXOZOA	Myxobolus cerebralis is a cnidarian- myxozoan parasite that causes salmonid whirling disease. M. cerebralis alternates between two hosts: (1) a vertebrate salmonid and (2) an invertebrate oligochaete, Tubifex tubifex. There is no successful treatment for salmonid whirling disease. MyxSP-1 is a M. cerebralis serine protease implicated in whirling disease pathogenesis. We hypothesized that short-interfering RNA (siRNA)-induced RNA interference (RNAi) can silence MyxSP-1 in the invertebrate host and abrogate the M. cerebralis life cycle. This would preclude whirling disease infection in the salmonid host. To test this hypothesis, we first developed a siRNA delivery protocol in T. tubifex. Second, we determined the effective dose for siRNA treatment of M. cerebralis-infected T. tubifex. M. cerebralis-infected T. tubifex were treated with different concentrations of MyxSP-1 or negative control siRNAs (1 mu M, 2 mu M, 5 mu M or 7 mu M) at 15 degrees C for 24h, 48h, 72h and 96h, respectively. We monitored MyxSP-1 knockdown using real-time quantitative PCR (qPCR). siRNA treatment with MyxSP-1 siRNA at 2 mu M concentration for 24h at 15 degrees C showed maximum significant MyxSP-1 knockdown in T. tubifex. Third, we determined the time points in the M. cerebralis life cycle in T. tubifex at which siRNA treatment was most effective. M. cerebralis-infected T. tubifex were treated with MyxSP-1 or negative control siRNAs (2 mu M concentration for 24h at 15 degrees C) at 24 hours post-infection (24hpi), 48hpi, 72hpi, 96hpi, 1 month post-infection (1mpi), 2mpi and 3mpi, respectively. We observed that siRNA treatment of T. tubifex was most effective at 1mpi, 2mpi and 3mpi. Fourth, we immersed specific-pathogen-free rainbow trout fry in water inhabited by MyxSP-1 siRNA-treated T. tubifex (at 1mpi, 2mpi and 3mpi). The salmonids did not develop whirling disease and showed significant MyxSP-1 knockdown. We also observed long-term RNAi in T. tubifex. Together these results demonstrate a novel RNAi-based therapeutic proof of concept in vivo against salmonid whirling disease.	[Sarker, Subhodeep; Menanteau-Ledouble, Simon; Kotob, Mohamed H.; El-Matbouli, Mansour] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Div Fish Med, Vienna, Austria; [Sarker, Subhodeep] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia; [Kotob, Mohamed H.] Assiut Univ, Dept Pathol, Fac Vet Med, Asyut, Egypt	University of Veterinary Medicine Vienna; University of Sydney; Egyptian Knowledge Bank (EKB); Assiut University	Sarker, S; El-Matbouli, M (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Div Fish Med, Vienna, Austria.; Sarker, S (corresponding author), Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW, Australia.	ssarker007k@gmail.com; mansour.el-matbouli@vetmeduni.ac.at	menanteau-ledouble, simon/ABD-9785-2020	menanteau-ledouble, simon/0000-0002-3435-9287; El-Matbouli, Mansour/0000-0001-8148-0218; Sarker, Subhodeep/0000-0002-2222-2072; Kotob, Mohamed/0000-0003-4183-5517	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF) [P29294-B25]	University of Veterinary Medicine Vienna, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded in part by the University of Veterinary Medicine Vienna, Vienna, Austria and the Austrian Science Fund (FWF) project no: P29294-B25 to ME-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerwald MR, 2011, HEREDITY, V106, P920, DOI 10.1038/hdy.2010.137; Baerwald MR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-37; Baerwald MR, 2013, FISH SHELLFISH IMMUN, V35, P965, DOI 10.1016/j.fsi.2013.07.008; Beauchamp KA, 2006, J INVERTEBR PATHOL, V91, P1, DOI 10.1016/j.jip.2005.08.006; Beauchamp KA, 2002, DIS AQUAT ORGAN, V51, P113, DOI 10.3354/dao051113; Beauchamp KA, 2001, MOL PHYLOGENET EVOL, V19, P216, DOI 10.1006/mpev.2001.0923; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Chang ES, 2015, P NATL ACAD SCI USA, V112, P14912, DOI 10.1073/pnas.1511468112; Da'dara AA, 2015, METHODS MOL BIOL, V1201, P143, DOI 10.1007/978-1-4939-1438-8_8; El-Matbouli M, 1998, INT J PARASITOL, V28, P195, DOI 10.1016/S0020-7519(97)00176-8; El-Matbouli M, 1999, DIS AQUAT ORGAN, V35, P1, DOI 10.3354/dao035001; ELMATBOULI M, 1991, DIS AQUAT ORGAN, V10, P109, DOI 10.3354/dao010109; Fetherman ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096954; Fetherman ER, 2012, DIS AQUAT ORGAN, V102, P97, DOI 10.3354/dao02543; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gilbert MA, 2001, J PARASITOL, V87, P101, DOI 10.1645/0022-3395(2001)087[0101:PIOMCT]2.0.CO;2; Granath WO, 2014, J PARASITOL, V100, P157, DOI 10.1645/13-398.1; Granath WO, 2002, AM FISH S S, V29, P79; Hedrick RP, 2000, DIS AQUAT ORGAN, V42, P53, DOI 10.3354/dao042053; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P37, DOI 10.3354/dao055037; Hofer B, 1903, ALLGEMEINE FISCHEREI, V28, P7; Kelley GO, 2004, DIS AQUAT ORGAN, V59, P235, DOI 10.3354/dao059235; Lima PC, 2013, FISH SHELLFISH IMMUN, V34, P729, DOI 10.1016/j.fsi.2012.11.037; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Nesnidal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054576; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Sarker S, 2015, NUCLEIC ACID THER, V25, P285, DOI 10.1089/nat.2015.0549; Sarker S, 2015, DIS AQUAT ORGAN, V114, P155, DOI 10.3354/dao02856; Schyth BD, 2008, J FISH BIOL, V72, P1890, DOI 10.1111/j.1095-8649.2008.01819.x; Schyth BD, 2007, MOL THER, V15, P1366, DOI 10.1038/sj.mt.6300150; Steinbach Elwell LC, 2009, WHIRLING DIS US SUMM; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a	34	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178687	10.1371/journal.pone.0178687	http://dx.doi.org/10.1371/journal.pone.0178687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575083	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300096
J	Wardhani, P; Aryati, A; Yohan, B; Trimarsanto, H; Setianingsih, TY; Puspitasari, D; Arfijanto, MV; Bramantono, B; Suharto, S; Sasmono, RT				Wardhani, Puspa; Aryati, Aryati; Yohan, Benediktus; Trimarsanto, Hidayat; Setianingsih, Tri Y.; Puspitasari, Dwiyanti; Arfijanto, Muhammad Vitanata; Bramantono, Bramantono; Suharto, Suharto; Sasmono, R. Tedjo			Clinical and virological characteristics of dengue in Surabaya, Indonesia	PLOS ONE			English	Article							SEROTYPE-SPECIFIC DIFFERENCES; HEMORRHAGIC-FEVER; MOLECULAR EVOLUTION; PHYLOGENETIC ANALYSIS; GLOBAL DISTRIBUTION; IMMUNE ACTIVATION; VIRUS SEROTYPE; SHOCK SYNDROME; ENVELOPE GENE; EPIDEMIC	Dengue disease is still a major health problem in Indonesia. Surabaya, the second largest city in the country, is endemic for dengue. We report here on dengue disease in Surabaya, investigating the clinical manifestations, the distribution of dengue virus (DENV) serotypes, and the relationships between clinical manifestations and the genetic characteristics of DENV. A total of 148 patients suspected of having dengue were recruited during February August 2012. One hundred one (68%) of them were children, and 47 (32%) were adults. Dengue fever (DF) and Dengue hemorrhagic fever (DHF) were equally manifested in all of the patients. We performed DENV serotyping on all of the samples using real-time RT-PCR. Of 148, 79 (53%) samples were detected as DENV positive, with DENV-1 as the predominant serotype (73%), followed by DENV-2 (8%), DENV-4 (8%), and DENV-3 (6%), while 5% were mixed infections. Based on the Envelope gene sequences, we performed phylogenetic analyses of 24 isolates to genotype the DENV circulating in Surabaya in 2012, and the analysis revealed that DENV-1 consisted of Genotypes I and IV, DENV-2 was of the Cosmopolitan genotype, the DENV-3 viruses were of Genotype I, and DENV-4 was detected as Genotype II. We correlated the infecting DENV serotypes with clinical manifestations and laboratory parameters; however, no significant correlations were found. Amino acid analysis of Envelope protein did not find any unique mutations related to disease severity.	[Wardhani, Puspa; Aryati, Aryati] Univ Airlangga, Sch Med, Dept Clin Pathol, Surabaya, Indonesia; [Wardhani, Puspa; Aryati, Aryati] Univ Airlangga, Inst Trop Dis, Surabaya, Indonesia; [Yohan, Benediktus; Trimarsanto, Hidayat; Setianingsih, Tri Y.; Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Puspitasari, Dwiyanti] Univ Airlangga, Sch Med, Dept Pediat, Surabaya, Indonesia; [Arfijanto, Muhammad Vitanata; Bramantono, Bramantono; Suharto, Suharto] Univ Airlangga, Sch Med, Dept Internal Med, Surabaya, Indonesia	Airlangga University; Airlangga University; Eijkman Institute; Airlangga University; Airlangga University	Sasmono, RT (corresponding author), Eijkman Inst Mol Biol, Jakarta, Indonesia.	sasmono@eijkman.go.id	Yohan, Benediktus/J-9039-2019; Wardhani, Puspa/AAY-7389-2021; Aryati, Aryati/CAI-7894-2022; Puspitasari, Dwiyanti/AAB-9709-2021; Aryati, Aryati/CAG-1058-2022; Sasmono, Tedjo/H-5680-2016	Yohan, Benediktus/0000-0003-2378-2386; Puspitasari, Dwiyanti/0000-0003-1773-4791; Sasmono, Tedjo/0000-0003-0986-2590; Wardhani, Puspa/0000-0003-2202-8090; Trimarsanto, Hidayat/0000-0003-2436-8283	PHKI; SINAS grants from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia	PHKI; SINAS grants from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study was partly funded by PHKI and SINAS 2012 grants from the Ministry of Research, Technology, and Higher Education of the Republic of Indonesia to AA and RTS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker M, 2011, WEST PAC SURVEILL RE, V2, P17, DOI [10.5365/WPSAR.2011.2.1.002, 10.5365/wpsar.2011.2.1.002]; Aryati A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-611; Aryati Wardhani P., 2010, INDONESIAN J CLIN PA, V17, P21; Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BLOK J, 1989, ARCH VIROL, V105, P39, DOI 10.1007/BF01311115; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; CHUNGUE E, 1993, J GEN VIROL, V74, P2765, DOI 10.1099/0022-1317-74-12-2765; Corwin AL, 2001, T ROY SOC TROP MED H, V95, P257, DOI 10.1016/S0035-9203(01)90229-9; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Trung DT, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P115, DOI 10.1079/9781845939649.0115; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003442; Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354; Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Imrie A, 2010, ANN TROP MED PARASIT, V104, P225, DOI 10.1179/136485910X12647085215570; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kosasih H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080891; Kotaki T, 2016, INFECT GENET EVOL, V37, P88, DOI 10.1016/j.meegid.2015.11.002; Kotaki T, 2014, INFECT GENET EVOL, V28, P48, DOI 10.1016/j.meegid.2014.09.002; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; LEE E, 1993, ARCH VIROL, V133, P113, DOI 10.1007/BF01309748; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Liu CC, 2002, J MED VIROL, V68, P241, DOI 10.1002/jmv.10198; Low JGH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001191; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Nusa R, 2014, J INFECT DEV COUNTR, V8, P733, DOI 10.3855/jidc.3959; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Ong SH, 2008, INFECT GENET EVOL, V8, P191, DOI 10.1016/j.meegid.2007.12.005; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Richards AL, 1997, AM J TROP MED HYG, V57, P49, DOI 10.4269/ajtmh.1997.57.49; Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; SARASOMBATH S, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P649; Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006; Sasmono RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103815; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SUHARYONO W, 1979, Asian Journal of Infectious Diseases, V3, P27; SUMARMO, 1983, B WORLD HEALTH ORGAN, V61, P693; Sumarmo, 1987, J TROP MED PUBLIC HL, V18, P269; Suroso T., 1998, Dengue Bulletin, V22, P45; Suwandono A, 2006, T ROY SOC TROP MED H, V100, P855, DOI 10.1016/j.trstmh.2005.11.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thai KTD, 2010, J INFECTION, V60, P229, DOI 10.1016/j.jinf.2010.01.003; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Usuku S, 2001, ARCH VIROL, V146, P1381, DOI 10.1007/s007050170098; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; WHO/SEARO, 2011, COMPR GUID PREV CONT; Yacoub S, 2013, CURR OPIN INFECT DIS, V26, P284, DOI 10.1097/QCO.0b013e32835fb938; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322; Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628	71	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178443	10.1371/journal.pone.0178443	http://dx.doi.org/10.1371/journal.pone.0178443			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575000	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000402624300053
J	Xue, YP; Zhang, RG; Deng, YF; Chen, K; Jiang, T				Xue, Yanping; Zhang, Rongguo; Deng, Yufeng; Chen, Kuan; Jiang, Tao			A preliminary examination of the diagnostic value of deep learning in hip osteoarthritis	PLOS ONE			English	Article							DYSPLASIA	Hip Osteoarthritis (OA) is a common disease among the middle-aged and elderly people. Conventionally, hip OA is diagnosed by manually assessing X-ray images. This study took the hip joint as the object of observation and explored the diagnostic value of deep learning in hip osteoarthritis. A deep convolutional neural network (CNN) was trained and tested on 420 hip X-ray images to automatically diagnose hip OA. This CNN model achieved a balance of high sensitivity of 95.0% and high specificity of 90.7%, as well as an accuracy of 92.8% compared to the chief physicians. The CNN model performance is comparable to an attending physician with 10 years of experience. The results of this study indicate that deep learning has promising potential in the field of intelligent medical image diagnosis practice.	[Xue, Yanping; Jiang, Tao] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiol, Beijing, Peoples R China; [Zhang, Rongguo; Deng, Yufeng; Chen, Kuan] Infervision, Beijing, Peoples R China	Capital Medical University	Jiang, T (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiol, Beijing, Peoples R China.; Deng, YF (corresponding author), Infervision, Beijing, Peoples R China.	dyufeng@infervision.com; jiangt8166@hotmail.com	Deng, Yufeng/AAW-5918-2020	Deng, Yufeng/0000-0003-2153-8494	Infervision	Infervision	Infervision provided support in the form of salaries for authors Rongguo Zhang, Yufeng Deng, and Kuan Chen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Banister J., 2010, EC CONSEQUENCES DEMO, P61, DOI [10.7208/9780226386881-005, DOI 10.7208/9780226386881-005]; Conrozier T, 2009, OSTEOARTHR CARTILAGE, V17, P864, DOI 10.1016/j.joca.2008.12.003; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Ertosun Mehmet Gunhan, 2015, AMIA Annu Symp Proc, V2015, P1899; Guermazi A, 2013, RHEUM DIS CLIN N AM, V39, P567, DOI 10.1016/j.rdc.2013.02.001; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kraus OZ, 2016, BIOINFORMATICS, V32, P52, DOI 10.1093/bioinformatics/btw252; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LAU EMC, 1995, ANN RHEUM DIS, V54, P965, DOI 10.1136/ard.54.12.965; Litjens G, 2016, SCI REP-UK, V6, DOI 10.1038/srep26286; Nepple JJ, 2014, AM J SPORT MED, V42, P2393, DOI 10.1177/0363546514542797; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Prasoon A, 2013, LECT NOTES COMPUT SC, V8150, P599; Prieto-Alhambra D, 2014, ANN RHEUM DIS, V73, P1659, DOI 10.1136/annrheumdis-2013-203355; Radcliff K, 2012, SPINE J, V12, pS68, DOI DOI 10.1016/j.spinee.2012.08.198; Roux CH, 2016, JOINT BONE SPINE, V83, P37, DOI 10.1016/j.jbspin.2015.04.013; Rusk N., 2015, NAT METHODS, V13, P35; WANG J, 2016, SCI REP, P1; Wu GR, 2013, LECT NOTES COMPUT SC, V8150, P649, DOI 10.1007/978-3-642-40763-5_80; Yu DH, 2015, RHEUMATOLOGY, V54, P2051, DOI 10.1093/rheumatology/kev231	22	64	73	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178992	10.1371/journal.pone.0178992	http://dx.doi.org/10.1371/journal.pone.0178992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575070	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300142
J	Suleymanova, N; Crudden, C; Shibano, T; Worrall, C; Oprea, I; Tica, A; Calin, GA; Girnita, A; Girnita, L				Suleymanova, N.; Crudden, C.; Shibano, T.; Worrall, C.; Oprea, I.; Tica, A.; Calin, G. A.; Girnita, A.; Girnita, L.			Functional antagonism of beta-arrestin isoforms balance IGF-1R expression and signalling with distinct cancer-related biological outcomes	ONCOGENE			English	Article							FACTOR-I RECEPTOR; PROTEIN-COUPLED RECEPTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; GROWTH-FACTOR RECEPTOR; BIASED AGONISM; INSULIN-LIKE-GROWTH-FACTOR-1 RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; G(BETA-GAMMA) SUBUNITS; PICROPODOPHYLLIN PPP; ADRENERGIC-RECEPTOR	With very similar 3D structures, the widely expressed beta-arrestin isoforms 1 and 2 play at times identical, distinct or even opposing roles in regulating various aspects of G protein-coupled receptors (GPCR) expression and signalling. Recent evidence recognizes the beta-arrestin system as a key regulator of not only GPCRs, but also receptor tyrosine kinases, including the highly cancer relevant insulin-like growth factor type 1 receptor (IGF-1R). Binding of beta-arrestin1 to IGF-1R leads to ligand-dependent degradation of the receptor and generates additional MAPK/ERK signalling, protecting cancer cells against anti-IGF-1R therapy. Because the interplay between beta-arrestin isoforms governs the biological effects for most GPCRs, as yet unexplored for the IGF-1R, we sought to investigate specifically the regulatory roles of the beta-arrestin2 isoform on expression and function of the IGF-1R. Results from controlled expression of either beta-arrestin isoform demonstrate that beta-arrestin2 acts in an opposite manner to beta-arrestin1 by promoting degradation of an unstimulated IGF-1R, but protecting the receptor against agonist-induced degradation. Although both isoforms co-immunoprecipitate with IGF-1R, the ligand-occupied receptor has greater affinity for beta-arrestin1; this association lasts longer, sustains MAPK/ERK signalling and mitigates p53 activation. Conversely, beta-arrestin2 has greater affinity for the ligand-unoccupied receptor; this interaction is transient, triggers receptor ubiquitination and degradation without signalling activation, and leads to a lack of responsiveness to IGF-1, cell cycle arrest and decreased viability of cancer cells. This study reveals contrasting abilities of IGF-1R to interact with each beta-arrestin isoform, depending on the presence of the ligand and demonstrates the antagonism between the two beta-arrestin isoforms in controlling IGF-1R expression and function, which could be developed into a practical anti-IGF-1R strategy for cancer therapy.	[Suleymanova, N.; Crudden, C.; Shibano, T.; Worrall, C.; Oprea, I.; Girnita, A.; Girnita, L.] Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Suleymanova, N.; Crudden, C.; Shibano, T.; Worrall, C.; Oprea, I.; Girnita, A.; Girnita, L.] Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Tica, A.] Univ Med & Pharm Craiova, Dept Pharmacol, Craiova, Romania; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA; [Girnita, A.] Karolinska Univ Hosp, Dermatol Dept, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Medicine & Pharmacy of Craiova; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska University Hospital	Girnita, L (corresponding author), Karolinska Inst, Canc Ctr Karolinska, Dept Oncol & Pathol, S-17176 Stockholm, Sweden.; Girnita, L (corresponding author), Karolinska Univ Hosp, S-17176 Stockholm, Sweden.	Leonard.Girnita@ki.se	Calin, George/E-9390-2011; 柴野, 卓志/AHB-7015-2022; TICA, ANDREI/AAK-8573-2020; Girnita, Ada/AAC-4518-2020; Girnita, Leonard/A-4168-2008; Crudden, Caitrin/Q-5172-2018	Girnita, Leonard/0000-0003-0280-9500; Crudden, Caitrin/0000-0002-7786-112X; TICA, ANDREI ADRIAN/0000-0002-3821-4018; Calin, George/0000-0001-6704-5615; Calin, George/0000-0002-7427-0578	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; Stockholm Cancer Society, Stockholm County; Karolinska Institute; NATIONAL CANCER INSTITUTE [R01CA182905] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; Stockholm Cancer Society, Stockholm County; Karolinska Institute(Karolinska Institutet); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Robert J Lefkowitz and Dr Renato Baserga for generously providing reagents and cell lines. Research support was received from the Swedish Research Council, Swedish Cancer Society, The Swedish Childhood Cancer Foundation, Crown Princess Margareta's Foundation for the Visually Impaired, Welander Finsen Foundation, King Gustaf V Jubilee Foundation, Stockholm Cancer Society, Stockholm County and Karolinska Institute.	Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; BASERGA R, 1995, CANCER RES, V55, P249; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Bowen-Pidgeon D, 2001, MOL PHARMACOL, V59, P1395, DOI 10.1124/mol.59.6.1395; CASTRO J, 1993, CYTOMETRY, V14, P793, DOI 10.1002/cyto.990140712; Conner DA, 1997, CIRC RES, V81, P1021; Crudden C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00064; Crudden C, 2015, GROWTH HORM IGF RES, V25, P2, DOI 10.1016/j.ghir.2014.10.002; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2337, DOI 10.1167/iovs.07-0819; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Girnita L, 2000, CANCER RES, V60, P5278; Girnita L, 2016, PROG MOL BIOL TRANSL, V141, P277, DOI 10.1016/bs.pmbts.2016.04.001; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Gurevich VV, 2013, PROG MOL BIOL TRANSL, V118, P57, DOI 10.1016/B978-0-12-394440-5.00003-6; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Hara MR, 2013, CELL CYCLE, V12, P219, DOI 10.4161/cc.23368; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Hongo A, 1996, ONCOGENE, V12, P1231; Hoshino R, 2001, J BIOL CHEM, V276, P2686, DOI 10.1074/jbc.M006132200; Hupfeld CJ, 2007, ANNU REV PHYSIOL, V69, P561, DOI 10.1146/annurev.physiol.69.022405.154626; Ibrahim IAAEH, 2012, J PHARMACOL SCI, V118, P408, DOI 10.1254/jphs.11R10CP; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Park JY, 2016, ARCH PHARM RES, V39, P293, DOI 10.1007/s12272-016-0712-1; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Sanni SJ, 2010, BRIT J PHARMACOL, V161, P150, DOI 10.1111/j.1476-5381.2010.00875.x; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Worrall C, 2017, ONCOGENE, V36, P3274, DOI 10.1038/onc.2016.472; Zhang MF, 2010, DEV BIOL, V339, P407, DOI 10.1016/j.ydbio.2009.12.042; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P20620, DOI 10.1073/pnas.1216348110; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	70	23	23	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5734	5744		10.1038/onc.2017.179	http://dx.doi.org/10.1038/onc.2017.179			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28581517	hybrid, Green Published			2022-12-26	WOS:000412843900007
J	Oskolkova, O; Gawlak, G; Tian, YF; Ke, YB; Sarich, N; Son, S; Andreasson, K; Bochkov, VN; Birukova, AA; Birukov, KG				Oskolkova, Olga; Gawlak, Grzegorz; Tian, Yufeng; Ke, Yunbo; Sarich, Nicolene; Son, Sophia; Andreasson, Katrin; Bochkov, Valery N.; Birukova, Anna A.; Birukov, Konstantin G.			Prostaglandin E receptor-4 receptor mediates endothelial barrier-enhancing and anti-inflammatory effects of oxidized phospholipids	FASEB JOURNAL			English	Article						acute lung injury; vascular permeability; cytoskeleton	LUNG VASCULAR-PERMEABILITY; SIGNALING PATHWAY; DIFFERENTIAL REGULATION; STAPHYLOCOCCUS-AUREUS; PROTECTIVE RESPONSE; OXIDATION-PRODUCTS; GENE-EXPRESSION; S1P(1) RECEPTOR; EP4 RECEPTORS; KNOCKOUT MICE	Unlike other agonists that cause transient endothelial cell (EC) response, the products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine (PAPC) oxidation that contain cyclopenthenone groups, which recapitulate prostaglandin-like structure, cause sustained enhancement of the pulmonary EC barrier. The mechanisms that drive the sustained effects by oxidized PAPC (OxPAPC) remain unexplored. On the basis of the structural similarity of iso-prostanoid moieties that are present in full-length oxygenated PAPC species, we used an inhibitory approach to perform the screening of prostanoid receptors as potential candidates that mediate OxPAPC effects. Results show that only prostaglandin E receptor-4 (EP4) was involved and mediated the sustained phase of the barrier-enhancing effects of OxPAPC that are associated with the activation of Rac GTPase and its cytoskeletal targets. EC incubation with OxPAPC also induced EP4 mRNA expression in pulmonary ECs and lung tissue. EP4 knockdown using gene-specific small interfering RNA did not affect the rapid phase of OxPAPC-induced EC barrier enhancement or the protective effects against thrombin-induced EC permeability, but abolished the advanced barrier enhancement phase and suppressed the protective effects of OxPAPC against more sustained EC barrier dysfunction and cell inflammatory response caused by TNF-alpha. Endothelial-specific knockout of the EP4 receptor in mice attenuated the protective effect of intravenous OxPAPC administration in the model of acute lung injury caused by intratracheal injection of LPS. Taken together, these results demonstrate a novel role for prostaglandin receptor EP4 in the mediation of barrier-enhancing and anti-inflammatory effects caused by oxidized phospholipids.	[Oskolkova, Olga; Gawlak, Grzegorz; Tian, Yufeng; Ke, Yunbo; Sarich, Nicolene; Son, Sophia; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Sect Pulm & Crit Med, Lung Injury Ctr, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Andreasson, Katrin] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Bochkov, Valery N.] Karl Franzens Univ Graz, Dept Pharmaceut Chem, Graz, Austria; [Ke, Yunbo; Birukova, Anna A.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Birukov, Konstantin G.] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA	University of Chicago; Stanford University; University of Graz; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Birukov, KG (corresponding author), Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA.; Birukov, KG (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, UMSOM Lung Biol Program, 20 Penn St,HSF 2,Room S145, Baltimore, MD 21201 USA.	kbirukov@anes.umm.edu	Birukov, Konstantin/FJB-5755-2022	Oskolkova, Olga/0000-0001-9443-8705	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL076259, HL087823, HL107920, HL130431]; NIH National Institute of General Medical Sciences [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL107920, R01HL076259, R01HL107920, R01HL130431, R01HL087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171, R01GM122940] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL076259, HL087823, HL107920, and HL130431 and NIH National Institute of General Medical Sciences Grant GM114171. The authors thank Mohan Tulapurkar (University of Maryland, Baltimore, MD, USA), for superior technical assistance and analysis of EP4 expression in lung tissue samples.	Alfranca A, 2006, CARDIOVASC RES, V70, P446, DOI 10.1016/j.cardiores.2005.12.020; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, EXP CELL RES, V313, P2504, DOI 10.1016/j.yexcr.2007.03.036; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2015, BBA-MOL BASIS DIS, V1852, P778, DOI 10.1016/j.bbadis.2014.12.016; Birukova AA, 2014, MOL BIOL CELL, V25, P2006, DOI 10.1091/mbc.E13-12-0743; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2013, TRANSL RES, V161, P495, DOI 10.1016/j.trsl.2012.12.008; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bochkov VN, 2002, BLOOD, V99, P199, DOI 10.1182/blood.V99.1.199; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bustos RI, 2008, CURR BIOL, V18, P1606, DOI 10.1016/j.cub.2008.09.019; BUTLER BD, 1989, AM J PHYSIOL, V257, pH1466, DOI 10.1152/ajpheart.1989.257.5.H1466; Cole AL, 2003, ARTERIOSCL THROM VAS, V23, P1384, DOI 10.1161/01.ATV.0000081215.45714.71; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Dudek SM, 2004, J BIOL CHEM, V279, P24692, DOI 10.1074/jbc.M313969200; Erridge C, 2008, J BIOL CHEM, V283, P24748, DOI 10.1074/jbc.M800352200; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Goolaerts A, 2011, THORAX, V66, P788, DOI 10.1136/thx.2010.155788; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Harding P, 2010, AM J PHYSIOL-HEART C, V298, pH623, DOI 10.1152/ajpheart.00746.2009; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; HOCKING DC, 1990, CIRC RES, V67, P68, DOI 10.1161/01.RES.67.1.68; Jacobson JR, 2006, AM J PHYSIOL-LUNG C, V291, pL289, DOI 10.1152/ajplung.00343.2005; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Khakpour S, 2015, INNATE IMMUN-LONDON, V21, P827, DOI 10.1177/1753425915606525; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Konya V, 2015, BRIT J PHARMACOL, V172, P4454, DOI 10.1111/bph.13229; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Legler DF, 2006, J IMMUNOL, V176, P966, DOI 10.4049/jimmunol.176.2.966; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Li M, 2005, BONE, V37, P46, DOI 10.1016/j.bone.2005.03.016; Li RS, 2006, CIRC RES, V98, P642, DOI 10.1161/01.RES.0000207394.39249.fc; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Lorenowicz MJ, 2008, EUR J CELL BIOL, V87, P779, DOI 10.1016/j.ejcb.2008.05.004; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma Z, 2004, AM J PHYSIOL-LUNG C, V286, pL808, DOI 10.1152/ajplung.00220.2003; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Meliton AY, 2015, AM J PHYSIOL-LUNG C, V308, pL550, DOI 10.1152/ajplung.00248.2014; Metrich M, 2010, PFLUG ARCH EUR J PHY, V459, P535, DOI 10.1007/s00424-009-0747-y; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Munoz Nilda M, 2012, Pulm Circ, V2, P182, DOI 10.4103/2045-8932.97604; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ratcliffe MJ, 2007, EUR RESPIR J, V29, P986, DOI 10.1183/09031936.00131606; REGAN JW, 1994, MOL PHARMACOL, V46, P213; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Tauseef M, 2008, CIRC RES, V103, P1164, DOI 10.1161/01.RES.0000338501.84810.51; Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377; Vallerie SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158316; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wu TH, 2013, TRANSL RES, V162, P45, DOI 10.1016/j.trsl.2013.03.005; Yagami T, 2016, MOL NEUROBIOL, V53, P4754, DOI 10.1007/s12035-015-9355-3; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195	74	10	11	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4187	4202		10.1096/fj.201601232RR	http://dx.doi.org/10.1096/fj.201601232RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572443	Green Published			2022-12-26	WOS:000408713300040
J	Eren, E; Berber, M; Ozoren, N				Eren, Elif; Berber, Mesut; Ozoren, Nesrin			NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; caspase 1 (CASP1); inflammasome; NLRP3; pathogen-associated molecular pattern (PAMP); ASC; NLRC3; inhibition; sterile inflammation	NF-KAPPA-B; COLD AUTOINFLAMMATORY SYNDROME; MUCKLE-WELLS-SYNDROME; NLRP3 INFLAMMASOME; ACTIVATION; CASPASE-1; CRYOPYRIN; RECOGNITION; ANTAGONIST; CRYSTALS	Inflammasomes are multiprotein complexes that sense pathogen-associated and danger-associated molecular patterns and induce inflammation in cells. The NALP3 inflammasome is tightly regulated by recently discovered control mechanisms, but other modulators still remain to be characterized. NLR family CARD-containing 3 (NLRC3) protein, a caspase recruitment domain (CARD)-containing member of the nucleotide oligomerization domain-like receptor (NLR) family, was found to down-regulate the NF-B pathway and stimulator of interferon genes (STING)-dependent cytokine secretion. However, the effect of NLRC3 on the NALP3 inflammasome or other inflammasomes is still unknown. We hypothesized that NLRC3 might inhibit NALP3 inflammasome complex assembly. Toward this end, we tested whether NLRC3 overexpression or knockdown influences NALP3 activity in human monocyte and HEK293FT cells when the complex is ectopically reconstituted. We found that NLRC3 indeed decreases NALP3-induced IL-1 maturation and secretion, pro-caspase-1 cleavage, and speck formation by apoptosis-associated speck-like protein containing a CARD (ASC) protein in response to NALP3 activators. We also show that endogenous NLRC3 interacts with both ASC and pro-caspase-1 but not with NALP3, disrupts ASC speck formation through its CARD, and impairs the ASC and pro-caspase-1 interaction. Moreover, the NLRC3 CARD alone could dampen IL-1 secretion and ASC speck formation induced by NALP3 mutants associated with autoinflammatory diseases. In conclusion, we show here that, besides its role in the inhibition of the NF-B pathway, NLRC3 interferes with the assembly and activity of the NALP3 inflammasome complex by competing with ASC for pro-caspase-1 binding.	[Eren, Elif; Berber, Mesut; Ozoren, Nesrin] Bogazici Univ, Apoptosis & Canc Immunol Lab AKIL, Dept Mol Biol & Genet, TR-34342 Bebek, Turkey; [Eren, Elif; Berber, Mesut; Ozoren, Nesrin] Bogazici Univ, Ctr Life Sci & Technol, TR-34342 Bebek, Turkey	Bogazici University; Bogazici University	Ozoren, N (corresponding author), Bogazici Univ, Dept Mol Biol & Genet, Kuzey Kampus Kuzey Pk Binasi, TR-34342 Istanbul, Turkey.	nesrin.ozoren@boun.edu.tr	EREN, Elif/AAO-2054-2020; Ozoren, Nesrin/AAS-3279-2020; Eren, Elif/A-6057-2016	EREN, Elif/0000-0002-0328-5609; OZOREN, NESRIN/0000-0002-8580-618X; Berber, Mesut/0000-0003-2157-2158	EMBO-SDIG [1468]; Bogazici University [BAP 6526 (11B01D10), BAP 7360 (13B01M3)]	EMBO-SDIG; Bogazici University(Bogazici University)	This work was supported by EMBO-SDIG 1468 and Bogazici University Research Fund Projects BAP 6526 (11B01D10) and BAP 7360 (13B01M3) (to N. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Gultekin Y, 2015, J INNATE IMMUN, V7, P25, DOI 10.1159/000363602; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Narayanan KB, 2015, APPL BIOCHEM BIOTECH, V175, P2883, DOI 10.1007/s12010-014-1471-4; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Schmidt FI, 2016, J EXP MED, V213, P771, DOI 10.1084/jem.20151790; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stack JH, 2005, J IMMUNOL, V175, P2630, DOI 10.4049/jimmunol.175.4.2630; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	32	25	26	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12691	12701		10.1074/jbc.M116.769695	http://dx.doi.org/10.1074/jbc.M116.769695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584053	Green Published, hybrid			2022-12-26	WOS:000406636900032
J	Iizuka-Hishikawa, Y; Hishikawa, D; Sasaki, J; Takubo, K; Goto, M; Nagata, K; Nakanishi, H; Shindou, H; Okamura, T; Ito, C; Toshimori, K; Sasaki, T; Shimizu, T				Iizuka-Hishikawa, Yoshiko; Hishikawa, Daisuke; Sasaki, Junko; Takubo, Keiyo; Goto, Motohito; Nagata, Katsuyuki; Nakanishi, Hiroki; Shindou, Hideo; Okamura, Tadashi; Ito, Chizuru; Toshimori, Kiyotaka; Sasaki, Takehiko; Shimizu, Takao			Lysophosphatidic acid acyltransferase 3 tunes the membrane status of germ cells by incorporating docosahexaenoic acid during spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SEMEN QUALITY; MALE REPRODUCTION; LIPID MEDIATORS; PLASMA; SPERM; GLYCEROPHOSPHOLIPIDS; DEFICIENCY; FERTILITY; NUTRITION	Docosahexaenoic acid (DHA) is one of the essential omega-3 polyunsaturated fatty acids with a wide range of physiological roles important for human health. For example, DHA renders cell membranes more flexible and is therefore important for cellular function, but information on the mechanisms that control DHA levels in membranes is limited. Specifically, it is unclear which factors determine DHA incorporation into cell membranes and how DHA exerts biological effects. We found that lysophosphatidic acid acyltransferase 3 (LPAAT3) is required for producing DHA-containing phospholipids in various tissues, such as the testes and retina. In this study, we report that LPAAT3-KO mice display severe male infertility with abnormal sperm morphology. During germ cell differentiation, the expression of LPAAT3 was induced, and germ cells obtained more DHA-containing phospholipids. Loss of LPAAT3 caused drastic reduction of DHA-containing phospholipids in spermatids that led to excess cytoplasm around its head, which is normally removed by surrounding Sertoli cells via endocytosis at the final stage of spermatogenesis. In vitro liposome filtration assay raised the possibility that DHA in phospholipids promotes membrane deformation that is required for the rapid endocytosis. These data suggest that decreased membrane flexibility in LPAAT3KO sperm impaired the efficient removal of sperm content through endocytosis. We conclude that LPAAT3-mediated enrichment of cell membranes with DHA-containing phospholipids endows these membranes with physicochemical properties needed for normal cellular processes, as exemplified by spermatogenesis.	[Iizuka-Hishikawa, Yoshiko; Hishikawa, Daisuke; Nagata, Katsuyuki; Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo 1628655, Japan; [Sasaki, Junko; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Takubo, Keiyo] Natl Ctr Global Hlth & Med, Dept Stem Cell Biol, Shinjuku Ku, Tokyo 1628655, Japan; [Goto, Motohito; Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Lab Anim Med, Shinjuku Ku, Tokyo 1628655, Japan; [Nakanishi, Hiroki] Akita Univ, Res Ctr Biosignal, Akita 0108543, Japan; [Okamura, Tadashi] Natl Ctr Global Hlth & Med, Dept Infect Dis, Sect Anim Models, Shinjuku Ku, Tokyo 1628655, Japan; [Ito, Chizuru; Toshimori, Kiyotaka] Chiba Univ, Grad Sch Med, Dept Reprod Biol & Med, Chiba 2608670, Japan; [Toshimori, Kiyotaka] Chiba Univ, Future Med Res Ctr, Chiba 2608670, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Takubo, Keiyo; Shindou, Hideo; Sasaki, Takehiko] Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo 1000004, Japan; [Goto, Motohito] Cent Inst Expt Anim, Anim Resources & Tech Res Ctr, Anim Resource Dev Lab, Kawasaki, Kanagawa 2100821, Japan	National Center for Global Health & Medicine - Japan; Akita University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Akita University; National Center for Global Health & Medicine - Japan; Chiba University; Chiba University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Hishikawa, D; Shimizu, T (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	dhishikawa@ri.ncgm.go.jp; tshimizu@ri.ncgm.go.jp	Takubo, Keiyo/AAX-5546-2020; Shimizu, Takao/AAV-7052-2021	Takubo, Keiyo/0000-0002-1736-7592; Sasaki, Takehiko/0000-0003-1837-3748; Ito, Chizuru/0000-0003-2697-0382; yuan ren, hou teng/0000-0001-6288-4583; Nakanishi, Hiroki/0000-0002-5108-1598	MEXT/JSPS KAKENHI [24229003, 26115005, 15K10638, 26253006, 26460380, 15H05899]; NCGM [26-001, 26A105]; JST-CREST; AMED-CREST; Takeda Science Foundation; Grants-in-Aid for Scientific Research [17K19375, 15H05897] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NCGM; JST-CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); AMED-CREST; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grants 24229003 (to T. Shimizu), 26115005 (to K. Takubo), 15K10638 (to C.I.), 26253006 and 26460380 (to H.S.), and 15H05899 (to T. Sasaki); NCGM Grants 26-001 (to K. Takubo) and 26A105 (to T.O.); JST-CREST (to H.S. and T. Sasaki); AMED-CREST (to H.S., T. Sasaki, and K. Takubo); and Takeda Science Foundation (to T. Shimizu). The authors declare that they have no conflicts of interest with the contents of this article.	Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Barelli H, 2016, CURR OPIN CELL BIOL, V41, P25, DOI 10.1016/j.ceb.2016.03.012; Bernhard K, 1940, J BIOL CHEM, V133, P707; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasky TM, 2013, JNCI-J NATL CANCER I, V105, P1132, DOI 10.1093/jnci/djt174; Burr G, 1932, J BIOL CHEM, V97, P1; Chavarro JE, 2014, HUM REPROD, V29, P429, DOI 10.1093/humrep/det464; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Esmaeili V, 2015, ANDROLOGY-US, V3, P450, DOI 10.1111/andr.12024; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208; Gulaya NM, 2001, ARCH ANDROLOGY, V46, P169; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Jensen TK, 2013, AM J CLIN NUTR, V97, P411, DOI 10.3945/ajcn.112.042432; Kidd PM, 2007, ALTERN MED REV, V12, P207; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Lenzi A, 1996, HUM REPROD UPDATE, V2, P246, DOI 10.1093/humupd/2.3.246; MAYSHOOPES LL, 1995, BIOL REPROD, V53, P1003, DOI 10.1095/biolreprod53.5.1003; Micallef M, 2009, BRIT J NUTR, V102, P1370, DOI 10.1017/S0007114509382173; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ogiso H, 2014, METABOLITES, V4, P98, DOI 10.3390/metabo4010098; Palmer Nicole O, 2012, Spermatogenesis, V2, P253; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Rice DS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7228; Roach C, 2004, BIOCHEMISTRY-US, V43, P6344, DOI 10.1021/bi049917r; Roqueta-Rivera M, 2011, BIOL REPROD, V85, P721, DOI 10.1095/biolreprod.110.089524; Roqueta-Rivera M, 2010, J LIPID RES, V51, P360, DOI 10.1194/jlr.M001180; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Spector AA, 2015, J LIPID RES, V56, P11, DOI 10.1194/jlr.R055095; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Stroud CK, 2009, J LIPID RES, V50, P1870, DOI 10.1194/jlr.M900039-JLR200; Teerds KJ, 2011, HUM REPROD UPDATE, V17, P667, DOI 10.1093/humupd/dmr017; Uauy R, 2006, NUTR REV, V64, pS24, DOI 10.1301/nr.2006.may.S24-S33; Wang S, 2016, STEM CELL REP, V7, P80, DOI 10.1016/j.stemcr.2016.05.013; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yuki K, 2009, J LIPID RES, V50, P860, DOI 10.1194/jlr.M800468-JLR200	49	36	37	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12065	12076		10.1074/jbc.M117.791277	http://dx.doi.org/10.1074/jbc.M117.791277			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28578315	Green Published, hybrid			2022-12-26	WOS:000406053300006
J	Prato, G; Thiriet, P; Di Franco, A; Francour, P				Prato, Giulia; Thiriet, Pierre; Di Franco, Antonio; Francour, Patrice			Enhancing fish Underwater Visual Census to move forward assessment of fish assemblages: An application in three Mediterranean Marine Protected Areas	PLOS ONE			English	Article							COASTAL LAGOON; DENSITY; SIZE; OBSERVERS; HABITATS; TRANSECT; RESERVES; ECOLOGY; COUNTS	Monitoring fish assemblages is needed to assess whether Marine Protected Areas (MPAs) are meeting their conservation and fisheries management goals, as it allows one to track the progress of recovery of exploited species and associated communities. Underwater Visual Census techniques (UVC) are used to monitor fish assemblages in MPAs. UVCs should be adapted to fish abundance, body-size and behaviour, which can strongly affect fish detectability. In Mediterranean subtidal habitats, however, UVC strip transects of one surface area (25x5 m(2)) are commonly used to survey the whole fish assemblage, from large shy fish to small crypto-benthic fish. Most high trophic level predators (HTLPs) are large shy fish which rarely swim close to divers and, consequently, their abundance may be under-estimated with commonly used transects. Here, we propose an improvement to traditional transect surveys to better account for differences in behaviour among and within species. First, we compared the effectiveness of combining two transect surface areas (large: 35x20 m(2); medium: 25x5 m(2)) in quantifying large, shy fish within and outside Mediterranean MPAs. We identified species-specific body-size thresholds defining a smaller and a larger size class better sampled by medium and large transects respectively. Combining large and medium transects provided more accurate biomass and species richness estimates for large, shy species than using medium transects alone. We thus combined the new approach with two other transect surface areas commonly used to survey crypto-benthic (10x1 m(2)) and necto-benthic (25x5 m(2)) species in order to assess how effectively MPAs protection the whole fish assemblage. We verified that MPAs offer significant protection for HTLPs, their response in terms of biomass and density increase in MPAs was always higher in magnitude than other functional groups. Inside MPAs, the contribution of HTLP reached >25% of total fish biomass, against <2% outside MPAs. Surveys with multiple transect surface areas allow for a more realistic assessment of the structure of the whole fish assemblage and better assessment of potential recovery of HTLPs within reserves of HTLP.	[Prato, Giulia; Thiriet, Pierre; Di Franco, Antonio; Francour, Patrice] Univ Cote Azur, CNRS, FRE ECOMERS 3729, Parc Valrose,Ave Valrose, Nice, France; [Thiriet, Pierre] UPMC, CNRS, UMR BOREA MNHN 7208, IRD 207,UCN,UA Museum Natl Hist Nat,DMPA,UMR BORE, Paris, France; [Thiriet, Pierre] Museum Nacl Hist Nat, Stn Marine Dinard CRESCO, Dinard, France; [Di Franco, Antonio] Univ Perpignan, CNRS, CRIOBE, USR CNRS EPHE 3278, Perpignan, France; [Di Franco, Antonio] Consorzio Interuniv Sci Mare, CoNISMa, Piazzale Flaminio 9, Rome, Italy; [Prato, Giulia] World Wide Fund Nat WWF Italia, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; CoNISMa	Prato, G (corresponding author), Univ Cote Azur, CNRS, FRE ECOMERS 3729, Parc Valrose,Ave Valrose, Nice, France.; Prato, G (corresponding author), World Wide Fund Nat WWF Italia, Rome, Italy.	giuliaprato.mi@gmail.com	; Di Franco, Antonio/A-8796-2010	THIRIET, Pierre, Daniel/0000-0002-5254-5948; Di Franco, Antonio/0000-0003-3411-7015	MMMPA - Training Network for Monitoring Mediterranean Marine Protected Areas; European Community's Seventh Framework Programme (FP7) [290056]	MMMPA - Training Network for Monitoring Mediterranean Marine Protected Areas; European Community's Seventh Framework Programme (FP7)(European Commission)	GP was funded by MMMPA - Training Network for Monitoring Mediterranean Marine Protected Areas, which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no. 290056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge Paolo Guidetti for the support provided during the development of the study. Special thanks to Pier Panzalis, Jose Antonio Garcia Charton, Emna Ben Lamine and the Porto San Paolo Dive Center for invaluable assistance during field work. The authors also wish to thank Augusto Navone (director of the Tavolara-Punta Coda Cavallo MPA) and his staff, and Jean-Marie Dominici (Scandola natural reserve) for helpful assistance. The present study was supported by the MMMPA - Training Network for Monitoring Mediterranean Marine Protected Areas, which has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no.290056. The authors wish to thank two anonymous reviewers and Prof. Carlotta Mazzoldi (University of Padua, Italy) for their useful comments which have helped us to significantly improve the manuscript.	Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; De Girolamo M, 2001, MAR ENVIRON RES, V51, P1, DOI 10.1016/S0141-1136(00)00028-3; Di Franco A, 2013, J SEA RES, V76, P73, DOI 10.1016/j.seares.2012.11.006; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Franco A, 2012, ESTUAR COAST SHELF S, V112, P115, DOI 10.1016/j.ecss.2011.08.015; Francour P, 2001, AQUAT CONSERV, V11, P155, DOI 10.1002/aqc.442; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, CONSERV BIOL, V21, P540, DOI 10.1111/j.1523-1739.2007.00657.x; Guidetti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091841; Halford A. R., 1994, VISUAL CENSUS SURVEY; Harmelin JG, 1995, MAR ECOL-P S Z N I, V16, P233, DOI 10.1111/j.1439-0485.1995.tb00408.x; Harmelin-Vivien M., 1975, Travaux Scientifiques du Parc National de Port-Cros, V1, P47; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Hothorn T, 2008, J STAT SOFTW, V28, P1; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Kovacic M, 2012, MAR BIOL, V159, P2731, DOI 10.1007/s00227-012-2030-6; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mapstone BD, 1998, GREAT BARRIER REEF M; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Minte-Vera CV, 2008, MAR ECOL PROG SER, V367, P283, DOI 10.3354/meps07511; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Pelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030536; Perez-Ruzafa A, 2006, MAR POLLUT BULL, V53, P107, DOI 10.1016/j.marpolbul.2005.09.014; PETERS RH, 1983, OECOLOGIA, V60, P89, DOI 10.1007/BF00379325; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; R Core Team, 2021, R LANGUAGE ENV STAT; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; SALE PF, 1981, ENVIRON BIOL FISH, V6, P333, DOI 10.1007/BF00005761; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SHORT J, 1985, J APPL ECOL, V22, P415, DOI 10.2307/2403174; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Soler GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140270; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Tessier A, 2013, AQUAT BIOL, V18, P229, DOI 10.3354/ab00506; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Hackradt CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098206; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721	53	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178511	10.1371/journal.pone.0178511	http://dx.doi.org/10.1371/journal.pone.0178511			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594836	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200036
J	Sasaki, T; Mita, M; Ikari, N; Kuboyama, A; Hashimoto, S; Kaneko, T; Ishiguro, M; Shimizu, M; Inoue, J; Sato, R				Sasaki, Takashi; Mita, Moeko; Ikari, Naho; Kuboyama, Ayane; Hashimoto, Shuzo; Kaneko, Tatsuya; Ishiguro, Masaji; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro			Identification of key amino acid residues in the hTGR5-nomilin interaction and construction of its binding model	PLOS ONE			English	Article							BILE-ACIDS; TGR5 AGONISTS; MEMBRANE-RECEPTOR; SITE; ACTIVATION; DESIGN; MICE; FXR	TGR5, a member of the G protein-coupled receptor (GPCR) family, is activated by bile acids. Because TGR5 promotes energy expenditure and improves glucose homeostasis, it is recognized as a key target in treating metabolic diseases. We previously showed that nomilin, a citrus limonoid, activates TGR5 and confers anti-obesity and anti-hyperglycemic effects in mice. Information on the TGR5-nomilin interaction regarding molecular structure, however, has not been reported. In the present study, we found that human TGR5 (hTGR5) shows higher nomilin responsiveness than does mouse TGR5 (mTGR5). Using mouse-human chimeric TGR5, we also found that three amino acid residues (Q77(ECL1), R80(ECL1), and Y89(3.29)) are important in the hTGR5-nomilin interaction. Based on these results, an hTGR5-nomilin binding model was constructed using in silico docking simulation, demonstrating that four hydrophilic hydrogen-bonding interactions occur between nomilin and hTGR5. The binding mode of hTGR5-nomilin is vastly different from those of other TGR5 agonists previously reported, suggesting that TGR5 forms various binding patterns depending on the type of agonist. Our study promotes a better understanding of the structure of TGR5, and it may be useful in developing and screening new TGR5 agonists.	[Sasaki, Takashi; Mita, Moeko; Ikari, Naho; Kuboyama, Ayane; Hashimoto, Shuzo; Kaneko, Tatsuya; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan; [Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata, Japan; [Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Niigata University; University of Tokyo	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan.; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo, Japan.; Sato, R (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp		Sasaki, Takashi/0000-0002-3352-0753	Ministry of Education, Culture, Sports, Science and Technology of Japan [15H05781, 16K18699]; Cross-ministerial Strategic Innovation Promotion Program [14533567]; Japanese Agency for Medical Research and Development (AMED-CREST) [16gm0910008h0001]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cross-ministerial Strategic Innovation Promotion Program; Japanese Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED))	This study was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 15H05781 to R.S., No. 16K18699 to T.S.), the Cross-ministerial Strategic Innovation Promotion Program (No. 14533567 to R.S.), and the Japanese Agency for Medical Research and Development (AMED-CREST, No. 16gm0910008h0001 to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuzawa N, 2007, J BIOCHEM, V141, P907, DOI 10.1093/jb/mvm100; Briere DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136873; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Cao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28676; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Di Leva FS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16605; Ding LL, 2016, HEPATOLOGY, V64, P760, DOI 10.1002/hep.28689; Duboc H, 2014, DIGEST LIVER DIS, V46, P302, DOI 10.1016/j.dld.2013.10.021; Finamore C, 2016, SCI REP-UK, V6, DOI 10.1038/srep29320; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Gertzen CGW, 2015, EUR J MED CHEM, V104, P57, DOI 10.1016/j.ejmech.2015.09.024; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Horiba T, 2015, BIOCHEM BIOPH RES CO, V463, P846, DOI 10.1016/j.bbrc.2015.06.022; Ishiguro M, 2004, CHEMBIOCHEM, V5, P298, DOI 10.1002/cbic.200300668; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Macchiarulo A, 2013, ACS MED CHEM LETT, V4, P1158, DOI 10.1021/ml400247k; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McGavigan A.K., 2015, GUT; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Sakurai T, 2010, J BIOL CHEM, V285, P28373, DOI 10.1074/jbc.M110.144444; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Sindhu T, 2015, MOL BIOSYST, V11, P1305, DOI 10.1039/c5mb00137d; Taoka H, 2016, WORLD J DIABETES, V7, P260, DOI 10.4239/wjd.v7.i13.260; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; van Nierop FS, 2016, LANCET DIABETES ENDO; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zhu JJ, 2013, CHEMMEDCHEM, V8, P1210, DOI 10.1002/cmdc.201300144	31	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179226	10.1371/journal.pone.0179226	http://dx.doi.org/10.1371/journal.pone.0179226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594916	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200106
J	Roxo, FF; Lujan, NK; Tagliacollo, VA; Waltz, BT; Silva, GSC; Oliveira, C; Albert, JS				Roxo, Fabio F.; Lujan, Nathan K.; Tagliacollo, Victor A.; Waltz, Brandon T.; Silva, Gabriel S. C.; Oliveira, Claudio; Albert, James S.			Shift from slow- to fast-water habitats accelerates lineage and phenotype evolution in a clade of Neotropical suckermouth catfishes (Loricariidae: Hypoptopomatinae)	PLOS ONE			English	Article							MORPHOLOGICAL DIVERSIFICATION; ADAPTIVE RADIATION; R PACKAGE; DIVERSITY; FISHES; TELEOSTEI; SELECTION; ISLAND; CONGO; SIZE	Identifying habitat characteristics that accelerate organismal evolution is essential to understanding both the origins of life on Earth and the ecosystem properties that are most critical to maintaining life into the future. Searching for these characteristics on a large scale has only recently become possible via advances in phylogenetic reconstruction, time-calibration, and comparative analyses. In this study, we combine these tools with habitat and phenotype data for 105 species in a clade of Neotropical suckermouth catfishes commonly known as cascudinhos. Our goal was to determine whether riverine mesohabitats defined by different flow rates (i.e., pools vs. rapids) and substrates (plants vs. rocks) have affected rates of cascudinho cladogenesis and morphological diversification. In contrast to predictions based on general theory related to life in fast-flowing, rocky riverine habitats, Neoplecostomini lineages associated with these habitats exhibited increased body size, head shape diversity, and lineage and phenotype diversification rates. These findings are consistent with a growing understanding of river rapids as incubators of biological diversification and specialization. They also highlight the urgent need to conserve rapids habitats throughout the major rivers of the world.	[Roxo, Fabio F.; Silva, Gabriel S. C.; Oliveira, Claudio] Univ Estadual Paulista, UNESP, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Lujan, Nathan K.] Univ Toronto Scarborough, Dept Biol, Toronto, ON, Canada; [Tagliacollo, Victor A.] Univ Fed Tocantins, Programa Ciencias Ambiente CIAMB, Palmas, TO, Brazil; [Waltz, Brandon T.; Albert, James S.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	Universidade Estadual Paulista; University of Toronto; University Toronto Scarborough; Universidade Federal do Tocantins (UFT); University of Louisiana Lafayette	Roxo, FF (corresponding author), Univ Estadual Paulista, UNESP, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil.	roxoff@hotmail.com.br	Tagliacollo, Victor A/C-9798-2012; Oliveira, Claudio/D-7713-2012	Tagliacollo, Victor A/0000-0003-1493-9409; Oliveira, Claudio/0000-0002-7010-8880; de Souza da Costa e Silva, Gabriel/0000-0002-9843-3175	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/05051-5, 2015/00691-9, 2012/01622-2]; Brazilian agency MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (Edital Universal) [441347/2014-2]; United States National Science Foundation [DEB 0614334, 0741450, 1354511]; Canadian Department of Fisheries and Oceans; Direct For Biological Sciences [1354511] Funding Source: National Science Foundation	Brazilian agency FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (Edital Universal)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United States National Science Foundation(National Science Foundation (NSF)); Canadian Department of Fisheries and Oceans; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Brazilian agencies FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, proc. 2014/05051-5 and 2015/00691-9 to FFR and proc. 2012/01622-2 to GSCS), MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (Edital Universal, proc. N. 441347/2014-2 coord. FFR), the United States National Science Foundation (DEB 0614334, 0741450 and 1354511) to JSA, and salary support to NKL from the Canadian Department of Fisheries and Oceans.; This research was supported by the Brazilian agencies FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, proc. 2014/05051-5 and 2015/00691-9 to FFR and proc. 2012/01622-2 to GSCS), MCT/CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (Edital Universal, proc. N. 441347/2014-2 coord. FFR), the United States National Science Foundation (DEB 0614334,0741450 and 1354511) to JSA, and salary support to NKL from the Canadian Department of Fisheries and Oceans.	Albert JS, 2012, EVOL BIOL, V39, P324, DOI 10.1007/s11692-011-9149-0; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Alter SE, 2017, MOL ECOLOGY IN PRESS; ARMBRUSTER J.W., 2003, ZOOTAXA, V344, P1, DOI DOI 10.11646/ZOOTAXA.344.1.1; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Betancur R, 2013, ECOL LETT, V15, P822; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; CG Winemiller, 2010, ECOL FRESHW FISH, V19, P216; Chiachio MC, 2008, MOL PHYLOGENET EVOL, V49, P606, DOI 10.1016/j.ympev.2008.08.013; Collar DC, 2010, J EVOLUTION BIOL, V23, P1033, DOI 10.1111/j.1420-9101.2010.01971.x; Conway KW, 2012, J MORPHOL, V273, P1127, DOI 10.1002/jmor.20049; Crampton WGR, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P165; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Fitzgerald DB, 2017, FUNCTIONAL ECOLOGY; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Geerinckx T, 2007, BELG J ZOOL, V137, P47; Goswami A, 2015, P NATL ACAD SCI USA, V112, P4891, DOI 10.1073/pnas.1403667112; HAMMER O, 2004, PAST PALEONTOLOGICAL; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hollingsworth PR, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-272; Hou ZE, 2011, P NATL ACAD SCI USA, V108, P14533, DOI 10.1073/pnas.1104636108; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; LAVIN PA, 1993, CAN J ZOOL, V71, P11, DOI 10.1139/z93-003; LIEM KF, 1975, AM ZOOL, V15, P427; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lujan NK, 2015, MOL PHYLOGENET EVOL, V82, P269, DOI 10.1016/j.ympev.2014.08.020; Lujan NK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-124; Lujan NK, 2011, FUNCT ECOL, V25, P1327, DOI 10.1111/j.1365-2435.2011.01883.x; Lujan NK., 2015, EXTREMOPHILE FISHES, P107, DOI DOI 10.1007/978-3-319-13362-1_6; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; Lundberg JG, 2007, P ACAD NAT SCI PHILA, V156, P39, DOI 10.1635/0097-3157(2007)156[39:DOARFT]2.0.CO;2; Markert JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-149; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Rabosky D. L., 2013, NATURE COMMUNICATION, V6, P4; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2014, SYST BIOL; Rambaut A, 2007, TREEANNOTATOR V1 7 5; Rambaut A, 2007, TRACERV1 5; Reis RE., 2003, CLOFFSCA CHECK LIST; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rieseberg LH, 2002, P NATL ACAD SCI USA, V99, P12242, DOI 10.1073/pnas.192360899; Roxo FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105564; Santini F, 2013, J EVOLUTION BIOL, V26, P1003, DOI 10.1111/jeb.12112; SCHLOSSER IJ, 1987, ECOLOGY, V68, P651, DOI 10.2307/1938470; Sidlauskas B, 2008, EVOLUTION, V62, P3135, DOI 10.1111/j.1558-5646.2008.00519.x; Steele SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106336; Stepien CA., 2015, BIOL CULTURE PERCID, P3; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Wellborn GA, 2008, MOL ECOL, V17, P2927, DOI 10.1111/j.1365-294X.2008.03805.x; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; WINEMILLER KO, 1995, ENVIRON BIOL FISH, V44, P235, DOI 10.1007/BF00005919; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217	61	21	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178240	10.1371/journal.pone.0178240	http://dx.doi.org/10.1371/journal.pone.0178240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591189	gold, Green Submitted, Green Published			2022-12-26	WOS:000402880700026
J	Thapa, K; Wikramanayake, E; Malla, S; Acharya, KP; Lamichhane, BR; Subedi, N; Pokharel, CP; Thapa, GJ; Dhakal, M; Bista, A; Borah, J; Gupta, M; Maurya, KK; Gurung, GS; Jnawali, SR; Pradhan, NMB; Bhata, SR; Koirala, S; Ghose, D; Vattakaven, J				Thapa, Kanchan; Wikramanayake, Eric; Malla, Sabita; Acharya, Krishna Prasad; Lamichhane, Babu Ram; Subedi, Naresh; Pokharel, Chiranjivi Prasad; Thapa, Gokarna Jung; Dhakal, Maheshwar; Bista, Ashish; Borah, Jimmy; Gupta, Mudit; Maurya, Kamlesh K.; Gurung, Ghana Shyam; Jnawali, Shant Raj; Pradhan, Narendra Man Babu; Bhata, Shiv Raj; Koirala, Saroj; Ghose, Dipankar; Vattakaven, Joseph			Tigers in the Terai: Strong evidence for meta-population dynamics contributing to tiger recovery and conservation in the Terai Arc Landscape	PLOS ONE			English	Article							GENE FLOW; CARNIVORE; DISPERSAL; PATTERNS	The source populations of tigers are mostly confined to protected areas, which are now becoming isolated. A landscape scale conservation strategy should strive to facilitate dispersal and survival of dispersing tigers by managing habitat corridors that enable tigers to traverse the matrix with minimal conflict. We present evidence for tiger dispersal along transboundary protected areas complexes in the Terai Arc Landscape, a priority tiger landscape in Nepal and India, by comparing camera trap data, and through population models applied to the long term camera trap data sets. The former showed that 11 individual tigers used the corridors that connected the transboundary protected areas. The estimated population growth rates using the minimum observed population size in two protected areas in Nepal, Bardia National Park and Suklaphanta National Park showed that the increases were higher than expected from growth rates due to in situ reproduction alone. These lines of evidence suggests that tigers are recolonizing Nepal's protected areas from India, after a period of population decline, and that the tiger populations in the transboundary protected areas complexes may be maintained as meta-population. Our results demonstrate the importance of adopting a landscape-scale approach to tiger conservation, especially to improve population recovery and long term population persistence.	[Thapa, Kanchan; Wikramanayake, Eric; Malla, Sabita; Thapa, Gokarna Jung; Gurung, Ghana Shyam; Jnawali, Shant Raj; Pradhan, Narendra Man Babu; Bhata, Shiv Raj; Koirala, Saroj] WWF Nepal, Kathmandu, Nepal; [Acharya, Krishna Prasad] Dept Forest, Kathmandu, Nepal; [Lamichhane, Babu Ram; Subedi, Naresh; Pokharel, Chiranjivi Prasad] Natl Trust Nat Conservat, Lalitpur, Nepal; [Dhakal, Maheshwar] Dept Natl Pk & Wildlife Conservat, Kathmandu, Nepal; [Bista, Ashish; Borah, Jimmy; Gupta, Mudit; Maurya, Kamlesh K.; Ghose, Dipankar] WWF India, New Delhi, India; [Vattakaven, Joseph] WWF Tigers Alive, New Delhi, India; [Dhakal, Maheshwar] Minist Forest & Soil Conservat, Environm Div, Kathmandu, Nepal; [Pradhan, Narendra Man Babu] Bird Conservat Nepal, Kathmandu, Nepal	World Wildlife Fund; World Wildlife Fund	Thapa, K (corresponding author), WWF Nepal, Kathmandu, Nepal.	kanchan.thapa@wwfnepal.org	Lamichhane, Babu Ram/O-2741-2013; Borah, Jimmy/E-7502-2011; Maurya, Kamlesh Kumar/A-9484-2012; Thapa, Kanchan/AGU-3365-2022	Lamichhane, Babu Ram/0000-0003-0580-7682; 				Areendran G, 2012, ASIAN J GEOINFORM, V12, P1; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Barber-Meyer SM, 2013, J ZOOL, V289, P10, DOI 10.1111/j.1469-7998.2012.00956.x; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bay RA, 2014, J HERED, V105, P295, DOI 10.1093/jhered/est086; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chanchani P, 2014, TIGERS TRANSBOUNDARY, P3; Chanchani P, 2015, CONSERVATION BIOL; Clevenger AP, 2005, GAIA, V14, P124, DOI 10.14512/gaia.14.2.12; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Cushman SA, 2016, LANDSCAPE ECOL, V31, P1337, DOI 10.1007/s10980-015-0292-3; Dhakal M., 2018, STATUS TIGERS PREY N, DOI 10.13140/2.1.3290.2407; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dixon JD, 2006, CONSERV BIOL, V20, P155, DOI 10.1111/j.1523-1739.2005.00292.x; Dou HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154254; Duangchantrasiri S, 2015, CONSERVATION BIOL; Dutta T, 2013, DIVERS DISTRIB, V19, P760, DOI 10.1111/ddi.12024; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Harihar A, 2015, GLOBAL ENVIRON CHANG, V33, P122, DOI 10.1016/j.gloenvcha.2015.05.004; Harihar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040105; Hiby L., 2009, BIOL LETT, prsbl; John K, 2014, P ROY SOC BIOL SCI, P281; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P145, DOI 10.1007/978-4-431-99495-4_9; Karanth KU, 2009, ORYX, V43, P1, DOI 10.1017/S003060530843106X; Karki JB, 2013, ORYX; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; McCarthy T, 2003, SNOW LEOPARD SURVIVA; McCullough D.R., 1996, METAPOPULATIONS WILD; McManus JS, 2015, ECOL EVOL, V5, P335, DOI 10.1002/ece3.1322; Miquelle D, 2010, AMUR TIGER CASE STUD, P325; Miquelle DG, 2015, INTEGR ZOOL, V10, P315, DOI 10.1111/1749-4877.12141; MoFSC, 2004, TER ARC LANDSC NEP B; MoFSC, 2016, STRAT ACT PLAN 2016; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Olivier PI, 2009, MAMMAL REV, V39, P178, DOI 10.1111/j.1365-2907.2009.00143.x; Primm SA, 1996, CONSERV BIOL, V10, P1036, DOI 10.1046/j.1523-1739.1996.10041036.x; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Seidensticker J, 2010, TIGER RANGE COLLAPSE, P305; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Smith J.L.D., 1987, P97; Smith JLD, 1998, CONSERV BIOL, V12, P1338, DOI 10.1046/j.1523-1739.1998.97068.x; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; Smythies E.A., 1942, BIG GAME SHOOTING NE; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thapa K, 2006, ANN WILD MON REP TER; Thapa K, 2016, INTEGRATIVE ZOOLOGY; Thapa K., 2006, SITUATION ANAL BABAI; Thapa K, 2014, THESIS; Thapa K, 2008, TIGER MONITORING SUK; Thapa K, 2014, ADV ECOLOGY; Thapa K, 2013, ORYX, V47, P345, DOI 10.1017/S0030605311001670; Vonholdt BM, 2010, MOL ECOL, V19, P4412, DOI 10.1111/j.1365-294X.2010.04769.x; Wiens JA, 1996, WILDLIFE PATCHY ENV, V439, P53; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wikramanayake E, 2010, TER ARC LANDSC TIG C; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	66	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177548	10.1371/journal.pone.0177548	http://dx.doi.org/10.1371/journal.pone.0177548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591175	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700009
J	Scharadin, TM; He, W; Yiannakou, Y; Tomilov, AA; Saldana, M; Cortopassi, GA; Carraway, KL; Coleman, MA; Henderson, PT				Scharadin, Tiffany M.; He, Wei; Yiannakou, Yianni; Tomilov, Alexey A.; Saldana, Matthew; Cortopassi, Gino A.; Carraway, Kermit L., III; Coleman, Matthew A.; Henderson, Paul T.			Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; ERBB SIGNALING NETWORK; HUMAN-BREAST-CANCER; ACQUIRED-RESISTANCE; NANOLIPOPROTEIN PARTICLES; JUXTAMEMBRANE REGION; ACTIVATION; MECHANISMS	ErbB (Erythroblastic Leukemia Viral Oncogene Homolog) receptor tyrosine kinases are critical for tissue development and maintenance, and frequently become oncogenic when mutated or overexpressed. In vitro analysis of ErbB receptor kinases can be difficult because of their large size and poor water solubility. Here we report improved production and assembly of the correctly folded full-length EGF receptor (EGFR) into nanolipoprotein particles (NLPs). NLPs are similar to 10 nm in diameter discoidal cell membrane mimics composed of apoli-poproteins surrounding a lipid bilayer. NLPs containing EGFR were synthesized via incubation of baculovirus-produced recombinant EGFR with apolipoprotein and phosphoplipids under conditions that favor self-assembly. The resulting EGFR-NLPs were the correct size, formed dimers and multimers, had intrinsic autophosphorylation activity, and retained the ability to interact with EGFR-targeted ligands and inhibitors consistent with previously-published in vitro binding affinities. We anticipate rapid adoption of EGFR-NLPs for structural studies of full-length receptors and drug screening, as well as for the in vitro characterization of ErbB heterodimers and disease-relevant mutants.	[Scharadin, Tiffany M.; Henderson, Paul T.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA; [He, Wei; Coleman, Matthew A.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Yiannakou, Yianni] Univ Calif Davis, Nutr, Davis, CA 95616 USA; [Tomilov, Alexey A.; Cortopassi, Gino A.] Univ Calif Davis, Sch Vet Med Mol Biosci, Davis, CA 95616 USA; [Saldana, Matthew; Carraway, Kermit L., III] Univ Calif Davis, Sch Med Biochem & Mol Med, Sacramento, CA 95817 USA; [Coleman, Matthew A.; Henderson, Paul T.] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Coleman, Matthew A.] Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Henderson, PT (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA.; Coleman, MA (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.; Coleman, MA; Henderson, PT (corresponding author), Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA.; Coleman, MA (corresponding author), Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA.	mcoleman@ucdavis.edu; phenderson@ucdavis.edu	He, Wei/X-1574-2019	He, Wei/0000-0003-2795-0324; Coleman, Matthew/0000-0003-1389-4018	NIH/NCI [R01-CA155642, P01 AG025532 09, T3208TS]; U.S. Department of Energy [DE-AC52-07NA27344]; IDAT through U.S. Department of Energy, Biological and Environmental Research; NATIONAL CANCER INSTITUTE [T32CA108459, P30CA093373] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy(United States Department of Energy (DOE)); IDAT through U.S. Department of Energy, Biological and Environmental Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the NIH/NCI (R01-CA155642, P01 AG025532 09 and T3208TS), PTH, MAC, KC, WH, AT, GC, MS, TS, www.nih.gov. Work was also performed under the auspices of the U.S. Department of Energy under contract number DE-AC52-07NA27344, which includes IDAT funding through the U.S. Department of Energy, Biological and Environmental Research, MAC, www.doe.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Baker SE, 2009, J AM CHEM SOC, V131, P7508, DOI 10.1021/ja809251f; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016536; Blanchette CD, 2009, INT J MOL SCI, V10, P2958, DOI 10.3390/ijms10072958; Brahmer JR, 2012, J THORAC ONCOL, V7, pS204; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; Cheng L, 2012, MODERN PATHOL, V25, P347, DOI 10.1038/modpathol.2011.215; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cortot AB, 2014, EUR RESPIR REV, V23, P356, DOI 10.1183/09059180.00004614; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Doumiati S, 2012, J MOL RECOGNIT, V25, P623, DOI 10.1002/jmr.2194; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; FELDER S, 1992, J CELL BIOL, V117, P203, DOI 10.1083/jcb.117.1.203; Fischer NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011643; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Ge GX, 2001, BIOCHEM BIOPH RES CO, V282, P511, DOI 10.1006/bbrc.2001.4600; Goddard AD, 2015, METHOD ENZYMOL, V556, P405, DOI 10.1016/bs.mie.2015.01.004; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12896; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hopper-Borge EA, 2009, EXPERT OPIN THER TAR, V13, P339, DOI [10.1517/14712590902735795 , 10.1517/14712590902735795]; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hubbard SR, 2009, CELL, V137, P1181, DOI 10.1016/j.cell.2009.06.008; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Khambata-Ford S, 2010, J CLIN ONCOL, V28, P918, DOI 10.1200/JCO.2009.25.2890; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Long AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046332; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Malhotra K, 2014, BIOTECHNOL GENET ENG, V30, P79, DOI 10.1080/02648725.2014.921502; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Mineev KS, 2015, BIOCHEMISTRY-US, V54, P6295, DOI 10.1021/acs.biochem.5b00851; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Ocana A, 2006, AM J CLIN ONCOL-CANC, V29, P90, DOI 10.1097/01.coc.0000190274.00570.0a; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Patel D, 2007, ANTICANCER RES, V27, P3355; Perez-Torres M, 2006, J BIOL CHEM, V281, P40183, DOI 10.1074/jbc.M607958200; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Scagliotti GV, 2004, CLIN CANCER RES, V10, p4227S, DOI 10.1158/1078-0432.CCR-040007; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Tom RL, 1995, APPL MICROBIOL BIOT, V44, P53; Varkondi E, 2005, J RECEPT SIG TRANSD, V25, P45, DOI 10.1081/RRS-200055095; Wang Z, 2013, ACS CHEM BIOL; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Zhang HZ, 2012, INT J CANCER, V131, P956, DOI 10.1002/ijc.26427	64	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0177761	10.1371/journal.pone.0177761	http://dx.doi.org/10.1371/journal.pone.0177761			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586369	Green Submitted, Green Published, gold			2022-12-26	WOS:000402875700006
J	Castello, MVD; Wheeler, KG; Cipolli, C; Gobbini, MI				Castello, Matteo Visconti di Oleggio; Wheeler, Kelsey G.; Cipolli, Carlo; Gobbini, M. Ida			Familiarity facilitates feature-based face processing	PLOS ONE			English	Article							CONFIGURAL INFORMATION; UNFAMILIAR FACES; NEURAL SYSTEMS; INVERSION; RECOGNITION; PERCEPTION; EXPERIENCE; LOOKING; SPEED	Recognition of personally familiar faces is remarkably efficient, effortless and robust. We asked if feature-based face processing facilitates detection of familiar faces by testing the effect of face inversion on a visual search task for familiar and unfamiliar faces. Because face inversion disrupts configural and holistic face processing, we hypothesized that inversion would diminish the familiarity advantage to the extent that it is mediated by such processing. Subjects detected personally familiar and stranger target faces in arrays of two, four, or six face images. Subjects showed significant facilitation of personally familiar face detection for both upright and inverted faces. The effect of familiarity on target absent trials, which involved only rejection of unfamiliar face distractors, suggests that familiarity facilitates rejection of unfamiliar distractors as well as detection of familiar targets. The preserved familiarity effect for inverted faces suggests that facilitation of face detection afforded by familiarity reflects mostly feature-based processes.	[Castello, Matteo Visconti di Oleggio; Wheeler, Kelsey G.; Gobbini, M. Ida] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Cipolli, Carlo; Gobbini, M. Ida] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Sch Med, Bologna, Italy	Dartmouth College; University of Bologna	Castello, MVD; Gobbini, MI (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.; Gobbini, MI (corresponding author), Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Sch Med, Bologna, Italy.	mvdoc.gr@dartmouth.edu; mariaida.gobbini@unibo.it						Analytics R, 2014, DOPARALLEL FOREACH P; Analytics R, 2015, FOREACH PROVIDES FOR; [Anonymous], 2014, IMPLEMENTING REPROD; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Balas B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001223; Barragan-Jason G, 2015, NEUROPSYCHOLOGIA, V75, P390, DOI 10.1016/j.neuropsychologia.2015.06.017; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; BRUCE V, 1994, Q J EXP PSYCHOL-A, V47, P5, DOI 10.1080/14640749408401141; Burton AM, 2015, PERSPECT PSYCHOL SCI, V10, P482, DOI 10.1177/1745691615583129; Burton AM, 2013, Q J EXP PSYCHOL, V66, P1467, DOI 10.1080/17470218.2013.800125; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Caharel S, 2014, J COGNITIVE NEUROSCI, V26, P81, DOI 10.1162/jocn_a_00451; Castello MVD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136548; Castello MVD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00678; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Efron B, 1994, INTRO BOOTSTRAP; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Fox J., 2014, R COMPANION APPL REG; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Freiwald WA, 2010, SCIENCE, V330, P845, DOI 10.1126/science.1194908; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2013, CONSCIOUS COGN, V22, P765, DOI 10.1016/j.concog.2013.05.002; Gobbini MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066620; Hancock P., 2000, TRENDS COGN SCI; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jenkins R, 2011, COGNITION, V121, P313, DOI 10.1016/j.cognition.2011.08.001; Jenkins R, 2011, PHILOS T R SOC B, V366, P1671, DOI 10.1098/rstb.2010.0379; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Le Grand R, 2001, NATURE, V410, P890, DOI 10.1038/35073749; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McKone E, 2009, PSYCHON B REV, V16, P778, DOI 10.3758/PBR.16.5.778; Nakayama K, 2011, VISION RES, V51, P1526, DOI 10.1016/j.visres.2010.09.003; Natu V, 2011, BRIT J PSYCHOL, V102, P726, DOI 10.1111/j.2044-8295.2011.02053.x; Piepers DW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00559; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ramon M, 2016, PEERJ, V4, DOI 10.7717/peerj.1465; RHODES G, 1988, PERCEPTION, V17, P43, DOI 10.1068/p170043; Robbins R, 2007, COGNITION, V103, P34, DOI 10.1016/j.cognition.2006.02.008; Robinson D, 2014, BROOM R PACKAGE CONV; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion B, 2009, ACTA PSYCHOL, V132, P300, DOI 10.1016/j.actpsy.2009.08.002; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Sternberg S., 1969, AM SCI; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tong F, 1999, J EXP PSYCHOL; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wickham H., 2015, DPLYR GRAMMAR DATA M; Wickham H., 2013, ASSERTTHAT EASY PRE; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; Xie Y., 2013, KNITR GEN PURPOSE PA; Xie Y., 2014, KNITR COMPREHENSIVE; Xu BY, 2013, J VISION, V13, DOI 10.1167/13.2.22; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	64	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178895	10.1371/journal.pone.0178895	http://dx.doi.org/10.1371/journal.pone.0178895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9KF	28582439	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600051
J	Martins, JG; de Paiva, HN; Paiva, PCP; Ferreira, RC; Pordeus, IA; Zarzar, PM; Kawachi, I				Martins, Juliana Gabrielle; de Paiva, Haroldo Neves; Pelli Paiva, Paula Cristina; Ferreira, Raquel Conceicao; Pordeus, Isabela Almeida; Zarzar, Patricia Maria; Kawachi, Ichiro			New evidence about the "dark side" of social cohesion in promoting binge drinking among adolescents	PLOS ONE			English	Article							ALCOHOL-USE; SUBSTANCE USE; BRAZILIAN ADOLESCENTS; SOCIOECONOMIC-STATUS; DRUG-USE; CONSUMPTION; BEHAVIOR; FRIENDS; HEALTH; RISK	Adolescence is characterized by heightened susceptibility to peer influence, which makes adolescents vulnerable to initiating or maintaining risky habits such as heavy drinking. The aim of the study was to investigate the association of social capital with longitudinal changes in the frequency of binge drinking among adolescents at public and private high schools in the city of Diamantina, Brazil. This longitudinal study used two waves of data collected when the adolescents were 12 and 13 years old. At the baseline assessment in 2013 a classroom survey was carried out with a representative sample of 588 students. In 2014, a follow-up survey was carried out with the same adolescents when they were aged 13 years. The Alcohol Use Disorder Identification Test-C (AUDIT C) was employed for the evaluation of alcohol intake. Our predictor variables included sociodemographic and economic characteristics (gender, type of school, mother's education, family income) and Social Capital. For evaluation of social capital, we used the Social Capital Questionnaire for Adolescent Students (SCQ-AS). Descriptive and bivariate analyzes were performed (p <0.05). The log-binomial model was used to calculate prevalence ratios (PR) and 95% confidence intervals. The two tailed p value was set at <0.05. The prevalence of binge drinking in 2013 was 23.1% and in 2014 the prevalence had risen to 30.1%. Gender (PR 1.48; 95% CI 0.87-2.52) and socioeconomic status (type of school and mother's education) were not associated with the increase in the frequency of binge drinking. However, higher social capital was significantly associated with an increase in binge drinking by students. Adolescents who reported that they had an increase in social cohesion in the community/neighborhood subscale were 3.4 times more likely (95%Cl 1.96-6.10) to binge drink themselves. Our results provide new evidence about the "dark side" of social cohesion in promoting binge drinking among adolescents.	[Martins, Juliana Gabrielle; Pordeus, Isabela Almeida; Zarzar, Patricia Maria] Univ Fed Minas Gerais, Sch Dent, Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [de Paiva, Haroldo Neves; Pelli Paiva, Paula Cristina] Fed Univ Jequitinhonha & Mucuri Valleys, Dept Dent, Sch Dent, Diamantina, MG, Brazil; [Ferreira, Raquel Conceicao] Univ Fed Minas Gerais, Sch Dent, Social & Prevent Dent, Belo Horizonte, MG, Brazil; [Kawachi, Ichiro] Harvard Sch Publ Hlth & Med Sch, Dept Social & Behav Sci, Boston, MA USA	Universidade Federal de Minas Gerais; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais; Harvard University; Harvard T.H. Chan School of Public Health	Martins, JG (corresponding author), Univ Fed Minas Gerais, Sch Dent, Pediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	julianagabrielle@hotmail.com	de araujo zarzar, patricia maria pereira/F-4237-2018; Ferreira, Raquel Conceição/J-5236-2015; de Araújo Zarzar, Patricia Maria Pereira/H-9534-2012; PORDEUS, ISABELA A/B-1570-2013	Ferreira, Raquel Conceição/0000-0001-8897-9345; de Araújo Zarzar, Patricia Maria Pereira/0000-0002-6952-5767; PORDEUS, ISABELA A/0000-0002-5902-7481				Ali MM, 2014, ADDICT BEHAV, V39, P918, DOI 10.1016/j.addbeh.2013.11.030; Almeida-Filho N, 2004, REV SAUDE PUBL, V38, P45, DOI 10.1590/S0034-89102004000100007; Armstrong JM, 2013, J STUD ALCOHOL DRUGS, V74, P746, DOI 10.15288/jsad.2013.74.746; Berkman LF., 2014, SOCIAL EPIDEMIOLOGY, V2nd ed.; Bucksch J, 2012, GESUNDHEITSWESEN, V74, pS56, DOI 10.1055/s-0032-1312635; Colletta JJ, 2000, VIOLENT CONFLICT AND; FISHER LA, 1988, J APPL SOC PSYCHOL, V18, P289, DOI 10.1111/j.1559-1816.1988.tb00018.x; Goodman E, 2002, ARCH PEDIAT ADOL MED, V156, P448, DOI 10.1001/archpedi.156.5.448; Hartup WW, 1997, PSYCHOL BULL, V121, P355, DOI 10.1037/0033-2909.121.3.355; Helms SW, 2014, DEV PSYCHOL, V50, P2697, DOI 10.1037/a0038178; Humensky JL, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-19; Hussong AM, 2000, J YOUTH ADOLESCENCE, V29, P107, DOI 10.1023/A:1005177306699; Kelly TM, 2002, ALCOHOL ALCOHOLISM, V37, P444, DOI 10.1093/alcalc/37.5.444; Kulis S, 2007, SOCIOL PERSPECT, V50, P273, DOI 10.1525/sop.2007.50.2.273; Lee A, 2004, PUBLIC HEALTH, V118, P88, DOI 10.1016/S0033-3506(03)00174-4; Li FZ, 2002, J BEHAV MED, V25, P293, DOI 10.1023/A:1015336929122; Lima CT, 2005, ALCOHOL ALCOHOLISM, V40, P584, DOI 10.1093/alcalc/agh202; Lorant V, 2015, HEALTH PROMOT INT, V30, P675, DOI 10.1093/heapro/dau007; MacArthur GJ, 2017, SOCIOL HEALTH ILL, V39, P30, DOI 10.1111/1467-9566.12467; Mayer RR, 1998, J STUD ALCOHOL, V59, P207, DOI 10.15288/jsa.1998.59.207; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Mendoza-Sassi RA, 2003, ADDICTION, V98, P799, DOI 10.1046/j.1360-0443.2003.00411.x; Meneses-Gaya C, 2010, ALCOHOL CLIN EXP RES, V34, P1417, DOI 10.1111/j.1530-0277.2010.01225.x; Paiva PCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103785; Pinsky I, 2010, REV BRAS PSIQUIATR, V32, P242, DOI 10.1590/S1516-44462010005000007; Poelen EAP, 2007, DRUG ALCOHOL DEPEN, V88, P163, DOI 10.1016/j.drugalcdep.2006.10.008; Sanchez ZM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-201; Spijkerman R, 2008, EUR ADDICT RES, V14, P26, DOI 10.1159/000110408; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; Weitzman ER, 2005, J EPIDEMIOL COMMUN H, V59, P303, DOI 10.1136/jech.2004.024711; Weitzman ER, 2000, AM J PUBLIC HEALTH, V90, P1936, DOI 10.2105/AJPH.90.12.1936; Williamson T, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-14; Wray-Lake L, 2012, J ADOLESCENT HEALTH, V51, P325, DOI 10.1016/j.jadohealth.2011.12.030; Zarzar PM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-257	36	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178652	10.1371/journal.pone.0178652	http://dx.doi.org/10.1371/journal.pone.0178652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575029	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300088
J	Miller, MA; Danhorn, T; Cruickshank-Quinn, CI; Leach, SM; Jacobson, S; Strand, MJ; Reisdorph, NA; Bowler, RP; Petrache, I; Kechris, K				Miller, Mikaela A.; Danhorn, Thomas; Cruickshank-Quinn, Charmion I.; Leach, Sonia M.; Jacobson, Sean; Strand, Matthew J.; Reisdorph, Nichole A.; Bowler, Russell P.; Petrache, Irina; Kechris, Katerina			Gene and metabolite time-course response to cigarette smoking in mouse lung and plasma	PLOS ONE			English	Article							MAINSTREAM TOBACCO-SMOKE; INDUCED EMPHYSEMA; OXIDATIVE STRESS; SECONDHAND SMOKE; TUMOR-SUPPRESSOR; MICE; PATHWAY; EXPRESSION; EXPOSURE; TRANSCRIPTOME	Prolonged cigarette smoking (CS) causes chronic obstructive pulmonary disease (COPD), a prevalent serious condition that may persist or progress after smoking cessation. To provide insight into how CS triggers COPD, we investigated temporal patterns of lung transcriptome expression and systemic metabolome changes induced by chronic CS exposure and smoking cessation. Whole lung RNA-seq data was analyzed at transcript and exon levels from C57BI/6 mice exposed to CS for 1- or 7 days, for 3-, 6-, or 9 months, or for 6 months followed by 3 months of cessation using age-matched littermate controls. We identified previously unreported dysregulation of pyrimidine metabolism and phosphatidylinositol signaling pathways and confirmed alterations in glutathione metabolism and circadian gene pathways. Almost all dysregulated pathways demonstrated reversibility upon smoking cessation, except the lysosome pathway. Chronic CS exposure was significantly linked with alterations in pathways encoding for energy, phagocytosis, and DNA repair and triggered differential expression of genes or exons previously unreported to associate with CS or COPD, including Lox, involved in matrix remodeling, Gp2, linked to goblet cells, and Slc22a12 and Agpat3, involved in purine and glycerolipid metabolism, respectively. CS induced lung metabolic pathways changes were validated using metabolomic profiles of matched plasma samples, indicating that dynamic metabolic gene regulation caused by CS is reflected in the plasma metabolome. Using advanced technologies, our study uncovered novel pathways and genes altered by chronic CS exposure, including those involved in pyrimidine metabolism, phosphatidylinositol signaling and lysosome function, highlighting their potential importance in the pathogenesis or diagnosis of CS-associated conditions.	[Miller, Mikaela A.; Kechris, Katerina] Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA; [Danhorn, Thomas; Leach, Sonia M.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO USA; [Cruickshank-Quinn, Charmion I.; Reisdorph, Nichole A.] Univ Colorado Anschutz Med Campus, Sch Pharm, Dept Pharmaceut Sci, Aurora, CO USA; [Jacobson, Sean; Bowler, Russell P.; Petrache, Irina] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Denver, CO 80206 USA; [Jacobson, Sean; Bowler, Russell P.; Petrache, Irina] Univ Colorado, Denver, CO 80202 USA; [Strand, Matthew J.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Petrache, Irina] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Denver; National Jewish Health; Indiana University System; Indiana University-Purdue University Indianapolis	Kechris, K (corresponding author), Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO 80045 USA.; Bowler, RP; Petrache, I (corresponding author), Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Denver, CO 80206 USA.; Bowler, RP; Petrache, I (corresponding author), Univ Colorado, Denver, CO 80202 USA.; Petrache, I (corresponding author), Indiana Univ, Dept Med, Indianapolis, IN 46202 USA.	BowlerR@njhealth.org; PetracheI@njhealth.org; katerina.kechris@ucdenver.edu	Strand, Matt/AAU-3762-2021; Reisdorph, Nichole/AAX-8774-2020; Petrache, Irina/AAZ-9648-2020	Strand, Matt/0000-0002-9083-5989; Reisdorph, Nichole/0000-0002-0425-8012; Cruickshank-Quinn, Charmion/0000-0002-5553-8663; Miller, Mikaela/0000-0002-9730-3408; Danhorn, Thomas/0000-0002-3861-8602	NIH [P20 HL113445]; Colorado Clinical and Translational Sciences Institute [NIH UL1 TR001082]; Genomics and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Grant [P30 CA046934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113445, R01HL129937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical and Translational Sciences Institute; Genomics and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by NIH P20 HL113445, the Colorado Clinical and Translational Sciences Institute NIH UL1 TR001082, and by the Genomics and Microarray Shared Resource of Colorado's NIH/NCI Cancer Center Support Grant P30 CA046934. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AR, 2012, AM J PHYSIOL-LUNG C, V303, pL889, DOI 10.1152/ajplung.00219.2012; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cavill R., 2015, BRIEF BIOINFORM; Cheng G, 2015, INT J ENV RES PUB HE, V12, P64, DOI 10.3390/ijerph120100064; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Clauss M, 2011, J CLIN INVEST, V121, P2470, DOI 10.1172/JCI43881; Cruickshank-Quinn CI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101855; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Halappanavar S, 2009, INHAL TOXICOL, V21, P78, DOI 10.1080/08958370802209165 ; Hedeker D., 2006, LONGITUDINAL DATA AN; Hooper JE, 2014, HUM GENOMICS, V8, DOI 10.1186/1479-7364-8-3; Hu JZ, 2015, METABOLOMICS, V5, P143; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Kaiser MF, 2013, BLOOD, V122, P219, DOI 10.1182/blood-2013-03-487884; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Kimura S, 2014, BIOMED RES-TOKYO, V35, P329, DOI 10.2220/biomedres.35.329; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; LINDEN M, 1989, INFLAMMATION, V13, P651, DOI 10.1007/BF00914309; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Miller M, 2015, AM J RESP CRIT CARE, V191; Morissette MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092498; R Core Team, 2013, R LANG ENV STAT COMP; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rangasamy T, 2009, AM J PHYSIOL-LUNG C, V296, pL888, DOI 10.1152/ajplung.90369.2008; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Tommasi S, 2015, INT J CANCER, V136, P2253, DOI 10.1002/ijc.29284; Tommasi S, 2012, EPIGENETICS-US, V7, P1302, DOI 10.4161/epi.22453; Vasu VT, 2009, INTEGR CANCER THER, V8, P321, DOI 10.1177/1534735409352027; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zewail A, 2003, P NATL ACAD SCI USA, V100, P3345, DOI 10.1073/pnas.0530118100	41	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178281	10.1371/journal.pone.0178281	http://dx.doi.org/10.1371/journal.pone.0178281			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575117	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300036
J	Saad, NJ; Patel, J; Minelli, C; Burney, PGJ				Saad, Neil J.; Patel, Jaymini; Minelli, Cosetta; Burney, Peter G. J.			Explaining ethnic disparities in lung function among young adults: A pilot investigation	PLOS ONE			English	Article							GRANDMATERNAL SMOKING PATTERNS; BIRTH-WEIGHT; SOCIOECONOMIC-STATUS; VENTILATORY FUNCTION; HEALTH-STATUS; LEG LENGTH; FOLLOW-UP; CHILDHOOD; ASTHMA; POPULATION	Background Ethnic disparities in lung function have been linked mainly to anthropometric factors but have not been fully explained. We conducted a cross-sectional pilot study to investigate how best to study ethnic differences in lung function in young adults and evaluate whether these could be explained by birth weight and socio-economic factors. Methods We recruited 112 university students of White and South Asian British ethnicity, measured post-bronchodilator lung function, obtained information on respiratory symptoms and socioeconomic factors through questionnaires, and acquired birth weight through data linkage. We regressed lung function against ethnicity and candidate predictors defined a priori using linear regression, and used penalised regression to examine a wider range of factors. We reviewed the implications of our findings for the feasibility of a larger study. Results There was a similar parental socio-economic environment and no difference in birth weight between the two ethnic groups, but the ethnic difference in FVC adjusted for sex, age, height, demi-span, father's occupation, birth weight, maternal educational attainment and maternal upbringing was 0.81L (95%Cl: -1.01 to -0.54L). Difference in body proportions did not explain the ethnic differences although parental immigration was an important predictor of FVC independent of ethnic group. Participants were comfortable with study procedures and we were able to link birth weight data to clinical measurements. Conclusion Studies of ethnic disparities in lung function among young adults are feasible. Future studies should recruit a socially more diverse sample and investigate the role of markers of acculturation in explaining such differences.	[Saad, Neil J.; Patel, Jaymini; Minelli, Cosetta; Burney, Peter G. J.] Imperial Coll London, Natl Heart & Lung Inst, London, England	Imperial College London	Saad, NJ; Burney, PGJ (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	ns11@ic.ac.uk; p.burney@ic.ac.uk	Saad, Neil J./AAI-4719-2021	Patel, Jaymini/0000-0001-5690-8630; Burney, Peter/0000-0001-8635-5678	National Heart and Lung Institute Foundation; Royal Brompton Respiratory Biomedical research unit; National Heart and Lung Institute Foundation; Royal Brompton Respiratory Biomedical research unit	National Heart and Lung Institute Foundation; Royal Brompton Respiratory Biomedical research unit; National Heart and Lung Institute Foundation; Royal Brompton Respiratory Biomedical research unit	NJS was supported by a PhD studentship from the National Heart and Lung Institute Foundation.r We would like to thank all study participants and the Royal Brompton Respiratory Biomedical research unit for their support.	Allen DS, 2002, AM J EPIDEMIOL, V155, P379, DOI 10.1093/aje/155.4.379; Bonner R, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2014.112; Braun L, 2013, EUR RESPIR J, V41, P1362, DOI 10.1183/09031936.00091612; Burney PGJ, 2012, INT J EPIDEMIOL, V41, P782, DOI 10.1093/ije/dys011; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Burney P, 2014, THORAX, V69, DOI 10.1136/thoraxjnl-2013-204460; Carey OJ, 1996, AM J RESP CRIT CARE, V154, P537, DOI 10.1164/ajrccm.154.2.8756835; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; De Caluwe JP, 2009, J FR OPHTALMOL, V32, P459, DOI 10.1016/j.jfo.2009.06.005; Denholm R, 2013, INT J EPIDEMIOL, V42, P1399, DOI 10.1093/ije/dyt169; Devakumar D, 2015, EUR RESPIR J, V45, P1566, DOI 10.1183/09031936.00188914; Devereux G, 2006, AM J RESP CRIT CARE, V174, P499, DOI 10.1164/rccm.200512-1946OC; Edmands WMB, 2015, AM J CLIN NUTR, V102, P905, DOI 10.3945/ajcn.114.101881; Ferrie JE, 2006, INT J EPIDEMIOL, V35, P1532, DOI 10.1093/ije/dyl184; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FuentesAfflick E, 1997, AM J EPIDEMIOL, V145, P148, DOI 10.1093/oxfordjournals.aje.a009085; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Garcia-Larsen V, 2011, EUR J CLIN NUTR, V65, P750, DOI 10.1038/ejcn.2011.15; Ghosh RE, 2016, ARCH DIS CHILD-FETAL, V101, pF451, DOI 10.1136/archdischild-2015-309540; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; Hole DJ, 1996, BRIT MED J, V313, P711; Hooper R, 2013, INT J TUBERC LUNG D, V17, P400, DOI 10.5588/ijtld.12.0591; HSI BP, 1983, J PEDIATR-US, V102, P860, DOI 10.1016/S0022-3476(83)80012-2; Johnston LW, 2013, DIABETES CARE, V36, P3599, DOI 10.2337/dc13-0254; Kervegant M, 2012, PRESSE MED, V41, P203, DOI 10.1016/j.lpm.2011.07.006; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Lind MV, 2016, EUR J EPIDEMIOL, V31, P717, DOI 10.1007/s10654-016-0166-2; Magnus MC, 2015, THORAX, V70, P237, DOI 10.1136/thoraxjnl-2014-206438; Margetts BM, 2002, J EPIDEMIOL COMMUN H, V56, P684, DOI 10.1136/jech.56.9.684; Martinez CH, 2015, CHEST, V148, P151, DOI 10.1378/chest.14-1814; Miller LL, 2014, CHEST, V145, P1213, DOI 10.1378/chest.13-1371; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moser Kath, 2008, Health Stat Q, P22; Parker JM, 1996, AM J RESP CRIT CARE, V154, P533, DOI 10.1164/ajrccm.154.2.8756834; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Saad NJ, 2017, ANN AM THORAC SOC; SCHWARTZ J, 1988, AM REV RESPIR DIS, V138, P1415, DOI 10.1164/ajrccm/138.6.1415; STINE RA, 1995, AM STAT, V49, P53, DOI 10.2307/2684812; Strippoli MPF, 2013, PEDIATRICS, V131, pE1842, DOI 10.1542/peds.2012-3003; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Todorovic V, 2003, MALNUTRITION UNIVERS; Toledano MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131521; Turner SW, 2010, THORAX, V65, P391, DOI 10.1136/thx.2008.111385; Van Sickle D, 2011, AM J RESP CRIT CARE, V184, P521, DOI 10.1164/rccm.201012-2095OC; West J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004805; Whitrow MJ, 2008, AM J RESP CRIT CARE, V177, P1262, DOI 10.1164/rccm.200706-867OC; Whittaker AL, 2005, ARCH DIS CHILD-FETAL, V90, pF423, DOI 10.1136/adc.2004.062497; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178962	10.1371/journal.pone.0178962	http://dx.doi.org/10.1371/journal.pone.0178962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575113	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300135
J	Scripcaru, G; Mateus, C; Nunes, C				Scripcaru, Gianina; Mateus, Ceu; Nunes, Carla			Adverse drug events-Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database	PLOS ONE			English	Article							RISK-FACTORS; ELDERLY-PATIENTS; COMPUTERIZED SURVEILLANCE; EMERGENCY-DEPARTMENT; OLDER PATIENTS; ADMISSIONS; PREVALENCE; AVOIDABILITY; METAANALYSIS; POPULATION	Purpose The goal of this study was to characterise adverse drug events (ADE), including both adverse drug reaction (ADR) and accidental poisoning by drugs (AP), considering age, gender, length of stay (LOS), number of deaths and year, during the period 2004-2013. Additionally distributions of the ten's most frequent ADR and AP were characterized, considering age-group and gender. Methods A retrospective descriptive nationwide study was conducted, based on the hospital discharges database in Portugal from 2004 to 2013, using ICD-9. Events were identified based on the following codes: from E930 to E949.9 and from E850 to E858.9. Results A total of 9 320 076 patients were discharged within this period, with 133 688 patients (1.46%) having at least one ADE, 4% of them related with AP. The mean age of these patients was 63.79 years (SD 21.31), 54.50% were female and the mean LOS was 14.05 days (SD 22.19). Patient with AP had a mean age of 41.06 years (SD 34.05), 54.70% were female and LOS was 7.15 days (SD 19.42). We have identified 10.691 deaths that represent 8.00% from the total of patients with an ADE. The patients above 65 years were more affected by ADR and children below 18 were more affected by AP. Conclusion In the last decade an increasing trend of ADR were observed and an AP pattern relatively stable. Elderly people and children were the age groups most affected. Antibiotics (in ADR) and benzodiazepine-based tranquilizers (in AP) were the major problems. This is a huge, increasing and challenging problem. Further research, using individual and contextual risk factors should be developed to understand spatiotemporal variability, promoting tailored interventions, within and across countries.	[Scripcaru, Gianina; Nunes, Carla] Univ NOVA Lisboa, Escola Nacl Saude Publ, Lisbon, Portugal; [Scripcaru, Gianina] Amgen Biofarmaceut Lda, Lisbon, Portugal; [Mateus, Ceu] Univ Lancaster, Hlth Econ Grp, Div Hlth Res, Lancaster, England; [Nunes, Carla] Univ NOVA Lisboa, Ctr Invest Saude Publ, Lisbon, Portugal	Universidade Nova de Lisboa; Lancaster University; Universidade Nova de Lisboa	Nunes, C (corresponding author), Univ NOVA Lisboa, Escola Nacl Saude Publ, Lisbon, Portugal.; Nunes, C (corresponding author), Univ NOVA Lisboa, Ctr Invest Saude Publ, Lisbon, Portugal.	cnunes@ensp.unl.pt	Nunes, Carla/H-1732-2011; Mateus, Ceu/AAC-8146-2021	Nunes, Carla/0000-0003-4562-1057; Mateus, Ceu/0000-0001-6219-219X	Fundacao para a Ciencia e a Technologia - Ministerio da Ciencia, Technologia e Ensino Superior, Portugal [SFRH/BD/79860/2011]	Fundacao para a Ciencia e a Technologia - Ministerio da Ciencia, Technologia e Ensino Superior, Portugal	The authors would like to thank the financial support given by the Fundacao para a Ciencia e a Technologia - Ministerio da Ciencia, Technologia e Ensino Superior, Portugal, Grant Number: SFRH/BD/79860/2011. The funder had no desicion to publish, or preparation of the manuscript.	Adams SA, 2013, STUD HEALTH TECHNOL, V194, P63, DOI 10.3233/978-1-61499-293-6-63; Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Alomar MJ, 2014, SAUDI PHARM J, V22, P83, DOI 10.1016/j.jsps.2013.02.003; Azaz-Livshits T, 1998, BRIT J CLIN PHARMACO, V45, P309, DOI 10.1046/j.1365-2125.1998.00685.x; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; Bourgeois FT, 2010, PHARMACOEPIDEM DR S, V19, P901, DOI 10.1002/pds.1984; Burgess CL, 2005, MED J AUSTRALIA, V182, P267, DOI 10.5694/j.1326-5377.2005.tb06698.x; Cano FG, 2009, CAD SAUDE PUBLICA, V25, pS360, DOI 10.1590/S0102-311X2009001500003; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Davies EC, 2006, J CLIN PHARM THER, V31, P335, DOI 10.1111/j.1365-2710.2006.00744.x; Dormann H, 2003, DRUG SAFETY, V26, P353, DOI 10.2165/00002018-200326050-00004; ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d; Evans RS, 2005, ANN PHARMACOTHER, V39, P1161, DOI 10.1345/aph.1E642; Franceschi M, 2008, DRUG SAFETY, V31, P545, DOI 10.2165/00002018-200831060-00009; Garcia MP, 2011, PHARMACOEPIDEM DR S, V20, P1295, DOI 10.1002/pds.2193; Goldstein LH, 2013, J CLIN PHARMACOL, V53, P1220, DOI 10.1002/jcph.149; Griffith Richard, 2013, Br J Nurs, V22, P484; HALLAS J, 1993, EUR J CLIN PHARMACOL, V45, P199, DOI 10.1007/BF00315383; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Herdeiro MT, 2012, DRUG SAFETY, V35, P655, DOI 10.2165/11599750-000000000-00000; Hougland P, 2008, ADV PATIENT SAFETY N, V1; Irujo M, 2007, DRUG SAFETY, V30, P1073, DOI 10.2165/00002018-200730110-00006; Jolivot PA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0643-5; Kanjanarat P, 2003, AM J HEALTH-SYST PH, V60, P1750, DOI 10.1093/ajhp/60.17.1750; Lagnaoui R, 2000, EUR J CLIN PHARMACOL, V56, P181, DOI 10.1007/s002280050738; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Mackichan JJ, 2010, DRUG INDUCED DIS PRE, P23; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; Mastroianni PD, 2009, BRAZ J PHARM SCI, V45, P163; McDonnell PJ, 2002, ANN PHARMACOTHER, V36, P1331, DOI 10.1345/aph.1A333; Miguel A, 2013, PHARMACOEPIDEM DR S, V22, P907, DOI 10.1002/pds.3468; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; Nebeker JR, 2004, ANN INTERN MED, V140, P795, DOI 10.7326/0003-4819-140-10-200405180-00009; Olivier P, 2009, DRUG AGING, V26, P475, DOI 10.2165/00002512-200926060-00004; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Passarelli MCG, 2005, DRUG AGING, V22, P767, DOI 10.2165/00002512-200522090-00005; Pedros C, 2014, EUR J CLIN PHARMACOL, V70, P361, DOI 10.1007/s00228-013-1630-5; Pintor-Marmol A, 2012, PHARMACOEPIDEM DR S, V21, P799, DOI 10.1002/pds.3296; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pouyanne P, 2000, BRIT MED J, V320, P1036, DOI 10.1136/bmj.320.7241.1036; Price SD, 2014, ANN PHARMACOTHER, V48, P6, DOI 10.1177/1060028013504904; Routledge P., 2004, STEPHENS DETECTION N, P91; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Salmeron-Garcia A, 2010, PHARM WORLD SCI, V32, P322, DOI 10.1007/s11096-010-9372-2; Seiber EE, 2007, HEALTH CARE FINANC R, V28, P83; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Somers A, 2003, EUR J CLIN PHARMACOL, V58, P707, DOI 10.1007/s00228-002-0535-5; Stausberg J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-125; Tisdale JE, 2010, DRUG INDUCED DIS PRE, P14; van den Bemt PMLA, 2000, PHARM WORLD SCI, V22, P62, DOI 10.1023/A:1008721321016; van der Hooft CS, 2006, DRUG SAFETY, V29, P161, DOI 10.2165/00002018-200629020-00006; Ventura MT, 2010, IMMUNOPHARM IMMUNOT, V32, P426, DOI 10.3109/08923970903468847; Wijman C A C, 2002, Ned Tijdschr Geneeskd, V146, P969; Wu C, 2012, DRUG SAFETY, V35, P769, DOI 10.2165/11599540-000000000-00000; Wu TY, 2010, J ROY SOC MED, V103, P239, DOI 10.1258/jrsm.2010.100113; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	57	13	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178626	10.1371/journal.pone.0178626	http://dx.doi.org/10.1371/journal.pone.0178626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575013	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300079
J	Wang, P; Zhang, XY; Ma, XW; Sun, Y; Liu, NN; Li, FG; Hou, YX				Wang, Ping; Zhang, Xueyan; Ma, Xiaowen; Sun, Yun; Liu, Nana; Li, Fuguang; Hou, Yuxia			Identification of CkSNAP33, a gene encoding synaptosomal-associated protein from Cynanchum komarovii, that enhances Arabidopsis resistance to Verticillium dahliae	PLOS ONE			English	Article							T-SNARE ATSNAP33; DISEASE RESISTANCE; MEMBRANE-FUSION; PLASMA-MEMBRANE; CELL-WALL; DEFENSE; RESPONSES; KNOLLE; RICE; CYTOKINESIS	SNARE proteins are essential to vesicle trafficking and membrane fusion in eukaryotic cells. In addition, the SNARE-mediated secretory pathway can deliver diverse defense products to infection sites during exocytosis-associated immune responses in plants. In this study, a novel gene (CkSNAP33) encoding a synaptosomal-associated protein was isolated from Cynanchum komaroviiand characterized. CkSNAP33 contains Qb- and Qc-SNARE domains in the N- and C-terminal regions, respectively, and shares high sequence identity with AtSNAP33 from Arabidopsis. CkSNAP33 expression was induced by H202, salicylic acid (SA), Verticillium dahliae, and wounding. Arabidopsis lines overexpressing CkSNAP33 had longer primary roots and larger seedlings than the wild type (WT). Transgenic Arabidopsis lines showed significantly enhanced resistance to V. dahliae, and displayed reductions in disease index and fungal biomass, and also showed elevated expression of PR1 and PR5. The leaves of transgenic plants infected with V. dahliae showed strong callose deposition and cell death that hindered the penetration and spread of the fungus at the infection site. Taken together, these results suggest that CkSNAP33 is involved in the defense response against V. dahliae and enhanced disease resistance in Arabidopsis.	[Wang, Ping; Ma, Xiaowen; Sun, Yun; Liu, Nana; Hou, Yuxia] China Agr Univ, Coll Sci, Beijing, Peoples R China; [Zhang, Xueyan; Li, Fuguang] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Hou, YX (corresponding author), China Agr Univ, Coll Sci, Beijing, Peoples R China.; Li, FG (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	aylifug@163.com; houyuxia@cau.edu.cn			State Key Laboratory of Cotton Biology Open Fund [CB2016B01]; "Seven Crop Breeding" National Major Project [2016YFD0101006]; Genetically Modified Organism Breeding Major Project [2014ZX08005-002]; Program of National Nature Science Foundation of China [31071751]	State Key Laboratory of Cotton Biology Open Fund; "Seven Crop Breeding" National Major Project; Genetically Modified Organism Breeding Major Project; Program of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the State Key Laboratory of Cotton Biology Open Fund (Grant No. CB2016B01), the "Seven Crop Breeding" National Major Project (Grant 2016YFD0101006), and the Genetically Modified Organism Breeding Major Project (Grant no. 2014ZX08005-002), the Program of National Nature Science Foundation of China (Grant no. 31071751). YH received the fundings. The funders had no role in study design.	Bao YM, 2008, MOL BIOL REP, V35, P145, DOI 10.1007/s11033-007-9064-8; Bao YM, 2008, MOL GENET GENOMICS, V279, P291, DOI 10.1007/s00438-007-0313-2; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Davletov B, 2007, CELL MOL LIFE SCI, V64, P1597, DOI 10.1007/s00018-007-6557-5; Eisenach C, 2012, PLANT J, V69, P241, DOI 10.1111/j.1365-313X.2011.04786.x; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Eschen-Lippold L, 2012, NEW PHYTOL, V193, P985, DOI 10.1111/j.1469-8137.2011.04024.x; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Grefen C, 2010, PLANT CELL, V22, P3076, DOI 10.1105/tpc.110.077768; Hachez C, 2014, PLANT CELL, V26, P3132, DOI 10.1105/tpc.114.127159; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Honsbein A, 2009, PLANT CELL, V21, P2859, DOI 10.1105/tpc.109.066118; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Liu MJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00544; Liu NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146959; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Luo J, 2016, PLANT GROWTH REGUL, V80, P37, DOI 10.1007/s10725-016-0152-4; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; Qiu WP, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2015.20; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Sanderfoot A, 2007, PLANT PHYSIOL, V144, P6, DOI 10.1104/pp.106.092973; Schilde C, 2008, EUKARYOT CELL, V7, P1387, DOI 10.1128/EC.00012-08; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Tarte VN, 2015, PLANT CELL REP, V34, P1127, DOI 10.1007/s00299-015-1771-3; Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49; Voigt CA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00168; Wang QH, 2012, PROTEIN SCI, V21, P865, DOI 10.1002/pro.2073; Wang QH, 2011, PLANT CELL REP, V30, P1303, DOI 10.1007/s00299-011-1042-x; Wang QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016930; Wang XX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002426; Wick P, 2003, PLANT PHYSIOL, V132, P343, DOI 10.1104/pp.102.012633; Yun HS, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1226456; Zhao T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004945; Zheng HY, 2002, PLANT PHYSIOL, V129, P530, DOI 10.1104/pp.003970; Zhu JH, 2002, PLANT CELL, V14, P3009, DOI 10.1105/tpc.006981; Zhu YF, 2014, PLANT CELL, V26, P4149, DOI 10.1105/tpc.114.128611	45	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178101	10.1371/journal.pone.0178101	http://dx.doi.org/10.1371/journal.pone.0178101			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575006	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300029
J	Sengupta, S; Nagalingam, A; Bonner, NMM; Bonner, MY; Mistriotis, P; Afthinos, A; Kuppusamy, P; Lanoue, D; Cho, S; Korangath, P; Shriver, M; Begum, A; Merino, VF; Huang, CY; Arbiser, JL; Matsui, W; Gyorffy, B; Konstantopoulos, K; Sukumar, S; Marignani, PA; Saxena, NK; Sharma, D				Sengupta, S.; Nagalingam, A.; Muniraj, N.; Bonner, M. Y.; Mistriotis, P.; Afthinos, A.; Kuppusamy, P.; Lanoue, D.; Cho, S.; Korangath, P.; Shriver, M.; Begum, A.; Merino, V. F.; Huang, C-Y; Arbiser, J. L.; Matsui, W.; Gyorffy, B.; Konstantopoulos, K.; Sukumar, S.; Marignani, P. A.; Saxena, N. K.; Sharma, D.			Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; MOLECULAR TARGETS; IN-VITRO; CELLS; LEPTIN; EXPRESSION; MIGRATION; INVASION; PATHWAY; INDUCTION	Tumor suppressor and upstream master kinase Liver kinase B1 (LKB1) plays a significant role in suppressing cancer growth and metastatic progression. We show that low-LKB1 expression significantly correlates with poor survival outcome in breast cancer. In line with this observation, loss-of-LKB1 rendered breast cancer cells highly migratory and invasive, attaining cancer stem cell-like phenotype. Accordingly, LKB1-null breast cancer cells exhibited an increased ability to form mammospheres and elevated expression of pluripotency-factors (Oct4, Nanog and Sox2), properties also observed in spontaneous tumors in Lkb1(-/-) mice. Conversely, LKB1-overexpression in LKB1-null cells abrogated invasion, migration and mammosphere-formation. Honokiol (HNK), a bioactive molecule from Magnolia grandiflora increased LKB1 expression, inhibited individual cell-motility and abrogated the stem-like phenotype of breast cancer cells by reducing the formation of mammosphere, expression of pluripotency-factors and aldehyde dehydrogenase activity. LKB1, and its substrate, AMP-dependent protein kinase (AMPK) are important for HNK-mediated inhibition of pluripotency factors since LKB1-silencing and AMPK-inhibition abrogated, while LKB1-overexpression and AMPK-activation potentiated HNK's effects. Mechanistic studies showed that HNK inhibited Stat3-phosphorylation/activation in an LKB1-dependent manner, preventing its recruitment to canonical binding-sites in the promoters of Nanog, Oct4 and Sox2. Thus, inhibition of the coactivation-function of Stat3 resulted in suppression of expression of pluripotency factors. Further, we showed that HNK inhibited breast tumorigenesis in mice in an LKB1-dependent manner. Molecular analyses of HNK-treated xenografts corroborated our in vitro mechanistic findings. Collectively, these results present the first in vitro and in vivo evidence to support crosstalk between LKB1, Stat3 and pluripotency factors in breast cancer and effective anticancer modulation of this axis with HNK treatment.	[Sengupta, S.; Nagalingam, A.; Muniraj, N.; Cho, S.; Korangath, P.; Shriver, M.; Begum, A.; Merino, V. F.; Matsui, W.; Sukumar, S.; Sharma, D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; [Sengupta, S.; Nagalingam, A.; Muniraj, N.; Cho, S.; Korangath, P.; Shriver, M.; Begum, A.; Merino, V. F.; Matsui, W.; Sukumar, S.; Sharma, D.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA; [Bonner, M. Y.] Emory Univ, Sch Med, Winship Canc Inst, Dept Dermatol, Atlanta, GA USA; [Mistriotis, P.; Afthinos, A.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Kuppusamy, P.; Saxena, N. K.] Univ Maryland, Sch Med, Dept Med, 660W Redwood St,Howard Hall,Rm 301, Baltimore, MD 21201 USA; [Lanoue, D.; Marignani, P. A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Huang, C-Y] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Biostat & Bioinformat, Baltimore, MD USA; [Arbiser, J. L.] Atlanta Vet Adm Med Ctr, Atlanta, GA USA; [Gyorffy, B.] MTA TTK Momentum Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, B.] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Saxena, N. K.] Natl Canc Inst, 9609 Med Ctr Dr, Rockville, MD 20850 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Emory University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Dalhousie University; Johns Hopkins University; Johns Hopkins Medicine; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Saxena, NK (corresponding author), Univ Maryland, Sch Med, Dept Med, 660W Redwood St,Howard Hall,Rm 301, Baltimore, MD 21201 USA.; Sharma, D (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, 1650 Orleans St,CRB 1,Rm 145, Baltimore, MD 21231 USA.	nsaxena@medicine.umaryland.edu; dsharma7@jhmi.edu	Bonner, Michael Yi/ABD-6756-2021; MUNIRAJ, NETHAJI/I-6017-2019; Mistriotis, Panagiotis/AAJ-5248-2020; Kuppusamy, Panjamurthy/AAT-1518-2021; sengupta, sonali/F-8830-2016; Gyorffy, Balazs/AAA-9135-2021	Bonner, Michael Yi/0000-0002-8184-0954; MUNIRAJ, NETHAJI/0000-0002-3820-2148; Mistriotis, Panagiotis/0000-0002-8069-3278; Kuppusamy, Panjamurthy/0000-0003-3293-7220; sengupta, sonali/0000-0002-9710-9576; Gyorffy, Balazs/0000-0002-5772-3766; Shriver, Marey/0000-0002-1644-6408; Marignani, Paola/0000-0001-8070-905X; Afthinos, Alexandros/0000-0001-6906-0771; Korangath, Preethi/0000-0002-6623-493X	NCI NIH [R21CA185943, R01AR47901, R01CA131294, R21CA155686]; OTKA [K108655]; Nova Scotia Health Research Foundation; Canadian Breast Cancer Foundation; Nova; Dalhousie Medical Research Foundation; Avon Foundation; Breast Cancer Research Foundation (BCRF) [90047965]; Fetting Fund; NATIONAL CANCER INSTITUTE [K24CA198315, R01CA131294, R21CA155686, R01CA193887, R21CA185943, P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047901] Funding Source: NIH RePORTER	NCI NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Nova Scotia Health Research Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Nova; Dalhousie Medical Research Foundation; Avon Foundation; Breast Cancer Research Foundation (BCRF); Fetting Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NCI NIH, R21CA185943 (to NKS); OTKA K108655 (to BG); NCI NIH R01AR47901 (to JLA); The Nova Scotia Health Research Foundation (DL); The Canadian Breast Cancer Foundation and The Nova and the Dalhousie Medical Research Foundation (PAM); NCI NIH R01CA131294, NCI NIH R21CA155686, Avon Foundation, Breast Cancer Research Foundation (BCRF) 90047965 and The Fetting Fund (to DS).	Andrade-Vieira R, 2014, ONCOTARGET, V5, P12738, DOI 10.18632/oncotarget.2818; Andrade-Vieira R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056567; Autanski DB, 2014, MOL ONCOL, V8, P565, DOI 10.1016/j.molonc.2014.01.004; Averett Courey, 2014, Enzymes, V36, P175, DOI 10.1016/B978-0-12-802215-3.00009-4; Avtanski DB, 2015, ONCOTARGET, V6, P16396, DOI 10.18632/oncotarget.3844; Azare J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027851; Bai XH, 2003, J BIOL CHEM, V278, P35501, DOI 10.1074/jbc.M302967200; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Burdelya L, 2002, MOL CANCER THER, V1, P893; Choi DY, 2012, BRAIN RES BULL, V87, P144, DOI 10.1016/j.brainresbull.2011.11.014; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hung WC, 2016, CELL REP, V15, P1430, DOI 10.1016/j.celrep.2016.04.035; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Li J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0070-0; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; Nagalingam A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3128; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Oh JH, 2009, CHEM-BIOL INTERACT, V180, P506, DOI 10.1016/j.cbi.2009.03.014; Prasad R, 2016, ONCOTARGET, V7, P7899, DOI 10.18632/oncotarget.6860; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Vaahtomeri K, 2011, FEBS LETT, V585, P944, DOI 10.1016/j.febslet.2010.12.034; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xu Q, 2008, PROG NEURO-PSYCHOPH, V32, P715, DOI 10.1016/j.pnpbp.2007.11.020; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhou JJ, 2014, FEBS LETT, V588, P566, DOI 10.1016/j.febslet.2013.11.041	49	67	69	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5709	5721		10.1038/onc.2017.164	http://dx.doi.org/10.1038/onc.2017.164			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28581518	Green Accepted, Green Submitted			2022-12-26	WOS:000412843900005
J	Branco, RCS; Camargo, RL; Batista, TM; Vettorazzi, JF; Borck, PC; dos Santos-Silva, JCR; Boschero, AC; Zoppi, CC; Carneiro, EM				Souto Branco, Renato Chaves; Camargo, Rafael Ludemann; Batista, Thiago Martins; Vettorazzi, Jean Franciesco; Borck, Patricia Cristine; Rebelo dos Santos-Silva, Junia Carolina; Boschero, Antonio Carlos; Zoppi, Claudio Cesar; Carneiro, Everardo Magalhaes			Protein malnutrition blunts the increment of taurine transporter expression by a high-fat diet and impairs taurine reestablishment of insulin secretion	FASEB JOURNAL			English	Article						undernutrition; obesity; NADP; pyruvate carboxylase; interleukin-6	PYRUVATE-CARBOXYLASE; MALNOURISHED MICE; ANTIOXIDANT ACTIVITY; DIABETES-MELLITUS; LEPTIN RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; GLUCOSE; ISLETS; CELLS	Taurine (Tau) restores beta-cell function in obesity; however, its action is lost in malnourished obese rodents. Here, we investigated the mechanisms involved in the lack of effects of Tau in this model. C57BL/6 mice were fed a control diet (CD) (14% protein) or a protein-restricted diet (RD) (6% protein) for 6 wk. Afterward, mice received a high-fat diet (HFD) for 8 wk [CD + HFD (CH) and RD + HFD (RH)] with or without 5% Tau supplementation after weaning on their drinking water [CH + Tau (CHT) and RH + Tau (RHT)]. The HFD increased insulin secretion through mitochondrial metabolism in CH and RH. Tau prevented all those alterations in CHT only. The expression of the taurine transporter (Tau-T), as well as Tau content in pancreatic islets, was increased in CH but had no effect on RH. Protein malnutrition programs beta cells and impairs Tau-induced restoration of mitochondrial metabolism and biogenesis. This may be associated with modulation of the expression of Tau-T in pancreatic islets, which may be responsible for the absence of effect of Tau in protein-malnourished obese mice.	[Souto Branco, Renato Chaves; Camargo, Rafael Ludemann; Batista, Thiago Martins; Vettorazzi, Jean Franciesco; Borck, Patricia Cristine; Rebelo dos Santos-Silva, Junia Carolina; Boschero, Antonio Carlos; Zoppi, Claudio Cesar; Carneiro, Everardo Magalhaes] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Branco, RCS (corresponding author), Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083970 Campinas, SP, Brazil.	renatocsb@gmail.com	Batista, Thiago M/C-9816-2014; Carneiro, Everardo/D-4758-2012; Silva, Junia C Santos/E-5052-2015	Batista, Thiago M/0000-0001-6971-1191; Silva, Junia C Santos/0000-0002-8667-8140; VETTORAZZI, JEAN/0000-0002-6411-2947	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil); Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil)	This study was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo, Brazil); the Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (Brasilia, Brazil); and the Instituto Nacional de Ciencia e Tecnologia (Brasilia, Brazil). C.C.Z. and M.C. share senior authorship. The authors declare no conflicts of interest.	Batista TM, 2013, MOL NUTR FOOD RES, V57, P423, DOI 10.1002/mnfr.201200345; Batista TM, 2012, J NUTR BIOCHEM, V23, P306, DOI 10.1016/j.jnutbio.2010.12.012; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Besseiche A, 2018, DIABETES METAB, V44, P45, DOI 10.1016/j.diabet.2017.01.007; BORDIN S, 1995, J MEMBRANE BIOL, V148, P177; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges CC, 2001, AM J PHYSIOL-CELL PH, V281, pC1825, DOI 10.1152/ajpcell.2001.281.6.C1825; Cappelli AP, 2014, LIVER INT, V34, P771, DOI 10.1111/liv.12291; Duque-Guimaraes DE, 2013, TRENDS ENDOCRIN MET, V24, P525, DOI 10.1016/j.tem.2013.05.006; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Haan C, 2002, BIOCHEM J, V361, P105, DOI 10.1042/0264-6021:3610105; Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Han J, 2010, J ENDOCRINOL, V204, P143, DOI 10.1677/JOE-09-0391; Hansen DB, 2012, J MEMBRANE BIOL, V245, P77, DOI 10.1007/s00232-012-9416-8; Hansen SH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S23; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HOFFMANN EK, 1983, J PHYSIOL-LONDON, V338, P613, DOI 10.1113/jphysiol.1983.sp014692; JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7; Kang YS, 2002, J NEUROCHEM, V83, P1188, DOI 10.1046/j.1471-4159.2002.01223.x; Kim KS, 2012, EXP MOL MED, V44, P665, DOI 10.3858/emm.2012.44.11.075; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Lambert IH, 2014, AM J PHYSIOL-CELL PH, V306, pC1028, DOI 10.1152/ajpcell.00005.2014; LAMBERT IH, 1993, J MEMBRANE BIOL, V131, P67, DOI 10.1007/BF02258535; Leite NC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33464; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; Maechler P, 2012, BEST PRACT RES CL EN, V26, P739, DOI 10.1016/j.beem.2012.07.003; Mayeur S, 2013, AM J PHYSIOL-ENDOC M, V304, pE14, DOI 10.1152/ajpendo.00332.2012; Mochizuki T, 2002, FEBS LETT, V517, P92, DOI 10.1016/S0014-5793(02)02584-X; Mollerup J, 1998, BBA-BIOMEMBRANES, V1371, P335, DOI 10.1016/S0005-2736(98)00033-9; Mollerup J, 1996, J MEMBRANE BIOL, V150, P73, DOI 10.1007/s002329900031; Oropeza D, 2015, MOL METAB, V4, P811, DOI 10.1016/j.molmet.2015.08.001; Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021; Parvez S, 2008, BASIC CLIN PHARMACOL, V102, P382, DOI 10.1111/j.1742-7843.2008.00208.x; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; QUINLAN TR, 1995, AM J PATHOL, V147, P728; da Silva PMR, 2012, METABOLISM, V61, P721, DOI 10.1016/j.metabol.2011.09.012; da Silva PMR, 2010, METABOLISM, V59, P911, DOI 10.1016/j.metabol.2009.10.014; Ribeiro RA, 2012, AMINO ACIDS, V43, P1791, DOI 10.1007/s00726-012-1263-5; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Soriano S, 2010, ENDOCRINOLOGY, V151, P3543, DOI 10.1210/en.2010-0008; Sugden MC, 2011, ISLETS, V3, P302, DOI 10.4161/isl.3.6.17806; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; Vettorazzi JF, 2014, AMINO ACIDS, V46, P2123, DOI 10.1007/s00726-014-1763-6; Voss JW, 2004, EUR J BIOCHEM, V271, P4646, DOI 10.1111/j.1432-1033.2004.04420.x; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9	65	7	7	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4078	4087		10.1096/fj.201600326RRR	http://dx.doi.org/10.1096/fj.201600326RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572444				2022-12-26	WOS:000408713300031
J	Johnson, CP; Kim, IK; Esmaeli, B; Amin-Mansour, A; Treacy, DJ; Carter, SL; Hodis, E; Wagle, N; Seepo, S; Yu, XX; Lane, AM; Gragoudas, ES; Vazquez, F; Nickerson, E; Cibulskis, K; McKenna, A; Gabriel, SB; Getz, G; Van Allen, EM; 't Hoen, PAC; Garraway, LA; Woodman, SE				Johnson, Chelsea Place; Kim, Ivana K.; Esmaeli, Bita; Amin-Mansour, Ali; Treacy, Daniel J.; Carter, Scott L.; Hodis, Eran; Wagle, Nikhil; Seepo, Sara; Yu, Xiaoxing; Lane, Anne Marie; Gragoudas, Evangelos S.; Vazquez, Francisca; Nickerson, Elizabeth; Cibulskis, Kristian; McKenna, Aaron; Gabriel, Stacey B.; Getz, Gad; Van Allen, Eliezer M.; 't Hoen, Peter A. C.; Garraway, Levi A.; Woodman, Scott E.			Systematic genomic and translational efficiency studies of uveal melanoma	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SOMATIC MUTATIONS; SF3B1 MUTATIONS; MONOSOMY 3; EIF1A; INITIATION; CANCER; BINDING; GNAQ; COMPLEXES	To further our understanding of the somatic genetic basis of uveal melanoma, we sequenced the protein-coding regions of 52 primary tumors and 3 liver metastases together with paired normal DNA. Known recurrent mutations were identified in GNAQ, GNA11, BAP1, EIF1AX, and SF3B1. The role of mutated EIF1AX was tested using loss of function approaches including viability and translational efficiency assays. Knockdown of both wild type and mutant EIF1AX was lethal to uveal melanoma cells. We probed the function of N-terminal tail EIF1AX mutations by performing RNA sequencing of polysome-associated transcripts in cells expressing endogenous wild type or mutant EIF1AX. Ribosome occupancy of the global translational apparatus was sensitive to suppression of wild type but not mutant EIF1AX. Together, these studies suggest that cells expressing mutant EIF1AX may exhibit aberrant translational regulation, which may provide clonal selective advantage in the subset of uveal melanoma that harbors this mutation.	[Johnson, Chelsea Place; Treacy, Daniel J.; Carter, Scott L.; Wagle, Nikhil; Van Allen, Eliezer M.; Garraway, Levi A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Johnson, Chelsea Place; Amin-Mansour, Ali; Carter, Scott L.; Hodis, Eran; Wagle, Nikhil; Seepo, Sara; Vazquez, Francisca; Nickerson, Elizabeth; Cibulskis, Kristian; McKenna, Aaron; Gabriel, Stacey B.; Getz, Gad; Van Allen, Eliezer M.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Kim, Ivana K.; Lane, Anne Marie; Gragoudas, Evangelos S.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Ocular Melanoma Ctr, Boston, MA USA; [Kim, Ivana K.; Lane, Anne Marie; Gragoudas, Evangelos S.] Harvard Med Sch, Dept Ophthalmol, Massachusetts Eye & Ear, Retina Serv, Boston, MA USA; [Esmaeli, Bita] Univ Texas MD Anderson Canc Ctr, Dept Plast Surg, Orbital Oncol & Ophthalm Plast Surg Program, Houston, TX 77030 USA; [Yu, Xiaoxing; Woodman, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Yu, Xiaoxing; Woodman, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [McKenna, Aaron] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; ['t Hoen, Peter A. C.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Johnson, Chelsea Place] Tango Therapeut, Cambridge, MA USA; [Garraway, Levi A.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Eli Lilly	Garraway, LA (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Woodman, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.; Woodman, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.; Garraway, LA (corresponding author), Eli Lilly & Co, Indianapolis, IN 46285 USA.	levi_garraway@dfci.harvard.edu; swoodman@mdanderson.org	Wagle, Nikhil/Q-7428-2019; Vazquez, Francisca/AAA-3751-2020; Hoen, Peter A 't/D-3950-2018; Vazquez, Francisca/ABC-4620-2020; Cibulskis, Kristian/AAC-7380-2019	Vazquez, Francisca/0000-0002-2857-4685; Hoen, Peter A 't/0000-0003-4450-3112; Kim, Ivana/0000-0003-0310-6129; Cibulskis, Kristian/0000-0003-1343-1582	National Human Genome Research Institute (NHGRI); Melanoma Research Foundation; Melanoma Research Alliance; Dr. Miriam & Sheldon G. Adelson Medical Research Foundation; National Cancer Institute of the National Institutes of Health [R21CA139300, F31CA171320, 5TL1RR025756]; Grimshaw Gudewicz Foundation; Rising Stars Award, University of Texas System; Cancer Center Support Grant, Faculty Award, NCI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Melanoma Research Foundation; Melanoma Research Alliance; Dr. Miriam & Sheldon G. Adelson Medical Research Foundation; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grimshaw Gudewicz Foundation; Rising Stars Award, University of Texas System; Cancer Center Support Grant, Faculty Award, NCI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Human Genome Research Institute (NHGRI; L.A.G.), CURE OM of the Melanoma Research Foundation (L.A.G.), the Melanoma Research Alliance (L.A.G.), the Dr. Miriam & Sheldon G. Adelson Medical Research Foundation (L.A.G), and the National Cancer Institute of the National Institutes of Health (L.A.G., I.K.K. #R21CA139300, C.P.J. #F31CA171320 and 5TL1RR025756), the Grimshaw Gudewicz Foundation (ESG), the Rising Stars Award, the University of Texas System (S.E.W), and the Cancer Center Support Grant, Faculty Award, NCI (S.E.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto Y, 2001, INVEST OPHTH VIS SCI, V42, P313; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chen X, 2014, ONCOGENE, V33, P4724, DOI 10.1038/onc.2013.418; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; GRAGOUDAS ES, 1991, OPHTHALMOLOGY, V98, P383; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; HORSMAN DE, 1993, CANCER, V71, P811, DOI 10.1002/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Khalili JS, 2012, CLIN CANCER RES, V18, P4345, DOI 10.1158/1078-0432.CCR-11-3227; Kilic E, 2006, INVEST OPHTH VIS SCI, V47, P3703, DOI 10.1167/iovs.06-0101; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lomakin IB, 2013, NATURE, V500, P307, DOI 10.1038/nature12355; Luke JJ, 2013, CANCER-AM CANCER SOC, V119, P3687, DOI 10.1002/cncr.28282; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moore AR, 2016, NAT GENET, V48, P675, DOI 10.1038/ng.3549; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Piperno-Neumann S, 2014, J CLIN ONCOL; Prescher G, 1996, LANCET, V347, P1222; PRESCHER G, 1995, CANCER GENET CYTOGEN, V80, P40, DOI 10.1016/0165-4608(94)00165-8; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wan YZ, 2013, BLOOD, V121, P4627, DOI 10.1182/blood-2013-02-427641; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wilson BG, 2014, MOL CELL BIOL, V34, P1136, DOI 10.1128/MCB.01372-13; Woodman SE, 2012, CANCER J, V18, P148, DOI 10.1097/PPO.0b013e31824bd256; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017; Zimmer L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118564	52	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178189	10.1371/journal.pone.0178189	http://dx.doi.org/10.1371/journal.pone.0178189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594900	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200019
J	Wang, L; Tang, CH; Xu, B; Yang, L; Qu, LL; Li, LL; Li, XY; Wang, WX; Qin, HF; Gao, HJ; He, K; Liu, XQ				Wang, Lin; Tang, Chuanhao; Xu, Bin; Yang, Lin; Qu, Lili; Li, Liangliang; Li, Xiaoyan; Wang, Weixia; Qin, Haifeng; Gao, Hongjun; He, Kun; Liu, Xiaoqing			Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma	PLOS ONE			English	Article							BIOMARKER DISCOVERY; CANCER PATIENTS; LATEST EVIDENCE; STAGE; ERLOTINIB; EXPRESSION	Background Although pemetrexed plus cis/carboplatin has become the most effective chemotherapy regimen for patients with advanced lung adenocarcinoma, predictive biomarkers are not yet available, and new tools to identify chemosensitive patients who would likely benefit from this treatment are desperately needed. In this study, we constructed and validated predictive peptide models using the serum peptidome profiles of two datasets. Methods One hundred eighty-three patients treated with first-line platinum-based pemetrexed treatment for advanced lung adenocarcinoma were retrospectively enrolled and randomized into the training (n = 92) or validation (n = 91) set, and pre-treatment serum samples were analyzed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and ClinProTools software. Serum peptidome profiles from the training set were used to identify potential predictive peptide biomarkers and construct a predictive peptide model for accurate group discrimination; which was then used to classify validation samples into "good" and "poor" outcome groups. The clinical outcomes of objective response rate (ORR), disease control rate (DCR), progression-free survival (PFS), and overall survival (OS) were analyzed based on the classification result. Results Eight potential peptide biomarkers were identified. A predictive peptide model based on four distinct m/z features (2,142.12, 3,316.19, 4,281.94, and 6,624.02 Da) was developed based on the clinical outcomes of training set patients after first-line pemetrexed plus platinum treatment. In the validation set, the good group had significantly higher ORR (49.1% vs. 8.3%, P < 0.001) and DCR (96.4% vs. 47.2%, P < 0.001), and longer PFS (7.3 months vs. 2.7 months, P < 0.001) vs. the poor group. However, the model did not predict OS (13.6 months vs. 12.7 months, P = 0.0675). Conclusion Our predictive peptide model could predict pemetrexed plus platinum treatment outcomes in patients with advanced lung adenocarcinoma and might thus facilitate appropriate patient selection. Further studies are needed to confirm these findings.	[Wang, Lin; Tang, Chuanhao; Yang, Lin; Qu, Lili; Li, Liangliang; Li, Xiaoyan; Wang, Weixia; Qin, Haifeng; Gao, Hongjun; Liu, Xiaoqing] Acad Mil Med Sci, Dept Lung Canc, Affiliated Hosp, Beijing, Peoples R China; [Xu, Bin; He, Kun] Natl Ctr Biomed Anal, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Liu, XQ (corresponding author), Acad Mil Med Sci, Dept Lung Canc, Affiliated Hosp, Beijing, Peoples R China.	liuxq@medmail.com.cn	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		National Key Scientific Instrument and Equipment Development Project [2011YQ170067]	National Key Scientific Instrument and Equipment Development Project	This work was supported by a grant from the National Key Scientific Instrument and Equipment Development Project (2011YQ170067).	Amann JM, 2010, J THORAC ONCOL, V5, P169, DOI 10.1097/JTO.0b013e3181c8cbd9; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Carbone DP, 2012, J THORAC ONCOL, V7, P1653, DOI 10.1097/JTO.0b013e31826c1155; Carbone DP, 2010, LUNG CANCER, V69, P337, DOI 10.1016/j.lungcan.2009.11.019; Chung CH, 2010, CANCER EPIDEM BIOMAR, V19, P358, DOI 10.1158/1055-9965.EPI-09-0937; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Ettinger DS, 2017, J NATL COMPR CANC NE, V15, P504, DOI 10.6004/jnccn.2017.0050; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; Freed GL, 2008, LARYNGOSCOPE, V118, P61, DOI 10.1097/MLG.0b013e31814cf389; Han Y, 2016, DIS MARKERS 2016, V2016; Kisluk J, 2014, J PHARMACEUT BIOMED, V101, P40, DOI 10.1016/j.jpba.2014.07.038; Klupczynska A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040410; Kuiper JL, 2012, BRIT J CANCER, V107, P1820, DOI 10.1038/bjc.2012.470; Lai ZW, 2015, BIOL CHEM, V396, P185, DOI 10.1515/hsz-2014-0207; Lazzari C, 2012, J THORAC ONCOL, V7, P40, DOI 10.1097/JTO.0b013e3182307f17; Liu Y, 2013, CANCER CHEMOTH PHARM, V72, P1125, DOI 10.1007/s00280-013-2299-2; Lu J, 2016, SEMINARS CANC BIOL; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Olaussen KA, 2016, ANN ONCOL; Orvisky E, 2006, PROTEOMICS, V6, P2895, DOI 10.1002/pmic.200500443; Petricoin EF, 2003, CLIN CHEM, V49, P1228; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schaub NP, 2009, J AM COLL SURGEONS, V208, P970, DOI 10.1016/j.jamcollsurg.2008.12.024; Schwamborn K, 2009, EUR UROL, V56, P989, DOI 10.1016/j.eururo.2009.02.031; Shea M, 2016, THER ADV RESPIR DIS, V10, P113, DOI 10.1177/1753465815617871; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sundar R, 2015, THER ADV MED ONCOL, V7, P85, DOI 10.1177/1758834014567470; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Tomasini P, 2016, THER ADV MED ONCOL, V8, P198, DOI 10.1177/1758834016644155; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Wang N, 2014, J GASTROEN HEPATOL, V29, P1544, DOI 10.1111/jgh.12545; Wu X, 2013, ONCOTARGETS THER, V6, P1481, DOI 10.2147/OTT.S51887; Xiao HQ, 2016, ONCOTARGETS THER, V9, P1471, DOI 10.2147/OTT.S96160; Yadav AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024442	34	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179000	10.1371/journal.pone.0179000	http://dx.doi.org/10.1371/journal.pone.0179000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594947	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200076
J	Nuchel, J; Svenning, JC				Nuchel, Jonas; Svenning, Jens-Christian			Recent tree cover increases in eastern China linked to low, declining human pressure, steep topography, and climatic conditions favoring tree growth	PLOS ONE			English	Article							FOREST RESOURCES ASSESSMENT; NATURE-RESERVES; VARIABLE IMPORTANCE; BIODIVERSITY; REFORESTATION; DESERTIFICATION; AFFORESTATION; OPPORTUNITIES; RESTORATION; ABANDONMENT	Globally, the extent of forest continues to decline, however, some countries have increased their forest extent in recent years. China is one of these countries and has managed to increase their tree cover through huge reforestation and afforestation programs during recent decades as well as land abandonment dynamics. This study investigates tree cover change in the eastern half of China between 2000 and 2010 on three different scales, using random forest modeling of remote sensing data for tree cover in relation to environmental and anthropogenic predictor variables. Our results show that between the years 2000 and 2010 2,667,875 km 2 experienced an increase in tree cover while 1,854,900 km(2) experienced a decline in tree cover. The area experiencing >= 10% increase in tree cover is almost twice as large as the area with >= 10% drop in tree cover. There is a clear relation between topography and tree cover change with steeper and mid-elevation areas having a larger response on tree cover increase than other areas. Furthermore, human influence, change in population density, and actual evapotranspiration are also important factors in explaining where tree cover has changed. This study adds to the understanding of tree cover change in China, as it has focus on the entire eastern half of China on three different scales and how tree cover change is linked to topography and anthropogenic pressure. Though, our results show an increase in tree cover in China, this study emphasizes the importance of incorporating anthropogenic factors together with biodiversity protection into the reforestation and afforestation programs in the future.	[Nuchel, Jonas; Svenning, Jens-Christian] Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark; [Nuchel, Jonas] Sinodanish Ctr Educ & Res, Beijing, Peoples R China	Aarhus University	Nuchel, J (corresponding author), Aarhus Univ, Dept Biosci, Sect Ecoinformat & Biodivers, Aarhus, Denmark.; Nuchel, J (corresponding author), Sinodanish Ctr Educ & Res, Beijing, Peoples R China.	j.nuchel@bios.au.dk	Svenning, Jens-Christian/C-8977-2012	Svenning, Jens-Christian/0000-0002-3415-0862	Aarhus University; Sino-Danish Center for Education and Research; VILLUM FONDEN	Aarhus University; Sino-Danish Center for Education and Research; VILLUM FONDEN(Villum Fonden)	Jonas Nuchel was funded by Aarhus University and Sino-Danish Center for Education and Research.; JCS considers this work a contribution to Danish National Research Foundation Niels Bohr professorship project Aarhus University Research on the Anthropocene (AURA) and to his VILLUM Investigator project "Biodiversity Dynamics in a Changing World" funded by VILLUM FONDEN.	Acacio V, 2010, ECOLOGY SOC, P15; Aerts Raf, 2011, BMC Ecology, V11, P29, DOI 10.1186/1472-6785-11-29; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; [Anonymous], 2010, NATION; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Cao GY, 2012, POPUL ENVIRON, V33, P137, DOI 10.1007/s11111-011-0140-6; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cao SX, 2011, AMBIO, V40, P828, DOI 10.1007/s13280-011-0150-8; Cao SX, 2011, EARTH-SCI REV, V104, P240, DOI 10.1016/j.earscirev.2010.11.002; Cao SX, 2010, AMBIO, V39, P279, DOI 10.1007/s13280-010-0038-z; Ceausu S, 2015, CONSERV BIOL, V29, P1017, DOI 10.1111/cobi.12533; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148121; CIESIN-CIAT, 2015, GRIDD POP WORLD VERS; Dalgaard T, J GEOGRAPHICAL SCI; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; DiMiceli C. M., 2017, ANN GLOBAL AUTOMATED; Du SQ, 2014, LAND-BASEL, V3, P34, DOI 10.3390/land3010034; Ender C, 2015, VIT VAR IMP TEST APP; FAO, 2020, GLOBAL FOREST RESOUR; FAO, 2015, 163 FAO; FAO, 2015, CHIN GLOB FOR RES AS; Federici S, 2015, FOREST ECOL MANAG, V352, P89, DOI 10.1016/j.foreco.2015.04.022; Gregorutti B, 2017, STAT COMPUT, V27, P659, DOI 10.1007/s11222-016-9646-1; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Hansen MC, 2003, EARTH INTERACT, V7; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harkness J, 1998, CHINA QUART, P911; Hua FY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12717; International Union for Conservation of Nature (IUCN), 2013, GUID REINTR OTH CONS; Jarvis A., 2008, HOLE FILLED SRTM GLO; Jim CY, 2004, GEOGR J, V170, P39, DOI 10.1111/j.0016-7398.2004.05038.x; Jim CY, 2003, MT RES DEV, V23, P222, DOI 10.1659/0276-4741(2003)023[0222:GOOTW]2.0.CO;2; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Keenleyside C, 2010, FARMLAND ABANDONMENT, P93; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Li L, 2009, ENVIRON SCI POLLUT R, V16, P474, DOI 10.1007/s11356-009-0130-8; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Liang Guofu, 2006, Journal of Geographical Sciences, V16, P415, DOI 10.1007/s11442-006-0404-8; Liaw A, 2002, CLASS REGR RAND ORES; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Liu X, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010032; Miura S, 2015, FOREST ECOL MANAG, V352, P35, DOI 10.1016/j.foreco.2015.03.039; MODIS Land Team, 2016, STAT VEG CONT FIELDS; National Bureau of Statistics of China, 2001, 2001 CHIN STAT YB RE; Navarro L., 2015, REWILDING EUROPEAN L, P3, DOI DOI 10.1007/978-3-319-12039-3_1; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Qin YY, 2015, BIOL CONSERV, V182, P72, DOI 10.1016/j.biocon.2014.10.036; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Sandel B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3474; Sayer J, 2004, FOREST ECOL MANAG, V201, P3, DOI 10.1016/j.foreco.2004.06.008; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Sloan S, 2015, FOREST ECOL MANAG, V352, P134, DOI 10.1016/j.foreco.2015.06.013; Townshend J., 2011, US GUID MODIS VEG CO; TRABUCCO A, 2010, CGIAR CONSORTIUM SPA; UNEP-WCMC IUCN, 2014, PROT PLAN WORLD DAT; Vie A J-C, 2009, WILDLIFE CHANGING WO; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37658; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105086; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang X, 2016, CATENA, P137; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Wildlife Conservation Society-WCS -and Center for Interntional Earth Science Infrmation Network D CIESIN D Columbia University, LAST WILD PROJ VERS; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Yin R., 2005, CHINA ENV SER, V7, P17; Zhang YX, 2006, J FOREST, V104, P383; Zhou HJ, 2009, LAND USE POLICY, V26, P954, DOI 10.1016/j.landusepol.2008.11.006	75	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177552	10.1371/journal.pone.0177552	http://dx.doi.org/10.1371/journal.pone.0177552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591146	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700010
J	Velez-Serrano, JF; Velez-Serrano, D; Hernandez-Barrera, V; Jimenez-Garcia, R; de Andres, AL; Garrido, PC; Alvaro-Meca, A				Velez-Serrano, Jose F.; Velez-Serrano, Daniel; Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo; Lopez de Andres, Ana; Carrasco Garrido, Pilar; Alvaro-Meca, Alejandro			Prediction of in-hospital mortality after pancreatic resection in pancreatic cancer patients: A boosting approach via a population-based study using health administrative data	PLOS ONE			English	Article							PERIOPERATIVE MORTALITY; RISK SCORE; VOLUME; SURGERY; CLASSIFICATION; IMPACT	Background One reason for the aggressiveness of the pancreatic cancer is that it is diagnosed late, which often limits both the therapeutic options that are available and patient survival. The long-term survival of pancreatic cancer patients is not possible if the tumor is not resected, even among patients who receive chemotherapy in the earliest stages. The main objective of this study was to create a prediction model for in-hospital mortality after a pancreatectomy in pancreatic cancer patients. Methods We performed a retrospective study of all pancreatic resections in pancreatic cancer patients in Spanish public hospitals (2013). Data were obtained from records in the Minimum Basic Data Set. To develop the prediction model, we used a boosting method. Results The in-hospital mortality of pancreatic resections in pancreatic cancer patients was 8.48% in Spain. Our model showed high predictive accuracy, with an AUC of 0.91 and a Brier score of 0.09, which indicated that the probabilities were well calibrated. In addition, a sensitivity analysis of the information available prior to the surgery revealed that our model has high predictive accuracy, with an AUC of 0.802. Conclusions In this study, we developed a nation-wide system that is capable of generating accurate and reliable predictions of in-hospital mortality after pancreatic resection in patients with pancreatic cancer. Our model could help surgeons understand the importance of the patients' characteristics prior to surgery and the health effects that may follow resection.	[Velez-Serrano, Jose F.] Rey Juan Carlos Univ, Dept Comp Sci, Madrid, Spain; [Velez-Serrano, Daniel] Univ Complutense Madrid, Dept Stat & Operat Res, Madrid, Spain; [Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo; Lopez de Andres, Ana; Carrasco Garrido, Pilar; Alvaro-Meca, Alejandro] Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain	Universidad Rey Juan Carlos; Complutense University of Madrid; Universidad Rey Juan Carlos	Alvaro-Meca, A (corresponding author), Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth, Madrid, Spain.	alejandro.alvaro@urjc.es	Lopez-de-Andres, Ana/AAD-8703-2019; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Velez, Jose/K-7708-2014	Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Velez, Jose/0000-0001-8903-4714; Alvaro-Meca, Alejandro/0000-0003-1315-4386; Hernandez-Barrera, Valentin/0000-0001-5790-1959	MINECO [ES-TIN2014-57458-R]	MINECO(Spanish Government)	This work has been supported by the MINECO ES-TIN2014-57458-R project.	Alfaro E, 2013, J STAT SOFTW, V54, P1; Alsfasser G, 2012, SURGERY, V152, pS50, DOI 10.1016/j.surg.2012.05.011; Alvaro-Meca A, 2012, CANCER EPIDEMIOL, V36, pE142, DOI 10.1016/j.canep.2011.12.005; Austin PC, 2013, J CLIN EPIDEMIOL, V66, P398, DOI 10.1016/j.jclinepi.2012.11.008; Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211; Bliss LA, 2014, HPB, V16, P899, DOI 10.1111/hpb.12283; Bosetti C, 1980, ANN ONCOL; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buanes TA, 2014, WORLD J GASTROENTERO, V20, P10405, DOI 10.3748/wjg.v20.i30.10405; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; de Wilde RF, 2012, BRIT J SURG, V99, P404, DOI 10.1002/bjs.8664; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ford DW, 2016, CRIT CARE MED, V44, P319, DOI 10.1097/CCM.0000000000001392; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Gawande AA, 2007, J AM COLL SURGEONS, V204, P201, DOI 10.1016/j.jamcollsurg.2006.11.011; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Goodney PP, 2002, J AM COLL SURGEONS, V195, P219, DOI 10.1016/S1072-7515(02)01228-0; Grendar J, 2012, ARCH SURG-CHICAGO, V147, P126, DOI 10.1001/archsurg.2011.296; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hill JS, 2010, ANN SURG ONCOL, V17, P1802, DOI 10.1245/s10434-010-0947-x; Ho V, 2003, ANN SURG, V237, P509, DOI 10.1097/00000658-200304000-00012; Jilesen AP, 2015, WORLD J SURG, P1; Karpoff HM, 2001, ARCH SURG-CHICAGO, V136, P44, DOI 10.1001/archsurg.136.1.44; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; McPhee JT, 2007, ANN SURG, V246, P246, DOI 10.1097/01.sla.0000259993.17350.3a; Mehta HB, 2016, J SURG RES, V204, P326, DOI 10.1016/j.jss.2016.05.008; Niculescu-Mizil A., 2005, MACH LEARN P 22 INT, P625, DOI 10.1145/1102351.1102430; Nimptsch U, 2016, ANN SURG, V264, P1082, DOI 10.1097/SLA.0000000000001693; Platt JC, 2000, ADV NEUR IN, P61; Pratt W, 2008, SURGERY, V143, P8, DOI 10.1016/j.surg.2007.07.035; R Core Team, 2021, R LANGUAGE ENV STAT; Ragulin-Coyne E, 2012, SURGERY, V152, pS120, DOI 10.1016/j.surg.2012.05.018; Riediger H, 2014, J GASTROINTEST SURG, V18, P1434, DOI 10.1007/s11605-014-2555-8; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Subdireccion General de Desarrollo Instituto Nacional de Salud Ministerio de Sanidad y Consumo, 2001, CONJ MIN BAS DAT DAT	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178757	10.1371/journal.pone.0178757	http://dx.doi.org/10.1371/journal.pone.0178757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591154	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700046
J	Kohara, M; Masuda, T; Shiizaki, K; Akimoto, T; Watanabe, Y; Honma, S; Sekiguchi, C; Miyazawa, Y; Kusano, E; Kanda, Y; Asano, Y; Kuro-o, M; Nagata, D				Kohara, Marina; Masuda, Takahiro; Shiizaki, Kazuhiro; Akimoto, Tetsu; Watanabe, Yuko; Honma, Sumiko; Sekiguchi, Chuji; Miyazawa, Yasuharu; Kusano, Eiji; Kanda, Yoshinobu; Asano, Yasushi; Kuro-o, Makoto; Nagata, Daisuke			Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; HEMODIALYSIS-PATIENTS; METABOLIC-ACTIVITY; SERUM-LEVELS; BETA-KLOTHO; PPAR-ALPHA; FGF21; LIVER; FIBROBLAST-GROWTH-FACTOR-21	Fibroblast growth factor 21 (FGF21) is an endocrine factor that regulates glucose and lipid metabolism. Circulating FGF21 predicts cardiovascular events and mortality in type 2 diabetes mellitus, including early-stage chronic kidney disease, but its impact on clinical outcomes in end-stage renal disease (ESRD) patients remains unclear. This study enrolled 90 ESRD patients receiving chronic hemodialysis who were categorized into low-and high-FGF21 groups by the median value. We investigated the association between circulating FGF21 levels and the cardiovascular event and mortality during a median follow-up period of 64 months. A Kaplan-Meier analysis showed that the mortality rate was significantly higher in the high-FGF21 group than in the low-FGF21 group (28.3% vs. 9.1%, log-rank, P = 0.034), while the rate of cardiovascular events did not significantly differ between the two groups (30.4% vs. 22.7%, log-rank, P = 0.312). In multivariable Cox models adjusted a high FGF21 level was an independent predictor of all-cause mortality (hazard ratio: 3.98; 95% confidence interval: 1.39-14.27, P = 0.009). Higher circulating FGF21 levels were associated with a high mortality rate, but not cardiovascular events in patient with ESRD, suggesting that circulating FGF21 levels serve as a predictive marker for mortality in these subjects.	[Kohara, Marina; Masuda, Takahiro; Akimoto, Tetsu; Watanabe, Yuko; Nagata, Daisuke] Jichi Med Univ, Div Nephrol, Dept Internal Med, Shimotsuke, Tochigi, Japan; [Shiizaki, Kazuhiro; Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, Div Antiaging Med, Shimotsuke, Tochigi, Japan; [Honma, Sumiko; Asano, Yasushi] Japanese Red Cross Koga Hosp, Dept Nephrol, Koga, Ibaraki, Japan; [Sekiguchi, Chuji; Miyazawa, Yasuharu] Nasu Minami Hosp, Nasukarasuyama, Tochigi, Japan; [Kusano, Eiji] JCHO Utsunomiya Hosp, Utsunomiya, Tochigi, Japan; [Kanda, Yoshinobu] Jichi Med Univ, Dept Med, Div Hematol, Shimotsuke, Tochigi, Japan; [Kuro-o, Makoto] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, Tokyo, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University	Masuda, T (corresponding author), Jichi Med Univ, Div Nephrol, Dept Internal Med, Shimotsuke, Tochigi, Japan.	takam@jichi.ac.jp	Masuda, Takahiro/GQQ-4751-2022	Masuda, Takahiro/0000-0002-6893-7188	Grants-in-Aid for Scientific Research [15K09269] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Gomez-Samano MA, 2017, REDOX BIOL, V11, P335, DOI 10.1016/j.redox.2016.12.024; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Crasto C, 2012, J AM GERIATR SOC, V60, P792, DOI 10.1111/j.1532-5415.2011.03879.x; Floege J, 2015, KIDNEY INT, V87, P996, DOI 10.1038/ki.2014.419; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gariani K, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0040; Gonzalez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151698; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Hindricks J, 2014, CLIN ENDOCRINOL, V80, P918, DOI 10.1111/cen.12380; Iglesias P, 2012, EUR J ENDOCRINOL, V167, P301, DOI 10.1530/EJE-12-0357; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jin YP, 2015, J DIABETES COMPLICAT, V29, P395, DOI 10.1016/j.jdiacomp.2014.12.015; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2014, DIABETES METAB J, V38, P245, DOI 10.4093/dmj.2014.38.4.245; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee CH, 2015, J CLIN ENDOCR METAB, V100, P1368, DOI 10.1210/jc.2014-3465; Lenart-Lipinska M, 2013, DIABETES RES CLIN PR, V101, P194, DOI 10.1016/j.diabres.2013.04.010; Li Q, 2016, J CLIN ENDOCR METAB, V101, P4886, DOI 10.1210/jc.2016-2308; Liu SQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02767; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P1272, DOI 10.1093/ndt/gfg074; Looker HC, 2015, KIDNEY INT, V88, P888, DOI 10.1038/ki.2015.199; Masuda T, 2011, NEPHROL DIAL TRANSPL, V26, P2289, DOI 10.1093/ndt/gfq756; Matsubara Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173468; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ong KL, 2015, DIABETOLOGIA, V58, P464, DOI 10.1007/s00125-014-3458-7; Otani-Takei N, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/406269; Patel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087102; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Qin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027155; Sacks DB, 2011, CLIN CHEM, V57, P793, DOI 10.1373/clinchem.2011.163634; Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Selmi C, 2007, EXP BIOL MED, V232, P1409, DOI 10.3181/0704-MR-103; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Summerfield A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27047; Taniguchi H, 2016, J CLIN ENDOCR METAB, V101, P190, DOI 10.1210/jc.2015-3308; Thiessen SE, 2015, J CLIN ENDOCR METAB, V100, pE1319, DOI 10.1210/jc.2015-2700; Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67; Ye DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19776; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	44	40	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178971	10.1371/journal.pone.0178971	http://dx.doi.org/10.1371/journal.pone.0178971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582462	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600064
J	Wang, HC; Liu, SW; Liu, SQ; Wei, W; Zhou, XL; Lin, F; Wang, JJ; Chen, JY; Zhang, GD; Pang, YB				Wang, Haichen; Liu, Shengwu; Liu, Shengqiang; Wei, Wei; Zhou, Xiaolong; Lin, Fang; Wang, Juanjuan; Chen, Jinye; Zhang, Guodong; Pang, Yongbing			Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; FIBROBLAST; HEART; RESVERATROL; HYPERTROPHY; INHIBITION; FAILURE; PATHWAY; REPAIR	Cardiac fibroblasts (CFs) phenotypic conversion to myofibroblasts (MFs) represents a crucial event in cardiac fibrosis that leads to impaired cardiac function. However, regulation of this phenotypic transformation remains unclear. Here, we showed that sirtuin-7 (Sirt7) plays an important role in the regulation of MFs differentiation. Sirt7 expression and phosphorylation were upregulated in CFs upon angiotensin-II (Ang-II) stimulation. Sirt7 depletion by siRNA in CFs resulted in decreased cell proliferation and extracellular matrix (ECM) deposition. Further, examination of Sirt7-depleted CFs demonstrated significantly lower expression of a-smooth muscle actin (a-SMA), the classical marker of MFs differentiation, and decreased formation of focal adhesions. Moreover, overexpression of Sirt7 increased aSMA expression in Ang-II treated CFs and exacerbated Ang-II-induced MFs differentiation. Moreover, Sirt7 depletion could largely reverse Ang-II induced increase of nuclear translocalization and activity of smad2 and extracellular regulated kinases (ERK) in CFs. Importantly, the increased differentiation of CFs to MFs was also abolished by smad2 siRNA or U0126. Our findings reveal a novel role of Sirt7 and its phosphorylation in the phenotypic conversion of CFs to MFs and might lead to the development of new therapeutic and prognostic tools for cardiac fibrosis.	[Wang, Haichen] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Xian, Shaanxi, Peoples R China; [Liu, Shengwu; Wang, Juanjuan] Yanan Univ, Affiliated Hosp, Dept Neurol, Yanan, Shaanxi, Peoples R China; [Liu, Shengqiang] Ankang Cent Hosp, Dept Cardiol, Ankang, Shaanxi, Peoples R China; [Wei, Wei; Pang, Yongbing] Yanan Univ, Affiliated Hosp, Dept Neurosurg, Yanan, Shaanxi, Peoples R China; [Zhou, Xiaolong] Baoji Cent Hosp, Dept Neurosurg, Baoji, Shaanxi, Peoples R China; [Lin, Fang] Yanan Univ, Affiliated Hosp, Dept Geriatr, Yanan, Shaanxi, Peoples R China; [Chen, Jinye] Ankang Cent Hosp, Dept Cardiovasc & Pulm, Ankang, Shaanxi, Peoples R China; [Zhang, Guodong] Baoji Cent Hosp, Dept Brain Tumor, Baoji, Shaanxi, Peoples R China	Xi'an Jiaotong University; Yanan University; Yanan University; Yanan University	Pang, YB (corresponding author), Yanan Univ, Affiliated Hosp, Dept Neurosurg, Yanan, Shaanxi, Peoples R China.; Chen, JY (corresponding author), Ankang Cent Hosp, Dept Cardiovasc & Pulm, Ankang, Shaanxi, Peoples R China.; Zhang, GD (corresponding author), Baoji Cent Hosp, Dept Brain Tumor, Baoji, Shaanxi, Peoples R China.	chenjinye3820@163.com; zhangguodun1964@163.com; pangyongbing1982@126.com	wang, juanjuan/GYV-5540-2022		National Natural Science Foundation of China [81172362]; Shaanxi Science & Technology Co-ordination & Innovation Project [2013KTCQ03-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Science & Technology Co-ordination & Innovation Project	National Natural Science Foundation of China [No. 81172362] and Shaanxi Science & Technology Co-ordination & Innovation Project [2013KTCQ03-08].; This work was supported by the National Natural Science Foundation of China [No. 81172362], and Shaanxi Science & Technology Co-ordination & Innovation Project [2013KTCQ03-08].	Araki S, 2015, CIRCULATION, V132, P1081, DOI 10.1161/CIRCULATIONAHA.114.014821; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Braunwald Eugene, 2015, Eur Heart J, V36, P1350, DOI 10.1093/eurheartj/ehv101; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chen TS, 2015, AM J PHYSIOL-HEART C, V308, pH424, DOI 10.1152/ajpheart.00454.2014; Dostal D, 2015, COMPR PHYSIOL, V5, P887, DOI 10.1002/cphy.c140053; Duan BA, 2016, CANCER LETT, V379, P70, DOI 10.1016/j.canlet.2016.05.027; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Manso AM, 2009, J INVEST MED, V57, P856, DOI 10.2310/JIM.0b013e3181c5e61f; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Ponnusamy M, 2014, J PHARMACOL EXP THER, V350, P243, DOI 10.1124/jpet.113.212076; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Simic P, 2013, CELL REP, V3, P1175, DOI 10.1016/j.celrep.2013.03.019; Sun LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12497; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tan KM, 2015, TRANSL RES, V165, P374, DOI 10.1016/j.trsl.2014.08.008; Yu H, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-32; Yu SS, 2013, BRIT J PHARMACOL, V168, P117, DOI 10.1111/j.1476-5381.2012.01903.x; Zhang YJ, 2015, ONCOTARGET, V6, P7244, DOI 10.18632/oncotarget.3133; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	26	11	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178530	10.1371/journal.pone.0178530	http://dx.doi.org/10.1371/journal.pone.0178530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582407	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600022
J	Cho, H; Kim, JH				Cho, Heeyeon; Kim, Jae Hyun			Prevalence of microalbuminuria and its associated cardiometabolic risk factors in Korean youth: Data from the Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							LIPOPROTEIN-CHOLESTEROL RATIO; BODY-MASS INDEX; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; WAIST CIRCUMFERENCE; RENAL INJURY; ADOLESCENTS; ALBUMINURIA; HYPERTENSION	Background Microalbuminuria is a known early predictive factor for renal and cardiovascular diseases, not only for patients with diabetes mellitus or hypertension but also in the general population. However, the prevalence and risk factors associated with microalbuminuria in Korean youth are unknown. Objectives The aims of this study are to evaluate the prevalence of microalbuminuria and the association between microalbuminuria and obesity or cardiometabolic risk factors in Korean children and adolescents without diabetes. Methods This study examines data obtained from the Korea National Health and Nutrition Examination Survey (between 2011 and 2014). It includes a total of 1,976 participants aged between 10 and 19 years (boys 1,128 and girls 848). Microalbuminuria was defined as a urine albumin-to-creatinine ratio (UACR) of >= 30 mg/g and < 300 mg/g. Association between microalbuminuria and the risk factors for cardiometabolic diseases including insulin resistance was evaluated. Results The prevalence of microalbuminuria was found to be 3.0% in Korean children and adolescents over this time period. The mean UACR for non-obese youth was significantly greater than that found in obese youth (3.2 +/- 0.1 mg/g in the non-obese group vs. 2.1 +/- 0.2 mg/g in the obese group; P < 0.001). In multiple logistic regression analysis, microalbuminuria was associated with hyperglycemia (OR 2.62, 95% CI 1.09-6.30) and hemoglobin A1c (OR 3.34, 95% CI 1.09-10.17) in the non-obese group and hypertension (OR 14.10, 95% CI 1.12-177.98) and HbAlc (OR 6.68, 95% CI 1.87-23.95) in the obese group. Conclusions The prevalence of microalbuminuria is not prominent in obese children and adolescents. Our findings demonstrated that the presence of hypertension and hyperglycemia was associated with microalbuminuria. Especially Hemoglobin Al c was associated with microalbuminuria in youths regardless of weight status. Microalbuminuria in pediatric population can be a helpful marker for the risk of cardiovascular disease.	[Cho, Heeyeon] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Pediat, Seoul, South Korea; [Kim, Jae Hyun] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Seongnam, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pediat, Seongnam, South Korea.	pedendo@snubh.org	Kim, Jae Hyun/S-1459-2019	Kim, Jae Hyun/0000-0002-0203-7443				Bartz SK, 2015, J CLIN ENDOCR METAB, V100, P3393, DOI 10.1210/JC.2015-2230; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Brambilla P, 2013, INT J OBESITY, V37, P943, DOI 10.1038/ijo.2013.32; Chen LH, 2014, ARCH DIS CHILD, V99, P39, DOI 10.1136/archdischild-2013-303967; Cirillo M, 2006, HYPERTENSION, V47, P56, DOI 10.1161/01.HYP.0000197953.91461.95; Ding W, 2015, PEDIATR NEPHROL, V30, P1, DOI 10.1007/s00467-014-2976-3; Folic N, 2015, SRP ARK CELOK LEK, V143, P146, DOI 10.2298/SARH1504146F; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Goknar N, 2015, PEDIATR NEPHROL, V30, P139, DOI 10.1007/s00467-014-2829-0; HOEGHOLM A, 1994, HYPERTENSION, V24, P101, DOI 10.1161/01.HYP.24.1.101; Huang XL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007429; International Diabetes Federation, 2007, IDF CONS DEF MET SYN; Invitti C, 2006, INT J OBESITY, V30, P627, DOI 10.1038/sj.ijo.0803151; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kelishadi R, 2013, J RES MED SCI, V18, P178; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee IT, 2013, J DIABETES COMPLICAT, V27, P243, DOI 10.1016/j.jdiacomp.2012.11.004; Lurbe E, 2013, J HYPERTENS, V31, P2230, DOI 10.1097/HJH.0b013e328364bcbf; Matsushita Y, 2014, OBESITY, V22, P287, DOI 10.1002/oby.20425; Moon JS, 2007, KOREAN J PEDIAT, V1, P1, DOI DOI 10.3345/KJP.2008.51.1.1; Nguyen S, 2008, PEDIATRICS, V121, P37, DOI 10.1542/peds.2007-3594; Onat A, 2010, J CLIN LIPIDOL, V4, P89, DOI 10.1016/j.jacl.2010.02.005; Park HK, 2013, J PEDIATR GASTR NUTR, V56, P686, DOI 10.1097/MPG.0b013e31828b4e67; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Pontremoli R, 2002, J AM SOC NEPHROL, V13, pS169, DOI 10.1097/01.ASN.0000032601.86590.F7; Rademacher ER, 2009, CURR OPIN NEPHROL HY, V18, P246, DOI 10.1097/MNH.0b013e3283294b98; Radhakishun NNE, 2013, PEDIATR NEPHROL, V28, P1145, DOI 10.1007/s00467-013-2451-6; Savino A, 2011, PEDIATR NEPHROL, V26, P749, DOI 10.1007/s00467-010-1659-y; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seo WJ, 2016, KOREAN J FAM MED, V37, P57, DOI 10.4082/kjfm.2016.37.1.57; Vega GL, 2014, J INVEST MED, V62, P345, DOI 10.2310/JIM.0000000000000044; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yilmaz Y, 2010, METABOLISM, V59, P1327, DOI 10.1016/j.metabol.2009.12.012	35	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178716	10.1371/journal.pone.0178716	http://dx.doi.org/10.1371/journal.pone.0178716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575100	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300103
J	Rungaldier, S; Umlauf, E; Mairhofer, M; Salzer, U; Thiele, C; Prohaska, R				Rungaldier, Stefanie; Umlauf, Ellen; Mairhofer, Mario; Salzer, Ulrich; Thiele, Christoph; Prohaska, Rainer			Structure-function analysis of human stomatin: A mutation study	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEIN; SENSING ION CHANNELS; PLASMA-MEMBRANE; SPFH DOMAIN; LIPID RAFTS; CAENORHABDITIS-ELEGANS; ANCIENT ORIGIN; BAND 7.2B; CHOLESTEROL; CELLS	Stomatin is an ancient, widely expressed, oligomeric, monotopic membrane protein that is associated with cholesterol-rich membranes/lipid rafts. It is part of the SPFH superfamily including stomatin-like proteins, prohibitins, flotillin/reggie proteins, bacterial HfIK/C proteins and erlins. Biochemical features such as palmitoylation, oligomerization, and hydrophobic "hairpin" structure show similarity to caveolins and other integral scaffolding proteins. Recent structure analyses of the conserved PHB/SPFH domain revealed amino acid residues and subdomains that appear essential for the structure and function of stomatin. To test the significance of these residues and domains, we exchanged or deleted them, expressed respective GFP-tagged mutants, and studied their subcellular localization, molecular dynamics and biochemical properties. We show that stomatin is a cholesterol binding protein and that at least two domains are important for the association with cholesterol-rich membranes. The conserved, prominent coiled-coil domain is necessary for oligomerization, while association with cholesterol-rich membranes is also involved in oligomer formation. FRAP analyses indicate that the C-terminus is the dominant entity for lateral mobility and binding site for the cortical actin cytoskeleton.	[Rungaldier, Stefanie; Mairhofer, Mario; Salzer, Ulrich; Prohaska, Rainer] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Umlauf, Ellen] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Thiele, Christoph] Rheinische Friedrich Wilhelms Univ Bonn, LIMES Inst, Bonn, Germany; [Rungaldier, Stefanie] Shire, Vienna, Austria; [Mairhofer, Mario] Ctr Adv Bioanal, Linz, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Bonn	Prohaska, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria.	rainer.prohaska@meduniwien.ac.at		Mairhofer, Mario/0000-0002-7218-6284; Salzer, Ulrich/0000-0002-3721-7225; Prohaska, Rainer/0000-0002-6145-217X	Fonds zur Forderung der wissenschaftlichen Forschung/Austrian Science Fund (FWF) [P22038-B12]	Fonds zur Forderung der wissenschaftlichen Forschung/Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fonds zur Forderung der wissenschaftlichen Forschung/Austrian Science Fund (FWF), grant number P22038-B12 (RP) (https://www.fwf.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2010, J BIOL CHEM, V285, P33371, DOI 10.1074/jbc.M110.153569; Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Brand J, 2012, EMBO J, V31, P3635, DOI 10.1038/emboj.2012.203; Brown AL, 2008, J GEN PHYSIOL, V131, P605, DOI 10.1085/jgp.200709910; Chen TW, 2016, CELL BIOL INT, V40, P926, DOI 10.1002/cbin.10636; Chen YS, 2015, P NATL ACAD SCI USA, V112, P11690, DOI 10.1073/pnas.1515968112; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Feuk-Lagerstedt E, 2002, J LEUKOCYTE BIOL, V72, P970; Fricke B, 2005, BRIT J HAEMATOL, V131, P265, DOI 10.1111/j.1365-2141.2005.05742.x; Fujiwara TK, 2016, MOL BIOL CELL, V27, P1101, DOI 10.1091/mbc.E15-04-0186; GALLAGHER PG, 1995, J BIOL CHEM, V270, P26358, DOI 10.1074/jbc.270.44.26358; Genetet S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46170; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Green JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-44; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1065, P195, DOI 10.1016/0005-2736(91)90230-6; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Hoegg MB, 2009, J BIOL CHEM, V284, P7766, DOI 10.1074/jbc.M809127200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kozlenkov A, 2014, J PHYSIOL-LONDON, V592, P557, DOI 10.1113/jphysiol.2013.258657; Kramer-Albers EM, 2006, J NEUROSCI, V26, P11743, DOI 10.1523/JNEUROSCI.3581-06.2006; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lapatsina L, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120096; Lapatsina L, 2012, EUR J CELL BIOL, V91, P240, DOI 10.1016/j.ejcb.2011.01.018; Lee JH, 2017, FASEB J, V31, P47, DOI 10.1096/fj.201600643R; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1395, P301, DOI 10.1016/S0167-4781(97)00178-4; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Rivera-Milla E, 2006, CELL MOL LIFE SCI, V63, P343, DOI 10.1007/s00018-005-5434-3; Rungaldier S, 2013, BBA-BIOMEMBRANES, V1828, P956, DOI 10.1016/j.bbamem.2012.11.030; SALZER U, 1993, BIOCHIM BIOPHYS ACTA, V1151, P149, DOI 10.1016/0005-2736(93)90098-K; Salzer U., 2007, DYN CELL BIOL, V1, P20; Schurek EM, 2014, J BIOL CHEM, V289, P11262, DOI 10.1074/jbc.M113.521773; Snyers L, 1997, EUR J CELL BIOL, V73, P281; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Tsuruta T, 2012, BIOMOL NMR ASSIGN, V6, P23, DOI 10.1007/s12104-011-9317-2; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Unfried I, 1995, GENOMICS, V30, P521, DOI 10.1006/geno.1995.1273; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Zhan HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039489; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	66	20	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178646	10.1371/journal.pone.0178646	http://dx.doi.org/10.1371/journal.pone.0178646			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575093	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300087
J	Valtuena, FJ; Rodriguez-Rlano, T; Lopez, J; Mayo, C; Ortega-Olivencia, A				Valtuena, Francisco J.; Rodriguez-Rlano, Tomas; Lopez, Josefa; Mayo, Carlos; Ortega-Olivencia, Ana			Peripatric speciation in an endemic Macaronesian plant after recent divergence from a widespread relative	PLOS ONE			English	Article							CHLOROPLAST DNA EVIDENCE; MOLECULAR PHYLOGENETICS; ISLAND COLONIZATION; MULTIPLE COLONIZATIONS; RETICULATE EVOLUTION; TRANSCRIBED SPACER; CANARY-ISLANDS; PATTERNS; NUCLEAR; SEQUENCES	The Macaronesian Scrophularia lowei is hypothesized to have arisen from the widespread S. arguta on the basis of several phylogenetic studies of the genus, but sampling has been limited. Although these two annual species are morphologically distinct, the origin of S. lowei is unclear because genetic studies focused on this Macaronesian species are lacking. We studied 5 S. lowei and 25 S. arguta populations to determine the relationship of both species and to infer the geographical origin of S. lowei. The timing of S. lowei divergence and differentiation was inferred by dating analysis of the ITS region. A phylogenetic analysis of two nuclear (ITS and ETS) and two chloroplast (psbJ-petA and psbA-trnH) DNA regions was performed to study the relationship between the two species, and genetic differentiation was analysed by AMOVA. Haplotype network construction and Bayesian phylogeographic analysis were conducted using chloroplast DNA regions and a spatial clustering analysis was carried out on a combined dataset of all studied regions. Our results indicate that both species constitute a well-supported Glade that diverged in the Miocene and differentiated in the Late Miocene-Pleistocene. Although S. lowei constitutes a well-supported Glade according to nDNA, cpDNA revealed a close relationship between S. lowei and western Canarian S. arguta, a finding supported by the spatial clustering analysis. Both species have strong population structure, with most genetic variability explained by inter-population differences. Our study therefore supports a recent peripatric speciation of S. lowei-a taxon that differs morphologically and genetically at the nDNA level from its closest relative, S. arguta, but not according to cpDNA, from the closest Macaronesian populations of that species. In addition, a recent dispersal of S. arguta to Madeira from Canary Islands or Selvagens Islands and a rapid morphological differentiation after the colonization to generate S. lowei is the most likely hypothesis to explain the origin of the last taxon.	[Valtuena, Francisco J.; Rodriguez-Rlano, Tomas; Lopez, Josefa; Mayo, Carlos; Ortega-Olivencia, Ana] Univ Extremadura, Fac Ciencias, Area Bot, Badajoz, Spain	Universidad de Extremadura	Valtuena, FJ (corresponding author), Univ Extremadura, Fac Ciencias, Area Bot, Badajoz, Spain.	fjvaltu@unex.es	Rodríguez-Riaño, Tomás/K-2413-2014; Ortega-Olivencia, Ana/F-6234-2015; Valtueña, Francisco J./J-9768-2014	Rodríguez-Riaño, Tomás/0000-0003-0260-1873; Ortega-Olivencia, Ana/0000-0002-5954-0226; Valtueña, Francisco J./0000-0001-9184-8864	Spanish Ministry of Science and Innovation [CGL2011-24140]; Economic and Infrastructure Council of Extremadura [GR15062]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Economic and Infrastructure Council of Extremadura; European Regional Development Fund(European Commission)	This work was supported by the Spanish Ministry of Science and Innovation (CGL2011-24140) and also in part by the Economic and Infrastructure Council of Extremadura (GR15062), both co-financed by the European Regional Development Fund.	Albaladejo RG, 2005, TAXON, V54, P987, DOI 10.2307/25065483; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; Allmon WD, 2016, BIOL J LINN SOC; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Barber JC, 2000, SYST BOT, V25, P633, DOI 10.2307/2666725; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Brauchler C, 2004, PLANT SYST EVOL, V248, P111, DOI 10.1007/s00606-004-0145-z; Bromham L, 2004, SYST BIOL, V53, P758, DOI 10.1080/10635150490522278; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Cheng L, 2013, MOL BIOL EVOL, V30, P1224, DOI 10.1093/molbev/mst028; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Dalgaard V., 1979, OPERA BOT, V51, P3; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Sousa F, 2016, PLANT SYST EVOL, V302, P493, DOI 10.1007/s00606-016-1278-6; Diaz-Perez AJ, 2012, MOL ECOL, V21, P1702, DOI 10.1111/j.1365-294X.2012.05495.x; Diaz-Perez A, 2008, SYST BIOL, V57, P732, DOI 10.1080/10635150802302450; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Fernandez-Mazuecos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017172; Fernandez-Palacios J.M., 2010, TERRESTRIAL ARTHROPO, P1; Franca Z, 2005, GEOLOGIA ACORES PERS; Francisco-Ortega J, 2002, AM J BOT, V89, P1984, DOI 10.3732/ajb.89.12.1984; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Ganders FR, 1984, PLANT BIOSYSTEMATICS, P179; Geldmacher J, 2005, EARTH PLANET SC LETT, V237, P85, DOI 10.1016/j.epsl.2005.04.037; Glemin S, 2006, P ROY SOC B-BIOL SCI, V273, P3011, DOI 10.1098/rspb.2006.3657; Gonzalez-Perez MA, 2009, ANN BOT-LONDON, V103, P79, DOI 10.1093/aob/mcn222; Hardion L, 2016, MOL PHYLOGENET EVOL, V97, P187, DOI 10.1016/j.ympev.2016.01.006; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Valtuena FJ, 2016, ECOL EVOL, V6, P4258, DOI 10.1002/ece3.2109; Johnson CM, 2014, EVOL ECOL, V28, P849, DOI 10.1007/s10682-014-9712-0; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002139; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Blanco-Pastor JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039089; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Meeus S, 2016, MOL PHYLOGENET EVOL, V98, P63, DOI 10.1016/j.ympev.2015.11.022; Miller M.A., 2012, P 2011 TERAGRID C SA; Moore AJ, 2013, AM J BOT, V100, P2412, DOI 10.3732/ajb.1300225; Moore MJ, 2002, AM J BOT, V89, P518, DOI 10.3732/ajb.89.3.518; Mort ME, 2002, SYST BOT, V27, P271; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Navarro-Perez ML, 2015, PERSPECT PLANT ECOL, V17, P263, DOI 10.1016/j.ppees.2015.05.002; Navarro-Perez ML, 2013, MOL PHYLOGENET EVOL, V69, P239, DOI 10.1016/j.ympev.2013.05.027; Novikova PY, 2016, NAT GENET, V48, P1077, DOI 10.1038/ng.3617; Ortega-Olivencia A., 2009, FLORA IBERICA, V13, P97; Ortega-Olivencia A, 1993, RUIZIA, V11; Panero JL, 1999, P NATL ACAD SCI USA, V96, P13886, DOI 10.1073/pnas.96.24.13886; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Press J.R., 1994, FLORA MADEIRA; Puppo P, 2015, MOL PHYLOGENET EVOL, V89, P160, DOI 10.1016/j.ympev.2015.04.017; Rambaut A, 2007, TRACER V1 6 MCMC TRA; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Rivas-Martinez S., 2009, MONOGRAFIA, V78, P255; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Schafer H., 2003, DISSERTATIONES BOT, V374; Scheunert A, 2014, MOL PHYLOGENET EVOL, V70, P296, DOI 10.1016/j.ympev.2013.09.023; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Silva L, 2010, LIST TERRESTRIAL MAR, P117; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STUESSY TF, 1990, SYST BOT, V15, P338, DOI 10.2307/2419187; Stuessy TF, 2014, PLANT SYSTEMATICS RE, V156; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Talavera M, 2013, ANN BOT-LONDON, V111, P249, DOI 10.1093/aob/mcs284; Triantis KA., 2010, TERRESTRIAL ARTRHROP, P49; Triantis KA, 2012, J BIOGEOGR, V39, P1179, DOI 10.1111/j.1365-2699.2011.02623.x; Trusty JL, 2005, MOL ECOL, V14, P1177, DOI 10.1111/j.1365-294X.2005.02487.x; Valcarcel V, 2013, PLANT SYST EVOL, V299, P447, DOI 10.1007/s00606-012-0734-1; Vargas P, 2014, J BIOGEOGR, V41, P932, DOI 10.1111/jbi.12253; Vaux F, 2016, BIOL J LINN SOC, V117, P165, DOI 10.1111/bij.12665; Vilatersana R, 2010, SYST BOT, V35, P907, DOI 10.1600/036364410X539952; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082692; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Williams BRM, 2015, AM J BOT, V102, P1736, DOI 10.3732/ajb.1500238	86	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178459	10.1371/journal.pone.0178459	http://dx.doi.org/10.1371/journal.pone.0178459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575081	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300055
J	Danziger, SA; Miller, LR; Singh, K; Whitney, GA; Peskind, ER; Li, G; Lipshutz, RJ; Aitchison, JD; Smith, JJ				Danziger, Samuel A.; Miller, Leslie R.; Singh, Karanbir; Whitney, G. Adam; Peskind, Elaine R.; Li, Ge; Lipshutz, Robert J.; Aitchison, John D.; Smith, Jennifer J.			An indicator cell assay for blood-based diagnostics	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GENE-EXPRESSION; MICROARRAY ANALYSIS; MOUSE MODELS; RECEPTORS; DISEASE; PROTEIN; CLASSIFICATION; BIOMARKERS; PATHOLOGY	We have established proof of principle for the Indicator Cell Assay Platform (TM) (iCAP (TM)), a broadly applicable tool for blood-based diagnostics that uses specifically-selected, standardized cells as biosensors, relying on their innate ability to integrate and respond to diverse signals present in patients' blood. To develop an assay, indicator cells are exposed in vitro to serum from case or control subjects and their global differential response patterns are used to train reliable, disease classifiers based on a small number of features. In a feasibility study, the iCAP detected pre-symptomatic disease in a murine model of amyotrophic lateral sclerosis (ALS) with 94% accuracy (p-Value = 3.81E-6) and correctly identified samples from a murine Huntington's disease model as non-carriers of ALS. Beyond the mouse model, in a preliminary human disease study, the iCAP detected early stage Alzheimer's disease with 72% cross-validated accuracy (p-Value = 3.10E-3). For both assays, iCAP features were enriched for disease-related genes, supporting the assay's relevance for disease research.	[Danziger, Samuel A.; Miller, Leslie R.; Singh, Karanbir; Lipshutz, Robert J.; Aitchison, John D.; Smith, Jennifer J.] Inst Syst Biol, Seattle, WA 98109 USA; [Danziger, Samuel A.; Aitchison, John D.; Smith, Jennifer J.] Ctr Infect Dis Res, Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Whitney, G. Adam; Lipshutz, Robert J.; Smith, Jennifer J.] PreCyte Inc, Seattle, WA 98109 USA; [Peskind, Elaine R.] VA Puget Sound, Northwest Network VISN 20, MIRECC, Seattle, VA USA; [Peskind, Elaine R.; Li, Ge] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Li, Ge] VA Puget Sound, Geriatr Res Educ & Clin Ctr, Vet Affairs VA Puget Sound Hlth Care Syst, Seattle, WA USA	Institute for Systems Biology (ISB); Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Aitchison, JD; Smith, JJ (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.; Aitchison, JD; Smith, JJ (corresponding author), Ctr Infect Dis Res, Seattle Biomed Res Inst, Seattle, WA 98109 USA.; Smith, JJ (corresponding author), PreCyte Inc, Seattle, WA 98109 USA.	John.Aitchison@systemsbiology.org; Jennifer@precyte.net	Danziger, Samuel/O-5613-2019	Danziger, Samuel/0000-0002-5669-414X; Whitney, G. Adam/0000-0003-0771-3532	Life Sciences Discovery Fund (LSDF); National Institute of General Medical Sciences of the National institutes of Health (NIH) [P50 GM076547]; National Institute of Aging (NIA) of the NIH [R44AG051282]; Luxembourg Center for Systems Biomedicine, University of Luxembourg; Pacific Northwest Udall Center [P50NS062684]; Department of Veterans Affairs; UW Alzheimer's Disease Research Center [P50AG05136]; NATIONAL CANCER INSTITUTE [R43CA203455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R44AG051282, P50AG005136] Funding Source: NIH RePORTER	Life Sciences Discovery Fund (LSDF); National Institute of General Medical Sciences of the National institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Aging (NIA) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Luxembourg Center for Systems Biomedicine, University of Luxembourg; Pacific Northwest Udall Center; Department of Veterans Affairs(US Department of Veterans Affairs); UW Alzheimer's Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the Life Sciences Discovery Fund (LSDF; http://www.lsdfa.org/), National Institute of General Medical Sciences of the National institutes of Health (NIH) under award number P50 GM076547, and National Institute of Aging (NIA) of the NIH under award number R44AG051282. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We also thank the Luxembourg Center for Systems Biomedicine, University of Luxembourg, UW Alzheimer's Disease Research Center (P50AG05136), Pacific Northwest Udall Center (P50NS062684) and Department of Veterans Affairs for support. JJS, GAW, and RJL are employees of PreCyte Inc., which is developing products related to the research described in this publication. The funders provided support in the form of research materials and salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are described in the 'author contributions' section.	Abel O, 2012, HUM MUTAT, V33, P1345, DOI 10.1002/humu.22157; Alderton GK, 2014, NAT REV CANCER, V14, P387; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Collins MA, 2015, J PROTEOME RES, V14, P4486, DOI 10.1021/acs.jproteome.5b00804; Danziger SA, 2007, BIOINFORMATICS, V23, pI104, DOI 10.1093/bioinformatics/btm166; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Fisher RA, 1914, BIOMETRIKA, V10, P507; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gagliardi S, 2010, NEUROBIOL DIS, V39, P198, DOI 10.1016/j.nbd.2010.04.008; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kursa MB, 2012, ARXIV12021121CSSTAT; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Mallucci G, 2013, BRAIN, V136, P994, DOI 10.1093/brain/awt072; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mougeot JLC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-74; Narayan M, 2016, BIOMARK MED, V10, P453, DOI 10.2217/bmm-2016-0025; Nassif M, 2010, ANTIOXID REDOX SIGN, V13, P1955, DOI 10.1089/ars.2009.2991; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; Perrin FE, 2005, HUM MOL GENET, V14, P3309, DOI 10.1093/hmg/ddi357; Platt J., 1999, FAST TRAINING SUPPOR; Pronto-Laborinho AC, 2016, CLIN HEMORHEOL MICRO; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reiss DJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv300; ROISEN FJ, 1982, MUSCLE NERVE, V5, P48, DOI 10.1002/mus.880050109; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Singh S, 2011, INT J NEUROSCI, V121, P589, DOI 10.3109/00207454.2011.598981; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Su XWW, 2014, MUSCLE NERVE, V49, P786, DOI 10.1002/mus.24198; Tateno M, 2004, HUM MOL GENET, V13, P2183, DOI 10.1093/hmg/ddh246; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Van AHT, 2012, BIOINFORMATICS, V28, P1766, DOI 10.1093/bioinformatics/bts238; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Warnes Liu P., 2012, ESTIMATE MICRARRAY S; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zhang J, 2008, AM J CLIN PATHOL, V129, P526, DOI 10.1309/W01Y0B808EMEH12L	55	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178608	10.1371/journal.pone.0178608	http://dx.doi.org/10.1371/journal.pone.0178608			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594877	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200042
J	Lucassen, F; Pritzkow, W; Rosner, M; Sepualveda, F; Vasquez, P; Wilke, H; Kasemann, SA				Lucassen, Friedrich; Pritzkow, Wolfgang; Rosner, Martin; Sepualveda, Fernando; Vasquez, Paulina; Wilke, Hans; Kasemann, Simone A.			The stable isotope composition of nitrogen and carbon and elemental contents in modern and fossil seabird guano from Northern Chile - Marine sources and diagenetic effects	PLOS ONE			English	Article							ORNITHOGENIC SEDIMENTS; URIC-ACID; DELTA-N-15; MANURE; MEJILLONES; PRODUCTIVITY; ANTARCTICA; C-13/C-12; MARITIME; ISLANDS	Seabird excrements (guano) have been preserved in the arid climate of Northern Chile since at least the Pliocene. The deposits of marine organic material in coastal areas potentially open a window into the present and past composition of the coastal ocean and its food web. We use the stable isotope composition of nitrogen and carbon as well as element contents to compare the principal prey of the birds, the Peruvian anchovy, with the composition of modern guano. We also investigate the impact of diagenetic changes on the isotopic composition and elemental contents of the pure ornithogenic sediments, starting with modern stratified deposits and extending to fossil guano. Where possible, C-14 systematics is used for age information. The nitrogen and carbon isotopic composition of the marine prey (Peruvian anchovy) of the birds is complex as it shows strong systematic variations with latitude. The detailed study of a modern profile that represents a few years of guano deposition up to present reveals systematic changes in nitrogen and carbon isotopic composition towards heavier values that increase with age, i.e. depth. Only the uppermost, youngest layers of modern guano show compositional affinity to the prey of the birds. In the profile, the simultaneous loss of nitrogen and carbon occurs by degassing, and non-volatile elements like phosphorous and calcium are passively enriched in the residual guano. Fossil guano deposits are very low in nitrogen and low in carbon contents, and show very heavy nitrogen isotopic compositions. One result of the study is that the use of guano for tracing nitrogen and carbon isotopic and elemental composition in the marine food web of the birds is restricted to fresh material. Despite systematic changes during diagenesis, there is little promise to retrieve reliable values of marine nitrogen and carbon signatures from older guano. However, the changes in isotopic composition from primary marine nitrogen isotopic signatures towards very heavy values generate a compositionally unique material. These compositions trace the presence of guano in natural ecosystems and its use as fertilizer in present and past agriculture.	[Lucassen, Friedrich; Kasemann, Simone A.] Univ Bremen, Dept Geosci, Bremen, Germany; [Lucassen, Friedrich; Kasemann, Simone A.] Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany; [Pritzkow, Wolfgang] Bundesanstalt Mat Forsch & Prufung BAM, Dept Analyt Chem & Reference Mat, Berlin, Germany; [Rosner, Martin] IsoAnal UG, Berlin, Germany; [Sepualveda, Fernando; Vasquez, Paulina] Serv Nacl Geol & Mineria, Geol Reg, Santiago, Chile; [Wilke, Hans] Univ Catolica Norte, Dept Geol, Antofagasta, Chile	University of Bremen; University of Bremen; Federal Institute for Materials Research & Testing; Universidad Catolica del Norte	Lucassen, F (corresponding author), Univ Bremen, Dept Geosci, Bremen, Germany.; Lucassen, F (corresponding author), Univ Bremen, MARUM Ctr Marine Environm Sci, Bremen, Germany.	lucassen@uni-bremen.de	Rosner, Martin/B-9264-2009	Kasemann, Simone Antonia/0000-0002-6913-7748	MARUM centre of marine environmental science incentive fund [44110577]	MARUM centre of marine environmental science incentive fund	The study was funded by a MARUM centre of marine environmental science incentive fund 44110577 to SK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding provided by MARUM covered only expenses of the field work in Chile (FL & SK) and 14C dating by the Poznan (Poland) facility.	Allmendinger RW, 2010, TECTONOPHYSICS, V495, P93, DOI 10.1016/j.tecto.2009.04.019; Amundson R, 2012, GEOL SOC AM BULL, P124; [Anonymous], 1981, 1188 US GEOL SURV; [Anonymous], 2002, HILLSH IM OBT SRTM M; Arancibia G, 2006, J GEOL SOC LONDON, V163, P107, DOI 10.1144/0016-764904-161; Atencio D, 2012, AM MINERAL, V97, P19, DOI 10.2138/am.2012.3867; Avadi A, 2014, J CLEAN PROD, V70, P118, DOI 10.1016/j.jclepro.2014.01.047; BACHRACH U, 1957, J GEN MICROBIOL, V17, P1; Baeza L., 1984, PETROGRAPHY TECTONIC; Biese W., 1950, ESTUDIOS GEOMORFOLOG; Bird MI, 2008, RAPID COMMUN MASS SP, V22, P3393, DOI 10.1002/rcm.3739; Blackall TD, 2008, ATMOS ENVIRON, V42, P6942, DOI 10.1016/j.atmosenv.2008.04.059; Bohlke JK, 1997, CHEM GEOL, V136, P135, DOI 10.1016/S0009-2541(96)00124-6; Brand WA, 2014, PURE APPL CHEM, V86, P425, DOI 10.1515/pac-2013-1023; Casciotti KL, 2016, ANNU REV MAR SCI, V8, P379, DOI 10.1146/annurev-marine-010213-135052; Catenazzi A, 2008, MAR ECOL PROG SER, V360, P285, DOI 10.3354/meps07393; Caut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039125; Chukanov NV, 2015, MINER PETROL, V109, P643, DOI 10.1007/s00710-015-0395-1; Conroy JL, 2015, GEO-GEOGR ENVIRON, V2, P137, DOI 10.1002/geo2.11; Cushman GT., 2014, GUANO OPENING PACIFI; De Pol-Holz R, 2009, DEEP-SEA RES PT II, V56, P1100, DOI 10.1016/j.dsr2.2008.09.014; Di Celma C, 2014, J MAPS, V10, P350, DOI 10.1080/17445647.2013.867419; Duffy David C., 1994, Birdlife Conservation Series, V1, P68; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; Espinoza P, 2014, J FISH BIOL, V84, P422, DOI 10.1111/jfb.12293; Espinoza P, 2008, PROG OCEANOGR, V79, P215, DOI 10.1016/j.pocean.2008.10.022; ESRI, DIGITALGLOBE GEOEYE; Etayo-Cadavid MF, 2013, GEOLOGY, V41, P599, DOI 10.1130/G34065.1; Fontannaz C., 2001, ESTADISTICA CLIMATOL, V1; FRANCE RL, 1994, MAR ECOL PROG SER, V115, P205, DOI 10.3354/meps115205; Freon P, 2014, INT J LIFE CYCLE ASS, V19, P1068, DOI 10.1007/s11367-014-0716-3; Gajardo A, 2004, SERIE RECURSOS MINER, P17; Garreaud RD, 2010, EARTH PLANET SC LETT, V292, P39, DOI 10.1016/j.epsl.2010.01.017; Gramain A, 2011, ENVIRON MICROBIOL, V13, P2105, DOI 10.1111/j.1462-2920.2011.02435.x; Hartley AJ, 2002, GEOLOGY, V30, P43, DOI 10.1130/0091-7613(2002)030<0043:LPAFTA>2.0.CO;2; HARTLEY AJ, 1995, J GEOL SOC LONDON, V152, P51, DOI 10.1144/gsjgs.152.1.0051; Hebbeln D, 2000, MAR GEOL, V164, P119, DOI 10.1016/S0025-3227(99)00129-2; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hoefs J., 2009, STABLE ISOTOPE GEOCH, V6th; Hoffman JC, 2010, DEEP-SEA RES PT I, V57, P956, DOI 10.1016/j.dsr.2010.05.003; Hofmann BA, 1998, CHEM GEOL, V149, P127, DOI 10.1016/S0009-2541(98)00043-6; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Hristov AN, 2009, J ENVIRON QUAL, V38, P2438, DOI 10.2134/jeq2009.0057; Hua Q, 2013, RADIOCARB, V55; Hutchinson G. E., 1950, B AM MUSEUM NATURAL, V96; Jordan R., 1963, REPORTS, VXI, P105; Jull AJT, 2013, QUATERN INT, V299, P64, DOI 10.1016/j.quaint.2012.10.028; KARLSSON JL, 1949, J BIOL CHEM, V178, P891; Kim YJ, 2008, BIORESOURCE TECHNOL, V99, P5452, DOI 10.1016/j.biortech.2007.11.012; Kirchmann H, 1998, NUTR CYCL AGROECOSYS, V51, P65, DOI 10.1023/A:1009709011820; KIRCHMANN H, 1989, PLANT SOIL, V115, P35, DOI 10.1007/BF02220692; KIRCHMANN H, 1992, BIORESOURCE TECHNOL, V40, P137, DOI 10.1016/0960-8524(92)90199-8; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Li L, 2012, GEOCHIM COSMOCHIM AC, V84, P280, DOI 10.1016/j.gca.2012.01.040; LINDEBOOM HJ, 1984, ECOLOGY, V65, P269, DOI 10.2307/1939479; Liu XD, 2006, EARTH PLANET SC LETT, V243, P424, DOI 10.1016/j.epsl.2006.01.018; Ludynia K, 2010, J ORNITHOL, V151, P103, DOI 10.1007/s10336-009-0431-1; Maeda K, 2016, BIOGEOSCIENCES, V13, P1341, DOI 10.5194/bg-13-1341-2016; MARIOTTI A, 1981, PLANT SOIL, V62, P413, DOI 10.1007/BF02374138; Marquardt C, 2005, INT S AND GEOD ISAG, P477; MCNABB FMA, 1980, CONDOR, V82, P219; Michelutti N, 2009, P ROY SOC B-BIOL SCI, V276, P591, DOI 10.1098/rspb.2008.1103; Michener R, 2007, ECOL METHOD CONCEPT, pXVII; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mizota C, 2007, GEOCHEM J, V41, P297, DOI 10.2343/geochemj.41.297; MIZUTANI H, 1986, BIOGEOCHEMISTRY, V2, P221, DOI 10.1007/BF02180160; Mollier-Vogel E., 2012, PERUVIAN OXYGEN MINI; Mollier-Vogel E, 2012, DEEP-SEA RES PT I, V70, P14, DOI 10.1016/j.dsr.2012.06.003; Montoya JP, 2007, ECOL METHOD CONCEPT, P176, DOI 10.1002/9780470691854.ch7; Nie YG, 2014, CHEM GEOL, V363, P91, DOI 10.1016/j.chemgeo.2013.10.031; Nielsen SN, 2013, PALAEONTOL Z, V87, P33, DOI 10.1007/s12542-012-0146-0; Ohkouchi N, 2015, PROG EARTH PLANET SC, V2, DOI 10.1186/s40645-015-0032-y; Ortlieb L, 2011, QUATERNARY RES, V75, P91, DOI 10.1016/j.yqres.2010.07.018; Paskoff R., RECHERCHES GEOMORPHO; Perez A, 2012, BIOESTRATINOMIA DEPO; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Poulson SR, 2013, J ARCHAEOL SCI, V40, P4576, DOI 10.1016/j.jas.2013.07.009; Radtke U., 1987, BERLINER GEOGRAPHISC, V25, P312; Radtke U., 1989, DUSSELDORFER GEOGRAP, V27; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ratusny A, 1988, HAMBURGER GEOGRAPHIS, P31; RAU GH, 1992, MAR ECOL PROG SER, V84, P1, DOI 10.3354/meps084001; RAU GH, 1983, ECOLOGY, V64, P1314, DOI 10.2307/1937843; Reddin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130789; Reich M, 2009, MINER DEPOSITA, V44, P497, DOI 10.1007/s00126-009-0229-3; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Riddick SN, 2012, ATMOS ENVIRON, V55, P319, DOI 10.1016/j.atmosenv.2012.02.052; Sabat P, 2004, COMP BIOCHEM PHYS A, V137, P391, DOI 10.1016/j.cbpb.2003.10.021; SCHEFFERLE HE, 1965, J APPL BACTERIOL, V28, P412, DOI 10.1111/j.1365-2672.1965.tb02171.x; Simas FNB, 2007, GEODERMA, V138, P191, DOI 10.1016/j.geoderma.2006.11.011; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Stenstrom K, 2011, NUCL PHYS; STUIVER M, 1993, RADIOCARBON, V35, P1, DOI 10.1017/S0033822200013874; Szpak P, 2012, J ARCHAEOL SCI, V39, P3721, DOI 10.1016/j.jas.2012.06.035; Szpak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033741; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Victor P, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007771; Whitehead P, 1988, FAO FISHERIES SYNO 2, V7, P322; Yang ww, 2010, FAST VIABILITY ASSES	102	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179440	10.1371/journal.pone.0179440	http://dx.doi.org/10.1371/journal.pone.0179440			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594902	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200126
J	McIntosh, TL; Lee, AJ; Sidari, MJ; Stower, RE; Sherlock, JM; Dixson, BJW				McIntosh, Toneya L.; Lee, Anthony J.; Sidari, Morgan J.; Stower, Rebecca E.; Sherlock, James M.; Dixson, Barnaby J. W.			Microbes and masculinity: Does exposure to pathogenic cues alter women's preferences for male facial masculinity and beardedness?	PLOS ONE			English	Article							SEXUAL ATTRACTIVENESS; MATE PREFERENCES; BODY HAIR; MENS ATTRACTIVENESS; HUMAN PHYSIQUE; MALE FACES; PERCEPTIONS; DIMORPHISM; SELECTION; DISGUST	Women's preferences for men's androgen dependent secondary sexual traits are proposed to be phenotypically plastic in response to exposure to pathogens and pathogen disgust. While previous studies report that masculinity in facial shape is more attractive to women who have recently been exposed to pathogenic cues and who are high in self-reported pathogen disgust, facial hair may reduce male attractiveness under conditions of high pathogens as beards are a possible breeding ground for disease carrying ectoparasites. In the present study, we test whether women's preferences for beardedness and facial masculinity vary due to exposure to different pathogenic cues. Participants (N = 688, mean age + 1SD = 31.94 years, SD = 6.69, range = 18-67) rated the attractiveness of facial composite stimuli of men when they were clean-shaven or fully bearded. These stimuli were also manipulated in order to vary sexual dimorphism by +/- 50%. Ratings were conducted before and after exposure to one of four experimental treatments in which participants were primed to either high pathogens (e.g. infected cuts), ectoparasites (e.g. body lice), a mixture of pathogens and ectoparasites, or a control condition (e.g. innocuous liquids). Participants then completed the threedomain disgust scale measuring attitudes to moral, sexual and pathogen disgust. We predicted that women would prefer facial masculinity following exposure to pathogenic cues, but would show reduced preferences for facial hair following exposure to ectoparasites. Women preferred full beards over clean-shaven faces and masculinised over feminised faces. However, none of the experimental treatments influenced the direction of preferences for facial masculinity or beardedness. We also found no association between women's self-reported pathogen disgust and their preferences for facial masculinity. However, there was a weak positive association between moral disgust scores and preferences for facial masculinity, which might reflect conservatism and preferences for gender typicality in faces. Women's preferences for beards were positively associated with their pathogen disgust, which runs contrary to our predictions and may reflect preferences for high quality individuals who can withstand any costs of beardedness, although further replications are necessary before firm conclusions can be made. We conclude that there is little support for pathogenic exposure being a mechanism that underpins women's directional preferences for masculine traits.	[McIntosh, Toneya L.; Sidari, Morgan J.; Stower, Rebecca E.; Sherlock, James M.; Dixson, Barnaby J. W.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Lee, Anthony J.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Queensland; University of Glasgow	Dixson, BJW (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	b.dixson@uq.edu.au	Stower, Rebecca/AAE-2469-2021; Lee, Anthony J./I-8220-2012	Stower, Rebecca/0000-0002-6158-4818; Lee, Anthony J./0000-0001-8288-3393; Dixson, Barnaby/0000-0003-0911-1244				Able DJ, 1996, P NATL ACAD SCI USA, V93, P2229, DOI 10.1073/pnas.93.5.2229; Adamo SA, 2009, ANIM BEHAV, V77, P67, DOI 10.1016/j.anbehav.2008.09.011; ADDISON WE, 1989, PERCEPT MOTOR SKILL, V68, P921, DOI 10.2466/pms.1989.68.3.921; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Blake Khandis R, 2017, Cogn Emot, V31, P1153, DOI 10.1080/02699931.2016.1202199; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; DeBruine LM, 2012, BEHAV BRAIN SCI, V35, P86, DOI 10.1017/S0140525X11000987; DeBruine LM, 2011, P ROY SOC B-BIOL SCI, V278, P813, DOI 10.1098/rspb.2010.2200; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; DeBruine LM, 2010, EVOL HUM BEHAV, V31, P69, DOI 10.1016/j.evolhumbehav.2009.09.003; Dixson AF, 2003, ARCH SEX BEHAV, V32, P29, DOI 10.1023/A:1021889228469; Dixson A, 2005, ANN REV SEX RES, V16, P1; Dixson B. J., 2017, BEHAV ECOLOGY; Dixson BJW, 2016, J EVOLUTION BIOL, V29, P2311, DOI 10.1111/jeb.12958; Dixson B. J. W., 2016, ENCY EVOLUTIONARY PS; Dixson BJ, 2007, ARCH SEX BEHAV, V36, P369, DOI 10.1007/s10508-006-9093-8; Dixson BJ, 2007, AM J HUM BIOL, V19, P88, DOI 10.1002/ajhb.20584; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; Dixson BJ, 2013, BEHAV ECOL, V24, P708, DOI 10.1093/beheco/ars211; Dixson BJ, 2012, BEHAV ECOL, V23, P481, DOI 10.1093/beheco/arr214; Dixson BJ, 2010, ARCH SEX BEHAV, V39, P798, DOI 10.1007/s10508-008-9441-y; Dixson BJW, 2017, EVOL HUM BEHAV, V38, P259, DOI 10.1016/j.evolhumbehav.2016.10.009; Dixson BJW, 2017, EVOL HUM BEHAV, V38, P164, DOI 10.1016/j.evolhumbehav.2016.08.004; Dixson BJW, 2016, ARCH SEX BEHAV, V45, P877, DOI 10.1007/s10508-015-0588-z; Dixson BJW, 2017, ARCH SEX BEHAV; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gettler LT, 2014, EVOL ANTHROPOL, V23, P146, DOI 10.1002/evan.21412; Grebe, 2014, EVOL BEHAV SCI, V8, P226, DOI [10.1037/ebs0000023, DOI 10.1037/EBS0000023]; Grueter CC, 2015, EVOL HUM BEHAV, V36, P398, DOI 10.1016/j.evolhumbehav.2015.03.003; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Herrick R, 2015, SOC SCI QUART, V96, P1301, DOI 10.1111/ssqu.12183; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Janif ZJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0958; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Jones BC, 2007, EVOL HUM BEHAV, V28, P439, DOI 10.1016/j.evolhumbehav.2007.07.006; Jones BC, 2013, BEHAV ECOL, V24, P373, DOI 10.1093/beheco/ars173; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Kruger DJ, 2006, PERS RELATIONSHIP, V13, P451, DOI 10.1111/j.1475-6811.2006.00129.x; Lee AJ, 2015, EVOL HUM BEHAV, V36, P249, DOI 10.1016/j.evolhumbehav.2014.12.001; Lee AJ, 2013, BEHAV ECOL, V24, P779, DOI 10.1093/beheco/ars199; Lindeholm YN, 2016, J HOSP INFECT, V93, P313, DOI 10.1016/j.jhin.2016.04.010; Little AC, 2011, P ROY SOC B-BIOL SCI, V278, P2032, DOI 10.1098/rspb.2010.1925; Lorenz AR, 2014, GLOB ECOL CONSERV, V2, P248, DOI 10.1016/j.gecco.2014.09.012; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McLure HA, 2000, ANAESTHESIA, V55, P173, DOI 10.1046/j.1365-2044.2000.055002173.x; Moore F. R., 2013, BIOL LETT, V9; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Muscarella F, 1996, ETHOL SOCIOBIOL, V17, P99, DOI 10.1016/0162-3095(95)00130-1; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; Oldmeadow JA, 2016, ARCH SEX BEHAV, V45, P785, DOI 10.1007/s10508-016-0723-5; Oldmeadow JA, 2016, ARCH SEX BEHAV, V45, P891, DOI 10.1007/s10508-015-0637-7; Pagel M, 2003, P R SOC B S1, P270; Parry JA, 2016, ORTHOPEDICS, V39, pE290, DOI 10.3928/01477447-20160301-01; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Prokop P, 2016, ANTHROPOL ANZ, V73, P169, DOI 10.1127/anthranz/2016/0583; Prokop P, 2014, BEHAV PROCESS, V107, P42, DOI 10.1016/j.beproc.2014.07.017; Prokop P, 2013, ARCH SEX BEHAV, V42, P1181, DOI 10.1007/s10508-012-0007-7; Prokop P, 2012, ACTA ETHOL, V15, P135, DOI 10.1007/s10211-011-0118-5; Prokop P, 2010, J ETHOL, V28, P345, DOI 10.1007/s10164-009-0195-3; Rantala MJ, 2007, J ZOOL, V273, P1, DOI 10.1111/j.1469-7998.2007.00295.x; Rantala MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1696; Rantala MJ, 2010, BEHAV ECOL, V21, P419, DOI 10.1093/beheco/arp206; Rantala MJ, 1999, INT J PARASITOL, V29, P1987, DOI 10.1016/S0020-7519(99)00133-2; Raudenbush SW, 2002, HIERARCHICAL LINEAR, V1; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0908; ROBINSON DE, 1976, AM J SOCIOL, V81, P1133, DOI 10.1086/226188; ROLL S, 1971, PSYCHOL REP, V28, P975, DOI 10.2466/pr0.1971.28.3.975; Ruxton GD, 2011, P NATL ACAD SCI USA, V108, P20965, DOI 10.1073/pnas.1113915108; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Sherlock JM, 2017, ADAPT HUM BEHAV PHYS, V3, P14, DOI 10.1007/s40750-016-0047-7; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R., 2014, PARASITE STRESS THEO, DOI DOI 10.1007/978-3-319-08040-6; Tybur JM, 2011, PHILOS T R SOC B, V366, P3375, DOI 10.1098/rstb.2011.0136; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; Valentova JV, 2017, EVOL HUM BEHAV, V38, P241, DOI 10.1016/j.evolhumbehav.2016.10.007; Vergara P, 2012, BEHAV ECOL, V23, P502, DOI 10.1093/beheco/arr216; Watkins CD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1549, DOI 10.1007/s00265-012-1408-2; Welling LLM, 2008, PERS INDIV DIFFER, V44, P161, DOI 10.1016/j.paid.2007.07.026; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Zietsch BP, 2015, PSYCHOL SCI, V26, P1440, DOI 10.1177/0956797615591770	87	25	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178206	10.1371/journal.pone.0178206	http://dx.doi.org/10.1371/journal.pone.0178206			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594843	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000402923200021
J	Yanagida, S; Anglesio, MS; Nazeran, TM; Lum, A; Inoue, M; Iida, Y; Takano, H; Nikaido, T; Okamoto, A; Huntsman, DG				Yanagida, Satoshi; Anglesio, Michael S.; Nazeran, Tayyebeh M.; Lum, Amy; Inoue, Momoko; Iida, Yasushi; Takano, Hirokuni; Nikaido, Takashi; Okamoto, Aikou; Huntsman, David G.			Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C > G FOXL2 mutation	PLOS ONE			English	Article							TERM-FOLLOW-UP; FOXL2; THERAPY; CANCER; EXPRESSION; CARCINOMA; HETEROGENEITY; CHEMOTHERAPY	Background Adult-type granulosa cell tumors of the ovary (aGCTs) are rare tumors that represent 2-5% of ovarian malignancies. The prognosis of this tumor is favorable, and it is characterized by slow progression. 10-30% of these tumors recur after 4-7 years of the primary surgery and the 5-year survival rate from the first recurrence is 55%, for the incompletely resected patients. At this time, complete resection is the only prognostic factor for better outcome, and establishing a novel strategy for identification and/or treatment of recurrent tumors is crucial. After the discovery of heterozygous c. 402C>G FOXL2 mutations in 97% of cases of aGCT, much effort has been made to find the role of the mutation on the pathogenesis of aGCT, however, little is known about the role of the mutation in disease progression. Methods We analyzed the clinical data of 56 aGCT patients to find a marker of recurrence. In particular, we compared the FOXL2 status in 5 matched primary and recurrent samples by immunohistochemistry, and TaqMan allelic discrimination assay to address the role of FOXL2 in potential mechanisms of recurrence. Results The clinical data analysis was consistent with complete resection as an indicator of disease eradication, though the sample size was limited. The genetic analysis showed all the samples, including recurrent tumor samples up to 14 years after the primary surgery, expressed heterozygous c. 402C>G FOXL2 mutation and the FOXL2 protein expression. Conclusion This report describes the preservation of heterozygous c. 402C>G FOXL2 mutation in recurrent aGCTs. This finding adds further credence to the concept that the c. 402C>G FOXL2 mutation is oncogenic and integral to this disease.	[Yanagida, Satoshi; Anglesio, Michael S.; Nazeran, Tayyebeh M.; Huntsman, David G.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada; [Yanagida, Satoshi; Anglesio, Michael S.; Nazeran, Tayyebeh M.; Huntsman, David G.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Yanagida, Satoshi; Inoue, Momoko; Iida, Yasushi; Takano, Hirokuni; Okamoto, Aikou] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan; [Lum, Amy; Huntsman, David G.] BC Canc Agcy, Dept Mol Oncol, Res Ctr, Vancouver, BC, Canada; [Nikaido, Takashi] Kosei Gen Hosp, Dept Pathol, Tokyo, Japan	University of British Columbia; University of British Columbia; Jikei University; British Columbia Cancer Agency; Sapporo Kosei General Hospital	Yanagida, S (corresponding author), Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada.; Yanagida, S (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.; Yanagida, S (corresponding author), Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo, Japan.	yanagi@jikei.ac.jp	Huntsman, David/ABE-6082-2020	takano, hirokuni/0000-0002-6465-7883	Terry Fox Research Institute [1021]	Terry Fox Research Institute	This study was supported in part by the Terry Fox Research Institute (Grant #1021 http://www.tfri.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085545; Bai HM, 2016, J CELL MOL MED, V20, P581, DOI 10.1111/jcmm.12771; Bayani J, 2011, MOL ONCOL, V5, P48, DOI 10.1016/j.molonc.2010.08.002; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bryk S, 2015, INT J GYNECOL CANCER, V25, P33, DOI 10.1097/IGC.0000000000000304; Caburet S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1283-0; Cheng JC, 2014, BIOCHEM BIOPH RES CO, V443, P537, DOI 10.1016/j.bbrc.2013.12.010; Farkkila A, 2014, CANCER MED-US, V3, P526, DOI 10.1002/cam4.230; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Freeman SA, 2006, GYNECOL ONCOL, V103, P755, DOI 10.1016/j.ygyno.2006.06.022; Garcia-Donas J, 2013, J CLIN ONCOL; Geiersbach KB, 2011, CANCER GENET-NY, V204, P596, DOI 10.1016/j.cancergen.2011.10.002; Homesley HD, 1999, GYNECOL ONCOL, V72, P131, DOI 10.1006/gyno.1998.5304; KENT SW, 1960, AM J OBSTET GYNECOL, V80, P430; Kim JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3936; Kobel M, 2016, J PATHOL CLIN RES, V2, P247, DOI 10.1002/cjp2.53; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kommoss S, 2013, MODERN PATHOL, V26, P860, DOI 10.1038/modpathol.2012.226; Konecny GE, 2016, GYNECOL ONCOL, V141, P379, DOI 10.1016/j.ygyno.2016.01.026; Lambrechts S, 2016, EUR J CANCER, V53, P51, DOI 10.1016/j.ejca.2015.11.001; Lamm W, 2016, J CLIN ONCOL, V34; Lee IH, 2011, J GYNECOL ONCOL, V22, P188, DOI 10.3802/jgo.2011.22.3.188; Mangili G, 2013, BRIT J CANCER, V109, P29, DOI 10.1038/bjc.2013.241; Mangili G, 2013, GYNECOL ONCOL, V130, P38, DOI 10.1016/j.ygyno.2013.04.047; McConechy MK, 2016, JNCI-J NATL CANCER I, V108, pdjw134; Oseto K, 2014, J OBSTET GYNAECOL RE, V40, P1197, DOI 10.1111/jog.12324; Paracchini L, 2016, ONCOTARGET IMPACT J, V5; Park JY, 2012, GYNECOL ONCOL, V125, P80, DOI 10.1016/j.ygyno.2011.12.442; SCHWEPPE KW, 1982, J CANCER RES CLIN, V104, P161, DOI 10.1007/BF00402064; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stewart CJR, 2013, HISTOPATHOLOGY, V62, P257, DOI 10.1111/j.1365-2559.2012.04334.x; Suh DS, 2015, J PROTEOME RES, V14, P2446, DOI 10.1021/pr501230b; Sun HD, 2012, GYNECOL ONCOL, V124, P244, DOI 10.1016/j.ygyno.2011.10.015; Tao X, 2009, GYNECOL ONCOL, V114, P431, DOI 10.1016/j.ygyno.2009.04.021; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Zannoni GF, 2016, ONCOL LETT, V12, P1159, DOI 10.3892/ol.2016.4711	36	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178989	10.1371/journal.pone.0178989	http://dx.doi.org/10.1371/journal.pone.0178989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594898	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200074
J	Yang, Y; Wang, Y; Kong, YW; Zhang, XN; Bai, LH				Yang, Yue; Wang, Yang; Kong, Yawei; Zhang, Xiaoning; Bai, Lunhao			The effects of different frequency treadmill exercise on lipoxin A(4) and articular cartilage degeneration in an experimental model of monosodium iodoacetate-induced osteoarthritis in rats	PLOS ONE			English	Article							NF-KAPPA-B; SUBCHONDRAL BONE; ARTHRITIS; HISTOPATHOLOGY; INFLAMMATION; METABOLISM; GUIDELINES; WALKING; TARGET; JOINTS	The aim was to investigate the effects of different frequencies treadmill exercise with total exercise time being constancy on articular cartilage, lipoxin A(4) (LXA(4)) and the NF-kappa B pathway in rat model of monosodium iodoacetate-induced osteoarthritis (OA). Fifty male Sprague- Dawley rats were randomly divided into five groups (n = 10): controls (CG), knee OA model (OAG), OA + treadmill exercise once daily (OAE1), OA + treadmill exercise twice daily, rest interval between exercise>4h (OAE2) and OA + treadmill exercise three times daily, rest interval between exercise>4h (OAE3). Rats were evaluated after completing the treadmill exercise program (speed, 18 m/min; total exercise time 60 min/day; 5 days/week for 8 weeks). Interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha, and LXA(4) in serum and intra-articular lavage fluid were measured by ELISA. Changes in articular cartilage were evaluated by histology, immunohistochemistry, western blotting and quantitative real-timePCR. LXA(4) in the serum and intra-articular lavage fluid increased in all OAE groups, and histological evaluation indicated that the OAE3 group had the best treatment response. The expression of COL2A1 and I kappa B-beta in articular cartilage increased in all OAE groups vs the OAG group, whereas expression of IL-1 beta, TNF-alpha, matrix metalloproteinase (MMP)-13, and NF-kappa B p65 was reduced in all OAE groups compared with the OAG. Under the condition of 60 min treadmill exercise with moderate-intensity, to fulfill in three times would have better chondroprotective effects than to fulfill in two or one time on monosodium iodoacetate-induced OA in rats. And it may be worked through the anti-inflammatory activity of LXA(4) and the NF-kappa B pathway.	[Yang, Yue; Zhang, Xiaoning; Bai, Lunhao] China Med Univ, Shengjing Hosp, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China; [Wang, Yang] China Med Univ, Shengjing Hosp, Dept Ultrasound, Shenyang, Liaoning, Peoples R China; [Kong, Yawei] Harvard Med Sch, Brigham & Womens Hosp, Int Patient Ctr, Boston, MA USA	China Medical University; China Medical University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bai, LH (corresponding author), China Med Univ, Shengjing Hosp, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China.	bailh@sj-hospital.org			National Natural Science Foundation of China [81272050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant Sponsor: National Natural Science Foundation of China; Grant Number: 81272050. URL:https://isisn.nsfc.gov.cn/egrantweb/.	Aupperle KR, 2001, J IMMUNOL, V166, P2705, DOI 10.4049/jimmunol.166.4.2705; Barbour KE, 2014, ARTHRIT CARE RES, V66, P139, DOI 10.1002/acr.22120; Barve RA, 2007, OSTEOARTHR CARTILAGE, V15, P1190, DOI 10.1016/j.joca.2007.03.014; Boudenot A, 2014, OSTEOARTHR CARTILAGE, V22, P1176, DOI 10.1016/j.joca.2014.05.020; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Cicuttini FM, 2016, MED J AUSTRALIA, V204, P47, DOI 10.5694/mja15.01069; Cifuentes DJ, 2010, OSTEOARTHR CARTILAGE, V18, P1088, DOI 10.1016/j.joca.2010.04.004; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Conte FP, 2010, BRIT J PHARMACOL, V161, P911, DOI 10.1111/j.1476-5381.2010.00950.x; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Galois L, 2004, OSTEOARTHR CARTILAGE, V12, P779, DOI 10.1016/j.joca.2004.06.008; Garstang SV, 2006, AM J PHYS MED REHAB, V85, pS2, DOI 10.1097/01.phm.0000245568.69434.1a; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Gierman LM, 2013, ARTHRITIS RHEUM-US, V65, P2606, DOI 10.1002/art.38081; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Iijima H, 2015, OSTEOARTHR CARTILAGE, V23, P1563, DOI 10.1016/j.joca.2015.04.015; Jeong YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134856; Kalunian KC, 2016, CURR OPIN RHEUMATOL, V28, P246, DOI 10.1097/BOR.0000000000000273; Knobloch TJ, 2008, CRIT REV EUKAR GENE, V18, P139, DOI 10.1615/CritRevEukarGeneExpr.v18.i2.30; Leandro CG, 2007, J STRENGTH COND RES, V21, P751; Liu-Bryan R, 2015, OSTEOARTHR CARTILAGE, V23, P1835, DOI 10.1016/j.joca.2014.12.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Malfait AM, 2016, OSTEOARTHR CARTILAGE, V24, P21, DOI 10.1016/j.joca.2015.09.010; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McMahon B, 2001, TRENDS PHARMACOL SCI, V22, P391, DOI 10.1016/S0165-6147(00)01771-5; Mohammadi MF, 2013, IRAN J BASIC MED SCI, V16, P683; Na SS, 2014, J PHYS THER SCI, V26, P487, DOI 10.1589/jpts.26.487; Nam J, 2011, ARTHRITIS RHEUM-US, V63, P1613, DOI 10.1002/art.30311; Ni GX, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/172392; Ni GX, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4101; Olivotto E, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000061; Otero M, 2012, J BIOL CHEM, V287, P3559, DOI 10.1074/jbc.M111.265744; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Qian J, 2014, EXP THER MED, V8, P377, DOI 10.3892/etm.2014.1746; Roman-Blas JA, 2006, OSTEOARTHR CARTILAGE, V14, P839, DOI 10.1016/j.joca.2006.04.008; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Siebelt M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4461; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Udo M, 2016, OSTEOARTHR CARTILAGE, V23, P1; VANDERSLUIJS JA, 1992, J ORTHOPAED RES, V10, P58, DOI 10.1002/jor.1100100107	42	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179162	10.1371/journal.pone.0179162	http://dx.doi.org/10.1371/journal.pone.0179162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594958	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200093
J	An, R; Alshalchi, S; Breimhurst, P; Munoz-Aguayo, J; Flores-Figueroa, C; Vidovic, S				An, Ran; Alshalchi, Sahar; Breimhurst, Peter; Munoz-Aguayo, Jeannette; Flores-Figueroa, Christian; Vidovic, Sinisa			Strong influence of livestock environments on the emergence and dissemination of distinct multidrug-resistant phenotypes among the population of non-typhoidal Salmonella	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ENTERICA; MUTATIONS; GYRA; SUSCEPTIBILITY; CIPROFLOXACIN; EVOLUTIONARY; ANIMALS; PROGRAM; DISEASE	The problem of emergence and dissemination of multidrug resistance, especially among Gram-negative bacteria, has reached alarming levels. This increases the need to develop surveillance methods that more effectively and accurately provide information about the emergence and spread of multidrug-resistant organisms. In this study, using a well-defined population of non-typhoidal Salmonella (NTS) isolates associated with avian, bovine and porcine hosts, we found that the livestock environments had a specific (P < 0.005) and profound (P < 0.005) effect on the evolution of multidrug-resistant phenotypes among population of NTS isolates. The MDR pattern containing penicillins, tetracyclines and macrolides and the evolving counterparts (i.e., penicillins, tetracyclines and macrolides + other antibiotic classes) were significantly (P < 0.005) associated with NTS isolates of porcine origin. Similarly, MDR patterns containing folate pathway inhibitors, macrolides and aminocyclitol or containing penicillins, cephalosporins, tetracyclines, phenicols and macrolides were significantly associated with avian (P < 0.005) and bovine (P < 0.005) NTS isolates, respectively. Furthermore, STRUCTURE, an evolutionary analysis, clearly showed that the host origin (i.e., livestock environment), and not the genetic background of different NTS serovars, was the most determinative factor for acquisition and spread of MDR phenotypes. In addition, we described a novel non-synonymous mutation, located outside of the QRDR at position 864 of GyrA, that was likely associated with fluoroquinolone resistance.	[An, Ran; Alshalchi, Sahar; Vidovic, Sinisa] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Breimhurst, Peter] Univ Minnesota, Coll Biol Sci, Minneapolis, MN USA; [Munoz-Aguayo, Jeannette; Flores-Figueroa, Christian] Univ Minnesota, Midcent Res & Outreach Ctr, Willmar, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System	Vidovic, S (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	svidovic@umn.edu		Vidovic, Sinisa/0000-0001-8264-3859	Department of Veterinary and Biomedical Sciences, University of Minnesota	Department of Veterinary and Biomedical Sciences, University of Minnesota	This work was supported by the start-up fund provided to S. Vidovic by the Department of Veterinary and Biomedical Sciences, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the start-up fund provided to S. Vidovic by the Department of Veterinary and Biomedical Sciences, University of Minnesota.	Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Bai L, 2016, ANTIMICROB AGENTS CH, V60, P3365, DOI 10.1128/AAC.02849-15; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Centers for Disease Control and Prevention, 2012, TRENDS FOODB ILLN US; Centers for Disease Control and Prevention, 2013, HUM IS FIN REP 2011; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Eaves DJ, 2002, J CLIN MICROBIOL, V40, P4121, DOI 10.1128/JCM.40.11.4121-4125.2002; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Feasey NA, 2016, NAT GENET, V48, P1211, DOI 10.1038/ng.3644; Gal-Mor O, 2010, EMERG INFECT DIS, V16, P1754, DOI 10.3201/eid1611.100100; Garcia-Fernandez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132065; Helms M, 2005, EMERG INFECT DIS, V11, P859, DOI 10.3201/eid1106.041017; Hopkins KL, 2007, J MICROBIOL METH, V68, P163, DOI 10.1016/j.mimet.2006.07.006; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HY, 2009, ANTIMICROB AGENTS CH, V53, P2696, DOI 10.1128/AAC.01297-08; Lokken KL, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw103; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Medalla F, 2017, EMERG INFECT DIS, V23, P29, DOI 10.3201/eid2301.160771; National Committee for Clinical Laboratory Standards, 2002, M31A2 NAT COMM CLIN; National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS; O'Reilly CE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001256; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Pritchard JK, 2000, GENETICS, V155, P945; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Threlfall E J, 2003, Euro Surveill, V8, P41; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Vidovic S, 2013, J CLIN MICROBIOL, V51, P2082, DOI 10.1128/JCM.00307-13; Wannaprasat W, 2011, INT J ANTIMICROB AG, V37, P457, DOI 10.1016/j.ijantimicag.2010.12.001; Wittum TE, 2012, APPL ENVIRON MICROB, V78, P7487, DOI 10.1128/AEM.01682-12; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	40	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179005	10.1371/journal.pone.0179005	http://dx.doi.org/10.1371/journal.pone.0179005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591163	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700071
J	Chen, HY; Wang, XS; Han, JM; Fan, ZM; Sadia, S; Zhang, RR; Guo, YS; Jiang, YY; Wu, YJ				Chen, Haiyan; Wang, Xusheng; Han, Jimin; Fan, Zhimeng; Sadia, Sobia; Zhang, Rongrong; Guo, Yingsheng; Jiang, Yuyang; Wu, Yaojiong			AKT and its related molecular feature in aged mice skin	PLOS ONE			English	Article							FACTOR-KAPPA-B; CELL-PROLIFERATION; PTEN; INFLAMMATION; ACTIVATION; EXPRESSION; PATHWAY; CANCER; REDUCTION	Previous studies suggest that Akt signaling promotes tissue regeneration and decreased Akt activities are found in aged tissues. However, this study finds that the expression and activation levels of Akt in the mice skin increased with age. Additionally, the expression levels of Pten, p16, p21 and p53 also elevated with increased age. Immuno-fluorescence analysis showed that Akt phosphorylation found in the epidermal cells (with increased levels of NF-kappa B activation) were also found. In vivo inhibition of AKT activity result in reduced NF-kappa B activation. Our results suggest that increasing Akt/NF-kappa B is a crucial mediator of skin aging, which can increase the susceptibility of cell transformation.	[Chen, Haiyan; Wu, Yaojiong] Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen, Peoples R China; [Chen, Haiyan; Wang, Xusheng; Han, Jimin; Fan, Zhimeng; Sadia, Sobia; Wu, Yaojiong] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Hlth Sci & Technol, Shenzhen, Peoples R China; [Chen, Haiyan; Jiang, Yuyang] Shenzhen Ctr Dis Control & Prevent, Med Key Lab Hlth Toxicol Shenzhen, Shenzhen, Peoples R China; [Han, Jimin; Fan, Zhimeng] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Zhang, Rongrong] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Nephrol, Shenzhen, Peoples R China; [Guo, Yingsheng] Second Peoples Hosp Futian Dist, Shenzhen, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Shenzhen Center for Disease Control & Prevention (SZCDC); Tsinghua University; Jinan University; Second People's Hospital of Shenzhen	Wu, YJ (corresponding author), Tsinghua Univ, Tsinghua Berkeley Shenzhen Inst, Shenzhen, Peoples R China.; Wu, YJ (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Hlth Sci & Technol, Shenzhen, Peoples R China.; Jiang, YY (corresponding author), Shenzhen Ctr Dis Control & Prevent, Med Key Lab Hlth Toxicol Shenzhen, Shenzhen, Peoples R China.	jiangyy@sz.tsinghua.edu.cn; wu.yaojiong@sz.tsinghua.edu.cn	Chen, Haiyan/HGB-6216-2022; jiang, yu/HGU-0029-2022		Natural Science Foundation of China [31371404, 31571429]; Natural Science Foundation of Guangdong [2015A030311041]; Shenzhen Science and Technology Innovation Committee [JCYJ20160301150838144, GJHZ20150316160614842]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Committee	This work was supported by grants from Natural Science Foundation of China (No. 31371404, 31571429), Natural Science Foundation of Guangdong (2015A030311041), and Shenzhen Science and Technology Innovation Committee (JCYJ20160301150838144, GJHZ20150316160614842).	Agarwal A, 2005, ONCOGENE, V24, P1021, DOI 10.1038/sj.onc.1208296; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Chung JH, 2007, J DERMATOL, V34, P593, DOI 10.1111/j.1346-8138.2007.00341.x; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di-Poi N, 2005, MOL CELL BIOL, V25, P1696, DOI 10.1128/MCB.25.5.1696-1712.2005; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Hartmann W, 2006, CLIN CANCER RES, V12, P3019, DOI 10.1158/1078-0432.CCR-05-2187; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu HZ, 2011, GUT, V60, P710, DOI 10.1136/gut.2010.220020; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Madi M, 2015, J MEMBRANE BIOL, V248, P903, DOI 10.1007/s00232-015-9791-z; Murayama K, 2007, ONCOGENE, V26, P4882, DOI 10.1038/sj.onc.1210274; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Segrelles C, 2014, STEM CELLS, V32, P1917, DOI 10.1002/stem.1669; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Takahashi H, 2012, AGING CELL, V11, P305, DOI 10.1111/j.1474-9726.2011.00787.x; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Wang XS, 2013, NAT PROTOC, V8, P302, DOI 10.1038/nprot.2013.002; Xia XJ, 2010, AM J PATHOL, V176, P2500, DOI 10.2353/ajpath.2010.091041; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zmajkovicova K, 2013, MOL CELL, V50, P43, DOI 10.1016/j.molcel.2013.01.037	31	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178969	10.1371/journal.pone.0178969	http://dx.doi.org/10.1371/journal.pone.0178969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591208	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700065
J	Ducarme, G; Hamel, JF; Brun, S; Madar, H; Merlot, B; Sentilhes, L				Ducarme, Guillaume; Hamel, Jean-Francois; Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic			Sexual function and postpartum depression 6 months after attempted operative vaginal delivery according to fetal head station: A prospective population-based cohort study	PLOS ONE			English	Article							POSTNATAL DEPRESSION; NEONATAL MORBIDITY; PRIMIPAROUS WOMEN; SCALE EPDS; CHILDBIRTH; PREGNANCY; MODE; RISK; 2ND-STAGE; HEALTH	Objective To evaluate the effect of the fetal head station at attempted operative vaginal delivery (aOVD), and specifically midpelvic or low aOVD, on female and male sexual function and symptoms of postpartum depression (PPD) at 6 months. Design Prospective population-based cohort study. Setting 1,941 women with singleton term fetuses in vertex presentation with midpelvic or low aOVD between 2008 and 2013 in a tertiary care university hospital. Methods Symptoms of female sexual dysfunction using the Pelvic Organ Prolapse/Urinary Incontinence/ Sexual Function Short Form Questionnaire (PISQ-12), symptoms of PPD using the Edinburgh Postnatal Depression Scale (EPDS) score, symptoms of male sexual dysfunction using the International Index of Erectile Function (IIEF-15) and perineal pain were assessed 6 months after aOVD. We measured the association between midpelvic or low aOVD and symptoms of female and male sexual function and symptoms of PPD at 6 months using multiple regression and adjusting for demographics, and risk factors of sexual dysfunction, symptoms of PPD and perineal pain with adjusted odds ratios (aORs) and 95% confidence intervals (95% CI). Results The study included 907 women (46.7%) who responded to the questionnaire; 18.4% (167/ 907) had midpelvic aOVD, and 81.6% (740/907) low. Most women (873/907 [96.3%]) of those with partners reported sexual activity at 6 months. No significant difference was observed for PISQ-12, EPDS, IIEF-15 scores and perineal pain between mid and low pelvic groups. Compared with low pelvic aOVD, midpelvic aOVD was not significantly associated with either female or male sexual dysfunction (p = 0.89 and p = 0.76, respectively), or maternal symptoms of PPD (p = 0.83). Perineal pain significantly increased the risk of male and female sexual dysfunction and maternal symptoms of PPD at 6 months (p = 0.02, p = 0.006, and p = 0.02, respectively). Conclusion Midpelvic compared with low pelvic aOVD was not associated with an increase in sexual dysfunction, nor with symptoms of PPD at 6 months.	[Ducarme, Guillaume] Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France; [Hamel, Jean-Francois] Angers Univ Hosp, Clin Res Ctr, Angers, France; [Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic] Bordeaux Univ Hosp, Dept Obstet & Gynecol, Bordeaux, France	CHD Vendee; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux	Ducarme, G (corresponding author), Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France.	g.ducarme@gmail.com	, DUCARME/I-1248-2019	, DUCARME/0000-0002-2549-353X	Angers University Hospital	Angers University Hospital	The Angers University Hospital provided the funding for the study. The funding source had no role in the design or conduct of the study, collection, analysis, or interpretation of the data, or writing the article or decision to submit for publication.	Adouard F, 2005, ARCH WOMEN MENT HLTH, V8, P89, DOI 10.1007/s00737-005-0077-9; [Anonymous], 2013, J GYNECOL OBST BIO R, V42, P1018, DOI 10.1016/j.jgyn.2013.09.023; Barbara G, 2016, J SEX MED, V13, P393, DOI 10.1016/j.jsxm.2016.01.004; Barrett G, 2000, BRIT J OBSTET GYNAEC, V107, P186, DOI 10.1111/j.1471-0528.2000.tb11689.x; Blom EA, 2010, BJOG-INT J OBSTET GY, V117, P1390, DOI 10.1111/j.1471-0528.2010.02660.x; BOYCE PM, 1992, MED J AUSTRALIA, V157, P172, DOI 10.5694/j.1326-5377.1992.tb137080.x; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brubaker L, 2008, OBSTET GYNECOL, V111, P1040, DOI 10.1097/AOG.0b013e318169cdee; Buhling KJ, 2006, EUR J OBSTET GYN R B, V124, P42, DOI 10.1016/j.ejogrb.2005.04.008; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Connolly AM, 2005, INT UROGYNECOL J, V16, P263, DOI 10.1007/s00192-005-1293-6; Cox J., 2003, PERINATAL MENTAL HLT; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Crane AK, 2013, FEMALE PELVIC MED RE, V19, P13, DOI 10.1097/SPV.0b013e31827bfd7b; Csatordai S, 2007, PATIENT EDUC COUNS, V67, P84, DOI 10.1016/j.pec.2007.02.004; De Souza A, 2015, BJOG-INT J OBSTET GY, V122, P1410, DOI 10.1111/1471-0528.13331; Ducarme G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168591; Ducarme G, 2015, OBSTET GYNECOL, V126, P521, DOI 10.1097/AOG.0000000000001000; Eisenach JC, 2008, PAIN, V140, P87, DOI 10.1016/j.pain.2008.07.011; Fatton B, 2009, J GYNECOL OBST BIO R, V38, P662, DOI 10.1016/j.jgyn.2009.02.008; Fehniger JE, 2013, OBSTET GYNECOL, V122, P988, DOI 10.1097/AOG.0b013e3182a7f3fc; Fritel X, 2008, BJOG-INT J OBSTET GY, V115, P247, DOI 10.1111/j.1471-0528.2007.01540.x; Gaillard A, 2014, PSYCHIAT RES, V215, P341, DOI 10.1016/j.psychres.2013.10.003; Giuliano F, 2013, PROG UROL, V23, P811, DOI 10.1016/j.purol.2013.01.006; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Hicks TL, 2004, J MIDWIFERY WOM HEAL, V49, P430, DOI 10.1016/j.jmwh.2004.04.007; Johnstone SJ, 2001, AUST NZ J PSYCHIAT, V35, P69, DOI 10.1046/j.1440-1614.2001.00862.x; Kumar RC, 1997, BRIT J PSYCHIAT, V171, P175, DOI 10.1192/bjp.171.2.175; Liebling RE, 2004, AM J OBSTET GYNECOL, V191, P4, DOI 10.1016/j.ajog.2004.01.013; McDonald EA, 2015, BJOG-INT J OBSTET GY, V122, P672, DOI 10.1111/1471-0528.13263; McDonald EA, 2013, BJOG-INT J OBSTET GY, V120, P823, DOI 10.1111/1471-0528.12166; Mous M, 2008, BJOG-INT J OBSTET GY, V115, P234, DOI 10.1111/j.1471-0528.2007.01502.x; Murphy DJ, 2001, LANCET, V358, P1203, DOI 10.1016/S0140-6736(01)06341-3; Olsson A, 2010, SCAND J CARING SCI, V24, P716, DOI 10.1111/j.1471-6712.2009.00768.x; Patel RR, 2005, BMJ-BRIT MED J, V330, P879, DOI 10.1136/bmj.38376.603426.D3; Pauls RN, 2008, J SEX MED, V5, P1915, DOI 10.1111/j.1743-6109.2008.00884.x; Peaceman AM, 2015, OBSTET GYNECOL, V126, pE56, DOI 10.1097/AOG.0000000000001147; Rogers RG, 2003, INT UROGYNECOL J PEL, V14, P164, DOI 10.1007/s00192-003-1063-2; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Safarinejad MR, 2009, J SEX MED, V6, P1645, DOI 10.1111/j.1743-6109.2009.01232.x; Sentilhes L, 2008, INT UROGYNECOL J, V19, P763, DOI 10.1007/s00192-007-0521-7; Serati M, 2010, J SEX MED, V7, P2782, DOI 10.1111/j.1743-6109.2010.01893.x; Signorello LB, 2001, AM J OBSTET GYNECOL, V184, P881, DOI 10.1067/mob.2001.113855; Sword W, 2011, BJOG-INT J OBSTET GY, V118, P966, DOI 10.1111/j.1471-0528.2011.02950.x; Thompson JF, 2002, BIRTH-ISS PERINAT C, V29, P83, DOI 10.1046/j.1523-536X.2002.00167.x; von Sydow K, 1999, J PSYCHOSOM RES, V47, P27, DOI 10.1016/S0022-3999(98)00106-8; Woolhouse H, 2014, MIDWIFERY, V30, P378, DOI 10.1016/j.midw.2013.03.006; Yang SN, 2011, J AFFECT DISORDERS, V132, P158, DOI 10.1016/j.jad.2011.02.009	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178915	10.1371/journal.pone.0178915	http://dx.doi.org/10.1371/journal.pone.0178915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591209	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700055
J	Asai, Y; Tsutsui, S; Oka, H; Yoshimura, N; Hashizume, H; Yamada, H; Akune, T; Muraki, S; Matsudaira, K; Kawaguchi, H; Nakamura, K; Tanaka, S; Yoshida, M				Asai, Yoshiki; Tsutsui, Shunji; Oka, Hiroyuki; Yoshimura, Noriko; Hashizume, Hiroshi; Yamada, Hiroshi; Akune, Toru; Muraki, Shigeyuki; Matsudaira, Ko; Kawaguchi, Hiroshi; Nakamura, Kozo; Tanaka, Sakae; Yoshida, Munehito			Sagittal spino-pelvic alignment in adults: The Wakayama Spine Study	PLOS ONE			English	Article							THORACIC KYPHOSIS; LUMBAR LORDOSIS; PLANE; BALANCE; PARAMETERS; DEFORMITY; STRENGTH; PATIENT; YOUNG; DISC	Objectives To establish the normal values of spino-pelvic alignment and to clarify the effect of age-related changes using large, community-based cohorts. Methods In this study, data from 1461 participants (466 men, 995 women) were analyzed. On lateral standing radiographs, the following parameters were measured: thoracic kyphosis (TK), lumbar lordosis (LL), pelvic tilt (PT), pelvic incidence (PI), and C7 sagittal vertical axis (SVA). All values are expressed as the mean +/- standard deviation. The Spearman rank correlation coefficient was used to examine correlations between variables of spino-pelvic parameters. Finally, we analyzed the relationship between age and spino-pelvic parameters. Therefore, we entered values for the body mass index (BMI), SVA, TK, and PI-LL into a multiple regression model to adjust for potential confounding factors. Results The SVA, TK, and PT increased with age, and LL decreased with age. Regarding sex differences, the TK was statistically significantly larger in men than in women, and LL, PT, and PI were statistically significantly smaller in men than in women. Correlation coefficients between the SVA and TK, between the SVA and PI-LL, and between TK and PI-LL were none, strong, and weak, respectively. Results of multiple regression analysis between age and spino-pelvic parameters showed that the standardized partial regression coefficients for the SVA, TK, and PI-LL were 0.17, 0.30, and 0.23, respectively, in men and 0.29, 0.32, and 0.23, respectively, in women. Conclusions We found that all parameters were significantly associated with age in men and women. The SVA, TK, and PT increased with age, and LL decreased with age. Results of multiple regression analysis also demonstrated that the SVA, TK, and PI-LL are related to age. Indeed, the PI-LL value increased with age. In this study, a more excessive PI-LL mismatch was shown, indicating an increased risk of spinal malalignment. Differences in the absolute values of spino-pelvic parameters in each sex were small yet statistically significant. Thus, further study should be performed to corroborate this finding.	[Asai, Yoshiki; Tsutsui, Shunji; Hashizume, Hiroshi; Yamada, Hiroshi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama, Wakayama, Japan; [Oka, Hiroyuki] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, 7-3-1 Hongo, Tokyo, Japan; Univ Tokyo, Dept Joint Dis Res, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan; [Akune, Toru; Nakamura, Kozo] Rehabil Serv Bur, Natl Rehabil Ctr Persons Disabil, Tokorozawa, Saitama, Japan; [Kawaguchi, Hiroshi] Japan Community Hlth Care Org Tokyo Shinjuku Med, Shinjuku Ku, 5-1 Tsukudocyo, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthoped Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Tsutsui, S (corresponding author), Wakayama Med Univ, Dept Orthoped Surg, 811-1 Kimiidera, Wakayama, Wakayama, Japan.	stsutsui1116@gmail.com	Hashizume, Hiroshi/V-6888-2019; Tanaka, Sakae/Y-3061-2019	Hashizume, Hiroshi/0000-0002-9064-0284; Tanaka, Sakae/0000-0001-9210-9414				Bartynski WS, 2005, AM J NEURORADIOL, V26, P2077; BERNHARDT M, 1989, SPINE, V14, P717, DOI 10.1097/00007632-198907000-00012; Blechacz B, 2008, NEW ENGL J MED, V358, pE28, DOI 10.1056/NEJMicm074057; DESMET AA, 1988, RADIOLOGY, V166, P497, DOI 10.1148/radiology.166.2.3336728; Dubousset J., 1994, PEDIAT SPINE PRINCIP; Endo K, 2014, ASIAN SPINE J, V8, P599, DOI 10.4184/asj.2014.8.5.599; FON GT, 1980, AM J ROENTGENOL, V134, P979, DOI 10.2214/ajr.134.5.979; GELB DE, 1995, SPINE, V20, P1351, DOI 10.1097/00007632-199506000-00005; Gilsanz V, 1998, J CLIN ENDOCR METAB, V83, P1420, DOI 10.1210/jc.83.5.1420; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7; Goh S, 1999, CLIN BIOMECH, V14, P439, DOI 10.1016/S0268-0033(98)00105-3; Grobler L., 1978, ORTHOP T, V2, P239; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hammerberg EM, 2003, J SPINAL DISORD TECH, V16, P44, DOI 10.1097/00024720-200302000-00008; HASDAY CA, 1983, SPINE, V8, P501, DOI 10.1097/00007632-198307000-00007; Hirose D, 2004, CLIN BIOMECH, V19, P57, DOI 10.1016/j.clinbiomech.2003.08.005; Janssen MMA, 2009, SPINE, V34, pE826, DOI 10.1097/BRS.0b013e3181a9fd85; Kim YB, 2014, EUR SPINE J, V23, P1400, DOI 10.1007/s00586-014-3236-8; LAGRONE MO, 1988, J BONE JOINT SURG AM, V70A, P569, DOI 10.2106/00004623-198870040-00014; Lee CS, 2011, SPINE, V36, pE1648, DOI 10.1097/BRS.0b013e318216b0fd; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Lonner BS, 2009, J SPINAL DISORD TECH, V22, P551, DOI 10.1097/BSD.0b013e318192d8ad; Mac-Thiong JM, 2007, EUR SPINE J, V16, P227, DOI 10.1007/s00586-005-0013-8; Mac-Thiong Jean-Marc, 2011, Eur Spine J, V20 Suppl 5, P572, DOI 10.1007/s00586-011-1923-2; Manns RA, 1996, CLIN RADIOL, V51, P258, DOI 10.1016/S0009-9260(96)80342-4; Marks MC, 2003, SPINE, V28, P1176, DOI 10.1097/00007632-200306010-00018; Mendoza-Lattes S, 2010, SPINE, V35, pE792, DOI 10.1097/BRS.0b013e3181d35ca9; MILNE JS, 1983, AGE AGEING, V12, P225, DOI 10.1093/ageing/12.3.225; Moe JH., 1977, ORTHOP T, V1, P131; NICHOLAS J A, 1963, Clin Orthop Relat Res, V26, P19; PROPSTPROCTOR SL, 1983, J PEDIATR ORTHOPED, V3, P344, DOI 10.1097/01241398-198307000-00013; Rose PS, 2009, SPINE, V34, P785, DOI 10.1097/BRS.0b013e31819d0c86; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Roussouly P, 2006, SPINE, V31, P2484, DOI 10.1097/01.brs.0000239155.37261.69; Roussouly P, 2006, SPINE, V31, pE320, DOI 10.1097/01.brs.0000218263.58642.ff; Roussouly P, 2010, EUR SPINE J, V19, P1824, DOI 10.1007/s00586-010-1476-9; ROWE C R, 1963, Clin Orthop Relat Res, V26, P34; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Schwab F, 2012, SPINE, V37, P1077, DOI 10.1097/BRS.0b013e31823e15e2; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Schwab F, 2009, SPINE, V34, P1828, DOI 10.1097/BRS.0b013e3181a13c08; Sinaki M, 1996, AM J PHYS MED REHAB, V75, P370, DOI 10.1097/00002060-199609000-00013; SINAKI M, 1986, MAYO CLIN PROC, V61, P116, DOI 10.1016/S0025-6196(12)65197-0; SINAKI M, 1993, OSTEOPOROSIS INT, V3, P8, DOI 10.1007/BF01623170; Sinaki M, 2005, OSTEOPOROSIS INT, V16, P1004, DOI 10.1007/s00198-004-1791-2; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; Takeda N, 2009, J ORTHOP SCI, V14, P748, DOI 10.1007/s00776-009-1394-z; TAKEMITSU Y, 1988, SPINE, V13, P1317, DOI 10.1097/00007632-198811000-00019; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Yoshimura N, 2015, MOD RHEUMATOL, V25, P438, DOI 10.3109/14397595.2014.972607; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1; Zhu ZZ, 2014, SPINE, V39, pE1, DOI 10.1097/BRS.0000000000000022	54	63	64	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178697	10.1371/journal.pone.0178697	http://dx.doi.org/10.1371/journal.pone.0178697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586366	Green Submitted, gold, Green Published			2022-12-26	WOS:000402875700023
J	Bian, SM; Li, XY; Mainali, H; Chen, L; Dhaubhadel, S				Bian, Shaomin; Li, Xuyan; Mainali, Hemanta; Chen, Ling; Dhaubhadel, Sangeeta			Genome-wide analysis of DWD proteins in soybean (Glycine max): Significance of Gm08DWD and GmMYB176 interaction in isoflavonoid biosynthesis	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; WD-REPEAT; NEGATIVE REGULATOR; ARABIDOPSIS; CUL4-DDB1; COMPLEX; FAMILY; DDB1; ACTS; ARCHITECTURE	A subset of WD40 proteins with DWD motif has been proposed to serve as substrate receptor of DDB-CUL4-ROC1 complex, thereby getting involved in protein degradation via ubiquitination pathway. Here, we identified a total of 161 potential DWD proteins in soybean (Glycine max) by searching DWD motif against the genome-wide WD40 repeats, and classified them into 20 groups on the basis of their functional domains and annotations. These putative DWD genes in soybean displayed tissue-specific expression patterns, and their genome localization and analysis of evolutionary relationship identified 48 duplicated gene pairs within 161 GmDWDs. Among the 161 soybean DWD proteins, Gm08DWD was previously found to interact with an isoflavonoid regulator, GmMYB176. Therefore, Gm08DWD and its homologue Gm05DWD were further investigated. Expression profile of both genes in different soybean tissues revealed that Gm08DWD was expressed higher in embryo, while Gm05DWD exhibited maximum transcript accumulation in leaf. Our protein-protein interaction studies demonstrated that Gm08DWD interacts with GmMYB176. Although Gm08DWD was localized both in nucleus and cytoplasm, the resulting complex of Gm08DWD and GmMYB176 was mainly observed in the nucleus. This finding is consistent with the functional localization of CUL4-E3 ligase complex. In conclusion, the survey on soybean potential DWD protein is useful reference for the further functional investigation of their DDB1-binding ability. Based on the functional investigation of Gm08DWD, we speculate that protein-protein interaction between Gm08DWD and GmMYB176 may lead to the degradation of GmMYB176 through CUL4-DDB1complex.	[Bian, Shaomin; Li, Xuyan] Jilin Univ, Coll Plant Sci, Changchun, Jilin, Peoples R China; [Bian, Shaomin; Li, Xuyan; Mainali, Hemanta; Chen, Ling; Dhaubhadel, Sangeeta] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada; [Dhaubhadel, Sangeeta] Western Univ, Dept Biol, London, ON, Canada	Jilin University; Agriculture & Agri Food Canada; Western University (University of Western Ontario)	Bian, SM (corresponding author), Jilin Univ, Coll Plant Sci, Changchun, Jilin, Peoples R China.; Bian, SM; Dhaubhadel, S (corresponding author), Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada.; Dhaubhadel, S (corresponding author), Western Univ, Dept Biol, London, ON, Canada.	shmbian@jlu.edu.cn; sangeeta.dhaubhadel@canada.ca			National Natural Science Foundation of China [31370340]; Agriculture and Agri-Food Canada's Genomics Research and Development Initiative grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture and Agri-Food Canada's Genomics Research and Development Initiative grant(Agriculture & Agri Food Canada)	This work was supported by the National Natural Science Foundation of China (No. 31370340) to SB and Agriculture and Agri-Food Canada's Genomics Research and Development Initiative grant to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Alex Molnar for his help with the preparation of the figures. This work was supported by the National Natural Science Foundation of China (No. 31370340) to SB and Agriculture and Agri-Food Canada's Genomics Research and Development Initiative grant to SD.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Aoki T, 2000, J PLANT RES, V113, P475, DOI 10.1007/PL00013958; Biedermann S, 2011, TRENDS PLANT SCI, V16, P38, DOI 10.1016/j.tplants.2010.09.007; Bjerkan KN, 2012, PLANT CELL, V24, P1013, DOI 10.1105/tpc.111.089425; Buscaino A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002499; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen HD, 2010, PLANT CELL, V22, P108, DOI 10.1105/tpc.109.065490; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Dumbliauskas E, 2011, EMBO J, V30, P731, DOI 10.1038/emboj.2010.359; Dutilleul C, 2016, PLANT CELL ENVIRON, V39, P185, DOI 10.1111/pce.12605; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hopfer U, 2006, J BIOL CHEM, V281, P8645, DOI 10.1074/jbc.M513751200; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kim HK, 2005, MOL CELLS, V19, P67; Kim SH, 2014, MOL CELLS, V37, P833, DOI 10.14348/molcells.2014.0224; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lee JH, 2011, PLANT SCI, V180, P352, DOI 10.1016/j.plantsci.2010.10.008; Lee JH, 2010, PLANT CELL, V22, P1716, DOI 10.1105/tpc.109.073783; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Li RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143280; Li XY, 2012, PLANT J, V71, P239, DOI 10.1111/j.1365-313X.2012.04986.x; Loeffler I, 2015, EUR J CLIN INVEST, V45, P294, DOI 10.1111/eci.12405; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Messina M, 2010, J NUTR, V140, p2289S, DOI 10.3945/jn.110.124107; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Phillips Donald A., 1995, Trends in Microbiology, V3, P58, DOI 10.1016/S0966-842X(00)88876-9; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Trevaskis B, 2002, MOL PLANT MICROBE IN, V15, P630, DOI 10.1094/MPMI.2002.15.7.630; van Nocker S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-50; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891; Zhu YY, 2015, PLANTA, V241, P1337, DOI 10.1007/s00425-015-2258-8	52	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178947	10.1371/journal.pone.0178947	http://dx.doi.org/10.1371/journal.pone.0178947			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586359	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700037
J	Wang, YK; Liu, AK; Li, WJ; Jiang, YQ; Song, SW; Li, Y; Chen, RY				Wang, Yikui; Liu, Ake; Li, Wenjia; Jiang, Yaqing; Song, Shiwei; Li, Yan; Chen, Riyuan			Comparative proteomic analysis of eggplant (Solanum melongena L.) heterostylous pistil development	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; DIFFERENT-FORMS; MESSENGER-RNA; DRAFT GENOME; PROTEIN; GENES; EXPRESSION; WHEAT; QUANTITATION; REDUCTASE	Heterostyly is a common floral polymorphism, but the proteomic basis of this trait is still largely unexplored. In this study, self- and cross-pollination of L-morph and S-morph flowers and comparison of embryo sac development in eggplant (Solanum melongena L.) suggested that lower fruit set from S-morph flowers results from stigma-pollen incompatibility. To explore the molecular mechanism underlying heterostyly development, we conducted isobaric tags for relative and absolute quantification (iTRAQ) proteomic analysis of eggplant pistils for L- and S-morph flowers. A total of 5,259 distinct proteins were identified during heterostyly development. Compared S-morph flowers with L-morph, we discovered 57 and 184 differentially expressed proteins (DEPs) during flower development and maturity, respectively. Quantitative real time polymerase chain reactions were used for nine genes to verify DEPs from the iTRAQ approach. During flower development, DEPs were mainly involved in morphogenesis, biosynthetic processes, and metabolic pathways. At flower maturity, DEPs primarily participated in biosynthetic processes, metabolic pathways, and the formation of ribosomes and proteasomes. Additionally, some proteins associated with senescence and programmed cell death were found to be upregulated in S-morph pistils, which may lead to the lower fruit set in S-morph flowers. Although the exact roles of these related proteins are not yet known, this was the first attempt to use an iTRAQ approach to analyze proteomes of heterostylous eggplant flowers, and these results will provide insights into biochemical events taking place during the development of heterostyly.	[Wang, Yikui; Song, Shiwei; Chen, Riyuan] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Wang, Yikui; Li, Wenjia; Jiang, Yaqing; Li, Yan] Guangxi Acad Agr Sci, Inst Vegetable Res, Nanning, Peoples R China; [Liu, Ake] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China	South China Agricultural University; Guangxi Academy of Agricultural Sciences; Fudan University	Chen, RY (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	rychen@scau.edu.cn	liu, houcheng/AAU-7920-2021	Liu, Ake/0000-0002-9086-9425; yikui, wang/0000-0003-0697-5696	National Natural Science Foundation of China [31660573]; China Agriculture Research System [CARS-25-C-04]; Guangxi Innovation Team Project of Vegetable of China Agriculture Research System [nycytxgxcxtd-03-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Guangxi Innovation Team Project of Vegetable of China Agriculture Research System	This study was financially supported by National Natural Science Foundation of China (31660573), China Agriculture Research System (CARS-25-C-04), and the Guangxi Innovation Team Project of Vegetable of China Agriculture Research System (nycytxgxcxtd-03-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; BARRETT SCH, 1990, TRENDS ECOL EVOL, V5, P144, DOI 10.1016/0169-5347(90)90220-8; Barrett SCH, 1992, EVOLUTION FUNCTION H, Vxi; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen JI, 2012, AM J BOT, V99, P797, DOI 10.3732/ajb.1100329; Cohen JI, 2010, AM J BOT, V97, P701, DOI 10.3732/ajb.0900395; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; Elliott MH, 2009, J MASS SPECTROM, V44, P1637, DOI 10.1002/jms.1692; Fu Y, 2016, J PROTEOMICS, V130, P108, DOI 10.1016/j.jprot.2015.09.006; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Handique A. K., 1995, Journal of Nuclear Agriculture and Biology, V24, P121; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hirakawa H, 2014, DNA RES, V21, P649, DOI 10.1093/dnares/dsu027; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Keller B, 2014, FUNCT ECOL, V28, P1413, DOI 10.1111/1365-2435.12274; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Liu PF, 2017, DEV COMP IMMUNOL, V72, P140, DOI 10.1016/j.dci.2017.02.013; Ma CY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1029; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; MOHAN R, 1990, PLANT PHYSIOL, V92, P276, DOI 10.1104/pp.92.1.276; Molina A, 1997, PLANT MOL BIOL, V33, P803, DOI 10.1023/A:1005712803130; Nowak MD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0567-z; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pandey DK, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0798-0; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; RYLSKI I, 1984, SCI HORTIC-AMSTERDAM, V22, P39, DOI 10.1016/0304-4238(84)90081-5; Sadanandom A, 2000, PLANT PHYSIOL, V123, P255, DOI 10.1104/pp.123.1.255; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Streitner C, 2008, PLANT J, V56, P239, DOI 10.1111/j.1365-313X.2008.03591.x; Ushijima K, 2012, PLANT J, V69, P317, DOI 10.1111/j.1365-313X.2011.04792.x; Vijayalalitha S. J., 2012, Advances in Plant Sciences, V25, P357; Wang J, 2016, J PROTEOMICS, V130, P120, DOI 10.1016/j.jprot.2015.09.014; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Weller SG, 2009, BOT J LINN SOC, V160, P249, DOI 10.1111/j.1095-8339.2009.00984.x; Yang MM, 2016, J PROTEOMICS, V136, P157, DOI 10.1016/j.jprot.2016.01.002; Yu SM, 2016, J PROTEOMICS, V142, P102, DOI 10.1016/j.jprot.2016.04.049; Zega A, 2016, PLANT PHYSIOL BIOCH, V108, P1, DOI 10.1016/j.plaphy.2016.06.033; Zi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074229	44	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179018	10.1371/journal.pone.0179018	http://dx.doi.org/10.1371/journal.pone.0179018			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586360	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700043
J	Yu, T; Su, XB; Pan, Y; Zhuang, HY				Yu, Teng; Su, Xubo; Pan, Yi; Zhuang, Hanyi			Receptor-transporting protein (RTP) family members play divergent roles in the functional expression of odorant receptors	PLOS ONE			English	Article							OLFACTORY RECEPTOR; MULTIGENE FAMILY; TASTE RECEPTORS; LIGANDS; REPERTOIRE; ACTIVATION; RETENTION; COPPER; MOUSE; STEPS	Receptor transporting protein (RTP) family members, RTP1S and RTP2, are accessory proteins to mammalian odorant receptors (ORs). They are expressed in the olfactory sensory neurons and facilitate OR trafficking to the cell-surface membrane and ligand-induced responses in heterologous cells. We previously identified different domains in RTP1S that are important for different stages of OR trafficking, odorant-mediated responses, and interaction with ORs. However, the exact roles of RTP2 and the significance of the requirement of the seemingly redundant co-expression of the two RTP proteins in vivo have received less attention in the past. Here we attempted to dissect the functional differences between RTP1S and RTP2 using a HEK293T cell-based OR heterologous expression system. When a set of 24 ORs were tested against 28 cognate ligands, unlike RTP1S, which always showed a robust ability to support odorant-mediated responses, RTP2 had little or no effect on OR responses and exhibited a suppressive effect over that of RTP1S for a subset of the ORs tested. RTP1S and RTP2 showed no significant difference in OR ligand selectivity and co-transfection with RTP2 increased the detection threshold for some ORs. A protein-protein interaction analysis showed positive interactions among OR, RTP1S, and RTP2, corroborating the functional linkages among the three molecules. Finally, further cell-surface and permeabilized immunocytochemical studies revealed that OR and the co-expressed RTP1S proteins were retained in the Golgi when co-transfected with RTP2, indicating that RTP1S and RTP2 could play different roles in the OR trafficking process. By examining the functional differentiations between the two RTP family members, we provided a molecular level explanation to the suppressive effect exerted by RTP2, shedding light on the divergent mechanisms underlying the RTP proteins in regulating the functional expression of ORs.	[Yu, Teng; Su, Xubo; Pan, Yi; Zhuang, Hanyi] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai, Peoples R China; [Zhuang, Hanyi] Shanghai Jiao Tong Univ, Inst Hlth Sci, Sch Med, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Zhuang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai, Peoples R China.; Zhuang, HY (corresponding author), Shanghai Jiao Tong Univ, Inst Hlth Sci, Sch Med, Shanghai Inst Biol Sci,Chinese Acad Sci, Shanghai, Peoples R China.	hanyizhuang@sjtu.edu.cn	Pan, Yi/AAJ-2341-2021		Chinese National Science Foundation [31070972]; Science and Technology Commission of Shanghai Municipality [16ZR1418300]; Program for Innovative Research Team of Shanghai Municipal Education Commission; Shanghai Eastern Scholar Program [J50201]; National Basic Research Program of China [2012CB910401]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Program for Innovative Research Team of Shanghai Municipal Education Commission; Shanghai Eastern Scholar Program; National Basic Research Program of China(National Basic Research Program of China)	The work was supported by the Chinese National Science Foundation (31070972), Science and Technology Commission of Shanghai Municipality (16ZR1418300), the Program for Innovative Research Team of Shanghai Municipal Education Commission, the Shanghai Eastern Scholar Program (J50201), and the National Basic Research Program of China (2012CB910401). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Block E, 2015, P NATL ACAD SCI USA, V112, pE2766, DOI 10.1073/pnas.1503054112; Branco AF, 2015, J CARDIOVASC PHARM, V65, P101, DOI 10.1097/FJC.0000000000000196; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Duan XF, 2012, P NATL ACAD SCI USA, V109, P3492, DOI 10.1073/pnas.1111297109; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hague C, 2004, P NATL ACAD SCI USA, V101, P13672, DOI 10.1073/pnas.0403854101; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Li SJ, 2016, J AM CHEM SOC, V138, P13281, DOI 10.1021/jacs.6b06983; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McClintock TS, 1997, MOL BRAIN RES, V48, P270, DOI 10.1016/S0169-328X(97)00099-5; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; PATTE F, 1979, CHEM SENS FLAV, V4, P267, DOI 10.1093/chemse/4.4.267; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Saraiva LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep18178; Scholz P, 2016, CHEM SENSES, V41, P313, DOI 10.1093/chemse/bjw003; Sharma R, 2017, ELIFE, V6, DOI 10.7554/eLife.21895; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Tadevosyan A, 2016, METHODS, V92, P72, DOI 10.1016/j.ymeth.2015.07.005; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zhuang HY, 2009, P NATL ACAD SCI USA, V106, P21247, DOI 10.1073/pnas.0808378106	34	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179067	10.1371/journal.pone.0179067	http://dx.doi.org/10.1371/journal.pone.0179067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586385	gold, Green Submitted, Green Published			2022-12-26	WOS:000402875700045
J	Einkemmer, L				Einkemmer, Lukas			Evaluation of the Intel Xeon Phi 7120 and NVIDIA K80 as accelerators for two-dimensional panel codes	PLOS ONE			English	Article							OPTIMIZATION	To optimize the geometry of airfoils for a specific application is an important engineering problem. In this context genetic algorithms have enjoyed some success as they are able to explore the search space without getting stuck in local optima. However, these algorithms require the computation of aerodynamic properties for a significant number of airfoil geometries. Consequently, for low-speed aerodynamics, panel methods are most often used as the inner solver. In this paper we evaluate the performance of such an optimization algorithm on modern accelerators (more specifically, the Intel Xeon Phi 7120 and the NVIDIA K80). For that purpose, we have implemented an optimized version of the algorithm on the CPU and Xeon Phi (based on OpenMP, vectorization, and the Intel MKL library) and on the GPU (based on CUDA and the MAGMA library). We present timing results for all codes and discuss the similarities and differences between the three implementations. Overall, we observe a speedup of approximately 2.5 for adding an Intel Xeon Phi 7120 to a dual socket workstation and a speedup between 3.4 and 3.8 for adding a NVIDIA K80 to a dual socket workstation.	[Einkemmer, Lukas] Univ Innsbruck, Dept Math, Innsbruck, Austria	University of Innsbruck	Einkemmer, L (corresponding author), Univ Innsbruck, Dept Math, Innsbruck, Austria.	lukas.einkemmer@uibk.ac.at	Einkemmer, Lukas/AAD-3574-2021	Einkemmer, Lukas/0000-0002-8798-2304	Austrian Science Fund (FWF) [P25346]; Austrian Science Fund (FWF) [P 25346] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is supported by the Austrian Science Fund (FWF) - project id: P25346 (http://www.fwf.ac.at/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Austrian Science Fund (FWF)-project id: P25346.	Casas VD, 2014, INT J COMPUTING, V4, P49; Chabalko C, 2013, 51 AIAA AER SCI M DA; Chabalko CC, 2014, J AEROSP INFORM SYST, V11, P372, DOI 10.2514/1.I010141; deVelder NB, 2014, FREE WAKE POTENTIAL; Dong TX, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, 2014 IEEE 6TH INTL SYMP ON CYBERSPACE SAFETY AND SECURITY, 2014 IEEE 11TH INTL CONF ON EMBEDDED SOFTWARE AND SYST (HPCC,CSS,ICESS), P157, DOI 10.1109/HPCC.2014.30; Fincham JHS, 2015, AEROSP SCI TECHNOL, V43, P245, DOI 10.1016/j.ast.2015.02.023; Gabor OS, 2012, IEEE IND ELEC, P5451, DOI 10.1109/IECON.2012.6388954; Gardner B, 2003, 41 AER SCI M EXH, P1; Kipouros T, 2012, 8 AIAA MULT DES OPT, P1; Moran J., 2003, INTRO THEORETICAL CO; Morgenthal G, 2014, J WIND ENG IND AEROD, V125, P69, DOI 10.1016/j.jweia.2013.12.002; Nordin A, 1989, JURNAL TEKNOLOGI, V14, P5; Poli R., 2008, FIELD GUIDE GENETIC; Rogalsky T., 2000, CAN AERONAUT SPACE J, V46, P183; Tavoularis S., THWAITES METHOD LAMI; Turkal M, 2014, J PHYS CONF SER, V524, DOI 10.1088/1742-6596/524/1/012100; Vladimirov A., 2015, FINE TUNING VECTORIZ, P1	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178156	10.1371/journal.pone.0178156	http://dx.doi.org/10.1371/journal.pone.0178156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582389	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600012
J	Qadeer, MI; Amar, A; Mann, JJ; Hasnain, S				Qadeer, Muhammad Imran; Amar, Ali; Mann, J. John; Hasnain, Shahida			Polymorphisms in dopaminergic system genes; association with criminal behavior and self-reported aggression in violent prison inmates from Pakistan	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; TRANSPORTER GENE; ALLELIC ASSOCIATION; RECEPTOR GENE; VARIABLE NUMBER; DAT1; WITHDRAWAL; DEPENDENCE; SYMPTOMS; CHILDREN	Genetic factors contribute to antisocial and criminal behavior. Dopamine transporter DAT-1 (SLC6A3) and DRD2 gene for the dopamine-2 receptor are dopaminergic system genes that regulate dopamine reuptake and signaling, and may be part of the pathogenesis of psychiatric disorders including antisocial behaviors and traits. No previous studies have analyzed DAT-1 and DRD2 polymorphisms in convicted murderers, particularly from Indian subcontinent. In this study we investigated the association of 40 bp VNTR polymorphism of DAT-1 and Taq1 variant of DRD2 gene (rs1800479) with criminal behavior and self-reported aggression in 729 subjects, including 370 men in Pakistani prisons convicted of first degree murder(s) and 359 control men without any history of violence or criminal tendency. The 9R allele of DAT-1 VNTR polymorphism was more prevalent in convicted murderers compared with control samples, for either one or two risk alleles (OR = 1.49 and 3.99 respectively, P = 0.003). This potential association of DAT-1 9R allele polymorphism with murderer phenotype was confirmed assuming different genetic models of inheritance. However, no genetic association was found for DRD2 Taq1 polymorphism. In addition, a combined haplotype (9R-A2) of DAT-1 and DRD2 genes was associated with this murderer phenotype. Further, 9R allele of DAT-1 was also associated with response to verbal abuse and parental marital complications, but not with other measures pertinent to self-reported aggression. These results suggest that 9R allele, which may influence levels of intra-synaptic dopamine in the brain, may contribute to criminal tendency in this sample of violent murderers of Pakistani origin. Future studies are needed to replicate this finding in other populations of murderers and see if this finding extends to other forms of violence and lesser degrees of aggression.	[Qadeer, Muhammad Imran; Hasnain, Shahida] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan; [Amar, Ali] Univ Hlth Sci, Dept Human Genet & Mol Biol, Lahore, Pakistan; [Mann, J. John] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Mann, J. John] Columbia Univ, Dept Psychiat, New York, NY USA; [Hasnain, Shahida] Women Univ Multan, Multan, Pakistan	University of Punjab; University of Health Science - Pakistan; New York State Psychiatry Institute; Columbia University	Qadeer, MI (corresponding author), Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan.	imranqadeer66@gmail.com		Hasnain, Shahida/0000-0002-5916-7759	University of the Punjab, Lahore; Higher Education Commission, Pakistan	University of the Punjab, Lahore; Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	We acknowledge the facilities and support provided by University of the Punjab, Lahore and Higher Education Commission, Pakistan. We thank Dr. Muhammad Aslam, Chief Medical Officer and Inspector General Punjab Prisons, Government of the Punjab for permission and facilities provided for interviews and blood sample collection from the sentenced prisoners in this study. Dr. Mann received royalties from the Research Foundation of Mental Hygiene for commercial use of the C-SSRS.	Bannon MJ, 2001, EUR NEUROPSYCHOPHARM, V11, P449, DOI 10.1016/S0924-977X(01)00122-5; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Blum K, 2011, INT J ENV RES PUB HE, V8, P4425, DOI 10.3390/ijerph8124425; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; de Almeida RMM, 2005, EUR J PHARMACOL, V526, P51, DOI 10.1016/j.ejphar.2005.10.004; DOUCETTESTAMM LA, 1995, GENET EPIDEMIOL, V12, P303, DOI 10.1002/gepi.1370120307; Ferguson CJ, 2010, J SOC PSYCHOL, V150, P160, DOI 10.1080/00224540903366503; Ferguson CJ, 2009, AGGRESS VIOLENT BEH, V14, P286, DOI 10.1016/j.avb.2009.03.005; Fuke S., 2001, Pharmacogenomics Journal, V1, P152; GELERNTER J, 1994, NEUROPSYCHOPHARMACOL, V11, P195, DOI 10.1038/sj.npp.1380106; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Guo G, 2007, HUM GENET, V121, P125, DOI 10.1007/s00439-006-0244-8; Haddley K, 2008, NEUROCHEM RES, V33, P652, DOI 10.1007/s11064-007-9521-8; Huesmann LR, 2009, AGGRESSIVE BEHAV, V35, P136, DOI 10.1002/ab.20300; Hussain R, 1998, J BIOSOC SCI, V30, P261, DOI 10.1017/S0021932098002612; Inoue-Murayama M, 2002, NEUROSCI LETT, V334, P206, DOI 10.1016/S0304-3940(02)01125-4; Janssens A, 2015, J YOUTH ADOLESCENCE, V44, P1441, DOI 10.1007/s10964-015-0304-2; Jorm AF, 2001, AM J MED GENET, V105, P346, DOI 10.1002/ajmg.1355; Joseph J, 2001, J MIND BEHAV, V22, P179; Laruelle M, 1998, MOL PSYCHIATR, V3, P261, DOI 10.1038/sj.mp.4000343; Lerman C, 1999, HEALTH PSYCHOL, V18, P14, DOI 10.1037/0278-6133.18.1.14; LYONS MJ, 1995, ARCH GEN PSYCHIAT, V52, P906; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; Miles DR, 1997, J PERS SOC PSYCHOL, V72, P207, DOI 10.1037/0022-3514.72.1.207; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Moffitt TE, 2005, PSYCHOL BULL, V131, P533, DOI 10.1037/0033-2909.131.4.533; NOBLE EP, 1991, ARCH GEN PSYCHIAT, V48, P648; OHARA BF, 1993, HUM HERED, V43, P209, DOI 10.1159/000154133; Persico AM, 1997, AM J MED GENET, V74, P53, DOI 10.1002/(SICI)1096-8628(19970221)74:1<53::AID-AJMG12>3.0.CO;2-Q; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Reef J, 2011, SOC PSYCH PSYCH EPID, V46, P1233, DOI 10.1007/s00127-010-0297-9; Reitz E, 2005, J YOUTH ADOLESCENCE, V34, P577, DOI 10.1007/s10964-005-8947-z; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Rowe DC, 1998, BEHAV GENET, V28, P215, DOI 10.1023/A:1021427314941; Sabol SZ, 1999, HEALTH PSYCHOL, V18, P7, DOI 10.1037/0278-6133.18.1.7; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Sander T, 1997, BIOL PSYCHIAT, V41, P299, DOI 10.1016/S0006-3223(96)00044-3; Schmidt LG, 1998, AM J PSYCHIAT, V155, P474, DOI 10.1176/ajp.155.4.474; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; Vassos E, 2014, MOL PSYCHIATR, V19, P471, DOI 10.1038/mp.2013.31; Waldman ID, 1998, AM J HUM GENET, V63, P1767, DOI 10.1086/302132; Young SE, 2002, AM J MED GENET, V114, P144, DOI 10.1002/ajmg.10155	46	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0173571	10.1371/journal.pone.0173571	http://dx.doi.org/10.1371/journal.pone.0173571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582390	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600002
J	Friedman, L; Nixon, MS; Komogortsev, OV				Friedman, Lee; Nixon, Mark S.; Komogortsev, Oleg V.			Method to assess the temporal persistence of potential biometric features: Application to oculomotor, gait, face and brain structure databases	PLOS ONE			English	Article							TEST-RETEST RELIABILITY	We introduce the intraclass correlation coefficient (ICC) to the biometric community as an index of the temporal persistence, or stability, of a single biometric feature. It requires, as input, a feature on an interval or ratio scale, and which is reasonably normally distributed, and it can only be calculated if each subject is tested on 2 or more occasions. For a biometric system, with multiple features available for selection, the ICC can be used to measure the relative stability of each feature. We show, for 14 distinct data sets (1 synthetic, 8 eye-movement related, 2 gait-related, and 2 face-recognition-related, and one brain-structure-related), that selecting the most stable features, based on the ICC, resulted in the best biometric performance generally. Analyses based on using only the most stable features produced superior Rank-1-Identification Rate (Rank-1-IR) performance in 12 of 14 databases (p = 0.0065, one tailed), when compared to other sets of features, including the set of all features. For Equal Error Rate (EER), using a subset of only high-ICC features also produced superior performance in 12 of 14 databases (p = 0. 0065, one-tailed). In general, then, for our databases, prescreening potential biometric features, and choosing only highly reliable features yields better performance than choosing lower ICC features or than choosing all features combined. We also determined that, as the ICC of a group of features increases, the median of the genuine similarity score distribution increases and the spread of this distribution decreases. There was no statistically significant similar relationships for the impostor distributions. We believe that the ICC will find many uses in biometric research. In case of the eye movement-driven biometrics, the use of reliable features, as measured by ICC, allowed to us achieve the authentication performance with EER = 2.01%, which was not possible before.	[Friedman, Lee; Komogortsev, Oleg V.] Texas State Univ, Dept Comp Sci, San Marcos, TX 78666 USA; [Nixon, Mark S.] Univ Southampton, Dept Elect & Comp Sci, Southampton, Hants, England	Texas State University System; Texas State University San Marcos; University of Southampton	Friedman, L (corresponding author), Texas State Univ, Dept Comp Sci, San Marcos, TX 78666 USA.	Lfriedman10@gmail.com			National Science Foundation [CNS-1250718]; National Institue of Standards and Technology [60NANB15D325, 60NANB16D293]; National Institute of Mental Health (NIMH) [U01MH092221, U01MH092250]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH092250, U01MH092221] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institue of Standards and Technology; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded by 3 grants to Dr. Komogortsev: (1) National Science Foundation, CNS-1250718, www.NSF.gov; (2) National Institue of Standards and Technology, 60NANB15D325, www.NIST.gov; (3) National Institue of Standards and Technology,60NANB16D293, www.NIST.gov.; The brain imaging data used to conduct these analyses were generated through the support of National Institute of Mental Health (NIMH), grants U01MH092221 and U01MH092250.	BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Carls J.W., 2008, P 8 IEEE INT C AUT F, P1, DOI [DOI 10.1109/AFGR.2008.4813331, 10.1109/AFGR.2008.4813331]; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Cohn JF, 2002, FOURTH IEEE INTERNATIONAL CONFERENCE ON MULTIMODAL INTERFACES, PROCEEDINGS, P491, DOI 10.1109/ICMI.2002.1167045; Czajka A., 2014, COMMUNICATIONS COMPU; Dror I, 2008, J FORENSIC SCI, V53, P900, DOI 10.1111/j.1556-4029.2008.00762.x; Fenker SP, 2013, IEEE ACCESS, V1, P266, DOI 10.1109/ACCESS.2013.2262916; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher R. A., 1946, Statistical methods for research workers.; Foster JP, 2003, PATTERN RECOGN LETT, V24, P2489, DOI 10.1016/S0167-8655(03)00094-1; Galbally J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069897; Geng X, 2007, IEEE T PATTERN ANAL, V29, P2234, DOI 10.1109/TPAMI.2007.70733; George A, 2016, PATTERN RECOGN LETT, V82, P207, DOI 10.1016/j.patrec.2015.11.020; Holland CD, 2013, INT CONF BIOMETR; Holland CD, 2013, IEEE T INF FOREN SEC, V8, P2115, DOI 10.1109/TIFS.2013.2285884; Ioannis Rigas OVK, 2014, P SPIE INT SOC OPT E, V9075; Iscan Z, 2015, HUM BRAIN MAPP, V36, P3472, DOI 10.1002/hbm.22856; Johnson DE, 1998, APPL MULTIVARIATE ME, Vxiv; Komogortsev O., 2014, ACM T APPL PERCEPT, V11, P1; Komogortsev OV, 2015, 2015 IEEE 7 INT C BI; Komogortsev OV, 2012, IEEE IARP INT C BIOM; Lanitis A, 2011, IET COMPUT VIS, V5, P338, DOI 10.1049/iet-cvi.2010.0197; Lanitis A, 2010, INT J BIOMETRICS, V2, P34, DOI 10.1504/IJBM.2010.030415; Lanitis A, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/239480; Ling H, 2007, 2007 IEEE 11 INT C C; Littell RC., 2006, SAS MIXED MODELS, Vxii; Manjani I, 2016, INT CONF BIOMETR THE; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Modi SK, 2009, 2009 IEEE 3RD INTERNATIONAL CONFERENCE ON BIOMETRICS: THEORY, APPLICATIONS AND SYSTEMS, P294; Napflin M, 2007, CLIN NEUROPHYSIOL, V118, P2519, DOI 10.1016/j.clinph.2007.07.022; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; Ortiz E, 2013, 2013 IEEE SIXTH INTERNATIONAL CONFERENCE ON BIOMETRICS: THEORY, APPLICATIONS AND SYSTEMS (BTAS); PROKOP RJ, 1992, CVGIP-GRAPH MODEL IM, V54, P438, DOI 10.1016/1049-9652(92)90027-U; Rahman SMM, 2015, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-015-0090-5; Ramanathan N, 2006, IEEE T IMAGE PROCESS, V15, P3349, DOI 10.1109/TIP.2006.881993; Rigas I, 2015, MULTISOURCE FUSION A; Rigas IF, 2017, ARXIV E PRINTS; Rigas I, 2016, ACM T APPL PERCEPT, V13, DOI 10.1145/2842614; Scheidat Tobias, 2012, Communications and Multimedia Security. 13th IFIP TC 6/TC 11 International Conference, CMS 2012. Proceedings, P107, DOI 10.1007/978-3-642-32805-3_9; Scheidat T, 2011, SPIE IS T, V7881; Selkainaho K, 1988, PATT REC 1988 9 INT; Shimon K, 2006, P 6 INT C REC ADV SO, P449; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shutler JD, 2004, ADV SOFT COMP, P339; Shutler JD, 2001, ZERNIKE VELOCITY MOM; SR-Research, 2015, EYELINK 1000; Tabachnick BG, 2013, USING MULTIVARIATE S, Vxxxi; Tome P, 2015, FORENSIC SCI INT, V257, P271, DOI 10.1016/j.forsciint.2015.09.002; Trokielewicz M, 2015, I W BIOMETRIC FORENS; Ulery BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032800; Winer B.J., 1991, STAT PRINCIPLES EXPT	55	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178501	10.1371/journal.pone.0178501	http://dx.doi.org/10.1371/journal.pone.0178501			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575030	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000402624300057
J	Gutierrez, L				Gutierrez, Luciano			Impacts of El Nino-Southern Oscillation on the wheat market: A global dynamic analysis	PLOS ONE			English	Article							LAGGED DEPENDENT-VARIABLES; ENSO; PRECIPITATION; PRICES; MODELS; US	Although the widespread influence of the El Nino-Southern Oscillation (ENSO) occurrences on crop yields of the main agricultural commodities is well known, the global socio-economic consequences of ENSO still remain uncertain. Given the global importance of wheat for global consumption by providing 20% of global calories and nourishment, the monitoring and prediction of ENSO-induced variations in the worldwide wheat market are essential for allowing national governments to manage the associated risks and to ensure the supplies of wheat for consumers, including the underprivileged. To this end, we propose a global dynamic model for the analysis of ENSO impacts on wheat yield anomalies, export prices, exports and stock-to-use ratios. Our framework focuses on seven countries/regions: the six main wheat-exporting countries-the United States, Argentina, Australia, Canada, the EU, and the group of the main Black Sea export countries, i.e. Russia, Ukraine, and Kazakhstan-plus the rest of the world. The study shows that La Nina exerts, on average, a stronger and negative impact on wheat yield anomalies, exports and stock-to-use ratios than El Nino. In contrast, wheat export prices are positively related to La Nina occurrences evidencing, once again, its steady impact in both the short and long run. Our findings emphasize the importance of the two ENSO extreme phases for the worldwide wheat market.	[Gutierrez, Luciano] Univ Sassari, Dept Agr Sci, Sassari, Italy; [Gutierrez, Luciano] Univ Sassari, Desertificat Res Ctr, Sassari, Italy	University of Sassari; University of Sassari	Gutierrez, L (corresponding author), Univ Sassari, Dept Agr Sci, Sassari, Italy.; Gutierrez, L (corresponding author), Univ Sassari, Desertificat Res Ctr, Sassari, Italy.	lgutierr@uniss.it	Gutierrez, Luciano/J-7694-2012	Gutierrez, Luciano/0000-0002-3450-2514				Barnston A, 2003, INT J CLIMATOLOGY, V23, P187; Barnston A, 2015, WHY ARE THERE SO MAN, P1; Bronnimann S, REV GEOPHYS; Brunner AD, 2002, REV ECON STAT, V84, P176, DOI 10.1162/003465302317332008; Cashin P, 2017, MACROECONOMIC EFFECT, V106, P37; Dees S, 2007, J APPL ECONOMET, V22, P1, DOI 10.1002/jae.932; Di Mauro F., 2013, GVAR HDB STRUCTURE A; GODFREY LG, 1978, ECONOMETRICA, V46, P1303, DOI 10.2307/1913830; GODFREY LG, 1978, ECONOMETRICA, V46, P1293, DOI 10.2307/1913829; Gutierrez L, 2015, AM J AGR ECON, V97, P1494, DOI 10.1093/ajae/aau103; Gutierrez L, 2013, EUR REV AGRIC ECON, V40, P217, DOI 10.1093/erae/jbs017; Hammer GL, 2000, APPL SEASONAL CLIMAT; Hodrick RJ, 1997, J MONEY CREDIT BANK, V29, P1, DOI 10.2307/2953682; Iizumi T, 2014, NATURE COMMUNICATION, V5, P904; JOHANSEN S, 1992, J ECONOMETRICS, V53, P211, DOI 10.1016/0304-4076(92)90086-7; Johansen S., 1995, LIKELIHOOD BASED INF, DOI DOI 10.1093/0198774508.001.0001; KEPPENNE CL, 1995, J CLIMATE, V8, P1685, DOI 10.1175/1520-0442(1995)008<1685:AESISF>2.0.CO;2; Laosuthi T, 2007, EAST ECON J, V33, P21, DOI 10.1057/eej.2007.2; Legler DM, 1999, CLIMATIC CHANGE, V42, P351, DOI 10.1023/A:1005401101129; Lutkepohl H., 2005, NEW INTRO MULTIPLE T, DOI DOI 10.1007/078-3-540-27752-1; Mallya G, 2013, J HYDROL ENG, V18, P737, DOI 10.1061/(ASCE)HE.1943-5584.0000786; Mazzarella A, 2013, THEOR APPL CLIMATOL, V111, P601, DOI 10.1007/s00704-012-0696-9; NICHOLLS N, 1985, J CLIMATOL, V5, P553, DOI 10.1002/joc.3370050508; NYBLOM J, 1989, J AM STAT ASSOC, V84, P223, DOI 10.2307/2289867; Pesaran MH, 2000, J ECONOMETRICS, V97, P293, DOI 10.1016/S0304-4076(99)00073-1; Pesaran MH, 2004, J BUS ECON STAT, V22, P129, DOI 10.1198/073500104000000019; PLOBERGER W, 1992, ECONOMETRICA, V60, P271, DOI 10.2307/2951597; Ravn MO, 2002, REV ECON STAT, V84, P371, DOI 10.1162/003465302317411604; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Rosenzweig C., 2008, CLIMATE CHANGE GLOBA; Shaman J, 2011, J CLIMATE, V24, P124, DOI 10.1175/2010JCLI3590.1; Ubilava D, 2013, AUST J AGR RESOUR EC, V57, P273, DOI 10.1111/j.1467-8489.2012.00616.x; Ubilava D, 2012, AGR ECON-BLACKWELL, V43, P17, DOI 10.1111/j.1574-0862.2011.00562.x; Wolter K, 1993, P 17 CLIM DIAGN WORK, P52; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	36	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179086	10.1371/journal.pone.0179086	http://dx.doi.org/10.1371/journal.pone.0179086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594886	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200084
J	Higgins, PG; Prior, K; Harmsen, D; Seifert, H				Higgins, Paul G.; Prior, Karola; Harmsen, Dag; Seifert, Harald			Development and evaluation of a core genome multilocus typing scheme for whole-genome sequence-based typing of Acinetobacter baumannii	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROTOCOLS; MOLECULAR EPIDEMIOLOGY; INTERLABORATORY REPRODUCIBILITY; REP-PCR; OUTBREAK; STRAIN; MLST; STANDARDIZATION; IDENTIFICATION; POPULATIONS	We have employed whole genome sequencing to define and evaluate a core genome multi-locus sequence typing (cgMLST) scheme for Acinetobacter baumannii. To define a core genome we downloaded a total of 1,573 putative A. baumannii genomes from NCBI as well as representative isolates belonging to the eight previously described international A. baumannii clonal lineages. The core genome was then employed against a total of fifty-three carbapenem-resistant A. baumannii isolates that were previously typed by PFGE and linked to hospital outbreaks in eight German cities. We defined a core genome of 2,390 genes of which an average 98.4% were called successfully from 1,339 A. baumannii genomes, while Acinetobacter nosocomialis, Acinetobacter pittii, and Acinetobacter calcoaceticus resulted in 71.2%, 33.3%, and 23.2% good targets, respectively. When tested against the previously identified outbreak strains, we found good correlation between PFGE and cgMLST clustering, with 0-8 allelic differences within a pulsotype, and 40-2,166 differences between pulso-types. The highest number of allelic differences was between the isolates representing the international clones. This typing scheme was highly discriminatory and identified separate A. baumannii outbreaks. Moreover, because a standardised cgMLST nomenclature is used, the system will allow inter-laboratory exchange of data.	[Higgins, Paul G.; Seifert, Harald] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Higgins, Paul G.; Seifert, Harald] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany; [Prior, Karola; Harmsen, Dag] Univ Hosp Muenster, Dept Periodontol & Restorat Dent, Munster, Germany	University of Cologne; German Center for Infection Research; University of Cologne; University of Munster	Higgins, PG (corresponding author), Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.; Higgins, PG (corresponding author), German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Cologne, Germany.	paul.higgins@uni-koeln.de	Higgins, Paul/B-6708-2011	Higgins, Paul/0000-0001-8677-9454	German Research Council (DFG) [FOR-2251]	German Research Council (DFG)(German Research Foundation (DFG))	PGH was supported by grant FOR-2251 from the German Research Council (DFG) (wwwacinetobacter.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Chmielarczyk A, 2012, J HOSP INFECT, V81, P239, DOI 10.1016/j.jhin.2012.05.010; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Fitzpatrick MA, 2016, J CLIN MICROBIOL, V54, P593, DOI 10.1128/JCM.01818-15; Fricke WF, 2014, NAT REV GENET, V15, P49, DOI 10.1038/nrg3624; Halachev MR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0070-x; Hammerum AM, 2015, J ANTIMICROB CHEMOTH, V70, P1965, DOI 10.1093/jac/dkv072; Higgins PG, 2012, J CLIN MICROBIOL, V50, P3493, DOI 10.1128/JCM.01759-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, ANTIMICROB AGENTS CH, V54, P5021, DOI 10.1128/AAC.00598-10; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hornsey M, 2011, J ANTIMICROB CHEMOTH, V66, P1499, DOI 10.1093/jac/dkr168; Husni RN, 1999, CHEST, V115, P1378, DOI 10.1378/chest.115.5.1378; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Kohlenberg A, 2009, J MED MICROBIOL, V58, P1499, DOI 10.1099/jmm.0.012302-0; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Molter G, 2016, J HOSP INFECT, V92, P194, DOI 10.1016/j.jhin.2015.11.007; Moran-Gilad J, 2015, EUROSURVEILLANCE, V20; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Salipante SJ, 2015, J CLIN MICROBIOL, V53, P1072, DOI 10.1128/JCM.03385-14; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Tomaschek F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153014; Turabelidze G, 2013, J CLIN MICROBIOL, V51, P3950, DOI 10.1128/JCM.01930-13; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Wagenvoort JHT, 2002, EUR J CLIN MICROBIOL, V21, P326, DOI 10.1007/s10096-002-0716-2; Wyres KL, 2014, PATHOGENS, V3, P437, DOI 10.3390/pathogens3020437; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	72	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179228	10.1371/journal.pone.0179228	http://dx.doi.org/10.1371/journal.pone.0179228			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594944	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200107
J	Maimaituxun, G; Shimabukuro, M; Salim, HM; Tabata, M; Yuji, D; Morimoto, Y; Akasaka, T; Matsuura, T; Yagi, S; Fukuda, D; Yamada, H; Soeki, T; Sugimoto, T; Tanaka, M; Takanashi, S; Sata, M				Maimaituxun, Gulinu; Shimabukuro, Michio; Salim, Hotimah Masdan; Tabata, Minoru; Yuji, Daisuke; Morimoto, Yoshihisa; Akasaka, Takeshi; Matsuura, Tomomi; Yagi, Shusuke; Fukuda, Daiju; Yamada, Hirotsugu; Soeki, Takeshi; Sugimoto, Takaki; Tanaka, Masashi; Takanashi, Shuichiro; Sata, Masataka			Gender-linked impact of epicardial adipose tissue volume in patients who underwent coronary artery bypass graft surgery or non-coronary valve surgery	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HEART-DISEASE; SEX-DIFFERENCES; WOMEN; FAT; RISK; MEN; ADIPONECTIN; ATHEROSCLEROSIS	Background Traditional and non-traditional risk factors for atherosclerotic cardiovascular disease (ASCVD) are different between men and women. Gender-linked impact of epicardial adipose tissue volume (EATV) in patients undergoing coronary artery bypass grafting (CABG) remains unknown. Methods Gender-linked impact of EATV, abdominal fat distribution and other traditional ASCVD risk factors were compared in 172 patients (men: 115; women: 57) who underwent CABG or non-coronary valvular surgery (non-CABG). Results In men, EATV, EATV index (EATV/body surface area) and the markers of adiposity such as body mass index, waist circumference and visceral fat area were higher in the CABG group than in the non-CABG group. Traditional ASCVD risk factors were also prevalent in the CABG group. In women, EATV and EATV index were higher in the CABG group, but other adiposity markers were comparable between CABG and non-CABG groups. Multivariate logistic regression analysis showed that in men, CABG was determined by EATV Index and other ASCVD risk factors including hypertension, dyslipidemia, adiponectin, high sensitive C-reactive protein (hsCRP) and type 2 diabetes mellitus (Corrected R-2 = 0.262, p < 0.0001), while in women, type 2 diabetes mellitus is a single strong predictor for CABG, excluding EATV Index (Corrected R-2 = 0.266, p = 0.005). Conclusions Our study found that multiple risk factors, including epicardial adipose tissue volume and traditional ASCVD factors are determinants for CABG in men, but type 2 diabetes mellitus was the sole determinant in women. Gender-specific disparities in risk factors of CABG prompt us to evaluate new diagnostic and treatment strategies and to seek underlying mechanisms.	[Maimaituxun, Gulinu; Salim, Hotimah Masdan; Matsuura, Tomomi; Yagi, Shusuke; Fukuda, Daiju; Yamada, Hirotsugu; Soeki, Takeshi; Sata, Masataka] Tokushima Univ, Grad Sch, Dept Cardiovasc Med, Inst Biomed Sci, Tokushima, Japan; [Shimabukuro, Michio] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima, Japan; [Shimabukuro, Michio] Fukushima Med Univ, Sch Med, Dept Diabet Endocrinol & Metab, Fukushima, Japan; [Tabata, Minoru; Takanashi, Shuichiro] Sakakibara Heart Inst, Dept Cardiovasc Surg, Tokyo, Japan; [Yuji, Daisuke; Tanaka, Masashi] Shonan Kamakura Gen Hosp, Dept Cardiovasc Surg, Kamakura, Kanagawa, Japan; [Morimoto, Yoshihisa; Sugimoto, Takaki] Awaji Med Ctr, Div Cardiovasc Surg, Sumoto, Hyogo, Japan; [Akasaka, Takeshi] Shonan Kamakura Gen Hosp, Cardiol Lab, Kamakura, Kanagawa, Japan; [Akasaka, Takeshi] Shonan Kamakura Gen Hosp, Catheterizat Lab, Kamakura, Kanagawa, Japan	Tokushima University; Tokushima University; Fukushima Medical University	Shimabukuro, M (corresponding author), Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Cardiodiabet Med, Tokushima, Japan.; Shimabukuro, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Diabet Endocrinol & Metab, Fukushima, Japan.	mshimabukuro-ur@umin.ac.jp	Morimoro, Yoshihisa/L-2710-2019; Salim, Hotimah Masdan/AAD-9710-2021; Salim, Hotimah Masdan/AAU-3173-2021; Fukuda, Daiju/AAO-6752-2021	Morimoro, Yoshihisa/0000-0002-3911-3606; Salim, Hotimah Masdan/0000-0002-0460-6830; Shimabukuro, Michio/0000-0001-7835-7665	JSPS [20590651, 23591314, 20590542, 16K01823, 25670390, 25293184]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Scientific Research (Number 20590651, 23591314, 20590542, 16K01823 to MiS, Number 25670390 and 25293184 to MaS).	Agra RM, 2014, EUR J CLIN INVEST, V44, P29, DOI 10.1111/eci.12186; Al-Alao BS, 2012, GEN THORAC CARDIOVAS, V60, P417, DOI 10.1007/s11748-012-0082-7; [Anonymous], 2014, OBESITY, V22, pS41, DOI 10.1002/oby.20660; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Britton KA, 2013, J AM COLL CARDIOL, V62, P921, DOI 10.1016/j.jacc.2013.06.027; Carr ME, J DIABETES ITS COMPL, V15, P44; Cheng VY, 2010, JACC-CARDIOVASC IMAG, V3, P352, DOI 10.1016/j.jcmg.2009.12.013; Dagvasumberel M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-106; Donahue RP, 2007, DIABETES CARE, V30, P354, DOI 10.2337/dc06-1772; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Garcia M, 2016, CIRC RES, V118, P1273, DOI 10.1161/CIRCRESAHA.116.307547; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Haffner SM, 1997, DIABETOLOGIA, V40, P711, DOI 10.1007/s001250050738; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Iacobellis G, 2015, NAT REV ENDOCRINOL, V11, P363, DOI 10.1038/nrendo.2015.58; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Klaus S, 2004, NUTRITION, V20, P115, DOI 10.1016/j.nut.2003.09.020; Kojima S, 2007, ATHEROSCLEROSIS, V194, P204, DOI 10.1016/j.atherosclerosis.2006.07.028; Lee HY, 2013, ATHEROSCLEROSIS, V230, P177, DOI 10.1016/j.atherosclerosis.2013.07.037; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Saxena A, 2012, EUR J CARDIO-THORAC, V41, P755, DOI 10.1093/ejcts/ezr039; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shahian DM, 2009, ANN THORAC SURG, V88, pS22, DOI DOI 10.1016/J; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Shimabukuro M, 2003, J CLIN ENDOCR METAB, V88, P3236, DOI 10.1210/jc.2002-021883; Shimabukuro M, 2016, BIOFACTORS, V42, P397, DOI 10.1002/biof.1287; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Shimabukuro M, 2009, CIRC J, V73, P27, DOI 10.1253/circj.CJ-08-1012; Shmilovich H, 2011, AM J CARDIOL, V108, P1680, DOI 10.1016/j.amjcard.2011.07.031; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; von Mering GO, 2004, CIRCULATION, V109, P722, DOI 10.1161/01.CIR.0000115525.92645.16; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Woods SE, 2003, J AM COLL SURGEONS, V196, P428, DOI 10.1016/S1072-7515(02)01756-8; Wu ZJ, 2014, METABOLISM, V63, P1157, DOI 10.1016/j.metabol.2014.05.001; Wu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078485; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	45	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e177170	10.1371/journal.pone.0177170	http://dx.doi.org/10.1371/journal.pone.0177170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594865	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200007
J	Li, LL; Li, H; He, YF; Bao, YX				Li, Luanluan; Hua, Li; He, Yafang; Bao, Yixiao			Differential effects of formaldehyde exposure on airway inflammation and bronchial hyperresponsiveness in BALB/c and C57BL/6 mice	PLOS ONE			English	Article							ALLERGIC LUNG INFLAMMATION; VOLATILE ORGANIC-COMPOUNDS; S-NITROSOGLUTATHIONE; MOUSE MODEL; ASTHMA; CHILDREN; BRONCHOCONSTRICTION; SYMPTOMS; RISK	Epidemiological evidence suggests that formaldehyde (FA) exposure may influence the prevalence and severity of allergic asthma. However, the role of genetic background in FA-induced asthma-like responses is poorly understood. In the present study, we investigated the nature and severity of asthma-like responses triggered by exposure to different doses of FA together with or without ovalbumin (OVA) in two genetically different mouse strains D BALB/c and C57BL/6. Both mouse strains were divided into two main groups: the non-sensitized group and the OVA-sensitized group. All the groups were exposed to 0, 0.5 or 3.0 mg/m(3) FA for 6 h/day over 25 consecutive days. At 24 h after the final FA exposure, the pulmonary parameters were evaluated. We found that FA exposure induced Th2-type allergic responses in non-sensitized BALB/c and C57BL/6 mice. In addition, FA-induced allergic responses were significantly more prominent in BALB/c mice than in C57BL/6 mice. In sensitized BALB/c mice, however, FA exposure suppressed the development of OVA-induced allergic responses. Exposure to 3.0 mg/m(3) FA in sensitized C57BL/6 mice also led to suppressed allergic responses, whereas exposure to 0.5 mg/m(3) FA resulted in exacerbated allergic responses to OVA. Our findings suggest that FA exposure can induce differential airway inflammation and bronchial hyperresponsiveness in BALB/c and C57BL/6 mice.	[Li, Luanluan; Hua, Li; He, Yafang; Bao, Yixiao] Shanghai Jiao Tong Univ, Dept Pediat Pulmonol, Xinhua Hosp, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Bao, YX (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Pulmonol, Xinhua Hosp, Sch Med, Shanghai, Peoples R China.	smilebao2016@126.com			National Natural Science Foundation of China [81570015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (no. 81570015 and URL: http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein JA, 2008, J ALLERGY CLIN IMMUN, V121, P585, DOI 10.1016/j.jaci.2007.10.045; Carlson Ryan M, 2004, Dermatitis, V15, P169, DOI 10.2310/6620.2004.04021; Casset A, 2006, REV MAL RESPIR, V23, pS25, DOI 10.1019/200530196; De Sanctis GT, 2001, J ALLERGY CLIN IMMUN, V108, P11, DOI 10.1067/mai.2001.116429; Franco ALD, 2009, TOXICOLOGY, V256, P157, DOI 10.1016/j.tox.2008.11.011; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ezratty V, 2007, ENVIRON HEALTH PERSP, V115, P210, DOI 10.1289/ehp.9414; Franklin P, 2000, AM J RESP CRIT CARE, V161, P1757, DOI 10.1164/ajrccm.161.5.9905061; Fujimaki H, 2004, TOXICOLOGY, V197, P1, DOI 10.1016/j.tox.2003.11.015; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Jung WW, 2007, ENVIRON TOXICOL PHAR, V24, P174, DOI 10.1016/j.etap.2007.05.001; Kita T, 2003, CLIN EXP ALLERGY, V33, P1747, DOI 10.1111/j.1365-2222.2003.01826.x; Kriebel D, 2001, ARCH ENVIRON HEALTH, V56, P11, DOI 10.1080/00039890109604049; Lecureur V, 2012, TOXICOLOGY, V292, P13, DOI 10.1016/j.tox.2011.11.011; Maiellaro M, 2014, TOXICOL APPL PHARM, V278, P266, DOI 10.1016/j.taap.2014.05.003; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Neghab M, 2011, IND HEALTH, V49, P89, DOI 10.2486/indhealth.MS1197; NORBACK D, 1995, OCCUP ENVIRON MED, V52, P388, DOI 10.1136/oem.52.6.388; Riedel F, 1996, ALLERGY, V51, P94, DOI 10.1111/j.1398-9995.1996.tb00041.x; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Sadakane Kaori, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P267; Sakai K, 2001, INT ARCH ALLERGY IMM, V126, P126, DOI 10.1159/000049503; Salthammer T, 2013, ANGEW CHEM INT EDIT, V52, P3320, DOI 10.1002/anie.201205984; Staab CA, 2008, BIOCHEM J, V413, P493, DOI 10.1042/BJ20071666; Takeda K, 2001, AM J PHYSIOL-LUNG C, V281, pL394, DOI 10.1152/ajplung.2001.281.2.L394; Thompson CM, 2008, J TOXICOL ENV HEAL A, V71, P244, DOI 10.1080/15287390701598259; Thompson CM, 2009, DRUG METAB DISPOS, V37, P1565, DOI 10.1124/dmd.109.027904; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062827; ZHANG J, 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/2935163	30	22	24	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179231	10.1371/journal.pone.0179231	http://dx.doi.org/10.1371/journal.pone.0179231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591193	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700095
J	Dencker, M; Gardinger, Y; Bjorgell, O; Hlebowicz, J				Dencker, Magnus; Gardinger, Ylva; Bjorgell, Ola; Hlebowicz, Joanna			Effect of food intake on 92 biomarkers for cardiovascular disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; BINDING PROTEIN-1 PROMOTER; INFLAMMATORY BIOMARKERS; PLASMA-LEVELS; INSULIN; RISK; STROKE; HEALTHY	Objective The present study evaluates the effect of food intake on 92 biomarkers for cardiovascular disease (CVD). Methods Twenty two healthy subjects (11 male and 11 female aged 25.9 +/- 4.2 years) were investigated. A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit. Results The levels for eight biomarkers decreased significantly (P<0.05) 30 minutes after food intake. The levels for seven biomarkers remained significantly decreased 120 minutes after food intake. Nine biomarker decreased significantly at 120 minutes after food intake. The changes were between 4-30%, most commonly around 5%. Only six biomarkers showed a difference of 10% or more due to food intake. The biggest differences were observed for Insulin-like growth factor-binding protein 1 (30%); Azurocidin, Cystatin-B, and Myeloperoxidase (13%); Monocyte chemotactic protein 1 (11%); and Myeloblastin (10%), all 120 minutes after food intake. Conclusions This study shows that food intake affects several different CVD biomarkers, but the effect is predominantly modest. Timing of blood sampling in relation to food intake, therefore, appears not to be a major concern. Further studies are warranted in older healthy subjects and in patients with various cardiac diseases to determine whether the findings are reproducible.	[Dencker, Magnus; Gardinger, Ylva; Bjorgell, Ola] Lund Univ, Skane Univ Hosp, Dept Med Imaging & Physiol, Malmo, Sweden; [Hlebowicz, Joanna] Lund Univ, Skane Univ Hosp, Dept Cardiol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Dencker, M (corresponding author), Lund Univ, Skane Univ Hosp, Dept Med Imaging & Physiol, Malmo, Sweden.	magnus.dencker@skane.se		Dencker, Magnus/0000-0001-9991-3712	Swedish Heart and Lung Association; Gyllenstierna Krapperup's Foundation; Lund University; Swedish Society of Medicine	Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Gyllenstierna Krapperup's Foundation; Lund University; Swedish Society of Medicine	Financial support for this study was received from the Swedish Heart and Lung Association, the Swedish Society of Medicine, the Gyllenstierna Krapperup's Foundation, and grants from Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2014, CURR OPIN LIPIDOL, V25, P254, DOI 10.1097/MOL.0000000000000095; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bjorgell O, 2016, CLIN PHYSIOL FUNCT I, V36, P396; Brunini F, 2016, AUTOIMMUN REV, V15, P1046, DOI 10.1016/j.autrev.2016.07.031; Cerletti C, 2015, THROMB RES, V135, P255, DOI 10.1016/j.thromres.2014.11.038; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Dencker M, 2011, ECHOCARDIOGR-J CARD, V28, P843, DOI 10.1111/j.1540-8175.2011.01451.x; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Edsfeldt A, 2016, CEREBROVASC DIS, V41, P199, DOI 10.1159/000443022; Gardinger Y, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-2; Goncalves I, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000353; Goncalves I, 2015, ARTERIOSCL THROM VAS, V35, P1723, DOI 10.1161/ATVBAHA.115.305631; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Hlebowicz J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-43; Hlebowicz J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-26; Jahn LA, 2016, J CLIN ENDOCR METAB, V101, P1198, DOI 10.1210/jc.2015-3293; Janszky I, 2010, INT J CARDIOL, V138, P50, DOI 10.1016/j.ijcard.2008.08.003; Li HY, 2017, FRONT BIOSCI-LANDMRK, V22, P504, DOI 10.2741/4498; Lind L, 2015, STROKE, V46, P3340, DOI 10.1161/STROKEAHA.115.010829; Lind L, 2015, ATHEROSCLEROSIS, V242, P205, DOI 10.1016/j.atherosclerosis.2015.07.023; Linde A, 2007, CARDIOVASC RES, V73, P26, DOI 10.1016/j.cardiores.2006.08.009; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; McFarlin BK, 2017, EUR J CLIN NUTR, V71, P239, DOI 10.1038/ejcn.2016.242; Quatela A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110670; Schiopu A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002851; Shi L, 2016, AM J PHYSIOL-ENDOC M, V310, pE612, DOI 10.1152/ajpendo.00289.2015; Wallander M, 2007, DIABETES CARE, V30, P2343, DOI 10.2337/dc07-0825; Watorek W, 2003, ACTA BIOCHIM POL, V50, P743; Wiklund K, 2016, AM J EMERG MED, V34, P370, DOI 10.1016/j.ajem.2015.10.052	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178656	10.1371/journal.pone.0178656	http://dx.doi.org/10.1371/journal.pone.0178656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586402	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700020
J	Gebauer, F; Kemper, M; Sauter, G; Prehm, P; Schumacher, U				Gebauer, Florian; Kemper, Marius; Sauter, Guido; Prehm, Peter; Schumacher, Udo			Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; METASTASIS; EXPRESSION; SURVIVAL; ENHANCE; CELLS	Background Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis and the number of PDAC-related deaths is rising. Recently the tumour stroma and in particular one of its main components, hyaluronan (HA), have attracted considerable attention as intravenous hyaluronidase treatment together with conventional chemotherapy considerably prolonged survival in HA-rich PDA patients. We therefore wanted to investigate the prognostic significance of HA deposition in PDA using both antibodies to HA and hyaluronan binding protein (HABP). Material and methods Tissue microarrays of PDAs of 184 patients and pancreatic xenografts tumours were immunohistochemically (IHC) stained for HA using either biotinylated hyaluronic acid binding protein (HABP) or anti-HA antibody. Results The pattern of staining with HABP differed significantly from that with antibody IHC. Antibody staining was found both within cancer cells and in the extracellular matrix and staining could not be eliminated by hyaluronidase predigestion of the tissue sections. In contrast, HABP staining was generally confined to the extracellular matrix and was completely abolished by hyaluronidase pretreatment. HA positivity as determined by HABP was associated with larger primary tumours (p = 0.046). There were no correlations between overall survival, disease-free survival and HA expression. Conclusion Presence of HA alone is not of prognostic importance in PDAC, and IHC with utilization of antibody detection shows no reliable staining pattern and should not be applied for HA IHC.	[Gebauer, Florian] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Kemper, Marius; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Dept Anat & Expt Morphol, Ctr Expt Med, Hamburg, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Ctr Diagnost, Hamburg, Germany; [Prehm, Peter] Hylitis, Nottuln, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Gebauer, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	fgebauer@uke.de		Prehm, Peter/0000-0002-8063-311X				Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; Cheng XB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080765, 10.1371/journal.pone.0080002]; Dancau AM, 2016, METHODS MOL BIOL, V1381, P53, DOI 10.1007/978-1-4939-3204-7_3; Dancau AM, 2010, METHODS MOL BIOL, V576, P49, DOI 10.1007/978-1-59745-545-9_4; Fuhrmann IK, 2015, ACTA HISTOCHEM, V117, P243, DOI 10.1016/j.acthis.2014.12.009; Gebauer F, 2013, GUT, V62, P741, DOI 10.1136/gutjnl-2011-300629; Gkretsi V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00214; Hingorani SR, 2016, CLIN CANCER RES, V22, P2848, DOI 10.1158/1078-0432.CCR-15-2010; Kalinina T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-295; Li P, 2015, INT J CLIN EXP PATHO, V8, P12101; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Maytin EV, 2016, GLYCOBIOLOGY, V26, P553, DOI 10.1093/glycob/cww033; Nogueira DR, 2014, ASIAN PAC J CANCER P, V15, P5977, DOI 10.7314/APJCP.2014.15.15.5977; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Ropponen K, 1998, CANCER RES, V58, P342; Setala LP, 1999, BRIT J CANCER, V79, P1133, DOI 10.1038/sj.bjc.6690180; Shepard HM, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00192; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Venning FA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00224; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Whatcott CJ, 2015, CANCER J, V21, P299, DOI 10.1097/PPO.0000000000000140	23	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178703	10.1371/journal.pone.0178703	http://dx.doi.org/10.1371/journal.pone.0178703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582436	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600031
J	Harris, BJ; Holzmayer, V; Qureshi, H; Khan, MA; Khan, SA; Salamat, N; Jafri, S; Brennan, CA				Harris, Barbara J.; Holzmayer, Vera; Qureshi, Huma; Khan, Mohammad Ayyub; Khan, Saleem Ahmed; Salamat, Nuzhat; Jafri, Sarfaraz; Brennan, Catherine A.			Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors	PLOS ONE			English	Article							VIRUS GENOTYPES; MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; PREVALENCE; INFECTIONS; FREQUENCY; KARACHI	Background The prevalence of chronic Hepatitis B Virus (HBV) infection is 2-4% in the Pakistani population, defining Pakistan as an intermediate prevalence country. In this study, hepatitis B surface antigen (HBsAg) reactive blood donations were screened using a combination of serological and molecular methods to identify immune escape HBV mutant strains and to determine the HBV genotypes and subtypes present in Pakistan. Methods Blood donations were collected at the Armed Forces Institute of Transfusion (AFIT) located in northern Pakistan and the Hussaini Blood Bank (HBB) located in the south. From 2009 to 2013 a total of 706,575 donations were screened with 2.04% (14,409) HBsAg reactive. A total of 2055 HBsAg reactive specimens, were collected and screened using a monoclonal antibody based research assay to identify immune escape mutants followed by PCR amplification and DNA sequencing to identify the mutation present. DNA sequences obtained from 192 specimens, including mutant candidates and wild type strains, were analyzed for escape mutations, genotype, and HBsAg subtype. Results Mutations were identified in approximately 14% of HBsAg reactive donations. Mutations at HBsAg amino acid positions 143-145 are the most common (46%) with the mutation serine 143 to leucine the most frequently occurring change (28%). While regional differences were observed, the most prevalent HBV strains are subgenotypes of D with subgenotype D1/subtype ayw2 accounting for the majority of infections; 90.2% at AFIT and 52.5% at HBB. Conclusions The high frequency of immune escape HBV mutants in HBV infected Pakistani blood donors highlights the need for more studies into the prevalence of escape mutants. Differences between vaccinated and unvaccinated populations, the correlation of escape mutant frequency with genotype, and impact of escape mutations in different genotype backgrounds on the performance of commercially available HBsAg assays represent avenues for further investigation.	[Harris, Barbara J.; Holzmayer, Vera; Brennan, Catherine A.] Abbott Diagnost, Infect Dis Res, Abbott Pk, IL USA; [Qureshi, Huma] Pakistan Med Res Council, Islamabad, Pakistan; [Khan, Mohammad Ayyub; Khan, Saleem Ahmed] Armed Forces Inst Transfus, Rawalpindi, Pakistan; [Salamat, Nuzhat] Army Med Coll, Rawalpindi, Pakistan; [Jafri, Sarfaraz] Hussaini Blood Bank, Karachi, Pakistan	Pakistan Medical Research Council; National University of Sciences & Technology - Pakistan	Harris, BJ (corresponding author), Abbott Diagnost, Infect Dis Res, Abbott Pk, IL USA.	Barbara.harris@abbott.com			Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	This study was funded by Abbott Laboratories. Abbott employees conceived, designed, and performed some of the experiments in this study.	Akhtar S, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-26; Alam MM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-64; Alam MM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-115; Alavian SM, 2013, J CLIN VIROL, V57, P201, DOI 10.1016/j.jcv.2012.04.027; Ali M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-102; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; [Anonymous], GENO2PHENO HBV V2 0; Attaullah S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-20; Attaullah S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-275; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Avellon A, 2011, J MED VIROL, V83, P95, DOI 10.1002/jmv.21943; Awan Z, 2010, INFECT GENET EVOL, V10, P1242, DOI 10.1016/j.meegid.2010.08.006; Beale MA, 2010, J GEN VIROL, V91, P68, DOI 10.1099/vir.0.013078-0; Bosan A, 2010, J PAK MED ASSOC, V60, P1045; Chen YCJ, 1996, P NATL ACAD SCI USA, V93, P1997, DOI 10.1073/pnas.93.5.1997; Echevarria JM, 2008, J MED VIROL, V80, P598, DOI 10.1002/jmv.21146; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; Forbi JC, 2013, J CLIN VIROL, V58, P59, DOI 10.1016/j.jcv.2013.06.028; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jafri W, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-101; Khan F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-225; Khattak M F, 2002, J Pak Med Assoc, V52, P398; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mumtaz K, 2011, HEPAT MON, V11, P14; Niazi SK, 2015, TRANSFUSION; Purdy MA, 2007, INTERVIROLOGY, V50, P45, DOI 10.1159/000096312; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; Revill P., 2005, Hepatitis B Annual, V2, P74; Safaar Rana M., 2011, Morbidity and Mortality Weekly Report, V60, P1385; Weber B, 2006, J MED VIROL, V78, pS59, DOI 10.1002/jmv.20610; World Health Organization, 2015, HEP B FACT SHEET; World Health Organization (WHO), 2014, WHO VACC PREV DIS MO	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178988	10.1371/journal.pone.0178988	http://dx.doi.org/10.1371/journal.pone.0178988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582431	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600067
J	Bove, GM; Chapelle, SL; Hanlon, KE; Diamond, MP; Mokler, DJ				Bove, Geoffrey M.; Chapelle, Susan L.; Hanlon, Katherine E.; Diamond, Michael P.; Mokler, David J.			Attenuation of postoperative adhesions using a modeled manual therapy	PLOS ONE			English	Article							CHRONIC PELVIC PAIN; SMALL-BOWEL OBSTRUCTION; LAPAROSCOPIC ADHESIOLYSIS; COLORECTAL SURGERY; ABDOMINAL MASSAGE; PHYSICAL-THERAPY; RISK-FACTORS; RAT; PREVENTION; ILEUS	Postoperative adhesions are pathological attachments that develop between abdominopelvic structures following surgery. Considered unavoidable and ubiquitous, postoperative adhesions lead to bowel obstructions, infertility, pain, and reoperations. As such, they represent a substantial health care challenge. Despite over a century of research, no preventive treatment exists. We hypothesized that postoperative adhesions develop from a lack of movement of the abdominopelvic organs in the immediate postoperative period while rendered immobile by surgery and opiates, and tested whether manual therapy would prevent their development. In a modified rat cecal abrasion model, rats were allocated to receive treatment with manual therapy or not, and their resulting adhesions were quantified. We also characterized macrophage phenotype. In separate experiments we tested the safety of the treatment on a strictureplasty model, and also the efficacy of the treatment following adhesiolysis. We show that the treatment led to reduced frequency and size of cohesive adhesions, but not other types of adhesions, such as those involving intraperitoneal fatty structures. This effect was associated with a delay in the appearance of trophic macrophages. The treatment did not inhibit healing or induce undesirable complications following strictureplasty. Our results support that that maintained movements of damaged structures in the immediate postoperative period has potential to act as an effective preventive for attenuating cohesive postoperative adhesion development. Our findings lay the groundwork for further research, including mechanical and pharmacologic approaches to maintain movements during healing.	[Bove, Geoffrey M.; Hanlon, Katherine E.; Mokler, David J.] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Stella Maris 102, Biddeford, ME 04005 USA; [Chapelle, Susan L.] Squamish Integrated Hlth, Squamish, BC, Canada; [Diamond, Michael P.] Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA	University of New England - Maine; University System of Georgia; Augusta University	Bove, GM (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Stella Maris 102, Biddeford, ME 04005 USA.	gbove@une.edu	Mokler, David J./H-3114-2019	Mokler, David J./0000-0001-7340-3431	National Institute General Medical Sciences of the National Institutes of Health [R01GM108041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108041] Funding Source: NIH RePORTER	National Institute General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute General Medical Sciences of the National Institutes of Health under award number R01GM108041 to GMB. The content does not necessarily represent the views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artinyan A, 2008, WORLD J SURG, V32, P1495, DOI 10.1007/s00268-008-9491-2; Attard JAP, 2007, CAN J SURG, V50, P291; Beck DE, 1999, DIS COLON RECTUM, V42, P241, DOI 10.1007/BF02237135; Bolnick A, 2015, J MINIM INVAS GYN, V22, P549, DOI 10.1016/j.jmig.2014.12.009; Bove GM, 2015, J PHARMACOL TOX MET, V74, P1, DOI 10.1016/j.vascn.2015.04.004; Bove GM, 2012, J BODYW MOV THER, V16, P76, DOI 10.1016/j.jbmt.2011.02.004; Bove GM, 2016, J INVEST SURG, P1; Bruggmann D, 2010, DTSCH ARZTEBL INT, V107, P789, DOI 10.3238/arztebl.2010.0769; Cedergren J, 2003, APMIS, V111, P963, DOI 10.1034/j.1600-0463.2003.1111008.x; Chapelle SL, 2013, J BODYW MOV THER, V17, P83, DOI 10.1016/j.jbmt.2012.05.004; Chaturvedi AA, 2014, INT J COLORECTAL DIS, V29, P1411, DOI 10.1007/s00384-014-2009-5; CONE DF, 1959, B JOHNS HOPKINS HOSP, V105, P8; Cravedi P, 2014, J AM SOC NEPHROL, V25, P2003, DOI 10.1681/ASN.2013090945; Cubukcu A, 2002, SURGERY, V131, P81, DOI 10.1067/msy.2002.118316; Davey AK, 2007, J MINIM INVAS GYN, V14, P15, DOI 10.1016/j.jmig.2006.07.013; Diamond MP, 2011, AM J OBSTET GYNECOL, V205, pS1, DOI 10.1016/j.ajog.2011.09.027; DIAMOND MP, 1994, FERTIL STERIL, V62, P984; Diamond MP, 2001, HUM REPROD UPDATE, V7, P567, DOI 10.1093/humupd/7.6.567; DiZerega, 2000, PERITONEAL SURG; Ernst E, 1999, FORSCH KOMPLEMENTMED, V6, P149, DOI 10.1159/000021240; Gomel V, 1996, J REPROD MED, V41, P35; Hammoud A, 2004, FERTIL STERIL, V82, P1483, DOI 10.1016/j.fertnstert.2004.07.948; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; KRESCH AJ, 1984, OBSTET GYNECOL, V64, P672; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Kutuk MS, 2012, HUM REPROD, V27, P733, DOI 10.1093/humrep/der439; Le Blanc-Louvry I, 2002, J GASTROINTEST SURG, V6, P43, DOI 10.1016/S1091-255X(01)00009-9; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Liu Z, 2005, J NEUROL, V252, P1280, DOI 10.1007/s00415-005-0825-9; LIVINGSTON EH, 1990, DIGEST DIS SCI, V35, P121, DOI 10.1007/BF01537233; Maeda K, 1997, INT IMMUNOL, V9, P993, DOI 10.1093/intimm/9.7.993; Metwally M, 2008, CURR OPIN OBSTET GYN, V20, P345, DOI 10.1097/GCO.0b013e3283073a6c; Nezhat F R, 2000, JSLS, V4, P281; Parker MC, 2007, COLORECTAL DIS, V9, P66, DOI 10.1111/j.1463-1318.2007.01342.x; PETERS AAW, 1992, BRIT J OBSTET GYNAEC, V99, P59, DOI 10.1111/j.1471-0528.1992.tb14394.x; Rice AD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7610387; Rice AD, 2015, ALTERN THER HEALTH M, V21, P36; Richardson EH, 1911, ANN SURG, V54, P758, DOI 10.1097/00000658-191112000-00004; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Saravelos HG, 1995, HUM REPROD, V10, P2895, DOI 10.1093/oxfordjournals.humrep.a135814; Sato Y, 2001, GASTROINTEST ENDOSC, V54, P476, DOI 10.1067/mge.2001.117760; SCHIFF CA, 1949, SURGERY, V25, P257; SCOTTCOOMBES DM, 1993, ANN ROY COLL SURG, V75, P123; SEKIYA S, 1989, J LEUKOCYTE BIOL, V46, P96, DOI 10.1002/jlb.46.2.96; Stanciu D, 2007, COLORECTAL DIS, V9, P35, DOI 10.1111/j.1463-1318.2007.01346.x; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Vather R, 2013, INT J COLORECTAL DIS, V28, P1385, DOI 10.1007/s00384-013-1704-y; WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5; Wong YY, 2015, J ORTHOP SPORT PHYS, V45, P1006, DOI 10.2519/jospt.2015.5766; Wurn BF, 2008, ALTERN THER HEALTH M, V14, P18	51	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178407	10.1371/journal.pone.0178407	http://dx.doi.org/10.1371/journal.pone.0178407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574997	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300048
J	Hazell, CM; Strauss, C; Cavanagh, K; Hayward, M				Hazell, Cassie M.; Strauss, Clara; Cavanagh, Kate; Hayward, Mark			Barriers to disseminating brief CBT for voices from a lived experience and clinician perspective	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; AUDITORY HALLUCINATIONS; SCHIZOPHRENIA; PSYCHOSIS; DISORDER; IMPLEMENTATION; EXPECTATIONS; ROGERS,CARL; GUIDELINES; BELIEFS	Access to psychological therapies continues to be poor for people experiencing psychosis. To address this problem, researchers are developing brief interventions that address the specific symptoms associated with psychosis, i.e., hearing voices. As part of the development work for a brief Cognitive Behaviour Therapy (CBT) intervention for voices we collected qualitative data from people who hear voices (study 1) and clinicians (study 2) on the potential barriers and facilitators to implementation and engagement. Thematic analysis of the responses from both groups revealed a number of anticipated barriers to implementation and engagement. Both groups believed the presenting problem (voices and psychosis symptoms) may impede engagement. Furthermore clinicians identified a lack of resources to be a barrier to implementation. The only facilitator to engagement was reported by people who hear voices who believed a compassionate, experienced and trustworthy therapist would promote engagement. The results are discussed in relation to how these barriers could be addressed in the context of a brief intervention using CBT techniques.	[Hazell, Cassie M.; Strauss, Clara; Cavanagh, Kate; Hayward, Mark] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Strauss, Clara; Hayward, Mark] Sussex Partnership NHS Fdn Trust, Sussex Educ Ctr, Res & Dev Dept, Hove, England	University of Sussex	Hayward, M (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.; Hayward, M (corresponding author), Sussex Partnership NHS Fdn Trust, Sussex Educ Ctr, Res & Dev Dept, Hove, England.	mih21@sussex.ac.uk	Hayward, Mark/AAJ-9858-2020	Hayward, Mark/0000-0001-6567-7723; Hazell, Cassie/0000-0001-5868-9902; Cavanagh, Kate/0000-0002-9863-1462; Strauss, Clara/0000-0002-0303-763X	Sussex Partnership NHS Foundation Trust; Economic and Social Research Council (ESRC) [ES/J500173/1]; Economic and Social Research Council [1363118] Funding Source: researchfish	Sussex Partnership NHS Foundation Trust; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Support was provided by Sussex Partnership NHS Foundation Trust and the Economic and Social Research Council (ESRC) (Grant reference: ES/J500173/1).	al-Issa I., 1995, BR J PSYCHIAT, V166; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2006, PRACT GUID TREATM PS; Berry C, 2015, SCHIZOPHR RES, V168, P153, DOI 10.1016/j.schres.2015.07.032; Berry K, 2008, PSYCHOL PSYCHOTHER-T, V81, P419, DOI 10.1348/147608308X329540; Birchwood M, 2014, LANCET PSYCHIAT, V1, P23, DOI 10.1016/S2215-0366(14)70247-0; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burns BJ, 2004, J AM ACAD CHILD PSY, V43, P960, DOI 10.1097/01.chi.0000127590.95585.65; Byrne MK, 2008, EVAL HEALTH PROF, V31, P390, DOI 10.1177/0163278708324441; Cavanagh K, 2013, ICST T AMBIENT SYST, V1, pe3, DOI DOI 10.4108/TRANS.AMSYS.01-06.2013.E3; CHADWICK P, 1994, BRIT J PSYCHIAT, V164, P190, DOI 10.1192/bjp.164.2.190; Chadwick P, 2011, PSYCHOTHER RES, V21, P277, DOI 10.1080/10503307.2011.565487; Coffey M, 2008, J CLIN NURS, V17, P1591, DOI 10.1111/j.1365-2702.2007.02185.x; Dark F, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0953-6; Dorahy MJ, 2009, J NERV MENT DIS, V197, P892, DOI 10.1097/NMD.0b013e3181c299ea; Evans-Jones C, 2009, BEHAV COGN PSYCHOTH, V37, P527, DOI 10.1017/S1352465809990269; Farber BA, 2007, PSYCHOTHERAPY, V44, P289, DOI 10.1037/0033-3204.44.3.289; Fielding-Smith SF, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01129; Freeman D, 2006, OVERCOMING PARANOID; Gaebel W, 2005, BRIT J PSYCHIAT, V187, P248, DOI 10.1192/bjp.187.3.248; Greenbaum ThomasL., 2000, MODERATING FOCUS GRO; Haddock G, 2014, J MENT HEALTH, V23, P162, DOI 10.3109/09638237.2013.869571; Hamner MB, 2000, J NERV MENT DIS, V188, P217, DOI 10.1097/00005053-200004000-00004; Hayward M, 2003, PSYCHOL PSYCHOTHER-T, V76, P369, DOI 10.1348/147608303770584737; Hayward M, 2012, OVERCOMING DISTRESSI; Hazell CM, 2016, CLIN PSYCHOL REV, V45, P183, DOI 10.1016/j.cpr.2016.03.004; Hepworth CR, 2013, CLIN PSYCHOL PSYCHOT, V20, P239, DOI 10.1002/cpp.791; Holdsworth E, 2014, CLIN PSYCHOL REV, V34, P428, DOI 10.1016/j.cpr.2014.06.004; Ince P, 2015, PSYCHOL PSYCHOTHER T; Kirschenbaum H, 2005, PSYCHOTHERAPY, V42, P37, DOI 10.1037/0033-3204.42.1.37; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; McCarthy-Jones S, 2014, SCHIZOPHRENIA BULL, V40, pS275, DOI 10.1093/schbul/sbu018; McCarthy-Jones S, 2014, SCHIZOPHRENIA BULL, V40, P225, DOI 10.1093/schbul/sbs156; McGorry P, 2005, AUST NZ J PSYCHIAT, V39, P1; Meaden A, 2013, COGNITIVE THERAPY CO; Mehl S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01450; Morrison AP, 1997, PSYCHOL MED, V27, P669, DOI 10.1017/S003329179700487X; Morrison AP, 2008, THINK YOURE CRAZY TH; Myhr G, 2006, CAN J PSYCHIAT, V51, P662, DOI 10.1177/070674370605101006; Naeem F, 2016, INT J COGN THER, V9, P73; National Institute for Health and Clinical Excellence (NICE), 2014, PSYCH SCHIZ AD PREV; Prytys M, 2011, CLIN PSYCHOL PSYCHOT, V18, P48, DOI 10.1002/cpp.691; Roberts A., 2015, HEAL FDN, P1, DOI DOI 10.1044/LEADER.PPL.20012015.20; Rogers CR, 2007, PSYCHOTHERAPY, V44, P240, DOI 10.1037/0033-3204.44.3.240; Russinova Z, 1999, J REHABIL, V65, P50; Schizophrenia Commission, 2012, AB ILLN REP SCHIZ CO; Shinn AK, 2012, COMPR PSYCHIAT, V53, P718, DOI 10.1016/j.comppsych.2011.11.003; Thomas N, 2014, SCHIZOPHRENIA BULL, V40, pS202, DOI 10.1093/schbul/sbu037; Waller H, 2013, J BEHAV THER EXP PSY, V44, P98, DOI 10.1016/j.jbtep.2012.07.013	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178715	10.1371/journal.pone.0178715	http://dx.doi.org/10.1371/journal.pone.0178715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575094	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300102
J	Kasashima, H; Yashiro, M; Nakamae, H; Masuda, G; Kinoshita, H; Morisaki, T; Fukuoka, T; Hasegawa, T; Nakane, T; Hino, M; Hirakawa, K; Ohira, M				Kasashima, Hiroaki; Yashiro, Masakazu; Nakamae, Hirohisa; Masuda, Go; Kinoshita, Haruhito; Morisaki, Tamami; Fukuoka, Tatsunari; Hasegawa, Tsuyoshi; Nakane, Takahiko; Hino, Masayuki; Hirakawa, Kosei; Ohira, Masaichi			Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma	PLOS ONE			English	Article							PANCREATIC DUCTAL ADENOCARCINOMA; MESENCHYMAL STEM-CELLS; BONE-MARROW; CANCER PROGRESSION; FIBROBLASTS; MYOFIBROBLASTS; METASTASIS; SURVIVAL; GROWTH; MODEL	Purpose It was reported that the chemokine (C-X-C motif) ligand 1 (CXCL1) from cancer cells stimulated the recruitment of bone marrow-derived mesenchymal cells (BM-MCs) into tumor stroma via chemokine (C-X-C motif) receptor 2 (CXCR2) signaling. We conducted this retrospective study to determine the clinicopathologic significance of the CXCL1-CXCR2 axis in human gastric cancer. Methods The correlations between the clinicopathological features of 270 primary gastric carcinomas and CXCL1 in cancer cells and CXCR2 in stromal cells were analyzed in immunohistochemical studies. The effect of gastric cancer cells on the expression of CXCR2 in BM-MCs was examined using diffuse-type gastric cancer cell lines in vitro. Results The expression of CXCL1 in cancer cells was correlated with T invasion (T2-T4), lymph node metastasis, lymphatic invasion, venous invasion, peritoneal cytology, peritoneal metastasis and CXCR2 expression in stromal cells. The expression of CXCR2 in stromal cells was correlated with macroscopic type-4 cancers, histological type, T invasion (T2-T4), lymph node metastasis, lymphatic invasion, infiltration, peritoneal cytology, peritoneal metastasis and CD271 expression in stromal cells. The overall survival of patients with CXCL1 and CXCR2-positive cancer was poorer than that of the patients with negative cancer. Both CXCL1 expression in cancer cells and CXCR2 expression in stromal cells were independent prognostic factors for gastric cancer patients. Conclusion The expressions of CXCL1 in cancer cells and CXCR2 in stromal cells are useful prognostic factors for gastric cancer patients.	[Kasashima, Hiroaki; Yashiro, Masakazu; Masuda, Go; Kinoshita, Haruhito; Morisaki, Tamami; Fukuoka, Tatsunari; Hasegawa, Tsuyoshi; Hirakawa, Kosei; Ohira, Masaichi] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Mol Oncol & Therapeut, Osaka, Japan; [Nakamae, Hirohisa; Nakane, Takahiko; Hino, Masayuki] Osaka City Univ, Grad Sch Med, Dept Hematol, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Mol Oncol & Therapeut, Osaka, Japan.	m9312510@med.osaka-cu.ac.jp			KAKENHI [23390329, 26293307]; Osaka City University	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka City University	This study is partially founded by KAKENHI (Grant-in-Aid for Scientific Research, Nos. 23390329 and 26293307) and by Priority Research Fund of Osaka City University.	[Anonymous], 2011, GASTRIC CANC, V14, P101; Fuyuhiro Y, 2012, CANCER SCI, V103, P797, DOI 10.1111/j.1349-7006.2012.02209.x; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kasashima H, 2015, BRIT J CANCER, V113, P443, DOI 10.1038/bjc.2015.236; Kasashima H, 2016, AM J PATHOL, V186, P3028, DOI 10.1016/j.ajpath.2016.07.024; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Le Rolle AF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0555-4; Lesina M, 2016, J CLIN INVEST, V126, P2919, DOI 10.1172/JCI86477; Li L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0247-1; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Tripathi M, 2012, CELL ADHES MIGR, V6, P231, DOI 10.4161/cam.20419; Wang D, 2017, CANC RES; Wang ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1793-9; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794; Wei ZW, 2015, CANCER LETT, V359, P335, DOI 10.1016/j.canlet.2015.01.033; YASHIRO M, 1995, BRIT J CANCER, V72, P1200, DOI 10.1038/bjc.1995.486; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11674	23	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178635	10.1371/journal.pone.0178635	http://dx.doi.org/10.1371/journal.pone.0178635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575019	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300083
J	Kurajoh, M; Kadoya, M; Morimoto, A; Miyoshi, A; Kanzaki, A; Kakutani-Hatayama, M; Hamamoto, K; Shoji, T; Moriwaki, Y; Yamamoto, T; Inaba, M; Namba, M; Koyama, H				Kurajoh, Masafumi; Kadoya, Manabu; Morimoto, Akiko; Miyoshi, Akio; Kanzaki, Akinori; Kakutani-Hatayama, Miki; Hamamoto, Kae; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Inaba, Masaaki; Namba, Mitsuyoshi; Koyama, Hidenori			Plasma brain- derived neurotrophic factor concentration is a predictor of chronic kidney disease in patients with cardiovascular risk factors - Hyogo Sleep Cardio-Autonomic Atherosclerosis study	PLOS ONE			English	Article							NERVOUS-SYSTEM; BLOOD-PRESSURE; FACTOR BDNF; EXPRESSION; ASSOCIATION; RECEPTORS; FAMILY; DEATH; HSCAA; HOSPITALIZATION	Background Brain-derived neurotrophic factor (BDNF) has been shown to have protective effects against cardiovascular diseases and death through neural and non-neural pathways via tropomyosin-related kinase B signaling. However, it is not known whether plasma BDNF concentration is a predictor of chronic kidney disease (CKD). Design This study was conducted as a prospective cohort study as part of the Hyogo Sleep Cardio-Autonomic Atherosclerosis. Methods We measured plasma BDNF concentration in 324 patients without CKD, defined as an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m(2), and with cardiovascular risk factors. As potential confounders, sleep condition, nocturnal hypertension, and autonomic function were quantitatively examined. The patients were followed for a median 37 months (range 2-59 months) and occurrence of CKD was noted. Results Plasma BDNF concentration was significantly and independently associated with CKD development, which occurred in 38 patients (11.7%). Kaplan-Meier analysis revealed that patients with reduced plasma BDNF concentration exhibited a significantly (p = 0.029) greater number of CKD events as compared to those with a higher concentration. Moreover,comparisons of key subgroups showed that the risk of CKD in association with low plasma BDNF concentration was more prominent in patients with a greater reduction of nocturnal systolic blood pressure, better movement index, higher standard deviations of the NN(RR) interval or average NN(RR) interval for each 5-minute period, and without past cardiovascular disease events, smoking habit, or albuminuria. Conclusions Plasma BDNF concentration is an independent predictor for development of CKD in patients with cardiovascular risk factors.	[Kurajoh, Masafumi; Kadoya, Manabu; Morimoto, Akiko; Miyoshi, Akio; Kanzaki, Akinori; Kakutani-Hatayama, Miki; Hamamoto, Kae; Shoji, Takuhito; Moriwaki, Yuji; Yamamoto, Tetsuya; Namba, Mitsuyoshi; Koyama, Hidenori] Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, Nishinomiya, Hyogo, Japan; [Kurajoh, Masafumi; Inaba, Masaaki] Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan	Hyogo College of Medicine; Osaka Metropolitan University	Kurajoh, M (corresponding author), Hyogo Coll Med, Div Diabet Endocrinol & Metab, Dept Internal Med, Nishinomiya, Hyogo, Japan.; Kurajoh, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Metab Endocrinol & Mol Med, Osaka, Japan.	mkurajoh@hyo-med.ac.jp	Koyama, Hidenori/AAU-2346-2020	Koyama, Hidenori/0000-0001-7930-2228	Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26461371]; Technological Seeds in Advanced Medicine, Hyogo College of Medicine	Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Technological Seeds in Advanced Medicine, Hyogo College of Medicine	This work is supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jsps.go.jp/jg rants in aid/index.html)(26461371 to HK), and a Grant-in-Aid for Promotion of Technological Seeds in Advanced Medicine, Hyogo College of Medicine (http://www.hyo-med.ac.jp/english.html)(toTY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 2000, J AM SOC NEPHROL, V11, P1469, DOI 10.1681/ASN.V1181469; Bachmann V, 2012, SLEEP, V35, P335, DOI 10.5665/sleep.1690; Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Brotman DJ, 2010, J AM SOC NEPHROL, V21, P1560, DOI 10.1681/ASN.2009111112; DURBEEJ M, 1993, DEVELOPMENT, V119, P977; Ejiri J, 2005, CIRCULATION, V112, P2114, DOI 10.1161/CIRCULATIONAHA.104.476903; Garcia-Suarez O, 2006, MICROSC RES TECHNIQ, V69, P1014, DOI 10.1002/jemt.20367; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Haroun MK, 2003, J AM SOC NEPHROL, V14, P2934, DOI 10.1097/01.ASN.0000095249.99803.85; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; Huber R, 2007, SLEEP, V30, P129, DOI 10.1093/sleep/30.2.129; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jiang H, 2011, BIOCHEM BIOPH RES CO, V415, P99, DOI 10.1016/j.bbrc.2011.10.020; Kadoya M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155116; Kadoya M, 2015, ATHEROSCLEROSIS, V238, P409, DOI 10.1016/j.atherosclerosis.2014.12.032; Kadoya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105977; Kielstein H, 2015, NEPHROL DIAL TRANSPL, V30, P1699, DOI 10.1093/ndt/gfv253; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x; Kurajoh M, 2016, PSYCHONEUROENDOCRINO, V74, P7, DOI 10.1016/j.psyneuen.2016.08.016; Kurajoh M, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0280-6; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Li M, 2015, J PATHOL, V235, P731, DOI 10.1002/path.4484; Manni L, 2005, INT J CARDIOL, V102, P169, DOI 10.1016/j.ijcard.2004.10.041; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McMullan CJ, 2016, KIDNEY INT, V89, P1324, DOI 10.1016/j.kint.2015.12.048; McMullan CJ, 2015, J HYPERTENS, V33, P1939, DOI 10.1097/HJH.0000000000000638; Minutolo R, 2007, AM J KIDNEY DIS, V50, P908, DOI 10.1053/j.ajkd.2007.07.020; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Petrov ME, 2014, SLEEP MED, V15, P1140, DOI 10.1016/j.sleep.2014.05.021; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Ravani P, 2005, J AM SOC NEPHROL, V16, P2449, DOI 10.1681/ASN.2005010076; Schneider SM, 2015, SEMIN NEPHROL, V35, P304, DOI 10.1016/j.semnephrol.2015.06.002; Shibayama E, 1996, AM J PATHOL, V148, P1807; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178686	10.1371/journal.pone.0178686	http://dx.doi.org/10.1371/journal.pone.0178686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575038	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300095
J	Schleicher, SB; Zaborski, JJ; Riester, R; Zenkner, N; Handgretinger, R; Kluba, T; Traub, F; Boehme, KA				Schleicher, Sabine B.; Zaborski, Julian J.; Riester, Rosa; Zenkner, Natascha; Handgretinger, Rupert; Kluba, Torsten; Traub, Frank; Boehme, Karen A.			Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-TRCP; EMBRYONAL RHABDOMYOSARCOMA; MULTIDRUG-RESISTANCE; SIGNALING PATHWAY; CANCER-CELLS; IN-VITRO; HEDGEHOG; INHIBITION; GLI3	Rhabdomyosarcomas (RMS) are the most prevalent soft tissue sarcomas affecting children and adolescents. Despite intensive treatment consisting of multimodal chemotherapy and surgery RMS patients diagnosed with metastatic disease expect long term survival rates of only 20%. Often multidrug resistance arises upon initial response emphasizing the need for new therapeutic drugs to improve treatment efficiency. Previously, we demonstrated the efficacy of the FDA approved drug arsenic trioxide (ATO) specifically inhibiting viability and clonal growth as well as inducing cell death in human RMS cell lines of different subtypes. In this study, we combined low dose ATO with lithium chloride (LiCI), which is approved as mood stabilizer for the treatment of bipolar disorder, but also inhibits growth and survival of different cancer cell types in pre-clinical research. Indeed, we could show additive effects of LiCI and ATO on viability reduction, decrease of colony formation as well as cell death induction. In the course of this, LiCI induced inhibitory glycogen synthase kinase-3I3 (GSK-313) serine 9 phosphorylation, whereas glioma associated oncogene family 1 (GLI1) protein expression was particularly reduced by combined ATO and LiCI treatment in RD and RH-30 cell lines, showing high rates of apoptotic cell death. These results imply that combination of ATO with LiCI or another drug targeting GSK-3 is a promising strategy to enforce the treatment efficiency in resistant and recurrent RMS.	[Schleicher, Sabine B.; Handgretinger, Rupert] Eberhard Karls Univ Tuebingen, Childrens Hosp, Dept Hematol & Oncol, Tubingen, Germany; [Zaborski, Julian J.; Riester, Rosa; Zenkner, Natascha; Traub, Frank; Boehme, Karen A.] Eberhard Karls Univ Tuebingen, Dept Orthoped Surg, Lab Cell Biol, Tubingen, Germany; [Kluba, Torsten; Traub, Frank] Eberhard Karls Univ Tuebingen, Dept Orthoped Surg, Tubingen, Germany; [Kluba, Torsten] Hosp Dresden Friedrichstadt, Dept Orthoped Surg, Dresden, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technische Universitat Dresden; Municipal Hospital Dresden	Boehme, KA (corresponding author), Eberhard Karls Univ Tuebingen, Dept Orthoped Surg, Lab Cell Biol, Tubingen, Germany.	karen.boehme@web.de		Traub, Frank/0000-0002-6400-3257; Boehme, Karen Andrea/0000-0001-9883-0501				Annavarapu SR, 2013, LAB INVEST, V93, P1090, DOI 10.1038/labinvest.2013.97; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Boehme KA, 2016, INT J ONCOL, V48, P801, DOI 10.3892/ijo.2015.3293; Breitfeld PP, 2001, J PEDIAT HEMATOL ONC, V23, P225, DOI 10.1097/00043426-200105000-00010; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen H, 2016, CANCER TREAT REV, V43, P8, DOI 10.1016/j.ctrv.2015.11.011; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciccarelli C, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0501-y; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Curran G, 2014, EXPERT REV NEUROTHER, V14, P1079, DOI 10.1586/14737175.2014.947965; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dionyssiou MG, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.58; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Graab U, 2015, ONCOTARGET, V6, P8722, DOI 10.18632/oncotarget.2726; Hosoi H, 2016, PEDIATR INT, V58, P81, DOI 10.1111/ped.12867; Huang HS, 2011, TOXICOL SCI, V121, P101, DOI 10.1093/toxsci/kfr023; Izeradjene K, 2004, CLIN CANCER RES, V10, P6650, DOI 10.1158/1078-0432.CCR-04-0576; Jahangiri A, 2013, CLIN CANCER RES, V19, P5811, DOI 10.1158/1078-0432.CCR-13-2177; Kashi VP, 2015, NAT REV CANCER, V15, P426, DOI 10.1038/nrc3961; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kelleher FC, 2012, PHARMACOL THERAPEUT, V136, P153, DOI 10.1016/j.pharmthera.2012.08.004; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Liu Z, 2014, ONCOGENE, V33, P65, DOI 10.1038/onc.2012.544; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; MOORE JA, 1995, REPROD TOXICOL, V9, P175, DOI 10.1016/0890-6238(94)00069-7; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Peng ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061457; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Ronchi A, 2010, INT J ONCOL, V37, P745, DOI 10.3892/ijo_00000724; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Subbarayan Pochi R, 2014, J Gastrointest Cancer, V45, P363, DOI 10.1007/s12029-014-9617-8; Takenaka K, 2007, BIOCHEM BIOPH RES CO, V353, P501, DOI 10.1016/j.bbrc.2006.12.058; Tan B, 2000, CURR OPIN ONCOL, V12, P450, DOI 10.1097/00001622-200009000-00011; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Trnski D, 2015, BBA-MOL BASIS DIS, V1852, P2574, DOI 10.1016/j.bbadis.2015.09.005; Vidal F, 2011, INT J ONCOL, V38, P1365, DOI 10.3892/ijo.2011.955; Vleeshouwer-Neumann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144320; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Watcharasit P, 2008, J APPL TOXICOL, V28, P466, DOI 10.1002/jat.1296; Watts JM, 2014, BLOOD REV, V28, P205, DOI 10.1016/j.blre.2014.07.001; Weigel BJ, 2016, J CLIN ONCOL, V34, P117, DOI 10.1200/JCO.2015.63.4048; Wu S, 2013, J BIOL CHEM, V288, P35500, DOI 10.1074/jbc.M113.479865; Yang LM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-654; Zeng FY, 2010, BIOCHEM BIOPH RES CO, V391, P1049, DOI 10.1016/j.bbrc.2009.12.017; Zinke J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0294-4	50	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178857	10.1371/journal.pone.0178857	http://dx.doi.org/10.1371/journal.pone.0178857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575066	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300127
J	Yao, J; Wu, B; Wu, GY; Li, X; Ye, JN; Sui, JF				Yao, Juan; Wu, Bing; Wu, Guang-yan; Li, Xuan; Ye, Jian-ning; Sui, Jian-feng			Establishment and transfer of classical eyeblink conditioning using electrical microstimulation of the hippocampus as the conditioned stimulus	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NICTITATING-MEMBRANE RESPONSE; CEREBELLAR INTERPOSITUS NUCLEUS; GUINEA-PIGS; UNCONDITIONED STIMULUS; SOMATOSENSORY CORTEX; PONTINE STIMULATION; EYELID RESPONSES; DISRUPTS TRACE; RABBITS	The present experiment was designed to determine whether classical eyeblink conditioning (EBC) can be established by using electrical microstimulation of the hippocampus as a conditioned stimulus (CS) paired with an air-puff unconditioned stimulus (US). We intended to examine whether EBC transfer could occur when a CS was shifted between microstimulation of the hippocampus as a CS (Hip-CS) and tone as a CS (tone-CS) and to compare the difference in transfer effectiveness between delay EBC (dEBC) and trace EBC (tEBC). Eight groups of guinea pigs, including 4 experimental groups and 4 control groups, were included in the study. First, the experimental groups received either a Hip-CS or a tone-CS paired with a US; then, these groups were exposed to a shifted CS (tone-CS or Hip-CS) paired with the US. The control groups received the corresponding Hip-CS or tone-CS, which was, however, pseudo-paired with the US. The control groups were then shifted to the tone-CS (or Hip-CS) paired with the US. The results show that EBC can be successfully established when using microstimulation of the hippocampus as a CS paired with an air-puff US, and that the acquisition rates of EBC are higher in the experimental groups than in the control groups after switching from the Hip-CS to the tone-CS or vice versa, indicating the occurrence of learning transfer between EBC established with the Hip-CS and tone-CS. The present study also demonstrated that the EBC re-acquisition rates were remarkably higher in dEBC than in tEBC with both types of transfer, which suggests that the saving effect was more evident in dEBC than tEBC. These results significantly expand our knowledge of EBC transfer as well as the functional neural circuit underlying EBC transfer.	[Yao, Juan; Wu, Bing; Sui, Jian-feng] Third Mil Med Univ, Dept Physiol, Coll Basic Med Sci, Chongqing, Peoples R China; [Yao, Juan; Wu, Bing; Wu, Guang-yan; Li, Xuan; Sui, Jian-feng] Third Mil Med Univ, Coll Basic Med Sci, Expt Ctr Basic Med, Chongqing, Peoples R China; [Ye, Jian-ning] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Sui, JF (corresponding author), Third Mil Med Univ, Dept Physiol, Coll Basic Med Sci, Chongqing, Peoples R China.; Sui, JF (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Expt Ctr Basic Med, Chongqing, Peoples R China.; Ye, JN (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.	jningye@tom.com; jfsui2003@163.com			National Natural Science Foundation of China [81571161]; Special Financial Grant from the China Postdoctoral Science Foundation [2014T81091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Financial Grant from the China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was mainly supported by Grant from National Natural Science Foundation of China (No. 81571161), and Special Financial Grant from the China Postdoctoral Science Foundation (No. 2014T81091).; We thank Professor Wen-Jun Gao from the Department of Neurobiology and Anatomy of Drexel University College of Medicine (Philadelphia, PA, USA) for the assistance with editing the manuscript. This work was mainly supported by Grant from National Natural Science Foundation of China (No. 81571161), and Special Financial Grant from the China Postdoctoral Science Foundation (No. 2014T81091).	BERGER TW, 1978, BRAIN RES, V145, P323, DOI 10.1016/0006-8993(78)90866-1; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Brown KL, 2008, DEV PSYCHOBIOL, V50, P647, DOI 10.1002/dev.20335; CAAN W, 1976, J PHYSIOL-LONDON, V258, pP20; Campolattaro MM, 2007, LEARN MEMORY, V14, P152, DOI 10.1101/lm.465507; Campolattaro MM, 2009, BEHAV NEUROSCI, V123, P292, DOI 10.1037/a0014483; Christian KM, 2005, BEHAV NEUROSCI, V119, P526, DOI 10.1037/0735-7044.119.2.526; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; DOTY RW, 1959, J NEUROPHYSIOL, V22, P428, DOI 10.1152/jn.1959.22.4.428; DOTY RW, 1965, J NEUROPHYSIOL, V28, P623, DOI 10.1152/jn.1965.28.4.623; DOTY RW, 1961, ELECTRICAL STIMULATI, P397; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fenton GE, 2014, NEUROSCIENCE, V265, P204, DOI 10.1016/j.neuroscience.2014.01.028; Freeman JH, 2004, INTEGR PHYS BEH SCI, V39, P180, DOI 10.1007/BF02734438; Freeman JH, 2008, DEV PSYCHOBIOL, V50, P640, DOI 10.1002/dev.20331; Freeman JH, 2007, LEARN MEMORY, V14, P842, DOI 10.1101/lm.716107; Garcia KS, 1999, J NEUROSCI, V19, P10940, DOI 10.1523/JNEUROSCI.19-24-10940.1999; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; GRIGORYAN GA, 1981, ACTA NEUROBIOL EXP, V41, P423; Halverson HE, 2008, LEARN MEMORY, V15, P532, DOI 10.1101/lm.1002508; Halverson HE, 2010, NEUROBIOL LEARN MEM, V93, P92, DOI 10.1016/j.nlm.2009.08.008; Halverson HE, 2009, LEARN MEMORY, V16, P300, DOI 10.1101/lm.1340909; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hu B, 2012, BEHAV BRAIN RES, V226, P529, DOI 10.1016/j.bbr.2011.10.011; Ivkovich D, 2000, DEV PSYCHOBIOL, V36, P148, DOI 10.1002/(SICI)1098-2302(200003)36:2<148::AID-DEV6>3.0.CO;2-L; Jimenez-Diaz L, 2004, J NEUROSCI, V24, P9138, DOI 10.1523/JNEUROSCI.2025-04.2004; Jirenhed DA, 2011, J NEUROSCI, V31, P9070, DOI 10.1523/JNEUROSCI.1653-11.2011; Kalmbach BE, 2009, LEARN MEMORY, V16, P86, DOI 10.1101/lm.1178309; KEHOE EJ, 1988, PSYCHOL REV, V95, P411, DOI 10.1037/0033-295X.95.4.411; KEHOE EJ, 1984, ANIM LEARN BEHAV, V12, P122, DOI 10.3758/BF03213130; KEHOE EJ, 1989, J EXP ANAL BEHAV, V52, P427, DOI 10.1901/jeab.1989.52-427; KIM JJ, 1995, BEHAV NEUROSCI, V109, P195, DOI 10.1037/0735-7044.109.2.195; KNOWLTON BJ, 1992, BEHAV NEUROSCI, V106, P509, DOI 10.1037/0735-7044.106.3.509; KNOWLTON BJ, 1989, BEHAV NEUROSCI, V103, P206, DOI 10.1037/0735-7044.103.1.206; Kotani S, 2003, EUR J NEUROSCI, V17, P1445, DOI 10.1046/j.1460-9568.2003.02566.x; KOUTALIDIS O, 1988, J NEUROSCI, V8, P417; Leal-Campanario R, 2006, P NATL ACAD SCI USA, V103, P10052, DOI 10.1073/pnas.0603584103; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; MURRAY EA, 1985, SCIENCE, V228, P604, DOI 10.1126/science.3983648; Oswald BB, 2008, BEHAV NEUROSCI, V122, P841, DOI 10.1037/0735-7044.122.4.841; Oswald BB, 2007, BEHAV BRAIN RES, V179, P111, DOI 10.1016/j.bbr.2007.01.016; Oswald BB, 2010, NEUROBIOL LEARN MEM, V93, P37, DOI 10.1016/j.nlm.2009.08.001; Poulos AM, 2004, INTEGR PHYS BEH SCI, V39, P83, DOI 10.1007/BF02734274; Powell DA, 2005, BEHAV NEUROSCI, V119, P180, DOI 10.1037/0735-7044.119.1.180; Rapisarda C, 1977, Arch Sci Biol (Bologna), V61, P1; ROSEN DJ, 1989, BEHAV NEURAL BIOL, V52, P51, DOI 10.1016/S0163-1047(89)90158-1; Shinkman PG, 1996, BEHAV NEUROSCI, V110, P914, DOI 10.1037/0735-7044.110.5.914; Simon B, 2005, J NEUROSCI, V25, P10740, DOI 10.1523/JNEUROSCI.3003-05.2005; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; STEINMETZ J E, 1986, Neuroscience Research, V3, P606, DOI 10.1016/0168-0102(86)90057-X; STEINMETZ JE, 1986, BEHAV NEUROSCI, V100, P878, DOI 10.1037/0735-7044.100.6.878; STEINMETZ JE, 1989, SYNAPSE, V3, P225, DOI 10.1002/syn.890030308; Takehara K, 2003, J NEUROSCI, V23, P9897; Takehara-Nishiuchi K, 2005, LEARN MEMORY, V12, P606, DOI 10.1101/lm.5905; Thompson RF, 1997, INT REV NEUROBIOL, V41, P151, DOI 10.1016/S0074-7742(08)60351-7; Troncoso J, 2004, LEARN MEMORY, V11, P724, DOI 10.1101/lm.81204; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Weible AP, 2003, J NEUROPHYSIOL, V90, P599, DOI 10.1152/jn.01097.2002; WOODY CD, 1972, J NEUROPHYSIOL, V35, P242, DOI 10.1152/jn.1972.35.2.242; Wu GY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10065; Wu GY, 2012, ACTA PHARMACOL SIN, V33, P717, DOI 10.1038/aps.2012.32; Wu GY, 2012, NEUROBIOL LEARN MEM, V97, P277, DOI 10.1016/j.nlm.2012.02.001; Wu GY, 2017, CEREBRAL CORTEX; Yao J, 2014, BEHAV BRAIN RES, V274, P19, DOI 10.1016/j.bbr.2014.07.051; Yeo CH, 1997, LEARN MEMORY, V3, P557, DOI 10.1101/lm.3.6.557	68	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178502	10.1371/journal.pone.0178502	http://dx.doi.org/10.1371/journal.pone.0178502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575003	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300058
J	Fettelschoss, V; Burda, P; Sagne, C; Coelho, D; De Laet, C; Lutz, S; Suormala, T; Fowler, B; Pietrancosta, N; Gasnier, B; Bornhauser, B; Froese, DS; Baumgartner, MR				Fettelschoss, Victoria; Burda, Patricie; Sagne, Corinne; Coelho, David; De Laet, Corinne; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Pietrancosta, Nicolas; Gasnier, Bruno; Bornhauser, Beat; Froese, D. Sean; Baumgartner, Matthias R.			Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B-12-trafficking proteins ABCD4 and LMBD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; fluorescence resonance energy transfer (FRET); homology modeling; inborn error of metabolism; protein-protein interaction; ABCD4; LMBD1; cblF; cblJ; vitamin B-12	PEROXISOMAL MEMBRANE-PROTEIN; GREEN FLUORESCENT PROTEIN; BINDING CASSETTE PROTEIN; INBORN ERROR; SUBCELLULAR-LOCALIZATION; METHYLMALONIC ACIDURIA; ENDOPLASMIC-RETICULUM; COENZYME B-12; LIVING CELLS; FOLLOW-UP	Vitamin B-12 (cobalamin (Cbl)), in the cofactor forms methyl-Cbl and adenosyl-Cbl, is required for the function of the essential enzymes methionine synthase and methylmalonyl-CoA mutase, respectively. Cbl enters mammalian cells by receptor-mediated endocytosis of protein-bound Cbl followed by lysosomal export of free Cbl to the cytosol and further processing to these cofactor forms. The integral membrane proteins LMBD1 and ABCD4 are required for lysosomal release of Cbl, and mutations in the genes LMBRD1 and ABCD4 result in the cobalamin metabolism disorders cblF and cblJ. We report a new (fifth) patient with the cblJ disorder who presented at 7 days of age with poor feeding, hypotonia, methylmalonic aciduria, and elevated plasma homocysteine and harbored the mutations c.1667_1668delAG [p.Glu556Glyfs*27] and c.1295G > A [p.Arg432Gln] in the ABCD4 gene. Cbl cofactor forms are decreased in fibroblasts from this patient but could be rescued by overexpression of either ABCD4 or, unexpectedly, LMBD1. Using a sensitive live-cell FRET assay, we demonstrated selective interaction between ABCD4 and LMBD1 and decreased interaction when ABCD4 harbored the patient mutations p.Arg432Gln or p.Asn141Lys or when artificial mutations disrupted the ATPase domain. Finally, we showed that ABCD4 lysosomal targeting depends on co-expression of, and interaction with, LMBD1. These data broaden the patient and mutation spectrum of cblJ deficiency, establish a sensitive live-cell assay to detect the LMBD1-ABCD4 interaction, and confirm the importance of this interaction for proper intracellular targeting of ABCD4 and cobalamin cofactor synthesis.	[Fettelschoss, Victoria; Burda, Patricie; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, Steinweisstr 75, CH-8032 Zurich, Switzerland; [Fettelschoss, Victoria; Burda, Patricie; Lutz, Seraina; Suormala, Terttu; Fowler, Brian; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp, Childrens Res Ctr, Steinweisstr 75, CH-8032 Zurich, Switzerland; [Sagne, Corinne; Gasnier, Bruno] Paris Descartes Univ, Sorbonne Paris Cite, CNRS, Neurophoton Lab,UMR 8250, F-75006 Paris, France; [Coelho, David] Nancy Univ, Fac Med, Nutr Genet Environm Risk Exposure, UMR S UL,INSERM,U954, Nancy, France; [Coelho, David] Nancy Univ, Fac Med, Reference Ctr Inborn Metab Dis, Nancy, France; [Coelho, David] Univ Hosp Ctr, Nancy, France; [De Laet, Corinne] Free Univ Brussels ULB, Queen Fabiola Childrens Univ Hosp, Nutr & Metab Unit, B-1020 Brussels, Belgium; [Pietrancosta, Nicolas] Paris Descartes Univ, CNRS, Sorbonne Paris Cite, CBMIT Team,UMR 8601, F-75006 Paris, France; [Bornhauser, Beat] Univ Childrens Hosp, Dept Oncol, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Froese, D. Sean; Baumgartner, Matthias R.] Univ Zurich, Clin Res Prior Program Rare Dis, Rare Dis Initiat Zurich Radiz, CH-8006 Zurich, Switzerland; [Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8006 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Froese, DS; Baumgartner, MR (corresponding author), Univ Childrens Hosp, Div Metab, Steinweisstr 75, CH-8032 Zurich, Switzerland.; Froese, DS; Baumgartner, MR (corresponding author), Univ Childrens Hosp, Childrens Res Ctr, Steinweisstr 75, CH-8032 Zurich, Switzerland.	sean.froese@kispi.uzh.ch; matthias.baumgartner@kispi.uzh.ch	Nicolas, PIetrancosta/P-4645-2017; Sagne, Corinne/K-7601-2017; Gasnier, Bruno/AAD-9124-2022; Coelho, David/AAE-9547-2020; pietrancosta, nicolas/AAC-2777-2019; Bornhauser, Beat/M-4437-2014; pietrancosta, nicolas/B-5235-2019; Coelho, David/F-6680-2011; Sagné, Corinne/AAY-1819-2021; Froese, D. Sean Sean/AAW-6899-2021; Baumgartner, Matthias/Q-2855-2017	Nicolas, PIetrancosta/0000-0002-9934-7818; Gasnier, Bruno/0000-0003-4458-6296; pietrancosta, nicolas/0000-0002-9934-7818; pietrancosta, nicolas/0000-0002-9934-7818; Coelho, David/0000-0001-7010-5789; Sagné, Corinne/0000-0001-5971-4831; Froese, D. Sean Sean/0000-0003-1557-3517; Baumgartner, Matthias/0000-0002-9270-0826; Bornhauser, Beat/0000-0003-2890-3191	Swiss National Science Foundation [SNSF 31003A_156907]; Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland	This work was supported by the Swiss National Science Foundation (SNSF 31003A_156907; to M. R. B.) and the Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich, Switzerland. The authors declare that they have no conflicts of interest with the contents of this article.	Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alfadhel M, 2011, AM J MED GENET A, V155A, P2571, DOI 10.1002/ajmg.a.34220; Armour CM, 2013, PEDIATRICS, V132, pE257, DOI 10.1542/peds.2013-0105; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bassila C, 2017, BBA-MOL BASIS DIS, V1863, P103, DOI 10.1016/j.bbadis.2016.10.016; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Burda P, 2017, J INHERIT METAB DIS, V40, P297, DOI 10.1007/s10545-016-9987-0; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; CONTRERAS M, 1994, FEBS LETT, V344, P211, DOI 10.1016/0014-5793(94)00400-5; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Deme JC, 2014, MOL MEMBR BIOL, V31, P250, DOI 10.3109/09687688.2014.990998; DUFOUR E, 1990, FEBS LETT, V277, P223, DOI 10.1016/0014-5793(90)80850-I; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Froese DS, 2015, J BIOL CHEM, V290, P29167, DOI 10.1074/jbc.M115.683268; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gailus S, 2010, J INHERIT METAB DIS, V33, P17, DOI 10.1007/s10545-009-9032-7; Hagen N, 2014, MOL CELL PROTEOMICS, V13, P1676, DOI 10.1074/mcp.M113.036301; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hatzimichael E, 2016, INT J HEMATOL, V103, P479, DOI 10.1007/s12185-016-1977-3; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jesina, 2016, J INHERIT METAB DIS, V39, P35; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jusufi J, 2014, J INHERIT METAB DIS, V37, P841, DOI 10.1007/s10545-014-9709-4; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kawaguchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30183; Kim JC, 2012, MOL GENET METAB, V107, P664, DOI 10.1016/j.ymgme.2012.10.005; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee A, 2014, BIOCHEM BIOPH RES CO, V453, P612, DOI 10.1016/j.bbrc.2014.09.133; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Oladipo O, 2011, PEDIATRICS, V128, pE1636, DOI 10.1542/peds.2010-3518; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Pahadiya Hans Raj, 2016, J Family Med Prim Care, V5, P485; Quadros EV, 2013, BIOCHIMIE, V95, P1008, DOI 10.1016/j.biochi.2013.02.004; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Santra Gouranga, 2014, J Assoc Physicians India, V62, P714; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Takeichi T, 2015, BRIT J DERMATOL, V172, P1111, DOI 10.1111/bjd.13413; Thyrock A, 2010, BIOCHEM BIOPH RES CO, V396, P679, DOI 10.1016/j.bbrc.2010.04.161; Tseng LTL, 2013, J BIOL CHEM, V288, P32424, DOI 10.1074/jbc.M113.479527; WATKINS D, 1986, AM J HUM GENET, V39, P404; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103; Zhao CG, 2006, N-S ARCH PHARMACOL, V372, P444, DOI 10.1007/s00210-005-0028-z	64	20	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11980	11991		10.1074/jbc.M117.784819	http://dx.doi.org/10.1074/jbc.M117.784819			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572511	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000405485600033
J	Maniga, A; Ghisaura, S; Perrotta, L; Marche, MG; Cella, R; Albani, D				Maniga, Antonio; Ghisaura, Stefania; Perrotta, Lara; Marche, Maria Giovanna; Cella, Rino; Albani, Diego			Distinctive features and differential regulation of the DRTS genes of Arabidopsis thaliana	PLOS ONE			English	Article							REDUCTASE-THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR-BINDING; GENOME-WIDE IDENTIFICATION; ONE-CARBON METABOLISM; DIHYDROFOLATE-REDUCTASE; FOLATE POLYGLUTAMYLATION; FUNCTIONAL-ANALYSIS; BETA-GLUCURONIDASE; CIS-ELEMENTS; HUMAN-CELLS	In plants and protists, dihydrofolate reductase (DHFR) and thymidylate synthase (TS) are part of a bifunctional enzyme (DRTS) that allows efficient recycling of the dihydrofolate resulting from TS activity. Arabidopsis thaliana possesses three DRTS genes, called AtDRTS1, AtDRTS2 and AtDRTS3, that are located downstream of three members of the sec14- like SFH gene family. In this study, a characterization of the AtDRTS genes identified alternatively spliced transcripts coding for AtDRTS isoforms which may account for monofunctional DHFR enzymes supporting pathways unrelated to DNA synthesis. Moreover, we discovered a complex differential regulation of the AtDRTS genes that confirms the expected involvement of the AtDRTS genes in cell proliferation and endoreduplication, but indicates also functions related to other cellular activities. AtDRTS1 is widely expressed in both meristematic and differentiated tissues, whereas AtDRTS2 expression is almost exclusively limited to the apical meristems and AtDRTS3 is preferentially expressed in the shoot apex, in stipules and in root cap cells. The differential regulation of the AtDRTS genes is associated to distinctive promoter architectures and the expression of AtDRTS1 in the apical meristems is strictly dependent on the presence of an intragenic region that includes the second intron of the gene. Upon activation of cell proliferation in germinating seeds, the activity of the AtDRTS1 and AtDRTS2 promoters in meristematic cells appears to be maximal at the G1/S phase of the cell cycle. In addition, the promoters of AtDRTS2 and AtDRTS3 are negatively regulated through E2F cis-acting elements and both genes, but not AtDRTS1, are downregulated in plants overexpressing the AtE2Fa factor. Our study provides new information concerning the function and the regulation of plant DRTS genes and opens the way to further investigations addressing the importance of folate synthesis with respect to specific cellular activities.	[Maniga, Antonio; Perrotta, Lara; Marche, Maria Giovanna; Albani, Diego] Univ Sassari, Dept Agr, Sassari, Italy; [Ghisaura, Stefania; Perrotta, Lara] Univ Sassari, Dept Sci Nat & Environm Resources, Sassari, Italy; [Cella, Rino] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy; [Albani, Diego] Univ Sassari, Ctr Excellence Biotechnol Dev & Biodivers Res, Sassari, Italy; [Ghisaura, Stefania] Porto Conte Ric Srl, Tramariglio, Alghero, Italy	University of Sassari; University of Sassari; University of Pavia; University of Sassari; Porto Conte Ricerche	Albani, D (corresponding author), Univ Sassari, Dept Agr, Sassari, Italy.; Albani, D (corresponding author), Univ Sassari, Ctr Excellence Biotechnol Dev & Biodivers Res, Sassari, Italy.	albani@uniss.it		Albani, Diego/0000-0002-1793-9212	Fondazione Banco di Sardegna [839/2010.0136]; Regione Autonoma della Sardegna	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Regione Autonoma della Sardegna(Regione Sardegna)	Part of this work was supported by grants from Fondazione Banco di Sardegna (Prot. N. 839/2010.0136) and Regione Autonoma della Sardegna (Premialita 2011) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abali EE, 2008, VITAM HORM, V79, P267, DOI 10.1016/S0083-6729(08)00409-3; Adachi S, 2006, PLANT CELL PHYSIOL, V47, P1683, DOI 10.1093/pcp/pcl034; Albani D, 2005, EUR J HISTOCHEM, V49, P107; Albani D, 2000, J BIOL CHEM, V275, P19258, DOI 10.1074/jbc.M909390199; Aloni R, 2003, PLANTA, V216, P841, DOI 10.1007/s00425-002-0937-8; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Barroco RM, 2005, PLANT PHYSIOL, V137, P127, DOI 10.1104/pp.104.049361; Berckmans B, 2011, PLANT PHYSIOL, V157, P1440, DOI 10.1104/pp.111.183384; Berckmans B, 2009, CURR OPIN PLANT BIOL, V12, P599, DOI 10.1016/j.pbi.2009.07.005; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; Blancquaert D, 2013, PLANT MOL BIOL, V83, P329, DOI 10.1007/s11103-013-0091-7; Bohme K, 2004, PLANT J, V40, P686, DOI 10.1111/j.1365-313X.2004.02245.x; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaianantakul N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-91; Chaubet N, 1996, PLANT J, V10, P425, DOI 10.1046/j.1365-313X.1996.10030425.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CLOWES FAL, 1968, NEW PHYTOL, V67, P631, DOI 10.1111/j.1469-8137.1968.tb05489.x; Cossins E, 2000, CAN J BOT, V78, P691, DOI 10.1139/cjb-78-6-691; Cox K, 1999, PLANT MOL BIOL, V41, P733, DOI 10.1023/A:1006324328355; De Buck S, 2004, CELL MOL LIFE SCI, V61, P2632, DOI 10.1007/s00018-004-4284-8; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; DEL2, 2010, PLANT MOL BIOL, V72, P381; Doyle J. J., 1987, PHYTOCHEM B, P11; Egelkrout EM, 2002, PLANT CELL, V14, P3225, DOI 10.1105/tpc.006403; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; Gambonnet B, 2001, J SCI FOOD AGR, V81, P835, DOI 10.1002/jsfa.870; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Groth M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11640; Hanson AD, 2002, CURR OPIN PLANT BIOL, V5, P244, DOI 10.1016/S1369-5266(02)00249-2; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Heckmann S, 2011, PLANT J, V68, P646, DOI 10.1111/j.1365-313X.2011.04715.x; Henaff E, 2014, PLANT J, V77, P852, DOI 10.1111/tpj.12434; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; LAZAR G, 1993, PLANT J, V3, P657, DOI 10.1111/j.1365-313X.1993.00657.x; Le Francois BG, 2007, BRIT J CANCER, V97, P1242, DOI 10.1038/sj.bjc.6604020; Lian T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0578-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo MZ, 1997, PLANT MOL BIOL, V33, P709, DOI 10.1023/A:1005798207693; LUO MZ, 1993, PLANT MOL BIOL, V22, P427, DOI 10.1007/BF00015973; Magyar Z, 2012, EMBO J, V31, P1480, DOI 10.1038/emboj.2012.13; Mariconti L, 2002, J BIOL CHEM, V277, P9911, DOI 10.1074/jbc.M110616200; Martin C, 2007, CURR OPIN PLANT BIOL, V10, P70, DOI 10.1016/j.pbi.2006.11.004; Mehrshahi P, 2010, PLANT J, V64, P267, DOI 10.1111/j.1365-313X.2010.04336.x; Mo PL, 2007, J PLANT PHYSIOL, V164, P478, DOI 10.1016/j.jplph.2006.03.014; MORGUNOVA E, 2015, NAT COMMUN, V6, DOI DOI 10.1038/NC0MMS10050; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; O'Neil RH, 2003, J BIOL CHEM, V278, P52980, DOI 10.1074/jbc.M310328200; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; PHILLIPS HL, 1971, PLANT PHYSIOL, V48, P213, DOI 10.1104/pp.48.2.213; Planchais S, 2002, PLANT MOL BIOL, V50, P111, DOI 10.1023/A:1016018711532; Ramalingam J, 2003, MOL PLANT MICROBE IN, V16, P14, DOI 10.1094/MPMI.2003.16.1.14; Ramirez-Parra E, 2003, PLANT J, V33, P801, DOI 10.1046/j.1365-313X.2003.01662.x; Ramirez-Parra E, 2008, ANN PLANT REV CELL C, V32, P138; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Sozzani R, 2006, PLANT PHYSIOL, V140, P1355, DOI 10.1104/pp.106.077990; Sozzani R, 2010, PLANT MOL BIOL, V72, P381, DOI 10.1007/s11103-009-9577-8; Srivastava AC, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0403-z; Stevens R, 2002, J BIOL CHEM, V277, P32978, DOI 10.1074/jbc.M205125200; Stokes ME, 2013, PLANT PHYSIOL, V162, P1552, DOI 10.1104/pp.113.215095; Strehmel N, 2014, PHYTOCHEMISTRY, V108, P35, DOI 10.1016/j.phytochem.2014.10.003; Sun LX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-152; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; TIMMERMANS MCP, 1990, J BIOTECHNOL, V14, P333, DOI 10.1016/0168-1656(90)90117-T; TOTH I, 1987, EMBO J, V6, P1853, DOI 10.1002/j.1460-2075.1987.tb02443.x; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Varadarajan J, 2010, NEW PHYTOL, V187, P67, DOI 10.1111/j.1469-8137.2010.03254.x; Vincent P, 2005, J CELL BIOL, V168, P801, DOI 10.1083/jcb.200412074; Waller JC, 2012, J EXP BOT, V63, P403, DOI 10.1093/jxb/err286; WANG MH, 1995, BBA-GENE STRUCT EXPR, V1261, P325, DOI 10.1016/0167-4781(94)00251-W; Welchen E, 2005, PLANT PHYSIOL, V139, P88, DOI 10.1104/pp.105.065920; Wen FS, 2009, PLANT PHYSIOL, V151, P820, DOI 10.1104/pp.109.142067; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P11646, DOI 10.1073/pnas.182157199; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wittek F, 2015, MOL PLANT PATHOL, V16, P616, DOI 10.1111/mpp.12216; Xuan W, 2015, CURR BIOL, V25, P1381, DOI 10.1016/j.cub.2015.03.046; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034; Zhang HM, 2012, PLANT CELL, V24, P1230, DOI 10.1105/tpc.112.096149; Zhou HR, 2013, PLANT CELL, V25, P2545, DOI 10.1105/tpc.113.114678; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399; Zolman BK, 2001, PLANT PHYSIOL, V127, P1266, DOI 10.1104/pp.010550	86	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179338	10.1371/journal.pone.0179338	http://dx.doi.org/10.1371/journal.pone.0179338			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594957	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200119
J	Nijboer, TCW; Buma, FE; Winters, C; Vansteensel, MJ; Kwakkel, G; Ramsey, NF; Raemaekers, M				Nijboer, Tanja C. W.; Buma, Floor E.; Winters, Caroline; Vansteensel, Mariska J.; Kwakkel, Gert; Ramsey, Nick F.; Raemaekers, Mathijs			No changes in functional connectivity during motor recovery beyond 5 weeks after stroke; A longitudinal resting-state fMRI study	PLOS ONE			English	Article							FUGL-MEYER ASSESSMENT; UPPER-LIMB RECOVERY; PARETIC UPPER-LIMB; CEREBRAL INFARCTION; RELIABILITY; IMPACT; BRAIN; REORGANIZATION; PERFORMANCE; IMPAIRMENT	Spontaneous motor recovery after stroke appears to be associated with structural and functional changes in the motor network. The aim of the current study was to explore time-dependent changes in resting-state (rs) functional connectivity in motor-impaired stroke patients, using rs-functional MRI at 5 weeks and 26 weeks post-stroke onset. For this aim, 13 stroke patients from the EXPLICIT-stroke Trial and age and gender-matched healthy control subjects were included. Patients' synergistic motor control of the paretic upper-limb was assessed with the upper extremity section of the Fugl-Meyer Assessment (FMA-UE) within 2 weeks, and at 5 and 26 weeks post-stroke onset. Results showed that the ipsilesional rs-functional connectivity between motor areas was lower compared to the contralesional rs-functional connectivity, but this difference did not change significantly over time. No relations were observed between changes in rs-functional connectivity and upper-limb motor recovery, despite changes in upper-limb function as measured with the FMA-UE. Last, overall rs-functional connectivity was comparable for patients and healthy control subjects. To conclude, the current findings did not provide evidence that in moderately impaired stroke patients the lower rs-functional connectivity of the ipsilesional hemisphere changed over time.	[Nijboer, Tanja C. W.] Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Buma, Floor E.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Buma, Floor E.] Hoogstr Rehabil, Utrecht, Netherlands; [Nijboer, Tanja C. W.; Buma, Floor E.; Vansteensel, Mariska J.; Ramsey, Nick F.; Raemaekers, Mathijs] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Buma, Floor E.; Kwakkel, Gert] Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Winters, Caroline; Kwakkel, Gert] Vrije Univ Amsterdam, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Winters, Caroline; Kwakkel, Gert] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Kwakkel, Gert] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Northwestern University	Nijboer, TCW (corresponding author), Univ Utrecht, Dept Expt Psychol, Helmholtz Inst, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Hoogstr Rehabil, Utrecht, Netherlands.; Nijboer, TCW (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	t.c.w.nijboer@uu.nl	Vansteensel, Mariska/K-8015-2019	ramsey, nick/0000-0002-7136-259X; Vansteensel, Mariska/0000-0002-9252-5116; Kwakkel, Gert/0000-0002-4041-4043	Netherlands Organization for Health Research and Development (ZonMw) [89000001]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The EXPLICIT-stroke research project is supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw; Grant No. 89000001).; The EXPLICIT-stroke research project is supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw; Grant No. 89000001).	ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Buma FE, 2010, NEUROREHAB NEURAL RE, V24, P589, DOI 10.1177/1545968310364058; Carey LM, 2011, NEUROREHAB NEURAL RE, V25, P443, DOI 10.1177/1545968310395777; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Kwakkel G, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-49; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Press WH, 1992, COMPUT PHYS, V6, P274, DOI [10.1063/1.4823074, DOI 10.1063/1.4823074]; Rossini P M, 2007, Eura Medicophys, V43, P241; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; van Kordelaar J, 2014, ARCH PHYS MED REHAB, V95, P338, DOI 10.1016/j.apmr.2013.10.006; van Kordelaar J, 2013, NEUROREHAB NEURAL RE, V27, P854, DOI 10.1177/1545968313496327; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Xu HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084729	38	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178017	10.1371/journal.pone.0178017	http://dx.doi.org/10.1371/journal.pone.0178017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594850	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200015
J	Sartori, AL; Minamisava, R; Bierrenbach, AL; Toscano, CM; Afonso, ET; Morais-Neto, OL; Antunes, JLF; Cristo, EB; Andrade, AL				Sartori, Ana L.; Minamisava, Ruth; Bierrenbach, Ana L.; Toscano, Cristiana M.; Afonso, Eliane T.; Morais-Neto, Otaliba L.; Antunes, Jose L. F.; Cristo, Elier B.; Andrade, Ana Lucia			Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; NONTYPABLE HAEMOPHILUS-INFLUENZAE; CHILDHOOD PNEUMONIA HOSPITALIZATIONS; HEALTH-CARE UTILIZATION; STREPTOCOCCUS-PNEUMONIAE; DOSING SCHEDULES; YOUNG-CHILDREN; UNITED-STATES; PHID-CV; IMPACT	Few studies have reported the effect of 10-valent pneumococcal conjugate vaccine (PCV10) on otitis media (OM) in infants. In particular, no population-based study in upper-middle income countries is available. In 2010, Brazil introduced PCV10 into its routine National Immunization Program using a 3+1 schedule. We measured the impact of PCV10 on all-cause OM in children. An interrupted time-series analysis was conducted in Goiania/Brazil considering monthly rates (per 100,000) of all-cause OM outpatient visits in children aged 2-23 months. We used case-based data from the Outpatient Visits Information System of the Unified Health System coded for ICD-10 diagnosis for the period of August/2008 to July/2015. As a comparator, we used rates of outpatient visits due to all-other causes. The relative reduction of all-cause OM and all-other causes of outpatient visits were calculated as the difference between the predicted and observed cumulative rates of the PCV10 post-vaccination period. We then subtracted the relative reduction of all-other causes of outpatient visits from all-cause OM to obtain the impact of PCV10 on OM. In total, 6,401 OM outpatient visits were recorded in 4,793 children aged 2-23 months. Of these, 922 (19.2%) children had more than one OM episode. A significant reduction in all-cause OM visits was observed (50.7%; 95% CI: 42.2-59.2%; p = 0.013), while the reduction in visits due to all-other causes was 7.7% (95% CI 0.8-14.7%; p<0.001). The impact of PCV10 on all-cause OM was thus estimated at 43.0% (95% CI 41.4-44.5). This is the first study to show significant PCV10 impact on OM outpatient visits in infants in a developing country. Our findings corroborate the available evidence from developed countries.	[Sartori, Ana L.; Bierrenbach, Ana L.; Toscano, Cristiana M.; Morais-Neto, Otaliba L.; Andrade, Ana Lucia] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil; [Sartori, Ana L.] Univ Fed Mato Grosso, Inst Hlth Sci, Sinop, Brazil; [Minamisava, Ruth] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil; [Afonso, Eliane T.] Univ Fed Goias, Sch Med, Goiania, Go, Brazil; [Antunes, Jose L. F.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil; [Cristo, Elier B.] Secretariat Hlth, Sao Paulo, SP, Brazil	Universidade Federal de Goias; Universidade Federal de Mato Grosso; Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Sao Paulo	Andrade, AL (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Dept Community Hlth, Goiania, Go, Brazil.	alssandrade@gmail.com	Sartori, Ana Lucia/ABC-6411-2020; Bierrenbach, Ana L/F-3185-2014; Antunes, Jose Leopoldo Ferreira/F-6969-2010; B. Cristo, Elier/L-3512-2017	Sartori, Ana Lucia/0000-0003-3832-031X; Bierrenbach, Ana L/0000-0002-6837-0636; Antunes, Jose Leopoldo Ferreira/0000-0003-3972-9723; B. Cristo, Elier/0000-0003-2233-1313; Minamisava, Ruth/0000-0001-9352-5567; TOSCANO, CRISTIANA/0000-0002-9453-2643	Brazilian Ministry of Health, Secretary of Health Surveillance; National Immunization Program [01/2012]; ALA [13286/20140]; CMT [312532/20148]; Brazilian National Council for Scientific and Technological Development (CNPq); Research Foundation of the Gois State/FAPEG-GO, Brazil [003/2013]	Brazilian Ministry of Health, Secretary of Health Surveillance; National Immunization Program; ALA; CMT; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Foundation of the Gois State/FAPEG-GO, Brazil	Funding provided by the Brazilian Ministry of Health, Secretary of Health Surveillance, National Immunization Program (grant# 01/2012). ALA (# 313286/20140), and CMT (# 312532/20148) receive scientific productivity scholarships from the Brazilian National Council for Scientific and Technological Development (CNPq). ALS receives scholarship from Research Foundation of the Goias State/FAPEG-GO, Brazil (# 003/2013).	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2016, HUM VACC IMMUNOTHER, V12, P285, DOI 10.1080/21645515.2015.1117713; Andrade AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098128; [Anonymous], 2015, NAT HOUS SAMPL SURV; Ansaldi F, 2008, J INT MED RES, V36, P1255, DOI 10.1177/147323000803600612; Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Bardach A, 2011, INT J PEDIATR OTORHI, V75, P1062, DOI 10.1016/j.ijporl.2011.05.014; Ben-Shimol S, 2014, CLIN INFECT DIS, V59, P1724, DOI 10.1093/cid/ciu683; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brazilian Observatory of the National Education Plan, 2016, GOIAS; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Ferreira Filho Joaquim Bento de Souza, 2006, Rev. Bras. Econ., V60, P363, DOI 10.1590/S0034-71402006000400003; Flasche S, 2016, AM J EPIDEMIOL, V184, P652, DOI 10.1093/aje/kww012; Fortanier AC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub4; FORTUNATO F, 2015, J IMMUNOL RES, V2015, DOI DOI 10.1155/2015/206757; Greenberg D, 2003, EUR J PEDIATR, V162, P576, DOI 10.1007/s00431-003-1260-5; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; IBGE, 2016, CENS BRAZ I GEOGR ST; IBGE, 2015, RES POP BRAZ I GEOGR; Lau WCY, 2015, VACCINE, V33, P5072, DOI 10.1016/j.vaccine.2015.08.022; Leach AJ, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0483-8; Leach AJ, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-200; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS161, DOI 10.1097/INF.0000000000000084; Macinko James, 2015, N Engl J Med, V372, P2177, DOI 10.1056/NEJMp1501140; Malta DC, 2016, CIENC SAUDE COLETIVA, V21, P327, DOI 10.1590/1413-81232015212.23602015; Marom T, 2014, JAMA PEDIATR, V168, P68, DOI 10.1001/jamapediatrics.2013.3924; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; Ministry of Health of Brazil, 2010, TECHN INF 10 VAL PNE; Ministry of Health of Brazil, 2016, IMM; Ministry of Health of Brazil. National Health Agency, 2015, BEN INF SYST; Oliveira Gisele Pinto de, 2016, Rev. Saúde Pública, V50, P49, DOI 10.1590/S1518-8787.2016050006327; Oliveira JR, 2016, VACCINE, V34, P2556, DOI 10.1016/j.vaccine.2016.04.015; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Poehling KA, 2007, PEDIATRICS, V119, P707, DOI 10.1542/peds.2006-2138; Azevedo LCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064524; Rocha R, 2010, HEALTH ECON, V19, P126, DOI 10.1002/hec.1607; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Shei A, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-10; Sigurdsson S, 2015, PEDIATR INFECT DIS J, V34, P1385, DOI 10.1097/INF.0000000000000899; Singleton RJ, 2009, PEDIATR INFECT DIS J, V28, P102, DOI 10.1097/INF.0b013e318188d079; Snedecor G.W., 1989, AMES IOWA STATE U PR; Stamboulidis K, 2011, PEDIATR INFECT DIS J, V30, P551, DOI 10.1097/INF.0b013e31821038d9; Suarez V, 2016, VACCINE, V34, P4738, DOI 10.1016/j.vaccine.2016.07.027; Syrjanen RK, 2006, PEDIATR INFECT DIS J, V25, P1032, DOI 10.1097/01.inf.0000241097.37428.1d; Taylor S, 2012, CLIN INFECT DIS, V54, P1765, DOI 10.1093/cid/cis292; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thompson WW, 2012, EPIDEMIOLOGY, V23, P839, DOI 10.1097/EDE.0b013e31826cc1df; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wals Philippe De, 2009, Pediatr Infect Dis J, V28, pe271, DOI 10.1097/INF.0b013e3181bad212; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076; Wolleswinkel-van den Bosch JH, 2010, VACCINE, V28, pG39, DOI 10.1016/j.vaccine.2010.06.014; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619	60	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179222	10.1371/journal.pone.0179222	http://dx.doi.org/10.1371/journal.pone.0179222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594913	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200104
J	Cunha, MPV; Saidenberg, AB; Moreno, AM; Ferreira, AJP; Vieira, MAM; Gomes, TAT; Knobl, T				Vieira Cunha, Marcos Paulo; Saidenberg, Andre Becker; Moreno, Andrea Micke; Piantino Ferreira, Antonio Jose; Midolli Vieira, Monica Aparecida; Tardelli Gomes, Tania Aparecida; Knobl, Terezinha			Pandemic extra-intestinal pathogenic Escherichia coli (ExPEC) clonal group O6-B2-ST73 as a cause of avian colibacillosis in Brazil	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; VIRULENCE; STRAINS; UK	Extra-intestinal pathogenic Escherichia coli (ExPEC) represent an emerging pathogen, with pandemic strains increasingly involved in cases of urinary tract infections (UTIs), bacteremia, and meningitis. In addition to affecting humans, the avian pathotype of ExPEC, avian pathogenic E. coli (APEC), causes severe economic losses to the poultry industry. Several studies have revealed overlapping characteristics between APEC and human ExPEC, leading to the hypothesis of a zoonotic potential of poultry strains. However, the description of certain important pandemic clones, such as Sequence Type 73 (ST73), has not been reported in food sources. We characterized 27 temporally matched APEC strains from diverse poultry farms in Brazil belonging to the O6 serogroup because this serogroup is frequently described as a causal factor in UTI and septicemia in humans in Brazil and worldwide. The isolates were genotypically characterized by identifying ExPEC virulence factors, phylogenetically tested by phylogrouping and multilocus sequence type (MLST) analysis, and compared to determine their similarity employing the pulsed field gel electrophoresis (PFGE) technique. The strains harbored a large number of virulence determinants that are commonly described in uropathogenic E. coli (UPEC) and sepsis associated E. coli (SEPEC) strains and, to a lesser extent in neonatal meningitis associated E. coli (NMEC), such as pap (85%), sfa (100%), usp (100%), cnf1 (22%), kpsMTII (66%), hlyA (52%), and ibeA (4%). These isolates also yielded a low prevalence of some genes that are frequently described in APEC, such as iss (37%), tsh, ompT, and hlyF (8% each), and cvi/cva (0%). All strains were classified as part of the B2 phylogroup and sequence type 73 (ST73), with a cluster of 25 strains showing a clonal profile by PFGE. These results further suggest the zoonotic potential of some APEC clonal lineages and their possible role in the epidemiology of human ExPEC, in addition to providing the first description of the O6-B2-ST73 clonal group in poultry.	[Vieira Cunha, Marcos Paulo; Saidenberg, Andre Becker; Piantino Ferreira, Antonio Jose; Knobl, Terezinha] Univ Sao Paulo, Dept Pathol, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Moreno, Andrea Micke] Univ Sao Paulo, Dept Vet Prevent Med, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Midolli Vieira, Monica Aparecida; Tardelli Gomes, Tania Aparecida] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Escola Paulista Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Knobl, T (corresponding author), Univ Sao Paulo, Dept Pathol, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.	tknobl@usp.br	Saidenberg, André Becker/I-6083-2018; Gomes, Tânia Aparecida Tardelli/H-3950-2012; Moreno, Andrea M/B-7861-2012; Saidenberg, André Becker/K-3682-2019	Saidenberg, André Becker/0000-0002-2672-0749; Gomes, Tânia Aparecida Tardelli/0000-0002-4525-8705; Moreno, Andrea M/0000-0002-3290-566X; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [05/57500-9-T, 11/182046-T, 14/11523-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Grants: 05/57500-9-T. Knobl; 11/182046-T. Knobl; 14/11523-7- M.P.V. Cunha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhashash F, 2016, J ANTIMICROB CHEMOTH, V71, P339, DOI 10.1093/jac/dkv365; Bauer RJ, 2002, J INFECT DIS, V185, P1521, DOI 10.1086/340206; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Braga JFV, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0762-0; Ciesielczuk H, 2016, EUR J CLIN MICROBIOL, V35, P1661, DOI 10.1007/s10096-016-2707-8; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; CLSI, 2014, CLIN LAB STAND I PER; Cordoni G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3289-7; Cunha MPV, 2014, SCI WORLD J, DOI 10.1155/2014/289024; da Silva APS, 2017, DIAGN MICRO IN PRESS; Day MJ, 2016, J ANTIMICROB CHEMOTH, V71, P2139, DOI 10.1093/jac/dkw145; Dias RCS, 2009, MICROB DRUG RESIST, V15, P303, DOI 10.1089/mdr.2009.0067; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ejrnaes K, 2011, DAN MED BULL, V58; Fam N, 2011, MICROB DRUG RESIST, V17, P67, DOI 10.1089/mdr.2010.0063; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Liu XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143335; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Sabate M, 2006, CLIN MICROBIOL INFEC, V12, P880, DOI 10.1111/j.1469-0691.2006.01461.x; Sola-Gine A s M, 2015, PLOS ONE, V10	24	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178970	10.1371/journal.pone.0178970	http://dx.doi.org/10.1371/journal.pone.0178970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594893	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200072
J	Baker, E; Iqbal, E; Johnston, C; Broadbent, M; Shetty, H; Stewart, R; Howard, R; Newhouse, S; Khondoker, M; Dobson, RJB				Baker, Elizabeth; Iqbal, Ehtesham; Johnston, Caroline; Broadbent, Matthew; Shetty, Hitesh; Stewart, Robert; Howard, Robert; Newhouse, Stephen; Khondoker, Mizanur; Dobson, Richard J. B.			Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; IMPAIRMENT; PROGRESSION; DEPRESSION; SERTRALINE; DIAGNOSIS; EFFICACY; SAFETY; MODEL	Background Modeling trajectories of decline can help describe the variability in progression of cognitive impairment in dementia. Better characterisation of these trajectories has significant implications for understanding disease progression, trial design and care planning. Methods Patients with at least three Mini-mental State Examination (MMSE) scores recorded in the South London and Maudsley NHS Foundation Trust Electronic Health Records, UK were selected (N = 3441) to form a retrospective cohort. Trajectories of cognitive decline were identified through latent class growth analysis of longitudinal MMSE scores. Demographics, Health of Nation Outcome Scales and medications were compared across trajectories identified. Results Four of the six trajectories showed increased rate of decline with lower baseline MMSE. Two trajectories had similar initial MMSE scores but different rates of decline. In the faster declining trajectory of the two, a higher incidence of both behavioral problems and sertraline prescription were present. Conclusions We find suggestive evidence for association of behavioral problems and sertraline prescription with rate of decline. Further work is needed to determine whether trajectories replicate in other datasets.	[Baker, Elizabeth; Iqbal, Ehtesham; Newhouse, Stephen; Dobson, Richard J. B.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England; [Johnston, Caroline; Broadbent, Matthew; Newhouse, Stephen; Dobson, Richard J. B.] South London & Maudlsey NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Mental Hlth &, London, England; [Shetty, Hitesh] South London & Maudsley NHS Fdn Trust, London, England; [Stewart, Robert] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol Med, London, England; [Howard, Robert] UCL, Fac Brain Sci, Div Psychiat, London, England; [Newhouse, Stephen; Dobson, Richard J. B.] UCL, UCL Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England; [Khondoker, Mizanur] Univ East Anglia, Norwich Med Sch, Dept Populat Hlth & Primary Care, Norwich, Norfolk, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of London; University College London; University of London; University College London; University of East Anglia	Dobson, RJB (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England.; Dobson, RJB (corresponding author), South London & Maudlsey NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Mental Hlth &, London, England.; Dobson, RJB (corresponding author), UCL, UCL Inst Hlth Informat, Farr Inst Hlth Informat Res, London, England.	richard.j.dobson@kcl.ac.uk	Khondoker, Mizanur/A-9860-2011; Stewart, Robert/B-1667-2010; Baker, Elizabeth/HGC-9161-2022; Khondoker, Mizanur/O-2656-2019; dobson, richard/C-9269-2011	Khondoker, Mizanur/0000-0002-1801-1635; Stewart, Robert/0000-0002-4435-6397; Khondoker, Mizanur/0000-0002-1801-1635; Iqbal, Ehtesham/0000-0001-9477-9745; Howard, Robert/0000-0002-3071-2338; dobson, richard/0000-0003-4224-9245	Janssen pharmaceuticals; National Institute for Health Research (NIHR) Biomedical Research Centre; Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; Wellcome Trust [MR/K006584/1]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; NIHR Biomedical Research Centre for Mental Health BRC Nucleus at the SLaM NHS Foundation Trust and Institute of Psychiatry, King's College London - Guy's and St Thomas' Trustees; NIHR Biomedical Research Centre for Mental Health BRC Nucleus at the SLaM NHS Foundation Trust and Institute of Psychiatry, King's College London - SLaM Trustees; Dementia Unit at SLaM NHS Foundation Trust; King's College London	Janssen pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); NIHR Biomedical Research Centre for Mental Health BRC Nucleus at the SLaM NHS Foundation Trust and Institute of Psychiatry, King's College London - Guy's and St Thomas' Trustees; NIHR Biomedical Research Centre for Mental Health BRC Nucleus at the SLaM NHS Foundation Trust and Institute of Psychiatry, King's College London - SLaM Trustees; Dementia Unit at SLaM NHS Foundation Trust; King's College London(General Electric)	This study presents independent research part funded by Janssen pharmaceuticals and the National Institute for Health Research (NIHR) Biomedical Research Centre and Dementia Unit at SLaM NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. RJBD & SN were supported by awards to establish the Farr Institute of Health Informatics Research, London, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1), as well as the National Institute for Health Research University College London Hospitals Biomedical Research Centre. SLaM CRIS is supported by the NIHR Biomedical Research Centre for Mental Health BRC Nucleus at the SLaM NHS Foundation Trust and Institute of Psychiatry, King's College London jointly funded by the Guy's and St Thomas' Trustees and the SLaM Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hazzouri AZ, 2014, J GERONTOL A-BIOL, V69, P595, DOI 10.1093/gerona/glt139; Amieva H, 2014, BRAIN, V137, P1167, DOI 10.1093/brain/awu035; Appleby BS, 2013, DEMENT GERIATR COGN, V35, P1, DOI 10.1159/000345791; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Burnham SC, 2016, LANCET NEUROL, V15, P1044, DOI 10.1016/S1474-4422(16)30125-9; Burns A, 1999, BRIT J PSYCHIAT, V174, P424, DOI 10.1192/bjp.174.5.424; Carcaillon L, 2007, DEMENT GERIATR COGN, V23, P439, DOI 10.1159/000102017; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Degen C, 2016, PSYCHIAT RES, V240, P42, DOI 10.1016/j.psychres.2016.04.009; Emanuel JE, 2011, AM J GERIAT PSYCHIAT, V19, P160, DOI 10.1097/JGP.0b013e3181e446c8; Finkel SI, 2004, INT J GERIATR PSYCH, V19, P9, DOI 10.1002/gps.998; Franco-Marina F, 2010, INT PSYCHOGERIATRICS, V22; Grun B, 2008, FLEXMIX VERSION 2 FI, V28, P35; Kohler S, 2014, HYPERTENSION, V63, P245, DOI 10.1161/HYPERTENSIONAHA.113.02096; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lai DB, 2016, J APPL STAT, V43, P2503, DOI 10.1080/02664763.2016.1141181; Leoutsakos JMS, 2015, INT J GERIATR PSYCH, V30, P824, DOI 10.1002/gps.4221; Lyketsos CG, 2003, ARCH GEN PSYCHIAT, V60, P737, DOI 10.1001/archpsyc.60.7.737; Muniz-Terrera G, 2016, STAT METHODS MED RES, V25, P741, DOI 10.1177/0962280212465500; Munro CA, 2012, AM J GERIAT PSYCHIAT, V20, P1036, DOI 10.1097/JGP.0b013e31826ce4c5; Nagin D, 1999, CHILD DEV, V70, P1181, DOI 10.1111/1467-8624.00086; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Perera G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008721; Perera G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109484; Perrett D., 2006, MULT LINEAR REGRES V, V32, P1; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Pietrzak RH, 2015, NEUROBIOL AGING, V36, P1231, DOI 10.1016/j.neurobiolaging.2014.12.015; RAMASWAMY V, 1993, MARKET SCI, V12, P103, DOI 10.1287/mksc.12.1.103; Saczynski JS, 2015, AM J MED, V128, P739, DOI 10.1016/j.amjmed.2015.01.007; Samtani MN, 2012, J CLIN PHARMACOL, V52, P629, DOI 10.1177/0091270011405497; Stewart R, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-51; Thalhauser CJ, 2012, J R SOC INTERFACE, V9, P119, DOI 10.1098/rsif.2011.0134; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vega JN, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0490-8; Verlinden VJA, 2015, ALZHEIMERS DEMENTIA; Wattmo C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt210; Weamer EA, 2009, INT PSYCHOGERIATR, V21, P78, DOI 10.1017/S1041610208007734; Wilkosz PA, 2010, INT PSYCHOGERIATR, V22, P281, DOI 10.1017/S1041610209991001; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Yu L, 2013, PSYCHOL AGING, V28, P1015, DOI 10.1037/a0031642; Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014	41	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178562	10.1371/journal.pone.0178562	http://dx.doi.org/10.1371/journal.pone.0178562			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591196	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000402880700038
J	Carmignani, L; Moncel, MH; Fernandes, P; Wilson, L				Carmignani, Leonardo; Moncel, Marie-Helene; Fernandes, Paul; Wilson, Lucy			Technological variability during the Early Middle Palaeolithic in Western Europe. Reduction systems and predetermined products at the Bau de l'Aubesier and Payre (South-East France)	PLOS ONE			English	Article							RAW-MATERIAL SELECTION; PLEISTOCENE HUMAN REMAINS; ORGNAC 3; SITE; BEHAVIOR; ARDECHE; OCCUPATION; EMERGENCE; FLANDIN; ASSEMBLAGES	The study of the lithic assemblages of two French sites, the Bau de l'Aubesier and Payre, contributes new knowledge of the earliest Neanderthal techno-cultural variability. In this paper we present the results of a detailed technological analysis of Early Middle Palaeolithic lithic assemblages of MIS 8 and 7 age from the two sites, which are located on opposite sides of the Rho A ne Valley in the south-east of France. The MIS 9-7 period is considered in Europe to be a time of new behaviours, especially concerning lithic strategies. The shift from the Lower Palaeolithic to the Early Middle Palaeolithic is "classically" defined by an increase in the number of core technologies, including standardized ones, which are stabilized in the full Middle Palaeolithic (MIS 5-3), associated with the decline of the "Acheulean" biface. Applying a common technological approach to the analysis of the two assemblages highlights their technological variability with respect to reduction systems and end products. Differences between Payre and the Bau de l'Aubesier concerning raw material procurement and faunal exploitation only partially explain this multifaceted technological variability, which in our opinion also reflects the existence of distinct technological strategies within the same restricted geographic area, which are related to distinct traditions, site uses, and/or as yet unknown parameters.	[Carmignani, Leonardo] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Carmignani, Leonardo] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Carmignani, Leonardo] Univ Ferrara, Dipartimento Studi Umanistici, Ferrara, Italy; [Carmignani, Leonardo] Maison Archeol & Ethnol, Anthropol Tech Espaces & Terr Pliocene & Pleistoc, UMR ArScAn 7041, Nanterre, France; [Moncel, Marie-Helene] Sorbonne Univ, UPVD, MNHN, UMR7194,HNHP,Dept Prehist,CNRS, Paris, France; [Fernandes, Paul] Paleotime, Villars De Lans, France; [Wilson, Lucy] Univ New Brunswick, Dept Biol Sci, St John, NB, Canada	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of New Brunswick	Carmignani, L (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain.; Carmignani, L (corresponding author), Univ Rovira & Virgili, Area Prehist, Tarragona, Spain.; Carmignani, L (corresponding author), Univ Ferrara, Dipartimento Studi Umanistici, Ferrara, Italy.; Carmignani, L (corresponding author), Maison Archeol & Ethnol, Anthropol Tech Espaces & Terr Pliocene & Pleistoc, UMR ArScAn 7041, Nanterre, France.	leonardo.carmignani76@gmail.com	Carmignani, Leonardo/ABD-3561-2020; Fernandes, Paul/H-2972-2013	Fernandes, Paul/0000-0003-4135-115X; Carmignani, Leonardo/0000-0002-6066-1818; Moncel, Marie-helene/0000-0002-0398-2316	IDQP (International Doctorate in Quaternary and Prehistory); French Ministry of Culture; Service Regional de l'Archeologie; Rhone Alpes and Provence-Alpes-Cote d'Azur; Social Sciences and Humanities Research Council of Canada; "Projet collectif de Recherche" - French Ministry of Culture	IDQP (International Doctorate in Quaternary and Prehistory); French Ministry of Culture; Service Regional de l'Archeologie; Rhone Alpes and Provence-Alpes-Cote d'Azur; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); "Projet collectif de Recherche" - French Ministry of Culture	This work was done with support of the IDQP (International Doctorate in Quaternary and Prehistory). The fieldwork at Payre and at the Bau de l'Aubesier have been financially supported by the French Ministry of Culture, Service Regional de l'Archeologie, Rhone Alpes and Provence-Alpes-Cote d'Azur, and by the Social Sciences and Humanities Research Council of Canada. The analyses of raw materials have been supported by a "Projet collectif de Recherche" financially supported by the French Ministry of Culture.	Adam A., 1991, PALEOLITHIQUE MESOLI, P41; Adam A, 1973, B SOC PREHISTORIQUE, V70, P293; Adler DS, 2014, SCIENCE, V345, P1609, DOI 10.1126/science.1256484; Alvarez-Alonso D, 2014, QUATERN INT, V326, P288, DOI 10.1016/j.quaint.2012.12.023; [Anonymous], 2005, INT S S; [Anonymous], [No title captured]; Auguste P., 2008, MEMOIRE SOC PREHISTO, V46, P51; Aureli D, PALAEOLITHIC ITALY; Aureli D, 2016, QUATERN INT, V393, P169, DOI 10.1016/j.quaint.2015.07.055; Baena J., 2014, QUATERNARY IN PRESS; Binford L.R., 1973, EXPLANATION CULTURE, P227; BINFORD LR, 1966, AM ANTHROPOL, V68, P238; Blackwell BAB, 2001, GEOARCHAEOLOGY, V16, P719, DOI 10.1002/gea.1018; Blaser F, 2012, BULL SOC PREHIST FR, V109, P5, DOI 10.3406/bspf.2012.14141; Boeda E., 1994, MONOGRAPHIE CRA, V9; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E., 1991, TECHNIQUES CULTURE, V17, P37; BORDES F, 1961, SCIENCE, V134, P803, DOI 10.1126/science.134.3482.803; BORDES F, 1970, WORLD ARCHAEOL, V2, P61, DOI 10.1080/00438243.1970.9979464; Bourguignon L., 1997, THESIS U PARIS X NAN; Bourguignon L., 1996, QUATERNARIA NOVA, V6, P149; Brenet, 2011, TERRA NOVA, V1; Brenet M, 2016, QUATERNARY IN PRESS; Browne CL, 2013, J ARCHAEOL SCI, V40, P3955, DOI 10.1016/j.jas.2013.05.012; Browne CL, 2011, J HUM EVOL, V61, P597, DOI 10.1016/j.jhevol.2011.08.004; Carmignani L, 2010, ORIGINI 32, VIV, P7; Chevrier B, 2013, RENC JEUN CHERCH 21, P1; Clark G., 1969, WORLD PREHISTORY NEW, DOI DOI 10.1016/j.jhevol.2018.01.003; CONARD NJ, 1990, J ANTHROPOL RES, V46, P243, DOI 10.1086/jar.46.3.3630426; Conard NJ, 1997, J ANTHROPOL RES, P147; Cresswell R, 1983, REV SEMESTRIELLE ANT, V2, P143; DARLAS A, 1994, ANTHROPOLOGIE, V98, P267; Daujeard C, 2008, BAR INT SERIES, V1867; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; Dauvois M, 1976, PERIGUEUX; Delagnes A, 2006, INTERD CONTRIB ARCH, P85, DOI 10.1007/0-387-24661-4_5; Desclaux E, 2008, MEMOIRE SOC PREHISTO, V46, P91; Dibble H.L., 1995, DEFINITION INTERPRET; Faivre JP, 2012, LITHIC TECHNOL, V37, P5, DOI 10.1179/lit.2012.37.1.5; Fernandes P., 2010, RIV SCI PREISTORICHE, VLVII, P31; Fernandes P, 2008, J ARCHAEOL SCI, V35, P2357, DOI 10.1016/j.jas.2008.02.012; Fernandez JMM, 2004, ANTHROPOLOGIE, V108, P367, DOI 10.1016/j.anthro.2004.10.009; Fernandez P, 2006, J ARCHAEOL SCI, V33, P176, DOI 10.1016/j.jas.2005.07.005; Fernandez P, 2003, J ARCHAEOL SCI, V30, P1577, DOI 10.1016/S0305-4403(03)00054-2; Fernandez P, 1998, 18 RENC INT ARCH HIS, P309; Fernandez P, 2006, DOCUMENTS LAB GEOLOG, V161; Fernandez P, 2001, THESIS U CLAUDEBERNA, P1; Fontana F, 2013, J ANTHROPOL ARCHAEOL, V32, P478, DOI 10.1016/j.jaa.2013.08.003; Fontana F, 2010, QUATERN INT, V223, P465, DOI 10.1016/j.quaint.2010.02.013; Fontana F, 2009, HUMAN EVOLUTION, V24, P43; Forestier H., 1993, PALEO, V5, P53, DOI [DOI 10.3406/PAL.1993.1104, 10.3406/pal.1993.1104]; Frouin M, 2014, J ARCHAEOL SCI, V52, P524, DOI 10.1016/j.jas.2014.09.012; Gagnepain J, 2004, BAR INT SERIES, V1239, P57; Gagnepain J, 2003, GROTTE BAUME BONNE Q, P73; Gamble C, 1999, MIDDLE PALAEOLITHIC, P3; Garcia-Medrano P, 2015, QUATERN INT, V368, P92, DOI 10.1016/j.quaint.2015.03.006; Chacon MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155316; Geneste J, 1991, TECNOLOGIA CADENAS O, VI, P1; Geneste J.M., 1991, TECHNIQUES CULTURE, V17-18, P1, DOI DOI 10.4000/TC.5013; Gouedo J. M., 1994, 18 CNRS, V18, P77; Grun R, 2008, GEOCHIM COSMOCHIM AC, V72, P5278, DOI 10.1016/j.gca.2008.08.007; HAESAERTS P., 1983, GALLIA PREHISTOIRE, V26, P189; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hong MY, 1993, ETUDE TECHNOLOGIQUE; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Inizan M.-L., 1995, TECHNOLOGIE PIERRE T; Iovita R, 2011, J HUM EVOL, V61, P61, DOI 10.1016/j.jhevol.2011.02.007; Jaubert J., 2005, PREMIERS PEUPLEMENTS, V1364, P227; Koehler H, 2011, THESIS; Koehler H, 2008, BULL SOC PREHIST FR, V105, P709, DOI 10.3406/bspf.2008.13781; Lamotte A., 1995, B SOC PREHISTORIQUE, V92, P193; Lamotte A., 2001, ACHEULEEN VALLEE SOM, P149; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Lebel S, 2001, P NATL ACAD SCI USA, V98, P11097, DOI 10.1073/pnas.181353998; LEBEL S, 2000, BILAN SCI 1999, P179; Lebel S., 2000, BAU AUBESIER MONIEUX; Locht J.-L., 2010, GALLIA PREHISTOIRE, V52, P1; Locht J-L, 2008, GISEMENT PALEOLITHIQ; Mathias C, 2016, QUATERN INT, V411, P193, DOI 10.1016/j.quaint.2016.01.033; Moncel M.-H., 2008, MEMOIRE SOC PREHISTO, VXLVI, P336; Moncel M.-H., 2008, MEM SOC PREHIST FR, V46, P309; Moncel M.-H, 1995, PALEO, V7, P157; Moncel MH, 2008, CR PALEVOL, V7, P315, DOI 10.1016/j.crpv.2008.03.005; Moncel MH, 2016, QUATERN INT, V409, P1, DOI 10.1016/j.quaint.2016.06.006; Moncel MH, 2015, QUATERN INT, V378, P22, DOI 10.1016/j.quaint.2013.12.009; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Moncel MH, 2010, QUATERNAIRE, V21, P385; Moncel MH, 2011, CURR ANTHROPOL, V52, P37, DOI 10.1086/658179; Moncel MH, 2012, QUATERN INT, V247, P103, DOI 10.1016/j.quaint.2010.10.030; Moncel MH, 2009, J ARCHAEOL SCI, V36, P1892, DOI 10.1016/j.jas.2009.04.018; Moncel MH, 2005, ANTHROPOLOGIE, V109, P451, DOI 10.1016/j.anthro.2005.06.002; Moncel MH, 2005, J ARCHAEOL SCI, V32, P1283, DOI 10.1016/j.jas.2005.03.014; Moncel MH, 2014, TRANSITIONS RUPTURES, V2, P43; Moncel MH, 2002, B SOC PREHISTORIQUE, V99, P249, DOI DOI 10.3406/bspf.2002.12656; Monnier GF, 2006, CURR ANTHROPOL, V47, P709, DOI 10.1086/506280; Monnier GF, 2014, QUATERN INT, V350, P59, DOI 10.1016/j.quaint.2014.06.053; MOULIN F, 1903, B ACAD VAR, V1, P1; Moulin MF, 1904, BULL SOC PREHIST FR, V1, P14, DOI 10.3406/bspf.1904.11230; Olle A, 2013, QUATERN INT, V295, P138, DOI 10.1016/j.quaint.2011.11.009; Pastoors A., 2010, Q R, V57, P25; Patou-Mathis M, 2008, MEMOIRE SOC PREHISTO, VXLVI, P41; Pedergnana A, 2016, ARCHAEOLOGICAL ANTHR; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J, 1988, ACT C INT EXP ARCH B, V2, P118; Pelegrin J, 2005, STONE KNAPPING NECES, P23; Pelegrin J., 1995, TECHNOLOGIE LITHIQUE, V20; Pelegrin J, 1988, NOTES MONOGRAPHIES T, P25; Peresani M., PALEO, V10, P123, DOI [10.3406/pal.1998.1133, DOI 10.3406/PAL.1998.1133]; Peresani M, 2013, CR PALEVOL, V12, P211, DOI 10.1016/j.crpv.2013.02.005; Peresani M, 2012, QUATERN INT, V247, P125, DOI 10.1016/j.quaint.2011.02.006; Peretto C, 2016, QUATERN INT, V411, P301, DOI 10.1016/j.quaint.2015.11.056; Perles C., 1991, 11 RENCONTRES INTERN, P35; Picin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076182; Premo LS, 2009, P NATL ACAD SCI USA, V106, P33, DOI 10.1073/pnas.0809194105; Revillion S, 1995, B SOC PREHISTORIQUE, V92, P425, DOI [10.3406/bspf.1995.10058, DOI 10.3406/BSPF.1995.10058]; REVILLON S., 1994, DOSSIERS DOCUMENTATI, P19; Richter D, 2015, J HUM EVOL, V89, P46, DOI 10.1016/j.jhevol.2015.06.003; Richter J, 2016, QUATERNARY IN PRESS; Richter J, 2011, VERTEBR PALEOBIOL PA, P7, DOI 10.1007/978-94-007-0415-2_2; Rivals F, 2009, J ARCHAEOL SCI, V36, P1070, DOI 10.1016/j.jas.2008.12.009; Rocca R, 2013, THESIS; Roebroeks W., 1999, MIDDLE PALAEOLITHIC, P121; Ruebens K, 2013, J HUM EVOL, V65, P341, DOI 10.1016/j.jhevol.2013.06.009; Santonja M, 2016, QUATERN INT, V411, P367, DOI 10.1016/j.quaint.2015.04.056; Slimak L., 2003, DISCOID LITHIC TECHN, P33; Slimak L., 2005, 14 C UISPP LIEG 2 8, P75; Slimak L, 1999, PALEO, V11, P89; Soressi M, 2002, THESIS, P1; Soressi M, 2004, SETTLEMENT DYN MIDDL, P343; Soriano S, 2000, THESIS, P10; Terradillos-Bernal M, 2014, CR PALEVOL, V13, P527, DOI 10.1016/j.crpv.2014.02.002; Terradillos-Bernal M, 2012, ANTHROPOLOGIE, V116, P348, DOI 10.1016/j.anthro.2012.06.001; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Trinkaus Erik, 2000, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V12, P207; Tuffreau A., 1987, THESIS; Tuffreau A, 1995, DEFINITION INTERPRET, P413; Tuffreau A, 2008, ANTHROPOLOGIE, V112, P104, DOI 10.1016/j.anthro.2008.01.003; Turq A., 1992, THESIS, P1; Valladas H, 2008, QUAT GEOCHRONOL, V3, P377, DOI 10.1016/j.quageo.2008.01.001; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; Wilson L., 2007, RECONSTRUCTING HUMAN, P234; Wilson L, 2007, J ARCHAEOL METHOD TH, V14, P388, DOI 10.1007/s10816-007-9042-4; Wilson L, 2007, J FIELD ARCHAEOL, V32, P315, DOI 10.1179/009346907791071539; Wilson L, 2014, J HUM EVOL, V75, P28, DOI 10.1016/j.jhevol.2013.12.018; Wilson L, 2011, GEOL SOC SPEC PUBL, V352, P163, DOI 10.1144/SP352.12; Wisniewski A, 2014, QUATERN INT, V326, P364, DOI 10.1016/j.quaint.2013.10.027	147	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178550	10.1371/journal.pone.0178550	http://dx.doi.org/10.1371/journal.pone.0178550			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591159	gold, Green Submitted, Green Published			2022-12-26	WOS:000402880700037
J	Monilor-Hurtado, A; Pennino, MG; Sanchez-Lizaso, JL				Monilor-Hurtado, Alberto; Grazia Pennino, Maria; Luis Sanchez-Lizaso, Jose			Shift in tuna catches due to ocean warming	PLOS ONE			English	Article							CLIMATE-CHANGE; PROPORTIONS; FISHES; SEA	Ocean warming is already affecting global fisheries with an increasing dominance of catches of warmer water species at higher latitudes and lower catches of tropical and subtropical species in the tropics. Tuna distributions are highly conditioned by sea temperature, for this reason and their worldwide distribution, their populations may be a good indicator of the effect of climate change on global fisheries. This study shows the shift of tuna catches in subtropical latitudes on a global scale. From 1965 to 2011, the percentage of tropical tuna in longliner catches exhibited a significantly increasing trend in a study area that included subtropical regions of the Atlantic and western Pacific Oceans and partially the Indian Ocean. This may indicate a movement of tropical tuna populations toward the poles in response to ocean warming. Such an increase in the proportion of tropical tuna in the catches does not seem to be due to a shift of the target species, since the trends in Atlantic and Indian Oceans of tropical tuna catches are decreasing. Our results indicate that as populations shift towards higher latitudes the catches of these tropical species did not increase. Thus, at least in the Atlantic and Indian Oceans, tropical tuna catches have reduced in tropical areas.	[Monilor-Hurtado, Alberto; Luis Sanchez-Lizaso, Jose] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Grazia Pennino, Maria] Fed Univ Rio Grande do Norte UFRN, Fishing Ecol Management & Econ, Campus Univ S-N, Natal, RN, Brazil; [Grazia Pennino, Maria] Ctr Oceanog Murcia, Inst Espanol Oceanog, C Varadero 1, Murcia, Spain; [Grazia Pennino, Maria] Univ Valencia, Dept Estadist & Invest Operat, Stat Modeling Ecol Grp, C Dr Moliner 50, Valencia, Spain	Universitat d'Alacant; Universidade Federal do Rio Grande do Norte; Spanish Institute of Oceanography; University of Valencia	Sanchez-Lizaso, JL (corresponding author), Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain.	Jl.sanchez@ua.es	Grazia, Maria/E-3454-2015; Lizaso, José Luis L Sánchez/J-4939-2017	Grazia, Maria/0000-0002-7577-2617; Lizaso, José Luis L Sánchez/0000-0002-3927-5699				Anker- Nilssen T., 2008, EFFECT CLIMATE CHANG; [Anonymous], 2021, LANG ENV STAT COMP; Arvedlund M, 2009, J MAR BIOL ASSOC UK, V89, P863, DOI 10.1017/S002531540900037X; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brill Richard W., 1994, Fisheries Oceanography, V3, P204, DOI 10.1111/j.1365-2419.1994.tb00098.x; Cheung W. W., 2011, ICES J MAR SCI; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; FAO, 2014, FISH STAT COLL GLOB; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Gamito R, 2015, FISH RES, V161, P207, DOI 10.1016/j.fishres.2014.07.014; Goujon M, 2000, BIOL CHARACTERISTICS; GRAHAM JB, 1983, CAN J ZOOL, V61, P2087, DOI 10.1139/z83-274; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Held L., 2010, STATISCIAL MODELLING, P111; Paradinas I., 2016, ICEJ MARINE SCI J; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sokal RR, 1995, BIOMETRY; Stevens ED, 1979, FISH PHYSIOL, P315; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Tavera J.J., 2008, MARINE BIODIVERSITY, V1, pe4, DOI DOI 10.1017/S175526720500028X; Venerus LA, 2007, J APPL ICHTHYOL, V23, P110, DOI 10.1111/j.1439-0426.2006.00800.x; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Zar JH, 1999, BIOSTATISTICAL ANAL	26	17	21	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178196	10.1371/journal.pone.0178196	http://dx.doi.org/10.1371/journal.pone.0178196			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591205	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700023
J	Bittaye, M; Cash, P; Forbes, K				Bittaye, Mustapha; Cash, Phil; Forbes, Ken			Proteomic variation and diversity in clinical Streptococcus pneumoniae isolates from invasive and non-invasive sites	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE BIOSYNTHESIS; TYROSINE PHOSPHORYLATION; MOLECULAR EPIDEMIOLOGY; PROTEIN EXPRESSION; PHASE VARIATION; VIRULENCE; PATHOGENESIS; STRAINS; DISEASE; CPSD	Streptococcus pneumoniae is responsible for a variety of invasive and non-invasive human infections. There are over 90 serotypes of S. pneumoniae differing in their ability to adapt to the different niches within the host. Two-dimensional gel electrophoresis was used to discriminate clinical S. pneumoniae isolates recovered from either blood cultures (invasive site isolates) or other sites, including sputum, tracheal aspirate, ear, eye and skin swabs (noninvasive site isolates). Global protein expression profiles for five invasive site and six noninvasive site isolates representing five different serotypes (serotypes 4, 6, 9, 14 and 23) were obtained for each isolate and combined into a single data set using Progenesis Same Spots TM software. One-hundred and eighty six protein spots (39% of the protein spots in the dataset) differed significantly (ANOVA, p<0.05) in abundance between the invasive site (101 upregulated protein spots) and non-invasive site (85 upregulated protein spots) isolates. Correlations between the bacterial proteomes and their sites of isolation were determined by Principal Component Analysis (PCA) using the significantly different protein spots. Out of the 186 variable protein spots, 105 exhibited a serotype-associated pattern of variability. The expression of the remaining 81 protein spots was concluded to be uniquely linked to the site of bacterial isolation. Mass spectrometry was used to identify selected protein spots that showed either constant or differential abundance levels. The identified proteins had a diverse range of functions including, capsule biogenesis, DNA repair, protein deglycation, translation, stress response and virulence as well as amino acid, carbohydrate, lipid and nucleotide metabolism. These findings provide insight on the proteins that contribute towards the adaptation of the bacteria to different sites within the host.	[Bittaye, Mustapha; Cash, Phil; Forbes, Ken] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland	University of Aberdeen	Bittaye, M (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland.	r02mb14@abdn.ac.uk		Cash, Phillip/0000-0002-8647-8595; Bittaye, Mustapha/0000-0001-6248-570X	Medical Research Council Unit, The Gambia	Medical Research Council Unit, The Gambia(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Mustapha Bittaye is a PhD student funded by the Medical Research Council Unit, The Gambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M, 2014, APPL ENVIRON MICROB, V80, P5349, DOI 10.1128/AEM.01370-14; Amezaga MR, 2002, J CLIN MICROBIOL, V40, P3313, DOI 10.1128/JCM.40.9.3313-3318.2002; ANDERSSON B, 1981, INFECT IMMUN, V32, P311, DOI 10.1128/IAI.32.1.311-317.1981; Bae SM, 2006, J BIOCHEM MOL BIOL, V39, P703; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bittaye M, 2015, EXPERT REV PROTEOMIC, V12, P607, DOI 10.1586/14789450.2015.1108844; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Cash Philip, 2009, V519, P131, DOI 10.1007/978-1-59745-281-6_9; Chaussee MA, 2008, ARCH MICROBIOL, V189, P27, DOI 10.1007/s00203-007-0290-1; Coffey TJ, 1999, MICROBIOL-SGM, V145, P2023, DOI 10.1099/13500872-145-8-2023; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Fowsantear W, 2014, J PROTEOMICS, V97, P245, DOI 10.1016/j.jprot.2013.07.016; Gennaris A, 2013, EMBO MOL MED, V5, P1798, DOI 10.1002/emmm.201303482; Guo Z, 2015, METALLOMICS, V7, P448, DOI 10.1039/c4mt00276h; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kim SW, 1998, FEMS MICROBIOL LETT, V161, P217, DOI 10.1111/j.1574-6968.1998.tb12951.x; Kolberg J, 2000, FEMS IMMUNOL MED MIC, V29, P289, DOI 10.1016/S0928-8244(00)00219-4; Lee KJ, 2006, PROTEOMICS, V6, P1274, DOI 10.1002/pmic.200500415; Lee MR, 2006, J MICROBIOL, V44, P375; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; McAllister LJ, 2011, INFECT IMMUN, V79, P4839, DOI 10.1128/IAI.05663-11; McEllistrem MC, 2004, J CLIN MICROBIOL, V42, P250, DOI 10.1128/JCM.42.1.250-256.2004; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2000, MOL MICROBIOL, V35, P1431, DOI 10.1046/j.1365-2958.2000.01808.x; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P15143, DOI 10.1073/pnas.191498798; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Ogunniyi AD, 2002, MICROBIOL-SGM, V148, P2045, DOI 10.1099/00221287-148-7-2045; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Park SA, 2006, PROTEOMICS, V6, P1319, DOI 10.1002/pmic.200500293; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Royal College of Physicians of Ireland. Immunisation Advisory Committee, 2008, IMM GUID IR; Sanchez CJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-245; Serrano I, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-67; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; SMART LE, 1986, J CLIN PATHOL, V39, P328, DOI 10.1136/jcp.39.3.328; Smith A, 2011, PROTEOMICS, V11, P2283, DOI 10.1002/pmic.201000626; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vila-Corcoles A, 2013, DRUG AGING, V30, P263, DOI 10.1007/s40266-013-0060-5; Weiser JN, 1998, MICROB DRUG RESIST, V4, P129, DOI 10.1089/mdr.1998.4.129; Yamamoto T, 1996, Nihon Saikingaku Zasshi, V51, P1025; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	54	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0179075	10.1371/journal.pone.0179075	http://dx.doi.org/10.1371/journal.pone.0179075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575057	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300147
J	Oortveld, MAW; van Vlijmen-Willems, IMJJ; Kersten, FFJ; Cheng, T; Verdoes, M; van Erp, PEJ; Verbeek, S; Reinheckel, T; Hendriks, WJAJ; Schalkwijk, J; Zeeuwen, PLJM				Oortveld, Merel A. W.; van Vlijmen-Willems, Ivonne M. J. J.; Kersten, Ferry F. J.; Cheng, Tsing; Verdoes, Martijn; van Erp, Piet E. J.; Verbeek, Sjef; Reinheckel, Thomas; Hendriks, Wiljan J. A. J.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.			Cathepsin B as a potential cystatin M/E target in the mouse hair follicle	FASEB JOURNAL			English	Article						proteases; cysteine protease inhibitor; epidermis; alopecia; activity-based probes	CYSTEINE PROTEINASE-INHIBITOR; EPIDERMAL CORNIFICATION; CORNEAL EPITHELIUM; DEFICIENT MICE; CROSS-LINKING; PROTEASES; CELLS; DIFFERENTIATION; MUTATION; COLOCALIZATION	Deficiency of the cysteine protease inhibitor cystatin M/E (Cst6) in mice leads to disturbed epidermal cornification, impaired barrier function, and neonatal lethality. We report the rescue of the lethal skin phenotype of ichq (Cst6-deficient; Cst6(-/-)) mice by transgenic, epidermis-specific, reexpression of Cst6 under control of the human involucrin (INV) promoter. Rescued Tg(INV-Cst6)Cst6(ichq/ichq) mice survive the neonatal phase, but display severe eye pathology and alopecia after 4 mo. We observed keratitis and squamous metaplasia of the corneal epithelium, comparable to Cst6(-/-)Ctsl(+/-) mice, as we have reported in other studies. We found the INV promoter to be active in the hair follicle infundibulum; however, we did not observe Cst6 protein expression in the lower regions of the hair follicle in Tg(INV-Cst6)Cst6(ichq/ichq) mice. This result suggests that unrestricted activity of proteases is involved in disturbance of hair follicle biology, eventually leading to baldness. Using quenched activity-based probes, we identified mouse cathepsin B (CtsB), which is expressed in the lower regions of the hair follicle, as an additional target of mouse Cst6. These data suggest that Cst6 is necessary to control CtsB activity in hair follicle morphogenesis and highlight Cst6-controlled proteolytic pathways as targets for preventing hair loss.-Oortveld, M. A. W., van Vlijmen-Willems, I. M. J. J., Kersten, F. F. J., Cheng, T., Verdoes, M., van Erp, P. E. J., Verbeek, S., Reinheckel, T., Hendriks, W. J. A. J., Schalkwijk, J., Zeeuwen, P. L. J. M. Cathepsin B as a potential cystatin M/E target in the mouse hair follicle.	[Oortveld, Merel A. W.; van Vlijmen-Willems, Ivonne M. J. J.; Kersten, Ferry F. J.; Cheng, Tsing; van Erp, Piet E. J.; Schalkwijk, Joost; Zeeuwen, Patrick L. J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Verdoes, Martijn] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Hendriks, Wiljan J. A. J.] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [Verbeek, Sjef] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Reinheckel, Thomas] Albert Ludwigs Univ, Inst Mol Med & Cell Res, Freiburg, Germany; [Reinheckel, Thomas] Albert Ludwigs Univ, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Freiburg; University of Freiburg	Schalkwijk, J; Zeeuwen, PLJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.schalkwijk@radboudumc.nl; patrick.zeeuwen@radboudumc.nl	van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; van Erp, Piet/B-4061-2008; Hendriks, Wiljan J.A.J./A-5214-2013; Kersten, Ferry F.J./ABC-7666-2020; Zeeuwen, Patrick/N-1779-2013; Verdoes, Martijn/A-4911-2015; Schalkwijk, Joost/N-1774-2013; Reinheckel, Thomas/AAL-9761-2021; Verdoes, Martijn/AAD-5239-2022; Schalkwijk, Joost/R-7509-2019	van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; van Erp, Piet/0000-0002-6955-8817; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Zeeuwen, Patrick/0000-0002-6878-2438; Verdoes, Martijn/0000-0001-8753-3528; Reinheckel, Thomas/0000-0001-9866-9105; Verdoes, Martijn/0000-0001-8753-3528; Schalkwijk, Joost/0000-0002-1308-1319; Cheng, Tsing/0000-0001-5191-3289	Earth and Life Sciences (ALW) from the Netherlands Organization for Health Research and Development (ZonMW) [821.02.013]; Deutsche Forschungsgemeinschaft [SFB 850]	Earth and Life Sciences (ALW) from the Netherlands Organization for Health Research and Development (ZonMW); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Daphne Reijnen (Central Animal Laboratory, Radboud University Nijmegen Medical Center) for assistance with the animal experiments. This work was supported by Earth and Life Sciences (ALW) Grant 821.02.013 (to J.S. and P.L.J.M.Z.) from the Netherlands Organization for Health Research and Development (ZonMW), and Deutsche Forschungsgemeinschaft SFB 850 Project B7 (to T.R.). The authors declare no conflicts of interest.	de Andrade FA, 2014, IMMUNOL RES, V60, P356, DOI 10.1007/s12026-014-8602-4; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Behringer R., 2014, MANIPULATING MOUSE E, P298; Berardi S, 2001, ARTHRITIS RHEUM, V44, P1819, DOI 10.1002/1529-0131(200108)44:8<1819::AID-ART319>3.0.CO;2-4; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Cheng T, 2009, J INVEST DERMATOL, V129, P1232, DOI 10.1038/jid.2008.353; De Paiva CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1625, DOI 10.1001/archophthalmol.2009.316; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Edgington-Mitchell LE, 2017, METHODS MOL BIOL, V1491, P145, DOI 10.1007/978-1-4939-6439-0_11; FIDLER IJ, 1975, CANCER RES, V35, P218; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Kos J, 2014, FUTURE MED CHEM, V6, P1355, DOI [10.4155/FMC.14.73, 10.4155/fmc.14.73]; Morioka K, 2001, ACTA HISTOCHEM CYTOC, V34, P337, DOI 10.1267/ahc.34.337; Ni J, 1997, J BIOL CHEM, V272, P10853; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Okada Y, 2008, JPN J OPHTHALMOL, V52, P1, DOI 10.1007/s10384-007-0499-1; Pavlova A, 2000, FEBS LETT, V487, P156, DOI 10.1016/S0014-5793(00)02337-1; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; RALPH P, 1977, J IMMUNOL, V119, P950; Reinheckel T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00133; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Sundberg JP, 1997, AM J PATHOL, V151, P293; Tholen S, 2013, MOL CELL PROTEOMICS, V12, P611, DOI 10.1074/mcp.M112.017962; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Tong XM, 2003, TRENDS MOL MED, V9, P79, DOI 10.1016/S1471-4914(02)00025-4; Turk B, 2002, BIOL CHEM, V383, P1035, DOI 10.1515/BC.2002.112; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; vanRuissen F, 1996, J CELL PHYSIOL, V168, P442; Verdoes M, 2013, J AM CHEM SOC, V135, P14726, DOI 10.1021/ja4056068; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480; Zeeuwen PLJM, 2010, FASEB J, V24, P3744, DOI 10.1096/fj.10-155879; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeeuwen PLJM, 2004, HUM MOL GENET, V13, P1069, DOI 10.1093/hmg/ddh115; Zeeuwen PLJM, 2002, HUM MOL GENET, V11, P2867, DOI 10.1093/hmg/11.23.2867; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	41	5	7	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4286	4294		10.1096/fj.201700267R	http://dx.doi.org/10.1096/fj.201700267R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596234	Green Published, hybrid			2022-12-26	WOS:000413397400009
J	Gao, SM; Wang, ZQ; Wang, WC; Hu, XL; Chen, PL; Li, JW; Feng, XH; Wong, JM; Du, JX				Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Feng, Xinhua; Wong, Jiemin; Du, James X.			The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein methylation; receptor; signal transduction; SMAD transcription factor; transcription regulation	HISTONE METHYLATION; CANCER; PHOSPHORYLATION; DIFFERENTIATION; MECHANISMS; EXPRESSION; INSIGHTS; PATHWAY; ROLES; CELLS	Lysine methylation of chromosomal and nuclear proteins is a well-known mechanism of epigenetic regulation, but relatively little is known about the role of this protein modification in signal transduction. Using an RNAi-based functional screening of the SMYD family of lysine methyltransferases (KMTs), we identified SMYD2 as a KMT essential for robust bone morphogenic protein (BMP)- but not TGF-induced target gene expression in HaCaT keratinocyte cells. A role for SMYD2 in BMP-induced gene expression was confirmed by shRNA knockdown and CRISPR/Cas9-mediated knock-out of SMYD2. We further demonstrate that SMYD2 knockdown or knock-out impairs BMP-induced phosphorylation of the signal-transducing protein SMAD1/5 and SMAD1/5 nuclear localization and interaction with SMAD4. The SMYD2 KMT activity was required to facilitate BMP-mediated signal transduction, as treatment with the SMYD2 inhibitor AZ505 suppressed BMP2-induced SMAD1/5 phosphorylation. Furthermore, we present evidence that SMYD2 likely modulates the BMP response through its function in the cytosol. We show that, although SMYD2 interacted with multiple components in the BMP pathway, it specifically methylated the kinase domain of BMP type II receptor BMPR2. Taken together, our findings suggest that SMYD2 may promote BMP signaling by directly methylating BMPR2, which, in turn, stimulates BMPR2 kinase activity and activation of the BMP pathway.	[Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Gao, Shuman; Wang, Zhiqiang; Wang, Wencai; Hu, Xueli; Chen, Peilin; Li, Jiwen; Wong, Jiemin; Du, James X.] East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Wong, Jiemin] East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China; [Wong, Jiemin] Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Feng, Xinhua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Feng, Xinhua] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	East China Normal University; East China Normal University; East China Normal University; Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Wong, JM; Du, JX (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China.; Wong, JM; Du, JX (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.; Wong, JM (corresponding author), East China Normal Univ, Joint Res Ctr Translat Med, Shanghai 201499, Peoples R China.; Wong, JM (corresponding author), Shanghai Fengxian Dist Cent Hosp, Shanghai 201499, Peoples R China.	jmweng@bio.ecnu.edu.cn; jxdu@bio.ecnu.edu.cn		Wong, Jiemin/0000-0002-5311-842X	Ministry of Science and Technology of China [2015CB910402]; National Natural Science Foundation of China [91419303]; Science and Technology Commission of Shanghai Municipality [14XD1401700, 11DZ2260300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Ministry of Science and Technology of China Grant 2015CB910402 (to J.W.), National Natural Science Foundation of China Grant 91419303, and Science and Technology Commission of Shanghai Municipality Grants 14XD1401700 and 11DZ2260300. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed H, 2016, J PROTEOME RES, V15, P2052, DOI 10.1021/acs.jproteome.6b00220; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Donlin LT, 2012, GENE DEV, V26, P114, DOI 10.1101/gad.177758.111; ELBENDARY A, 1994, CELL GROWTH DIFFER, V5, P1301; Elkouris M, 2016, CELL REP, V15, P2733, DOI 10.1016/j.celrep.2016.05.051; Falnes PO, 2016, BIOCHEM J, V473, P1995, DOI 10.1042/BCJ20160117; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hamamoto R, 2015, NAT REV CANCER, V15, P110, DOI 10.1038/nrc3884; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu XH, 2013, ISRN MATH PHYS, V2013, P1, DOI DOI 10.1016/J.MICR0REL.2012.06.140; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nakakido M, 2015, NEOPLASIA, V17, P367, DOI 10.1016/j.neo.2015.03.002; Nimura K, 2010, J MOL MED, V88, P1213, DOI 10.1007/s00109-010-0668-4; OGATA T, 1993, P NATL ACAD SCI USA, V90, P9219, DOI 10.1073/pnas.90.19.9219; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pradhan S, 2009, EPIGENETICS, V4, P383, DOI DOI 10.4161/EPI.4.6.9450; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Xu GL, 2015, J BIOL CHEM, V290, P5414, DOI 10.1074/jbc.M114.610345; Xu J, 2013, MOL CELL, V51, P5, DOI 10.1016/j.molcel.2013.05.004; Xu ST, 2011, J MOL CELL BIOL, V3, P293, DOI 10.1093/jmcb/mjr015; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4	37	19	19	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12702	12712		10.1074/jbc.M117.776278	http://dx.doi.org/10.1074/jbc.M117.776278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588028	Green Published, hybrid			2022-12-26	WOS:000406636900033
J	Chang, HT; Ai, D; Zhang, J; Dong, SL; Liu, Y; Wang, GR				Chang, Hetan; Ai, Dong; Zhang, Jin; Dong, Shuanglin; Liu, Yang; Wang, Guirong			Candidate odorant binding proteins and chemosensory proteins in the larval chemosensory tissues of two closely related noctuidae moths, Helicoverpa armigera and H-assulta	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS LEPIDOPTERA; OLFACTORY RECEPTORS; ANTENNAL LOBE; MANDUCA-SEXTA; BOMBYX-MORI; PAPILIO-MACHAON; OVIPOSITION PREFERENCES; CHEMICAL COMMUNICATION; OSTRINIA-NUBILALIS; SOLUBLE-PROTEINS	In order to acquire enough nutrients and energy for further development, larvae need to invest a large portion of their sensory equipments to identify food sources. Yet, the molecular basis of odor-driven behavior in larvae has been poorly investigated. Information on olfactory genes, particularly odorant binding proteins (OBPs) and chemosensory proteins (CSPs) which are involved in the initial steps of olfaction is very scarce. In this study, we have identified 26 OBP and 21 CSP genes from the transcriptomes of Helicoverpa armigera larval antennae and mouthparts. A comparison with the 34 OBP and 18 CSP genes of the adult antenna, revealed four novel OBPs and seven novel CSPs. Similarly, 27 OBPs (six novel OBPs) and 20 CSPs (6 novel CSPs) were identified in the transcriptomes of Helicoverpa assulta larval antennae and mouthparts. Tissue-specific profiles of these soluble proteins in H. armigera showed that 6 OBP and 4 CSP genes are larval tissue-specific, 15 OBPs and 13 CSPs are expressed in both larvae and adult, while the rest are adult-specific. Our data provide useful information for functional studies of genes involved in larval foraging.	[Chang, Hetan; Zhang, Jin; Dong, Shuanglin] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Chang, Hetan; Ai, Dong; Zhang, Jin; Liu, Yang; Wang, Guirong] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Dong, SL (corresponding author), Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.; Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	sldong@njau.edu.cn; yangliu@ippcaas.cn		Liu, Yang/0000-0002-3424-7111; Zhang, Jin/0000-0002-0077-0748	National Natural Science Foundation of China [31372264, 31230062, 31321004, 31471833]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31372264 to SD, 31230062 to GW, 31321004 to GW&YL, and 31471833 to YL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Junfeng Dong (Henan University of Science and Technology) for providing the H. assulta and Miss Liyan Yang for insect rearing. This work was supported by National Natural Science Foundation of China (31372264 to SD, 31230062 to GW, 31321004 to GW&YL, and 31471833 to YL).	Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Carlsson MA, 2002, CHEM SENSES, V27, P231, DOI 10.1093/chemse/27.3.231; Chang HT, 2016, SCI REP-UK, V6, DOI 10.1038/srep18742; Chang HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13093; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; DETHIER VG, 1969, ENTOMOL EXP APPL, V12, P535, DOI 10.1007/BF00297084; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HANSSON BS, 1995, EXPERIENTIA, V51, P1003, DOI 10.1007/BF01946910; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hovanitz W, 1962, J RES LEPIDOPTERA, V1; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Jackson RE, 2005, J COTTON SCI, V9, P199; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Kanost MR, 2016, INSECT BIOCHEM MOLEC, V76, P118, DOI 10.1016/j.ibmb.2016.07.005; Kester KM, 2002, CHEMOECOLOGY, V12, P1, DOI 10.1007/s00049-002-8320-6; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; Knolhoff LM, 2014, ANNU REV ENTOMOL, V59, P263, DOI 10.1146/annurev-ento-011613-161945; Koenig C, 2015, INSECT BIOCHEM MOLEC, V63, P72, DOI 10.1016/j.ibmb.2015.06.001; Laue M, 2000, ARTHROPOD STRUCT DEV, V29, P57, DOI 10.1016/S1467-8039(00)00013-X; Leal WS, 2003, ANNU REV ENTOMOL, V58, P373; Liu NY, 2015, INT J BIOL SCI, V11, P1036, DOI 10.7150/ijbs.12020; Liu NY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-597; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Ma DKK, 2015, CELL, V161, P1152, DOI 10.1016/j.cell.2015.04.026; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Marinotti O, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-15; Marion-Poll F, 2002, J INSECT PHYSIOL, V48, P467, DOI 10.1016/S0022-1910(02)00068-9; PATS P, 1992, ENVIRON ENTOMOL, V21, P1110, DOI 10.1093/ee/21.5.1110; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Poivet E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2050; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schoonhoven L, 1964, ARCH NEERL ZOOI, V16, P497; Singh AK, 2002, J APPL ENTOMOL, V126, P14, DOI 10.1046/j.1439-0418.2002.00600.x; Skiri HT, 2005, J COMP NEUROL, V491, P367, DOI 10.1002/cne.20692; Sun MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062098; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vogt RG, 2015, INSECT BIOCHEM MOLEC, V62, P142, DOI 10.1016/j.ibmb.2015.03.003; Wang HL, 2008, J INSECT PHYSIOL, V54, P813, DOI 10.1016/j.jinsphys.2008.02.011; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WIKLUND C, 1974, ENTOMOL EXP APPL, V17, P189, DOI 10.1007/BF00335875; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421; WIKLUND C, 1973, ENTOMOL EXP APPL, V16, P232, DOI 10.1111/j.1570-7458.1973.tb00269.x; Xu W, 2015, INSECT MOL BIOL, V24, P253, DOI 10.1111/imb.12153; Yin XW, 2013, CELL MOL LIFE SCI, V70, P3029, DOI 10.1007/s00018-013-1308-2; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhao XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35204; Zhao XC, 2013, CELL TISSUE RES, V353, P399, DOI 10.1007/s00441-013-1657-z; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114; Zhu J, 2016, INSECT BIOCHEM MOLEC, V72, P10, DOI 10.1016/j.ibmb.2016.03.005	70	13	16	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179243	10.1371/journal.pone.0179243	http://dx.doi.org/10.1371/journal.pone.0179243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594956	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200109
J	Martelli, F; Lambert, M; Butt, P; Cheney, T; Tatone, FA; Callaby, R; Rabie, A; Gosling, RJ; Fordon, S; Crocker, G; Davies, RH; Smith, RP				Martelli, Francesca; Lambert, Mark; Butt, Paul; Cheney, Tanya; Tatone, Fabrizio Antonio; Callaby, Rebecca; Rabie, Andre; Gosling, Rebecca J.; Fordon, Steve; Crocker, Graham; Davies, Robert H.; Smith, Richard Piers			Evaluation of an enhanced cleaning and disinfection protocol in Salmonella contaminated pig holdings in the United Kingdom	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; RATS RATTUS-RATTUS; RISK-FACTORS; SUBSP ENTERICA; PERSISTENCE; EFFICACY; TRANSMISSION; ENTERITIDIS; FARMS; SENSITIVITY	Salmonella is the second most commonly reported zoonotic gastrointestinal pathogen in the European Union, and a significant proportion of the cases are linked to the consumption of contaminated pork. Reduction of Salmonella at the farm level helps to mininimise the contamination pressure at the slaughterhouse, and therefore the number of Salmonella bacteria entering the food chain. Cleaning and disinfection (C&D) between batches of pigs is an intervention measure that has potential to reduce the transmission of Salmonella contamination within farms. In this study, two pig finisher buildings in each of 10 Salmonella positive farms were sampled pre-C&D, post-C&D, post-restocking with the following batch of pigs, and shortly before these pigs were sent to slaughter. The incoming batch of pigs was also sampled before it reached the study building (pre-restocking). At each visit, pooled and individual faecal samples were collected and Salmonella isolation was carried out according to an ISO 6579: 2002 Annex D-based method. One building on each farm (intervention) was cleaned and disinfected according to a rigorous protocol consisting of several steps and a Defra-approved disinfectant used at the General Orders concentration, whilst the other building (control) was cleaned and disinfected as per normal farm routine. At the post-C&D visit, Enterobacteriaceae and total bacterial counts were determined to evaluate residual faecal contamination and general hygiene levels. Rodent specialists visited the farms before and after C&D and rodent carcasses were collected for Salmonella testing. The intervention buildings were significantly less likely (p = 0.004) to be positive for Salmonella after C&D. The pre-restocking pigs had the highest likelihood (p<0.001) of being Salmonella positive (often with multiple serovars) and there was no significant difference between intervention and control buildings in Salmonella prevalence at the post-restocking visit (p = 0.199). However, the pigs housed in the intervention buildings were significantly less likely (p = 0.004) to be positive for Salmonella at slaughter age. Multivariable analysis suggested that cleaning all fixtures of buildings, leaving the pens empty for 2-3 days and using an effective disinfectant are factors significantly improving the likelihood of removing Salmonella contamination during C&D. Signs of rodents were recorded in all farms, but rodent activity and harbourage availability decreased between visits. All the rats tested were Salmonella negative. S. Typhimurium or its monophasic variants were isolated from 6 mouse carcasses in 3 farms where the same serovars were isolated from pigs. This study demonstrates that an appropriate C&D programme significantly reduces the likelihood of residual contamination in Salmonella positive pig buildings, and suggests a significant reduction in the prevalence of Salmonella in the pigs in appropriately cleaned and disinfected buildings when sampled before slaughter. Due to a high prevalence of infection in replacement pigs, control of Salmonella in pig farms is challenging. Rodents may also contribute to the carry-over of infection between batches. C&D is a useful measure to help reduce the number of infected pigs going to the slaughterhouse, but should be supplemented by other control measures along the pig breeding and production chain.	[Martelli, Francesca; Tatone, Fabrizio Antonio; Rabie, Andre; Gosling, Rebecca J.; Davies, Robert H.] Anim & Plant Hlth Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Lambert, Mark; Callaby, Rebecca] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Sand Hutton, England; [Butt, Paul] Agr Dev & Advisory Serv, Pendeford, England; [Cheney, Tanya; Smith, Richard Piers] Anim & Plant Hlth Agcy, Dept Epidemiol Sci, Addlestone, Surrey, England; [Fordon, Steve; Crocker, Graham] Quill Product, Pulham, England	Animal & Plant Health Agency UK; Animal & Plant Health Agency UK; Animal & Plant Health Agency UK	Martelli, F (corresponding author), Anim & Plant Hlth Agcy, Dept Bacteriol, Addlestone, Surrey, England.	Francesca.Martelli@apha.gsi.gov.uk	Lambert, Mark/G-5962-2014; Lambert, Mark/GPP-3645-2022	Lambert, Mark/0000-0001-6037-8601; Lambert, Mark/0000-0001-6037-8601	Department of Food, Environment and Rural Affairs (United Kingdom) [OZ0344]; Defra [OZ0344]	Department of Food, Environment and Rural Affairs (United Kingdom); Defra(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department of Food, Environment and Rural Affairs (United Kingdom) with grant OZ0344 (https://www.gov.uk/government-organisations/department-for-environment-food-rural-affairs). The funder provided support in the form of salaries for authors [FM, PB, TC, RC, AR, RG, RD and RS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.). ADAS provided support in the form of salaries for authors (PB) and Quill Productions provided support in the form of salaries for authors [SF, GC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The disinfectant products were supplied free of charge by Evans Vanodine. Quills Production (SF and GC) provided in kind logistic support for the distribution of the disinfectant products to the contractors performing the cleaning and disinfection in the intervention buildings.; The Authors would like to thank all the farmers that have taken part in these trials. Also, we thank Evans Vanodine for supplying the products used in the intervention buildings and Valerie Fotheringham for her expert technical support. This work was funded by Defra grant OZ0344.	Akil L, 2014, FOODBORNE PATHOG DIS, V11, P974, DOI 10.1089/fpd.2014.1802; Andres VM, 2015, OMREHENSIVE REV FOOD; Andres-Barranco S, 2014, FOODBORNE PATHOG DIS, V11, P689, DOI 10.1089/fpd.2014.1755; APHA, 2015, SALM LIV PROD GB; Arnold ME, 2015, EPIDEMIOL INFECT, V143, P1681, DOI 10.1017/S0950268814002453; Arnold ME, 2005, J R SOC INTERFACE, V2, P365, DOI 10.1098/rsif.2005.0057; Bahnson PB, 2006, PREV VET MED, V76, P249, DOI 10.1016/j.prevetmed.2006.05.009; Baloda SB, 2001, APPL ENVIRON MICROB, V67, P2859, DOI 10.1128/AEM.67.6.2859-2862.2001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beloeil PA, 2004, PREV VET MED, V63, P103, DOI 10.1016/j.prevetmed.2004.01.010; Beloeil PA, 2007, VET RES, V38, P835, DOI 10.1051/vetres:2007034; Berriman ADC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066054; Bjornson B, 1969, PUBLIC HLTH SERVIC P; Bollaerts K, 2010, RISK ANAL, V30, P853, DOI 10.1111/j.1539-6924.2010.01368.x; Carrique-Mas JJ, 2009, EPIDEMIOL INFECT, V137, P837, DOI 10.1017/S0950268808001568; Carrique-Mas JJ, 2009, AVIAN PATHOL, V38, P419, DOI 10.1080/03079450903193768; Davies R, 2003, VET REC, V152, P283, DOI 10.1136/vr.152.10.283; DAVIES RH, 1995, VET REC, V137, P337, DOI 10.1136/vr.137.14.337; De Busser EV, 2013, VET J, V196, P20, DOI 10.1016/j.tvjl.2013.01.002; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.135r; EFSA, 2008, EFSA J, V7, P1377; Engeman RM, 2005, WILDLIFE RES, V32, P203, DOI 10.1071/WR03120; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; Fosse J, 2009, ZOONOSES PUBLIC HLTH, V56, P429, DOI 10.1111/j.1863-2378.2008.01185.x; Gautam R, 2014, EPIDEMIOL INFECT, V142, P1034, DOI 10.1017/S0950268813001805; Gosling RJ, 2016, AVIAN PATHOL, V45, P576, DOI 10.1080/03079457.2016.1188369; Gradel KO, 2004, POULTRY SCI, V83, P1636, DOI 10.1093/ps/83.10.1636; Grimont PA, 2007, ANTIGENIC FORMULAE S, V9th; Hancox LR, 2013, VET REC, V173, P167, DOI 10.1136/vr.101392; HENZLER DJ, 1992, AVIAN DIS, V36, P625, DOI 10.2307/1591757; Lambert M, 2016, PEST MANAGEMEN UNPUB; Lambert MS, 2008, J APPL ECOL, V45, P1753, DOI 10.1111/j.1365-2664.2008.01543.x; Lapuz R, 2008, EPIDEMIOL INFECT, V136, P1235, DOI 10.1017/S095026880700948X; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Luyckx K, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0810-9; Luyckx K, 2015, POULTRY SCI, V94, P740, DOI 10.3382/ps/pev019; Luyckx KY, 2015, POULTRY SCI, V94, P1986, DOI 10.3382/ps/pev143; Madec F, 1999, J VET MED B, V46, P37, DOI 10.1046/j.1439-0450.1999.00201.x; Mannion C, 2007, VET REC, V161, P371, DOI 10.1136/vr.161.11.371; Martelli F, 2016, AVIAN PATHOL, V45, P261, DOI 10.1080/03079457.2016.1146820; Martelli F, 2016, AVIAN PATHO IN PRESS; McLaren I, 2011, AVIAN PATHOL, V40, P33, DOI 10.1080/03079457.2010.537303; Mueller-Doblies D, 2010, J APPL MICROBIOL, V109, P471, DOI 10.1111/j.1365-2672.2010.04667.x; Mueller-Doblies D, 2013, PREV VET MED, V110, P447, DOI 10.1016/j.prevetmed.2013.02.023; Powell LF, 2016, EPIDEMIOL INFECT, V144, P1538, DOI 10.1017/S0950268815002794; Rose N, 2000, PREV VET MED, V44, P9, DOI 10.1016/S0167-5877(00)00100-8; Sandvang D, 2000, FEMS MICROBIOL LETT, V187, P21, DOI 10.1111/j.1574-6968.2000.tb09130.x; Stringfellow K, 2009, POULTRY SCI, V88, P1151, DOI 10.3382/ps.2008-00455; Thomson J. R., 2007, Pig Journal, V60, P15; Umali DV, 2012, AVIAN DIS, V56, P288, DOI 10.1637/9911-090411-Reg.1; Wales AD, 2009, VET REC, V165, P648, DOI 10.1136/vr.165.22.648	52	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178897	10.1371/journal.pone.0178897	http://dx.doi.org/10.1371/journal.pone.0178897			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594930	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200064
J	Mvumbi, DM; Bobanga, TL; Kayembe, JMN; Mvumbi, GL; Situakibanza, HNT; Benoit-Vical, F; Melin, P; De Mol, P; Hayette, MP				Mvumbi, Dieudonne Makaba; Bobanga, Thierry Lengu; Kayembe, Jean-Marie Ntumba; Mvumbi, Georges Lelo; Situakibanza, Hippolyte Nani-Tuma; Benoit-Vical, Francoise; Melin, Pierrette; De Mol, Patrick; Hayette, Marie-Pierre			Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo	PLOS ONE			English	Article							PFMDR1 COPY NUMBER; AMODIAQUINE RESISTANCE; ARTEMETHER-LUMEFANTRINE; MEFLOQUINE RESISTANCE; TRANSPORTER GENE; MALARIA; CHLOROQUINE; PFCRT; POLYMORPHISMS; ALLELES	Malaria is a major public health problem in the Democratic Republic of Congo. Despite progress achieved over the past decade in the fight against malaria, further efforts have to be done such as in the surveillance and the containment of Plasmodium falciparum resistant strains. We investigated resistance to artemisinin-based combination therapies currently in use in Democratic Republic of Congo by surveying molecular polymorphisms in three genes: pfcrt, pfmdr1 and pfk13 to explore possible emergence of amodiaquine, lumefantrine or artemisinin resistance in Democratic Republic of Congo. This study essentially revealed that resistance to chloroquine is still decreasing while polymorphism related to amodiaquine resistance seems to be not present in Democratic Republic of Congo, that three samples, located in the east of the country, harbor Pfmdr1 amplification and that none of the mutations found in South-East Asia correlated with artemisinine resistance have been found in Democratic Republic of Congo. But new mutations have been identified, especially the M476K, occurred in the same position that the M476I previously identified in the F32-ART strain, strongly resistant to artemisinine. Antimalarial first-line treatments currently in use in Democratic Republic of Congo are not associated with emergence of molecular markers of resistance.	[Mvumbi, Dieudonne Makaba; Mvumbi, Georges Lelo] Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, DEM REP CONGO; [Mvumbi, Dieudonne Makaba; Melin, Pierrette; De Mol, Patrick; Hayette, Marie-Pierre] Univ Hosp Liege, Dept Clin Microbiol, Liege, Belgium; [Bobanga, Thierry Lengu; Situakibanza, Hippolyte Nani-Tuma] Univ Kinshasa, Sch Med, Dept Parasitol & Trop Med, Kinshasa, DEM REP CONGO; [Kayembe, Jean-Marie Ntumba; Situakibanza, Hippolyte Nani-Tuma] Univ Kinshasa, Sch Med, Dept Internal Med, Kinshasa, DEM REP CONGO; [Benoit-Vical, Francoise] CNRS, LCC, Toulouse, France; [Benoit-Vical, Francoise] Univ Toulouse, UPS, Toulouse, France	Universite de Kinshasa; University of Liege; Universite de Kinshasa; Universite de Kinshasa; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mvumbi, DM (corresponding author), Univ Kinshasa, Sch Med, Dept Basic Sci, Biochem & Mol Biol Unit, Kinshasa, DEM REP CONGO.; Mvumbi, DM (corresponding author), Univ Hosp Liege, Dept Clin Microbiol, Liege, Belgium.	didimvumbi@gmail.com	Mvumbi, Dieudonné/AAC-9875-2020; Benoit-Vical, Francoise/E-3938-2016	Mvumbi, Dieudonné/0000-0001-6991-5178; Benoit-Vical, Francoise/0000-0002-9468-4823; Hayette, Marie Pierre/0000-0002-9025-6493; Melin, Pierrette/0000-0002-2159-5774	"Academie de Recherche et d'Enseignement Superieur" (ARES), Begium	"Academie de Recherche et d'Enseignement Superieur" (ARES), Begium	This work was supported by the "Academie de Recherche et d'Enseignement Superieur" (ARES), Begium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifrangis M, 2006, J INFECT DIS, V193, P1738, DOI 10.1086/504269; [Anonymous], 1986, CHEMOTHERAPY MALARIA; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Beshir K, 2010, ANTIMICROB AGENTS CH, V54, P3714, DOI 10.1128/AAC.00358-10; Chavchich M, 2010, ANTIMICROB AGENTS CH, V54, P2455, DOI 10.1128/AAC.00947-09; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Duah NO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-377; Gadalla NB, 2011, ANTIMICROB AGENTS CH, V55, P5408, DOI 10.1128/AAC.05102-11; Gama BE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-174; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Lobo E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-300; Mbenda HGN, 2014, J ANTIMICROB CHEMOTH, V69, P400, DOI 10.1093/jac/dkt388; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; Mekonnen SK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-244; Menard D, 2016, NEW ENGL J MED, V374, P2453, DOI 10.1056/NEJMoa1513137; Mobula L, 2009, AM J TROP MED HYG, V80, P555, DOI 10.4269/ajtmh.2009.80.555; Mungthin M, 2010, AM J TROP MED HYG, V83, P1005, DOI 10.4269/ajtmh.2010.10-0339; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mvumbi DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0892-z; Mvumbi DM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-459; Mvumbi DM, 2016, MALAR RES TREAT, DOI DOI 10.1155/2016/5405802; Ngalah BS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08308; Nyunt MH, 2015, CLIN INFECT DIS, V60, P1208, DOI 10.1093/cid/ciu1160; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; Phillips M, 1996, PHARMACOECONOMICS, V10, P225, DOI 10.2165/00019053-199610030-00004; Plowe CV, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-121; Pradines B, 2010, REV FRANCOPH LAB, V2010, P51, DOI [DOI 10.1016/S1773-035X(10)70510-4, 10.1016/S1773-035X(10, DOI 10.1016/S1773-035X(10]; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Price RN, 2001, DRUG RESIST UPDATE, V4, P187, DOI 10.1054/drup.2001.0195; Sa JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-374; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Uhlemann AC, 2005, J INFECT DIS, V192, P1830, DOI 10.1086/497337; Wang ZL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0672-9; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2016, UPD ART ACT RES APR; WHO, 2015, GLOB TECHN STRAT MAL; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2015, GUID TREATM MAL, Vthird; WWARN, 2011, MOL MOD 2011	44	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179142	10.1371/journal.pone.0179142	http://dx.doi.org/10.1371/journal.pone.0179142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594879	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200089
J	de la Haye, K; Dijkstra, JK; Lubbers, MJ; van Rijsewijk, L; Stolk, R				de la Haye, Kayla; Dijkstra, Jan Kornelis; Lubbers, Miranda J.; van Rijsewijk, Loes; Stolk, Ronald			The dual role of friendship and antipathy relations in the marginalization of overweight children in their peer networks: The TRAILS Study	PLOS ONE			English	Article							SOCIOMETRIC STATUS; SOCIAL NETWORKS; ADOLESCENTS; OBESITY; WEIGHT; HEALTH; PREADOLESCENTS; VICTIMIZATION; SIMILARITIES; BEHAVIOR	Weight-based stigma compromises the social networks of overweight children. To date, research on the position of overweight children in their peer network has focused only on friendship relations, and not on negative relationship dimensions. This study examined how overweight was associated with relations of friendship and dislike (antipathies) in the peer group. Exponential random graph models (ERGM) were used to examine friendship and antipathy relations among overweight children and their classmates, using a sub-sample from the TRacking Adolescents' Individual Lives Survey (N = 504, M age 11.4). Findings showed that overweight children were less likely to receive friendship nominations, and were more likely to receive dislike nominations. Overweight children were also more likely than their non-overweight peers to nominate classmates that they disliked. Together, the results indicate that positive and negative peer relations are impacted by children's weight status, and are relevant to addressing the social marginalization of overweight children.	[de la Haye, Kayla] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA; [Dijkstra, Jan Kornelis; van Rijsewijk, Loes] Univ Groningen, Interuniv Ctr Social Sci Theory & Methodol ICS, Groningen, Netherlands; [Dijkstra, Jan Kornelis; van Rijsewijk, Loes] Univ Groningen, Dept Sociol, Groningen, Netherlands; [Lubbers, Miranda J.] Autonomous Univ Barcelona, Dept Social & Cultural Anthropol, Barcelona, Spain; [Stolk, Ronald] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands	University of Southern California; University of Groningen; University of Groningen; Autonomous University of Barcelona; University of Groningen	de la Haye, K (corresponding author), Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA.	delahaye@usc.edu	Lubbers, Miranda/P-1250-2018	Lubbers, Miranda/0000-0001-8398-6044; Stolk, Ronald/0000-0002-0518-1205	Netherlands Organization for Scientific Research NWO [GB-MW 940-38-011]; ZonMW Brainpower [100-001-004]; ZonMw Risk Behavior and Dependence [60-60600-98-018, 60-60600-97-118]; ZonMw Culture and Health [261-98-710]; Social Sciences Council [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Social Sciences Council project [GB-MaGW 457-03-018, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; NWO [175.010.2003.005]; Sophia Foundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); University Medical Center; University of Groningen; Erasmus University Medical Center Rotterdam; University of Utrecht; Radboud Medical Center Nijmegen; Trimbos Institute	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); ZonMW Brainpower; ZonMw Risk Behavior and Dependence; ZonMw Culture and Health; Social Sciences Council; Social Sciences Council project; NWO(Netherlands Organization for Scientific Research (NWO)); Sophia Foundation for Medical Research; Dutch Ministry of Justice (WODC); University Medical Center; University of Groningen; Erasmus University Medical Center Rotterdam; University of Utrecht; Radboud Medical Center Nijmegen; Trimbos Institute	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-98-018 and 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 457-03-018, GB-MaGW 452-04-314, an GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005); the Sophia Foundation for Medical Research (projects 301 and 393), the Dutch Ministry of Justice (WODC), and the participating universities which include University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Trimbos Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2012, ECON HUM BIOL, V10, P20, DOI 10.1016/j.ehb.2011.10.001; [Anonymous], 2003, OBES RES, DOI DOI 10.1038/oby.2003.61; Berger C, 2013, J RES ADOLESCENCE, V23, P586, DOI 10.1111/jora.12048; Burke MA, 2007, ECON INQ, V45, P571, DOI 10.1111/j.1465-7295.2007.00025.x; Card NA, 2010, DEV PSYCHOL, V46, P516, DOI 10.1037/a0017199; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; CORSARO WA, 1990, ANNU REV SOCIOL, V16, P197, DOI 10.1146/annurev.so.16.080190.001213; Crosnoe R, 2008, SOC FORCES, V86, P1189; de la Haye K, 2013, J RES ADOLESCENCE, V23, P524, DOI 10.1111/jora.12045; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Fowler JH, 2008, J HEALTH ECON, V27, P1400, DOI 10.1016/j.jhealeco.2008.07.001; Gifford-Smith ME, 2003, J SCHOOL PSYCHOL, V41, P235, DOI 10.1016/S0022-4405(03)00048-7; Giordano PC, 2003, ANNU REV SOCIOL, V29, P257, DOI 10.1146/annurev.soc.29.010202.100047; Gray WN, 2009, PSYCHOL SCHOOLS, V46, P720, DOI 10.1002/pits.20410; Halliday TJ, 2009, ECON HUM BIOL, V7, P181, DOI 10.1016/j.ehb.2009.05.002; Hammond RA, 2014, ANN NY ACAD SCI, V1331, P34, DOI 10.1111/nyas.12344; KUPERSMIDT JB, 1995, J SOC PERS RELAT, V12, P439, DOI 10.1177/0265407595123007; Lubbers MJ, 2003, SOC NETWORKS, V25, P309, DOI 10.1016/S0378-8733(03)00013-3; Lusher D., 2012, EXPONENTIAL RANDOM G; NEWCOMB AF, 1993, PSYCHOL BULL, V113, P99, DOI 10.1037/0033-2909.113.1.99; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; OLLENDICK TH, 1992, J CONSULT CLIN PSYCH, V60, P80, DOI 10.1037/0022-006X.60.1.80; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Rambaran JA, 2015, SOC NETWORKS, V43, P162, DOI 10.1016/j.socnet.2015.05.003; Rasbash J, 2009, MLWIN VERSION 21; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Shoham David A, 2015, Curr Epidemiol Rep, V2, P71; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Snijders TAB, 2003, J MATH SOCIOL, V27, P123, DOI 10.1080/00222500305892; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Valente TW, 2009, J ADOLESCENT HEALTH, V45, P202, DOI 10.1016/j.jadohealth.2009.01.007; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Wang P., 2006, PNET PROGRAM SIMULAT; WENTZEL KR, 1995, CHILD DEV, V66, P754, DOI 10.2307/1131948	42	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178130	10.1371/journal.pone.0178130	http://dx.doi.org/10.1371/journal.pone.0178130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591210	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700021
J	Eshel, G; Carmel, Y				Eshel, Gidon; Carmel, Yohay			Expanded view of ecosystem stability: A grazed grassland case study	PLOS ONE			English	Article							TRANSIENT DYNAMICS; OPTIMAL EXCITATION; RESILIENCE; MODELS; COMPETITION; REACTIVITY; GROWTH	Analysis of stability under linearized dynamics is central to ecology. We highlight two key limitations of the widely used traditional analysis. First, we note that while stability at fixed points is often the focus, ecological systems may spend less time near fixed points, and more time responding to stochastic environmental forcing by exhibiting wide zero-mean fluctuations about those states. If non-steady, uniquely precarious states along the nonlinear flow are analyzed instead of fixed points, transient growth is possible and indeed common for ecosystems with stable attractive fixed points. Second, we show that in either steady or non-steady states, eigenvalue based analysis can misleadingly suggest stability while eigenvector geometry arising from the non-self-adjointness of the linearized operator can yield large finite-time instabilities. We offer a simple alternative to eigenvalue based stability analysis that naturally and straightforwardly overcome these limitations.	[Eshel, Gidon] Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA; [Carmel, Yohay] Technion, Dept Agr Engn, Haifa, Israel	Harvard University; Technion Israel Institute of Technology	Eshel, G (corresponding author), Harvard Univ, Radcliffe Inst Adv Study, Cambridge, MA 02138 USA.	geshel@gmail.com	Carmel, Yohay/G-4362-2011	Carmel, Yohay/0000-0002-5883-0184				Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Arnoldi JF, 2016, J THEOR BIOL, V389, P47, DOI 10.1016/j.jtbi.2015.10.012; BERRYMAN AA, 1992, ECOLOGY, V73, P1530, DOI 10.2307/1940005; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Butler KM, 1992, PHYS FLUIDS A-FLUID, V5, p1390 ; Caswell H, 2005, J DIFFER EQU APPL, V11, P295, DOI 10.1080/10236190412331335382; Cortez MH, 2011, ECOL LETT, V14, P202, DOI 10.1111/j.1461-0248.2010.01572.x; Courant R., 1966, METHODS MATH PHYS, V1; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Eichner Thomas, 2006, Journal of Bioeconomics, V8, P121, DOI 10.1007/s10818-006-0005-8; Eshel G., 2012, SPATIOTEMPORAL DATA; Farrel BF, 2000, J GEOPHYS RES-ATMOS, V105, P9303, DOI 10.1029/1999JD901021; FARRELL BF, 1993, PHYS FLUIDS A-FLUID, V5, P2298, DOI 10.1063/1.858534; Farrell BF, 1999, ASTROPHYS J, V522, P1079, DOI 10.1086/307662; Farrell BF, 1996, J ATMOS SCI, V53, P2041, DOI 10.1175/1520-0469(1996)053<2041:GSTPIN>2.0.CO;2; FARRELL BF, 1982, J ATMOS SCI, V39, P1663, DOI 10.1175/1520-0469(1982)039<1663:TIGODI>2.0.CO;2; FARRELL BF, 1989, J ATMOS SCI, V46, P1193, DOI 10.1175/1520-0469(1989)046<1193:OEOBW>2.0.CO;2; Farrell BF, 1996, PHYS FLUIDS, V8, P1257, DOI 10.1063/1.868897; Farrell BF, 1996, J ATMOS SCI, V53, P2025, DOI 10.1175/1520-0469(1996)053<2025:GSTPIA>2.0.CO;2; Farrell BF, 1999, ASTROPHYS J, V522, P1088, DOI 10.1086/307663; Farrell BF, 1983, J ATMOS SCI, V41, P668; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hastings A, 2001, ECOL LETT, V4, P215, DOI 10.1046/j.1461-0248.2001.00220.x; Hastings A, 2010, ECOLOGY, V91, P3471, DOI 10.1890/10-0776.1; Holling C. S., 1959, Canadian Entomologist, V91, P385; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling C. S, 1996, ENG ECOLOGICAL CONST, P31, DOI DOI 10.17226/4919; HOLT RD, 1985, AM NAT, V126, P196, DOI 10.1086/284409; HSU SB, 1978, MATH BIOSCI, V39, P1, DOI 10.1016/0025-5564(78)90025-1; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kershenbaum A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036730; Lafferty KD, 2015, SCIENCE, V349, P854, DOI 10.1126/science.aaa6224; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Lele S, 1998, ECOLOGY, V79, P1489, DOI 10.2307/176771; LESLIE PH, 1960, BIOMETRIKA, V47, P219, DOI 10.1093/biomet/47.3-4.219; Livermore PW, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021397; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Neubert MG, 1997, ECOLOGY, V78, P653, DOI 10.1890/0012-9658(1997)078[0653:ATRFMT]2.0.CO;2; Nilsson KA, 2016, THEOR ECOL-NETH, V9, P59, DOI 10.1007/s12080-015-0282-8; Rao F, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/03/P03014; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Ryu K, 2003, DISCRETE CONT DYN S, V9, P1049; Strang G., 1986, INTRO APPL MATH, V16; Sun GQ, 2009, INT J MOD PHYS C, V20, P71, DOI 10.1142/S0129183109013467; Townley S, 2007, J APPL ECOL, V44, P1243, DOI 10.1111/j.1365-2664.2007.01333.x; Volterra V, 1931, ANIMAL ECOLOGY, P409; Wang WG, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016201; WOLKOWICZ GSK, 1992, SIAM J APPL MATH, V52, P222, DOI 10.1137/0152012	50	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178235	10.1371/journal.pone.0178235	http://dx.doi.org/10.1371/journal.pone.0178235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591229	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700025
J	Hastings, KK; Jemison, LA; Pendleton, GW; Raum-Suryan, KL; Pitcher, KW				Hastings, Kelly K.; Jemison, Lauri A.; Pendleton, Grey W.; Raum-Suryan, Kimberly L.; Pitcher, Kenneth W.			Natal and breeding philopatry of female Steller sea lions in southeastern Alaska	PLOS ONE			English	Article							CONTROL-REGION SEQUENCES; PUPPING-SITE FIDELITY; ANTARCTIC FUR SEALS; EUMETOPIAS-JUBATUS; POPULATION-STRUCTURE; DISPERSAL; CONSERVATION; SURVIVAL; CONSEQUENCES; VARIABILITY	Information on drivers of dispersal is critical for wildlife conservation but is rare for long-lived marine mammal species with large geographic ranges. We fit multi-state mark-recapture models to resighting data of 369 known-aged Steller sea lion (Eumetopias jubatus) females marked as pups on their natal rookeries in southeastern Alaska from 1994-2005 and monitored from 2001-15. We estimated probabilities of females being first observed parous at their natal site (natal philopatry), and of not moving breeding sites among years (breeding philopatry) at large (> 400 km, all five rookeries in southeastern Alaska) and small (< 4 km, all islands within the largest rookery, Forrester Island Complex, F) spatial scales. At the rookery scale, natal philopatry was moderately high (0.776-0.859) for most rookeries and breeding philopatry was nearly 1, with < 3% of females switching breeding rookeries between years. At more populous islands at F, natal philopatry was 0.500-0.684 versus 0.295-0.437 at less populous islands, and breeding philopatry was 0.919-0.926 versus 0.604-0.858. At both spatial scales, the probability of pupping at a non-natal site increased with population size of, and declined with distance from, the destination site. Natal philopatry of < 1 would increase gene flow, improve population resilience, and promote population recovery after decline in a heterogeneous environment. Very high breeding philopatry suggests that familiarity with neighboring females and knowledge of the breeding site (the topography of pupping sites and nearby foraging locations) may be a critical component to reproductive strategies of sea lions.	[Hastings, Kelly K.; Jemison, Lauri A.; Pendleton, Grey W.; Pitcher, Kenneth W.] Alaska Dept Fish & Game, Div Wildlife Conservat, Anchorage, AK 99518 USA; [Raum-Suryan, Kimberly L.] Natl Marine Fisheries Serv, Protected Resources Div, Juneau, AK USA	Alaska Department of Fish & Game; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Hastings, KK (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Anchorage, AK 99518 USA.	kelly.hastings@alaska.gov			Alaska Department of Fish and Game by the State of Alaska; National Oceanic and Atmospheric Administration Fisheries Alaska Region [NA17FX1079, NA04NMF4390170, NA08NMF4390544, NA11NMF4390200, NA15NMF4390170]	Alaska Department of Fish and Game by the State of Alaska; National Oceanic and Atmospheric Administration Fisheries Alaska Region	Funding for this research was provided to the Alaska Department of Fish and Game by the State of Alaska and by the National Oceanic and Atmospheric Administration Fisheries Alaska Region, through awards NA17FX1079, NA04NMF4390170, NA08NMF4390544, NA11NMF4390200, and NA15NMF4390170. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, 2 INT S INF THEOR, P267; Altukhov AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127292; Avise John C., 1994, pi; Baker AR, 2005, J MAMMAL, V86, P1075, DOI 10.1644/04-MAMM-A-113R1.1; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; Bickham JW, 1998, J MAMMAL, V79, P1390, DOI 10.2307/1383029; Burkanov V N., 2005, MAR FISH REV, V67, P1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cameron MF, 2007, ANTARCT SCI, V19, P149, DOI 10.1017/S0954102007000223; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Cassini MH, 1999, BEHAV ECOL, V10, P612, DOI 10.1093/beheco/10.5.612; Chilvers BL, 2008, WILDLIFE RES, V35, P463, DOI 10.1071/WR07053; Cooch E., 2017, PROGRAM MARK GENTLE, V12th edition; Dobson FS, 2013, ANIM BEHAV, V85, P299, DOI 10.1016/j.anbehav.2012.11.014; Fritz L, 2015, RESULTS STELLER SEA; Gentry RL, 1970, THESIS; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hastings KK, 2017, J MAMMAL, V98, P397, DOI 10.1093/jmammal/gyw182; Hoffman JI, 2006, MOL ECOL, V15, P2821, DOI 10.1111/j.1365-294X.2006.02991.x; Hoffman JI, 2012, MAMM BIOL, V77, P71, DOI 10.1016/j.mambio.2011.09.002; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; King JE., 1983, SEALS WORLD BRIT MUS; Laake J., 2013, 201301 AFSC NAT OC A; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; Lopes F, 2015, CONSERV GENET, V16, P1099, DOI 10.1007/s10592-015-0725-1; LOUGHLIN TR, 1992, MAR MAMMAL SCI, V8, P220, DOI 10.1111/j.1748-7692.1992.tb00406.x; Loughlin TR., 1998, BIOSPH CONSER NAT WI, V1, P91, DOI [10.20798/biospherecons.1.2_91, DOI 10.20798/BIOSPHERECONS.1.2_91]; LUNN NJ, 1991, J MAMMAL, V72, P202, DOI 10.2307/1381999; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111523; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; NICHOLS JD, 1992, ECOLOGY, V73, P306, DOI 10.2307/1938741; O'Corry-Crowe G, 2006, CAN J ZOOL, V84, P1796, DOI 10.1139/Z06-167; O'Corry-Crowe G, 2014, MOL ECOL, V23, P5415, DOI 10.1111/mec.12944; Parker P, 2008, CAN J ZOOL, V86, P826, DOI 10.1139/Z08-058; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Phillips CD, 2011, J MAMMAL, V92, P1091, DOI 10.1644/10-MAMM-A-305.1; Pinsky ML, 2010, MOL ECOL, V19, P2418, DOI 10.1111/j.1365-294X.2010.04671.x; Pitcher KW, 2007, FISH B-NOAA, V105, P102; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; R Development Core Team, 2016, R FDN STAT COMP, DOI 10.1007/978-3-540-74686-7; Raum-Suryan KL, 2002, MAR MAMMAL SCI, V18, P746, DOI 10.1111/j.1748-7692.2002.tb01071.x; Rehberg MJ, 2009, MAR MAMMAL SCI, V25, P588, DOI 10.1111/j.1748-7692.2008.00278.x; Sandegren FE, 1970, THESIS; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Taylor RL, 2012, ECOL MODEL, V243, P73, DOI 10.1016/j.ecolmodel.2012.06.013; Valtonen M, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-22; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; York Anne E., 1996, P259; Younger JL, 2016, GLOBAL CHANGE BIOL, V22, P474, DOI 10.1111/gcb.13104	57	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0176840	10.1371/journal.pone.0176840	http://dx.doi.org/10.1371/journal.pone.0176840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591130	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700004
J	MacVicar, S; Berrang-Ford, L; Harper, S; Huang, Y; Bambaiha, DN; Yang, S				MacVicar, Sarah; Berrang-Ford, Lea; Harper, Sherilee; Huang, Yi; Bambaiha, Didacus Namanya; Yang, Seungmi			Whether weather matters: Evidence of association between in utero meteorological exposures and foetal growth among Indigenous and non-Indigenous mothers in rural Uganda	PLOS ONE			English	Article							CLIMATE-CHANGE; GESTATIONAL-AGE; BIRTH-WEIGHT; FUNDAL HEIGHT; HEALTH; PREGNANCY; TEMPERATURE; ULTRASOUND; OUTCOMES; PRECIPITATION	Pregnancy and birth outcomes have been found to be sensitive to meteorological variation, yet few studies explore this relationship in sub-Saharan Africa where infant mortality rates are the highest in the world. We address this research gap by examining the association between meteorological factors and birth weight in a rural population in southwestern Uganda. Our study included hospital birth records (n = 3197) from 2012 to 2015, for which we extracted meteorological exposure data for the three trimesters preceding each birth. We used linear regression, controlling for key covariates, to estimate the timing, strength, and direction of meteorological effects on birth weight. Our results indicated that precipitation during the third trimester had a positive association with birth weight, with more frequent days of precipitation associated with higher birth weight: we observed a 3.1g (95% CI: 1.0-5.3g) increase in birth weight per additional day of exposure to rainfall over 5mm. Increases in average daily temperature during the third trimester were also associated with birth weight, with an increase of 41.8g (95% CI: 0.6-82.9g) per additional degree Celsius. When the sample was stratified by season of birth, only infants born between June and November experienced a significant associated between meteorological exposures and birth weight. The association of meteorological variation with foetal growth seemed to differ by ethnicity; effect sizes of meteorological were greater among an Indigenous subset of the population, in particular for variation in temperature. Effects in all populations in this study are higher than estimates of the African continental average, highlighting the heterogeneity in the vulnerability of infant health to meteorological variation in different contexts. Our results indicate that while there is an association between meteorological variation and birth weight, the magnitude of these associations may vary across ethnic groups with differential socioeconomic resources, with implications for interventions to reduce these gradients and offset the health impacts predicted under climate change.	[MacVicar, Sarah; Berrang-Ford, Lea] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Harper, Sherilee] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Huang, Yi] McGill Univ, Dept Atmospher & Ocean Sci, Montreal, PQ, Canada; [Bambaiha, Didacus Namanya] Minist Hlth, Kampala, Uganda; [Yang, Seungmi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [MacVicar, Sarah] Univ British Columbia, Fac Med, Vancouver, BC, Canada	McGill University; University of Guelph; McGill University; McGill University; University of British Columbia	MacVicar, S (corresponding author), McGill Univ, Dept Geog, Montreal, PQ, Canada.; MacVicar, S (corresponding author), Univ British Columbia, Fac Med, Vancouver, BC, Canada.	sarah.macvicar@mail.mcgill.ca; lea.berrangford@mcgill.ca	Huang, Yi/E-9479-2016; Yang, Seungmi/AAB-3990-2019	Huang, Yi/0000-0002-5065-4198; 	International Research Development Center (IDRC) Tri-Council Initiative on Adaptation to Climate Change, Indigenous Health Adaptation to Climate Change (IHACC) [106372-003, 004, 005]; Canadian Institutes of Health Research (CIHR) [298312]; Canadian Institutes of Health Research	International Research Development Center (IDRC) Tri-Council Initiative on Adaptation to Climate Change, Indigenous Health Adaptation to Climate Change (IHACC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the International Research Development Center (IDRC) Tri-Council Initiative on Adaptation to Climate Change (https://www.idrc.ca./), Indigenous Health Adaptation to Climate Change (IHACC), IDRC File nos. 106372-003, 004, 005; LBF received the funding. Funding was also provided by the Canadian Institutes of Health Research (CIHR) Open Operating Grant (http://www.cihr-irsc.gc.ca/ e/193.html), Adaptation to the health effects of climate change among Indigenous peoples in the global south (IP-ADAPT), Application no. 298312; LBF received the funding. Further support was provided to SM in the form of a Banting & Best Canada Graduate Scholarship provided by the Canadian Institutes of Health Research (http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/CGSM-BESCM_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amegah AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069181; [Anonymous], 2012, UG DEM HLTH SURV 201; Anyah RO, 2012, INT J CLIMATOL, V32, P347, DOI 10.1002/joc.2270; Auger N, 2012, ANN EPIDEMIOL, V22, P160, DOI 10.1016/j.annepidem.2012.01.004; Barnett, 2010, ANAL SEASONAL HLTH D; BCH BCH, 2009, BWINDI COMMUNITY HOS, V2, P2; BCH BCH, 2014, HMIS ANN REP 2 UNPUB; Beltran AJ, 2014, INT J ENV RES PUB HE, V11, P91, DOI 10.3390/ijerph110100091; Berrang-Ford L, 2012, SOC SCI MED, V75, P1067, DOI 10.1016/j.socscimed.2012.04.016; Birungi M. R. E., 2010, COMP STUDY HIV RISK; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Butte NF, 2005, PUBLIC HEALTH NUTR, V8, P1010, DOI 10.1079/PHN2005793; Carolan-Olah M, 2014, MIDWIFERY, V30, P50, DOI 10.1016/j.midw.2013.01.011; Christensen J, 2013, CLIM CHANG 2013 PHYS; Clark S, 2015, EPIDEMIOL INFECT, V143, P2287, DOI 10.1017/S0950268814003124; COPPER RL, 1993, OBSTET GYNECOL, V81, P161; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; Donnelly B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1299-1; Elmen H., 1996, European Journal of Public Health, V6, P137, DOI 10.1093/eurpub/6.2.137; Grace K, 2015, GLOBAL ENVIRON CHANG, V35, P125, DOI 10.1016/j.gloenvcha.2015.06.010; Jackson D, 2006, HLTH SITUATION WOMEN; Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030; Jukic AM, 2013, HUM REPROD, V28, P2848, DOI 10.1093/humrep/det297; Kane RJ, 2011, SOC SCI MED, V73, P1585, DOI 10.1016/j.socscimed.2011.08.035; Karigahi W., 2015, AUDITS BWINDI UNPUB; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Laaidi M, 2011, ENVIRON RISQUE SANTE, V10, P128, DOI 10.1684/ers.2011.0432; Labbe J., 2015, MITIG ADAPT STRAT GL, P1; Lawlor DA, 2005, BJOG-INT J OBSTET GY, V112, P647, DOI 10.1111/j.1471-0528.2004.00488.x; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Levy BS, 2015, ANN GLOB HEALTH, V81, P310, DOI 10.1016/j.aogh.2015.08.008; MacVicar S., 2015, COMMUNICATION; Magrath J., 2008, TURNING HEAT CLIMATE; Mathule MSL, 2005, AFRICAN J FOOD AGR N, V5; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; McMichael AJ, 2013, INT J ENV RES PUB HE, V10, P6096, DOI 10.3390/ijerph10116096; McSweeney C., 2010, UNDP CLIMATE CHANGE; Molina O, 2017, ECON HUM BIOL, V24, P111, DOI 10.1016/j.ehb.2016.11.009; Mongelli M, 1999, OBSTET GYNECOL, V94, P591, DOI 10.1016/S0029-7844(99)00380-4; Neufeld L, 1999, AM J HUM BIOL, V11, P638, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<638::AID-AJHB7>3.0.CO;2-Q; Ngo NS, 2016, ENVIRON RES, V144, P158, DOI 10.1016/j.envres.2015.11.016; Novella NS, 2013, J APPL METEOROL CLIM, V52, P588, DOI 10.1175/JAMC-D-11-0238.1; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; Patricola CM, 2011, CLIM DYNAM, V37, P1165, DOI 10.1007/s00382-010-0907-y; Patterson K, SOCIAL SCI IN PRESS; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pike IL, 2000, AM J PHYS ANTHROPOL, V113, P31, DOI 10.1002/1096-8644(200009)113:1<31::AID-AJPA4>3.0.CO;2-W; Sauer J. C., 2017, MALNUTRITION INDIGEN; Smith KR, 2008, ANN NY ACAD SCI, V1140, P31, DOI 10.1196/annals.1454.032; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Stein Z., 1975, FAMINE HUM DEV DUTCH; Strand LB, 2011, ENVIRON RES, V111, P451, DOI 10.1016/j.envres.2011.01.023; Strand LB, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-49; SUSSER M, 1994, NUTR REV, V52, P84, DOI 10.1111/j.1753-4887.1994.tb01395.x; UNICEF, 2014, STAT WORLDS CHILDR 2; Vos AA, 2014, ACTA OBSTET GYN SCAN, V93, P727, DOI 10.1111/aogs.12430; Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6; White LJ, 2012, J R SOC INTERFACE, V9, P503, DOI 10.1098/rsif.2011.0376; Williams AP, 2011, CLIM DYNAM, V37, P2417, DOI 10.1007/s00382-010-0984-y; World Health Organization (WHO), 2014, GENDER CLIMATE CHANG; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179010	10.1371/journal.pone.0179010	http://dx.doi.org/10.1371/journal.pone.0179010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591162	Green Published, gold			2022-12-26	WOS:000402880700072
J	Style, S; Tondeur, M; Grijalva-Eternod, C; Pringle, J; Kassim, I; Wilkinson, C; Oman, A; Dolan, C; Spiegel, P; Seal, A				Style, Sarah; Tondeur, Melody; Grijalva-Eternod, Carlos; Pringle, Josephine; Kassim, Ismail; Wilkinson, Caroline; Oman, Allison; Dolan, Carmel; Spiegel, Paul; Seal, Andrew			Assessment of the effectiveness of a small quantity lipid-based nutrient supplement on reducing anaemia and stunting in refugee populations in the Horn of Africa: Secondary data analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; VITAMIN-A-DEFICIENCY; IRON STATUS; CHILD UNDERNUTRITION; COMPLEMENTARY FOODS; HOME FORTIFICATION; MICRONUTRIENT SUPPLEMENTS; YOUNG-CHILDREN; GROWTH; INFANTS	Stunting and micronutrient malnutrition are persistent public health problems in refugee populations. UNHCR and its partner organisations implement blanket supplementary feeding programmes using a range of special nutritional products as one approach to address these issues. The evidence base for the efficacy and effectiveness of a small quantity lipid-based nutrient supplement, Nutributter (R), in reducing stunting and anaemia is limited. Secondary data analysis was used to assess the effectiveness of Nutributter (R) distribution on anaemia and stunting in children aged 6-23 months (programme target group) and 6-59 months (the standard age group sampled in routine nutrition surveys). Analysis was conducted using routine pre and post-intervention cross-sectional nutrition survey data collected between 2008-2011 in five refugee camps in Kenya and Djibouti. Changes in total anaemia (Haemoglobin<110g/L), anaemia categories (mild, moderate and severe), and stunting (height-for-age z-score <-2) were explored using available data on the Nutributter (R) programme and contextual factors. A significant reduction in the prevalence of anaemia in children aged 6-23 months and 6-59 months was seen in four of five, and in all five camps, respectively (p<0.05). Reductions ranged from 12.4 to 23.0, and 18.3 to 29.3 percentage points in each age group. Improvements were largely due to reductions in moderate and severe anaemia and occurred where the prevalence of acute malnutrition was stable or increasing. No change in stunting was observed in four of five camps. The replicability of findings across five sites strongly suggests that Nutributter (R) distribution was associated with a reduction in anaemia, but not stunting, among refugee children in the Horn of Africa. Benefits were not restricted to the 6-23 month target group targeted by the nutrition programme. However, even following this intervention anaemia remained a serious public health problem and additional work to define and evaluate an effective intervention package is warranted.	[Style, Sarah; Grijalva-Eternod, Carlos; Pringle, Josephine; Seal, Andrew] UCL, Inst Global Hlth, London, England; [Tondeur, Melody; Kassim, Ismail; Wilkinson, Caroline; Oman, Allison; Spiegel, Paul] United Nations High Commissioner Refugees, Geneva, Switzerland; [Dolan, Carmel] Emergency Nutr Network, Oxford, England	University of London; University College London	Seal, A (corresponding author), UCL, Inst Global Hlth, London, England.	a.seal@ucl.ac.uk	Spiegel, Paul/AAL-3238-2021; Seal, Andrew/C-8550-2014; Grijalva-Eternod, Carlos S/A-2809-2010	Spiegel, Paul/0000-0002-6158-6661; Seal, Andrew/0000-0003-3656-4054; Grijalva-Eternod, Carlos S/0000-0002-2461-9954				Abbeddou S, 2014, MATERN CHILD NUTR; Adu-Afarwuah S, 2008, AM J CLIN NUTR, V87, P929, DOI 10.1093/ajcn/87.4.929; Adu-Afarwuah S, 2007, AM J CLIN NUTR, V86, P412, DOI 10.1093/ajcn/86.2.412; Adu-Afarwuah S, 2016, AM J CLIN NUTR, V104, P797, DOI 10.3945/ajcn.116.134692; Adu-Afarwuah S, 2011, MATERN CHILD NUTR, V7, P344, DOI 10.1111/j.1740-8709.2010.00286.x; [Anonymous], 1995, PHYS STAT UINT ANT; Arimond M, 2013, MATERNCHILD NUTR; Ashom P, 2014, AM J CLIN NUTR, V99, P1522, DOI 10.3945/ajcn.114.083535; Ashorn P, 2015, J NUTR, V145, P1345, DOI 10.3945/jn.114.207225; Ashorn U, 2015, J NUTR, V145, P1588, DOI 10.3945/jn.114.209593; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blanck HM, 2002, AM J CLIN NUTR, V76, P430, DOI 10.1093/ajcn/76.2.430; CDC/WFP, 2005, MAN MEAS INT MALN MO; Chaparro CM, 2010, MATERN CHILD NUTR, V6, P1, DOI 10.1111/j.1740-8709.2009.00224.x; de Pee S, 2011, FOOD NUTR BULL, V32, P256, DOI 10.1177/156482651103200311; de Pee S, 2009, FOOD NUTR BULL, V30, pS434, DOI 10.1177/15648265090303S305; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2013, J NUTR, V143, P2050, DOI 10.3945/jn.113.182527; Dewey KG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001314; Dewey KG, 2009, MATERN CHILD NUTR, V5, P283, DOI 10.1111/j.1740-8709.2009.00190.x; FAO/WHO, 2005, VIT MIN REQ HUM NUTR, V2nd ed.; Gera T, 2007, J PEDIATR GASTR NUTR, V44, P468, DOI 10.1097/01.mpg.0000243440.85452.38; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Grijalva-Eternod CS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001320; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hassan K, 1997, J NUTR, V127, P2194, DOI 10.1093/jn/127.11.2194; Henjum S, 2012, PUBLIC HEALTH NUTR, V15, P1512, DOI 10.1017/S1368980011002886; Hess SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122242; Hess SY, 2011, MATERN CHILD NUTR, V7, P357, DOI 10.1111/j.1740-8709.2010.00287.x; Iannotti LL, 2014, AM J CLIN NUTR, V99, P198, DOI 10.3945/ajcn.113.063883; *INACG, 2002, ADJ HEM VAL PROGR SU; Kemmer TM, 2003, J NUTR, V133, P4143, DOI 10.1093/jn/133.12.4143; Khara T, 2014, TECHNICAL BRIEFING P; Kodish S, 2011, FOOD NUTR BULL, V32, P292, DOI 10.1177/156482651103200315; Lesorogol C, 2014, MATERNCHILD NUTR, V2014; Maleta KM, 2015, J NUTR, V145, P1909, DOI 10.3945/jn.114.208181; Mangani C, 2013, MATERN CHILD NUTR; McGready R, 2003, ANN TROP PAEDIATR, V23, P193, DOI 10.1179/027249303322296510; Mridha MK, 2016, AM J CLIN NUTR, V103, P236, DOI 10.3945/ajcn.115.111336; Ndemwa P, 2011, FOOD NUTR BULL, V32, P286, DOI 10.1177/156482651103200314; ODK, OP DAT KIT MAGN HUM; Phuka J, 2011, MATERN CHILD NUTR, V7, P368, DOI 10.1111/j.1740-8709.2011.00297.x; Phuka JC, 2008, ARCH PEDIAT ADOL MED, V162, P619, DOI 10.1001/archpedi.162.7.619; Phuka JC, 2009, AM J CLIN NUTR, V89, P382, DOI 10.3945/ajcn.2008.26483; Sanchis-Gomar F, 2013, JALA-J LAB AUTOM, V18, P198, DOI 10.1177/2211068212457560; Seal AJ, 2005, J NUTR, V135, P808, DOI 10.1093/jn/135.4.808; Seal A, 2008, PUBLIC HEALTH NUTR, V11, P720, DOI 10.1017/S1368980007001486; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Style S, 2013, FOOD NUTR BULL, V34, P420, DOI 10.1177/156482651303400407; Tadesse S, 2009, ACC PACK PERC STUD A; UNHCR, 2013, STAND EXP NUTR SURV; UNHCR, 2008, UNHCR STRAT PLAN AN, P2008; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2000, MAN NUTR MAJ EM GEN; Woodruff BA, 2006, PUBLIC HEALTH NUTR, V9, P26, DOI 10.1079/PHN2005825; World Health Organization, 2006, CHILD GROWTH STAND	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177556	10.1371/journal.pone.0177556	http://dx.doi.org/10.1371/journal.pone.0177556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591166	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700011
J	Poldervaart, MT; Goversen, B; de Ruijter, M; Abbadessa, A; Melchels, FPW; Oner, FC; Dhert, WJA; Vermonden, T; Alblas, J				Poldervaart, Michelle T.; Goversen, Birgit; de Ruijter, Mylene; Abbadessa, Anna; Melchels, Ferry P. W.; Oner, F. Cumhur; Dhert, Wouter J. A.; Vermonden, Tina; Alblas, Jacqueline			3D bioprinting of methacrylated hyaluronic acid (MeHA) hydrogel with intrinsic osteogenicity	PLOS ONE			English	Article							CONTROLLED DEGRADATION; MATRIX ELASTICITY; CELLS; DIFFERENTIATION; CONSTRUCTS; DESIGN	In bone regenerative medicine there is a need for suitable bone substitutes. Hydrogels have excellent biocompatible and biodegradable characteristics, but their visco-elastic properties limit their applicability, especially with respect to 3D bioprinting. In this study, we modified the naturally occurring extracellular matrix glycosaminoglycan hyaluronic acid (HA), in order to yield photo-crosslinkable hydrogels with increased mechanical stiffness and long-term stability, and with minimal decrease in cytocompatibility. Application of these tailor-made methacrylated hyaluronic acid (MeHA) gels for bone tissue engineering and 3D bioprinting was the subject of investigation. Visco-elastic properties of MeHA gels, measured by rheology and dynamic mechanical analysis, showed that irradiation of the hydrogels with UV light led to increased storage moduli and elastic moduli, indicating increasing gel rigidity. Subsequently, human bone marrow derived mesenchymal stromal cells (MSCs) were incorporated into MeHA hydrogels, and cell viability remained 64.4% after 21 days of culture. Osteogenic differentiation of MSCs occurred spontaneously in hydrogels with high concentrations of MeHA polymer, in absence of additional osteogenic stimuli. Addition of bone morphogenetic protein-2 (BMP-2) to the culture medium further increased osteogenic differentiation, as evidenced by increased matrix mineralisation. MeHA hydrogels demonstrated to be suitable for 3D bioprinting, and were printed into porous and anatomically shaped scaffolds. Taken together, photosensitive MeHA-based hydrogels fulfilled our criteria for cellular bioprinted bone constructs within a narrow window of concentration.	[Poldervaart, Michelle T.; Goversen, Birgit; de Ruijter, Mylene; Melchels, Ferry P. W.; Oner, F. Cumhur; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Goversen, Birgit; Abbadessa, Anna; Vermonden, Tina] Univ Utrecht, UIPS, Dept Pharmaceut, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.alblas@umcutrecht.nl	Melchels, Ferry/V-8212-2017; Goversen, Birgit/AGN-3948-2022	Melchels, Ferry/0000-0002-5881-837X; de Ruijter, Mylene/0000-0002-8685-8379; Abbadessa, Anna/0000-0003-3095-4086; Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Goversen, Birgit/0000-0002-1003-3223	BioMedical Materials institute [P2.04 BONE-IP]; Dutch Ministry of Economic Affairs; Dutch Arthritis Foundation; ReumaFonds [LLP-12] Funding Source: researchfish	BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Dutch Arthritis Foundation; ReumaFonds	MP: This research forms part of the Project P2.04 BONE-IP of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. Funding sources had no role in study design, data collection and analysis or data interpretation. JA was supported by the Dutch Arthritis Foundation.; This research forms part of the Project P2.04 BONE-IP of the research program of the BioMedical Materials institute.	Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233; Arcaute K, 2010, TISSUE ENG C; Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078; Bulpitt P, 1999, J BIOMED MATER RES, V47, P152; Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a; Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X; DELPECH B, 1987, J IMMUNOL METHODS, V104, P223, DOI 10.1016/0022-1759(87)90508-4; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fedorovich N, 2011, TISSUE ENG C; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.TEA.2011.0019, 10.1089/ten.tea.2011.0019]; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2473, DOI [10.1089/ten.tea.2011.0001, 10.1089/ten.TEA.2011.0001]; Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gaetani R, 2012, BIOMATERIALS, V33, P1782, DOI 10.1016/j.biomaterials.2011.11.003; Hachet E, 2012, BIOMACROMOLECULES, V13, P1818, DOI 10.1021/bm300324m; Hayami JWS, 2015, EUROPEAN POLYM J; Hirama H, 2012, BIOMED MICRODEVICES, V14, P689, DOI 10.1007/s10544-012-9649-4; Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037; Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821; Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605; Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012; Munarin F, 2012, J APPL BIOMATER FUNC, V10, P67, DOI 10.5301/JABFM.2012.9418; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004; Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068; Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047; Peltola SM, 2008, ANN MED, V40, P268, DOI 10.1080/07853890701881788; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q; Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1; Xue RY, 2013, J ORTHOP RES, V31, P1360, DOI 10.1002/jor.22374; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Yoon HY, 2013, BIOMATERIALS, V34, P5273, DOI 10.1016/j.biomaterials.2013.03.050	40	172	185	10	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0177628	10.1371/journal.pone.0177628	http://dx.doi.org/10.1371/journal.pone.0177628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586346	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700005
J	Steffens, MC; Reese, G; Ehrke, F; Jonas, KJ				Steffens, Melanie C.; Reese, Gerhard; Ehrke, Franziska; Jonas, Kai J.			When does activating diversity alleviate, when does it increase intergroup bias? An ingroup projection perspective	PLOS ONE			English	Article							COLOR-BLINDNESS; GROUP PROTOTYPICALITY; GAY MEN; INTERETHNIC IDEOLOGY; PREJUDICE REDUCTION; SELF-ESTEEM; ATTITUDES; MULTICULTURALISM; IDENTIFICATION; THREAT	The question how intergroup bias can be alleviated is of much theoretical and practical interest. Whereas diversity training and the multiculturalism ideology are two approaches prominent in practice, most theoretical models on reducing intergroup bias are based on social-identity theory and self-categorization theory. This social-identity perspective assumes that similar processes lead to intergroup bias in very different intergroup contexts if people identify with the respective social groups. A recent prominent model based on these theories is the ingroup-projection model. As this model assumes, an ingroup's norms and standards are applied to outgroups included in a common superordinate category (this is called ingroup projection). Intergroup bias results because the outgroup fulfils these norms and standards less than the ingroup. Importantly, if the diversity of the superordinate category is induced as the norm, ingroup projection and thus intergroup bias should be reduced. The present research delineates and tests how general this process is. We propose that ingroup prototypicality is not only an outcome variable, as the ingroup-projection model originally assumes, but can also be an important moderator. We hypothesize that for members considering their ingroup highly prototypical ("pars pro toto", large majorities), the superordinate group's diversity may question their ingroup's position and thus elicit threat and intergroup bias. In contrast, for members who consider their group as less prototypical (one among several, or "una inter pares" groups), activating diversity should, as originally assumed in the ingroup-projection model, reduce intergroup bias. Three experiments (total N = 345) supported these predictions in the contexts of groups defined by gender or nationality. Taken together, the ingroup-projection model can explain under which conditions activating superordinate-category diversity induces tolerance, and when it may backfire. We discuss in how far the ingroup-projection model can integrate conflicting findings on the multiculturalism ideology.	[Steffens, Melanie C.; Reese, Gerhard; Ehrke, Franziska] Univ Koblenz Landau, Fac Psychol, Dept Social Environm & Econ Psychol, Landau, Germany; [Jonas, Kai J.] Maastricht Univ, Fac Psychol & Neurosci, Dept Work & Social Psychol, Maastricht, Netherlands	University of Koblenz & Landau; Maastricht University	Steffens, MC (corresponding author), Univ Koblenz Landau, Fac Psychol, Dept Social Environm & Econ Psychol, Landau, Germany.	steffens@uni-landau.de	Ehrke, Franziska/AAN-5992-2021; Jonas, Kai/AAB-3120-2021; Reese, Gerhard/U-9446-2019	Jonas, Kai/0000-0001-6607-1993; Reese, Gerhard/0000-0001-6672-3832	German Science Foundation	German Science Foundation(German Research Foundation (DFG))	The funders, the German Science Foundation, gave us a grant. We decided to employ Gerhard Reese, the second author, using the grant money. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Their URL is: http://www.dfg.de.	Asbrock F, 2015, J SOC PSYCHOL, V155, P553, DOI 10.1080/00224545.2015.1038497; Banse R, 2001, Z EXP PSYCHOL, V48, P145; Berthold A, 2012, EUR J SOC PSYCHOL, V42, P682, DOI 10.1002/ejsp.1878; Bianchi M, 2010, PERS SOC PSYCHOL B, V36, P960, DOI 10.1177/0146167210367488; Bortz J., 1999, STAT SOZIALWISSENSCH; Bosson JK, 2011, CURR DIR PSYCHOL SCI, V20, P82, DOI 10.1177/0963721411402669; Branscombe N.R., 1999, SOCIAL IDENTITY CONT, P35, DOI DOI 10.4135/9781446200919.N23; Brauer M, 2011, J EXP SOC PSYCHOL, V47, P871, DOI 10.1016/j.jesp.2011.03.003; Brewer M.B., 1984, GROUPS CONTACT PSYCH, P281, DOI DOI 10.1016/B978-0-12-497780-8.50019-X; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Brown R, 2005, ADV EXP SOC PSYCHOL, V37, P255, DOI 10.1016/S0065-2601(05)37005-5; Castano E, 2003, EUR J SOC PSYCHOL, V33, P735, DOI 10.1002/ejsp.175; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Correll J, 2008, GROUP PROCESS INTERG, V11, P471, DOI 10.1177/1368430208095401; Craig MA, 2014, PERS SOC PSYCHOL B, V40, P750, DOI 10.1177/0146167214524993; Crisp RJ, 2006, PERS SOC PSYCHOL B, V32, P230, DOI 10.1177/0146167205280908; Devos T, 2005, J PERS SOC PSYCHOL, V88, P447, DOI 10.1037/0022-3514.88.3.447; Dieckmann J, GROUP PROCE IN PRESS; Dovidio JF, 2010, PSYCHOL INQ, V21, P108, DOI 10.1080/1047840X.2010.486071; Ehrke F, 2015, DIVERSITAT DIVERSIFI, P205; Ehrke F, 2014, J EXP SOC PSYCHOL, V53, P193, DOI 10.1016/j.jesp.2014.03.013; Esses VM, 2006, INT J INTERCULT REL, V30, P653, DOI 10.1016/j.ijintrel.2006.07.002; Falomir-Pichastor JM, 2013, J EXP SOC PSYCHOL, V49, P72, DOI 10.1016/j.jesp.2012.08.016; Falomir-Pichastor JM, 2009, PERS SOC PSYCHOL B, V35, P1233, DOI 10.1177/0146167209338072; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaertner S.L., 2000, SOCIAL IDENTITY PROC, P133, DOI [https://doi.org/10.4135/9781446218617.n9, DOI 10.4135/9781446218617.N9]; Guimond S, 2013, J PERS SOC PSYCHOL; Gutierrez AS, 2010, J EXP SOC PSYCHOL, V46, P775, DOI 10.1016/j.jesp.2010.03.010; HADDOCK G, 1993, J PERS SOC PSYCHOL, V65, P1105, DOI 10.1037/0022-3514.65.6.1105; Hahn A, 2010, PSYCHOL INQ, V21, P120, DOI 10.1080/1047840X.2010.483997; Hayes A. F., 2013, BRIT J MATH STAT PSY; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Herek G. M., 1994, LESBIAN GAY PSYCHOL, P206, DOI DOI 10.4135/9781483326757.N11; Hogg M. A., 2000, EUR REV SOC PSYCHOL, V11, P223, DOI DOI 10.1080/14792772043000040; HOGG MA, 1987, BRIT J SOC PSYCHOL, V26, P325, DOI 10.1111/j.2044-8309.1987.tb00795.x; Hogg MA, 2005, ADV GROUP PROCESS, V22, P203, DOI 10.1016/S0882-6145(05)22008-8; Holoien DS, 2012, J EXP SOC PSYCHOL, V48, P562, DOI 10.1016/j.jesp.2011.09.010; Hornsey MJ, 2000, PERS SOC PSYCHOL REV, V4, P143, DOI 10.1207/S15327957PSPR0402_03; Hutchison P, 2011, J EXP SOC PSYCHOL, V47, P1155, DOI 10.1016/j.jesp.2011.06.011; Jansen WS, 2015, GROUP PROCESS INTERG, V18, P817, DOI 10.1177/1368430214566892; Jetten J, 1997, EUR J SOC PSYCHOL, V27, P635, DOI 10.1002/(SICI)1099-0992(199711/12)27:6<635::AID-EJSP835>3.0.CO;2-#; Jetten J., 2000, GROUP DYN-THEOR RES, V4, P184, DOI DOI 10.1037/1089-2699.4.2.184; Kauff M, 2012, SOC PSYCHOL PERS SCI, V3, P714, DOI 10.1177/1948550611435942; Kauff M, 2013, PERS SOC PSYCHOL B, V39, P305, DOI 10.1177/0146167212473160; Kessler T, 2010, EUR J SOC PSYCHOL, V40, P985, DOI 10.1002/ejsp.673; Kite ME, 1996, PERS SOC PSYCHOL B, V22, P336, DOI 10.1177/0146167296224002; Kochan T, 2003, HUM RESOUR MANAGE-US, V42, P3, DOI 10.1002/hrm.10061; Levin S, 2012, J EXP SOC PSYCHOL, V48, P207, DOI 10.1016/j.jesp.2011.06.019; Lie JLY, 2012, J SOC PSYCHOL, V152, P510, DOI 10.1080/00224545.2011.643325; Machunsky M, 2009, EXP PSYCHOL, V56, P156, DOI 10.1027/1618-3169.56.3.156; Machunsky M, 2009, SOC COGNITION, V27, P57, DOI 10.1521/soco.2009.27.1.57; Minescu A, 2008, J SOC ISSUES, V64, P321, DOI 10.1111/j.1540-4560.2008.00564.x; Morrison KR, 2010, PERS SOC PSYCHOL B, V36, P1648, DOI 10.1177/0146167210386118; Mummendey A, 1999, Pers Soc Psychol Rev, V3, P158, DOI 10.1207/s15327957pspr0302_4; Paluck EL, 2009, ANNU REV PSYCHOL, V60, P339, DOI 10.1146/annurev.psych.60.110707.163607; Peker M, 2010, GROUP PROCESS INTERG, V13, P525, DOI 10.1177/1368430209360205; Pendry LF, 2007, J OCCUP ORGAN PSYCH, V80, P27, DOI 10.1348/096317906X118397; Plaut VC, 2011, J PERS SOC PSYCHOL, V101, P337, DOI 10.1037/a0022832; Plaut VC, 2010, PSYCHOL INQ, V21, P77, DOI 10.1080/10478401003676501; Plaut VC, 2010, PSYCHOL INQ, V21, P168, DOI 10.1080/1047840X.2010.492753; Plaut VC, 2009, PSYCHOL SCI, V20, P444, DOI 10.1111/j.1467-9280.2009.02318.x; Rattan A, 2013, EUR J SOC PSYCHOL, V43, P12, DOI 10.1002/ejsp.1892; Reese G, 2016, INT J INTERCULT REL, V50, P39, DOI 10.1016/j.ijintrel.2015.11.003; Reese G, 2014, J COMMUNITY APPL SOC, V24, P340, DOI 10.1002/casp.2169; Reese G, 2012, POLIT PSYCHOL, V33, P683, DOI 10.1111/j.1467-9221.2012.00892.x; Richeson JA, 2004, J EXP SOC PSYCHOL, V40, P417, DOI 10.1016/j.jesp.2003.09.002; Riek BM, 2006, PERS SOC PSYCHOL REV, V10, P336, DOI 10.1207/s15327957pspr1004_4; Roccas S, 2011, J EXP SOC PSYCHOL, V47, P898, DOI 10.1016/j.jesp.2011.03.011; Rosa M, 2012, J EXP SOC PSYCHOL, V48, P669, DOI 10.1016/j.jesp.2011.12.004; Rubin M, 2012, J SOC PSYCHOL, V152, P386, DOI 10.1080/00224545.2011.614648; Rudman LA, 2007, J PERS SOC PSYCHOL, V93, P798, DOI 10.1037/0022-3514.93.5.798; Rutchick AM, 2010, BASIC APPL SOC PSYCH, V32, P109, DOI 10.1080/01973531003738353; Ryan CS, 2007, GROUP PROCESS INTERG, V10, P617, DOI 10.1177/1368430207084105; Ryan CS, 2010, J SOC ISSUES, V66, P29, DOI 10.1111/j.1540-4560.2009.01631.x; Sindic D, 2008, J EXP SOC PSYCHOL, V44, P1425, DOI 10.1016/j.jesp.2008.05.007; SPENCE JT, 1973, B PSYCHONOMIC SOC, V2, P219; Steffens MC, 2005, J HOMOSEXUAL, V49, P39, DOI 10.1300/J082v49n02_03; Steffens MC, 2016, INGROUP PROTOTYPICAL; Steffens MC, 2015, J SEX RES, V52, P898, DOI 10.1080/00224499.2014.966047; Stevens FG, 2008, J APPL BEHAV SCI, V44, P116, DOI 10.1177/0021886308314460; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Ullrich J, 2006, EUR J SOC PSYCHOL, V36, P857, DOI 10.1002/ejsp.319; Ullrich J, 2009, EUR J SOC PSYCHOL, V39, P299, DOI 10.1002/ejsp.540; van Veelen R, 2013, EXPT PSYCHOL; Verkuyten M, 2005, J PERS SOC PSYCHOL, V88, P121, DOI 10.1037/0022-3514.88.1.121; Verkuyten M., 2011, GROUP PROCESS INTERG, P1; Vorauer JD, 2010, J EXP SOC PSYCHOL, V46, P133, DOI 10.1016/j.jesp.2009.08.013; Vorauer JD, 2009, PSYCHOL SCI, V20, P838, DOI 10.1111/j.1467-9280.2009.02369.x; Waldzus S, 2005, J EXP SOC PSYCHOL, V41, P76, DOI 10.1016/j.jesp.2004.05.006; Waldzus S, 2003, J EXP SOC PSYCHOL, V39, P31, DOI 10.1016/S0022-1031(02)00507-3; Waldzus S., 2010, PSYCHOL SOCIAL CULTU, P224, DOI DOI 10.1002/9781444325447.CH10; Weber U, 2002, EUR J SOC PSYCHOL, V32, P449, DOI 10.1002/ejsp.102; Wenzel M, 2003, PERS SOC PSYCHOL B, V29, P461, DOI 10.1177/0146167202250913; Wenzel M, 2007, EUR REV SOC PSYCHOL, V18, P331, DOI 10.1080/10463280701728302; Wenzel M, 2017, CAMBRIDGE HANDBOOK OF THE PSYCHOLOGY OF PREJUDICE, P65; Whitley BE, 2009, INT J PSYCHOL RELIG, V19, P21, DOI 10.1080/10508610802471104; Wolsko C, 2000, J PERS SOC PSYCHOL, V78, P635, DOI 10.1037//0022-3514.78.4.635; Wolsko C., 2006, SOCIAL JUSTICE RES, V19, P277, DOI [10.1007/s11211-006-0014-8, DOI 10.1007/S11211-006-0014-8]; Yogeeswaran K, 2014, J PERS SOC PSYCHOL, V106, P772, DOI 10.1037/a0035830; Zick A, 2001, J SOC ISSUES, V57, P541, DOI 10.1111/0022-4537.00228	100	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178738	10.1371/journal.pone.0178738	http://dx.doi.org/10.1371/journal.pone.0178738			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9KF	28582443	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600033
J	Carriot, J; Jamali, M; Cullen, KE; Chacron, MJ				Carriot, Jerome; Jamali, Mohsen; Cullen, Kathleen E.; Chacron, Maurice J.			Envelope statistics of self-motion signals experienced by human subjects during everyday activities: Implications for vestibular processing	PLOS ONE			English	Article							PERIPHERAL INNERVATION PATTERNS; 2ND-ORDER STIMULUS FEATURES; SLOW ROTATION ROOM; SINGLE NEURONS; NATURAL SOUNDS; VISUAL-CORTEX; INFORMATION-TRANSMISSION; ELECTROSENSORY NEURONS; TEMPORAL DECORRELATION; DETECTION THRESHOLDS	There is accumulating evidence that the brain's neural coding strategies are constrained by natural stimulus statistics. Here we investigated the statistics of the time varying envelope (i.e. a second-order stimulus attribute that is related to variance) of rotational and translational self-motion signals experienced by human subjects during everyday activities. We found that envelopes can reach large values across all six motion dimensions (similar to 450 deg/s for rotations and similar to 4 G for translations). Unlike results obtained in other sensory modalities, the spectral power of envelope signals decreased slowly for low (< 2 Hz) and more sharply for high (>2 Hz) temporal frequencies and thus was not well-fit by a power law. We next compared the spectral properties of envelope signals resulting from active and passive self-motion, as well as those resulting from signals obtained when the subject is absent (i.e. external stimuli). Our data suggest that different mechanisms underlie deviation from scale invariance in rotational and translational self-motion envelopes. Specifically, active selfmotion and filtering by the human body cause deviation from scale invariance primarily for translational and rotational envelope signals, respectively. Finally, we used well-established models in order to predict the responses of peripheral vestibular afferents to natural envelope stimuli. We found that irregular afferents responded more strongly to envelopes than their regular counterparts. Our findings have important consequences for understanding the coding strategies used by the vestibular system to process natural second-order self-motion signals.	[Carriot, Jerome; Jamali, Mohsen; Cullen, Kathleen E.; Chacron, Maurice J.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Chacron, MJ (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	maurice.chacron@mcgill.ca		Chacron, Maurice/0000-0002-3032-452X	Canadian Institutes of Health Research; Canada research chairs; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002390] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada research chairs(Canada Research ChairsCGIAR); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by Canadian Institutes of Health Research (K.E.C.,M.J.C.),and the Canada research chairs (M.J.C.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1997, ADV NEUR IN, V9, P27; Attias H, 1998, ADV NEUR IN, V10, P103; Bagnall MW, 2008, NEURON, V60, P343, DOI 10.1016/j.neuron.2008.10.002; BAIRD RA, 1988, J NEUROPHYSIOL, V60, P182, DOI 10.1152/jn.1988.60.1.182; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; Baker CL, 2001, PROG BRAIN RES, V134, P171; Bertoncini J, 2009, J SPEECH LANG HEAR R, V52, P682, DOI 10.1044/1092-4388(2008/07-0273); Carriot J, 2014, J NEUROSCI, V34, P8347, DOI 10.1523/JNEUROSCI.0692-14.2014; Chang AEB, 2016, NEURON, V92, P888, DOI 10.1016/j.neuron.2016.09.059; Cohen B, 2008, PROG BRAIN RES, V171, P543, DOI 10.1016/S0079-6123(08)00677-8; CRAMER DB, 1978, ACTA OTO-LARYNGOL, V85, P74, DOI 10.3109/00016487809121426; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Cullen KE, 2011, CURR OPIN NEUROBIOL, V21, P587, DOI 10.1016/j.conb.2011.05.022; Cullen KE, 2004, J NEUROPHYSIOL, V91, P1919, DOI 10.1152/jn.00988.2003; Dan Y, 1996, J NEUROSCI, V16, P3351; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Edelman G, 1988, AUDITORY FUNCTION NE, P337; EGGERMONT JJ, 1990, HEARING RES, V43, P181, DOI 10.1016/0378-5955(90)90227-G; FAIRLEY TE, 1989, J BIOMECH, V22, P81, DOI 10.1016/0021-9290(89)90031-6; FERNANDEZ C, 1988, J NEUROPHYSIOL, V60, P167, DOI 10.1152/jn.1988.60.1.167; Fitzpatrick RC, 2015, J PHYSIOL-LONDON, V593, P2389, DOI 10.1113/JP270334; Fotowat H, 2013, J NEUROSCI, V33, P13758, DOI 10.1523/JNEUROSCI.0998-13.2013; Goldberg JM, 2000, EXP BRAIN RES, V130, P277, DOI 10.1007/s002210050033; GRAYBIEL A, 1978, AVIAT SPACE ENVIR MD, V49, P914; GRAYBIEL A, 1978, Aviation Space and Environmental Medicine, V49, P1; GRAYBIEL A, 1968, AEROSPACE MED, V39, P950; Graybiel A, 1968, 1968113 NASA, P1; GUEDRY FE, 1961, J APPL PHYSIOL, V16, P215, DOI 10.1152/jappl.1961.16.2.215; Heil P, 2003, SPEECH COMMUN, V41, P123, DOI 10.1016/S0167-6393(02)00099-7; Huang CJG, 2016, J NEUROSCI, V36, P9859, DOI 10.1523/JNEUROSCI.1433-16.2016; Huang CJG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11353; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kim CH, 2014, CLIN OTOLARYNGOL, V39, P261, DOI 10.1111/coa.12286; Kuang XT, 2012, CURR BIOL, V22, P510, DOI 10.1016/j.cub.2012.01.050; LACKNER JR, 1994, J CLIN PHARMACOL, V34, P644, DOI 10.1002/j.1552-4604.1994.tb02018.x; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAWTHER A, 1987, J ACOUST SOC AM, V82, P957, DOI 10.1121/1.395295; Levine ME, 2000, AVIAT SPACE ENVIR MD, V71, P1111; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis RF, 2011, J VESTIBUL RES-EQUIL, V21, P323, DOI 10.3233/VES-2011-0422; Lundstrom BN, 2008, NAT NEUROSCI, V11, P1335, DOI 10.1038/nn.2212; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Martinez D, 2016, J NEUROPHYSIOL, V116, P2909, DOI 10.1152/jn.00594.2016; Massot C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001365; Massot C, 2011, J NEUROPHYSIOL, V105, P1798, DOI 10.1152/jn.00910.2010; McGillivray P, 2012, J NEUROSCI, V32, P5510, DOI 10.1523/JNEUROSCI.0478-12.2012; Metzen MG, 2015, P NATL ACAD SCI USA, V112, P4791, DOI 10.1073/pnas.1418224112; Metzen MG, 2015, J NEUROSCI, V35, P3124, DOI 10.1523/JNEUROSCI.3946-14.2015; Metzen MG, 2014, J EXP BIOL, V217, P1381, DOI 10.1242/jeb.098574; Randall JM, 1997, ERGONOMICS, V40, P879, DOI 10.1080/001401397187711; REASON JT, 1970, AEROSPACE MED, V41, P73; Rodriguez FA, 2010, J NEUROSCI, V30, P15969, DOI 10.1523/JNEUROSCI.0966-10.2010; Rosenberg A, 2011, NEURON, V71, P348, DOI 10.1016/j.neuron.2011.05.044; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Sadeghi SG, 2007, J NEUROSCI, V27, P771, DOI 10.1523/JNEUROSCI.4690-06.2007; Savard M, 2011, NEUROSCIENCE, V172, P270, DOI 10.1016/j.neuroscience.2010.10.061; Schneider AD, 2015, J NEUROSCI, V35, P5522, DOI 10.1523/JNEUROSCI.3841-14.2015; Shannon RV, 1998, J ACOUST SOC AM, V104, P2467, DOI 10.1121/1.423774; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; St George RJ, 2011, J PHYSIOL-LONDON, V589, P843, DOI 10.1113/jphysiol.2010.197053; Stamper SA, 2013, J EXP BIOL, V216, P2393, DOI 10.1242/jeb.082321; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; Theunissen FE, 2014, NAT REV NEUROSCI, V15, P355, DOI 10.1038/nrn3731; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Zhang ZBD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28716; ZHOU YX, 1993, SCIENCE, V261, P98, DOI 10.1126/science.8316862	71	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178664	10.1371/journal.pone.0178664	http://dx.doi.org/10.1371/journal.pone.0178664			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575032	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300091
J	Klimley, AP; Wyman, MT; Kavet, R				Klimley, A. Peter; Wyman, Megan T.; Kavet, Robert			Chinook salmon and green sturgeon migrate through San Francisco Estuary despite large distortions in the local magnetic field produced by bridges	PLOS ONE			English	Article							ACIPENSER-MEDIROSTRIS; SACRAMENTO RIVER; ONCORHYNCHUS-TSHAWYTSCHA; BAY ESTUARY; MOVEMENTS; ORIENTATION; BEHAVIOR; SMOLTS	Empirical evidence exists that some marine animals perceive and orient to local distortions in the earth's main static geomagnetic field. The magnetic fields produced by undersea electric power cables that carry electricity from hydrokinetic energy sources to shore-based power stations may produce similar local distortions in the earth's main field. Concerns exist that animals migrating along the continental shelves might orient to the magnetic field from the cables, and move either inshore or offshore away from their normal path. We have studied the effect of the Trans Bay Cable (TBC), an 85-km long, high voltage, direct current (DC) transmission line leading underwater from Pittsburg, CA to San Francisco, CA, on fishes migrating through the San Francisco Estuary. These included Chinook salmon smolts (Oncorhynchus tshawytscha) that migrate downstream through the San Francisco Estuary to the Pacific Ocean and adult green sturgeon (Acipenser medirostris), which migrate upstream from the ocean through the estuary to their spawning habitat in the upper Sacramento River and return to the ocean after spawning occurs. Based on a detailed gradiometer survey, we found that the distortions in the earth's main field produced by bridges across the estuary were much greater than those from the Trans Bay Cable. The former anomalies exceeded the latter by an order of magnitude or more. Significant numbers of tagged Chinook salmon smolts migrated past bridges, which produced strong magnetic anomalies, to the Golden Gate Bridge, where they were recorded by dual arrays of acoustic tag-detecting monitors moored in lines across the mouth of the bay. In addition, adult green sturgeon successfully swam upstream and downstream through the estuary on the way to and from their spawning grounds. Hence, the large anomalies produced by the bridges do not appear to present a strong barrier to the natural seasonal movement patterns of salmonid smolts and adult green sturgeon.	[Klimley, A. Peter; Wyman, Megan T.] Univ Calif Davis, Dept Fish Wildlife & Conservat Biol, Biotelemetry Lab, Davis, CA 95616 USA; [Kavet, Robert] Elect Power Res Inst, Environm Sect, Palo Alto, CA USA	University of California System; University of California Davis; Electric Power Research Institute (EPRI)	Klimley, AP (corresponding author), Univ Calif Davis, Dept Fish Wildlife & Conservat Biol, Biotelemetry Lab, Davis, CA 95616 USA.	apklimley@ucdavis.edu			US Department of Energy, Office of Energy Efficiency and Renewable Energy [DE-EE0006382]; US Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, DC [M14PG00012]; Electric Power Research Institute [1-105902]	US Department of Energy, Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); US Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, DC; Electric Power Research Institute	This study was funded by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, award no. DE-EE0006382 and by the US Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, DC, through Interagency Agreement Number M14PG00012. It was funded through a cost share agreement with the Electric Power Research Institute (Project 1-105902).; We would like to kindly thank Trans Bay Cable LLC for providing cable load data for our study. We also thank the boat operators and crew who helped conduct the gradiometer survey (Ryan Battleson, Tommy Agosta, Eric Chapman, Matt Pagel, Mike Thomas, Gabe Singer, and Jamilynn Poletto) and the staff at Geometrics for their training and support (especially Mikhail Tchernychev, Ross Johnson, Randl Rivera, and Naiema Jackson). This study was funded by the US Department of Energy, Office of Energy Efficiency and Renewable Energy, award no. DE-EE0006382 and by the US Department of the Interior, Bureau of Ocean Energy Management, Environmental Studies Program, Washington, DC, through Interagency Agreement Number M14PG00012. It was funded through a cost share agreement with the Electric Power Research Institute (Project 1-105902).	Haugh CV, 1998, J NAVIGATION, V51, P35, DOI 10.1017/S0373463397007595; Hearn AR, 2014, ENVIRON BIOL FISH, V97, P851, DOI 10.1007/s10641-013-0184-9; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Kavet R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148543; Kelly JT, 2007, ENVIRON BIOL FISH, V79, P281, DOI 10.1007/s10641-006-0036-y; Kelly JT, 2012, ENVIRON BIOL FISH, V93, P151, DOI 10.1007/s10641-011-9898-8; KIRSCHVINK JL, 1986, J EXP BIOL, V120, P1; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klinowska M., 1985, AQUAT MAMM, V1, P27; Michel CJ, 2013, ENVIRON BIOL FISH, V96, P257, DOI 10.1007/s10641-012-9990-8; Putman NF, 2013, CURR BIOL, V23, P312, DOI 10.1016/j.cub.2012.12.041; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1983, CAN J FISH AQUAT SCI, V40, P1598, DOI 10.1139/f83-185; Skiles D.D., 1985, MAGNETITE BIOMINERAL, P43; TAYLOR PB, 1986, J FISH BIOL, V28, P607, DOI 10.1111/j.1095-8649.1986.tb05196.x; Tchernychev M., 2013, MAGPICK MAGNETIC MAP; Thomas MJ, 2014, ENVIRON BIOL FISH, V97, P133, DOI 10.1007/s10641-013-0132-8; Tricas T. C., 2012, CELL PHYSL SOURCE BO, P705; Westerberg H, 2008, FISHERIES MANAG ECOL, V15, P369, DOI 10.1111/j.1365-2400.2008.00630.x; Westerberg H., 2000, P149	20	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0169031	10.1371/journal.pone.0169031	http://dx.doi.org/10.1371/journal.pone.0169031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575021	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300008
J	Parashar, S; Mukhopadhyay, A				Parashar, Smriti; Mukhopadhyay, Amitabha			GTPase Sar1 regulates the trafficking and secretion of the virulence factor gp63 in Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE PROTEASE GP63; ENDOPLASMIC-RETICULUM; HEMOGLOBIN ENDOCYTOSIS; PLASMODIUM-FALCIPARUM; METALLOPROTEASE GP63; SELECTIVE EXPORT; FLAGELLAR POCKET; CYTOPLASMIC TAIL; COAT PROTEINS; VESICLE COAT	Metalloprotease gp63 (Leishmania donovani gp63 (Ldgp63)) is a critical virulence factor secreted by Leishmania. However, how newly synthesized Ldgp63 exits the endoplasmic reticulum (ER) and is secreted by this parasite is unknown. Here, we cloned, expressed, and characterized the GTPase LdSar1 and other COPII components like LdSec23, LdSec24, LdSec13, and LdSec31 from Leishmania to understand their role in ER exit of Ldgp63. Using dominant-positive (LdSar1: H74L) and dominant-negative (LdSar1: T34N) mutants of LdSar1, we found that GTP-bound LdSar1 specifically binds to LdSec23, which binds, in turn, with LdSec24(1-702) to form a prebudding complex. Moreover, LdSec13 specifically interacted with His(6)-LdSec31(1-603), and LdSec31 bound the prebudding complex via LdSec23. Interestingly, dileucine 594/595 and valine 597 residues present in the Ldgp63 C-terminal domain were critical for binding with LdSec24(703-966), and GFP-Ldgp63(L594A/) (L595A) or GFP-Ldgp63(V597S) mutants failed to exit from the ER. Moreover, Ldgp63-containing COPII vesicle budding from the ER was inhibited by LdSar1: T34N in an in vitro budding assay, indicating that GTP-bound LdSar1 is required for budding of Ldgp63-containing COPII vesicles. To directly demonstrate the function of LdSar1 in Ldgp63 trafficking, we coexpressed RFP-Ldgp63 along with LdSar1: WT-GFP or LdSar1: T34N-GFP and found that LdSar1: T34N overexpression blocks Ldgp63 trafficking and secretion in Leishmania. Finally, we noted significantly compromised survival of LdSar1: T34N-GFP-overexpressing transgenic parasites in macrophages. Taken together, these results indicated that Ldgp63 interacts with the COPII complex via LdSec24 for Ldgp63 ER exit and subsequent secretion.	[Parashar, Smriti; Mukhopadhyay, Amitabha] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Cell Biol Lab, New Delhi 110067, India.	amitabha@nii.res.in			National Institute of Immunology (NII) from the Department of Biotechnology, Government of India; Department of Science and Technology, Government of India [SR/S2/JCB-24/2009]; Council of Scientific and Industrial Research, Government of India [09/485(0236)/2012-EMR-1]	National Institute of Immunology (NII) from the Department of Biotechnology, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a core grant of the National Institute of Immunology (NII) from the Department of Biotechnology, Government of India and JC Bose Fellowship SR/S2/JCB-24/2009 from the Department of Science and Technology, Government of India (to A. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Council of Scientific and Industrial Research, Government of India, Fellowship 09/485(0236)/2012-EMR-1.	Adisa A, 2001, J CELL SCI, V114, P3377; Agarwal S, 2013, BBA-MOL CELL RES, V1833, P1065, DOI 10.1016/j.bbamcr.2013.01.006; Bahl S, 2015, J BIOL CHEM, V290, P29993, DOI 10.1074/jbc.M115.670018; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bhattacharya N, 2012, J MOL BIOL, V420, P324, DOI 10.1016/j.jmb.2012.04.024; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Ding JZ, 2016, MOL BIOL CELL, V27, P127, DOI 10.1091/mbc.E15-09-0631; Duncan R., 2011, MOL BIOL INT, V2011; Ellis M, 2002, J BIOL CHEM, V277, P27968, DOI 10.1074/jbc.M202047200; Faso C, 2013, CELL MICROBIOL, V15, P537, DOI 10.1111/cmi.12054; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Guha R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006406; Isnard A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00072; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MCGWIRE B, 1994, MOL BIOCHEM PARASIT, V66, P345, DOI 10.1016/0166-6851(94)90160-0; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; MOSSER DM, 1985, J IMMUNOL, V135, P2785; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NAKANO A, 1994, J BIOCHEM-TOKYO, V116, P243, DOI 10.1093/oxfordjournals.jbchem.a124513; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Olivier M, 2012, MICROBES INFECT, V14, P1377, DOI 10.1016/j.micinf.2012.05.014; Patel N, 2008, P NATL ACAD SCI USA, V105, P3980, DOI 10.1073/pnas.0800404105; Rastogi R, 2016, J BIOL CHEM, V291, P14732, DOI 10.1074/jbc.M116.716514; RUSSELL DG, 1986, J IMMUNOL, V136, P2613; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Shanmugam SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep37058; Sharma DK, 2000, BIOCHEM J, V351, P717, DOI 10.1042/0264-6021:3510717; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Singh SB, 2003, EMBO J, V22, P5712, DOI 10.1093/emboj/cdg557; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Struck NS, 2008, J CELL SCI, V121, P2123, DOI 10.1242/jcs.021154; Wickert H, 2003, MOL BIOCHEM PARASIT, V129, P209, DOI 10.1016/S0166-6851(03)00117-8; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0	56	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12111	12125		10.1074/jbc.M117.784033	http://dx.doi.org/10.1074/jbc.M117.784033			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28576830	Green Published, hybrid			2022-12-26	WOS:000406053300011
J	Dold, L; Luda, C; Schwarze-Zander, C; Boesecke, C; Hansel, C; Nischalke, HD; Lutz, P; Mohr, R; Wasmuth, JC; Strassburg, CP; Trebicka, J; Rockstroh, JK; Spengler, U				Dold, Leona; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Hansel, Cordula; Nischalke, Hans-Dieter; Lutz, Philipp; Mohr, Raphael; Wasmuth, Jan-Christian; Strassburg, Christian P.; Trebicka, Jonel; Rockstroh, Juergen Kurt; Spengler, Ulrich			Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; TRANSIENT ELASTOGRAPHY; NONALCOHOLIC STEATOHEPATITIS; CONFERS SUSCEPTIBILITY; NONINVASIVE EVALUATION; HEPATIC STEATOSIS; WIDE ASSOCIATION; MORBID-OBESITY; PNPLA3; CIRRHOSIS	Hepatic steatosis can occur with any antiretroviral therapy (cART). Although single nucleotide polymorphisms (SNPs) have been identified to predispose to alcoholic and non-alcoholic fatty liver disease, their role for treatment-associated steatosis in HIV-positive patients remains unclear. We determined the frequency of PNPLA3 (rs738409), CSPG3/NCAN (rs2228603), GCKR (rs780094), PPP1R3B (rs4240624), TM6SF (rs8542926), LYPLAL1 (rs12137855) and MBOAT7 (rs626283) by RT-PCR in 117 HIV-positive patients on cART and stratified participants based on their "controlled attenuation parameter" (CAP) into probable (CAP: 215-300 dB/m) and definite (CAP>300 dB/m) hepatic steatosis. We analyzed CAP values and routine metabolic parameters according to the allele frequencies. Sixty-five (55.6%) and 13 (11.1%) patients were allocated to probable and definite steatosis. CAP values (p = 0.012) and serum triglycerides (p = 0.043) were increased in carriers of the GCKR (rs780094) A allele. Cox logistic regression identified triglycerides (p = 0.006), bilirubin (p = 0.021) and BMI (p = 0.068), but not the genetic parameters as risk factors for the occurrence of hepatic steatosis. Taken together, according to the limited sample size, this exploratory study generates the hypothesis that genetic polymorphisms seem to exert minor effects on the risk for fatty liver disease in HIV-positive patients on cART. Nevertheless, SNPs may modify metabolic complications once metabolic abnormalities have developed. Hence, subsequent analysis of a larger cohort is needed.	[Dold, Leona; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Nischalke, Hans-Dieter; Lutz, Philipp; Mohr, Raphael; Wasmuth, Jan-Christian; Strassburg, Christian P.; Trebicka, Jonel; Rockstroh, Juergen Kurt; Spengler, Ulrich] Rheinische Friedrich Wilhelms Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Dold, Leona; Luda, Carolin; Schwarze-Zander, Carolynne; Boesecke, Christoph; Nischalke, Hans-Dieter; Lutz, Philipp; Mohr, Raphael; Wasmuth, Jan-Christian; Strassburg, Christian P.; Rockstroh, Juergen Kurt; Spengler, Ulrich] German Ctr Infect Res DZIF, Partner Site Cologne Bonn, Bonn, Germany; [Hansel, Cordula] Univ Aachen, Dept Internal Med 3, Aachen, Germany	University of Bonn; German Center for Infection Research; RWTH Aachen University	Dold, L (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Dold, L (corresponding author), German Ctr Infect Res DZIF, Partner Site Cologne Bonn, Bonn, Germany.	Leona.Dold@ukb.uni-bonn.de		Nischalke, Hans Dieter/0000-0002-3457-0023; Mohr, Raphael/0000-0003-2403-4275; Lutz, Philipp/0000-0002-4921-200X	German center for infection research (DZIF)	German center for infection research (DZIF)	The study was supported by a grant from the German center for infection research (DZIF) to US and JKR. The funding sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Ahn JM, 2016, GUT LIVER, V10, P295, DOI 10.5009/gnl15155; Anstee QM, 2015, SEMIN LIVER DIS, V35, P270, DOI 10.1055/s-0035-1562947; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Buch S, 2015, NAT GENET, V47, P1443, DOI 10.1038/ng.3417; CANNINGS C, 1968, ANN HUM GENET, V31, P421, DOI 10.1111/j.1469-1809.1968.tb00575.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Crum-Cianflone N, 2010, CLIN GASTROENTEROL H, V8, P183, DOI 10.1016/j.cgh.2009.09.025; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Dold L BC, 2013, CLIN RES HIV AIDS PR; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Jimenez-Sousa MA, 2016, AIDS, V30, P465, DOI 10.1097/QAD.0000000000000908; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Karlas T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091987; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kwok R, 2015, GUT; Leon-Mimila P, 2015, EXP MOL PATHOL, V98, P178, DOI 10.1016/j.yexmp.2015.01.012; Lin YC, 2014, AM J CLIN NUTR, V99, P869, DOI 10.3945/ajcn.113.079749; Macias J, 2014, AIDS, V28, P1279, DOI 10.1097/QAD.0000000000000248; Mahdessian H, 2014, P NATL ACAD SCI USA, V111, P8913, DOI 10.1073/pnas.1323785111; Morse CG, 2015, CLIN INFECT DIS, V60, P1569, DOI 10.1093/cid/civ101; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Nischalke HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027087; Perez-Matute P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/493413; Polyzos SA, 2012, J CLIN GASTROENTEROL, V46, P272, DOI 10.1097/MCG.0b013e31824587e0; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sagir A, 2015, INFECT DIS THER, V4, P355, DOI 10.1007/s40121-015-0073-y; Sasso M, 2012, CLIN RES HEPATOL GAS, V36, P13, DOI 10.1016/j.clinre.2011.08.001; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2011, J HEPATOL, V55, P906, DOI 10.1016/j.jhep.2011.01.028	36	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178685	10.1371/journal.pone.0178685	http://dx.doi.org/10.1371/journal.pone.0178685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594920	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200043
J	Hijmans, RS; Shrestha, P; Sarpong, KA; Yazdani, S; el Masri, R; de Jong, WHA; Navis, G; Vives, RR; van den Born, J				Hijmans, Ryanne S.; Shrestha, Pragyi; Sarpong, Kwaku A.; Yazdani, Saleh; el Masri, Rana; de Jong, Wilhelmina H. A.; Navis, Gerjan; Vives, Romain R.; van den Born, Jacob			High sodium diet converts renal proteoglycans into pro-inflammatory mediators in rats	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; L-SELECTIN; BLOOD-PRESSURE; SALT INTAKE; RESTRICTION; GLYCOSAMINOGLYCANS; BINDING; INHIBITION; BLOCKADE; LIGANDS	Background High dietary sodium aggravates renal disease by affecting blood pressure and by its recently shown pro-inflammatory and pro-fibrotic effects. Moreover, pro-inflammatory modification of renal heparan sulfate (HS) can induce tissue remodeling. We aim to investigate if high sodium intake in normotensive rats converts renal HS into a pro-inflammatory phenotype, able to bind more sodium and orchestrate inflammation, fibrosis and lymphangiogenesis. Methods Wistar rats received a normal diet for 4 weeks, or 8% NaCl diet for 2 or 4 weeks. Blood pressure was monitored, and plasma, urine and tissue collected. Tissue sodium was measured by flame spectroscopy. Renal HS and tubulo-interstitial remodeling were studied by biochemical, immunohistochemical and qRT-PCR approaches. Results High sodium rats showed a transient increase in blood pressure (week 1; p < 0.01) and increased sodium excretion (p < 0.05) at 2 and 4 weeks compared to controls. Tubulo-interstitial T-cells, myofibroblasts and mRNA levels of VCAM1, TGF-beta 1 and collagen type III significantly increased after 4 weeks (all p < 0.05). There was a trend for increased macrophage infiltration and lymphangiogenesis (both p = 0.07). Despite increased dermal sodium over time (p < 0.05), renal concentrations remained stable. Renal HS of high sodium rats showed increased sulfation (p = 0.05), increased L-selectin binding to HS (p < 0,05), and a reduction of sulfation-sensitive anti-HS mAbs JM403 (p < 0.001) and 10E4 (p < 0.01). Hyaluronan expression increased under high salt conditions (p < 0.01) without significant changes in the chondroitin sulfate proteoglycan versican. Statistical analyses showed that sodium-induced tissue remodeling responses partly correlated with observed HS changes. Conclusion We show that high salt intake by healthy normotensive rats convert renal HS into high sulfated pro-inflammatory glycans involved in tissue remodeling events, but not in increased sodium storage.	[Hijmans, Ryanne S.; Shrestha, Pragyi; Sarpong, Kwaku A.; Yazdani, Saleh; Navis, Gerjan; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands; [el Masri, Rana; Vives, Romain R.] Univ Grenoble Alpes, IBS, Grenoble, France; [de Jong, Wilhelmina H. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Yazdani, Saleh] Katholieke Univ Leuven, Lab Nephrol, Dept Microbiol & Immunol, Leuven, Belgium	University of Groningen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Groningen; KU Leuven	Hijmans, RS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Internal Med, Groningen, Netherlands.	r.s.hijmans@umcg.nl						Adepu S, 2014, AM J TRANSPLANT, V14, P2328, DOI 10.1111/ajt.12842; Alhasan AA, 2014, J BIOL CHEM, V289, P20295, DOI 10.1074/jbc.M114.554691; BLIZARD DA, 1991, CLIN EXP HYPERTENS A, V13, P687, DOI 10.3109/10641969109042072; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Celie JWAM, 2005, J BIOL CHEM, V280, P26965, DOI 10.1074/jbc.M502188200; Celie JWAM, 2005, J IMMUNOL METHODS, V298, P155, DOI 10.1016/j.jim.2005.01.009; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; El Masri R., 2016, GLYCOCONJ J; Faller CE, 2015, J PHYS CHEM B, V119, P6063, DOI 10.1021/jp511431q; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Heidari-Hamedani G, 2015, CELL SIGNAL, V27, P2054, DOI 10.1016/j.cellsig.2015.07.017; Hofmeister L, 2015, PFLUG ARCH EUR J PHY, V467, P551, DOI 10.1007/s00424-014-1685-x; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Humalda JK, 2014, CURR OPIN NEPHROL HY, V23, P533, DOI 10.1097/MNH.0000000000000073; HUNTER GK, 1988, ARCH BIOCHEM BIOPHYS, V260, P161, DOI 10.1016/0003-9861(88)90437-7; HUNTER GK, 1987, ANAL BIOCHEM, V165, P435, DOI 10.1016/0003-2697(87)90293-4; Ito T, 2016, EUR J INTERN MED, V28, P70, DOI 10.1016/j.ejim.2015.10.013; Katta K, 2013, AM J PATHOL, V183, P1571, DOI 10.1016/j.ajpath.2013.07.030; Keyzer CA, 2015, CLIN J AM SOC NEPHRO, V10, P2119, DOI 10.2215/CJN.03830415; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Kwakernaak AJ, 2014, LANCET DIABETES ENDO, V2, P385, DOI 10.1016/S2213-8587(14)70030-0; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Linz P, 2015, NMR BIOMED, V28, P54, DOI 10.1002/nbm.3224; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; McMahon EJ, 2013, J AM SOC NEPHROL, V24, P2096, DOI 10.1681/ASN.2013030285; Oberleithner H, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00188; Oberleithner H, 2012, ANN MED, V44, pS143, DOI 10.3109/07853890.2011.653397; Pegeot M, 2015, GLYCOBIOLOGY, V25, P151, DOI 10.1093/glycob/cwu114; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1917, DOI 10.1681/ASN.2012040390; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schnabelrauch M, 2013, CURR MED CHEM, V20, P2501, DOI 10.2174/0929867311320200001; Slagman MCJ, 2012, NEPHROL DIAL TRANSPL, V27, P978, DOI 10.1093/ndt/gfr402; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; Titze J, 2004, AM J PHYSIOL-HEART C, V287, pH203, DOI 10.1152/ajpheart.01237.2003; Titze J, 2003, AM J PHYSIOL-RENAL, V285, pF1108, DOI 10.1152/ajprenal.00200.2003; Titze J, 2009, SEMIN DIALYSIS, V22, P253, DOI 10.1111/j.1525-139X.2009.00569.x; Uchimura K, 2006, TRENDS IMMUNOL, V27, P559, DOI 10.1016/j.it.2006.10.007; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Zante A, 2003, BIOCHEM SOC T, V31, P313, DOI 10.1042/BST0310313; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1991, LAB INVEST, V65, P287; VANKUPPEVELT THMSM, 1994, MICROSC RES TECHNIQ, V28, P125, DOI 10.1002/jemt.1070280204; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vassal-Stermann E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047933; Vegter S, 2012, J AM SOC NEPHROL, V23, P165, DOI 10.1681/ASN.2011040430; Zaferani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106732	54	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178940	10.1371/journal.pone.0178940	http://dx.doi.org/10.1371/journal.pone.0178940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594849	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200068
J	Gutierrez, AM; De la Cruz-Sanchez, E; Montes, A; Sotillo, J; Gutierrez-Panizo, C; Fuentes, P; Tornel, PL; Cabezas-Herrera, J				Maria Gutierrez, Ana; De la Cruz-Sanchez, Ernesto; Montes, Ana; Sotillo, Juan; Gutierrez-Panizo, Candido; Fuentes, Pablo; Luis Tornel, Pedro; Cabezas-Herrera, Juan			Easy and non-invasive disease detection in pigs by adenosine deaminase activity determinations in saliva	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; LIPID-PEROXIDATION; ADA; ISOENZYMES	The quantification of adenosine deaminase (ADA) in porcine saliva samples has been analyzed for its use as a marker of disease. First, an analytical validation of the enzymatic assay used for ADA measurements was performed. Afterwards, saliva samples were collected from 50 healthy animals and 64 animals with different symptoms of disease, which were divided into local inflammation, gastrointestinal disorder, respiratory disorder and growth retardation. To optimize ADA measurements, total ADA (tADA), specific ADA (sADA) and ADA isoforms 1 and 2 activities were calculated. Moreover, to preliminarily estimate the diagnostic value of tADA activity measurements for disease detection, receiver operating characteristic (ROC) analyses was performed and compared to the results obtained for salivary acute phase proteins, haptoglobin (Hp) and C-reactive protein (CRP). The salivary levels of tADA activity were significantly elevated in animals with local inflammation, gastrointestinal disorder and respiratory disorder. The calculation of the different ADA activities did not provide additional information to tADA activity quantification for disease detection. The diagnostic value of tADA activity was superior to those observed for Hp and CRP measurements in the present study. It might be concluded that ADA analysis in saliva could be used as a simple, rapid, economic and non-invasive diagnostic tool in porcine production in field conditions.	[Maria Gutierrez, Ana; Montes, Ana; Sotillo, Juan; Gutierrez-Panizo, Candido] Univ Murcia, Dept Anim Med & Surg, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [De la Cruz-Sanchez, Ernesto] Univ Murcia, Dept Phys Act & Sport, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Fuentes, Pablo] Cefu SA, Murcia, Spain; [Luis Tornel, Pedro] Univ Hosp Virgen de la Arrixaca, Clin Anal Serv, Murcia, Spain; [Cabezas-Herrera, Juan] Univ Hosp Virgen de la Arrixaca, Mol Therapy & Biomarkers Res Grp, Clin Anal Serv, IMIB Arrixaca, Murcia, Spain	University of Murcia; University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Gutierrez, AM (corresponding author), Univ Murcia, Dept Anim Med & Surg, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	agmontes@um.es	De la Cruz-Sánchez, Ernesto/F-7406-2010; Gutiérrez, Ana/AAF-8423-2019; Gutiérrez, Ana/J-5387-2015; CABEZAS-HERRERA, JUAN/J-9434-2015	De la Cruz-Sánchez, Ernesto/0000-0002-4718-7058; Gutiérrez, Ana/0000-0002-1052-935X; Gutiérrez, Ana/0000-0002-1052-935X; CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Montes Cepeda, Ana Maria/0000-0003-4160-5754; SOTILLO MESANZA, JUAN/0000-0003-3268-3144				Aldrich MB, 2000, BIOCHEM BIOPH RES CO, V272, P311, DOI 10.1006/bbrc.2000.2773; Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; Baldissera MD, 2016, MICROB PATHOGENESIS, V99, P191, DOI 10.1016/j.micpath.2016.08.028; Beyazit Y, 2012, J CROHNS COLITIS, V6, P102, DOI 10.1016/j.crohns.2011.07.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakal B, 2010, J CLIN LAB ANAL, V24, P323, DOI 10.1002/jcla.20410; Chielle EO, 2015, CLIN CHEM LAB MED, V53, P1041, DOI 10.1515/cclm-2014-1086; Demir Gulseren, 2014, Open Rheumatol J, V8, P24, DOI 10.2174/1874312901408010024; Gakis C, 1996, EUR RESPIR J, V9, P632, DOI 10.1183/09031936.96.09040632; Groschl M, 2001, STEROIDS, V66, P737, DOI 10.1016/S0039-128X(01)00111-8; Gutierrez AM, 2013, VET J, V196, P167, DOI 10.1016/j.tvjl.2012.10.003; Gutierrez AM, 2013, VET IMMUNOL IMMUNOP, V151, P73, DOI 10.1016/j.vetimm.2012.10.007; Gutierrez AM, 2012, ANIMAL, V6, P321, DOI 10.1017/S1751731111001662; Gutierrez AM, 2009, VET IMMUNOL IMMUNOP, V132, P218, DOI 10.1016/j.vetimm.2009.06.013; Hashikawa T, 2004, FASEB J, V18, P131, DOI 10.1096/fj.03-0011fje; Jadhav AA, 2012, ARCH PHYSIOL BIOCHEM, V118, P6, DOI 10.3109/13813455.2011.645545; Khodadadi I, 2011, CLIN BIOCHEM, V44, P980, DOI 10.1016/j.clinbiochem.2011.05.020; Khosrowbeygi A, 2016, ENDOCRINE, V51, P245, DOI 10.1007/s12020-015-0697-4; Luo FY, 2016, FASEB J, V30, P874, DOI 10.1096/fj.15-274845; Rai AK, 2011, PARASITE IMMUNOL, V33, P632, DOI 10.1111/j.1365-3024.2011.01315.x; Rai B, 2011, CLIN ORAL INVEST, V15, P347, DOI 10.1007/s00784-010-0404-z; Ramirez A, 2012, PREV VET MED, V104, P292, DOI 10.1016/j.prevetmed.2011.11.008; Saghiri R, 2012, RHEUMATOL INT, V32, P1633, DOI 10.1007/s00296-011-1836-8; UNGERER JPJ, 1992, CLIN CHEM, V38, P1322; Vinapamula KS, 2015, J CLIN DIAGN RES, V9, pBC8, DOI 10.7860/JCDR/2015/14296.6483	25	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179299	10.1371/journal.pone.0179299	http://dx.doi.org/10.1371/journal.pone.0179299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594948	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200115
J	Nguyen, PH; Sanghvi, T; Tran, LM; Afsana, K; Mahmud, Z; Aktar, B; Haque, R; Menon, P				Nguyen, Phuong Hong; Sanghvi, Tina; Tran, Lan Mai; Afsana, Kaosar; Mahmud, Zeba; Aktar, Bachera; Haque, Raisul; Menon, Purnima			The nutrition and health risks faced by pregnant adolescents: Insights from a cross-sectional study in Bangladesh	PLOS ONE			English	Article							RURAL BANGLADESH; CHILDREN; GIRLS	Little is known about nutrition and well-being indicators of pregnant adolescents and the availability and use of nutrition interventions delivered through maternal, newborn, and child health (MNCH) programs. This study compared the differences between pregnant adolescents and adult pregnant women in services received, and in maternal and child nutrition and health conditions. A survey of 2,000 recently delivered women with infants <6 months of age was carried out in 20 sub-districts in Bangladesh where MNCH program is being implemented. Differences in service use and outcomes between pregnant adolescents and adult women were tested using multivariate regression models. The coverage of antenatal care and nutrition services was similar for adolescent and adult mothers. Compared to adult mothers, adolescent mothers had significantly fewer ownership of assets and lower decision making power. Adolescent mothers weighed significantly less than adult women (45.8 vs 47.1 kg, p = 0.001), and their body mass index was significantly lower (19.7 vs 21.3, p = 0.001). Adolescents recovered later and with greater difficulty after childbirth. Infants of adolescent mothers had significant lower height-for-age z-score (-0.89 vs -0.74, p = 0.04), lower weight-for age z-score (-1.21 vs -1.08, p = 0.02) and higher underweight prevalence (22.4% vs 17.9%, p = 0.04) compared to infants of adult women. In conclusion, this study confirms that adolescent pregnancy poses substantial risks for maternal and infant outcomes, and emphasizes that these risks are significant even where services during pregnancy are available and accessed. A focus on preventing adolescent pregnancy is imperative, while also strengthening health and nutrition services for all pregnant women, whether adult or adolescent.	[Nguyen, Phuong Hong; Menon, Purnima] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Sanghvi, Tina; Tran, Lan Mai; Mahmud, Zeba] FHI 360, Washington, DC USA; [Afsana, Kaosar; Aktar, Bachera; Haque, Raisul] BRAC, Dhaka, Bangladesh	CGIAR; International Food Policy Research Institute (IFPRI); Bangladesh Rural Advancement Committee BRAC	Nguyen, PH (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	P.H.Nguyen@cgiar.org	Aktar, Bachera/AFS-4218-2022	Aktar, Bachera/0000-0003-0242-1792	Canadian Department of Foreign Affairs, Trade and Development [7060808]	Canadian Department of Foreign Affairs, Trade and Development	This work was supported by the Canadian Department of Foreign Affairs, Trade and Development Grant No. 7060808, managed by FHI 360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah K, 2007, ACTA PAEDIATR, V96, P396, DOI 10.1111/j.1651-2227.2007.00117.x; [Anonymous], 2013, DHAKA BANGLADESH BAN; BRAC, MAT NEON CHILD HLTH; Branca F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4173; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cogill B, 2003, ANTHROPOMETRIC INDIC; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; Firoz T, 2013, B WORLD HEALTH ORGAN, V91, P794, DOI 10.2471/BLT.13.117564; Gwatkin D R, 2007, Niger J Clin Pract, V10, P272; ICN, 2014, 2 INT C NUTR C OUTC; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Loaiza E, ADOLESCENT PREGNANCY; Martorell R, 2015, PAHO USAID SEMINAR; Nahar Q, DESIRABLE DIETARY PA; Nasreen H, 2010, RES MONOGRAPH SERIES, V32; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rahman A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1632-y; SUGARMAN RG, 1984, CAN FAM PHYSICIAN, V30, P2121; Temmerman M, 2015, BMJ-BRIT MED J, V351; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2014, 2  CHANC 2 DEC; WHO, 2010, NUTR LANDS INF SYST; WHO: World Health Organization, 2010, WHO CHILD GROWTH STA; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2015, GLOB STRAT WOM CHILD; World Health Organization, AD PREGN; World Health Organization, 2013, ESS NUTR ACT IMPR MA; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; World Health Organization (WHO), 2010, MEAS HLTH DIS MAN WH	30	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178878	10.1371/journal.pone.0178878	http://dx.doi.org/10.1371/journal.pone.0178878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594949	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200061
J	Salvagno, L; Albarella, U				Salvagno, Lenny; Albarella, Umberto			A morphometric system to distinguish sheep and goat postcranial bones	PLOS ONE			English	Article							SHETLAND SHEEP; CAPRA; OVIS; SEX	Distinguishing between the bones of sheep and goat is a notorious challenge in zooarchaeology. Several methodological contributions have been published at different times and by various people to facilitate this task, largely relying on a macro-morphological approach. This is now routinely adopted by zooarchaeologists but, although it certainly has its value, has also been shown to have limitations. Morphological discriminant criteria can vary in different populations and correct identification is highly dependent upon a researcher's experience, availability of appropriate reference collections, and many other factors that are difficult to quantify. There is therefore a need to establish a more objective system, susceptible to scrutiny. In order to fulfil such a requirement, this paper offers a comprehensive morphometric method for the identification of sheep and goat postcranial bones, using a sample of more than 150 modern skeletons as a basis, and building on previous pioneering work. The proposed method is based on measurements-some newly created, others previously published-and its use is recommended in combination with the more traditional morphological approach. Measurement ratios, used to translate morphological traits into biometrical attributes, are demonstrated to have substantial diagnostic potential, with the vast majority of specimens correctly assigned to species. The efficacy of the new method is also tested with Discriminant Analysis, which provides a successful verification of the biometrical indices, a statistical means to select the most promising measurements, and an additional line of analysis to be used in conjunction with the others.	[Salvagno, Lenny; Albarella, Umberto] Univ Sheffield, Dept Archaeol, Northgate House, Sheffield, S Yorkshire, England	University of Sheffield	Salvagno, L (corresponding author), Univ Sheffield, Dept Archaeol, Northgate House, Sheffield, S Yorkshire, England.	prp12ls@sheffield.ac.uk			University of Sheffield; Arts and Humanities Research Council (AHRC) [129416016]; British Academy [MD130100]	University of Sheffield; Arts and Humanities Research Council (AHRC); British Academy	This paper originates from aspects of Lenny Salvagno's PhD project funded by the University of Sheffield and the Arts and Humanities Research Council (AHRC) (grant n.129416016; http://www.ahrc.ac.uk/funding/). Umberto Albarella carried out part of the work on this paper while on research leave funded by the British Academy (grant n. MD130100; http://www.britac.ac.uk/ funding-opportunities).	Baxter M. J., 2003, STAT ARCHAEOLOGY; Boessneck J., 1969, SCI ARCHAEOLOGY COMP, P311; Boessneck J, 1964, KUHN ARCH, V78, P129; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Buitenhuis H., 1995, ARCHAEOLOGY NEAR E 2, P140; Burns RB, 2008, BUSINESS RES METHODS, P590; Clutton-Brock J., 1990, Bulletin of the British Museum (Natural History) Zoology, V56, P1; Cornevin C., 1891, B SOC ANTHR LON, V10, P47, DOI [10.3406/linly.1891.16337, DOI 10.3406/LINLY.1891.16337]; Davis S.J.M., 2016, WHAT BONES TELL USEL, V12, P35; Davis SJM, 1996, J ARCHAEOL SCI, V23, P593, DOI 10.1006/jasc.1996.0056; DAVIS SJM, 1983, J ZOOL, V199, P521; Driesch A. von den, 1976, PEABODY MUSEUM B, V1; Fernandez H, 2001, THESIS U GENEVE GENE; Field A., DISCOVERING STAT USI, P3; Gromova V. I., 1953, OSTEOLOGICESKIE OTLI, V10, P3; Helmer D., 1994, FICHES DOSTE OLOGIE; Hildebrand M., 1955, CALIF FISH GAME, V42, P327; Jonhstone C.J., 2004, THESIS U YORK DEP AR; Kratochvil Z., 1969, ACTA VET BRNO, V38, P483; Noddle B., 1994, S ASS ENV ARCHAEOLOG, V12, P117; Onar V, 2008, REV MED VET-TOULOUSE, V159, P150; PAYNE S, 1987, J ARCHAEOL SCI, V14, P609, DOI 10.1016/0305-4403(87)90079-3; Payne S, 1973, AS, V23, P292; Payne S., 1988, ARCHAEOZOOLOGIA, V2, P27; Payne S.A., 1969, DOMEST EXPLOIT PLANT, P295; Popkin PRW, 2012, J ARCHAEOL SCI, V39, P1775, DOI 10.1016/j.jas.2012.01.018; PRUMMEL W, 1986, J ARCHAEOL SCI, V13, P567, DOI 10.1016/0305-4403(86)90041-5; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Rowley-Conwy P, 1998, J ARCHAEOL SCI, V25, P251, DOI 10.1006/jasc.1997.0204; Salvagno L., 2020, ANN MED HEALTH SCI R; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Ulijaszek SJ., 1994, ANTHROPOMETRY INDIVI, P30, DOI DOI 10.1017/CBO9780511600500.004; Utemohle C.J., 1982, AM J PHYS ANTHROPOL, V57, P303; Zeder MA, 2010, J ARCHAEOL SCI, V37, P2887, DOI 10.1016/j.jas.2010.06.032; Zeder MA, 2010, J ARCHAEOL SCI, V37, P225, DOI 10.1016/j.jas.2009.10.002	36	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178543	10.1371/journal.pone.0178543	http://dx.doi.org/10.1371/journal.pone.0178543			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594831	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200037
J	Ban, JW; Wallace, E; Stevens, R; Perera, R				Ban, Jong-Wook; Wallace, Emma; Stevens, Richard; Perera, Rafael			Why do authors derive new cardiovascular clinical prediction rules in the presence of existing rules? A mixed methods study	PLOS ONE			English	Article							OTTAWA ANKLE RULES; CORONARY-ARTERY-DISEASE; DEEP VENOUS THROMBOSIS; VENTRICULAR EJECTION FRACTION; SUSPECTED PULMONARY-EMBOLISM; MYOCARDIAL-INFARCTION; HEART-FAILURE; PRIMARY-CARE; RISK SCORE; ATRIAL-FIBRILLATION	Background Researchers should examine existing evidence to determine the need for a new study. It is unknown whether developers evaluate existing evidence to justify new cardiovascular clinical prediction rules (CPRs). Objective We aimed to assess whether authors of cardiovascular CPRs cited existing CPRs, why some authors did not cite existing CPRs, and why they thought existing CPRs were insufficient. Method Derivation studies of cardiovascular CPRs from the International Register of Clinical Prediction Rules for Primary Care were evaluated. We reviewed the introduction sections to determine whether existing CPRs were cited. Using thematic content analysis, the stated reasons for determining existing cardiovascular CPRs insufficient were explored. Study authors were surveyed via e-mail and post. We asked whether they were aware of any existing cardiovascular CPRs at the time of derivation, how they searched for existing CPRs, and whether they thought it was important to cite existing CPRs. Results Of 85 derivation studies included, 48 (56.5%) cited existing CPRs, 33 (38.8%) did not cite any CPR, and four (4.7%) declared there was none to cite. Content analysis identified five categories of existing CPRs insufficiency related to: (1) derivation (5 studies; 11.4% of 44), (2) construct (31 studies; 70.5%), (3) performance (10 studies; 22.7%), (4) transferability (13 studies; 29.5%), and (5) evidence (8 studies; 18.2%). Authors of 54 derivation studies (71.1% of 76 authors contacted) responded to the survey. Twenty-five authors (46.3%) reported they were aware of existing CPR at the time of derivation. Twenty-nine authors (53.7%) declared they conducted a systematic search to identify existing CPRs. Most authors (90.7%) indicated citing existing CPRs was important. Conclusion Cardiovascular CPRs are often developed without citing existing CPRs although most authors agree it is important. Common justifications for new CPRs concerned construct, including choice of predictor variables or relevance of outcomes. Developers should clearly justify why new CPRs are needed with reference to existing CPRs to avoid unnecessary duplication.	[Ban, Jong-Wook] Univ Oxford, Ctr Evidence Based Med, Evidence Based Hlth Care Programme, Oxford, England; [Wallace, Emma] Royal Coll Surgeons Ireland, HRB Ctr Primary Care Res, Dublin, Ireland; [Stevens, Richard; Perera, Rafael] Univ Oxford, Med Sci Div, Nuffield Dept Primary Care Hlth Sci, Oxford, England	University of Oxford; Health Research Board - Ireland; Royal College of Surgeons - Ireland; University of Oxford	Ban, JW (corresponding author), Univ Oxford, Ctr Evidence Based Med, Evidence Based Hlth Care Programme, Oxford, England.	jong-wook.ban@conted.ox.ac.uk	Ban, Jong-Wook/N-4285-2019	Ban, Jong-Wook/0000-0002-6433-1250; Stevens, Richard/0000-0002-9258-4060; Perera, Rafael/0000-0003-2418-2091; wallace, emma/0000-0002-9315-2956	Health Research Board (HRB) Centre for Primary Care Research In Ireland [HRC-2014-1]	Health Research Board (HRB) Centre for Primary Care Research In Ireland	EW is funded by the Health Research Board (HRB) Centre for Primary Care Research In Ireland under grant code HRC-2014-1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CMC, 1984, J NEUROL NEUROSUR PS, V47, P475, DOI 10.1136/jnnp.47.5.475; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Auble TE, 2005, ACAD EMERG MED, V12, P514, DOI 10.1197/j.aem.2004.11.026; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Auleley GR, 1997, JAMA-J AM MED ASSOC, V277, P1935; Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bessen T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3056; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chan WS, 2009, ANN INTERN MED, V151, P85, DOI 10.7326/0003-4819-151-2-200907210-00004; Christenson J, 2006, ANN EMERG MED, V47, P1, DOI 10.1016/j.annemergmed.2005.08.007; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; Clarke M., 2013, Journal of the Bahrain Medical Society, V24, P145; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Clarke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102670; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook JA, 2015, BRIT J SURG, V102, pE93, DOI 10.1002/bjs.9723; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Dowling S, 2009, ACAD EMERG MED, V16, P277, DOI 10.1111/j.1553-2712.2008.00333.x; Falk G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2899; FARKOUH ME, 2002, INT J ANGIOL, V11, P41, DOI DOI 10.1007/S00547-001-0052-X; Gagne P, 2009, PRESSE MED, V38, P525, DOI 10.1016/j.lpm.2008.09.022; Green J, 2014, QUALITATIVE METHODS, Vxvii; Hendriksen JMT, 2013, J THROMB HAEMOST, V11, P129, DOI 10.1111/jth.12262; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Jain A P, 1993, J Assoc Physicians India, V41, P17; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Jenkin M, 2010, J ATHL TRAINING, V45, P480, DOI 10.4085/1062-6050-45.5.480; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Keogh C, 2014, ANN FAM MED, V12, P359, DOI 10.1370/afm.1640; KERNAN WN, 1991, ANN INTERN MED, V114, P552, DOI 10.7326/0003-4819-114-7-552; Kidwell C S, 1998, Prehosp Emerg Care, V2, P267, DOI 10.1080/10903129808958878; Kline JA, 2004, J THROMB HAEMOST, V2, P1247, DOI 10.1111/j.1538-7836.2004.00790.x; Lauer MS, 2007, ANN INTERN MED, V147, P821, DOI 10.7326/0003-4819-147-12-200712180-00001; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lumley T, 2002, J CLIN EPIDEMIOL, V55, P129, DOI 10.1016/S0895-4356(01)00434-6; Lund H, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5440; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; MCNAMARA RF, 1988, AM J CARDIOL, V62, P192, DOI 10.1016/0002-9149(88)90210-X; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Moons KGM, 2002, J EPIDEMIOL COMMUN H, V56, pI30, DOI 10.1136/jech.56.suppl_1.i30; Morise AP, 1997, AM J MED, V102, P350, DOI 10.1016/S0002-9343(97)00086-7; NORRIS RM, 1969, LANCET, V1, P274; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Pluddemann A, 2014, BRIT J GEN PRACT, V64, pE233, DOI 10.3399/bjgp14X677860; Pocock SJ, 2001, BMJ-BRIT MED J, V323, P75, DOI 10.1136/bmj.323.7304.75; PRYOR DB, 1983, AM J MED, V75, P771, DOI 10.1016/0002-9343(83)90406-0; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Sanders S, 2016, J CLIN EPIDEMIOL, V69, P32, DOI 10.1016/j.jclinepi.2015.05.006; SELKER HP, 1991, MED CARE, V29, P1196, DOI 10.1097/00005650-199112000-00003; Selker HP, 1997, ANN INTERN MED, V127, P538, DOI 10.7326/0003-4819-127-7-199710010-00006; SILVER MT, 1994, ANN INTERN MED, V121, P750, DOI 10.7326/0003-4819-121-10-199411150-00004; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Steyerberg EW., 2009, CLIN PREDICTION MODE, Vxxviii, P497; STIELL I, 1995, BRIT MED J, V311, P594, DOI 10.1136/bmj.311.7005.594; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; Stoffers HEJH, 1997, MED DECIS MAKING, V17, P61, DOI 10.1177/0272989X9701700107; Subramaniam RM, 2006, AM J ROENTGENOL, V186, P206, DOI 10.2214/AJR.04.1398; TIERNEY WM, 1985, CRIT CARE MED, V13, P526, DOI 10.1097/00003246-198507000-00002; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Uresandi F, 2007, ARCH BRONCONEUMOL, V43, P617; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; van Walraven C, 2003, ARCH INTERN MED, V163, P936, DOI 10.1001/archinte.163.8.936; Walker NJ, 2001, ACAD EMERG MED, V8, P703, DOI 10.1111/j.1553-2712.2001.tb00188.x; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Wang SJ, 2001, COMPUT BIOL MED, V31, P1, DOI 10.1016/S0010-4825(00)00022-6; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Organization of National Colleges Academies and Academic Associations of General Practitioners/Family Physicians, 1998, ICPC 2 INT CLASS PRI; Younge BR, 2004, MAYO CLIN PROC, V79, P483, DOI 10.4065/79.4.483; Zhang XR, 2005, ARCH BIOCHEM BIOPHYS, V440, P111, DOI 10.1016/j.abb.2005.06.004	83	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179102	10.1371/journal.pone.0179102	http://dx.doi.org/10.1371/journal.pone.0179102			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591223	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700088
J	Ghaly, TM; Chow, L; Asher, AJ; Waldron, LS; Gillings, MR				Ghaly, Timothy M.; Chow, Louise; Asher, Amy J.; Waldron, Liette S.; Gillings, Michael R.			Evolution of class 1 integrons: Mobilization and dispersal via food-borne bacteria	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; GRAM-NEGATIVE BACTERIA; CASSETTES; DNA; TRANSPOSITION; INTEGRASES; EXPRESSION; COMMENSAL; TN5053; FAMILY	Class 1 integrons have played a major role in the global dissemination of antibiotic resistance. Reconstructing the history of class 1 integrons might help us control further spread of antibiotic resistance by understanding how human activities influence microbial evolution. Here we describe a class 1 integron that represents an intermediate stage in the evolutionary history of clinical integrons. It was embedded in a series of nested transposons, carried on an IncP plasmid resident in Enterobacter, isolated from the surface of baby spinach leaves. Based on the structure of this integron, we present a modified hypothesis for integron assembly, where the ancestral clinical class 1 integron was captured from a betaproteobacterial chromosome to form a Tn402-like transposon. This transposon then inserted into a plasmid-borne Tn21-like ancestor while in an environmental setting, possibly a bacterium resident in the phyllosphere. We suggest that the qacE gene cassette, conferring resistance to biocides, together with the mercury resistance operon carried by Tn21, provided a selective advantage when this bacterium made its way into the human commensal flora via food. The integron characterized here was located in Tn6007, which along with Tn6008, forms part of the larger Tn6006 transposon, itself inserted into another transposable element to form the Tn21-like transposon, Tn6005. This element has previously been described from the human microbiota, but with a promoter mutation that upregulates integron cassette expression. This element we describe here is from an environmental bacterium, and supports the hypothesis that the ancestral class 1 integron migrated into anthropogenic settings via foodstuffs. Selection pressures brought about by early antimicrobial agents, including mercury, arsenic and disinfectants, promoted its initial fixation, the acquisition of promoter mutations, and subsequent dissemination into various species and pathogens.	[Ghaly, Timothy M.; Chow, Louise; Asher, Amy J.; Waldron, Liette S.; Gillings, Michael R.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia	Macquarie University	Ghaly, TM (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.	timothy.ghaly@mq.edu.au	Gillings, Michael R/C-6553-2008; Gillings, Michael/AAF-5772-2020	Gillings, Michael R/0000-0002-4043-4351; Gillings, Michael/0000-0002-4043-4351; Ghaly, Timothy/0000-0002-5162-4054	Australian Research Council Discovery [DP130103839]	Australian Research Council Discovery(Australian Research Council)	This work was funded by an Australian Research Council Discovery Grant (grant number: DP130103839). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Gillings MR, 2008, FEMS MICROBIOL LETT, V287, P56, DOI 10.1111/j.1574-6968.2008.01291.x; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Gillings MR, 2014, MICROBIOL MOL BIOL R, V78, P257, DOI 10.1128/MMBR.00056-13; Gillings MR, 2014, METHODS MOL BIOL, V1096, P17, DOI 10.1007/978-1-62703-712-9_2; Gillings MR, 2009, ISME J, V3, P209, DOI 10.1038/ismej.2008.98; Gillings MR, 2016, ANN NEW YORK ACAD SC; Goldstein C, 2001, ANTIMICROB AGENTS CH, V45, P723, DOI 10.1128/AAC.45.3.723-726.2001; Guerin E, 2011, J BACTERIOL, V193, P5675, DOI 10.1128/JB.05246-11; Hall RM, 1998, DRUG RESIST UPDATE, V1, P109, DOI 10.1016/S1368-7646(98)80026-5; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; Holmes AJ, 2003, ENVIRON MICROBIOL, V5, P383, DOI 10.1046/j.1462-2920.2003.00429.x; JAGURA-BURDZY G, 1992, J MOL BIOL, V225, P651, DOI 10.1016/0022-2836(92)90392-W; Jove T, 2010, INVERSE CORRELATION; Keller R, 1998, INFECT IMMUN, V66, P645, DOI 10.1128/IAI.66.2.645-649.1998; KHOLODII GY, 1995, MOL MICROBIOL, V17, P1189, DOI 10.1111/j.1365-2958.1995.mmi_17061189.x; Koenig JE, 2011, ISME J, V5, P962, DOI 10.1038/ismej.2010.193; Labbate M, 2008, J BACTERIOL, V190, P5318, DOI 10.1128/JB.00199-08; Lane D.J., 1991, NUCL ACID TECHNIQUES, P125; Lavizzari T, 2010, J FOOD PROTECT, V73, P385, DOI 10.4315/0362-028X-73.2.385; LEVESQUE C, 1994, GENE, V142, P49, DOI 10.1016/0378-1119(94)90353-0; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Liu WY, 2012, J BACTERIOL, V194, P5965, DOI 10.1128/JB.01394-12; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Minakhina S, 1999, MOL MICROBIOL, V33, P1059, DOI 10.1046/j.1365-2958.1999.01548.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; PAULSEN IT, 1993, ANTIMICROB AGENTS CH, V37, P761, DOI 10.1128/AAC.37.4.761; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Skold O, 2000, DRUG RESIST UPDATE, V3, P155, DOI 10.1054/drup.2000.0146; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Tsuda Kazuhisa, 2001, Journal of General Plant Pathology, V67, P78, DOI 10.1007/PL00012993; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Waldron LS, 2015, JOVE-J VIS EXP, DOI 10.3791/52889; Walia S, 2013, INT J ENVIRON HEAL R, V23, P108, DOI 10.1080/09603123.2012.708916; Wang G, 2004, INFECT IMMUN, V72, P1391, DOI 10.1128/IAI.72.3.1391-1396.2004	41	57	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179169	10.1371/journal.pone.0179169	http://dx.doi.org/10.1371/journal.pone.0179169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586403	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700052
J	Cardozo, FTGD; Baimukanova, G; Lanteri, MC; Keating, SM; Ferreira, FM; Heitman, J; Pannuti, CS; Pati, S; Romano, CM; Sabino, EC				Gomes de Sousa Cardozo, Francielle Tramontini; Baimukanova, Gyulnar; Lanteri, Marion Christine; Keating, Sheila Marie; Ferreira, Frederico Moraes; Heitman, John; Pannuti, Claudio Sergio; Pati, Shibani; Romano, Camila Malta; Sabino, Ester Cerdeira			Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro	PLOS ONE			English	Article							T-CELLS; CYTOKINES; EXPRESSION; CHEMOKINES; RECEPTOR; BETA; PERMEABILITY; RESPONSES; ALPHA; GAMMA	Background Although most of cases of dengue infections are asymptomatic or mild symptomatic some individuals present warning signs progressing to severe dengue in which plasma leakage is a hallmark. Methodology/Principal findings The present study used Electric Cell-substrate Impedance Sensing (ECIS (R)) which allows for electrical monitoring of cellular barrier function measuring changes in Transendothelial Electric Resistance (TEER) to investigate the parameters associated with dengue induced leakage. Three groups of individuals were tested: dengue-positives with plasma leakage (leakage), dengue-positives without plasma leakage (no leakage), and dengue-negatives (control). Data show that TEER values of human umbilical vein endothelial cells (HUVECs) was significantly lower after incubation with serum from subjects of the leakage group in comparison to the no leakage or control groups. The serum levels of CXCL1, EGF, eotaxin, IFN-gamma, sCD40L, and platelets were significantly decreased in the leakage group, while IL-10, IL-6, and IP-10 levels were significantly increased. We also found a strong correlation between TEER values and augmented levels of IP-10, GM-CSF, IL-1 alpha, and IL-8, as well as decreased levels of CXCL1 and platelets. Conclusions/Significance The present work shows that the magnitude of the immune response contributes to the adverse plasma leakage outcomes in patients and that serum components are important mediators of changes in endothelial homeostasis during dengue infections. In particular, the increased levels of IP-10 and the decreased levels of CXCL1 and platelets seem to play a significant role in the disruption of vascular endothelium associated with leakage outcomes after DENV infection. These findings may have important implications for both diagnostic and therapeutic approaches to predict and mitigate vascular permeabilization in those experiencing the most severe clinical disease outcomes after dengue infection.	[Gomes de Sousa Cardozo, Francielle Tramontini; Pannuti, Claudio Sergio; Romano, Camila Malta; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Dept Infect & Parasit Dis, Sao Paulo, SP, Brazil; [Baimukanova, Gyulnar; Lanteri, Marion Christine; Keating, Sheila Marie; Heitman, John; Pati, Shibani] BSRI, San Francisco, CA USA; [Lanteri, Marion Christine; Keating, Sheila Marie] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ferreira, Frederico Moraes] Univ Sao Paulo, Sch Med, Div Immunol, Heart Inst, Sao Paulo, SP, Brazil; [Ferreira, Frederico Moraes] Univ Santo Amaro, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA)	Cardozo, FTGD (corresponding author), Univ Sao Paulo, Inst Trop Med, Dept Infect & Parasit Dis, Sao Paulo, SP, Brazil.	francielletg@gmail.com	Romano, Camila M/C-8185-2013; Sabino, Ester C/F-7750-2010; Romano, Camila/ABC-2883-2020; de Sousa Cardozo, Francielle Tramontini Gomes/A-5347-2013; Ferreira, Frederico/A-4622-2013	Sabino, Ester C/0000-0003-2623-5126; Romano, Camila/0000-0003-4550-1987; Ferreira, Frederico/0000-0002-7403-9165; Keating, Sheila/0000-0002-8324-3694; Tramontini, Francielle/0000-0002-3168-0278	Conselho Nacional de Desenvolvimento Cientifiico e Tecnologico [151180/2013-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/15381-7, 2013/01690-0, 2013/01702-9]; National Heart, Lung, and Blood Institute [RC2HL101]	Conselho Nacional de Desenvolvimento Cientifiico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifiico e Tecnologico [http://www.cnpq.br/; 151180/2013-0 to F.T.G.S.C.], Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [http://www.fapesp.br/; 2012/15381-7 to CMR, 2013/01690-0 to E.C.S., and 2013/01702-9 to F.T.G.S.C.], and National Heart, Lung, and Blood Institute [https://www.nhlbi.nih.gov/; RC2HL101 to M.C.L.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; [Anonymous], B EPIDEMIOLOGICO; Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606; Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Butthep P, 2012, PEDIATR INFECT DIS J, V31, pE232, DOI 10.1097/INF.0b013e31826fd456; Cheng SS, 2002, J IMMUNOL, V168, P2887, DOI 10.4049/jimmunol.168.6.2887; Conroy AL, 2015, INT J INFECT DIS, V40, P45, DOI 10.1016/j.ijid.2015.07.027; Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027; Hernandez SID, 2016, MEM I OSWALDO CRUZ, V111, P161, DOI 10.1590/0074-02760150359; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Fujisawa N, 1999, CYTOKINE, V11, P231, DOI 10.1006/cyto.1998.0418; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Hoh BP, 2015, HUM IMMUNOL, V76, P421, DOI 10.1016/j.humimm.2015.03.019; Hottz E, 2011, DRUG DISCOVERY TODAY, V8, P33, DOI [10.1016/j. ddmec.2011.09.001, DOI 10.1016/J.DDMEC.2011.09.001]; John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee YH, 2016, J GEN VIROL, V97, P3103, DOI 10.1099/jgv.0.000637; Liehn EA, 2004, ARTERIOSCL THROM VAS, V24, P1891, DOI 10.1161/01.ATV.0000143135.71440.75; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; McElroy AK, 2014, J INFECT DIS; Miyake M, 2013, LAB INVEST, V93, P768, DOI 10.1038/labinvest.2013.71; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; Ooi EE, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P78, DOI 10.1079/9781845939649.0078; Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6; Rachman Andhika, 2006, Acta Med Indones, V38, P105; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Romano CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070318; Romano E, 2005, CYTOKINE, V30, P359; Royall J, 1989, AM J PHYSIOL, V257, P410; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Taylor SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003470; Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI 10.4269/ajtmh.2010.10-0138; van de Weg CAM, 2013, PLOS NEGLECT TROP D, V7, P1; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Ferreira RAX, 2015, ACTA TROP, V149, P138, DOI 10.1016/j.actatropica.2015.04.023	47	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178820	10.1371/journal.pone.0178820	http://dx.doi.org/10.1371/journal.pone.0178820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586397	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700028
J	Molina, D; Perez-Beteta, J; Martinez-Gonzalez, A; Martino, J; Velasquez, C; Arana, E; Perez-Garcia, VM				Molina, David; Perez-Beteta, Julian; Martinez-Gonzalez, Alicia; Martino, Juan; Velasquez, Carlos; Arana, Estanislao; Perez-Garcia, Victor M.			Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization	PLOS ONE			English	Article							HETEROGENEITY; FEATURES; DISCRIMINATION; CLASSIFICATION; DISCRETIZATION; GLIOBLASTOMA; RADIOMICS; PROTOCOLS; PET	Purpose Textural measures have been widely explored as imaging biomarkers in cancer. However, their robustness under dynamic range and spatial resolution changes in brain 3D magnetic resonance images (MRI) has not been assessed. The aim of this work was to study potential variations of textural measures due to changes in MRI protocols. Materials and methods Twenty patients harboring glioblastoma with pretreatment 3D T1-weighted MRIs were included in the study. Four different spatial resolution combinations and three dynamic ranges were studied for each patient. Sixteen three-dimensional textural heterogeneity measures were computed for each patient and configuration including co-occurrence matrices (CM) features and run-length matrices (RLM) features. The coefficient of variation was used to assess the robustness of the measures in two series of experiments corresponding to (i) changing the dynamic range and (ii) changing the matrix size. Results No textural measures were robust under dynamic range changes. Entropy was the only textural feature robust under spatial resolution changes (coefficient of variation under 10% in all cases). Conclusion Textural measures of three-dimensional brain tumor images are not robust neither under dynamic range nor under matrix size changes. Standards should be harmonized to use textural features as imaging biomarkers in radiomic-based studies. The implications of this work go beyond the specific tumor type studied here and pose the need for standardization in textural feature calculation of oncological images.	[Molina, David; Perez-Beteta, Julian; Martinez-Gonzalez, Alicia; Perez-Garcia, Victor M.] Univ Castilla La Mancha, Math Oncol Lab MOLAB, Ciudad Real, Spain; [Martino, Juan; Velasquez, Carlos] Hosp Univ Marques Valdecilla, Neurosurg Dept, Santander, Spain; [Martino, Juan; Velasquez, Carlos] Fdn Inst Invest Marques Valdecilla, Santander, Spain; [Arana, Estanislao] Fdn Inst Valenciano Oncol, Radiol Dept, Valencia, Spain	Universidad de Castilla-La Mancha; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Instituto Valenciano De Oncologia	Molina, D (corresponding author), Univ Castilla La Mancha, Math Oncol Lab MOLAB, Ciudad Real, Spain.	david.molina@uclm.es	Martínez-González, Alicia/Q-5117-2017; Pérez-García, Víctor M./C-8892-2011; Velasquez, Carlos/N-6669-2016; Perez-Beteta, Julian/Q-6404-2017	Martínez-González, Alicia/0000-0002-6938-0932; Pérez-García, Víctor M./0000-0002-6575-495X; Velasquez, Carlos/0000-0002-4443-5888; Perez-Beteta, Julian/0000-0003-0317-6215	Ministerio de Economia y Competitividad/FEDER, Spain [MTM2015-71200-R]; Consejeria de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain [PEII-2014-031-P]; James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer [220020420, 220020450]	Ministerio de Economia y Competitividad/FEDER, Spain; Consejeria de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha); James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer	This work has been supported by Ministerio de Economia y Competitividad/FEDER, Spain [grant number MTM2015-71200-R], Consejeria de Educacion Cultura y Deporte from Junta de Comunidades de Castilla-La Mancha, Spain [grant number PEII-2014-031-P] and James S. Mc. Donnell Foundation 21st Century Science Initiative in Mathematical and Complex Systems Approaches for Brain Cancer [Special Initiative Collaborative-Planning Grant 220020420 and Collaborative award 220020450]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; Arai K, 2012, INT J ADV COMP SCI A, V3, P4; Assefa D, 2010, MED PHYS, V37, P1722, DOI 10.1118/1.3357289; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P1292, DOI 10.1007/s00259-013-2430-y; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Depeursinge A, 2014, MED IMAGE ANAL, V18, P176, DOI 10.1016/j.media.2013.10.005; Ellingson BM, 2015, NEURO-ONCOLOGY, V17, P1188, DOI 10.1093/neuonc/nov095; Ellingson BM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0506-0; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Ganeshan B, 2010, CANCER IMAGING, V10, P137, DOI 10.1102/1470-7330.2010.0021; Georgiadis P, 2009, MAGN RESON IMAGING, V27, P120, DOI 10.1016/j.mri.2008.05.017; Ginsburg SB, 2016, J MAGN RESO IN PRESS; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Just N, 2014, BRIT J CANCER, V111, P2205, DOI 10.1038/bjc.2014.512; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Kurani A. S, 2004, 7 IASTED INT C COMP; Larroza A, 2015, J MAGN RESON IMAGING, V42, P1362, DOI 10.1002/jmri.24913; Lee J, 2016, AM J NEURORADIOL, V37, P37, DOI 10.3174/ajnr.A4534; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Liu J, 2016, J MAGN RESON IMAGING, V44, P445, DOI 10.1002/jmri.25156; Lu L, 2016, PLOS ONE, V9; Luk-Pat GT, 2001, MAGNET RESON MED, V45, P269, DOI 10.1002/1522-2594(200102)45:2<269::AID-MRM1036>3.0.CO;2-5; Mahmoud-Ghoneim D, 2003, MAGN RESON IMAGING, V21, P983, DOI 10.1016/S0730-725X(03)00201-7; Mayerhoefer ME, 2009, MED PHYS, V36, P1236, DOI 10.1118/1.3081408; Molina D, 2016, COMPUT BIOL MED, V78, P49, DOI 10.1016/j.compbiomed.2016.09.011; Molina D, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160242; Nardone V, 2016, CUREUS, V8, DOI 10.7759/cureus.584; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Perez-Beteta J, 2016, EUR RADIOL; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Suo ST, 2016, ACAD RADIOL, V23, P1115, DOI 10.1016/j.acra.2016.04.009; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Waugh SA, 2016, EUR RADIOL, V26, P322, DOI 10.1007/s00330-015-3845-6; Waugh SA, 2011, MED PHYS, V38, P5058, DOI 10.1118/1.3622605; Xu D-H, 2004, HEART, V27, P25; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhou M, 2016, J MAGN RESO IN PRESS	43	36	37	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178843	10.1371/journal.pone.0178843	http://dx.doi.org/10.1371/journal.pone.0178843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586353	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700030
J	Cavalcante, CCB; Maschio, C; Santos, AA; Schiozer, D; Rocha, A				Cavalcante, Cristina C. B.; Maschio, Celio; Santos, Antonio Alberto; Schiozer, Denis; Rocha, Anderson			History matching through dynamic decision-making	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK	History matching is the process of modifying the uncertain attributes of a reservoir model to reproduce the real reservoir performance. It is a classical reservoir engineering problem and plays an important role in reservoir management since the resulting models are used to support decisions in other tasks such as economic analysis and production strategy. This work introduces a dynamic decision-making optimization framework for history matching problems in which new models are generated based on, and guided by, the dynamic analysis of the data of available solutions. The optimization framework follows a 'learning-from-data' approach, and includes two optimizer components that use machine learning techniques, such as unsupervised learning and statistical analysis, to uncover patterns of input attributes that lead to good output responses. These patterns are used to support the decision-making process while generating new, and better, history matched solutions. The proposed framework is applied to a benchmark model (UNISIM-I-H) based on the Namorado field in Brazil. Results show the potential the dynamic decision-making optimization framework has for improving the quality of history matching solutions using a substantial smaller number of simulations when compared with a previous work on the same benchmark.	[Cavalcante, Cristina C. B.; Rocha, Anderson] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil; [Maschio, Celio; Santos, Antonio Alberto; Schiozer, Denis] Univ Estadual Campinas, Ctr Petr Studies, Sch Mech Engn, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas	Cavalcante, CCB (corresponding author), Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil.	cristina.cavalcante@ic.unicamp.br			CAPES; CAPES DeepEyes project; Microsoft Research; Petrobras (Rede SIGER); UNISIM-CEPETRO-UNICAMP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES DeepEyes project(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Microsoft Research(Microsoft); Petrobras (Rede SIGER); UNISIM-CEPETRO-UNICAMP	This work was partially supported by CAPES, CAPES DeepEyes project, Microsoft Research, Petrobras (Rede SIGER), and UNISIM-CEPETRO-UNICAMP.	Avansi GD, 2015, OFFSH TECHN C 2015 M; Bishop Christopher M., 2006, PATTERN RECOGNITION; Caeiro MH, 2015, MATH GEOSCIENCES; Hajizadeh Y, 2011, J PETROL SCI ENG, V77, P78, DOI 10.1016/j.petrol.2011.02.005; Ho YC, 2002, J OPTIMIZ THEORY APP, V115, P549, DOI 10.1023/A:1021251113462; Maschio C, 2014, J PETROL SCI ENG, V123, P62, DOI 10.1016/j.petrol.2014.05.016; Maschio C, 2015, ENG OPTIMIZ, V47, P72, DOI 10.1080/0305215X.2013.868453; Maschio C, 2015, J PETROL SCI ENG, V127, P387, DOI 10.1016/j.petrol.2015.01.033; Mesquita FB, 2015, SYSTEMATIC APPROACH; Mohamed L, 2010, SPE J, V15, P31, DOI 10.2118/119139-PA; Oliver DS, 2011, COMPUTAT GEOSCI, V15, P185, DOI 10.1007/s10596-010-9194-2; Schiozer DJ, 2017, J BRAZILIAN SOC MECH; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Yaser S .A.-M., 2012, LEARNING DATA	15	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178507	10.1371/journal.pone.0178507	http://dx.doi.org/10.1371/journal.pone.0178507			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582413	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600019
J	Fauk, NK; Merry, MS; Sigilipoe, MA; Putra, S; Mwanri, L				Fauk, Nelsensius Klau; Merry, Maria Silvia; Sigilipoe, Mitra Andhini; Putra, Sukma; Mwanri, Lillian			Culture, social networks and HIV vulnerability among men who have sex with men in Indonesia	PLOS ONE			English	Article							ANAL INTERCOURSE; RISK-FACTORS; GAY MEN; HEALTH; INTERVENTION; INFECTION; BEHAVIOR	The current study aimed to explore cultural and social network influence on HIV vulnerability among Men who have Sex with Men (MSM) population in Yogyakarta, Indonesia. A qualitative inquiry employing in-depth one-on-one interviews was carried out with 24 MSM participants in July 2015. Data were analysed using a framework analysis and guided by the Social Networks Theory (SNT) as a conceptual framework. Findings indicated that prohibitive cultural perspectives and norms against same-sex marriage made them to conceal their sexual orientation and thus secretively engaging in unprotected sex that increased their predisposition to HIV transmission. The prohibitive cultures were also instrumental in the formation of MSM sexual networks that provided supportive environment for HIV-risky sexual practices among network partners. These findings provide information that can be used to improve HIV/AIDS service practices and policies. However, further studies with large numbers of MSM would be needed to improve the understanding of other HIV vulnerability determinants, the unique needs of MSM, and what and how programs could be conducted to reduce HIV vulnerability among MSM population.	[Fauk, Nelsensius Klau] Inst Resource Governance & Social Change, Jl RW Monginsidi 2, Kupang, Nusa Tenggara T, Indonesia; [Merry, Maria Silvia; Sigilipoe, Mitra Andhini] Duta Wacana Christian Univ, Med Fac, Jl Doktor Wahidin Sudiro Husodo, Yogyakarta, Indonesia; [Putra, Sukma] Bina Nusantara Univ Int, Jl Hang Lekir 1, Jakarta, Indonesia; [Mwanri, Lillian] Flinders Univ S Australia, Sch Hlth Sci, Discipline Publ Hlth, Adelaide, SA, Australia	Universitas Kristen Duta Wacana; Universitas Bina Nusantara; Flinders University South Australia	Fauk, NK (corresponding author), Inst Resource Governance & Social Change, Jl RW Monginsidi 2, Kupang, Nusa Tenggara T, Indonesia.	nelsen_klau@yahoo.com	Fauk, Nelsensius/L-8024-2015; Mwanri, Lillian/AGG-3711-2022	Fauk, Nelsensius/0000-0002-1325-2640; Mwanri, Lillian/0000-0002-5792-7785; Sigilipoe, Mitra Andini/0000-0001-6746-2574				Allsop J., 2013, RES HLTH QUALITATIVE; Balan IC, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.1.14; Berg RC, 2011, HEALTH-LONDON, V15, P517, DOI 10.1177/1363459310384494; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Boellstorff T, 2004, ETHNOS, V69, P465, DOI 10.1080/0014184042000302308; Boellstorff T., 2005, GAY ARCHIPELAGO SEXU; Budiman A., 1979, LELAKI PERINDU LELAK; Colby DJ, 2003, JAIDS-J ACQ IMM DEF, V32, P80, DOI 10.1097/00126334-200301010-00012; Coreil J, 1995, Med Anthropol, V16, P193; Crosby R, 2005, INT J STD AIDS, V16, P158, DOI 10.1258/0956462053057530; De Santis JP, 2009, J ASSOC NURSE AIDS C, V20, P362, DOI 10.1016/j.jana.2009.06.005; Dillon PJ, 2014, HEALTH COMMUN, V29, P182, DOI 10.1080/10410236.2012.732911; ELSAYED N, 1994, KNOWLEDGE ATTITUDE P; Fauk N, 2014, INT J APPL PHARM SCI, V3, P291; Fauk NK, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0233-7; Fauk NK, 2015, INT J HUM RIGHTS HEA, V8, P144, DOI 10.1108/IJHRH-10-2014-0028; Fauk NK, 2014, INT J RES SOC SCI, V4, P578; Fauk NK, 2008, HIV AIDS PMS DAN MAS; Fellin P, 2001, STRATEGIES COMMUNITY; Flowers P, 2002, INT J STD AIDS, V13, P102, DOI 10.1258/0956462021924721; Garofalo R, 2010, J URBAN HEALTH, V87, P318, DOI 10.1007/s11524-009-9430-z; Han CS, 2010, CULT HEALTH SEX, V12, P387, DOI 10.1080/13691050903549030; HEYINK JW, 1993, SOC INDIC RES, V29, P291, DOI 10.1007/BF01079517; Human Rights Watch, IND LGBT COMM THREAT; Jogja Tribun, 2016, MINTA WARGA DIY TOLE; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kementrian Kesehatan RI, 2016, LAP SIT PERK HIV AID; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; KPA Pronpinsi DIY, 2016, DAT KAS HIV AIDS DIY; Lombard Denys, 2005, NUSA JAWA SILANG BUD; Marsden P., 1994, ADV SOCIAL NETWORK A, P3, DOI [DOI 10.4135/9781452243528.N1, 10.4135/9781452243528.n1]; Marvasti AB, 2004, QUALITATIVE RES SOCI, P1; Minichiello V., 1990, DEPTH INTERVIEWING R; Morineau G, 2011, AIDS BEHAV, V15, P1033, DOI 10.1007/s10461-009-9590-6; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Notoatmodjo S, 2003, PENGANTAR PENDIDIKAN; Nusantara GAYa, 2014, INFORM TEMPAT NGEBER; Offord B, 2001, J HOMOSEXUAL, V40, P233, DOI 10.1300/J082v40n03_12; Parsons JT, 2007, AIDS BEHAV, V11, P277, DOI 10.1007/s10461-006-9135-1; Parsons JT, 2002, AIDS CARE, V14, P815, DOI 10.1080/0954012021000031886; PEPFAR, TECHN GUID COMB PREV; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Poon MK, 2013, CAN J HUM SEX, V22, P77; Prasetyo AA, 2014, SE ASIAN J TROP MED, V45, P1032; Putri T., LGBT KESEHATAN01 05; Rice PL., 2005, QUALITATIVE RES METH; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Rosser BRS, 2002, AIDS EDUC PREV, V14, P59, DOI 10.1521/aeap.14.4.59.23885; Ryan C, 2009, PEDIATRICS, V123, P346, DOI 10.1542/peds.2007-3524; Semple SJ, 2003, AIDS CARE, V15, P3, DOI 10.1080/713990434; Statistics Indonesia, 2010, POP IND PROV; The Jakarta Post, 2013, REC AB LGBT LIP ICEB; Torres HL, 2013, J LGBT YOUTH, V10, P173, DOI 10.1080/19361653.2013.799000; UNAIDS, THE GAP REP; UNAIDS, GLOB HIV STAT JOINT; UNDP, 2011, UN ACC EX MUN HIV PR; Wardhana H., 2016, SEKILAS TENTANG LGBT; Warren JC, 2008, AIDS BEHAV, V12, P459, DOI 10.1007/s10461-007-9291-y; Weiss R.S., 1974, DOING ONTO OTHERS; Wolitski RJ, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000167356.94664.59; Wong WCW, 2006, SEX TRANSM INFECT, V82, P127, DOI 10.1136/sti.2005.016790	61	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178736	10.1371/journal.pone.0178736	http://dx.doi.org/10.1371/journal.pone.0178736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9KF	28582451	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600032
J	Mowrey, DD; Xu, L; Mei, YW; Pasek, DA; Meissner, G; Dokholyan, NV				Mowrey, David D.; Xu, Le; Mei, Yingwu; Pasek, Daniel A.; Meissner, Gerhard; Dokholyan, Nikolay V.			Ion-pulling simulations provide insights into the mechanisms of channel opening of the skeletal muscle ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium transport; conformational change; molecular dynamics; molecular modeling; ryanodine receptor	CALCIUM-RELEASE CHANNEL; STEERED MOLECULAR-DYNAMICS; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; CA2+ RELEASE; INOSITOL 1,4,5-TRISPHOSPHATE; ELECTROSTATICS CALCULATIONS; ENDOPLASMIC-RETICULUM; POTASSIUM CHANNEL; PROTEIN STABILITY	The type 1 ryanodine receptor (RyR1) mediates Ca2+ release from the sarcoplasmic reticulum to initiate skeletal muscle contraction and is associated with muscle diseases, malignant hyperthermia, and central core disease. To better understand RyR1 channel function, we investigated the molecular mechanisms of channel gating and ion permeation. An adequate model of channel gating requires accurate, high-resolution models of both open and closed states of the channel. To this end, we generated an open-channel RyR1 model using molecular simulations to pull Ca2+ through the pore constriction site of a closed-channel RyR1 structure determined at 3.8-angstrom resolution. Importantly, we find that our open-channel model is consistent with the RyR1 and cardiac RyR (RyR2) open-channel structures reported while this paper was in preparation. Both our model and the published structures show similar rotation of the upper portion of the pore-lining S6 helix away from the 4-fold channel axis and twisting of Ile-4937 at the channel constriction site out of the channel pore. These motions result in a minimum open-channel pore radius of approximate to 3 angstrom formed by Gln-4933, rather than Ile-4937 in the closed-channel structure. We also present functional support for our model by mutations around the closed- and open-channel constriction sites (Gln-4933 and Ile-4937). Our results indicate that use of ion-pulling simulations produces a RyR1 open-channel model, which can provide insights into the mechanisms of channel opening complementing those from the structural data.	[Mowrey, David D.; Xu, Le; Mei, Yingwu; Pasek, Daniel A.; Meissner, Gerhard; Dokholyan, Nikolay V.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Mei, Yingwu] Zhengzhou Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Zhengzhou 450001, Henan, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Zhengzhou University	Meissner, G; Dokholyan, NV (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu; dokh@unc.edu	Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Euden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066542; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isralewitz B, 2001, J MOL GRAPH MODEL, V19, P13, DOI 10.1016/S1093-3263(00)00133-9; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mei YW, 2015, J BIOL CHEM, V290, P17535, DOI 10.1074/jbc.M115.659672; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Monticelli L, 2004, FEBS LETT, V564, P325, DOI 10.1016/S0014-5793(04)00271-6; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; RADERMACHER M, 1992, BIOPHYS J, V61, P936, DOI 10.1016/S0006-3495(92)81900-8; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Seo MD, 2015, BBA-MOL CELL RES, V1853, P1980, DOI 10.1016/j.bbamcr.2014.11.023; Seo MD, 2012, NATURE, V483, P108, DOI 10.1038/nature10751; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Shimizu H, 2008, CELL, V132, P67, DOI 10.1016/j.cell.2007.11.040; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; Sutko JL, 1997, PHARMACOL REV, V49, P53; Swanson JMJ, 2007, J CHEM THEORY COMPUT, V3, P170, DOI 10.1021/ct600216k; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	54	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12947	12958		10.1074/jbc.M116.760199	http://dx.doi.org/10.1074/jbc.M116.760199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28584051	hybrid, Green Published			2022-12-26	WOS:000407220100023
J	Gao, SY; Zheng, GS; Wang, L; Liang, YJ; Zhang, SE; Lao, XM; Li, K; Liao, GQ				Gao, Si-yong; Zheng, Guang-sen; Wang, Lin; Liang, Yu-jie; Zhang, Si-en; Lao, Xiao-mei; Li, Kan; Liao, Gui-qing			Zoledronate suppressed angiogenesis and osteogenesis by inhibiting osteoclasts formation and secretion of PDGF-BB	PLOS ONE			English	Article							IN-VIVO; GROWTH; BISPHOSPHONATES; DIFFERENTIATION; MODULATION; MECHANISM; JAWS	Purpose Bisphosphonates related osteonecrosis of jaw (BRONJ) is a severe complication of systemic BPs administration, the mechanism of which is still unclarified. Recently, platelet-derived growth factor-BB (PDGF-BB) secreted by preosteoclasts was reported to promote angiogenesis and osteogenesis. This study aimed to clarify whether bisphosphonates suppressed preosteoclasts releasing PDGF-BB, and whether the suppression harmed coupling of angiogenesis and osteogenesis, which could contribute to BRONJ manifestation. Methods and results Zoledronate significantly inhibited osteoclast formation by tartrate-resistant acid phosphatase (TRAP) staining and PDGF-BB secretion tested by ELISA. In line with decreasing secretion of PDGF-BB by preosteoclasts exposed to zoledronate, conditioned medium (CM) from the cells significantly induced less migration of endothelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs) compared to CM from unexposed preosteoclasts. Meanwhile, angiogenic function of EPCs and osteoblastic differentiation of MSCs also declined when culturing with CM from preosteoclasts treated by zoledronate (PZ-CM), evidenced by tube formation assay of EPCs and alkaline phosphatase activity of MSCs. Western blot assay showed that the expression of VEGF in EPCs and OCN, RUNX2 in MSCs declined when culturing with PZ-CM compared to CM from preostoeclasts without exposure of zoledronate. Conclusion Our study found that zoledronate was able to suppress preosteoclasts releasing PDGF-BB, resulting in suppression of angiogenesis and osteogenesis. Our study may partly contributed to the mechanism of BRONJ.	[Gao, Si-yong; Zheng, Guang-sen; Liang, Yu-jie; Zhang, Si-en; Lao, Xiao-mei; Li, Kan; Liao, Gui-qing] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangdong Prov Key Lab, Guangzhou, Guangdong, Peoples R China; [Wang, Lin] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Oral Implant, Guangdong Prov Key Lab, Guangzhou, Guangdong, Peoples R China; [Liao, Gui-qing] Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liao, GQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangdong Prov Key Lab, Guangzhou, Guangdong, Peoples R China.; Liao, GQ (corresponding author), Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China.	drliaoguiqing@hotmail.com			National Natural Science Foundation of China [81172566, 81372884, 81302367]; Guangdong Sceience and Technology Department [2013B022000038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Sceience and Technology Department	National Natural Science Foundation of China (grant numbers: 81172566, 81372884, 81302367; website:http://www.nsfc.gov.cn/publish/portal1/) Guangdong Sceience and Technology Department (grant numbers: 2013B022000038 website: http://www.gdstc.gov.cn/eng/mission.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda K, 2015, SPINE, V40, pE601, DOI 10.1097/BRS.0000000000000862; ANDERSON HC, 1989, LAB INVEST, V60, P320; Arnold F, 2000, PHARMACOL THERAPEUT, V52, P407; Ballmoos MWV, 2010, PLOS ONE, V5; Basso FG, 2013, GERONTOLOGY, V59, P534, DOI 10.1159/000351194; Caraglia M, 2006, ENDOCR-RELAT CANCER, V13, P7, DOI 10.1677/erc.1.01094; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cornish J, 2011, BONE, V49, P710, DOI 10.1016/j.bone.2011.07.020; De Luca A, 2011, EXPERT OPIN DRUG MET, V7, P911, DOI 10.1517/17425255.2011.585156; Escudero N. D., 2012, BONE MARROW RES, V2012, DOI DOI 10.1155/2012/526236; Guevarra CS, 2015, J ORAL IMPLANTOL, V41, pE24, DOI 10.1563/AAID-JOI-D-13-00074; Guo PJ, 2005, INT J ORAL MAXILLOF, V34, P87; Hasmim M, 2007, J THROMB HAEMOST, V5, P166, DOI 10.1111/j.1538-7836.2006.02259.x; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lang M, 2016, BRIT J ORAL MAX SURG; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Misso G, 2012, CANCER BIOL THER, V13, P1491, DOI 10.4161/cbt.22274; Nakagawa T, 2015, ARCH ORAL BIOL, V60, P557, DOI 10.1016/j.archoralbio.2014.09.012; Ohe JY, 2012, CLIN ORAL INVEST, V16, P1153, DOI 10.1007/s00784-011-0614-z; Pabst AM, 2014, CLIN ORAL INVEST, V18, P1015, DOI 10.1007/s00784-013-1060-x; Rahman MM, 2015, BIOCHEM BIOPH RES CO, V462, P159, DOI 10.1016/j.bbrc.2015.04.115; Rao MVS, 2009, INT J MOL MED, V23, P407, DOI 10.3892/ijmm_00000145; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Santini D, 2003, CLIN CANCER RES, V9, P2893; Schreuder WH, 2014, J ORAL MAXIL SURG, V72, P1301, DOI 10.1016/j.joms.2014.02.017; Thudium CS, 2016, CALCIFIED TISSUE INT, P1; Tseng HC, 2015, ONCOTARGET, V6, P20002, DOI 10.18632/oncotarget.4755; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668; Yang JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046511; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	33	39	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179248	10.1371/journal.pone.0179248	http://dx.doi.org/10.1371/journal.pone.0179248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594896	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200110
J	Schieffer, KM; Bruffy, SM; Rauscher, R; Koltun, WA; Yochum, GS; Gallagher, CJ				Schieffer, Kathleen M.; Bruffy, Shannon M.; Rauscher, Richard; Koltun, Walter A.; Yochum, Gregory S.; Gallagher, Carla J.			Reduced total serum bilirubin levels are associated with ulcerative colitis	PLOS ONE			English	Article							HUMAN UDP-GLUCURONOSYLTRANSFERASES; OXIDATIVE STRESS; ANTIOXIDANT; DISEASE; UGT1A1; POLYMORPHISM; PROMOTER; RISK; BILE	Chronic inflammation associated with inflammatory bowel disease (IBD) results in increased oxidative stress that damages the colonic microenvironment. Low levels of serum bilirubin, an endogenous antioxidant, have been associated with increased risk for Crohn's disease (CD). Therefore, the aim of this study was to examine whether total serum bilirubin levels are associated with ulcerative colitis (UC). We identified a retrospective case-control population (n = 6,649) from a single tertiary care center, Penn State Hershey Medical Center (PSU) and a validation cohort (n = 1,996) from Virginia Commonwealth University Medical Center (VCU). Cases were age- and sex-matched to controls (PSU: CD n = 254, UC n = 187; VCU: CD n = 233, UC n = 124). Total serum bilirubin levels were obtained from de-identified medical records and segregated into quartiles. Logistic regression analysis was performed on each quartile of total serum bilirubin compared to the last quartile (highest bilirubin levels) to determine the association of total serum bilirubin with UC. Similar to CD patients, UC patients demonstrated reduced levels of total serum bilirubin compared to controls at PSU and VCU. The lowest quartile of total serum bilirubin was independently associated with UC for the PSU (OR: 1.98 [95% CI: 1.09-3.63]) and VCU cohorts (OR: 6.07 [95% CI: 3.01-12.75]). Lower levels of the antioxidant bilirubin may reduce the capability of UC patients to remove reactive oxygen species leading to an increase in intestinal injury. Therapeutics that reduce oxidative stress may be beneficial for these patients.	[Schieffer, Kathleen M.; Koltun, Walter A.; Yochum, Gregory S.] Penn State Univ, Coll Med, Div Colon & Rectal Surg, Dept Surg, Hershey, PA 17033 USA; [Bruffy, Shannon M.] Virginia Commonwealth Univ, Ctr Clin & Translat Res, Richmond, VA USA; [Rauscher, Richard] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Yochum, Gregory S.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Gallagher, Carla J.] Lincoln Univ, Dept Chem & Phys, Lincoln Univ, PA 19352 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Lincoln University - Pennsylvania	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Div Colon & Rectal Surg, Dept Surg, Hershey, PA 17033 USA.; Yochum, GS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA.; Gallagher, CJ (corresponding author), Lincoln Univ, Dept Chem & Phys, Lincoln Univ, PA 19352 USA.	gsy3@psu.edu; cgallagher@lincoln.edu	Schieffer, Kathleen/AAA-1388-2021	Schieffer, Kathleen/0000-0002-2688-8680	National Institutes of Health [R00 CA131477]; Pennsylvania State Department of Health Tobacco Settlement Funds CURE; National Center for Advancing Translational Sciences [UL1 TR000127, TL1 TR000125]; Carlino Fund for IBD research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014, TL1TR002016, TL1TR000125, UL1TR000127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State Department of Health Tobacco Settlement Funds CURE; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Carlino Fund for IBD research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health, R00 CA131477, CJG; Pennsylvania State Department of Health Tobacco Settlement Funds CURE, CJG; National Center for Advancing Translational Sciences, UL1 TR000127 and TL1 TR000125, KMS and the Carlino Fund for IBD research, KMS, WAK, GSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmus IM, 2016, SAUDI J GASTROENTERO, V22, P3, DOI 10.4103/1319-3767.173753; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Brink MA, 1999, GASTROENTEROLOGY, V116, P1420, DOI 10.1016/S0016-5085(99)70507-X; CARMEL R, 1985, JAMA-J AM MED ASSOC, V253, P3416, DOI 10.1001/jama.253.23.3416; de Vries HS, 2012, J CROHNS COLITIS, V6, P597, DOI 10.1016/j.crohns.2011.11.010; Fischman D., 2003, J CLIN MED RES, V2, P256; Fischman Daniel, 2010, J Clin Med Res, V2, P256, DOI 10.4021/jocmr444w; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ho DE., 2011, J STAT SOFTW, V42, P1, DOI DOI 10.18637/JSS.V042.I08; Innocenti F, 2002, PHARMACOGENETICS, V12, P725, DOI 10.1097/00008571-200212000-00006; JUPING D, 2017, J CLIN LAB ANAL; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lapidus A, 2006, WORLD J GASTROENTERO, V12, P70, DOI 10.3748/wjg.v12.i1.70; Lenicek M, 2014, INFLAMM BOWEL DIS, V20, P481, DOI 10.1097/01.MIB.0000440817.84251.98; Levinson SS, 1997, ANN CLIN LAB SCI, V27, P185; Matsui K, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-57; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Salomone F, 2013, J GASTROEN HEPATOL, V28, P1202, DOI 10.1111/jgh.12155; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SCHWERTNER HA, 1994, CLIN CHEM, V40, P18; SKAR V, 1988, SCAND J GASTROENTERO, V23, P83, DOI 10.3109/00365528809093853; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Tukey RH, 2002, MOL PHARMACOL, V62, P446, DOI 10.1124/mol.62.3.446; Tuzun A, 2002, CLIN BIOCHEM, V35, P569, DOI 10.1016/S0009-9120(02)00361-2; Zhang DL, 2007, DRUG METAB DISPOS, V35, P2270, DOI 10.1124/dmd.107.017806; Zhou XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5573; Zhou ZX, 2016, J CLIN LAB ANAL, V30, P768, DOI 10.1002/jcla.21936; Zucker SD, 2015, AM J PHYSIOL-GASTR L, V309, pG841, DOI 10.1152/ajpgi.00149.2014	31	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179267	10.1371/journal.pone.0179267	http://dx.doi.org/10.1371/journal.pone.0179267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594959	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200112
J	Spodzieja, M; Lach, S; Iwaszkiewicz, J; Cesson, V; Kalejta, K; Olive, D; Michielin, O; Speiser, DE; Zoete, V; Derre, L; Rodziewicz-Motowidlo, S				Spodzieja, Marta; Lach, Slawomir; Iwaszkiewicz, Justyna; Cesson, Valerie; Kalejta, Katarzyna; Olive, Daniel; Michielin, Olivier; Speiser, Daniel E.; Zoete, Vincent; Derre, Laurent; Rodziewicz-Motowidlo, Sylwia			Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses	PLOS ONE			English	Article							HERPESVIRUS ENTRY MEDIATOR; LYMPHOCYTE ATTENUATOR; B-LYMPHOCYTE; CANCER-IMMUNOTHERAPY; CHECKPOINT BLOCKADE; UNTREATED MELANOMA; ACTIVATION; IPILIMUMAB; RECEPTOR; BTLA	Antibody based immune-checkpoint blockade therapy is a major breakthrough in oncology, leading to clinical benefit for cancer patients. Among the growing family of inhibitory receptors, the B and T lymphocyte attenuator (BTLA), which interacts with herpes virus entry mediator (HVEM), is a promising target for immunotherapy. Indeed, BTLA inhibits T-cell proliferation and cytokine production. The crystal structure of the BTLA/HVEM complex has shown that the HVEM(26-38) fragment is directly involved in protein binding. We designed and analyzed the capacity of several analogs of this fragment to block the ligation between BTLA and HVEM, using competitive ELISA and cellular assay. We found that the HVEM (23-39) peptide can block BTLA/HVEM ligation. However, the blocking ability was due to the Cys encompassed in this peptide and that even free cysteine targeted the BTLA protein and blocked its interaction with HVEM. These data highlight a Cys-related artefact in vitro, which should be taken in consideration for future development of BTLA/HVEM blocking compounds.	[Spodzieja, Marta; Lach, Slawomir; Kalejta, Katarzyna; Rodziewicz-Motowidlo, Sylwia] Univ Gdansk, Dept Chem, Gdansk, Poland; [Iwaszkiewicz, Justyna; Michielin, Olivier; Zoete, Vincent] SIB Swiss Inst Bioinformat, Quartier Sorge, Batiment Genopode, Lausanne, Switzerland; [Cesson, Valerie; Derre, Laurent] Univ Hosp Lausanne CHUV, Urol Dept, Urol Res Unit, Lausanne, Switzerland; [Olive, Daniel] Aix Marseille Univ, Inst Paoli Calmettes, CNRS, Team Immun & Canc,Inserm U1068,UMR7258,CRCM,CNRS, Marseille, France; [Michielin, Olivier] Univ Lausanne, Ludwig Ctr Canc Res, Epalinges, Switzerland; [Michielin, Olivier] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Michielin, Olivier] Univ Hosp Lausanne CHUV, Lausanne, Switzerland; [Speiser, Daniel E.] Ludwig Canc Res Ctr, Dept Oncol, Epalinges, Switzerland; [Zoete, Vincent] Univ Lausanne, Dept Fundamental Oncol, Epalinges, Switzerland	Fahrenheit Universities; University of Gdansk; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); University of Lausanne; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Derre, L (corresponding author), Univ Hosp Lausanne CHUV, Urol Dept, Urol Res Unit, Lausanne, Switzerland.	laurent.derre@chuv.ch	Lach, Sławomir/T-7061-2019; Laurent, Derré/AAE-1010-2020; Michielin, Olivier/ABE-7924-2020; Speiser, Daniel E./F-2173-2013; olive, daniel/B-9702-2012	Lach, Sławomir/0000-0002-3985-2214; Laurent, Derré/0000-0002-3403-161X; olive, daniel/0000-0003-1299-4113; Spodzieja, Marta/0000-0003-2712-0048; Kuncewicz, Katarzyna/0000-0003-4730-3343; Rodziewicz-Motowidlo, Sylwia/0000-0002-4471-5951; Iwaszkiewicz, Justyna/0000-0003-3494-589X	"Design of BTLA inhibitors as new drugs against melanoma" financed by a grant from Switzerland through the Swiss Contribution to the enlarged European Union [PSPB-070/2010]; Interdisciplinary Fund from the Faculty of Biology and Medicine (FBM) of Lausanne	"Design of BTLA inhibitors as new drugs against melanoma" financed by a grant from Switzerland through the Swiss Contribution to the enlarged European Union; Interdisciplinary Fund from the Faculty of Biology and Medicine (FBM) of Lausanne	This work was supported by Grant project no. PSPB-070/2010 Design of BTLA inhibitors as new drugs against melanoma financed by a grant from Switzerland through the Swiss Contribution to the enlarged European Union; and by the Interdisciplinary Fund from the Faculty of Biology and Medicine (FBM) of Lausanne.	Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Carlino MS, 2016, CLIN CANCER RES, V22, P3992, DOI 10.1158/1078-0432.CCR-15-2944; Chang HN, 2015, ANGEW CHEM INT EDIT, V54, P11760, DOI 10.1002/anie.201506225; College, 2011, PAFOH INV IMM REC PD; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Company B-MS, INV US IMM; Croft M, 2005, TRENDS IMMUNOL, V26, P292, DOI 10.1016/j.it.2005.03.010; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gertner-Dardenne J, 2013, BLOOD, V122, P922, DOI 10.1182/blood-2012-11-464685; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Heinzerling L, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0152-y; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Krieg C, 2005, J IMMUNOL, V175, P6420, DOI 10.4049/jimmunol.175.10.6420; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LINSLEY PS, 1991, J EXP MED, V174, P561, DOI 10.1084/jem.174.3.561; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Otsuki N, 2006, BIOCHEM BIOPH RES CO, V344, P1121, DOI 10.1016/j.bbrc.2006.03.242; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pasero C, 2013, IMMUNOL LETT, V151, P71, DOI 10.1016/j.imlet.2013.01.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Shindo Y, 2017, J SURG RES, V208, P33, DOI 10.1016/j.jss.2016.08.099; Spain L, 2016, CANCER TREAT REV, V44, P51, DOI 10.1016/j.ctrv.2016.02.001; Spodzieja M, 2013, J MOL RECOGNIT, V26, P415, DOI 10.1002/jmr.2283; Spodzieja M, 2012, J MOL RECOGNIT, V25, P513, DOI 10.1002/jmr.2220; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Zak KM, 2016, ONCOTARGET, V7, P30323, DOI 10.18632/oncotarget.8730; Zarganes-Tzitzikas T, 2016, EXPERT OPIN THER PAT, V26, P973, DOI 10.1080/13543776.2016.1206527	43	22	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179201	10.1371/journal.pone.0179201	http://dx.doi.org/10.1371/journal.pone.0179201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594868	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200101
J	Trnovska, J; Silhavy, J; Kuda, O; Landa, V; Zidek, V; Mlejnek, P; Slimakova, M; Strnad, H; Skop, V; Oliyarnyk, O; Kazdova, L; Haluzik, M; Pravenec, M				Trnovska, Jaroslava; Silhavy, Jans; Kuda, Ondrej; Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Slimakova, Miroslava; Strnad, Hynek; Skop, Vojtech; Oliyarnyk, Olena; Kazdova, Ludmila; Haluzik, Martin; Pravenec, Michal			Salsalate ameliorates metabolic disturbances by reducing inflammation in spontaneously hypertensive rats expressing human C-reactive protein and by activating brown adipose tissue in nontransgenic controls	PLOS ONE			English	Article							FALSE DISCOVERY RATE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; OBESITY; ACIDS	Chronic low-grade inflammation plays an important role in the pathogenesis of insulin resistance. In the current study, we tested the effects of salsalate, a non-steroidal anti-inflammatory drug, in an animal model of inflammation and metabolic syndrome using spontaneously hypertensive rats (SHR) that transgenically express human C-reactive protein (SHR-CRP rats). We treated 15-month-old male transgenic SHR-CRP rats and nontransgenic SHR with salsalate (200 mg/kg/day) mixed as part of a standard diet for 4 weeks. A corresponding untreated control group of male transgenic SHR-CRP and SHR rats were fed a standard diet without salsalate. In the SHR-CRP transgenic strain, salsalate treatment decreased circulating concentrations of the inflammatory markers TNF-alpha and MCP-1, reduced oxidative stress in the liver and kidney, increased sensitivity of skeletal muscles to insulin action and improved tolerance to glucose. In SHR controls with no CRP-induced inflammation, salsalate treatment reduced body weight, decreased concentrations of serum free fatty acids and total and HDL cholesterol and increased palmitate oxidation and incorporation in brown adipose tissue. Salsalate regulated inflammation by affecting the expression of genes from MAPK signalling and NOD-like receptor signalling pathways and lipid metabolism by affecting hepatic expression of genes that favour lipid oxidation from PPAR-alpha signalling pathways. These findings suggest that salsalate has metabolic effects beyond suppressing inflammation.	[Trnovska, Jaroslava; Skop, Vojtech; Oliyarnyk, Olena; Kazdova, Ludmila; Haluzik, Martin] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic; [Silhavy, Jans; Kuda, Ondrej; Landa, Vladimir; Zidek, Vaclav; Mlejnek, Petr; Slimakova, Miroslava; Pravenec, Michal] Czech Acad Sci, Inst Physiol, Prague, Czech Republic; [Strnad, Hynek] Czech Acad Sci, Inst Mol Genet, Prague, Czech Republic; [Haluzik, Martin] Charles Univ Prague, Fac Med 1, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Haluzik, Martin] Gen Univ Hosp, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; General University Hospital Prague	Pravenec, M (corresponding author), Czech Acad Sci, Inst Physiol, Prague, Czech Republic.	pravenec@biomed.cas.cz	Mlejnek, Petr/C-2305-2012; Simakova, Miroslava/B-7493-2012; Oliyarnyk, Olena/Q-6380-2019; Kuda, Ondrej/B-7990-2012; Silhavy, Jan/B-5292-2014; Pravenec, Michal/B-1666-2012	Mlejnek, Petr/0000-0002-4218-8983; Kuda, Ondrej/0000-0001-7034-4536; Silhavy, Jan/0000-0001-8042-5890; Pravenec, Michal/0000-0001-9197-5871; Trnovska, Jaroslava/0000-0001-6468-8244; Skop, Vojtech/0000-0002-4685-4429; Oliyarnyk, Olena/0000-0002-4912-6187	MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM) [IN 0002301]; Grant Agency of the Czech Republic [14-04420S]	MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grant MH CZ - DRO ("Institute for Clinical and Experimental Medicine - IKEM, IN 0002301") and grant 14-04420S from Grant Agency of the Czech Republic.	Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697; Amir S, 2006, NEUROSCI LETT, V407, P254, DOI 10.1016/j.neulet.2006.08.057; Anderson K, 2014, AM HEALTH DRUG BENEF, V7, P231; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carvalho SD, 1996, ENDOCRINOLOGY, V137, P5519, DOI 10.1210/en.137.12.5519; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Gouma E, 2012, LAB ANIM-UK, V46, P40, DOI 10.1258/la.2011.011021; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Liang W, 2015, BRIT J PHARMACOL, V172, P5293, DOI 10.1111/bph.13315; Maiorino MI, 2017, ENDOCRINE, V55, P360, DOI 10.1007/s12020-016-0993-7; Malinska H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150924; Mracek T, 2004, CYTOKINE, V26, P9, DOI 10.1016/j.cyto.2003.12.001; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pravenec M, 2016, PHYSIOL GENOMICS, V48, P420, DOI 10.1152/physiolgenomics.00122.2015; Pravenec M, 2011, HYPERTENSION, V57, P731, DOI 10.1161/HYPERTENSIONAHA.110.164350; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Silhavy J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101906; Silhavy J, 2014, CARDIOVASC THER, V32, P59, DOI 10.1111/1755-5922.12061; Skop V, 2016, PHYSIOL RES, V65, P891, DOI 10.33549/physiolres.933304; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; van Dam AD, 2015, DIABETES, V64, P1544, DOI 10.2337/db14-1125; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Wang R, 1999, THYROID, V9, P359, DOI 10.1089/thy.1999.9.359; Wang X, 2014, DIABETES METAB SYNDR, V7, P381, DOI 10.2147/DMSO.S65818; WARD PA, 1985, J CLIN INVEST, V76, P517, DOI 10.1172/JCI112001; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	39	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179063	10.1371/journal.pone.0179063	http://dx.doi.org/10.1371/journal.pone.0179063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586387	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700044
J	Bi, RY; Meng, Z; Zhang, P; Wang, XD; Ding, Y; Gan, YH				Bi, Rui-Yun; Meng, Zhen; Zhang, Peng; Wang, Xue-Dong; Ding, Yun; Gan, Ye-Hua			Estradiol upregulates voltage-gated sodium channel 1.7 in trigeminal ganglion contributing to hyperalgesia of inflamed TMJ	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; TEMPOROMANDIBULAR-JOINT; INFLAMMATORY PAIN; SEX-DIFFERENCES; NA(V)1.7 PN1; DORSAL-HORN; PC12 CELLS; ESTROGEN; NEURONS; RAT	Background Temporomandibular disorders (TMDs) have the highest prevalence in women of reproductive age. The role of estrogen in TMDs and especially in TMDs related pain is not fully elucidated. Voltage-gated sodium channel 1.7 (Nav1.7) plays a prominent role in pain perception and Nav1.7 in trigeminal ganglion (TG) is involved in the hyperalgesia of inflamed Temporomandibular joint (TMJ). Whether estrogen could upregulate trigeminal ganglionic Nav1.7 expression to enhance hyperalgesia of inflamed TMJ remains to be explored. Methods Estrous cycle and plasma levels of 17 beta estradiol in female rats were evaluated with vaginal smear and enzyme linked immunosorbent assay, respectively. Female rats were ovariectomized and treated with 17 beta-estradiol at 0 mu g, 20 mu g and 80 mu g, respectively, for 10 days. TMJ inflammation was induced using complete Freund's adjuvant. Head withdrawal thresholds and food intake were measured to evaluate the TMJ nociceptive responses. The expression of Nav1.7 in TG was examined using real-time PCR and western blot. The activity of Nav1.7 promoter was examined using luciferase reporter assay. The locations of estrogen receptors (ER alpha and ER beta), the G protein coupled estrogen receptor (GPR30), and Nav1.7 in TG were examined using immunohistofluorescence. Results Upregulation of Nav1.7 in TG and decrease in head withdrawal threshold were observed with the highest plasma 17 beta-estradiol in the proestrus of female rats. Ovariectomized rats treated with 80 mu g 17 beta-estradiol showed upregulation of Nav1.7 in TG and decrease in head withdrawal threshold as compared with that of the control or ovariectomized rats treated with 0 mu g or 20 mu g. Moreover, 17 beta-estradiol dose-dependently potentiated TMJ inflammation-induced upregulation of Nav1.7 in TG and also enhanced TMJ inflammationinduced decrease of head withdrawal threshold in ovariectomized rats. In addition, the estrogen receptor antagonist, ICI 182,780, partially blocked the 17 beta-estradiol effect on Nav1.7 expression and head withdrawal threshold in ovariectomized rats. ER alpha and ER beta, but not GPR30, were mostly co-localized with Nav1.7 in neurons in TG. In the nerve growth factor-induced and ERa-transfected PC12 cells, 17 beta-estradiol dose-dependently enhanced Nav1.7 promoter activity, whereas mutations of the estrogen response element at -1269/1282 and -1214/-1227 in the promoter completely abolished its effect on the promoter activity. Conclusion Estradiol could upregulate trigeminal ganglionic Nav1.7 expression to contribute to hyperalgesia of inflamed TMJ.	[Bi, Rui-Yun; Ding, Yun] Peking Univ, Sch & Hosp Stomatol, Dent Ctr 3, Beijing, Peoples R China; [Meng, Zhen; Zhang, Peng; Gan, Ye-Hua] Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China; [Zhang, Peng; Gan, Ye-Hua] Peking Univ, Sch & Hosp Stomatol, Ctr Temporomandibular Disorders & Orofacial Pain, Beijing, Peoples R China; [Wang, Xue-Dong] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Ding, Y (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dent Ctr 3, Beijing, Peoples R China.; Gan, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, Beijing, Peoples R China.; Gan, YH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Temporomandibular Disorders & Orofacial Pain, Beijing, Peoples R China.	yunding666@126.com; kqyehuagan@bjmu.edu.cn			National Natural Science Foundation of China [81070849, 81271173]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no. 81070849 and no. 81271173).; The authors wish to express their appreciation to Dr. Xiao-Xing Kou for his excellent technical assistance. The authors have no conflicts of interest to report. This work was supported by the National Natural Science Foundation of China (Grant No. 81070849 and No. 81271173).	Bereiter DA, 2001, CELLS TISSUES ORGANS, V169, P226, DOI 10.1159/000047886; Berwick DC, 2010, J BIOL CHEM, V285, P15286, DOI 10.1074/jbc.M109.071456; Bi RY, 2013, EUR J PAIN, V17, P983, DOI 10.1002/j.1532-2149.2012.00262.x; Bi RY, 2015, MED HYPOTHESES, V84, P100, DOI 10.1016/j.mehy.2014.12.010; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Black JA, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-82; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Diss JKJ, 2008, MOL CELL NEUROSCI, V37, P537, DOI 10.1016/j.mcn.2007.12.002; Diss JKJ, 2006, PROSTATE CANCER P D, V9, P83, DOI 10.1038/sj.pcan.4500837; Djouhri L, 2003, J PHYSIOL-LONDON, V546, P565, DOI 10.1113/jphysiol.2002.026559; Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321; Evrard HC, 2006, AM J PHYSIOL-REG I, V291, pR291, DOI 10.1152/ajpregu.00930.2005; Ferriere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069081; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Flake NM, 2005, J NEUROPHYSIOL, V93, P1585, DOI 10.1152/jn.00269.2004; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hertrampf T, 2007, BONE, V40, P1529, DOI 10.1016/j.bone.2007.02.006; Hoyt SB, 2007, BIOORG MED CHEM LETT, V17, P6172, DOI 10.1016/j.bmcl.2007.09.032; JADOT G, 1983, J PHARMACOL-PARIS, V14, P373; Kou XX, 2013, CARCINOGENESIS, V34, P58, DOI 10.1093/carcin/bgs336; Kou XX, 2011, ARTHRITIS RHEUM-US, V63, P1888, DOI 10.1002/art.30334; Kramer PR, 2009, ENDOCRINOLOGY, V150, P3680, DOI 10.1210/en.2008-1707; LeResche L, 1997, PAIN, V69, P153, DOI 10.1016/S0304-3959(96)03230-7; Li L, 2009, PAIN, V143, P37, DOI 10.1016/j.pain.2009.01.005; LUSTIG RH, 1994, J NEUROSCI, V14, P3945; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; MURAKAMI K, 1991, J ORAL MAXIL SURG, V49, P1159, DOI 10.1016/0278-2391(91)90407-D; Murakami K, 1991, J ORAL MAXILLOFACIAL, V49, P62; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nishimura M, 2002, ORAL SURG ORAL MED O, V94, P328, DOI 10.1067/moe.2002.124106; Nishimura Y, 2014, NEUROSCI LETT, V570, P1, DOI 10.1016/j.neulet.2014.04.014; Ren J, 2012, CALCIFIED TISSUE INT, V90, P411, DOI 10.1007/s00223-012-9581-x; Ren K, 1999, PHYSIOL BEHAV, V67, P711, DOI 10.1016/S0031-9384(99)00136-5; Simpson ER, 2003, J STEROID BIOCHEM, V86, P225, DOI 10.1016/S0960-0760(03)00360-1; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Tamura R, 2014, ANESTH ANALG, V118, P318, DOI 10.1213/ANE.0000000000000085; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Uysal-Onganer P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-76; Wada A, 2006, J PHARMACOL SCI, V102, P253, DOI 10.1254/jphs.CRJ06012X; Waxman SG, 2006, NATURE, V444, P831, DOI 10.1038/444831a; Wu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055212; [吴亚晶 Wu Yajing], 2010, [复杂系统与复杂性科学, Complex Systems and Complexity Science], V7, P1; Wu YW, 2015, ARCH ORAL BIOL, V60, P1310, DOI 10.1016/j.archoralbio.2015.05.011; Wu YW, 2012, J PAIN, V13, P555, DOI 10.1016/j.jpain.2012.03.005; Yeomans DC, 2005, HUM GENE THER, V16, P271, DOI 10.1089/hum.2005.16.271; Zhang P, 2017, INFLAMMATION; Zhang ZG, 2002, BIOCHEM BIOPH RES CO, V294, P926, DOI 10.1016/S0006-291X(02)00348-0	48	42	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178589	10.1371/journal.pone.0178589	http://dx.doi.org/10.1371/journal.pone.0178589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582470	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600024
J	Gao, XA; Yan, Y; Xiang, ST; Zeng, GY; Liu, SP; Sha, TT; He, QO; Li, HY; Tan, S; Chen, C; Li, L; Yan, QA				Gao, Xiao; Yan, Yan; Xiang, Shiting; Zeng, Guangyu; Liu, Shiping; Sha, Tingting; He, Qiong; Li, Hongyan; Tan, Shan; Chen, Cheng; Li, Ling; Yan, Qiang			The mutual effect of pre-pregnancy body mass index, waist circumference and gestational weight gain on obesity-related adverse pregnancy outcomes: A birth cohort study	PLOS ONE			English	Article							TO-HIP RATIO; SUBCUTANEOUS FAT THICKNESS; RISK; ASSOCIATIONS; MACROSOMIA; PREDICTOR	Objective The aim of this study was to examine the mutual effect of pre-pregnancy body mass index (BMI), waist circumference (WC) and gestational weight gain (GWG) on obesity-related adverse pregnancy outcomes. Methods This birth cohort study was conducted in three Streets in Changsha, China, including a total of 976 mother-child pairs. All data was collected within 15 days after deliveries from a selfadministered questionnaire, maternal health manual and perinatal health care information system. Multivariate logistic regression models were conducted to estimate the effects of maternal pre-pregnancy BMI, WC and GWG on obesity-related adverse pregnancy outcomes including gestational diabetes mellitus (GDM), primary cesarean section (P-CS), large for gestational age (LGA) and composite outcome (one or more adverse pregnancy outcomes) Results After controlling for all confounders, both maternal pre-pregnancy overweight/obesity and central adiposity contributed to increased risks of GDM [ORs 95% Cls = 2.19 (1.02-4.76) and 2.26 (1.11-4.60), respectively], P-CS [ORs 95% Cls = 1.66 (1.05-2.65) and 1.71 (1.11-2.63), respectively], LGA [ORs 95% Cls = 1.93 (1.07-3.50) and 2.14 (1.21-3.75), respectively] and composite outcome [ORs 95% Cls = 1.82 (1.15-2.87) and 1.98 (1.303.01), respectively] compared with mothers with normal pre-pregnancy weight and normal WC. Excessive GWG was found to be associated with an increased risk of LGA [OR 95%CI = 1.74 (1.05-2.89)], but was not significantly related to higher risks of GDM, P -CS and composite outcome [ORs 95% CIs = 0.90 (0.47-1.72), 1.08 (0.77-1.52), and 1.30 (0.941.79), respectively]. In terms of the joint effect of maternal pregestational BMI and WC on obesity -related composite outcome, mothers with both pre-pregnancy overweight and central adiposity had the highest risk of composite outcome [OR 95% CI = 3.96 (2.40-6.54)], compared with mothers without pre-pregnancy overweight or central adiposity. Conclusions The results of this study suggest that maternal pre-pregnancy overweight/obesity and central adiposity may contribute to multiple obesity-related adverse pregnancy outcomes, excessive weight gain during pregnancy is associated with an increased risk of LGA. Healthcare providers should carry out health education, and guide women to keep an ideal BMI and WC prior to pregnancy and help them gain optimal weight during pregnancy based on their pre-pregnancy BMI and WC.	[Gao, Xiao; Yan, Yan; Xiang, Shiting; Zeng, Guangyu; Liu, Shiping; Sha, Tingting; He, Qiong; Li, Hongyan; Tan, Shan; Chen, Cheng; Li, Ling] Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Yan, Qiang] Kaifu Dist Hlth Bur, Dept Maternal & Child Hlth, Changsha, Hunan, Peoples R China	Central South University	Yan, Y (corresponding author), Cent S Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China.	yanyan802394@126.com		Yan, Yan/0000-0001-7479-637X	National Natural Science Foundation of China [81373101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China(81373101).	Alberico S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-23; Aliyu MH, 2010, MATURITAS, V66, P88, DOI 10.1016/j.maturitas.2010.02.016; Cho EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140376; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Drehmer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054704; El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249; Fraser A, 2011, AM J CLIN NUTR, V93, P1285, DOI 10.3945/ajcn.110.008326; Kennedy NJ, 2016, BJOG-INT J OBSTET GY, V123, P225, DOI 10.1111/1471-0528.13758; Kerrigan AM, 2010, MIDWIFERY, V26, P138, DOI 10.1016/j.midw.2008.12.005; Kirkegaard H, 2015, AM J CLIN NUTR, V102, P393, DOI 10.3945/ajcn.114.099184; Kirkegaard H, 2014, AM J CLIN NUTR, V99, P312, DOI 10.3945/ajcn.113.067405; Leng JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129536; Li CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136850; Li GH, 2014, PAEDIATR PERINAT EP, V28, P345, DOI 10.1111/ppe.12133; Li N, 2013, PLOS ONE, V8; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; [李晓燕 Li Xiaoyan], 2012, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V46, P683; Ma Guan-sheng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P311; Mamun AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-62; McDonnold M, 2016, AM J PERINAT, V33, P618, DOI 10.1055/s-0035-1569986; de Oliveira MAM, 2010, ARQ BRAS CARDIOL, V94, P478, DOI 10.1590/S0066-782X2010005000012; Morken NH, 2013, ACTA OBSTET GYN SCAN, V92, P809, DOI 10.1111/aogs.12115; Murakami Maki, 2005, Archives of Gynecology and Obstetrics, V271, P311, DOI 10.1007/s00404-004-0629-7; Qiao Q, 2010, EUR J CLIN NUTR, V64, P30, DOI 10.1038/ejcn.2009.93; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Salem W, 2012, BJOG-INT J OBSTET GY, V119, P291, DOI 10.1111/j.1471-0528.2011.03167.x; Salihu HM, 2009, EUR J OBSTET GYN R B, V144, P119, DOI 10.1016/j.ejogrb.2009.02.047; Sun CH, 2012, NUTR FOOD HYGIENE, P266; Suresh A, 2012, AUST NZ J OBSTET GYN, V52, P420, DOI 10.1111/j.1479-828X.2012.01471.x; Taebi M, 2015, HYPERTENS RES, V38, P80, DOI 10.1038/hr.2014.133; Tanaka T, 2014, J OBSTET GYNAECOL RE, V40, P1296, DOI 10.1111/jog.12353; Van Der Linden EL, 2016, OBESITY, V24, P215, DOI 10.1002/oby.21210; Yang SP, 2015, PAEDIATR PERINAT EP, V29, P462, DOI 10.1111/ppe.12213; Yang SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116168; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zilberlicht A, 2016, GYNECOL ENDOCRINOL, V32, P416, DOI 10.3109/09513590.2015.1127911	36	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177418	10.1371/Journal.pone.0177418	http://dx.doi.org/10.1371/Journal.pone.0177418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575041	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300013
J	Jirschitzka, J; Kimmerle, J; Halatchliyski, I; Hancke, J; Meurers, D; Cress, U				Jirschitzka, Jens; Kimmerle, Joachim; Halatchliyski, Iassen; Hancke, Julia; Meurers, Detmar; Cress, Ulrike			A productive clash of perspectives? The interplay between articles' and authors' perspectives and their impact on Wikipedia edits in a controversial domain	PLOS ONE			English	Article							PREFERENCE-INCONSISTENT RECOMMENDATIONS; REDUCING CONFIRMATION BIAS; KNOWLEDGE CONSTRUCTION; SELECTIVE EXPOSURE; POLARIZATION; INFORMATION; SCIENCE	This study examined predictors of the development of Wikipedia articles that deal with controversial issues. We chose a corpus of articles in the German-language version of Wikipedia about alternative medicine as a representative controversial issue. We extracted edits made until March 2013 and categorized them using a supervised machine learning setup as either being pro conventional medicine, pro alternative medicine, or neutral. Based on these categories, we established relevant variables, such as the perspectives of articles and of authors at certain points in time, the (im)balance of an article's perspective, the number of non-neutral edits per article, the number of authors per article, authors' heterogeneity per article, and incongruity between authors' and articles' perspectives. The underlying objective was to predict the development of articles' perspectives with regard to the controversial topic. The empirical part of the study is embedded in theoretical considerations about editorial biases and the effectiveness of norms and rules in Wikipedia, such as the neutral point of view policy. Our findings revealed a selection bias where authors edited mainly articles with perspectives similar to their own viewpoint. Regression analyses showed that an author's perspective as well as the article's previous perspectives predicted the perspective of the resulting edits, albeit both predictors interact with each other. Further analyses indicated that articles with more non-neutral edits were altogether more balanced. We also found a positive effect of the number of authors and of the authors' heterogeneity on articles' balance. However, while the effect of the number of authors was reserved to pro-conventional medicine articles, the authors' heterogenity effect was restricted to pro-alternative medicine articles. Finally, we found a negative effect of incongruity between authors' and articles' perspectives that was pronounced for the pro-alternative medicine articles.	[Jirschitzka, Jens; Kimmerle, Joachim; Halatchliyski, Iassen; Hancke, Julia; Cress, Ulrike] Leibniz Inst Wissensmedien, Tubingen, Germany; [Kimmerle, Joachim; Cress, Ulrike] Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany; [Meurers, Detmar] Eberhard Karls Univ Tubingen, Dept Linguist, Tubingen, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Kimmerle, J (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.; Kimmerle, J (corresponding author), Eberhard Karls Univ Tubingen, Dept Psychol, Tubingen, Germany.	joachim.kimmerle@uni-tuebingen.de	Cress, Ulrike/AAB-4264-2020; Meurers, Detmar/AAQ-6659-2020; Cress, Ulrike/A-5615-2013; Kimmerle, Joachim/ABE-8803-2020	Cress, Ulrike/0000-0002-8996-8303; Meurers, Detmar/0000-0002-9740-7442; Cress, Ulrike/0000-0002-8996-8303; 	Leibniz ScienceCampus Tuebingen; Deutsche Forschungsgemeinschaft; Eberhard Karls University of Tuebingen; LeibnizInstitut fOr Wissensmedien, Tuebingen; Leibniz ScienceCampus Tuebingen [WCT-TP2.2]	Leibniz ScienceCampus Tuebingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eberhard Karls University of Tuebingen; LeibnizInstitut fOr Wissensmedien, Tuebingen; Leibniz ScienceCampus Tuebingen	The research reported here was supported by a grant from the Leibniz ScienceCampus Tuebingen (https://www.wissenschaftscampus-tuebingen.de/www/en/index.html) awarded to Ulrike Cress (WCT-TP2.2). We also acknowledge support by Deutsche Forschungsgemeinschaft http://www.dfg.de/en/index.jsp), Open Access Publishing Fund (JK) of Eberhard Karls University of Tuebingen (http://www.uni-tuebingen.de/einrichtungen/universitaetsbibliothek/forschen-publizierer/open-access-publikationsfonds.html), and the LeibnizInstitut fOr Wissensmedien, Tuebingen (https:// MNI.V.1,vm-tuebingen.de/vmv/entindext.tml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the Wikipedia Community for creating and maintaining the wonderful Internet encyclopedia Wikipedia. The research reported here was supported by a grant from the Leibniz ScienceCampus Tuebingen awarded to Ulrike Cress (WCT-TP2.2). We also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Eberhard Karls University of Tuebingen.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Aiken L. S., 1991, MULTIPLE REGRESSION; Benkler Y, 2006, J POLIT PHILOS, V14, P394, DOI 10.1111/j.1467-9760.2006.00235.x; Blumenstock JE., 2008, P 17 INT C WORLD WID, DOI DOI 10.1145/1367497.1367673; Bohnet B., 2010, P 23 COLING C, P89; Borra E, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P193, DOI 10.1145/2702123.2702436; Brandes U, 2008, INFORM VISUAL, V7, P34, DOI 10.1057/palgrave.ivs.9500171; Bykau S, 2015, PROC INT CONF DATA, P1573, DOI 10.1109/ICDE.2015.7113426; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Cress U, 2007, P 8 IT C COMP SUPP C, P156; Cress U, 2016, COMPUT-SUPP COLLAB L, V16, P85, DOI 10.1007/978-3-319-13536-6_5; Cress U, 2016, COMPUT-SUPP COLLAB L, V16, P3, DOI 10.1007/978-3-319-13536-6_1; Cress U, 2008, INT J COMP-SUPP COLL, V3, P105, DOI 10.1007/s11412-007-9035-z; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Detienne F, 2016, INT J HUM-COMPUT ST, V86, P11, DOI 10.1016/j.ijhcs.2015.09.002; Eysenbach G, 2001, BRIT MED J, V323, P1103, DOI 10.1136/bmj.323.7321.1103; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Greenstein S, 2012, 18167 NBER; Greenstein S, 2016, 15023 HBS; Halatchliyski I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111958; Halatchliyski I, 2014, INT J COMP-SUPP COLL, V9, P97, DOI 10.1007/s11412-013-9182-3; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hampton K., 2014, SOCIAL MEDIA SPIRAL; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hewitt-Taylor J, 2012, J MED INTERNET RES, V14, P301, DOI 10.2196/jmir.2068; Holtz P, 2012, J MEDIA PSYCHOL-GER, V24, P55, DOI 10.1027/1864-1105/a000062; Hookway N, 2008, QUAL RES, V8, P91, DOI 10.1177/1468794107085298; IBM Corp, 2011, IBM SPSS STAT WIND V; Jirschitzka J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148283; Jonas E, 2001, J PERS SOC PSYCHOL, V80, P557, DOI 10.1037/0022-3514.80.4.557; Kievit RA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00513; Kimmerle J, 2015, EDUC PSYCHOL-US, V50, P120, DOI 10.1080/00461520.2015.1036273; Kimmerle J, 2013, COMPUT HUM BEHAV, V29, P1078, DOI 10.1016/j.chb.2012.09.010; Kimmerle J, 2011, EDUC TECHNOL SOC, V14, P138; Kimmerle J, 2010, INFORM COMMUN SOC, V13, P1099, DOI 10.1080/13691180903521547; Kittur A, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P453; Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030; Kobayashi T, 2009, INFORM COMMUN SOC, V12, P929, DOI 10.1080/13691180802158490; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li CL, 2012, SOC NETW ANAL MIN, V2, P265, DOI 10.1007/s13278-011-0037-5; Lih A., 2004, 5 INT S ONL JOURN; Liu J., 2011, ACM T MANAGE INF SYS, V2, P1, DOI DOI 10.1145/1985347.1985352; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; MacKinnon DP, 2008, HEALTH PSYCHOL, V27, pS99, DOI 10.1037/0278-6133.27.2(Suppl.).S99; Mojzisch A, 2010, EUR J SOC PSYCHOL, V40, P946, DOI 10.1002/ejsp.660; Moskaliuk J, 2009, J COMPUT ASSIST LEAR, V25, P549, DOI [10.1111/j.1365-2729.2009.00331.x, 10.1111/J.1365-2729.2009.00331.x]; Moskaliuk J, 2012, COMPUT EDUC, V58, P1049, DOI 10.1016/j.compedu.2011.11.024; Muhr T, 2004, USERS MANUAL ATLAS T; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Noelle-Neumann E., 1980, OFFENTLICHE MEINUNG; Oeberst A, 2014, J LEARN SCI, V23, P149, DOI 10.1080/10508406.2014.888352; Pariser E., 2011, FILTER BUBBLE WHAT I; Pritschet L, PSYCHOL SCI; Rad HS, 2012, C P 8 ANN INT S WIK; Rad HS, 2011, P 20 INT C COMP WORL, P117; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Royston P, 1992, STAT COMPUT, V2, P117, DOI [DOI 10.1007/BF01891203, 10.1007/BF01891203]; Schwind C, 2012, COMPUT HUM BEHAV, V28, P2280, DOI 10.1016/j.chb.2012.06.035; Schwind C, 2012, COMPUT EDUC, V58, P787, DOI 10.1016/j.compedu.2011.10.003; SHINE LC, 1980, EDUC PSYCHOL MEAS, V40, P331, DOI 10.1177/001316448004000207; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Steyer R., 2003, WAHRSCHEINLICHKEIT R; Streiner DL, 2003, CAN J PSYCHIAT, V48, P756, DOI 10.1177/070674370304801108; Sumi R., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P724, DOI 10.1109/PASSAT/SocialCom.2011.47; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Tapscott D., 2006, WIKINOMICS MASS COLL; Vuong B.-Q., 2008, MODELS AND WSDM, V2008, P171, DOI DOI 10.1145/1341531.1341556; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wyatt S, 2016, SCI TECHNOL STUD, V29, P13; Yasseri T., 2014, GLOBAL WIKIPEDIA INT, DOI DOI 10.2139/SSRN.2269392; Yasseri T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030091, 10.1371/journal.pone.0038869]	72	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178985	10.1371/journal.pone.0178985	http://dx.doi.org/10.1371/journal.pone.0178985			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575077	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300140
J	Pezzella, C; Macellaro, G; Sannia, G; Raganati, F; Olivieri, G; Marzocchella, A; Schlosser, D; Piscitelli, A				Pezzella, Cinzia; Macellaro, Gemma; Sannia, Giovanni; Raganati, Francesca; Olivieri, Giuseppe; Marzocchella, Antonio; Schlosser, Dietmar; Piscitelli, Alessandra			Exploitation of Trametes versicolor for bioremediation of endocrine disrupting chemicals in bioreactors	PLOS ONE			English	Article							WHITE-ROT FUNGI; HOSPITAL WASTE-WATER; BISPHENOL-A; PLEUROTUS-OSTREATUS; ESTROGENIC ACTIVITY; LIGNINOLYTIC FUNGI; REMOVAL; BIODEGRADATION; NONYLPHENOL; PHARMACEUTICALS	Endocrine disrupting chemicals (EDCs) are environmental contaminants causing increasing concerns due to their toxicity, persistence and ubiquity. In the present study, degradative capabilities of Trametes versicolor, Pleurotus ostreatus and Phanerochaete chrysosporium to act on five EDCs, which represent different classes of chemicals (phenols, parabens and phthalate) and were first applied as single compounds, were assessed. T. versicolor was selected due to its efficiency against target EDCs and its potentialities were exploited against a mixture of EDCs in a cost-effective bioremediation process. A fed-batch approach as well as a starvation strategy were applied in order to reduce the need for input of 'fresh' biomass, and avoid the requirement for external nutrients. The fungus was successfully operated in two different bioreactors over one week. Semi-batch cultures were carried out by daily adding a mixture of EDCs to the bioreactors in a total of five consecutive degradation cycles. T. versico/orwas able to efficiently remove all compounds during each cycle converting up to 21 mg L-1 day-1 of the tested EDCs. The maintained ability of T. versicolorto remove EDCs without any additional nutrients represents the main outcome of this study, which enables to forecast its application in a water treatment process.	[Pezzella, Cinzia; Macellaro, Gemma; Sannia, Giovanni; Piscitelli, Alessandra] Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy; [Raganati, Francesca; Olivieri, Giuseppe; Marzocchella, Antonio] Univ Napoli Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy; [Schlosser, Dietmar] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany	University of Naples Federico II; University of Naples Federico II; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Piscitelli, A (corresponding author), Univ Napoli Federico II, Dipartimento Sci Chim, Naples, Italy.	apiscite@unina.it	Raganati, Francesca/J-8950-2019; Pezzella, Cinzia/L-2753-2014; Piscitelli, Alessandra/J-8414-2013	Raganati, Francesca/0000-0002-9988-1164; Piscitelli, Alessandra/0000-0002-3818-6539; SANNIA, Giovanni/0000-0002-7986-6223; Marzocchella, Antonio/0000-0002-8124-9419				Alexander M., 1994, BIODEGRADATION BIORE; Armenante A, 2010, GLYCOBIOLOGY, V20, P594, DOI 10.1093/glycob/cwq009; Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Badia-Fabregat M, 2016, APPL MICROBIOL BIOT, V100, P2401, DOI 10.1007/s00253-015-7105-0; Badia-Fabregat M, 2014, CHEMOSPHERE, V103, P336, DOI 10.1016/j.chemosphere.2013.12.029; Blanquez P, 2008, J HAZARD MATER, V150, P459, DOI 10.1016/j.jhazmat.2007.09.085; Cabana H, 2007, CHEMOSPHERE, V67, P770, DOI 10.1016/j.chemosphere.2006.10.037; Cajthaml T, 2015, ENVIRON MICROBIOL, V17, P4822, DOI 10.1111/1462-2920.12460; Cajthaml T, 2012, ENVIRON SCI-GER, P291, DOI 10.1007/978-3-642-23789-8_11; Cajthaml T, 2009, CHEMOSPHERE, V75, P745, DOI 10.1016/j.chemosphere.2009.01.034; Catapane M, 2013, J HAZARD MATER, V248, P337, DOI 10.1016/j.jhazmat.2013.01.031; Chau HW, 2009, MYCOL RES, V113, P1046, DOI 10.1016/j.mycres.2009.06.007; Cruz-Morato C, 2014, SCI TOTAL ENVIRON, V493, P365, DOI 10.1016/j.scitotenv.2014.05.117; Faraco V, 2009, BIODEGRADATION, V20, P209, DOI 10.1007/s10532-008-9214-2; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Golan-Rozen N, 2011, ENVIRON SCI TECHNOL, V45, P6800, DOI 10.1021/es200298t; Hanano A, 2015, CHEMOSPHERE, V135, P418, DOI 10.1016/j.chemosphere.2014.11.011; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Harvey PW, 2004, J APPL TOXICOL, V24, P167, DOI 10.1002/jat.978; Hata T, 2010, BIODEGRADATION, V21, P681, DOI 10.1007/s10532-010-9334-3; Hofmann U, 2016, APPL MICROBIOL BIOT, V100, P2381, DOI 10.1007/s00253-015-7113-0; Howe SR, 1998, FOOD ADDIT CONTAM A, V15, P370; Huang QG, 2005, ENVIRON SCI TECHNOL, V39, P6029, DOI 10.1021/es050036x; Hwang SS, 2008, J MICROBIOL BIOTECHN, V18, P767; Iandolo D, 2011, APPL BIOCHEM BIOTECH, V163, P40, DOI 10.1007/s12010-010-9014-0; Ishibashi H, 2004, COMPARATIVE MED, V54, P54; Junghanns C, 2005, MICROBIOL-SGM, V151, P45, DOI 10.1099/mic.0.27431-0; Lewis J B, 1999, Clin Oral Investig, V3, P107, DOI 10.1007/s007840050087; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Macellaro G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/614038; Mir-Tutusaus JA, 2016, J HAZARD MATER, V318, P561, DOI 10.1016/j.jhazmat.2016.07.036; Mizuno H, 2009, BIODEGRADATION, V20, P533, DOI 10.1007/s10532-008-9242-y; Nguyen LN, 2014, INT BIODETER BIODEGR, V88, P169, DOI 10.1016/j.ibiod.2013.12.017; Nimrod AC, 1996, CRIT REV TOXICOL, V26, P335, DOI 10.3109/10408449609012527; Novotny C, 2004, SOIL BIOL BIOCHEM, V36, P1545, DOI 10.1016/j.soilbio.2004.07.019; Olivieri G, 2003, CHEM ENG J, V96, P45, DOI 10.1016/j.cej.2003.08.003; Pointing SB, 2001, APPL MICROBIOL BIOT, V57, P20; Soares A, 2005, APPL MICROBIOL BIOT, V66, P719, DOI 10.1007/s00253-004-1747-7; Soni MG, 2001, FOOD CHEM TOXICOL, V39, P513, DOI 10.1016/S0278-6915(00)00162-9; Torres-Duarte C, 2012, APPL BIOCHEM BIOTECH, V168, P864, DOI 10.1007/s12010-012-9825-2; Tsai MJ, 2012, KAOHSIUNG J MED SCI, V28, pS28, DOI 10.1016/j.kjms.2012.05.007; Tsutsumi Y, 2001, CHEMOSPHERE, V42, P271, DOI 10.1016/S0045-6535(00)00081-3; Wang JQ, 2014, CHEMOSPHERE, V109, P128, DOI 10.1016/j.chemosphere.2014.01.029; Waring RH, 2005, MOL CELL ENDOCRINOL, V244, P2, DOI 10.1016/j.mce.2005.02.007; Yang SF, 2013, INT BIODETER BIODEGR, V85, P483, DOI 10.1016/j.ibiod.2013.03.012; Yang S, 2013, BIORESOURCE TECHNOL, V141, P97, DOI 10.1016/j.biortech.2013.01.173; Zhang C, 2016, CRIT REV ENV SCI TEC, V46, P1, DOI 10.1080/10643389.2015.1061881	47	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178758	10.1371/journal.pone.0178758	http://dx.doi.org/10.1371/journal.pone.0178758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575092	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300109
J	Taitt, CR; Leski, TA; Erwin, DP; Odundo, EA; Kipkemoi, NC; Ndonye, JN; Kirera, RK; Ombogo, AN; Walson, JL; Pavlinac, PB; Hulseberg, C; Vora, GJ				Taitt, Chris Rowe; Leski, Tomasz A.; Erwin, Daniel P.; Odundo, Elizabeth A.; Kipkemoi, Nancy C.; Ndonye, Janet N.; Kirera, Ronald K.; Ombogo, Abigael N.; Walson, Judd L.; Pavlinac, Patricia B.; Hulseberg, Christine; Vora, Gary J.			Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in Kenya	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; TEM-1 BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; INTESTINAL COLONIZATION; GASTROINTESTINAL-TRACT; ENTERIC PATHOGENS; CHILDREN; GENE; HYPERPRODUCTION; INFECTIONS	We sought to determine the genetic and phenotypic antimicrobial resistance (AMR) profiles of commensal Klebsiella spp. circulating in Kenya by testing human stool isolates of 87 K. pneumoniae and three K. oxytoca collected at eight locations. Over one-third of the isolates were resistant to >= 3 categories of antimicrobials and were considered multidrug-resistant (MDR). We then compared the resistance phenotype to the presence/absence of 238 AMR genes determined by a broad-spectrum microarray and PCR. Forty-six genes/gene families were identified conferring resistance to beta-lactams (ampabla(DHA), bia(cmy/LAT), bia(OKp-NoKp-B1), bia(OXA-i-like) family, bia(OXY-1), bIa(SHV), bia(TEM), bia(CTX-M-1) and bia(CTX-M-2) families), aminoglycos ides (aac(3)-III, aac(6)-Ib, aad(A1/A2), aad(A4), aph(AI), aph3/str(A), aph6/str(B), and rmtB), macrol ides (mac(A), mac(B), mph(A)/mph(K)), tetracyclines (tet(A), tet(B), tet(D), tet(G)), ansamycins (arr), phenicols (catA1/cat4, floR, cm/A, cmr), fluoroquinolones (qnrS), quaternary amines (qacE Delta 1,1), streptothricin (sat2), sulfonamides (sul1, sul2, sul3), and diaminopyrimidines (dfrA1, dfrA5, dfrA7, dfrA8, dfrAl2, dfrA13/21/22/23 family, dfrA14, dfrA15, dfrA16, dfrA17). This is the first profile of genes conferring resistance to multiple categories of antimicrobial agents in western and central Kenya. The large number and wide variety of resistance genes detected suggest the presence of significant selective pressure. The presence of five or more resistance determinants in almost two-thirds of the isolates points to the need for more effective, targeted public health policies and infection control/prevention measures.	[Taitt, Chris Rowe; Leski, Tomasz A.; Vora, Gary J.] Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Erwin, Daniel P.; Hulseberg, Christine] Walter Reed Army Inst Res, US Army Med Res Directorate Kenya, Kericho, Kenya; [Odundo, Elizabeth A.; Kipkemoi, Nancy C.; Ndonye, Janet N.; Kirera, Ronald K.; Ombogo, Abigael N.] Walter Reed Army Inst Res, KEMRI US Army Med Res Directorate Kenya, Kericho, Kenya; [Walson, Judd L.; Pavlinac, Patricia B.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Walson, Judd L.] Univ Washington, Dept Med, Seattle, WA USA; [Walson, Judd L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Taitt, CR (corresponding author), Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	chris.taitt@nrl.navy.mil	Walson, Judd/R-7269-2019; Walson, Judd/HGC-4359-2022; Vora, Gary J./AAT-7842-2021; Leski, Tomasz A/K-6916-2013	Walson, Judd/0000-0003-4836-720X; Vora, Gary J./0000-0002-0657-8597; Leski, Tomasz A/0000-0001-7688-9887; Taitt, Chris/0000-0002-0125-9239	Office of Naval Research/NRL through internal Core funds [WU] [69-4888-05]; Armed Forces Health Surveillance Branch-Global Emerging Infections Surveillance and Response Systems (AFHSB-GEIS); National Institutes of Health [U19-A2090882]; Center for AIDS Research (CFAR) Enterics Study Team [A1027757]; University of Washington STD/AIDS Research Training Program [T32-A1007140]	Office of Naval Research/NRL through internal Core funds [WU]; Armed Forces Health Surveillance Branch-Global Emerging Infections Surveillance and Response Systems (AFHSB-GEIS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research (CFAR) Enterics Study Team; University of Washington STD/AIDS Research Training Program	This work was supported by the Office of Naval Research/NRL through internal Core funds [WU # 69-4888-05], the Armed Forces Health Surveillance Branch-Global Emerging Infections Surveillance and Response Systems (AFHSB-GEIS), and the National Institutes of Health [grant number U19-A2090882]. JLW and PBP are supported by the Center for AIDS Research (CFAR) Enterics Study Team (grant #A1027757) and PBP is also supported by the University of Washington STD/AIDS Research Training Program (grant number T32-A1007140). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtova K, 2012, ANTIMICROB AGENTS CH, V56, P4013, DOI 10.1128/AAC.05859-11; Blomberg S, 2005, J CLIN MICROBIOL, P43; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; CLSI, 2015, PERF STAND ANT SUSC; Conlan S, 2016, MBIO, V7; DuPont HL, 2016, CDC HLTH INFORM INT; Ford PJ, 2004, J ANTIMICROB CHEMOTH, V54, P69, DOI 10.1093/jac/dkh251; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; French GL, 1996, J CLIN MICROBIOL, V34, P358, DOI 10.1128/JCM.34.2.358-363.1996; Fung CP, 2012, EMERG INFECT DIS, V18, P1322, DOI 10.3201/eid1808.111053; Garrec H, 2011, J CLIN MICROBIOL, V49, P1048, DOI 10.1128/JCM.02130-10; Global Antibiotic Resistance Partnership-Kenya Working Group, 2011, SIT AN REC ANT US RE; Gona F, 2014, CLIN MICROBIOL INFEC, V20, pO633, DOI 10.1111/1469-0691.12577; Goren MG, 2010, EMERG INFECT DIS, V16, P1014, DOI 10.3201/eid1606.091671; Guan J, 2014, ANTIMICROB AGENTS CH, V58, P1039, DOI 10.1128/AAC.01632-13; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Jaglic Z, 2012, VET MED-CZECH, V57, P275, DOI 10.17221/6013-VETMED; Kariuki S, 2015, ANTIMICROB AGENTS CH, V59, P3133, DOI 10.1128/AAC.00078-15; Kariuki S, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P177, DOI 10.1007/978-0-387-89370-9_11; Kiiru J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-109; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; Kirika, 2009, ANTIMICROBIAL RESIST; Kohli R, 2010, East Afr Med J, V87, P74; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Leski TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069507; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maina D, 2012, J INFECT DEV COUNTR, V6, P470, DOI 10.3855/jidc.1456; Martin RM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00261-16; Ministry of Medical Services and Ministry of Public Health and Sanitation, 2010, KEN ESS MED LIST; Ministry of Medical Services and Ministry of Public Health and Sanitation, 2010, KEN SERV PROV ASS SU; Mitema ES, 2001, J VET PHARMACOL THER, V24, P385, DOI 10.1046/j.1365-2885.2001.00360.x; Musembi KP, 2016, DRUG CONSUMPTION PAT; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Muvunyi CM, 2011, AM J TROP MED HYG, V84, P923, DOI 10.4269/ajtmh.2011.11-0057; Mwambete KD, 2013, CLIN MICROBIOL REV, V3; Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Okoche D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135745; Pavlinac PB, 2014, AIDS, V28, P2287, DOI 10.1097/QAD.0000000000000396; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Rogawski ET, 2017, B WORLD HEALTH ORGAN, V95, P49, DOI 10.2471/BLT.16.176123; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Schjorring Susanne, 2011, Int J Microbiol, V2011, P312956, DOI 10.1155/2011/312956; SELDEN R, 1971, ANN INTERN MED, V74, P657, DOI 10.7326/0003-4819-74-5-657; SHANNON K, 1990, FEMS MICROBIOL LETT, V67, P319, DOI 10.1016/0378-1097(90)90016-J; Sidjabat HE, 2009, CLIN INFECT DIS, V49, P1736, DOI 10.1086/648077; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Steffen R, 2003, AM J GASTROENTEROL, V98, P1073, DOI [10.1016/S0002-9270(02)06005-7, 10.1111/j.1572-0241.2003.07283.x]; Taitt CR, 2015, J GLOB ANTIMICROB RE, V3, P198, DOI 10.1016/j.jgar.2015.05.006; Taitt CR, 2014, ANTIMICROB AGENTS CH, V58, P767, DOI 10.1128/AAC.01897-13; Thi PLN, 2003, EMERG INFECT DIS, V9, P135; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Vila J, 1999, ANTIMICROB AGENTS CH, V43, P3022, DOI 10.1128/AAC.43.12.3022; Wanyiri JW, 2013, T ROY SOC TROP MED H, V107, P631, DOI 10.1093/trstmh/trt078; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; World Health Organization, 2004, MED PRIC KEN; Wu PJ, 1995, J ANTIMICROB CHEMOTH, V36, P927, DOI 10.1093/jac/36.6.927	63	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178880	10.1371/journal.pone.0178880	http://dx.doi.org/10.1371/journal.pone.0178880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575064	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300129
J	Pistore, C; Giannoni, E; Colangelo, T; Rizzo, F; Magnani, E; Muccillo, L; Giurato, G; Mancini, M; Rizzo, S; Riccardi, M; Sahnane, N; Del Vescovo, V; Kishore, K; Mandruzzato, M; Macchi, F; Pelizzola, M; Denti, MA; Furlan, D; Weisz, A; Colantuoni, V; Chiarugi, P; Bonapace, IM				Pistore, C.; Giannoni, E.; Colangelo, T.; Rizzo, F.; Magnani, E.; Muccillo, L.; Giurato, G.; Mancini, M.; Rizzo, S.; Riccardi, M.; Sahnane, N.; Del Vescovo, V.; Kishore, K.; Mandruzzato, M.; Macchi, F.; Pelizzola, M.; Denti, M. A.; Furlan, D.; Weisz, A.; Colantuoni, V.; Chiarugi, P.; Bonapace, I. M.			DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells	ONCOGENE			English	Article							STEM-CELLS; EXPRESSION ANALYSIS; MIRNA EXPRESSION; TUMOR-SUPPRESSOR; FEEDBACK LOOP; PROMOTES; ZEB1; METASTASIS; METHYLTRANSFERASES; INHIBITION	Widespread genome hypo-methylation and promoter hyper-methylation of epithelium-specific genes are hallmarks of stable epithelial-to-mesenchymal transition (EMT), which in prostate cancer (PCa) correlates with castration resistance, cancer stem cells generation, chemoresistance and worst prognosis. Exploiting our consolidated 'ex-vivo' system, we show that cancer-associated fibroblasts (CAFs) released factors have pivotal roles in inducing genome methylation changes required for EMT and stemness in EMT-prone PCa cells. By global DNA methylation analysis and RNA-Seq, we provide compelling evidence that conditioned media from CAFs explanted from two unrelated patients with advanced PCa, stimulates concurrent DNA hypo-and hyper-methylation required for EMT and stemness in PC3 and DU145, but not in LN-CaP and its derivative C4-2B, PCa cells. CpG island (CGI) hyper-methylation associates with repression of genes required for epithelial maintenance and invasion antagonism, whereas activation of EMT markers and stemness genes correlate with CGI hypo-methylation. Remarkably, methylation variations and EMT-regulated transcripts almost completely reverse qualitatively and quantitatively during MET. Unsupervised clustering analysis of the PRAD TCGA data set with the differentially expressed (DE) and methylated EMT signature, identified a gene cluster of DE genes defined by a CAF+ and AR-phenotype and worst diagnosis. This gene cluster includes the relevant factors for EMT and stemness, which display DNA methylation variations in regulatory regions inversely correlated to their expression changes, thus strongly sustaining the ex-vivo data. DNMT3A-dependent methylation is essential for silencing epithelial maintenance and EMT counteracting genes, such as CDH1 and GRHL2, that is, the direct repressor of ZEB1, the key transcriptional factor for EMT and stemness. Accordingly, DNMT3A knock-down prevents EMT entry. These results shed light on the mechanisms of establishment and maintenance of coexisting DNA hypo-and hyper-methylation patterns during cancer progression, the generation of EMT and cell stemness in advanced PCa, and may pave the way to new therapeutic implications.	[Pistore, C.; Magnani, E.; Rizzo, S.; Riccardi, M.; Mandruzzato, M.; Macchi, F.; Bonapace, I. M.] Univ Insubria, Dept Biotechnol & Life Sci, Busto Arsizio, VA, Italy; [Giannoni, E.; Chiarugi, P.] Univ Florence, Dept Biomed Expt & Clin Sci Mario Serio, Florence, Italy; [Colangelo, T.; Muccillo, L.; Colantuoni, V.] Univ Sannio, Dept Sci & Technol, Benevento, Italy; [Rizzo, F.; Muccillo, L.; Weisz, A.] Univ Salerno, Dept Med Surg & Dent, Schola Med Salernitana, Lab Mol Med & Gen, Baronissi, SA, Italy; [Sahnane, N.; Furlan, D.] Univ Insubria, Dept Surg & Morphol Sci, Anat Pathol Unit, Varese, Italy; [Kishore, K.; Pelizzola, M.] Italian Inst Technol, Ctr Genom Sci, Milan, Italy; [Del Vescovo, V.; Denti, M. A.] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Colangelo, T.] IRCCS, Casa Sollievo Sofferenza, Inst Stem Cell Biol Regenerat Med & Innovat Thera, San Giovanni Rotondo, Italy	University of Insubria; University of Florence; University of Sannio; University of Salerno; University of Insubria; Istituto Italiano di Tecnologia - IIT; University of Trento; IRCCS Casa Sollievo Della Sofferenza	Bonapace, IM (corresponding author), Univ Insubria I, Dept Biotechnol & Life Sci, Via Manara 7, I-21052 Busto Arsizio, Lombardia, Italy.	ian.bonapace@uninsubria.it	Giurato, Giorgio/K-3859-2018; Rizzo, Francesca/K-3057-2016; Sahnane, Nora/L-1983-2019; Weisz, Alessandro/A-1317-2014; Giannoni, Elisa/AAE-2092-2020; FURLAN, DANIELA/AAB-8271-2022; Chiarugi, Paola/CDD-7988-2022; Denti, Michela A./ABI-4085-2020; COLANGELO, TOMMASO/B-6119-2017	Giurato, Giorgio/0000-0002-0538-8978; Rizzo, Francesca/0000-0003-1783-5015; Sahnane, Nora/0000-0002-6227-8628; Weisz, Alessandro/0000-0003-0455-2083; FURLAN, DANIELA/0000-0002-5958-5379; Denti, Michela A./0000-0001-7203-7062; BONAPACE, IAN MARC/0000-0001-6580-8893; Macchi, Filippo/0000-0001-8226-4816; Pelizzola, Mattia/0000-0001-6672-9636; COLANGELO, TOMMASO/0000-0002-6927-403X; Chiarugi, Paola/0000-0001-7655-2969; Mancini, Monica/0000-0003-4128-9018; Kishore, Kamal/0000-0002-4650-8745	Epigenomics Flagship Project (EPIGEN-CNR-IT); Italian Association for Cancer Research (AIRC) [IG-8797, IG-17426]; AIRC [19548]	Epigenomics Flagship Project (EPIGEN-CNR-IT); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Epigenomics Flagship Project (EPIGEN-CNR-IT: to IMB, VC, DF and AW); Italian Association for Cancer Research (AIRC: grants IG-8797 to PC and IG-17426 to AW). TC is now supported by a three year AIRC fellowship (Project code: 19548). The Ethics approval and consent to participate at the study named 'Ruolo del microambiente stromale nella immunomodulazione e nella progression del carcinoma prostatico (Role of the stromal microenvironment for immunomodulation and for cancer progression in prostatic carcinoma)' was released with reference number 'BIO 15.016' from the Ethics committee 'Area Vasta Centro' of the 'Azienda Ospedaliera Universitaria Correggi' in Florence-Italy on the 26th of June 2015.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aue A, 2015, J AM SOC NEPHROL, V26, P2704, DOI 10.1681/ASN.2014080759; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Babbio F, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-19; Bernhart SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37393; Bhatt T, 2013, CELL COMMUN ADHES, V20, P189, DOI 10.3109/15419061.2013.854778; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cardenas H, 2014, EPIGENETICS-US, V9, P1461, DOI 10.4161/15592294.2014.971608; Carmona FJ, 2014, CANCER RES, V74, P5608, DOI 10.1158/0008-5472.CAN-13-3659; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Cheung AKL, 2015, ONCOTARGET, V6, P13434; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cui H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123926; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Ficz G, 2015, J EXP BIOL, V218, P14, DOI 10.1242/jeb.107961; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; de Herreros AG, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00071; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Giannoni E, 2013, J MOL MED, V91, P103, DOI 10.1007/s00109-012-0941-9; Giannoni E, 2011, ANTIOXID REDOX SIGN, V14, P2361, DOI 10.1089/ars.2010.3727; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Grega-Larson NE, 2015, MOL BIOL CELL, V26, P3803, DOI 10.1091/mbc.E15-06-0443; Guo M, 2012, CANCER RES, V72, P2017, DOI 10.1158/0008-5472.CAN-11-3985; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hong T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004569; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kgatle MM, 2016, PROSTATE CANCER, V2016, DOI 10.1155/2016/5653862; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Lawlor H, 2015, TUMOR BIOL, V36, P6019, DOI 10.1007/s13277-015-3278-5; Lee B, 2014, DEV CELL, V29, P47, DOI 10.1016/j.devcel.2014.03.005; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Liu FT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-66; Lu ZX, 2015, MOL CANCER RES, V13, P305, DOI 10.1158/1541-7786.MCR-14-0366; Malouf GG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r144; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Morita S, 2013, INT J MOL SCI, V14, P14647, DOI 10.3390/ijms140714647; Nogales V, 2016, ONCOTARGET, V7, P3084, DOI 10.18632/oncotarget.6413; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Parpart S, 2014, HEPATOLOGY, V60, P872, DOI 10.1002/hep.27200; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Preca BT, 2015, INT J CANCER, V137, P2566, DOI 10.1002/ijc.29642; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Ru P, 2012, MOL CANCER THER, V11, P1166, DOI 10.1158/1535-7163.MCT-12-0100; Sauer E, 2014, FORENSIC SCI INT-GEN, V13, P217, DOI 10.1016/j.fsigen.2014.08.005; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Spans L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090002; Stefanoli M, 2014, NEUROENDOCRINOLOGY, V100, P26, DOI 10.1159/000365449; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Taddei ML, 2014, MOL ONCOL, V8, P1729, DOI 10.1016/j.molonc.2014.07.009; Taddei ML, 2011, MOL CANCER RES, V9, P149, DOI 10.1158/1541-7786.MCR-10-0298; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; von Meyenn F, 2016, MOL CELL, V62, P848, DOI 10.1016/j.molcel.2016.04.025; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Yang LL, 2012, CARCINOGENESIS, V33, P1863, DOI 10.1093/carcin/bgs226; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; Yaqinuddin A, 2009, J UROLOGY, V182, P756, DOI 10.1016/j.juro.2009.03.082; Zhang PJ, 2015, CELL CYCLE, V14, P481, DOI 10.1080/15384101.2015.1006048; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhang YJ, 2015, DEVELOPMENT, V142, P3383, DOI 10.1242/dev.125393; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	80	55	57	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5551	5566		10.1038/onc.2017.159	http://dx.doi.org/10.1038/onc.2017.159			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581528	Green Submitted			2022-12-26	WOS:000412293600001
J	Jian, W; Yan, BW; Huang, SM; Qiu, Y				Jian, Wei; Yan, Bowen; Huang, Suming; Qiu, Yi			Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly	FASEB JOURNAL			English	Article						TFIID; downstream promoter element; HDAC1; HDACi; acetylation	ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MURINE ERYTHROLEUKEMIA-CELLS; PROMOTER ELEMENT; TERMINAL DIFFERENTIATION; ERYTHROID-CELLS; GAMMA-GLOBIN; TATA-BOX; GATA-1; ERYTHROPOIESIS	Histone acetyltransferases and histone deacetylases (HDACs) are important epigenetic coregulators. It has been thought that HDACs associate with corepressor complexes and repress gene transcription; however, in this study, we have found that PU.1-a key master regulator for hematopoietic self-renewal and lineage specification-requires HDAC activity for gene activation. Deregulated PU.1 gene expression is linked to dysregulated hematopoiesis and the development of leukemia. In this study, we used erythroid differentiation as a model to analyze how the PU.1 gene is regulated. We found that active HDAC1 is directly recruited to active PU.1 promoter in progenitor cells, whereas acetylated HDAC1, which is inactive, is on the silenced PU.1 promoter in differentiated erythroid cells. We then studied the mechanism of HDAC1-mediated activation. We discovered that HDAC1 activates PU.1 gene transcription via deacetylation of TATA-binding protein-associated factor 9 (TAF9), a component in the transcription factor IID (TFIID) complex. Treatment with HDAC inhibitor results in an increase in TAF9 acetylation. Acetylated TAF9 does not bind to the PU.1 gene promoter and subsequently leads to the disassociation of the TFIID complex and transcription repression. Thus, these results demonstrate a key role for HDAC1 in PU.1 gene transcription and, more importantly, uncover a novel mechanism of TFIID recruitment and gene activation.	[Jian, Wei; Yan, Bowen; Qiu, Yi] Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Huang, Suming] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Macau University of Science & Technology	Qiu, Y (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, 2033 Mowry Rd, Gainesville, FL 32610 USA.	qiuy@ufl.edu		, Yi/0000-0002-3282-6072	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL095674]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK110108]; American Heart Association [AHA16GRNT31020032]; Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110108] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); Florida Bankhead Coley Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL095674 (to Y.Q.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK110108 (to S.H.), American Heart Association Grant AHA16GRNT31020032 (to S.H.), and the Florida Bankhead Coley Research Foundation (to Y.Q.). The authors thank Dr. Jim Bieker (Icahn School of Medicine at Mount Sinai, New York, NY, USA) for TAF9 plasmids and Dr. Robert Roeder (The Rockefeller University, New York, NY, USA) for discussion and constructive suggestions. The authors declare no conflicts of interest.	Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Atar O, 2005, BIOCHEM BIOPH RES CO, V329, P1288, DOI 10.1016/j.bbrc.2005.02.109; Back J, 2005, EXP HEMATOL, V33, P395, DOI 10.1016/j.exphem.2004.12.010; Back J, 2004, BLOOD, V103, P3615, DOI 10.1182/blood-2003-11-4089; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1996, GENE DEV, V10, P711, DOI 10.1101/gad.10.6.711; Chen HM, 1996, J BIOL CHEM, V271, P15743, DOI 10.1074/jbc.271.26.15743; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; Chen Z, 2003, MOL CELL BIOL, V23, P7350, DOI 10.1128/MCB.23.20.7350-7362.2003; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fathallah H, 2007, BLOOD, V110, P3391, DOI 10.1182/blood-2007-02-076091; Ferrara FF, 2001, CANCER RES, V61, P2; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kastner P, 2008, INT J BIOCHEM CELL B, V40, P22, DOI 10.1016/j.biocel.2007.01.026; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; KISTLER B, 1995, ONCOGENE, V11, P1095; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Laribee RN, 2001, J IMMUNOL, V167, P5160, DOI 10.4049/jimmunol.167.9.5160; LOZZIO CB, 1979, NATURE, V281, P709, DOI 10.1038/281709b0; Luo Y, 2009, J BIOL CHEM, V284, P34901, DOI 10.1074/jbc.M109.038356; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; McCaffrey PG, 1997, BLOOD, V90, P2075, DOI 10.1182/blood.V90.5.2075; Minucci S, 2001, ONCOGENE, V20, P3110, DOI 10.1038/sj.onc.1204336; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Oikawa T, 1999, CELL DEATH DIFFER, V6, P599, DOI 10.1038/sj.cdd.4400534; Pace BS, 2000, EXP HEMATOL, V28, P283, DOI 10.1016/S0301-472X(99)00153-8; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Qiu Y, 2011, J BIOL CHEM, V286, P7641, DOI 10.1074/jbc.M110.185488; Rao G, 1997, ONCOGENE, V14, P123, DOI 10.1038/sj.onc.1200807; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Richardson CL, 2013, J CLIN INVEST, V123, P3614, DOI 10.1172/JCI68487; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Verbiest T, 2015, CARCINOGENESIS, V36, P413, DOI 10.1093/carcin/bgv016; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Walker AK, 2001, EMBO J, V20, P5269, DOI 10.1093/emboj/20.18.5269; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wang Q, 2007, LEUKEMIA, V21, P1015, DOI 10.1038/sj.leu.2404644; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yamada T, 1997, BLOOD, V89, P1383, DOI 10.1182/blood.V89.4.1383; Yamada T, 2001, BLOOD, V97, P2300, DOI 10.1182/blood.V97.8.2300; Yang T, 2012, J BIOL CHEM, V287, P40279, DOI 10.1074/jbc.M112.349704; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu YT, 2013, J BIOL CHEM, V288, P8805, DOI 10.1074/jbc.M112.423756; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	70	16	17	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4104	4116		10.1096/fj.201700022R	http://dx.doi.org/10.1096/fj.201700022R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28572446	Green Published			2022-12-26	WOS:000408713300033
J	Kiewiet, MBG; Dekkers, R; Gros, M; van Neerven, RJJ; Groeneveld, A; de Vos, P; Faas, MM				Kiewiet, M. B. Gea; Dekkers, Renske; Gros, Marjan; van Neerven, R. J. Joost; Groeneveld, Andre; de Vos, Paul; Faas, Marijke M.			Toll-like receptor mediated activation is possibly involved in immunoregulating properties of cow's milk hydrolysates	PLOS ONE			English	Article							BOVINE BETA-CASEIN; PATTERN-RECOGNITION RECEPTORS; LIMULUS AMEBOCYTE LYSATE; PROTEIN HYDROLYSATE; BIOACTIVE PEPTIDES; IN-VITRO; ENHANCES PROLIFERATION; IMMUNE-RESPONSES; EPITHELIAL-CELLS; IL-8 SECRETION	Immunomodulating proteins and peptides are formed during the hydrolysis of cow's milk proteins. These proteins are potential ingredients in functional foods used for the management of a range of immune related problems, both in infants and adults. However, the mechanism behind these effects is unknown. We hypothesize that the interaction of peptides with Toll-like receptors (TLRs) can induce immune effects, since these receptors are known to sample many dietary molecules in the intestine in order to regulate immune effects. To investigate this, we compared the immune effects and TLR activation and inhibition by whey and casein hydrolysates with different hydrolysis levels. We first measured cytokine production in primary peripheral blood mononuclear cells stimulated with either whey, casein, or their hydrolysates. IL-10 and TNF alpha were induced by whey hydrolysates (decreasing with increasing hydrolysis level), but not by casein hydrolysates. Next, the activation of TLR 2, 3, 5 and 9 receptors were observed by intact and mildly hydrolysed whey proteins only and not by casein hydrolysates in TLR reporter cell lines. Many casein hydrolysates inhibited TLR signaling (mainly TLR 5 and 9). These results demonstrate that the effects of cow's milk proteins on the immune system are protein type and hydrolysis dependent. TLR signaling is suggested as a possible mechanism for differences in effect. This knowledge contributes to a better understanding of the immune effects of hydrolysates and the design of infant formula, and nutrition in general, with specific immunoregulatory effects.	[Kiewiet, M. B. Gea; de Vos, Paul; Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol,Div Med Biol, Groningen, Netherlands; [Dekkers, Renske; Gros, Marjan; van Neerven, R. J. Joost; Groeneveld, Andre] FrieslandCampina, Amersfoort, Netherlands; [Faas, Marijke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Groningen; University of Groningen	Kiewiet, MBG (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Immunoendocrinol,Div Med Biol, Groningen, Netherlands.	m.b.g.kiewiet@umcg.nl	de Vos, Paul/A-3170-2013; van Neerven, Joost/GWZ-3214-2022	van Neerven, R.J.Joost/0000-0002-3991-5297; de vos, paul/0000-0001-9618-2408				Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Baldi A, 2005, J DAIRY RES, V72, P66, DOI 10.1017/S002202990500110X; Basha S, 2014, EXPERT REV CLIN IMMU, V10, P1171, DOI 10.1586/1744666X.2014.942288; Bermudez-Brito M, 2015, MOL NUTR FOOD RES, V23; Chabance B, 1998, BIOCHIMIE, V80, P155, DOI 10.1016/S0300-9084(98)80022-9; Chen L, 2013, J PHARMACEUT BIOMED, V80, P180, DOI 10.1016/j.jpba.2013.03.011; Cheng X, 2015, NUTRIENTS, V7, P3119, DOI 10.3390/nu7053119; Duan CC, 2012, ASIAN PAC J ALLERGY, V30, P32; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hill M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023995; Iskandar MM, 2013, BRIT J NUTR, V110, P58, DOI 10.1017/S0007114512004655; Kazlauskaite J, 2005, INT IMMUNOPHARMACOL, V5, P1936, DOI 10.1016/j.intimp.2005.06.015; Lahart N, 2011, INT DAIRY J, V21, P777, DOI 10.1016/j.idairyj.2011.03.014; Lebrun I, 2004, MEDIAT INFLAMM, V13, P263, DOI 10.1080/09629350400003068; Ledoux N, 1999, NAHRUNG, V43, P196, DOI 10.1002/(SICI)1521-3803(19990601)43:3&lt;196::AID-FOOD196&gt;3.0.CO;2-N; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; Malinowski J, 2014, FOOD CHEM, V165, P129, DOI 10.1016/j.foodchem.2014.05.075; Mao XY, 2005, MILCHWISSENSCHAFT, V60, P119; Martinez-Maqueda D, 2013, INT DAIRY J, V32, P13, DOI 10.1016/j.idairyj.2013.03.010; Meisel H, 2004, BIOFACTORS, V21, P55, DOI 10.1002/biof.552210111; Michallet MC, 2013, CURR OPIN MICROBIOL, V16, P296, DOI 10.1016/j.mib.2013.04.003; Mukhopadhya A, 2015, FOOD FUNCT, V6, P612, DOI 10.1039/c4fo00689e; NANDAN R, 1977, J LAB CLIN MED, V89, P910; Ndiaye F, 2012, EUR J NUTR, V51, P29, DOI 10.1007/s00394-011-0186-3; Nielsen DSG, 2012, J ANIM SCI, V90, P403, DOI 10.2527/jas.53953; Ortega-Gonzalez M, 2014, BRIT J NUTR, V111, P1202, DOI 10.1017/S0007114513003590; Pan DD, 2013, J DAIRY SCI, V96, P4958, DOI 10.3168/jds.2013-6758; Paredes-Juarez GA, 2014, MATERIALS, V7, P2087, DOI 10.3390/ma7032087; Perez-Cano FJ, 2007, BRIT J NUTR, V98, pS80, DOI 10.1017/S0007114507838074; Piccolomini AF, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.17549; Prioult G, 2004, CLIN DIAGN LAB IMMUN, V11, P266, DOI 10.1128/CDLI.11.2.266-271.2004; Raikos V, 2014, DAIRY SCI TECHNOL, V94, P91, DOI 10.1007/s13594-013-0152-3; Ren CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34561; Rodriguez-Carrio J, 2014, INT DAIRY J, V34, P65, DOI 10.1016/j.idairyj.2013.07.004; Sahasrabudhe NM, 2015, MOL NUTR FOOD RES, V23; Sandre C, 2001, J NUTR, V131, P2936, DOI 10.1093/jn/131.11.2936; Sutas Y, 1996, J ALLERGY CLIN IMMUN, V98, P216, DOI 10.1016/S0091-6749(96)70245-2; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tavares TG, 2013, INT DAIRY J, V32, P156, DOI 10.1016/j.idairyj.2013.05.010; Tobita K, 2006, J AGR FOOD CHEM, V54, P8013, DOI 10.1021/jf0610864; Trompette A, 2003, J NUTR, V133, P3499, DOI 10.1093/jn/133.11.3499; van Neerven RJ, 2009, J PERINATOL, V29, P79; Vogt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068367; Wada Y, 2015, PEDIATR RES, V77, P546, DOI 10.1038/pr.2015.10; Willems F, 2009, EUR J IMMUNOL, V39, P26, DOI 10.1002/eji.200838391; Wong CW, 1996, IMMUNOL CELL BIOL, V74, P323, DOI 10.1038/icb.1996.58; Wong KF, 1998, J DAIRY SCI, V81, P1825, DOI 10.3168/jds.S0022-0302(98)75752-2; Wynn JL, 2009, J PERINATOL, V29, P79, DOI 10.1038/jp.2008.132; Zaczynska E, 2014, ADV CLIN EXP MED, V23, P871, DOI 10.17219/acem/30168	50	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178191	10.1371/journal.pone.0178191	http://dx.doi.org/10.1371/journal.pone.0178191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594834	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200020
J	Oja, R; Soe, E; Valdmann, H; Saarma, U				Oja, Ragne; Soe, Egle; Valdmann, Harri; Saarma, Urmas			Non-invasive genetics outperforms morphological methods in faecal dietary analysis, revealing wild boar as a considerable conservation concern for ground-nesting birds	PLOS ONE			English	Article							SUS-SCROFA; PREDATION; FOREST; CAPERCAILLIE; SUCCESS; TRENDS; AREA; POPULATIONS; NUMBERS; EUROPE	Capercaillie (Tetrao urogallus) and other grouse species represent conservation concerns across Europe due to their negative abundance trends. In addition to habitat deterioration, predation is considered a major factor contributing to population declines. While the role of generalist predators on grouse predation is relatively well known, the impact of the omnivorous wild boar has remained elusive. We hypothesize that wild boar is an important predator of ground-nesting birds, but has been neglected as a bird predator because traditional morphological methods underestimate the proportion of birds in wild boar diet. To distinguish between different mammalian predator species, as well as different grouse prey species, we developed a molecular method based on the analysis of mitochondrial DNA that allows accurate species identification. We collected 109 wild boar faeces at protected capercaillie leks and surrounding areas and analysed bird consumption using genetic methods and classical morphological examination. Genetic analysis revealed that the proportion of birds in wild boar faeces was significantly higher (17.3%; 4.5x) than indicated by morphological examination (3.8%). Moreover, the genetic method allowed considerably more precise taxonomic identification of consumed birds compared to morphological analysis. Our results demonstrate: (i) the value of using genetic approaches in faecal dietary analysis due to their higher sensitivity, and (ii) that wild boar is an important predator of ground-nesting birds, deserving serious consideration in conservation planning for capercaillie and other grouse.	[Oja, Ragne; Soe, Egle; Valdmann, Harri; Saarma, Urmas] Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Dept Zool, Inst Ecol & Earth Sci, Tartu, Estonia.	Urmas.Saarma@ut.ee	Saarma, Urmas/AAC-9813-2019	Saarma, Urmas/0000-0002-3222-571X	Estonian Ministry of Education and Research [IUT20-32]; State Forest Management Centre	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); State Forest Management Centre	This work was supported by the institutional research funding (IUT20-32) from the Estonian Ministry of Education and Research, and the State Forest Management Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ECOLOGY WILD BOAR NE; [Anonymous], 2016, METS EL MAAR TEG KOM; Ballari SA, 2015, MAMMAL RES, V60, P81, DOI 10.1007/s13364-014-0202-0; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Beja-Pereira A, 2009, MOL ECOL RESOUR, V9, P1279, DOI 10.1111/j.1755-0998.2009.02699.x; Briedermann L., 1990, SCHWARZWILD, V2nd ed.; Calenge C, 2004, EUR J WILDLIFE RES, V50, P112, DOI 10.1007/s10344-004-0047-y; Carpio AJ, 2014, EUR J WILDLIFE RES, V60, P391, DOI 10.1007/s10344-013-0786-8; Cellina S, 2008, THESIS U SUSSEX; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Gimenez-Anaya A, 2008, WETLANDS, V28, P197, DOI 10.1672/07-18.1; Hannon SJ, 2006, J ZOOL, V269, P422, DOI 10.1111/j.1469-7998.2006.00159.x; Hindrikson M, 2016, BIOL REV; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kornacher P, 2009, EUR J WILDLIFE RES, V55, P517; Laurimaa L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0796-3; Laurimaa L, 2015, EMERG INFECT DIS, V21, P163, DOI 10.3201/eid2101.140136; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Merta D, 2016, WILDLIFE BIOL, V22, P130, DOI 10.2981/wlb.00208; Milner JM, 2014, J WILDLIFE MANAGE, V78, P1322, DOI 10.1002/jwmg.798; Monterroso P, 2013, J ZOOL, V289, P243, DOI 10.1111/jzo.12000; Moreno-Opo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139837; Moss R, 2010, WILDLIFE BIOL, V16, P1, DOI 10.2981/09-055; Oja R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135254; Oja R, 2014, ACTA THERIOL, V59, P553, DOI 10.1007/s13364-014-0190-0; Podgorski T, 2013, J MAMMAL, V94, P109, DOI 10.1644/12-MAMM-A-038.1; Purger JJ, 2006, BIRD CONSERV INT, V16, P309, DOI 10.1017/S0959270906000451; Regnaut S, 2006, CONSERV GENET, V7, P665, DOI 10.1007/s10592-005-9097-2; Rosner S, 2014, EUR J WILDLIFE RES, V60, P789, DOI 10.1007/s10344-014-0848-6; Saniga M, 2002, FOLIA ZOOL, V51, P205; Senserini D., 2016, Wildlife Biology in Practice, V12, P15; Sirkia S, 2012, WILDLIFE BIOL, V18, P337, DOI 10.2981/11-073; Sirkia S, 2010, BIOL CONSERV, V143, P1540, DOI 10.1016/j.biocon.2010.03.038; Storch I, 2007, WILDLIFE BIOL, V13, P5, DOI 10.2981/0909-6396(2007)13[5:CSOGWA]2.0.CO;2; Suld K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096358; Summers RW, 2004, J APPL ECOL, V41, P513, DOI 10.1111/j.0021-8901.2004.00891.x; Svobodova J, 2012, EUR J WILDLIFE RES, V58, P315, DOI 10.1007/s10344-011-0582-2; Vander Lee BA, 1999, J WILDLIFE MANAGE, V63, P1299, DOI 10.2307/3802848; Viht Ene, 2002, Hirundo Supplementum, V5, P1; Vulla E, 2009, ANN ZOOL FENN, V46, P395, DOI 10.5735/086.046.0601; Wegge P, 2011, FOREST ECOL MANAG, V261, P1520, DOI 10.1016/j.foreco.2011.01.041; Wilcox JT, 2009, J MAMMAL, V90, P114, DOI 10.1644/08-MAMM-A-017.1; Wilson DE, 2011, HOOFED MAMMALS, V2	43	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179463	10.1371/journal.pone.0179463	http://dx.doi.org/10.1371/journal.pone.0179463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594953	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200128
J	Sunwoo, L; Kim, YJ; Choi, SH; Kim, KG; Kang, JH; Kang, Y; Bae, YJ; Yoo, RE; Kim, J; Lee, KJ; Lee, SH; Choi, BS; Jung, C; Sohn, CH; Kim, JH				Sunwoo, Leonard; Kim, Young Jae; Choi, Seung Hong; Kim, Kwang-Gi; Kang, Ji Hee; Kang, Yeonah; Bae, Yun Jung; Yoo, Roh-Eul; Kim, Jihang; Lee, Kyong Joon; Lee, Seung Hyun; Choi, Byung Se; Jung, Cheolkyu; Sohn, Chul-Ho; Kim, Jae Hyoung			Computer-aided detection of brain metastasis on 3D MR imaging: Observer performance study	PLOS ONE			English	Article							WHOLE-BRAIN; STEREOTACTIC RADIOSURGERY; CT COLONOGRAPHY; RADIOLOGISTS DETECTION; SCREENING MAMMOGRAPHY; LUNG NODULES; CLASSIFICATION; TEXTURE; READER; CANCER	Purpose To assess the effect of computer-aided detection (CAD) of brain metastasis (BM) on radiologists' diagnostic performance in interpreting three-dimensional brain magnetic resonance (MR) imaging using follow-up imaging and consensus as the reference standard. Materials and methods The institutional review board approved this retrospective study. The study cohort consisted of 110 consecutive patients with BM and 30 patients without BM. The training data set included MR images of 80 patients with 450 BM nodules. The test set included MR images of 30 patients with 134 BM nodules and 30 patients without BM. We developed a CAD system for BM detection using template-matching and K-means clustering algorithms for candidate detection and an artificial neural network for false-positive reduction. Four reviewers (two neuroradiologists and two radiology residents) interpreted the test set images before and after the use of CAD in a sequential manner. The sensitivity, false positive (FP) per case, and reading time were analyzed. A jackknife free-response receiver operating characteristic (JAFROC) method was used to determine the improvement in the diagnostic accuracy. Results he sensitivity of CAD was 87.3% with an FP per case of 302.4. CAD significantly improved the diagnostic performance of the four reviewers with a figure-of-merit (FOM) of 0.874 (without CAD) vs. 0.898 (with CAD) according to JAFROC analysis (p < 0.01). Statistically significant improvement was noted only for less-experienced reviewers (FOM without vs. with CAD, 0.834 vs. 0.877, p < 0.01). The additional time required to review the CAD results was approximately 72 sec (40% of the total review time). Conclusion CAD as a second reader helps radiologists improve their diagnostic performance in the detection of BM on MR imaging, particularly for less-experienced reviewers.	[Sunwoo, Leonard; Choi, Seung Hong; Bae, Yun Jung; Yoo, Roh-Eul; Kim, Jihang; Lee, Kyong Joon; Choi, Byung Se; Jung, Cheolkyu; Sohn, Chul-Ho; Kim, Jae Hyoung] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Sunwoo, Leonard; Bae, Yun Jung; Kim, Jihang; Lee, Kyong Joon; Choi, Byung Se; Jung, Cheolkyu; Kim, Jae Hyoung] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Kim, Young Jae; Kim, Kwang-Gi] Gachon Univ, Dept Biomed Engn, Incheon, South Korea; [Kim, Young Jae; Lee, Seung Hyun] Kwangwoon Univ, Dept Plasma Bio Display, Seoul, South Korea; [Choi, Seung Hong; Kang, Ji Hee; Yoo, Roh-Eul; Sohn, Chul-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kang, Yeonah] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul Metropolitan Govt, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University; Kwangwoon University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Kim, KG (corresponding author), Gachon Univ, Dept Biomed Engn, Incheon, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	verocay@snuh.org; kimkg@gachon.ac.kr	, 배윤정/J-8327-2019; Choi, Byung Se/J-9022-2018; Sohn, ChulHo/AAV-4565-2021	, 배윤정/0000-0002-1779-4949; Choi, Byung Se/0000-0001-6310-1798; Sunwoo, Leonard/0000-0003-0374-8658; Kang, Yeonah/0000-0002-5078-3213; Lee, Kyong Joon/0000-0002-0658-433X; Kim, Jihang/0000-0003-0077-3655	SNUH Research Fund [0320140350 (2014-1078)]; National Research Foundation of Korea [NRF-2015R1C1A1A02037475]	SNUH Research Fund; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the SNUH Research Fund (No. 0320140350 (2014-1078); http://www.snuh.org), and a grant from the National Research Foundation of Korea (NRF-2015R1C1A1A02037475; http://nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini RD, 2010, J MAGN RESON IMAGING, V31, P85, DOI 10.1002/jmri.22009; Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Baker ME, 2007, RADIOLOGY, V245, P140, DOI 10.1148/radiol.2451061116; Bollschweiler EH, 2004, ANN SURG ONCOL, V11, P506, DOI 10.1245/ASO.2004.04.018; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Chakraborty DP, 2006, ACAD RADIOL, V13, P1187, DOI 10.1016/j.acra.2006.06.016; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; CHAN HP, 1990, INVEST RADIOL, V25, P1102, DOI 10.1097/00004424-199010000-00006; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chang WS, 2010, J NEUROSURG, V113, P73, DOI 10.3171/2010.8.GKS10994; CHAO JH, 1954, CANCER, V7, P682, DOI 10.1002/1097-0142(195407)7:4<682::AID-CNCR2820070409>3.0.CO;2-S; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; Dachman AH, 2010, RADIOLOGY, V256, P827, DOI 10.1148/radiol.10091890; Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867; El Gantery MM, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-116; Farjam R, 2012, MAGN RESON IMAGING, V30, P824, DOI 10.1016/j.mri.2012.02.024; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Jagannathan P, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E6; Juang LH, 2010, MEASUREMENT, V43, P941, DOI 10.1016/j.measurement.2010.03.013; Kakeda S, 2007, EUR RADIOL, V17, P2345, DOI 10.1007/s00330-007-0599-9; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Kobayashi T, 1996, RADIOLOGY, V199, P843, DOI 10.1148/radiology.199.3.8638015; Korchiyne R, 2014, SIGNAL IMAGE PROCESS, V5, P85; Lee GN, 2007, 9 BIENN C AUSTR PATT, P92, DOI [10.1109/DICTA.2007.4426781, DOI 10.1109/DICTA.2007.4426781]; Montavon G, 1998, LECT NOTES COMPUTER, DOI DOI 10.1007/3-540-49430-81016/J.ACRA.2006.06.016; Park J, 2010, MAGN RESON MED, V63, P553, DOI 10.1002/mrm.22261; Perez-Ramirez U, 2014, IEEE ENG MED BIO, P2384, DOI 10.1109/EMBC.2014.6944101; Perez-Ramrez U, 2016, J MAGN RESON IMAGING, P1; Petrick N, 2008, RADIOLOGY, V246, P148, DOI 10.1148/radiol.2453062161; Pohle R, 2001, PROC SPIE, V4322, P1337, DOI 10.1117/12.431013; Ramoni M, 2001, ARTIF INTELL, V125, P209, DOI 10.1016/S0004-3702(00)00085-0; Ranasinghe Moksha G, 2007, Neurosurg Focus, V22, pE2; Revol-Muller C, 2002, PATTERN RECOGN LETT, V23, P137, DOI 10.1016/S0167-8655(01)00116-7; RICHARDS P, 1963, BRIT MED J, P15; Sahiner B, 2009, ACAD RADIOL, V16, P1518, DOI 10.1016/j.acra.2009.08.006; Sarvaiya J. N., 2009, Proceedings of the 2009 International Conference on Advances in Computing, Control, & Telecommunication Technologies (ACT 2009), P819, DOI 10.1109/ACT.2009.207; Sergyan S, 2008, 2008 6TH INTERNATIONAL SYMPOSIUM ON APPLIED MACHINE INTELLIGENCE AND INFORMATICS, P206; Sundstrom JT, 1998, ANN MED, V30, P296, DOI 10.3109/07853899809005858; Tallet AV, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-77; Taylor SA, 2008, RADIOLOGY, V246, P463, DOI 10.1148/radiol.2461070190; Xu Y, 2012, EUR J RADIOL, V81, pE451, DOI 10.1016/j.ejrad.2011.04.031; Yamamoto M, 2014, LANCET ONCOL, V15, P387, DOI 10.1016/S1470-2045(14)70061-0; Yang S, 2013, INVEST RADIOL, V48, P113, DOI 10.1097/RLI.0b013e318277f078; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	45	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178265	10.1371/journal.pone.0178265	http://dx.doi.org/10.1371/journal.pone.0178265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594923	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200023
J	Ishikawa, C; Li, HY; Ogura, R; Yoshimura, Y; Kudo, T; Shirakawa, M; Shiba, D; Takahashi, S; Morita, H; Shiga, T				Ishikawa, Chihiro; Li, Haiyan; Ogura, Rin; Yoshimura, Yuko; Kudo, Takashi; Shirakawa, Masaki; Shiba, Dai; Takahashi, Satoru; Morita, Hironobu; Shiga, Takashi			Effects of gravity changes on gene expression of BDNF and serotonin receptors in the mouse brain	PLOS ONE			English	Article							LONG-TERM SPACEFLIGHT; NEUROTROPHIC FACTOR; 5-HT1B RECEPTORS; MOOD DISORDERS; HYPERGRAVITY; DEPRESSION; STRESS; MICE; MICROGRAVITY; RATS	Spaceflight entails various stressful environmental factors including microgravity. The effects of gravity changes have been studied extensively on skeletal, muscular, cardiovascular, immune and vestibular systems, but those on the nervous system are not well studied. The alteration of gravity in ground-based animal experiments is one of the approaches taken to address this issue. Here we investigated the effects of centrifugation-induced gravity changes on gene expression of brain-derived neurotrophic factor (BDNF) and serotonin receptors (5-HTRs) in the mouse brain. Exposure to 2g hypergravity for 14 days showed differential modulation of gene expression depending on regions of the brain. BDNF expression was decreased in the ventral hippocampus and hypothalamus, whereas increased in the cerebellum. 5-HT1BR expression was decreased in the cerebellum, whereas increased in the ventral hippocampus and caudate putamen. In contrast, hypergravity did not affect gene expression of 5-HT1AR, 5-HT2AR, 5-HT2CR, 5-HT4R and 5-HT7R. In addition to hypergravity, decelerating gravity change from 2g hypergravity to 1g normal gravity affected gene expression of BDNF, 5-HT1AR, 5-HT1BR, and 5-HT2AR in various regions of the brain. We also examined involvement of the vestibular organ in the effects of hypergravity. Surgical lesions of the inner ear's vestibular organ removed the effects induced by hypergravity on gene expression, which suggests that the effects of hypergravity are mediated through the vestibular organ. In summary, we showed that gravity changes induced differential modulation of gene expression of BDNF and 5-HTRs (5-HT1AR, 5-HT1BR and 5-HT2AR) in some brain regions. The modulation of gene expression may constitute molecular bases that underlie behavioral alteration induced by gravity changes.	[Ishikawa, Chihiro; Li, Haiyan; Ogura, Rin; Yoshimura, Yuko; Shiga, Takashi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Neurobiol, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Kudo, Takashi; Shirakawa, Masaki; Shiba, Dai; Takahashi, Satoru; Morita, Hironobu; Shiga, Takashi] Japan Aerosp Explorat Agcy JAXA, ISS Kibo Expt, Mouse Epigenet Project, Tsukuba, Ibaraki, Japan; [Shirakawa, Masaki; Shiba, Dai] JAXA, Human Spaceflight Technol Directorate, JEM Utilizat Ctr, Tsukuba, Ibaraki, Japan; [Morita, Hironobu] Gifu Univ, Grad Sch Med, Dept Physiol, Gifu, Japan; [Shiga, Takashi] Univ Tsukuba, Dept Neurobiol, Fac Med, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Aerospace Exploration Agency (JAXA); Japan Aerospace Exploration Agency (JAXA); Gifu University; University of Tsukuba	Shiga, T (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Lab Neurobiol, Tsukuba, Ibaraki, Japan.; Shiga, T (corresponding author), Japan Aerosp Explorat Agcy JAXA, ISS Kibo Expt, Mouse Epigenet Project, Tsukuba, Ibaraki, Japan.; Shiga, T (corresponding author), Univ Tsukuba, Dept Neurobiol, Fac Med, Tsukuba, Ibaraki, Japan.	tshiga@md.tsukuba.ac.jp		Kudo, Takashi/0000-0001-5477-7235	Japan Aerospace Exploration Agency (JAXA) [14YPTK-005512]	Japan Aerospace Exploration Agency (JAXA)	14YPTK-005512 from Japan Aerospace Exploration Agency (JAXA).	Abe C, 2011, NEUROSCI LETT, V502, P138, DOI 10.1016/j.neulet.2011.06.041; Abe C, 2010, J APPL PHYSIOL, V109, P1635, DOI 10.1152/japplphysiol.00515.2010; Akatsu S, 2015, NEUROSCI RES, V101, P15, DOI 10.1016/j.neures.2015.07.002; Artigas F, 2013, PHARMACOL THERAPEUT, V137, P119, DOI 10.1016/j.pharmthera.2012.09.006; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bojados M, 2014, BEHAV BRAIN RES, V264, P64, DOI 10.1016/j.bbr.2014.01.018; BRESSA GM, 1987, INT J CLIN PHARM RES, V7, P111; Carlino D, 2013, NEUROSCIENTIST, V19, P345, DOI 10.1177/1073858412469444; CARR GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI DOI 10.1007/s00213-010-2097-z; Clark M S, 2001, Psychopharmacol Bull, V35, P170; Dayer A, 2014, DIALOGUES CLIN NEURO, V16, P29; Del Signore A, 2004, EUR J NEUROSCI, V19, P667, DOI 10.1111/j.0953-816X.2004.03171.x; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; EDWARDS E, 1991, NEUROPHARMACOLOGY, V30, P101, DOI 10.1016/0028-3908(91)90050-L; Eriksson TM, 2008, NEUROPHARMACOLOGY, V54, P1041, DOI 10.1016/j.neuropharm.2008.02.007; Fakhoury M., 2015, MOL NEUROBIOL; Frigeri A, 2008, EXP BRAIN RES, V191, P289, DOI 10.1007/s00221-008-1523-5; Grabherr L, 2010, J VESTIBUL RES-EQUIL, V20, P53, DOI 10.3233/VES-2010-0364; Gray JD, 2013, NEUROSCIENCE, V239, P214, DOI 10.1016/j.neuroscience.2012.08.034; Gueguinou N, 2012, PSYCHONEUROENDOCRINO, V37, P137, DOI 10.1016/j.psyneuen.2011.05.015; Ishii M, 2004, ACTA MED OKAYAMA, V58, P143; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; Leone G, 1998, BRAIN RES REV, V28, P203, DOI 10.1016/S0165-0173(98)00040-X; Licznerski P, 2013, NEUROSCIENCE, V251, P33, DOI 10.1016/j.neuroscience.2012.09.057; Lin D, 2002, PHARMACOL BIOCHEM BE, V71, P581, DOI 10.1016/S0091-3057(01)00712-2; Mandillo S, 2003, NEUROSCI LETT, V336, P147, DOI 10.1016/s0304-3940(02)01282-X; Manzey D, 1998, BRAIN RES REV, V28, P215, DOI 10.1016/S0165-0173(98)00041-1; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matsuda T, 2004, BRAIN RES, V1028, P140, DOI 10.1016/j.brainres.2004.09.004; Meyer JH, 2003, AM J PSYCHIAT, V160, P90, DOI 10.1176/appi.ajp.160.1.90; Mitani K, 2004, COGNITIVE BRAIN RES, V22, P94, DOI 10.1016/j.cogbrainres.2004.08.002; Morita H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133981; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Notaras M, 2015, NEUROSCI BIOBEHAV R, V51, P15, DOI 10.1016/j.neubiorev.2014.12.016; Patel JG, 2004, SYNAPSE, V52, P73, DOI 10.1002/syn.10308; Petrak J, 2008, ANN NY ACAD SCI, V1148, P201, DOI 10.1196/annals.1410.060; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Popova NK, 2015, MOL NEUROBIOL, V51, P1443, DOI 10.1007/s12035-014-8821-7; Pytliak M, 2011, PHYSIOL RES, V60, P15, DOI 10.33549/physiolres.931903; Reschke MF, 1998, BRAIN RES REV, V28, P102, DOI 10.1016/S0165-0173(98)00031-9; Santucci D, 2002, J GRAVIT PHYSL, V9, P39; Santucci D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040112; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; Sarkar P, 2008, NEUROCHEM RES, V33, P2335, DOI 10.1007/s11064-008-9738-1; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schmidt Heath D, 2008, Drug Discov Today Ther Strateg, V5, P151, DOI 10.1016/j.ddstr.2008.10.003; Shelton RC, 2009, NEUROSCIENCE, V158, P1406, DOI 10.1016/j.neuroscience.2008.11.036; Tateishi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141650; Tsybko AS, 2015, J NEUROSCI RES, V93, P1399, DOI 10.1002/jnr.23600; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Zhang GL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00225	53	12	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177833	10.1371/journal.pone.0177833	http://dx.doi.org/10.1371/journal.pone.0177833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591153	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700013
J	Xie, DH; Wang, H; Liu, ZY; Fang, JQ; Yang, TB; Zhou, SJ; Wang, AH; Qin, JB; Xiong, LL				Xie, Donghua; Wang, Hua; Liu, Zhiyu; Fang, Junqun; Yang, Tubao; Zhou, Shujin; Wang, Aihua; Qin, Jiabi; Xiong, Lili			Perinatal outcomes and congenital heart defect prognosis in 53313 non-selected perinatal infants	PLOS ONE			English	Article							DIAGNOSED IN-UTERO; DISEASE; MALFORMATIONS; POPULATION; PREGNANCY; FETUSES	Objective To evaluate perinatal outcomes and congenital heart defect (CHD) prognosis in a non-selected population. Methods The population-based surveillance data used in this assessment of CHDs were based on birth defect surveillance data collected from 2010-2012 in Liuyang City, China. Infants living with CHDs were followed up for 5 years to determine their prognosis. Prevalence, prenatal diagnosis, perinatal outcomes, and total and type-specific prognosis data were assessed using SPSS 18.0. Results In total, 190 CHD cases were identified among the 53313 included perinatal infants (PIs), indicating a CHD prevalence of 35.64 per 10000 PIs in this non-selected population. The five most frequently identified types of CHDs were ventricular septal defects (VSDs, 38.95%), atrial septal defects (ASDs, 15.79%), cardiomegaly (7.89%), tetralogy of Fallot (TOF, 5.79%), and atrioventricular septal defects (AVSDs, 5.26%). Of the 190 CHD cases, 110 (57.89%) were diagnosed prenatally, 30 (15.79%) were diagnosed with associated malformations, and 69 (36.32%) resulted in termination of pregnancy (TOP). Moreover, 15 (7.89%) PIs died within 7 days after delivery, and 42 (22.10%) died within 1 year. In contrast, 79 (41.58%) were still alive after 5 years. When TOP cases were included, the 5-year survival rate of PIs with prenatally detected CHDs was lower than that of PIs with postnatally detected CHDs (25.45% vs. 63.75%). The CHD subtype associated with the highest rate of infant (less than 1 year old) mortality was transposition of the great arteries (100%). The subtypes associated with higher 5-year survival rates were patent ductus arteriosus (80%), ASD (63.33%), VSD (52.70%) and AVSD (50%). Conclusions The rates of prenatal CHD detection and TOP were high in this study population, and the 5-year survival rate of PIs with CHDs was low. The government should strengthen efforts to educate pediatricians regarding this issue and provide financial assistance to improve the prognosis of infants living with CHDs, especially during the first year of life.	[Xie, Donghua; Liu, Zhiyu; Wang, Aihua; Xiong, Lili] Maternal & Childrens Hosp Hunan Prov, Dept Informat Management, Changsha, Hunan, Peoples R China; [Xie, Donghua; Yang, Tubao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Wang, Hua; Fang, Junqun; Qin, Jiabi] Maternal & Childrens Hosp Hunan Prov, Dept Hlth Care Management, Changsha, Hunan, Peoples R China; [Zhou, Shujin] Maternal & Childrens Hosp Liuyang City, Dept Hlth Care Management, Liuyang, Hunan, Peoples R China	Central South University	Liu, ZY (corresponding author), Maternal & Childrens Hosp Hunan Prov, Dept Informat Management, Changsha, Hunan, Peoples R China.; Wang, H (corresponding author), Maternal & Childrens Hosp Hunan Prov, Dept Hlth Care Management, Changsha, Hunan, Peoples R China.	xiangyabob0606@126.com; wanghua213@aliyun.com; 315038356@qq.com			Natural Science Foundation of Hunan Province [2016JJ6051, 2016JJ6053]	Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This work was supported by Natural Science Foundation of Hunan Province (2016JJ6051 and 2016JJ6053).	Allan LD, 2003, CURR OPIN OBSTET GYN, V15, P143, DOI 10.1097/00001703-200304000-00009; Anagnostou K, 2013, ARCH DIS CHILD-FETAL, V98, pF218, DOI 10.1136/archdischild-2011-300488; [Anonymous], 1980, PEDIATRICS 2, V65, P375; Arroll N, 2013, NEW ZEAL MED J, V126, P46; Boldt T, 2002, SCAND CARDIOVASC J, V36, P73, DOI 10.1080/140174302753675339; Brick DH, 2002, PEDIATR CARDIOL, V23, P449, DOI 10.1007/s00246-002-1330-x; Carvalho JS, 2002, HEART, V88, P387, DOI 10.1136/heart.88.4.387; Changlani TD, 2015, INDIAN PEDIATR, V52, P852; Chaoui R, 2003, ULTRASOUND OBST GYN, V22, P3, DOI 10.1002/uog.187; Chen Y., 2009, EC BURDEN MAI BIRTH; Egbe A, 2014, PEDIATR CARDIOL, V35, P1232, DOI 10.1007/s00246-014-0921-7; Eronen M, 1997, ARCH DIS CHILD-FETAL, V77, pF41, DOI 10.1136/fn.77.1.F41; Almeida LFG, 2016, REV BRAS GINECOL OBS, V38, P348, DOI 10.1055/s-0036-1586160; Garne E, 2004, SCAND CARDIOVASC J, V38, P357, DOI 10.1080/14017430410024379; Garne E, 2005, ULTRASOUND OBST GYN, V25, P6, DOI 10.1002/uog.1784; Garne E, 2010, BJOG-INT J OBSTET GY, V117, P660, DOI 10.1111/j.1471-0528.2010.02531.x; Han F., 2012, J PRACTICAL OBSTET G, V28, P170; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Jensen E. T., 2017, BJOG; Long B., 2013, ZONGHEYIXUE, V10, P136; Mathur NB, 2015, INDIAN PEDIATR, V52, P769, DOI 10.1007/s13312-015-0714-y; Olney RS, 2015, SEMIN PERINATOL, V39, P230, DOI 10.1053/j.semperi.2015.03.007; Pradat P, 2003, PEDIATR CARDIOL, V24, P195, DOI 10.1007/s00246-002-9401-6; Stoll C., 2001, Community Genet, V4, P225, DOI 10.1159/000064197; Talner NS, 1998, PEDIATRICS, V102, P258; Tegnander E, 2006, ULTRASOUND OBST GYN, V27, P252, DOI 10.1002/uog.2710; Xie DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147280	27	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177229	10.1371/journal.pone.0177229	http://dx.doi.org/10.1371/journal.pone.0177229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591192	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700006
J	Harayama, T; Riezman, H				Harayama, Takeshi; Riezman, Howard			Detection of genome-edited mutant clones by a simple competition-based PCR method	PLOS ONE			English	Article							CRISPR/CAS9; DESIGN; CAS9	Genome editing by the CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats / CRISPR-associated protein 9) system is a revolutionary strategy to study gene functions. Since the efficiency of gene disruption in cell culture does not reach 100% typically, cloning of mutant cells is often performed to obtain fully mutated cells. Therefore, a method to discriminate accurately mutated clones easily and quickly is crucial to accelerate the research using CRISPR/Cas9. Here, we show that knockout cells can be discriminated by a competition-based PCR, using a mixture of three primers, among which one primer overlaps with the Cas9 cleavage site. Together, we show how to optimize primer design in order to improve the effectiveness of the discrimination. Finally, we applied this method to show that mutations conferring drug resistance can be detected with high accuracy. The provided method is easy to perform and requires only basic laboratory equipment, making it suitable for almost all laboratories.	[Harayama, Takeshi; Riezman, Howard] Univ Geneva, Dept Biochem, Geneva, Switzerland; Univ Geneva, NCCR Chem Biol, Sci 2, Geneva, Switzerland	University of Geneva; University of Geneva	Harayama, T; Riezman, H (corresponding author), Univ Geneva, Dept Biochem, Geneva, Switzerland.	harayama-t@umin.net; Howard.Riezman@unige.ch	Harayama, Takeshi/AAD-8852-2022	Harayama, Takeshi/0000-0003-2255-4197; Riezman, Howard/0000-0003-4680-9422	Swiss National Science Foundation (SNSF) [31003A-146142]; National Centre of Competence in Research (NCCR) Chemical Biology [51NF40-160589]; Japan Society for the Promotion of Science (JSPS); Canton of Geneva; SystemsX [LipidX]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR) Chemical Biology(Swiss National Science Foundation (SNSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canton of Geneva; SystemsX [LipidX]	This work was supported by the Swiss National Science Foundation (SNSF) [31003A-146142 to HR]; the National Centre of Competence in Research (NCCR) Chemical Biology [51NF40-160589]; SystemsX (evaluated by the SNSF) [LipidX]; and the Canton of Geneva. TH was supported by the Japan Society for the Promotion of Science (JSPS) Postdoctoral Fellowships for Research Abroad. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agrotis A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00300; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liang XQ, 2015, J BIOTECHNOL, V208, P44, DOI 10.1016/j.jbiotec.2015.04.024; Liao SR, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv675; MORRISON C, 1994, BBA-GENE STRUCT EXPR, V1219, P493, DOI 10.1016/0167-4781(94)90076-0; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368	21	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179165	10.1371/journal.pone.0179165	http://dx.doi.org/10.1371/journal.pone.0179165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586390	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700051
J	de Franca, GVA; Rolfe, ED; Horta, BL; Gigante, DP; Yudkin, JS; Ong, KK; Victora, CG				Araujo de Franca, Giovanny Vinicius; Rolfe, Emanuella De Lucia; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Yudkin, John S.; Ong, Ken K.; Victora, Cesar Gomes			Genomic ancestry and education level independently influence abdominal fat distributions in a Brazilian admixed population	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; GRANDE-DO-SUL; SOCIOECONOMIC-STATUS; COMPUTED-TOMOGRAPHY; WAIST CIRCUMFERENCE; GENETIC ADMIXTURE; RISK-FACTORS; OBESITY; RACE; ULTRASONOGRAPHY	We aimed to identify the independent associations of genomic ancestry and education level with abdominal fat distributions in the 1982 Pelotas birth cohort study, Brazil. In 2,890 participants (1,409 men and 1,481 women), genomic ancestry was assessed using genotype data on 370,539 genome-wide variants to quantify ancestral proportions in each individual. Years of completed education was used to indicate socio-economic position. Visceral fat depth and subcutaneous abdominal fat thickness were measured by ultrasound at age 29-31y; these measures were adjusted for BMI to indicate abdominal fat distributions. Linear regression models were performed, separately by sex. Admixture was observed between European (median proportion 85.3), African (6.6), and Native American (6.3) ancestries, with a strong inverse correlation between the African and European ancestry scores (rho = -0.93; p<0.001). Independent of education level, African ancestry was inversely associated with both visceral and subcutaneous abdominal fat distributions in men (both P = 0.001), and inversely associated with subcutaneous abdominal fat distribution in women (p = 0.009). Independent of genomic ancestry, higher education level was associated with lower visceral fat, but higher subcutaneous fat, in both men and women (all p<0.001). Our findings, from an admixed population, indicate that both genomic ancestry and education level were independently associated with abdominal fat distribution in adults. African ancestry appeared to lower abdominal fat distributions, particularly in men.	[Araujo de Franca, Giovanny Vinicius; Horta, Bernardo Lessa; Gigante, Denise Petrucci; Victora, Cesar Gomes] Univ Fed Pelotas, Postgrad Program Epidemiol, Bairro Ctr Pelotas, Rua Marechal Deodoro,1160-3 Piso, Pelotas, RS, Brazil; [Araujo de Franca, Giovanny Vinicius; Rolfe, Emanuella De Lucia; Ong, Ken K.] Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge, England; [Yudkin, John S.] UCL, London, England	Universidade Federal de Pelotas; University of Cambridge; University of London; University College London	de Franca, GVA (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Bairro Ctr Pelotas, Rua Marechal Deodoro,1160-3 Piso, Pelotas, RS, Brazil.; de Franca, GVA (corresponding author), Univ Cambridge, Sch Clin Med, Epidemiol Unit, MRC,Inst Metab Sci, Cambridge, England.	nutrigio@gmail.com	Victora, Cesar Gomes/Y-2455-2019; Horta, Bernardo/A-7604-2008; Yudkin, John S/C-1988-2008; de França, Giovanny Vinícius Araújo/L-7385-2018	Victora, Cesar Gomes/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; de França, Giovanny Vinícius Araújo/0000-0002-7530-2017	Wellcome Trust; FundaEarlier phases - International Development Research Centre (Canada); WHO (Department of Child and Adolescent Health and Development and Human Reproduction Programme); Overseas Development Administration; European Union; United Nations Development Fund for Women; National Program for Centres of Excellence; Pastorate of the Child (Brazil); National Council for Scientific and Technological Development (CNPq; Brazil); Ministry of Health (Brazil); Brazilian Coordination of Improvement of Higher Education Personnel [BEX 5077/13-3]; Medical Research Council [MC_UU_12015/2]; MRC [MC_UU_12015/2] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); FundaEarlier phases - International Development Research Centre (Canada); WHO (Department of Child and Adolescent Health and Development and Human Reproduction Programme); Overseas Development Administration; European Union(European Commission); United Nations Development Fund for Women; National Program for Centres of Excellence; Pastorate of the Child (Brazil); National Council for Scientific and Technological Development (CNPq; Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil); Brazilian Coordination of Improvement of Higher Education Personnel; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The last phase of the 1982 Pelotas (Brazil) birth cohort study was supported by the Wellcome Trust and the FundaEarlier phases were funded by the International Development Research Centre (Canada), the WHO (Department of Child and Adolescent Health and Development and Human Reproduction Programme), the Overseas Development Administration (currently the Department for International Development, United Kingdom), the European Union, the United Nations Development Fund for Women, the National Program for Centres of Excellence, the Pastorate of the Child (Brazil), the National Council for Scientific and Technological Development (CNPq; Brazil), and the Ministry of Health (Brazil). GVAF was supported by the Brazilian Coordination of Improvement of Higher Education Personnel (scholarship process BEX 5077/13-3). EDLR and KKO are supported by the Medical Research Council [Unit Programme number MC_UU_12015/2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.cao de Aparo a Pesquisa do Estado do Rio Grande do Sul; Brazil (Edital 04/2012 - PQG; Processo 12/2185-9).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bailey SR, 2013, SOC SCI RES, V42, P106, DOI 10.1016/j.ssresearch.2012.06.006; Barreto Mauricio L, 2006, BMC Pulm Med, V6, P15, DOI 10.1186/1471-2466-6-15; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Bazzocchi A, 2013, ACAD RADIOL, V20, P1278, DOI 10.1016/j.acra.2013.07.009; BELL S, 1993, J HIST GEOGR, V19, P399, DOI 10.1006/jhge.1993.1025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; De Lucia, 2010, OBESITY, V18, P625, DOI DOI 10.1038/0BY.2009.309; De Lucia, 2011, OBESITY, V19, P1892; Demerath EW, 2007, OBESITY, V15, P2984, DOI 10.1038/oby.2007.356; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Fernandez JR, 2004, NUTR REV, V62, pS69, DOI 10.1111/j.1753-4887.2004.tb00091.x; Gonzalez DA, 2009, PUBLIC HEALTH NUTR, V12, P2225, DOI 10.1017/S1368980009990607; Goonesekera SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122808; Gradmark AMI, 2010, BRIT J NUTR, V104, P582, DOI 10.1017/S0007114510000796; Hsueh WC, 2006, DIABETES, V55, pA259; Katzmarzyk PT, 2010, AM J CLIN NUTR, V91, P7, DOI 10.3945/ajcn.2009.28136; Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112; Klimentidis YC, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00089; Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Marrero AR, 2005, AM J HUM BIOL, V17, P496, DOI 10.1002/ajhb.20404; McCarthy PL, 2000, PEDIATRICS, V105, P1349; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mira Prado C., 2012, OPEN J ENDOCRINE MET, V02, P63, DOI 10.4236/ojemd.2012.24010; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rahman M, 2009, METABOLISM, V58, P1329, DOI 10.1016/j.metabol.2009.04.017; Rolfe ED, 2013, J OBES, V2013, DOI 10.1155/2013/951954; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stolk RP, 2003, AM J CLIN NUTR, V77, P857, DOI 10.1093/ajcn/77.4.857; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0179085	10.1371/journal.pone.0179085	http://dx.doi.org/10.1371/journal.pone.0179085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582437	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600073
J	Desclozeaux, M; Robbins, A; Jelocnik, M; Khan, SA; Hanger, J; Gerdts, V; Potter, A; Polkinghorne, A; Timms, P				Desclozeaux, Marion; Robbins, Amy; Jelocnik, Martina; Khan, Shahneaz Ali; Hanger, Jon; Gerdts, Volker; Potter, Andrew; Polkinghorne, Adam; Timms, Peter			Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance	PLOS ONE			English	Article							T-CELL ANTIGENS; MALE GENITAL-TRACT; PHASCOLARCTOS-CINEREUS; TRACHOMATIS INFECTION; GENETIC DIVERSITY; ACQUIRED-IMMUNITY; INTERFERON-GAMMA; SECRETORY IGA; MURIDARUM; STRAINS	We assessed the effects of two different single-dose anti-Chlamydia pecorum (C. pecorum) vaccines (containing either Major Outer Membrane Protein (3MOMP) or Polymorphic Membrane Protein (Pmp) as antigens) on the immune response of a group of wild koalas. Both vaccines elicited a systemic humoral response as seen by the production of anti-chlamydial IgG antibodies in more than 90% of vaccinated koalas. A mucosal immune response was also observed, with an increase in Chlamydia-specific mucosal IgG and/or IgA antibodies in some koalas post-vaccination. Both vaccines elicited a cell-mediated immune response as measured by the production of the cytokines IFN-gamma and IL-17 post-vaccination. To determine the level of protection provided by the vaccines under natural conditions we assessed C. pecorum infection loads and chlamydial disease status of all vaccinated koalas pre-and post-vaccination, compared to a non-vaccinated cohort from the same habitat. The MOMP vaccinated koalas that were infected on the day of vaccination showed significant clearance of their infection at 6 months post-vaccination. In contrast, the number of new infections in the PMP vaccine was similar to the control group, with some koalas progressing to disease. Genotyping of the ompA gene from the C. pecorum strains infecting the vaccinated animals, identified genetic variants of ompA-F genotype and a new genotype ompA-O. We found that those animals that were the least well protected became infected with strains of C. pecorum not covered by the vaccine. In conclusion, a single dose vaccine formulated with either recombinant PmpG or MOMP can elicit both cell-mediated and humoral (systemic and mucosal) immune responses, with the MOMP vaccine showing clearance of infection in all infected koalas. Although the capability of our vaccines to stimulate an adaptive response and be protective needs to be fully evaluated, this work illustrates the necessity to combine epitopes most relevant to a large panel of variable strains with an efficient adjuvant.	[Desclozeaux, Marion; Jelocnik, Martina; Khan, Shahneaz Ali; Polkinghorne, Adam; Timms, Peter] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Maroochydore, Qld, Australia; [Robbins, Amy; Hanger, Jon] Endeavour Vet Ecol Pty Ltd, Toorbul, Qld, Australia; [Gerdts, Volker; Potter, Andrew] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, Saskatoon, SK, Canada	University of the Sunshine Coast; University of Saskatchewan	Timms, P (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Ctr Anim Hlth Innovat, Maroochydore, Qld, Australia.	ptimms@usc.edu.au		Gerdts, Volker/0000-0001-8229-1611; Robbins, Amy/0000-0001-9231-0636; Timms, Peter/0000-0002-1682-0025; Jelocnik, Martina/0000-0003-1340-2562; Polkinghorne, Adam/0000-0002-6567-2962	Australian Research Council (ARC, Linkage Scheme) [LP1202000051]; Queensland Government (Department of Transport and Main Roads); Moreton Bay Rail Link project team; Australian Research Council	Australian Research Council (ARC, Linkage Scheme)(Australian Research Council); Queensland Government (Department of Transport and Main Roads); Moreton Bay Rail Link project team; Australian Research Council(Australian Research Council)	This project was financially supported by Australian Research Council (ARC, Linkage Scheme LP1202000051) to PT and A. Polkinghorne. This project was significantly supported by the Queensland Government (Department of Transport and Main Roads) and specifically the Moreton Bay Rail Link project team. AR and JH were employed by Endeavour Veterinary Ecology (EVE). EVE provided support in the form of salaries for AR and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Australian Research Council also did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials. The specific roles of these authors are articulated in the 'author contributions' section.	Armitage CW, 2014, IMMUNOLOGY, V143, P520, DOI 10.1111/imm.12317; Bachmann NL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-667; Badamchi-Zadeh A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00162; BEATTY PR, 1994, J IMMUNOL, V153, P4588; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; Becker E, 2014, MICROBIOLOGYOPEN, V3, P544, DOI 10.1002/mbo3.186; Boje S, 2016, IMMUNOL CELL BIOL, V94, P185, DOI 10.1038/icb.2015.79; Carey AJ, 2010, AM J REPROD IMMUNOL, V63, P161, DOI 10.1111/j.1600-0897.2009.00776.x; Coler RN, 2009, FEMS IMMUNOL MED MIC, V55, P258, DOI 10.1111/j.1574-695X.2008.00527.x; Cunningham KA, 2008, AM J REPROD IMMUNOL, V60, P405, DOI 10.1111/j.1600-0897.2008.00637.x; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Everett KDE, 2000, VET MICROBIOL, V75, P109, DOI 10.1016/S0378-1135(00)00213-3; Feher VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068934; Garg R, 2014, J GEN VIROL, V95, P1043, DOI 10.1099/vir.0.062570-0; Garlapati S, 2012, VACCINE, V30, P5206, DOI 10.1016/j.vaccine.2012.06.011; Hadad R, 2016, APMIS, V124, P1078, DOI 10.1111/apm.12605; Jelocnik M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2053-8; Johnson RM, 2016, INFECT IMMUN, V84, P868, DOI 10.1128/IAI.01378-15; Johnson RM, 2012, INFECT IMMUN, V80, P2204, DOI 10.1128/IAI.06339-11; Karunakaran KP, 2008, J IMMUNOL, V180, P2459, DOI 10.4049/jimmunol.180.4.2459; Karunakaran KP, 2016, METHODS MOL BIOL, V1403, P419, DOI 10.1007/978-1-4939-3387-7_23; Karunakaran KP, 2015, VACCINE, V33, P2159, DOI 10.1016/j.vaccine.2015.02.055; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156094; Khan SA, 2014, VACCINE, V32, P5781, DOI 10.1016/j.vaccine.2014.08.037; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Kollipara A, 2013, VACCINE, V31, P1217, DOI 10.1016/j.vaccine.2012.12.057; Legione AR, 2016, J MED MICROBIOL, V65, P420, DOI 10.1099/jmm.0.000241; Li LX, 2015, IMMUNOL LETT, V164, P88, DOI 10.1016/j.imlet.2015.02.004; Liu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124992; Lorenzen E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00628; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, GENE, V527, P570, DOI 10.1016/j.gene.2013.06.019; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; Mehlitz A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-90; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Nunes A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131695; O'Meara CP, 2016, MUCOSAL IMMUNOL, V9, P1076, DOI 10.1038/mi.2015.125; O'Meara CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061962; Pan Q, 2015, VACCINE, V33, P1865, DOI 10.1016/j.vaccine.2015.02.007; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Redgrove KA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00534; Rhodes JR, 2006, CONSERV BIOL, V20, P449, DOI 10.1111/j.1523-1739.2006.00330.x; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sait M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-23; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; Tifrea DF, 2014, J IMMUNOL, V192, P5201, DOI 10.4049/jimmunol.1303392; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; Vasilevsky S, 2016, VIRULENCE, V7, P11, DOI 10.1080/21505594.2015.1111509; Wheelhouse N, 2012, TRANSBOUND EMERG DIS, V59, P283, DOI 10.1111/j.1865-1682.2011.01274.x; Yu H, 2014, VACCINE, V32, P4672, DOI 10.1016/j.vaccine.2014.06.002; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11; Yu H, 2010, INFECT IMMUN, V78, P2272, DOI 10.1128/IAI.01374-09; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	56	17	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178786	10.1371/journal.pone.0178786	http://dx.doi.org/10.1371/journal.pone.0178786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575080	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300116
J	Zhang, ZJ; Liu, D; Sun, WQ; Liu, J; He, LH; Hu, J; Gu, M; Wang, XQ; Liu, XW; Hu, SL; Chen, SJ; Peng, DX; Liu, XF				Zhang, Zhujun; Liu, Dong; Sun, Wenqiang; Liu, Jing; He, Lihong; Hu, Jiao; Gu, Min; Wang, Xiaoquan; Liu, Xiaowen; Hu, Shunlin; Chen, Sujuan; Peng, Daxin; Liu, Xiufan			Multiplex one-step Real-time PCR by Taqman-MGB method for rapid detection of pan and H5 subtype avian influenza viruses	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; RT-PCR; COMPETITIVE ELISA; ANTIBODIES; DISEASE	Avian influenza virus (AIV) can infect a variety of avian species and mammals, leading to severe economic losses in poultry industry and posing a substantial threat to public health. Currently, traditional virus isolation and identification is inadequate for the early diagnosis because of its labor-intensive and time-consuming features. Real-time RT-PCR (RRT-PCR) is an ideal method for the detection of AIV since it is highly specific, sensitive and rapid. In addition, as the new quencher MGB is used in RRT-PCR, it only needs shorter probe and helps the binding of target gene and probe. In this study, a pan-AIV RRT-PCR for the detection of all ATVs and H5-AIV RRT-PCR for detection of H5 AIV based on NP gene of AIV and HA gene of H5 AIV were successfully established using Taqman-MGB method. We tested 14 AIV strains in total and the results showed that the pan-AIV RRT-PCR can detect AIV of various HA subtypes and the H5-AIV RRT-PCR can detect H5 AIV circulating in poultry in China in recent three years, including H5 viruses of Glade 7.2, Glade 2.3.4.4 and Glade 2.3.2.1. Furthermore, the multiplex detection limit for pan-AIV and H5-AIV RRT-PCR was 5 copies per reaction. When this multiplex method was applied in the detection of experimental and live poultry market samples, the detection rates of pan-AIV and H5 AIV in RRT-PCR were both higher than the routine virus isolation method with embryonated chicken eggs. The multiplex RRT-PCR method established in our study showed high sensitivity, reproducibility and specificity, suggesting the promising application of our method for surveillance of both pan AIV and prevalent H5 AIV in live poultry markets and clinical samples.	[Zhang, Zhujun; Liu, Dong; Sun, Wenqiang; Liu, Jing; He, Lihong; Hu, Jiao; Gu, Min; Wang, Xiaoquan; Liu, Xiaowen; Hu, Shunlin; Chen, Sujuan; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Sch Vet Med, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China; [Zhang, Zhujun; Liu, Dong; Sun, Wenqiang; Liu, Jing; He, Lihong; Hu, Jiao; Gu, Min; Wang, Xiaoquan; Liu, Xiaowen; Hu, Shunlin; Chen, Sujuan; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Zhang, Zhujun; Liu, Dong; Sun, Wenqiang; Liu, Jing; He, Lihong; Hu, Jiao; Gu, Min; Wang, Xiaoquan; Liu, Xiaowen; Hu, Shunlin; Chen, Sujuan; Peng, Daxin; Liu, Xiufan] Yangzhou Univ 26116120, Key Lab Prevent & Control Biol Hazard Factors Ani, Minist Agr China, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Ministry of Agriculture & Rural Affairs	Liu, XF (corresponding author), Yangzhou Univ, Sch Vet Med, Anim Infect Dis Lab, Yangzhou, Jiangsu, Peoples R China.; Liu, XF (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Liu, XF (corresponding author), Yangzhou Univ 26116120, Key Lab Prevent & Control Biol Hazard Factors Ani, Minist Agr China, Yangzhou, Jiangsu, Peoples R China.	xfliu@yzu.edu.cn	Peng, Daxin/AAJ-3476-2021; He, lihong/AAQ-4912-2020		National key research and development project of China [2016YFD0501601, 2016YFD0500202]; National Key Technologies R&393 D Program of China [2015BAD12601-3]; National Natural Science Foundation of China [31502076]; Modern Agro-industry Technology Research System [nycytx-41-G07]; Jiangsu Provincial Natural Science Foundation of China [BK20150444]; Special Financial Grant from the China Postdoctoral Science Foundation [2016T90515]; Cover Letter Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China [15KJB230006]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National key research and development project of China; National Key Technologies R&393 D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System; Jiangsu Provincial Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province); Special Financial Grant from the China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Cover Letter Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National key research and development project of China (2016YFD0501601, 2016YFD0500202), by the National Key Technologies R&393 D Program of China (2015BAD12601-3), by the National Natural Science Foundation of China (31502076), by the earmarked fund for Modern Agro-industry Technology Research System (nycytx-41-G07), by the Jiangsu Provincial Natural Science Foundation of China (BK20150444), by the Special Financial Grant from the China Postdoctoral Science Foundation (2016T90515), by the Cover Letter Natural Science Foundation of the Higher Education Institutions of Jiangsu Province, China (15KJB230006) and by A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akkutay AZ, 2014, ARCH VIROL, V159, P2989, DOI 10.1007/s00705-014-2165-5; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Chaharaein B, 2006, ARCH VIROL, V151, P2447, DOI 10.1007/s00705-006-0809-9; Chang CW, 2010, WATER SCI TECHNOL, V62, P2141, DOI 10.2166/wst.2010.405; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gall A, 2009, J CLIN MICROBIOL, V47, P327, DOI 10.1128/JCM.01330-08; Gao Zheng-qin, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P226; Gu M, 2013, EMERG INFECT DIS, V19, P2021, DOI 10.3201/eid1912.130340; Gu M, 2011, EMERG INFECT DIS, V17, P1060, DOI [10.3201/eid1706.101406, 10.3201/eid/1706.101406]; Hashemi M, 2010, WORLD ACAD SCI ENG T, P1019; Heine HG, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0250-3; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jin ML, 2004, AVIAN DIS, V48, P870, DOI 10.1637/7226-062204r; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Li J, 2016, ARCH VIROL, V161, P289, DOI 10.1007/s00705-015-2661-2; Liu Q, 2010, MODERN PREVENTIVE ME; Lu YY, 2008, LETT APPL MICROBIOL, V46, P20, DOI 10.1111/j.1472-765X.2007.02253.x; MINGXIAO M, 2013, PLOS ONE, V0008; Naeem K, 2003, AVIAN PATHOL, V32, P285, DOI [10.1080/1030794503100009788, 10.1080/0307945031000097886]; Payungporn S, 2006, J VIROL METHODS, V131, P143, DOI 10.1016/j.jviromet.2005.08.004; Peng DP, 2007, VET IMMUNOL IMMUNOP, V117, P17, DOI 10.1016/j.vetimm.2007.01.022; Saha R, 2011, INT BIODETER BIODEGR, V65, P460, DOI 10.1016/j.ibiod.2010.10.013; Silvano FD, 1997, J VET MED SCI, V59, P205, DOI 10.1292/jvms.59.205; SNYDER DB, 1986, AVIAN DIS, V30, P19, DOI 10.2307/1590607; Song DS, 2009, J VET SCI, V10, P323, DOI 10.4142/jvs.2009.10.4.323; [宋洁 SONG Jie], 2008, [计算机工程与科学, Computer Engineering and Science], V30, P30; Steyer AF, 2010, J VIROL METHODS, V166, P28, DOI 10.1016/j.jviromet.2010.02.012; Sun HL, 2014, J VIROL, V88, P725, DOI 10.1128/JVI.02510-13; Teng QY, 2015, J VIROL METHODS, V217, P64, DOI 10.1016/j.jviromet.2015.02.025; Tomas G, 2012, J VIROL METHODS, V185, P101, DOI 10.1016/j.jviromet.2012.06.012; Upadhyay C, 2009, VIROL J, V6, P177; Wang RH, 2009, TALANTA, V79, P159, DOI 10.1016/j.talanta.2009.03.017; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu T, 2006, AM J RESP CRIT CARE, V174, P1011, DOI 10.1164/rccm.200511-1751OC; Yu ZJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10704; [赵广英 ZHAO Guangying], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P1442; Zhao G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046183; Zhirnov OP, 2007, INFLUENZA OTHER RESP, V1, P71, DOI 10.1111/j.1750-2659.2007.00010.x; Zhou EM, 1998, AVIAN DIS, V42, P517, DOI 10.2307/1592678; [周杰英 Zhou Jieying], 2014, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V28, P129	41	11	15	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178634	10.1371/journal.pone.0178634	http://dx.doi.org/10.1371/journal.pone.0178634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575115	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300082
J	Pedersen, K; Bilal, F; Morales, CB; Salcedo, MT; Macarulla, T; Masso-Valles, D; Mohan, V; Vivancos, A; Carreras, MJ; Serres, X; Abu-Suboh, M; Balsells, J; Allende, E; Sagi, I; Soucek, L; Tabernero, J; Arribas, J				Pedersen, K.; Bilal, F.; Bernado Morales, C.; Salcedo, M. T.; Macarulla, T.; Masso-Valles, D.; Mohan, V.; Vivancos, A.; Carreras, M-J; Serres, X.; Abu-Suboh, M.; Balsells, J.; Allende, E.; Sagi, I.; Soucek, L.; Tabernero, J.; Arribas, J.			Pancreatic cancer heterogeneity and response to Mek inhibition	ONCOGENE			English	Article							PATIENT-DERIVED XENOGRAFTS; DUCTAL ADENOCARCINOMA; SURVIVAL; MICE; GEMCITABINE; ACTIVATION; PATHWAY	Our increasing knowledge of the mechanisms behind the progression of pancreatic cancer (PC) has not yet translated into effective treatments. Many promising drugs have failed in the clinic, highlighting the need for better preclinical models to assess drug efficacy and characterize mechanisms of resistance. Using different experimental models, including patient-derived xenografts (PDXs), we gauged the efficacy of therapies aimed at two hallmark lesions of PCs: activation of signaling pathways by oncogenic KRAS and inactivation of tumor-suppressor genes. Although the drug targeting inactivation of tumor suppressors by DNA methylation had little effect, the inhibition of Mek, a K-Ras effector, in combination with the standard of care (chemotherapy consisting of gemcitabine/Nab-paclitaxel), reduced the growth of three out of five PC-PDXs and impaired metastasis. The two least responding PC-PDXs were composed of genetically diverse cells, which displayed sensitivities to the Mek inhibitor differing by 410-fold. Unexpectedly, our analysis of this genetic diversity unveiled different KRAS mutations. As mutation in KRAS occurs early during progression, this heterogeneity may reflect the simultaneous appearance of different malignant cellular clones or, alternatively, that cells containing two mutations of KRAS are selected during tumor evolution. In vitro and in vivo analyses indicated that the intratumoral heterogeneity, along with the selective pressure imposed by the Mek inhibitor, resulted in rapid selection of resistant cells. Together with the gemcitabine/Nab-paclitaxel backbone, Mek inhibition could be effective in treatment of PC. However, resistance because of intratumoral heterogeneity is likely to develop frequently, pointing to the necessity of identifying the factors and mechanisms of resistance to further develop this therapy.	[Pedersen, K.; Bilal, F.; Bernado Morales, C.; Masso-Valles, D.; Soucek, L.; Tabernero, J.; Arribas, J.] VHIO, Preclin Res Program, Barcelona, Spain; [Bilal, F.; Bernado Morales, C.; Tabernero, J.; Arribas, J.] CIBER ONC, Barcelona, Spain; [Bilal, F.; Masso-Valles, D.; Soucek, L.; Arribas, J.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Campus UAB, Bellaterra, Spain; [Salcedo, M. T.; Macarulla, T.; Carreras, M-J; Serres, X.; Abu-Suboh, M.; Balsells, J.; Allende, E.; Tabernero, J.] Vall Hebron Univ Hosp HUVH, Barcelona, Spain; [Salcedo, M. T.; Macarulla, T.; Tabernero, J.] Univ Autonoma Barcelona, Barcelona, Spain; [Mohan, V.; Sagi, I.] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Vivancos, A.; Tabernero, J.] VHIO, Clin Res Program, Barcelona, Spain; [Soucek, L.; Arribas, J.] ICREA, Barcelona, Spain	Vall d'Hebron Institut d'Oncologia (VHIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Weizmann Institute of Science; Vall d'Hebron Institut d'Oncologia (VHIO); ICREA	Arribas, J (corresponding author), VHIO, C Natzaret 115-117, Barcelona 08035, Spain.	jarribas@vhio.net	Macarulla, Teresa/AAG-9230-2019; Soucek, Laura/AAG-7393-2019; Soucek, Laura/AAG-8377-2019; Arribas, Joaquin/M-4482-2014; Tabernero, Josep/AAG-5026-2019; Miquel, Josep Maria/AAG-3508-2019; Vivancos, Ana/AAG-8331-2019	Soucek, Laura/0000-0002-4750-7971; Arribas, Joaquin/0000-0002-0504-0664; Tabernero, Josep/0000-0002-2495-8139; Vivancos, Ana/0000-0003-2888-6512; Balsells Valls, Joaquim/0000-0002-1202-4136; Bernado Morales, Cristina/0000-0003-1376-0407; Abu-Suboh Abadia, Monder/0000-0003-2373-6400; Macarulla, Teresa/0000-0002-5856-4082; Masso-Valles, Daniel/0000-0003-4231-0456; Serres-Creixams, Xavier/0000-0001-8642-467X	Instituto de Salud Carlos III [PI16/00253]; AECC; AGAUR-FIDGR predoctoral fellowship; Instituto de Salud Carlos III (CIBER-ONC)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); AECC; AGAUR-FIDGR predoctoral fellowship; Instituto de Salud Carlos III (CIBER-ONC)(Instituto de Salud Carlos III)	We thank Faye Su from Novartis and Daniel Pierce from Celgene for providing reagents and valuable insights. This work was supported by funds from the Instituto de Salud Carlos III (PI16/00253 and CIBER-ONC). KP was supported by the postdoctoral program from the AECC. FB was supported by the AGAUR-FIDGR-2014 predoctoral fellowship.	Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Byrne AT, 2017, NAT REV CANCER, V17, P254, DOI 10.1038/nrc.2016.140; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Collisson EA, 2012, CANCER DISCOV, V2, P685, DOI 10.1158/2159-8290.CD-11-0347; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kopetz S, 2012, CLIN CANCER RES, V18, P5160, DOI 10.1158/1078-0432.CCR-12-2408; Missiaglia E, 2005, ONCOGENE, V24, P199, DOI 10.1038/sj.onc.1208018; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; VANCUTSEM E, 2015, J CLIN ONCOL S, V33; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Weisenberger DJ, 2014, J CLIN INVEST, V124, P17, DOI 10.1172/JCI69740; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	19	15	15	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5639	5647		10.1038/onc.2017.174	http://dx.doi.org/10.1038/onc.2017.174			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581516				2022-12-26	WOS:000412293600008
J	Hsu, K; Lee, TY; Periasamy, A; Kao, FJ; Li, LT; Lin, CY; Lin, HJ; Lin, M				Hsu, Kate; Lee, Ting-Ying; Periasamy, Ammasi; Kao, Fu-Jen; Li, Li-Tzu; Lin, Chuang-Yu; Lin, Hui-Ju; Lin, Marie			Adaptable interaction between aquaporin-1 and band 3 reveals a potential role of water channel in blood CO2 transport	FASEB JOURNAL			English	Article						anion exchanger-1; erythrocyte; FLIM-FRET; Miltenberger subtype III	CARBONIC-ANHYDRASE-II; CELL; MEMBRANE; PROTEIN; MI.III; LOCALIZATION; EXPRESSION; METABOLON; COMPLEX; DOMAIN	Human CO2 respiration requires rapid conversion between CO2 and HCO3-. Carbonic anhydrase II facilitates this reversible reaction inside red blood cells, and band 3 [anion exchanger 1 (AE1)] provides a passage for HCO3- flux across the cell membrane. These 2 proteins are core components of the CO2 transport metabolon. Intracellular H2O is necessary for CO2/HCO3- conversion. However, abundantly expressed aquaporin 1 (AQP1) in erythrocytes is thought not to be part of band 3 complexes or the CO2 transport metabolon. To solve this conundrum, we used Forster resonance energy transfer (FRET) measured by fluorescence lifetime imaging (FLIM-FRET) and identified interaction between aquaporin-1 and band 3 at a distance of 8 nm, within the range of dipole-dipole interaction. Notably, their interaction was adaptable to membrane tonicity changes. This suggests that the function of AQP1 in tonicity response could be coupled or correlated to its function in band 3-mediated CO2/HCO3- exchange. By demonstrating AQP1 as a mobile component of the CO2 transport metabolon, our results uncover a potential role of water channel in blood CO2 transport and respiration.-Hsu, K., Lee, T.-Y., Periasamy, A., Kao, F.-J., Li, L.-T., Lin, C.-Y., Lin, H.-J., Lin, M. Adaptable interaction between aquaporin-1 and band 3 reveals a potential role of water channel in blood CO2 transport.	[Hsu, Kate; Lee, Ting-Ying; Lin, Hui-Ju; Lin, Marie] Mackay Mem Hosp, Transfus Med Lab, 45 Min Sheng Rd,Res Bldg 616, Tamsui 251, Taiwan; [Periasamy, Ammasi] Univ Virginia, WM Keck Ctr Cellular Imaging, Charlottesville, VA USA; [Kao, Fu-Jen] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Li, Li-Tzu] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Chuang-Yu] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan	Mackay Memorial Hospital; University of Virginia; National Yang Ming Chiao Tung University; National Defense Medical Center; Kyoto University	Hsu, K (corresponding author), Mackay Mem Hosp, Transfus Med Lab, 45 Min Sheng Rd,Res Bldg 616, Tamsui 251, Taiwan.	khsu1@mmh.org.tw	Kao, Fu-Jen/C-8269-2012; Kao, Fu-Jen/GYQ-6902-2022	Hsu, Kate/0000-0003-1009-0997; Kao, Fu-Jen/0000-0001-8361-3942	National Health Research Institute (NHRI) of Taiwan [EX103-10122SI]; Taiwan Ministry of Science & Technology (MOST) [103-2320-B-195-001-MY3]; Mackay Memorial Hospital [104-49, 105-52, 106-23]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016446] Funding Source: NIH RePORTER	National Health Research Institute (NHRI) of Taiwan(National Health Research Institutes - Taiwan); Taiwan Ministry of Science & Technology (MOST); Mackay Memorial Hospital; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. John Yu (Chang Gung University, Taoyuan City, Taiwan and Academia Sinica-Taiwan, Taipei, Taiwan) and Dr. Hsin-Hung Lin (University of California, San Diego, San Diego, CA, USA and Academia Sinica-Taiwan) for support with the FLIM instrumentation, Dr. Yu-Jun Lai (MMH) for support with the MetaMorph software. This work was supported by Grant EX103-10122SI from National Health Research Institute (NHRI) of Taiwan; Grant 103-2320-B-195-001-MY3 from the Taiwan Ministry of Science & Technology (MOST); and Mackay Memorial Hospital Grants 104-49, 105-52, and 106-23 (to K.H.). K. H. and T.-Y.L. share equal first authorship. The authors declare no conflicts of interest.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; AGRE P, 1993, AM J PHYSIOL, V265, pF463; Arakawa T, 2015, SCIENCE, V350, P680, DOI 10.1126/science.aaa4335; Beachey W., 2013, RESP CARE ANATOMY PH, Vthird; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Cabral PD, 2012, AM J PHYSIOL-RENAL, V303, pF621, DOI 10.1152/ajprenal.00268.2012; Cho MR, 1999, BIOPHYS J, V76, P1136, DOI 10.1016/S0006-3495(99)77278-4; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Endeward V, 2008, FASEB J, V22, P64, DOI 10.1096/fj.07-9097com; FORSTER RE, 1975, J APPL PHYSIOL, V38, P710, DOI 10.1152/jappl.1975.38.4.710; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Hall J. E., 2011, GUYTON HALL TXB MED; Heckwolf M, 2011, PLANT J, V67, P795, DOI 10.1111/j.1365-313X.2011.04634.x; Hsu K, 2015, VOX SANG, V108, P403, DOI 10.1111/vox.12236; Hsu K, 2012, VOX SANG, V102, P221, DOI 10.1111/j.1423-0410.2011.01535.x; Hsu K, 2011, VOX SANG, V100, P389, DOI 10.1111/j.1423-0410.2010.01436.x; Hsu K., 2011, ISBT SCI SERIES, V6, P302, DOI DOI 10.1111/J.1751-2824.2011; Hsu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10327; Hsu K, 2013, TRANSFUS APHER SCI, V49, P370, DOI 10.1016/j.transci.2013.05.011; Hsu K, 2013, TRANSFUSION, V53, P962, DOI 10.1111/j.1537-2995.2012.03861.x; Hsu K, 2009, BLOOD, V114, P1919, DOI 10.1182/blood-2008-12-195180; HUANG CH, 1991, J BIOL CHEM, V266, P7248; Issitt PD, 1985, APPL BLOOD GROUP SER; Jiang JR, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/529489; Kuchel PW, 2005, BIOSYSTEMS, V82, P189, DOI 10.1016/j.biosystems.2005.07.002; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lodish H, 2000, MOL CELL BIOL; MA TH, 1993, J BIOL CHEM, V268, P22756; MARCHESI VT, 1967, J CELL BIOL, V35, P385, DOI 10.1083/jcb.35.2.385; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; NIIZEKI K, 1983, JPN J PHYSIOL, V33, P635, DOI 10.2170/jjphysiol.33.635; Periasamy A., 2010, FLIM MICROSCOPY BIOL; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Reithmeier RAF, 2001, BLOOD CELL MOL DIS, V27, P85, DOI 10.1006/bcmd.2000.0353; Reithmeier RAF, 2016, BBA-BIOMEMBRANES, V1858, P1507, DOI 10.1016/j.bbamem.2016.03.030; Rhoades R.A., 2017, MED PHYSL PRINCIPLES; Sinanoglu O., 1965, MODERN QUANTUM CHEM; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Spence M.T.Z., 2010, MOL PROBES HDB GUIDE; STECK TL, 1978, J SUPRAMOL STR CELL, V8, P311, DOI 10.1002/jss.400080309; Sterling D, 2001, JOP, V2, P165; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Tani K, 2014, BBA-GEN SUBJECTS, V1840, P1605, DOI 10.1016/j.bbagen.2013.10.007; Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025; Vilas G, 2015, MOL BIOL CELL, V26, P1106, DOI 10.1091/mbc.E14-03-0812; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Zhang DC, 2000, BLOOD, V96, P2925	52	10	10	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4256	4264		10.1096/fj.201601282R	http://dx.doi.org/10.1096/fj.201601282R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596233	Green Published			2022-12-26	WOS:000413397400006
J	de Mayo, T; Conget, P; Becerra-Bayona, S; Sossa, CL; Galvis, V; Arango-Rodriguez, ML				de Mayo, Tomas; Conget, Paulette; Becerra-Bayona, Silvia; Sossa, Claudia L.; Galvis, Virgilio; Arango-Rodriguez, Martha L.			The role of bone marrow mesenchymal stromal cell derivatives in skin wound healing in diabetic mice	PLOS ONE			English	Article							STEM-CELLS; CONDITIONED MEDIUM; IN-VITRO; REPAIR; MURINE; MSCS; COLLAGEN; THERAPY; MODEL	Mesenchymal stromal cells (MSCs) have shown to be a promising tool in cell therapies to treat different conditions. Several pre-clinical and clinical studies have proved that the transplantation of MSCs improves wound healing. Here, we compare the beneficial effects of mouse bone marrow-derived allogeneic MSCs (allo-mBM-MSCs) and their acelullar derivatives (allo-acd-mMSCs) on skin wound healing in Non-Obese Diabetic (NOD) mice. One dose of allo-mBM-MSCs (1x10(6) cells) or one dose of allo-acd-mMSCs (1X) were intradermally injected around wounds in 8-10 week old female NOD mice. Wound healing was evaluated macroscopically (wound closure) every two days, and microscopically (reepithelialization, dermoepidermal junction, skin appendage regeneration, leukocyte infiltration, vascularization, granulation tissue formation, and density of collagen fibers in the dermis) after 16 days of MSC injection. In addition, we measured growth factors and specific proteins that were present in the allo-acd-mMSCs. Results showed significant differences in the wound healing kinetics of lesions that received allo-acd-mMSCs compared to lesions that received vehicle or allo-mBM-MSCs. In particular, mice treated with allo-acd-mMSCs reached significantly higher percentages of wound closure at day 4, 6 and 8, relative to the allo-mBM-MSCs and vehicle groups (p < 0.05), while wound closure percentages could not be statistically distinguished between the allo-mBM-MSCs and vehicle groups. Also, alloacd- mMSCs had a greater influence in the skin would healing process. Specifically, they caused a less pronounced inflammatory severe response (p < 0.0001), more granulation tissue formation at an advanced stage (p < 0.0001), and higher density of collagen fibers (p < 0.05) compared to the other groups. Nevertheless, at day 16, both allo-mBM-MSCs and allo-acd-mMSCs revealed a higher effect on the recovery of the quality skin (continuous epidermis; regular dermoepidermal junction and skin appendages) relative to untreated lesions (p < 0.0001), but not between them. On the other hand, ELISA analyses indicated that the allo-acd-mMSCs contained growth factors and proteins relevant to wound healing such as IGF-1, KGF, HGF, VEGF, ANG-2, MMP-1, CoL-1 and PGE2. Compared to alloacd-mMSCs, the administration of allo-mBM-MSCs is insufficient for wound healing in diabetic mice and delays the therapeutic effect, which maybe explained by the fact that trophic factors secreted by MSCs are critical for skin regeneration, and not the cells per se, suggesting that MSCs may require some time to secrete these factors after their administration.	[de Mayo, Tomas] Univ Desarrollo, Sch Med Clin Alemana, Santiago, Chile; [Conget, Paulette] Univ Desarrollo, Sch Med Clin Alemana, Ctr Regenerat Med, Santiago, Chile; [Becerra-Bayona, Silvia; Sossa, Claudia L.; Galvis, Virgilio] Univ Autonoma Bucaramanga UNAB, Bucaramanga, Colombia; [Sossa, Claudia L.; Arango-Rodriguez, Martha L.] Fdn Ofalmol Santander, Clin Carlos Ardila Lulle FOSCAL Int, Prod Unity Adv Therapy, Bucaramanga, Colombia; [Galvis, Virgilio] Ctr Oftalmol Virgilio Galvis, Bucaramanga, Colombia; [Galvis, Virgilio] Fdn Ofalmol Santander FOSCAL, Bucaramanga, Colombia	Universidad del Desarrollo; Universidad del Desarrollo	Arango-Rodriguez, ML (corresponding author), Fdn Ofalmol Santander, Clin Carlos Ardila Lulle FOSCAL Int, Prod Unity Adv Therapy, Bucaramanga, Colombia.	martha.arango@foscal.com.co		Becerra-Bayona, Silvia Milena/0000-0002-4499-5885; Arango, Martha/0000-0003-0409-1512; Sossa-Melo, Claudia/0000-0001-9876-222X	Fondo Nacional de Desarrollo Cientifico y Tecnologico [11110009]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by a grant from the Fondo Nacional de Desarrollo Cientifico y Tecnologico # 11110009 which was awarded to Martha L Arango Rodriguez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Aguilera V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111025; Badillo AT, 2007, CELL TISSUE RES, V329, P301, DOI 10.1007/s00441-007-0417-3; Ball SG, 2007, J CELL MOL MED, V11, P1012, DOI 10.1111/j.1582-4934.2007.00120.x; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Basiouny Hend Shafik, 2013, International Journal of Stem Cells, V6, P12; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Bruna F, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1461648; Bura A, 2014, CYTOTHERAPY, V16, P245, DOI 10.1016/j.jcyt.2013.11.011; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096161; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007119; de la Garza-Rodea AS, 2011, DERMATOLOGY, V223, P266, DOI 10.1159/000334628; El Haddad N, 2011, BLOOD, V117, P1176, DOI 10.1182/blood-2010-06-287979; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Ezquer M, 2011, J HEPATOL, V55, P1112, DOI 10.1016/j.jhep.2011.02.020; Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278; Fan K, 2011, PLAST RECONSTR SURG, V127, p44S, DOI 10.1097/PRS.0b013e3181fbe275; Fiorina P, 2010, CELL TRANSPLANT, V19, P1369, DOI 10.3727/096368910X514288; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Fong CY, 2014, J CELL BIOCHEM, V115, P290, DOI 10.1002/jcb.24661; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gardien KLM, 2014, REGEN MED, V9, P201, DOI 10.2217/rme.13.97; Heo SC, 2011, J INVEST DERMATOL, V131, P1559, DOI 10.1038/jid.2011.64; Hong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055640; Hoogduijn MJ, 2014, CURR OPIN ORGAN TRAN, V19, P41, DOI 10.1097/MOT.0000000000000036; Jun EK, 2014, INT J MOL SCI, V15, P605, DOI 10.3390/ijms15010605; Khosrotehrani K, 2013, EXP DERMATOL, V22, P307, DOI 10.1111/exd.12141; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Kong PR, 2013, BIOCHEM BIOPH RES CO, V438, P410, DOI 10.1016/j.bbrc.2013.07.088; Kuo YR, 2011, PLAST RECONSTR SURG, V128, P872, DOI 10.1097/PRS.0b013e3182174329; Li MR, 2015, INT J LOW EXTR WOUND, V14, P73, DOI 10.1177/1534734615569053; Li TS, 2008, CELL TRANSPLANT, V17, P695, DOI 10.3727/096368908786092702; Liu LY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088348, 10.1371/journal.pone.0104748]; Ma D, 2015, CYTOTHERAPY, V17, P1036, DOI 10.1016/j.jcyt.2015.04.001; Mehanna RA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846062; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Miot HA, 2010, AN BRAS DERMATOL, V85, P361, DOI 10.1590/S0365-05962010000300010; Morton LM, 2016, J AM ACAD DERMATOL, V74, P589, DOI 10.1016/j.jaad.2015.08.068; Nakamura Y, 2013, BIOMATERIALS, V34, P9393, DOI 10.1016/j.biomaterials.2013.08.053; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Shrestha C, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/592454; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stoff A, 2009, EXP DERMATOL, V18, P362, DOI 10.1111/j.1600-0625.2008.00792.x; Tamari M, 2013, INT J ORAL MAX IMPL, V28, pE369, DOI 10.11607/jomi.te17; Uccelli A, 2010, CURR OPIN IMMUNOL, V22, P768, DOI 10.1016/j.coi.2010.10.012; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; Vojtassak J, 2006, NEUROENDOCRINOL LETT, V27, P134; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xu YA, 2012, J TISSUE ENG REGEN M, V6, P645, DOI 10.1002/term.468; Zangi L, 2009, STEM CELLS, V27, P2865, DOI 10.1002/stem.217; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0; Zhang SY, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2183	63	39	40	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177533	10.1371/journal.pone.0177533	http://dx.doi.org/10.1371/journal.pone.0177533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594903	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200011
J	Emuren, L; Welles, S; Evans, AA; Polansky, M; Okulicz, JF; Macalino, G; Agan, BK				Emuren, Leonard; Welles, Seth; Evans, Alison A.; Polansky, Marcia; Okulicz, Jason F.; Macalino, Grace; Agan, Brian K.		Infect Dis Clinical Res Program HI	Health-related quality of life among military HIV patients on antiretroviral therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV-1-INFECTED PATIENTS; MENTAL-HEALTH; UNITED-STATES; COHORT; EFAVIRENZ; HIV/AIDS; ADHERENCE; OUTCOMES; HAART	Objective The aims of this study were: (i) to determine the factors associated with HRQOL at baseline in our cohort, and (ii) to evaluate if there are differences in baseline HRQOL measures by antiretroviral treatment. Methods The Short Form 36 (SF-36) was administered between 2006 and 2010 among members of the United States HIV Natural History Study cohort (NHS), and participants who completed the SF-36 were included in the study. Physical component summary (PCS) and mental component summary (MCS) scores were computed based on standard algorithms. Multivariate linear regression models were constructed for PCS and MCS to estimate the association between selected variables and HRQOL scores. Results Antiretroviral therapy (ART) was not independently associated with HRQOL scores. Factors associated with PCS were CD4+ count <200 cells/mm(3) (beta = -5.84, 95% CI: -7.63, -4.06), mental comorbidity (beta = -2.82, 95% CI: -3.79, -1.85), medical comorbidity (beta = -2.51, 95% CI: -3.75, -1.27), AIDS diagnosis (beta = -2.38, 95% CI: -3.79, -0.98). Others were gender, military rank, marital status, and age. Factors independently associated with MCS were CD4+ count <200 cells/mm(3) (beta = -1.93, 95% CI: -3.85, -0.02), mental comorbidity (beta = -6.25, 95% CI: -7.25, -5.25), age (beta = 0.37, 95% CI: 0.14, 0.60), and being African American (beta = 1.55, 95% CI: 0.63, 2.47). Conclusion Among military active duty and beneficiaries with HIV, modifiable factors associated with HRQOL measures included advanced HIV disease, and mental or medical comorbidity. Addressing these factors may improve quality of life of HIV-infected individuals in the NHS cohort.	[Emuren, Leonard; Welles, Seth; Evans, Alison A.; Polansky, Marcia] Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Emuren, Leonard] South Univ, Publ Hlth Program, Virginia Beach, VA 23452 USA; [Okulicz, Jason F.; Macalino, Grace; Agan, Brian K.; Infect Dis Clinical Res Program HI] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Macalino, Grace; Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA	Drexel University; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Emuren, L (corresponding author), Drexel Univ, Dornsife Sch Publ Hlth, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA.; Emuren, L (corresponding author), South Univ, Publ Hlth Program, Virginia Beach, VA 23452 USA.	leoemuren@yahoo.com		Agan, Brian/0000-0002-5114-1669	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) programthrough the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) programthrough the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The Views expressed are those of the authors and do not necessarily reflect the official views of the Uniformed Services University of the Health Sciences, the NIH, or the Departments of the Army, Navy or Air Force, or the Department of Defense.	Anastos K, 2004, ANN INTERN MED, V140, P256, DOI 10.7326/0003-4819-140-4-200402170-00007; Anis AH, 2009, JAIDS-J ACQ IMM DEF, V51, P631, DOI 10.1097/QAI.0b013e3181a4f00d; Armon C, 2012, QUAL LIFE RES, V21, P993, DOI 10.1007/s11136-011-0017-2; Figuero LSB, 2011, HIV MED, V12, P22, DOI 10.1111/j.1468-1293.2010.00844.x; Brodine SK, 2003, AIDS, V17, P2521, DOI 10.1097/00002030-200311210-00016; Burgoyne RW, 2008, J ANTIMICROB CHEMOTH, V61, P469, DOI 10.1093/jac/dkm499; Call SA, 2000, QUAL LIFE RES, V9, P977, DOI 10.1023/A:1016668802328; Campo RE, 2010, INT J STD AIDS, V21, P166, DOI 10.1258/ijsa.2009.008487; Carrieri P, 2003, JAIDS-J ACQ IMM DEF, V32, P38, DOI 10.1097/00126334-200301010-00006; Centers for Disease Control and Prevention (CDC), 2011, MMRI, V60; Centers for Disease Control and Prevention (CDC), 2015, RAT DIAGN HIV INF AD; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Chun HM, 2010, CLIN INFECT DIS, V50, P426, DOI 10.1086/649885; Corless IB, 2005, AIDS PATIENT CARE ST, V19, P577, DOI 10.1089/apc.2005.19.577; Degroote S, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-40; Degroote S, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18643; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fleming CA, 2004, CLIN INFECT DIS, V38, P572, DOI 10.1086/381263; Fumaz CR, 2002, J ACQ IMMUN DEF SYND, V29, P244, DOI 10.1097/00042560-200203010-00004; Gakhar H, 2013, DRUGS, V73, P651, DOI 10.1007/s40265-013-0040-4; Gibson K, 2011, AIDS PATIENT CARE ST, V25, P371, DOI 10.1089/apc.2010.0165; Gill CJ, 1999, J ACQ IMMUN DEF SYND, V30, P485; Grossman Howard A, 2003, AIDS Read, V13, P583; Hays RD, 2000, AM J MED, V108, P714, DOI 10.1016/S0002-9343(00)00387-9; Hays RD, 2014, SAS CODE SCORING 36; Hopman WM, 2009, CAN J PUBLIC HEALTH, V100, P449, DOI 10.1007/BF03404342; Jayaweera D, 2009, HIV CLIN TRIALS, V10, P375, DOI 10.1310/hct1006-375; Jia HG, 2007, QUAL LIFE RES, V16, P961, DOI 10.1007/s11136-007-9214-4; Jin YT, 2014, INT J STD AIDS, V25, P771, DOI 10.1177/0956462414525769; Kowal J, 2008, J PAIN SYMPTOM MANAG, V36, P247, DOI 10.1016/j.jpainsymman.2007.10.012; Langius-Eklof A, 2009, AIDS PATIENT CARE ST, V23, P59, DOI 10.1089/apc.2008.0076; Lifson AR, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12237; Liu C, 1999, J ACQ IMMUN DEF SYND, V2006, P470; Liu C. Y., 2006, J LIAONING ADM COLL, V8, P9; Mrus JM, 2005, QUAL LIFE RES, V14, P479, DOI 10.1007/s11136-004-4693-z; Murri R, 2003, AIDS CARE, V15, P581, DOI 10.1080/0954012031000134818; Nicholas PK, 2005, APPL NURS RES, V18, P55, DOI 10.1016/j.apnr.2004.09.012; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Perez IR, 2005, QUAL LIFE RES, V14, P1301, DOI 10.1007/s11136-004-4715-x; Potard V, 2010, AIDS CARE, V22, P54, DOI 10.1080/09540120903033250; Preau M, 2007, DRUG ALCOHOL DEPEN, V86, P175, DOI 10.1016/j.drugalcdep.2006.06.012; Preau M, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000255081.24105.d7; Protopopescu C, 2007, QUAL LIFE RES, V16, P577, DOI 10.1007/s11136-006-9151-7; RAND, SCOR INSTR 36 IT SHO; Rao D, 2007, AIDS PATIENT CARE ST, V21, P339, DOI 10.1089/apc.2006.0124; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Rueda S, 2011, AIDS CARE, V23, P435, DOI 10.1080/09540121.2010.507952; Smith TC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-340; Spaulding AB, 2012, SEX TRANSM INFECT, V88, P266, DOI 10.1136/sextrans-2011-050173; Tarwater PM, 2004, AIDS, V18, P2419; van Leth F, 2004, ANTIVIR THER, V9, P721; Zinkernagel C, 1999, J ACQ IMMUN DEF SYND, V28, p240 	53	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178953	10.1371/journal.pone.0178953	http://dx.doi.org/10.1371/journal.pone.0178953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591161	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700062
J	Hamidi, R; de Biseau, JC; Bourguignon, T; Segundo, GBM; Fontenelle, MTMB; Quinet, Y				Hamidi, Rachid; de Biseau, Jean-Christophe; Bourguignon, Thomas; Martins Segundo, Glauco Bezerra; Marinho Bezerril Fontenelle, Matheus Torres; Quinet, Yves			Dispersal strategies in the highly polygynous ant Crematogaster (Orthocrema) pygmaea Forel (Formicidae: Myrmicinae)	PLOS ONE			English	Article							IMPORTED FIRE ANT; COLONY FOUNDATION; QUEEN NUMBER; POPULATION-STRUCTURE; STORAGE PROTEINS; HYMENOPTERA; EVOLUTION; SUCCESS; SIZE; WORKERS	In ants, dispersal strategies and morphology of female sexuals are generally linked to the mode of colony founding. In species using long-range dispersal tactics, queen/worker dimorphism is generally high and young queens are able to initiate new colonies by themselves, using their metabolic reserves. By contrast, in species using short-range dispersal strategies, queen/worker dimorphism is generally low and, due to their limited metabolic reserves, queens have lost the capacity to raise their brood alone and to found their colony independently. Moreover, polygyny is also often associated with short-range dispersal strategies, although the relationship between the number of queens and the dispersal strategy in ants is not clear-cut. Here, dispersal strategies were investigated in C. pygmaea, a highly polygynous and polydomous ant species from northeastern Brazil. Field observations and laboratory experiments show that this ant exhibits a suite of traits that are more commonly associated with long-range dispersal and independent colony foundation: functional wings in both males and females, high queen/worker dimorphism, strong weight loss in mature queens, nuptial flights and, in the lab, ability of young queens to found new colonies in haplometrotic conditions. On the other hand, this species shows a high degree of polygyny with a strong seasonal component, and, at least under laboratory conditions, mature queens seem able to develop propagules if they are accompanied by at least 10 workers. These features strongly suggest that (1) some of the gynes do not engage in a long-range dispersal but become new queens in their mother colony and (2) that budding events are possible in this species. We therefore speculate that C. pygmaea has a dual dispersal strategy probably related to environmental conditions: some gynes engage in long-range dispersal followed by independent colony foundation at the beginning of rainy season, while others mate in the parental colony and are re-adopted leading to high polygyny. During the rainy season, budding events can lead to colony extension and increased polydomy. Polydomy is commonly thought to improve resource discovery and exploitation through decentralized foraging behavior, a significant advantage during the rainy season when food ressources (mainly floral/extrafloral nectaries and hemipteran honeydew) are more abundant and when colony needs for food supplies are highest.	[Hamidi, Rachid; de Biseau, Jean-Christophe] Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium; [Bourguignon, Thomas] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Bourguignon, Thomas] Czech Univ Life Sci, Fac Forestry & Wood Sci, Prague, Czech Republic; [Bourguignon, Thomas] Okinawa Inst Sci & Technol Grad Univ, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan; [Martins Segundo, Glauco Bezerra; Marinho Bezerril Fontenelle, Matheus Torres; Quinet, Yves] Univ Estadual Ceara, Inst Super Ciencias Biomed, Lab Entomol, Fortaleza, Ceara, Brazil; [Hamidi, Rachid] Univ Paris Diderot, UPEC, iEES Paris, INRA,UPMC,CNRS,IRD, Route St Cyr, Versailles, France	Universite Libre de Bruxelles; University of Sydney; Czech University of Life Sciences Prague; Okinawa Institute of Science & Technology Graduate University; Universidade Estadual do Ceara; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Hamidi, R (corresponding author), Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium.; Hamidi, R (corresponding author), Univ Paris Diderot, UPEC, iEES Paris, INRA,UPMC,CNRS,IRD, Route St Cyr, Versailles, France.	rachid.hamidi@inra.fr	Quinet, Yves P./H-9525-2012; Rachid, Hamidi/GQZ-2116-2022; Hamidi, Rachid/AAC-4139-2021	Hamidi, Rachid/0000-0002-1651-8440	Fond National de la Recherche Scientifique (FNRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473939/2004-5]; Fundagao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)	Fond National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP)	This study was supported by Fond National de la Recherche Scientifique (FNRS), no grant number (to RH, http://www.frs-fnrs.be/) Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number 473939/2004-5 (to YQ, http://cnpq.br/); Fundagao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP), no grant number (to GBMS, http://www.funcap.ce.gov.br/); Fond National de la Recherche Scientifique (FNRS), no grant number (to JCDB, http://www.frs-fnrs.be/); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), no grant number (to MTMBF, http://cnpq.br/).	Bernasconi G, 1998, BEHAV ECOL, V9, P478, DOI 10.1093/beheco/9.5.478; Carlos J., THESIS; Cherix D, 1991, ETHOL ECOL EVOL S1, V3, P60; Cole Blaine J., 2009, P74; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; Dalecky A, 2005, BIOL J LINN SOC, V86, P133, DOI 10.1111/j.1095-8312.2005.00524.x; Debout G, 2007, BIOL J LINN SOC, V90, P319, DOI 10.1111/j.1095-8312.2007.00728.x; DeHeer CJ, 2002, ANIM BEHAV, V64, P655, DOI 10.1006/anbe.2002.3095; DESLIPPE RJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P1; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; Drescher J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013581; Dunn RR, 2007, ECOL ENTOMOL, V32, P135, DOI 10.1111/j.1365-2311.2006.00839.x; Elmes Graham W., 1993, P294; Fernandez-Escudero I, 2001, INSECT SOC, V48, P80, DOI 10.1007/PL00001750; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; Hamidi R, 2012, EUR J ENTOMOL, V109, P95, DOI 10.14411/eje.2012.012; Hee JJ, 2000, CONSERV BIOL, V14, P559, DOI 10.1046/j.1523-1739.2000.99040.x; Heinze Juergen, 2009, P26; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holldobler B., 1990, pi; Ito F, 2016, ENTOMOL SCI, V19, P312, DOI 10.1111/ens.12198; Kautz S, 2009, MOL ECOL, V18, P5180, DOI 10.1111/j.1365-294X.2009.04395.x; KELLER L, 1989, OECOLOGIA, V80, P236, DOI 10.1007/BF00380157; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; KELLER L, 1991, ETHOL ECOL EVOL, V3, P307, DOI 10.1080/08927014.1991.9525359; Keller L., 1993, QUEEN NUMBER SOCIALI; Keller RA, 2014, ELIFE, V3, DOI 10.7554/eLife.01539; Laskis KO, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0201; MARTINEZ T, 1994, J INSECT PHYSIOL, V40, P723, DOI 10.1016/0022-1910(94)90100-7; Segundo GBM, 2012, BEHAV PROCESS, V91, P282, DOI 10.1016/j.beproc.2012.09.009; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; PASSERA L, 1990, J COMP PHYSIOL B, V160, P207, DOI 10.1007/BF00300955; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2015, MYRMECOL NEWS, V21, P117; Peeters C, 2013, ARTHROPOD STRUCT DEV, V42, P257, DOI 10.1016/j.asd.2013.02.003; Peeters C, 2012, MYRMECOL NEWS, V16, P75; Peeters C, 2010, ANT ECOLOGY, P159; PORTER SD, 1986, ANN ENTOMOL SOC AM, V79, P723, DOI 10.1093/aesa/79.4.723; Quinet Y, 2009, ZOOTAXA, P45, DOI 10.11646/zootaxa.2075.1.3; REDDY SJ, 1983, PESQUI AGROPECU BRAS, V18, P823; Robinson EJH, 2014, CURR OPIN INSECT SCI, V5, P37, DOI 10.1016/j.cois.2014.09.002; Rosengren Rainer, 1993, P308; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; SOMMER K, 1995, ANIM BEHAV, V50, P287, DOI 10.1006/anbe.1995.0244; Stille M, 1996, OECOLOGIA, V105, P87, DOI 10.1007/BF00328795; Sundstrom L, 2005, ANN ZOOL FENN, V42, P163; Thurin N, 2009, J EVOLUTION BIOL, V22, P2481, DOI 10.1111/j.1420-9101.2009.01864.x; TOOM PM, 1976, J INSECT PHYSIOL, V22, P217, DOI 10.1016/0022-1910(76)90028-7; TSCHINKEL WR, 1993, BEHAV ECOL SOCIOBIOL, V33, P209, DOI 10.1007/BF02027118; Tschinkel WR, 2006, FIRE ANTS; Tsuji K, 1996, OIKOS, V76, P83, DOI 10.2307/3545750; WHEELER DE, 1995, COMP BIOCHEM PHYS B, V112, P15, DOI 10.1016/0305-0491(95)00035-7	53	6	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178813	10.1371/journal.pone.0178813	http://dx.doi.org/10.1371/journal.pone.0178813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591211	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700049
J	Harting, TP; Stubbendorff, M; Hammer, SC; Schadzek, P; Ngezahayo, A; Escobar, HM; Nolte, I				Harting, Tatjana P.; Stubbendorff, Mandy; Hammer, Susanne C.; Schadzek, Patrik; Ngezahayo, Anaclet; Escobar, Hugo Murua; Nolte, Ingo			Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; CONGENITAL LACTIC-ACIDOSIS; IN-VITRO; CANCER-CELLS; SODIUM DICHLOROACETATE; DCA; GROWTH; MIGRATION; TUMORS; PERSPECTIVE	Targeting mitochondrial energy metabolism is a novel approach in cancer research and can be traced back to the description of the Warburg effect. Dichloroacetate, a controversially discussed subject of many studies in cancer research, is a pyruvate dehydrogenase kinase inhibitor. Dichloroacetate causes metabolic changes in cancerous glycolysis towards oxidative phosphorylation via indirect activation of pyruvate dehydrogenase in mitochondria. Canine mammary cancer is frequently diagnosed but after therapy prognosis still remains poor. In this study, canine mammary carcinoma, adenoma and non-neoplastic mammary gland cell lines were treated using 10 mM Dichloroacetate. The effect on cell number, lactate release and PDH expression and cell respiration was investigated. Further, the effect on apoptosis and several apoptotic proteins, proliferation, and microRNA expression was evaluated. Dichloroacetate was found to reduce cell proliferation without inducing apoptosis in all examined cell lines.	[Harting, Tatjana P.; Hammer, Susanne C.; Escobar, Hugo Murua; Nolte, Ingo] Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany; [Harting, Tatjana P.; Hammer, Susanne C.; Escobar, Hugo Murua] Univ Rostock, Div Med Clin Hematol Oncol & Palliat Med 3, Rostock, Germany; [Stubbendorff, Mandy] Evotec AG, Hamburg, Germany; [Schadzek, Patrik; Ngezahayo, Anaclet] Leibniz Univ Hannover, Inst Biophys, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Rostock; Evotec; Leibniz University Hannover	Nolte, I (corresponding author), Univ Vet Med Hannover, Small Anim Clin, Hannover, Germany.	Ingo.Nolte@tiho-hannover.de	Ngezahayo, Anaclet/Y-4468-2019	Ngezahayo, Anaclet/0000-0002-3686-923X; Schadzek, Patrik/0000-0002-0131-5093				Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Babu E, 2011, ONCOGENE, V30, P4026, DOI 10.1038/onc.2011.113; Bauer G, 2000, ANTICANCER RES, V20, P4115; Betz D, 2012, TIERAERZTL PRAX K H, V40, P235; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Cao WG, 2008, PROSTATE, V68, P1223, DOI 10.1002/pros.20788; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Dunbar EM, 2014, INVEST NEW DRUG, V32, P452, DOI 10.1007/s10637-013-0047-4; Feuerecker B, 2015, AM J CANCER RES, V5, P812; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Han T, 2015, MOL MED REP, V11, P4115, DOI 10.3892/mmr.2015.3294; Harting T, 2016, INT J ONCOL, V49, P2341, DOI 10.3892/ijo.2016.3720; Ho N, 2015, EXP CELL RES, V331, P73, DOI 10.1016/j.yexcr.2014.12.006; Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376; Kankotia S, 2014, BBA-REV CANCER, V1846, P617, DOI 10.1016/j.bbcan.2014.08.005; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; KNAPP DW, 1995, AM J VET RES, V56, P801; Kwitniewski M, 2011, PHOTOCH PHOTOBIO SCI, V10, P25, DOI 10.1039/c0pp00193g; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; LUKAS G, 1980, J PHARM SCI, V69, P419, DOI 10.1002/jps.2600690415; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Maisenbacher HW, 2013, J BIOCHEM MOL TOXIC, V27, P522, DOI 10.1002/jbt.21518; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; MORRIS JS, 1993, VET REC, V133, P539, DOI 10.1136/vr.133.22.539; PARK R, 1982, J CLIN INVEST, V70, P853, DOI 10.1172/JCI110682; Plas David R, 2002, Trends Endocrinol Metab, V13, P75, DOI 10.1016/S1043-2760(01)00528-8; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Ruggieri V, 2015, ONCOTARGET, V6, P1217, DOI 10.18632/oncotarget.2721; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; SARTIN EA, 1993, ANTICANCER RES, V13, P229; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Simon D, 2001, AM J VET RES, V62, P1825, DOI 10.2460/ajvr.2001.62.1825; Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Stander XX, 2011, CELL PROLIFERAT, V44, P567, DOI 10.1111/j.1365-2184.2011.00789.x; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Tang L, 2016, CANC GENE THER; Vella S, 2012, INT J CANCER, V130, P1484, DOI 10.1002/ijc.26173; Wagner S, 2015, ANTICANCER RES, V35, P145; Wang ZR, 2016, ONCOL REP, V35, P2943, DOI 10.3892/or.2016.4640; WARBURG OTTO, 1926, KLIN WOCHENSCHR, V5, P829, DOI 10.1007/BF01726240; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wong JYY, 2008, GYNECOL ONCOL, V109, P394, DOI 10.1016/j.ygyno.2008.01.038; Zhang Y, 2015, ANTI-CANCER DRUG, V26, P698, DOI 10.1097/CAD.0000000000000234; Zhang ZY, 2016, J CONTROL RELEASE, V235, P125, DOI 10.1016/j.jconrel.2016.05.046; Zheng MZ, 2016, TUMOR BIOL, V37, P8189, DOI 10.1007/s13277-015-4722-2; Zhou J, 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI 10.1155/2014/761507	53	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178744	10.1371/journal.pone.0178744	http://dx.doi.org/10.1371/journal.pone.0178744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591165	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700045
J	Maisonneuve, E; Cateau, E; Leveque, N; Kaaki, S; Beby-Defaux, A; Rodier, MH				Maisonneuve, Elodie; Cateau, Estelle; Leveque, Nicolas; Kaaki, Sihem; Beby-Defaux, Agnes; Rodier, Marie-Helene			Acanthamoeba castellanii is not be an adequate model to study human adenovirus interactions with macrophagic cells	PLOS ONE			English	Article							FREE-LIVING AMEBAS; WATER; BACTERIA; INFECTION; VIRUSES; CULTURE	Free living amoebae (FLA) including Acanthamoeba castellanii, are protozoa that feed on different microorganisms including viruses. These microorganisms show remarkable similarities with macrophages in cellular structures, physiology or ability to phagocyte preys, and some authors have therefore wondered whether Acanthamoeba and macrophages are evolutionary related. It has been considered that this amoeba may be an in vitro model to investigate relationships between pathogens and macrophagic cells. So, we intended in this study to compare the interactions between a human adenovirus strain and A. castellanii or THP-1 macrophagic cells. The results of molecular and microscopy techniques following co-cultures experiments have shown that the presence of the adenovirus decreased the viability of macrophages, while it has no effect on amoebic viability. On another hand, the viral replication occurred only in macrophages. These results showed that this amoebal model is not relevant to explore the relationships between adenoviruses and macrophages in in vitro experiments.	[Maisonneuve, Elodie; Cateau, Estelle; Rodier, Marie-Helene] Univ Poitiers, Lab Ecol & Biol Interact, Equipe Microbiol Eau, UMR CNRS 7267, Poitiers, France; [Cateau, Estelle; Rodier, Marie-Helene] CHU La Miletrie, Lab Parasitol & Mycol Med, Poitiers, France; [Leveque, Nicolas; Beby-Defaux, Agnes] CHU La Miletrie, Lab Virol & Mycobacteriol, Poitiers, France; [Leveque, Nicolas] Univ Poitiers, Lab Inflammat Tissus Epitheliaux & Cytokines, EA 4331, Poitiers, France; [Kaaki, Sihem] CHU La Miletrie, Unite Pathol Ultrastruct & Expt, Lab Anat & Cytol Pathol, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Maisonneuve, E (corresponding author), Univ Poitiers, Lab Ecol & Biol Interact, Equipe Microbiol Eau, UMR CNRS 7267, Poitiers, France.	elodie.maisonneuve@univ-poitiers.fr		CATEAU, Estelle/0000-0003-4424-7606				Ashbolt Nicholas J, 2015, Curr Environ Health Rep, V2, P95, DOI 10.1007/s40572-014-0037-5; BOWERS B, 1977, EXP CELL RES, V110, P409, DOI 10.1016/0014-4827(77)90307-X; Cateau E, 2014, J HOSP INFECT, V87, P131, DOI 10.1016/j.jhin.2014.05.001; CHU Y, 1992, VIROLOGY, V188, P793, DOI 10.1016/0042-6822(92)90534-V; Cosson P, 2014, CELL MICROBIOL, V16, P816, DOI 10.1111/cmi.12291; Delafont V, 2013, WATER RES, V47, P6958, DOI 10.1016/j.watres.2013.07.047; Di Paolo NC, 2013, CELL REP, V3, P1840, DOI 10.1016/j.celrep.2013.05.025; ENRIQUEZ PM, 1995, BIOCONJUGATE CHEM, V6, P195, DOI 10.1021/bc00032a007; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Hsueh TY, 2015, APPL ENVIRON MICROB, V81, P4005, DOI 10.1128/AEM.00649-15; Jhanji V, 2015, SURV OPHTHALMOL, V60, P435, DOI 10.1016/j.survophthal.2015.04.001; Khan, 2009, ACANTHAMOEBA BIOL PA; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Lorenzo-Morales J, 2007, AM J TROP MED HYG, V77, P753, DOI 10.4269/ajtmh.2007.77.753; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Mastroeni P, 1985, G Batteriol Virol Immunol, V78, P262; Mena KD, 2009, REV ENVIRON CONTAM T, V198, P133, DOI 10.1007/978-0-387-09647-6_4; Mercer J, 2013, TRENDS MICROBIOL, V21, P380, DOI 10.1016/j.tim.2013.06.001; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Rames E, 2016, WATER RES, V96, P308, DOI 10.1016/j.watres.2016.03.042; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Scheid P, 2015, PARASITOL RES, V114, P3959, DOI 10.1007/s00436-015-4731-5; Scheid P, 2012, PARASITOL RES, V111, P479, DOI 10.1007/s00436-012-2828-7; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; Siddiqui R, 2012, EXP PARASITOL, V130, P95, DOI 10.1016/j.exppara.2011.11.005; Sinclair RG, 2009, J APPL MICROBIOL, V107, P1769, DOI 10.1111/j.1365-2672.2009.04367.x; Tan DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151199; Thomas V, 2011, ENVIRON MICROBIOL, V13, P1454, DOI 10.1111/j.1462-2920.2011.02446.x; Toth K, 2008, P NATL ACAD SCI USA, V105, P7293, DOI 10.1073/pnas.0800200105; Trabelsi H, 2012, PATHOL BIOL, V60, P399, DOI 10.1016/j.patbio.2012.03.002; Verani M, 2016, EUR J PROTISTOL, V54, P11, DOI 10.1016/j.ejop.2016.02.006; Waye MMY, 2010, PHARMACEUTICALS-BASE, V3, P3343, DOI 10.3390/ph3103343; Wong K, 2010, APPL ENVIRON MICROB, V76, P6441, DOI 10.1128/AEM.02685-09; Yan L, 2004, EUKARYOT CELL, V3, P567, DOI 10.1128/EC.3.3.567-578.2004; Zaiss AK, 1950, J IMMUNOL BALTIM MD, V182, P7058; Zsengeller Z, 2000, J VIROL, V74, P9655, DOI 10.1128/JVI.74.20.9655-9667.2000	37	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178629	10.1371/journal.pone.0178629	http://dx.doi.org/10.1371/journal.pone.0178629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591183	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700041
J	Piralla, A; Rovida, F; Girello, A; Premoli, M; Mojoli, F; Belliato, M; Braschi, A; Iotti, G; Pariani, E; Bubba, L; Zanetti, AR; Baldanti, F				Piralla, Antonio; Rovida, Francesca; Girello, Alessia; Premoli, Marta; Mojoli, Francesco; Belliato, Mirko; Braschi, Antonio; Iotti, Giorgio; Pariani, Elena; Bubba, Laura; Zanetti, Alessandro R.; Baldanti, Fausto			Frequency of respiratory virus infections and next-generation analysis of influenza A/H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; A(H1N1) VIRUS; HEMAGGLUTININ; D222G; SURVEILLANCE; VIRULENCE	Recent molecular diagnostic methods have significantly improved the diagnosis of viral pneumonia in intensive care units (ICUs). It has been observed that 222G/N changes in the HA gene of H1N1pdm09 are associated with increased lower respiratory tract (LRT) replication and worse clinical outcome. In the present study, the frequency of respiratory viruses was assessed in respiratory samples from 88 patients admitted to 16 ICUs during the 2014-2015 winter-spring season in Lombardy. Sixty-nine out of 88 (78.4%) patients were positive for a respiratory viral infection at admission. Of these, 57/69 (82.6%) were positive for influenza A (41 A/H1N1pdm09 and 15 A/H3N2), 8/69 (11.6%) for HRV, 2/69 (2.9%) for RSV and 2/69 (2.9%) for influenza B. Phylogenetic analysis of influenza A/H1N1pdm09 strains from 28/41 ICU-patients and 21 patients with mild respiratory syndrome not requiring hospitalization, showed the clear predominance of subgroup 6B strains. The median influenza A load in LRT samples of ICU patients was higher than that observed in the upper respiratory tract (URT) (p<0.05). Overall, a greater number of H1N1pdm09 virus variants were observed using next generation sequencing on partial HA sequences (codons 180-286) in clinical samples from the LRT as compared to URT. In addition, 222G/N/A mutations were observed in 30% of LRT samples from ICU patients. Finally, intra-host evolution analysis showed the presence of different dynamics of viral population in LRT of patients hospitalized in ICU with a severe influenza infection.	[Piralla, Antonio; Rovida, Francesca; Girello, Alessia; Premoli, Marta; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy; [Mojoli, Francesco; Braschi, Antonio; Iotti, Giorgio] Univ Pavia, Sect Surg & Anesthesiol, Unit Anesthesia Intens Care & Pain Therapy, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy; [Belliato, Mirko; Iotti, Giorgio] Fdn IRCCS Policlin San Matteo, Dept Anesthesia & Intens Care, Pavia, Italy; [Pariani, Elena; Bubba, Laura; Zanetti, Alessandro R.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Bubba, Laura] European Ctr Dis Prevent & Control ECDC, European Programme Publ Hlth Microbiol Training E, Stockholm, Sweden; [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Milan; European Centre for Disease Prevention & Control; University of Pavia	Baldanti, F (corresponding author), Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Microbiol & Virol Dept, Pavia, Italy.; Baldanti, F (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.	f.baldanti@smatteo.pv.it	Piralla, Antonio/K-4756-2018; Rovida, Francesca/K-7984-2016; belliato, mirko/Y-6159-2019; Girello, Alessia/J-5350-2018; Baldanti, Fausto/J-4924-2018; Mojoli, Francesco/Q-1478-2019; PARIANI, ELENA/M-3491-2016	Piralla, Antonio/0000-0002-6062-2579; Rovida, Francesca/0000-0003-2345-2790; belliato, mirko/0000-0002-3411-6293; Girello, Alessia/0000-0002-9498-157X; Baldanti, Fausto/0000-0002-3358-8969; PARIANI, ELENA/0000-0001-5681-3455; Bubba, Laura/0000-0003-4561-7971	Ministero della Salute; Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente [80622]; Progetto Cariplo, Milan, Italy [2011-0517]	Ministero della Salute(Ministry of Health, Italy); Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Progetto Cariplo, Milan, Italy	This work was supported by the Ministero della Salute, Fondazione IRCCS Policlinico San Matteo, Ricerca Corrente (grant 80622) and Progetto Cariplo 2011-0517, Milan, Italy.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P281; [Anonymous], INFL VIR CHAR SUMM E; Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Greve FV, 2016, J CLIN VIROL, V83, P37, DOI 10.1016/j.jcv.2016.08.295; Hong HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095865; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Luchsinger V, 2013, THORAX, V68, P1000, DOI 10.1136/thoraxjnl-2013-203551; Luyt CE, 2006, INTENS CARE MED, V32, P968, DOI 10.1007/s00134-006-0203-9; Patel PA, 2011, J CLIN MICROBIOL, V49, P2266, DOI [10.1128/JCM.02431-10, 10.1128/JCM.00698-11]; Piralla A, 2014, DIAGN MICR INFEC DIS, V79, P183, DOI 10.1016/j.diagmicrobio.2014.02.010; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Resende PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092789; Schnell D, 2014, J MED VIROL, V86, P1198, DOI 10.1002/jmv.23760; Seidel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104233; Selleri M, 2013, CLIN MICROBIOL INFEC, V19, P668, DOI 10.1111/j.1469-0691.2012.03984.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Wansaula Z, 2016, INFLUENZA OTHER RESP, V10, P161, DOI 10.1111/irv.12360; Wedde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057059; Wiemken T, 2013, EUR J CLIN MICROBIOL, V32, P705, DOI 10.1007/s10096-012-1802-8	31	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178926	10.1371/journal.pone.0178926	http://dx.doi.org/10.1371/journal.pone.0178926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591230	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700057
J	Weltz, K; Lyle, JM; Ovenden, J; Morgan, JAT; Moreno, DA; Semmens, JM				Weltz, Kay; Lyle, Jeremy M.; Ovenden, Jennifer; Morgan, Jessica A. T.; Moreno, David A.; Semmens, Jayson M.			Application of environmental DNA to detect an endangered marine skate species in the wild	PLOS ONE			English	Article							DIVERSITY; CONSERVATION; COMMUNITY; SHARKS	Environmental DNA (eDNA) techniques have only recently been applied in the marine environment to detect the presence of marine species. Species-specific primers and probes were designed to detect the eDNA of the endangered Maugean skate (Zearaja maugeana) from as little as 1 L of water collected at depth (10-15 m) in Macquarie Harbour (MH), Tasmania. The identity of the eDNA was confirmed as Z. maugeana by sequencing the qPCR products and aligning these with the target sequence for a 100% match. This result has validated the use of this eDNA technique for detecting a rare species, Z. maugeana, in the wild. Being able to investigate the presence, and possibly the abundance, of Z. maugeana in MH and Bathurst harbour (BH), would be addressing a conservation imperative for the endangered Z. maugeana. For future application of this technique in the field, the rate of decay was determined for Z. maugeana eDNA under ambient dissolved oxygen (DO) levels (55% saturation) and lower DO (20% saturation) levels, revealing that the eDNA can be detected for 4 and 16 hours respectively, after which eDNA concentration drops below the detection threshold of the assay. With the rate of decay being influenced by starting eDNA concentrations, it is recommended that samples be filtered as soon as possible after collection to minimize further loss of eDNA prior to and during sample processing.	[Weltz, Kay; Lyle, Jeremy M.; Moreno, David A.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia; [Ovenden, Jennifer] Univ Queensland, Sch Biomed Sci, Mol Fisheries Lab, Brisbane, Qld, Australia; [Morgan, Jessica A. T.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia	University of Tasmania; University of Queensland; University of Queensland	Weltz, K (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Fisheries & Aquaculture Ctr, Hobart, Tas, Australia.	Kay.Weltz@utas.edu.au	Lyle, Jeremy M/J-7170-2014; Morgan, Jess/E-7188-2012; Weltz, Kay/J-4645-2013; Ovenden, Jenny/A-3717-2010	Lyle, Jeremy M/0000-0001-9670-5854; Morgan, Jess/0000-0002-3590-4806; Weltz, Kay/0000-0003-3866-8148; Ovenden, Jenny/0000-0001-7538-1504; Semmens, Jayson/0000-0003-1742-6692	Fisheries Research and the Development Corporation (FRDC) [2013/008]; Winifred Violet Scott Charitable Trust [S0021766]; Holsworth Wildlife Research Endowment Trust [S0022263]; Tasmania Graduate Research Scholarship	Fisheries Research and the Development Corporation (FRDC); Winifred Violet Scott Charitable Trust; Holsworth Wildlife Research Endowment Trust; Tasmania Graduate Research Scholarship	This study was funded by the Fisheries Research and the Development Corporation (FRDC) (grant number 2013/008, http://frdc.com.au/Pages/home.aspx); the Winifred Violet Scott Charitable Trust (grant number S0021766, https://vivo.utas.edu.au/vivo/display/n14784); and the Holsworth Wildlife Research Endowment Trust, grant number S0022263, http://www.eqt.com.au/ charities-and-not-for-profits/grants/animals-and-environment -grants). No individuals employed or contracted by the funders (other than the named authors) played any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This eDNA work forms part of a doctoral thesis (KW), supported by a Tasmania Graduate Research Scholarship. The authors would like to thank IMAS Senior Technical Officers Graeme Ewing and Edward Forbes for field assistance and data collection; Laboratory managers Adam Smolenski and Sharee McCammon of the Central Science Laboratories (UTAS) for laboratory assistance and guidance; and all staff of Life Science Technology and the Australian Genome Research Facility involved in primer and probe designs. Ethics project number A0013468 and A0014280. Finally, authors would like to acknowledge editor Dr. Ulrich Melcher and reviewer Professor Eske Willerslev of PLOS ONE for improving the manuscript with their comments.	Arkhipkin A, 2012, J FISH BIOL, V80, P1704, DOI 10.1111/j.1095-8649.2012.03260.x; Bell J, 2016, MOVEMENT HABITAT UTI; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Buxton C., 2014, 201016 FISH RES DEV; DeFlaun M, 1987, MAR SCI FAC PUBL U; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Denman SE, 2005, METHODS GUT MICR DEC, P1; DPIPWE, 2016, MACQ HARB STAT REP U; Dulvy NK, 2002, CONSERV BIOL, V16, P440, DOI 10.1046/j.1523-1739.2002.00416.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Edgar GJ, 2010, AQUAT CONSERV, V20, P297, DOI 10.1002/aqc.1079; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Glaab WE, 1999, MUTAT RES MOL MECH M, V430; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Goodwin HB, 2012, THESIS; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Knight B, 2015, MACQUARIE HARBOUR EN; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; MHDOWG, 2014, MACQ HARB DISS OX WO; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; RCore Team, 2020, R LANG ENV STAT COMP; Research Corbett, 2006, ROT GEN 6000 OP MAN, P67; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Simpfendorfer CA, 2016, ENDANGER SPECIES RES, V30, P109, DOI 10.3354/esr00731; Sollmann R, 2013, ECOLOGY, V94, P553, DOI 10.1890/12-1256.1; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevenson DE, 2008, FISH B-NOAA, V106, P24; Stow A, 2006, BIOL LETTERS, V2, P308, DOI 10.1098/rsbl.2006.0441; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Takazawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040154; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Treloar MAA, 2016, MAR FRESHWATER RES; Vaudo JJ, 2012, MAR FRESHWATER RES, V63, P1077, DOI 10.1071/MF11226; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786	47	47	51	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178124	10.1371/journal.pone.0178124	http://dx.doi.org/10.1371/journal.pone.0178124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591215	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000402880700020
J	Tan, LK; McGarry, MDJ; Van Houten, EEW; Ji, M; Solamen, L; Zeng, W; Weaver, JB; Paulsen, KD				Tan, Likun; McGarry, Matthew D. J.; Van Houten, Elijah E. W.; Ji, Ming; Solamen, Ligin; Zeng, Wei; Weaver, John B.; Paulsen, Keith D.			A numerical framework for interstitial fluid pressure imaging in poroelastic MRE	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; IN-VIVO QUANTIFICATION; NONLINEAR INVERSION; OXYGEN MEASUREMENTS; FREQUENCY RANGE; SKELETAL-MUSCLE; ELASTIC WAVES; BREAST-CANCER; SOLID TUMORS; MODEL	A numerical framework for interstitial fluid pressure imaging (IFPI) in biphasic materials is investigated based on three-dimensional nonlinear finite element poroelastic inversion. The objective is to reconstruct the time-harmonic pore-pressure field from tissue excitation in addition to the elastic parameters commonly associated with magnetic resonance elastography (MRE). The unknown pressure boundary conditions (PBCs) are estimated using the available full-volume displacement data from MRE. A subzone-based nonlinear inversion (NLI) technique is then used to update mechanical and hydrodynamical properties, given the appropriate subzone PBCs, by solving a pressure forward problem (PFP). The algorithm was evaluated on a single-inclusion phantom in which the elastic property and hydraulic conductivity images were recovered. Pressure field and material property estimates had spatial distributions reflecting their true counterparts in the phantom geometry with RMS errors around 20% for cases with 5% noise, but degraded significantly in both spatial distribution and property values for noise levels > 10%. When both shear moduli and hydraulic conductivity were estimated along with the pressure field, property value error rates were as high as 58%, 85% and 32% for the three quantities, respectively, and their spatial distributions were more distorted. Opportunities for improving the algorithm are discussed.	[Tan, Likun; Solamen, Ligin; Zeng, Wei; Weaver, John B.; Paulsen, Keith D.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [McGarry, Matthew D. J.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Van Houten, Elijah E. W.] Univ Sherbrooke, Dept Mech Engn, Sherbrooke, PQ J1K 2R1, Canada; [Ji, Ming] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Weaver, John B.] Dartmouth Hitchcock Med Ctr, Dept Radiol, Lebanon, NH 03756 USA; [Paulsen, Keith D.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Columbia University; University of Sherbrooke; Johns Hopkins University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Paulsen, KD (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Paulsen, KD (corresponding author), Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA.	Keith.D.Paulsen@dartmouth.edu	/N-1293-2015	/0000-0001-8473-9299	National Institute of Health [R01 EB018230]; National Institute of Biomedical Imaging and Bioengineering	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institute of Health, grant number R01 EB018230, which was awarded by the National Institute of Biomedical Imaging and Bioengineering to KDP (https.//projectreporter.nih.gov/project_info_description.cfm?aid=91235808&icde=31166196&ddparam=&ddvalue=&ddsub=&cr=2&csb=FY&cs=DESC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; BIOT MA, 1956, J ACOUST SOC AM, V28, P168, DOI 10.1121/1.1908239; BIOT MA, 1956, J ACOUST SOC AM, V28, P179, DOI 10.1121/1.1908241; BOUCHER Y, 1991, CANCER RES, V51, P6691; CHENG AHD, 1991, J ENG MECH, V117, P1136, DOI 10.1061/(ASCE)0733-9399(1991)117:5(1136); Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; CURTI BD, 1993, CANCER RES, V53, P2204; Draper NR, 1966, APPL REGRESSION ANAL, V3; Dresner MA, 2001, J MAGN RESON IMAGING, V13, P269, DOI 10.1002/1522-2586(200102)13:2<269::AID-JMRI1039>3.3.CO;2-T; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gade TPF, 2009, CLIN CANCER RES, V15, P247, DOI 10.1158/1078-0432.CCR-08-0611; Gulliksrud K, 2011, INT J RADIAT ONCOL, V80, P258, DOI 10.1016/j.ijrobp.2010.11.042; Gulliksrud K, 2009, RADIOTHER ONCOL, V91, P107, DOI 10.1016/j.radonc.2008.08.015; GUTMANN R, 1992, CANCER RES, V52, P1993; Guyton A.C., 2006, TXB MED PHYSL; Haider MA, 2005, INT J RADIAT ONCOL, V62, P1100, DOI 10.1016/j.ijrobp.2004.12.064; Hassid Y, 2006, CANCER RES, V66, P4159, DOI 10.1158/0008-5472.CAN-05-3289; Hassid Y, 2008, MICROVASC RES, V76, P94, DOI 10.1016/j.mvr.2008.06.002; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; JAIN RK, 1987, CANCER RES, V47, P3039; Kemper J, 2004, ROFO-FORTSCHR RONTG, V176, P1094, DOI 10.1055/s-2004-813279; Kuszyk BS, 2001, AM J ROENTGENOL, V177, P747, DOI 10.2214/ajr.177.4.1770747; LESS JR, 1992, CANCER RES, V52, P6371; Liu LD, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-2; Lorenzen J, 2002, ROFO-FORTSCHR RONTG, V174, P830, DOI 10.1055/s-2002-32690; McGarry MDJ, 2015, MED PHYS, V42, P947, DOI 10.1118/1.4905048; McGarry MDJ, 2012, MED PHYS, V39, P6388, DOI 10.1118/1.4754649; McGarry MDJ, 2011, PHYS MED BIOL, V56, pN153, DOI 10.1088/0031-9155/56/13/N02; McGarry M, 2013, IEEE T MED IMAGING, V32, P1901, DOI 10.1109/TMI.2013.2268978; McKnight AL, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781411; Miga M. I., 2002, BIOMEDICAL IMAGING 2, P9; Miga MI, 2000, J BIOMECH ENG-T ASME, V122, P354, DOI 10.1115/1.1288207; Miga MI, 2000, IEEE T BIO-MED ENG, V47, P266, DOI 10.1109/10.821778; Milosevic M, 2001, CANCER RES, V61, P6400; NAGASHIMA T, 1990, ACT NEUR S, V51, P155; NAGASHIMA T, 1994, ACTA NEUROCHIR, P165; NATHANSON SD, 1994, ANN SURG ONCOL, V1, P333, DOI 10.1007/BF03187139; Ozerdem U, 2005, MICROVASC RES, V70, P116, DOI 10.1016/j.mvr.2005.07.003; Ozerdem U, 2009, MICROVASC RES, V77, P226, DOI 10.1016/j.mvr.2008.08.002; Pattison AJ, 2014, IEEE T MED IMAGING, V33, P1373, DOI 10.1109/TMI.2014.2311456; Paulsen KD, 1999, IEEE T BIO-MED ENG, V46, P213, DOI 10.1109/10.740884; Perrinez PR, 2010, MED PHYS, V37, P3518, DOI 10.1118/1.3443563; Perrinez PR, 2010, IEEE T MED IMAGING, V29, P746, DOI 10.1109/TMI.2009.2035309; Perrinez PR, 2009, IEEE T BIO-MED ENG, V56, P598, DOI 10.1109/TBME.2008.2009928; Platenik LA, 2002, IEEE T BIO-MED ENG, V49, P823, DOI 10.1109/TBME.2002.800760; Polyfitn D'Errico J., 2015, MATLAB CENTRAL FILE; Ringleb SI, 2007, J MAGN RESON IMAGING, V25, P301, DOI 10.1002/jmri.20817; Rofstad EK, 2010, CLIN CANCER RES, V16, P936, DOI 10.1158/1078-0432.CCR-09-2718; Rofstad EK, 2002, CANCER RES, V62, P661; ROH HD, 1991, CANCER RES, V51, P6695; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Tan L, MED IMAGING IEEE T; Van Houten EEW, 2003, J MAGN RESON IMAGING, V17, P72, DOI 10.1002/jmri.10232; Van Houten EEW, 1999, MAGNET RESON MED, V42, P779, DOI 10.1002/(SICI)1522-2594(199910)42:4<779::AID-MRM21>3.0.CO;2-Z; Van Houten EEW, 2000, MED PHYS, V27, P101, DOI 10.1118/1.598861; Van Houten EEW, 2001, MAGNET RESON MED, V45, P827, DOI 10.1002/mrm.1111; Van Houtena EEW, 2011, MED PHYS, V38, P1993, DOI 10.1118/1.3557469; Weaver JB, 2012, PHYS MED BIOL, V57, P7275, DOI 10.1088/0031-9155/57/22/7275; Yin M, 2007, MAGN RESON MED, V58, P346, DOI 10.1002/mrm.21286	62	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178521	10.1371/journal.pone.0178521	http://dx.doi.org/10.1371/journal.pone.0178521			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586393	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700016
J	de Willige, SU; Keane, FM; Bowen, DG; Malfliet, JJMC; Zhang, HE; Maneck, B; McCaughan, GW; Leebeek, FWG; Rijken, DC; Gorrell, MD				de Willige, Shirley Uitte; Keane, Fiona M.; Bowen, David G.; Malfliet, Joyce J. M. C.; Zhang, H. Emma; Maneck, Bharvi; McCaughan, Geoffrey W.; Leebeek, Frank W. G.; Rijken, Dingeman C.; Gorrell, Mark D.			Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease	PLOS ONE			English	Article							NEUROPEPTIDE-Y; EXPRESSION; PLASMA; ALPHA; ALPHA-2-ANTIPLASMIN; SUBSTRATE; CIRRHOSIS; CLEAVAGE; FIBROSIS; ENZYME	Background and aim Circulating fibroblast activation protein (cFAP) is a constitutively active enzyme expressed by activated fibroblasts that has both dipeptidyl peptidase and endopeptidase activities. We aimed to assess the correlation between cFAP activity and antigen levels and to compare variations in levels. Methods In plasma of 465 control individuals, 368 patients with coronary heart disease (CHD) and 102 hepatitis C virus (HCV) infected patients with severe liver disease before and after liver transplant, cFAP activity levels were measured with a newly developed cFAP activity assay. In the same samples, cFAP antigen levels were measured using a commercially available cFAP ELISA. Correlation analyses between activity and antigen levels were performed by calculating Pearson's correlation coefficient (rho). Additionally, normal ranges, determinants and differences between cohorts and between anticoagulants were investigated. Results cFAP activity and antigen levels significantly correlated in controls (rho: 0.660, p<0.001) and in CHD patients (rho: 0.709, p<0.001). cFAP activity and antigen levels in the HCV cohort were significantly lower in the samples taken after liver transplantation (p<0.001) and normalized toward levels of healthy individuals. Furthermore, cFAP activity and antigen levels were higher in men and significantly associated with body mass index. Also, cFAP activity and antigen levels were higher in EDTA plasma as compared to the levels in citrated plasma from the same healthy individuals. Conclusions For analyzing cFAP levels, either activity levels or antigen levels can be measured to investigate differences between individuals. However, it is of importance that blood samples are collected in the same anticoagulant.	[de Willige, Shirley Uitte; Malfliet, Joyce J. M. C.; Leebeek, Frank W. G.; Rijken, Dingeman C.] Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands; [Keane, Fiona M.; Bowen, David G.; Zhang, H. Emma; Maneck, Bharvi; McCaughan, Geoffrey W.; Gorrell, Mark D.] Univ Sydney, Sydney Med Sch, Centenary Inst, Dept Mol Hepatol, Sydney, NSW, Australia; [Maneck, Bharvi; McCaughan, Geoffrey W.] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia	Erasmus University Rotterdam; Erasmus MC; University of Sydney; Centenary Institute; University of Sydney	de Willige, SU (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol, Rotterdam, Netherlands.	s.uittedewillige@erasmusmc.nl	Zhang, Hui Emma/J-6888-2019; Gorrell, Mark Douglas/H-7231-2019; Gorrell, Mark/AAX-6394-2021	Zhang, Hui Emma/0000-0002-4699-4237; Gorrell, Mark Douglas/0000-0002-0528-2604; MCCAUGHAN, GEOFFREY/0000-0002-1483-1636; Bowen, David/0000-0002-7965-5581	National Health and Medical Research Council of Australia [1105238]; Rebecca L. Cooper Medical Research Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation	This research was supported by grants from the National Health and Medical Research Council of Australia (grant 1105238; MDG) and from the Rebecca L. Cooper Medical Research Foundation (MDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; De Willige SU, 2013, J THROMB HAEMOST, V11, P2029, DOI 10.1111/jth.12396; de Willige SU, 2015, INT J CARDIOL, V178, P105, DOI 10.1016/j.ijcard.2014.10.091; Dunshee DR, 2016, J BIOL CHEM, V291, P5986, DOI 10.1074/jbc.M115.710582; Hamson EJ, 2014, PROTEOM CLIN APPL, V8, P454, DOI 10.1002/prca.201300095; Keane FM, 2014, FEBS OPEN BIO, V4, P43, DOI 10.1016/j.fob.2013.12.001; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lee KN, 2004, BLOOD, V103, P3783, DOI 10.1182/blood-2003-12-4240; Levy MT, 2002, LIVER, V22, P93, DOI 10.1034/j.1600-0676.2002.01503.x; Osborne B, 2014, BBA-PROTEINS PROTEOM, V1844, P1248, DOI 10.1016/j.bbapap.2014.03.015; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Sanchez-Garrido MA, 2016, MOL METAB, V5, P1015, DOI 10.1016/j.molmet.2016.07.003; Sinnathurai P, 2016, INT J RHEUMATOLOGY D; Tan SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171194; Tillmanns J, 2013, INT J CARDIOL, V168, P3926, DOI 10.1016/j.ijcard.2013.06.061; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Williams KH, 2015, DIABETES RES CLIN PR, V108, P466, DOI 10.1016/j.diabres.2015.02.024; Wong PF, 2016, PEPTIDES, V75, P80, DOI 10.1016/j.peptides.2015.11.004; Zhang Jiping, 2010, Front Biosci (Elite Ed), V2, P1154	20	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178987	10.1371/journal.pone.0178987	http://dx.doi.org/10.1371/journal.pone.0178987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582421	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600066
J	Jansen, CHP; Reimann, C; Brangsch, J; Botnar, RAM; Makowski, MR				Jansen, Christian H. P.; Reimann, Carolin; Brangsch, Julia; Botnar, Rene A. M.; Makowski, Marcus R.			In vivo MR-angiography for the assessment of aortic aneurysms in an experimental mouse model on a clinical MRI scanner: Comparison with high-frequency ultrasound and histology	PLOS ONE			English	Article							E-DEFICIENT MICE; PROGRESSION; STATE; RISK	Background MR-angiography currently represents one of the clinical reference-standards for the assessment of aortic-dimensions. For experimental research in mice, dedicated preclinical highfield MRI scanners are used in most studies. This type of MRI scanner is not available in most institutions. The aim of this study was to evaluate the potential of MR-angiography performed on a clinical MR scanner for the assessment of aortic aneurysms in an experimental mouse model, compared to a preclinical high-resolution ultrasound imaging system and histopathology. Methods All in vivo MR imaging was performed with a clinical 3T MRI system (Philips Achieva) equipped with a clinical gradient system in combination with a single-loop surface-coil (47 mm). All MR sequences were based on clinically used sequences. For ultrasound, a dedicated preclinical high-resolution system (30 MHz linear transducer, Vevo770, VisualSonics) was used. All imaging was performed with an ApoE knockout mouse-model for aortic aneurysms. Histopathology was performed as reference-standard at all stages of aneurysm development. Results MR-angiography on a clinical 3T system enabled the clear visualization of the aortic lumen and aneurysmal dilation at different stages of aneurysm development. A close correlation (R-2 = 0.98; p < 0.001) with histological area measurements was found. Additionally, a good agreement between MR and ultrasound area measurements in systole (R-2 = 0.91; p < 0.001) and diastole (R-2 = 0.94; p < 0.001) were measured. Regarding interobserver reproducibility, MRI measurements yielded a smaller 95% confidence interval and a closer interreader correlation compared to ultrasound measurements (-0.37 - 0.46; R-2 = 0.97 vs. - 0.78- 0.88; R-2 = 0.87). Conclusion This study demonstrates that MR-angiography, performed on a clinical 3T MR scanner, enables the reliable detection and quantification of the aortic dilatation at different stages of aneurysm development in an experimental mouse model.	[Jansen, Christian H. P.; Botnar, Rene A. M.; Makowski, Marcus R.] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Reimann, Carolin; Brangsch, Julia; Makowski, Marcus R.] Charite, Dept Radiol, Berlin, Germany; [Botnar, Rene A. M.; Makowski, Marcus R.] Kings Coll London, BHF Ctr Excellence, London, England; [Botnar, Rene A. M.] Kings Coll London, Wellcome Trust, London, England; [Botnar, Rene A. M.] Kings Coll London, EPSRC Med Engn Ctr, London, England; [Botnar, Rene A. M.] Kings Coll London, NIHR Biomed Res Ctr, London, England; [Botnar, Rene A. M.] Pontificia Univ Catolica Chile, Sch Engn, Santiago, Chile	University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; University of London; King's College London; University College London; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; King's College London; University of London; King's College London; Pontificia Universidad Catolica de Chile	Reimann, C (corresponding author), Charite, Dept Radiol, Berlin, Germany.	carolin.reimann@charite.de	Botnar, Rene Michael/AAZ-2112-2020; Makowski, Marcus R/Q-7957-2018; Botnar, Rene/E-6875-2012	Botnar, Rene/0000-0002-9447-4367; Botnar, Rene/0000-0003-2811-2509	British Heart Foundation [PG/09/061]; Deutsche Forschungsgemeinschaft [MA 5943/3-1, MA 5943/4-1/9-1]	British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by the British Heart Foundation www.bhf.org.uk (PG/09/061) and the Deutsche Forschungsgemeinschaft [http:// www.dfg.de/] (MA 5943/3-1/and MA 5943/4-1/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otherwise, there are no financial or other relations that could lead to a conflict of interest.	Argenta Rodrigo, 2009, J. vasc. bras., V8, P148, DOI 10.1590/S1677-54492009000200009; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bengtsson H, 1996, ANN NY ACAD SCI, V800, P1, DOI 10.1111/j.1749-6632.1996.tb33294.x; Botnar RM, 2014, CIRC-CARDIOVASC IMAG, V7, P679, DOI 10.1161/CIRCIMAGING.113.001131; Buijs RVC, 2013, J VASC SURG, V57, P851, DOI 10.1016/j.jvs.2012.10.097; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Daugherty A, 2006, ANN NY ACAD SCI, V1085, P82, DOI 10.1196/annals.1383.035; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Erentug V, 2003, ANN VASC SURG, V17, P682, DOI 10.1007/s10016-003-0076-0; Evangelista A, 2014, HEART, V100, P909, DOI 10.1136/heartjnl-2013-305048; Forsythe RO, 2016, HEART, V102, P817, DOI 10.1136/heartjnl-2015-308779; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Hallett JW, 2000, MAYO CLIN PROC, V75, P395, DOI 10.4065/75.4.395; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; Kent KC, 2014, NEW ENGL J MED, V371, P2101, DOI 10.1056/NEJMcp1401430; Kniemeyer HW, 2000, EUR J VASC ENDOVASC, V19, P190, DOI 10.1053/ejvs.1999.0980; MacDonald ME, 2015, NMR BIOMED, V28, P767, DOI 10.1002/nbm.3322; Makowski MR, 2011, NAT MED, V17, P383, DOI 10.1038/nm.2310; MATSUMURA K, 1991, ANGIOLOGY, V42, P308, DOI 10.1177/000331979104200408; Moritz AR, 1932, AM J PATHOL, V8, P717; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Schouten O, 2005, CURR OPIN ANESTHESIO, V18, P51, DOI 10.1097/00001503-200502000-00009; Todd DJ, 2016, ANNU REV MED, V67, P273, DOI 10.1146/annurev-med-063014-124936; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Tsui Janice C, 2010, Open Cardiovasc Med J, V4, P221, DOI 10.2174/1874192401004010221; Wanhainen A, 2016, ARTERIOSCL THROM VAS, V36, P236, DOI 10.1161/ATVBAHA.115.306538; Yoo Young Sun, 2015, Vasc Specialist Int, V31, P1, DOI 10.5758/vsi.2015.31.1.1	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178682	10.1371/journal.pone.0178682	http://dx.doi.org/10.1371/journal.pone.0178682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582441	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600029
J	Joksimovic, J; Selakovic, D; Matovic, M; Zaletel, I; Puskas, N; Rosic, G				Joksimovic, Jovana; Selakovic, Dragica; Matovic, Milovan; Zaletel, Ivan; Puskas, Nela; Rosic, Gvozden			The role of neuropeptide-Y in nandrolone decanoate-induced attenuation of antidepressant effect of exercise	PLOS ONE			English	Article							PHYSICAL-EXERCISE; PREFRONTAL CORTEX; RAT MODEL; DEPRESSION; NPY; HIPPOCAMPUS; TESTOSTERONE; EXPRESSION; CORTISOL; BEHAVIOR	Since the increased prevalence of anabolic androgenic steroids abuse in last few decades is usually accompanied by various exercise protocols, the scope of our study was to evaluate the effects of chronic nandrolone decanoate administration in supraphysiological dose and a prolonged swimming protocol (alone and simultaneously with nandrolone decanoate) on depressive state in male rats. Simultaneously, we investigated the possible alterations in neuropeptide Y (NPY) content in blood and the hippocampus, in order to determine the role of NPY in the modulation of depressive-like behavior. Exercise induced antidepressant effects in tail suspension test (decrease of the total duration of immobility), as well as significant increase in the number of hippocampal NPY-interneurons in CA1 region. Chronic nandrolone decanoate treatment attenuated the beneficial antidepressant effects of exercise as measured by the tail suspension test parameters. Simultaneously, nandrolone decanoate treatment resulted in diminution of NPY content both in blood (decreased serum levels) and in hippocampus (the significant decrease in NPY expression in all three investigated hippocampal regions-CA1, CA2/3 and DG). Our findings indicate that alterations in serum and hippocampal NPY contents may underlie the changes in depressive state in rats. The exercise was beneficial as it exerted antidepressant effect, while chronic nandrolone decanoate treatment resulted in depressive-like behavior. Furthermore, the behavioral indicators of depression showed strong correlations with the serum levels and the hippocampal content of NPY.	[Joksimovic, Jovana; Selakovic, Dragica; Rosic, Gvozden] Univ Kragujevac, Dept Physiol, Fac Med Sci, Kragujevac, Serbia; [Matovic, Milovan] Univ Kragujevac, Clin Ctr Kragujevac, Deparment Nucl Med, Fac Med Sci, Kragujevac, Serbia; [Zaletel, Ivan; Puskas, Nela] Univ Belgrade, Inst Histol & Embryol Aleksandar Kostic, Sch Med, Belgrade, Serbia	University of Kragujevac; University of Kragujevac; University of Belgrade	Rosic, G (corresponding author), Univ Kragujevac, Dept Physiol, Fac Med Sci, Kragujevac, Serbia.	grosic@medf.kg.ac.rs	Zaletel, Ivan/O-4681-2016	Zaletel, Ivan/0000-0002-4841-788X; Selakovic, Dragica/0000-0003-4814-8664; Rosic, Gvozden/0000-0001-7424-8357; Rosic, Gvozden/0000-0003-2003-4358; Joksimovic, Jovana/0000-0002-8775-2752; Selakovic, Dragica/0000-0001-8264-2477; Matovic, Milovan/0000-0002-2950-2915	Faculty of Medical Sciences, University of Kragujevac, Serbia [JP 01/13]; Ministry of Education, Science, and Technological Development of Serbia [175061]	Faculty of Medical Sciences, University of Kragujevac, Serbia; Ministry of Education, Science, and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by Faculty of Medical Sciences, University of Kragujevac, Serbia (JP 01/13) and Ministry of Education, Science, and Technological Development of Serbia(Grant No 175061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge B, 2010, NEUROPEPTIDES, V44, P215, DOI 10.1016/j.npep.2009.12.014; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Bucinskaite V, 1996, EUR J NEUROSCI, V8, P382, DOI 10.1111/j.1460-9568.1996.tb01221.x; Buddenberg TE, 2009, BRAIN RES BULL, V79, P182, DOI 10.1016/j.brainresbull.2009.02.008; Busardo FP, 2015, CURR NEUROPHARMACOL, V13, P122, DOI 10.2174/1570159X13666141210225822; Caberlotto L, 1998, MOL BRAIN RES, V59, P58, DOI 10.1016/S0169-328X(98)00137-5; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; CHERMAT R, 1986, J PHARMACOL-PARIS, V17, P348; Domschke K, 2010, EUR NEUROPSYCHOPHARM, V20, P301, DOI 10.1016/j.euroneuro.2009.09.006; Duszczyk M, 2015, ACTA NEUROBIOL EXP, V75, P364; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; HEILIG M, 1988, EUR J PHARMACOL, V147, P465, DOI 10.1016/0014-2999(88)90182-3; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Jameel MK, 2014, J CLIN DIAGN RES, V8, P181, DOI 10.7860/JCDR/2014/7210.4116; Jiang P, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/729827; Jimenez-Vasquez PA, 2000, J PSYCHIAT RES, V34, P405, DOI 10.1016/S0022-3956(00)00036-4; Kalueff AV, 2004, ACTA NEUROBIOL EXP, V64, P439; KANAYAMA G, 2008, Patent No. 200898; Keshtkar B, 2014, J ZANJAN U MED SCI, V22, P96; Kindlundh AMS, 2001, EUR J PUBLIC HEALTH, V11, P322, DOI 10.1093/eurpub/11.3.322; KOHLER C, 1987, NEUROSCI LETT, V78, P1, DOI 10.1016/0304-3940(87)90551-9; Koren L, 2012, GEN COMP ENDOCR, V177, P113, DOI 10.1016/j.ygcen.2012.02.020; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Contarteze RVL, 2008, COMP BIOCHEM PHYS A, V151, P415, DOI 10.1016/j.cbpa.2007.03.005; Liu X, 2010, NEUROSCI LETT, V476, P99, DOI 10.1016/j.neulet.2010.04.011; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; Martinez-Sanchis S, 1998, PSYCHONEUROENDOCRINO, V23, P275, DOI 10.1016/S0306-4530(98)00005-5; Matrisciano F, 2010, NEUROPHARMACOLOGY, V58, P1078, DOI 10.1016/j.neuropharm.2010.01.015; MCDONALD JK, 1987, NEUROENDOCRINOLOGY, V46, P538, DOI 10.1159/000124877; Melas PA, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.31; Milner TA, 1997, J COMP NEUROL, V386, P46; Motaghinejad Majid, 2015, Adv Biomed Res, V4, P134, DOI 10.4103/2277-9175.161528; Naveera Shabir, 2015, Global Veterinaria, V14, P432; Nowak B, 2010, PHARMACOL REP, V62, P1204, DOI 10.1016/S1734-1140(10)70383-2; Opmeer EM, 2014, SOC COGN AFFECT NEUR, V9, P601, DOI 10.1093/scan/nst025; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piacentino D, 2015, CURR NEUROPHARMACOL, V13, P101, DOI 10.2174/1570159X13666141210222725; Rainer Q, 2014, NEUROPHARMACOLOGY, V83, P79, DOI 10.1016/j.neuropharm.2014.03.015; Ramos-Pratts KM, 2010, FASEB J S, V24, P639; Redrobe JP, 2002, LIFE SCI, V71, P2921, DOI 10.1016/S0024-3205(02)02159-8; Rocha VM, 2007, STRESS, V10, P326, DOI 10.1080/10253890701281344; Rosic G, 2014, NEUROENDOCRINOL LETT, V35, P703; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sigwalt AR, 2011, NEUROSCIENCE, V192, P661, DOI 10.1016/j.neuroscience.2011.05.075; Sommer WH, 2010, HUM MUTAT, V31, pE1594, DOI 10.1002/humu.21299; Stogner KA, 2000, EUR J PHARMACOL, V387, pR9, DOI 10.1016/S0014-2999(99)00800-6; Strickland PL, 2002, BRIT J PSYCHIAT, V180, P168, DOI 10.1192/bjp.180.2.168; Talih F, 2007, CLEV CLIN J MED, V74, P341, DOI 10.3949/ccjm.74.5.341; Webster I, 2010, MED TECHNOL SA, V24, P37; Westrin A, 1999, EUR NEUROPSYCHOPHARM, V9, P205, DOI 10.1016/S0924-977X(98)00026-1; WIDERLOV E, 1988, J PSYCHIATR RES, V22, P69, DOI 10.1016/0022-3956(88)90030-1; Wood RI, 2008, FRONT NEUROENDOCRIN, V29, P490, DOI 10.1016/j.yfrne.2007.12.002; Zajadacz B, 2009, BIOL SPORT, V26, P309, DOI 10.5604/20831862.901136; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc; Zotti M, 2014, STEROIDS, V79, P7, DOI 10.1016/j.steroids.2013.10.005	59	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178922	10.1371/journal.pone.0178922	http://dx.doi.org/10.1371/journal.pone.0178922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582442	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600055
J	Mesbahi-Vasey, S; Veras, L; Yonkunas, M; Johnson, JW; Kurnikova, MG				Mesbahi-Vasey, Samaneh; Veras, Lea; Yonkunas, Michael; Johnson, Jon W.; Kurnikova, Maria G.			All atom NMDA receptor transmembrane domain model development and simulations in lipid bilayers and water	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-STRUCTURE REFINEMENT; GLUTAMATE; CHANNELS; ACTIVATION; PATHWAYS; CALCIUM; BINDING; BLOCK; ACCESSIBILITY	N-methyl-D-aspartate receptors (NMDARs) are members of the ionotropic glutamate receptor family that mediate excitatory synaptic transmission in the central nervous system. The channels of NMDARs are permeable to Ca2+ but blocked by Mg2+, distinctive properties that underlie essential brain processes such as induction of synaptic plasticity. However, due to limited structural information about the NMDAR transmembrane ion channel forming domain, the mechanism of divalent cation permeation and block is understood poorly. In this paper we developed an atomistic model of the transmembrane domain (TMD) of NMDARs composed of GluN1 and GluN2A subunits (GluN1/2A receptors). The model was generated using (a) a homology model based on the structure of the NaK channel and a partially resolved structure of an AMPA receptor (AMPAR), and (b) a partially resolved X-ray structure of GluN1/2B NMDARs. Refinement and extensive Molecular Dynamics (MD) simulations of the NMDAR TMD model were performed in explicit lipid bilayer membrane and water. Targeted MD with simulated annealing was introduced to promote structure refinement. Putative positions of the Mg2+ and Ca2+ ions in the ion channel divalent cation binding site are proposed. Differences in the structural and dynamic behavior of the channel protein in the presence of Mg2+ or Ca2+ are analyzed. NMDAR protein conformational flexibility was similar with no ion bound to the divalent cation binding site and with Ca2+ bound, whereas Mg2+ binding reduced protein fluctuations. While bound at the binding site both ions retained their preferred ligand coordination numbers: 6 for Mg2+, and 7-8 for Ca2+. Four asparagine side chain oxygens, a back-bone oxygen, and a water molecule participated in binding a Mg2+ ion. The Ca2+ ion first coordination shell ligands typically included four to five side-chain oxygen atoms of the binding site asparagine residues, two water molecules and zero to two backbone oxygens of the GluN2B subunits. These results demonstrate the importance of high-resolution channel structures for elucidation of mechanisms of NMDAR permeation and block.	[Mesbahi-Vasey, Samaneh; Veras, Lea; Yonkunas, Michael; Kurnikova, Maria G.] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Johnson, Jon W.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Johnson, Jon W.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kurnikova, MG (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	kurnikova@cmu.edu	Yonkunas, Michael/P-8397-2019; Kurnikova, maria G/H-4510-2017; Veras, Lea/P-4295-2015	Yonkunas, Michael/0000-0002-4570-279X; Kurnikova, maria G/0000-0002-8010-8374; Veras, Lea/0000-0002-6785-6722	National Institute of Mental Health [R01MH045817]; Direct For Mathematical & Physical Scien [1563291] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045817] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grant R01MH045817 (to JWJ and MK) from the National Institute of Mental Health (https://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Antonov SM, 1999, P NATL ACAD SCI USA, V96, P14571, DOI 10.1073/pnas.96.25.14571; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blanke ML, 2008, MOL PHARMACOL, V74, P454, DOI 10.1124/mol.107.044115; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Case DA, 2012, AMBER 12; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Dudev T, 2000, J PHYS CHEM B, V104, P3692, DOI 10.1021/jp9941559; Feig M, 2016, PROTEINS, V84, P282, DOI 10.1002/prot.24871; Glusker J.P., 1999, RIGAKU J, V16, P8, DOI DOI 10.1201/9781482289893; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Helm L, 2005, CHEM REV, V105, P1923, DOI 10.1021/cr030726o; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Iacobucci GJ, 2017, NAT REV NEUROSCI, V18, P236, DOI 10.1038/nrn.2017.24; Janardhan Vallabh, 2004, Curr Cardiol Rep, V6, P117, DOI 10.1007/s11886-004-0009-8; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jones KS, 2002, J NEUROSCI, V22, P2044, DOI 10.1523/JNEUROSCI.22-06-02044.2002; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; Kullmann DM, 2000, CELL MOL LIFE SCI, V57, P1551, DOI 10.1007/PL00000640; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kupper J, 1996, P NATL ACAD SCI USA, V93, P8648, DOI 10.1073/pnas.93.16.8648; Kurnikov IV, 1999, HARLEM HAMILTONIANS; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Lu W, 2017, SCIENCE, V355, DOI 10.1126/science.aal3729; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Martell A.E., 1996, METAL COMPLEXES IN A; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; Merrill D, 2011, INORG CHEM, V50, P8348, DOI 10.1021/ic200905f; Mirjalili V, 2013, J CHEM THEORY COMPUT, V9, P1294, DOI 10.1021/ct300962x; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Murthy SE, 2012, J GEN PHYSIOL, V140, P267, DOI 10.1085/jgp.201210786; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Retchless BS, 2012, NAT NEUROSCI, V15, P406, DOI 10.1038/nn.3025; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Schmidt T, 2014, DRUG DISCOV TODAY, V19, P890, DOI 10.1016/j.drudis.2013.10.027; Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Siddons CJ, 2004, CHEM COMMUN, P1632, DOI 10.1039/b404316m; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stone JE, 2010, J MOL GRAPH MODEL, V29, P116, DOI 10.1016/j.jmgm.2010.06.010; Stout AK, 1996, J PHYSIOL-LONDON, V492, P641, DOI 10.1113/jphysiol.1996.sp021334; Tajima N, 2016, NATURE, V534, P63, DOI 10.1038/nature17679; Tikhonov DB, 2007, MOL MEMBR BIOL, V24, P135, DOI 10.1080/09687860601008806; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wollmuth LP, 1998, J PHYSIOL-LONDON, V506, P13, DOI 10.1111/j.1469-7793.1998.013bx.x; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Xu D, 2010, ANN REP COMP CHEM, V6, P3, DOI 10.1016/S1574-1400(10)06001-9; Yuan HJ, 2005, J BIOL CHEM, V280, P29708, DOI 10.1074/jbc.M414215200; Zhu SJ, 2016, CELL, V165, P704, DOI 10.1016/j.cell.2016.03.028	76	18	18	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0177686	10.1371/journal.pone.0177686	http://dx.doi.org/10.1371/journal.pone.0177686			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582391	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600005
J	Chen, XJ; Oshima, K; Schott, D; Wu, H; Hall, W; Song, YQ; Tao, YL; Li, DJ; Zheng, C; Knechtges, P; Erickson, B; Li, XA				Chen, Xiaojian; Oshima, Kiyoko; Schott, Diane; Wu, Hui; Hall, William; Song, Yingqiu; Tao, Yalan; Li, Dingjie; Zheng, Cheng; Knechtges, Paul; Erickson, Beth; Li, X. Allen			Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study	PLOS ONE			English	Article							BODY RADIATION-THERAPY; COMPUTED-TOMOGRAPHY; NECK-CANCER; TUMORS; DENSITY; CHEMORADIOTHERAPY; RADIOTHERAPY; NUMBER; VOLUME; HEAD	Purpose In an effort for early assessment of treatment response, we investigate radiation induced changes in quantitative CT features of tumor during the delivery of chemoradiation therapy (CRT) for pancreatic cancer. Methods Diagnostic-quality CT data acquired daily during routine CT-guided CRT using a CT-on rails for 20 pancreatic head cancer patients were analyzed. On each daily CT, the pancreatic head, the spinal cord and the aorta were delineated and the histograms of CT number (CTN) in these contours were extracted. Eight histogram-based radiomic metrics including the mean CTN (MCTN), peak position, volume, standard deviation (SD), skewness, kurtosis, energy and entropy were calculated for each fraction. Paired t-test was used to check the significance of the change of specific metric at specific time. GEE model was used to test the association between changes of metrics over time for different pathology responses. Results In general, CTN histogram in the pancreatic head (but not in spinal cord) changed during the CRT delivery. Changes from the 1st to the 26th fraction in MCTN ranged from - 15.8 to 3.9 HU with an average of -4.7 HU (p<0.001). Meanwhile the volume decreased, the skewness increased (less skewed), and the kurtosis decreased (less peaked). The changes of MCTN, volume, skewness, and kurtosis became significant after two weeks of treatment. Patient pathological response is associated with the changes of MCTN, SD, and skewness. In cases of good response, patients tend to have large reductions in MCTN and skewness, and large increases in SD and kurtosis. Conclusions Significant changes in CT radiomic features, such as the MCTN, skewness, and kurtosis in tumor were observed during the course of CRT for pancreas cancer based on quantitative analysis of daily CTs. These changes may be potentially used for early assessment of treatment response and stratification for therapeutic intensification.	[Chen, Xiaojian; Schott, Diane; Wu, Hui; Hall, William; Song, Yingqiu; Tao, Yalan; Li, Dingjie; Erickson, Beth; Li, X. Allen] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Oshima, Kiyoko] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Wu, Hui; Li, Dingjie] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Song, Yingqiu] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Canc, Union Hosp, Wuhan, Peoples R China; [Tao, Yalan] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China; [Zheng, Cheng] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Biostat, Milwaukee, WI USA; [Knechtges, Paul] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Zhengzhou University; Huazhong University of Science & Technology; Sun Yat Sen University; University of Wisconsin System; University of Wisconsin Milwaukee; Medical College of Wisconsin	Li, XA (corresponding author), Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA.	ali@mcw.edu	Oshima, Kiyoko/CAF-1543-2022; Zheng, Cheng/AAJ-8384-2020	Zheng, Cheng/0000-0002-6562-870X; Schott, Diane/0000-0003-4502-5319				Asselin MC, 2012, EUR J CANCER, V48, P447, DOI 10.1016/j.ejca.2011.12.025; Bentzen SM, INT J RAD ONCOLOGY B, V11, P1228; Black DF, 2011, AM J NEURORADIOL, V32, P1354, DOI 10.3174/ajnr.A2504; Boyle J, 2015, J GASTROINTEST ONCOL, V6, P436, DOI 10.3978/j.issn.2078-6891.2015.014; Cao Y, 2008, INT J RADIAT ONCOL, V72, P1287, DOI 10.1016/j.ijrobp.2008.08.024; Charlie CM, 2006, MED DOSIM, V31, P30, DOI 10.1016/j.meddos.2005.12.010; Chen X, 2016, MED PHYS, V43, P3385, DOI 10.1118/1.4955826; Choi JC, 1993, CHANGES CT NUMBER VA; De Ruysscher D, 2013, ACTA ONCOL, V52, P1405, DOI 10.3109/0284186X.2013.813074; Diot Q, 2012, INT J RADIAT ONCOL, V84, P1024, DOI 10.1016/j.ijrobp.2011.11.080; Feng M, 2015, INT J RADIAT ONCOL, V91, P1041, DOI 10.1016/j.ijrobp.2014.12.057; Fike JR, 1980, AMERICAN JOURNAL OF, V42, P275; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Hammel P, 2016, JAMA-J AM MED ASSOC, V315, P1844, DOI 10.1001/jama.2016.4324; Herfarth KK, 2003, INT J RADIAT ONCOL, V57, P444, DOI 10.1016/S0360-3016(03)00586-8; Howells CC, 2012, INT J RADIAT ONCOL, V84, pE441, DOI 10.1016/j.ijrobp.2012.04.041; HUSBAND JE, 1982, RADIOLOGY, V144, P553, DOI 10.1148/radiology.144.3.7100471; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Li XA, 2011, IMAG MED DIAGN THER, P1; Mayer R, 1998, Radiat Oncol Investig, V6, P281; Parekh V, 2016, EXPERT REV PRECIS ME, V1, P207, DOI 10.1080/23808993.2016.1164013; Ryan R, 2005, HISTOPATHOLOGY, V47, P141, DOI 10.1111/j.1365-2559.2005.02176.x; SWANKBORDEWIJK SCG, 1984, INT J RADIAT ONCOL, V10, P659, DOI 10.1016/0360-3016(84)90297-9; Thalacker U, 1998, STRAHLENTHER ONKOL, V174, P14, DOI 10.1007/BF03038222; Wang M., 2014, ADV STAT, V2014	25	44	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178961	10.1371/journal.pone.0178961	http://dx.doi.org/10.1371/journal.pone.0178961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575105	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300134
J	Dierick, F; Dehas, M; Isambert, JL; Injeyan, S; Bouche, AF; Bleyenheuft, Y; Portnoy, S				Dierick, Frederic; Dehas, Melanie; Isambert, Jean-Luc; Injeyan, Soizic; Bouche, Anne-France; Bleyenheuft, Yannick; Portnoy, Sigal			Hemorrhagic versus ischemic stroke: Who can best benefit from blended conventional physiotherapy with robotic-assisted gait therapy?	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; FUNCTIONAL RECOVERY; POSTURAL CONTROL; REHABILITATION; BALANCE; LOKOMAT; SCALE; CLASSIFICATION; HEMIPARESIS; INFARCTION	Background Contrary to common belief of clinicians that hemorrhagic stroke survivors have better functional prognoses than ischemic, recent studies show that ischemic survivors could experience similar or even better functional improvements. However, the influence of stroke subtype on gait and posture outcomes following an intervention blending conventional physiotherapy with robotic-assisted gait therapy is missing. Objective This study compared gait and posture outcome measures between ambulatory hemorrhagic patients and ischemic patients, who received a similar 4 weeks' intervention blending a conventional bottom-up physiotherapy approach and an exoskeleton top-down robotic-assisted gait training (RAGT) approach with Lokomat. Methods Forty adult hemiparetic stroke inpatient subjects were recruited: 20 hemorrhagic and 20 ischemic, matched by age, gender, side of hemisphere lesion, stroke severity, and locomotor impairments. Functional Ambulation Category, Postural Assessment Scale for Stroke, Tinetti Performance Oriented Mobility Assessment, 6 Minutes Walk Test, Timed Up and Go and 10-Meter Walk Test were performed before and after a 4-week long intervention. Functional gains were calculated for all tests. Results Hemorrhagic and ischemic subjects showed significant improvements in Functional Ambulation Category (P<0.001 and P = 0.008, respectively), Postural Assessment Scale for Stroke (P<0.001 and P = 0.003), 6 Minutes Walk Test (P = 0.003 and P = 0.015) and 10 Meter Walk Test (P = 0.001 and P = 0.024). lschemic patients also showed significant improvements in Timed Up and Go. Significantly greater mean Functional Ambulation Category and Tinetti Performance Oriented Mobility Assessment gains were observed for hemorrhagic compared to ischemic, with large (dz = 0.81) and medium (dz = 0.66) effect sizes, respectively. Conclusion Overall, both groups exhibited quasi similar functional improvements and benefits from the same type, length and frequency of blended conventional physiotherapy and RAGT protocol. The use of intensive treatment plans blending top p-down physiotherapy and bottom-up robotic approaches is promising for post-stroke rehabilitation.	[Dierick, Frederic; Dehas, Melanie; Bouche, Anne-France] Haute Ecole Louvain Hainaut, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Montignies Sur Sambre, Belgium; [Dierick, Frederic] Catholic Univ Louvain, Fac Motor Sci, Louvain La Neuve, Belgium; [Isambert, Jean-Luc; Injeyan, Soizic] Le Normandy Rehabil Ctr, Granville, OH, France; [Bouche, Anne-France] Rehabil Unit Le Richemont, Bioul, Belgium; [Bleyenheuft, Yannick] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Portnoy, Sigal] Tel Aviv Univ, Sackler Sch Med, Dept Occupat Therapy, Tel Aviv, Israel	Universite Catholique Louvain; Universite Catholique Louvain; Tel Aviv University; Sackler Faculty of Medicine	Dierick, F (corresponding author), Haute Ecole Louvain Hainaut, Dept Phys Therapy, Forme & Fonctionnement Humain Res Unit, Montignies Sur Sambre, Belgium.; Dierick, F (corresponding author), Catholic Univ Louvain, Fac Motor Sci, Louvain La Neuve, Belgium.	frederic.dierick@gmail.com	sahely, ahmad/R-6293-2017; Bleyenheuft, Yannick/ABA-1472-2021	Bleyenheuft, Yannick/0000-0002-6688-932X; Dierick, Frederic/0000-0003-2061-0968				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bang DH, 2016, NEUROREHABILITATION, V38, P343, DOI 10.3233/NRE-161325; Belda-Lois JM, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-66; Benaim C, 1999, STROKE, V30, P1862, DOI 10.1161/01.STR.30.9.1862; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Bowden MG, 2013, CURR OPIN NEUROL, V26, P37, DOI 10.1097/WCO.0b013e32835c5ba0; Bragoni Maura, 2013, Am J Phys Med Rehabil, V92, pe16, DOI 10.1097/PHM.0b013e3182a20a34; Chae J, 1996, AM J PHYS MED REHAB, V75, P177, DOI 10.1097/00002060-199605000-00004; Chisari C, 2015, EUR J PHYS REHAB MED, V51, P59; Chiu D, 2010, J STROKE CEREBROVASC, V19, P225, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.002; Cho DY, 2015, J PHYS THER SCI, V27, P3053, DOI 10.1589/jpts.27.3053; Conesa L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-13; Dias D, 2007, Eura Medicophys, V43, P499; Dobkin BH, 2004, LANCET NEUROL, V3, P528, DOI 10.1016/S1474-4422(04)00851-8; Enright Paul L, 2003, Respir Care, V48, P783; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Gama GL, 2017, TOP STROKE REHABIL, V24, P388, DOI 10.1080/10749357.2017.1304865; Geroin C, 2013, J REHABIL MED, V45, P987, DOI 10.2340/16501977-1234; Goto A, 2009, J STROKE CEREBROVASC, V18, P60, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.003; Graham JV, 2009, TOP STROKE REHABIL, V16, P57, DOI 10.1310/tsr1601-57; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hillis Argye E, 2014, Adv Med, V2014; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Iosa M, 2011, J REHABIL RES DEV, V48, P135, DOI 10.1682/JRRD.2010.04.0069; JORGENSEN HS, 1995, ANN NEUROL, V38, P45, DOI 10.1002/ana.410380110; Katrak PH, 2009, PM&R, V1, P427, DOI 10.1016/j.pmrj.2009.03.002; Kelley CP, 2013, DISABIL REHABIL-ASSI, V8, P161, DOI 10.3109/17483107.2012.714052; Kelly PJ, 2003, ARCH PHYS MED REHAB, V84, P968, DOI 10.1016/S0003-9993(03)00040-6; Kim JY, 2017, J STROKE, V19, P28, DOI 10.5853/jos.2016.01935; Knaepen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140626; Koh GCH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003483; Kugler C, 2003, J NEUROL, V250, P676, DOI 10.1007/s00415-003-1054-8; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Laufer Y, 2003, NEUROREHAB NEURAL RE, V17, P207, DOI 10.1177/0888439003259169; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lombardi R, 2001, Technol Health Care, V9, P403; LUNDGREN J, 1982, SCAND J REHABIL MED, V14, P141; MAHONEY F I, 1965, Md State Med J, V14, P61; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; Masiero S, 2014, EXPERT REV MED DEVIC, V11, P187, DOI 10.1586/17434440.2014.882766; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Mehrholz J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub3; Mehrholz J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002840.pub3; Mehrholz J, 2012, J REHABIL MED, V44, P193, DOI 10.2340/16501977-0943; Mestriner RG, 2011, EXP NEUROL, V227, P53, DOI 10.1016/j.expneurol.2010.09.009; Morone G, 2012, STROKE, V43, P1140, DOI 10.1161/STROKEAHA.111.638148; Morone G, 2011, NEUROREHAB NEURAL RE, V25, P636, DOI 10.1177/1545968311401034; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Obembe AO, 2012, J MED MED SCI, V3, P556; Paolucci S, 2003, STROKE, V34, P2861, DOI 10.1161/01.STR.0000102902.39759.D3; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Perna R, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/891651; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Peurala SH, 2004, J NEUROL, V251, P449, DOI 10.1007/s00415-004-0352-0; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Poli P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/153872; Pollock A, 2007, CLIN REHABIL, V21, P395, DOI 10.1177/0269215507073438; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Roth DL, 2011, STROKE, V42, P626, DOI 10.1161/STROKEAHA.110.595322; Schepers VPM, 2008, J REHABIL MED, V40, P487, DOI 10.2340/16501977-0198; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Taveggia G, 2016, INT J REHABIL RES, V39, P29, DOI 10.1097/MRR.0000000000000137; Ucar DE, 2014, NEUROREHABILITATION, V34, P447, DOI 10.3233/NRE-141054; Vaughan-Graham J, 2015, DISABIL REHABIL, V37, P1793, DOI 10.3109/09638288.2014.985802; Veerbeek JM, 2011, STROKE, V42, P3311, DOI 10.1161/STROKEAHA.111.623819; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Ween JE, 1996, NEUROLOGY, V47, P388, DOI 10.1212/WNL.47.2.388; Werner C, 2002, EUR J NEUROL, V9, P639, DOI 10.1046/j.1468-1331.2002.00492.x; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; WHO, 2001, WHO INT CLASS FUNCT; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Yoshikawa K, 2017, NEUROREHABILITATION, V40, P87, DOI 10.3233/NRE-161393	83	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178636	10.1371/journal.pone.0178636	http://dx.doi.org/10.1371/journal.pone.0178636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575054	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300084
J	Klotter, V; Gunchick, C; Siemers, E; Rath, T; Hudel, H; Naehrlich, L; Roderfeld, M; Roeb, E				Klotter, Victoria; Gunchick, Caroline; Siemers, Enno; Rath, Timo; Hudel, Helge; Naehrlich, Lutz; Roderfeld, Martin; Roeb, Elke			Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study	PLOS ONE			English	Article							CYSTIC-FIBROSIS; TRANSIENT ELASTOGRAPHY; FOLLOW-UP; DISEASE; MANAGEMENT	About 30% of patients with Cystic Fibrosis (CF) develop CF-associated liver disease (CFLD). Recent studies have shown that transient elastography (TE), as a method to quantify liver stiffness, allows non-invasive diagnosis of CFLD in adults and children with CF. Within this study we aimed to prospectively identify patients at risk for development of CFLD by longitudinal analysis of liver stiffness and fibrosis scores in a 5-year follow-up. 36 pediatric and 16 adult patients with initial liver stiffness below the cut-off value indicative of CFLD (6.3 kPa) were examined by transient elastography for 4-5 years. TE, APRI-, and FIB-4scores were assessed and compared by Kruskal-Wallis test and receiver operating characteristic (ROC)-analysis. Frequencies were compared by Chi 2-test. Among the 36 patients participating in this study, a subgroup of 9 patients developed liver stiffness >6.3 kPa after 4-5 years with an increase of.TE >0.38 kPa/a (the group with increasing liver stiffness was labelled TEinc). APRI-and FIB-4 scores confirmed the rationale for grouping. The frequency of CFLD assessed by conventional diagnosis was significantly higher in TEinc-group compared to the control group (TEnorm). None of the adult CF patients matched criteria for TEincgroup. For the first time it was shown that the non-invasive longitudinal assessment of TE allows identification of patients with progression of CFLD in a subgroup of juvenile but not in adult CF patients. Comparing TE to conventional fibrosis-scores underlined the strength of the continuous assessment of liver stiffness for the exact diagnosis of progressive CFLD. The newly described cut-off for pathologic increase of liver stiffness,triangle TEcutoff = 0.38kPa/a, might enable to detect developing CFLD using consequent follow up TE measurements before reaching the level of stiffness indicating established CFLD. Nevertheless, the limited size of the analyzed cohort should encourage a prospective, multi-center, long term follow up study to confirm the suggested cut-off for the rise in liver stiffness.	[Klotter, Victoria; Gunchick, Caroline; Siemers, Enno; Roderfeld, Martin; Roeb, Elke] Justus Liebig Univ, Div Gastroenterol, Dept Internal Med, Giessen, Germany; [Rath, Timo] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany; [Hudel, Helge] Justus Liebig Univ, Inst Med Informat, Giessen, Germany; [Naehrlich, Lutz] Justus Liebig Univ, Div Pulmonol, Dept Pediat, Giessen, Germany	Justus Liebig University Giessen; University of Erlangen Nuremberg; Justus Liebig University Giessen; Justus Liebig University Giessen	Roeb, E (corresponding author), Justus Liebig Univ, Div Gastroenterol, Dept Internal Med, Giessen, Germany.	Elke.Roeb@innere.med.uni-giessen.de	, Martin/AHD-5202-2022; Naehrlich, Lutz/F-4574-2015	, Martin/0000-0002-3232-1277; Naehrlich, Lutz/0000-0002-7146-6997	Deutsche Forschungsgemeinschaft [RO957/ 10-1]; University Medical Center Giessen Marburg [UKGM7/2014GI]; Mukoviszidose FoErderverein Giessen; von Behring-Roentgen-Foundation, Marburg, Germany [60-0002]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Medical Center Giessen Marburg; Mukoviszidose FoErderverein Giessen; von Behring-Roentgen-Foundation, Marburg, Germany	This work was supported by grants from the Deutsche Forschungsgemeinschaft (RO957/ 10-1), are search grant from the University Medical Center Giessen & Marburg (UKGM7/2014GI), the Mukoviszidose FoErderverein Giessen, and by a grant from the von Behring-Roentgen-Foundation, Marburg, Germany (60-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colombo C, 2006, J PEDIATR GASTR NUTR, V43, pS49, DOI 10.1097/01.mpg.0000226390.02355.52; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Friedrich-Rust M, 2013, J CYST FIBROS, V12, P431, DOI 10.1016/j.jcf.2012.12.013; Herrmann U, 2010, BEST PRACT RES CL GA, V24, P585, DOI 10.1016/j.bpg.2010.08.003; Karlas T, 2013, J CYST FIBROS, V12, P826, DOI 10.1016/j.jcf.2013.04.004; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kitson MT, 2013, LIVER INT, V33, P698, DOI 10.1111/liv.12113; Knapp EA, 2016, ANN AM THORAC SOC, V13, P1173, DOI 10.1513/AnnalsATS.201511-781OC; Leung DH, 2015, HEPATOLOGY, V62, P1576, DOI 10.1002/hep.28016; Nash KL, 2008, J CYST FIBROS, V7, P252, DOI 10.1016/j.jcf.2007.10.004; Rath T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115847; Rath T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058955; Rath T, 2012, DIGEST LIVER DIS, V44, P780, DOI 10.1016/j.dld.2012.04.008; Roderfeld M, 2009, J CYST FIBROS, V8, P338, DOI 10.1016/j.jcf.2009.06.001; Sokol RJ, 1999, J PEDIATR GASTR NUTR, V28, pS1, DOI 10.1097/00005176-199900001-00001; Van Biervliet S, 2016, ULTRASOUND MED BIOL, V42, P848, DOI 10.1016/j.ultrasmedbio.2015.11.011	17	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178784	10.1371/journal.pone.0178784	http://dx.doi.org/10.1371/journal.pone.0178784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575039	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300115
J	Liu, X; Liu, YY; Li, XH; Zhao, J; Geng, Y; Ning, W				Liu, Xue; Liu, Yingying; Li, Xiaohe; Zhao, Jing; Geng, Yan; Ning, Wen			Follistatin like-1 (FstI1) is required for the normal formation of lung airway and vascular smooth muscle at birth	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DEPENDENT MECHANISM; FGF10 EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; TRANSCRIPTION; PROGENITORS; MYOCARDIN; EMBRYOS; MIDKINE	Fst11, a secreted protein of the BMP antagonist class, has been implicated in the regulation of lung development and alveolar maturation. Here we generated a Fst11-lacZ reporter mouse line as well as a Fstll knockout allele. We localized Fstll transcript in lung smooth muscle cells and identified Fstll as essential regulator of lung smooth muscle formation. Deletion of Fstll in mice led to postnatal death as a result of respiratory failure due to multiple defects in lung development. Analysis of the mutant phenotype showed impaired airway smooth muscle (SM) manifested as smaller SM line in trachea and discontinued SM surrounding bronchi, which were associated with decreased transcriptional factors myocardin/ serum response factor (SRF) and impaired differentiation of SM cells. Fstll knockout mice also displayed abnormal vasculature SM manifested as hyperplasia SM in pulmonary artery. This study indicates a pivotal role for Fstll in early stage of lung airway smooth muscle development.	[Liu, Xue; Liu, Yingying; Li, Xiaohe; Ning, Wen] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Zhao, Jing; Geng, Yan] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [Geng, Yan] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi, Jiangsu, Peoples R China	Nankai University; Nanjing University; Jiangnan University	Ning, W (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	ningwen108@nankai.edu.cn	LIU, YING/GZL-7252-2022; zhao, jing/B-3868-2019; Liu, Xue/ABC-1127-2021; Geng, Yan/ABH-7789-2022	Liu, Xue/0000-0002-2104-9335; Geng, Yan/0000-0001-8861-7686	National Natural Science Foundation of China [31471373, 31271559, 31071241]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grants 31471373, 31271559, 31071241. The receiver of the funding was WN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2007, GENE EXPR PATTERNS, V7, P491, DOI 10.1016/j.modgep.2006.10.009; Adams DC, 2010, AM J PHYSIOL-RENAL, V299, pF1320, DOI 10.1152/ajprenal.00325.2010; Badri Kameswara Rao, 2008, Proc Am Thorac Soc, V5, P4, DOI 10.1513/pats.200704-049VS; Chaly Y, 2014, IMMUNOL RES, V59, P266, DOI 10.1007/s12026-014-8526-z; Chan QKY, 2009, CARCINOGENESIS, V30, P114, DOI 10.1093/carcin/bgn215; Dong YY, 2015, J EXP MED, V212, P235, DOI 10.1084/jem.20121878; Gabella G, 2002, RES PRO CEL, V38, P1; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Geng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054959; Goss AM, 2011, DEV BIOL, V356, P541, DOI 10.1016/j.ydbio.2011.06.011; Herrmann J, 2007, BBA-MOL BASIS DIS, V1772, P1250, DOI 10.1016/j.bbadis.2007.10.006; Hines EA, 2013, P NATL ACAD SCI USA, V110, P19444, DOI 10.1073/pnas.1313223110; Javerzat S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007856; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Li L, 2013, BIOSCI TRENDS, V7, P93, DOI 10.5582/bst.2013.v7.2.93; Liu S, 2006, EXP MOL PATHOL, V80, P132, DOI 10.1016/j.yexmp.2005.07.005; Liu S, 2010, AM J PHYSIOL-ENDOC M, V299, pE351, DOI 10.1152/ajpendo.00005.2010; Liu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26689; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Mailleux AA, 2005, DEVELOPMENT, V132, P2157, DOI 10.1242/dev.01795; McCulley D, 2015, CURR OPIN GENET DEV, V32, P98, DOI 10.1016/j.gde.2015.01.011; Miano JM, 2002, RES PRO CEL, V38, P39; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murakami K, 2012, FEBS LETT, V586, P319, DOI 10.1016/j.febslet.2012.01.010; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Reynolds PR, 2004, J BIOL CHEM, V279, P37124, DOI 10.1074/jbc.M405254200; Reynolds PR, 2003, DEV DYNAM, V227, P227, DOI 10.1002/dvdy.10304; ROMAN J, 1992, AM J RESP CELL MOL, V6, P472, DOI 10.1165/ajrcmb/6.5.472; Shannon JM, 2004, ANNU REV PHYSIOL, V66, P625, DOI 10.1146/annurev.physiol.66.032102.135749; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Singhal PK, 2016, P NATL ACAD SCI USA, V113, P122, DOI 10.1073/pnas.1522401112; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Sylva M, 2013, BIRTH DEFECTS RES C, V99, P61, DOI 10.1002/bdrc.21030; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Turcatel G, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-117; Wang N, 2012, IUBMB LIFE, V64, P331, DOI 10.1002/iub.1003; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Xu JY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032554, 10.1371/journal.pone.0038665]; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhou XY, 2016, ONCOTARGET, V7, P16433, DOI 10.18632/oncotarget.7654	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177899	10.1371/journal.pone.0177899	http://dx.doi.org/10.1371/journal.pone.0177899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574994	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300021
J	Mabidi, A; Bird, MS; Perissinotto, R				Mabidi, Annah; Bird, Matthew S.; Perissinotto, Renzo			Distribution and diversity of aquatic macroinvertebrate assemblages in a semiarid region earmarked for shale gas exploration (Eastern Cape Karoo, South Africa)	PLOS ONE			English	Article							COMMUNITY STRUCTURE; WATER-QUALITY; INVERTEBRATE COMMUNITIES; CONSERVATION STATUS; LARGE BRANCHIOPODS; CLIMATE-CHANGE; CHLOROPHYLL-A; WESTERN CAPE; TEMPORARY; PONDS	This study aims to investigate macroinvertebrate assemblage structure and composition across the three major waterbody types (temporary rivers, depression wetlands and semipermanent dams) of the Eastern Cape Karoo, and to identify important environmental and spatial correlates of macroinvertebrate assemblage composition in the region. A total of 33 waterbodies (9 dams, 13 depression wetlands and 11 rivers) were sampled. Altogether, 91 taxa were recorded in November 2014 and 82 in April 2015. Twenty-seven taxa were common to all three waterbody types (across both sampling occasions), with 17 of these observed in November and 19 in April. The ANOSIM tests revealed significant differences in assemblage composition between the depression wetlands and rivers for both sampling occasions, but dams did not differ from the other waterbody types. SIMPER analyses indicated that the notonectid Anisops varia and the corixid Micronecta scutellaris were abundant across all three waterbody types during both sampling occasions. The mayfly Cloeon africanum and the damselfly Pseudagrion sp. were abundant in river habitats during both sampling occasions, while the gastropod mollusc Bulinus tropicus and the copepod Lovenula falcifera best characterised depression wetlands on both occasions. Non-metric multidimensional scaling ordination highlighted a clear separation of assemblages between November and April, while distance-based Redundancy Analysis revealed that conductivity, altitude, turbidity and pH were the most important variables explaining the variation in macroinvertebrate assemblage patterns. These results provide baseline information which is important for future biological monitoring of impacts associated with hydraulic fracturing activities and climatic changes in the region.	[Mabidi, Annah; Bird, Matthew S.; Perissinotto, Renzo] Nelson Mandela Metropolitan Univ, DST NRF Res Chair Shallow Water Ecosyst, Port Elizabeth, South Africa; [Mabidi, Annah] Nelson Mandela Metropolitan Univ, Africa Earth Observ Network, Port Elizabeth, South Africa	Nelson Mandela University; National Research Foundation - South Africa; Nelson Mandela University	Mabidi, A (corresponding author), Nelson Mandela Metropolitan Univ, DST NRF Res Chair Shallow Water Ecosyst, Port Elizabeth, South Africa.; Mabidi, A (corresponding author), Nelson Mandela Metropolitan Univ, Africa Earth Observ Network, Port Elizabeth, South Africa.	annahanusa@gmail.com	Bird, Matthew/AAB-5127-2020; Mabidi, Annah/AAK-6167-2021	Bird, Matthew/0000-0001-9163-1008; Mabidi, Annah/0000-0001-7899-7056	South African Department of Science and Technology through the National Research Foundation (DST/NRF) as part of the South African Research Chairs Initiative (SARChI) [84375]; Eastern Cape Department of Economic Affairs; Environmental Affairs and Tourism (Cacadu Region); South African National Parks; AGRI Eastern Cape	South African Department of Science and Technology through the National Research Foundation (DST/NRF) as part of the South African Research Chairs Initiative (SARChI); Eastern Cape Department of Economic Affairs; Environmental Affairs and Tourism (Cacadu Region); South African National Parks; AGRI Eastern Cape	This project was funded by the South African Department of Science and Technology through the National Research Foundation (DST/NRF) as part of the South African Research Chairs Initiative (SARChI), Unique Grant Number 84375.; We are grateful to the Eastern Cape Department of Economic Affairs, Environmental Affairs and Tourism (Cacadu Region), South African National Parks and AGRI Eastern Cape for granting permits and supporting this research project. In particular, we thank the various farmers involved for granting permission to work on their property. We thank the staff and management at Mountain Zebra National Park for their logistical support and cooperation. Special thanks go to Bradley Ah Yui, Daniel Lemley, Jacqueline Raw, Liza Rishworth, Lynette Clennell, Natasha Roussouw, Nicholas Galuszynski, Nuette Gordon, Shayla Tricam and Sourav Paul for their assistance during field trips and laboratory analysis of samples. We acknowledge Yanasivan Kisten for assistance in manuscript preparation. This paper benefitted greatly from insightful comments and suggestions from two anonymous reviewers.	Allanson B.R., 1990, INLAND WATERS SO AFR; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Angeler DG, 2000, J PLANKTON RES, V22, P2075, DOI 10.1093/plankt/22.11.2075; [Anonymous], 2006, BIOL TEMPORARY WATER; Apinda-Legnouo EA, 2013, AQUAT CONSERV, V24, P525; ASSAf, 2016, S AFR TECHN READ SUP; Barbour MT, 1996, J N AM BENTHOL SOC, V15, P386, DOI 10.2307/1467285; BATE GC, 1975, J APPL ECOL, V12, P941, DOI 10.2307/2402100; Beauchard O, 2003, J BIOGEOGR, V30, P1821, DOI 10.1111/j.1365-2699.2003.00954.x; Bird MS, 2016, HYDROBIOLOGIA, V782, P169, DOI 10.1007/s10750-016-2804-9; Bird MS, 2013, HYDROBIOLOGIA, V720, P19, DOI 10.1007/s10750-013-1618-2; Blettler MCM, 2016, INT J ENVIRON RES, V10, P65; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Boix D, 2005, AQUAT CONSERV, V15, P635, DOI 10.1002/aqc.750; Boven L, 2009, FUND APPL LIMNOL, V174, P147, DOI 10.1127/1863-9135/2009/0174-0147; Brendonck L, 2008, HYDROBIOLOGIA, V595, P167, DOI 10.1007/s10750-007-9119-9; Brock MA, 2005, FRESHWATER BIOL, V50, P1376, DOI 10.1111/j.1365-2427.2005.01408.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cherry J, 2014, ENV IMPACTS SHALE GA; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CORNELL HV, 1992, J ANIM ECOL, V61, P1, DOI 10.2307/5503; Dallas HF, 2014, S AFR J SCI, V110, DOI 10.1590/sajs.2014/20130274; Darwall W. R. T., 2011, DIVERSITY LIFE AFRIC; Davies BR, 1995, RIVER STREAM ECOSYST, V22, P537; Day, 2002, 18202 WRC TT, V6; Day J, 2010, 43409 WRC TT, P129; Day J., 2001, 14801 WRC TT; Day J., 2001, 14101 WRC TT; Day J. A, 2002, 16702 WRC TT, V5; Day JA, 1999, 12100 WRC TT, V2; Day JA, 2003, 20102 WRC TT, V9; De Meester L, 2005, AQUAT CONSERV, V15, P715, DOI 10.1002/aqc.748; De Moor I. J., 2003, 21403 WRC TT, V8; de Moor I.J, 2003, 20703 WRC TT, V7; De Roeck ER, 2007, WETLANDS, V27, P162, DOI 10.1672/0277-5212(2007)27[162:CSOLBI]2.0.CO;2; Dean WRJ, 1999, ECOLOGICAL PATTERNS; Della Bella V, 2005, AQUAT CONSERV, V15, P583, DOI 10.1002/aqc.743; Desmet P.G., 1999, KAROO ECOLOGICAL PAT, P3; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Eaton AD., 2005, STANDARD METHODS EXA, P21; Econometrix, 2012, KAR SHAL GAS REP SPE; EPA U.S., 2011, PLAN STUD POT IMP HY; Estlander S, 2009, HYDROBIOLOGIA, V620, P109, DOI 10.1007/s10750-008-9621-8; Feld CK, 2007, FRESHWATER BIOL, V52, P1380, DOI 10.1111/j.1365-2427.2007.01749.x; FELDMAN RS, 1992, FRESHWATER BIOL, V27, P261, DOI 10.1111/j.1365-2427.1992.tb00538.x; Fossati O, 2001, ARCH HYDROBIOL, V151, P33; Gaston KJ, 1996, OIKOS, V76, P211, DOI 10.2307/3546192; Geel C, 2013, ENRGY PROCED, V40, P256, DOI 10.1016/j.egypro.2013.08.030; Gotelli N., 2013, ENCY BIODIVERSITY, V5, P195, DOI DOI 10.1016/B978-0-12-384719-5.00424-X; HAMER ML, 1991, HYDROBIOLOGIA, V212, P105, DOI 10.1007/BF00025993; HART RC, 1986, FRESHWATER BIOL, V16, P351, DOI 10.1111/j.1365-2427.1986.tb00976.x; Henri AJ, 2014, HYDROBIOLOGIA, V738, P35, DOI 10.1007/s10750-014-1913-6; Henriques-Oliveira AL, 2010, BIOTA NEOTROP, V10, P115, DOI 10.1590/S1676-06032010000300012; Hill MJ, 2017, HYDROBIOLOGIA, V793, P95, DOI 10.1007/s10750-016-2856-x; Hill MJ, 2017, GLOBAL CHANGE BIOL, V23, P986, DOI 10.1111/gcb.13401; Hodkinson ID, 2005, ENVIRON MANAGE, V35, P649, DOI 10.1007/s00267-004-0211-x; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Jun YC, 2016, WATER-SUI, V8, DOI 10.3390/w8010027; King RS, 2002, J N AM BENTHOL SOC, V21, P150, DOI 10.2307/1468306; Laursen SK, 2015, INLAND WATERS, V5, P263, DOI 10.5268/IW-5.3.818; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lougheed VL, 1998, CAN J FISH AQUAT SCI, V55, P1189, DOI 10.1139/cjfas-55-5-1189; Mabidi A, 2017, MARINE FRESHWATER RE; Mabidi A, 2016, ZOOKEYS, P15, DOI 10.3897/zookeys.618.9212; Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McBroom M, 2012, WATER-SUI, V4, P944, DOI 10.3390/w4040944; MEINTJES S, 1994, HYDROBIOLOGIA, V281, P79, DOI 10.1007/BF00006437; Mhlanga Lindah, 2006, African Journal of Aquatic Science, V31, P271, DOI 10.2989/16085910609503896; Miserendino ML, 2003, NEW ZEAL J MAR FRESH, V37, P525, DOI 10.1080/00288330.2003.9517187; Mlambo MC, 2011, AFR J AQUAT SCI, V36, P299, DOI 10.2989/16085914.2011.636903; Mucina L., 2006, VEGETATION S AFRICA, P324; Nhiwatiwa T, 2009, HYDROBIOLOGIA, V630, P169, DOI 10.1007/s10750-009-9790-0; Nielsen DL, 2009, CLIMATIC CHANGE, V95, P523, DOI 10.1007/s10584-009-9564-8; Ollis DJ, 2015, WATER SA, V41, P727, DOI [10.4314/wsa.v41i5.16, 10.4314/WSA.V41I5.16]; Panov Vadim E., 2007, Monographiae Biologicae, V84, P187; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Perez-Bilbao A, 2015, ASSESSMENT EFFECTS D, V74; Porst G, 2012, HYDROBIOLOGIA, V696, P47, DOI 10.1007/s10750-012-1181-2; Riato L, 2014, AFR ZOOL, V49, P113, DOI 10.3377/004.049.0113; ROSEMOND AD, 1992, FRESHWATER BIOL, V27, P193, DOI 10.1111/j.1365-2427.1992.tb00533.x; Rundle SD, 2002, FRESHWATER BIOL, V47, P1571, DOI 10.1046/j.1365-2427.2002.00886.x; SAMWAYS MJ, 1989, BIOL CONSERV, V48, P181, DOI 10.1016/0006-3207(89)90117-1; Sanderson RA, 2005, ECOGRAPHY, V28, P355, DOI 10.1111/j.0906-7590.2005.04093.x; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; Schulze R. E., 1997, P21; Schulze R.E., 1997, TT8296 WRC; Sciullo L, 2012, COMMUNITY ECOL, V13, P203, DOI 10.1556/ComEc.13.2012.2.10; Simaika JP, 2016, BIODIVERS CONSERV, V25, P1921, DOI 10.1007/s10531-016-1168-9; Sovell LA, 1999, J N AM BENTHOL SOC, V18, P420, DOI 10.2307/1468455; Stals R., 2007, 32007 WRC TT, V10; Temunovic Martina, 2007, ENTOMOLOGIA CROATICA, V11, P13; Trigal C, 2009, HYDROBIOLOGIA, V618, P109, DOI 10.1007/s10750-008-9569-8; Tucker AR, 2015, SCI ENG ETHICS, V21, P631, DOI 10.1007/s11948-014-9563-7; Uys AC, 1997, THESIS; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Vanschoenwinkel B, 2009, FRESHWATER BIOL, V54, P1487, DOI 10.1111/j.1365-2427.2009.02198.x; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Vieira A.C.B., 2009, Acta Limnologica Brasiliensia, V21, P349; Vinson MR, 1996, J N AM BENTHOL SOC, V15, P392, DOI 10.2307/1467286; Wantzen KM, 2006, AQUAT CONSERV, V16, P733, DOI 10.1002/aqc.813; Waterkeyn A, 2008, FRESHWATER BIOL, V53, P1808, DOI 10.1111/j.1365-2427.2008.02005.x; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Yule CM, 2010, MAR FRESHWATER RES, V61, P204, DOI 10.1071/MF09065; Zedler PH, 2003, WETLANDS, V23, P597, DOI 10.1672/0277-5212(2003)023[0597:VPATCO]2.0.CO;2	110	25	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178559	10.1371/journal.pone.0178559	http://dx.doi.org/10.1371/journal.pone.0178559			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575059	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300064
J	Stoll, A; Harpke, D; Schutte, C; Stefanczyk, N; Brandt, R; Blattner, FR; Quandt, D				Stoll, Alexandra; Harpke, Doerte; Schuette, Claudia; Stefanczyk, Nadine; Brandt, Ronny; Blattner, Frank R.; Quandt, Dietmar			Development of microsatellite markers and assembly of the plastid genome in Cistanthe longiscapa (Montiaceae) based on low coverage whole genome sequencing	PLOS ONE			English	Article							WESTERN AMERICAN PORTULACACEAE; DNA EVIDENCE; SOFTWARE; PLANTS; L.	Cistanthe longiscapa is an endemic annual herb and characteristic element of the Chilean Atacama Desert. Principal threats are the destruction of its seed deposits by human activities and reduced germination rates due to the decreasing occurrence of precipitation events. To enable population genetic and phylogeographic analyses in this species we performed paired-end shotgun sequencing (2x100 bp) of genomic DNA on the Illumina HiSeq platform and identified microsatellite (SSR) loci in the resulting sequences. From 29 million quality-filtered read pairs we obtained 549,174 contigs (average length 614 bp; N50 = 904). Searching for SSRs revealed 10,336 loci with microsatellite motifs. Initially, we designed primers for 96 loci, which were tested for PCR amplification on three C. longiscapa individuals. Successfully amplifying loci were further tested on eight individuals to screen for length variation in the resulting amplicons, and the alleles were exemplarily sequenced to infer the basis for the observed length variation. Finally we arrived at 26 validated SSR loci for population studies in C. longiscapa, which resulted in 146 bi-allelic SSR markers in our test sample of eight individuals. The genomic sequences were also used to assemble the plastid genome of C. longiscapa, which provides an additional set of maternally inherited genetic markers.	[Stoll, Alexandra] Univ La Serena, CEAZA, La Serena, Chile; [Stoll, Alexandra; Schuette, Claudia; Stefanczyk, Nadine; Quandt, Dietmar] Univ Bonn, Nees Inst Biodivers Plants, Bonn, Germany; [Harpke, Doerte; Brandt, Ronny; Blattner, Frank R.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Blattner, Frank R.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Universidad de La Serena; University of Bonn; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Stoll, A (corresponding author), Univ La Serena, CEAZA, La Serena, Chile.; Stoll, A (corresponding author), Univ Bonn, Nees Inst Biodivers Plants, Bonn, Germany.	alexandra.stoll@ceaza.cl	Blattner, Frank/G-7402-2014; Quandt, Dietmar/F-1821-2010; Harpke, Doerte/AAN-9739-2021; Stoll, Alexandra/ABD-4733-2021	Blattner, Frank/0000-0001-7731-7741; Quandt, Dietmar/0000-0003-4304-6028; Stoll, Alexandra/0000-0001-6115-1628; Harpke, Dorte/0000-0003-1667-2912	Fondecyt Regular grant [1131089]	Fondecyt Regular grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by a Fondecyt Regular grant 1131089 (http://www.conicyt.cl/fondecyt/) to AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sandra DrieBlein, Petra Oswald and Susanne Konig for expert technical help in the lab. Funding for this work by a Fondecyt Regular grant (1131089) to AS is acknowledged.	[Anonymous], 2010, FASTQC QUALITY CONTR; Applequist WL, 2001, SYST BOT, V26, P406; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Cota-Sanchez JH, 2006, PLANT MOL BIOL REP, V24, P161, DOI 10.1007/BF02914055; Fischer D, 1998, BIOTECHNIQUES, V24, P796, DOI 10.2144/98245st03; Garza JC, 1996, GENOME RES, V6, P211, DOI 10.1101/gr.6.3.211; Hershkovitz MA, 2000, MOL PHYLOGENET EVOL, V15, P419, DOI 10.1006/mpev.1999.0720; Hershkovitz Mark A, 2006, Gayana Bot., V63, P13; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jansen R.K., 1992, PLANT MOL EVOLUTION, V2, P13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Muller K, PHYDE PHYLOGENETIC D; Nyffeler R, 2010, TAXON, V59, P227, DOI 10.1002/tax.591021; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pleines T, 2009, PLANT SYST EVOL, V282, P281, DOI 10.1007/s00606-008-0036-9; Riedemann P., 2006, FLORA NATIVA VALOR O; SQUEO F. A., 2001, LIBRO ROJO FLORA NAT; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang YZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030362; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Zuloaga FO, 2008, MONOGRAPHS SYSTEMATI, V107	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178402	10.1371/journal.pone.0178402	http://dx.doi.org/10.1371/journal.pone.0178402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575007	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300046
J	Venturini, D; de Souza, AR; Caracelli, I; Morgon, NH; da Silva, LC; Ximenes, VF				Venturini, Diego; de Souza, Aguinaldo Robinson; Caracelli, Ignez; Morgon, Nelson Henrique; da Silva-Filho, Luiz Carlos; Ximenes, Valdecir Farias			Induction of axial chirality in divanillin by interaction with bovine serum albumin	PLOS ONE			English	Article							CIRCULAR-DICHROISM; FLUORESCENCE SPECTROSCOPY; GENETIC ALGORITHM; BINDING; VANILLIN; DRUG; CYCLOPHOSPHAMIDE; DIAPOCYNIN; SITES; STATE	Vanillin is a plant secondary metabolite and has numerous beneficial health applications. Divanillin is the homodimer of vanillin and used as a taste enhancer compound and also a promissory anticancer drug. Here, divanillin was synthesized and studied in the context of its interaction with bovine serum albumin (BSA). We found that divanillin acquires axial chirality when complexed with BSA. This chiroptical property was demonstrated by a strong induced circular dichroism (ICD) signal. In agreement with this finding, the association constant between BSA and divanillin (3.3 x 105 mori L) was higher compared to its precursor vanillin (7.3 x 104 mai L). The ICD signal was used for evaluation of the association constant, demonstration of the reversibility of the interaction and determination of the binding site, revealing that divanillin has preference for Sudlow's site I in BSA. This property was confirmed by displacement of the fluorescent markers warfarin (site I) and dansyl-L-proline (site II). Molecular docking simulation confirmed the higher affinity of divanillin to site I. The highest scored conformation obtained by docking (dihedral angle 242) was used for calculation of the circular dichroism spectrum of divanillin using Time -Dependent Density Functional Theory (TDDFT). The theoretical spectrum showed good similarity with the experimental ICD. In summary, we have demonstrated that by interacting with the chiral cavities in BSA, divanillin became a atropos biphenyl, i.e., the free rotation around the single bound that links the aromatic rings was impeded. This phenomenon can be explained considering the interactions of divanillin with amino acid residues in the binding site of the protein. This chiroptical property can be very useful for studying the effects of divanillin in biological systems. Considering the potential pharmacological application of divanillin, these findings will be helpful for researchers interested in the pharmacological properties of this compound.	[Venturini, Diego; de Souza, Aguinaldo Robinson; da Silva-Filho, Luiz Carlos; Ximenes, Valdecir Farias] UNESP Sao Paulo State Univ, Fac Sci, Dept Chem, Sao Paulo, Brazil; [Caracelli, Ignez] Univ Fed Sao Carlos, Dept Phys, BioMat, Sao Carlos, SP, Brazil; [Morgon, Nelson Henrique] Campinas State Univ UNICAMP, Inst Chem, Dept Phys Chem, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Carlos; Universidade Estadual de Campinas	Ximenes, VF (corresponding author), UNESP Sao Paulo State Univ, Fac Sci, Dept Chem, Sao Paulo, Brazil.	vfximenes@fc.unesp.br	Ximenes, Valdecir/A-5323-2008; Morgon, Nelson H/D-9820-2018; Morgon, Nelson/ABF-4226-2021; Caracelli, Ignez/B-9461-2008; de Souza, Aguinaldo Robinson/AAT-7932-2020; UNICAMP, CCES -/J-7787-2015; da Silva-Filho, Luiz Carlos/I-1303-2012	Ximenes, Valdecir/0000-0003-2636-3080; Morgon, Nelson H/0000-0002-8349-8179; Caracelli, Ignez/0000-0003-4945-7485; de Souza, Aguinaldo Robinson/0000-0003-2373-267X; da Silva-Filho, Luiz Carlos/0000-0001-6674-2160	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2016/20594-5, 2015/22338-9, 308480/2016-3, INCT.Bio.Nat 2014/50926-0]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [302793/2016-0, 440503/2014-0]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); GRIDUNESP	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); GRIDUNESP	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants 2016/20594-5, 2015/22338-9, 308480/2016-3 and INCT.Bio.Nat 2014/50926-0), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grants 302793/2016-0 and 440503/2014-0) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and GRIDUNESP.	Abraham MH, 2010, J PHARM SCI-US, V99, P1500, DOI 10.1002/jps.21922; Ahmadi SK, 2015, J BIOMOL STRUCT DYN, V33, P1880, DOI 10.1080/07391102.2014.977351; Amiri M, 2010, J PHARMACEUT BIOMED, V51, P1097, DOI 10.1016/j.jpba.2009.11.011; Azimi O, 2011, MOLECULES, V16, P9792, DOI 10.3390/molecules16129792; Bertucci C, 1999, CHIRALITY, V11, P33, DOI 10.1002/(SICI)1520-636X(1999)11:1<33::AID-CHIR6>3.3.CO;2-L; Bezerra DP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9734816; Bujacz A, 2014, PROTEINS, V82, P2199, DOI 10.1002/prot.24583; Chamani J, 2003, J CHEM THERMODYN, V35, P199, DOI 10.1016/S0021-9614(02)00312-9; Dasari MS, 2008, J CHEM EDUC, V85, P411; De D, 2013, CHEM-ASIAN J, V8, P728, DOI 10.1002/asia.201201060; de Vasconcelos DN, 2015, SPECTROCHIM ACTA A, V150, P321, DOI 10.1016/j.saa.2015.05.089; Dhanalakshmi C, 2016, NEUROCHEM RES, V41, P1899, DOI 10.1007/s11064-016-1901-5; Dranka BP, 2013, NEUROSCI LETT, V549, P57, DOI 10.1016/j.neulet.2013.05.034; Frisch M. J., 1998, GAUSSIAN 98; Gallage NJ, 2015, MOL PLANT, V8, P40, DOI 10.1016/j.molp.2014.11.008; Gawronski J, 2003, ORG LETT, V5, P3301, DOI 10.1021/ol0352456; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Graciani FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076849; Haberhauer G, 2013, EUR J ORG CHEM, V2013, P2325, DOI 10.1002/ejoc.201300087; Ismail HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110708; Jantaree P, 2017, J AGR FOOD CHEMISTRY; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Krings U, 2015, FLAVOUR FRAG J, V30, P362, DOI 10.1002/ffj.3251; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lammers I, 2013, SPECTROCHIM ACTA A, V105, P67, DOI 10.1016/j.saa.2012.12.007; Maciazek-Jurczyk M, 2011, SPECTROCHIM ACTA A, V82, P181, DOI 10.1016/j.saa.2011.07.030; MAES V, 1982, MOL PHARMACOL, V21, P100; Moosavi-Movahedi Z, 2006, PROTEIN J, V25, P193, DOI 10.1007/s10930-006-9002-y; Moosavi-Movahedi Z, 2007, BIOPHYS CHEM, V125, P375, DOI 10.1016/j.bpc.2006.09.013; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Patel S, 2015, SPECTROCHIM ACTA A, V138, P925, DOI 10.1016/j.saa.2014.10.015; Pescitelli G, 2011, CHEM SOC REV, V40, P4603, DOI 10.1039/c1cs15036g; Peters T., 1996, ALL ALBUMIN BIOCH GE; Potje SR, 2017, FREE RADICAL BIO MED, V106, P148, DOI 10.1016/j.freeradbiomed.2017.02.026; Priefert H, 2001, APPL MICROBIOL BIOT, V56, P296, DOI 10.1007/s002530100687; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roy S, 2004, METHOD ENZYMOL, V379, P175; Shahabadi N, 2014, SPECTROCHIM ACTA A, V118, P422, DOI 10.1016/j.saa.2013.08.110; Sharif-Barfeh Z, 2017, J SOLUTION CHEM, V46, P488, DOI 10.1007/s10953-017-0590-2; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; 't Hart BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/298020; Tai A, 2011, BBA-GEN SUBJECTS, V1810, P170, DOI 10.1016/j.bbagen.2010.11.004; Tayyab S, 2016, J PHOTOCH PHOTOBIO B, V162, P386, DOI 10.1016/j.jphotobiol.2016.06.049; Tedesco D, 2015, J PHARMACEUT BIOMED, V113, P34, DOI 10.1016/j.jpba.2015.02.024; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; Varlan A, 2010, MOLECULES, V15, P3905, DOI 10.3390/molecules15063905; Venturini D, 2015, RSC ADV, V5, P62220, DOI 10.1039/c5ra10960d; Virdis A, 2016, VASC PHARMACOL, V87, P1, DOI 10.1016/j.vph.2016.08.006; Wang XR, 2011, FOOD CHEM, V127, P705, DOI 10.1016/j.foodchem.2010.12.128; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Zhivkova ZD, 2015, CURR PHARM DESIGN, V21, P1817, DOI 10.2174/1381612821666150302113710; Zsila F, 2005, J AGR FOOD CHEM, V53, P10179, DOI 10.1021/jf051944g	55	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178597	10.1371/journal.pone.0178597	http://dx.doi.org/10.1371/journal.pone.0178597			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575123	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300068
J	Li, H; Xiao, N; Wang, Y; Wang, R; Chen, Y; Pan, W; Liu, D; Li, S; Sun, J; Zhang, K; Sun, Y; Ge, X				Li, H.; Xiao, N.; Wang, Y.; Wang, R.; Chen, Y.; Pan, W.; Liu, D.; Li, S.; Sun, J.; Zhang, K.; Sun, Y.; Ge, X.			Smurf1 regulates lung cancer cell growth and migration through interaction with and ubiquitination of PIPKI gamma	ONCOGENE			English	Article							PHOSPHATIDYLINOSITOL-PHOSPHATE KINASE; I-GAMMA; LIGASE SMURF1; CADHERIN TRAFFICKING; ACQUIRED-RESISTANCE; SPLICE VARIANT; TALIN HEAD; C2 DOMAIN; TARGETS; PHOSPHORYLATION	Type I. phosphatidylinositol phosphate kinase (PIPKI gamma), a phospholipid kinase generating PIP2, is positively expressed in breast cancer tissues, which correlates intimately with the progression of patients. However, little is known about the expression level of PIPKI. in patients with other cancer types as well as their underlying regulation mechanisms. Here, we report that PIPKI. is highly expressed in lung cancer tissues and its expression level is critical for lung cancer cell proliferation, which may serve as a prognostic marker for lung cancer patients. Meanwhile, we show that E3 ubiquitin ligase Smurf1 directly interacts with PIPKI. and targets PIPKI. for ubiquitination and degradation in lung cancer cells. Also, we discover that Smurf1 directly binds to the kinase domain of PIPKI. via its C2 domain while Lysine 255 in PIPKI. acts as the major ubiquitin acceptor site for Smurf1. In addition, we demonstrate that the phosphorylation mimicking mutant of Smurf1, Smurf1 T306D, prevents PIPKI gamma i2 from ubiquitination and subsequent degradation similar to the effect of forskolin-potentiated cAMP formation, suggesting that Thr306 in Smurf1 is critical for its phosphorylation by PKA. Moreover, PKA-Smurf1-PIPKI. signal transduction takes a significant part in lung cancer cell growth and in vivo tumorigenesis. Thus, we propose that the PKA-Smurf1-PIPKI. pathway has an important role in pulmonary tumorigenesis and imposes substantial clinical impact on development of novel diagnostic markers and therapeutic targets for lung cancer treatment.	[Li, H.; Ge, X.] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China; [Li, H.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Key Lab Pediat Hematol & Oncol,Minist Hlth, Shanghai, Peoples R China; [Li, H.; Xiao, N.; Wang, Y.; Chen, Y.; Pan, W.; Liu, D.; Li, S.; Sun, J.; Zhang, K.] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Li, H.; Xiao, N.; Wang, Y.; Chen, Y.; Pan, W.; Liu, D.; Li, S.; Sun, J.; Zhang, K.] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Xiao, N.] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai Peoples Hosp 9,Dept Burns & Plast Surg, Shanghai, Peoples R China; [Wang, Y.] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Hematol, Shanghai, Peoples R China; [Wang, R.] Fudan Univ, Canc Inst, Canc Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Sun, Y.] Virginia Commonwealth Univ, Sch Dent, Philips Inst Oral Hlth Res, Richmond, VA USA; [Sun, Y.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA	Tongji University; Shanghai Jiao Tong University; East China Normal University; East China Normal University; Shanghai Jiao Tong University; Tongji University; Fudan University; Virginia Commonwealth University; Virginia Commonwealth University	Ge, X (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Clin Lab Med, Shanghai 200072, Peoples R China.	gexx0019@163.com			National Basic Research Program of China (973 program) [2012CB910404, 2010CB529704]; National Natural Science Foundation of China [30971521, 81502559, 81500112, 81602515, 81572645, 30800587, 31171338]; Science and Technology Commission of Shanghai Municipality [11DZ2260300]; Science and Technology Commission of Pudong New Area Foundation [PKJ2016-Y37]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Commission of Pudong New Area Foundation	We thank Dr Dianqing Wu, Jian Luo, Hongrui, Wang, and Lingqiang Zhang for kindly providing reagents. We also appreciate the assistance from other members of the lab. This work was supported by grants from National Basic Research Program of China (973 program 2012CB910404 and 2010CB529704), National Natural Science Foundation of China (30971521, 81502559, 81500112, 81602515, 81572645, 30800587 and 31171338), grant from the Science and Technology Commission of Shanghai Municipality (11DZ2260300) and the Science and Technology Commission of Pudong New Area Foundation (PKJ2016-Y37).	Akieda-Asai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011755; Ayoola A, 2012, CANCER INVEST, V30, P433, DOI 10.3109/07357907.2012.666691; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Cao Y, 2013, CELL MOL LIFE SCI, V70, P2305, DOI 10.1007/s00018-012-1170-7; Chen C, 2015, ONCOGENE, V34, P4635, DOI 10.1038/onc.2014.393; Chen Z, 2016, BIOCHEMISTRY-US, V55, P3658, DOI 10.1021/acs.biochem.6b00448; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hu J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9205; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jafari N, 2016, J BIOL CHEM, V291, P25729, DOI 10.1074/jbc.M116.742742; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Le OTT, 2015, BBA-MOL CELL RES, V1853, P2432, DOI 10.1016/j.bbamcr.2015.07.001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sangadala S, 2007, J BIOMOL STRUCT DYN, V25, P11, DOI 10.1080/07391102.2007.10507151; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Schill NJ, 2014, J CELL SCI, V127, P2189, DOI 10.1242/jcs.132423; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schill NJ, 2009, BIOCHEM J, V418, P247, DOI 10.1042/BJ20081844; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Suzuki C, 2002, J BIOL CHEM, V277, P39919, DOI 10.1074/jbc.M201901200; Thapa N, 2017, ONCOGENE, V36, P899, DOI 10.1038/onc.2016.267; Wan LX, 2011, MOL CELL, V44, P721, DOI 10.1016/j.molcel.2011.09.024; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang YF, 2008, P NATL ACAD SCI USA, V105, P14064, DOI 10.1073/pnas.0804139105; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wieffer M, 2012, METHOD CELL BIOL, V108, P209, DOI 10.1016/B978-0-12-386487-1.00011-0; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Williamson A, 2013, MOL CELL, V49, P591, DOI 10.1016/j.molcel.2013.01.028; Xia Y, 2011, BIOCHEM BIOPH RES CO, V411, P416, DOI 10.1016/j.bbrc.2011.06.168; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Xu WW, 2010, IMMUNITY, V33, P340, DOI 10.1016/j.immuni.2010.08.015; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yoon YD, 2012, J BIOL CHEM, V287, P34078, DOI 10.1074/jbc.M112.372789; Yu YL, 2011, J BIOL CHEM, V286, P9657, DOI 10.1074/jbc.M110.185124; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	70	30	30	0	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5668	5680		10.1038/onc.2017.166	http://dx.doi.org/10.1038/onc.2017.166			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28581524				2022-12-26	WOS:000412843900002
J	Shahi, P; Wang, CY; Chou, J; Hagerling, C; Velozo, HG; Ruderisch, A; Yu, Y; Lai, MD; Werb, Z				Shahi, P.; Wang, C-Y; Chou, J.; Hagerling, C.; Velozo, H. Gonzalez; Ruderisch, A.; Yu, Y.; Lai, M-D; Werb, Z.			GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis	ONCOGENE			English	Article							LUNG-CANCER; CHROMOSOME 3P21.3; LIM-KINASE; EXPRESSION; GROWTH; DIFFERENTIATION; REGULATOR; MORPHOGENESIS; NEUROPILIN-1; RECEPTORS	Semaphorin 3B (SEMA3B) is a secreted axonal guidance molecule that is expressed during development and throughout adulthood. Recently, SEMA3B has emerged as a tumor suppressor in non-neuronal cells. Here, we show that SEMA3B is a direct target of GATA3 transcriptional activity. GATA3 is a key transcription factor that regulates genes involved in mammary luminal cell differentiation and tumor suppression. We show that GATA3 relies on SEMA3B for suppression of tumor growth. Loss of SEMA3B renders GATA3 inactive and promotes aggressive breast cancer development. Overexpression of SEMA3B in cells lacking GATA3 induces a GATA3-like phenotype and higher levels of SEMA3B are associated with better cancer patient prognosis. Moreover, SEMA3B interferes with activation of LIM kinases (LIMK1 and LIMK2) to abrogate breast cancer progression. Our data provide new insights into the role of SEMA3B in mammary gland and provides a new branch of GATA3 signaling that is pivotal for inhibition of breast cancer progression and metastasis.	[Shahi, P.; Wang, C-Y; Chou, J.; Hagerling, C.; Velozo, H. Gonzalez; Ruderisch, A.; Yu, Y.; Werb, Z.] Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,BOX 0452, San Francisco, CA 94143 USA; [Shahi, P.; Wang, C-Y; Chou, J.; Hagerling, C.; Velozo, H. Gonzalez; Ruderisch, A.; Yu, Y.; Werb, Z.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 513 Parnassus Ave,BOX 0452, San Francisco, CA 94143 USA; [Shahi, P.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Wang, C-Y; Lai, M-D] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol, Tainan, Taiwan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; National Cheng Kung University	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,BOX 0452, San Francisco, CA 94143 USA.; Werb, Z (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 513 Parnassus Ave,BOX 0452, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu	Lai, Ming-Derg/M-8028-2014	Wang, Chih-Yang/0000-0002-4137-5074	National Cancer Institute [R01 CA129523, R01 CA190851]; Institutional National Research Service Award [T32 CA108462]; Ministry of Science and Technology, Taiwan [104-2917-I-006-002]; Tegger Foundation; Wenner-Gren Foundations; Sweden-America Foundation; Swedish Society of Medicine; Swedish Society for Medical Research; Becas Chile Scholarship; NATIONAL CANCER INSTITUTE [R01CA129523, T32CA108462, R01CA190851] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Tegger Foundation; Wenner-Gren Foundations; Sweden-America Foundation; Swedish Society of Medicine; Swedish Society for Medical Research; Becas Chile Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge Dr Gera Neufeld for providing the SEMA3B overexpression DNA construct. We thank Dr Luca Tamagnone for his generous gift of lentiviral SEMA3B short hairpin RNA constructs. We thank Elena Atamaniuc for technical assistance. This study was supported by funds from the National Cancer Institute (R01 CA129523 and R01 CA190851 to ZW); PS was supported by an Institutional National Research Service Award (T32 CA108462); C-YW was supported by a grant from the Ministry of Science and Technology, Taiwan (104-2917-I-006-002); CH was supported by funds from the Tegger Foundation, Wenner-Gren Foundations, Sweden-America Foundation, Swedish Society of Medicine and Swedish Society for Medical Research; and HGV was supported by a Becas Chile Scholarship.	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Ballard MS, 2015, CELL REP, V13, P290, DOI 10.1016/j.celrep.2015.09.006; Bernatchez PN, 2002, J CELL BIOCHEM, V85, P629, DOI 10.1002/jcb.10155; Bertucci F, 2000, HUM MOL GENET, V9, P2981, DOI 10.1093/hmg/9.20.2981; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Du F, 2015, MED RES REV, V35, P1300, DOI 10.1002/med.21362; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hall C, 2001, J BIOL CHEM, V276, P43482, DOI 10.1074/jbc.C100455200; Hoch RV, 1999, INT J CANCER, V84, P122; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Jiang YZ, 2014, CANCER-AM CANCER SOC, V120, P1329, DOI 10.1002/cncr.28566; Jin Z, 1997, J NEUROSCI, V17, P6256; Johnson EO, 2012, J CELL SCI, V125, P1204, DOI 10.1242/jcs.092304; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kuroki T, 2003, CANCER RES, V63, P3352; Lagoutte E, 2016, SCI REP-UK, V6, DOI 10.1038/srep24925; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; McConnell BV, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-75; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sekido Y, 1996, P NATL ACAD SCI USA, V93, P4120, DOI 10.1073/pnas.93.9.4120; Sellheyer K, 2010, J CUTAN PATHOL, V37, P357, DOI 10.1111/j.1600-0560.2009.01416.x; Shea KF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003398; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Tse C, 2002, CANCER RES, V62, P542; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wilson BJ, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-49; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029	51	31	35	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5567	5575		10.1038/onc.2017.165	http://dx.doi.org/10.1038/onc.2017.165			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581515	Green Accepted, Green Submitted			2022-12-26	WOS:000412293600002
J	Linnemann, AK; Blumer, J; Marasco, MR; Battiola, TJ; Umhoefer, HM; Han, JY; Lamming, DW; Davis, DB				Linnemann, Amelia K.; Blumer, Joseph; Marasco, Michelle R.; Battiola, Therese J.; Umhoefer, Heidi M.; Han, Jee Young; Lamming, Dudley W.; Davis, Dawn Belt			Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy	FASEB JOURNAL			English	Article						pancreas; islet; diabetes	CHAPERONE-MEDIATED AUTOPHAGY; INFLAMMATORY CYTOKINES; SERINE PHOSPHORYLATION; MAXIMAL ACTIVATION; ADIPOSE-TISSUE; IN-VITRO; STAT3; MICE; MTOR; MECHANISMS	IL-6 is a pleiotropic cytokinewith complex roles in inflammation and metabolic disease. The role of IL-6 as a pro-or anti-inflammatory cytokine is still unclear. Within the pancreatic islet, IL-6 stimulates secretion of the prosurvival incretin hormone glucagon-like peptide 1 (GLP-1) by a cells and acts directly on beta cells to stimulate insulin secretion in vitro. Uncovering physiologic mechanisms promoting beta-cell survival under conditions of inflammation and stress can identify important pathways for diabetes prevention and treatment. Given the established role of GLP-1 in promoting beta-cell survival, we hypothesized that IL-6 may also directly protect beta cells from apoptosis. Herein, we show that IL-6 robustly activates signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in autophagy. IL-6 stimulates LC3 conversion and autophagosome formation in cultured beta cells. In vivo IL-6 infusion stimulates a robust increase in lysosomes in the pancreas that is restricted to the islet. Autophagy is critical for beta-cell homeostasis, particularly under conditions of stress and increased insulin demand. The stimulation of autophagy by IL-6 is regulated via multiple complementary mechanisms including inhibition of mammalian target of rapamycin complex 1 (mTORC1) and activation of Akt, ultimately leading to increases in autophagy enzyme production. Pretreatment with IL-6 renders beta cells resistant to apoptosis induced by proinflammatory cytokines, and inhibition of autophagy with chloroquine prevents the ability of IL-6 to protect from apoptosis. Importantly, we find that IL-6 can activate STAT3 and the autophagy enzyme GABARAPL1 in human islets. We also see evidence of decreased IL-6 pathway signaling in islets from donors with type 2 diabetes. On the basis of our results, we propose direct stimulation of autophagy as a novel mechanism for IL-6-mediated protection of beta cells from stress-induced apoptosis.	[Linnemann, Amelia K.; Blumer, Joseph; Battiola, Therese J.; Umhoefer, Heidi M.; Han, Jee Young; Lamming, Dudley W.; Davis, Dawn Belt] Univ Wisconsin Madison, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI USA; [Linnemann, Amelia K.; Marasco, Michelle R.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Lamming, Dudley W.; Davis, Dawn Belt] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Linnemann, AK (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, 635 Barnhill Dr,MS 2051, Indianapolis, IN 46202 USA.	aklinnem@iu.edu	Lamming, Dudley/O-7191-2015; Davis, Dawn/B-1624-2013	Lamming, Dudley/0000-0002-0079-4467; Davis, Dawn/0000-0002-0239-4715; Han, Jee Young/0000-0002-1306-6899	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K01DK102492]; Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine; Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant [P30 DK097512]; NIH National Institute on Aging [AG041765, AG050135]; Glenn Foundation Award for Research in the Biological Mechanisms of Aging; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR); Department of Veterans Affairs [I01BX001880]; NIH/NIDDK [R01DK110324]; University of Wisconsin-Madison Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512, K01DK102492, R01DK110324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041765, R21AG050135, K99AG041765] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001880] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine; Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation Award for Research in the Biological Mechanisms of Aging; UW-Madison Department of Medicine; American Federation for Aging Research (AFAR); Department of Veterans Affairs(US Department of Veterans Affairs); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Wisconsin-Madison Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank M. Kimple and M. Merrins (both from the University of Wisconsin), as well as all the members of the Davis, Lamming, Kimple, and Merrins laboratories, for their assistance and insight. The authors thank A. Strohecker (The Ohio State University, Columbus, OH, USA), B. Layden, and M. Priyadarshini (both from Northwestern University, Evanston, IL, USA) for helpful comments and assistance with data interpretation. The authors thank M. Kimple for providing some human islet samples from donors with type 2 diabetes. A.K.L. is supported by a Research Scientist Development Award from the U.S. National Institutes of Health (NIH)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; K01DK102492), the Herman B. Wells Center for Pediatric Research at Indiana University School of Medicine, and a Pilot and Feasibility Award within the Indiana University CDMD NIH/NIDDK Grant P30 DK097512. The Lamming lab is supported by grants from the NIH National Institute on Aging (AG041765 and AG050135), a Glenn Foundation Award for Research in the Biological Mechanisms of Aging, and the UW-Madison Department of Medicine. This research was conducted while D.W.L. was an American Federation for Aging Research (AFAR) grant recipient. D.B.D. is supported by a merit award from the Department of Veterans Affairs (I01BX001880), NIH/NIDDK (R01DK110324), and the University of Wisconsin-Madison Department of Medicine. This work was supported using facilities and resources from the William S. Middleton Memorial Veterans Hospital, and does not represent the views of the Department of Veterans Affairs or the United States Government. The authors declare no conflicts of interest.	Ardestani A, 2014, NAT MED, V20, P385, DOI 10.1038/nm.3482; Arias E, 2015, MOL CELL, V59, P270, DOI 10.1016/j.molcel.2015.05.030; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Centers for Disease Control and Prevention, 2014, NAT DIAB STAT REP ES; Cho Yoon Ju, 2011, Lab Anim Res, V27, P197, DOI 10.5625/lar.2011.27.3.197; Choi SE, 2004, TRANSPL IMMUNOL, V13, P43, DOI 10.1016/j.trim.2004.04.001; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; Dimberg LY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-318; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Febbraio MA, 2003, J PHYSIOL-LONDON, V549, P607, DOI 10.1113/jphysiol.2003.042374; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Gorogawa S, 2004, BIOCHEM BIOPH RES CO, V319, P1159, DOI 10.1016/j.bbrc.2004.05.095; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Gu YY, 2011, DIABETES, V60, P827, DOI 10.2337/db10-1194; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herder C, 2005, DIABETES, V54, pS11, DOI 10.2337/diabetes.54.suppl_2.S11; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Krause MD, 2012, J ENDOCRINOL, V214, P301, DOI 10.1530/JOE-12-0223; Liu Y, 2013, AGE, V35, P1531, DOI 10.1007/s11357-012-9456-0; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Ost A, 2010, MOL MED, V16, P235, DOI 10.2119/molmed.2010.00023; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Qin BB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15701; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuringa JJ, 2000, BIOCHEM J, V347, P89, DOI 10.1042/0264-6021:3470089; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Sultan A, 2009, CIRC RES, V104, P961, DOI 10.1161/CIRCRESAHA.108.190280; Suzuki T, 2011, DIABETES, V60, P537, DOI 10.2337/db10-0796; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; You LK, 2015, AUTOPHAGY, V11, P729, DOI 10.1080/15548627.2015.1017192; Yuan T, 2017, DIABETOLOGIA, V60, P668, DOI 10.1007/s00125-016-4188-9; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	50	55	56	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4140	4152		10.1096/fj.201700061RR	http://dx.doi.org/10.1096/fj.201700061RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592636	Green Published			2022-12-26	WOS:000408713300036
J	Jones, DR; Uddin, MS; Gruninger, RJ; Pham, TTM; Thomas, D; Boraston, AB; Briggs, J; Pluvinage, B; McAllister, TA; Forster, RJ; Tsang, A; Selinger, LB; Abbott, DW				Jones, Darryl R.; Uddin, Muhammed Salah; Gruninger, Robert J.; Thi Thanh My Pham; Thomas, Dallas; Boraston, Alisdair B.; Briggs, Jonathan; Pluvinage, Benjamin; McAllister, Tim A.; Forster, Robert J.; Tsang, Adrian; Selinger, L. Brent; Abbott, D. Wade			Discovery and characterization of family 39 glycoside hydrolases from rumen anaerobic fungi with polyspecific activity on rare arabinosyl substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate; enzyme; fungi; galactose; glycoside hydrolase; arabinose; rumen	PLANT-CELL WALL; L-ARABINOFURANOSIDASE; POLYSACCHARIDE; ENZYMES; COMPLEX; PECTIN; ARABINOXYLANS; DEGRADATION; ARABINANASE; EXPRESSION	Enzyme activities that improve digestion of recalcitrant plant cell wall polysaccharides may offer solutions for sustainable industries. To this end, anaerobic fungi in the rumen have been identified as a promising source of novel carbohydrate active enzymes (CAZymes) that modify plant cell wall polysaccharides and other complex glycans. Many CAZymes share insufficient sequence identity to characterized proteins from other microbial ecosystems to infer their function; thus presenting challenges to their identification. In this study, four rumen fungal genes (nf2152, nf2215, nf2523, and pr2455) were identified that encode family 39 glycoside hydrolases (GH39s), and have conserved structural features with GH51s. Two recombinant proteins, NF2152 and NF2523, were characterized using a variety of biochemical and structural techniques, and were determined to have distinct catalytic activities. NF2152 releases a single product, 1,2-arabinobiose (Ara(2)) from sugar beet arabinan (SBA), and 1,2-Ara(2) and -1,2-galactoarabinose (Gal-Ara) from rye arabinoxylan (RAX). NF2523 exclusively releases -1,2-Gal-Ara from RAX, which represents the first description of a galacto-(-1,2)-arabinosidase. Both -1,2-Ara(2) and -1,2-Gal-Ara are disaccharides not previously described within SBA and RAX. In this regard, the enzymes studied here may represent valuable new biocatalytic tools for investigating the structures of rare arabinosyl-containing glycans, and potentially for facilitating their modification in industrial applications.	[Jones, Darryl R.; Uddin, Muhammed Salah; Gruninger, Robert J.; Thomas, Dallas; McAllister, Tim A.; Forster, Robert J.; Abbott, D. Wade] Agr & Agrifood Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada; [Uddin, Muhammed Salah; Selinger, L. Brent; Abbott, D. Wade] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 6T5, Canada; [Thi Thanh My Pham; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; [Boraston, Alisdair B.; Pluvinage, Benjamin] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Briggs, Jonathan] Newcastle Univ, Sch Biol, Ridley Bldg 2,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Agriculture & Agri Food Canada; University of Lethbridge; Concordia University - Canada; University of Victoria; Newcastle University - UK	Abbott, DW (corresponding author), Agr & Agrifood Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB T1J 4B1, Canada.; Abbott, DW (corresponding author), Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 6T5, Canada.	wade.abbott@agr.gc.ca	Briggs, Jonathon/AAT-5145-2020; McAllister, Tim A./R-9201-2017	Briggs, Jonathon/0000-0003-4181-2809; McAllister, Tim A./0000-0002-8266-6513; Boraston, Alisdair/0000-0001-6417-0592; Abbott, Wade/0000-0003-4893-5799	Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program [AIP-P022]; Elanco Animal Health; Natural Sciences and Engineering Research Council of Canada [FRN 04355]	Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program(Agriculture & Agri Food Canada); Elanco Animal Health; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Agriculture and Agri-Food Canada (AAFC) through Agriculture Innovation Program Grant AIP-P022 and Elanco Animal Health, and Natural Sciences and Engineering Research Council of Canada Discovery Grant FRN 04355 (to A. B. B.). The intellectual property surrounding the field of use for these enzymes has been protected with a United States provisional patent (No. 62/380,741 under AAFC's patent docket, PAT-13830). D. R. J., M. S. U., T. A. M., A. T., and D. W. A. are co-inventors on this patent.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Badhan A, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-31; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Peled C., 2008, BIOMASS RECALCITRANC, V94-187, P94, DOI DOI 10.1002/9781444305418.CH5; BENGTSSON S, 1992, CARBOHYD POLYM, V17, P277, DOI 10.1016/0144-8617(92)90170-U; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; BOCK K, 1984, ADV CARBOHYD CHEM BI, V42, P193, DOI 10.1016/S0065-2318(08)60125-0; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Couger MB, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0390-0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dai X, 2015, APPL ENVIRON MICROB, V81, P1375, DOI 10.1128/AEM.03682-14; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Duus JO, 2000, CHEM REV, V100, P4589, DOI 10.1021/cr990302n; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2013, BIOSCI BIOTECH BIOCH, V77, P1363, DOI 10.1271/bbb.130183; Fujita K, 2014, J BIOL CHEM, V289, P5240, DOI 10.1074/jbc.M113.528711; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Gao NG, 2005, METHODS, V35, P323, DOI 10.1016/j.ymeth.2004.10.003; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gruninger RJ, 2014, FEMS MICROBIOL ECOL, V90, P1, DOI 10.1111/1574-6941.12383; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Im DH, 2012, BIOSCI BIOTECH BIOCH, V76, P423, DOI 10.1271/bbb.110902; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Jones L, 2003, P NATL ACAD SCI USA, V100, P11783, DOI 10.1073/pnas.1832434100; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLean R, 2015, J BIOL CHEM, V290, P21231, DOI 10.1074/jbc.M115.664847; Mewis K, 2016, APPL ENVIRON MICROB, V82, P1686, DOI 10.1128/AEM.03453-15; Morgavi DP, 2013, ANIMAL, V7, P184, DOI 10.1017/S1751731112000419; Morrison JM, 2016, PEERJ, V4, DOI 10.7717/peerj.2289; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020521; Rambaut A, 2014, FIGTREE TREE FIGURE; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Ribeiro GO, 2016, ANIM FRONT, V6, P20, DOI 10.2527/af.2016-0019; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3319, DOI 10.1128/AEM.67.7.3319-3321.2001; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Santos CR, 2012, ACTA CRYSTALLOGR D, V68, P1339, DOI 10.1107/S0907444912028491; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi H, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-35; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon KV, 2016, SCIENCE, V351, P1192, DOI 10.1126/science.aad1431; Tan L, 2013, PLANT CELL, V25, P270, DOI 10.1105/tpc.112.107334; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; VINKX CJA, 1993, CEREAL CHEM, V70, P311; Vinkx CJA, 1996, J CEREAL SCI, V24, P1, DOI 10.1006/jcrs.1996.0032; Woods Group, 2017, CARB BUILD GLYCAM WE; Yapo BM, 2011, POLYM REV, V51, P391, DOI 10.1080/15583724.2011.615962; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479	71	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12606	12620		10.1074/jbc.M117.789008	http://dx.doi.org/10.1074/jbc.M117.789008			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588026	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000406636900025
J	Altamiranda-Saavedra, M; Arboleda, S; Parra, JL; Peterson, AT; Correa, MM				Altamiranda-Saavedra, Mariano; Arboleda, Sair; Parra, Juan L.; Peterson, A. Townsend; Correa, Margarita M.			Potential distribution of mosquito vector species in a primary malaria endemic region of Colombia	PLOS ONE			English	Article							ANOPHELES-DARLINGI ROOT; DIPTERA-CULICIDAE; LAND-COVER; GEOGRAPHIC-DISTRIBUTION; SPATIAL-DISTRIBUTION; NATURAL INFECTIVITY; ECOLOGICAL NICHE; ALBIMANUS; DEFORESTATION; TRANSMISSION	Rapid transformation of natural ecosystems changes ecological conditions for important human disease vector species; therefore, an essential task is to identify and understand the variables that shape distributions of these species to optimize efforts toward control and mitigation. Ecological niche modeling was used to estimate the potential distribution and to assess hypotheses of niche similarity among the three main malaria vector species in northern Colombia: Anopheles nuneztovari, An. albimanus, and An. darlingi. Georeferenced point collection data and remotely sensed, fine-resolution satellite imagery were integrated across the Uraba-Bajo Cauca-Alto Sinu malaria endemic area using a maximum entropy algorithm. Results showed that An. nuneztovari has the widest geographic distribution, occupying almost the entire study region; this niche breadth is probably related to the ability of this species to colonize both, natural and disturbed environments. The model for An. darlingi showed that most suitable localities for this species in Bajo Cauca were along the Cauca and Nechi river. The riparian ecosystems in this region and the potential for rapid adaptation by this species to novel environments, may favor the establishment of populations of this species. Apparently, the three main Colombian Anopheles vector species in this endemic area do not occupy environments either with high seasonality, or with low seasonality and high NDVI values. Estimated overlap in geographic space between An. nuneztovari and An. albimanus indicated broad spatial and environmental similarity between these species. An. nuneztovari has a broader niche and potential distribution. Dispersal ability of these species and their ability to occupy diverse environmental situations may facilitate sym-patry across many environmental and geographic contexts. These model results may be useful for the design and implementation of malaria species-specific vector control interventions optimized for this important malaria region.	[Altamiranda-Saavedra, Mariano; Correa, Margarita M.] Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia; [Arboleda, Sair] Univ Antioquia, Grp Biol & Control Enfermedades Infecciosas, Medellin, Colombia; [Parra, Juan L.] Univ Antioquia, Inst Biol, Grp Ecol & Evoluc Vertebrados, Medellin, Colombia; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; University of Kansas	Correa, MM (corresponding author), Univ Antioquia, Escuela Microbiol, Grp Microbiol Mol, Medellin, Colombia.	margaritcorrea@gmail.com	Correa, Margarita/AAW-8277-2020	Correa, Margarita/0000-0003-2419-7269	Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia [596-2013]; Estrategia para la Sostenibilidad de Grupos de Investigacion [ES84160123]; COLCIENCIAS, Colombia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Estrategia para la Sostenibilidad de Grupos de Investigacion; COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, project code no. 596-2013 and Estrategia para la Sostenibilidad de Grupos de Investigacion 2016-2017 code no. ES84160123. MA received financial support for his doctoral studies from COLCIENCIAS, Colombia, Convocatoria 528, 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; Alimi TO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1052-1; Alimi TO, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1033-9; [Anonymous], REV BIOMEDICA; [Anonymous], 2018, SANTIAGO CALI U VALL, DOI DOI 10.25100/PEU.309; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Bejarano Eduar E., 2003, Neotrop. entomol., V32, P517, DOI 10.1590/S1519-566X2003000300025; FARAN M E, 1980, Contributions of the American Entomological Institute, V15, P1; Betancur T, 2009, REV FAC ING-UNIV ANT, P107; Brochero HL, 2005, J AM MOSQUITO CONTR, V21, P182, DOI 10.2987/8756-971X(2005)21[182:BAABSO]2.0.CO;2; Cabrera E, 2011, MEMORIA TECNICA CUAN; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; Dwyer J, 2006, EARTH SCIENCE SATELLITE REMOTE SENSING: DATA, COMPUTATIONAL PROCESSING, AND TOOLS, VOL 2, P162, DOI 10.1007/978-3-540-37294-3_9; Feilhauer H, 2012, REMOTE SENS-BASEL, V4, P2057, DOI 10.3390/rs4072057; Foley DH, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-11; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fuller DO, 2014, APPL GEOGR, V48, P1, DOI 10.1016/j.apgeog.2014.01.002; Fuller DO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-264; Fuller DO, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-13; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gomez GF, 2014, ACTA TROP, V135, P75, DOI 10.1016/j.actatropica.2014.03.020; Gomez-Palacio A, 2015, INFECT GENET EVOL, V36, P15, DOI 10.1016/j.meegid.2015.08.035; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Idohou R, 2016, GENET RESOUR CROP EV, P1; INS. Instituto Nacional de Salud Boletin epidemiologico Semanal, 2016, B EP SEM EST SIST VI; Lainhart W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0863-4; Laporta GZ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1038-4; Laporta GZ, 2011, MEM I OSWALDO CRUZ, V106, P239, DOI 10.1590/S0074-02762011000900029; Lash R. Ryan, 2008, Geocarto International, V23, P451, DOI 10.1080/10106040802121010; Ahumada ML, 2013, BIOMEDICA, V33, P241, DOI 10.7705/biomedica.v33i2.1492; Loaiza JR, 2010, MOL PHYLOGENET EVOL, V57, P1341, DOI 10.1016/j.ympev.2010.09.016; Lourenco PM, 2011, J VECTOR ECOL, V36, P279, DOI 10.1111/j.1948-7134.2011.00168.x; Magris M, 2007, MEM I OSWALDO CRUZ, V102, P303, DOI 10.1590/S0074-02762007005000049; Manguin S, 1996, J MED ENTOMOL, V33, P205, DOI 10.1093/jmedent/33.2.205; McKeon SN, 2013, AM J TROP MED HYG, V88, P1079, DOI 10.4269/ajtmh.12-0203; Merow C, 2016, GLOBAL ECOL BIOGEOGR, V25, P1022, DOI 10.1111/geb.12453; Montoya R, 2011, EPIDEMIOLOGY CONTROL, V1, P114; Mota-Vargas C, 2016, J NAT CONSERV, V29, P1, DOI 10.1016/j.jnc.2015.10.003; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Ospina M, 2015, B EPIDEMIOLOGICO SEM, P1; Overgaard HJ, 2003, LANDSCAPE ECOL, V18, P605, DOI 10.1023/A:1026074910038; Parra-Henao G, 2008, B MALARIOL SALUD AMB, V48, P95; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinault LL, 2012, J VECTOR ECOL, V37, P124, DOI 10.1111/j.1948-7134.2012.00209.x; Qiao H, 2016, ECOGRAPHY; Qiao HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01313-2; Roberts DR, 2002, J VECTOR ECOL, V27, P21; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Stefani A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-192; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Turvey CG, 2012, WEATHER CLIM SOC, V4, P271, DOI 10.1175/WCAS-D-11-00059.1; Villarreal-Trevino C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1037-0; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; World Health Organization, WORLD MAL REP 2015; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67	68	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179093	10.1371/journal.pone.0179093	http://dx.doi.org/10.1371/journal.pone.0179093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594942	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200086
J	Yang, CF; Ho, HL; Lin, SC; Hsu, CY; Ho, DMT				Yang, Ching-Fen; Ho, Hsiang-Ling; Lin, Shih-Chieh; Hsu, Chih-Yi; Ho, Donald Ming-Tak			Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects	PLOS ONE			English	Article							COLORECTAL-CANCER; NERVOUS-SYSTEM; PERIPHERAL-BLOOD; MALIGNANT GLIOMA; BRAIN-TUMORS; INFECTION; ASSOCIATION; MULTIFORME; PROGNOSIS; CELLS	The relationship between human cytomegalovirus (HCMV) and glioblastoma (GBM) has been debated for more than a decade. We investigated the presence of HCMV genes, RNA and protein in GBMs and their relationships with tumor progression. Results of quantitative PCR for HCMV UL73, nested PCR for HCMV UL144, in situ hybridization (ISH) for RNA transcript, and immunohistochemistry (IHC) for protein expression and their relationship to the prognosis of 116 patients with GBM were evaluated. Nine (7.8%) cases revealed a low concentration of HCMV UL73, and only 2 of the 9 (1.7%) cases showed consistent positivity on repeat PCR testing. HCMV UL144, ISH and IHC assays were all negative. The HCMV UL73 positive cases did not show significant difference in the clinicopathological characters including age, gender, Karnofsky performance status, extent of resection, bevacizumab treatment, isocitrate dehydrogenase 1 mutation, O-6-methylguanine-DNA-methyltranferase status and Ki67 labeling index, and did not reveal prognostic significance. As only one HCMV gene was detected at low concentration in 7.8% of GBMs and there was no evidence of transcription, protein expression or prognostic impact, we cannot conclude a relationship between HCMV and GBM in Taiwanese patients.	[Yang, Ching-Fen; Ho, Hsiang-Ling; Lin, Shih-Chieh; Hsu, Chih-Yi; Ho, Donald Ming-Tak] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yang, Ching-Fen; Ho, Hsiang-Ling; Lin, Shih-Chieh; Hsu, Chih-Yi; Ho, Donald Ming-Tak] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hsu, CY; Ho, DMT (corresponding author), Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan.; Hsu, CY; Ho, DMT (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	cyhsu@vghtpe.gov.tw; mtho@vghtpe.gov.tw			Taipei Veterans General Hospital [V104C-170, V104C-187, V105C-185, V105C-187, V106C-037]; The Ministry of Science and Technology, Executive Yuan, R.O.C [MOST 104-2320-B-075-003, MOST 104-2320-B-075-004]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); The Ministry of Science and Technology, Executive Yuan, R.O.C	The corresponding authors CYH and DMH received funding from "Taipei Veterans General Hospital, Grant Number: V104C-170, V104C-187, V105C-185, V105C-187, V106C-037 (https://www.vghtpe.gov.tw/index.action)"; and from "The Ministry of Science and Technology, Executive Yuan, R.O.C., Grant Number: MOST 104-2320-B-075-003, MOST 104-2320-B-075-004 (https://www.most.gov.tw/)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirian ES, 2013, CANCER MED-US, V2, P57, DOI 10.1002/cam4.44; [Anonymous], 2012, ANN REP TAIW CANC RE; Baumgarten P, 2014, NEURO-ONCOLOGY, V16, P1469, DOI 10.1093/neuonc/nou167; Bhattacharjee B, 2012, J VIROL, V86, P6815, DOI 10.1128/JVI.00015-12; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Chen HP, 2016, J GEN VIROL, V97, P152, DOI 10.1099/jgv.0.000315; Chen HP, 2015, J GEN VIROL, V96, P3613, DOI 10.1099/jgv.0.000308; Chen HP, 2012, J CLIN VIROL, V54, P240, DOI 10.1016/j.jcv.2012.04.007; Chen MH, 2008, J PAEDIATR CHILD H, V44, P166, DOI 10.1111/j.1440-1754.2007.01215.x; Cimino PJ, 2014, EXP MOL PATHOL, V96, P310, DOI 10.1016/j.yexmp.2014.03.010; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Cobbs CS, 2014, METHODS MOL BIOL, V1119, P165, DOI 10.1007/978-1-62703-788-4_11; Cobbs CS, 2002, CANCER RES, V62, P3347; Ding DL, 2014, J NEURO-ONCOL, V116, P515, DOI 10.1007/s11060-013-1350-9; dos Santos CJ, 2014, J MED VIROL, V86, P1953, DOI 10.1002/jmv.23820; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Fonseca RF, 2012, MEM I OSWALDO CRUZ, V107, P953, DOI 10.1590/S0074-02762012000700020; Fornara O, 2016, CELL DEATH DIFFER, V23, P261, DOI 10.1038/cdd.2015.91; Hashida Y, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/1750-9378-10-3; Hsu CY, 2015, J NEURO-ONCOL, V122, P179, DOI 10.1007/s11060-014-1701-1; Huang R, 2015, ONCOL LETT, V10, P2812, DOI 10.3892/ol.2015.3638; Khoury JD, 2013, J VIROL, V87, P8916, DOI 10.1128/JVI.00340-13; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Lau SK, 2005, MODERN PATHOL, V18, P838, DOI 10.1038/modpathol.3800352; Lehrer S, 2015, NEURO-ONCOLOGY, V17, P320, DOI 10.1093/neuonc/nou325; Lehrer S, 2012, ANTICANCER RES, V32, P1113; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Poltermann S, 2006, J NEUROVIROL, V12, P90, DOI 10.1080/13550280600654573; Rahbar A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.982391; Rahbar A, 2013, J CLIN VIROL, V57, P36, DOI 10.1016/j.jcv.2012.12.018; Ranganathan P, 2012, J VIROL, V86, P854, DOI 10.1128/JVI.06097-11; Sabatier J, 2005, BRIT J CANCER, V92, P747, DOI 10.1038/sj.bjc.6602339; Scheurer ME, 2008, ACTA NEUROPATHOL, V116, P79, DOI 10.1007/s00401-008-0359-1; Sinclair JH, 2013, VIRUSES-BASEL, V5, P2803, DOI 10.3390/v5112803; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soderberg-Naucler Cecilia, 2015, World J Exp Med, V5, P1, DOI 10.5493/wjem.v5.i1.1; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Stragliotto G, 2013, INT J CANCER, V133, P1204, DOI 10.1002/ijc.28111; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taha MS, 2016, BRIT J NEUROSURG, V30, P307, DOI 10.3109/02688697.2015.1119241; Tang KW, 2015, INT J CANCER, V136, P977, DOI 10.1002/ijc.29042; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Vidone M, 2014, NEURO-ONCOLOGY, V16, P298, DOI 10.1093/neuonc/not140; Wakefield A, 2015, J NEURO-ONCOL, V125, P307, DOI 10.1007/s11060-015-1905-z; Yamashita Y, 2014, MODERN PATHOL, V27, P922, DOI 10.1038/modpathol.2013.219	51	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179366	10.1371/journal.pone.0179366	http://dx.doi.org/10.1371/journal.pone.0179366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594901	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200123
J	Yin, K; Zhu, RJ; Wang, SH; Zhao, RC				Yin, Kan; Zhu, Rongjia; Wang, Shihua; Zhao, Robert Chunhua			Low level laser (LLL) attenuate LPS-induced inflammatory responses in mesenchymal stem cells via the suppression of NF-kappa B signaling pathway in vitro	PLOS ONE			English	Article							AMELIORATES DISEASE PROGRESSION; STROMAL CELLS; MOUSE MODEL; THERAPY; ACTIVATION; EXPRESSION; NM; IRRADIATION; INDUCTION	Background Considering promising results in animal models and patients, therapeutic use of MSCs for immune disease is likely to undergo continued evaluation. Low-lever laser (LLL) has been widely applied to retard the inflammatory reaction. LLL treatment can potentially be applied in anti-inflammatory therapy followed by stem cell therapy. Aim of the study The purpose of this study was to investigate the effect of LLL (660 nm) on the inflammatory reaction induced by LPS in human adipose derived mesenchymal stem cells (hADSCs) and pertinent mechanism. Materials and methods Anti-inflammatory activity of LLL was investigated by LPS-induced mesenchymal stem cells. The production and expression of pro-inflammatory cytokines were evaluated by ELISA kits and RT-qPCR. Nuclear translocation of NF-kappa B was indicated by immunofluorescent staining. Phosphorylation status of NF-kappa B p65 and I kappa Ba were illustrated by western blot assay. ROS generation was measured with CM-H2DCFDA, and NO secretion was determined by DAF-FM. We studied surface expression of lymphocyte activation markers when Purified peripheral blood mononuclear cell (PBMC) were activated by phytohaemagglutinin (PHA) in the presence of 3 types of treated MSCs. Results LLL reduced the secretion of IL-1 beta, IL-6, IL8, ROS and NO in LPS treated MSCs. Immunofluorescent assay demonstrated the nuclear translocation decrease of NF-kappa B in LLL treated LPS induced MSCs. Western blot analysis also suggested that LLL suppressed NF-.B activation via regulating the phosphorylation of p65 and I kappa B alpha. MSC significantly reduced the expression of activation markers CD25 and CD69 on PHA-stimulated lymphocytes. Conclusion The results indicate that LLL suppressed the activation of NF-kappa B signaling pathway in LPS treated MSCs through inhibiting phosphorylation of p65 and I kappa Ba, which results in good antiinflammatory effect. In addition, LLL attenuated activation- associated markers CD25 and CD69 in co-cultures of PBMC and 3 types of treated MSCs.	[Zhao, Robert Chunhua] Chinese Acad Med Sci, Ctr Excellence Tissue Engn, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, RC (corresponding author), Chinese Acad Med Sci, Ctr Excellence Tissue Engn, Beijing, Peoples R China.	zhaochunhua@vip.163.com			Natural Science Foundation of China [81370466, 81370879]; Key Program for Beijing Municipal Natural Science Foundation [7141006]; National key research and development program [2016YFA0101000, 2016YFA0101003]; National Collaborative Innovation Program	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Beijing Municipal Natural Science Foundation; National key research and development program; National Collaborative Innovation Program	This study was supported by grants from Natural Science Foundation of China, http://www.nsfc.gov.cn/(No.81370466, No.81370879) to RCHZ, Key Program for Beijing Municipal Natural Science Foundation, http://www.bjnsf.org/ (No. 7141006) to RCHZ, National key research and development program, http://program.most.gov.cn/(No. 2016YFA0101000, No. 2016YFA0101003) to RCHZ, and National Collaborative Innovation Program, http://program.most.gov.cn/ (for Biotherapy) to RCHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse H, 2012, PHOTOMED LASER SURG, V30, P681, DOI 10.1089/pho.2012.9881; Adams V, 2002, CARDIOVASC RES, V54, P95, DOI 10.1016/S0008-6363(02)00228-6; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Betancourt AM, 2013, ADV BIOCHEM ENG BIOT, V130, P163, DOI 10.1007/10_2012_141; Boschi ES, 2008, LASER SURG MED, V40, P500, DOI 10.1002/lsm.20658; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Correa F, 2007, PHOTOMED LASER SURG, V25, P245, DOI 10.1089/pho.2007.2079; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Fan XL, 2015, FOOD CHEM, V166, P609, DOI 10.1016/j.foodchem.2014.06.022; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Fikackova H, 2007, PHOTOMED LASER SURG, V25, P297, DOI 10.1089/pho.2007.2053; Goncalves ED, 2016, AUTOIMMUNITY, V49, P132, DOI 10.3109/08916934.2015.1124425; Haddad R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/216806; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kushibiki T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/974864; Kwon DJ, 2014, BMB REP, V47, P318, DOI 10.5483/BMBRep.2014.47.6.200; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Liang XL, 2016, J CELL SCI, V129, P2182, DOI 10.1242/jcs.170373; Lubart R, 2005, PHOTOMED LASER SURG, V23, P3, DOI 10.1089/pho.2005.23.3; Morgan MJ, CROSSTALK REACTIVE O, P103; Mounayar M, 2015, STEM CELLS, V33, P1892, DOI 10.1002/stem.1986; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Nagata MJH, 2013, J PHOTOCH PHOTOBIO B, V121, P6, DOI 10.1016/j.jphotobiol.2013.01.013; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Pires D, 2011, LASER MED SCI, V26, P85, DOI 10.1007/s10103-010-0811-z; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Wang S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3269267; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054067, 10.1371/journal.pone.0067644]; Yang CC, 2016, J TISSUE ENG REGEN M, V10, P120, DOI 10.1002/term.1714; Yin K, 2017, STEM CELLS DEV; Zhai XT, 2016, J ETHNOPHARMACOL, V194, P153, DOI 10.1016/j.jep.2016.09.013	37	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179175	10.1371/journal.pone.0179175	http://dx.doi.org/10.1371/journal.pone.0179175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594941	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200096
J	Zhang, YR; Liu, Q				Zhang, Yurong; Liu, Quan			Video based object representation and classification using multiple covariance matrices	PLOS ONE			English	Article								Video based object recognition and classification has been widely studied in computer vision and image processing area. One main issue of this task is to develop an effective representation for video. This problem can generally be formulated as image set representation. In this paper, we present a new method called Multiple Covariance Discriminative Learning (MCDL) for image set representation and classification problem. The core idea of MCDL is to represent an image set using multiple covariance matrices with each covariance matrix representing one cluster of images. Firstly, we use the Nonnegative Matrix Factorization (NMF) method to do image clustering within each image set, and then adopt Covariance Discriminative Learning on each cluster (subset) of images. At last, we adopt KLDA and nearest neighborhood classification method for image set classification. Promising experimental results on several datasets show the effectiveness of our MCDL method.	[Zhang, Yurong; Liu, Quan] Wuhan Univ Technol, Sch Informat Engn, Wuhan, Peoples R China; [Zhang, Yurong] HuiShang Vocat Tech Coll, Elect Informat Dept, Hefei, Peoples R China	Wuhan University of Technology	Zhang, YR (corresponding author), Wuhan Univ Technol, Sch Informat Engn, Wuhan, Peoples R China.; Zhang, YR (corresponding author), HuiShang Vocat Tech Coll, Elect Informat Dept, Hefei, Peoples R China.	zhangyurong815@163.com						Arandjelovic O, 2005, PROC CVPR IEEE, P581; Arsigny V, 2007, SIAM J MATRIX ANAL A, V29, P328, DOI 10.1137/050637996; Baudat G, 2000, NEURAL COMPUT, V12, P2385, DOI 10.1162/089976600300014980; Cevikalp H., 2010, PROC CVPR IEEE, P2567, DOI DOI 10.1109/CVPR.2010.5539965; Chen L, 2014, PROC CVPR IEEE, P2673, DOI 10.1109/CVPR.2014.342; Chen SK, 2014, IEEE WINT CONF APPL, P1074, DOI 10.1109/WACV.2014.6835985; Cui Z, 2012, PROC CVPR IEEE, P2626, DOI 10.1109/CVPR.2012.6247982; Ding C, 2005, SIAM PROC S, P606; Gross R., CMU MOTION BODY MOB; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Hamm J., 2008, P 25 INT C MACH LEAR, P376, DOI DOI 10.1145/1390156.1390204; Hu Y, 2011, PROC CVPR IEEE, P121, DOI 10.1109/CVPR.2011.5995500; Ji R., 2016, PATTERN RECOGN, P2658; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Kim M, 2008, PROC CVPR IEEE, P1787; Kim TK, 2007, IEEE T PATTERN ANAL, V29, P1005, DOI 10.1109/TPAMI.2007.1037; Kim Tae-Kyun, 2007, P IEEE C COMP VIS PA, P1; Lee DD, 2001, ADV NEUR IN, V13, P556; Lee KC, 2003, PROC CVPR IEEE, P313; Leibe B., 2003, COMP VIS PATT REC 20, V2, pII; Nishiyama M, 2005, LECT NOTES COMPUT SC, V3546, P71; Ren J., BIDIRECTIONAL COVARI; Shakhnarovich G, 2002, LECT NOTES COMPUT SC, V2352, P851, DOI 10.1007/3-540-47977-5_56; Wang RP, 2008, PROC CVPR IEEE, P2940; Wang RP, 2012, PROC CVPR IEEE, P2496, DOI 10.1109/CVPR.2012.6247965; Wang RP, 2009, PROC CVPR IEEE, P429, DOI 10.1109/CVPRW.2009.5206850; Wang W, 2015, PROC CVPR IEEE, P2048, DOI 10.1109/CVPR.2015.7298816; Yamaguchi O, 1998, AUTOMATIC FACE AND GESTURE RECOGNITION - THIRD IEEE INTERNATIONAL CONFERENCE PROCEEDINGS, P318, DOI 10.1109/AFGR.1998.670968; Yang M., 2013, PROC 10 IEEE INT C W, P1, DOI DOI 10.1109/FG.2013.6553727; Zhang J., ARXIV161008619; Zhang Y, 2015, SIGNAL PROCESS, V112, P17, DOI 10.1016/j.sigpro.2014.08.029; Zhu PF, 2013, IEEE I CONF COMP VIS, P2664, DOI 10.1109/ICCV.2013.331	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0176598	10.1371/journal.pone.0176598	http://dx.doi.org/10.1371/journal.pone.0176598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594823	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200005
J	Belben, RA; Underwood, CJ; Johanson, Z; Twitchett, RJ				Belben, Rachel A.; Underwood, Charlie J.; Johanson, Zerina; Twitchett, Richard J.			Ecological impact of the end-Cretaceous extinction on lamniform sharks	PLOS ONE			English	Article							BODY-SIZE; FISHES; TEETH; CHONDRICHTHYES; PERFORMANCE; DIVERSITY; SHRINKING; DIET	Lamniform sharks are apex marine predators undergoing dramatic local and regional decline worldwide, with consequences for marine ecosystems that are difficult to predict. Through their long history, lamniform sharks have faced widespread extinction, and understanding those 'natural experiments' may help constrain predictions, placing the current crisis in evolutionary context. Here we show, using novel morphometric analyses of fossil shark teeth, that the end-Cretaceous extinction of many sharks had major ecological consequences. Post-extinction ecosystems supported lower diversity and disparity of lamniforms, and were dominated by significantly smaller sharks with slimmer, smoother and less robust teeth. Tooth shape is intimately associated with ecology, feeding and prey type, and by integrating data from extant sharks we show that latest Cretaceous sharks occupied similar niches to modern lamniforms, implying similar ecosystem structure and function. By comparison, species in the depauperate post-extinction community occupied niches most similar to those of juvenile sand tigers (Carcharias taurus). Our data show that quantitative tooth morphometrics can distinguish lamniform sharks due to dietary differences, providing critical insights into ecological consequences of past extinction episodes.	[Belben, Rachel A.; Johanson, Zerina; Twitchett, Richard J.] Nat Hist Museum, Dept Earth Sci, London, England; [Underwood, Charlie J.] Birkbeck Univ London, Dept Earth & Planetary Sci, London, England	Natural History Museum London; University of London; Birkbeck University London	Belben, RA (corresponding author), Nat Hist Museum, Dept Earth Sci, London, England.	rachel.belben@gmail.com		Johanson, Zerina/0000-0002-8444-6776	Natural Environment Research Council [NE/1005641/2, NE/K01434X/1]; NERC [NE/K01434X/1, NE/I005641/2] Funding Source: UKRI; Natural Environment Research Council [NE/I005641/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Support was provided by the Natural Environment Research Council: grant NE/1005641/2 awarded to RJT and grant NE/K01434X/1 awarded to ZJ.	Aberhan M, 2007, GEOLOGY, V35, P227, DOI 10.1130/G23197A.1; [Anonymous], 2014, R LANG ENV STAT COMP; Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bemis WE, 2015, COPEIA, V103, P961, DOI 10.1643/CG-14-109; Cappetta H., 1987, Handbook of Paleoichthyology, V3B, P1; Cappetta H, 2014, PALAEOGEOGR PALAEOCL, V409, P217, DOI 10.1016/j.palaeo.2014.04.020; Cavin L, 2002, GEOLOGICAL AND BIOLOGICAL EFFECTS OF IMPACT EVENTS, P141; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Compagno LJV, 2001, SHARKS WORLD ANNOTAT; Ebert DA, 2012, AM SOC ICHTHYOLOGIST, P27; Foster WJ, 2014, NAT GEOSCI, V7, P233, DOI [10.1038/ngeo2079, 10.1038/NGEO2079]; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Huber DR, 2009, PHYSIOL BIOCHEM ZOOL, V82, P20, DOI 10.1086/588177; Keller G, 2009, PALAEOGEOGR PALAEOCL, V284, P47, DOI 10.1016/j.palaeo.2009.08.029; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kriwet J, 2004, PALAEOGEOGR PALAEOCL, V214, P181, DOI 10.1016/j.palaeo.2004.02.049; Lucifora LO, 2001, CYBIUM, V25, P23; Macleod N, 1997, J GEOL SOC LONDON, V154, P265, DOI 10.1144/gsjgs.154.2.0265; Maia A, 2006, ENVIRON BIOL FISH, V77, P157, DOI 10.1007/s10641-006-9067-7; McGhee GR, 2013, PALAEOGEOGR PALAEOCL, V370, P260, DOI 10.1016/j.palaeo.2012.12.019; Moyer JK, 2017, ZOOLOGY, V120, P101, DOI 10.1016/j.zool.2016.05.007; Nairn, 1995, OCEAN BASIN MARGIN, V8, P367, DOI DOI 10.1007/978-1-4899-1558-03; Noubhani Abdelmajid, 1997, Palaeo Ichthyologica, V8, P1; Sallan L, 2015, SCIENCE, V350, P812, DOI 10.1126/science.aac7373; Schwimmer DR, 1997, PALAIOS, V12, P71, DOI 10.2307/3515295; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Sibert EC, 2014, NAT GEOSCI, V7, P667, DOI 10.1038/NGEO2227; Smale MJ, 2005, AFR J MAR SCI, V27, P331, DOI 10.2989/18142320509504091; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Varghese SP, 2014, HYDROBIOLOGIA, V736, P99, DOI 10.1007/s10750-014-1895-4; Walker Sally E., 2002, Paleontological Society Papers, V8, P119; Whitenack LB, 2011, J MORPHOL, V272, P169, DOI 10.1002/jmor.10903; Whitenack LB, 2010, BIOL J LINN SOC, V100, P271, DOI 10.1111/j.1095-8312.2010.01421.x; Wiest LA, 2015, PALAEOGEOGR PALAEOCL, V417, P105, DOI 10.1016/j.palaeo.2014.10.034; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	38	21	21	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178294	10.1371/journal.pone.0178294	http://dx.doi.org/10.1371/journal.pone.0178294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591222	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000402880700028
J	Katz, JVE; Jeffres, C; Conrad, JL; Sommer, TR; Martinez, J; Brumbaugh, S; Corline, N; Moyle, PB				Katz, Jacob V. E.; Jeffres, Carson; Conrad, J. Louise; Sommer, Ted R.; Martinez, Joshua; Brumbaugh, Steve; Corline, Nicholas; Moyle, Peter B.			Floodplain farm fields provide novel rearing habitat for Chinook salmon	PLOS ONE			English	Article							SACRAMENTO RIVER; RICE FIELDS; ONCORHYNCHUS-TSHAWYTSCHA; WINTER MANAGEMENT; CALIFORNIA; GROWTH; WATER; ZOOPLANKTON; STEELHEAD; MIGRATION	When inundated by floodwaters, river floodplains provide critical habitat for many species of fish and wildlife, but many river valleys have been extensively leveed and floodplain wetlands drained for flood control and agriculture. In the Central Valley of California, USA, where less than 5% of floodplain wetland habitats remain, a critical conservation question is how can farmland occupying the historical floodplains be better managed to improve benefits for native fish and wildlife. In this study fields on the Sacramento River floodplain were intentionally flooded after the autumn rice harvest to determine if they could provide shallow-water rearing habitat for Sacramento River fall-run Chinook salmon (Oncorhynchus tshawytscha). Approximately 10,000 juvenile fish (ca. 48 mm, 1.1 g) were reared on two hectares for six weeks (Feb-March) between the fall harvest and spring planting. A subsample of the fish were uniquely tagged to allow tracking of individual growth rates (average 0.76 mm/day) which were among the highest recorded in fresh water in California. Zooplankton sampled from the water column of the fields were compared to fish stomach contents. The primary prey was zooplankton in the order Cladocera, commonly called water fleas. The compatibility, on the same farm fields, of summer crop production and native fish habitat during winter demonstrates that land management combining agriculture with conservation ecology may benefit recovery of native fish species, such as endangered Chinook salmon.	[Katz, Jacob V. E.; Corline, Nicholas; Moyle, Peter B.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Katz, Jacob V. E.; Jeffres, Carson; Moyle, Peter B.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Katz, Jacob V. E.] Calif Trout, San Francisco, CA 94104 USA; [Conrad, J. Louise; Sommer, Ted R.; Martinez, Joshua; Brumbaugh, Steve] Dept Water Resources, Aquat Ecol Sect, Div Environm Serv, West Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Katz, JVE (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.; Katz, JVE (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jkatz@caltrout.org			California Water Foundation [2012-0043]	California Water Foundation	California Water Foundation (http://www.californiawaterfoundation.org/) funded J. Katz, grant #2012-0043. Other authors did not receive funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2006, FRESHWATER BIOL, V51, P1417, DOI 10.1111/j.1365-2427.2006.01580.x; Benigno GM, 2008, HYDROBIOLOGIA, V600, P297, DOI 10.1007/s10750-007-9239-2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Carlson SM, 2011, CAN J FISH AQUAT SCI, V68, P1579, DOI 10.1139/F2011-084; CRADDOCK DR, 1976, T AM FISH SOC, V105, P72, DOI 10.1577/1548-8659(1976)105<72:OAUOZB>2.0.CO;2; DRENNER RW, 1978, J FISH RES BOARD CAN, V35, P1370, DOI 10.1139/f78-215; Eadie J.M., 2008, CONSERVATION RICELAN, P7; Elphick CS, 1998, J APPL ECOL, V35, P95, DOI 10.1046/j.1365-2664.1998.00274.x; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; Garone Philip, 2011, FALL RIS WETL CAL; Gliwicz ZM, 2002, FRESHWATER BIOL, V47, P2296; Grosholz E, 2006, HYDROBIOLOGIA, V568, P91, DOI 10.1007/s10750-006-0029-z; Hanak E., 2011, MANAGING CALIFORNIAS; Hayes SA, 2008, T AM FISH SOC, V137, P114, DOI 10.1577/T07-043.1; Healey M.C., 1991, P311; Henery RE, 2010, T AM FISH SOC, V139, P550, DOI 10.1577/T08-112.1; Jeffres CA, 2008, ENVIRON BIOL FISH, V83, P449, DOI 10.1007/s10641-008-9367-1; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Kelley R., 1998, BATTLING INLAND SEA; Koehler ME, 2006, T AM FISH SOC, V135, P1580, DOI 10.1577/T05-178.1; Limm MP, 2009, ENVIRON BIOL FISH, V85, P141, DOI 10.1007/s10641-009-9473-8; Lindley S.T., 2009, WHAT CAUSED SACRAMEN; McCormick SD, 1998, CAN J FISH AQUAT SCI, V55, P77, DOI 10.1139/d98-011; Merritt R. W., 2008, INTRO AQUATIC INSECT; Merz JE, 2002, SOUTHWEST NAT, V47, P195, DOI 10.2307/3672907; Mount J.F., 1995, CALIFORNIA RIVERS ST; Moyle P.B., 2007, SAN FRANC ESTUARY WA, V5, DOI [10.15447/sfews.2007v5iss3art1, DOI 10.15447/SFEWS.2007V5ISS3ART1]; Muller-Solger AB, 2002, LIMNOL OCEANOGR, V47, P1468; Myrick CA, 2004, REV FISH BIOL FISHER, V14, P113, DOI 10.1007/s11160-004-2739-5; Perry RW, 2010, N AM J FISH MANAGE, V30, P142, DOI 10.1577/M08-200.1; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; RICKER W E, 1975, P382; Schemel LE, 2004, HYDROBIOLOGIA, V513, P129, DOI 10.1023/B:hydr.0000018178.85404.1c; Sommer T, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:CYB>2.0.CO;2; Sommer TR, 2005, N AM J FISH MANAGE, V25, P1493, DOI 10.1577/M04-208.1; Sommer TR, 2004, AQUAT CONSERV, V14, P247, DOI 10.1002/aqc.620; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; Strum KM, 2013, AGR ECOSYST ENVIRON, V179, P116, DOI 10.1016/j.agee.2013.08.003; Thorp JH, 2010, AQUAT ECOL SER, P1; Unwin MJ, 1997, CAN J FISH AQUAT SCI, V54, P1246, DOI 10.1139/cjfas-54-6-1246; Whipple A.A., 2012, SAN FRANCISCO ESTUAR; WILLIAMS JG, 2012, SAN FRANC ESTUARY WA, V10; Yoshiyama Ronald M., 1998, North American Journal of Fisheries Management, V18, P487, DOI 10.1577/1548-8675(1998)018<0487:HAADOC>2.0.CO;2	44	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177409	10.1371/journal.pone.0177409	http://dx.doi.org/10.1371/journal.pone.0177409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591141	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700008
J	Stone, DB; Cherry, MJ; Martin, JA; Cohen, BS; Miller, KV				Stone, David B.; Cherry, Michael J.; Martin, James A.; Cohen, Bradley S.; Miller, Karl V.			Breeding chronology and social interactions affect ungulate foraging behavior at a concentrated food resource	PLOS ONE			English	Article							WHITE-TAILED DEER; YELLOWSTONE-NATIONAL-PARK; PREDATION RISK; GROUP-SIZE; ROE DEER; TEMPORAL VARIATION; NORTH-AMERICA; SPACE USE; VIGILANCE; ELK	Prey species must balance predator avoidance behavior with other essential activities including foraging, breeding, and social interactions. Anti-predator behaviors such as vigilance can impede resource acquisition rates by altering foraging behavior. However, in addition to predation risk, foraging behavior may also be affected by socio-sexual factors including breeding chronology and social interactions. Therefore, we investigated how time-of-day, distance-to-forest, group size, social interactions (presence of different sex-age class), and breeding chronology (pre-breeding, breeding, post-breeding seasons) affected probability of feeding (hereafter: feeding) for different sex and age-classes (mature males, immature males, adult females, and juveniles) of white-tailed deer at feed sites. We developed a set of candidate models consisting of social, habitat, reproductive, and abiotic factors and combinations of these factors. We then used generalized linear mixed models (GLMMs) to estimate the probability of feeding and used model averaging of competing models for multimodel inference. Each adult sex-age class' feeding was influenced by breeding chronology. Juveniles were more likely to be feeding than adults in all seasons. Feeding increased with group size for all sex-age classes. The presence of a mature male negatively influenced the feeding of immature males and juveniles were more likely to be feeding when an adult female was present. Feeding decreased with increasing distance-to-forest for mature males but not for other sex-age classes. Our results indicate that each sex-age class modulates vigilance levels in response to socio-sexual factors according to the unique pressures placed upon them by their reproductive status and social rank.	[Stone, David B.; Martin, James A.; Cohen, Bradley S.; Miller, Karl V.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Cherry, Michael J.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [Martin, James A.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Stone, DB (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	dbstone@uga.edu			Georgia Wildlife Resources Division [W-82]	Georgia Wildlife Resources Division	Funding for this project was provided by the Georgia Wildlife Resources Division through the Wildlife Restoration Program, which derives monies through an excise tax on sporting arms and ammunition paid by hunters and recreational shooters; Grant Number: W-82, http://www.georgiawildlife.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank land owners for access to their properties and D. Crawford and C. Evans for assistance with field data collection. Funding for this project was provided by the Georgia Wildlife Resources Division through the Wildlife Restoration Program, which derives monies through an excise tax on sporting arms and ammunition paid by hunters and recreational shooters.	APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; ArcGIS E, 2012, ARCGIS E 10 1; Banks PB, 1999, OIKOS, V85, P247, DOI 10.2307/3546490; Benhaiem S, 2008, ANIM BEHAV, V76, P611, DOI 10.1016/j.anbehav.2008.03.012; Bongi P, 2008, J ZOOL, V276, P242, DOI 10.1111/j.1469-7998.2008.00481.x; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; BURGER J, 1994, BEHAVIOUR, V131, P153, DOI 10.1163/156853994X00415; Burger Joanna, 2000, Acta Ethologica, V2, P97, DOI 10.1007/s102119900013; Burnham K P, 2003, MODEL SELECT MULTIMO; CHAO CC, 1984, COMP BIOCHEM PHYS A, V77, P299; Cherry MJ, 2015, BEHAV ECOL, V26, P1091, DOI 10.1093/beheco/arv054; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Donohue RN, 2013, J WILDLIFE MANAGE, V77, P1401, DOI 10.1002/jwmg.606; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Kilgo JC, 2010, J WILDLIFE MANAGE, V74, P929, DOI 10.2193/2009-263; Knopff KH, 2014, WILDLIFE SOC B, V38, P116, DOI 10.1002/wsb.369; KNOX WM, 1988, J MAMMAL, V69, P384, DOI 10.2307/1381395; LAGORY KE, 1986, BEHAVIOUR, V98, P168, DOI 10.1163/156853986X00955; Lark AM, 2008, AM MIDL NAT, V159, P67, DOI 10.1674/0003-0031(2008)159[67:VIVIWD]2.0.CO;2; Lashley MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090652; LAZARUS J, 1979, ANIM BEHAV, V27, P855, DOI 10.1016/0003-3472(79)90023-X; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Michel ES, 2016, BEHAVIOUR, V153, P49, DOI 10.1163/1568539X-00003323; Richards D, 2003, OBSERVING EVALUATING; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; SARGENT RC, 1985, BEHAV ECOL SOCIOBIOL, V17, P43, DOI 10.1007/BF00299427; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Shorrocks B, 2005, AFR J ECOL, V43, P91, DOI 10.1111/j.1365-2028.2005.00541.x; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; Stickles J.H., 2015, J SE ASS FISH WILDLI, V2, P202; Team RC, 2014, R LANG ENV STAT COMP; THOULESS CR, 1990, ANIM BEHAV, V40, P105, DOI 10.1016/S0003-3472(05)80669-4; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; TOWNSEND TW, 1981, AM MIDL NAT, V106, P92, DOI 10.2307/2425138; VERME LJ, 1981, J WILDLIFE MANAGE, V45, P710, DOI 10.2307/3808704; WARREN RJ, 1981, J WILDLIFE MANAGE, V45, P926, DOI 10.2307/3808100; White KS, 2001, CAN J ZOOL, V79, P2055, DOI 10.1139/cjz-79-11-2055; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zheng W, 2013, CURR ZOOL, V59, P265, DOI 10.1093/czoolo/59.2.265	50	9	9	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178477	10.1371/journal.pone.0178477	http://dx.doi.org/10.1371/journal.pone.0178477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591136	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700035
J	Lee, SE; Hyun, H; Park, R; Choi, Y; Son, YJ; Park, YG; Jeong, SG; Shin, MY; Ha, HJ; Hong, HS; Choi, MK; Im, GS; Park, EW; Kim, YH; Park, C; Kim, EY; Park, SP				Lee, Seung-Eun; Hyun, Hyuk; Park, Mi-Ryung; Choi, Youngsok; Son, Yeo-Jin; Park, Yun-Gwi; Jeong, Sang-Gi; Shin, Min-Young; Ha, Hee-Jin; Hong, Hyun-Sok; Choi, Min-Keyung; Im, Gi-Sun; Park, Eung-Woo; Kim, Young-Ho; Park, Chankyu; Kim, Eun-Young; Park, Se-Pill			Production of transgenic pig as an Alzheimer's disease model using a multi-cistronic vector system	PLOS ONE			English	Article							NEURONS; FETAL	Alzheimer's disease (AD) is a progressive neurodegenerative disease associated with memory loss and cognitive impairments. An AD transgenic (Tg) pig model would be useful for preclinical testing of therapeutic agents. We generated an AD Tg pig by somatic cell nuclear transfer (SCNT) using a multi-cistronic vector that harbored three AD-related genes with a total of six well-characterized mutations: hAPP (K670N/M671L, I716V, and V717I), hTau (P301L), and hPS1 (M146V and L286P). Four AD Tg cell lines were established from Jeju black pig ear fibroblasts (JB-PEFs); the resultant JB-PEFAD cells harbored transgene integration, expressed transgene mRNAs, and had normal karyotypes. Tg line #2-1, which expressed high levels of the transgenes, was used for SCNT; cleavage and blastocyst rates of embryos derived from this line were lower than those of Non-Tg. These embryos yielded three piglets (Jeju National University AD-Tg pigs, JNUPIGs) revealed by microsatellite testing to be genetically identical to JB-PEFAD. Transgenes were expressed in multiple tissues, and at especially high levels in brain, and A beta-40/42, total Tau, and GFAP levels were high in brains of the Tg animals. Five or more copies of transgenes were inserted into chromosome X. This is the first report of an AD Tg pig derived from a multi-cistronic vector.	[Lee, Seung-Eun; Hyun, Hyuk; Son, Yeo-Jin; Park, Yun-Gwi; Jeong, Sang-Gi; Shin, Min-Young; Kim, Eun-Young; Park, Se-Pill] Jeju Natl Univ, Fac Biotechnol, Coll Appl Life Sci, Jeju Si, Jeju Special Se, South Korea; [Lee, Seung-Eun; Hyun, Hyuk; Son, Yeo-Jin; Park, Yun-Gwi; Jeong, Sang-Gi; Shin, Min-Young; Kim, Eun-Young; Park, Se-Pill] Jeju Natl Univ, Stem Cell Res Ctr, Jeju Si, Jeju Special Se, South Korea; [Park, Mi-Ryung; Im, Gi-Sun; Park, Eung-Woo] Rural Dev Adm, Anim Biotechnol Div, Natl Inst Anim Sci, Jeollabuk Do, South Korea; [Choi, Youngsok] CHA Univ, Dept Biomed Sci, Pocheon Si, Gyeonggi Do, South Korea; [Ha, Hee-Jin; Hong, Hyun-Sok; Kim, Young-Ho] Medifron DBT, Ansan, Gyeonggi Do, South Korea; [Choi, Min-Keyung; Park, Chankyu] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Kim, Eun-Young; Park, Se-Pill] Mirae Cell Bio, Seoul, South Korea	Jeju National University; Jeju National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Pochon Cha University; Konkuk University	Kim, EY; Park, SP (corresponding author), Jeju Natl Univ, Fac Biotechnol, Coll Appl Life Sci, Jeju Si, Jeju Special Se, South Korea.; Kim, EY; Park, SP (corresponding author), Jeju Natl Univ, Stem Cell Res Ctr, Jeju Si, Jeju Special Se, South Korea.; Kim, EY; Park, SP (corresponding author), Mirae Cell Bio, Seoul, South Korea.	jlokey@daum.net; spppark@jejunu.ac.kr	Park, Chankyu/D-8775-2011	Choi, Youngsok/0000-0002-3862-4105; Park, Chankyu/0000-0003-4855-2210	Cooperative Research Program for Agriculture Science & Technology Development, RDA, Republic of Korea [PJ009103]	Cooperative Research Program for Agriculture Science & Technology Development, RDA, Republic of Korea	to publish, or preparation of the manuscript.This research was funded by the Cooperative Research Program for Agriculture Science & Technology Development, RDA, Republic of Korea, Grant number: PJ009103. The funders had no role in study design, data collection and analysis, decision	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Garcia-Lara JMA, 2010, REV INVEST CLIN, V62, P343; Barone E, 2012, J NEUROCHEM, V120, P135, DOI 10.1111/j.1471-4159.2011.07538.x; Barone E, 2011, PHARMACOL RES, V63, P172, DOI 10.1016/j.phrs.2010.12.007; Braak H, 1991, NEUROPATHOLOGICA, V82, P259; Brussow KP, 2000, REPROD NUTR DEV, V40, P469, DOI 10.1051/rnd:2000111; Butterfield DA, 2012, INT J NEUROPSYCHOPH, V15, P981, DOI 10.1017/S1461145711001118; Butterfield DA, 2011, PHARMACOL RES, V64, P180, DOI 10.1016/j.phrs.2011.04.007; Carter D. Bart, 2002, Cloning and Stem Cells, V4, P131, DOI 10.1089/153623002320253319; Fujimura T, 2008, MOL REPROD DEV, V75, P1372, DOI 10.1002/mrd.20890; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Handler M, 2000, DEVELOPMENT, V127, P2593; Hyun H, 2016, CELL REPROGRAM, V18, P195, DOI 10.1089/cell.2015.0090; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JG, 2011, INT J SUSTAIN ENG, V4, P215, DOI 10.1080/19397038.2011.556757; Laurijssens Bart, 2013, Drug Discov Today Technol, V10, pe319, DOI 10.1016/j.ddtec.2012.04.001; Lee GS, 2005, THERIOGENOLOGY, V63, P973, DOI 10.1016/j.theriogenology.2004.04.017; Liu BH, 2004, GENE THER, V11, P52, DOI 10.1038/sj.gt.3302126; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mhillaj E, 2017, BEHAV PHARMACOL, V28, P95, DOI 10.1097/FBP.0000000000000296; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang DS, 2010, HUM MOL GENET, V19, P3983, DOI 10.1093/hmg/ddq313	31	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0177933	10.1371/journal.pone.0177933	http://dx.doi.org/10.1371/journal.pone.0177933			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586343	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700008
J	Lv, YY				Lv, Yangyong			Proteome-wide profiling of protein lysine acetylation in Aspergillus flavus	PLOS ONE			English	Article							ACETYLOME ANALYSIS REVEALS; SECONDARY METABOLISM; S-ADENOSYLMETHIONINE; NONENZYMATIC ACETYLATION; FUSARIUM-GRAMINEARUM; AFLATOXIN PRODUCTION; COA SYNTHETASE; GENE; IDENTIFICATION; NIDULANS	Protein lysine acetylation is a prevalent post-translational modification that plays pivotal roles in various biological processes in both prokaryotes and eukaryotes. Aspergillus flavus, as an aflatoxin-producing fungus, has attracted tremendous attention due to its health impact on agricultural commodities. Here, we performed the first lysine-acetylome mapping in this filamentous fungus using immune-affinity-based purification integrated with high-resolution mass spectrometry. Overall, we identified 1383 lysine-acetylation sites in 652 acetylated proteins, which account for 5.18% of the total proteins in A. flavus. According to bioinformatics analysis, the acetylated proteins are involved in various cellular processes involving the ribosome, carbon metabolism, antibiotic biosynthesis, secondary metabolites, and the citrate cycle and are distributed in diverse subcellular locations. Additionally, we demonstrated for the first time the acetylation of fatty acid synthase a and beta encoded by aflA and aflB involved in the aflatoxinbiosynthesis pathway (cluster 54), as well as backbone enzymes from secondary metabolite clusters 20 and 21 encoded by AFLA_062860 and AFLA_064240, suggesting important roles for acetylation associated with these processes. Our findings illustrating abundant lysine acetylation in A. flavus expand our understanding of the fungal acetylome and provided insight into the regulatory roles of acetylation in secondary metabolism.	[Lv, Yangyong] Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China	Henan University of Technology	Lv, YY (corresponding author), Henan Univ Technol, Coll Biol Engn, Zhengzhou, Peoples R China.	lvyangyong2011@163.com	Lv, Yangyong/HDN-1832-2022		Natural Science Foundation of China [31501575, 31371850]; natural science foundation of Henan provincial education department [16A180025]; natural science foundation of youth support plan of Henan University of Technology [2015QNJHO6]; high level research fund for qualified people of Henan University of Technology [2015BS016]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Henan provincial education department; natural science foundation of youth support plan of Henan University of Technology; high level research fund for qualified people of Henan University of Technology	This research was financially supported by grants from the Natural Science Foundation of China grants (31501575, 31371850), natural science foundation of Henan provincial education department (16A180025), natural science foundation of youth support plan of Henan University of Technology (2015QNJHO6) and and high level research fund for qualified people of Henan University of Technology (2015BS016).; This research was financially supported by grants from the Natural Science Foundation of China grants (31501575, 31371850), natural science foundation of Henan provincial education department (16A180025), natural science foundation of youth support plan of Henan University of Technology (2015QNJHO6) and high level research fund for qualified people of Henan University of Technology (2015BS016). We also thanked Yuansen Hu for editing this manuscript.	Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Amaike S, 2011, ANNU REV PHYTOPATHOL, V49, P107, DOI 10.1146/annurev-phyto-072910-095221; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Amare MG, 2014, FUNGAL GENET BIOL, V66, P11, DOI 10.1016/j.fgb.2014.02.008; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; BAYMAN P, 1993, CAN J BOT, V71, P23, DOI 10.1139/b93-003; Bok JW, 2013, MOL MICROBIOL, V89, P963, DOI 10.1111/mmi.12326; Brosch G, 2008, FEMS MICROBIOL REV, V32, P409, DOI 10.1111/j.1574-6976.2007.00100.x; Brown DW, 1996, P NATL ACAD SCI USA, V93, P14873, DOI 10.1073/pnas.93.25.14873; Brown SH, 2009, MOL PLANT MICROBE IN, V22, P882, DOI 10.1094/MPMI-22-7-0882; Bryson BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126242; Chang PK, 2014, FUNGAL GENET BIOL, V68, P39, DOI 10.1016/j.fgb.2014.04.007; Chang PK, 2012, FUNGAL BIOL-UK, V116, P298, DOI 10.1016/j.funbio.2011.12.003; Chang PK, 2004, J BIOTECHNOL, V107, P245, DOI 10.1016/j.jbiotec.2003.10.012; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Collier TS, 2008, ANAL CHEM, V80, P4994, DOI 10.1021/ac800254z; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; De-La-Pena C, 2012, MOL PLANT PATHOL, V13, P388, DOI 10.1111/j.1364-3703.2011.00757.x; DELPECH M, 1983, BIOCHIMIE, V65, P291, DOI 10.1016/S0300-9084(83)80281-8; Ehrlich KC, 2010, APPL ENVIRON MICROB, V76, P3374, DOI 10.1128/AEM.02495-09; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gao X, 2016, MOL PLANT, V9, P1018, DOI 10.1016/j.molp.2016.03.012; Georgianna DR, 2008, J PROTEOME RES, V7, P2973, DOI 10.1021/pr8001047; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Hedtke M, 2015, MOL MICROBIOL, V97, P733, DOI 10.1111/mmi.13062; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Hou YX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0541-2; Huang D, 2015, APPL MICROBIOL BIOT, V99, P1399, DOI 10.1007/s00253-014-6144-2; Kale SP, 2008, FUNGAL GENET BIOL, V45, P1422, DOI 10.1016/j.fgb.2008.06.009; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kuhn ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094816; Lan HH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01324; Li DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29897; Li Y, 2017, TOXICON, V127, P112, DOI 10.1016/j.toxicon.2017.01.013; Liao GJ, 2014, J PROTEOMICS, V106, P260, DOI 10.1016/j.jprot.2014.04.017; Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20108; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Lv BN, 2016, SCI REP-UK, V6, DOI 10.1038/srep29313; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Minto RE, 1997, CHEM REV, V97, P2537, DOI 10.1021/cr960032y; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Nallamilli BRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089283; Noventa-Jordao MA, 2000, BBA-GENE STRUCT EXPR, V1490, P237, DOI 10.1016/S0167-4781(99)00242-0; Nutzmann HW, 2011, P NATL ACAD SCI USA, V108, P14282, DOI 10.1073/pnas.1103523108; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Pan JY, 2014, J PROTEOME RES, V13, P3294, DOI 10.1021/pr500133t; Park JM, 2015, PROTEIN CELL, V6, P804, DOI 10.1007/s13238-015-0204-y; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; Reyes-Dominguez Y, 2008, EUKARYOT CELL, V7, P656, DOI 10.1128/EC.00184-07; Sadoul K, 2016, BIOCHEM J, V473, P1859, DOI 10.1042/BCJ20160172; Schroder S, 2013, MOL CELL, V52, P314, DOI 10.1016/j.molcel.2013.10.009; Seo JA, 2005, GENETICS, V171, P81, DOI 10.1534/genetics.105.042796; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Si H, 2016, MYCOLOGIA, P15; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Strauss J, 2011, FUNGAL GENET BIOL, V48, P62, DOI 10.1016/j.fgb.2010.07.009; Sun ML, 2016, ACTA BIOCH BIOPH SIN, V48, P723, DOI 10.1093/abbs/gmw066; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang H., 2016, J SENSORS, V2016, P8, DOI DOI 10.1130/L528.1; Wang HM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0513-6; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZZ, 2012, J PROTEOME RES, V11, P2739, DOI 10.1021/pr201105d; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wijayasinghe YS, 2014, BIOCHEMISTRY-US, V53, P1521, DOI 10.1021/bi401556p; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Wu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097814; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Xing SF, 2012, TRENDS PLANT SCI, V17, P423, DOI 10.1016/j.tplants.2012.03.008; Xiong YH, 2016, J PROTEOMICS, V138, P20, DOI 10.1016/j.jprot.2016.01.019; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou WC, 2006, PROTEOMICS, V6, P4599, DOI 10.1002/pmic.200600052; Zhuang ZH, 2016, TOXINS, V8, DOI 10.3390/toxins8010029	93	16	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178603	10.1371/journal.pone.0178603	http://dx.doi.org/10.1371/journal.pone.0178603			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582408	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600026
J	Poh, AH; Moghavvemi, M; Shafiei, MM; Leong, CS; Lau, YL; Adikan, FRM; Bakhtiari, M; Hassan, MAA				Poh, Abdul Halim; Moghavvemi, Mahmoud; Shafiei, M. M.; Leong, C. S.; Lau, Yee Ling; Adikan, Faisal Rafiq Mahamd; Bakhtiari, Majid; Hassan, Mahmood Ameen Abdulla			Effects of low-powered RF sweep between 0.01-20 GHz on female Aedes Aegypti mosquitoes: A collective behaviour analysis	PLOS ONE			English	Article							ELECTROMAGNETIC-FIELDS; WAVES; ORIENTATION; TARGETS; ODOR	There are many products claiming to be an electronic solution towards repelling mosquitoes. Several reviews were published in debunking these claims. However, there is a lack of a systematic study on effects of electromagnetic (EM) or more specifically, radio frequency (RF) waves against mosquitoes due to the conclusions made in those years. Therefore, we attempt to establish a fundamental study on female Aedes Aegypti (Linnaeus) mosquitoes by quantifying the collective behavior of the mosquitoes against a continuous stream of low-powered RF signals via a broadband horn antenna using image processing methods. By examining the average lateral and vertical positions of the mosquitoes versus frequency and time, the data shows negligible consistency in the reactions of the mosquitoes toward the different frequencies ranging from 10 to 20,000.00 MHz, with a step of 10 MHz. This was done by examining 33 hours of spatiotemporal data, which was divided into three sessions. All three sessions showed totally different convolutions in the positions in arbitrary units based on the raster scan of the image processing output. Several frequencies apparently showed up to 0.2-70% shift in both lateral and vertical components along the spectrum, without repeatability for all three sessions. This study contributes to the following: A pilot study for establishing the collective effects of RF against mosquitoes, open-source use, and finally low-cost and easily adaptable platform for the study of EM effects against any insects.	[Poh, Abdul Halim; Moghavvemi, Mahmoud; Shafiei, M. M.; Adikan, Faisal Rafiq Mahamd] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Poh, Abdul Halim; Moghavvemi, Mahmoud; Shafiei, M. M.] Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud] Univ Sci & Culture, Tehran, Iran; [Leong, C. S.; Lau, Yee Ling] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur, Malaysia; [Bakhtiari, Majid] Univ Technol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Hassan, Mahmood Ameen Abdulla] Univ Malaya, Dept Biomed Sci, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Teknologi Malaysia; Universiti Malaya	Moghavvemi, M (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Sci & Culture, Tehran, Iran.	mahmoud@um.edu.my	Lau, Yee Ling/C-6996-2009; Shafiei, Mohammad Mahdi/C-7950-2014; Moghavvemi, Mahmoud/B-8912-2010; ADIKAN, FAISAL RAFIQ MAHAMD/B-8038-2010	Lau, Yee Ling/0000-0002-2037-2165; Shafiei, Mohammad Mahdi/0000-0003-1063-1060; Moghavvemi, Mahmoud/0000-0001-6447-4203; 	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme [FRGS, FP003-2014B, FRGS/2/2014/TK03/UM/01/1]; Ministry of Higher Education Malaysia, UM High Impact Research Grant [UM.C/HIR/MOHE/MED/16]; Department of Parasitology, University of Malaya	Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme; Ministry of Higher Education Malaysia, UM High Impact Research Grant; Department of Parasitology, University of Malaya	This study was supported by Malaysia's Ministry of Higher Education's Fundamental Research Grant Scheme, grant number: FRGS, grant number FP003-2014B (ref: FRGS/2/2014/TK03/UM/01/1), website: https://jpt.mohe.gov.my/menupenyehdik.php (author who received funding: MM); Ministry of Higher Education Malaysia, UM High Impact Research Grant, grant number: UM.C/HIR/MOHE/MED/16, website: http://hir.um.edu.my/ (author who received funding: YLL).r The author would like to express utmost gratitude to the Department of Parasitology, University of Malaya for providing support, especially in form of mosquitoes, aspirators and handling techniques of the mosquitoes. Also to the staff of Development and Maintenance Unit of Engineering Faculty, University of Malaya for providing reused materials for the chamber reconstruction, Mr Christopher Fearday of Aerospace Lab, Faculty of Engineering, University Malaya, for equipment used for the chamber construction, Mr Nik Remeli for aiding the function generator access, and Mr Shahrilhafiz Zainol for supplying the web camera. Also, special thanks to Mr Jarrett Liner of Analog Devices for helping access the software for controlling the function generator, to Ms Yean Pin of JMP Technical Support for help with the statistical analytics and finally to the developers in the OpenCV forum who have been providing much info on the programming.	Agarwal A, 2009, FERTIL STERIL, V92, P1318, DOI 10.1016/j.fertnstert.2008.08.022; Alfaifi B, 2016, INNOV FOOD SCI EMERG, V37, P125, DOI 10.1016/j.ifset.2016.08.012; Balmori A, 2016, SCI TOTAL ENVIRON, V543, P662, DOI 10.1016/j.scitotenv.2015.11.073; Balmori A, 2015, SCI TOTAL ENVIRON, V518, P58, DOI 10.1016/j.scitotenv.2015.02.077; Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9; Chambers EW, 2013, MED VET ENTOMOL, V27, P332, DOI 10.1111/j.1365-2915.2012.01065.x; Cheng XE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129657; Chou CK, 2015, ELECTROMAGN BIOL MED, V34, P175, DOI 10.3109/15368378.2015.1076439; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Hou LX, 2016, POSTHARVEST BIOL TEC, V113, P106, DOI 10.1016/j.postharvbio.2015.11.011; Kamerman A, 1997, PERS IND MOB RAD COM; KIM KH, 2016, ENVIRON MONIT ASSESS, V188, P1, DOI DOI 10.1007/S10661-016-5227-1; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Lazaro A, 2016, J INSECT CONSERV, V20, P315, DOI 10.1007/s10841-016-9868-8; Lopez-Iturri P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/603260; Main BJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006303; MARINO AA, 1977, PHYSIOL CHEM PHYS M, V9, P131; Ohm JR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1392-x; Poh AH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171555; Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400; Soghomonyan D, 2016, APPL MICROBIOL BIOT, V100, P4761, DOI 10.1007/s00253-016-7538-0; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; van Breugel F, 2015, CURR BIOL, V25, P2123, DOI 10.1016/j.cub.2015.06.046; WAIT JR, 1977, IEEE J OCEANIC ENG, V2, P161, DOI 10.1109/JOE.1977.1145337; Webster B, 2015, J CHEM ECOL, V41, P59, DOI 10.1007/s10886-014-0542-x; Wilkinson DA, 2014, J INSECT PHYSIOL, V71, P114, DOI 10.1016/j.jinsphys.2014.10.005; Wilmink GJ, 2011, J INFRARED MILLIM TE, V32, P1074, DOI 10.1007/s10762-011-9794-5; Zamanian A., 2005, HIGH FREQUENCY ELECT, V4, P16	29	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178766	10.1371/journal.pone.0178766	http://dx.doi.org/10.1371/journal.pone.0178766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582398	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600038
J	Rani, M; Schwacha, MG				Rani, Meenakshi; Schwacha, Martin G.			The composition of T-cell subsets are altered in the burn wound early after injury	PLOS ONE			English	Article							GAMMA-DELTA; EARLY ACTIVATION; IMMUNE-RESPONSE; LYMPH-NODE; IN-VIVO; LYMPHOCYTES; INFILTRATION; INFLAMMATION; EXPRESSION; CD4(+)	Background Burn-induced inflammation leads to impaired immune responses resulting in increased morbidity and mortality. T-cells are central in the immune response and circulating CD4 and CD8 T-cells have been used to evaluate immune status; however, the role of these T-cell subsets in the burn wound is unknown. Methods Male C57BU6 mice were subjected to a major 3rd degree scald burn or sham treatment. Twenty-four hours later, full thickness skin samples from sham mice and the burn wounds were collected and single cells were isolated and analyzed for alpha beta TCR, gamma delta TCR, CD3, CD4, CD8 and CD69 expressions by flow cytometry. Results The burn wound contained significantly greater numbers of T-cells than skin from sham mice, due to a profound infiltration of alpha beta T-cells. These infiltrating alpha beta T-cells were primarily suppressor T-cells with a CD8(+) or CD8(-)CD4(-) phenotype. The 15-fold increase in CD8(+) T-cells caused a decrease in the CD4:CD8 ratio from 0.7 in sham skin to 0.3 in the burn wound. In contrast, the majority of the gamma delta T-cells in sham skin were CD4(-)CD8(-), which decreased 9-fold in the burn wound. CD69 expression was suppressed on burn wound ctI3 T-cells, but increased on gamma delta T-cells in the burn wound. Conclusions The infiltrating burn wound alpha beta T-cells likely act to quell inflammation. In contrast wound gamma delta T-cells were activated with elevated CD4 and CD69 expression. Thus, these two distinct T cell subsets likely differentially regulate the burn wound inflammatory response.	[Rani, Meenakshi; Schwacha, Martin G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Schwacha, MG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA.	Schwacha@uthscsa.edu			NIH [GM079122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by NIH grant GM079122.	Alexander M, 2006, J BURN CARE RES, V27, P18, DOI 10.1097/01.bcr.0000188325.71515.19; Boag SE, 2015, J CLIN INVEST, V125, P3063, DOI 10.1172/JCI80055; Boyce DE, 2000, BRIT J DERMATOL, V143, P59, DOI 10.1046/j.1365-2133.2000.03591.x; Cowley SC, 2005, J EXP MED, V202, P309, DOI 10.1084/jem.20050569; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; De Silva K, 2001, WOUND REPAIR REGEN, V9, P495, DOI 10.1046/j.1524-475x.2001.00495.x; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Frederiksen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137635; Gao Y, 2015, HUM IMMUNOL, V76, P801, DOI 10.1016/j.humimm.2015.09.039; Guo ZJ, 2003, J IMMUNOL, V171, P3983, DOI 10.4049/jimmunol.171.8.3983; Ipaktchi K, 2006, J IMMUNOL, V177, P8065, DOI 10.4049/jimmunol.177.11.8065; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; Leoni G, 2015, MUCOSAL IMMUNOL, V8, P959, DOI 10.1038/mi.2015.63; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Mace JE, 2012, BURNS, V38, P599, DOI 10.1016/j.burns.2011.10.013; Matsuo R, 1997, J TRAUMA, V42, P635, DOI 10.1097/00005373-199704000-00009; Matsushima A, 2004, SHOCK, V22, P11, DOI 10.1097/01.shk.0000129203.84330.b3; Moore K, 1997, BRIT J DERMATOL, V137, P188, DOI 10.1046/j.1365-2133.1997.18041895.x; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Purcell EM, 2006, SHOCK, V25, P135, DOI 10.1097/01.shk.0000190824.51653.32; Pyter LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161537; Rani M, 2015, SHOCK, V43, P589, DOI 10.1097/SHK.0000000000000358; Rani M, 2015, INNATE IMMUN-LONDON, V21, P140, DOI 10.1177/1753425913519350; Rani M, 2014, SHOCK, V42, P133, DOI 10.1097/SHK.0000000000000176; Rani M, 2014, J BURN CARE RES, V35, P46, DOI 10.1097/01.bcr.0000440705.91099.cc; Sasaki JR, 2011, BURNS, V37, P646, DOI 10.1016/j.burns.2011.01.028; Schwacha MG, 2009, BURNS, V35, P318, DOI 10.1016/j.burns.2008.08.002; Serrano-Villar S, 2015, LANCET HIV, V2, pE76, DOI 10.1016/S2352-3018(15)00018-1; Wang K, 2008, BURNS, V34, P234, DOI 10.1016/j.burns.2007.03.011; Wistuba-Hamprecht K, 2016, INT J CANCER, V138, P698, DOI 10.1002/ijc.29818; Zhang JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062001	36	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0179015	10.1371/journal.pone.0179015	http://dx.doi.org/10.1371/journal.pone.0179015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575063	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300144
J	Turku, A; Rinne, MK; af Gennas, GB; Xhaard, H; Lindholm, D; Kukkonen, JP				Turku, Ainoleena; Rinne, Maiju K.; af Gennas, Gustav Boije; Xhaard, Henri; Lindholm, Dan; Kukkonen, Jyrki P.			Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity	PLOS ONE			English	Article							OX1 RECEPTOR; CELL-DEATH; ANTAGONISTS; WAKEFULNESS; NARCOLEPSY; APOPTOSIS; CANCER; MODEL	Two promising lead structures of small molecular orexin receptor agonist have been reported, but without detailed analyses of the pharmacological properties. One of them, 1(3,4-dichloropheny1)-242-imino-3-(4-methylbenzy1)-2,3-dihydro-1H-benzo[climidazol-1-yl] ethan-1-ol (Yan 7874), is commercially available, and we set out to analyze its properties. As test system we utilized human OX1 and OX2 orexin receptor -expressing Chinese hamster ovary (CHO) K1 cells as well as control CHO-K1 and neuro-2a neuroblastoma cells. Gq-coupling was assessed by measurement of intracellular Ca2+ and phospholipase C activity, and the coupling to G(i) and G(s) by adenylyl cyclase inhibition and stimulation, respectively. At concentrations above 1 pM, strong Ca' and low phospholipase C responses to Yan 7874 were observed in both OX1- and OX2-expressing cells. However, a major fraction of the response was not mediated by orexin receptors, as determined utilizing the nonselective orexin receptor antagonist N-biphenyl-2-y1-1-{[(1-methyl-1H-benzimidazol-2-y1) sulfanyl]acetyl}-L-prolinamide (TCS 1102) as well as control CHO-K1 cells. Yan 7874 did not produce any specific adenylyl cyclase response. Some experiments suggested an effect on cell viability by Yan 7874, and we thus analyzed this. Within a few hours of exposure, Yan 7874 markedly changed cell morphology (shrunken, rich in vacuoles), reduced growth, promoted cell detachment, and induced necrotic cell death. The effect was equal in cells expressing orexin receptors or not. Thus, Yan 7874 is a weak partial agonist of orexin receptors. It also displays strong off -target effects in the same concentration range, culminating in necrotic cell demise. This makes Yan 7874 unsuitable as orexin receptor agonist.	[Turku, Ainoleena; Rinne, Maiju K.; Kukkonen, Jyrki P.] Univ Helsinki, Dept Vet Biosci, Biochem & Cell Biol, Helsinki, Finland; [Turku, Ainoleena; Rinne, Maiju K.; af Gennas, Gustav Boije; Xhaard, Henri] Univ Helsinki, Div Pharmaceut Chem & Technol, Fac Pharm, Helsinki, Finland; [Lindholm, Dan] Univ Helsinki, Dept Biochem & Dev Biol, Med, Fac Med, Helsinki, Finland; [Lindholm, Dan] Minerva Fdn, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Kukkonen, JP (corresponding author), Univ Helsinki, Dept Vet Biosci, Biochem & Cell Biol, Helsinki, Finland.	jyrki.kukkonen@helsinki.fi	Boije af Gennas, Gustav/N-4545-2015	Boije af Gennas, Gustav/0000-0002-0099-6085; Rinne, Maiju/0000-0003-3218-2841; Kukkonen, Jyrki/0000-0002-6989-1564; Turku, Ainoleena/0000-0003-0959-7221	Academy of Finland [257685]; Finnish Cultural Foundation; University of Helsinki Research Funds; Waldemar von Frenckell Foundation; Liv & Halsa Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); University of Helsinki Research Funds; Waldemar von Frenckell Foundation; Liv & Halsa Foundation	Support was provided by the Academy of Finland, Gustav Boije af Gennas, grant number 257685 [http://www.aka.fi/en/]; Finnish Cultural Foundation, Ainoleena Turku [https://skr.fi/en]; University of Helsinki Research Funds, Henri Xhaard [https://www.helsinki.fi/en/studying/during-your-studies/apply-for-a-grant]; Magnus Ehrnrooth Foundation, Dan Lindholm, Jyrki Kukkonen [http://www.magliusehrnroothinsaatio.fi/en/]; Waldemar von Frenckell Foundation, Gustav Boije of Gennas [http://www.fourdationweb.net/frenckell/]; Liv & Halsa Foundation, Dan Lindholm, Jyrki Kukkonen [http://www.livochhalda.fi/].	Alexandre D, 2014, EUR J CANCER, V50, P2126, DOI 10.1016/j.ejca.2014.05.008; Ammoun S, 2006, J BIOL CHEM, V281, P834, DOI 10.1074/jbc.M508603200; Coleman PJ, 2010, EXPERT OPIN THER PAT, V20, P307, DOI 10.1517/13543770903567085; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Gotter AL, 2012, PROG BRAIN RES, V198, P163, DOI 10.1016/B978-0-444-59489-1.00010-0; Hasegawa E, 2014, J CLIN INVEST, V124, P604, DOI 10.1172/JCI71017; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; Holmqvist T, 2002, FEBS LETT, V526, P11, DOI 10.1016/S0014-5793(02)03101-0; Jantti MH, 2012, BRIT J PHARMACOL, V165, P1109, DOI 10.1111/j.1476-5381.2011.01565.x; Kantor S, 2013, SLEEP, V36, P1129, DOI 10.5665/sleep.2870; Kukkonen JP, 2016, BIOCHEM BIOPH RES CO, V476, P379, DOI 10.1016/j.bbrc.2016.05.130; Kukkonen JP, 2016, CELL SIGNAL, V28, P51, DOI 10.1016/j.cellsig.2015.11.009; Kukkonen JP, 2013, AM J PHYSIOL-CELL PH, V304, pC2, DOI 10.1152/ajpcell.00227.2012; Leonard CS, 2014, BRIT J PHARMACOL, V171, P294, DOI 10.1111/bph.12296; Lund PE, 2000, J BIOL CHEM, V275, P30806, DOI 10.1074/jbc.M002603200; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Nagahara T, 2015, J MED CHEM, V58, P7931, DOI 10.1021/acs.jmedchem.5b00988; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Perez-Leighton CE, 2013, INT J OBESITY, V37, P167, DOI 10.1038/ijo.2012.30; Putula J, 2011, NEUROSCI LETT, V494, P57, DOI 10.1016/j.neulet.2011.02.055; Roecker AJ, 2008, CURR TOP MED CHEM, V8, P977, DOI 10.2174/156802608784936746; Roecker AJ, 2016, J MED CHEM, V59, P504, DOI 10.1021/acs.jmedchem.5b00832; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Turku A, 2016, J MED CHEM, V59, P8263, DOI 10.1021/acs.jmedchem.6b00333; Turunen PM, 2012, MOL PHARMACOL, V82, P156, DOI 10.1124/mol.112.078063; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; Yanagisawa M., 2010, Patent US, Patent No. [20100150840A1, 20100150840, US 2010/0150840 A1]	30	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178526	10.1371/journal.pone.0178526	http://dx.doi.org/10.1371/journal.pone.0178526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575023	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300061
J	Uemura, H; Katsuura-Kamano, S; Yamaguchi, M; Bahari, T; Ishizu, M; Fujioka, M; Arisawa, K				Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Bahari, Tirani; Ishizu, Masashi; Fujioka, Miho; Arisawa, Kokichi			Relationships of serum high-sensitivity Creactive protein and body size with insulin resistance in a Japanese cohort	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FOOD FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; ARTERIAL STIFFNESS; MASS INDEX; INFLAMMATION; METAANALYSIS; POPULATION; OBESITY	Background Impacts of chronic systemic inflammation and body size and their interaction effect on insulin resistance in Asian populations, in whom obesity is less common, are not fully understood. This study evaluated combined relationships of systemic inflammation and body size with insulin resistance in a Japanese cohort. Methods We analyzed cross-sectional data from 1,074 eligible subjects (536 men and 538 women) aged 35-69 years who participated in the baseline survey of a cohort study in Tokushima Prefecture, Japan. Systemic inflammation level was assessed by serum high-sensitivity Creactive protein (hs-CRP), and the degree of insulin resistance and beta-cell function were evaluated by the homeostasis model assessment insulin resistance (HOMA-IR) and betacell function (HOMA-beta), respectively. Overweight and obesity were defined as a body mass index (BMI) of 23.0-24.9 kg/m(2) and >= 25.0 kg/m(2), respectively. Associations between serum hs-CRP (assessed as quartiles and additionally continuous values after log-transformation) and indices of glucose homeostasis were analysed adjusting for probable covariates, including BMI (quartiles). Combined associations of serum hs-CRP (<= median, >median) and body size (normal, overweight, obese) with insulin resistance as well as their interaction effect on insulin resistance were also evaluated. Results Serum hs-CRP was dose-dependently associated with HOMA-IR, but not HOMA-beta, after adjustment for probable covariates, including BMI. Subjects with obesity and elevated serum hs-CRP (>median) showed a high multivariable-adjusted HOMA-IR value of 1.32 (95% confidence interval (CI) 1.23, 1.41) compared with subjects with normal BMI and low serum hs-CRP (<= median) whose multivariable-adjusted HOMA-IR value was 1.14 (95% CI 1.06, 1.21). The interaction effect between body size (normal, overweight, obese) and serum hs-CRP (<= median, >median) on HOMA-IR was significant (P for interaction <0.001). Conclusions Our study suggests that elevated systemic inflammation is dose-dependently associated with increased insulin resistance, independent of the known risk factors, in a Japanese population. Concomitant obesity and elevated systemic inflammation may synergistically contribute to increased insulin resistance.	[Uemura, Hirokazu; Katsuura-Kamano, Sakurako; Yamaguchi, Miwa; Bahari, Tirani; Ishizu, Masashi; Fujioka, Miho; Arisawa, Kokichi] Tokushima Univ, Inst Biomed Sci, Dept Prevent Med, Tokushima, Tokushima, Japan	Tokushima University	Uemura, H (corresponding author), Tokushima Univ, Inst Biomed Sci, Dept Prevent Med, Tokushima, Tokushima, Japan.	uemura.hirokazu@tokushima-u.ac.jp		Uemura, Hirokazu/0000-0002-0443-4266; Ishizu, Masashi/0000-0003-1209-0878	Scientific Research on Priority Areas of Cancer [17015018]; Innovative Areas [221S0001]; Platform of Supporting Cohort Study and Biospecimen Analysis (JSPSKAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology [JP16H06277]; Japan Society for the Promotion of Science [JP15K08778]	Scientific Research on Priority Areas of Cancer; Innovative Areas; Platform of Supporting Cohort Study and Biospecimen Analysis (JSPSKAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in partby Grants-in-Aid for Scientific Research on Priority Areas of Cancer (No.17015018) (KA), on Innovative Areas (No.221S0001) (KA), and Platform of Supporting Cohort Study and Biospecimen Analysis (JSPSKAKENHI Grant Number JP16H06277) (KA)from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/),and by Grants-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant Number JP15K08778) (HU,KA, SK-K)from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bermudez V., 2016, ADV PREV MED, V2016; Bertoni AG, 2010, DIABETES CARE, V33, P804, DOI 10.2337/dc09-1679; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Festa A, 2003, CIRCULATION, V108, P1822, DOI 10.1161/01.CIR.0000091339.70120.53; Fowler MJ, 2011, CLIN DIABETES, V29, P116, DOI [10.2337/diaclin.29.3.116, DOI 10.2337/DIACLIN.29.3.116]; Fujimoto WY, 1996, DIABETIC MED, V13, pS7; Goto C., 2006, Scandinavian Journal of Food & Nutrition, V50, P77, DOI 10.1080/11026480600568720; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herder C, 2016, EUR J ENDOCRINOL, V175, P367, DOI 10.1530/EJE-16-0528; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Imaeda N, 2007, J EPIDEMIOL, V17, P100, DOI 10.2188/jea.17.100; Kanazawa M, 2002, ASIA PAC J CLIN NUTR, V11, pS732, DOI 10.1046/j.1440-6047.11.s8.19.x; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Lee WY, 2004, INT J CARDIOL, V97, P101, DOI 10.1016/j.ijcard.2003.08.016; Low S, 2009, ANN ACAD MED SINGAP, V38, P66; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; The International Association for the Study of Obesity and the International Obesity Task Force, 2000, THE ASIA PACIFIC PER; Tokudome Shinkan, 2004, Asian Pac J Cancer Prev, V5, P40; Tokudome Y, 2005, J EPIDEMIOL, V15, P135, DOI 10.2188/jea.15.135; Uemura H, 2015, ATHEROSCLEROSIS, V238, P83, DOI 10.1016/j.atherosclerosis.2014.11.021; Uemura H, 2014, BRIT J NUTR, V112, P1333, DOI 10.1017/S0007114514002153; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Xi LA, 2011, HEPATOLOGY, V53, P127, DOI 10.1002/hep.24011	37	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178672	10.1371/journal.pone.0178672	http://dx.doi.org/10.1371/journal.pone.0178672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575103	Green Published, gold			2022-12-26	WOS:000402624300093
J	Carreras-Torres, R; Johansson, M; Haycock, PC; Wade, KH; Relton, CL; Martin, RM; Smith, GD; Albanes, D; Aldrich, MC; Andrew, A; Arnold, SM; Bickeboller, H; Bojesen, SE; Brunnstrom, H; Manjer, J; Bruske, I; Caporaso, NE; Chen, C; Christiani, DC; Christian, WJ; Doherty, JA; Duell, EJ; Field, JK; Davies, MPA; Marcus, MW; Goodman, GE; Grankvist, K; Haugen, A; Hong, YC; Kiemeney, LA; van der Heijden, EHFM; Kraft, P; Johansson, MB; Lam, S; Landi, MT; Lazarus, P; Le Marchand, L; Liu, G; Melander, O; Park, SL; Rennert, G; Risch, A; Haura, EB; Scelo, G; Zaridze, D; Mukeriya, A; Savic, M; Lissowska, J; Swiatkowska, B; Janout, V; Holcatova, I; Mates, D; Schabath, MB; Shen, HB; Tardon, A; Teare, D; Woll, P; Tsao, MS; Wu, XF; Yuan, JM; Hung, RJ; Amos, CI; McKay, J; Brennan, P				Carreras-Torres, Robert; Johansson, Mattias; Haycock, Philip C.; Wade, Kaitlin H.; Relton, Caroline L.; Martin, Richard M.; Smith, George Davey; Albanes, Demetrius; Aldrich, Melinda C.; Andrew, Angeline; Arnold, Susanne M.; Bickeboeller, Heike; Bojesen, Stig E.; Brunnstrom, Hans; Manjer, Jonas; Brueske, Irene; Caporaso, Neil E.; Chen, Chu; Christiani, David C.; Christian, W. Jay; Doherty, Jennifer A.; Duell, Eric J.; Field, John K.; Davies, Michael P. A.; Marcus, Michael W.; Goodman, Gary E.; Grankvist, Kjell; Haugen, Aage; Hong, Yun-Chul; Kiemeney, Lambertus A.; van der Heijden, Erik H. F. M.; Kraft, Peter; Johansson, Mikael B.; Lam, Stephen; Landi, Maria Teresa; Lazarus, Philip; Le Marchand, Loic; Liu, Geoffrey; Melander, Olle; Park, Sungshim L.; Rennert, Gad; Risch, Angela; Haura, Eric B.; Scelo, Ghislaine; Zaridze, David; Mukeriya, Anush; Savic, Milan; Lissowska, Jolanta; Swiatkowska, Beata; Janout, Vladimir; Holcatova, Ivana; Mates, Dana; Schabath, Matthew B.; Shen, Hongbing; Tardon, Adonina; Teare, Dawn; Woll, Penella; Tsao, Ming-Sound; Wu, Xifeng; Yuan, Jian-Min; Hung, Rayjean J.; Amos, Christopher I.; McKay, James; Brennan, Paul			Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study	PLOS ONE			English	Article							BODY-MASS INDEX; GENETIC-VARIATION; ADIPOSITY; VARIANTS; IDENTIFY; INSIGHTS; TRAITS; LIPIDS; LINK	Background Assessing the relationship between lung cancer and metabolic conditions is challenging because of the confounding effect of tobacco. Mendelian randomization (MR), or the use of genetic instrumental variables to assess causality, may help to identify the metabolic drivers of lung cancer. Methods and findings We identified genetic instruments for potential metabolic risk factors and evaluated these in relation to risk using 29,266 lung cancer cases (including 11,273 adenocarcinomas, 7,426 squamous cell and 2,664 small cell cases) and 56,450 controls. The MR risk analysis suggested a causal effect of body mass index (BMI) on lung cancer risk for two of the three major histological subtypes, with evidence of a risk increase for squamous cell carcinoma (odds ratio (OR) [95% confidence interval (CI)] = 1.20 [1.01-1.43] and for small cell lung cancer (OR [95% CI] = 1.52 [1.15-2.00]) for each standard deviation (SD) increase in BMI [4.6 kg/m(2)]), but not for adenocarcinoma (OR [95% CI] = 0.93 [0.79-1.08]) (P-heterogeneity = 4.3x10(-3)). Additional analysis using a genetic instrument for BMI showed that each SD increase in BMI increased cigarette consumption by 1.27 cigarettes per day (P = 2.1x10(-3)), providing novel evidence that a genetic susceptibility to obesity influences smoking patterns. There was also evidence that low-density lipoprotein cholesterol was inversely associated with lung cancer overall risk (OR [95% CI] = 0.90 [0.84-0.97] per SD of 38 mg/dl), while fasting insulin was positively associated (OR [95% CI] = 1.63 [1.25-2.13] per SD of 44.4 pmol/l). Sensitivity analyses including a weighted-median approach and MR-Egger test did not detect other pleiotropic effects biasing the main results. Conclusions Our results are consistent with a causal role of fasting insulin and low-density lipoprotein cholesterol in lung cancer etiology, as well as for BMI in squamous cell and small cell carcinoma. The latter relation may be mediated by a previously unrecognized effect of obesity on smoking behavior.	[Carreras-Torres, Robert; Johansson, Mattias; Scelo, Ghislaine; McKay, James; Brennan, Paul] IARC, Genet Sect, Lyon, France; [Haycock, Philip C.; Wade, Kaitlin H.; Relton, Caroline L.; Martin, Richard M.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol, Bristol, Avon, England; [Martin, Richard M.] Diet & Lifestyle Univ Hosp Bristol NHS Fdn Trust, Res Biomed Res Unit Nutr, NIH, Bristol, Avon, England; [Martin, Richard M.] Univ Bristol, Bristol, Avon, England; [Albanes, Demetrius] NIH, Natl Canc Inst, DCEG, Metab Epidemiol Branch, Rockville, MD USA; [Aldrich, Melinda C.] Vanderbilt Univ, Med Ctr, Dept Thorac Surg, Div Epidemiol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Andrew, Angeline] Norris Cotton Canc Ctr, Lebanon, NH USA; [Arnold, Susanne M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Bickeboeller, Heike] Univ Med Ctr Gottingen, Gottingen, Germany; [Bojesen, Stig E.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Brunnstrom, Hans; Manjer, Jonas] Lund Univ, Dept Clin Sci Lund, Lab Med Reg Skane, Lund, Sweden; [Brueske, Irene] Helmholtz Zentrum Munchen, Munich, Germany; [Caporaso, Neil E.; Landi, Maria Teresa] NIH, Natl Canc Inst, DCEG, Genet Epidemiol Branch, Rockville, MD USA; [Chen, Chu] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, 1124 Columbia St, Seattle, WA 98104 USA; [Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Christiani, David C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Christiani, David C.] Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Christian, W. Jay] Univ Kentucky, Coll Publ Hlth, Dept Epidemiol, Lexington, KY USA; [Doherty, Jennifer A.] Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, 1 Med Ctr Dr, Lebanon, NH 03756 USA; [Duell, Eric J.] Catalan Inst Oncol ICO IDIBELL, Unit Nutr & Canc, Canc Epidemiol Res Program, Barcelona, Spain; [Field, John K.; Davies, Michael P. A.; Marcus, Michael W.] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England; [Goodman, Gary E.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Grankvist, Kjell; Johansson, Mikael B.] Umea Univ, Dept Med Biosci, Umea, Sweden; [Haugen, Aage] Natl Inst Occupat Hlth, Oslo, Norway; [Hong, Yun-Chul] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kiemeney, Lambertus A.; van der Heijden, Erik H. F. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Kraft, Peter] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Lam, Stephen] British Columbia Canc Agcy, Vancouver, BC, Canada; [Lazarus, Philip] Washington State Univ, Coll Pharm, Spokane, WA USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Liu, Geoffrey] Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Park, Sungshim L.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Rennert, Gad] Technion Israel Inst Technol, Clalit Natl Canc Control Ctr, Haifa, Israel; [Rennert, Gad] Technion Israel Inst Technol, Dept Community Med & Epidemiol, Carmel Med Ctr, Haifa, Israel; [Rennert, Gad] Technion Israel Inst Technol, B Rappaport Fac Med, Haifa, Israel; [Risch, Angela] Univ Salzburg, Salzburg, Austria; [Risch, Angela] Canc Cluster Salzburg, Salzburg, Austria; [Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Zaridze, David; Mukeriya, Anush] Russian NN Blokhin Canc Res Ctr, Moscow, Russia; [Savic, Milan] Clin Ctr Serbia, Dept Thorac Surg, Belgrade, Serbia; [Lissowska, Jolanta] Maria Sklodowska Curie Inst Oncol Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Swiatkowska, Beata] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland; [Janout, Vladimir] Univ Ostrava, Fac Med, Dept Epidemiol & Publ Hlth, Ostrava, Czech Republic; [Holcatova, Ivana] Charles Univ Prague, Fac Med 2, Inst Publ Hlth & Prevent Med, Prague, Czech Republic; [Mates, Dana] Natl Inst Publ Hlth, Bucharest, Romania; [Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Collaborat Innovat Ctr Canc Personalized Med,Dept, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China; [Tardon, Adonina] Univ Oviedo, IUOPA, Oviedo, Spain; [Tardon, Adonina] CIBERESP, Oviedo, Spain; [Teare, Dawn; Woll, Penella] Univ Sheffield, Sheffield, S Yorkshire, England; [Tsao, Ming-Sound] Princess Margaret Canc Ctr, Toronto, ON, Canada; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Hung, Rayjean J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Amos, Christopher I.] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, 1 Med Ctr Dr, Lebanon, NH 03756 USA	World Health Organization; International Agency for Research on Cancer (IARC); University of Bristol; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Norris Cotton Cancer Center; University of Kentucky; University of Gottingen; University of Copenhagen; Lund University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Kentucky; Dartmouth College; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Liverpool; Fred Hutchinson Cancer Center; Umea University; Seoul National University (SNU); Radboud University Nijmegen; Harvard University; Harvard T.H. Chan School of Public Health; British Columbia Cancer Agency; Washington State University; Cancer Research Center of Hawaii; University of Hawaii System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Lund University; Lund University; Skane University Hospital; University of Southern California; Technion Israel Institute of Technology; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Salzburg University; H Lee Moffitt Cancer Center & Research Institute; N.N. Blokhin Russian Cancer Research Center; Clinical Centre of Serbia; Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Ostrava; Charles University Prague; H Lee Moffitt Cancer Center & Research Institute; Nanjing Medical University; University of Oviedo; Instituto Universitario de Oncologia de Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Sheffield; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Dartmouth College	Brennan, P (corresponding author), IARC, Genet Sect, Lyon, France.	gep@iarc.fr	Risch, Angela/H-2669-2013; Tsao, Ming-Sound/M-3503-2017; Brunnström, Hans/AAZ-6803-2020; TARDON, ADONINA/B-6563-2014; Johansson, Mattias/ABF-3365-2020; Hong, Yun-Chul/J-5725-2012; Carreras-Torres, Robert/E-3887-2019; Davies, Michael/GWV-2527-2022; Schabath, Matthew B./J-3763-2016; Bickeböller, Heike/V-2318-2018; Relton, Caroline/AAC-5904-2019; Field, John K./AAD-5674-2020; van der Heijden, Erik H.F.M/D-3774-2009; Johansson, Mikael/AAI-7688-2020; Arnold, S./L-4176-2015; Lissowska, Jolanta/AAH-3252-2020; Kraft, Peter/GQH-8448-2022; Tsao, Ming Sound/AFQ-7332-2022; Kiemeney, Lambertus A./D-3357-2009; Davey Smith, George/A-7407-2013; Scelo, Ghislaine/CAF-8077-2022; Hung, Rayjean J/A-7439-2013; Haycock, Philip/I-6188-2019	Risch, Angela/0000-0002-8026-5505; Brunnström, Hans/0000-0001-7402-138X; TARDON, ADONINA/0000-0001-5150-1209; Carreras-Torres, Robert/0000-0002-2925-734X; Schabath, Matthew B./0000-0003-3241-3216; Bickeböller, Heike/0000-0002-3361-5488; Field, John K./0000-0003-3951-6365; van der Heijden, Erik H.F.M/0000-0003-3596-518X; Lissowska, Jolanta/0000-0003-2695-5799; Tsao, Ming Sound/0000-0002-9160-5405; Kiemeney, Lambertus A./0000-0002-2368-1326; Davey Smith, George/0000-0002-1407-8314; Haycock, Philip/0000-0001-5001-3350; Bojesen, Stig/0000-0002-4061-4133; Melander, Olle/0000-0002-2581-484X; Johansson, Mattias/0000-0002-3116-5081; Teare, Marion Dawn/0000-0003-3994-0051; Liu, Geoffrey/0000-0002-2603-7296; Swiatkowska, Beata/0000-0003-3757-3868; Relton, Caroline/0000-0003-2052-4840; Rennert, Gad/0000-0002-8512-068X; Wade, Kaitlin/0000-0003-3362-6280; Christian, Warren/0000-0001-6904-3971; Hung, Rayjean/0000-0002-4486-7496; Woll, Penella/0000-0002-1118-0831; Martin, Richard/0000-0002-7992-7719; Grankvist, Kjell/0000-0003-4289-2097; Arnold, Susanne/0000-0001-6542-9551; Kraft, Peter/0000-0002-4472-8103; Shen, Hongbing/0000-0002-2581-5906; Davies, Michael Peter Alan/0000-0002-7609-4977; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Cancer Research UK [C18281/A19169]; National Institute for Health Research (NIHR) Bristol Nutritional Biomedical Research Unit basedat University Hospitals Bristol NHS Foundation Trust; University of Bristol; MRC Integrative Epidemiology Unit at the University of Bristol [MC_UU_12013/1, MC_UU_12013/2]; Cancer Research UK Population Research Postdoctoral Fellowship [C52724/A20138]; Department of Defense [10153006 (W81XWH-11-1-0781)]; UK Center for Clinical and Translational Science [UL1TR000117]; U.S. National Institutes of Health [R01 CM 44034, UM1 CM 82876]; National Cancer Institute; National Institute of Health [5-UM1-CA-167462, U01-CA63673, R01-CA111703, 5R01-CA151989-01A1]; MRC [MC_UU_12013/2, MC_UU_12013/1] Funding Source: UKRI; Cancer Research UK [20622, 19169] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1, MC_UU_12013/2] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA119997, UM1CA167462, ZIACP010195, P30CA076292, K07CA172294, P30CA023108, R35CA197449, R01CA151989] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Bristol Nutritional Biomedical Research Unit basedat University Hospitals Bristol NHS Foundation Trust; University of Bristol; MRC Integrative Epidemiology Unit at the University of Bristol(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Population Research Postdoctoral Fellowship; Department of Defense(United States Department of Defense); UK Center for Clinical and Translational Science; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RCT, MJ, PCH, KHW, CR, RMM, GDS, and PB are investigators or researchers on a Cancer Research UK (C18281/A19169) Programme Grant (the Integrative Cancer Epidemiology Programme). RMM is supported by the National Institute for Health Research (NIHR) Bristol Nutritional Biomedical Research Unit basedat University Hospitals Bristol NHS Foundation Trust and the University of Bristol. CLR and GDS are supported by funding from the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_12013/1, MC_UU_12013/2). PCH is supported by a Cancer Research UK Population Research Postdoctoral Fellowship (C52724/A20138). SMA was supported by the Department of Defense under award number: 10153006 (W81XWH-11-1-0781) and by the UK Center for Clinical and Translational Science, (UL1TR000117). JMY is partially supported by the U.S. National Institutes of Health Grants (R01 CM 44034 and UM1 CM 82876). CARET investigators would like to thank the study participants for their involvement and acknowledge the National Cancer Institute and National Institute of Health for their grant support: 5-UM1-CA-167462, (PI Gary E. Goodman), U01-CA63673 (Pls G. Omenn, G. Goodman), R01-CA111703 (PI Chu Chen), and 5R01-CA151989-01A1 (PI Jennifer Doherty).	Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Bowden J, 2016, INT J EPIDEMIOL, P1; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Burgess S, 2014, EUR J EPIDEMIOL, P1; Burgess S, 2016, J CLIN EPIDEMIOL, V69, P208, DOI 10.1016/j.jclinepi.2015.08.001; Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Carreras-Torres R, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx012; Carreras-Torres R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31121; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gao C, 2016, INT J EPIDEMIOL, V45, P896, DOI 10.1093/ije/dyw129; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Hemani G, 2016, BIORXIV; Ho GYF, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw012; International Agency for Research on Cancer, 2015, LIST CLASS CANC SIT, V1; Kabat GC, 2008, AM J EPIDEMIOL, V168, P158, DOI 10.1093/aje/kwn109; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kucharska-Newton AM, 2008, LUNG CANCER, V61, P292, DOI 10.1016/j.lungcan.2008.01.015; Lam TK, 2013, PLOS ONE, P8; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; McKay JD, 2017, NAT GENET; Melkonian SC, 2016, CANCER EPIDEM BIOMAR, V25, P532, DOI 10.1158/1055-9965.EPI-15-0765; Nead KT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv178; Puchades-Carrasco L, 2016, ONCOTARGET, V7, P12904, DOI 10.18632/oncotarget.7354; Radisauskas R, 2016, MEDICINA-LITHUANIA, V52, P89, DOI 10.1016/j.medici.2016.03.002; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Taylor AE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004799; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Winslow UC, 2015, INT J EPIDEMIOL, V44, P540, DOI 10.1093/ije/dyu276; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719	42	59	64	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177875	10.1371/journal.pone.0177875	http://dx.doi.org/10.1371/journal.pone.0177875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594918	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000402923200013
J	Pielech, R; Zajac, K; Kadej, M; Malicki, M; Malkiewicz, A; Tarnawski, D				Pielech, Remigiusz; Zajac, Krzysztof; Kadej, Marcin; Malicki, Marek; Malkiewicz, Adam; Tarnawski, Dariusz			Ellenberg's indicator values support prediction of suitable habitat for pre-diapause larvae of endangered butterfly Euphydryas aurinia	PLOS ONE			English	Article							MARSH FRITILLARY; METAPOPULATION STRUCTURE; VEGETATION; LEPIDOPTERA; TOOL; REQUIREMENTS; CONSERVATION; POPULATIONS; GRASSLANDS; ROTTEMBURG	In spite of the great popularity of Ellenberg's Indicator Values (EIVs) in plant ecology, animal ecologists seldom use EIVs to address ecological questions. In this study we used EIVs to test their potential usefulness for the prediction of suitable habitat for pre-diapause larvae of the endangered butterfly species Euphydryas aurinia. Nine transects crossing grasslands in SW Poland with abundant populations of E. aurinia were designed. We sampled 76 vegetation plots along the transects. In addition, the presence of the larval webs of E. aurinia in sampled plots was also recorded. We then calculated the mean community EIVs of light, nitrogen, soil reaction, moisture and temperature for each sample plots. Generalized linear mixed-effects models (GLMMs) were used to assess which factors determine the local occurrence of larval webs of E. aurinia. We found the larval webs only in 12 plots, while the host plant was present in 39 of the examined plots. The presence of the host plant was the most important predictor in both models including all plots or including only plots with host plants. The other significant predictor was the mean EIV of light, and its importance increased in models considering all plots. We attributed the importance of the EIV of light to the site openness and density of the vegetation layer. A positive relationship between this predictor and the presence of larval webs indicates that sites with looser vegetation, a lower contribution of shrubs and tall herbs and better penetration of photosynthetically active radiation to lower vegetation layers are preferred by E. aurinia for oviposition. Moreover, the significance of EIV of light may be linked with management practices. Many light-demanding species decline after cessation of mowing as a result of litter accumulation and the dominance of tall herbs. An absence of light-demanding species decreases the community's mean EIV of light and thus indicates the influence of meadow abandonment.	[Pielech, Remigiusz] Univ Agr, Inst Forest Ecol & Silviculture, Dept Forest Biodivers, Krakow, Poland; [Zajac, Krzysztof; Kadej, Marcin; Malkiewicz, Adam; Tarnawski, Dariusz] Univ Wroclaw, Dept Invertebrate Biol Evolut & Conservat, Inst Environm Biol, Wroclaw, Poland; [Malicki, Marek] Univ Wroclaw, Dept Bot, Inst Environm Biol, Wroclaw, Poland	Agricultural University Krakow; University of Wroclaw; University of Wroclaw	Kadej, M (corresponding author), Univ Wroclaw, Dept Invertebrate Biol Evolut & Conservat, Inst Environm Biol, Wroclaw, Poland.	marcin.kadej@uwr.edu.pl	Zając, Krzysztof/AAI-5437-2020; Pielech, Remigiusz/A-7403-2015; Pielech, Remigiusz/K-9932-2019; Kadej, Marcin/E-5916-2018	Zając, Krzysztof/0000-0001-9030-0477; Pielech, Remigiusz/0000-0001-8879-3305; Kadej, Marcin/0000-0001-5983-0402; Malkiewicz, Adam/0000-0001-6244-7121; Malicki, Marek/0000-0003-0517-3560	University of Wrocoaw [1076/S/IBS/2017]	University of Wrocoaw	This work was supported by the University of Wrocoaw no. 1076/S/IBS/2017 to DT and MK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2010-1.RLTS; Anthes N, 2003, J INSECT CONSERV, V7, P175, DOI 10.1023/A:1027330422958; Bates D.B., 2015, PACKAGE LME4 LINEAR; Betzholtz PE, 2007, J INSECT CONSERV, V11, P343, DOI 10.1007/s10841-006-9048-3; Botham MS, 2011, J INSECT CONSERV, V15, P269, DOI 10.1007/s10841-010-9344-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chytry A M, 2013, VEGETATION CZECH REP; Chytry A M, 2007, VEGETATION CZECH REP; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Diversity K., 2015, PHYTOCOENOLOGIA, V45, P85; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Durak T, 2015, FOREST ECOL MANAG, V351, P47, DOI 10.1016/j.foreco.2015.05.001; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1, DOI DOI 10.1002/FEDR.19931040323; Feest A, 2014, ECOL INDIC, V39, P115, DOI 10.1016/j.ecolind.2013.12.008; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harmuszkiewicz J., 2011, SYLWAN, V155, P572; Hennekens SM, 2001, J VEG SCI, V12, P589, DOI 10.2307/3237010; Hill MO, 1997, J VEG SCI, V8, P579, DOI 10.2307/3237210; Horsak M, 2007, ACTA OECOL, V32, P161, DOI 10.1016/j.actao.2007.03.011; Huhta AP, 2001, J VEG SCI, V12, P677, DOI 10.2307/3236908; Hula V, 2004, ENTOMOL FENNICA, V15, P231; Janecek S, 2013, J VEG SCI, V24, P898, DOI 10.1111/jvs.12012; Jensen K, 2001, PLANT ECOL, V155, P169, DOI 10.1023/A:1013270628964; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Kadej M, TRWALE ZACHOWANIE ZA; Kappes H, 2014, POL J ECOL, V62, P739, DOI 10.3161/104.062.0416; kodova I, 2015, SUBMONTANE SEMINATUR; Kondracki J., 2002, GEOGRAFIA REGIONALNA; Konvicka M, 2003, EUR J ENTOMOL, V100, P313, DOI 10.14411/eje.2003.050; Lemon J, 2015, PACKAGE PLOTRIX VARI; Liu WH, 2006, J INSECT CONSERV, V10, P351, DOI 10.1007/s10841-006-9009-x; Meister H, 2015, J INSECT CONSERV, V19, P691, DOI 10.1007/s10841-015-9792-3; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ockinger E, 2006, BIOL CONSERV, V133, P291, DOI 10.1016/j.biocon.2006.06.009; Oostermeijer JGB, 1998, BIOL CONSERV, V86, P271, DOI 10.1016/S0006-3207(98)00040-8; Pakeman RJ, 2008, J VEG SCI, V19, P201, DOI 10.3170/2007-8-18353; Pinzari Manuela, 2016, Bollettino della Societa Entomologica Italiana, V148, P120; PORTER K, 1982, OIKOS, V38, P308, DOI 10.2307/3544670; Puchalka R, 2015, ACTA SOC BOT POL, V84, P449, DOI 10.5586/asbp.2015.043; Roo-Zielinska E., 2004, FITOINDYKACJA JAKO N; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sebesta J, 2011, FOREST ECOL MANAG, V262, P1265, DOI 10.1016/j.foreco.2011.06.024; Smee M, 2011, J INSECT CONSERV, V15, P153, DOI 10.1007/s10841-010-9334-y; Staffa M, 2003, SLOWNIK GEOGRAFII TU; Stevens CJ, 2016, APPL VEG SCI, V19, P187, DOI 10.1111/avsc.12206; Su, 2015, PACKAGE ARM DATA ANA; Sumberova K, 2013, PHYTOCOENOLOGIA, V43, P13, DOI 10.1127/0340-269X/2013/0043-0529; Szymura TH, 2014, ECOL INDIC, V46, P495, DOI 10.1016/j.ecolind.2014.07.013; Tiitsaar A, 2016, J INSECT CONSERV, V20, P265, DOI 10.1007/s10841-016-9861-2; Tjomiov RS, 2015, J INSECT CONSERV, V19, P377; Tomaselli M, 2005, FLORA, V200, P175, DOI 10.1016/j.flora.2004.04.002; van der Meer S, 2014, POPUL ECOL, V56, P151, DOI 10.1007/s10144-013-0400-7; Van Swaay CAM, 2010, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2010-1.RLTS.T39491A10232607.en; VANDERMAAREL E, 1979, VEGETATIO, V39, P97, DOI 10.1007/BF00052021; Wagner M, 2007, APPL VEG SCI, V10, P15, DOI 10.1111/j.1654-109X.2007.tb00499.x; Wahlberg N, 2002, ECOGRAPHY, V25, P224, DOI 10.1034/j.1600-0587.2002.250210.x; Weber Sonja, 2003, Myrmecologische Nachrichten, V5, P15; Williams CD, 2009, AQUAT ECOL, V43, P117, DOI 10.1007/s10452-007-9149-4; Zeleny D, 2012, J VEG SCI, V23, P419, DOI 10.1111/j.1654-1103.2011.01366.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; [No title captured]	61	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179026	10.1371/journal.pone.0179026	http://dx.doi.org/10.1371/journal.pone.0179026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594890	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200079
J	Carrasco-Marginet, M; Castizo-Olier, J; Rodriguez-Zamora, L; Iglesias, X; Rodriguez, FA; Chaverri, D; Brotons, D; Irurtia, A				Carrasco-Marginet, Marta; Castizo-Olier, Jorge; Rodriguez-Zamora, Lara; Iglesias, Xavier; Rodriguez, Ferran A.; Chaverri, Diego; Brotons, Daniel; Irurtia, Alfredo			Bioelectrical impedance vector analysis (BIVA) for measuring the hydration status in young elite synchronized swimmers	PLOS ONE			English	Article							BODY-COMPOSITION ANALYSIS; BIOIMPEDANCE VECTOR; DEHYDRATION; PERFORMANCE; EXERCISE; HYPOHYDRATION; CHILDREN; HEAT; MASS	Purpose The assessment of body hydration is a complex process, and no measurement is valid for all situations. Bioelectrical impedance vector analysis (BIVA) has emerged as a relatively novel technique for assessing hydration status in sports. We applied BIVA a) to determine hydration changes evoked by an intense synchronized swimming (SS) training session; b) to characterize the sample of young elite swimmers in relation with a nonathletic reference population; and c) to generate its 50%, 75% and 95% percentiles of the bioelectrical variables. Methods Forty-nine elite SS female swimmers of two age categories, comen (C-o: 13.9 +/- 0.9 years, n = 34) and junior (Jr: 16.3 +/- 0.6 years, n = 15), performed a long, high intensity training session. Body mass (BM) and bioelectrical variables (R, resistance; Xc, reactance; PA, phase angle; and Z, impedance module) were assessed pre-and post-training. BIVA was used to characterize 1) the distribution pattern of the bioelectrical vector (BIA vector) for both age groups, and 2) pre- to post-training BIA vector migration. Bioelectrical variables were also correlated with BM change values. Results Most swimmers were mostly located outside the 75% and some beyond the 95% percentile of the bioelectrical tolerance ellipses of the general population. The BIA vector showed statistically significant differences in both Co (T-2 = 134.7, p = 0.0001) and Jr (T-2 = 126.2, p < 0.001). Both groups were also bioelectrically different (T-2 = 17.6, p < 0.001). After the training session, a decrease in BM (p = 0.0001) and an increase in BIA variables (p = 0.01) was observed. BIVA also showed a significant pre-post vector migration both in Co (T-2 = 82.1; p < 0.001) and Jr (T-2 = 41.8; p < 0.001). No correlations were observed between BM changes and bioelectrical variables. Conclusions BIVA showed specific bioelectrical characteristics in young elite SS athletes. Considering the decrease in BM and the migration of the BIA vector, we conclude that the homeostatic hydration status of these young elite female swimmers was affected by the execution of intense training sessions. From a methodological perspective, BIVA appears to be sensitive enough to detect subtle hydration changes, but further research is needed to ensure its validity and reliability. Moreover, these findings highlight the importance of ensuring adequate fluid intake during training in young SS athletes.	[Carrasco-Marginet, Marta; Castizo-Olier, Jorge; Iglesias, Xavier; Rodriguez, Ferran A.; Chaverri, Diego; Irurtia, Alfredo] Univ Barcelona, Natl Inst Phys Educ Catalonia, INEFC Barcelona Sports Sci Res Grp, Barcelona, Spain; [Rodriguez-Zamora, Lara] Mid Sweden Univ, Dept Hlth Sci, Ostersund, Sweden; [Rodriguez-Zamora, Lara] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Ostersund, Sweden; [Brotons, Daniel] Govt Catalonia, Sport & Hlth Area Catalan Sport Council, Barcelona, Spain	University of Barcelona; Mid-Sweden University; Mid-Sweden University	Irurtia, A (corresponding author), Univ Barcelona, Natl Inst Phys Educ Catalonia, INEFC Barcelona Sports Sci Res Grp, Barcelona, Spain.	airurtia@gencat.cat	Iglesias, X/M-7292-2013; Castizo-Olier, Jorge/AAU-4921-2021; Chaverri, Diego DCJ/L-5830-2017; Carrasco-Marginet, Marta/Z-3918-2019; IRURTIA, ALFREDO/R-3360-2019; Rodriguez, Ferran A./H-4892-2011	Iglesias, X/0000-0001-6813-6527; Castizo-Olier, Jorge/0000-0003-0517-9110; Chaverri, Diego DCJ/0000-0003-1885-2677; Carrasco-Marginet, Marta/0000-0002-8531-0993; Rodriguez, Ferran A./0000-0002-2280-8962; Irurtia, Alfredo/0000-0002-3463-6643	Generalitat de Catalunya, Institut Catala de les Dones [U-34/10]; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGUAR) [VCP/3346/2009]; Consejo Superior de Deportes [001/UPB10/11]; AGAUR [VCP/3346/2009]	Generalitat de Catalunya, Institut Catala de les Dones; Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGUAR); Consejo Superior de Deportes; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by research grants from Generalitat de Catalunya, Institut Catala de les Dones (U-34/10) http://www20.gencat.cat/portal/site/icdones, and Agenda de Gestio d'Ajuts Universitaris i de Recerca (AGUAR), (VCP/3346/2009) http://agaur.gencat.cat/es/inici/, and Consejo Superior de Deportes (001/UPB10/11) http://www.csd.gob.es/. Marta Carrasco-Marginet was a pre doctoral researcher also supported by AGAUR (VCP/3346/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli A, 2001, MED SCI SPORT EXER, V33, P507; [Anonymous], 1996, Am J Clin Nutr, V64, p524S, DOI 10.1093/ajcn/64.3.524S; [Anonymous], SCAND J MED SCI SPOR; Aranceta J, 2001, PUBLIC HEALTH NUTR, V4, P1439, DOI 10.1079/PHN2001235; Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Baldwin CE, 2012, JPEN-PARENTER ENTER, V36, P306, DOI 10.1177/0148607111433055; BAROR O, 1980, J APPL PHYSIOL, V48, P104, DOI 10.1152/jappl.1980.48.1.104; Berneis K, 2000, CLIN NUTR, V19, P361, DOI 10.1054/clnu.2000.0133; BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Castillo-Martinez L, 2012, NUTRITION, V28, P886, DOI 10.1016/j.nut.2011.11.024; CATON JR, 1988, MED SCI SPORT EXER, V20, P489; CHERTOW GM, 1995, J AM SOC NEPHROL, V6, P75; Cheuvront SN, 2010, J APPL PHYSIOL, V109, P1989, DOI 10.1152/japplphysiol.00367.2010; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collodel L, 1997, MED SPORT, V50, P197; CONVERTINO V A, 1991, Medicine and Science in Sports and Exercise, V23, P1338; De Lorenzo A, 1985, J APPL PHYSL 1985, V82, P1542; De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0; DEURENBERG P, 1988, EUR J CLIN NUTR, V42, P1017; Evans WD, 1998, APPL RADIAT ISOTOPES, V49, P485, DOI 10.1016/S0969-8043(97)00061-4; FELLMANN N, 1992, SPORTS MED, V13, P37, DOI 10.2165/00007256-199213010-00004; Fortes MB, 2012, APPL PHYSIOL NUTR ME, V37, P850, DOI [10.1139/h2012-054, 10.1139/H2012-054]; Foster C, 1996, Wis Med J, V95, P370; Gatterer H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109729; Gatterer H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073185; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gerth W. A., 1990, Proceedings of Third Annual IEEE Symposium on Computer-Based Medical Systems (Cat. No.90CH2845-6), P446, DOI 10.1109/CBMSYS.1990.109432; GLEICHAUF CN, 1989, AM J CLIN NUTR, V50, P903, DOI 10.1093/ajcn/50.5.903; Goovaerts HG, 1998, PHYSIOL MEAS, V19, P517, DOI 10.1088/0967-3334/19/4/006; Gualdi-Russo E, 2002, HOMO, V53, P1, DOI 10.1078/0018-442X-00035; Jamnik V, 1987, EVALUATION PHYSL RES; Koury JC, 2014, INT J SPORT PHYSIOL, V9, P798, DOI [10.1123/IJSPP.2013-0397, 10.1123/ijspp.2013-0397]; Kushner RF, 1996, AM J CLIN NUTR, V64, P423, DOI 10.1093/ajcn/64.3.423S; Laferriere P, 2011, IEEE T INSTRUM MEAS, V60, P3259, DOI 10.1109/TIM.2011.2164279; LIANG MTC, 1993, MED SCI SPORT EXER, V25, P1231; LOFGREN B, 1951, Acta Physiol Scand Suppl, V81, P1; Lukaski H.C., 2012, HDB ANTHROPOMETRY, P287, DOI [10.1007/978-1-4419-1788-1_16, DOI 10.1007/978-1-4419-1788-1]; LUKASKI HC, 1990, J SPORT MED PHYS FIT, V30, P434; Lukaski HC, 1996, AM J CLIN NUTR, V64, P397, DOI 10.1093/ajcn/64.3.397S; Lukaski HC, 2007, NUTRITION, V23, P543, DOI 10.1016/j.nut.2007.05.001; Lundy B, 2011, INT J SPORT NUTR EXE, V21, P436, DOI 10.1123/ijsnem.21.5.436; LUSSEVELD EM, 1993, ANN NUTR METAB, V37, P44, DOI 10.1159/000177748; Mascherini G, 2015, J SPORT MED PHYS FIT, V55, P749; Maughan RJ, 2007, J SPORT SCI, V25, P797, DOI 10.1080/02640410600875143; McGarvey J, 2010, BRIT J SPORT MED, V44, P716, DOI 10.1136/bjsm.2008.053249; McKee J, 1997, AM J HUM BIOL, V9, P155, DOI 10.1002/(SICI)1520-6300(1997)9:2<155::AID-AJHB1>3.0.CO;2-#; Meyer F, 2012, AM J LIFESTYLE MED, V6, P489, DOI 10.1177/1559827612444525; Micheli ML, 2014, INT J SPORT PHYSIOL, V9, P532, DOI [10.1123/ijspp.2013-0119, 10.1123/IJSPP.2013-0119]; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Moreno MV, 2015, MED BIOL ENG COMPUT, V53, P989, DOI 10.1007/s11517-015-1305-8; Mountjoy M, 1999, CLIN SPORT MED, V18, P321, DOI 10.1016/S0278-5919(05)70148-4; Mountjoy M, 2009, CURR SPORT MED REP, V8, P255, DOI 10.1249/JSR.0b013e3181b84a09; Nescolarde L, 2016, EUR J CLIN NUTR, V70, P1401, DOI 10.1038/ejcn.2016.121; Nescolarde L, 2015, PHYSIOL MEAS, V36, P27, DOI 10.1088/0967-3334/36/1/27; Norman K, 2008, BRIT J NUTR, V100, P590, DOI 10.1017/S0007114508911545; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; O'Brien C, 2002, INT J SPORTS MED, V23, P361, DOI 10.1055/s-2002-33145; Peiffer JJ, 2009, J SCI MED SPORT, V12, P91, DOI 10.1016/j.jsams.2007.10.011; Piccoli A, 2005, CONTRIB NEPHROL, V149, P150, DOI 10.1159/000085478; Piccoli A, 2004, KIDNEY INT, V65, P1050, DOI 10.1111/j.1523-1755.2004.00467.x; Piccoli A, 1996, MED SCI SPORT EXER, V28, P1517, DOI 10.1097/00005768-199612000-00012; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Piccoli A., 2002, BIVA SOFTWARE; Piccoli A, 2010, CONTRIB NEPHROL, V164, P143, DOI 10.1159/000313727; Pillon L, 2003, U.S. Patent Application, Patent No. [10/740,911, 10740911]; Psycharakis SG, 2011, J STRENGTH COND RES, V25, P420, DOI 10.1519/JSC.0b013e3181bff58c; Rodriguez G, 2000, J PEDIATR GASTR NUTR, V30, P305, DOI 10.1097/00005176-200003000-00017; Rodriguez-Zamora L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049098; Rush EC, 2006, OBESITY, V14, P252, DOI 10.1038/oby.2006.32; SAWKA MN, 1992, MED SCI SPORT EXER, V24, P657; Slinde F, 2003, CLIN NUTR, V22, P153, DOI 10.1054/clnu.2002.0616; Sperelakis N., 2012, CELL PHYSL SOURCE BO, P123; Stewart A., 2011, INT STANDARDS ANTHRO, V137; Walter-Kroker A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-35; Zhu F, 1998, J APPL PHYSIOL, V85, P497, DOI 10.1152/jappl.1998.85.2.497	75	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178819	10.1371/journal.pone.0178819	http://dx.doi.org/10.1371/journal.pone.0178819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591135	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700050
J	Fang, CY; Wu, CC; Fang, CL; Chen, WY; Chen, CL				Fang, Chih-Yeu; Wu, Chung-Chun; Fang, Chia-Lang; Chen, Wei-Yu; Chen, Chi-Long			Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines	PLOS ONE			English	Article							FETAL BOVINE SERUM; NASOPHARYNGEAL CARCINOMA-CELLS; HUMAN PLATELET LYSATE; CULTURE MEDIA; HORSE SERUM; CALF SERUM; VIRUS; FIBROBLASTS; REPLACEMENT	Fetal bovine serum (FBS) is depended upon by investigators as an indispensable supplement in cell and tissue culture systems. Due to increased demand and limited availability, the price of FBS has increased by greater than 300% in the past few years. In addition, there are ethical and scientific controversies about the collection and use of FBS in culture systems. In response to the shortage of FBS, many FBS alternative serum products have been developed. Although many have claimed comparable performance to FBS, their support of long-term cell growth and effects on cell phenotype have not been revealed. In this study, we examined the performances of six bovine calf serum-based FBS alternatives in six head and neck cell lines and compared them with FBS. The results indicate that some of these sera had growth promoting capabilities comparable or superior to that of FBS. Additionally, these alternative sera supported long-term (30 passages) growth of tested cells and exhibited plating efficiencies comparable to that of FBS. Cells cultured in alternative sera also exhibited comparable anchorage-independent growth and similar drug inhibition responses in FBS. Still, caution should be taken in choosing suitable sera given that changes in cell morphology and variations in chemotactic responses were noted for cells maintained in certain sera. These FBS alternatives are more readily available, cost less, and are associated with less ethical concerns, thus making them attractive alternatives to FBS in cell culture systems.	[Fang, Chih-Yeu; Fang, Chia-Lang; Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Fang, Chih-Yeu; Fang, Chia-Lang; Chen, Wei-Yu; Chen, Chi-Long] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Wu, Chung-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Health Research Institutes - Taiwan; Taipei Medical University; Taipei Medical University Hospital	Chen, CL (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan.; Chen, CL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan.	chencl@tmu.edu.tw	Fang, Chih-Yeu/AAH-5170-2021	Fang, Chih-Yeu/0000-0002-8280-3012	Ministry of Science and Technology, Taiwan [MOST104-2320-B-038-043, MOST105-2320-B-038-051]; Taipei Medical University-Wanfang Hospital research program [104-WF-EVA-09]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wanfang Hospital research program	This work was supported in part by Ministry of Science and Technology, Taiwan (MOST104-2320-B-038-043 and MOST105-2320-B-038-051), and Taipei Medical University-Wanfang Hospital research program (104-WF-EVA-09).	[Anonymous], JCRB0623 HSC 3; BETTGER WJ, 1986, PHYSIOL REV, V66, P1, DOI 10.1016/0034-5687(86)90134-9; Bieback K, 2013, TRANSFUS MED HEMOTH, V40, P326, DOI 10.1159/000354061; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Canovas D, 2012, ALTEX-ALTERN ANIM EX, V29, P426, DOI 10.14573/altex.2012.4.426; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; DAHLING DR, 1990, J VIROL METHODS, V27, P287, DOI 10.1016/0166-0934(90)90097-Y; Fang CY, 2015, INT J MOL SCI, V16, P2530, DOI 10.3390/ijms16022530; Fang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044810; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Franke J, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-119; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GOODHEART CR, 1973, APPL MICROBIOL, V26, P525, DOI 10.1128/AEM.26.4.525-528.1973; Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275; Gstraunthaler G, 2013, CYTOTECHNOLOGY, V65, P791, DOI 10.1007/s10616-013-9633-8; HEATON DE, 1982, PRENATAL DIAG, V2, P281, DOI 10.1002/pd.1970020407; Hemeda H, 2014, CYTOTHERAPY, V16, P170, DOI 10.1016/j.jcyt.2013.11.004; HODGSON J, 1995, BIO-TECHNOL, V13, P333, DOI 10.1038/nbt0495-333; Hyclone, 2013, THERM SCI HYCLONE FE; Hyclone, 2010, GROWTH COMP STUD FBS; Jayme D W, 1985, Adv Biotechnol Processes, V5, P1; JAYME DW, 1988, NATURE, V334, P547, DOI 10.1038/334547a0; Jochems CEA, 2002, ATLA-ALTERN LAB ANIM, V30, P219, DOI 10.1177/026119290203000208; JOHNSTON S, 1990, J CLIN MICROBIOL, V28, P643, DOI 10.1128/JCM.28.4.643-645.1990; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; LIN CT, 1990, LAB INVEST, V62, P713; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Nielsen O., 1995, NAT BIOTECHNOL, V13, P626, DOI DOI 10.1038/NBT0795-626; OBERLY TJ, 1990, MUTAT RES, V244, P105, DOI 10.1016/0165-7992(90)90057-Q; Paranjape Smita, 2004, Indian Journal of Experimental Biology, V42, P26; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Rauch C, 2011, ALTEX-ALTERN ANIM EX, V28, P305, DOI 10.14573/altex.2011.4.305; RHEINWALD JG, 1981, CANCER RES, V41, P1657; RMBIO, 2016, FET BOV SER SUPPL DE; RMBIO, 2016, COMP FBS OTH BOV SER; RMBIO, 2016, FET BOV GROWTH SER; Shanskii YD, 2013, B EXP BIOL MED+, V156, P146, DOI 10.1007/s10517-013-2298-7; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Witzeneder K, 2013, TRANSFUS MED HEMOTH, V40, P417, DOI 10.1159/000356236; YANG CY, 1994, J DENT RES, V73, P1407, DOI 10.1177/00220345940730080301; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; ZAMANSKY GB, 1983, J CELL SCI, V61, P289; Ziegler A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0880-8	43	42	44	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178960	10.1371/journal.pone.0178960	http://dx.doi.org/10.1371/journal.pone.0178960			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591207	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700064
J	Muleta, KT; Bulli, P; Rynearson, S; Chen, XM; Pumphrey, MC				Muleta, Kebede T.; Bulli, Peter; Rynearson, Sheri; Chen, Xianming; Pumphrey, Michael			Loci associated with resistance to stripe rust (Puccinia striiformis f. sp tritici) in a core collection of spring wheat (Triticum aestivum)	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; YELLOW RUST; LEAF RUST; DURABLE RESISTANCE; GENE; IDENTIFICATION; POPULATION; COMPONENTS	Stripe rust, caused by Puccinia striiformis Westend. f. sp. tritici Erikss. (Pst) remains one of the most significant diseases of wheat worldwide. We investigated stripe rust resistance by genome-wide association analysis (GWAS) in 959 spring wheat accessions from the United States Department of Agriculture-Agricultural Research Service National Small Grains Collection, representing major global production environments. The panel was characterized for field resistance in multi-environment field trials and seedling resistance under greenhouse conditions. A genome-wide set of 5,619 informative SNP markers were used to examine the population structure, linkage disequilibrium and marker-trait associations in the germplasm panel. Based on model-based analysis of population structure and hierarchical Ward clustering algorithm, the accessions were clustered into two major subgroups. These subgroups were largely separated according to geographic origin and improvement status of the accessions. A significant correlation was observed between the population sub-clusters and response to stripe rust infection. We identified 11 and 7 genomic regions with significant associations with stripe rust resistance at adult plant and seedling stages, respectively, based on a false discovery rate multiple correction method. The regions harboring all, except three, of the QTL identified from the field and greenhouse studies overlap with positions of previously reported QTL. Further work should aim at validating the identified QTL using proper germplasm and populations to enhance their utility in marker assisted breeding.	[Muleta, Kebede T.; Bulli, Peter; Rynearson, Sheri; Pumphrey, Michael] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, USDA ARS, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University; Washington State University	Pumphrey, MC (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	m.pumphrey@wsu.edu	Pumphrey, Michael/V-8830-2019; Muleta, Kebede/K-4978-2019; Bulli, Peter/H-6637-2019	Muleta, Kebede/0000-0001-5403-5098; Bulli, Peter/0000-0002-7223-7838; Pumphrey, Michael/0000-0001-7524-9634	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-68002-30029]; Monsanto-Beachell Borlaug Fellowship program; Washington Grain Commission; Hatch project	National Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Monsanto-Beachell Borlaug Fellowship program; Washington Grain Commission; Hatch project(United States Department of Agriculture (USDA))	This project was funded by the National Research Initiative Competitive Grant 2011-68002-30029 (Triticeae-CAP) from the USDA National Institute of Food and Agriculture, the Monsanto-Beachell Borlaug Fellowship program, the Washington Grain Commission, and through Hatch project funds to Washington State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the National Research Initiative Competitive Grant 2011-68002-30029 (Triticeae-CAP) from the USDA National Institute of Food and Agriculture, the Monsanto-Beachell Borlaug Fellowship program, the Washington Grain Commission, and through Hatch project funds to Washington State University. John Kuehner, Victor DeMacon and Dr. Kent Evans are appreciated for providing technical support.	Agenbag GM, 2012, THEOR APPL GENET, V125, P109, DOI 10.1007/s00122-012-1819-5; Bansal UK, 2014, MOL BREEDING, V33, P51, DOI 10.1007/s11032-013-9933-x; Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Basnet BR, 2014, CROP SCI, V54, P1361, DOI 10.2135/cropsci2013.09.0625; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Boyd LA, 2005, J AGR SCI-CAMBRIDGE, V143, P233, DOI 10.1017/S0021859605005095; Bulli P, 2016, G3-GENES GENOM GENET, V6, P2237, DOI 10.1534/g3.116.028407; Burdon JJ, 2014, EVOL APPL, V7, P609, DOI 10.1111/eva.12175; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Cheng P, 2014, THEOR APPL GENET, V127, P2267, DOI 10.1007/s00122-014-2378-8; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellis Jessica J, 2014, Front Psychol, V5, P679, DOI 10.3389/fpsyg.2014.00679; Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng JY, 2014, MOL BREEDING, V33, P601, DOI 10.1007/s11032-013-9977-y; Forrest K, 2014, MOL BREEDING, V34, P2109, DOI 10.1007/s11032-014-0166-4; Guo Q, 2008, PHYTOPATHOLOGY, V98, P803, DOI 10.1094/PHYTO-98-7-0803; Gurung S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108179; Herrera-Foessel SA, 2012, THEOR APPL GENET, V124, P1475, DOI 10.1007/s00122-012-1802-1; Hovmoller MS, 2011, ANNU REV PHYTOPATHOL, V49, P197, DOI 10.1146/annurev-phyto-072910-095230; Hulbert S, 2014, MOL PLANT MICROBE IN, V27, P207, DOI 10.1094/MPMI-09-13-0295-FI; Kertho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129580; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Lan CX, 2014, MOL BREEDING, V34, P789, DOI 10.1007/s11032-014-0075-6; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Li Y, 2009, THEOR APPL GENET, V118, P339, DOI 10.1007/s00122-008-0903-3; Li ZF, 2013, MOL BREEDING, V32, P821, DOI 10.1007/s11032-013-9909-x; Li ZF, 2006, THEOR APPL GENET, V112, P1098, DOI 10.1007/s00122-006-0211-8; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Line RF, 1992, US DEPARTMENT OF AGR, P44; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lowe I, 2011, EUPHYTICA, V179, P69, DOI 10.1007/s10681-010-0311-z; Ma JX, 2001, EUPHYTICA, V120, P219, DOI 10.1023/A:1017510331721; Maccaferri M, 2015, G3-GENES GENOM GENET, V5, P449, DOI 10.1534/g3.114.014563; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; McIntosh R, 2013, CAT GEN SYMB WHEAT 1; Murphy LR, 2009, CROP SCI, V49, P1786, DOI 10.2135/cropsci2008.10.0621; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Prins R, 2011, MOL BREEDING, V27, P259, DOI 10.1007/s11032-010-9428-y; Pritchard JK, 2000, GENETICS, V155, P945; Ren RS, 2012, THEOR APPL GENET, V125, P847, DOI 10.1007/s00122-012-1877-8; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Sorensen C, 2014, PHYTOPATHOLOGY, V2011, P1; Steele KA, 2001, PLANT PATHOL, V50, P174, DOI 10.1046/j.1365-3059.2001.00558.x; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Sui XX, 2009, PHYTOPATHOLOGY, V99, P1209, DOI 10.1094/PHYTO-99-10-1209; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Vasudevan K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00505; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; Xu HX, 2014, EUPHYTICA, V198, P317, DOI 10.1007/s10681-014-1108-2; Xu LS, 2013, THEOR APPL GENET, V126, P523, DOI 10.1007/s00122-012-1998-0; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou XL, 2014, THEOR APPL GENET, V127, P2349, DOI 10.1007/s00122-014-2381-0; Zhou XL, 2014, THEOR APPL GENET, V127, P935, DOI 10.1007/s00122-014-2269-z; Zhou XL, 2011, THEOR APPL GENET, V123, P431, DOI 10.1007/s00122-011-1595-7; Zurn JD, 2014, MOL BREEDING, V34, P871, DOI 10.1007/s11032-014-0081-8; Zwart RS, 2010, MOL BREEDING, V26, P107, DOI 10.1007/s11032-009-9381-9	75	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179087	10.1371/journal.pone.0179087	http://dx.doi.org/10.1371/journal.pone.0179087			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591221	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700085
J	Pauzuolis, M; Eich, T; Burman, J				Pauzuolis, Mindaugas; Eich, Torsten; Burman, Joachim			Quantification of (Y)delta T cells and HLA-DR plus NK cells does not predict emergence of new contrast enhancing lesions in MS patients suspending natalizumab treatment	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WITHDRAWAL	Background Natalizumab (NTZ) is a drug that has been widely used in the treatment of multiple sclerosis (MS). NTZ is very effective in suppressing inflammation, but if treatment is suspended many patients will experience relapses. Objective To investigate if quantification of (Y)delta T cells and HLA-DR+ NK cells could predict early disease reactivation after NTZ suspension. Methods Absolute counts of (Y)delta T cells and HLA-DR+ NK cells in whole blood were determined with flow cytometry in fifteen patients treated with NTZ. NTZ treatment was then withdrawn and patients were followed with clinical visits and MR investigations. Results Patients with recurrent disease had higher absolute counts of (Y)delta T cells 129 (+/- 156) cells/mu l in comparison to patients with stable disease 50.0 (+/- 51.0) cells/mu l but the difference was not statistically significant and largely driven by outliers. Patients with recurrent and stable disease had similar absolute counts of HLA-DR+ NK cells. Conclusion Quantification of (Y)delta T cells and HLA-DR+ NK cells could not predict active disease after NTZ suspension.	[Pauzuolis, Mindaugas] Uppsala Univ, Biol Educ Ctr, Uppsala, Sweden; [Eich, Torsten] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Burman, Joachim] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Burman, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	joachim.burman@neuro.uu.se	Burman, Joachim/H-7230-2019	Burman, Joachim/0000-0002-7045-1806				Bsteh G, 2016, MULT SCLER; Fagius J, 2017, MULT SCLER RELAT DIS; Haas J, 2016, MULT SCLER; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kister I, 2016, J NEUROL NEUROSURG P; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koudriavtseva T, 2014, CLIN EXP IMMUNOL, V176, P320, DOI 10.1111/cei.12261; Lo Re M, 2015, NEUROL THER, V4, P147, DOI 10.1007/s40120-015-0038-9; McGuigan C, 2016, J NEUROL NEUROSUR PS, V87, P117, DOI 10.1136/jnnp-2015-311100; Mellergard J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081685; Miravalle A, 2011, ARCH NEUROL-CHICAGO, V68, P186, DOI 10.1001/archneurol.2010.257; O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a; Putzki N, 2010, EUR NEUROL, V63, P311, DOI 10.1159/000302687; Rinaldi L, 2006, BRAIN, V129, P1993, DOI 10.1093/brain/awl179; Vellinga MM, 2008, NEUROLOGY, V70, P1150, DOI 10.1212/01.wnl.0000265393.03231.e5; Vidal-Jordana A, 2015, MULT SCLER J, V21, P780, DOI 10.1177/1352458514549401; Wipfler P, 2014, ACTA NEUROL SCAND, V129, pE12, DOI 10.1111/ane.12182	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179095	10.1371/journal.pone.0179095	http://dx.doi.org/10.1371/journal.pone.0179095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586378	Green Submitted, Green Published, gold			2022-12-26	WOS:000402875700046
J	Pipkins, HR; Bradshaw, JL; Keller, LE; Swiatlo, E; McDaniel, LS				Pipkins, Haley R.; Bradshaw, Jessica L.; Keller, Lance E.; Swiatlo, Edwin; McDaniel, Larry S.			Polyamine transporter potABCD is required for virulence of encapsulated but not nonencapsulated Streptococcus pneumoniae	PLOS ONE			English	Article							POTD PROTECTS MICE; NASOPHARYNGEAL COLONIZATION; ESCHERICHIA-COLI; OTITIS-MEDIA; PNEUMOCOCCAL PNEUMONIA; CONJUGATE VACCINE; UNITED-STATES; IMMUNIZATION; PATHOGENESIS; DISEASE	Streptococcus pneumoniae is commonly found in the human nasopharynx and is the causative agent of multiple diseases. Since invasive pneumococcal infections are associated with encapsulated pneumococci, the capsular polysaccharide is the target of licensed pneumococcal vaccines. However, there is an increasing distribution of non-vaccine serotypes, as well as nonencapsulated S. pneumoniae (NESp). Both encapsulated and nonencapsulated pneumococci possess the polyamine oligo-transport operon (potABCD). Previous research has shown inactivation of the pot operon in encapsulated pneumococci alters protein expression and leads to a significant reduction in pneumococcal murine colonization, but the role of the pot operon in NESp is unknown. Here, we demonstrate deletion of potD from the NESp NCC1 strain MNZ67 does impact expression of the key proteins pneumolysin and PspK, but it does not inhibit murine colonization. Additionally, we show the absence of potD significantly increases biofilm production, both in vitro and in vivo. In a chinchilla model of otitis media (OM), the absence of potD does not significantly affect MNZ67 virulence, but it does significantly reduce the pathogenesis of the virulent encapsulated strain TIGR4 (serotype 4). Deletion of potD also significantly reduced persistence of TIGR4 in the lungs but increased persistence of PIP01 in the lungs. We conclude the pot operon is important for the regulation of protein expression and biofilm formation in both encapsulated and NCC1 nonencapsulated Streptococcus pneumoniae. However, in contrast to encapsulated pneumococcal strains, polyamine acquisition via the pot operon is not required for MNZ67 murine colonization, persistence in the lungs, or full virulence in a model of OM. Therefore, NESp virulence regulation needs to be further established to identify potential NESp therapeutic targets.	[Pipkins, Haley R.; Bradshaw, Jessica L.; Keller, Lance E.; Swiatlo, Edwin; McDaniel, Larry S.] Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA; [Keller, Lance E.] Univ Groningen, Dept Mol Genet, Groningen, Netherlands	University of Mississippi; University of Mississippi Medical Center; University of Groningen	McDaniel, LS (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA.	Lmcdaniel@umc.edu	McDaniel, Larry/AAC-8459-2020; Keller, Lance/AAY-8626-2020	McDaniel, Larry/0000-0002-1649-7563; 	institutional research funds	institutional research funds	This study was funded by institutional research funds. There was no additional external funding received for this study.	Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; BERRY AM, 1995, INFECT IMMUN, V63, P1969, DOI 10.1128/IAI.63.5.1969-1974.1995; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Castiglia P, 2014, ADV THER, V31, P1011, DOI 10.1007/s12325-014-0157-1; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Cohen S.S., 1997, GUIDE POLYAMINES; Converso TR, 2017, VACCINE, V35, P149, DOI 10.1016/j.vaccine.2016.11.027; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; Faden H, 1998, PEDIATR INFECT DIS J, V17, P1105, DOI 10.1097/00006454-199812000-00002; FORRESTER HL, 1987, AM J MED, V83, P425, DOI 10.1016/0002-9343(87)90751-0; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hotomi M, 2016, J INFECT CHEMOTHER, V22, P72, DOI 10.1016/j.jiac.2015.10.006; Jung IL, 2003, J BIOL CHEM, V278, P22846, DOI 10.1074/jbc.M212055200; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005; Keller LE, 2013, INFECT IMMUN, V81, P173, DOI 10.1128/IAI.00755-12; Keller LE, 2016, MBIO, V7, DOI 10.1128/mBio.01792-15; Keller LE, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu037; Marks LR, 2012, MBIO, V3, DOI 10.1128/mBio.00200-12; MUSHER DM, 1992, CLIN INFECT DIS, V14, P801, DOI 10.1093/clinids/14.4.801; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Rai AN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26964; Shah P, 2006, INFECT IMMUN, V74, P5888, DOI 10.1128/IAI.00553-06; Shah P, 2008, MOL MICROBIOL, V68, P4, DOI 10.1111/j.1365-2958.2008.06126.x; Shah P, 2011, MICROBIOL-SGM, V157, P504, DOI 10.1099/mic.0.042564-0; Shah P, 2009, EXP BIOL MED, V234, P403, DOI 10.3181/0809-RM-269; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Ware D, 2006, INFECT IMMUN, V74, P352, DOI 10.1128/IAI.74.1.352-361.2006; Ware D, 2005, J MICROBIOL, V43, P398	39	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179159	10.1371/journal.pone.0179159	http://dx.doi.org/10.1371/journal.pone.0179159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586394	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700050
J	Sun, MM; Zhang, Y; Ma, J; Yuan, WP; Li, XL; Cheng, X				Sun, Minmin; Zhang, Yuan; Ma, Jing; Yuan, Wenping; Li, Xianglan; Cheng, Xiao			Satellite data based estimation of methane emissions from rice paddies in the Sanjiang Plain in northeast China	PLOS ONE			English	Article							NITROUS-OXIDE; FIELDS; MITIGATION; REGION; MODEL	The Sanjiang Plain (SJP), one of the major rice producing regions in China, is an important source of methane (CH4) emissions. However, there have been large uncertainties in the estimates of CH4 emissions from this area during the past few years. In this study, we estimated CH4 emissions using a process-based model derived by rice area, CH4 flux, land surface temperature (LST), and the ratio of precipitation (P) and evapotranspiration (ET) in rice paddies in the SJP during the rice growing seasons in 2000, 2006, and 2010, respectively. The results showed that the total area of rice fields was 1.64 million ha in 2010, which was approximately 35 and 13% higher than in 2000 and 2006, respectively. The average LST was 22.1 degrees C in 2000 which was higher than in 2006 (21.6 degrees C) and 2010 (21.5 degrees C). Monthly ET and P displayed similar seasonal and annual variability. The monthly ET was 61.7, 66.5, and 63.0 mm month(-1) and P was 85.1, 80.6 and 85.9 mm month(-1) during the rice growing seasons in 2000, 2006, and 2010, respectively. The averaged CH4 flux rates were 24.83, 24.63, and 24.59 ton km(-2), and the estimated mean annual CH4 emissions from rice paddies were 0.30, 0.36, and 0. 40 Tg yr(-1) in 2000, 2006, and 2010, respectively. The CH4 emissions displayed obvious spatial variations that decreased from east to west in the SJP, and were mainly affected by temperature. The results will improve our understanding of the interannual and spatial variations of CH4 emissions and provide a more accurate regional budget of CH4 emissions from rice paddies in the Sanjiang Plain.	[Sun, Minmin; Li, Xianglan] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; [Sun, Minmin; Li, Xianglan; Cheng, Xiao] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing, Peoples R China; [Sun, Minmin; Li, Xianglan; Cheng, Xiao] Beijing Normal Univ, Joint Ctr Global Change Studies, Beijing, Peoples R China; [Zhang, Yuan] East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China; [Zhang, Yuan] East China Normal Univ, Sch Geog Sci, Shanghai, Peoples R China; [Ma, Jing] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Yuan, Wenping] Sun Yat Sen Univ, Sch Atmospher Sci, Zhuhai, Guangdong, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Sun Yat Sen University	Li, XL (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China.; Li, XL; Cheng, X (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing, Peoples R China.; Li, XL; Cheng, X (corresponding author), Beijing Normal Univ, Joint Ctr Global Change Studies, Beijing, Peoples R China.	xlli@bnu.edu.cn; xcheng@bnu.edu.cn			State Key Laboratory of Earth Surface Processes and Resource Ecology; State Key Laboratory of Surface Processes and Resource Ecology, Beijing Normal University	State Key Laboratory of Earth Surface Processes and Resource Ecology; State Key Laboratory of Surface Processes and Resource Ecology, Beijing Normal University	This research was partially supported by the Project Supported by State Key Laboratory of Earth Surface Processes and Resource Ecology.; We acknowledged the project supported by State Key Laboratory of Surface Processes and Resource Ecology, Beijing Normal University. The authors would like to thank the editor and reviewers for their instructive comments that helped to improve this manuscript. Besides, we would like to thank Fei Feng from Beijing Normal University, China, for his suggestions.	Agnihotri S, 1999, ENVIRON MONIT ASSESS, V58, P95, DOI 10.1023/A:1006081317688; Akumu C. E., 2010, REMOTE SENS, V2, P855; Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Aulakh MS, 2001, ADV AGRON, V70, P193, DOI 10.1016/S0065-2113(01)70006-5; Chen WW, 2013, AGR ECOSYST ENVIRON, V178, P64, DOI 10.1016/j.agee.2013.05.008; Ehhalt D, 2001, ATMOSPHERIC CHEM GRE, P228; Feng F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160150; Field C.B., 2015, GUANGDONG AGR SCI, V285, P25987; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P292, DOI 10.1016/j.agee.2009.06.014; Gutierrez J, 2013, FIELD CROP RES, V146, P16, DOI 10.1016/j.fcr.2013.03.003; Khalil MAK, 1998, J GEOPHYS RES-ATMOS, V103, P25241, DOI 10.1029/98JD01114; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Lobell DB, 2010, J ENVIRON QUAL, V39, P35, DOI 10.2134/jeq2009.0140; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; PAUSTIAN K., 2006, 2006 IPCC GUIDELINES, V2, P48; Reshu Agarwal, 2007, J INDIAN SOC REMOT S, V35, P331; Sass RL, 2002, P NATL ACAD SCI USA, V99, P11993, DOI 10.1073/pnas.202483599; Shamsi SRF, 2012, ARCH AGRON SOIL SCI, V59, P1; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; [王德宣 Wang Dexuan], 2002, [地理科学, Scientia Geographica Sinica], V22, P500; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang YiYong, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P170; Wang ZY, 2000, NUTR CYCL AGROECOSYS, V58, P55, DOI 10.1023/A:1009878115811; Xie BH, 2010, PLANT SOIL, V326, P393, DOI 10.1007/s11104-009-0020-3; Xu H, 2003, SOIL SCI SOC AM J, V67, P1147, DOI 10.2136/sssaj2003.1147; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x; Yan XY, 2003, GLOBAL CHANGE BIOL, V9, P237, DOI 10.1046/j.1365-2486.2003.00564.x; Zhang Y, 2011, BIOGEOSCIENCES, V8, P1225, DOI 10.5194/bg-8-1225-2011; Zhang Y, 2012, PLOS ONE, V7, P108; Zhu Q, 2014, GEOSCI MODEL DEV, V7, P981, DOI 10.5194/gmd-7-981-2014; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	32	12	13	9	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0176765	10.1371/journal.pone.0176765	http://dx.doi.org/10.1371/journal.pone.0176765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586357	Green Submitted, gold, Green Published			2022-12-26	WOS:000402875700004
J	Ding, LP; Chen, YJ; Wei, XL; Ni, M; Zhang, JW; Wang, HZ; Zhu, Z; Wei, JH				Ding, Liping; Chen, Yajuan; Wei, Xiaoli; Ni, Mi; Zhang, Jiewei; Wang, Hongzhi; Zhu, Zhen; Wei, Jianhua			Laboratory evaluation of transgenic Populus davidianaxPopulus bolleana expressing Cry1Ac + SCK, Cry1Ah3, and Cry9Aa3 genes against gypsy moth and fall webworm	PLOS ONE			English	Article							FIELD-EVALUATION; TRANSFORMATION; RESISTANCE; POPLAR; GENES; NIGRA	Transgenic poplar lines 'Shanxin' (Populus davidianaxPopulus bolleana) were generated via Agrobacterium-mediated transformation. The transgenic lines carried the expression cassettes of Cry1Ac + SCK, Cry1Ah3, and Cry9Aa3, respectively. The expression levels of the exogenous insect resistance genes in the transgenic lines were determined by Q-PCR and Western blot. Leaves of the transgenic lines were used for insect feeding bioassays on first instar larvae of the gypsy moth (Lymantria dispar) and fall webworm (Hyphantria cunea). At 5 d of feeding, the mean mortalities of larvae feeding on Cry1Ac + SCK and Cry1Ah3 transgenic poplars leaves were 97% and 91%, while mortality on Cry9Aa3 transgenic lines was about 49%. All gypsy moth and fall webworm larvae were killed in 7-9 days after feeding on leaves from Cry1Ac + SCK or Cry1Ah3 transgenic poplars, while all the fall webworm larvae were killed in 11 days and about 80% of gypsy moth larvae were dead in 14 days after feeding on those from Cry9Aa3 transgenic lines. It was concluded that the transgenic lines of Cry1Ac + SCK and Cry1Ah3 were highly toxic to larvae of both insect species while lines with Cry9Aa3 had lower toxicity, and H. cunea larvae are more sensitive to the insecticidal proteins compared to L. dispar. Transgenic poplar lines toxic to L. dispar and H. cunea could be used to provide Lepidoptera pest resistance to selected strains of poplar trees.	[Ding, Liping; Chen, Yajuan; Zhang, Jiewei; Wang, Hongzhi; Wei, Jianhua] Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China; [Wei, Xiaoli; Ni, Mi; Zhu, Zhen] Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China; [Wei, Xiaoli; Ni, Mi; Zhu, Zhen] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wei, JH (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Key Lab Agr Gene Resource & Biotechnol, Beijing, Peoples R China.; Zhu, Z (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Inst Genet & Dev Biol, Beijing, Peoples R China.; Zhu, Z (corresponding author), Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Genet & Dev Biol, Beijing, Peoples R China.	zzhu@genetics.ac.cn; weijianhua@baafs.net.cn		Ni, Mi/0000-0002-8930-6887	National High-Tech RD Program [2013AA102702, 2013AA102701]; BAAFS Fund for Young Scholar [QNJJ201415]; Beijing Natural Science Foundation [6163028]; Innovation and Capacity Building Fund in BAAFS	National High-Tech RD Program; BAAFS Fund for Young Scholar; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Innovation and Capacity Building Fund in BAAFS	This work was supported by the National High-Tech R&D Program (2013AA102702 and 2013AA102701), BAAFS Fund for Young Scholar (QNJJ201415), Beijing Natural Science Foundation (6163028) and the Innovation and Capacity Building Fund in BAAFS.	Cao CW, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20001; Dong Y, 2015, CAN J FOREST RES, V45, P60, DOI 10.1139/cjfr-2014-0335; [高宝嘉 Gao Baojia], 2004, [生态学报, Acta Ecologica Sinica], V24, P297; Hu JJ, 2001, EUPHYTICA, V121, P123, DOI 10.1023/A:1012015709363; Hu JJ, 2008, FOR RES, V20, P656; Lu MS, 2009, INT J PROD RES, V47, P6433, DOI 10.1080/00207540802270104; MCCOWN BH, 1991, PLANT CELL REP, V9, P590, DOI 10.1007/BF00232339; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Su HuiQin, 2010, Acta Phytophylacica Sinica, V37, P541; Swamy HMM, 2011, CURR MICROBIOL, V63, P420, DOI 10.1007/s00284-011-9998-x; Wang HH, 2011, PLANT CELL REP, V30, P2037, DOI 10.1007/s00299-011-1111-1; Yang RL, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028635; Ye X, 2011, CRIT REV PLANT SCI, V30, P415, DOI 10.1080/07352689.2011.605737; Zhang BY, 2011, TREE PHYSIOL, V31, P567, DOI 10.1093/treephys/tpr032; Zhang HC, 2006, AGR STAT CHINA, P378; Zhang Qian, 2002, Forestry Studies in China, V4, P27; Zheng JunBao, 2000, Scientia Silvae Sinicae, V36, P13; Zhu Z., 2001, B CHINESE ACAD SCI, V5, P353	18	9	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178754	10.1371/journal.pone.0178754	http://dx.doi.org/10.1371/journal.pone.0178754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582405	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600035
J	Kim, JK; Bae, SE; Lee, SJ; Yoon, MG				Kim, Jin-Koo; Bae, Seung Eun; Lee, Soo Jeong; Yoon, Moon Geun			New insight into hybridization and unidirectional introgression between Ammodytes japonicus and Ammodytes heian (Trachiniformes, Ammodytidae)	PLOS ONE			English	Article							CORAL-REEF FISHES; SECONDARY CONTACT; GENETIC-STRUCTURE; NORTHWESTERN PACIFIC; LATEOLABRAX-JAPONICUS; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; DEMOGRAPHIC HISTORY; NORTH PACIFIC; INDO-PACIFIC	Based on northern (NOL) and southern (SOL) mitochondrial lineages, recently, it proposed the new species Ammodytes heian and revived the species name Ammodytes japonicus to describe sand lances from the northwestern Pacific Ocean. This study used molecular methods to investigate genetic relationships between the two sand lance species in Korea and Japan. In total, 154 specimens were collected from four locations in Korea (Baengnyeongdo in the Yellow Sea, Tongyeong in the Korean Strait, and Jumunjin and Gijang in the East Sea), and 50 specimens were collected from a single location in Japan (Wakkanai in the Okhotsk Sea). Mitochondrial DNA analysis demonstrated that the individuals from Baengnyeongdo and Tongyeong all belonged to the SOL, whereas those from Gijang, Jumunjin, and Wakkanai included individuals from both the NOL and SOL (over 75% NOL). Population structure analyses were performed on the same individuals using seven microsatellite DNA markers. The population structure analysis based on 201 specimens identified two clusters (named as northern group and southern group), with the admixture proportion (q) of < 0.1 for the northern group in the Backyeongdo and Tongyeong sand lances and < 0.1 for the southern group in the Wakkanai sand lances. The high heterogeneity indicated that the former was probably A. japonicus and the latter probably A. heian. However, the admixture proportion in the Jumunjin and Gijang sand lances was 0.71-0.75 for the southern group, indicating that hybridization and unidirectional introgression from SOL to NOL occurs in southwestern margin of the East Sea. Our findings illustrate the speciation process based on different patterns of gene flow between Korean and Japanese sand lance, which is strongly influenced by both the paleo-climatic change and the contemporary local oceanic current pattern.	[Kim, Jin-Koo; Bae, Seung Eun; Lee, Soo Jeong] Pukyong Natl Univ, Dept Marine Biol, Busan, South Korea; [Lee, Soo Jeong] Natl Inst Fisheries Sci, East Sea Fisheries Res Inst, Fisheries Resources & Environm Div, Kangnung, South Korea; [Yoon, Moon Geun] Marine Biodivers Inst Korea, Seocheon Gun, Chungcheongnam, South Korea	Pukyong National University; National Institute of Fisheries Science; Marine Biodiversity Institute of Korea (MABIK)	Kim, JK (corresponding author), Pukyong Natl Univ, Dept Marine Biol, Busan, South Korea.	taengko@hanmail.net	Kim, Jin-Koo/AEC-6629-2022; Kim, Jin-Koo/AAG-5659-2022	Kim, Jin-Koo/0000-0002-8499-406X	Marine Fish Resources Bank of Korea (MFRBK) under the Minstry of Oceans and Fisheries, Korea; National Institute of Fisheries Science, Korea [R2017030]	Marine Fish Resources Bank of Korea (MFRBK) under the Minstry of Oceans and Fisheries, Korea; National Institute of Fisheries Science, Korea	This research was supported by the Marine Fish Resources Bank of Korea (MFRBK) under the Minstry of Oceans and Fisheries, Korea (http://www.mof.go.kr) and also supported by the National Institute of Fisheries Science, Korea (R2017030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Adams SM, 2006, MOL ECOL, V15, P1109, DOI 10.1111/j.1365-294X.2006.02859.x; ASTRALDI M, 1995, OCEANOL ACTA, V18, P139; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Bae SE, 2016, BIOCHEM SYST ECOL, V66, P98, DOI 10.1016/j.bse.2016.03.006; Banks MA, 2000, CAN J FISH AQUAT SCI, V57, P915, DOI 10.1139/cjfas-57-5-915; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bernal MA, 2017, MOL ECOL, V26, P639, DOI 10.1111/mec.13937; Bossu CM, 2013, GENETICA, V141, P75, DOI 10.1007/s10709-013-9707-8; Canestrelli D, 2014, SCI REP-UK, V4, DOI 10.1038/srep06516; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Choleva L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080641; Damerau M, 2012, POLAR BIOL, V35, P1073, DOI 10.1007/s00300-012-1155-x; Durand JD, 2005, MAR BIOL, V147, P313, DOI 10.1007/s00227-005-1564-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037425; Hobbs JPA, 2009, BIOL LETTERS, V5, P258, DOI 10.1098/rsbl.2008.0561; Ivanova NV, 2007, MOL ECOL NOTES, V7, P544, DOI 10.1111/j.1471-8286.2007.01748.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kai Y, 2011, ICHTHYOL RES, V58, P366, DOI 10.1007/s10228-011-0226-2; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kim J.K., 2008, J ICHTHYOL, V48, P904, DOI DOI 10.1134/S003294520810007X; Kim JK, 2006, KOREAN J GENETIC, V28, P343; Kim JK, 2010, GENES GENOM, V32, P437, DOI 10.1007/s13258-010-0017-6; Kim JK, 2015, BIOCHEM SYST ECOL, V61, P319, DOI 10.1016/j.bse.2015.06.038; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V39, P799, DOI 10.1016/j.ympev.2006.01.009; Machado-Schiaffino G, 2010, MOL PHYLOGENET EVOL, V55, P552, DOI 10.1016/j.ympev.2010.01.034; Magalhaes IS, 2015, MOL ECOL, V24, P4505, DOI 10.1111/mec.13316; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martinez P, 2007, J FISH BIOL, V71, P195, DOI 10.1111/j.1095-8649.2007.01551.x; Martinsen GD, 2001, EVOLUTION, V55, P1325, DOI 10.1111/j.0014-3820.2001.tb00655.x; Miralles L, 2014, J SEA RES, V86, P69, DOI 10.1016/j.seares.2013.11.009; Mojekwu TO, 2013, IOSR J ENV SCI TOXIC, V5, P43, DOI DOI 10.9790/2402-0544348; Montanari SR, 2014, MOL ECOL, V23, P2757, DOI 10.1111/mec.12762; Muths D, 2015, MAR ECOL-EVOL PERSP, V36, P447, DOI 10.1111/maec.12153; Orr JW, 2015, FISH B-NOAA, V113, P129, DOI 10.7755/FB.113.2.3; Palero F, 2011, BIOL J LINN SOC, V104, P407, DOI 10.1111/j.1095-8312.2011.01728.x; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; Rabone M, 2015, MAR BIOL, V162, P1611, DOI 10.1007/s00227-015-2697-6; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ren GJ, 2015, BIOCHEM SYST ECOL, V61, P303, DOI 10.1016/j.bse.2015.06.031; Ren GJ, 2009, CONSERV GENET, V10, P1837, DOI 10.1007/s10592-009-9828-x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; ROUSSET F, 1995, GENETICS, V140, P1413; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schunter C, 2011, MOL ECOL, V20, P5167, DOI 10.1111/j.1365-294X.2011.05355.x; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Slate J, 2007, J EVOLUTION BIOL, V20, P1415, DOI 10.1111/j.1420-9101.2007.01339.x; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; TURANOV SV, 2014, RUSS J MAR BIOL+, V40, P447, DOI DOI 10.1134/S1063074014060212; Turner GF, 1999, REV FISH BIOL FISHER, V9, P281, DOI 10.1023/A:1008903228512; von der Heyden S, 2012, AFR J MAR SCI, V34, P505, DOI 10.2989/1814232X.2012.733142; Waples RS, 2015, J HERED, V106, P1, DOI 10.1093/jhered/esu062; Was A, 2010, MAR BIOL, V157, P447, DOI 10.1007/s00227-009-1331-x; Wielgoss S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-61; Xue DX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095436; Yaakub SM, 2006, MOL PHYLOGENET EVOL, V40, P84, DOI 10.1016/j.ympev.2006.02.012; Yamada H, 1998, NIPPON SUISAN GAKK, V64, P440	67	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178001	10.1371/journal.pone.0178001	http://dx.doi.org/10.1371/journal.pone.0178001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582394	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600007
J	Tung, CH; Han, MS; Qi, JJ				Tung, Ching-Hsuan; Han, Myung Shin; Qi, Jianjun			Total control of fat cells from adipogenesis to apoptosis using a xanthene analog	PLOS ONE			English	Article							INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; PPAR-GAMMA; OBESITY; REDUCTION; ATX-101; RESVERATROL; EXPRESSION; MECHANISM; DRUG	Overcrowded adipocytes secrete excess adipokines and cytokines under stress, which results in a deregulated metabolism. This negative response to stress increases the possibility of obesity and several of its associated diseases, such as cancer and atherosclerosis. Therefore, a reduction in the number of adipocytes may be a rational strategy to relieve the undesired expansion of adipose tissue. A newly synthesized xanthene analog, MI-401, was found to have two distinct effects on the regulation of the adipocyte's life cycle. MI-401 efficiently down regulated the expression of transcription factors, PPAR gamma and C/EBP alpha, and lipogenesis proteins, FAS and FABP4. This down regulation resulted in the inhibition of adipogenesis. Without newly differentiated adipocytes, the total number of adipocytes will not increase. In addition to this inhibitory effect, MI-401 was able to actively kill mature adipocytes. It specifically triggered apoptosis in adipocytes at low micro molar concentration and spared preadipocytes and fibroblasts. These dual functionalities make MI-401 an effective agent in the regulation of the birth and death of adipocytes.	[Tung, Ching-Hsuan; Han, Myung Shin] Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA; [Qi, Jianjun] Houston Methodist Res Inst, Dept Translat Imaging, Houston, TX USA	Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Tung, CH (corresponding author), Weill Cornell Med, Dept Radiol, Mol Imaging Innovat Inst, New York, NY 10065 USA.	cht2018@med.cornell.edu	Tung, Ching-Hsuan/AIE-6009-2022; Tung, Ching-Hsuan/AHC-5070-2022	Tung, Ching-Hsuan/0000-0001-6648-6195; Tung, Ching-Hsuan/0000-0001-6648-6195	NIH [GM094880]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by NIH GM094880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander W, 2010, P T, V35, P474; Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015; Choi JW, 2016, LIFE SCI, V144, P103, DOI 10.1016/j.lfs.2015.11.028; COMBES RD, 1982, MUTAT RES, V98, P101, DOI 10.1016/0165-1110(82)90015-X; Cooke D, 2006, NAT REV DRUG DISCOV, V5, P919, DOI 10.1038/nrd2136; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030831; Dayan SH, 2016, DERMATOL SURG, V42, pS263, DOI 10.1097/DSS.0000000000000870; Desarzens S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094127; Ding LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057477; Fischer-Posovszky P, 2007, HORM METAB RES, V39, P186, DOI 10.1055/s-2007-970416; He YH, 2013, BIOCHEM BIOPH RES CO, V436, P169, DOI 10.1016/j.bbrc.2013.05.068; Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008; Herold C, 2013, APOPTOSIS, V18, P911, DOI 10.1007/s10495-013-0848-0; Hirota K, 2010, J AGR FOOD CHEM, V58, P5821, DOI 10.1021/jf903911e; Humphrey S, 2016, J AM ACAD DERMATOL, V75, P788, DOI 10.1016/j.jaad.2016.04.028; Jang BC, 2016, BIOCHEM BIOPH RES CO, V474, P220, DOI 10.1016/j.bbrc.2016.04.109; Jang MK, 2014, BIOCHEM BIOPH RES CO, V454, P58, DOI 10.1016/j.bbrc.2014.10.028; Jun DY, 2011, J MED FOOD, V14, P454, DOI 10.1089/jmf.2010.1385; Kim HK, 2010, J PHYSIOL BIOCHEM, V66, P197, DOI 10.1007/s13105-010-0024-8; Kim JR, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6120243; Kim SH, 2008, BIOCHEM BIOPH RES CO, V372, P108, DOI 10.1016/j.bbrc.2008.04.188; Kim YS, 2011, J CONTROL RELEASE, V156, P315, DOI 10.1016/j.jconrel.2011.08.016; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Lazar I, 2016, CANCER RES, V76, P4051, DOI 10.1158/0008-5472.CAN-16-0651; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Li H, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-91; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes V, 2008, J AGR FOOD CHEM, V56, P11631, DOI 10.1021/jf802233q; Mizutani T, 2009, J ENV PUBL HLTH, V2009; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; Park YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109344; Poledne R, 2015, PHYSIOL RES, V64, pS395, DOI 10.33549/physiolres.933152; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; REWCASTLE GW, 1991, J MED CHEM, V34, P491, DOI 10.1021/jm00106a003; Rotunda AM, 2009, LASER SURG MED, V41, P714, DOI 10.1002/lsm.20807; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Singh J, 2014, PHYTOMEDICINE, V21, P1733, DOI 10.1016/j.phymed.2014.08.014; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Urs S, 2012, ADIPOCYTE, V1, P46, DOI 10.4161/adip.19186; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wollina U, 2015, EXPERT OPIN PHARMACO, V16, P755, DOI 10.1517/14656566.2015.1019465; Wong CP, 2014, J NAT MED-TOKYO, V68, P253, DOI 10.1007/s11418-014-0822-3; Yang JY, 2008, OBESITY, V16, P16, DOI 10.1038/oby.2007.24; Zhang Y, 2012, BIOCHEM BIOPH RES CO, V417, P1, DOI 10.1016/j.bbrc.2011.11.158	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0179158	10.1371/journal.pone.0179158	http://dx.doi.org/10.1371/journal.pone.0179158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582464	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600074
J	Hung, YC; Lee, YJ; Tsai, LC				Hung, Yu-Chen; Lee, Ya-Jung; Tsai, Li-Chiun			Vowel production of Mandarin-speaking hearing aid users with different types of hearing loss	PLOS ONE			English	Article							SPEECH PRODUCTION INTELLIGIBILITY; COCHLEAR IMPLANT RECIPIENTS; ACOUSTIC CHARACTERISTICS; IMPAIRED CHILDREN; DEAF; YOUNG; PERCEPTION; SPACE; SPEAKERS; LANGUAGE	In contrast with previous research focusing on cochlear implants, this study examined the speech performance of hearing aid users with conductive (n = 11), mixed (n = 10), and sensorineural hearing loss (n = 7) and compared it with the speech of hearing control. Speech intelligibility was evaluated by computing the vowel space area defined by the Mandarin Chinese corner vowels /a, u, i/. The acoustic differences between the vowels were assessed using the Euclidean distance. The results revealed that both the conductive and mixed hearing loss groups exhibited a reduced vowel working space, but no significant difference was found between the sensorineural hearing loss and normal hearing groups. An analysis using the Euclidean distance further showed that the compression of vowel space area in conductive hearing loss can be attributed to the substantial lowering of the second formant of N. The differences in vowel production between groups are discussed in terms of the occlusion effect and the signal transmission media of various hearing devices.	[Hung, Yu-Chen; Lee, Ya-Jung; Tsai, Li-Chiun] Childrens Hearing Fdn, Speech & Hearing Sci Res Inst, Taipei, Taiwan		Hung, YC (corresponding author), Childrens Hearing Fdn, Speech & Hearing Sci Res Inst, Taipei, Taiwan.	yuchenhung@chfn.org.tw			Children's Hearing Foundation	Children's Hearing Foundation	YCH, YJL, and LCT's effort was funded by Children's Hearing Foundation (http://www.chfn.org.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 1998, AM J OTOL, V19, P742; Blamey PJ, 1996, HEARING RES, V99, P139, DOI 10.1016/S0378-5955(96)00095-0; Boersma P., 2013, PRAAT DOING PHONETIC; BOONE DR, 1966, VOLTA REV, V68, P686; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; BRANNON JB, 1966, LANG SPEECH, V9, P127, DOI 10.1177/002383096600900206; Bunton K, 2001, CLIN LINGUIST PHONET, V15, P181; Burnham D, 2002, SCIENCE, V296, P1435, DOI 10.1126/science.1069587; Calmels MN, 2004, INT J PEDIATR OTORHI, V68, P347, DOI 10.1016/j.ijporl.2003.11.006; Calvert DR., 1975, SPEECH DEAFNESS TEXT; Calvert DR, 1975, SPEECH DEAFNESS; Cancio ML, 2007, FUNCTIONAL PHONETICS; Carr J, 1953, J SPEECH HEAR DISORD, V18, P22, DOI 10.1044/jshd.1801.22; Chang B-L., 2000, B SPEC ED, P53; Dang J. W., 2004, ACOUSTICAL SCI TECHN, V25, P318; DuHadway CM, 2012, J MED SPEECH-LANG PA, V20, P59; Ertmer DJ, 2011, LANG SPEECH HEAR SER, V42, P52, DOI 10.1044/0161-1461(2010/09-0081); FARNETANI E, 1993, LANG SPEECH, V36, P279, DOI 10.1177/002383099303600309; Flege JE, 1997, J PHONETICS, V25, P437, DOI 10.1006/jpho.1997.0052; Flipsen P, 2012, CLIN LINGUIST PHONET, V26, P926, DOI 10.3109/02699206.2012.720634; GEFFNER D, 1980, J COMMUN DISORD, V13, P443, DOI 10.1016/0021-9924(80)90044-1; Green JR, 2002, J SPEECH LANG HEAR R, V45, P66, DOI 10.1044/1092-4388(2002/005); Habib MG, 2010, INT J PEDIATR OTORHI, V74, P855, DOI 10.1016/j.ijporl.2010.04.009; Harrington J., 1997, AUST J LINGUIST, V17, P155, DOI 10.1080/07268609708599550; Hedrick W.R, 2012, TECHNOLOGY DIAGNOSTI; Heider F, 1941, VOLTA REV, V43, P10; Higgins CM, 2002, J MED SPEECH-LANG PA, V10, P271; Horga D, 2006, CLIN LINGUIST PHONET, V20, P211, DOI 10.1080/02699200400027015; Hudgins C.V., 1942, GENET PSYCHOL MONOGR; Hudgins CV, 1934, PEDAGOG SEMIN J GEN, V44, P3; Hung YC, 2016, J SPEECH LANG HEAR R, V59, P349, DOI 10.1044/2015_JSLHR-H-15-0026; Ibertsson T., 2008, J ACOUST SOC AM, V123, P3330; Kiese-Himmel C, 2006, J LARYNGOL OTOL, V120, P619, DOI 10.1017/S0022215106001319; Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Kuhl PK, 2000, P NATL ACAD SCI USA, V97, P11850, DOI 10.1073/pnas.97.22.11850; Ladefoged P., 2006, COURSE PHONETICS; Liker M, 2007, CLIN LINGUIST PHONET, V21, P1, DOI 10.1080/02699200400026991; Liu HM, 2003, DEVELOPMENTAL SCI, V6, pF1, DOI 10.1111/1467-7687.00275; Liu HM, 2005, J ACOUST SOC AM, V117, P3879, DOI 10.1121/1.1898623; Liu J-X., 1986, B SPEC ED, V2, P127; Lofqvist A, 2010, J ACOUST SOC AM, V128, P3064, DOI 10.1121/1.3466850; MARKIDES A, 1986, British Journal of Audiology, V20, P165, DOI 10.3109/03005368609079011; MARKIDES A, 1970, BRIT J DISORD COMMUN, V5, P126; Martony J., 1965, STUDIES SPEECH DEAF; McDermott HJ, 2006, HEARING RES, V218, P81, DOI 10.1016/j.heares.2006.05.002; METZ DE, 1990, J SPEECH HEAR RES, V33, P476, DOI 10.1044/jshr.3303.476; Miyamoto RT, 1996, ACTA OTO-LARYNGOL, V116, P240, DOI 10.3109/00016489609137832; Mondain M, 1997, ARCH OTOLARYNGOL, V123, P181; MONSEN RB, 1974, J SPEECH HEAR RES, V17, P386, DOI 10.1044/jshr.1703.386; MONSEN RB, 1978, J SPEECH HEAR RES, V21, P197, DOI 10.1044/jshr.2102.197; Most T, 2012, J DEAF STUD DEAF EDU, V17, P259, DOI 10.1093/deafed/enr049; Neumeyer V, 2010, CLIN LINGUIST PHONET, V24, P734, DOI 10.3109/02699206.2010.491173; Nguyen N, 2014, P 15 AUSTR INT C SP; NOBER EH, 1967, EXCEPT CHILDREN, V33, P611, DOI 10.1177/001440296703300902; Nober EH, 1977, HEARING LOSS CHILDRE, P630; Osberger M. J., 1992, INTELLIGIBILITY SPEE, V74, P233; OSBERGER MJ, 1993, J SPEECH HEAR RES, V36, P186, DOI 10.1044/jshr.3601.186; Osberger MJ, 1982, SPEECH LANGUAGE ADV; Peng SC, 2004, J SPEECH LANG HEAR R, V47, P1227, DOI 10.1044/1092-4388(2004/092); Pettinato M, 2016, J PHONETICS, V54, P1, DOI 10.1016/j.wocn.2015.07.002; Robbins A. Mcconkey, 1995, Annals of Otology Rhinology and Laryngology, V104, P399; SAMAR VJ, 1988, J SPEECH HEAR RES, V31, P307, DOI 10.1044/jshr.3103.307; Schiavetti N., 1992, INTELLIGIBILITY SPEE, P11, DOI DOI 10.1075/SSPCL.1.02SCH; Seifpanahi S, 2008, LOGOP PHONIATR VOCO, V33, P153, DOI 10.1080/14015430802045230; SMITH CR, 1975, J SPEECH HEAR RES, V18, P795, DOI 10.1044/jshr.1804.795; Stenfelt S, 2007, INT J AUDIOL, V46, P595, DOI 10.1080/14992020701545880; STEVENS KN, 1976, J SPEECH HEAR RES, V19, P393, DOI 10.1044/jshr.1902.393; Svirsky M.A., 2007, AUDIOL MED, V5, P293, DOI DOI 10.1080/16513860701727847; Svirsky MA, 2000, VOLTA REV, V102, P175; Tseng SC, 2011, CLIN LINGUIST PHONET, V25, P784, DOI 10.3109/02699206.2011.565906; TURNER GS, 1995, J SPEECH HEAR RES, V38, P1001, DOI 10.1044/jshr.3805.1001; TYEMURRAY N, 1995, J SPEECH HEAR RES, V38, P327, DOI 10.1044/jshr.3802.327; Uchanski RM, 2003, EAR HEARING, V24, p90S, DOI 10.1097/01.AUD.0000051744.24290.C1; Verhoeven J, 2016, J COMMUN DISORD, V59, P24, DOI 10.1016/j.jcomdis.2015.10.007; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Wake M, 2004, EAR HEARING, V25, P1, DOI 10.1097/01.AUD.0000111262.12219.2F; Warner-Czyz AD, 2010, J SPEECH LANG HEAR R, V53, P2, DOI 10.1044/1092-4388(2009/0163); Weismer G, 2000, FOLIA PHONIATR LOGO, V52, P201, DOI 10.1159/000021536; Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; World Health Organization, 2004, GUIDELINES FOR HEARI; Yang J, 2015, J ACOUST SOC AM, V138, P2791, DOI 10.1121/1.4932165	83	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178588	10.1371/journal.pone.0178588	http://dx.doi.org/10.1371/journal.pone.0178588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575087	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300067
J	Itaguchi, Y; Yamada, C; Yoshihara, M; Fukuzawa, K				Itaguchi, Yoshihiro; Yamada, Chiharu; Yoshihara, Masahiro; Fukuzawa, Kazuyoshi			Writing in the air: A visualization tool for written languages	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; FINGER MOVEMENTS; TIME-COURSE; DISCONNECTION; IMPAIRMENT; DYSTYPIA; APHASIA; MEMORY; ALEXIA; ARM	The present study investigated interactions between cognitive processes and finger actions called"kusho," meaning "air-writing" in Japanese. Kanji-culture individuals often employ kusho behavior in which they move their fingers as a substitute for a pen to write mostly done when they are trying to recall the shape of a Kanji character or the spelling of an English word. To further examine the visualization role of kusho behavior on cognitive processing, we conducted a Kanji construction task in which a stimulus (i.e., sub-parts to be constructed) was simultaneously presented. In addition, we conducted a Kanji vocabulary test to reveal the relation between the kusho benefit and vocabulary size. The experiment provided two sets of novel findings. First, executing kusho behavior improved task performance (correct responses) as long as the participants watched their finger movements while solving the task. This result supports the idea that visual feedback of kusho behavior helps cognitive processing for the task. Second, task performance was positively correlated with the vocabulary score when stimuli were presented for a relatively long time, whereas the kusho benefits and vocabulary score were not correlated regardless of stimulus-presentation time. These results imply that a longer stimulus-presentation could allow participants to utilize their lexical resources for solving the task. The current findings together support the visualization role of kusho behavior, adding experimental evidence supporting the view that there are interactions between cognition and motor behavior.	[Itaguchi, Yoshihiro] Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan; [Itaguchi, Yoshihiro] Japan Soc Promot Sci, Tokyo, Japan; [Yamada, Chiharu; Yoshihara, Masahiro; Fukuzawa, Kazuyoshi] Waseda Univ, Fac Letters Arts & Sci, Psychol Sect, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science; Waseda University	Itaguchi, Y (corresponding author), Keio Univ, Dept Syst Design Engn, Yokohama, Kanagawa, Japan.; Itaguchi, Y (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	itaguchi.y@gmail.com	Itaguchi, Yoshihiro/AAK-7239-2020; Yamada, Chiharu/ABA-5897-2020	Itaguchi, Yoshihiro/0000-0002-2033-2171; Yamada, Chiharu/0000-0003-1018-095X; Yoshihara, Masahiro/0000-0002-3904-6394	Japan Society for the Promotion of Science KAKENHI Grant [15K17329, 15K04195]; Grants-in-Aid for Scientific Research [15K04195, 16J00325] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers 15K17329 and 15K04195 [http://www.jsps.go.jp/english/index.html]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S., 1999, NIHONGO NO GOI TOKUS; Amano S, 1998, ICSLP; BENDER MB, 1982, J NEUROL SCI, V53, P531, DOI 10.1016/0022-510X(82)90249-0; Cook F. A. B., 2013, BMJ CASE REP, V2013, pbcr2013200257, DOI 10.1136/bcr-2013-200257; DARCAIS GBF, 1995, J EXP PSYCHOL LEARN, V21, P34; Dejerine J., 1891, M M SOC BIOL, V3, P197; DUFFY RJ, 1989, BRAIN COGNITION, V10, P220, DOI 10.1016/0278-2626(89)90054-7; Endo Y., 1988, PRACTICAL ASPECTS ME, V2, P459; Forster KI, 2013, J MEM LANG, V69, P563, DOI 10.1016/j.jml.2013.07.004; Fukatsu R, 1998, BRAIN, V121, P843, DOI 10.1093/brain/121.5.843; Fukuzawa K, 1986, IMPAIRMENT ABILITY O; Glenberg AM, 2010, WIRES COGN SCI, V1, P586, DOI 10.1002/wcs.55; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; GOODGLASS H, 1963, BRAIN, V86, P703, DOI 10.1093/brain/86.4.703; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Hoosain R, 1991, PSYCHOLINGUISTIC IMP; Ihori N, 2000, EUR NEUROL, V44, P65, DOI 10.1159/000008199; Inui, 2002, JPN J NEUROPSYCHOL, V18, P68; Itaguchi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128419; Itaguchi Y, 2012, EXP BRAIN RES, V222, P77, DOI 10.1007/s00221-012-3196-3; Itaguchi Y, 2012, PERCEPT MOTOR SKILL, V114, P757, DOI 10.2466/25.26.PMS.114.3.757-773; KASHIWAGI T, 1989, APHASIOLOGY, V3, P75, DOI 10.1080/02687038908248977; Kashu K, 1979, JINBUN KENKYU, V29, P103; Kess JF, 1994, JAPANESE PSYCHOLINGU; Kess JF, 2001, JAPAN GLOBAL AGE, P175; LANDIS T, 1982, PSYCHOL MED, V12, P515, DOI 10.1017/S0033291700055616; LEVINE DN, 1988, BRAIN LANG, V35, P172, DOI 10.1016/0093-934X(88)90107-1; Maher LM, 1998, J INT NEUROPSYCH SOC, V4, P636, DOI 10.1017/S1355617798466128; Matsuo K, 2003, COGNITIVE BRAIN RES, V17, P263, DOI 10.1016/S0926-6410(03)00114-9; Matsuo K, 2001, BRAIN RES BULL, V55, P549, DOI 10.1016/S0361-9230(01)00564-0; Michaux N, 2013, EXP PSYCHOL, V60, P197, DOI 10.1027/1618-3169/a000188; Naka M, 1998, MEM COGNITION, V26, P804, DOI 10.3758/BF03211399; Nakamura K, 2000, BRAIN, V123, P954, DOI 10.1093/brain/123.5.954; Otsuki M, 2002, EUR NEUROL, V47, P136, DOI 10.1159/000047971; Plaut DC, 1999, COGNITIVE SCI, V23, P543, DOI 10.1207/s15516709cog2304_7; Purcell JJ, 2011, NEUROIMAGE, V55, P750, DOI 10.1016/j.neuroimage.2010.11.042; Pylkkanen L, 2003, TRENDS COGN SCI, V7, P187, DOI 10.1016/S1364-6613(03)00092-5; RASMUSSEN JL, 1993, EDUC PSYCHOL MEAS, V53, P329, DOI 10.1177/0013164493053002003; Reichle ED, 2009, TRENDS COGN SCI, V13, P115, DOI 10.1016/j.tics.2008.12.002; Ryu DW, 2012, ALZ DIS ASSOC DIS, V26, P285, DOI 10.1097/WAD.0b013e318231e614; SASAKI M, 1987, INT J BEHAV DEV, V10, P135, DOI 10.1177/016502548701000201; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Thomas M., 2013, JOHNSON SCH RES PAPE, V23, P23; Thomas M, 2015, LANG LEARN, V65, P631, DOI 10.1111/lang.12128; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Yamashita H, 2014, PSYCHOLOGY, V5, P213; Yap MJ, 2012, J EXP PSYCHOL HUMAN, V38, P53, DOI 10.1037/a0024177; Yim-Ng YY, 2000, INT J LANG COMM DIS, V35, P561	49	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178735	10.1371/journal.pone.0178735	http://dx.doi.org/10.1371/journal.pone.0178735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575084	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300104
J	Mukai, T; Hosomi, N; Tsunematsu, M; Sueda, Y; Shimoe, Y; Ohshita, T; Torii, T; Aoki, S; Nezu, T; Maruyama, H; Kakehashi, M; Matsumoto, M				Mukai, Tomoya; Hosomi, Naohisa; Tsunematsu, Miwako; Sueda, Yoshimasa; Shimoe, Yutaka; Ohshita, Tomohiko; Torii, Tsuyoshi; Aoki, Shiro; Nezu, Tomohisa; Maruyama, Hirofumi; Kakehashi, Masayuki; Matsumoto, Masayasu		Hiroshima Emergency Weather	Various meteorological conditions exhibit both immediate and delayed influences on the risk of stroke events: The HEWS-stroke study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SEASONAL-VARIATION; BLOOD-PRESSURE; AMBIENT-TEMPERATURE; WEATHER; CLASSIFICATION; ADMISSIONS	We hypothesized that meteorological conditions on the onset day and conditions on the former days may play important roles in the modulation of physical conditions. Associations of meteorological factors and their changes in former days with stroke onset are of interest. We conducted a multicenter retrospective study to evaluate the frequency of stroke events and their interaction with meteorological conditions and their daily changes. Acute stroke patients (n = 3935, 73.5 +/- 12.4 years, 1610 females) who were admitted to 7 stroke hospitals in three restricted areas were enrolled in this study. Poisson regression models involving time-lag variables was used to compare daily rates of stroke events with mean thermohydrological index (THI), atmospheric pressure, and their daily changes. We divided onset days into quintiles based on the THI, atmospheric pressure, and their daily changes for the last 7 days. The frequencies of ischemic stroke significantly increased when THI varied either cooler or warmer from a previous day (extremely cooler, risk ratio (RR) 1.19, 95% confidence interval (CI) 1.05 to 1.34; extremely warmer, RR 1.16, 95% CI 1.03 to 1.31; r2 = 0.001 for the best regression, p = 0.001). Intracerebral hemorrhage frequencies significantly decreased on high-THI days (extremely high, RR 0.72, 95% CI 0.54 to 0.95; r(2) = 0.013 for the best regression, p<0.001) and increased in high atmospheric pressure days (high, RR 1.31, 95% CI 1.04 to 1.65; r(2) = 0.009 for the best regression, p<0.001). Additionally, even after adjusting for the THI on the onset day and its changes for the other days, intracerebral hemorrhage increased when THI got extremely cooler in 4 days prior (RR 1.33, 95% CI 1.03 to 1.71, r(2) = 0.006 for the best regression, p<0.001). Various meteorological conditions may exhibit influences on stroke onset. And, when temperature cooled, there may be a possibility to show delayed influence on the frequency of intracerebral hemorrhage 4 days later.	[Mukai, Tomoya; Hosomi, Naohisa; Aoki, Shiro; Nezu, Tomohisa; Maruyama, Hirofumi; Matsumoto, Masayasu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Tsunematsu, Miwako; Kakehashi, Masayuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Hlth Informat, Hiroshima, Japan; [Sueda, Yoshimasa; Torii, Tsuyoshi] Natl Hosp Org, Kure Med Ctr, Dept Neurol, Kure, Japan; [Shimoe, Yutaka] Ota Mem Hosp, Brain Attack Ctr, Dept Neurol, Fukuyama, Hiroshima, Japan; [Ohshita, Tomohiko] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan	Hiroshima University; Hiroshima University	Hosomi, N (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.	nhosomi@hiroshima-u.ac.jp	Hosomi, Naohisa/H-8660-2019; Yoshimoto, Takeshi/AAR-1805-2020; OCHI, Kazuhide/Q-7830-2016; Maruyama, Hirofumi/B-9333-2011	Yoshimoto, Takeshi/0000-0003-3178-8171; OCHI, Kazuhide/0000-0003-1921-9603; Maruyama, Hirofumi/0000-0001-7613-8717; Aoki, Shiro/0000-0001-5348-5783; Yamazaki, Yu/0000-0002-0806-4960; Nezu, Tomohisa/0000-0003-4877-2336; NAGANO, YOSHITO/0000-0002-7974-4824	JSPS KAKENHI [23590598, 15K08615]; Tsuchiya Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tsuchiya Foundation(Tsuchiya Foundation)	This study was supported in part by research grants from JSPS KAKENHI (Grant Number 23590598,15K08615) and the Tsuchiya Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aoki S, 2011, HYPERTENS RES, V34, P617, DOI 10.1038/hr.2011.17; Basu R, 2012, EPIDEMIOLOGY, V23, P813, DOI 10.1097/EDE.0b013e31826b7f97; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; CHEN ZY, 1995, STROKE, V26, P569, DOI 10.1161/01.STR.26.4.569; Feigin VL, 1998, EUR J NEUROL, V5, P23, DOI 10.1046/j.1468-1331.1998.510023.x; Goggins WB, 2012, INT J BIOMETEOROL, V56, P865, DOI 10.1007/s00484-011-0491-9; Hong YC, 2003, EPIDEMIOLOGY, V14, P473, DOI 10.1097/01.ede.0000078420.82023.e3; Jimenez-Conde J, 2008, CEREBROVASC DIS, V26, P348, DOI 10.1159/000151637; Lian H, 2015, INT J ENV RES PUB HE, V12, P9068, DOI 10.3390/ijerph120809068; Myint PK, 2007, NEUROEPIDEMIOLOGY, V28, P79, DOI 10.1159/000098550; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; ROSE G, 1961, NATURE, V189, P235, DOI 10.1038/189235a0; Rothwell PM, 1996, LANCET, V347, P934, DOI 10.1016/S0140-6736(96)91415-4; Shimoyama T, 2014, EUR J NEUROL, V21, P402, DOI 10.1111/ene.12280; SHINKAWA A, 1990, STROKE, V21, P1262, DOI 10.1161/01.STR.21.9.1262; Sueda Y, 2015, J STROKE CEREBROVASC, V24, P1500, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.013; Toyoda K, 2010, STROKE, V41, P1440, DOI 10.1161/STROKEAHA.110.580506; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang HB, 2002, INT J BIOMETEOROL, V47, P13, DOI 10.1007/s00484-002-0147-x; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080381; Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6; Wang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099599	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178223	10.1371/journal.pone.0178223	http://dx.doi.org/10.1371/journal.pone.0178223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575005	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300033
J	Ogawa, Y; Kaizu, K; Yanagi, Y; Takada, S; Sakuraba, H; Oishi, K				Ogawa, Yasuhiro; Kaizu, Katsutoshi; Yanagi, Yusuke; Takada, Subaru; Sakuraba, Hitoshi; Oishi, Kazuhiko			Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CORTICAL TISSUES; IN-VITRO; NEURONS; GENERATION; NOTCH; MICE; GANGLIOSIDOSIS; PROGENITORS; BRAIN	In Sandhoff disease (SD), the activity of the lysosomal hydrolytic enzyme, p-hexosaminidase (Hex), is lost due to a Hexb gene defect, which results in the abnormal accumulation of the substrate, GM2 ganglioside (GM2), in neuronal cells, causing neuronal loss, microglial activation, and astrogliosis. We established induced pluripotent stem cells from the cells of SD mice (SD-iPSCs). In the present study, we investigated the occurrence of abnormal differentiation and development of a neural lineage in the asymptomatic phase of SD in vitro using SD mouse fetus-derived neural stem cells (NSCs) and SD-iPSCs. It was assumed that the number of SD mouse fetal brain-derived NSCs was reduced and differentiation was promoted, resulting in the inhibition of differentiation into neurons and enhancement of differentiation into astrocytes. The number of SD-iPSC-derived NSCs was also reduced, suggesting that the differentiation of NSCs was promoted, resulting in the inhibition of differentiation into neurons and enhancement of that into astrocytes. This abnormal differentiation of SD-iPSCs toward a neural lineage was reduced by the glucosylceramide synthase inhibitor, miglustat. Furthermore, abnormal differentiation toward a neural lineage was reduced in SD-iPSCs with Hexb gene transfection. Therefore, differentiation ability along the time axis appears to be altered in SD mice in which the differentiation ability of NSCs is promoted and differentiation into neurons is completed earlier, while the timing of differentiation into astrocytes is accelerated. These results clarified that the abnormal differentiation of SD-iPSCs toward a neural lineage in vitro was shown to reflect the pathology of SD.	[Ogawa, Yasuhiro; Kaizu, Katsutoshi; Yanagi, Yusuke; Takada, Subaru; Oishi, Kazuhiko] Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Meiji Pharmaceutical University; Meiji Pharmaceutical University	Oishi, K (corresponding author), Meiji Pharmaceut Univ, Dept Pharmacol, Tokyo, Japan.	oishikz@my-pharm.ac.jp		Ogawa, Yasuhiro/0000-0003-3306-277X	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (KAKENHI) [16K08281]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KO was supported by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (KAKENHI; 16K08281). URL: https://www.jsps.go.jp/english/e-grants/index/html	BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cau E, 1997, DEVELOPMENT, V124, P1611; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Denny CA, 2007, J NEUROCHEM, V101, P1294, DOI 10.1111/j.1471-4159.2007.04525.x; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, NAT PROTOC, V7, P69, DOI 10.1038/nprot.2011.429; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kanzaki S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012105; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kiecker C, 2012, ANNU REV NEUROSCI, V35, P347, DOI 10.1146/annurev-neuro-062111-150543; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Ogawa Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep40518; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055856; Oishi K, 2004, J PHARMACOL SCI, V96, P208, DOI 10.1254/jphs.FP0040373; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Pelled D, 2003, NEUROPATH APPL NEURO, V29, P341, DOI 10.1046/j.1365-2990.2003.00455.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sango K, 2002, NEUROPATH APPL NEURO, V28, P23, DOI 10.1046/j.1365-2990.2002.00366.x; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sargeant TJ, 2011, HUM MOL GENET, V20, P4371, DOI 10.1093/hmg/ddr364; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Yamaguchi A, 2004, J CLIN INVEST, V113, P200, DOI 10.1172/JCI200419639	38	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178978	10.1371/journal.pone.0178978	http://dx.doi.org/10.1371/journal.pone.0178978			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575132	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300139
J	Park, KH; Greenwood-Quaintance, KE; Uhl, JR; Cunningham, SA; Chia, N; Jeraldo, PR; Sampathkumar, P; Nelson, H; Patel, R				Park, Kyung-Hwa; Greenwood-Quaintance, Kerryl E.; Uhl, James R.; Cunningham, Scott A.; Chia, Nicholas; Jeraldo, Patricio R.; Sampathkumar, Priya; Nelson, Heidi; Patel, Robin			Molecular epidemiology of Staphylococcus aureus bacteremia in a single large Minnesota medical center in 2015 as assessed using MLST, core genome MLST and spa typing	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; UNITED-STATES; INFECTIONS; RESOLUTION; OUTBREAK; CLONES; MRSA	Staphylococcus aureus is a leading cause of bacteremia in hospitalized patients. Whether or not S. aureus bacteremia (SAB) is associated with clonality, implicating potential nosocomial transmission, has not, however, been investigated. Herein, we examined the epidemiology of SAB using whole genome sequencing (WGS). 152 SAB isolates collected over the course of 2015 at a single large Minnesota medical center were studied. Staphylococcus protein A (spa) typing was performed by PCR/Sanger sequencing; multilocus sequence typing (MLST) and core genome MLST (cgMLST) were determined by WGS. Forty-eight isolates (32%) were methicillin resistant S. aureus (MRSA). The isolates encompassed 66 spa types, clustered into 11 spa clonal complexes (CCs) and 10 singleton types. 88% of 48 MRSA isolates belonged to spa CC-002 or-008. Methicillin-susceptible S. aureus (MSSA) isolates were more genotypically diverse, with 61% distributed across four spa CCs (CC 002, CC-012, CC-008 and CC-084). By MLST, there was 31 sequence types (STs), including 18 divided into 6 CCs and 13 singleton STs. Amongst MSSA isolates, the common MLST clones were CC5 (23%), CC30 (19%), CC8 (15%) and CC15 (11%). Common MRSA clones were CC5 (67%) and CC8 (25%); there were no MRSA isolates in CC45 or CC30. By cgMLST analysis, there were 9 allelic differences between two isolates, with the remaining 150 isolates differing from each other by over 40 alleles. The two isolates were retroactively epidemiologically linked by medical record review. Overall, cgMLST analysis resulted in higher resolution epidemiological typing than did multilocus sequence or spa typing.	[Park, Kyung-Hwa; Greenwood-Quaintance, Kerryl E.; Uhl, James R.; Cunningham, Scott A.; Patel, Robin] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA; [Park, Kyung-Hwa] Chonnam Natl Univ, Med Sch, Dept Infect Dis, Gwangju, South Korea; [Chia, Nicholas; Jeraldo, Patricio R.; Nelson, Heidi] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Chia, Nicholas; Jeraldo, Patricio R.; Nelson, Heidi] Mayo Clin, Dept Surg, Rochester, MN USA; [Sampathkumar, Priya; Patel, Robin] Mayo Clin, Div Infect Dis, Dept Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Chonnam National University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.; Patel, R (corresponding author), Mayo Clin, Div Infect Dis, Dept Internal Med, Rochester, MN 55905 USA.	patel.robin@mayo.edu	Jeraldo, Patricio/H-8178-2019; Sampathkumar, Priya/AAH-7033-2019; Cunningham, Scott A/ABC-6171-2020	Jeraldo, Patricio/0000-0003-0282-4217; Patel, Robin/0000-0001-6344-4141; Cunningham, Scott/0000-0002-7589-1712	Mayo Clinic Center for Individualized Medicine	Mayo Clinic Center for Individualized Medicine	The authors thank the Mayo Clinic Center for Individualized Medicine for generously supporting this study. We thank Dag Harmsen, University of Munster, for his thoughtful review of the manuscript draft.	BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Bertelli C, 2013, CLIN MICROBIOL INFEC, V19, P803, DOI 10.1111/1469-0691.12217; Blanc DS, 2002, INFECT GENET EVOL, V2, P145, DOI 10.1016/S1567-1348(02)00093-X; Bletz S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.11.005; Blumental S, 2013, J ANTIMICROB CHEMOTH, V68, P1517, DOI 10.1093/jac/dkt080; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Clinical and Laboratory Standards Institute, 2016, PERFORMANCE STANDARD; Cunningham SA, 2017, J CLIN MICROBIOL; El Atrouni WI, 2009, CLIN INFECT DIS, V49, pE130, DOI 10.1086/648442; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jolley KA, 2012, J CLIN MICROBIOL, V50, P3046, DOI 10.1128/JCM.01312-12; Joseph SJ, 2010, TRENDS BIOTECHNOL, V28, P611, DOI 10.1016/j.tibtech.2010.09.001; Kim ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114127; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Miko BA, 2013, J CLIN MICROBIOL, V51, P874, DOI 10.1128/JCM.00923-12; Mu WB, 2016, J MOL DIAGN, V18, P923, DOI 10.1016/j.jmoldx.2016.07.006; Ruppitsch W, 2006, J CLIN MICROBIOL, V44, P2442, DOI 10.1128/JCM.00113-06; van Belkum A, 1998, J CLIN MICROBIOL, V36, P1653, DOI 10.1128/JCM.36.6.1653-1659.1998	29	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0179003	10.1371/journal.pone.0179003	http://dx.doi.org/10.1371/journal.pone.0179003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575112	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300143
J	Vidal, E; Sayols, S; Moran, S; Guillaumet-Adkins, A; Schroeder, MP; Royo, R; Orozco, M; Gut, M; Gut, I; Lopez-Bigas, N; Heyn, H; Esteller, M				Vidal, E.; Sayols, S.; Moran, S.; Guillaumet-Adkins, A.; Schroeder, M. P.; Royo, R.; Orozco, M.; Gut, M.; Gut, I.; Lopez-Bigas, N.; Heyn, H.; Esteller, M.			A DNA methylation map of human cancer at single base-pair resolution	ONCOGENE			English	Article							EPIGENETIC LANDSCAPE; HYPOMETHYLATION; METHYLOME; REVEALS; SITES	Although single base-pair resolution DNA methylation landscapes for embryonic and different somatic cell types provided important insights into epigenetic dynamics and cell-type specificity, such comprehensive profiling is incomplete across human cancer types. This prompted us to perform genome-wide DNA methylation profiling of 22 samples derived from normal tissues and associated neoplasms, including primary tumors and cancer cell lines. Unlike their invariant normal counterparts, cancer samples exhibited highly variable CpG methylation levels in a large proportion of the genome, involving progressive changes during tumor evolution. The whole-genome sequencing results from selected samples were replicated in a large cohort of 1112 primary tumors of various cancer types using genome-scale DNA methylation analysis. Specifically, we determined DNA hypermethylation of promoters and enhancers regulating tumor-suppressor genes, with potential cancer-driving effects. DNA hypermethylation events showed evidence of positive selection, mutual exclusivity and tissue specificity, suggesting their active participation in neoplastic transformation. Our data highlight the extensive changes in DNA methylation that occur in cancer onset, progression and dissemination.	[Vidal, E.; Sayols, S.; Moran, S.; Heyn, H.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Vidal, E.] BIST, Ctr Genom Regulat CRG, Barcelona, Spain; [Vidal, E.; Guillaumet-Adkins, A.; Gut, M.; Gut, I.; Heyn, H.] UPF, Barcelona, Spain; [Guillaumet-Adkins, A.; Gut, M.; Gut, I.; Heyn, H.] BIST, Ctr Genom Regulat CRG, CNAG CRG, Barcelona, Spain; [Schroeder, M. P.; Lopez-Bigas, N.] IMIM Hosp, Med Res Inst, Res Program Biomed Informat, Biomed Genom Lab, Barcelona, Spain; [Schroeder, M. P.; Lopez-Bigas, N.] Univ Pompeu Fabra, Barcelona, Spain; [Royo, R.; Orozco, M.] Barcelona Inst Sci & Technol, IRB Barcelona, Joint IRB BSC Program Computat Biol, Barcelona, Spain; [Orozco, M.] IRB Barcelona, Barcelona, Spain; [Orozco, M.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Lopez-Bigas, N.; Esteller, M.] ICREA, Barcelona, Spain; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; ICREA; University of Barcelona	Heyn, H; Esteller, M (corresponding author), Hosp Llobregat, Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Av Gran Via Hosp 199-203, Barcelona 08908, Catalonia, Spain.	hheyn@idibell.cat; mesteller@idibell.cat	Vidal, Enrique/R-5593-2019; Esteller, Manel/L-5956-2014; Lopez-Bigas, Nuria/F-6193-2011; Gut, Ivo/ABF-3188-2020; Moran, Sebastian/G-5293-2013	Vidal, Enrique/0000-0002-4217-1807; Esteller, Manel/0000-0003-4490-6093; Lopez-Bigas, Nuria/0000-0003-4925-8988; Gut, Ivo/0000-0001-7219-632X; Moran, Sebastian/0000-0003-4192-8983; Sayols, Sergi/0000-0002-3877-4170; Schroeder, Michael P/0000-0002-7563-509X; Heyn, Holger/0000-0002-3276-1889; Orozco Lopez, Modesto/0000-0002-8608-3278	Institute of Health Carlos III ISCIII Project [PI11/00321]; Spanish Cancer Research Network (RTICC) [RD12/0036/0039]; European Development Regional Fund; 'A way to achieve Europe' ERDF [SAF2014-55000-R]; Sandra Ibarra Foundation; Olga Torres Foundation; Cellex Foundation; AGAUR [2014SGR633]; Health and Science Departments of the Catalan government (Generalitat de Catalunya); European Community's Seventh Framework Program (FP7) [HEALTH-F5-2011-282510 - BLUEPRINT]	Institute of Health Carlos III ISCIII Project; Spanish Cancer Research Network (RTICC); European Development Regional Fund(European Commission); 'A way to achieve Europe' ERDF; Sandra Ibarra Foundation; Olga Torres Foundation; Cellex Foundation(Foundation CELLEX); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Health and Science Departments of the Catalan government (Generalitat de Catalunya); European Community's Seventh Framework Program (FP7)	This work was supported by Institute of Health Carlos III ISCIII Project no. PI11/00321, Spanish Cancer Research Network (RTICC) no. RD12/0036/0039; European Development Regional Fund, 'A way to achieve Europe' ERDF (SAF2014-55000-R), Sandra Ibarra Foundation; Olga Torres Foundation; Cellex Foundation; AGAUR 2014SGR633 grant; Health and Science Departments of the Catalan government (Generalitat de Catalunya) and European Community's Seventh Framework Program (FP7/2007-2013), grant HEALTH-F5-2011-282510 - BLUEPRINT. HH is a Miguel Servet (CP14/00229) ISCII researcher. ME and NLB are ICREA Research Professors.	Agirre X, 2015, GENOME RES, V25, P478, DOI 10.1101/gr.180240.114; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bender S, 2013, CANCER CELL, V24, P660, DOI 10.1016/j.ccr.2013.10.006; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Burger L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt599; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heyn H, 2013, CANCER CELL, V23, P563, DOI 10.1016/j.ccr.2013.04.028; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kretzmer H, 2015, NAT GENET, V47, P1316, DOI 10.1038/ng.3413; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kumar N, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-21; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger F, 2013, GENOME RES, V23, P1601, DOI 10.1101/gr.157271.113; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	49	49	50	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5648	5657		10.1038/onc.2017.176	http://dx.doi.org/10.1038/onc.2017.176			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581523	Green Published, hybrid			2022-12-26	WOS:000412293600009
J	Cheng, MH; Garcia-Olivares, J; Wasserman, S; DiPietro, J; Bahar, I				Cheng, Mary Hongying; Garcia-Olivares, Jennie; Wasserman, Steven; DiPietro, Jennifer; Bahar, Ivet			Allosteric modulation of human dopamine transporter activity under conditions promoting its dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; dopamine transporter; molecular dynamics; mutagenesis; protein assembly	HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; RAT GABA TRANSPORTER-1; MOLECULAR-DYNAMICS; NEUROTRANSMITTER TRANSPORTERS; OLIGOMER FORMATION; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIVING CELLS; BINDING-SITE	The human dopamine (DA) transporter (hDAT) is a key regulator of neurotransmission and a target for antidepressants and addictive drugs. Despite the recent resolution of dDAT structures from Drosophila melanogaster, complete understanding of its mechanism of function and even information on its biological assembly is lacking. The resolved dDAT structures are monomeric, but growing evidence suggests that hDAT might function as a multimer, and its oligomerization may be relevant to addictive drug effects. Here, using structure-based computations, we examined the possible mechanisms of hDAT dimerization and its dynamics in a lipid bilayer. Using a combination of site-directed mutagenesis, DA-uptake, and cross-linking experiments that exploited the capacity of Cys-306 to form intermonomeric disulfide bridges in the presence of an oxidizing agent, we tested the effects of mutations at transmembrane segment (TM) 6 and 12 helices in HEK293 cells. The most probable structural model for hDAT dimer suggested by computations and experiments differed from the dimeric structure resolved for the bacterial homolog, LeuT, presumably because of a kink at TM12 preventing favorable monomer packing. Instead, TM2, TM6, and TM11 line the dimer interface. Molecular dynamics simulations of the dimeric hDAT indicated that the two subunits tend to undergo cooperative structural changes, both on local (extracellular gate opening/closure) and global (transition between outward-facing and inward-facing states) scales. These observations suggest that hDAT transport properties may be allosterically modulated under conditions promoting dimerization. Our study provides critical insights into approaches for examining the oligomerization of neurotransmitter transporters and sheds light on their drug modulation.	[Cheng, Mary Hongying; Bahar, Ivet] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Garcia-Olivares, Jennie; Wasserman, Steven; DiPietro, Jennifer] NIMH, Lab Mol & Cellular Neurobiol, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bahar, I (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, 3064 BST 3,3501 Fifth Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020; Cheng, Mary Hongying/AAU-3768-2021	Cheng, Mary Hongying/0000-0001-5833-8221	National Institutes of Health [R01-GM099738, P30DA035778, P41GM103712]; ZIA [MH002946-04]; Anton machine [P41GM103712]; NSF TeraGrid [TG-MCB130006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103712, R01GM099738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA035778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZIA; Anton machine; NSF TeraGrid(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R01-GM099738, P30DA035778, and P41GM103712 (to I.B.) and ZIA MH002946-04 (to S. G. Amara and J. G.-O.) and by the Anton machine (P41GM103712). This work was also supported by a computing award from the NSF TeraGrid (TG-MCB130006). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Anderluh A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14089; Anderluh A, 2014, J BIOL CHEM, V289, P4387, DOI 10.1074/jbc.M113.531632; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BERGER SP, 1994, MOL PHARMACOL, V46, P726; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Cheng MH, 2015, STRUCTURE, V23, P2171, DOI 10.1016/j.str.2015.09.001; Cheng MHY, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00134; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Forrest LR, 2013, SCIENCE, V339, P399, DOI 10.1126/science.1228465; Gur M, 2017, J PHYS CHEM B, V121, P3657, DOI 10.1021/acs.jpcb.6b09876; Gur M, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936133; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang J, 2011, P NATL ACAD SCI USA, V108, P15141, DOI 10.1073/pnas.1112216108; Khafizov K, 2012, P NATL ACAD SCI USA, V109, pE3035, DOI 10.1073/pnas.1209039109; Khelashvili G, 2015, ACS CHEM NEUROSCI, V6, P1825, DOI 10.1021/acschemneuro.5b00179; Kilic F, 2000, P NATL ACAD SCI USA, V97, P3106, DOI 10.1073/pnas.060408997; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reith M. E., 2002, NEUROTRANSMITTER TRA; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sitte HH, 2015, J NEUROCHEM, V133, P163, DOI 10.1111/jnc.13086; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Stockner T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002909; Thomas JR, 2012, BIOPHYS J, V103, pL01, DOI 10.1016/j.bpj.2012.05.002; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025; Zomot E, 2015, J BIOL CHEM, V290, P544, DOI 10.1074/jbc.M114.617555; Zomot E, 2012, J BIOL CHEM, V287, P31823, DOI 10.1074/jbc.M112.397364	59	17	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12471	12482		10.1074/jbc.M116.763565	http://dx.doi.org/10.1074/jbc.M116.763565			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584050	Green Published, hybrid			2022-12-26	WOS:000406636900012
J	Lee, KH; Jeong, J; Koo, YJ; Jang, AH; Lee, CH; Yoo, CG				Lee, Kyoung-Hee; Jeong, Jiyeong; Koo, Yoon-Jung; Jang, An-Hee; Lee, Chang-Hoon; Yoo, Chul-Gyu			Exogenous neutrophil elastase enters bronchial epithelial cells and suppresses cigarette smoke extract-induced heme oxygenase-1 by cleaving sirtuin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						antioxidant; chronic obstructive pulmonary disease (COPD); oxidative stress; pathogenesis; sirtuin 1 (SIRT1); cigarette smoke extract; heme oxygenase 1; neutrophil elastase		An imbalance between oxidative stress and antioxidant activity plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Cigarette smoke, a major risk factor of COPD, induces cellular oxidative stress, but levels of antioxidants such as heme oxygenase-1 (HO-1) are reduced in individuals with severe COPD. In this study, we evaluated the molecular mechanism of reduced HO-1 expression in human bronchial epithelial cells. We found that cigarette smoke extract (CSE) increases HO-1 levels via activation of NFE2-related factor 2 (Nrf2). However, pretreating cells with the protease neutrophil elastase (NE) suppressed the CSE-induced expression of HO-1 mRNA and protein. NE also decreased the sirtuin 1 (SIRT1) level, but did not inhibit CSE-induced nuclear translocation and DNA-binding activity of Nrf2. Transfection of cells with a Myc/His-tagged SIRT1 expression vector completely blocked the NE-mediated suppression of HO-1 expression. We further noted that the NE-induced down-regulation of SIRT1 was not due to decreased transcription or proteasomal/lysosomal degradation or loss of solubility. Immunofluorescence staining revealed that NE enters the cell cytoplasm, and we observed that NE directly cleaved SIRT1 in vitro, indicating that SIRT1 levels are decreased via direct degradation by internalized NE. Of note, we observed decreased SIRT1 levels in NE-treated primary human bronchial epithelial cells and in lung homogenates from both smokers and patients with COPD. In conclusion, NE suppresses CSE-induced HO-1 expression by cleaving SIRT1. This finding indicates the importance of cross-talk between oxidative stress and protease responses in the pathogenesis of COPD.	[Lee, Kyoung-Hee; Jeong, Jiyeong; Koo, Yoon-Jung; Jang, An-Hee; Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul 110744, South Korea; [Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoo, CG (corresponding author), Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul 110744, South Korea.; Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021						0	15	15	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11970	11979		10.1074/jbc.M116.771089	http://dx.doi.org/10.1074/jbc.M116.771089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28588027	hybrid, Green Published			2022-12-26	WOS:000405485600032
J	Bankova, A; Andres, Y; Horn, MP; Alberio, L; Nagler, M				Bankova, Andriyana; Andres, Yvonne; Horn, Michael P.; Alberio, Lorenzo; Nagler, Michael			Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: Comparison of diagnostic accuracy, reproducibility, and costs in clinical practice	PLOS ONE			English	Article							MULTIPLE ELECTRODE AGGREGOMETRY; OPTICAL-DENSITY; ACUSTAR HIT; 4TS SCORE; ANTIBODY; ELISA; METAANALYSIS; AGGREGATION; COMBINATION; EXPERIENCE	Background Immunoassays are crucial in the work-up of patients with suspected heparin-induced thrombocytopenia (HIT) and rapid tests have been recently developed. However, comparative data on diagnostic accuracy, reproducibility, and analytical costs of different immunoassays in clinical practice are limited. Methods Samples of 179 consecutive patients evaluated for suspected HIT in clinical practice using a polyspecific enzyme-linked immunoabsorbent assay (GTI diagnostics; ELISA) and a rapid particle gel immunoassay (PaGIA), were additionally analysed with a IgG-specific chemiluminescent immunoassay (AcuStar HIT-IgG). Presence of HIT was defined as a positive functional heparin-induced platelet aggregation test. Diagnostic accuracy was determined for low, intermediate and high thresholds as previously established (ELISA: optical density 0.4, 1.3, and 2.0 respectively; PaGIA: positive/negative, titre of 4, titre of 32; AcuStar HITIgG: 1.0 U/ml, 2.8, 9.4) and reproducibility was assessed by repeated measurements. Costs of test determination were calculated taking reagents, controls, and working time of technicians according to Swiss health care system into account. Results Data on PaGIA results were available for 171 patients (95.5%), ELISA for 144 patients (80.4%), and AcuStar HIT-IgG for 179 patients (100%). Sensitivity was above 95% for all assays at low and intermediate thresholds. Specificity increased with higher thresholds and was above 90% for all assays with intermediate and high thresholds. Specificity of AcuStar HIT-IgG (92.8%; 95% CI 87.7, 96.2) was significantly higher than PaGIA (83.0%; 95% CI 76.3, 88.5) and higher than ELISA (81.8%, 95% CI 74.2, 88.0) at low threshold (p< 0.05). Reproducibility was adequate for all assays. Total costs per test were CHF 51.02 for ELISA, 117.70 for AcuStar HIT-IgG, and 83.13 for PaGIA. Conclusions We observed favourable diagnostic accuracy measures and a high reproducibility for PaGIA and AcuStar HIT-IgG. Implementation into 24-hours-service might improve patient care but the results must be confirmed in other settings and larger populations as well.	[Bankova, Andriyana] Luzerner Kantonsspital, Div Haematol, Luzern, Switzerland; [Bankova, Andriyana] Luzerner Kantonsspital, Cent Haematol Lab, Luzern, Switzerland; [Andres, Yvonne] Kreisspital Freiamt, Muri, Switzerland; [Horn, Michael P.] Univ Bern, Bern Univ Hosp, Inselspital, Univ Inst Clin Chem, Bern, Switzerland; [Horn, Michael P.] Univ Bern, Bern Univ Hosp, Inselspital, Ctr Lab Med, Bern, Switzerland; [Alberio, Lorenzo] CHU Vaudois, Div Hematol, Lausanne, Switzerland; [Alberio, Lorenzo] CHU Vaudois, Cent Hematol Lab, Lausanne, Switzerland; [Alberio, Lorenzo] Univ Lausanne, Lausanne, Switzerland; [Nagler, Michael] Univ Bern, Bern Univ Hosp, Inselspital, Dept Haematol, Bern, Switzerland; [Nagler, Michael] Univ Bern, Dept Clin Res, Bern, Switzerland	Lucerne Cantonal Hospital; Lucerne Cantonal Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Bern; University Hospital of Bern; University of Bern	Alberio, L (corresponding author), CHU Vaudois, Div Hematol, Lausanne, Switzerland.; Alberio, L (corresponding author), CHU Vaudois, Cent Hematol Lab, Lausanne, Switzerland.; Alberio, L (corresponding author), Univ Lausanne, Lausanne, Switzerland.	lorenzo.alberio@chuv.ch	Nagler, Michael/H-6715-2019	Nagler, Michael/0000-0003-4319-2367; Bankova, Andriyana/0000-0002-5072-9591; Alberio, Lorenzo/0000-0001-9686-9920				Alberio L, 2003, AM J MED, V114, P528, DOI 10.1016/S0002-9343(03)00080-9; Althaus K, 2013, THROMB RES, V131, pE85, DOI 10.1016/j.thromres.2013.01.005; Althaus K, 2011, THROMB RES, V128, P256, DOI 10.1016/j.thromres.2011.05.003; Archambault AJ, 2012, AM J HEMATOL, V87, pS184; Aydin S, 2015, PEPTIDES, V72, P4, DOI 10.1016/j.peptides.2015.04.012; Bakchoul T, 2009, J THROMB HAEMOST, V7, P1260, DOI 10.1111/j.1538-7836.2009.03465.x; Caton S, 2016, THROMB RES, V140, P155, DOI 10.1016/j.thromres.2016.01.025; CHONG BH, 1993, THROMB HAEMOSTASIS, V69, P344; Cuker A, 2012, BLOOD, V120, P4160, DOI 10.1182/blood-2012-07-443051; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Favaloro EJ, 2015, BLOOD, V126, P563, DOI 10.1182/blood-2015-05-644740; Legnani C, 2010, THROMB HAEMOSTASIS, V104, P402, DOI 10.1160/TH10-01-0002; Linkins LA, 2015, BLOOD, V126, P597, DOI 10.1182/blood-2014-12-618165; Minet V, 2014, THROMB RES, V133, P1074, DOI 10.1016/j.thromres.2014.01.014; Minet V, 2013, THROMB RES, V132, P352, DOI 10.1016/j.thromres.2013.06.004; Nagler M, 2012, J THROMB HAEMOST, V10, P151, DOI 10.1111/j.1538-7836.2011.04552.x; Nagler M, 2016, THROMB HAEMOSTASIS, V116, P823, DOI 10.1160/TH16-03-0240; Nagler M, 2016, BLOOD, V127, P546, DOI 10.1182/blood-2015-07-661215; Nellen V, 2012, HAEMATOL-HEMATOL J, V97, P89, DOI 10.3324/haematol.2011.048074; Schneiter S, 2009, J THROMB HAEMOST, V7, P1649, DOI 10.1111/j.1538-7836.2009.03507.x; Schuetz GM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6717; Smock KJ, 2014, SEMIN THROMB HEMOST, V40, P254, DOI 10.1055/s-0034-1365842; STRICKER H, 1988, AM J MED, V85, P721; Sun L, 2016, THROMB HAEMOST, V115; Van Hoecke F, 2012, INT J LAB HEMATOL, V34, P410, DOI 10.1111/j.1751-553X.2012.01413.x; Warkentin TE, 2008, J THROMB HAEMOST, V6, P1304, DOI 10.1111/j.1538-7836.2008.03025.x; Warkentin TE, 2011, HEMATOL-AM SOC HEMAT, P143, DOI 10.1182/asheducation-2011.1.143; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178289	10.1371/journal.pone.0178289	http://dx.doi.org/10.1371/journal.pone.0178289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594835	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200025
J	Pekar, L; Matusu, R; Prokop, R				Pekar, Libor; Matusu, Radek; Prokop, Roman			Gridding discretization-based multiple stability switching delay search algorithm: The movement of a human being on a controlled swaying bow	PLOS ONE			English	Article							DESCRIPTOR SYSTEM APPROACH; AVERAGE CONSENSUS; DEPENDENT STABILITY; MULTIAGENT SYSTEMS; ROBUST STABILITY; STABILIZATION; BIFURCATION; TOPOLOGIES; DISCRETE; CRITERIA	Delay represents a significant phenomenon in the dynamics of many human-related systems D including biological ones. It has i.a.a decisive impact on system stability, and the study of this influence is often mathematically demanding. This paper presents a computationally simple numerical gridding algorithm for the determination of stability margin delay values in multiple-delay linear systems. The characteristic quasi-polynomial D the roots of which decide about stability D is subjected to iterative discretization by means of pre-warped bilinear transformation. Then, a linear and a quadratic interpolation are applied to obtain the associated characteristic polynomial with integer powers. The roots of the associated characteristic polynomial are closely related to the estimation of roots of the original characteristic quasi-polynomial which agrees with the system's eigenvalues. Since the stability border is crossed by the leading one, the switching root locus is enhanced using the Regula Falsi interpolation method. Our methodology is implemented on D and verified by D a numerical bio-cybernetic example of the stabilization of a human-being's movement on a controlled swaying bow. The advantage of the proposed novel algorithm lies in the possibility of the rapid computation of polynomial zeros by means of standard programs for technical computing; in the low level of mathematical knowledge required; and, in the sufficiently high precision of the roots loci estimation. The relationship to the direct search QuasiPolynomial (mapping) Rootfinder algorithm and computational complexity are discussed as well. This algorithm is also applicable for systems with non-commensurate delays.	[Pekar, Libor] Tomas Bata Univ Zlin, Fac Appl Informat, Dept Automat & Control Engn, Zlin, Czech Republic; [Matusu, Radek] Tomas Bata Univ Zlin, Fac Appl Informat, Reg Res Ctr CEBIA Tech, Zlin, Czech Republic; [Prokop, Roman] Tomas Bata Univ Zlin, Dept Math, Fac Appl Informat, Zlin, Czech Republic	Tomas Bata University Zlin; Tomas Bata University Zlin; Tomas Bata University Zlin	Pekar, L (corresponding author), Tomas Bata Univ Zlin, Fac Appl Informat, Dept Automat & Control Engn, Zlin, Czech Republic.	pekar@fai.utb.cz	Pekar, Libor/H-6373-2012; Matušů, Radek/H-6355-2012	Pekar, Libor/0000-0002-2401-5886; 	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme [LO1303 (MSMT-7778/2014)]; European Regional Development Fund under the project CEBIA-Tech Instrumentation [CZ.1.05/2.1.00/19.0376]	Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme; European Regional Development Fund under the project CEBIA-Tech Instrumentation	The work was supported by the Ministry of Education, Youth and Sports of the Czech Republic within the National Sustainability Programme project no. LO1303 (MSMT-7778/2014), https://www.isvav.cz/projectDetail.do? rowId=L01303. This work was supported by the European Regional Development Fund under the project CEBIA-Tech Instrumentation No. CZ.1.05/2.1.00/19.0376, http://www.risy.cz/cs/vyhledavace/projektyeu/detail?id=141580. The authors are members of the team that received the funding but they are not responsible persons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusaksaka AB, 2014, SYST CONTROL LETT, V64, P43, DOI 10.1016/j.sysconle.2013.11.009; [Anonymous], 2004, J AUTOMATIC CONTROL; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Ayasun S, 2010, ELECTR ENG, V91, P347, DOI 10.1007/s00202-009-0142-x; Bellmann R, 1969, DIFFERENTIAL DIFFERE; Burke JV, 2005, SIAM J OPTIMIZ, V15, P751, DOI 10.1137/030601296; Cao JW, 2013, J FRANKLIN I, V350, P790, DOI 10.1016/j.jfranklin.2012.12.026; CHEN J, 1995, SYST CONTROL LETT, V26, P107, DOI 10.1016/0167-6911(94)00111-8; Chiasson J., 2007, APPL TIME DELAY SYST; Delice II, 2012, IEEE T AUTOMAT CONTR, V57, P963, DOI 10.1109/TAC.2011.2168992; Fridman E, 2002, IEEE T AUTOMAT CONTR, V47, P253, DOI 10.1109/9.983353; Gahinet P, 1995, LMI CONTROL TOOLBOX; Gu K., 2003, STABILITY TIME DELAY; Hale J.K, 2013, INTRO FUNCTIONAL DIF, V99; Ji JC, 2003, MECH RES COMMUN, V30, P217, DOI 10.1016/S0093-6413(03)00006-5; Kwon OM, 2012, IET CONTROL THEORY A, V6, P2567, DOI 10.1049/iet-cta.2012.0257; Li X, 1997, IEEE T AUTOMAT CONTR, V42, P1144, DOI 10.1109/9.618244; Michiels W, 2007, ADV DES CONTROL, P3; Moon YS, 2001, INT J CONTROL, V74, P1447, DOI 10.1080/00207170110067116; Olgac N, 2004, AUTOMATICA, V40, P847, DOI 10.1016/j.automatica.2003.12.010; Oppenheim A. V., 2010, DISCRETE TIME SIGNAL; Orosz G, 2010, PHILOS T R SOC A, V368, P4455, DOI 10.1098/rsta.2010.0205; Pekar L., 2013, INT J MATH COMPUT SI, V7, P59; Pepe P, 2006, SYST CONTROL LETT, V55, P1006, DOI 10.1016/j.sysconle.2006.06.013; Qiao W, 2012, LECT NOTES CONTR INF, V423, P395; Rekasius Z., 1980, P JOINT AUT CONTR C, V7, P39; Saha D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040564; Shang YL, 2014, APPL MATH COMPUT, V244, P457, DOI 10.1016/j.amc.2014.07.019; Shang YL, 2014, LINEAR ALGEBRA APPL, V459, P411, DOI 10.1016/j.laa.2014.07.019; Song YL, 2006, APPL MATH COMPUT, V181, P1745, DOI 10.1016/j.amc.2006.03.025; Sonmez S, 2016, IEEE T POWER SYST, V31, P370, DOI 10.1109/TPWRS.2015.2403865; Suzuki Y, 2012, J THEOR BIOL, V310, P55, DOI 10.1016/j.jtbi.2012.06.019; Talebi S, 2016, T I MEAS CONTROL, V38, P364, DOI 10.1177/0142331215576989; Vanbiervliet J, 2008, ESAIM CONTR OPTIM CA, V14, P478, DOI 10.1051/cocv:2007060; Varszegi B, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0345; Vyhlidal T, 2003, P IFAC WORKSH TIM DE; Vyhlidal T, 2014, ADV DELAY DYN, V1, P299, DOI 10.1007/978-3-319-01695-5_22; Vyhlidal T, 2009, IEEE T AUTOMAT CONTR, V54, P171, DOI 10.1109/TAC.2008.2008345; WALTON K, 1987, IEE PROC-D, V134, P101, DOI 10.1049/ip-d.1987.0018; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Xu Q, 2016, AUTOMATICA, V70, P153, DOI 10.1016/j.automatica.2016.03.028; Xu S, 2005, IEE P-CONTR THEOR AP, V152, P147, DOI 10.1049/ip-cta:20045023; Yu H, 2011, P IEEE AFR 2011 SEP, P423; Zenzeri J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099087; Zhang QJ, 2011, INT J CONTROL AUTOM, V9, P1209, DOI 10.1007/s12555-011-0623-3; Zhang W, 2001, IEEE CONTR SYST MAG, V21, P84, DOI 10.1109/37.898794; Zhu XL, P AM CONTR C 2008 JU; Zitek P, 2008, KYBERNETIKA, V44, P633	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178950	10.1371/journal.pone.0178950	http://dx.doi.org/10.1371/journal.pone.0178950			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594904	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200071
J	Xie, MX; Wang, JY; Chen, K				Xie, Mingxia; Wang, Jiayao; Chen, Ke			The coordinating evaluation and spatial correlation analysis of CSGC: A case study of Henan province, China	PLOS ONE			English	Article							COMPLEX-SYSTEMS; ENVIRONMENT; ECONOMY; DPSIR; URBANIZATION; SOCIETY; BASIN; MODEL	This study investigates the basic characteristics and proposes a concept for the complex system of geographical conditions (CSGC). By analyzing the DPSIR model and its correlation with the index system, we selected indexes for geographical conditions according to the resources, ecology, environment, economy and society parameters to build a system. This system consists of four hierarchies: index, classification, element and target levels. We evaluated the elements or indexes of the complex system using the TOPSIS method and a general model coordinating multiple complex systems. On this basis, the coordination analysis experiment of geographical conditions is applied to cities in the Henan province in China. The following conclusions were reached:. According to the pressure, state and impact of geographical conditions, relatively consistent measures are taken around the city, but with conflicting results.. The coordination degree of geographical conditions is small among regions showing large differences in classification index value. The degree of coordination of such regions is prone to extreme values; however, the smaller the difference the larger the coordination degree.. The coordinated development of geographical conditions in the Henan province is at the stage of the point axis.	[Xie, Mingxia] Changjiang Spatial Informat Technol Engn CO LTD, Wuhan, Peoples R China; [Wang, Jiayao; Chen, Ke] Informat Engn Univ, Inst Surveying & Mapping, Zhengzhou, Peoples R China	PLA Information Engineering University	Xie, MX (corresponding author), Changjiang Spatial Informat Technol Engn CO LTD, Wuhan, Peoples R China.	xmx0424@aliyun.com						Armon R. H., 2015, ENV INDICATORS, P277; Boone RB., 2014, UNDERSTANDING SOC NA, P179, DOI DOI 10.1007/978-94-017-8959-2_9; Carr ER, 2007, INT J SUST DEV WORLD, V14, P543, DOI 10.1080/13504500709469753; [陈俊勇 Chen Junyong], 2012, [测绘学报, Acta Geodetica et Cartographica Sinica], V41, P633; Chen Y, 2006, INTRO SYSTEM SCI MET; [陈洋波 Chen Yangbo], 2004, [水利学报, Journal of Hydraulic Engineering], V0, P98; Cui H.R., 2010, J BEIJING I TECHNOLO, V12, P23; Espinosa A, 2011, LEARN ORGAN, V18, P54, DOI 10.1108/09696471111096000; [樊华 FAN Hua], 2006, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology. Natural science], V35, P515; Giddings B, 2002, SUSTAIN DEV, V10, P187, DOI 10.1002/sd.199; Giupponi C., 2002, MULINO INT C POL TOO; Guan DJ, 2011, ECOL INDIC, V11, P1333, DOI 10.1016/j.ecolind.2011.02.007; Guo YT, 2015, HABITAT INT, V45, P135, DOI 10.1016/j.habitatint.2014.06.030; Haken H., 2005, SYNERGTICS MYSTERIES; Henan Province Bureau of Statistics, 2013, HEN STAT YB; Hwang C-L., 1981, MULTIPLE ATTRIBUTE D, V186, P58, DOI [DOI 10.1007/978-3-642-48318-9, 10.1007/978-3-642-48318-9]; Jago-on KAB, 2009, SCI TOTAL ENVIRON, V407, P3089, DOI 10.1016/j.scitotenv.2008.08.004; KAMBO NS, 1991, ENERG BUILDINGS, V16, P537, DOI 10.1016/0378-7788(91)90022-U; Li HF, 2007, GEOGR ANAL, V39, P357, DOI 10.1111/j.1538-4632.2007.00708.x; [李玉照 Li Yuzhao], 2012, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V48, P971; Liu Y, 2014, ENV SCI, V40, P115; Liu YQ, 2014, SUSTAINABILITY-BASEL, V6, P1946, DOI 10.3390/su6041946; Local chronicles Compilation Committee of Henan Province, 2013, HEN YB; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; MALONE TW, 1994, ACM COMPUT SURV, V26, P87, DOI 10.1145/174666.174668; Mao H Y., 1991, ACTA GEOGRAPHICA SIN, V46, P385; Maxim L, 2009, ECOL ECON, V69, P12, DOI 10.1016/j.ecolecon.2009.03.017; National Administration of Surveying, 2013, CONT GEOGR COND CENS; Niemi G.J., 2015, ENV INDICATORS, P265, DOI DOI 10.1007/978-94-017-9499-2_16; San Miguel M, 2012, EUR PHYS J-SPEC TOP, V214, P245, DOI 10.1140/epjst/e2012-01694-y; Svarstad H, 2008, LAND USE POLICY, V25, P116, DOI 10.1016/j.landusepol.2007.03.005; Vattam SS, 2011, EDUC TECHNOL SOC, V14, P66; Wei YM, 2004, INT J SUST DEV WORLD, V11, P235, DOI 10.1080/13504500409469828; Wenxiu M.Q.H., 2000, J TIANJIN U SCI TECH, V2000, P444; Yan L, 2014, P 2012 INT C CYB INF; Young O, 2006, ECOL SOC, V11; ZADEH LA, 1973, IEEE T SYST MAN CYB, VSMC3, P28, DOI 10.1109/TSMC.1973.5408575	37	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0174543	10.1371/journal.pone.0174543	http://dx.doi.org/10.1371/journal.pone.0174543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594859	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200002
J	Xue, H; Cao, SY; Li, HX; Zhang, J; Niu, J; Chen, LN; Zhang, FH; Zhao, DG				Xue, Hui; Cao, Shangyin; Li, Haoxian; Zhang, Jie; Niu, Juan; Chen, Lina; Zhang, Fuhong; Zhao, Diguang			De novo transcriptome assembly and quantification reveal differentially expressed genes between soft-seed and hard-seed pomegranate (Punica granatum L.)	PLOS ONE			English	Article							RNA-SEQ DATA; LIGNIN BIOSYNTHESIS; JUICE; GENOME; ARABIDOPSIS; ANTIOXIDANT; DATABASE; BLOOD; TOOL	Pomegranate (Punica granatum L.) belongs to Punicaceae, and is valued for its social, ecological, economic, and aesthetic values, as well as more recently for its health benefits. The 'Tunisia' variety has softer seeds and big arils that are easily swallowed. It is a widely popular fruit; however, the molecular mechanisms of the formation of hard and soft seeds is not yet clear. We conducted a de novo assembly of the seed transcriptome in P. granatum L. and revealed differential gene expression between the soft-seed and hard-seed pomegranate varieties. A total of 35.1 Gb of data were acquired in this study, including 280,881,106 raw reads. Additionally, de novo transcriptome assembly generated 132,287 transcripts and 105,743 representative unigenes; approximately 13,805 unigenes (37.7%) were longer than 1,000 bp. Using bioinformatics annotation libraries, a total of 76,806 unigenes were annotated and, among the high-quality reads, 72.63% had at least one significant match to an existing gene model. Gene expression and differentially expressed genes were analyzed. The seed formation of the two pomegranate cultivars involves lignin biosynthesis and metabolism, including some genes encoding laccase and peroxidase, WRKY, MYB, and NAC transcription factors. In the hard-seed pomegranate, lignin-related genes and cellulose synthesis-related genes were highly expressed; in soft-seed pomegranates, expression of genes related to flavonoids and programmed cell death was slightly higher. We validated selection of the identified genes using qRT-PCR. This is the first transcriptome analysis of P. granatum L. This transcription sequencing greatly enriched the pomegranate molecular database, and the high-quality SSRs generated in this study will aid the gene cloning from pomegranate in the future. It provides important insights into the molecular mechanisms underlying the formation of soft seeds in pomegranate.	[Xue, Hui; Cao, Shangyin; Li, Haoxian; Zhang, Jie; Niu, Juan; Chen, Lina; Zhang, Fuhong; Zhao, Diguang] CAAS, Zhengzhou Fruit Res Inst, Zhengzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Zhengzhou Fruit Research Institute, CAAS	Cao, SY (corresponding author), CAAS, Zhengzhou Fruit Res Inst, Zhengzhou, Peoples R China.	13937192127@163.com			Investigation and Collection of Indigenous Varieties of Deciduous Fruit trees in Predominance Region [2012FY110100]; Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences: characteristics of fruit trees resources and breeding [CAAS-ASTIP-201X-ZFRI]	Investigation and Collection of Indigenous Varieties of Deciduous Fruit trees in Predominance Region; Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences: characteristics of fruit trees resources and breeding	This experiment was supported by "Investigation and Collection of Indigenous Varieties of Deciduous Fruit trees in Predominance Region" (2012FY110100) and "Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences: characteristics of fruit trees resources and breeding" (CAAS-ASTIP-201X-ZFRI).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banihani SA, 2014, NUTR RES, V34, P862, DOI 10.1016/j.nutres.2014.08.003; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Cao Danqin, 2015, Xibei Zhiwu Xuebao, V35, P23, DOI 10.7606/j.issn.1000-4025.2015.01.0023; Cao S., 2013, CHIN FRUIT CHI POM V, P9; Chen YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090842; Dalimov DN, 2003, CHEM NAT COMPD+, V39, P37, DOI 10.1023/A:1024128512801; [邓泱泱 DENG Yangyang], 2006, [计算机工程, Computer Engineering], V32, P71; Feng Hu, 2015, Acta Botanica Boreali-Occidentalia Sinica, V35, P1497; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant EH, 2010, PLANTA, V232, P337, DOI 10.1007/s00425-010-1181-2; HAN G., 2014, SCREEN DIFF EXPR GEN; Hu H, 2011, PHYSIOL PLANTARUM, V142, P390, DOI 10.1111/j.1399-3054.2011.01479.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Liu C., 2013, MODERN AGR SCI TECHN, V8, P228; LIU D., 2008, EFF MAN LIGN BIOS RE; Lucci P, 2015, FOOD CHEM, V167, P475, DOI 10.1016/j.foodchem.2014.06.123; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Lynn A, 2012, PLANT FOOD HUM NUTR, V67, P309, DOI 10.1007/s11130-012-0295-z; Malviya S, 2014, J FOOD SCI TECH MYS, V51, P4132, DOI 10.1007/s13197-013-0956-4; Matthaiou CM, 2014, FOOD CHEM TOXICOL, V73, P1, DOI 10.1016/j.fct.2014.07.027; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; MISA, MICROSATELLITE ID TO; Opara LU, 2009, FOOD BIOPROCESS TECH, V2, P315, DOI 10.1007/s11947-008-0095-5; Pantuck A J, 2006, CURRENT UROLOGY REPO, V7, pA1; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Srinivas NR, 2013, EUR J DRUG METAB PH, V38, P223, DOI 10.1007/s13318-013-0137-x; Tapias V, 2014, NEUROBIOL AGING, V35, P1162, DOI 10.1016/j.neurobiolaging.2013.10.077; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Wenping Z., 2001, J HUAQIAO U NATURAL, V4; Zhang ShuiMing, 2015, Journal of Tropical and Subtropical Botany, V23, P65; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zhong RQ, 2012, PLANT CELL PHYSIOL, V53, P368, DOI 10.1093/pcp/pcr185	37	18	26	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178809	10.1371/journal.pone.0178809	http://dx.doi.org/10.1371/journal.pone.0178809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594931	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200054
J	Yip, SSF; Parmar, C; Blezek, D; Estepar, RSJ; Pieper, S; Kim, J; Aerts, HJWL				Yip, Stephen S. F.; Parmar, Chintan; Blezek, Daniel; Estepar, Raul San Jose; Pieper, Steve; Kim, John; Aerts, Hugo J. W. L.			Application of the 3D slicer chest imaging platform segmentation algorithm for large lung nodule delineation	PLOS ONE			English	Article							SOLITARY PULMONARY NODULES; 1-YEAR FOLLOW-UP; VOLUMETRIC MEASUREMENT; DATABASE CONSORTIUM; SPIRAL CT; BASE-LINE; CANCER; CLASSIFICATION; BENIGN; TRIAL	Purpose Accurate segmentation of lung nodules is crucial in the development of imaging biomarkers for predicting malignancy of the nodules. Manual segmentation is time consuming and affected by inter-observer variability. We evaluated the robustness and accuracy of a publically available semiautomatic segmentation algorithm that is implemented in the 3D Slicer Chest Imaging Platform (CIP) and compared it with the performance of manual segmentation. Methods CT images of 354 manually segmented nodules were downloaded from the LIDC database. Four radiologists performed the manual segmentation and assessed various nodule characteristics. The semiautomatic CIP segmentation was initialized using the centroid of the manual segmentations, thereby generating four contours for each nodule. The robustness of both segmentation methods was assessed using the region of uncertainty (delta) and Dice similarity index (DSI). The robustness of the segmentation methods was compared using the Wilcoxon-signed rank test (p(Wilcoxon) < 0.05). The Dice similarity index (DSIAgree) between the manual and CIP segmentations was computed to estimate the accuracy of the semiautomatic contours. Results The median computational time of the CIP segmentation was 10 s. The median CIP and manually segmented volumes were 477 ml and 309 ml, respectively. CIP segmentations were significantly more robust than manual segmentations (median delta(CIP) = 14ml, median dsi(CIP) = 99% vs. median delta(manual) = 222ml, median dsi(manual) = 82%) with p(Wilcoxon)similar to 10(-16). The agreement between CIP and manual segmentations had a median DSIAgree of 60%. While 13% (47/354) of the nodules did not require any manual adjustment, minor to substantial manual adjustments were needed for 87% (305/354) of the nodules. CIP segmentations were observed to perform poorly (median DSIAgree approximate to 50%) for non-/sub-solid nodules with subtle appearances and poorly defined boundaries. Conclusion Semi-automatic CIP segmentation can potentially reduce the physician workload for 13% of nodules owing to its computational efficiency and superior stability compared to manual segmentation. Although manual adjustment is needed for many cases, CIP segmentation provides a preliminary contour for physicians as a starting point.	[Yip, Stephen S. F.; Parmar, Chintan; Aerts, Hugo J. W. L.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA; [Yip, Stephen S. F.; Parmar, Chintan; Estepar, Raul San Jose; Aerts, Hugo J. W. L.] Harvard Med Sch, Boston, MA 02115 USA; [Blezek, Daniel] Mayo Grad Sch Med Rochester, Dept Biomed Engn, Rochester, MN USA; [Estepar, Raul San Jose; Aerts, Hugo J. W. L.] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Pieper, Steve] Isomics Inc, Cambridge, MA USA; [Kim, John] Univ Michigan Hlth Syst, Dept Radiol, Ann Arbor, MI USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan	Yip, SSF (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA.; Yip, SSF (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	Stephen_Yip@dfci.harvard.edu	San Jose Estepar, Raul/AAQ-5657-2020; Aerts, Hugo/ABF-2821-2020; parmar, chintan/J-2977-2019	San Jose Estepar, Raul/0000-0002-3677-1996; Aerts, Hugo/0000-0002-2122-2003; parmar, chintan/0000-0002-2140-814X; Kim, John/0000-0002-9223-7640; Yip, Stephen SF/0000-0001-8626-5736	National Institutes of Health [U01CA190234, U24CA194354, 1R01HL116931]; American Association of Physicists in Medicine; Isomics, Inc.; NATIONAL CANCER INSTITUTE [U01CA190234, U24CA194354] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015902] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association of Physicists in Medicine; Isomics, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors would like to acknowledge support from the National Institutes of Health (award number U01CA190234 and U24CA194354) and research seed funding grant from the American Association of Physicists in Medicine. The Chest Imaging Platform (CIP) is supported by the National Institutes of Health award number 1R01HL116931. Isomics, Inc. provided support in the form of salaries for author SP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; The authors would like to acknowledge support from the National Institute of Health (Award Number U01CA190234 and U24CA194354) and research seed funding grant from the American Association of Physicists in Medicine. The Chest Imaging Platform (CIP) is supported by the National Institute of Health award number 1R01HL116931. Furthermore, we would like to thank Dr. Elizabeth Huynh for editorial assistance.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Armato SG, 2003, MED PHYS, V30, P1188, DOI 10.1118/1.1573210; Armato SG, 1999, RADIOGRAPHICS, V19, P1303, DOI 10.1148/radiographics.19.5.g99se181303; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chen K, 2014, SIGNAL PROCESS, V103, P273, DOI 10.1016/j.sigpro.2013.09.009; Chong SM, 2005, J KOREAN MED SCI, V20, P402, DOI 10.3346/jkms.2005.20.3.402; Coroller TP, 2016, RADIOTHER ONCOL, V119, P480, DOI 10.1016/j.radonc.2016.04.004; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; de Hoop B, 2010, RADIOLOGY, V255, P199, DOI 10.1148/radiol.09090571; Dehmeshi J, 2008, IEEE T MED IMAGING, V27, P467, DOI 10.1109/TMI.2007.907555; Dhara AK, 2016, J DIGIT IMAGING, V29, P466, DOI 10.1007/s10278-015-9857-6; Erasmus JJ, 2000, RADIOGRAPHICS, V20, P43, DOI 10.1148/radiographics.20.1.g00ja0343; Farag A, 2010, LECT NOTES COMPUT SC, V6455, P79; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Goo JM, 2005, RADIOLOGY, V235, P850, DOI 10.1148/radiol.2353040737; Hawkins S, 2016, J THORACIC ONCOLOGY; Jirapatnakul AC, 2011, INT J BIOMED IMAGING, V2011, DOI 10.1155/2011/632195; Krishnan K, 2010, OPT EXPRESS, V18, P15256, DOI 10.1364/OE.18.015256; Kubota T, 2011, MED IMAGE ANAL, V15, P133, DOI 10.1016/j.media.2010.08.005; Kuhnigk JM, 2006, IEEE T MED IMAGING, V25, P417, DOI 10.1109/TMI.2006.871547; Lassen BC, 2015, PHYS MED BIOL, V60, P1307, DOI 10.1088/0031-9155/60/3/1307; Leader JK, 2005, AM J ROENTGENOL, V185, P973, DOI 10.2214/AJR.04.1225; Lee YH, 2011, KOREAN J RADIOL, V12, P559, DOI 10.3348/kjr.2011.12.5.559; Li F, 2004, RADIOLOGY, V233, P793, DOI 10.1148/radiol.2333031018; Ma J, 2016, AUTOMATIC LUNG NODUL; McNitt-Gray MF, 1999, COMPUT MED IMAG GRAP, V23, P339, DOI 10.1016/S0895-6111(99)00033-6; Messay T, 2015, MED IMAGE ANAL, V22, P48, DOI 10.1016/j.media.2015.02.002; Nawa T, 2002, CHEST, V122, P15, DOI 10.1378/chest.122.1.15; Orozco HM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0003-y; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Revel MP, 2006, AM J ROENTGENOL, V187, P135, DOI 10.2214/AJR.05.1228; Ross JC, 2009, LECT NOTES COMPUT SC, V5762, P690, DOI 10.1007/978-3-642-04271-3_84; Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1; Shah SK, 2005, ACAD RADIOL, V12, P1310, DOI 10.1016/j.acra.2005.06.005; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Steenbakkers RJHM, 2006, INT J RADIAT ONCOL, V64, P435, DOI 10.1016/j.ijrobp.2005.06.034; Tachibana R, 2006, P SPIE; Tan YQ, 2013, MED PHYS, V40, DOI 10.1118/1.4793409; Tao Y, 2009, LECT NOTES COMPUT SC, V5762, P715; The Cancer Imaging Archive (TCIA) Public Access, LUNG IM DAT CONS IM; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Velazquez ER, 2013, SCI REP-UK, V3, DOI 10.1038/srep03529; Washko GR., 2015, C66 LUNG IMAGING 2 N, pA4975, DOI [10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4975., DOI 10.1164/AJRCCM-CONFERENCE.2015.191.1_MEETINGABSTRACTS.A4975]; WHO, 2013, WHO METHODS DATA SOU; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhou J, 2006, ENG MED BIOL SOC 200; Zhu YJ, 2012, J DIGIT IMAGING, V25, P409, DOI 10.1007/s10278-011-9435-5	55	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178944	10.1371/journal.pone.0178944	http://dx.doi.org/10.1371/journal.pone.0178944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594880	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200070
J	Zhao, XK; Li, ZY; Zhu, QK; Zhu, DH; Liu, HF				Zhao, Xingkai; Li, Zengyao; Zhu, Qingke; Zhu, Danhong; Liu, Huifang			Climatic and drought characteristics in the loess hilly-gully region of China from 1957 to 2014	PLOS ONE			English	Article							SOIL-MOISTURE; RIVER-BASIN; PLATEAU; VARIABILITY; INDEX; TREND	The loess hilly-gully region is a focus region of the "Grain for Green" program in China. Drought is the main problem in the study region. Precipitation and temperature are two indicators that directly characterize climatic drought. A thorough analysis of the precipitation, temperature and drought characteristics of the loess hilly-gully region can clarify the current water and heat conditions in the region to improve regional water resource management and provide a reliable reference for effectively improving water use efficiency. In this study, we fully analyzed the precipitation and temperature characteristics at 11 representative synoptic stations in the loess hilly-gully region over the period from 1957 to 2014 using a combination of trend-free pre-whitening, linear trend estimation, Spearman's rho test, the Mann-Kendall (M-K) trend and abrupt change tests and wavelet analysis. The standardized precipitation evapotranspiration index was calculated and analyzed on different time scales. The following conclusions were drawn: (1) There were significant spatial differences and interannual variations in precipitation at the 11 synoptic stations in the study area between 1957 and 2014; the precipitation consistently decreased with fluctuations, and the extent of the decrease varied from a maximum of 17.74 mm/decade to a minimum of 2.92 mm/decade. Except for the downward trends of the autumn and winter mean temperatures at Hequ, the seasonal and annual mean temperatures at the stations showed upward trends, including highly significant upward trends. (2) Alternating drought and wetness occurred in the study area; the wet period mainly appeared in the 1960s, and the main dry period lasted from the late 20th century to 2012. There were fewer dry and wet years than normal years; however, the study area still showed a drying trend, and the severity of the drought was increasing. (3) The annual precipitation and annual mean temperature showed marked cyclical fluctuations at each synoptic station, and the first primary cycle was approximately 28 years. The seasonal precipitation and seasonal temperature showed different cycle lengths; the seasonal cycles of precipitation for spring, summer, autumn and winter were 10, 28, 10 and 26 years long, respectively, and the cycles of the temperature fluctuations for all four seasons were approximately 28 years long.	[Zhao, Xingkai; Li, Zengyao; Zhu, Qingke] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China; [Zhu, Danhong] State Forestry Adm, Planning & Design Inst Forest Prod Ind, Beijing, Peoples R China; [Liu, Huifang] China Inst Water Resources & Hydropower Res, State Key Lab Simulat & Regulat Water Cyclein Riv, Beijing, Peoples R China	Beijing Forestry University; China Institute of Water Resources & Hydropower Research	Zhu, QK (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China.	zhuqingke@sohu.com			National Science & Technology Pillar Program [2015BAD07B02]	National Science & Technology Pillar Program	The study was funded by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (2015BAD07B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JJ, IEEE J SELECTED TOPI, V7, P4581; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Brown K, 2002, SCIENCE, V297, P926, DOI 10.1126/science.297.5583.926; Cochran F, 2016, SUSTAIN SCI, V11, P69, DOI 10.1007/s11625-015-0303-y; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ficklin DL, 2015, COMPUT GEOSCI-UK, V85, P136, DOI 10.1016/j.cageo.2015.09.013; Fu C, 2008, ARID ZONE RES, V25, P447; Gao P, 2015, HYDROLOGICAL PROCESS, V29; Gao ZD, 2017, AGR FOREST METEOROL, V232, P106, DOI 10.1016/j.agrformet.2016.08.006; [韩翠华 Han Cuihua], 2013, [地理科学进展, Progress in Geography], V32, P887; He Y, 2015, ATMOS RES, V166, P120, DOI 10.1016/j.atmosres.2015.06.022; Huang HP, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/1536135; Jia XX, 2015, J HYDROL, V528, P152, DOI 10.1016/j.jhydrol.2015.06.025; Jia YH, 2014, J HYDROL, V519, P523, DOI 10.1016/j.jhydrol.2014.07.043; Kendall M.G., 1975, RANK CORRELATION MEA; Li BQ, 2015, WATER-SUI, V7, P5474, DOI 10.3390/w7105474; [刘引鸽 LIU Yinge], 2007, [干旱区研究, Arid Zone Research], V24, P49; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Martinez-Fernandez J, 2003, SOIL SCI SOC AM J, V67, P1647, DOI 10.2136/sssaj2003.1647; McKee T.B., 1993, P 8 C APPL CLIM; National climate center, 2006, 204812006 GBT NAT CL; Palmer W.C., 1965, METEOROLOGICAL DROUG, V45, P58; Sales JD, 1980, APPL MODELING HYDROL; Sen AK, 2016, THEOR APPL CLIMATOL, V123, P733, DOI 10.1007/s00704-015-1388-z; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sneyers R., 1990, 143 WORLD MET ORG; Stagge JH, 2015, INT J CLIMATOL, V35, P4027, DOI 10.1002/joc.4267; Stocker T. F., 2013, CLIMATE CHANGE 2013; Storch HV, ANAL CLIMATE VARIABI; [孙智辉 Sun Zhihui], 2013, [中国沙漠, Journal of Desert Research], V33, P1560; Svoboda M., 2012, 1090 WMO; Theil H., 1950, KONINKLIJKE NEDERLAN, V53, P1397; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Wang LN, 2015, NAT HAZARDS, V77, P479, DOI 10.1007/s11069-015-1594-0; [王林 Wang Lin], 2014, [高原气象, Plateau Meteorology], V33, P423; Wei J, 2006, CATENA, V68, P10, DOI 10.1016/j.catena.2006.04.011; Xie J, 2016, AGR FOREST METEOROL, V218, P209, DOI 10.1016/j.agrformet.2015.12.059; Yan WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134902; [姚雪玲 Yao Xueling], 2012, [生态学报, Acta Ecologica Sinica], V32, P4961; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100; Zhang BQ, 2014, HYDROL PROCESS, V28, P1689, DOI 10.1002/hyp.9724; Zhao WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141662; [赵兴凯 Zhao Xingkai], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P155; Zheng BM, 2004, THEORY PRACTICE SMAL; Zhu QK, 2012, NEAR NATURAL VEGETAT; [庄少伟 Zhuang Shaowei], 2013, [气候与环境研究, Climatic and Environmental Research], V18, P617	49	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178701	10.1371/journal.pone.0178701	http://dx.doi.org/10.1371/journal.pone.0178701			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594936	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200044
J	Merz, TM; Pereira, AJ; Schurch, R; Schefold, JC; Jakob, SM; Takala, J; Djafarzadeh, S				Merz, Tobias M.; Pereira, Adriano J.; Schuerch, Roger; Schefold, Joerg C.; Jakob, Stephan M.; Takala, Jukka; Djafarzadeh, Siamak			Mitochondrial function of immune cells in septic shock: A prospective observational cohort study	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RESPIRATORY CAPACITY; CYTOKINE PRODUCTION; ORGAN DYSFUNCTION; DR EXPRESSION; SEVERE SEPSIS; ACTIVATION; MONOCYTES; HYPOXIA; METABOLISM	Background Reduced cellular ATP synthesis due to impaired mitochondrial function of immune cells may be a factor influencing the immune response in septic shock. We investigate changes in mitochondrial function and bioenergetics of human monocytes and lymphocyte subsets. Methods Thirty patients with septic shock were studied at ICU admission, after 24 and 48 hours, and after resolution of shock. Enzymatic activities of citrate synthase and mitochondrial complexes I, IV, and ATP synthase and ATP content of monocytes, T-cells and B-cells and proinflammatory (IL-1 beta and IL-6) and anti-inflammatory (IL-10) cytokine plasma concentrations were compared to samples from 20 healthy volunteers. Results Large variations in mitochondrial enzymatic activities of immune cells of septic patients were detected. In monocytes, maximum levels of citrate synthase activity in sepsis were significantly lower when compared to controls (p = 0.021). Maximum relative enzymatic activity (ratio relative to citrate synthase activity) of complex I (p<0.001), complex IV (p = 0.017) and ATP synthase (p<0.001) were significantly higher. In T-cells, maximum levels of citrate synthase (p = 0.583) and relative complex IV (p = 0.602) activity did not differ between patients and controls, whereas levels of relative complex I (p = 0.006) and ATP synthase (p = 0.032) were significantly higher in septic patients. In B-cells of patients, maximum levels of citrate synthase activity (p = 0.004) and relative complex I (p<0.001) were significantly higher, and mean levels of relative complex IV (p = 0.042) lower than the control values, whereas relative ATP synthase activity did not differ (p = 1.0). No significant difference in cellular ATP content was detected in any cell line (p = 0.142-0.519). No significant correlations between specific cytokines and parameters of mitochondrial enzymatic activities or ATP content were observed. Conclusions Significant changes of mitochondrial enzymatic activities occur in human peripheral blood immune cells in septic shock when compared to healthy controls. Assessed sub-types of immune cells showed differing patterns of regulation. Total ATP-content of human immune cells did not differ between patients in septic shock and healthy volunteers.	[Merz, Tobias M.; Pereira, Adriano J.; Schefold, Joerg C.; Jakob, Stephan M.; Takala, Jukka; Djafarzadeh, Siamak] Univ Bern, Bern Univ Hosp, Dept Intens Care Med, CH-3010 Bern, Switzerland; [Schuerch, Roger] Univ Bern, Inst Social & Prevent Med, Div Stat, Clin Trials Unit, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Merz, TM (corresponding author), Univ Bern, Bern Univ Hosp, Dept Intens Care Med, CH-3010 Bern, Switzerland.	tobias.merz@insel.ch	Schurch, Roger/J-8744-2019; Pereira, Adriano/F-9342-2014; Merz, Tobias/AAE-8323-2020	Schurch, Roger/0000-0001-9075-8912; Pereira, Adriano/0000-0002-3528-3800; Schefold, Joerg C./0000-0001-9162-5724	Stiftung fur die Forschung in Anasthesiologie und Intensivmedizin, Bern, Switzerland; Gottfried und Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland	Stiftung fur die Forschung in Anasthesiologie und Intensivmedizin, Bern, Switzerland; Gottfried und Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland	This study was supported by grants from the following research foundations: "Stiftung fur die Forschung in Anasthesiologie und Intensivmedizin" and "Gottfried und Julia Bangerter-Rhyner-Stiftung", both Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Belikova I, 2007, CRIT CARE MED, V35, P2702, DOI 10.1097/01.CCM.0000295593.25106.C4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blumenstein M, 1997, SHOCK, V8, P73, DOI 10.1097/00024382-199707000-00012; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Buttgereit F, 2000, IMMUNOL TODAY, V21, P192; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Crouser ED, 2002, CRIT CARE MED, V30, P2722, DOI 10.1097/00003246-200212000-00017; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Dawson HJ, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/516015; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Delmastro-Greenwood MM, 2013, AM J CLIN EXP IMMUNO, V2, P30; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dziurla R, 2010, IMMUNOL LETT, V131, P97, DOI 10.1016/j.imlet.2010.02.008; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Holt JP, 2007, CELL MOTIL CYTOSKEL, V64, P756, DOI 10.1002/cm.20220; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Japiassu AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Ledderose C, 2016, CLIN THER, V38, P1054, DOI 10.1016/j.clinthera.2016.04.002; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MELA L, 1983, CIRC SHOCK, V10, P371; MELA L, 1971, AM J PHYSIOL, V220, P571, DOI 10.1152/ajplegacy.1971.220.2.571; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Porta F, 2006, CRIT CARE, V10, DOI 10.1186/cc5013; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; RUSTIN P, 1994, J PEDIATR-US, V124, P224, DOI 10.1016/S0022-3476(94)70308-6; Schefold JC, 2010, INTENS CARE MED, V36, P1810, DOI 10.1007/s00134-010-1965-7; Sica A, 2011, J MOL MED, V89, P657, DOI 10.1007/s00109-011-0724-8; Sjovall F, 2013, CRIT CARE, V17, DOI 10.1186/cc12831; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Volk HD, 2000, CHEM IMMUNOL, V74, P162; Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309; Weiss SL, 2015, PEDIATR CRIT CARE ME, V16, pE4, DOI 10.1097/PCC.0000000000000277; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	51	21	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178946	10.1371/journal.pone.0178946	http://dx.doi.org/10.1371/journal.pone.0178946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591158	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700061
J	Miller-Struttmann, NE; Heise, D; Schul, J; Geib, JC; Galen, C				Miller-Struttmann, Nicole E.; Heise, David; Schul, Johannes; Geib, Jennifer C.; Galen, Candace			Flight of the bumble bee: Buzzes predict pollination services	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; PLANT REPRODUCTION; COMPETITION; EFFICIENCY; DIVERSITY; ABUNDANCE; PATTERNS	Multiple interacting factors drive recent declines in wild and managed bees, threatening their pollination services. Widespread and intensive monitoring could lead to more effective management of wild and managed bees. However, tracking their dynamic populations is costly. We tested the effectiveness of an inexpensive, noninvasive and passive acoustic survey technique for monitoring bumble bee behavior and pollination services. First, we assessed the relationship between the first harmonic of the flight buzz (characteristic frequency) and pollinator functional traits that influence pollination success using flight cage experiments and a literature search. We analyzed passive acoustic survey data from three locations on Pennsylvania Mountain, Colorado to estimate bumble bee activity. We developed an algorithm based on Computational Auditory Scene Analysis that identified and quantified the number of buzzes recorded in each location. We then compared visual and acoustic estimates of bumble bee activity. Using pollinator exclusion experiments, we tested the power of buzz density to predict pollination services at the landscape scale for two bumble bee pollinated alpine forbs (Trifolium dasyphyllum and T. parryi). We found that the characteristic frequency was correlated with traits known to affect pollination efficacy, explaining 30-52% of variation in body size and tongue length. Buzz density was highly correlated with visual estimates of bumble bee density (r = 0.97), indicating that acoustic signals are predictive of bumble bee activity. Buzz density predicted seed set in two alpine forbs when bumble bees were permitted access to the flowers, but not when they were excluded from visiting. Our results indicate that acoustic signatures of flight can be deciphered to monitor bee activity and pollination services to bumble bee pollinated plants. We propose that applications of this technique could assist scientists and farmers in rapidly detecting and responding to bee population declines.	[Miller-Struttmann, Nicole E.] Webster Univ, Biol Sci Dept, St Louis, MO 63119 USA; [Heise, David] Lincoln Univ, Dept Comp Sci Technol & Math, Jefferson City, MO USA; [Schul, Johannes; Galen, Candace] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Geib, Jennifer C.] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA	Webster University; Lincoln University - Missouri; University of Missouri System; University of Missouri Columbia; University of North Carolina; Appalachian State University	Miller-Struttmann, NE (corresponding author), Webster Univ, Biol Sci Dept, St Louis, MO 63119 USA.	nicolem42@webster.edu	Miller-Struttmann, Nicole/AAZ-1535-2020	Miller-Struttmann, Nicole/0000-0002-4799-4802	Mountain Research Station, University of Colorado; Beaver Ponds Environmental Education Center; United States National Science Foundation awards [1045322, 1410586, 1355406]; NSF [1045322, 1410586, 1355406]; Office of Integrative Activities [1355406] Funding Source: National Science Foundation	Mountain Research Station, University of Colorado; Beaver Ponds Environmental Education Center; United States National Science Foundation awards; NSF(National Science Foundation (NSF)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	We acknowledge the support of the Mountain Research Station, University of Colorado and Beaver Ponds Environmental Education Center. Niwot Ridge LTER (NSF DEB 1027341) and Mountain Area Land Trust (Pennsylvania Mountain) provided access to research sites. This research was supported by United States National Science Foundation awards (awards 1045322, 1410586, and 1355406) and Deborah K. Snider, B. A., M.A. Data are archived at DOI:10.5061/dryad.43f8k (http://dx.doi.org/10.5061/dryad.43f8k). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Kimberly Bowman, Elizabeth Hedrick, Zack Miller, and Zoe Moffet for assistance in field and laboratory data collection. Kaitlyn Irwin supplied the blueberry fruit photograph for S1 Fig. We acknowledge the support of the Mountain Research Station, University of Colorado and Beaver Ponds Environmental Education Center. Niwot Ridge LTER (NSF DEB 1027341) and Mountain Area Land Trust (Pennsylvania Mountain) provided access to research sites. This research was supported by NSF (awards 1045322, 1410586, and 1355406) and Deborah K. Snider, B.A., M.A. Data are archived at DOI:10.5061/dryad.43f8k (hitp://dx.doi.org/10.5061/ciryact43f8k). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2012, P ROY SOC B-BIOL SCI, V279, P4845, DOI 10.1098/rspb.2012.1621; [Anonymous], 1998, PRINCIPLES ANIMAL CO; Appel HM, 2014, OECOLOGIA, V175, P1257, DOI 10.1007/s00442-014-2995-6; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Blitzer EJ, 2016, AGR ECOSYST ENVIRON, V221, P1, DOI 10.1016/j.agee.2016.01.004; Bluthgen N, 2011, BASIC APPL ECOL, V12, P282, DOI 10.1016/j.baae.2010.11.001; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Brock MT, 2009, OECOLOGIA, V161, P241, DOI 10.1007/s00442-009-1383-0; Burd M, 2008, AM NAT, V171, P400, DOI 10.1086/527499; Burkart Andreas, 2011, Journal of Pollination Ecology, V6, P118; Byron PA, 1980, THESIS; De Luca PA, 2014, NATURWISSENSCHAFTEN, V101, P331, DOI 10.1007/s00114-014-1161-7; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Edens-Meier R, 2011, J TORREY BOT SOC, V138, P287, DOI 10.3159/TORREY-D-11-00024.1; Ellis AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114805; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Geib JC, 2015, ECOL APPL, V25, P768, DOI 10.1890/14-0151.1; Geib JC, 2012, ECOLOGY, V93, P1581, DOI 10.1890/11-1271.1; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; HAIG D, 1988, AM NAT, V131, P757, DOI 10.1086/284817; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HARDER LD, 1985, ECOLOGY, V66, P198, DOI 10.2307/1941320; Harmon-Threatt AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060446; Heinrich B., 2004, BUMBLEBEE EC; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hutto RL, 2009, J FIELD ORNITHOL, V80, P387, DOI 10.1111/j.1557-9263.2009.00245.x; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kirschel ANG, 2011, IBIS, V153, P255, DOI 10.1111/j.1474-919X.2011.01102.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight TM, 2005, ANNU REV ECOL EVOL S, V36, P467, DOI 10.1146/annurev.ecolsys.36.102403.115320; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lebuhn G, 2013, CONSERV BIOL, V27, P113, DOI 10.1111/j.1523-1739.2012.01962.x; MACIOR L W, 1974, Melanderia, V15, P1; Mankin R. W., 2011, American Entomologist, V57, P30; Martins L., 2008, THESIS; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Miller-Struttmann NE, 2014, OECOLOGIA, V176, P1033, DOI 10.1007/s00442-014-3066-8; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.1890/0012-9658(2002)083[2416:GPIPPM]2.0.CO;2; Ollerton J, 2014, SCIENCE, V346, P1360, DOI 10.1126/science.1257259; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Orford KA, 2016, J APPL ECOL, V53, P906, DOI 10.1111/1365-2664.12608; Pineiro J, 2011, NLME LINEAR NONLINEA; Pollinator Health Task Force, 2015, NAT STRAT PROM HLTH, P1; Pyke GH, 2012, ENVIRON ENTOMOL, V41, P1332, DOI 10.1603/EN11284; R Development Core Team, 2014, R LANG ENV STAT COMP; R Development Core Team, 2015, MUMIN MULTIMODEL INF; Riede K, 1998, J INSECT CONSERV, V2, P217, DOI 10.1023/A:1009695813606; Rodriguez-Girones MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002992; Sorn J, 2016, BIOACOUSTICS, V4622, P1; Stang M, 2009, ANN BOT-LONDON, V103, P1459, DOI 10.1093/aob/mcp027; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Swiston KA, 2009, J FIELD ORNITHOL, V80, P42, DOI 10.1111/j.1557-9263.2009.00204.x; Tang M, 2015, METHODS ECOL EVOL, V6, P1034, DOI 10.1111/2041-210X.12416; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Wickham H., 2016, GGPLOT2 CREATE ELEGA; Williams NM, 2001, ECOLOGY SOC, V5, P1; Willmer PG, 2014, J POLLINAT ECOL, V14, P244, DOI DOI 10.26786/1920-7603(2014)22; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; [No title captured]; [No title captured]; [No title captured]	63	14	15	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179273	10.1371/journal.pone.0179273	http://dx.doi.org/10.1371/journal.pone.0179273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591213	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700097
J	Stojisavljevic, S; Djikanovic, B; Matejic, B				Stojisavljevic, Stela; Djikanovic, Bosiljka; Matejic, Bojana			'The Devil has entered you': A qualitative study of Men Who Have Sex With Men (MSM) and the stigma and discrimination they experience from healthcare professionals and the general community in Bosnia and Herzegovina	PLOS ONE			English	Article								Men who have sex with men (MSM) are often exposed to unequal treatment in societies worldwide as well as to various forms of stigma and discrimination in healthcare services. Bosnia and Herzegovina (B&H) is a postconflict developing country located in Southeast Europe and the Western Balkans, where little is known about the experiences of MSM regarding their communities and interactions with healthcare services. The aim of this study was to explore the types of experiences MSM face and to assess the level of stigma and discrimination they are exposed to in this setting. We conducted twelve in-depth face-to-face interviews with MSM who were 16 to 45 years old and residing in B&H. The main findings indicated that they all experienced various levels of stigma, discrimination, prejudice and inequities in treatment and attitudes from different segments of society, including the health care sector, that prevented them from fully developing their human and health potential. Additionally, these experiences were adversely related to opportunities to receive good quality health care services due to the insufficiently educated and old-fashioned health professionals who sometimes believed in black magic practices. The findings present numerous opportunities for educational trainings and structural reform to create a society that provides and guarantees equal opportunities for all.	[Stojisavljevic, Stela] Publ Hlth Inst Republ Srpska, Banja Luka, Bosnia & Herceg; [Djikanovic, Bosiljka; Matejic, Bojana] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Djikanovic, Bosiljka; Matejic, Bojana] Univ Belgrade, Fac Med, Ctr Sch Publ Hlth, Belgrade, Serbia	University of Belgrade; University of Belgrade	Stojisavljevic, S (corresponding author), Publ Hlth Inst Republ Srpska, Banja Luka, Bosnia & Herceg.	stela.blk@gmail.com	Stojisavljevic, Stela/AAI-1700-2019	Matejic, Bojana/0000-0001-6372-3298				AIDS Projects Management Group, 2013, IZVJ PROCJ VEL MSM P; Amnesty international, 2013, ANN REP BOSN HERZ; [Anonymous], NONG ORG BANJ LUK; [Anonymous], SPEC REP RIGHTS LGBI; [Anonymous], ISTR HIV STIGM DISKR; [Anonymous], BIO BIH SURV POP MEN; [Anonymous], 2016, 2015 ANN REP RES ACT; [Anonymous], 2010, SOC DISCR MEN HAV SE; Buchmueller T, 2010, AM J PUBLIC HEALTH, V100, P489, DOI 10.2105/AJPH.2009.160804; Carabez R, 2015, J PROF NURS, V31, P323, DOI 10.1016/j.profnurs.2015.01.003; Causevic J, 2014, BROJEVI KOJI RAVNOPR; European Centre for Disease Prevention and Control / WHO Regional Office for Europe, 2014, HIV AIDS VEILL EUR 2; Frye V, 2015, AIDS BEHAV, V19, P257, DOI 10.1007/s10461-014-0937-2; Fusch PI, 2015, QUAL REP, V20, P1408; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jalali S, 2015, PREHOSP DISASTER MED, V30, P163, DOI 10.1017/S1049023X15000151; King R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082937; Lama TT, 2011, AIDS ED PREVENTION; Lim DV, 2014, AM J NURS, V114, P24; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mole RCM, 2014, ETHNIC HEALTH, V19, P86, DOI 10.1080/13557858.2013.789829; Pachankis JE, 2015, AIDS, V29, P1239, DOI 10.1097/QAD.0000000000000724; Rispel LC, 2015, SAHARA J-J SOC ASP H, V12, P10, DOI 10.1080/17290376.2015.1014403; Ross MW, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2014-006175, 10.1136/bmjopen-2012-001928]; Simunovic Vladimir J, 2007, Confl Health, V1, P7, DOI 10.1186/1752-1505-1-7; UNDP, 2010, REP EXPL LINK MSM HO; USAID, 2010, MEN HAV SEX MEN E EU; van der Elst EM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18741; Vasic V, 2014, HOMOPHOBIC TRANSPHOB	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179101	10.1371/journal.pone.0179101	http://dx.doi.org/10.1371/journal.pone.0179101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591214	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700087
J	Guo, SJ; Xue, YF; He, QM; He, XB; Guo, KB; Dong, P; Yao, K; Yang, GW; Chen, D; Li, ZS; Li, XD; Qin, ZK; Liu, ZW; Cheng, WJ; Guo, C; Zhang, M; Han, H; Zhou, FJ				Guo, Shengjie; Xue, Yunfei; He, Qiuming; He, Xiaobo; Guo, Kunbin; Dong, Pei; Yao, Kai; Yang, Guangwei; Chen, Dong; Li, Zaishang; Li, Xiangdong; Qin, Zike; Liu, Zhuowei; Cheng, Wenjie; Guo, Chao; Zhang, Meng; Han, Hui; Zhou, Fangjian			Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITORS; CATHEPSIN-D; CREATININE CLEARANCE; CANCER; EXPRESSION; MARKER; PREDICTION; SURVIVAL; INVASION; DISEASE	Purpose The prognostic value of serum cystatin-C (Cys-C) in renal cell carcinoma (RCC) remains unknown. The purpose of this study is to explore the prognostic value of Cys-C for RCC patients. Patients and methods The levels of preoperative Cys-C, creatinine (CRE) and estimated glomerular filtration rate (e-GFR) were retrospectively collected in 325 RCC patients undergoing surgery. The cutoff values of Cys-C, CRE and e-GFR were determined by the standardized Cutoff Finder algorithm. The receiver operating characteristic (ROC) curve and pairwise comparison were performed to compare the three variables. Univariate and multivariate Cox regression analyses were performed to investigate the prognostic value of serum Cys-C in RCC. Results Based on the analysis of Cutoff Finder algorithm, ROC curve and pairwise comparison, the preoperative Cys-C was superior to CRE and e-GFR as a predictive factor in RCC. Multivariate Cox regression analyses showed that high preoperative Cys-C (> 1.09 mg/L) was significantly associated with shorter overall survival (OS) in all RCC patients (hazard ratio [HR], 1.59; P = 0.012), patients at pT1-2 (P<0.001), pN0 (P<0.001) and pM0 stages (P<0.001). Moreover, Multivariate Cox regression analyses also showed that in the 306 patients without metastasis, high preoperative Cys-C was also associated with shorter disease-free survival (DFS) (HR, 3.50; P = 0.013). Conclusions An elevated preoperative Cys-C level was demonstrated to be related with worse survival in patients with RCC. Measuring preoperative serum Cys-C might be a simple way for finding poor prognostic patients and patients with elevated preoperative Cys-C level should be more closely followed up.	[Guo, Shengjie; He, Qiuming; Dong, Pei; Yao, Kai; Chen, Dong; Li, Zaishang; Li, Xiangdong; Qin, Zike; Liu, Zhuowei; Han, Hui; Zhou, Fangjian] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Urol,Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Xue, Yunfei; Zhang, Meng] Sun Yat Sen Univ, Med Sch, Guangzhou, Guangdong, Peoples R China; [He, Xiaobo] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Oncol, Zhuhai, Peoples R China; [Guo, Kunbin] Guangzhou Univ Chinese Med, Inst Clin Pharmacol, Guangzhou, Guangdong, Peoples R China; [Cheng, Wenjie] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Urol, Zhuhai, Peoples R China; [Guo, Chao] Yangjiang Peoples Hosp, Jiangcheng Branch, Yangjiang, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University	Han, H; Zhou, FJ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Urol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.	hanhui@sysucc.org.cn; zhoufj@sysucc.org.cn	Guo, Kunbin/GZL-4006-2022	Chen, Dong/0000-0002-6114-9752	National Natural Science Foundation of China [81302224, 81202013]; Medical Scientific Research Foundation of Guangdong Province, China [2016A030310174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province, China	This study was funded by National Natural Science Foundation of China (Grant No. 81302224 and 81202013) and Medical Scientific Research Foundation of Guangdong Province, China (2016A030310174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; Berdowska I, 2004, CLIN CHIM ACTA, V342, P41, DOI 10.1016/j.cccn.2003.12.016; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Chen HH, 2010, J AM COLL CARDIOL, V56, P1937, DOI 10.1016/j.jacc.2010.06.049; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Ebert E, 1997, ADV EXP MED BIOL, V421, P259; Eggener SE, 2006, J CLIN ONCOL, V24, P3101, DOI 10.1200/JCO.2005.04.8280; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Friedrich B, 1999, EUR J CANCER, V35, P138, DOI 10.1016/S0959-8049(98)00273-1; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; JACOBSSON B, 1995, HISTOPATHOLOGY, V26, P559, DOI 10.1111/j.1365-2559.1995.tb00275.x; Jayson M, 1998, UROLOGY, V51, P203, DOI 10.1016/S0090-4295(97)00506-2; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jovanovic D, 2003, RENAL FAILURE, V25, P123, DOI 10.1081/JDI-120017475; Kim SP, 2011, J UROLOGY, V185, P2035, DOI 10.1016/j.juro.2011.02.059; Kirschke H, 1997, J CANCER RES CLIN, V123, P402, DOI 10.1007/s004320050078; Kolwijck E, 2010, EUR J CLIN INVEST, V40, P591, DOI 10.1111/j.1365-2362.2010.02305.x; Kos J, 2000, INT J BIOL MARKER, V15, P84, DOI 10.1177/172460080001500116; Kumaresan Ramanathan, 2011, Oman Med J, V26, P421, DOI 10.5001/omj.2011.107; Launay-Vacher V, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000091; Luciani LG, 2000, UROLOGY, V56, P58, DOI 10.1016/S0090-4295(00)00534-3; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Merseburger AS, 2005, EUR UROL, V48, P519, DOI 10.1016/j.eururo.2005.03.019; Merseburger AS, 2007, UROL INT, V79, P41, DOI 10.1159/000102912; Mori J, 2016, CANCER SCI, V107, P298, DOI 10.1111/cas.12881; Nuckel H, 2012, INT J HEMATOL, V95, P545, DOI 10.1007/s12185-012-1049-2; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Randers E, 2000, CLIN NEPHROL, V54, P203; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Softic A, 2011, MED GLAS, V8, P97; Sokol JP, 2004, MOL CANCER RES, V2, P183; Stabuc B, 2000, CLIN CHEM, V46, P193; Vasudev NS, 2009, BRIT J CANCER, V101, P1175, DOI 10.1038/sj.bjc.6605250; Volpe A, 2010, WORLD J UROL, V28, P319, DOI 10.1007/s00345-010-0540-8; Wegiel B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007953; Werle B, 2006, ONCOL REP, V16, P647; Yang Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003728; Zeng QH, 2011, TUMORI, V97, P203, DOI 10.1700/667.7784; Zeng QH, 2010, MOL MED REP, V3, P607, DOI 10.3892/mmr_00000304; Zhang W, 2014, ONCOL REP, V31, P1334, DOI 10.3892/or.2014.2967	44	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178823	10.1371/journal.pone.0178823	http://dx.doi.org/10.1371/journal.pone.0178823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586363	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700029
J	Becker, MG; Walker, PL; Pulgar-Vidal, NC; Belmonte, MF				Becker, Michael G.; Walker, Philip L.; Pulgar-Vidal, Nadege C.; Belmonte, Mark F.			SeqEnrich: A tool to predict transcription factor networks from co-expressed Arabidopsis and Brassica napus gene sets	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; FACTOR-BINDING SITES; EXPRESSION DATA; FAMILY; SEED; THALIANA; RICE; DNA; IDENTIFICATION; CONSERVATION	Transcription factors and their associated DNA binding sites are key regulatory elements of cellular differentiation, development, and environmental response. New tools that predict transcriptional regulation of biological processes are valuable to researchers studying both model and emerging-model plant systems. SeqEnrich predicts transcription factor networks from co-expressed Arabidopsis or Brassica napus gene sets. The networks produced by SeqEnrich are supported by existing literature and predicted transcription factor DNA interactions that can be functionally validated at the laboratory bench. The program functions with gene sets of varying sizes and derived from diverse tissues and environmental treatments. SeqEnrich presents as a powerful predictive framework for the analysis of Arabidopsis and Brassica napus co-expression data, and is designed so that researchers at all levels can easily access and interpret predicted transcriptional circuits. The program outperformed its ancestral program ChipEnrich, and produced detailed transcription factor networks from Arabidopsis and Brassica napus gene expression data. The SeqEnrich program is ideal for generating new hypotheses and distilling biological information from large-scale expression data.	[Becker, Michael G.; Walker, Philip L.; Belmonte, Mark F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Pulgar-Vidal, Nadege C.] Univ Manitoba, Dept Comp Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Belmonte, MF (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	Mark.Belmonte@umanitoba.ca			National Science and Engineering Research Council of Canada; Vanier Scholarship; USRA	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Vanier Scholarship; USRA	This work was supported by Discovery and Accelerator Program grants from the National Science and Engineering Research Council of Canada to MFB, a Vanier Scholarship to MGB and USRA to NCPV.	Austin RS, 2016, PLANT J, V88, P490, DOI 10.1111/tpj.13261; Babur O, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-642; Becker MG, 2017, PLANT J; Belmonte MF, 2013, P NATL ACAD SCI USA, V110, pE435, DOI 10.1073/pnas.1222061110; Blatti C, 2014, NUCLEIC ACIDS RES, V42, pW20, DOI 10.1093/nar/gku456; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chan A, 2013, BOTANY, V91, P671, DOI 10.1139/cjb-2013-0141; Chan AC, 2016, J EXP BOT, V67, P3561, DOI 10.1093/jxb/erw179; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Dai XB, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv200; Du HAI, 2013, DNA RES, V1, P1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Haynes BC, 2013, GENOME RES, V23, P1319, DOI 10.1101/gr.150904.112; Hemberg M, 2011, NUCLEIC ACIDS RES, V39, P7092, DOI 10.1093/nar/gkr404; Kaplan-Levy RN, 2012, TRENDS PLANT SCI, V17, P163, DOI 10.1016/j.tplants.2011.12.002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawai-Yamada M, 2009, J BIOL CHEM, V284, P27998, DOI 10.1074/jbc.M109.037234; Kelemen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141044; Khan D, 2015, PLANT J, V82, P41, DOI 10.1111/tpj.12790; Kim WC, 2014, PLANT MOL BIOL, V85, P589, DOI 10.1007/s11103-014-0205-x; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lechner E, 2002, GENE, V290, P63, DOI 10.1016/S0378-1119(02)00556-5; Li QF, 2016, MOL PLANT, V9, P113, DOI 10.1016/j.molp.2015.08.014; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Mele G, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0896-x; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Pan R, 2016, P NATL ACAD SCI US; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P224, DOI 10.1093/nar/gkg076; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Silva AT, 2016, PLANT PHYSIOL, V170, P2218, DOI 10.1104/pp.15.01704; Stender EG, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1010967; Tapia-Lopez R, 2008, PLANT PHYSIOL, V146, P1182, DOI 10.1104/pp.107.108647; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Vaistij FE, 2013, P NATL ACAD SCI USA, V110, P10866, DOI 10.1073/pnas.1301647110; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Yu CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25164	47	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178256	10.1371/journal.pone.0178256	http://dx.doi.org/10.1371/journal.pone.0178256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575075	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300035
J	Kurtelius, A; Kallionpaa, RA; Huttunen, J; Huttunen, TJ; Helin, K; Koivisto, T; Frosen, J; zu Fraunberg, MV; Peltonen, S; Peltonen, J; Jaaskelainen, JE; Lindgren, AE				Kurtelius, Arttu; Kallionpaa, Roope A.; Huttunen, Jukka; Huttunen, Terhi J.; Helin, Katariina; Koivisto, Timo; Frosen, Juhana; zu Fraunberg, Mikael von Und; Peltonen, Sirkku; Peltonen, Juha; Jaaskelainen, Juha E.; Lindgren, Antti E.			Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; PREVALENCE; CHILDREN; ABNORMALITIES; POPULATION; EPIDEMIOLOGY; VASCULOPATHY; MANAGEMENT; SPECTRUM; TUMOR	Background The prevalence of intracranial aneurysms (IAs) has been proposed to be elevated in the patients with neurofibromatosis type 1 (NF1). Our aims were to determine the prevalence of NF1 in a large Finnish population based cohort of IA patients and, on the other hand, the occurrences of subarachnoid haemorrhage and unruptured intracranial aneurysms in a nationwide population-based cohort of NF1 patients and its matched ten-fold control cohort. Methods The Kuopio IA Database (www.kuopioneurosurgery.fi) includes all ruptured and unruptured IA cases admitted to the Kuopio University Hospital (KUH) from its defined Eastern Finnish catchment population since 1980. In this registry-based study, we cross-linked the Kuopio IA database with the Finnish national registry covering all hospital diagnoses. The NF1 diagnoses of the 4543 patients with either saccular of fusiform IA were identified from 1969 to 2015 and verified from patient records. Our second approach was to analyze the occurrence of aneurysmal subarachnoid haemorrhage (aSAH) and unruptured IAs in a nationwide population-based database of 1410 NF1 patients and its ten-fold matched control cohort (n = 14030) using national registry of hospital diagnoses between 1987 and 2014. Results One NF1 patient was identified among the 4543 IA patients. Three verified IA cases (one unruptured IA and two aSAH cases) were identified in the cohort of 1410 NF1 patients, with similar occurrences in the control cohort. Conclusions We found no evidence in our population-based cohorts to support the conception that NF1 is associated with IAs. Our results indicate that the incidence of aSAH is not elevated in patients with NF1. Further studies are required to confirm that there is no association between NF1 and unruptured IAs.	[Kurtelius, Arttu; Huttunen, Jukka; Huttunen, Terhi J.; Helin, Katariina; Koivisto, Timo; Frosen, Juhana; zu Fraunberg, Mikael von Und; Jaaskelainen, Juha E.; Lindgren, Antti E.] Kuopio Univ Hosp, Neurosurg, NeuroCtr, Kuopio, Finland; [Kurtelius, Arttu; Huttunen, Jukka; Huttunen, Terhi J.; Koivisto, Timo; Frosen, Juhana; zu Fraunberg, Mikael von Und; Jaaskelainen, Juha E.; Lindgren, Antti E.] Univ Eastern Finland, Inst Clin Med, Neurosurg, Kuopio, Finland; [Kallionpaa, Roope A.; Peltonen, Juha] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Peltonen, Sirkku] Univ Turku, Dept Dermatol, Turku, Finland; [Peltonen, Sirkku] Turku Univ Hosp, Turku, Finland	Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Turku; University of Turku; University of Turku	Lindgren, AE (corresponding author), Kuopio Univ Hosp, Neurosurg, NeuroCtr, Kuopio, Finland.; Lindgren, AE (corresponding author), Univ Eastern Finland, Inst Clin Med, Neurosurg, Kuopio, Finland.	antti.lindgren@kuh.fi	Peltonen, Juha/O-7159-2019; Peltonen, Juha TK/C-2817-2008; Kallionpää, Roope A./H-4609-2017; Peltonen, Sirkku/C-3133-2008; Lindgren, Antti/J-2517-2019	Peltonen, Juha/0000-0002-5732-4167; Peltonen, Juha TK/0000-0002-5732-4167; Kallionpää, Roope A./0000-0002-7512-2980; Peltonen, Sirkku/0000-0003-0990-1430; Lindgren, Antti/0000-0002-1264-7667; von und zu Fraunberg, Mikael/0000-0002-8457-4639	Petri Honkanen Foundation; PaEivikki and Sakari Sohlberg Foundation; Maire Taponen Foundation; North Savo Regional Fund of Finnish Cultural Foundation; Kuopio University Hospital; Academy of Finland	Petri Honkanen Foundation; PaEivikki and Sakari Sohlberg Foundation; Maire Taponen Foundation; North Savo Regional Fund of Finnish Cultural Foundation; Kuopio University Hospital; Academy of Finland(Academy of Finland)	This study was funded by The Petri Honkanen Foundation, The PaEivikki and Sakari Sohlberg Foundation, The Maire Taponen Foundation, The North Savo Regional Fund of Finnish Cultural Foundation, Kuopio University Hospital and The Academy of Finland.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Baldauf J, 2005, Neurol India, V53, P213; Bekiesinska-Figatowska M, 2014, NEUROL NEUROCHIR POL, V48, P15, DOI 10.1016/j.pjnns.2013.05.002; Brown RD, 2014, LANCET NEUROL, V13, P393, DOI 10.1016/S1474-4422(14)70015-8; Cairns AG, 2008, J NEUROL NEUROSUR PS, V79, P1165, DOI 10.1136/jnnp.2007.136457; Conforti R, 2014, NEUROPSYCH DIS TREAT, V10, P135, DOI 10.2147/NDT.S49784; Conway JE, 2001, STROKE, V32, P2481, DOI 10.1161/hs1101.098329; Delis Konstantinos T, 2006, Perspect Vasc Surg Endovasc Ther, V18, P226, DOI 10.1177/1531003506296488; Dubov T, 2016, PEDIATR NEPHROL, V31, P131, DOI 10.1007/s00467-015-3191-6; Ellis MJ, 2011, J NEUROSURG-PEDIATR, V8, P346, DOI 10.3171/2011.7.PEDS11151; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Ghosh PS, 2013, J CHILD NEUROL, V28, P95, DOI 10.1177/0883073812441059; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Gonzalez-Tortosa J, 2011, J NEUROSURG, V114, P1812, DOI 10.3171/2010.12.JNS101589; Hirbe AC, 2014, LANCET NEUROL, V13, P834, DOI 10.1016/S1474-4422(14)70063-8; Huttunen J, 2015, NEUROLOGY, V84, P2229, DOI 10.1212/WNL.0000000000001643; Huttunen T, 2010, NEUROSURGERY, V66, P631, DOI 10.1227/01.NEU.0000367634.89384.4B; Jouhilahti EM, 2011, AM J PATHOL, V178, P1932, DOI 10.1016/j.ajpath.2010.12.056; Kaas B, 2013, J CHILD NEUROL, V28, P561, DOI 10.1177/0883073812448531; Kim ST, 2016, AM J NEURORADIOL, V37, P1422, DOI 10.3174/ajnr.A4718; Korja M, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.228; Kurki MI, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004134; Lindgren AE, 2014, ANN MED, V46, P169, DOI 10.3109/07853890.2014.883168; Mitsui Y, 2001, INTERNAL MED, V40, P948, DOI 10.2169/internalmedicine.40.948; NORTON KK, 1995, NEUROBIOL DIS, V2, P13, DOI 10.1006/nbdi.1995.0002; Oderich GS, 2007, J VASC SURG, V46, P475, DOI 10.1016/j.jvs.2007.03.055; Patil Tushar B, 2015, J Nat Sci Biol Med, V6, P436, DOI 10.4103/0976-9668.160029; Poyhonen M, 2000, J MED GENET, V37, P632, DOI 10.1136/jmg.37.8.632; Rea D, 2009, PEDIATRICS, V124, pE476, DOI 10.1542/peds.2009-0152; Rosser TL, 2005, NEUROLOGY, V64, P553, DOI 10.1212/01.WNL.0000150544.00016.69; Schievink WI, 2005, AM J MED GENET A, V134A, P45, DOI 10.1002/ajmg.a.30475; Statistics Finland, 2016, PREL POP STAT; Terry AR, 2016, STROKE, V47, P60, DOI 10.1161/STROKEAHA.115.011406; Upadhyaya M., 2012, NEUROFIBROMATOSIS TY; Uusitalo E, 2015, J INVEST DERMATOL, V135, P904, DOI 10.1038/jid.2014.465; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; You Myung Won, 2011, Neurointervention, V6, P34, DOI 10.5469/neuroint.2011.6.1.34; Zhao JZ, 1998, SURG NEUROL, V50, P592, DOI 10.1016/S0090-3019(97)00376-5	40	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178711	10.1371/journal.pone.0178711	http://dx.doi.org/10.1371/journal.pone.0178711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575128	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300100
J	Umair, M; Altaf, M; Abbasi, AM				Umair, Muhammad; Altaf, Muhammad; Abbasi, Arshad Mehmood			An ethnobotanical survey of indigenous medicinal plants in Hafizabad district, Punjab-Pakistan	PLOS ONE			English	Article							XANTHOCARPUM FRUIT EXTRACT; ETHNOPHARMACOLOGICAL SURVEY; SOLANUM-XANTHOCARPUM; TRADITIONAL KNOWLEDGE; RELATIVE IMPORTANCE; LESSER HIMALAYAS; HAINAN ISLAND; HERBAL DRUGS; FOOD PLANTS; WILD	Present paper offers considerable information on traditional uses of medicinal plants by the inhabitants of Hafizabad district, Punjab-Pakistan. This is the first quantitative ethnobotanical study from the area comprising popularity level of medicinal plant species intendedby using relative popularity level (RPL) and rank order priority (ROP) indices.Ethnobotanical data were collected by interviewing 166 local informants and 35 traditional health practioners (THPs) from different localities of Hafizabad district. Demographic features of informants; life form, part used, methods of preparation, modes of application and ethnomedicinal uses were documented. Ethnobotanical data were analyzed using quantitative tools, i.e. Relative frequency citation (RFC), use value (UV), informant consensus factor (ICF) fidelity level (FL), RPL and ROP indices. A total of 85 species belonging to 71 genera and 34 families were documented along with ethnomedicinal uses. Solanum surattense, Withania somnifera, Cyperus rotundus, Solanum nigrum and Melia azedarach were the most utilized medicinal plant species with highest used value. The reported ailments were classified into 11 disease categories based on ICF values and highest number of plant species was reported to treat dermatological and gastrointestinal disorders. Withania somnifera and Ranunculus sceleratus with maximum FL (100%), were used against gastrointestinal and urinary disorders, respectively. The RPL and ROP values were calculated to recognize the folk medicinal plant wealth; six out of 32 plant species (19%) were found popular, based on citation by more than half of the maximum number of informant viz. 26. Consequently, the ROP value for these species was more than 75. The comparative assessment with reported literature revealed 15% resemblance and 6% variation to previous data;however79% uses of the reported species were recorded for the first time. The diversity of medicinal plant species and associated traditional knowledge is significant in primary health care system. Medicinal plant species with high RPL values should be screened for comprehensive phytochemical and pharmacological studies. This could be useful in novel drug discovery and to validate the ethomendicinal knowledge.	[Umair, Muhammad] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Umair, Muhammad] Shanghai Jiao Tong Univ, Res Ctr Low Carbon Agr, Shanghai, Peoples R China; [Altaf, Muhammad] Women Univ Azad Jammu & Kahmir, Dept Zool, Bagh, Pakistan; [Abbasi, Arshad Mehmood] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan	Shanghai Jiao Tong University; Shanghai Jiao Tong University; COMSATS University Islamabad (CUI)	Abbasi, AM (corresponding author), COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad, Pakistan.	arshad799@yahoo.com	Altaf, Muhammad/P-5081-2018; Abbasi, Arshad Mehmood/J-9314-2015; Altaf, Muhammad/T-8161-2019; MUHAMMAD, UMAIR/AAA-1375-2022	Abbasi, Arshad Mehmood/0000-0001-9978-3866; MUHAMMAD, UMAIR/0000-0003-2411-2499				Abbasi A. M., 2013, COMPOSITAE INTRODUCT, V9, P84; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-84; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Ahmad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-36; Ahmad SS, 2008, PAK J BOT, V40, P1005; Ahmed E, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-13; Ahmed N, 2014, J ETHNOPHARMACOL, V155, P1263, DOI 10.1016/j.jep.2014.07.007; Ahmed N, 2014, J ETHNOPHARMACOL, V155, P509, DOI 10.1016/j.jep.2014.05.052; Akhtar N, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-25; Alexiades MN., 1996, SELECTED GUIDELINES; Ali S.I, 1972, FLORA W PAKISTAN ANN; Ali-Shtayeh MS, 2000, J ETHNOPHARMACOL, V73, P221, DOI 10.1016/S0378-8741(00)00316-0; Altaf M, 2014, J ANIM PLANT SCI-PAK, V24, P1342; Altaf M., 2013, BIOL PAKISTAN, V59, P131; [Anonymous], 2006, WAG UR FRON; Arshad M, 2014, J ETHNOPHARMACOL, V10, P13; Arshad M, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-13; Ayyanar M, 2011, J ETHNOPHARMACOL, V134, P851, DOI 10.1016/j.jep.2011.01.029; Belayneh A, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-18; Bernhoft A., 2010, BIOACTIVE COMPOUNDS, V50, P11; Bibi T, 2014, J ETHNOPHARMACOL, V157, P79, DOI 10.1016/j.jep.2014.08.042; Boudjelal A, 2013, J ETHNOPHARMACOL, V148, P395, DOI 10.1016/j.jep.2013.03.082; Bradacs G, 2011, J ETHNOPHARMACOL, V137, P434, DOI 10.1016/j.jep.2011.05.050; BROWN CH, 1977, AM ANTHROPOL, V79, P317, DOI 10.1525/aa.1977.79.2.02a00080; Budhiraja R.D., 1987, J SCI IND RES; Cakilcioglu U, 2011, J ETHNOPHARMACOL, V137, P469, DOI 10.1016/j.jep.2011.05.046; Chaitanya M. V. N. L., 2013, African Journal of Agricultural Research, V8, P3505; Colvard MD, 2006, J ETHNOPHARMACOL, V107, P134, DOI 10.1016/j.jep.2006.04.005; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Cox PA, 2000, SCIENCE, V287, P44, DOI 10.1126/science.287.5450.44; De Wet H, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-51; Devi P. Uma, 1993, Indian Journal of Experimental Biology, V31, P607; Farnsworth NR., 1988, BIODIVERSITY; Frei B, 1998, J ETHNOPHARMACOL, V62, P149, DOI 10.1016/S0378-8741(98)00051-8; FRIEDMAN J, 1986, J ETHNOPHARMACOL, V16, P275, DOI 10.1016/0378-8741(86)90094-2; Giday M, 2010, J ETHNOPHARMACOL, V132, P75, DOI 10.1016/j.jep.2010.07.046; Gilani AH, 2005, J ETHNOPHARMACOL, V100, P43, DOI 10.1016/j.jep.2005.06.001; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Govindan S, 1999, J ETHNOPHARMACOL, V66, P205, DOI 10.1016/S0378-8741(98)00160-3; Hayta S, 2014, J ETHNOPHARMACOL, V155, P171; Heinrich M., 1998, SOC SCI MED, V47, P1859, DOI 10.1016/s0277-9536(98)00181-6; Heinrich M, 2009, J ETHNOPHARMACOL, V124, P1, DOI 10.1016/j.jep.2009.03.043; Hussain Talib, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P454, DOI 10.1016/S2221-1691(12)60075-6; Ibrar M, 2007, PAKISTAN J BOT, V39, P329; Ignacimuthu S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-25; Inta A, 2013, J ETHNOPHARMACOL, V149, P344, DOI 10.1016/j.jep.2013.06.047; Jin JH, 2011, ARCH PHARM RES, V34, P223, DOI 10.1007/s12272-011-0207-z; Ju Y, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-28; Kadir MF, 2014, J ETHNOPHARMACOL, V155, P495, DOI 10.1016/j.jep.2014.05.043; Kadir MF, 2012, J ETHNOPHARMACOL, V144, P627, DOI 10.1016/j.jep.2012.10.003; Kaval I, 2014, J ETHNOPHARMACOL, V155, P171, DOI 10.1016/j.jep.2014.05.014; Kayani S, 2014, J ETHNOPHARMACOL, V156, P47, DOI 10.1016/j.jep.2014.08.005; Khaling Mikawlrawng, 2014, International Journal of Herbal Medicine, V2, P1; Lai YJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21050553; Leto C, 2013, J ETHNOPHARMACOL, V146, P90, DOI 10.1016/j.jep.2012.11.042; Luitel DR, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-5; Mahmood A, 2013, J ETHNOPHARMACOL, V148, P714, DOI 10.1016/j.jep.2013.05.035; Mahmood A, 2011, J MED PLANTS RES, V5, P2348; MANANDHAR NP, 1995, ECON BOT, V49, P371, DOI 10.1007/BF02863087; Moerman DE, 1996, J ETHNOPHARMACOL, V52, P1, DOI 10.1016/0378-8741(96)01393-1; Mollik M. A. H., 2010, Ethnobotany Research and Applications, V8, P195; Mugisha MK, 2014, J ETHNOPHARMACOL, V155, P194, DOI 10.1016/j.jep.2014.05.012; Murad W, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-77; Neeraj Kumar, 2010, Indian Journal of Natural Products and Resources, V1, P470; Njoroge N. G., 2004, Lyonia, V7, P71; Padmavathi B, 2005, EVID-BASED COMPL ALT, V2, P99, DOI 10.1093/ecam/neh064; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patel PK, 2012, J YOUNG PHARM, V4, P164, DOI 10.4103/0975-1483.100022; PHILLIPS O, 1993, ECON BOT, V47, P33, DOI 10.1007/BF02862204; Priya P., 2010, Pharmacognosy Journal, V2, P400; Purohit S, 2004, MEDICINAL PLANT CULT; Qureshi RA, 2009, PAK J BOT, V41, P19; Ragupathy S, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-8; Rahman MA, 2004, FITOTERAPIA, V75, P149, DOI 10.1016/j.fitote.2003.12.012; Raunkiaer C., 1937, PLANT LIFE FORMS; Raunkiaer C, 1934, LIFE FORMS PLANTS ST; Revathi P., 2013, Journal of Medicinal Plants Research, V7, P2083; Rokaya MB, 2010, J ETHNOPHARMACOL, V130, P485, DOI 10.1016/j.jep.2010.05.036; Sakkir S., 2012, Journal of Medicinal Plants Research, V6, P1304; Saqib Z, 2014, J ETHNOPHARMACOL, V151, P820, DOI 10.1016/j.jep.2013.11.034; Saric-Kundalic B, 2010, J ETHNOPHARMACOL, V131, P33, DOI 10.1016/j.jep.2010.05.061; Shinwari MI, 2000, J ETHNOPHARMACOL, V69, P45, DOI 10.1016/S0378-8741(99)00135-X; Singh AG, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-19; Singh H, 2014, J ETHNOPHARMACOL, V154, P98, DOI 10.1016/j.jep.2014.03.026; Singh OM, 2010, J SCI IND RES INDIA, V69, P732; Song MJ, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-48; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Ssegawa P, 2007, J ETHNOPHARMACOL, V113, P521, DOI 10.1016/j.jep.2007.07.014; Stepp JR, 2001, J ETHNOPHARMACOL, V75, P19, DOI 10.1016/S0378-8741(00)00385-8; Tabuti JRS, 2003, J ETHNOPHARMACOL, V88, P19, DOI 10.1016/S0378-8741(03)00161-2; Tardio J, 2008, ECON BOT, V62, P24, DOI 10.1007/s12231-007-9004-5; Ugulu I, 2009, J MED PLANTS RES, V3, P345; Ullah S, 2014, J ETHNOPHARMACOL, V158, P412, DOI 10.1016/j.jep.2014.09.048; Uniyal SK, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-14; Vendruscolo Giovana Secretti, 2006, Iheringia Serie Botanica, V61, P83; Verma AK, 2007, J ETHNOBIOL ETHNOMED, V3, DOI 10.1186/1746-4269-3-35; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024; Zheng XL, 2013, J ETHNOPHARMACOL, V148, P964, DOI 10.1016/j.jep.2013.05.051; Zheng XL, 2009, J ETHNOPHARMACOL, V124, P197, DOI 10.1016/j.jep.2009.04.042; [No title captured]; [No title captured]; [No title captured]; [No title captured]	103	100	104	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177912	10.1371/journal.pone.0177912	http://dx.doi.org/10.1371/journal.pone.0177912			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574986	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300022
J	VanLeuven, JT; Ridenhour, BJ; Gonzalez, AJ; Miller, CR; Miura, TA				VanLeuven, James T.; Ridenhour, Benjamin J.; Gonzalez, Andres J.; Miller, Craig R.; Miura, Tanya A.			Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; INFLUENZA-A-VIRUS; HUMAN RHINOVIRUS INFECTION; DOUBLE-STRANDED-RNA; AIRWAY INFLAMMATION; IMMUNE-RESPONSE; MURINE CORONAVIRUS; HOST RESPONSE; IN-VITRO; MODEL	The severity of respiratory viral infections is partially determined by the cellular response mounted by infected lung epithelial cells. Disease prevention and treatment is dependent on our understanding of the shared and unique responses elicited by diverse viruses, yet few studies compare host responses to viruses from different families while controlling other experimental parameters. Murine models are commonly used to study the pathogenesis of respiratory viral infections, and in vitro studies using murine cells provide mechanistic insight into the pathogenesis observed in vivo. We used microarray analysis to compare changes in gene expression of murine lung epithelial cells infected individually by three respiratory viruses causing mild (rhinovirus, RV1B), moderate (coronavirus, MHV-1), and severe (influenza A virus, PR8) disease in mice. RV1B infection caused numerous gene expression changes, but the differential effect peaked at 12 hours post-infection. PR8 altered an intermediate number of genes whose expression continued to change through 24 hours. MHV-1 had comparatively few effects on host gene expression. The viruses elicited highly overlapping responses in antiviral genes, though MHV-1 induced a lower type I interferon response than the other two viruses. Signature genes were identified for each virus and included host defense genes for PR8, tissue remodeling genes for RV1B, and transcription factors for MHV-1. Our comparative approach identified universal and specific transcriptional signatures of virus infection that can be used to distinguish shared and virus-specific mechanisms of pathogenesis in the respiratory tract.	[VanLeuven, James T.; Ridenhour, Benjamin J.; Gonzalez, Andres J.; Miller, Craig R.; Miura, Tanya A.] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Ridenhour, Benjamin J.; Gonzalez, Andres J.; Miller, Craig R.; Miura, Tanya A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Miller, Craig R.] Univ Idaho, Dept Math, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Miura, TA (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.; Miura, TA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	tmiura@uidaho.edu	Miller, Craig/GWQ-5012-2022	Van Leuven, James/0000-0002-2730-0287	National Institute of General Medical Sciences of the National Institutes of Health [P20GM104420, P30GM103324, P30GM103397, P20GM103408]; University of Idaho Office of Research and Economic Development; IBEST Genomics Resources Core; IBEST Optical Imaging Core; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104420] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Idaho Office of Research and Economic Development; IBEST Genomics Resources Core; IBEST Optical Imaging Core; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute of General Medical Sciences of the National Institutes of Health under grant numbers P20GM104420, P30GM103324, P30GM103397, and P20GM103408 and a seed grant from the University of Idaho Office of Research and Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Kathryn Holmes, University of Colorado at Denver School of Medicine, Dr. Elizabeth Fortunato, University of Idaho, and Dr. Julian Leibowitz, Texas A&M University for cells and antibodies that were used in this study. The following reagents were obtained through the NIH Biodefense and Emerging Infections Research Resources Repository, NIAID, NIH: Influenza A Virus, A/Puerto Rico/8/34 (H1N1), NR-3169 and Polyclonal Anti-Influenza Virus H1 (H0) Hemagglutinin (HA), A/Puerto Rico/8/34 (H1H1), (Antiserum, Goat), NR-3148. Dr. Matthew Settles, Dr. Sam Hunter and Mr. Dan New in the IBEST Genomics Resources Core provided support with microarray processing and analysis. Ms. Ann Norton in the IBEST Optical Imaging Core provided support with microscopy. Mr. John Clary provided technical assistance.	Alberts R, 2010, MICROBES INFECT, V12, P309, DOI 10.1016/j.micinf.2010.01.008; Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0; Baig E, 2008, ANTIVIR THER, V13, P409; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bosco A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2405-z; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Christiansen SC, 2008, INT ARCH ALLERGY IMM, V147, P299, DOI 10.1159/000144037; Clarke DL, 2014, CLIN SCI, V126, P567, DOI 10.1042/CS20130149; De Albuquerque N, 2006, J VIROL, V80, P10382, DOI 10.1128/JVI.00747-06; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Han MY, 2016, J ALLERGY CLIN IMMUN, V138, P1619, DOI 10.1016/j.jaci.2016.01.037; Hewson CA, 2010, EUR RESPIR J, V36, P1425, DOI 10.1183/09031936.00026910; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kebaabetswe LP, 2015, VIROLOGY, V483, P96, DOI 10.1016/j.virol.2015.03.045; Kebaabetswe LP, 2013, VIRUS RES, V175, P110, DOI 10.1016/j.virusres.2013.04.008; Khanolkar A, 2010, J IMMUNOL, V185, P1132, DOI 10.4049/jimmunol.0902749; Khanolkar A, 2009, J VIROL, V83, P9258, DOI 10.1128/JVI.00355-09; Khanolkar A, 2009, J VIROL, V83, P8946, DOI 10.1128/JVI.01857-08; Kim TK, 2015, VIROLOGY, V486, P146, DOI 10.1016/j.virol.2015.08.014; Kindler E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006195; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Lee S, 2016, INT FORUM ALLERGY RH, V6, P1131, DOI 10.1002/alr.21805; Leibowitz JL, 2010, J VIROL, V84, P9278, DOI 10.1128/JVI.00330-10; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14; Miura TA, 2009, J LEUKOCYTE BIOL, V86, P1145, DOI 10.1189/jlb.0209078; NACLERIO RM, 1988, J INFECT DIS, V157, P133, DOI 10.1093/infdis/157.1.133; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Rose KM, 2009, VIRUSES-BASEL, V1, P689, DOI 10.3390/v1030689; Rosenblum EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049924; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Rzepka JP, 2012, AM J RESP CELL MOL, V46, P833, DOI 10.1165/rcmb.2011-0230OC; Sims AC, 2000, J VIROL, V74, P5647, DOI 10.1128/JVI.74.12.5647-5654.2000; Sims AC, 2013, J VIROL, V87, P3885, DOI 10.1128/JVI.02520-12; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Stegemann-Koniszewski S, 2016, MBIO, V7, DOI 10.1128/mBio.00276-16; STONER GD, 1978, EXP MOL PATHOL, V29, P102, DOI 10.1016/0014-4800(78)90030-8; STURMAN LS, 1972, INFECT IMMUN, V6, P501, DOI 10.1128/IAI.6.4.501-507.1972; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Tate MD, 2011, VIRAL IMMUNOL, V24, P77, DOI 10.1089/vim.2010.0118; Tuthill TJ, 2003, J GEN VIROL, V84, P2829, DOI 10.1099/vir.0.19109-0; van der Meer Y, 1999, J VIROL, V73, P7641, DOI 10.1128/JVI.73.9.7641-7657.1999; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729; Zaritsky LA, 2015, J VIROL, V89, P11534, DOI 10.1128/JVI.01727-15; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06; Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979	65	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178408	10.1371/journal.pone.0178408	http://dx.doi.org/10.1371/journal.pone.0178408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575086	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300049
J	Andersen, M; Norgaard-Pedersen, D; Brandt, J; Pettersson, I; Slaaby, R				Andersen, Mie; Norgaard-Pedersen, Dorte; Brandt, Jakob; Pettersson, Ingrid; Slaaby, Rita			IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718	PLOS ONE			English	Article							GROWTH-FACTOR-II; LIGAND-BINDING; HYBRID RECEPTORS; ALPHA-SUBUNIT; AFFINITY; ACTIVATION; EPITOPES; CANCER; IR	Methods Alanine scan of insulin receptor (IR)-B exon 11 and site-directed mutagenesis of amino acid 718 in human IR-A and IR-B were performed. Ligand affinities to wild type and mutated receptors were studied by displacement of radioactive insulin in binding assay on secreted soluble midi receptors or solubilized semi-purified full length receptors stably expressed in Baby Hamster Kidney cells. Phosphorylation of IR in response to insulin, IGF1 and IGF2 was measured using ELISA. Results Insulin, insulin detemir and insulin glargine maximally showed two fold differences in affinity for human IR-A and IR-B, but IGF1 and IGF2 had up to 10 fold preference for IR-A. Alanine scan of exon 11 revealed that position 718 is important for low IGF1 affinity to IR-B. Mutational analysis of amino acid residue 718 in IR-A and IR-B demonstrated that charge is important for IGF1 and IGF2 affinity but not important for insulin affinity. The affinity of IGF1 and IGF2 for the mutant IR-A P718K was comparable to the wild type IR-B whereas the affinity of IGF1 and IGF2 for the mutant IR-B K718P was comparable to the wild type IR-A. Changes in affinity were also reflected in the IR activation pattern. Conclusion Mutating position 718 in human IR-B to the proline found at position 718 in human IR-A increased IGF1 and IGF2 affinity to a level comparable to IR-A and mutating position 718 in IR-A to the lysine found at position 718 in IR-B decreased IGF1 and IGF2 affinity to a level comparable to IR-B, whereas a negatively charged glutamate did not. These changes in the affinities were also reflected in the IR phosphorylation pattern, meaning that position 718 is important for both affinity and activation of the receptor. It should be emphasized that none of the mutations affected insulin affinity, indicating that the mutations did not alter the overall receptor structure and that the effect is ligand specific.	[Andersen, Mie; Norgaard-Pedersen, Dorte; Brandt, Jakob; Pettersson, Ingrid; Slaaby, Rita] Novo Nordisk, Novo Nordisk Pk, Malov, Denmark	Novo Nordisk	Slaaby, R (corresponding author), Novo Nordisk, Novo Nordisk Pk, Malov, Denmark.	risl@novonordisk.com			Novo Nordisk	Novo Nordisk(Novo Nordisk)	Novo Nordisk provided support in the form of chemicals for the study and in the form of salary for DNP, IP, JB and RS, but had no additional role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Alvino CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027488; Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; [Anonymous], 2016, SCHROD REL 2016 2; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Cieniewicz AM, 2016, CELL SIGNAL, V28, P1037, DOI 10.1016/j.cellsig.2016.05.001; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; CZECH MP, 1982, CELL, V31, P8, DOI 10.1016/0092-8674(82)90399-3; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2006, ENDOCRINOLOGY, V147, P1029, DOI 10.1210/en.2005-0736; Denley A, 2003, HORM METAB RES, V35, P778; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frystyk J, 2004, GROWTH HORM IGF RES, V14, P337, DOI 10.1016/j.ghir.2004.06.001; Janssen JAMJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150453; KUROSE T, 1994, J BIOL CHEM, V269, P29190; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Rajapaksha H, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00107; SATO A, 1993, INT J PEPT PROT RES, V41, P433; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; SEN S, 2010, J BIOL CHEM, V285, P25426, DOI DOI 10.1074/JBC.M109.095224; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vienberg SG, 2011, BIOCHEM J, V440, P301, DOI 10.1042/BJ20110880; Westermeier F, 2016, DIABETES-METAB RES, V32, P350, DOI 10.1002/dmrr.2729; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132	38	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178885	10.1371/journal.pone.0178885	http://dx.doi.org/10.1371/journal.pone.0178885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570711	Green Submitted, Green Published, gold			2022-12-26	WOS:000402611800132
J	Aguirre, M; Abad, D; Albaina, A; Cralle, L; Goni-Urriza, MS; Estonba, A; Zarraonaindia, I				Aguirre, Mikel; Abad, David; Albaina, Aitor; Cralle, Lauren; Goni-Urriza, Maria Soledad; Estonba, Andone; Zarraonaindia, Iratxe			Unraveling the environmental and anthropogenic drivers of bacterial community changes in the Estuary of Bilbao and its tributaries	PLOS ONE			English	Article							MICROBIAL COMMUNITY; POLLUTION-ABATEMENT; WATER-QUALITY; VARIABILITY; RIVER; BAY; DIVERSITY; ABUNDANCE; GRADIENT; COMAMONADACEAE	In this study, 16S rRNA gene sequencing was used to characterize the changes in taxonomic composition and environmental factors significantly influencing bacterial community structure across an annual cycle in the Estuary of Bilbao as well as its tributaries. In spite of this estuary being small and characterized by a short residence time, the environmental factors most highly correlated with the bacterial community mirrored those reported to govern larger estuaries, specifically salinity and temperature. Additionally, bacterial community changes in the estuary appeared to vary with precipitation. For example, an increase in freshwater bacteria (Comamonadaceae and Sphingobacteriaceae) was observed in high precipitation periods compared to the predominately marine-like bacteria (Rhodobacterales and Oceanospirillales) that were found in low precipitation periods. Notably, we observed a significantly higher relative abundance of Comamonadaceae than previously described in other estuaries. Furthermore, anthropic factors could have an impact on this particular estuary's bacterial community structure. For example, ecosystem changes related to the channelization of the estuary likely induced a low dissolved oxygen (DO) concentration, high temperature, and high chlorophyll concentration period in the inner euhaline water in summer (samples with salinity >30 ppt). Those samples were characterized by a high abundance of facultative anaerobes. For instance, OTUs classified as Cryomorphaceae and Candidatus Aquiluna rubra were negatively associated with DO concentration, while Oleiphilaceae was positively associated with DO concentration. Additionally, microorganisms related to biological treatment of wastewater (e.g Bdellovibrio and Zoogloea) were detected in the samples immediately downstream of the Bilbao Wastewater Treatment Plant (WWTP). There are several human activities planned in the region surrounding the Estuary of Bilbao (e.g. sediment draining, architectural changes, etc.) which will likely affect this ecosystem. Therefore, the addition of bacterial community profiling and diversity analysis into the estuary's ongoing monitoring program would provide a more comprehensive view of the ecological status of the Estuary of Bilbao.	[Aguirre, Mikel; Abad, David; Albaina, Aitor; Estonba, Andone; Zarraonaindia, Iratxe] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leio, Spain; [Albaina, Aitor] Environm Studies Ctr CEA, Vitoria 01008, Spain; [Cralle, Lauren] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Goni-Urriza, Maria Soledad] Univ Pau & Pays Adour, UMR CNRS 5254, IPREM, Equipe Microbiol & Environm, Batiment IBEAS,BP1155, Pau, France; [Zarraonaindia, Iratxe] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	University of Basque Country; University of Chicago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Basque Foundation for Science	Aguirre, M; Zarraonaindia, I (corresponding author), Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leio, Spain.; Zarraonaindia, I (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	mikel.aguirre@ehu.eus; iratxe.zarraonaindia@ehu.eus	Rodrigo, Mikel Aguirre/H-1448-2018; rodrigo, mikel aguirre/U-8202-2019; Albaina, Aitor/E-6267-2015; Zarraonaindia, Iratxe/ABF-4618-2020	Rodrigo, Mikel Aguirre/0000-0001-5823-2777; rodrigo, mikel aguirre/0000-0001-5823-2777; Albaina, Aitor/0000-0003-3353-6090; Zarraonaindia, Iratxe/0000-0002-0615-0187; Abad, David/0000-0001-5423-3537; Estonba, Andone/0000-0003-2851-5201; Goni Urriza, Marisol/0000-0001-7694-6511	Geonomic resources group [IT558-10]; SIEBM XVIII congress (Gijon)	Geonomic resources group; SIEBM XVIII congress (Gijon)	The authors received funding from Geonomic resources group (Grant IT558-10) to AE, and supported by SIEBM XVIII congress (Gijon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaina A, 2009, J PLANKTON RES, V31, P739, DOI 10.1093/plankt/fbp025; Bernardet JF, 1996, INT J SYST BACTERIOL, V46, P128, DOI 10.1099/00207713-46-1-128; Breiman L., 2001, MACH LEARN, V45, P5; Cajaraville MP, 2016, ESTUAR COAST SHELF S, P1; Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cearreta A, 2004, ELSEV OCEANOGR SERIE, V70, P27; Cearreta A, 2000, ESTUAR COAST SHELF S, V50, P571, DOI 10.1006/ecss.1999.0582; Chow CET, 2013, ISME J, V7, P2259, DOI 10.1038/ismej.2013.122; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Garcia-Barcina JM, 2006, WATER RES, V40, P951, DOI 10.1016/j.watres.2006.01.004; Gifford SM, 2013, ISME J, V7, P281, DOI 10.1038/ismej.2012.96; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hewson I, 2004, APPL ENVIRON MICROB, V70, P3425, DOI 10.1128/AEM.70.6.3425-3433.2004; HOCH MP, 1993, MAR ECOL PROG SER, V98, P283, DOI 10.3354/meps098283; Intxausti L, 2012, J MARINE SYST, V94, P87, DOI 10.1016/j.jmarsys.2011.10.015; Iriarte A, 2008, AQUAT MICROB ECOL, V52, P273, DOI 10.3354/ame01237; Jeffries TC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01438; Kang I, 2012, J BACTERIOL, V194, P3550, DOI 10.1128/JB.00586-12; Khan ST, 2002, APPL ENVIRON MICROB, V68, P3206, DOI 10.1128/AEM.68.7.3206-3214.2002; Kimmerer WJ, 2002, MAR ECOL PROG SER, V243, P39, DOI 10.3354/meps243039; Kisand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043630; Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x; Liao PC, 2007, MICROB ECOL, V54, P497, DOI 10.1007/s00248-007-9217-2; Mason OU, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01048; Massana R, 2011, ANNU REV MICROBIOL, V65, P91, DOI 10.1146/annurev-micro-090110-102903; McLusky D.S., 2004, ESTUARINE ECOSYSTEM; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meziti A, 2016, ENVIRON MICROBIOL, V18, P4640, DOI 10.1111/1462-2920.13303; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Moran XAG, 2013, MAR ECOL PROG SER, V489, P75, DOI 10.3354/meps10428; Mukherjee S, 2013, INDIAN J BIOTECHNOL, V12, P80; NA J, 2011, SICKLE SLIDING WINDO; Oksanen J, 2022, R PACKAGE VERSION; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Poretsky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093827; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Shanks OC, 2013, APPL ENVIRON MICROB, V79, P2906, DOI 10.1128/AEM.03448-12; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith D., 2012, FASTQ BARCODE PL; Sugimoto R, 2006, ESTUAR COAST SHELF S, V66, P267, DOI 10.1016/j.ecss.2005.08.014; SW J, 1997, MONOGRAPHS OCEANOGRA, P19; Uriarte I, 2014, ESTUAR COAST SHELF S, V150, P312, DOI 10.1016/j.ecss.2014.04.007; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Villate F, 1997, J PLANKTON RES, V19, P1617, DOI 10.1093/plankt/19.11.1617; Villate F, 2013, MAR POLLUT BULL, V70, P234, DOI 10.1016/j.marpolbul.2013.03.010; Wang P, 2015, MICROB ECOL MICROBIA, DOI https://doi.org/10.1007/s00248-015-0700-xPMID:26577577; Wasserman RJ, 2015, MICROB ECOL, V69, P245, DOI 10.1007/s00248-014-0505-3; Wen Y, 2015, POL J ENVIRON STUD, V24, P1809, DOI 10.15244/pjoes/38456; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P445, DOI 10.1099/00207713-41-3-445; Willems A., 2014, FAMILY COMAMONADACEA, P777, DOI [DOI 10.1007/978-3-642-30197-1_238, 10.1007/978-3-642-30197-1_238]; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15; Ye L, 2013, APPL MICROBIOL BIOT, V97, P2681, DOI 10.1007/s00253-012-4082-4; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	63	18	18	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178755	10.1371/journal.pone.0178755	http://dx.doi.org/10.1371/journal.pone.0178755			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594872	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200050
J	Espirito-Santo, RF; Meira, CS; Costa, RD; Souza, VP; Evangelista, AF; Trossini, GHG; Ferreira, GM; Velozo, ED; Villarreal, CF; Soares, MBP				Espirito-Santo, Renan Fernandes; Meira, Cassio Santana; Costa, Rafael dos Santos; Souza Filho, Vio Passos; Evangelista, Afranio Ferreira; Goulart Trossini, Gustavo Henrique; Ferreira, Glaucio Monteiro; Velozo, Eudes da Silva; Villarreal, Cristiane Flora; Pereira Soares, Milena Botelho			The anti-inflammatory and immunomodulatory potential of braylin: Pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; IMMUNE CELL-FUNCTION; NERVE GROWTH-FACTOR; INFLAMMATORY HYPERALGESIA; TGF-BETA; PHOSPHODIESTERASE-4 INHIBITORS; PRENYLATED COUMARINS; CYCLIC-AMP; TNF-ALPHA; CYTOKINES	Braylin belongs to the group of natural coumarins, a group of compounds with a wide range of pharmacological properties. Here we characterized the pharmacological properties of braylin in vitro, in silico and in vivo in models of inflammatory/immune responses. In in vitro assays, braylin exhibited concentration-dependent suppressive activity on activated macrophages. Braylin (10-40 mu M) reduced the production of nitrite, IL-1 beta, TNF-alpha and IL-6 by J774 cells or peritoneal exudate macrophages stimulated with LPS and IFN-gamma. Molecular docking calculations suggested that braylin present an interaction pose to act as a glucocorticoid receptor ligand. Corroborating this idea, the inhibitory effect of braylin on macrophages was prevented by RU486, a glucocorticoid receptor antagonist. Furthermore, treatment with braylin strongly reduced the NF-.B-dependent transcriptional activity on RAW 264.7 cells. Using the complete Freund's adjuvant (CFA)-induced paw inflammation model in mice, the pharmacological properties of braylin were demonstrated in vivo. Braylin (12.5-100 mg/kg) produced dose-related antinociceptive and antiedematogenic effects on CFA model. Braylin did not produce antinociception on the tail flick and hot plate tests in mice, suggesting that braylin-induced antinociception is not a centrally-mediated action. Braylin exhibited immunomodulatory properties on the CFA model, inhibiting the production of pro-inflammatory cytokines IL-1 beta, TNF-a and IL-6, while increased the anti-inflammatory cytokine TGF-beta. Our results show, for the first time, anti-inflammatory, antinociceptive and immunomodulatory effects of braylin, which possibly act through the glucocorticoid receptor activation and by inhibition of the transcriptional activity of NF-.B. Because braylin is a phosphodiesterase-4 inhibitor, this coumarin could represent an ideal prototype of glucocorticoid receptor ligand, able to induce synergic immunomodulatory effects.	[Espirito-Santo, Renan Fernandes; Costa, Rafael dos Santos; Souza Filho, Vio Passos; Velozo, Eudes da Silva; Villarreal, Cristiane Flora] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil; [Meira, Cassio Santana; Evangelista, Afranio Ferreira; Villarreal, Cristiane Flora; Pereira Soares, Milena Botelho] Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil; [Goulart Trossini, Gustavo Henrique; Ferreira, Glaucio Monteiro] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, SP, Brazil; [Pereira Soares, Milena Botelho] Hosp Sao Rafael, Ctr Biotecnol & Terapia Celular, Salvador, BA, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Villarreal, CF (corresponding author), Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.; Villarreal, CF (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil.	cfv@ufba.br	Trossini, Gustavo/AAQ-2537-2020; Trossini, Gustavo/A-5789-2013; Soares, Milena B. P./O-3771-2018; Costa, Rafael/AAW-8489-2020; Ferreira, Glaucio Monteiro/X-6909-2018; Villarreal, Cristiane F/M-5200-2016	Trossini, Gustavo/0000-0003-3634-2531; Trossini, Gustavo/0000-0003-3634-2531; Ferreira, Glaucio Monteiro/0000-0002-1952-9428; Espirito-Santo, Renan Fernandes do/0000-0001-9075-9421; Villarreal, Cristiane Flora/0000-0002-0113-7864	Fundacao de Amparo a Pesquisa do Estado da Bahia - FAPESB [DTE 0046/2011, PNX0009/2009]	Fundacao de Amparo a Pesquisa do Estado da Bahia - FAPESB	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia - FAPESB, grant numbers: DTE 0046/2011 CFV, PNX0009/2009 MBPS.The funders had no role in study design,data collection and analysis,decision to publish, or preparation of the manuscript.	ANEJA R, 1958, TETRAHEDRON, V2, P203, DOI 10.1016/0040-4020(58)88041-2; Baeumer Wolfgang, 2007, Inflammation & Allergy Drug Targets, V6, P17, DOI 10.2174/187152807780077318; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen NF, 2013, J PAIN, V14, P1671, DOI 10.1016/j.jpain.2013.08.010; Chen WJ, 1998, J IMMUNOL, V161, P6297; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha FQ, 2003, ADV EXP MED BIOL, V521, P22; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; de Lima FO, 2011, J NAT PROD, V74, P596, DOI 10.1021/np100621c; de Oliveira CM, 2011, J NAT PROD, V74, P2062, DOI 10.1021/np200232s; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Echeverry S, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-16; Edman K, 2015, STRUCTURE, V23, P2280, DOI 10.1016/j.str.2015.09.012; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Fehrenbacher JC, 2012, CURR PROTOC PHARM; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Fylaktakidou KC, 2004, CURR PHARM DESIGN, V10, P3813, DOI 10.2174/1381612043382710; Gama KB, 2013, J NAT PROD, V76, P559, DOI 10.1021/np3007342; Giembycz MA, 2015, F1000PRIME REP; GITTER BD, 1989, IMMUNOLOGY, V66, P196; Grande JP, 1997, P SOC EXP BIOL MED, V214, P27; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hapgood JP, 2016, PHARMACOL THERAPEUT, V165, P93, DOI 10.1016/j.pharmthera.2016.06.002; Hohjoh H, 2014, BIOCHIMIE; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huang GJ, 2012, J AGR FOOD CHEM, V60, P1673, DOI 10.1021/jf204297e; Jin YX, 2000, J AUTOIMMUN, V14, P213, DOI 10.1006/jaut.2000.0364; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Kuek A, 2007, POSTGRAD MED J, V83, P251, DOI 10.1136/pgmj.2006.052688; Le Bars D, 2001, PHARMACOL REV, V53, P597; Letterio JJ, 1997, CLIN IMMUNOL IMMUNOP, V84, P244, DOI 10.1006/clin.1997.4409; Li ZP, 2011, EUR J PHARMACOL, V661, P118, DOI 10.1016/j.ejphar.2011.04.024; Lima MD, 2013, EUR J PHARMACOL, V699, P112, DOI 10.1016/j.ejphar.2012.11.040; Lin TT, 2014, J NAT PROD, V77, P955, DOI 10.1021/np401040d; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; Pages L, 2009, EXPERT OPIN THER PAT, V19, P1501, DOI 10.1517/13543770903313753; Peng XM, 2013, CURR PHARM DESIGN, V19, P3884, DOI 10.2174/1381612811319210013; Randrianarivelojosia M, 2005, BIOCHEM SYST ECOL, V33, P301, DOI 10.1016/j.bse.2004.06.007; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Salari P, 2012, EXPERT OPIN INV DRUG, V21, P261, DOI 10.1517/13543784.2012.658915; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Strand V, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-82; Venugopala KN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/963248; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Verpoorte R, 2000, TRANSGENIC RES, V9, P323, DOI 10.1023/A:1008966404981; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Williams JP, 2002, AM J MANAG CARE, V8, pS664; Woolf CJ, 1997, BRIT J PHARMACOL, V121, P417, DOI 10.1038/sj.bjp.0701148; Woolfe G, 1944, J PHARMACOL EXP THER, V80, P300; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; ZUCALI JR, 1986, J CLIN INVEST, V77, P1857, DOI 10.1172/JCI112512	60	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179174	10.1371/journal.pone.0179174	http://dx.doi.org/10.1371/journal.pone.0179174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594906	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200095
J	Gamez-Pozo, A; Trilla-Fuertes, L; Prado-Vazquez, G; Chiva, C; Lopez-Vacas, R; Nanni, P; Berges-Soria, J; Grossmann, J; Diaz-Almiron, M; Ciruelos, E; Sabido, E; Espinosa, E; Vara, JAF				Gamez-Pozo, Angelo; Trilla-Fuertes, Lucia; Prado-Vazquez, Guillermo; Chiva, Cristina; Lopez-Vacas, Rocio; Nanni, Paolo; Berges-Soria, Julia; Grossmann, Jonas; Diaz-Almiron, Mariana; Ciruelos, Eva; Sabido, Eduard; Espinosa, Enrique; Fresno Vara, Juana Angel			Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics	PLOS ONE			English	Article							HUMAN BILIVERDIN REDUCTASE; CLINICAL-SIGNIFICANCE; EXPRESSION PROFILES; GENE; SUBTYPES; METASTASIS; IDENTIFICATION; PROGNOSIS; OVEREXPRESSION; CLASSIFICATION	Background Triple-negative breast cancer (TNBC) accounts for 15 - 20% of all breast cancers and usually requires the administration of adjuvant chemotherapy after surgery but even with this treatment many patients still suffer from a relapse. The main objective of this study was to identify proteomics-based biomarkers that predict the response to standard adjuvant chemotherapy, so that patients at are not going to benefit from it can be offered therapeutic alternatives. Methods We analyzed the proteome of a retrospective series of formalin-fixed, paraffin-embedded TNBC tissue applying high-throughput label-free quantitative proteomics. We identified several protein signatures with predictive value, which were validated with quantitative targeted proteomics in an independent cohort of patients and further evaluated in publicly available transcriptomics data. Results Using univariate Cox analysis, a panel of 18 proteins was significantly associated with distant metastasis-free survival of patients (p< 0.01). A reduced 5-protein profile with prognostic value was identified and its prediction performance was assessed in an independent targeted proteomics experiment and a publicly available transcriptomics dataset. Predictor P5 including peptides from proteins RAC2, RAB6A, BIEA and IPYR was the best performance protein combination in predicting relapse after adjuvant chemotherapy in TNBC patients. Conclusions This study identified a protein combination signature that complements histopathological prognostic factors in TNBC treated with adjuvant chemotherapy. The protein signature can be used in paraffin-embedded samples, and after a prospective validation in independent series, it could be used as predictive clinical test in order to recommend participation in clinical trials or a more exhaustive follow-up.	[Gamez-Pozo, Angelo; Prado-Vazquez, Guillermo; Lopez-Vacas, Rocio; Berges-Soria, Julia; Fresno Vara, Juana Angel] Hosp Univ La Paz IdiPAZ, Inst Genet Med & Mol INGEMM, Mol Oncol & Pathol Lab, Madrid, Spain; [Gamez-Pozo, Angelo; Trilla-Fuertes, Lucia; Fresno Vara, Juana Angel] Biomed Mol Med SL, Madrid, Spain; [Chiva, Cristina; Sabido, Eduard] Barcelona Inst Sci & Technol, Prote Unit, Ctr Genom Regulat CRG, Barcelona, Spain; [Chiva, Cristina; Sabido, Eduard] Univ Pompeu Fabra, Prote Unit, Barcelona, Spain; [Nanni, Paolo; Grossmann, Jonas] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Diaz-Almiron, Mariana] Hosp Univ La Paz IdiPAZ, Biostat Unit, Madrid, Spain; [Ciruelos, Eva] Hosp Univ Doce Octubre I 12, Inst Invest, Med Oncol Serv, Madrid, Spain; [Espinosa, Enrique] Hosp Univ La Paz IdiPAZ, Med Oncol Serv, Madrid, Spain; [Espinosa, Enrique; Fresno Vara, Juana Angel] Inst Salud Carlos III, CIBERONC, Madrid, Spain	Hospital Universitario La Paz; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Hospital Universitario La Paz; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III	Vara, JAF (corresponding author), Hosp Univ La Paz IdiPAZ, Inst Genet Med & Mol INGEMM, Mol Oncol & Pathol Lab, Madrid, Spain.; Vara, JAF (corresponding author), Biomed Mol Med SL, Madrid, Spain.; Vara, JAF (corresponding author), Inst Salud Carlos III, CIBERONC, Madrid, Spain.	juanangel.fresno@salud.madrid.org	RODRIGUEZ, CRISTINA CHIVA/AAH-7862-2020; Trilla, Lucia/AAG-8392-2019; Prado-Vazquez, Guillermo/T-1861-2017; Vara, Juan Ángel Fresno/Y-9928-2019; Sabido, Eduard/F-7914-2015; Gamez-Pozo, Angelo/N-2506-2014	RODRIGUEZ, CRISTINA CHIVA/0000-0001-8150-6203; Trilla, Lucia/0000-0002-4452-3474; Prado-Vazquez, Guillermo/0000-0003-2456-6191; Vara, Juan Ángel Fresno/0000-0003-1527-1252; Espinosa Arranz, Enrique/0000-0001-6562-7902; Nanni, Paolo/0000-0001-8429-3557; Sabido, Eduard/0000-0001-6506-7714; Gamez-Pozo, Angelo/0000-0002-8931-0624	Instituto de Salud Carlos III; Spanish Economy and Competitiveness Ministry [RD09/0076/00073, RD09/0076/00118, DI-15-07614, PT13/0001]; Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid; Spanish Economy and Competitiveness Ministry, Spain - FEDER program, "Una forma de hacer Europa" [PI12/00444, PI12/01016, PI15/01310]; ISCIII [PT13/0001]; Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa [SEV-2012-0208]; "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya" [2014SGR678]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Economy and Competitiveness Ministry(Spanish Government); Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid; Spanish Economy and Competitiveness Ministry, Spain - FEDER program, "Una forma de hacer Europa"; ISCIII(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa(Spanish Government); "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya"	We want to particularly acknowledge the patients in this study for their participation and to the IdiPAZ and I+12 Biobanks for the generous gifts of clinical samples used in this work. The IdiPAZ and I+12 Biobanks are supported by Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry (RD09/0076/00073 and RD09/0076/00118 respectively) and Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid. This work was supported by Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry, Spain and co-funded by FEDER program, "Una forma de hacer Europa" (PI12/00444, PI12/01016 and PI15/01310). LT-F is supported by Spanish Economy and Competitiveness Ministry (DI-15-07614). The CRG/UPF Proteomics Unit is part of the "Plataforma de Recursos Biomoleculares y Bioinformaticos (ProteoRed)" supported by grant PT13/0001 of ISCIII and Spanish Ministry of Economy and Competitiveness. We acknowledge support of the Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa 2013-2017", SEV-2012-0208, and from "Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya" (2014SGR678). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Albergaria A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-299; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bianchini G, 2010, CANCER RES, V70, P8852, DOI 10.1158/0008-5472.CAN-10-1039; Chen J, 2012, J SURG ONCOL, V106, P260, DOI 10.1002/jso.22153; COX DR, 1972, J R STAT SOC B, V34, P187; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Ellis MJ, 2013, CANCER DISCOV, V3, P1108, DOI 10.1158/2159-8290.CD-13-0219; Gamez-Pozo A, 2015, CANCER RES, P2243; Gamez-Pozo A, 2013, PROTEOM CLIN APPL, V7, P283, DOI 10.1002/prca.201200048; Gamez-Pozo A, 2011, MOL BIOSYST, V7, P2368, DOI 10.1039/c1mb05113j; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Gildea JJ, 2002, CANCER RES, V62, P6418; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hirshfield KM, 2014, CURR OPIN OBSTET GYN, V26, P34, DOI 10.1097/GCO.0000000000000038; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jeong SH, 2012, TUMOR BIOL, V33, P1889, DOI 10.1007/s13277-012-0449-5; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim SS, 2013, ANTICANCER RES, V33, P4913; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JA, 2011, J BREAST CANCER, V14, P269, DOI 10.4048/jbc.2011.14.4.269; Lee U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082125; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; Liu NQ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt376; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luo DH, 2016, CANCER MED-US, V5, P2800, DOI 10.1002/cam4.894; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Martin H, 2013, J CLIN INVEST, V123, P4449, DOI 10.1172/JCI67509; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mishra DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124864; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Ouyang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096228; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Raphael BJ, 2013, NAT METHODS, V10, P1077, DOI 10.1038/nmeth.2704; Laimito KR, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.632; Sanchez-Navarro I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-336; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986	52	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178296	10.1371/journal.pone.0178296	http://dx.doi.org/10.1371/journal.pone.0178296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594844	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200026
J	Leon, ME; Assefa, M; Kassa, E; Bane, A; Gemechu, T; Tilahun, Y; Endalafer, N; Ferro, G; Straif, K; Ward, E; Aseffa, A; Schuz, J; Jemal, A				Leon, Maria E.; Assefa, Mathewos; Kassa, Endale; Bane, Abate; Gemechu, Tufa; Tilahun, Yared; Endalafer, Nigatu; Ferro, Gilles; Straif, Kurt; Ward, Elizabeth; Aseffa, Abraham; Schuz, Joachim; Jemal, Ahmedin			Qat use and esophageal cancer in Ethiopia: A pilot case-control study	PLOS ONE			English	Article							KHAT CATHA-EDULIS; SQUAMOUS-CELL CARCINOMA; SOUTH-AFRICA; RISK-FACTORS; ORAL-MUCOSA; TOBACCO; YEMEN; METAANALYSIS; CONSUMPTION; ALCOHOL	Background Qat (Catha edulis) chewing is reported to induce lesions in the buccal mucosa, irritation of the esophagus, and esophageal reflux. Case series suggest a possible etiological role in oral and esophageal cancers. This pilot study aimed to generate preliminary estimates of the magnitude and direction of the association between qat use and esophageal cancer (EC) risk and to inform the logistics required to conduct a multi-center case-control study. Methods Between May 2012 and May 2013, 73 EC cases (including 12 gastro-esophageal junction cases) and 133 controls matched individually on sex, age, and residence were enrolled at two endoscopy clinics and a cancer treatment hospital in Addis Ababa. A face-to-face structured questionnaire was administered. Qat use was defined as ever having chewed qat once a week or more frequently for at least one year. Odds ratios were calculated using conditional logistic regression. Results Only 8% of cases resided in Addis Ababa. Qat use was more frequent in cases (36%) than in controls (26%). A 2-fold elevation in EC risk was observed in ever qat chewers compared with never users in unadjusted conditional logistic regression (OR = 2.12; 95% Cl = 0.94, 4.74), an association that disappeared after adjusting for differences in tobacco use, consumption of alcohol and green vegetables, education level, and religion (OR = 0.95; 0.22, 4.22). Among never tobacco users, however, a non-significant increase in EC risk was suggested in ever qat users also after adjustment. Increases in EC risk were observed with ever tobacco use, alcohol consumption, low consumption of green vegetables, a salty diet, illiteracy, and among Muslims; the four latter associations were significant. Conclusions This pilot study generated EC risk estimates in association with a habit practiced by millions of people and never before studied in a case-control design. Results must be interpreted cautiously in light of possible selection bias, with some demographics such as education level and religion differing between cases and controls. A large case-control study with enrolment of EC cases and carefully matched controls at health facilities from high-risk areas in the countryside, where the majority of cases occur, is needed to further investigate the association between qat use and EC.	[Leon, Maria E.; Ferro, Gilles; Schuz, Joachim] IARC, Sect Environm & Radiat, Lyon, France; [Assefa, Mathewos; Kassa, Endale; Bane, Abate; Tilahun, Yared] Addis Ababa Univ, Fac Med, Dept Internal Med, Addis Ababa, Ethiopia; [Gemechu, Tufa] Addis Ababa Univ, Fac Med, Pathol, Addis Ababa, Ethiopia; [Endalafer, Nigatu; Aseffa, Abraham] AHRI, Addis Ababa, Ethiopia; [Straif, Kurt] IARC, Sect IARC Monographs, Lyon, France; [Ward, Elizabeth; Jemal, Ahmedin] ACS, Surveillance & Hlth Serv Res, Atlanta, GA USA	World Health Organization; International Agency for Research on Cancer (IARC); Addis Ababa University; Addis Ababa University; World Health Organization; International Agency for Research on Cancer (IARC)	Leon, ME (corresponding author), IARC, Sect Environm & Radiat, Lyon, France.	leonrouxm@iarc.fr	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	American cancer Society; International Agency for Research on Cancer	American cancer Society(American Cancer Society); International Agency for Research on Cancer	This pilot study was funded by the American cancer Society and the International Agency for Research on Cancer. Researchers from both Institutions designed the study and coauthored the manuscript reporting results. All analysis was conducted at IARC. The actual data collection was done by researchers from the Ethiopian Institutions. IARC and ACS were not directly involved in the collection of the data.	Abnet CC, 2015, GASTROENTEROLOGY, V148, P1234, DOI 10.1053/j.gastro.2015.02.007; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Ali AA, 2004, J ORAL PATHOL MED, V33, P368, DOI 10.1111/j.1600-0714.2004.00145.x; Ali AA, 2007, ORAL SURG ORAL MED O, V103, pE55, DOI 10.1016/j.tripleo.2006.10.008; Balint EE, 2009, WIEN KLIN WOCHENSCHR, V121, P604, DOI 10.1007/s00508-009-1259-7; Coleman HG, 2013, NUTR REV, V71, P474, DOI 10.1111/nure.12032; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; Daba D, 2011, B ENVIRON CONTAM TOX, V86, P336, DOI 10.1007/s00128-011-0207-1; Dar NA, 2015, INT J CANCER, V136, pE704, DOI 10.1002/ijc.29204; Date J, 2004, INT J ENVIRON HEAL R, V14, P405, DOI 10.1080/09603120400012884; El-Zaemey S, 2015, INT J OCCUP ENV MED, V6, P129, DOI 10.15171/ijoem.2015.537; Fasanmade A, 2007, ORAL SURG ORAL MED O, V104, pE53, DOI 10.1016/j.tripleo.2007.01.010; Feyisa TH, 2003, MT RES DEV, V23, P185, DOI 10.1659/0276-4741(2003)023[0185:KEITEH]2.0.CO;2; Gebissa E, 2008, SUBST USE MISUSE, V43, P784, DOI 10.1080/10826080701738950; GUNAID AA, 1995, BRIT J CANCER, V71, P409, DOI 10.1038/bjc.1995.83; Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8; Haile D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130460; HALBACH H, 1972, B WORLD HEALTH ORGAN, V47, P21; Halboub Essam, 2009, Acta Medica (Hradec Kralove), V52, P155; Hassan N. A. G. M., 2007, Eastern Mediterranean Health Journal, V13, P706; International Agency for Research on Cancer, 2012, REV HUM CARC E; KALIX P, 1984, B WORLD HEALTH ORGAN, V62, P681; KALIX P, 1984, GEN PHARMACOL, V15, P179, DOI 10.1016/0306-3623(84)90156-3; Kassie F, 2001, INT J CANCER, V92, P329, DOI 10.1002/ijc.1195; Kassim S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-448; Kennedy JG, 1987, FLOWER PARADISE I US; Khat Lemessa D., 2001, KHAT CATHA EDULIS BO; Li DP, 2008, CLIN CHEM LAB MED, V46, P323, DOI 10.1515/CCLM.2008.073; Li JH, 1998, MUTAGENESIS, V13, P557, DOI 10.1093/mutage/13.6.557; Ligani S, 2014, B ENVIRON CONTAM TOX, V93, P591, DOI 10.1007/s00128-014-1385-4; Lin SH, 2015, INT J CANCER, V137, P582, DOI 10.1002/ijc.29406; Liu J, 2013, INT J CANCER, V133, P473, DOI 10.1002/ijc.28024; Loomis D, 2015, LANCET ONCOL, V16, P891, DOI 10.1016/S1470-2045(15)00081-9; Lukandu OM, 2010, J DENT RES, V89, P270, DOI 10.1177/0022034509354980; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Negatu B, 2016, ANN OCCUP HYG; Pacella-Norman R, 2002, BRIT J CANCER, V86, P1751, DOI 10.1038/sj.bjc.6600338; Sawair FA, 2007, INT J ENVIRON HEAL R, V17, P185, DOI 10.1080/09603120701254813; Sewram V, 2016, CANCER EPIDEMIOL, V41, P113, DOI 10.1016/j.canep.2016.02.001; Sewram V, 2014, NUTR CANCER, V66, P791, DOI 10.1080/01635581.2014.916321; SOUFI HE, 1991, J LARYNGOL OTOL, V105, P643, DOI 10.1017/S0022215100116913; Tesfaye Fikru, 2008, Prev Chronic Dis, V5, pA89; The DHS program, 2012, ETH DEM HLTH SURV 20; Toennes SW, 2003, BRIT J CLIN PHARMACO, V56, P125, DOI 10.1046/j.1365-2125.2003.01834.x; WHO, WHO TECHN REP SER; Yarom N, 2010, ORAL SURG ORAL MED O, V109, pE60, DOI 10.1016/j.tripleo.2010.02.022	46	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178911	10.1371/journal.pone.0178911	http://dx.doi.org/10.1371/journal.pone.0178911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594883	Green Published, gold			2022-12-26	WOS:000402923200065
J	Luo, SL; Cao, NN; Tang, Y; Gu, WR				Luo, Shouling; Cao, Nannan; Tang, Yao; Gu, Weirong			Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis	PLOS ONE			English	Article							INHIBITS TROPHOBLAST INVASION; CELL-DEATH; EXPRESSION; APOPTOSIS; CONTRIBUTES; PROTEINS; HYPOXIA; ONSET	Preeclampsia is a leading cause of perinatal maternal-foetal mortality and morbidity. The aim of this study is to identify the key microRNAs and genes in preeclampsia and uncover their potential functions. We downloaded the miRNA expression profile of GSE84260 and the gene expression profile of GSE73374 from the Gene Expression Omnibus database. Differentially expressed miRNAs and genes were identified and compared to miRNA-target information from MiRWalk 2.0, and a total of 65 differentially expressed miRNAs (DEMIs), including 32 up-regulated miRNAs and 33 down-regulated miRNAs, and 91 differentially expressed genes (DEGs), including 83 up-regulated genes and 8 down-regulated genes, were identified. The pathway enrichment analyses of the DEMIs showed that the up-regulated DEMIs were enriched in the Hippo signalling pathway and MAPK signalling pathway, and the down-regulated DEMIs were enriched in HTLV-I infection and miRNAs in cancers. The gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) enrichment analyses of the DEGs were performed using Multifaceted Analysis Tool for Human Transcriptome. The up-regulated DEGs were enriched in biological processes (BPs), including the response to cAMP, response to hydrogen peroxide and cell-cell adhesion mediated by integrin; no enrichment of down-regulated DEGs was identified. KEGG analysis showed that the up-regulated DEGs were enriched in the Hippo signalling pathway and pathways in cancer. A PPI network of the DEGs was constructed by using Cytoscape software, and FOS, STAT1, MMP14, ITGB1, VCAN, DUSP1, LDHA, MCL1, MET, and ZFP36 were identified as the hub genes. The current study illustrates a characteristic microRNA profile and gene profile in preeclampsia, which may contribute to the interpretation of the progression of preeclampsia and provide novel biomarkers and therapeutic targets for preeclampsia.	[Luo, Shouling; Cao, Nannan; Tang, Yao; Gu, Weirong] Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai, Peoples R China; [Luo, Shouling] Shanghai Key Lab Female Reprod Endocrine Related, Huangpu Area, Shanghai, Peoples R China	Fudan University	Gu, WR (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Obstet, Shanghai, Peoples R China.	guweirong163@163.com			Natural Science Foundation of China [81471470]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (Grant No. 81471470 to W-RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Anton L, 2013, AM J PATHOL, V183, P1437, DOI 10.1016/j.ajpath.2013.07.021; Bae J.M., 2016, ONCOTARGET; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Ding D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7618342; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Erkkila K, 2002, MOL HUM REPROD, V8, P109, DOI 10.1093/molehr/8.2.109; Gene Ontology Consortium, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI [10.1093/nar/gkj021, DOI 10.1093/NAR/GKJ021]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hromadnikova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138383; Jiang F, 2015, GENET MOL RES, V14, P6598, DOI 10.4238/2015.June.18.2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kay HH, 2007, PLACENTA, V28, P854, DOI 10.1016/j.placenta.2006.11.011; Kidger AM, 2017, P NATL ACAD SCI USA, V114, pE317, DOI 10.1073/pnas.1614684114; Kim SY, 2013, J MATERN-FETAL NEO M, V26, P860, DOI 10.3109/14767058.2013.769952; Lee GSR, 2010, ARCH GYNECOL OBSTET, V282, P363, DOI 10.1007/s00404-009-1222-x; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Lin L., 2016, TUMOUR BIOL; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu XP, 2016, AM J REPROD IMMUNOL, V76, P307, DOI 10.1111/aji.12555; Liu XR, 2016, J MATERN-FETAL NEO M, V29, P3776, DOI 10.3109/14767058.2016.1144744; Luo RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19588; Luo X, 2011, CELL TISSUE RES, V344, P551, DOI 10.1007/s00441-011-1164-z; Nikuei P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011920; Prenzler F, 2016, EUR J CELL BIOL, V95, P277, DOI 10.1016/j.ejcb.2016.04.007; Ray J, 2009, PLACENTA, V30, pS96, DOI 10.1016/j.placenta.2008.11.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soleymanlou N, 2005, CELL DEATH DIFFER, V12, P441, DOI 10.1038/sj.cdd.4401593; Soleymanlou N, 2007, AM J PATHOL, V171, P496, DOI 10.2353/ajpath.2007.070094; Song J, 2015, REPROD SCI, V22, P954, DOI 10.1177/1933719115570898; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsoi SCM, 2001, PLACENTA, V22, P317, DOI 10.1053/plac.2000.0620; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; Yu LL, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-26; Zeng X, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.032; Zhang M, 2016, P NATL ACAD SCI USA, V113, pE7069, DOI 10.1073/pnas.1607849113; Zhu XM, 2015, MOL MED REP, V12, P2701, DOI 10.3892/mmr.2015.3724	42	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178549	10.1371/journal.pone.0178549	http://dx.doi.org/10.1371/journal.pone.0178549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594854	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200038
J	Cai, DR; Liu, H; Sang, N; Huang, XZ				Cai, Darun; Liu, Hui; Sang, Na; Huang, Xianzhong			Identification and characterization of CONSTANS-like (COL) gene family in upland cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PHOTOPERIODIC CONTROL; FUNCTIONAL-ANALYSIS; CIRCADIAN CLOCK; ARABIDOPSIS; PROTEIN; LIGHT; TRANSCRIPTION; FT; EXPRESSION; EVOLUTION	The CONSTANS/FLOWERING LOCUS T (CO/FT) regulon plays a central role in the control of flowering time in photoperiod-sensitive plants. Flowering time in wild cotton (Gossypium spp.) has strict photoperiod sensitivity, but domesticated cotton is day-neutral. Information on the molecular characterization of the CO and CO-like (COL) genes in cotton is very limited. In this study, we identified 42 COL homologs (GhCOLs) in the G. hirsutum genome, and many of them were previously unreported. We studied their chromosome distribution, phylogenetic relationships, and structures of genes and proteins. Our results showed that GhCOLs were classified into three groups, and 14 COLs in group I showed conserved structure when compared with other plants. Two homoeologous pairs, GhCOL1-A and GhCOL1-D in Group I, showed the highest sequence similarity to Arabidopsis thaliana CO and rice CO homologous gene Heading date1 (Hd1). Tissue-specific expression showed that 42 GhCOL genes may function as tissue-specific regulators in different cells or organs. We cloned and sequenced the 14 GhCOL genes in Group I related to flowering induction to study their diurnal expression pattern, and found that their expression showed distinct circadian regulation. Most of them peaked at dawn and decreased rapidly to their minima at dusk, then started to accumulate until following dawn under long-or short-day conditions. Transgenic study in the Arabidopsis co-2 mutant demonstrated that GhCOL1-A and GhCOL1-D fully rescued the late-flowering phenotype, whereas GhCOL3-A, GhCOL3-D, GhCOL7-A, and GhCOL7-D partially rescued the late-flowering phenotype, and the other five homoeologous pairs in Group I did not promote flowering. These results indicate that GhCOL1-A and GhCOL1-D were potential flowering inducers, and are candidate genes for research in flowering regulation in cotton.	[Cai, Darun; Liu, Hui; Sang, Na; Huang, Xianzhong] Shihezi Univ, Coll Life Sci, Special Plant Genom Lab, Shihezi, Xinjiang, Peoples R China	Shihezi University	Huang, XZ (corresponding author), Shihezi Univ, Coll Life Sci, Special Plant Genom Lab, Shihezi, Xinjiang, Peoples R China.	xianzhongh106@163.com		Huang, xianzhong/0000-0003-1264-8106	National Natural Science Foundation of China [31360366]; Program for New Century Excellent Talents in University [NCET-12-1072]; Scientific and Technological Innovation Leading Talents of Xinjiang Production and Construction Corps [2006BC001]; Innovation Team Project for Xinjiang Production and Construction Corps [2014CC005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific and Technological Innovation Leading Talents of Xinjiang Production and Construction Corps; Innovation Team Project for Xinjiang Production and Construction Corps	This work was financially supported by the National Natural Science Foundation of China (31360366) to XH; the Program for New Century Excellent Talents in University (grant no. NCET-12-1072) to XH; the Scientific and Technological Innovation Leading Talents of Xinjiang Production and Construction Corps (2006BC001) to XH; the Innovation Team Project for Xinjiang Production and Construction Corps (2014CC005) to XH.	Ballerini ES, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00081; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Chaurasia AK, 2016, PHYSIOL MOL BIOL PLA, V22, P1, DOI 10.1007/s12298-016-0345-3; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Chia TYP, 2008, J EXP BOT, V59, P2735, DOI 10.1093/jxb/ern129; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; Datta S, 2007, PLANT CELL, V19, P3242, DOI 10.1105/tpc.107.054791; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Fu JX, 2015, MOL GENET GENOMICS, V290, P1039, DOI 10.1007/s00438-014-0977-3; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Gonzalez-Schain ND, 2008, BIOL PLANTARUM, V52, P251, DOI 10.1007/s10535-008-0054-z; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo DL, 2015, J INTEGR PLANT BIOL, V57, P522, DOI 10.1111/jipb.12316; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2004, PLANT PHYSIOL, V135, P677; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Lazaro A, 2015, PLANT CELL, V27, P2437, DOI 10.1105/tpc.15.00529; Lazaro A, 2012, PLANT CELL, V24, P982, DOI 10.1105/tpc.110.081885; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Lian HL, 2011, GENE DEV, V25, P1023, DOI 10.1101/gad.2025111; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; Liu TM, 2015, GENE, V560, P63, DOI 10.1016/j.gene.2015.01.045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; PUTTERILL J, 1993, MOL GEN GENET, V239, P145, DOI 10.1007/BF00281613; Saha S, 2006, GENETICS, V172, P1927, DOI 10.1534/genetics.105.053371; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Song XM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14631; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas B., 1997, PHOTOPERIODISM PLANT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wong ACS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00486; Wu FQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085754, 10.1371/journal.pone.0087251]; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JW, 2008, MOL CELL, V32, P617, DOI 10.1016/j.molcel.2008.09.026; Zhang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118669; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	58	19	28	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179038	10.1371/journal.pone.0179038	http://dx.doi.org/10.1371/journal.pone.0179038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591177	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700076
J	Han, EC; Ryoo, SB; Park, JW; Yi, JW; Oh, HK; Choe, EK; Ha, HK; Park, BK; Moon, SH; Jeong, SY; Park, KJ				Han, Eon Chul; Ryoo, Seung-Bum; Park, Ji Won; Yi, Jin Wook; Oh, Heung-Kwon; Choe, Eun Kyung; Ha, Heon-Kyun; Park, Byung Kwan; Moon, Sang Hui; Jeong, Seung-Yong; Park, Kyu Joo			Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study	PLOS ONE			English	Article							RED-BLOOD-CELLS; HEPATITIS-B; COLON-CANCER; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; RARE OCCURRENCE; DISEASE MELD; SERUM SODIUM; SURGERY; METASTASIS	The management of colorectal cancer in patients with liver cirrhosis requires a thorough understanding of both diseases. This study evaluated the effect of liver cirrhosis on oncologic and surgical outcomes and prognostic factors in colorectal cancer patients. Fifty-five consecutive colorectal cancer patients with liver cirrhosis underwent colorectal resection (LC group). Using a prospectively maintained database, these patients were matched 1: 4 using propensity scoring with R programming language, package "MatchIt" and "optmatch" by sex, age, cancer location, and tumor stage with 220 patients without liver cirrhosis (non-LC group), resulting in 275 patients. The 5-year overall survival (OS) was significantly worse in the LC group than in the non-LC group (46.7% vs. 76.2% respectively, P < 0.001); however, the 5-year proportion of recurrence free (PRF) rates were similar (73.1% vs. 84.5% respectively, P = 0.094). On multivariate analysis of the LC group, tumor-node-metastasis (TNM) stage >= III disease, venous invasion, and a model for end-stage liver disease plus serum sodium (MELD-Na) score >10 were prognostic factors for OS. However, the OS was not different between the LC group with MELD-Na score <= 10 and the non-LC group (5-year OS rate, TNM stage <= II, 85.7 vs 89.5%, p = 0.356; TNM stage >= III, 41.1 vs 66.2%, p = 0.061). Colorectal cancer patients with liver cirrhosis have poorer OS compared to those without liver cirrhosis; however, the PRF rates are similar. It might be due to the mortality from the liver, and surgical treatment should be actively considered for patients with MELD-Na score <10.	[Han, Eon Chul] Dongnam Inst Radiol & Med Sci, Dept Surg, Busan, South Korea; [Ryoo, Seung-Bum; Park, Ji Won; Yi, Jin Wook; Moon, Sang Hui; Jeong, Seung-Yong; Park, Kyu Joo] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea; [Oh, Heung-Kwon] Seoul Natl Univ, Dept Surg, Bundang Hosp, Coll Med, Seoul, South Korea; [Choe, Eun Kyung] Seoul Natl Univ Hosp, Gangnam Ctr, Seoul, South Korea; [Ha, Heon-Kyun] Seonam Univ, Dept Surg, Coll Med, Myongji Hosp, Goyang, Gyeonggi Provin, South Korea; [Park, Byung Kwan] Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Myongji Hospital; Seonam University; Chung Ang University; Chung Ang University Hospital	Ryoo, SB (corresponding author), Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea.	sbryoomd@gmail.com	Oh, Heung-Kwon/S-1292-2019; Ryoo, Seung-Bum/AGL-0507-2022	Han, Eon Chul/0000-0001-5987-3752; Oh, Heung-Kwon/0000-0002-8066-2367; Park, Byung Kwan/0000-0002-2283-8483; Yi, Jin Wook/0000-0002-9296-8443				Acheson AG, 2012, ANN SURG, V256, P235, DOI 10.1097/SLA.0b013e31825b35d5; Amato A, 2006, PERIOPERATIVE BLOOD; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Arroyo V, 2000, J HEPATOL, V32, P157, DOI 10.1016/S0168-8278(00)80423-7; BARSKY SH, 1988, J NATL CANCER I, V80, P102, DOI 10.1093/jnci/80.2.102; Ben  Hansen B., 2012, J COMPUTATIONAL GRAP; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Bhangui P, 2012, J HEPATOL, V57, P874, DOI 10.1016/j.jhep.2012.03.037; Biggins SW, 2006, GASTROENTEROLOGY, V130, P1652, DOI 10.1053/j.gastro.2006.02.010; Blei AT, 2007, J CLIN GASTROENTEROL, V41, pS323, DOI 10.1097/MCG.0b013e318157188e; Cabibbo G, 2012, LIVER INT, V32, P21, DOI 10.1111/j.1478-3231.2011.02629.x; Colombo M, 2001, Clin Liver Dis, V5, P109, DOI 10.1016/S1089-3261(05)70156-2; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Dahl E, 2011, HEPATOL RES, V41, P618, DOI 10.1111/j.1872-034X.2011.00813.x; Friedman Lawrence S, 2010, Trans Am Clin Climatol Assoc, V121, P192; Friedman LS, 2010, T AM CLIN CLIMAT ASS, V121, P5; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Ghaferi AA, 2010, ANN SURG, V252, P345, DOI 10.1097/SLA.0b013e3181e982d6; Grimshaw K, 2011, TRANSFUSION, V51, P874, DOI 10.1111/j.1537-2995.2011.03095.x; Han EC, 2015, INT J COLORECTAL DIS, V30, P1495, DOI 10.1007/s00384-015-2315-6; Ho D, 2006, MATCHIT NONPARAMETRI, P2; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Hsu CY, 2010, DIGEST LIVER DIS, V42, P137, DOI 10.1016/j.dld.2009.06.004; Huo TI, 2009, J CLIN GASTROENTEROL, V43, P773, DOI 10.1097/MCG.0b013e31818dd962; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Kim In Sung, 2012, Korean J Gastroenterol, V59, P224; Krarup PM, 2012, COLORECTAL DIS, V14, pE661, DOI 10.1111/j.1463-1318.2012.03079.x; Lim Young Suk, 2011, Korean J Gastroenterol, V57, P333; Madbouly KM, 2013, DIS COLON RECTUM, V56, P577, DOI 10.1097/DCR.0b013e318286f8fc; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Sabbagh C, 2015, SURG ONCOL, V24, P187, DOI 10.1016/j.suronc.2015.06.010; Schiergens TS, 2015, DIS COLON RECTUM, V58, P74, DOI 10.1097/DCR.0000000000000233; Seymour K, 1999, BRIT J SURG, V86, P1237, DOI 10.1046/j.1365-2168.1999.01228.x; Slade JH, 2009, CLIN COLORECTAL CANC, V8, P225, DOI 10.3816/CCC.2009.n.038; Song E, 2001, AM J SURG, V181, P529, DOI 10.1016/S0002-9610(01)00634-1; Song E, 2001, BRIT J CANCER, V84, P1265, DOI 10.1054/bjoc.2000.1737; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; UETSUJI S, 1992, AM J SURG, V164, P176, DOI 10.1016/S0002-9610(05)80380-0; UTSUNOMIYA T, 1993, AM J SURG, V166, P776, DOI 10.1016/S0002-9610(05)80698-1; Utsunomiya T, 1999, AM J SURG, V177, P279, DOI 10.1016/S0002-9610(99)00045-8; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; WALLACH JB, 1953, AM J CLIN PATHOL, V23, P989; Wang YW, 2007, J CLIN GASTROENTEROL, V41, P706, DOI 10.1097/MCG.0b013e31802dabb3; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wong VWS, 2007, LIVER TRANSPLANT, V13, P1228, DOI 10.1002/lt.21222; Zimmerman JE, 1996, HEPATOLOGY, V23, P1393, DOI 10.1002/hep.510230615	46	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178920	10.1371/journal.pone.0178920	http://dx.doi.org/10.1371/journal.pone.0178920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586376	gold, Green Published, Green Submitted			2022-12-26	WOS:000402875700036
J	Beshkar, F; Zinatloo-Ajabshir, S; Bagheri, S; Salavati-Niasari, M				Beshkar, Farshad; Zinatloo-Ajabshir, Sahar; Bagheri, Samira; Salavati-Niasari, Masoud			Novel preparation of highly photocatalytically active copper chromite nanostructured material via a simple hydrothermal route	PLOS ONE			English	Article							CUCR2O4 SPINEL NANOPARTICLES; THERMAL-DECOMPOSITION; SUPPORTED COPPER; CATALYST; OXIDATION; KINETICS	Highly photocatalytically active copper chromite nanostructured material were prepared via a novel simple hydrothermal reaction between [Cu(en)(2)(H2O)(2)]Cl2 and [Cr(en)(3)]Cl-3.3H(2)O at low temperature, without adding any pH regulator or external capping agent. The as-synthesized nanostructured copper chromite was analyzed by transmission electron microscopy (TEM), UV-vis diffuse reflectance spectroscopy, energy dispersive X-ray microanalysis (EDX), scanning electron microscopy (SEM), X-ray diffraction (XRD) and Fourier transform infrared (FT-IR) spectroscopy. Results of the morphological investigation of the as-synthesized products illustrate that the shape and size of the copper chromite depended on the surfactant sort, reaction duration and temperature. Moreover, the photocatalytic behavior of as-obtained copper chromite was evaluated by photodegradation of acid blue 92 (anionic dye) as water pollutant.	[Beshkar, Farshad; Zinatloo-Ajabshir, Sahar; Salavati-Niasari, Masoud] Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran; [Bagheri, Samira] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia	University Kashan; Universiti Malaya	Salavati-Niasari, M (corresponding author), Univ Kashan, Inst Nano Sci & Nano Technol, Kashan, Iran.; Bagheri, S (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, IPS Bldg, Kuala Lumpur, Malaysia.	samira_bagheri@um.edu.my; salavati@kashanu.ac.ir	Zinatloo-Ajabshir, Sahar/AAV-3160-2020; Salavati-Niasari, Masoud/AAX-4106-2020	Zinatloo-Ajabshir, Sahar/0000-0002-9283-9203; Salavati-Niasari, Masoud/0000-0002-7356-7249	University Malaya Research Grant [RP038B-15HTM]	University Malaya Research Grant	This work is financially supported by University Malaya Research Grant (RP038B-15HTM).	Acharyya SS, 2015, CATAL COMMUN, V59, P145, DOI 10.1016/j.catcom.2014.10.015; Acharyya SS, 2014, IND ENG CHEM RES, V53, P20056, DOI 10.1021/ie5026634; Acharyya SS, 2014, CATAL SCI TECHNOL, V4, P4232, DOI 10.1039/c4cy00615a; Acharyya SS, 2014, ACS SUSTAIN CHEM ENG, V2, P584, DOI 10.1021/sc5000545; Aranha PE, 2007, POLYHEDRON, V26, P1373, DOI 10.1016/j.poly.2006.11.005; Beshkar F, 2015, CHEM ENG J, V279, P605, DOI 10.1016/j.cej.2015.05.076; Beshkar F, 2015, J MATER SCI-MATER EL, V26, P5043, DOI 10.1007/s10854-015-3024-1; Dandekar A, 1999, J CATAL, V184, P421, DOI 10.1006/jcat.1998.2357; Durrani SK, 2012, TURK J CHEM, V36, P111, DOI 10.3906/kim-1104-61; Earnshaw A, 1996, J CHEM SOC, P1339; Kawamoto AM, 2004, AEROSP SCI TECHNOL, V8, P591, DOI 10.1016/j.ast.2004.06.010; Lahmar H, 2012, J MOL CATAL-A CHEM, V74-79, P353; LAINE J, 1990, APPL CATAL, V65, P253, DOI 10.1016/S0166-9834(00)81601-2; Mortazavi-Derazkola S, 2015, RSC ADV, V5, P56666, DOI 10.1039/c5ra08394j; Moshtaghi S, 2016, J MATER SCI-MATER EL, V27, P425, DOI 10.1007/s10854-015-3770-0; Prasad R, 2005, MATER LETT, V59, P3945, DOI 10.1016/j.matlet.2005.07.041; Prasad R, 2011, BULL CHEM REACT ENG, V6, P63, DOI 10.9767/bcrec.6.2.829.63-113; RAJEEV R, 1995, THERMOCHIM ACTA, V254, P235, DOI 10.1016/0040-6031(94)01961-F; Robinson PP, 2010, J THERM ANAL CALORIM, V100, P733, DOI 10.1007/s10973-009-0209-y; Valdes-Solis T, 2006, CATAL TODAY, V116, P354, DOI 10.1016/j.cattod.2006.05.063; Yan JH, 2009, SOL ENERGY, V83, P1534, DOI 10.1016/j.solener.2009.05.004; Yuan WH, 2014, APPL SURF SCI, V319, P350, DOI 10.1016/j.apsusc.2014.07.158; Zhong JB, 2012, J MOL CATAL A-CHEM, V357, P101, DOI 10.1016/j.molcata.2012.01.026; Zinatloo-Ajabshir S, 2016, INT J APPL CERAM TEC, V13, P108, DOI 10.1111/ijac.12393; Zinatloo-Ajabshir S, 2015, NEW J CHEM, V39, P3948, DOI 10.1039/c4nj02106a; Zinatloo-Ajabshir S, 2015, RSC ADV, V5, P33792, DOI 10.1039/c5ra00817d; Zinatloo-Ajabshir S, 2014, J IND ENG CHEM, V20, P3313, DOI 10.1016/j.jiec.2013.12.013	27	62	62	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0158549	10.1371/journal.pone.0158549	http://dx.doi.org/10.1371/journal.pone.0158549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582420	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600001
J	Guerbaii, RA; Fustier, G; Ennezat, PV; Ringle, A; Trouillet, C; Graux, P; Vincentelli, AA; Tribouilloy, C; Marechaux, S				Guerbaii, Raphaelle-Ashley; Fustier, Gabriel; Ennezat, Pierre-Vladimir; Ringle, Anne; Trouillet, Camille; Graux, Pierre; Vincentelli, Andre A.; Tribouilloy, Christophe; Marechaux, Sylvestre			Asymptomatic aortic stenosis: An assessment of patients' and of their general practitioners' knowledge, after an indexed specialized assessment in community practice	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; VALVE CLINICS; WORKING GROUP; RECOMMENDATIONS; ORGANIZATION; MANAGEMENT; SOCIETY	Background Clinical and echocardiography follow-up is recommended in patients with aortic stenosis to detect symptom onset, thus a watchful waiting approach has to be safe and effective. For both AS patients and their general practitioners, evaluation of valvular heart disease (VHD) knowledge, after the indexed specialized assessment has never been measured. Aims To evaluate the knowledge of clinical symptoms of aortic stenosis by both patients and their general practitioner. Methods Sixty-four patients, with moderate to severe and initially asymptomatic AS (median AVA (interquartile range) 1.01(0.80-1.15) cm(2)) previously referred to a tertiary center and medically managed for at least 6 months after the index echocardiogram, and their primary care doctors were interviewed on the phone and asked to answer specific questions related to knowledge of aortic stenosis symptoms. Results Fifty-six percent of patients quoted shortness of breath as one of the aortic stenosis symptoms, and only 16% knew the 3 aortic stenosis symptoms. Fifty percent of patients reported having received sufficient information regarding aortic stenosis; only 48% remembered receiving information regarding specific symptoms. Only 14% general practitioners quoted the 3 specific symptoms. According to the initial recommendation, only 41 patients (64%) benefitted from a 6-to-12 month clinical and echocardiography follow up. Conclusion GPs are not sufficiently trained to safely manage AS patients in the community and to ensure adequate follow-up and monitoring. AS patients were not properly informed about their diagnosis and symptomatology. Hence, therapeutic education should be improved for patients with asymptomatic AS and continuous medical education on VHD should be reinforced, for GPs.	[Guerbaii, Raphaelle-Ashley; Ennezat, Pierre-Vladimir] Ctr Hosp Reg Univ Grenoble Alpes, Dept Cardiol, Grenoble, France; [Fustier, Gabriel; Ringle, Anne; Graux, Pierre; Marechaux, Sylvestre] Univ Catholique Lille, GCS Grp Hop Inst Catholique Lille GHICL, Dept Cardiol, Fac Med & Maieut Lille, Lille, France; [Fustier, Gabriel; Ringle, Anne; Graux, Pierre; Marechaux, Sylvestre] Univ Catholique Lille, GCS Grp Hop Inst Catholique Lille GHICL, Heart Valve Ctr, Fac Med & Maieut Lille, Lille, France; [Ringle, Anne; Tribouilloy, Christophe; Marechaux, Sylvestre] Univ Picardie, INSERM, U 1088, Amiens, France; [Trouillet, Camille] Univ Catholique Lille, Fac Med & Maieut Lille, GCS Grp Hop Inst Catholique Lille GHICL, Dept Clin Res, Lille, France; [Vincentelli, Andre A.] CHRU Lille, Dept Cardiac Surg, Lille, France; [Tribouilloy, Christophe] Ctr Hosp Univ Amiens, Cardiol Dept B, Amiens, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Catholique de Lille; Universite Catholique de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite Catholique de Lille; Universite de Lille - ISITE; CHU Lille; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Marechaux, S (corresponding author), Univ Catholique Lille, GCS Grp Hop Inst Catholique Lille GHICL, Dept Cardiol, Fac Med & Maieut Lille, Lille, France.; Marechaux, S (corresponding author), Univ Catholique Lille, GCS Grp Hop Inst Catholique Lille GHICL, Heart Valve Ctr, Fac Med & Maieut Lille, Lille, France.; Marechaux, S (corresponding author), Univ Picardie, INSERM, U 1088, Amiens, France.	sylvestre.marechaux@gmail.com		Guerbaai, Raphaelle Ashley/0000-0002-0893-2633; Vincentelli, Andre/0000-0003-4081-786X				Bhattacharyya S, 2015, QJM-INT J MED, V108, P113, DOI 10.1093/qjmed/hcu164; Chambers JB, 2013, HEART, V99, P1714, DOI 10.1136/heartjnl-2013-303754; Czarny MJ, 2014, CLIN MED INSIGHTS-CA, V8, P15, DOI 10.4137/CMC.S15716; d'Arcy JL, 2011, HEART, V97, P91, DOI 10.1136/hrt.2010.205096; Lancellotti P, 2013, EUR HEART J, V34, P1597, DOI 10.1093/eurheartj/ehs443; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; LINDROOS M, 1994, EUR HEART J, V15, P865; Marechaux S, 2017, HEART, V103, P258, DOI 10.1136/heartjnl-2016-310399; Marechaux S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003146; Monckeberg JG, 1904, VIRCHOWS ARCH A, V176, P472, DOI 10.1007/BF02041318; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Parkin D, 2012, BR J CARDIOL, V19, P204, DOI DOI 10.5837/BJC.2012.015; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rosenhek R, 2004, EUR HEART J, V25, P199, DOI 10.1016/j.ehj.2003.12.002; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Tribouilloy C, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005121; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Zilberszac R, 2017, EUR HEART J-CARD IMG, V18, P138, DOI 10.1093/ehjci/jew133	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178932	10.1371/journal.pone.0178932	http://dx.doi.org/10.1371/journal.pone.0178932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582434	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600058
J	Qattan, MY; Bakker, EY; Rajendran, R; Chen, DWC; Saha, V; Liu, JZ; Zeef, L; Schwartz, JM; Mutti, L; Demonacos, C; Krstic-Demonacos, M				Qattan, Malak Yahia; Bakker, Emyr Yosef; Rajendran, Ramkumar; Chen, Daphne Wei-Chen; Saha, Vaskar; Liu, Jizhong; Zeef, Leo; Schwartz, Jean-Marc; Mutti, Luciano; Demonacos, Constantinos; Krstic-Demonacos, Marija			Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED APOPTOSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR PHOSPHORYLATION; MOLECULAR-MECHANISMS; INDUCE APOPTOSIS; PROTEIN-KINASE; NECROPTOSIS; GENES; CANCER; IDENTIFICATION	Glucocorticoids (GCs) and topoisomerase II inhibitors are used to treat acute lymphoblastic leukaemia (ALL) as they induce death in lymphoid cells through the glucocorticoid receptor (GR) and p53 respectively. Mechanisms underlying ALL cell death and the contribution of the bone marrow microenvironment to drug response/resistance remain unclear. The role of the microenvironment and the identification of chemoresistance determinants were studied by transcriptomic analysis in ALL cells treated with Dexamethasone (Dex), and Etoposide (Etop) grown in the presence or absence of bone marrow conditioned media (CM). The necroptotic (RIPK1) and the apoptotic (caspase-8/3) markers were downregulated by CM, whereas the inhibitory effects of chemotherapy on the autophagy marker Beclin-1 (BECN1) were reduced suggesting CM exerts cytoprotective effects. GCs upregulated the RIPK1 ubiquitinating factor BIRC3 (cIAP2), in GC-sensitive (CEM-C7-14) but not in resistant (CEMC1-15) cells. In addition, CM selectively affected GR phosphorylation in a site and cell-specific manner. GR is recruited to RIPK1, BECN1 and BIRC3 promoters in the sensitive but not in the resistant cells with phosphorylated GR forms being generally less recruited in the presence of hormone. FACS analysis and caspase-8 assays demonstrated that CM promoted a pro-survival trend. High molecular weight proteins reacting with the RIPK1 antibody were modified upon incubation with the BIRC3 inhibitor AT406 in CEM-C7-14 cells suggesting that they represent ubiquitinated forms of RIPK1. Our data suggest that there is a correlation between microenvironment-induced ALL proliferation and altered response to chemotherapy.	[Qattan, Malak Yahia] King Saud Univ, Coll Appl Med Sci & Community Serv, Riyadh, Saudi Arabia; [Bakker, Emyr Yosef; Mutti, Luciano; Krstic-Demonacos, Marija] Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England; [Rajendran, Ramkumar] Int Med Univ, Sch Pharm, Kuala Lumpur, Malaysia; [Chen, Daphne Wei-Chen; Saha, Vaskar; Liu, Jizhong; Zeef, Leo; Schwartz, Jean-Marc; Demonacos, Constantinos] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Saha, Vaskar] Tata Translat Canc Res Ctr, Kolkata, India	King Saud University; University of Salford; International Medical University Malaysia; University of Manchester	Krstic-Demonacos, M (corresponding author), Univ Salford, Sch Environm & Life Sci, Salford, Lancs, England.	M.Krstic-Demonacos@salford.ac.uk	Demonacos, Constantinos/K-1277-2019; Bakker, Emyr/AAX-8129-2020; Schwartz, Jean-Marc/AAS-8274-2020; Mutti, Luciano/A-3545-2011	Demonacos, Constantinos/0000-0002-4515-755X; Schwartz, Jean-Marc/0000-0002-6472-0184; Bakker, Emyr/0000-0002-0091-1029; Saha, Vaskar/0000-0002-2916-9649; Mutti, Luciano/0000-0002-1578-2637	King Saud Universities; Manchester Universities; Salford Universities; GIME	King Saud Universities; Manchester Universities; Salford Universities; GIME	We are grateful to the King Saud, Manchester and Salford Universities and GIME for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the King Saud, Manchester and Salford Universities and GIME for support.	Adzic M, 2009, INT J BIOCHEM CELL B, V41, P2181, DOI 10.1016/j.biocel.2009.04.001; Bakker E, 2016, BBA-MOL CELL RES, V1863, P414, DOI 10.1016/j.bbamcr.2015.08.003; Bell BD, 2009, AUTOPHAGY, V5, P238, DOI 10.4161/auto.5.2.7512; Belz K, 2014, BLOOD, V124, P240, DOI 10.1182/blood-2013-05-500918; Berrou I, 2012, GLUCOCORTICOIDS NEW, P151; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Cardoso BA, 2008, BRAZ J MED BIOL RES, V41, P344, DOI 10.1590/S0100-879X2008005000016; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chen DWC, 2013, ONCOGENE, V32, P3039, DOI 10.1038/onc.2012.321; Chen DWC, 2010, PHARMACOGENOMICS, V11, P1545, DOI [10.2217/pgs.10.125, 10.2217/PGS.10.125]; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; Davies L, 2011, MOL ENDOCRINOL, V25, P58, DOI 10.1210/me.2010-0212; Demonacos C, 2001, MOL CELL, V8, P71, DOI 10.1016/S1097-2765(01)00277-5; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Garza AS, 2009, LEUKEMIA RES, V33, P717, DOI 10.1016/j.leukres.2008.10.006; Greenstein S, 2002, CLIN CANCER RES, V8, P1681; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Jing DH, 2015, BLOOD, V125, P273, DOI 10.1182/blood-2014-05-576470; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Krstic MD, 1997, MOL CELL BIOL, V17, P3947, DOI 10.1128/MCB.17.7.3947; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Liu JZ, 2015, ONCOTARGET, V6, P43048, DOI 10.18632/oncotarget.5528; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Lynch JT, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-38; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Peng HM, 2012, MOL BIOSYST, V8, P1366, DOI 10.1039/c2mb05184b; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; Rajendran R, 2013, INT J ONCOL, V42, P1961, DOI 10.3892/ijo.2013.1907; Ramamoorthy S, 2016, RHEUM DIS CLIN N AM, V42, P15, DOI 10.1016/j.rdc.2015.08.002; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Skindersoe ME, 2012, CYTOM PART A, V81A, P430, DOI 10.1002/cyto.a.22032; Smith CCT, 2011, J CELL MOL MED, V15, P1797, DOI 10.1111/j.1582-4934.2011.01341.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramaniam MM, 2009, BBA-REV CANCER, V1796, P315, DOI 10.1016/j.bbcan.2009.07.004; Szczepanski MJ, 2011, HAEMATOL-HEMATOL J, V96, P1302, DOI 10.3324/haematol.2010.039743; Thompson EB, 2003, RECENT PROG HORM RES, V58, P175, DOI 10.1210/rp.58.1.175; Tian K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072303; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Tricot GJ, 2002, INT J HEMATOL, V76, P334, DOI 10.1007/BF03165279; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Zhang JP, 2000, CLIN EXP IMMUNOL, V122, P20, DOI 10.1046/j.1365-2249.2000.01344.x; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006	69	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178606	10.1371/journal.pone.0178606	http://dx.doi.org/10.1371/journal.pone.0178606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582465	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600027
J	Shi, JM; Li, X; Dong, M; Graham, M; Yadav, N; Liang, C				Shi, Jieming; Li, Xi; Dong, Min; Graham, Mitchell; Yadav, Nehul; Liang, Chun			JNSViewer-A JavaScript-based Nucleotide Sequence Viewer for DNA/RNA secondary structures	PLOS ONE			English	Article							STRUCTURE PREDICTION; WEB SERVER; RNA; DNA; TRANSCRIPTOME; IDENTIFICATION; CRUCIFORM; BINDING	Many tools are available for visualizing RNA or DNA secondary structures, but there is scarce implementation in JavaScript that provides seamless integration with the increasingly popular web computational platforms. We have developed JNSViewer, a highly interactive web service, which is bundled with several popular tools for DNA/RNA secondary structure prediction and can provide precise and interactive correspondence among nucleotides, dot-bracket data, secondary structure graphs, and genic annotations. In JNSViewer, users can perform RNA secondary structure predictions with different programs and settings, add customized genic annotations in GFF format to structure graphs, search for specific linear motifs, and extract relevant structure graphs of sub-sequences. JNSViewer also allows users to choose a transcript or specific segment of Arabidopsis thaliana genome sequences and predict the corresponding secondary structure. Popular genome browsers (i.e., JBrowse and BrowserGenome) were integrated into JNSViewer to provide powerful visualizations of chromosomal locations, genic annotations, and secondary structures. In addition, we used StructureFold with default settings to predict some RNA structures for Arabidopsis by incorporating in vivo high-throughput RNA structure profiling data and stored the results in our web server, which might be a useful resource for RNA secondary structure studies in plants. JNSViewer is available at http://bioinfolab.miamioh.edu/jnsviewer/index.html.	[Shi, Jieming; Li, Xi; Dong, Min; Graham, Mitchell; Yadav, Nehul; Liang, Chun] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Li, Xi] Guangxi Univ Nationalities, Coll Informat Sci & Engn, Nanning, Guangxi, Peoples R China; [Dong, Min] Xiamen Univ, Dept Automat, Xiamen, Fujian, Peoples R China	University System of Ohio; Miami University; Guangxi Minzu University; Xiamen University	Liang, C (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	liangc@miamioh.edu		Liang, Chun/0000-0003-1996-6027	NIGMS [1R15GM094732-01A1]; Committee on Faculty Research (CFR) program; Office for the Advancement of Research & Scholarship (OARS); Miami University	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Committee on Faculty Research (CFR) program; Office for the Advancement of Research & Scholarship (OARS); Miami University	This work is supported, in part, by NIGMS (1R15GM094732-01A1 to CL), and by Committee on Faculty Research (CFR) program, the Office for the Advancement of Research & Scholarship (OARS), Miami University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLERS T, 1995, J MOL BIOL, V252, P70, DOI 10.1006/jmbi.1994.0476; Auber D., 2006, J GRAPH ALGORITHMS A, V10, P329; Bellaousov S, 2013, NUCLEIC ACIDS RES, V41, pW471, DOI 10.1093/nar/gkt290; Blythe AJ, 2015, BIOCH BIOPHYS ACTA; Breaker RR, 1997, CURR OPIN CHEM BIOL, V1, P26, DOI 10.1016/S1367-5931(97)80105-6; Brown Miguel, 2013, Frontiers in Genetics, V4, P145, DOI 10.3389/fgene.2013.00145; Byun Y, 2009, BIOINFORMATICS, V25, P1435, DOI 10.1093/bioinformatics/btp252; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; CUENOUD B, 1995, NATURE, V375, P611, DOI 10.1038/375611a0; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Evers D, 1999, BIOINFORMATICS, V15, P32, DOI 10.1093/bioinformatics/15.1.32; Foley SW, 2015, CURR OPIN PLANT BIOL, V27, P36, DOI 10.1016/j.pbi.2015.05.021; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hecker N, 2013, BIOINFORMATICS, V29, P2941, DOI 10.1093/bioinformatics/btt496; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kwok CK, 2015, TRENDS BIOCHEM SCI, V40, P221, DOI 10.1016/j.tibs.2015.02.005; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Li F, 2012, PLANT CELL, V24, P4346, DOI 10.1105/tpc.112.104232; Li YF, 1999, P NATL ACAD SCI USA, V96, P2746, DOI 10.1073/pnas.96.6.2746; Liang XG, 2006, BIOPHYS J, V90, P2877, DOI 10.1529/biophysj.105.074104; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2015, MOL BIOSYST, V11, P1194, DOI 10.1039/c5mb00050e; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; MATHEWS DH, 2014, CURR PROTOC BIOINFOR, V46, DOI [DOI 10.1002/0471250953.BI1206S46, 10.1002/0471250953.bi1206s46]; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Narberhaus F, 2010, RNA BIOL, V7, P84, DOI 10.4161/rna.7.1.10501; Rouillard JM, 2003, NUCLEIC ACIDS RES, V31, P3057, DOI 10.1093/nar/gkg426; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Schmid-Burgk JL, 2015, NAT METHODS, V12, P1001, DOI 10.1038/nmeth.3615; Siegfried NA, 2014, NAT METHODS, V11, P959, DOI [10.1038/nmeth.3029, 10.1038/NMETH.3029]; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Sloma MF, 2015, METHOD ENZYMOL, V553, P91, DOI 10.1016/bs.mie.2014.10.053; Sreedhara A, 2004, J AM CHEM SOC, V126, P3454, DOI 10.1021/ja039713i; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Tang Y, 2015, BIOINFORMATICS, V31, P2668, DOI 10.1093/bioinformatics/btv213; Tyrrell J, 2013, BIOCHEMISTRY-US, V52, P8777, DOI 10.1021/bi401207q; Vandivier LE, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24301; Wan Y, 2014, NATURE, V505, P706, DOI 10.1038/nature12946; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Waugh A, 2002, RNA, V8, P707, DOI 10.1017/S1355838202028017; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Yan K, 2016, INT J MOL SCI, P17; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0179040	10.1371/journal.pone.0179040	http://dx.doi.org/10.1371/journal.pone.0179040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582416	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600070
J	Beck, SC; Feng, YX; Sothilingam, V; Garrido, MG; Tanimoto, N; Acar, N; Shan, SL; Seebauer, B; Berger, W; Hammes, HP; Seeliger, MW				Beck, Susanne C.; Feng, Yuxi; Sothilingam, Vithiyanjali; Garrido, Marina Garcia; Tanimoto, Naoyuki; Acar, Niyazi; Shan, Shenliang; Seebauer, Britta; Berger, Wolfgang; Hammes, Hans-Peter; Seeliger, Mathias W.			Long-term consequences of developmental vascular defects on retinal vessel homeostasis and function in a mouse model of Norrie disease	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; PERICYTE MIGRATION; HYPOXIA; ANGIOGENESIS; GENE; PREMATURITY	Loss of Norrin signalling due to mutations in the Norrie disease pseudoglioma gene causes severe vascular defects in the retina, leading to visual impairment and ultimately blindness. While the emphasis of experimental work so far was on the developmental period, we focus here on disease mechanisms that induce progression into severe adult disease. The goal of this study was the comprehensive analysis of the long-term effects of the absence of Norrin on vascular homeostasis and retinal function. In a mouse model of Norrie disease retinal vascular morphology and integrity were studied by means of in vivo angiography; the vascular constituents were assessed in detailed histological analyses using quantitative retinal morphometry. Finally, electroretinographic analyses were performed to assess the retinal function in adult Norrin deficient animals. We could show that the primary developmental defects not only persisted but developed into further vascular abnormalities and microangio-pathies. In particular, the overall vessel homeostasis, the vascular integrity, and also the cellular constituents of the vascular wall were affected in the adult Norrin deficient retina. Moreover, functional analyses indicated to persistent hypoxia in the neural retina which was suggested as one of the major driving forces of disease progression. In summary, our data provide evidence that the key to adult Norrie disease are ongoing vascular modifications, driven by the persistent hypoxic conditions, which are ineffective to compensate for the primary Norrin-dependent defects.	[Beck, Susanne C.; Sothilingam, Vithiyanjali; Garrido, Marina Garcia; Tanimoto, Naoyuki; Acar, Niyazi; Seeliger, Mathias W.] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Feng, Yuxi; Shan, Shenliang] Heidelberg Univ, Med Fac Mannheim, Inst Expt & Clin Pharmacol & Toxicol, Mannheim, Germany; [Seebauer, Britta; Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Berger, Wolfgang] ETH, Zurich, Switzerland; [Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Dept Med 5, Mannheim, Germany; [Acar, Niyazi] Univ Bourgogne, Ctr Sci Gout & Alimentat, CNRS, Eye & Nutr Res Grp,UMR1324,UMR6265, Dijon, France	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne	Beck, SC (corresponding author), Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany.	su.beck@uni-tuebingen.de	Hammes, Hans-Peter/S-3719-2019		Deutsche Forschungsgemeinschaft [Se837/6-2, Ha1755/10-1, GRK 1874]; European Foundation for the Study of Diabetes; Open Access Publishing Fund of University of Tuebingen; Deutsche Forschungsgemeinschaft; European Foundation for the Study of Diabetes [Nov 2014_3] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Foundation for the Study of Diabetes; Open Access Publishing Fund of University of Tuebingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Foundation for the Study of Diabetes	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grant number Se837/6-2, grant number Ha1755/10-1 and GRK 1874) and the European Foundation for the Study of Diabetes [https://www.easd.ord. The publication was supported by Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 1996, HUM MOL GENET, V5, P51, DOI 10.1093/hmg/5.1.51; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; Black GCM, 1999, HUM MOL GENET, V8, P2031, DOI 10.1093/hmg/8.11.2031; BRINCHMANN-HANSEN O, 1989, Eye (London), V3, P768; Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; Kowluru RA, 2004, DIABETES, V53, P3233, DOI 10.2337/diabetes.53.12.3233; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; Pearce WJ, 2006, ADV EXP MED BIOL, V578, P87; PETTIGREW JD, 1990, NATURE, V343, P362, DOI 10.1038/343362a0; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Pfister F, 2013, PFLUG ARCH EUR J PHY, V465, P789, DOI 10.1007/s00424-013-1272-6; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Ruether K, 1997, INVEST OPHTH VIS SCI, V38, P710; Sapieha P, 2010, J CLIN INVEST, V120, P3022, DOI 10.1172/JCI42142; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015; Shortt AJ, 2004, J ANAT, V205, P349, DOI 10.1111/j.0021-8782.2004.00351.x; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tanimoto N, 2016, ADV EXP MED BIOL, V854, P619, DOI 10.1007/978-3-319-17121-0_82; Tanimoto Naoyuki, 2013, Methods Mol Biol, V935, P69, DOI 10.1007/978-1-62703-080-9_4; TAZAWA Y, 1972, INVEST OPHTH VISUAL, V11, P691; Tipoe George L., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P199, DOI 10.2174/187152506777698290; Valdez CN, 2014, AM J PATHOL, V184, P2618, DOI 10.1016/j.ajpath.2014.06.011; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; WARBURG M, 1975, ACTA OPHTHALMOL, V53, P217; WIEDMAN M, 1975, ARCH OPHTHALMOL-CHIC, V93, P401; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zuercher J, 2012, HUM MOL GENET, V21, P2619, DOI 10.1093/hmg/dds087	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178753	10.1371/journal.pone.0178753	http://dx.doi.org/10.1371/journal.pone.0178753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575130	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000402624300107
J	Hsieh, YH; Huang, YJ; Zhang, H; Liu, Q; Lu, Y; Yang, H; Houghton, J; Jiang, C; Sui, SF; Tai, PC				Hsieh, Ying-hsin; Huang, Ying-ju; Zhang, Hao; Liu, Qian; Lu, Yang; Yang, Hsiuchin; Houghton, John; Jiang, Chun; Sui, Sen-Fang; Tai, Phang C.			Dissecting structures and functions of SecA-only protein-conducting channels: ATPase, pore structure, ion channel activity, protein translocation, and interaction with SecYEG/SecDF center dot YajC	PLOS ONE			English	Article							ESCHERICHIA-COLI SECA; SIGNAL-PEPTIDE-SPECIFICITY; BACTERIAL PROTEIN; IN-VITRO; PREPROTEIN TRANSLOCATION; PRECURSOR PROTEINS; MEMBRANE INSERTION; SECRETORY PROTEINS; STATIONARY-PHASE; INNER MEMBRANE	SecA is an essential protein in the major bacterial Sec-dependent translocation pathways. E. coli SecA has 901 aminoacyl residues which form multi-functional domains that interact with various ligands to impart function. In this study, we constructed and purified tethered C-terminal deletion fragments of SecA to determine the requirements for N-terminal domains interacting with lipids to provide ATPase activity, pore structure, ion channel activity, protein translocation and interactions with SecYEG-SecDF center dot YajC. We found that the N-terminal fragment SecAN493 (SecA(1-493)) has low, intrinsic ATPase activity. Larger fragments have greater activity, becoming highest around N619-N632. Lipids greatly stimulated the ATPase activities of the fragments N608-N798, reaching maximal activities around N619. Three helices in amino-acyl residues SecA(619-831), which includes the "Helical Scaffold" Domain (SecA(619-668)) are critical for pore formation, ion channel activity, and for function with SecYEG-SecDF center dot YajC. In the presence of liposomes, N-terminal domain fragments of SecA form pore-ring structures at fragment-size N640, ion channel activity around N798, and protein translocation capability around N831. SecA domain fragments ranging in size between N643-N669 are critical for functional interactions with SecYEG-SecDF center dot YajC. In the presence of liposomes, inactive C-terminal fragments complement smaller non-functional N-terminal fragments to form SecA-only pore structures with ion channel activity and protein translocation ability. Thus, SecA domain fragment interactions with liposomes defined critical structures and functional aspects of SecA-only channels. These data provide the mechanistic basis for SecA to form primitive, low-efficiency, SecA-only protein-conducting channels, as well as the minimal parameters for SecA to interact functionally with SecYEG-SecDF center dot YajC to form high-efficiency channels.	[Hsieh, Ying-hsin; Huang, Ying-ju; Zhang, Hao; Liu, Qian; Lu, Yang; Yang, Hsiuchin; Houghton, John; Jiang, Chun; Tai, Phang C.] Georgia State Univ, Dept Biol, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, State Key Lab Membrane Biol, Beijing, Peoples R China	University System of Georgia; Georgia State University; Tsinghua University	Tai, PC (corresponding author), Georgia State Univ, Dept Biol, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA.	biopct@gsu.edu			NIH [GM34766, AI104168]; NSFC [31230016, 31370717]; Georgia State University internal funding, from Molecular Basis of Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI104168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); Georgia State University internal funding, from Molecular Basis of Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by NIH grants GM34766 and AI104168, and by NSFC 31230016 and 31370717 (to SFS). This work was also supported by Georgia State University internal funding, including fellowships from Molecular Basis of Diseases.	Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; ARKOWITZ RA, 1994, EMBO J, V13, P954, DOI 10.1002/j.1460-2075.1994.tb06340.x; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1987, NATURE, V328, P164, DOI 10.1038/328164a0; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; Dalal K, 2009, EMBO REP, V10, P762, DOI 10.1038/embor.2009.87; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Das S, 2008, J BACTERIOL, V190, P7302, DOI 10.1128/JB.00593-08; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Ding HY, 2003, BIOCHEMISTRY-US, V42, P13468, DOI 10.1021/bi035099b; Ding HY, 2001, BIOCHEMISTRY-US, V40, P1835, DOI 10.1021/bi002058w; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Floyd JH, 2014, BIOCHEM BIOPH RES CO, V453, P138, DOI 10.1016/j.bbrc.2014.09.080; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hsieh YH, 2015, ANAL BIOCHEM, V480, P58, DOI 10.1016/j.ab.2015.04.005; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Hu HJ, 2007, IEEE T NANOBIOSCI, V6, P168, DOI 10.1109/TNB.2007.897486; Huang YJ, 2012, CHEMMEDCHEM, V7, P571, DOI 10.1002/cmdc.201100594; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jilaveanu LB, 2006, J BACTERIOL, V188, P335, DOI 10.1128/JB.188.1.335-338.2006; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Keller RCA, 2011, CELL MOL BIOL LETT, V16, P40, DOI 10.2478/s11658-010-0036-y; KIM YJ, 1994, CELL, V78, P845; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Lin BR, 2006, J MEMBRANE BIOL, V214, P103, DOI 10.1007/s00232-006-0079-1; Lin BR, 2012, J MEMBRANE BIOL, V245, P747, DOI 10.1007/s00232-012-9477-8; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Mao CF, 2013, P NATL ACAD SCI USA, V110, P11815, DOI 10.1073/pnas.1303289110; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Nakatogawa H, 2000, J BIOL CHEM, V275, P33209, DOI 10.1074/jbc.C000550200; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; OLIVER DB, 1982, J BACTERIOL, V150, P686, DOI 10.1128/JB.150.2.686-691.1982; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2004, EMBO REP, V5, P807, DOI 10.1038/sj.embor.7400206; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; POGLIANO JA, 1994, EMBO J, V13, P554, DOI 10.1002/j.1460-2075.1994.tb06293.x; Price A, 1996, J BIOL CHEM, V271, P31580, DOI 10.1074/jbc.271.49.31580; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; SILHAVY TJ, 1983, METHOD ENZYMOL, V97, P11; Singh R, 2014, J BIOL CHEM, V289, P7190, DOI 10.1074/jbc.M113.506634; Snyders S, 1997, J BIOL CHEM, V272, P11302; TAI PC, 1991, METHOD CELL BIOL, V34, P167; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; Wang HY, 2008, J BACTERIOL, V190, P1413, DOI 10.1128/JB.01633-07; Wang HY, 2014, BIOCHEM BIOPH RES CO, V447, P250, DOI 10.1016/j.bbrc.2014.03.116; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; WATANABE M, 1990, P NATL ACAD SCI USA, V87, P1960, DOI 10.1073/pnas.87.5.1960; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Yang CK, 2013, CURR MICROBIOL, V67, P682, DOI 10.1007/s00284-013-0421-7; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Yang YB, 1997, J BIOL CHEM, V272, P13660, DOI 10.1074/jbc.272.21.13660; Yang YB, 1997, J BACTERIOL, V179, P7386, DOI 10.1128/jb.179.23.7386-7393.1997; You ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072560; Zhang H, 2013, BIOCHEM BIOPH RES CO, V437, P212, DOI 10.1016/j.bbrc.2013.06.039; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	79	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178307	10.1371/journal.pone.0178307	http://dx.doi.org/10.1371/journal.pone.0178307			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575061	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300038
J	Schofield, JS; Schoepp, KR; Williams, HE; Carey, JP; Marasco, PD; Hebert, JS				Schofield, Jonathon S.; Schoepp, Katherine R.; Williams, Heather E.; Carey, Jason P.; Marasco, Paul D.; Hebert, Jacqueline S.			Characterization of interfacial socket pressure in transhumeral prostheses: A case series	PLOS ONE			English	Article								One of the most important factors in successful upper limb prostheses is the socket design. Sockets must be individually fabricated to arrive at a geometry that suits the user's morphology and appropriately distributes the pressures associated with prosthetic use across the residual limb. In higher levels of amputation, such as transhumeral, this challenge is amplified as prosthetic weight and the physical demands placed on the residual limb are heightened. Yet, in the upper limb, socket fabrication is largely driven by heuristic practices. An analytical understanding of the interactions between the socket and residual limb is absent in literature. This work describes techniques, adapted from lower limb prosthetic research, to empirically characterize the pressure distribution occurring between the residual limb and well-fit transhumeral prosthetic sockets. A case series analyzing the result of four participants with transhumeral amputation is presented. A Tekscan VersaTek pressure measurement system and FaroArm Edge coordinate measurement machine were employed to capture socket-residual limb interface pressures and geometrically register these values to the anatomy of participants. Participants performed two static poses with their prosthesis under two separate loading conditions. Surface pressure maps were constructed from the data, highlighting pressure distribution patterns, anatomical locations bearing maximum pressure, and the relative pressure magnitudes. Pressure distribution patterns demonstrated unique characteristics across the four participants that could be traced to individual socket design considerations. This work presents a technique that implements commercially available tools to quantitatively characterize upper limb socket-residual limb interactions. This is a fundamental first step toward improved socket designs developed through informed, analytically-based design tools.	[Schofield, Jonathon S.; Williams, Heather E.; Carey, Jason P.] Univ Alberta, Dept Mech Engn, Fac Engn, Edmonton, AB, Canada; [Schoepp, Katherine R.; Hebert, Jacqueline S.] Univ Alberta, Fac Med & Dent, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Marasco, Paul D.] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44106 USA; [Marasco, Paul D.] Vet Affairs Med Ctr, Adv Platform Technol Ctr Excellence, Louis Stokes Cleveland Dept, Cleveland, OH USA; [Hebert, Jacqueline S.] Alberta Hlth Serv, Glenrose Rehabil Hosp, Edmonton, AB, Canada	University of Alberta; University of Alberta; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Alberta Health Services (AHS)	Hebert, JS (corresponding author), Univ Alberta, Fac Med & Dent, Div Phys Med & Rehabil, Edmonton, AB, Canada.; Hebert, JS (corresponding author), Alberta Hlth Serv, Glenrose Rehabil Hosp, Edmonton, AB, Canada.	jhebert@ualberta.ca	Hebert, Jacqueline/E-1881-2016; Williams, Heather E/AAD-2088-2019	Hebert, Jacqueline/0000-0003-0788-0568; Marasco, Paul/0000-0002-1689-7161	National Institutes of Health: Common Fund Transformative R01 Research [1R01NS081710-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081710] Funding Source: NIH RePORTER	National Institutes of Health: Common Fund Transformative R01 Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the National Institutes of Health: Common Fund Transformative R01 Research Award- 1R01NS081710-01 (primary holder: PDM).	Alley RD, 2011, J REHABIL RES DEV, V48, P679, DOI 10.1682/JRRD.2009.12.0197; [Anonymous], 2013, MEMEA 2013 IEEE INT; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss E, 2007, DISABIL REHABIL-ASSI, V2, P346, DOI 10.1080/17483100701714733; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Brenner CD., 2004, ATLAS AMPUTATION LIM, P223; Buis AWP, 1997, PROSTHET ORTHOT INT, V21, P179; Daly W., 2015, J PROSTHET ORTHOT, V26, P99; Dumbleton T, 2009, J REHABIL RES DEV, V46, P405, DOI 10.1682/JRRD.2008.01.0015; Heinemann AW, 2003, PROSTHET ORTHOT INT, V27, P191, DOI 10.1080/03093640308726682; Kahle JT, 2013, J REHABIL RES DEV, V50, P1241, DOI 10.1682/JRRD.2013.01.0003; Lake C., 2008, JPO J PROSTHET ORTHO, V20, P85, DOI [10.1097/JPO.0b013e31817d2f08, DOI 10.1097/JPO.0B013E31817D2F08]; Lake Chris, 2006, Phys Med Rehabil Clin N Am, V17, P49, DOI 10.1016/j.pmr.2005.10.004; McFarland LV, 2010, J REHABIL RES DEV, V47, P299, DOI 10.1682/JRRD.2009.03.0027; Pirouzi G, 2014, SCI WORLD J, DOI 10.1155/2014/849073; Polliack AA, 2000, PROSTHET ORTHOT INT, V24, P63, DOI 10.1080/03093640008726523; Resnik L, 2016, DISABIL REHABIL-ASSI, V11, P423, DOI 10.3109/17483107.2014.981876; Rogers B., 2008, JPO, V20, P1, DOI [10.1097/JPO.0b013e31815ea839, DOI 10.1097/JPO.0B013E31815EA839]; Sanders J., 2005, STUMP SOCKET INTERFA, P129; SANDERS JE, 1995, MED BIOL ENG COMPUT, V33, P509, DOI 10.1007/BF02522507; Schofield JS, 2016, J BIOMECH, V49, P786, DOI 10.1016/j.jbiomech.2016.01.022; Schultz AE, 2007, J REHABIL RES DEV, V44, P483, DOI 10.1682/JRRD.2006.08.0087; SilverThorn MB, 1996, J REHABIL RES DEV, V33, P253; Ziegler-Graham K, 2008, ARCH PHYS MED REHAB, V89, P422, DOI 10.1016/j.apmr.2007.11.005	24	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178517	10.1371/journal.pone.0178517	http://dx.doi.org/10.1371/journal.pone.0178517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575012	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300059
J	Singh, V; Singh, B; Joshi, R; Jaju, P; Pati, PK				Singh, Varinder; Singh, Baldev; Joshi, Robin; Jaju, Puneet; Pati, Pratap Kumar			Changes in the leaf proteome profile of Withania somnifera (L.) Dunal in response to Alternaria alternata infection	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; PHENYLALANINE AMMONIA-LYASE; RECALCITRANT PLANT-TISSUES; TRANSGENIC TOBACCO PLANTS; ABIOTIC STRESS; PSEUDOMONAS-SYRINGAE; DISEASE RESISTANCE; SPOT DISEASE; ARABIDOPSIS; EXTRACTION	Withania somnifera is a high value medicinal plant which is used against large number of ailments. The medicinal properties of the plant attributes to a wide array of important secondary metabolites. The plant is predominantly infected with leaf spot pathogen Alternaria alternata, which leads to substantial biodeterioration of pharmaceutically important metabolites. To develop an effective strategy to combat this disease, proteomics based approach could be useful. Hence, in the present study, three different protein extraction methods trisbuffer based, phenol based and trichloroacetic acid-acetone (TCA-acetone) based method were comparatively evaluated for two-dimensional electrophoresis (2-DE) analysis of W. somnifera. TCA-acetone method was found to be most effective and was further used to identify differentially expressed proteins in response to fungal infection. Thirty-eight differentially expressed proteins were identified by matrix assisted laser desorption/ionization time of flight-mass spectrometry (MALDI TOF/TOF MS/MS). The known proteins were categorized into eight different groups based on their function and maximum proteins belonged to energy and metabolism, cell structure, stress and defense and RNA/DNA categories. Differential expression of some key proteins were also crosschecked at transcriptomic level by using qRT-PCR and were found to be consistent with the 2-DE data. These outcomes enable us to evaluate modifications that take place at the proteomic level during a compatible host pathogen interaction. The comparative proteome analysis conducted in this paper revealed the involvement of many key proteins in the process of pathogenesis and further investigation of these identified proteins could assist in the discovery of new strategies for the development of pathogen resistance in the plant.	[Singh, Varinder; Singh, Baldev; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Joshi, Robin] CSIR, Inst Himalayan Bioresource Technol, Biotechnol Div, Palampur, Himachal Prades, India; [Jaju, Puneet] Biorad Labs India Pvt Ltd, Field Applicat Specialist Life Sci Grp, Bangalore, Karnataka, India	Guru Nanak Dev University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	pkpati@yahoo.com		pati, pratap/0000-0001-9017-7608	Life Science Group, Bio-rad Laboratories (India) Pvt. Ltd	Life Science Group, Bio-rad Laboratories (India) Pvt. Ltd	PJ received supporting in the form of a salary from Life Science Group, Bio-rad Laboratories (India) Pvt. Ltd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Agorio A, 2007, PLANT CELL, V19, P3778, DOI 10.1105/tpc.107.054494; Azevedo, 2009, WORLD C COMP AGR, P1; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Cheng LB, 2010, MOL BREEDING, V26, P1, DOI 10.1007/s11032-009-9371-y; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Dhar RS, 2012, J PLANT BIOCHEM BIOT, V21, P77, DOI 10.1007/s13562-011-0083-0; Dogra V, 2013, J PROTEOMICS, V78, P26, DOI 10.1016/j.jprot.2012.10.025; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Fan R, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-16; Faurobert Mireille, 2007, V355, P9; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GRANIER F, 1988, ELECTROPHORESIS, V9, P712, DOI 10.1002/elps.1150091106; Hao RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124723; Howles PA, 1996, PLANT PHYSIOL, V112, P1617, DOI 10.1104/pp.112.4.1617; Islam N, 2004, PROTEOMICS, V4, P1903, DOI 10.1002/pmic.200300816; Kaur D, 2015, PROTEOMICS, V15, P1291, DOI 10.1002/pmic.201400049; Kaur G, 2014, BIOTECHNOL ADV, V32, P551, DOI 10.1016/j.biotechadv.2014.02.002; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117559; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Laluk K, 2011, PLANT PHYSIOL, V156, P2053, DOI 10.1104/pp.111.177501; Liu D, 2013, MOL BIOL+, V47, P515, DOI 10.1134/S0026893313040109; LOOMIS WD, 1966, PHYTOCHEMISTRY, V5, P423, DOI 10.1016/S0031-9422(00)82157-3; Magdeldin S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-16; Maldonado AM, 2008, J PROTEOMICS, V71, P461, DOI 10.1016/j.jprot.2008.06.012; Mishra L C, 2000, Altern Med Rev, V5, P334; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Pomastowski P, 2014, TRAC-TREND ANAL CHEM, V53, P167, DOI 10.1016/j.trac.2013.09.010; Quecine MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145343; Rao B. R. R., 2012, Journal of Pharmacognosy, V3, P88; Sabir F, 2013, PROTOPLASMA, V250, P539, DOI 10.1007/s00709-012-0438-y; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sgherri C, 2002, PLANT PHYSIOL BIOCH, V40, P591, DOI 10.1016/S0981-9428(02)01421-3; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Sharma A, 2014, ANN APPL BIOL, V165, P429, DOI 10.1111/aab.12148; Sharma A, 2011, PHYTOPHARMACOL, V1, P54; Sharma P, 2010, ASSAM U J SCI TECHNO, V6, P37; Singh R, 2007, CHEM PHARM BULL, V55, P1371, DOI 10.1248/cpb.55.1371; Singh V, 2017, J APPL MICROBIOL, V122, P153, DOI 10.1111/jam.13314; Singh V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118860; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun CZ, 2014, J PROTEOMICS, V98, P15, DOI 10.1016/j.jprot.2013.11.028; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Takaoka S, 2014, NEW PHYTOL, V202, P1297, DOI 10.1111/nph.12754; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Wang N, 2016, FRONTIERS PLANT SCI, V7; Wang W, 2008, J SEP SCI, V31, P2032, DOI 10.1002/jssc.200800087; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Xu XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163368; Yuan H, 2012, PLANT J, V70, P432, DOI 10.1111/j.1365-313X.2011.04883.x; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zhang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122233; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178924	10.1371/journal.pone.0178924	http://dx.doi.org/10.1371/journal.pone.0178924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575108	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300131
J	Quan, NH; Sun, WQ; Wang, L; Chen, X; Bogan, JS; Zhou, XC; Cates, C; Liu, Q; Zheng, Y; Li, J				Quan, Nanhu; Sun, Wanqing; Wang, Lin; Chen, Xu; Bogan, Jonathan S.; Zhou, Xinchun; Cates, Courtney; Liu, Quan; Zheng, Yang; Li, Ji			Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism	FASEB JOURNAL			English	Article						aging; AMPK; glucose transport	ACTIVATED PROTEIN-KINASE; MYOCARDIAL-ISCHEMIA; GLUCOSE-UPTAKE; MITOCHONDRIAL BIOGENESIS; SIGNALING PATHWAY; ELDERLY-PATIENTS; SENESCENT HEART; SKELETAL-MUSCLE; IN-VIVO; AMPK	A novel stress-inducible protein, Sestrin2 (Sesn2), declines in the heart with aging. AMPK has emerged as a pertinent stress-activated kinase that has been shown to have cardioprotective capabilities against myocardial ischemic injury. We identified the interaction between Sesn2 and AMPK in the ischemic heart. To determine whether ischemic AMPK activation-modulated by the Sesn2-AMPK complex in the heart-is impaired in aging that sensitizes the heart to ischemic insults, young C57BL/6 mice (age 3-4 mo), middle-aged mice (age 10-12 mo), and aged mice (age 24-26 mo) were subjected to left anterior descending coronary artery occlusion for in vivo regional ischemia. The ex vivo working heart system was used for measuring substrate metabolism. The protein level of Sesn2 in hearts was gradually decreased with aging. Of interest, ischemic AMPK activation was blunted in aged hearts compared with young hearts (P < 0.05); the AMPK downstream glucose uptake and the rate of glucose oxidation were significantly impaired in aged hearts during ischemia and reperfusion (P < 0.05 vs. young hearts). Myocardial infarction size was larger in aged hearts (P < 0.05 vs. young hearts). Immunoprecipitation with Sesn2 Ab revealed that cardiac Sesn2 forms a complex with AMPK and upstream liver kinase B1 (LKB1) during ischemia. Of interest, the binding affinity between Sesn2 and AMPK upstream LKB1 is impaired in aged hearts during ischemia (P < 0.05 vs. young hearts). Furthermore, Sesn2-knockout hearts demonstrate a cardiac phenotype and response to ischemic stress that is similar to wild-type aged hearts (i.e., impaired ischemic AMPK activation and higher sensitivity to ischemia-and reperfusion-induced injury). Adeno-associated virus-Sesn2 was delivered to aged hearts via a coronary delivery approach and significantly rescued the protein level of Sesn2 and the ischemic tolerance of aged hearts; therefore, Sesn2 is a scaffold protein that mediates AMPK activation in the ischemic myocardium via an interaction with AMPK upstream LKB1. Decreased Sesn2 levels in aging lead to a blunted ischemic AMPK activation, alterations in substrate metabolism, and an increased sensitivity to ischemic insults	[Quan, Nanhu; Sun, Wanqing; Wang, Lin; Liu, Quan; Zheng, Yang] Jilin Univ, Hosp 1, Cardiovasc Ctr, Changchun 130000, Jilin, Peoples R China; [Quan, Nanhu; Sun, Wanqing; Wang, Lin; Chen, Xu; Cates, Courtney; Li, Ji] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Heart Res, G559 Guyton Res Bldg,2500 N State St, Jackson, MS 39216 USA; [Zhou, Xinchun] Univ Mississippi, Med Ctr, Dept Pathol, Inst Canc, Jackson, MS 39216 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, New Haven, CT 06510 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Jilin University; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Yale University; Yale University	Zheng, Y (corresponding author), Jilin Univ, Hosp 1, Cardiovasc Ctr, Changchun 130000, Jilin, Peoples R China.; Li, J (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Heart Res, G559 Guyton Res Bldg,2500 N State St, Jackson, MS 39216 USA.	zhengyang@jlu.edu.cn; jli3@umc.edu	Quan, Nanhu/AAC-8561-2020; Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	American Diabetes Association [1-17-IBS-296]; U.S. National Institutes of Health (NIH) National Institute on Aging [R21AG044820, R01AG049835]; NIH National Heart, Lung and Blood Institute [P01HL051971]; NIH National Institute of General Medical Sciences [P20GM104357]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01DK092661]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044820, R01AG049835] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health (NIH) National Institute on Aging; NIH National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Thomas Rousselle (Mississippi Center for Heart Research, University of Mississippi Medical Center) for contributions in performing substrate metabolism measurements and proofreading the manuscript. These studies were supported by American Diabetes Association Grant 1-17-IBS-296, U.S. National Institutes of Health (NIH) National Institute on Aging Grants R21AG044820 and R01AG049835, NIH National Heart, Lung and Blood Institute Grant P01HL051971, NIH National Institute of General Medical Sciences Grant P20GM104357, and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK092661. The authors declare no conflicts of interest.	Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Costa R, 2012, J THROMB HAEMOST, V10, P1736, DOI 10.1111/j.1538-7836.2012.04833.x; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Essler S, 2009, FEBS LETT, V583, P3531, DOI 10.1016/j.febslet.2009.10.017; Feng ZH, 2007, P NATL ACAD SCI USA, V104, P16633, DOI 10.1073/pnas.0708043104; Gonzalez AA, 2004, AM J PHYSIOL-REG I, V287, pR1270, DOI 10.1152/ajpregu.00409.2004; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Hue L, 2007, ESSAYS BIOCHEM, V43, P121, DOI 10.1042/bse0430121; JAEGER AA, 1994, J AM COLL CARDIOL, V24, P104, DOI 10.1016/0735-1097(94)90548-7; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; LINDSAY J, 1994, AM HEART J, V128, P697, DOI 10.1016/0002-8703(94)90267-4; Ma H, 2010, CIRCULATION, V122, P282, DOI 10.1161/CIRCULATIONAHA.110.953208; Ma YN, 2015, COMPR PHYSIOL, V5, P667, DOI 10.1002/cphy.c140041; Ma YN, 2015, THROMB HAEMOSTASIS, V113, P338, DOI 10.1160/TH14-04-0360; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Miller EJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1922, DOI 10.1152/ajpendo.00170.2006; Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814; Morrison A, 2011, AM J PHYSIOL-HEART C, V301, pH895, DOI 10.1152/ajpheart.00137.2011; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Moussa A, 2012, ACTA PHARM SIN B, V2, P368, DOI 10.1016/j.apsb.2012.06.001; Olson N, 2011, AM J PHYSIOL-LUNG C, V301, pL993, DOI 10.1152/ajplung.00250.2011; Ommen SR, 2000, CIRCULATION, V102, P1788; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Seo K, 2015, CELL SIGNAL, V27, P1533, DOI 10.1016/j.cellsig.2015.03.003; Shi XD, 2017, J CEREBR BLOOD F MET, V37, P1447, DOI 10.1177/0271678X16656201; Shi XD, 2016, NEUROBIOL DIS, V95, P111, DOI 10.1016/j.nbd.2016.07.016; Starnes JW, 1997, AGING-CLIN EXP RES, V9, P268, DOI 10.1007/BF03341829; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; STONE GW, 1995, J AM COLL CARDIOL, V25, P370, DOI 10.1016/0735-1097(94)00367-Y; SUN DQ, 1994, CIRCULATION, V89, P793, DOI 10.1161/01.CIR.89.2.793; Sun W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/9748378; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Tong C, 2013, FASEB J, V27, P4332, DOI 10.1096/fj.12-216473; Turdi S, 2010, AGING CELL, V9, P592, DOI 10.1111/j.1474-9726.2010.00586.x; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wang J, 2013, J THROMB HAEMOST, V11, P1020, DOI 10.1111/jth.12243; Wang J, 2011, J THROMB HAEMOST, V9, P1308, DOI 10.1111/j.1538-7836.2011.04331.x; Wang JY, 2013, CIRCULATION, V128, P225, DOI 10.1161/CIRCULATIONAHA.112.000862; Yang H, 2016, BIOCHEM PHARMACOL, V108, P47, DOI 10.1016/j.bcp.2016.03.019; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Young LH, 2008, CIRCULATION, V117, P832, DOI 10.1161/CIRCULATIONAHA.107.713115; Young LH, 1997, CIRCULATION, V95, P415; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	68	81	88	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4153	4167		10.1096/fj.201700063R	http://dx.doi.org/10.1096/fj.201700063R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28592638	Green Published			2022-12-26	WOS:000408713300037
J	Pirone, L; Ripoll-Rozada, J; Leone, M; Ronca, R; Lombardo, F; Fiorentino, G; Andersen, JF; Pereira, PJB; Arca, B; Pedone, E				Pirone, Luciano; Ripoll-Rozada, Jorge; Leone, Marilisa; Ronca, Raffaele; Lombardo, Fabrizio; Fiorentino, Gabriella; Andersen, John F.; Pereira, Pedro Jose Barbosa; Arca, Bruno; Pedone, Emilia			Functional analyses yield detailed insight into the mechanism of thrombin inhibition by the antihemostatic salivary protein cE5 from Anopheles gambiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme inhibitor; hemostasis; intrinsically disordered protein; protein-protein interaction; Anopheles; mosquito saliva	PEPTIDES; SEQUENCE; TRIFLUOROETHANOL; IDENTIFICATION; DATABASE; BINDING; CLONING; SYSTEM	Saliva of blood-feeding arthropods carries several antihemostatic compounds whose physiological role is to facilitate successful acquisition of blood. The identification of novel natural anticoagulants and the understanding of their mechanism of action may offer opportunities for designing new antithrombotics disrupting blood clotting. We report here an in-depth structural and functional analysis of the anophelin family member cE5, a salivary protein from the major African malaria vector Anopheles gambiae that specifically, tightly, and quickly binds and inhibits thrombin. Using calorimetry, functional assays, and complementary structural techniques, we show that the central region of the protein, encompassing amino acids Asp-31-Arg-62, is the region mainly responsible for -thrombin binding and inhibition. As previously reported for the Anopheles albimanus orthologue anophelin, cE5 binds both thrombin exosite I with segment Glu-35-Asp-47 and the catalytic site with the region Pro-49-Arg-56, which includes the highly conserved DPGR tetrapeptide. Moreover, the N-terminal Ala-1-Ser-30 region of cE5 (which includes an RGD tripeptide) and the additional C-terminal serine-rich Asn-63-Glu-82 region (absent in orthologues from anophelines of the New World species A. albimanus and Anopheles darlingi) also played some functionally relevant role. Indeed, we observed decreased thrombin binding and inhibitory properties even when using the central cE5 fragment (Asp-31-Arg-62) alone. In summary, these results shed additional light on the mechanism of thrombin binding and inhibition by this family of salivary anticoagulants from anopheline mosquitoes.	[Pirone, Luciano; Leone, Marilisa; Pedone, Emilia] CNR, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy; [Ripoll-Rozada, Jorge; Pereira, Pedro Jose Barbosa] Univ Porto, IBMC, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Ripoll-Rozada, Jorge; Pereira, Pedro Jose Barbosa] Univ Porto, Inst Invest & Inovacao Saude, Rua Alfredo Allen 208, P-4200135 Oporto, Portugal; [Ronca, Raffaele; Fiorentino, Gabriella] Univ Napoli Federico II, Dept Biol, Via Cinthia, I-80126 Naples, Italy; [Lombardo, Fabrizio; Arca, Bruno] Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Andersen, John F.] NIAID, NIH, Lab Malaria & Vector Res, Rockville, MD 20852 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; University of Naples Federico II; Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Pedone, E (corresponding author), CNR, Inst Biostruct & Bioimaging, Via Mezzocannone 16, I-80134 Naples, Italy.; Arca, B (corresponding author), Sapienza Univ Rome, Div Parasitol, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	bruno.arca@uniroma1.it; empedone@unina.it	Pereira, Pedro/F-8972-2011; Pirone, Luciano/ABG-2892-2020; Rozada, Jorge Ripoll/AAA-8049-2020; Ripoll Rozada, Jorge/L-1574-2016; Pedone, Emilia Maria/K-2229-2015; Pedone, Emilia/HDN-2342-2022; Lombardo, Fabrizio/J-8511-2014; FIORENTINO, Gabriella/E-2843-2017; Arca, Bruno/C-8383-2012	Pereira, Pedro/0000-0003-0969-5438; Pirone, Luciano/0000-0002-7014-4689; Rozada, Jorge Ripoll/0000-0001-7235-317X; Ripoll Rozada, Jorge/0000-0001-7235-317X; Pedone, Emilia Maria/0000-0003-0203-8611; Pedone, Emilia/0000-0003-0203-8611; Lombardo, Fabrizio/0000-0002-8563-0612; FIORENTINO, Gabriella/0000-0002-4089-3822; LEONE, MARILISA/0000-0002-3811-6960; Arca, Bruno/0000-0002-4029-0984	European Community [227764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012] Funding Source: NIH RePORTER	European Community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge J. M. C. Ribeiro for kindly providing the anophelin peptide, the European Synchrotron Radiation Facility (ESRF) for provision of synchrotron radiation facilities, and the ESRF staff for help with data collection. Transnational Access to the High Throughput Crystallization Laboratory of the European Molecular Biology Laboratory Grenoble Outstation was supported by the European Community-Seventh Framework Program (FP7/2007-2013) Grant Protein Production Platform (PCUBE Agreement 227764).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson VL, 2010, P NATL ACAD SCI USA, V107, P18850, DOI 10.1073/pnas.1012336107; Arca B, 1999, P NATL ACAD SCI USA, V96, P1516, DOI 10.1073/pnas.96.4.1516; Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8; Assumpcao TCF, 2012, TOXINS, V4, P296, DOI 10.3390/toxins4050296; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Contursi P, 2014, NUCLEIC ACIDS RES, V42, P5993, DOI 10.1093/nar/gku215; De Cristofaro R, 2003, J THROMB THROMBOLYS, V15, P151, DOI 10.1023/B:THRO.0000011370.80989.7b; de Paola I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121149; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueiredo AC, 2012, P NATL ACAD SCI USA, V109, pE3649, DOI 10.1073/pnas.1211614109; Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Gandhi PS, 2010, J BIOL CHEM, V285, P15393, DOI 10.1074/jbc.M110.115337; Goddard T. D., SPARKY 3; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Gruet A, 2016, FEBS J, V283, P576, DOI 10.1111/febs.13631; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Liu CC, 2007, J AM CHEM SOC, V129, P10648, DOI 10.1021/ja0735002; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Maestro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056904; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522; Pellecchia M, 2005, CHEM BIOL, V12, P961, DOI 10.1016/j.chembiol.2005.08.013; Potenza E, 2015, NUCLEIC ACIDS RES, V43, pD315, DOI 10.1093/nar/gku982; Raffler NA, 2003, CHEM BIOL, V10, P69, DOI 10.1016/S1074-5521(02)00309-5; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ronca R, 2012, INSECT BIOCHEM MOLEC, V42, P610, DOI 10.1016/j.ibmb.2012.04.008; Sharma R, 2015, FEBS LETT, V589, P2533, DOI 10.1016/j.febslet.2015.07.022; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stark KR, 1996, PARASITOL TODAY, V12, P430, DOI 10.1016/0169-4758(96)10064-8; Valenzuela JG, 1999, BIOCHEMISTRY-US, V38, P11209, DOI 10.1021/bi990761i; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams J W, 1979, Methods Enzymol, V63, P437; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zaccaro L, 2009, CURR MED CHEM, V16, P780, DOI 10.2174/092986709787549307	50	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12632	12642		10.1074/jbc.M117.788042	http://dx.doi.org/10.1074/jbc.M117.788042			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28592490	hybrid, Green Published			2022-12-26	WOS:000406636900027
J	Goldstein, JH; Tallis, H; Cole, A; Schill, S; Martin, E; Heiner, M; Paiz, MC; Aldous, A; Apse, C; Nickel, B				Goldstein, Joshua Howard; Tallis, Heather; Cole, Aaron; Schill, Steven; Martin, Erik; Heiner, Michael; Paiz, Marie-Claire; Aldous, Allison; Apse, Colin; Nickel, Barry			Spatial planning for a green economy: National-level hydrologic ecosystem services priority areas for Gabon	PLOS ONE			English	Article							LAND-USE; CONSERVATION	Rapidly developing countries contain both the bulk of intact natural areas and biodiversity, and the greatest untapped natural resource stocks, placing them at the forefront of "green" economic development opportunities. However, most lack scientific tools to create development plans that account for biodiversity and ecosystem services, diminishing the real potential to be sustainable. Existing methods focus on biodiversity and carbon priority areas across large geographies (e.g., countries, states/provinces), leaving out essential services associated with water supplies, among others. These hydrologic ecosystem services (HES) are especially absent from methods applied at large geographies and in data-limited contexts. Here, we present a novel, spatially explicit, and relatively simple methodology to identify countrywide HES priority areas. We applied our methodology to the Gabonese Republic, a country undergoing a major economic transformation under a governmental commitment to balance conservation and development goals. We present the first national-scale maps of HES priority areas across Gabon for erosion control, nutrient retention, and groundwater recharge. Priority sub-watersheds covered 44% of the country's extent. Only 3% of the country was identified as a priority area for all HES simultaneously, highlighting the need to conserve different areas for each different hydrologic service. While spatial tradeoffs occur amongst HES, we identified synergies with two other conservation values, given that 66% of HES priority areas intersect regions of above average area-weighted (by sub-watersheds) total forest carbon stocks and 38% intersect with terrestrial national parks. Considering implications for development, we identified HES priority areas overlapping current or proposed major roads, forestry concessions, and active mining concessions, highlighting the need for proactive planning for avoidance areas and compensatory offsets to mitigate potential conflicts. Collectively, our results provide insight into strategies to protect HES as part of Gabon's development strategy, while providing a replicable methodology for application to new scales, geographies, and policy contexts.	[Goldstein, Joshua Howard] Nature Conservancy, Off Chief Scientist, Ft Collins, CO 80522 USA; [Tallis, Heather] Nature Conservancy, Off Chief Scientist, Santa Cruz, CA USA; [Cole, Aaron; Nickel, Barry] Univ Calif Santa Cruz, Ctr Integrated Spatial Res, Santa Cruz, CA 95064 USA; [Schill, Steven] Nature Conservancy, Caribbean Program, Provo, UT USA; [Martin, Erik] Nature Conservancy, Eastern Conservat Team, Brunswick, ME USA; [Heiner, Michael] Nature Conservancy, Dev Design, Ft Collins, CO USA; [Paiz, Marie-Claire] Nature Conservancy, Gabon Country Program, Libreville, Gabon; [Aldous, Allison] Nature Conservancy, Oregon Program, Portland, OR USA; [Apse, Colin] Nature Conservancy, Africa Program, Portland, ME USA	Nature Conservancy; Nature Conservancy; University of California System; University of California Santa Cruz; Nature Conservancy; Nature Conservancy; Nature Conservancy	Goldstein, JH (corresponding author), Nature Conservancy, Off Chief Scientist, Ft Collins, CO 80522 USA.	jgoldstein@tnc.org	Martin, Erik/R-3693-2019; BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Schill, Steven R/0000-0002-9066-434X	Anne Ray Charitable Trust	Anne Ray Charitable Trust	Funding was provided by the Anne Ray Charitable Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are not aware of any competing interests on the part of the funder.	African Development Bank, 2011, REP GAB COUNTR STRAT; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], DEAC0500OR22725 LLC; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bhagabati NK, 2014, BIOL CONSERV, V169, P147, DOI 10.1016/j.biocon.2013.11.010; Bongo Ondimba A., 2012, GABON INVESTING FUTU; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; ESRI, 2018, ARCGIS DESKTOP RELEA; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Griggs D, 2013, NATURE, V495, P305, DOI 10.1038/495305a; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Guswa AJ, 2014, WATER RESOUR RES, V50, P4535, DOI 10.1002/2014WR015497; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hayes D.J., 2014, ENVTL L REP NEWS ANA, V44, P10016; International Finance Corporation, 2012, 6 INT FIN CORP; Kiesecker J, 2011, PLOS ONE, P6; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Mandle L, 2015, FRONT ECOL ENVIRON, V13, P309, DOI 10.1890/140337; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin D., 1981, SOLS GABON PEADOGENE; Mu Q, 2009, MOD16 GLOBAL TERREST; Natural Capital Project, 2014, RES INV OPT SYST RIO; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; OECD, 2012, STRAT TRANSP INFR NE; Polasky S, 2015, P NATL ACAD SCI USA, V112, P7356, DOI 10.1073/pnas.1406490112; Quetier F, 2011, BIOL CONSERV, V144, P2991, DOI 10.1016/j.biocon.2011.09.002; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saenz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081831; Sharp R, 2014, INVEST 3 0 1 US GUID; Sonter LJ, 2014, GLOBAL ENVIRON CHANG, V26, P63, DOI 10.1016/j.gloenvcha.2014.03.014; Tallis HT, 2012, UNU IHDP UNEP INCLUS, P195; Tanis H, 2015, ENVIRON IMPACT ASSES, V55, P21, DOI 10.1016/j.eiar.2015.06.005; The Biodiversity Consultancy, 2013, GOV POL BIOD OFFS; United Nations, 2014, WORLD STAT POCK; US Geological Survey and US Department of Agriculture Natural Resources Conservation Service. Federal standards and procedures for the national watershed boundary dataset (WBD), 2011, US GEOLOGICAL SURVEY, V11-A3; Verhegghen A, 2010, 3 RECENT ADV QUANTIT, P608; Vogl A., 2013, RESOURCE INVESTMENT; Vrieling A, 2014, GLOBAL PLANET CHANGE, V115, P33, DOI 10.1016/j.gloplacha.2014.01.009; World Resources Institute, 2013, GAB FOR ATL; WorldClim, CURR COND PREC 1950	46	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179008	10.1371/journal.pone.0179008	http://dx.doi.org/10.1371/journal.pone.0179008			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594870	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200078
J	Huang, KL; Zhang, ML; Ma, GJ; Wu, H; Wu, XM; Ren, F; Li, XB				Huang, Ke-Lin; Zhang, Mei-Li; Ma, Guang-Jing; Wu, Huan; Wu, Xiao-Ming; Ren, Feng; Li, Xue-Bao			Transcriptome profiling analysis reveals the role of silique in controlling seed oil content in Brassica napus	PLOS ONE			English	Article							OILSEED RAPE; TRIACYLGLYCEROL ACCUMULATION; DEVELOPMENTAL REGULATION; DEVELOPING EMBRYOS; EXPRESSION; GENE; MATURATION; METABOLISM; PROTEIN; PLANT	Seed oil content is an important agronomic trait in oilseed rape. However, the molecular mechanism of oil accumulation in rapeseeds is unclear so far. In this report, RNA sequencing technique (RNA-Seq) was performed to explore differentially expressed genes in siliques of two Brassica napus lines (HFA and LFA which contain high and low oil contents in seeds, respectively) at 15 and 25 days after pollination (DAP). The RNA-Seq results showed that 65746 and 66033 genes were detected in siliques of low oil content line at 15 and 25 DAP, and 65236 and 65211 genes were detected in siliques of high oil content line at 15 and 25 DAP, respectively. By comparative analysis, the differentially expressed genes (DEGs) were identified in siliques of these lines. The DEGs were involved in multiple pathways, including metabolic pathways, biosynthesis of secondary metabolic, photosynthesis, pyruvate metabolism, fatty metabolism, glycophospholipid metabolism, and DNA binding. Also, DEGs were related to photosynthesis, starch and sugar metabolism, pyruvate metabolism, and lipid metabolism at different developmental stage, resulting in the differential oil accumulation in seeds. Furthermore, RNA-Seq and qRT-PCR data revealed that some transcription factors positively regulate seed oil content. Thus, our data provide the valuable information for further exploring the molecular mechanism of lipid biosynthesis and oil accumulation in B. nupus.	[Huang, Ke-Lin; Zhang, Mei-Li; Ma, Guang-Jing; Wu, Huan; Ren, Feng; Li, Xue-Bao] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Wu, Xiao-Ming] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China	Central China Normal University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS	Ren, F; Li, XB (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	renfeng@mail.ccnu.edu.cn; xbli@mail.ccnu.edu.cn			Project of National Research and Development of China [2016YFD0100202]; National Natural Science Foundation of China [31271637, 31571572]	Project of National Research and Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project of National Research and Development of China (Grant No. 2016YFD0100202) and the National Natural Science Foundation of China (grant No. 31271637 and 31571572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Baud S, 2009, PLANT J, V60, P933, DOI 10.1111/j.1365-313X.2009.04011.x; Baud S, 2009, PLANT PHYSIOL BIOCH, V47, P448, DOI 10.1016/j.plaphy.2008.12.006; Bennett EJ, 2011, NEW PHYTOL, V190, P838, DOI 10.1111/j.1469-8137.2011.03714.x; Bourrellier ABF, 2010, P NATL ACAD SCI USA, V107, P502, DOI 10.1073/pnas.0910097107; Chen HY, 2015, J EXP BOT, V66, P2079, DOI 10.1093/jxb/erv010; Dekkers BJW, 2016, PLANT J, V85, P451, DOI 10.1111/tpj.13118; Dubousset L, 2010, J EXP BOT, V61, P4313, DOI 10.1093/jxb/erq233; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Ekman A, 2008, J EXP BOT, V59, P4247, DOI 10.1093/jxb/ern266; Fait A, 2006, PLANT PHYSIOL, V142, P839, DOI 10.1104/pp.106.086694; Fatihi A, 2016, PLANT SCI, V250, P198, DOI 10.1016/j.plantsci.2016.06.013; Fernandes FS, 2011, NUTRITION, V27, P1040, DOI 10.1016/j.nut.2010.11.001; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fu X, 2016, SCI CHINA LIFE SCI, V59, P516, DOI 10.1007/s11427-016-5021-x; Gao MJ, 2009, PLANT CELL, V21, P54, DOI 10.1105/tpc.108.061309; Goffman FD, 2005, PLANT PHYSIOL, V138, P2269, DOI 10.1104/pp.105.063628; Graef G, 2009, PLANT BIOTECHNOL J, V7, P411, DOI 10.1111/j.1467-7652.2009.00408.x; Guerriero G, 2009, NEW PHYTOL, V184, P552, DOI 10.1111/j.1469-8137.2009.02977.x; Hill LM, 2003, PLANT PHYSIOL, V131, P228, DOI 10.1104/pp.010868; Hofvander P, 2016, PLANT BIOTECHNOL J, V14, P1883, DOI 10.1111/pbi.12550; Hua SJ, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-34; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Jin J, 2015, ANN BOT-LONDON, V116, P987, DOI 10.1093/aob/mcv088; Kim HU, 2015, PLANT BIOTECHNOL J, V13, P1346, DOI 10.1111/pbi.12354; Kumar A, 2016, CURR GENOMICS, V17, P230, DOI 10.2174/1389202917666160202220107; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li-Beisson Y., 2010, ARABIDOPSIS BOOK, V8, DOI [10.1199/tab.0161, DOI 10.1199/TAB.0133, 10.1199/tab.0133]; Lin L, 2013, NUTR REV, V71, P370, DOI 10.1111/nure.12033; Liu J, 2012, J EXP BOT, V63, P3727, DOI 10.1093/jxb/ers066; Ma W, 2015, PLANT J, V83, P864, DOI 10.1111/tpj.12933; Maeo K, 2009, PLANT J, V60, P476, DOI 10.1111/j.1365-313X.2009.03967.x; North H, 2010, PLANT J, V61, P971, DOI 10.1111/j.1365-313X.2009.04095.x; Roscoe TT, 2015, PLANT CELL PHYSIOL, V56, P1215, DOI 10.1093/pcp/pcv049; Rossato L, 2001, J EXP BOT, V52, P1655, DOI 10.1093/jexbot/52.361.1655; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schwender J, 2015, PLANT PHYSIOL, V168, P828, DOI 10.1104/pp.15.00385; Schwender J, 2006, J BIOL CHEM, V281, P34040, DOI 10.1074/jbc.M606266200; Shen Y, 2015, PLANT BIOTECHNOL J, V13, P811, DOI 10.1111/pbi.12315; Si P, 2003, AUST J AGR RES, V54, P397, DOI 10.1071/AR01203; Sreenivasulu N, 2013, ANNU REV PLANT BIOL, V64, P189, DOI 10.1146/annurev-arplant-050312-120215; Suzuki M, 2008, CURR OPIN PLANT BIOL, V11, P548, DOI 10.1016/j.pbi.2008.06.015; Tsukagoshi H, 2007, P NATL ACAD SCI USA, V104, P2543, DOI 10.1073/pnas.0607940104; Wallis JG, 2010, PLANT J, V61, P1092, DOI 10.1111/j.1365-313X.2010.04125.x; Wang XF, 2010, EUPHYTICA, V173, P17, DOI 10.1007/s10681-009-0062-x; White JA, 2009, PLANT PHYSIOL, V124, P1582; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Wu JG, 2006, GENET MOL BIOL, V29, P533, DOI 10.1590/S1415-47572006000300023; Yang P, 2012, THEOR APPL GENET, V125, P285, DOI 10.1007/s00122-012-1833-7; Zhang H, 2009, MOL PLANT, V2, P610, DOI 10.1093/mp/ssp027; Zhang LW, 2011, THEOR APPL GENET, V122, P21, DOI 10.1007/s00122-010-1419-1; Zhang M, 2016, PLANT J, V88, P95, DOI 10.1111/tpj.13233	55	5	6	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179027	10.1371/journal.pone.0179027	http://dx.doi.org/10.1371/journal.pone.0179027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594951	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200080
J	Besser, TE; Cassirer, EF; Potter, KA; Foreyt, WJ				Besser, Thomas E.; Cassirer, E. Frances; Potter, Kathleen A.; Foreyt, William J.			Exposure of bighorn sheep to domestic goats colonized with Mycoplasma ovipneumoniae induces sub-lethal pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISEASE; ASSOCIATION; CANADENSIS; FLOCKS	Background Bronchopneumonia is a population limiting disease of bighorn sheep (Ovis canadensis) that has been associated with contact with domestic Caprinae. The disease is polymicrobial but is initiated by Mycoplasma ovipneumoniae, which is commonly carried by both domestic sheep (O. aries) and goats (Capra aegagrus hircus). However, while previous bighorn sheep comingling studies with domestic sheep have resulted in nearly 100% pneumonia mortality, only sporadic occurrence of fatal pneumonia was reported from previous comingling studies with domestic goats. Here, we evaluated the ability of domestic goats of defined M. ovipneumoniae carriage status to induce pneumonia in comingled bighorn sheep. Methodology/Principal findings In experiment 1, three bighorn sheep naive to M. ovipneumoniae developed non-fatal respiratory disease (coughing, nasal discharge) following comingling with three naturally M. ovipneumoniae-colonized domestic goats. Gross and histological lesions of pneumonia, limited to small areas on the ventral and lateral edges of the anterior and middle lung lobes, were observed at necropsies conducted at the end of the experiment. A control group of three bighorn sheep from the same source housed in isolation during experiment 1 remained free of observed respiratory disease. In experiment 2, three bighorn sheep remained free of observed respiratory disease while comingled with three M. ovipneumoniae-free domestic goats. In experiment 3, introduction of a domestic goat-origin strain of M. ovipneumoniae to the same comingled goats and bighorn sheep used in experiment 2 resulted in clinical signs of respiratory disease (coughing, nasal discharge) in both host species. At the end of experiment 3, gross and histological evidence of pneumonia similar to that observed in experiment 1 bighorn sheep was observed in both affected bighorn sheep and domestic goats. Conclusions/Significance M. ovipneumoniae strains carried by domestic goats were transmitted to comingled bighorn sheep, triggering development of pneumonia. However, the severity of the disease was markedly milder than that seen in similar experiments with domestic sheep strains of the bacterium.	[Besser, Thomas E.; Potter, Kathleen A.; Foreyt, William J.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Cassirer, E. Frances] Idaho Dept Fish & Game, Lewiston, ID USA	Washington State University	Besser, TE (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbesser@vetmed.wsu.edu		Besser, Thomas/0000-0003-0449-1989	Wild Sheep Foundation / Foundation for North American Wild Sheep	Wild Sheep Foundation / Foundation for North American Wild Sheep	Wild Sheep Foundation / Foundation for North American Wild Sheep Grant-in-Aid funding to T. Besser (https://www.wildsheepfoundation. org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 1999, NEW ZEAL VET J, V47, P155, DOI 10.1080/00480169.1999.36135; Bernatowicz J, 2016, P BIENN S N IN PRESS; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Besser TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110039; Besser TE, 2013, PREV VET MED, V108, P85, DOI 10.1016/j.prevetmed.2012.11.018; Besser TE, 2012, EMERG INFECT DIS, V18, P406, DOI 10.3201/eid1803.111554; Besser TE, 2012, J WILDLIFE DIS, V48, P168, DOI 10.7589/0090-3558-48.1.168; Cassirer E.F., 1996, BIENN S NO WILD SHEE, V10, P78; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Cassirer EF, 2017, J WILDLIFE MANAGE, V81, P133, DOI 10.1002/jwmg.21172; Cassirer EF, 2013, J ANIM ECOL, V82, P518, DOI 10.1111/1365-2656.12031; Foreyt W.J., 1994, P BIENN S NO WILD SH, V9, P7; Foreyt WJ, 2009, J WILDLIFE DIS, V45, P272, DOI 10.7589/0090-3558-45.2.272; FOREYT WJ, 1982, J WILDLIFE DIS, V18, P163, DOI 10.7589/0090-3558-18.2.163; George JL, 2008, J WILDLIFE DIS, V44, P388, DOI 10.7589/0090-3558-44.2.388; Goncalves R, 2010, VET J, V183, P219, DOI 10.1016/j.tvjl.2008.10.005; Goodson N. J., 1982, P BIENN S NO WILD SH, V3, P287; Heinse LM, 2016, WILDLIFE SOC B, V40, P625, DOI 10.1002/wsb.718; Lawrence PK, 2010, J WILDLIFE DIS, V46, P1346; Maksimovic Z, 2017, VET REC, V180, DOI 10.1136/vr.103699; Manlove K, 2016, ECOLOGY, V97, P2593, DOI 10.1002/ecy.1520; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Niang M, 1998, AM J VET RES, V59, P557; Nicholas R, 2008, MYCOPLASMA DISEASES OF RUMINANTS, P1, DOI 10.1079/9780851990125.0000; Rifatbegovic M, 2011, VET REC, V168, DOI 10.1136/vr.d886; Roug A, 2017, J WILDLIFE DIS, V53, P188, DOI 10.7589/2016-03-061; Rudolph KM, 2003, J WILDLIFE DIS, V39, P897, DOI 10.7589/0090-3558-39.4.897; RYDER TJ, 1992, P BIENN S NO WILD SH, V8, P136; Shanthalingam S, 2014, J WILDLIFE DIS, V50, P1, DOI 10.7589/2012-09-225; SPRAKER T R, 1984, Journal of Wildlife Diseases, V20, P319; Walsh DP, 2016, WILDLIFE SOC B, V40, P634, DOI 10.1002/wsb.721; Ziegler JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095698	32	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178707	10.1371/journal.pone.0178707	http://dx.doi.org/10.1371/journal.pone.0178707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591169	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700044
J	V-Ghaffari, B; Kouhnavard, M; Elbasiouny, SM				V-Ghaffari, Babak; Kouhnavard, M.; Elbasiouny, Sherif M.			Mixed-mode oscillations in pyramidal neurons under antiepileptic drug conditions	PLOS ONE			English	Article							MEMBRANE-POTENTIAL OSCILLATIONS; PERSISTENT SODIUM CURRENT; ENTORHINAL CORTEX; SUBTHRESHOLD OSCILLATIONS; FREQUENCY PREFERENCES; RESONANT BEHAVIOR; CALCIUM-CHANNELS; CORTICAL-NEURONS; STELLATE CELLS; LAYER II	Subthreshold oscillations in combination with large-amplitude oscillations generate mixed-mode oscillations (MMOs), which mediate various spatial and temporal cognition and memory processes and behavioral motor tasks. Although many studies have shown that canard theory is a reliable method to investigate the properties underlying the MMOs phenomena, the relationship between the results obtained by applying canard theory and conductance-based models of neurons and their electrophysiological mechanisms are still not well understood. The goal of this study was to apply canard theory to the conductance-based model of pyramidal neurons in layer V of the Entorhinal Cortex to investigate the properties of MMOs under antiepileptic drug conditions (i.e., when persistent sodium current is inhibited). We investigated not only the mathematical properties of MMOs in these neurons, but also the electrophysiological mechanisms that shape spike clustering. Our results show that pyramidal neurons can display two types of MMOs and the magnitude of the slow potassium current determines whether MMOs of type I or type II would emerge. Our results also indicate that slow potassium currents with large time constant have significant impact on generating the MMOs, as opposed to fast inward currents. Our results provide complete characterization of the subthreshold activities in MMOs in pyramidal neurons and provide explanation to experimental studies that showed MMOs of type I or type II in pyramidal neurons under antiepileptic drug conditions.	[V-Ghaffari, Babak; Elbasiouny, Sherif M.] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, Dayton, OH 45435 USA; [V-Ghaffari, Babak; Elbasiouny, Sherif M.] Wright State Univ, Coll Sci & Math, Dayton, OH 45435 USA; [Kouhnavard, M.] Univ Technol Malaysia, Malaysia Japan Int Inst Tech, Kuala Lumpur, Malaysia; [Elbasiouny, Sherif M.] Wright State Univ, Dept Biomed Ind & Human Factors Engn, Coll Engn & Comp Sci, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton; University System of Ohio; Wright State University Dayton; Universiti Teknologi Malaysia; University System of Ohio; Wright State University Dayton	V-Ghaffari, B; Elbasiouny, SM (corresponding author), Wright State Univ, Dept Neurosci Cell Biol & Physiol, Boonshoft Sch Med, Dayton, OH 45435 USA.; V-Ghaffari, B; Elbasiouny, SM (corresponding author), Wright State Univ, Coll Sci & Math, Dayton, OH 45435 USA.; Elbasiouny, SM (corresponding author), Wright State Univ, Dept Biomed Ind & Human Factors Engn, Coll Engn & Comp Sci, Dayton, OH 45435 USA.	babak.vazifehkhahghaffari@wright.edu; sherif.elbasiouny@wright.edu		Vazifehkhahghaffari, Babak/0000-0003-2845-7080; Vazifehkhah Ghaffari, Babak/0000-0002-0365-6748	National Institute of Neurological Disorders and Stroke [NS091836]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091836] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by the National Institute of Neurological Disorders and Stroke under award number NS091836. The project leader is Serif Elbasiouny [https:// projectreporter.nih.gov/reporter_searchresults.cfm].	Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; Agrawal N, 2001, NEUROSCIENCE, V102, P53, DOI 10.1016/S0306-4522(00)00455-3; ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Baroni F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003574; Bazzigaluppi P, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00091; Benoit E, 1981, COLLECT MATH, V31, P37; Brons M, 2006, FIELDS I COMMUN, V49, P39; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cain SM, 2013, BBA-BIOMEMBRANES, V1828, P1572, DOI 10.1016/j.bbamem.2012.07.028; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Choi S, 2010, J PHYSIOL-LONDON, V588, P3031, DOI 10.1113/jphysiol.2009.184705; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055329; del Negro CA, 1999, J NEUROPHYSIOL, V81, P1478, DOI 10.1152/jn.1999.81.4.1478; Desroches M, 2012, SIAM REV, V54, P211, DOI 10.1137/100791233; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Dickson CT, 2000, ANN NY ACAD SCI, V911, P127; Dong Y, 2003, J NEUROSCI, V23, P2686; Engel TA, 2008, J NEUROPHYSIOL, V100, P1576, DOI 10.1152/jn.01282.2007; Epstein IR, 1996, J PHYS CHEM-US, V100, P13132, DOI 10.1021/jp953547m; Ermentrout B, 2009, SIAM J APPL DYN SYST, V8, P253, DOI 10.1137/080724010; Ghaffari BV, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/135787; Golomb D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109205; Guckenheimer J, 2000, PHYSICA D, V139, P195, DOI 10.1016/S0167-2789(99)00225-0; GUTFREUND Y, 1995, J PHYSIOL-LONDON, V483, P621, DOI 10.1113/jphysiol.1995.sp020611; Harvey E, 2011, J NONLINEAR SCI, V21, P639, DOI 10.1007/s00332-011-9096-z; Hermann L, 1905, PFLUGERS ARCH EUROPE, V110, P254; Heys JG, 2010, J NEUROPHYSIOL, V104, P258, DOI 10.1152/jn.00492.2009; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Iglesias C, 2011, J NEUROSCI, V31, P5829, DOI 10.1523/JNEUROSCI.6363-10.2011; Jalics J, 2010, DYNAM SYST, V25, P445, DOI 10.1080/14689360903535760; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jones CKRT, 1995, LECT NOTES MATH, V1609, P44; KOPER MTM, 1995, PHYSICA D, V80, P72, DOI 10.1016/0167-2789(95)90061-6; Krupa M, 2010, J DIFFER EQUATIONS, V248, P2841, DOI 10.1016/j.jde.2010.02.006; Kuo JJ, 2006, J PHYSIOL-LONDON, V574, P819, DOI 10.1113/jphysiol.2006.107094; Lampl I, 1997, NEUROSCIENCE, V78, P325, DOI 10.1016/S0306-4522(96)00588-X; LARTER R, 1991, PHILOS T ROY SOC A, V337, P291, DOI 10.1098/rsta.1991.0124; Latorre R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145830; Lau T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018983; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Manuel M, 2011, J INTEGR NEUROSCI, V10, P243, DOI 10.1142/S0219635211002786; MAURO A, 1970, J GEN PHYSIOL, V55, P497, DOI 10.1085/jgp.55.4.497; Medvedev GS, 2004, PHYSICA D, V194, P333, DOI 10.1016/j.physd.2004.02.006; Milik A, MULTIPLE TIME SCALE, DOI [10.1007/978-1-4613-0117-2_5, DOI 10.1007/978-1-4613-0117-2_5]; Narayanan R, 2008, J NEUROSCI, V28, P5846, DOI 10.1523/JNEUROSCI.0835-08.2008; Narayanan R, 2007, NEURON, V56, P1061, DOI 10.1016/j.neuron.2007.10.033; Pezzoli M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06825; PUIL E, 1994, J NEUROPHYSIOL, V71, P575, DOI 10.1152/jn.1994.71.2.575; Reboreda A, 2003, J PHYSIOL-LONDON, V551, P191, DOI 10.1113/jphysiol.2003.039917; Richardson MJE, 2003, J NEUROPHYSIOL, V89, P2538, DOI 10.1152/jn.00955.2002; Rotstein H. G., 2013, ENCY COMPUTATIONAL N, P1, DOI [DOI 10.1007/978-1-4614-7320-6_31-1, 10.1007/978-1-4614-7320-6_31-1]; Rotstein HG, 2006, J COMPUT NEUROSCI, V21, P271, DOI 10.1007/s10827-006-8096-8; Rotstein HG, 2014, J COMPUT NEUROSCI, V37, P9, DOI 10.1007/s10827-013-0483-3; Rotstein HG, 2008, SIAM J APPL DYN SYST, V7, P1582, DOI 10.1137/070699093; Rubin J, 2007, BIOL CYBERN, V97, P5, DOI 10.1007/s00422-007-0153-5; Rubin J, 2008, CHAOS, V18, DOI 10.1063/1.2789564; Safiulina VF, 2008, J PHYSIOL-LONDON, V586, P5437, DOI 10.1113/jphysiol.2008.156257; Schmitz D, 1998, NEUROSCIENCE, V85, P999, DOI 10.1016/S0306-4522(98)00113-4; Stafstrom Carl E, 2007, Epilepsy Curr, V7, P15, DOI 10.1111/j.1535-7511.2007.00156.x; Teka W, 2011, J MATH NEUROSCI, V1, DOI 10.1186/2190-8567-1-12; Teka W, 2012, CHAOS, V22, DOI 10.1063/1.4766943; Tohidi V, 2009, J NEUROSCI, V6427, P6435, DOI DOI 10.1523/JNEUR0SCI.0545-09.2009; Toporikova N, 2008, NEURAL COMPUT, V20, P436, DOI 10.1162/neco.2007.08-06-310; Torben-Nielsen B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002580; Vera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085826; Verechtchaguina T, 2007, BIOSYSTEMS, V89, P63, DOI 10.1016/j.biosystems.2006.03.014; Vo T, 2014, J COMPUT NEUROSCI, V36, P259, DOI 10.1007/s10827-013-0470-8; Vo T, 2012, DISCRETE CONT DYN-A, V32, P2879, DOI 10.3934/dcds.2012.32.2879; Wechselberger M, 2005, SIAM J APPL DYN SYST, V4, P101, DOI 10.1137/030601995; Yoshida M, 2007, J NEUROPHYSIOL, V98, P2779, DOI 10.1152/jn.00033.2007; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975	79	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178244	10.1371/journal.pone.0178244	http://dx.doi.org/10.1371/journal.pone.0178244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591171	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700027
J	Davies-Tuck, ML; Davey, MA; Wallace, EM				Davies-Tuck, Miranda L.; Davey, Mary-Ann; Wallace, Euan M.			Maternal region of birth and stillbirth in Victoria, Australia 2000-2011: A retrospective cohort study of Victorian perinatal data	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; HIGH-INCOME COUNTRIES; GESTATIONAL-AGE; RISK-FACTORS; WOMEN; ETHNICITY; PREGNANCIES; OUTCOMES; WEIGHT; ONSET	Background There is growing evidence from high-income countries that maternal country of birth is a risk factor for stillbirth. We aimed to examine the association between maternal region of birth and stillbirth between 2000 and 2011 inclusive in Victoria, Australia. Methods Retrospective population based cohort study of all singleton births at 24 or more weeks gestational age from 2000-2011 in Victoria, Australia. Stillbirths due to termination of pregnancy, babies with congenital anomalies and Indigenous mothers were excluded. Main Outcome Measure: Stillbirth. Results Over the 12-year period there were 685,869 singleton births and 2299 stillbirths, giving an overall stillbirth rate of 3 . 4 per 1000 births. After adjustment for risk factors, compared to women born in Australia/New Zealand, women born in South Asia (aOR 1.27, 95% CI 1.01-1.53, p = 0.01), were more likely to have a stillbirth whereas women born in South East and East Asia were (aOR 0.60, (95% CI 0.49-0.72, p < 0.001) less likely to have a stillbirth. Additionally, the increasing rate of stillbirth as gestation length progressed began to rise earlier and more steeply in the South Asian compared to Australian/New Zealand born women. The following risk factors were also significantly associated with an increased odds of stillbirth in multivariate analyses: maternal age < 20 and 35 years and more, nulliparity, low socio-economic status, previous stillbirth, no ultrasound reported in 1 st trimester, pre-existing hypertension, antepartum haemorrhage and failure to detect growth restriction antenatally. Conclusion Maternal region of birth is an independent risk factor for stillbirth. Improvements in the rate of stillbirth, particularly late pregnancy stillbirth, are likely to be gained in high-income settings where clinical care is informed by maternal region of birth.	[Davies-Tuck, Miranda L.; Wallace, Euan M.] Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Davey, Mary-Ann; Wallace, Euan M.] Monash Univ, Sch Clin Sci, Dept Obstet & Gynaecol, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University	Davies-Tuck, ML (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.	Miranda.davies@hudson.org.au	Wallace, Euan M/K-6774-2015	Wallace, Euan M/0000-0002-4506-5233; Davies-Tuck, Miranda/0000-0003-1918-5538	Stillbirth Foundation of Australia; National Health and Medical Research Council of Australia; Victorian Governments' Operational Infrastructure	Stillbirth Foundation of Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Governments' Operational Infrastructure	MDT received support from the Stillbirth Foundation of Australia to undertake this project. MDT also receives support from the National Health and Medical Research Council of Australia Fellowship program. EW receives funding from the Victorian Governments' Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BMC PREGNANCY CHILDB, DOI DOI 10.1186/1471-2393-8-11; Balchin I, 2007, BRIT MED J, V334, P833, DOI 10.1136/bmj.39132.482025.80; Balchin I, 2011, OBSTET GYNECOL, V117, P828, DOI 10.1097/AOG.0b013e3182117a26; Barbour B, 2009, J BIOSOC SCI, V41, P505, DOI 10.1017/S0021932009003290; Carberry AE, 2014, COCHRANE DATABASE SY, V16; Dahlen HG, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-100; Davey MA, 2013, HEALTH INF MANAG J, V42, P12, DOI 10.1177/183335831304200301; de Bernis L, 2016, LANCET, V387, P703, DOI 10.1016/S0140-6736(15)00954-X; de Graaff EC, 2016, J MATERN-FETAL NEO M, V9, P1; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Drysdale H, 2012, MED J AUSTRALIA, V197, P278, DOI 10.5694/mja12.10125; Ekeus C, 2011, EUR J PUBLIC HEALTH, V21, P788, DOI 10.1093/eurpub/ckq200; Flenady V, 2016, LANCET, V387, P691, DOI 10.1016/S0140-6736(15)01020-X; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Flood MM, 2017, HLTH INFORM IN PRESS; Gardosi J, 2014, PUBLIC HEALTH, V128, P698, DOI 10.1016/j.puhe.2014.06.022; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gibson-Helm M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0392-0; Kazemier BM, 2014, BJOG-INT J OBSTET GY, V121, P1274, DOI 10.1111/1471-0528.12938; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; MacDonald TM, 2015, AUST NZ J OBSTET GYN, V55, P3, DOI 10.1111/ajo.12264; Maghsoudlou S, 2015, ACTA OBSTET GYN SCAN, V94, P1095, DOI 10.1111/aogs.12699; Manktelow BM, 2015, INFANT MORTALITY MOR; Manktelow BN, 2016, INFANT MORTALITY MOR; MCFADYEN IR, 1984, BRIT J OBSTET GYNAEC, V91, P968, DOI 10.1111/j.1471-0528.1984.tb03672.x; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Raleigh V S, 1990, Indian J Pediatr, V57, P551, DOI 10.1007/BF02726768; Ravelli ACJ, 2011, J EPIDEMIOL COMMUN H, V65, P696, DOI 10.1136/jech.2009.095406; Roberts CL, 1999, MED J AUST, V179; Sivarao S, 2002, PLACENTA, V23, P691, DOI 10.1053/plac.2002.0817; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith R, 2013, PLACENTA, V34, P310, DOI 10.1016/j.placenta.2013.01.015; Sovio U, 2015, LANCET, V386, P2089, DOI 10.1016/S0140-6736(15)00131-2; Steer PJ, 2015, BJOG-INT J OBSTET GY, V122, P464, DOI 10.1111/1471-0528.13170; UN, 2011, COMP MACR CONT REG G; VIEGAS OAC, 1995, J BIOSOC SCI, V27, P151, DOI 10.1017/S0021932000022665	36	39	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178727	10.1371/journal.pone.0178727	http://dx.doi.org/10.1371/journal.pone.0178727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586367	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700024
J	Borsodi, F; Culea, V; Langkammer, C; Khalil, M; Pirpamer, L; Quasthoff, S; Enzinger, C; Schmidt, R; Fazekas, F; Ropele, S				Borsodi, Florian; Culea, Valeriu; Langkammer, Christian; Khalil, Michael; Pirpamer, Lukas; Quasthoff, Stefan; Enzinger, Christian; Schmidt, Reinhold; Fazekas, Franz; Ropele, Stefan			Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis	PLOS ONE			English	Article							CORTICOSPINAL TRACT; DIFFUSION; ALS; TRACTOGRAPHY; BRAIN; DEGENERATION; PROGRESSION; PROFILE; LESIONS; BULBAR	Several quantitative magnetic resonance imaging (MRI) techniques have been proposed to investigate microstructural tissue changes in amyotrophic lateral sclerosis (ALS) including diffusion tensor imaging (DTI), magnetization transfer imaging, and R2* mapping. Here, in this study, we compared these techniques with regard to their capability for detecting ALS related white matter (WM) changes in the brain and their association with clinical findings. We examined 27 ALS patients and 35 age-matched healthy controls. MRI was performed at 3T, after which we analyzed the diffusion properties, the magnetization transfer ratio (MTR), and the effective transversal relaxation rate R2* in 18 WM tracts that were obtained by a fully automated segmentation technique. ALS patients, especially with a bulbar onset, showed a bilateral increase in radial and mean diffusivity, as well as a reduction in fractional anisotropy of the corticospinal tract (CST), and diffusion changes in the parietal and temporal superior longitudinal fasciculus. A reduction of the MTR was found in both CSTs and an R2* reduction was seen only in the left CST. Tract-specific diffusion properties were not related to clinical status in a cross-sectional manner but demonstrated some association with disease progression over three subsequent months. DTI reveals more widespread WM tissue changes than MTR and R2*. These changes are not restricted to the CST, but affect also other WM tracts (especially in patients with bulbar onset), and are associated with the short term course of the disease.	[Borsodi, Florian; Culea, Valeriu; Langkammer, Christian; Khalil, Michael; Pirpamer, Lukas; Quasthoff, Stefan; Enzinger, Christian; Schmidt, Reinhold; Fazekas, Franz; Ropele, Stefan] Med Univ Graz, Dept Neurol, Graz, Austria; [Enzinger, Christian] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria	Medical University of Graz; Medical University of Graz	Ropele, S (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	stefan.ropele@medunigraz.at	Langkammer, Christian/AAC-9044-2020; Schmidt, Reinhold/E-1137-2014	Langkammer, Christian/0000-0002-7097-9707; Khalil, Michael/0000-0002-5350-3328	Austrian Science Fund (FWF project) [P23576-B18]	Austrian Science Fund (FWF project)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF project P23576-B18, SR). www.fwf.ac.at.	Agosta F, 2010, AM J NEURORADIOL, V31, P1457, DOI 10.3174/ajnr.A2105; Bastin ME, 2013, J MAGN RESON IMAGING, V38, P1140, DOI 10.1002/jmri.24073; Beeldman E, 2016, J NEUROL NEUROSUR PS, V87, P611, DOI 10.1136/jnnp-2015-310734; Bender B, 2010, NMR BIOMED, V23, P1071, DOI 10.1002/nbm.1534; Blain CRV, 2011, J NEUROL NEUROSUR PS, V82, P843, DOI 10.1136/jnnp.2010.236018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cardenas-Blanco A, 2014, J NEUROL, V261, P1961, DOI 10.1007/s00415-014-7434-4; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Charil A, 2009, AMYOTROPH LATERAL SC, V10, P269, DOI 10.3109/17482960902777339; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Cosottini M, 2011, AM J NEURORADIOL, V32, P704, DOI 10.3174/ajnr.A2356; da Rocha AJ, 2012, ARQ NEURO-PSIQUIAT, V70, P532, DOI 10.1590/S0004-282X2012000700012; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hartung V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104894; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Ignjatovic A, 2013, J MAGN RESON IMAGING, V38, P1472, DOI 10.1002/jmri.24121; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kato Y, 1997, AM J NEURORADIOL, V18, P1541; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241; Langkammer C, 2010, J MAGN RESON IMAGING, V31, P1339, DOI 10.1002/jmri.22185; Lloyd CM, 2000, BRAIN, V123, P2289, DOI 10.1093/brain/123.11.2289; Menke RAL, 2016, NEUROTHERAPEUTICS, P1; Prell T, 2013, CLIN NEUROL NEUROSUR, V115, P1281, DOI 10.1016/j.clineuro.2012.11.031; Sage CA, 2007, NEUROIMAGE, V34, P486, DOI 10.1016/j.neuroimage.2006.09.025; Sarica A, 2014, J NEUROSCI METH, V224, P79, DOI 10.1016/j.jneumeth.2013.12.014; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schmierer K, 2004, ANN NEUROL, V56, P407, DOI 10.1002/ana.20202; Schweitzer AD, 2015, AM J ROENTGENOL, V204, P1086, DOI 10.2214/AJR.14.13459; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stanton BR, 2009, ARCH NEUROL-CHICAGO, V66, P109, DOI 10.1001/archneurol.2008.527; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Tanabe JL, 1998, MAGN RESON IMAGING, V16, P1163, DOI 10.1016/S0730-725X(98)00129-5; Verstraete E, 2014, AMYOTROPH LAT SCL FR, V15, P84, DOI 10.3109/21678421.2013.844168; Wang SM, 2011, NEUROTHERAPEUTICS, V8, P63, DOI 10.1007/s13311-010-0011-3; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Woo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105753; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	40	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178371	10.1371/journal.pone.0178371	http://dx.doi.org/10.1371/journal.pone.0178371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575122	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300043
J	Chakravartula, S; Indic, P; Sundaram, B; Killingback, T				Chakravartula, Shilpa; Indic, Premananda; Sundaram, Bala; Killingback, Timothy			Emergence of local synchronization in neuronal networks with adaptive couplings	PLOS ONE			English	Article							1ST-ORDER DIFFERENTIAL-EQUATIONS; LONG-TERM MODULATION; ELECTRICAL SYNAPSES; INFERIOR OLIVE; PHASE SYNCHRONIZATION; MAMMALIAN BRAIN; VISUAL-CORTEX; GAP-JUNCTIONS; MODEL; OSCILLATIONS	Local synchronization, both prolonged and transient, of oscillatory neuronal behavior in cortical networks plays a fundamental role in many aspects of perception and cognition. Here we study networks of Hindmarsh-Rose neurons with a new type of adaptive coupling, and show that these networks naturally produce both permanent and transient synchronization of local clusters of neurons. These deterministic systems exhibit complex dynamics with 1/f(n) power spectra, which appears to be a consequence of a novel form of self-organized criticality.	[Chakravartula, Shilpa] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol Res, Boston, MA USA; [Indic, Premananda] Univ Texas Tyler, Dept Elect Engn, Tyler, TX 75799 USA; [Sundaram, Bala] Univ Massachusetts, Dept Phys, Boston, MA 02125 USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Texas System; University of Texas at Tyler; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Boston, MA 02125 USA.	timothy.killingback@umb.edu	Sundaram, Bala/A-6532-2010	Sundaram, Bala/0000-0002-1728-704X				Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bajec IL, 2009, ANIM BEHAV, V78, P777, DOI 10.1016/j.anbehav.2009.07.007; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bayati M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011925; Beggs JM, 2003, J NEUROSCI, V23, P11167; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Belykh VN, 2005, PHYSICA D, V200, P81, DOI 10.1016/j.physd.2004.10.008; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blenkinsop TA, 2006, J NEUROSCI, V26, P1739, DOI 10.1523/JNEUROSCI.3677-05.2006; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; De Gruijl JR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002814; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; di Volo M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032801; Esfahani ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep23471; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Gollo LL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0532; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haas JS, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0090-z; Hebb D. O., 2005, THE ORGANIZATION OF; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; HINDMARSH JL, 1982, NATURE, V296, P162, DOI 10.1038/296162a0; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; JIANG ZP, 1993, J OPT SOC AM B, V10, P155, DOI 10.1364/JOSAB.10.000155; Jirsa VK, 2008, COGN NEURODYNAMICS, V2, P29, DOI 10.1007/s11571-007-9030-0; KOURTCHATOV SY, 1995, PHYS REV A, V52, P4089, DOI 10.1103/PhysRevA.52.4089; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Levnajic Z, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016231; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Ma J, 2013, NONLINEAR DYNAM, V73, P73, DOI 10.1007/s11071-013-0767-1; Maistrenko YL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.066207; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mathy A, 2014, NEURON, V81, P1290, DOI 10.1016/j.neuron.2014.01.005; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; O'Brien J, 2014, CURR OPIN NEUROBIOL, V29, P64, DOI 10.1016/j.conb.2014.05.011; Ostojic S, 2009, J COMPUT NEUROSCI, V26, P369, DOI 10.1007/s10827-008-0117-3; Pereda AE, 2013, BBA-BIOMEMBRANES, V1828, P134, DOI 10.1016/j.bbamem.2012.05.026; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rubinov M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002038; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Storace M, 2008, CHAOS, V18, DOI 10.1063/1.2975967; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Traub RD, 1995, J COMPUT NEUROSCI, V2, P283, DOI 10.1007/BF00961440; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Valizadeh A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144520; Villegas P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05990; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; WALKER TJ, 1969, SCIENCE, V166, P891, DOI 10.1126/science.166.3907.891; Wang QY, 2013, CHAOS SOLITON FRACT, V56, P19, DOI 10.1016/j.chaos.2013.05.003; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiesenfeld K, 1998, PHYS REV E, V57, P1563, DOI 10.1103/PhysRevE.57.1563; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; YORK RA, 1991, IEEE T MICROW THEORY, V39, P1000, DOI 10.1109/22.81670	67	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178975	10.1371/journal.pone.0178975	http://dx.doi.org/10.1371/journal.pone.0178975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575125	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300138
J	Helmy, YA; Krucken, J; Abdelwhab, ESM; von Samson-Himmelstjerna, G; Hafez, HM				Helmy, Yosra A.; Kruecken, Juergen; Abdelwhab, El-Sayed M.; von Samson-Himmelstjerna, Georg; Hafez, Hafez M.			Molecular diagnosis and characterization of Cryptosporidium spp. in turkeys and chickens in Germany reveals evidence for previously undetected parasite species	PLOS ONE			English	Article							BROILER-CHICKENS; PHYLOGENETIC ANALYSIS; ISMAILIA PROVINCE; LIVESTOCK ANIMALS; DOMESTIC-ANIMALS; INFECTION; HUMANS; MELEAGRIDIS; GENOTYPES; GIARDIA	A total of 256 fecal specimens were randomly collected from farmed poultry in Germany and screened for the presence of Cryptosporidium spp. by PCR and further characterized by direct automated DNA sequencing. Using a nested PCR amplifying approximately 830 bp 18S rDNA fragment, 7.03% (n = 18) of the samples were Cryptosporidium-positive. In detail, Cryptosporidium was detected in 9.3% (8/86) of turkeys, 5.7% (9/158) of broilers and 8.3% (1/12) of layers. After DNA sequencing, Cryptosporidium parvum the most frequently observed species was identified in 5.1% (13/256) of all poultry species, including 8.1% (7/86) of turkeys, 3.2% (5/158) of broilers and 8.3% (1/12) of layers. Cryptosporidium baileyi was detected in 1.3% (2/256) of the broilers only. Three novel unclassified Cryptosporidium spp. were detected in 1.2% (1/86) of turkeys and 1.3% (2/158) of broilers. The infection rate was high in 13-20 week old turkeys, 1-6 weeks old broilers and >20 weeks old layers but differences between age groups were not significant. This is the first study in Germany uses molecular methods for the detection of Cryptosporidium in poultry. The results indicate that Cryptosporidium parasites are common among broilers and turkeys in Germany. Considering the large size of the poultry industry, the large amount of poultry meat that is consumed and the fact that C. parvum is also the most common Cryptosporidium parasite in humans, poultry might also be a source of human infections.	[Helmy, Yosra A.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Vet Prevent Med, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Helmy, Yosra A.] Suez Canal Univ, Fac Vet Med, Dept Anim Hyg Zoonoses & Anim Ethol, Ismailia, Egypt; [Helmy, Yosra A.; Kruecken, Juergen; von Samson-Himmelstjerna, Georg] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Abdelwhab, El-Sayed M.] Friedrich Loeffler Inst, Inst Mol Biol, Fed Res Inst Anim Hlth, Greifswald, Germany; [Hafez, Hafez M.] Free Univ Berlin, Inst Poultry Dis, Berlin, Germany	University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Suez Canal University; Free University of Berlin; Friedrich Loeffler Institute; Free University of Berlin	Hafez, HM (corresponding author), Free Univ Berlin, Inst Poultry Dis, Berlin, Germany.	hafez@vetmed.fu-berlin.de	Krücken, Jürgen/CAF-6903-2022; Abdelwhab, Elsayed M./A-9232-2016; Krücken, Jürgen/AAE-3133-2021; Helmy, Yosra A./I-9426-2019; Krücken, Jürgen/B-6794-2009	Krücken, Jürgen/0000-0002-2842-8100; Abdelwhab, Elsayed M./0000-0003-2103-0922; Krücken, Jürgen/0000-0002-2842-8100; Helmy, Yosra A./0000-0003-1470-5418; Krücken, Jürgen/0000-0002-2842-8100				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baroudi D, 2013, VET PARASITOL, V196, P334, DOI 10.1016/j.vetpar.2013.02.022; Berrilli F, 2012, T ROY SOC TROP MED H, V106, P191, DOI 10.1016/j.trstmh.2011.12.005; Bomfim T. C. B., 2013, Open Veterinary Science Journal, V7, P12, DOI 10.2174/1874318801307010012; de Graaf DC, 1999, INT J PARASITOL, V29, P1269, DOI 10.1016/S0020-7519(99)00076-4; Fayer R., 1997, CRYPTOSPORIDIUM CRYP; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Gerlach U, 1998, FELDSTUDIE VORKOMMEN; Graczyk TK, 1997, PARASITOL TODAY, V13, P348, DOI 10.1016/S0169-4758(97)01076-4; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helmy YA, 2015, EPIDEMIOL INFECT, V143, P1208, DOI 10.1017/S0950268814001824; Helmy YA, 2014, PARASITOL RES, V113, P211, DOI 10.1007/s00436-013-3645-3; Helmy YA, 2013, VET PARASITOL, V193, P15, DOI 10.1016/j.vetpar.2012.12.015; Huber F, 2007, VET PARASITOL, V150, P65, DOI 10.1016/j.vetpar.2007.08.018; ITAKURA C, 1984, AVIAN PATHOL, V13, P487, DOI 10.1080/03079458408418550; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kichou F, 1996, AVIAN PATHOL, V25, P103, DOI 10.1080/03079459608419124; Majewska AC, 2009, PARASITOL RES, V104, P1093, DOI 10.1007/s00436-008-1293-9; McDougald LR, 2013, DIS POULTRY, V13, P1085; McEvoy JM, 2009, LETT APPL MICROBIOL, V48, P302, DOI 10.1111/j.1472-765X.2008.02516.x; Messenger AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089055; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Morgan UM, 2001, INT J PARASITOL, V31, P289, DOI 10.1016/S0020-7519(00)00164-8; Nakamura AA, 2009, VET PARASITOL, V166, P47, DOI 10.1016/j.vetpar.2009.07.033; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Ng-Hublin JSY, 2013, J CLIN MICROBIOL, V51, P2463, DOI 10.1128/JCM.00424-13; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; PAPADOPOULOU C, 1988, AVIAN DIS, V32, P842, DOI 10.2307/1591010; Pedraza-Diaz S, 2000, FEMS MICROBIOL LETT, V189, P189, DOI 10.1016/S0378-1097(00)00278-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramirez NE, 2004, MICROBES INFECT, V6, P773, DOI 10.1016/j.micinf.2004.02.021; RANDALL CJ, 1982, AVIAN PATHOL, V11, P95, DOI 10.1080/03079458208436084; Ryan UM, 2003, J PARASITOL, V89, P809, DOI 10.1645/GE-74RI; Ryan U, 2010, EXP PARASITOL, V124, P113, DOI 10.1016/j.exppara.2009.02.002; Shemshadi B, 2010, COMP CLIN PATHOLOGY, V20, P143; Smith HV, 2007, VET PARASITOL, V149, P29, DOI 10.1016/j.vetpar.2007.07.015; Soltane R, 2007, PARASITE, V14, P335, DOI 10.1051/parasite/2007144335; Sreter T, 2000, VET PARASITOL, V87, P261, DOI 10.1016/S0304-4017(99)00178-8; van Zeeland YRA, 2008, AVIAN DIS, V52, P357, DOI 10.1637/8121-100207-Case.1; Wang LM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014035; Wang YF, 2014, INT J PARASITOL, V44, P515, DOI 10.1016/j.ijpara.2014.03.003; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x	44	22	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177150	10.1371/journal.pone.0177150	http://dx.doi.org/10.1371/journal.pone.0177150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575116	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300011
J	Soto-Centeno, JA; Simmons, NB; Steadman, DW				Soto-Centeno, J. Angel; Simmons, Nancy B.; Steadman, David W.			The bat community of Haiti and evidence for its long-term persistence at high elevations	PLOS ONE			English	Article							BIRD COMMUNITY; EXTINCTION; HISPANIOLA; AVES; CONSERVATION; CHIROPTERA; CHRONOLOGY; TYTO	Accurate accounts of both living and fossil mammal communities are critical for creating biodiversity inventories and understanding patterns of changing species diversity through time. We combined data from froml4 new fossil localities with literature accounts and museum records to document the bat biodiversity of Haiti through time. We also report an assemblage of late-Holocene (1600-600 Cal BP) bat fossils from a montane cave (Trouing Jean Paul,-1825m) in southern Haiti. The nearly 3000 chiropteran fossils from Trouing Jean Paul represent 15 species of bats including nine species endemic to the Caribbean islands. The fossil bat assemblage from Trouing Jean Paul is dominated by species still found on Hispaniola (15 of 15 species), much as with the fossil bird assemblage from the same locality (22 of 23 species). Thus, both groups of volant vertebrates demonstrate long-term resilience, at least at high elevations, to the past 16 centuries of human presence on the island.	[Soto-Centeno, J. Angel; Simmons, Nancy B.] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Steadman, David W.] Florida Museum Nat Hist, Dept Ornithol, Gainesville, FL USA	American Museum of Natural History (AMNH)	Soto-Centeno, JA (corresponding author), Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA.	asoto-centeno@amnh.org		Soto-Centeno, J. Angel/0000-0002-1729-1153	American Museum of Natural History; U.S. National Science Foundation [BCS-1118369, GSS-1461496]	American Museum of Natural History; U.S. National Science Foundation(National Science Foundation (NSF))	Financial support was provided by the American Museum of Natural History as a Theodore Roosevelt Postdoctoral Fellowship and a Gerstner Scholarship to JAS-C (www.amnh.org) and U.S. National Science Foundation grants (BCS-1118369, GSS-1461496) to DWS (fittps://nsf.gov).	Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Davalos Liliana M., 2012, P157; DAVALOS LM, 2001, COTINGA, V16, P36; Deagan KathleenA., 2002, ARCHAEOLOGY ISABELA; Fitzpatrick SM, 2006, LAT AM ANTIQ, V17, P389; Gannon M. R., 2005, BATS PUERTO RICO ISL; Genoways Hugh H., 2005, Texas Tech University Museum Special Publications, V48, P1; Helmus MR, 2014, NATURE, V513, P543, DOI 10.1038/nature13739; KLINGENER D, 1978, Annals of Carnegie Museum, V47, P81; KOOPMAN KARL F., 1955, JOUR MAMMAL, V36, P109, DOI 10.2307/1375730; KURTA A, 1990, Mammalian Species, P1, DOI 10.2307/3504258; Ladle RJ, 2012, CONSERV BIOL, V26, P978, DOI 10.1111/j.1523-1739.2012.01936.x; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; LATTA S., 2006, BIRDS DOMINICAN REPU; MAC ARTHUR ROBERT H., 1967; MacPhee RDE, 2007, CARIBB J SCI, V43, P94; MacPhee R. D. E., 2009, P169, DOI 10.1007/978-1-4020-8793-6_9; MARTI CD, 1992, BIRDS N AM; Miller G. S., 1930, Smithsonian Miscellaneous Collections, V82, P1; Miller G. S., 1918, Proceedings of the Biological Society of Washington, V31; MILLER GERRIT S., 1929, SMITHSONIAN MISC COLL, V81, P1; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Morgan Gary S., 2001, P369; NUNEZ-NOVAS M. S., 2011, NOVIT CARIBAEA, V4, P109; Nunez-Novas MS, 2016, ACTA CHIROPTEROL, V18, P269, DOI 10.3161/15081109ACC2016.18.1.016; PREGILL G, 1981, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Rodriguez-Duran Armando, 2001, P355; Rodriguez-Duran Armando, 2009, P265; Rodrioguez-Duran A, 2012, BREVARIO MURCIE LGOS; Russo A., 2015, PLOS ONE, V10, P1, DOI 10.1371/journal.pone.0133571; Sanborn Colin Campbell, 1941, FIELD MUS NAT HIST ZOOL SER, V27, P371; SCHWARTZ A., 1980, STUD FAUNA CURACAO, V61, P86; Sergile Florence E., 2001, P547; Shump K.A. Jr, 1982, Mammalian Species, P1; Silva Taboada G., 1979, MURCIELAGOS CUBA; Silva-Taboada G., 1952, REV ARQUEOLOGIA ETNO, V15-16, P203; Sly ND, 2010, CONSERV GENET, V11, P2121, DOI 10.1007/s10592-010-0098-4; Soto-Centeno JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07971; Steadman DW, 2015, J BIOGEOGR, V42, P426, DOI 10.1111/jbi.12418; Steadman DW, 2013, HOLOCENE, V23, P936, DOI 10.1177/0959683613479683; Steadman DW, 2005, P NATL ACAD SCI USA, V102, P11763, DOI 10.1073/pnas.0502777102; Steadman DW, 1999, SM C PALEOB, P75; Takano OM, 2015, ZOOTAXA, V4032, P117, DOI 10.11646/zootaxa.4032.1.6; Tejedor A, 2011, B AM MUS NAT HIST, P1; Tejedor Adrian, 2006, Boletin de la Sociedad Venezolana de Espeleologia, V39, P10; Velazco PM, 2013, AM MUS NOVIT, P1; Wiley JW, 2010, J RAPTOR RES, V44, P87, DOI 10.3356/JRR-08-100.1; WILSON SM, 2001, BIOGEOGRAPHY W INDIE, P519; Woods C.A., 1992, NATURAL HIST SO HAIT; Woods CA, 1986, MAMM NAT PARKS UNPUB	50	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178066	10.1371/journal.pone.0178066	http://dx.doi.org/10.1371/journal.pone.0178066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574990	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300026
J	Zhang, H; Ma, RR; Wang, XJ; Su, ZX; Chen, X; Shi, DB; Guo, XY; Liu, HT; Gao, P				Zhang, H.; Ma, R-R; Wang, X-J; Su, Z-X; Chen, X.; Shi, D-B; Guo, X-Y; Liu, H-T; Gao, P.			KIF26B, a novel oncogene, promotes proliferation and metastasis by activating the VEGF pathway in gastric cancer	ONCOGENE			English	Article							KINESIN; EXPRESSION; THERAPY; GENE; THERAPEUTICS; INHIBITION; PROTEINS; ADHESION; BIOLOGY; STAGE	Tumor metastasis is the main reason of cancer-related death for gastric cancer (GC) patients and gene expression microarray data indicate that kinesin family member 26B (KIF26B) is one of the most upregulated genes in metastatic GC samples. Specifically, KIF26B expression was upregulated in a stepwise manner from non-tumorous gastric mucosa, primary GC tissues without metastasis, via primary GC tissues with metastasis, to secondary lymph node metastatic (LNM) foci. Increased expression of KIF26B was correlated with tumor size, positive LNM or distant metastases and poor prognosis. KIF26B, negatively regulated by miR-372, promoted GC cell proliferation and metastasis in vitro and in vivo. Mechanistic investigations confirmed that the main target of KIF26B was the vascular endothelial growth factor (VEGF) signaling pathway, particularly by inhibition or overexpression of VEGFA, PXN, FAK, PIK3CA, BCL2 and CREB1. Thus, KIF26B, a novel oncogene regulated by miR-372, promotes proliferation and metastasis through the VEGF pathway in GC.	[Zhang, H.; Ma, R-R; Wang, X-J; Chen, X.; Shi, D-B; Guo, X-Y; Liu, H-T; Gao, P.] Shandong Univ, Sch Med, Dept Pathol, Jinan Wen Hua Xi Rd 44, Jinan 250012, Shandong, Peoples R China; [Zhang, H.] Shandong Univ, Qilu Hosp, Dept Pathol, Shandong, Peoples R China; [Su, Z-X] Shandong Prov Hosp, Dept Hepatobiliary Surg, Shandong, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences	Gao, P (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan Wen Hua Xi Rd 44, Jinan 250012, Shandong, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81372856, 81672842]; Taishan Scholars Program of Shandong Province [ts201511096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province	We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of the manuscript. This study was supported by the National Natural Science Foundation of China (grant no. 81372856 and 81672842) and the Taishan Scholars Program of Shandong Province (grant no. ts201511096).	Adomas A, 2008, TREE PHYSIOL, V28, P885, DOI 10.1093/treephys/28.6.885; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Crociani O, 2014, CLIN CANCER RES, V20, P1502, DOI 10.1158/1078-0432.CCR-13-2633; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FIDLER IJ, 1990, CANCER RES, V50, P6130; Gandhi NS, 2014, J CONTROL RELEASE, V194, P238, DOI 10.1016/j.jconrel.2014.09.001; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Grothey A, 2013, LANCET ONCOL, V14, P2, DOI 10.1016/S1470-2045(12)70516-8; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hippo Y, 2002, CANCER RES, V62, P233; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Liu XR, 2013, CANCER SCI, V104, P651, DOI 10.1111/cas.12138; Paul-Samojedny M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768181; Petri A, 2009, CANCER RES, V69, P393, DOI 10.1158/0008-5472.CAN-08-2749; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Terabayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039714; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; Waller T, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0052-6; Wang JT, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0129-6; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061640; Wang YW, 2015, ONCOTARGET, V6, P10646, DOI 10.18632/oncotarget.3392; Wu DW, 2016, ONCOGENE, V35, P621, DOI 10.1038/onc.2015.120; Wu G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-107; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zhou RY, 2009, CELL, V139, P802, DOI 10.1016/j.cell.2009.10.023	36	43	43	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5609	5619		10.1038/onc.2017.163	http://dx.doi.org/10.1038/onc.2017.163			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581513				2022-12-26	WOS:000412293600005
J	Ghosh, S; Kaushik, A; Khurana, S; Varshney, A; Singh, AK; Dahiya, P; Thakur, JK; Sarin, SK; Gupta, D; Malhotra, P; Mukherjee, SK; Bhatnagar, RK				Ghosh, Subhanita; Kaushik, Abhinav; Khurana, Sachin; Varshney, Aditi; Singh, Avishek Kumar; Dahiya, Pradeep; Thakur, Jitendra K.; Sarin, Shiv Kumar; Gupta, Dinesh; Malhotra, Pawan; Mukherjee, Sunil K.; Bhatnagar, Raj K.			An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; drug screening; flow cytometry; hepatitis B virus (HBV; Hep B); molecular dynamics; RNA interference (RNAi); short hairpin RNA (shRNA); surface plasmon resonance (SPR); viral protein; small molecule inhibitor; viral RNAi suppressor; HBx; antiviral agent	INFLUENZA-A VIRUS; X-PROTEIN; HBX PROTEIN; IN-VIVO; INTERFERING RNAS; VIRAL SUPPRESSOR; MAMMALIAN-CELLS; GENE; PREDICTION; INFECTION	Persistent or chronic infection with the hepatitis B virus (HBV) represents one of the most common viral diseases in humans. The hepatitis B virus deploys the hepatitis B virus X protein (HBx) as a suppressor of host defenses consisting of RNAi-based silencing of viral genes. Because of its critical role in countering host defenses, HBx represents an attractive target for antiviral drugs. Here, we developed and optimized a loss-of-function screening procedure, which identified a potential pharmacophore that abrogated HBx RNAi suppression activity. In a survey of 14,400 compounds in the Maybridge Screening Collection, we prioritized candidate compounds via high-throughput screening based on reversal of green fluorescent protein (GFP)-reported, RNAi-mediated silencing in a HepG2/GFP-shRNA RNAi sensor line. The screening yielded a pharmacologically active compound, N-(2,4-difluorophenyl)-N-[3-(1H-imidazol-1-yl) propyl] thiourea (IR415), which blocked HBx-mediated RNAi suppression indicated by the GFP reporter assay. We also found that IR415 reversed the inhibitory effect of HBx protein on activity of the Dicer endoribonuclease. We further confirmed the results of the primary screen in IR415-treated, HBV-infected HepG2 cells, which exhibited a marked depletion of HBV core protein synthesis and down-regulation of pre-genomic HBV RNA. Using a molecular interaction analysis system, we confirmed that IR415 selectively targets HBx in a concentration-dependent manner. The screening assay presented here allows rapid and improved detection of small-molecule inhibitors of HBx and related viral proteins. The assay may therefore potentiate the development of next-generation RNAi pathway-based therapeutics and promises to accelerate our search for novel and effective drugs in antiviral research.	[Ghosh, Subhanita; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Kaushik, Abhinav; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Translat Bioinformat Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Khurana, Sachin; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, Malaria Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India; [Varshney, Aditi; Singh, Avishek Kumar; Sarin, Shiv Kumar] Inst Liver & Biliary Sci, D-1, New Delhi 110070, India; [Dahiya, Pradeep; Thakur, Jitendra K.] Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India; [Mukherjee, Sunil K.] Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India; [Ghosh, Subhanita] Univ Massachusetts, Program Mol Med, Sch Med, 373 Plantation St, Worcester, MA 01605 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Institute of Liver & Biliary Sciences (ILBS); Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; University of Massachusetts System; University of Massachusetts Worcester	Bhatnagar, RK (corresponding author), Int Ctr Genet Engn & Biotechnol, Insect Resistance Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Malhotra, P (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Biol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.; Mukherjee, SK (corresponding author), Indian Agr Res Inst, Div Plant Pathol, New Delhi 110012, India.	pawanmal@gmail.com; sunilm@icgeb.res.in; raj@icgeb.res.in	Bhatnagar, Raj/AAP-2311-2021; Dahiya, Pradeep/AAF-1283-2021; Gupta, Dinesh/C-1079-2009; Gupta, Dinesh/AAW-4243-2020; Singh, Avishek Kumar/AAA-4913-2021; Thakur, Jitendra/AAN-8674-2021	Dahiya, Pradeep/0000-0003-0178-5375; Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835; kaushik, abhinav/0000-0001-5682-0209; Ghosh, Subhanita/0000-0002-7919-1043; Thakur, Jitendra Kumar/0000-0001-7874-1923	Government of India, Department of Biotechnology Grant [BT/PR10673/AGR/36/579/2008]; Bioinformatics Infrastructure (BIF) Grant [BT/BI/25/066/2012]	Government of India, Department of Biotechnology Grant; Bioinformatics Infrastructure (BIF) Grant	This work was supported by Government of India, Department of Biotechnology Grant BT/PR10673/AGR/36/579/2008 and Bioinformatics Infrastructure (BIF) Grant BT/BI/25/066/2012. The authors declare that they have no conflicts of interest with the contents of this article.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/nchem.1243, 10.1038/NCHEM.1243]; BLUM HE, 1991, J VIROL, V65, P1836, DOI 10.1128/JVI.65.4.1836-1842.1991; Bouchard MJ, 2003, J VIROL, V77, P7713, DOI 10.1128/JVI.77.14.7713-7719.2003; Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Carmona S, 2006, MOL THER, V13, P411, DOI 10.1016/j.ymthe.2005.10.013; Cha MY, 2009, J GEN VIROL, V90, P978, DOI 10.1099/vir.0.009928-0; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; CHEN HS, 1993, J VIROL, V67, P1218, DOI 10.1128/JVI.67.3.1218-1226.1993; Chinnappan M, 2014, BIOCHEM J, V462, P347, DOI 10.1042/BJ20140316; Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162; Dasgupta T, 2009, ACS CHEM BIOL, V4, P29, DOI 10.1021/cb8002804; Ekins S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063240; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamasaki K, 2003, FEBS LETT, V543, P51, DOI 10.1016/S0014-5793(03)00400-9; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Keasler VV, 2007, J VIROL, V81, P2656, DOI 10.1128/JVI.02020-06; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kock J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001082; Lara-Pezzi E, 1998, EMBO J, V17, P7066, DOI 10.1093/emboj/17.23.7066; Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; LUCITO R, 1992, J VIROL, V66, P983, DOI 10.1128/JVI.66.2.983-991.1992; MAGUIRE HF, 1991, SCIENCE, V252, P842, DOI 10.1126/science.1827531; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Major LL, 2011, MOL BIOL INT, V2011; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Nicolas FE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003089; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Singh G, 2009, FASEB J, V23, P1845, DOI 10.1096/fj.08-125120; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Terradillos O, 1998, ONCOGENE, V17, P2115, DOI 10.1038/sj.onc.1202432; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wahome PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049075; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WHO, 2017, WHO PUBLISHES LIST B; WILLIAMS JS, 1995, P NATL ACAD SCI USA, V92, P3819, DOI 10.1073/pnas.92.9.3819; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994; Zoutendijk R, 2011, J INFECT DIS, V204, P415, DOI 10.1093/infdis/jir282	54	7	7	5	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12577	12588		10.1074/jbc.M117.775155	http://dx.doi.org/10.1074/jbc.M117.775155			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584057	hybrid, Green Published			2022-12-26	WOS:000406636900022
J	Razavi, AM; Delemotte, L; Berlin, JR; Carnevale, V; Voelz, VA				Razavi, Asghar M.; Delemotte, Lucie; Berlin, Joshua R.; Carnevale, Vincenzo; Voelz, Vincent A.			Molecular simulations and free-energy calculations suggest conformation-dependent anion binding to a cytoplasmic site as a mechanism for Na+/K+-ATPase ion selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; molecular dynamics; Na+; K+-ATPase; potassium transport; sodium transport; anion binding site; free energy perturbation; membrane transporter; protonation; selectivity	SODIUM-POTASSIUM PUMP; SARCOPLASMIC-RETICULUM CA2+-ATPASE; POLARIZABLE FORCE-FIELD; CRYSTAL-STRUCTURE; K+-ATPASE; ADENOSINE-TRIPHOSPHATASE; ALPHA-SUBUNIT; NA/K PUMP; NA,K-ATPASE; TRANSPORT	Na+/K+-ATPase transports Na+ and K+ ions across the cell membrane via an ion-binding site becoming alternatively accessible to the intra- and extracellular milieu by conformational transitions that confer marked changes in ion-binding stoichiometry and selectivity. To probe the mechanism of these changes, we used molecular simulation and free-energy perturbation approaches to identify probable protonation states of Na+- and K+-coordinating residues in E1P and E2P conformations of Na+/K+-ATPase. Analysis of these simulations revealed a molecular mechanism responsible for the change in protonation state: the conformation-dependent binding of an anion (a chloride ion in our simulations) to a previously unrecognized cytoplasmic site in the loop between transmembrane helices 8 and 9, which influences the electrostatic potential of the crucial Na+-coordinating residue Asp(926). This mechanistic model is consistent with experimental observations and provides a molecular-level picture of how E1P to E2P enzyme conformational transitions are coupled to changes in ion-binding stoichiometry and selectivity.	[Razavi, Asghar M.; Carnevale, Vincenzo; Voelz, Vincent A.] Temple Univ, Dept Chem, Beury 240,1901 N 13th St, Philadelphia, PA 19122 USA; [Delemotte, Lucie; Carnevale, Vincenzo; Voelz, Vincent A.] Temple Univ, Inst Computat Mol Sci, SERC 704C,N 12th St, Philadelphia, PA 19122 USA; [Delemotte, Lucie] KTH Royal Inst Technol, Dept Theoret Phys, Sci Life Lab, S-11428 Stockholm, Sweden; [Berlin, Joshua R.] Rutgers State Univ, New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Royal Institute of Technology; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Voelz, VA (corresponding author), Temple Univ, Dept Chem, Beury 240,1901 N 13th St, Philadelphia, PA 19122 USA.; Carnevale, V (corresponding author), Temple Univ, Inst Computat Mol Sci, SERC 704C,N 12th St, Philadelphia, PA 19122 USA.	vincenzo.carnevale@temple.edu; voelz@temple.edu	Voelz, Vincent/HCI-4181-2022	Delemotte, Lucie/0000-0002-0828-3899; Voelz, Vincent/0000-0002-1054-2124	National Science Foundation [ACI-1614804, MCB-1412508]; National Institutes of Health [GM057253, S10OD020095]; National Science Foundation Major Research Instrumentation Grant [CNS-09-58854]; European Union [PIOF-GA-2012-329534]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057253] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020095] Funding Source: NIH RePORTER; Direct For Biological Sciences [1412508] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation Grant(National Science Foundation (NSF)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grants ACI-1614804 (to V. C.) and MCB-1412508 (to A. M. R. and V. A. V.), National Institutes of Health Grants GM057253 (to J. R. B.), and S10OD020095 (to V. C. and V. A. V.), and National Science Foundation Major Research Instrumentation Grant CNS-09-58854. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of funding from European Union Seventh Framework Program 979 "Voltsens" Grant PIOF-GA-2012-329534.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Clarke RJ, 2015, BIOPHYS J, V109, P1513, DOI 10.1016/j.bpj.2015.08.022; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiorin G, 2013, MOL PHYS, V111, P3345, DOI 10.1080/00268976.2013.813594; Ganea C, 1999, BIOPHYS J, V77, P267, DOI 10.1016/S0006-3495(99)76888-8; Grossfield A, 2003, J AM CHEM SOC, V125, P15671, DOI 10.1021/ja037005r; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorgensen PL, 1997, ANN NY ACAD SCI, V834, P161, DOI 10.1111/j.1749-6632.1997.tb52248.x; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Klimovich PV, 2015, J COMPUT AID MOL DES, V29, P397, DOI 10.1007/s10822-015-9840-9; KLODOS I, 1994, J BIOL CHEM, V269, P1734; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li H, 2015, J PHYS CHEM B, V119, P9401, DOI 10.1021/jp510560k; Lim HH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001441; Mahmmoud YA, 2015, J BIOL CHEM, V290, P3720, DOI 10.1074/jbc.M114.577486; Milanick MA, 2002, J GEN PHYSIOL, V120, P497, DOI 10.1085/jgp.20028573; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; Ogawa H, 2010, PROTEIN SCI, V19, P544, DOI 10.1002/pro.332; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Pedersen PA, 1998, BIOCHEMISTRY-US, V37, P17818, DOI 10.1021/bi981898w; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1965, J BIOL CHEM, V240, P1437; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schwinger RHG, 2003, CARDIOVASC RES, V57, P913, DOI 10.1016/S0008-6363(02)00767-8; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Skou JC, 1998, BIOSCIENCE REP, V18, P155, DOI 10.1023/A:1020196612909; Suzuki K, 1997, J GEN PHYSIOL, V109, P537, DOI 10.1085/jgp.109.5.537; Tadini-Buoninsegni F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14282; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Weigand KM, 2014, BBA-BIOMEMBRANES, V1838, P1693, DOI 10.1016/j.bbamem.2014.03.022; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	51	7	7	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12412	12423		10.1074/jbc.M117.779090	http://dx.doi.org/10.1074/jbc.M117.779090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28588025	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000406636900007
J	Yang, DH; Subramanian, G; Duan, JM; Gao, SB; Bai, L; Chandramohanadas, R; Ai, Y				Yang, Dahou; Subramanian, Gowtham; Duan, Jinming; Gao, Shaobing; Bai, Li; Chandramohanadas, Rajesh; Ai, Ye			A portable image-based cytometer for rapid malaria detection and quantification	PLOS ONE			English	Article							SEMIAUTOMATED MICRODILUTION TECHNIQUE; MEDIATED ISOTHERMAL AMPLIFICATION; PLASMODIUM-FALCIPARUM MALARIA; TOTAL GENERALIZED VARIATION; POLYMERASE-CHAIN-REACTION; DIAGNOSIS; ASSAY; MICROSCOPY; BLOOD; SENSITIVITY	Increasing resistance by malaria parasites to currently used antimalarials across the developing world warrants timely detection and classification so that appropriate drug combinations can be administered before clinical complications arise. However, this is often challenged by low levels of infection (referred to as parasitemia) and presence of predominantly young parasitic forms in the patients' peripheral blood. Herein, we developed a simple, inexpensive and portable image-based cytometer that detects and numerically counts Plasmodium falciparum infected red blood cells (iRBCs) from Giemsa-stained smears derived from infected blood. Our cytometer is able to classify all parasitic subpopulations by quantifying the area occupied by the parasites within iRBCs, with high specificity, sensitivity and negligible false positives (similar to 0.0025%). Moreover, we demonstrate the application of our image-based cytometer in testing anti-malarial efficacy against a commercial flow cytometer and demonstrate comparable results between the two methods. Collectively, these results highlight the possibility to use our image-based cytometer as a cheap, rapid and accurate alternative for antimalarial testing without compromising on efficiency and minimal processing time. With appropriate filters applied into the algorithm, to rule out leukocytes and reticulocytes, our cytometer may also be used for field diagnosis of malaria.	[Yang, Dahou; Subramanian, Gowtham; Chandramohanadas, Rajesh; Ai, Ye] Singapore Univ Technol & Design, Pillar Engn Prod Dev, Singapore, Singapore; [Duan, Jinming; Bai, Li] Univ Nottingham, Sch Comp Sci, Nottingham, England; [Gao, Shaobing] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu, Peoples R China	Singapore University of Technology & Design; University of Nottingham; University of Electronic Science & Technology of China	Chandramohanadas, R; Ai, Y (corresponding author), Singapore Univ Technol & Design, Pillar Engn Prod Dev, Singapore, Singapore.	rajesh@sutd.edu.sg; aiye@sutd.edu.sg	Chandramohanadas, Rajesh/GLT-0218-2022; Duan, Jinming/AAC-4150-2019; Subramanian, Gowtham/GYD-6120-2022; Ai, Ye/F-3411-2011	Yang, Dahou/0000-0001-9075-9528; Ai, Ye/0000-0001-8638-1649; Duan, Jinming/0000-0002-5108-2128; SUBRAMANIAN, GOWTHAM/0000-0003-1044-6770; Chandramohanadas, Rajesh/0000-0002-8760-0396	Ministry of Education (MOE), Singapore; SUTD-MIT International Design Centre [IDG11300101]; A*STAR-India Collaboration Grant [RGAST1503]; Singapore Ministry of Education Academic Research Fund Tier 2 [T2MOE1603]; Astar-India Collaboration Grant [RGAST1503]	Ministry of Education (MOE), Singapore(Ministry of Education, Singapore); SUTD-MIT International Design Centre(Singapore University of Technology & Design); A*STAR-India Collaboration Grant; Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore); Astar-India Collaboration Grant	DY and GS gratefully acknowledge the President's Graduate Fellowship awarded by the Ministry of Education (MOE), Singapore. YA and RC gratefully acknowledge the support provided by SUTD-MIT International Design Centre (IDG11300101). RC also acknowledges A*STAR-India Collaboration Grant (RGAST1503) for funding support. YA also acknowledge the support from the Singapore Ministry of Education Academic Research Fund Tier 2 (T2MOE1603).; DY and GS gratefully acknowledge the President's Graduate Fellowship awarded by the Ministry of Education (MOE), Singapore. YA and RC gratefully acknowledge the support provided by SUTD-MIT International Design Centre (IDG11300101). RC also acknowledges Astar-India Collaboration Grant (RGAST1503) for funding support. YA also acknowledges the support from the Singapore Ministry of Education Academic Research Fund Tier 2 (T2MOE1603).	Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; Cho D, 2001, PARASITOL RES, V87, P445, DOI 10.1007/s004360000360; de Langen AJ, 2006, TROP MED INT HEALTH, V11, P809, DOI 10.1111/j.1365-3156.2006.01634.x; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ding Y., 2016, IEEE ACM T COMPUTATI; Doderer C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-19; Dondorp AM, 1999, AM J TROP MED HYG, V60, P733, DOI 10.4269/ajtmh.1999.60.733; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duan J., 2016, ARXIV160902214; Duan JM, 2016, BIOMED SIGNAL PROCES, V24, P120, DOI 10.1016/j.bspc.2015.09.012; Duffy S, 2012, AM J TROP MED HYG, V86, P84, DOI 10.4269/ajtmh.2012.11-0302; Durrheim DN, 1997, S AFR MED J, V87, P609; ELABBADI N, 1992, ANTIMICROB AGENTS CH, V36, P50, DOI 10.1128/AAC.36.1.50; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Fontecha GA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-119; Frean J, 2013, SAMJ S AFR MED J, V103, P789, DOI [10.7196/samj.7442, 10.7196/SAMJ.7442]; Gascoyne P, 2004, ACTA TROP, V89, P357, DOI 10.1016/j.actatropica.2003.11.009; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Iber P K, 1975, J Med Assoc Thai, V58, P559; Iqbal J, 2002, J CLIN MICROBIOL, V40, P4675, DOI 10.1128/JCM.40.12.4675-4678.2002; John SM, 1998, ANN TROP MED PARASIT, V92, P621, DOI 10.1080/00034989859320; Knoll F, 2011, MAGN RESON MED, V65, P480, DOI 10.1002/mrm.22595; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; Lee YQ, 2014, ANTIMICROB AGENTS CH, V58, P550, DOI 10.1128/AAC.01441-13; Lema OE, 1999, AM J TROP MED HYG, V60, P177, DOI 10.4269/ajtmh.1999.60.177; Liu RW, 2014, MAGN RESON IMAGING, V32, P702, DOI 10.1016/j.mri.2014.03.004; Lu W., 2016, MATH METHODS APPL SC; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Memeu D. M., 2013, OPEN J CLIN DIAGNOST, V3, P183; Moon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061812; Morassin B, 2002, AM J TROP MED HYG, V66, P503, DOI 10.4269/ajtmh.2002.66.503; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Polley SD, 2010, J CLIN MICROBIOL, V48, P2866, DOI 10.1128/JCM.00355-10; Poon LLM, 2006, CLIN CHEM, V52, P303; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Richardson DC, 2002, J CLIN MICROBIOL, V40, P4528, DOI 10.1128/JCM.40.12.4528-4530.2002; Ross NE, 2006, MED BIOL ENG COMPUT, V44, P427, DOI 10.1007/s11517-006-0044-2; Scholkopf B, 1997, IEEE T SIGNAL PROCES, V45, P2758, DOI 10.1109/78.650102; Shapiro HA, 2007, CYTOM PART A, V71A, P643, DOI 10.1002/cyto.a.20453; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; Somasekar J, 2015, COMPUT ELECTR ENG, V45, P336, DOI 10.1016/j.compeleceng.2015.04.009; Steenkeste N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-108; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Subramanian G, 2016, BIOORG MED CHEM LETT, V26, P3300, DOI 10.1016/j.bmcl.2016.05.049; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; Tek FB, 2010, COMPUT VIS IMAGE UND, V114, P21, DOI 10.1016/j.cviu.2009.08.003; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsai MH, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0280-9; WHO, 2015, WORLD MAL REP 2015; Wilson DW, 2013, ANTIMICROB AGENTS CH, V57, P1455, DOI 10.1128/AAC.01881-12	59	32	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179161	10.1371/journal.pone.0179161	http://dx.doi.org/10.1371/journal.pone.0179161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594960	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200092
J	Schaffrath, J; Schmoll, HJ; Voigt, W; Muller, LP; Muller-Tidow, C; Mueller, T				Schaffrath, Judith; Schmoll, Hans-Joachim; Voigt, Wieland; Mueller, Lutz P.; Mueller-Tidow, Carsten; Mueller, Thomas			Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-I RECEPTOR; HUMAN EMBRYONAL CARCINOMA; METASTATIC TESTICULAR CANCER; KINASE INHIBITOR NVP-AEW541; YOLK-SAC CARCINOMA; TYROSINE KINASE; HEPATOCELLULAR-CARCINOMA; MAMMALIAN TARGET; MICROSATELLITE INSTABILITY	Testicular germ cell tumors (TGCTs) are the most common malignancies in men between the age of 15 and 35. Although cisplatin-based chemotherapy is highly effective in advanced disease, approximately 20% of patients have an unfavorable prognosis due to primary or acquired cisplatin resistance. For these patients, new therapeutic options are urgently needed. In numerous tumor entities, combinations of monoclonal antibodies or kinase inhibitors with chemotherapy exerted promising preclinical or clinical results, which have led to new treatment concepts. This prompted us to investigate the activity of different targeted agents alone or in combination with cisplatin in a panel of TGCT cell lines. Methods The in vitro activity of kinase inhibitors targeting mTOR (RAD001), EGFR, HER2/neu, VEGFR (AEE788) and IGF-1R (AEW541) alone or in combination with cisplatin was tested in the cisplatin sensitive TGCT cell lines H12.1 and GCT72 as well as in the resistant cell lines H12.1RA, H12.1D, 1411HP and 1777NRpmet using the sulforhodamin-B-(SRB)-cytotoxicity- assay. To evaluate the activity of the kinase inhibitors, western blot analysis of the targeted receptors and their phosphorylated state was performed before and after exposure to each substance. Results The different kinase inhibitors demonstrated significant cell growth inhibition in both cisplatin sensitive and resistant cell lines. The examined cell lines showed different protein expression levels of the targeted receptors. However there was no correlation between the targeted receptor expression and phosphorylation level and the antiproliferative effect of the respective agent. Furthermore, the combination of cisplatin and the kinase inhibitors exerted both additive and antagonistic effects in the studied cell lines. Conclusion Our data suggest potential activity of the investigated kinase inhibitors in both cisplatin sensitive and resistant TGCT cell lines as a single agent. However, when combined with cisplatin they did not demonstrate any promising ability to overcome cisplatin resistance in TGCTs.	[Schaffrath, Judith; Mueller, Lutz P.; Mueller, Thomas] Martin Luther Univ Halle Wittenberg, Dept Internal Med Oncol Hematol 4, Halle, Saale, Germany; [Schmoll, Hans-Joachim] Martin Luther Univ Halle Wittenberg, Workgrp Clin Studies Oncol, Halle, Saale, Germany; [Voigt, Wieland] Steinbeis Univ, Med Innovat & Management, Innovat Oncol, Berlin, Germany; [Mueller-Tidow, Carsten] Heidelberg Univ Hosp, Dept Internal Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Ruprecht Karls University Heidelberg	Mueller, T (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Internal Med Oncol Hematol 4, Halle, Saale, Germany.	thomas.mueller@medizin.uni-halle.de	schmoll, hans-joachim/AAO-5219-2021; Mueller, Thomas/ABE-4197-2020; Schmoll, Hans-Joachim/AAG-5888-2019; Müller-Tidow, Carsten/O-7207-2018	schmoll, hans-joachim/0000-0001-8705-0593; Müller-Tidow, Carsten/0000-0002-7166-5232; Mueller, Thomas/0000-0003-4637-0157	Novartis Pharma GmbH	Novartis Pharma GmbH	The study was financially supported by Novartis Pharma GmbH (www.novartis.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers P, 2011, EUR UROL, V60, P304, DOI 10.1016/j.eururo.2011.05.038; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Battelli Chiara, 2011, Therapy, V8, P359; Baumann P, 2009, ANTI-CANCER DRUG, V20, P259, DOI 10.1097/CAD.0b013e328328d18b; Berney DM, 2016, HISTOPATHOLOGY, V69, P7, DOI 10.1111/his.12958; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bitelman C, 2013, CANCER LETT, V335, P153, DOI 10.1016/j.canlet.2013.02.009; BORING CC, 1993, CA-CANCER J CLIN, V43, P7, DOI 10.3322/canjclin.43.1.7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONSON DL, 1984, CELL DIFFER DEV, V15, P129, DOI 10.1016/0045-6039(84)90064-2; Browne BC, 2012, BREAST CANCER RES TR, V136, P717, DOI 10.1007/s10549-012-2260-9; CASPER J, 1987, INT J ANDROL, V10, P105, DOI 10.1111/j.1365-2605.1987.tb00171.x; Einhorn LH, 2002, P NATL ACAD SCI USA, V99, P4592, DOI 10.1073/pnas.072067999; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Ferte C, 2013, MOL CANCER THER, V12, P1213, DOI 10.1158/1535-7163.MCT-12-1067; Fukuda S, 1999, CANCER, V85, P1323, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1323::AID-CNCR15>3.3.CO;2-7; Funakoshi T, 2014, CANCER TREAT REV, V40, P636, DOI 10.1016/j.ctrv.2014.02.004; Gao J, 2012, CANCER RES, V72, P3, DOI 10.1158/0008-5472.CAN-11-0550; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032; Ghavamnasiri MR, 2010, UROL J, V7, P26; Gotlieb WH, 2006, GYNECOL ONCOL, V100, P389, DOI 10.1016/j.ygyno.2005.09.048; Goudar RK, 2005, MOL CANCER THER, V4, P101; Grabinski N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-85; Grunwald V, 2003, JNCI-J NATL CANCER I, V95, P851, DOI 10.1093/jnci/95.12.851; Guo XF, 2013, DIS ESOPHAGUS, V26, P487, DOI 10.1111/j.1442-2050.2012.01332.x; Harari PM, 2004, ENDOCR-RELAT CANCER, V11, P689, DOI 10.1677/erc.1.00600; Honecker F, 2009, J CLIN ONCOL, V27, P2129, DOI 10.1200/JCO.2008.18.8623; Hopfner M, 2006, BIOCHEM PHARMACOL, V71, P1435, DOI 10.1016/j.bcp.2006.02.006; Houldsworth J, 2006, J CLIN ONCOL, V24, P5512, DOI 10.1200/JCO.2006.08.4285; Ioannou N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-41; Jordan NJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3604; Juengel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-152; Juengel E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-161; Juliachs M, 2013, INT J CANCER, V133, P235, DOI 10.1002/ijc.28009; Kollmannsberger C, 2008, EXPERT OPIN PHARMACO, V9, P2259, DOI 10.1517/14656566.9.13.2259 ; Liu Y, 2014, TUMOR BIOL, V35, P9171, DOI 10.1007/s13277-014-1719-1; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; Mahipal A, 2014, CANCER CONTROL, V21, P74, DOI 10.1177/107327481402100111; Maiso P, 2008, BRIT J HAEMATOL, V141, P470, DOI 10.1111/j.1365-2141.2008.07049.x; Mandoky L, 2003, ANTICANCER RES, V23, P3447; Mannuel HD, 2011, CURR OPIN ONCOL, V23, P265, DOI 10.1097/CCO.0b013e32834579f0; Mayer F, 2002, CANCER RES, V62, P2758; McHugh LA, 2007, UROLOGY, V69, P390, DOI 10.1016/j.urology.2006.12.003; Moroni M, 2001, CLIN CANCER RES, V7, P2770; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Mueller T, 2006, TUMOR BIOL, V27, P71, DOI 10.1159/000092324; Mueller T, 2003, CANCER RES, V63, P513; Mukohara T, 2009, CANCER LETT, V282, P14, DOI 10.1016/j.canlet.2009.02.056; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Onen H, 2014, HUM EXP TOXICOL; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Ou DL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-2; Park YW, 2005, CLIN CANCER RES, V11, P1963, DOI 10.1158/1078-0432.CCR-04-1665; PENG HQ, 1993, CANCER RES, V53, P3574; PERA MF, 1987, INT J CANCER, V40, P334, DOI 10.1002/ijc.2910400309; Perry J, 2010, MOL CANCER THER, V9, P3322, DOI 10.1158/1535-7163.MCT-10-0197; Pignochino Y, 2013, CLIN CANCER RES, V19, P2117, DOI 10.1158/1078-0432.CCR-12-2293; Porcu P, 2000, J CLIN ONCOL, V18, P1181, DOI 10.1200/JCO.2000.18.6.1181; Reardon DA, 2012, CANCER CHEMOTH PHARM, V69, P281, DOI 10.1007/s00280-011-1754-1; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Schrader C, 2012, ANTICANCER RES, V32, P3191; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Soule S, 2002, J CLIN PATHOL, V55, P656, DOI 10.1136/jcp.55.9.656; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Tazzari PL, 2007, LEUKEMIA, V21, P886, DOI 10.1038/sj.leu.2404643; Traxler P, 2004, CANCER RES, V64, P4931, DOI 10.1158/0008-5472.CAN-03-3681; Usanova S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-248; van de Geijn GJM, 2009, BIRTH DEFECTS RES C, V87, P96, DOI 10.1002/bdrc.20140; Velasco A, 2008, INT J CANCER, V122, P1774, DOI 10.1002/ijc.23291; Viglietto G, 1996, ONCOGENE, V13, P577; VOGELZANG NJ, 1985, CANCER, V55, P2584, DOI 10.1002/1097-0142(19850601)55:11<2584::AID-CNCR2820551110>3.0.CO;2-B; Wang X, 2008, MODERN PATHOL, V22, P7; Wang ZG, 2010, ONCOL REP, V23, P1167, DOI 10.3892/or_00000747; Wedel S, 2011, CANCER LETT, V301, P17, DOI 10.1016/j.canlet.2010.11.003; Winter C, 2011, NAT REV ENDOCRINOL, V7, P43, DOI 10.1038/nrendo.2010.196; Wolf S, 2010, WORLD J GASTROENTERO, V16, P156, DOI 10.3748/wjg.v16.i2.156; Yamaguchi H, 2013, CLIN CANCER RES, V19, P845, DOI 10.1158/1078-0432.CCR-12-2621; Younes MN, 2006, MOL CANCER THER, V5, P2696, DOI 10.1158/1535-7163.MCT-05-0228; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663	86	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178930	10.1371/journal.pone.0178930	http://dx.doi.org/10.1371/journal.pone.0178930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591197	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700058
J	Zhou, KN; Wang, DL; Li, HX; Wei, XL; Yin, J; Liang, PF; Kou, LL; Hao, MM; You, LJ; Li, XM; Zhuang, GH				Zhou, Kaina; Wang, Duolao; Li, Hengxin; Wei, Xiaoli; Yin, Juan; Liang, Peifeng; Kou, Lingling; Hao, Mengmeng; You, Lijuan; Li, Xiaomei; Zhuang, Guihua			Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment	PLOS ONE			English	Article							DEPENDENT INDIVIDUALS; HEROIN USERS; HEPATITIS-C; DRUG-USERS; PREDICTORS; TAIWAN; HIV; OUTCOMES; ADDICTS; THERAPY	This study aimed to explore the bidirectional relationships between retention and health-related quality of life (HRQoL) in patients from mainland China receiving methadone maintenance treatment (MMT). This prospective cohort study recruited 1,212 eligible MMT patients from the two largest MMT clinics (one privately and another publicly funded) in Xi'an. This study started in March 2012 with a 2-year follow-up until March 2014. Retention was assessed by repeated terminations, past treatment duration, premature terminations, and follow-up treatment duration. HRQoL was evaluated using the Chinese (simple) short-form 36 health survey version 2 (SF-36v2) and the quality of life scale for drug addicts (QOL-DAv2.0). Linear and Cox regression analyses were used to explore relationships between retention and HRQoL. A general linear model was used to further examine the global effect of past treatment duration on HRQoL. Multivariate analyses showed that repeated terminations had no significant impact on HRQoL scores in MMT patients; however, past treatment time (year) influenced the SF-36v2PCS (P = 0.004): treatment for >= 4 years showed a lower SF-36v2PCS score (regression coefficient: -2.39; 95% confidence interval [CI]: -3.80, -0.97; P = 0.001) than treatment for <1 year. In addition, patients with an SF-36v2PCS score >49 (hazard ratio: 0.83; 95% CI: 0.69, 0.98; P = 0.03) were 17% less likely to terminate MMT than those with scores of <= 49. In conclusion, retention and HRQoL tended to have a bidirectional relationship, which should be considered in the development of retention and health-management programs for patients with MMT.	[Zhou, Kaina; Yin, Juan; Liang, Peifeng; Kou, Lingling; Hao, Mengmeng; You, Lijuan; Li, Xiaomei; Zhuang, Guihua] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Li, Hengxin; Wei, Xiaoli] Xian Ctr Dis Control & Prevent, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Liverpool School of Tropical Medicine; University of Liverpool	Zhuang, GH (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China.	Zhuanggh@mail.xjtu.edu.cn	Zhou, Kaina/J-6601-2018	Zhou, Kaina/0000-0002-1898-6379; Wang, Duolao/0000-0003-2788-2464; Liang, Peifeng/0000-0002-8473-9843; Li, Heng Xin/0000-0002-5547-0080	National T & S Major Project of China [2012ZX10002001]	National T & S Major Project of China	This study was supported by the National T & S Major Project of China (grant no.: 2012ZX10002001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaie Ensiyeh, 2013, Addict Health, V5, P16; Tran BX, 2012, QUAL LIFE RES, V21, P613, DOI 10.1007/s11136-011-9963-y; Batki SL, 2009, DRUG ALCOHOL DEPEN, V101, P176, DOI 10.1016/j.drugalcdep.2008.12.012; Chang KC, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0076-8; China Disease Control and Prevention Center, 2011, MAN COMPR INT HIV AI; Chou YC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-190; Darker CD, 2015, IR J MED SCI; De Maeyer J, 2013, INT J DRUG POLICY, V24, P342, DOI 10.1016/j.drugpo.2012.09.005; Fareed A, 2011, J ADDICT DIS, V30, P27, DOI 10.1080/10550887.2010.531672; Fei JTB, 2016, AM J ADDICTION, V25, P49, DOI 10.1111/ajad.12317; Iskandar S, 2013, AM J ADDICTION, V22, P425, DOI 10.1111/j.1521-0391.2013.00334.x; Jaremko KM, 2015, J SUBST ABUSE TREAT, V48, P117, DOI 10.1016/j.jsat.2014.08.006; Jiang HF, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-11; Lambdin BH, 2014, CLIN INFECT DIS, V59, P735, DOI 10.1093/cid/ciu382; Maruish M.E., USERS MANUAL SF 36V2, V3; Narcotics Control Bureau of the Ministry of Public Security, 2014, NARC CONTR BUR MIN P; National Health and Family Planning Commission of the People's Republic of China, 2013, BACKGR AIDS CONTR CH; Noori R, 2012, SUBST USE MISUSE, V47, P767, DOI 10.3109/10826084.2010.517726; Perreault M, 2015, SUBST USE MISUSE, V50, P24, DOI 10.3109/10826084.2014.957769; Proctor SL, 2015, PSYCHOL ADDICT BEHAV, V29, P906, DOI 10.1037/adb0000090; Richardson L, 2012, J SUBST ABUSE TREAT, V43, P276, DOI 10.1016/j.jsat.2011.12.008; Saris-Baglama RN, QUALITYMETRIC HLTH O; Schoofs N, 2014, PSYCHIAT PRAX, V41, P82, DOI 10.1055/s-0033-1349627; Schreuder I, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-25; Sepulveda-Arias JC, 2014, J INFECT DEV COUNTR, V8, P1228, DOI 10.3855/jidc.4525; Sun HM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005997; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Wan CH, 2011, INT J NURS STUD, V48, P1080, DOI 10.1016/j.ijnurstu.2011.02.012; Wang HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113816; Wang PW, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0047-0; Wang PW, 2012, AM J DRUG ALCOHOL AB, V38, P213, DOI 10.3109/00952990.2011.649222; White WL, 2014, J PSYCHOACTIVE DRUGS, V46, P114, DOI 10.1080/02791072.2014.901587; WHO, 1997, MEAS QUAL LIF; [颜兴伟 Yan Xingwei], 2015, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V19, P851; Yen YF, 2015, J CHIN MED ASSOC, V78, P292, DOI 10.1016/j.jcma.2015.01.001; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068906; Zhang ZD, 2011, MODERN PREVENTIVE ME, V38, P4665; Zhou KN, 2017, PSYCHOL HEALTH MED, V22, P493, DOI 10.1080/13548506.2016.1164873; Zhou KN, 2014, ADDICT BEHAV, V39, P22, DOI 10.1016/j.addbeh.2013.09.001; Zhou KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079828; Zou X, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008162	41	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							0179009	10.1371/journal.pone.0179009	http://dx.doi.org/10.1371/journal.pone.0179009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586356	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000402875700041
J	Walker, J; Chaar, BB; Vera, N; Pillai, AS; Lim, JS; Bero, L; Moles, RJ				Walker, Josephine; Chaar, Betty B.; Vera, Numa; Pillai, Alvish S.; Lim, Jessy S.; Bero, Lisa; Moles, Rebekah J.			Medicine shortages in Fiji: A qualitative exploration of stakeholders' views	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; DRUGS; OUTCOMES; RECOMMENDATIONS; MANAGEMENT; LOGISTICS; ADHERENCE; CARE	Objectives Medicine access is a human right; yet, concerningly, there are international instances of shortages. Quantitative data has allowed WHO to propose global solutions; however, individualised understanding of specific regions is still required to work towards national solutions. Fiji has an established issue with medication supply and the aim of this study was to use qualitative methods to gain a fuller understanding of this context. Methods Semi-structured interviews were used to gain the perspective of key stakeholders involved in the Fijian medicine supply chain in regards to causes, impacts and possible solutions of medicine shortages. Thematic analysis was used to analyse the interview data. Results In total, 48 stakeholders participated and the information was synthesised into three main themes, causes, impacts and solutions and the sub-themes including; political, system and patient causes, adverse health effects on patients, professional dissatisfaction, monetary loss and loss of faith in the health system, workarounds, operation improvements, government intervention and education and training. Conclusions The situation in Fiji is not dissimilar to other instances of shortages around the world and hence international solutions like that proposed by WHO are feasible; however, they must be modified to be uniquely Fijian to work in this context.	[Walker, Josephine; Chaar, Betty B.; Lim, Jessy S.; Bero, Lisa; Moles, Rebekah J.] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [Vera, Numa; Pillai, Alvish S.] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji; [Bero, Lisa] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia	University of Sydney; Fiji National University (FNU); University of Sydney	Walker, J (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.	jwal7710@uni.sydney.edu.au	Lim, Jessy/GLU-0166-2022	Bero, Lisa/0000-0003-1893-6651				[Anonymous], 2016, WHO Drug Information, V30, P180; [Anonymous], 2013, SA PHARM J, V80, P45; Araszkiewicz A Aleksander, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P549, DOI 10.1586/14737167.8.6.549; Bailey M., 2004, AFFORDABILITY MEDICI; Banek K, 2015, HEALTH POLICY PLANN, V30, P451, DOI 10.1093/heapol/czu033; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bateman C, 2013, SAMJ S AFR MED J, V103, P69, DOI [10.7196/samj.6663, 10.7196/SAMJ.6663]; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Besancon L, 2013, REP INT SUMM MED SHO; Bhaskarabhatla A., 2016, HLTH POLICY PLAN; Bogaert P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125691; Bossert TJ, 2007, HEALTH POLICY PLANN, V22, P73, DOI 10.1093/heapol/czl041; Brown MT, 2011, MAYO CLIN PROC, V86, P304, DOI 10.4065/mcp.2010.0575; Chaar BB, 2014, AUSTRALAS MED J, V7, P161, DOI 10.4066/AMJ.2014.1943; Colquhoun S, 2016, GLOBAL HEART, V11, pe61, DOI DOI 10.1016/J.GHEART.2016.03.214; Comission FC, 2014, DET PRIC ESS PHARM P; Corrao G, 2014, EUR J INTERN MED, V25, P745, DOI 10.1016/j.ejim.2014.08.002; Corrao G, 2014, EUR J CLIN INVEST, V44, P933, DOI 10.1111/eci.12326; DeRoeck D, 2006, INT J HEALTH PLAN M, V21, P23, DOI 10.1002/hpm.822; Dowswell T, 1998, J ADV NURS, V28, P1326, DOI 10.1046/j.1365-2648.1998.00841.x; Dunne SS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0415-3; Duong M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143654; Evans D, 2002, J MED LIBR ASSOC, V90, P290; Fry G, 2015, NEW PACIFIC DIPLOMACY, P3; Gagne JJ, 2014, ANN INTERN MED, V161, P400, DOI 10.7326/M13-2942; Garuoliene K, 2011, EXPERT REV PHARM OUT, V11, P343, DOI [10.1586/ERP.11.24, 10.1586/erp.11.24]; Gijbels Harry, 2010, Nurse Educ Pract, V10, P64, DOI 10.1016/j.nepr.2009.03.011; Godman B, 2013, EXPERT REV PHARM OUT, V13, P469, DOI 10.1586/14737167.2013.820956; Graham Roberts FNU, 2011, FIJI ISLANDS HLTH SY, P19; Griffith MM, 2012, CLIN INFECT DIS; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Hassali MA, 2014, SAUDI PHARM J, V22, P491, DOI 10.1016/j.jsps.2013.12.017; Hogerzeil HV, 2006, B WORLD HEALTH ORGAN, V84, P371, DOI 10.2471/BLT.06.031153; Kessaram T, 2015, AUST NZ J PUBL HEAL, V39, P336, DOI 10.1111/1753-6405.12398; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Kesselheim AS, 2010, DRUGS, V70, P605, DOI 10.2165/10898530-000000000-00000; Lopes GD, 2013, NAT REV CLIN ONCOL, V10, P314, DOI 10.1038/nrclinonc.2013.55; Lubinga SJ, 2014, IMPLEMENT SCI, V9, P1; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ministry of Health and Medical Services F, 2015, FIJ FREE MED PROGR; Mohammed J, 2016, INT J HEALTH POLICY, V5, P173, DOI 10.15171/ijhpm.2015.199; MoHaMS Fiji, 2015, FIJI ESSENTIAL MED L; Mudaliar LA, 2017, EMIGRANTS EXPERIENCE; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Paton C, 2006, BRIT J PSYCHIAT, V189, P184, DOI 10.1192/bjp.bp.105.017079; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Qureshi NA, 2015, MEDITERRANEAN J MED, V2; Ravindra SS, ARXIV150703659; Rinaldi F, CANADIAN J CARDIOLOG; Scheyvens R, 2012, TOURISM GEOGR, V14, P1, DOI 10.1080/14616688.2011.593188; Statisics FBo, 2017, POP DEM FIJI BUR STA; Tan YX, 2016, INT J CLIN PHARM-NET, V38, P1133, DOI 10.1007/s11096-016-0342-1; Veronin MA, 2011, J PHARM HEALTH SERV, V2, P135, DOI 10.1111/j.1759-8893.2011.00059.x; Wertz F., 2011, 5 WAYS DOING QUALITA; Wu YCJ, 2013, COMPUT HUM BEHAV, V29, P323, DOI 10.1016/j.chb.2012.07.027	55	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178429	10.1371/journal.pone.0178429	http://dx.doi.org/10.1371/journal.pone.0178429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9KF	28582409	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600016
J	Enyedi, KN; Toth, S; Szakacs, G; Mezo, G				Enyedi, Kata Nora; Toth, Szilard; Szakacs, Gergely; Mezo, Gabor			NGR-peptide-drug conjugates with dual targeting properties	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PHAGE DISPLAY LIBRARY; AMINOPEPTIDASE-N; CYCLIC NGR; INTEGRIN ALPHA(V)BETA(3); FACTOR-ALPHA; ANTITUMOR; DELIVERY; MOTIF; DAUNORUBICIN	Peptides containing the asparagine-glycine-arginine (NGR) motif are recognized by CD13/aminopeptidase N (APN) receptor isoforms that are selectively overexpressed in tumor neo-vasculature. Spontaneous decomposition of NGR peptides can result in isoAsp derivatives, which are recognized by RGD-binding integrins that are essential for tumor metastasis. Peptides binding to CD13 and RGD-binding integrins provide tumor-homing, which can be exploited for dual targeted delivery of anticancer drugs. We synthesized small cyclic NGR peptide-daunomycin conjugates using NGR peptides of varying stability (c[KNGRE]-NH2, Ac-c[CNGRC]-NH2 and the thioether bond containing c[CH2-CO-NGRC]-NH2, c[CH2-COKNGRC]-NH2). The cytotoxic effect of the novel cyclic NGR peptide-Dau conjugates were examined in vitro on CD13 positive HT-1080 (human fibrosarcoma) and CD13 negative HT-29 (human colon adenocarcinoma) cell lines. Our results confirm the influence of structure on the antitumor activity and dual acting properties of the conjugates. Attachment of the drug through an enzyme-labile spacer to the C-terminus of cyclic NGR peptide resulted in higher antitumor activity on both CD13 positive and negative cells as compared to the branching versions.	[Enyedi, Kata Nora; Mezo, Gabor] Eotvos Lorand Univ, Fac Sci, Inst Chem, Pazmany P Setany 1-A, Budapest, Hungary; [Toth, Szilard; Szakacs, Gergely] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Magyar Tudosok Korutja 2, Budapest, Hungary; [Szakacs, Gergely] Med Univ Vienna, Inst Canc Res, Borschkegasse 8a, Vienna, Austria	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Medical University of Vienna	Mezo, G (corresponding author), Eotvos Lorand Univ, Fac Sci, Inst Chem, Pazmany P Setany 1-A, Budapest, Hungary.	gmezo@elte.hu	Tóth, Szilárd/AGB-3548-2022; Enyedi, Kata Nora/J-1182-2018; Enyedi, Kata Nóra/P-6092-2019; Szakacs, Gergely/A-2580-2009	Tóth, Szilárd/0000-0002-0168-3531; Enyedi, Kata Nora/0000-0003-3724-5936; Enyedi, Kata Nóra/0000-0003-3724-5936; Szakacs, Gergely/0000-0002-9311-7827	Hungarian National Science Fund [OTKAK 119552, K119552]; Hungarian Academy of Sciences	Hungarian National Science Fund; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This project has received funding from the Hungarian National Science Fund (OTKAK 119552 and K119552). G.Sz. was supported by a Momentum grant of the Hungarian Academy of Sciences.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Burvenich I, 2008, MOL CANCER THER, V7, P3771, DOI 10.1158/1535-7163.MCT-08-0600; Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200; Chen K, 2013, MOL PHARMACEUT, V10, P417, DOI 10.1021/mp3005676; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2011, J CELL SCI, V124, P515, DOI 10.1242/jcs.077172; Crippa L, 2008, CANCER RES, V68, P1154, DOI 10.1158/0008-5472.CAN-07-2085; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Curnis F, 2005, CANCER RES, V65, P2906, DOI 10.1158/0008-5472.CAN-04-4282; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Curnis F, 2002, CANCER RES, V62, P867; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Curnis F, 2010, J BIOL CHEM, V285, P9114, DOI 10.1074/jbc.M109.044297; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Enyedi KN, 2015, J MED CHEM, V58, P1806, DOI 10.1021/jm501630j; Fuzery AK, 2005, J PEPT SCI, V11, P53, DOI 10.1002/psc.588; Graziadio A, 2016, BIOCONJUGATE CHEM, V27, P1332, DOI 10.1021/acs.bioconjchem.6b00136; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; Hegedus R, 2012, EUR J MED CHEM, V56, P155, DOI 10.1016/j.ejmech.2012.08.014; Huang YY, 2016, BIOMATER SCI-UK, V4, P494, DOI 10.1039/c5bm00429b; Kapuvari B, 2016, INVEST NEW DRUG, V34, P416, DOI 10.1007/s10637-016-0354-7; Kiss K, 2016, J PEPT SCI, V22, pS182; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Liu LQ, 2000, J VIROL, V74, P5320, DOI 10.1128/JVI.74.11.5320-5328.2000; Majhen D, 2006, BIOCHEM BIOPH RES CO, V348, P278, DOI 10.1016/j.bbrc.2006.07.051; MARAGOUDAKIS ME, 1994, ANN NY ACAD SCI, V732, P280, DOI 10.1111/j.1749-6632.1994.tb24743.x; Mate G, 2015, EUR J PHARM SCI, V69, P61, DOI 10.1016/j.ejps.2015.01.002; Ndinguri MW, 2009, BIOCONJUGATE CHEM, V20, P1869, DOI 10.1021/bc900065r; Negussie AH, 2010, J CONTROL RELEASE, V143, P265, DOI 10.1016/j.jconrel.2009.12.031; Orban E, 2011, AMINO ACIDS, V41, P469, DOI 10.1007/s00726-010-0766-1; Pasqualini R, 2000, CANCER RES, V60, P722; Roxin A, 2012, FUTURE MED CHEM, V4, P1601, DOI [10.4155/FMC.12.75, 10.4155/fmc.12.75]; Sacchi A, 2004, CANCER RES, V64, P7150, DOI 10.1158/0008-5472.CAN-04-1445; Schlage P, 2011, J CONTROL RELEASE, V156, P170, DOI 10.1016/j.jconrel.2011.08.005; STEINER R, 1992, ANGIOGENESIS KEY PRI, P449; Strebhardt K, 2011, NATURE REV CANC, V8, P473; Szabo I, 2009, BIOCONJUGATE CHEM, V20, P656, DOI 10.1021/bc800542u; Tugyi R, 2005, J PEPT SCI, V11, P642, DOI 10.1002/psc.669; van Hensbergen Y, 2002, BIOCHEM PHARMACOL, V63, P897, DOI 10.1016/S0006-2952(01)00928-5; Wang RSE, 2011, AM J NUCL MED MOLEC, V1, P36	42	26	27	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178632	10.1371/journal.pone.0178632	http://dx.doi.org/10.1371/journal.pone.0178632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575020	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000402624300080
J	Kikkert, LHJ; de Groot, MH; van Campen, JP; Beijnen, JH; Hortobagyi, T; Vuillerme, N; Lamoth, CCJ				Kikkert, Lisette H. J.; de Groot, Maartje H.; van Campen, Jos P.; Beijnen, Jos H.; Hortobagyi, Tibor; Vuillerme, Nicolas; Lamoth, Claudine C. J.			Gait dynamics to optimize fall risk assessment in geriatric patients admitted to an outpatient diagnostic clinic	PLOS ONE			English	Article							POSTURAL CONTROL; WALKING SPEED; OLDER-ADULTS; STRENGTH; COORDINATION; STABILITY; COGNITION; ENTROPY; FRAILTY; ABILITY	Fall prediction in geriatric patients remains challenging because the increased fall risk involves multiple, interrelated factors caused by natural aging and/or pathology. Therefore, we used a multi-factorial statistical approach to model categories of modifiable fall risk factors among geriatric patients to identify fallers with highest sensitivity and specificity with a focus on gait performance. Patients (n = 61, age = 79; 41% fallers) underwent extensive screening in three categories: (1) patient characteristics (e.g., handgrip strength, medication use, osteoporosis-related factors) (2) cognitive function (global cognition, memory, executive function), and (3) gait performance (speed-related and dynamic outcomes assessed by tri-axial trunk accelerometry). Falls were registered prospectively (mean follow-up 8.6 months) and one year retrospectively. Principal Component Analysis (PCA) on 11 gait variables was performed to determine underlying gait properties. Three fall-classification models were then built using Partial Least Squares-Discriminant Analysis (PLS-DA), with separate and combined analyses of the fall risk factors. PCA identified 'pace', 'variability', and 'coordination' as key properties of gait. The best PLS-DA model produced a fall classification accuracy of AUC = 0.93. The specificity of the model using patient characteristics was 60% but reached 80% when cognitive and gait outcomes were added. The inclusion of cognition and gait dynamics in fall classification models reduced misclassification. We therefore recommend assessing geriatric patients' fall risk using a multi-factorial approach that incorporates patient characteristics, cognition, and gait dynamics.	[Kikkert, Lisette H. J.; Hortobagyi, Tibor; Lamoth, Claudine C. J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kikkert, Lisette H. J.; Vuillerme, Nicolas] Univ Grenoble Alpes, EA AGEIS, Grenoble, France; [Kikkert, Lisette H. J.; de Groot, Maartje H.; van Campen, Jos P.] MC Slotervaart Hosp, Dept Geriatr Med, Amsterdam, Netherlands; [de Groot, Maartje H.] The Hague Univ Appl Sci, Fac Hlth Nutr & Sport, The Hague, Netherlands; [Beijnen, Jos H.] MC Slotervaart Hosp, Dept Pharm & Pharmacol, Amsterdam, Netherlands; [Beijnen, Jos H.] Univ Utrecht, Sci Fac, Dept Pharmaceut Sci, Utrecht, Netherlands; [Vuillerme, Nicolas] Inst Univ France, Paris, France	University of Groningen; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Slotervaart Hospital; Slotervaart Hospital; Utrecht University; Institut Universitaire de France	Kikkert, LHJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; Kikkert, LHJ (corresponding author), Univ Grenoble Alpes, EA AGEIS, Grenoble, France.; Kikkert, LHJ (corresponding author), MC Slotervaart Hosp, Dept Geriatr Med, Amsterdam, Netherlands.	l.h.j.kikkert@umcg.nl	Lamoth, Claudine JC/N-4325-2013; VUILLERME, Nicolas/U-5767-2019	Lamoth, Claudine JC/0000-0002-6495-2823; VUILLERME, Nicolas/0000-0003-3773-393X	French National Research Agency in the framework of the "Programme d'Investissements d'Avenir IRT Nanoelec," [ANR-10-AIRT-05, ANR-15- I DEX-02]	French National Research Agency in the framework of the "Programme d'Investissements d'Avenir IRT Nanoelec,"(French National Research Agency (ANR))	This study was supported by the French National Research Agency in the framework of the "Programme d'Investissements d'Avenir IRT Nanoelec," grants ANR-10-AIRT-05 and ANR-15- I DEX-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI 10.1007/s12603-011-0016-6; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Beijersbergen CMI, 2013, AGEING RES REV, V12, P618, DOI 10.1016/j.arr.2013.03.001; Bellanca JL, 2013, J BIOMECH, V46, P828, DOI 10.1016/j.jbiomech.2012.12.008; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; de Groot MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149888; de Groot MH, 2014, GAIT POSTURE, V39, P767, DOI 10.1016/j.gaitpost.2013.10.015; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Holtzer R, 2014, J GERONTOL A-BIOL, V69, P1375, DOI 10.1093/gerona/glu052; Hortobagyi T, 2015, SPORTS MED, V45, P1627, DOI 10.1007/s40279-015-0371-2; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kaptein RG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-120; Kikkert LHJ, 2016, AGEING RES REV, V27, P1, DOI 10.1016/j.arr.2016.02.001; Kosse NM, 2015, ANN BIOMED ENG, V43, P1935, DOI 10.1007/s10439-014-1232-0; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Miyazaki J, 2013, ARCH GERONTOL GERIAT, V56, P141, DOI 10.1016/j.archger.2012.09.004; Morris R, 2016, NEUROSCI BIOBEHAV R, V64, P326, DOI 10.1016/j.neubiorev.2016.02.012; Papegaaij S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00028; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Riva F, 2013, GAIT POSTURE, V38, P170, DOI 10.1016/j.gaitpost.2013.05.002; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van der Jagt-Willems HC, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0018-z; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; van Schooten KS, 2015, J GERONTOL A-BIOL, V70, P608, DOI 10.1093/gerona/glu225; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127; Verlinden VJA, 2014, ALZHEIMERS DEMENT, V10, P328, DOI 10.1016/j.jalz.2013.03.009; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	44	23	25	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178615	10.1371/journal.pone.0178615	http://dx.doi.org/10.1371/journal.pone.0178615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW6MJ	28575126	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300075
J	Maeoka, Y; Naito, T; Irifuku, T; Shimizu, Y; Ogawa, T; Masaki, T				Maeoka, Yujiro; Naito, Takayuki; Irifuku, Taisuke; Shimizu, Yuka; Ogawa, Takahiko; Masaki, Takao			Seasonal variation in hemodialysis initiation: A single-center retrospective analysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; RESPIRATORY SYNCYTIAL VIRUS; HEART-FAILURE; BLOOD-PRESSURE; UNITED-STATES; WEIGHT-GAIN; DIALYSIS; MORTALITY; HOSPITALIZATIONS	The number of new dialysis patients has been increasing worldwide, particularly among elderly individuals. However, information on seasonal variation in hemodialysis initiation in recent decades is lacking, and the seasonal distribution of patients' conditions immediately prior to starting dialysis remains unclear. Having this information could help in developing a modifiable approach to improving pre-dialysis care. We retrospectively investigated the records of 297 patients who initiated hemodialysis at Hiroshima Prefectural Hospital from January 1st, 2009 to December 31st, 2013. Seasonal differences were assessed by chi(2) or Kruskal-Wallis tests. Multiple comparison analysis was performed with the Steel test. The overall number of patients starting dialysis was greatest in winter (n = 85, 28.6%), followed by spring (n = 74, 24.9%), summer (n = 70, 23.6%), and autumn (n = 68, 22.9%), though the differences were not significant. However, there was a significant winter peak in dialysis initiation among patients aged >= 65 years, but not in those aged <65 years. Fluid overload assessed by clinicians was the most common uremic symptom among all patients, but a winter peak was only detected in patients aged >= 65 years. The body weight gain ratio showed a similar trend to fluid overload assessed by clinicians. Pulmonary edema was most pronounced in winter among patients aged >= 65 years compared with other seasons. The incidences of infection were modestly increased in summer and winter, but not statistically significant. Cardiac complications were similar in all seasons. This study demonstrated the existence of seasonal variation in dialysis initiation, with a winter peak among patients aged >= 65 years. The winter increment in dialysis initiation was mainly attributable to increased fluid overload. These findings suggest that elderly individuals should be monitored particularly closely during the winter.	[Maeoka, Yujiro; Irifuku, Taisuke; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Naito, Takayuki; Shimizu, Yuka; Ogawa, Takahiko] Hiroshima Prefectural Hosp, Div Nephrol & Dialysis, Hiroshima, Japan; [Irifuku, Taisuke] Natl Hosp Org Higashihiroshima, Med Ctr, Dept Nephrol, Higashihiroshima, Japan	Hiroshima University	Naito, T (corresponding author), Hiroshima Prefectural Hosp, Div Nephrol & Dialysis, Hiroshima, Japan.	chonbori.chorori.chu@yahoo.co.jp	Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; Maeoka, Yujiro/0000-0003-1808-2772				Afsar B, 2013, GEN HOSP PSYCHIAT, V35, P28, DOI 10.1016/j.genhosppsych.2012.08.007; Boulay F, 1999, CIRCULATION, V100, P280, DOI 10.1161/01.CIR.100.3.280; Cotter G, 2008, EUR J HEART FAIL, V10, P165, DOI 10.1016/j.ejheart.2008.01.007; DeFilippi CR, 2005, AM J KIDNEY DIS, V46, P35, DOI 10.1053/j.ajkd.2005.04.007; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; FAGIUS J, 1991, ACTA PHYSIOL SCAND, V142, P201, DOI 10.1111/j.1748-1716.1991.tb09148.x; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Foote C, 2012, NEPHROL DIAL TRANSPL, V27, P3581, DOI 10.1093/ndt/gfs096; Hajat S, 2004, EUR J EPIDEMIOL, V19, P959, DOI 10.1007/s10654-004-5731-4; HATA T, 1982, CLIN EXP HYPERTENS, V4, P341, DOI 10.3109/10641968209060747; Hirai M, 2015, CIRC J, V79, P129, DOI 10.1253/circj.CJ-14-0710; Iseki K, 1996, AM J NEPHROL, V16, P375, DOI 10.1159/000169028; IZZO JL, 1990, AM J HYPERTENS, V3, P405, DOI 10.1093/ajh/3.5.405; Kausz AT, 2000, J AM SOC NEPHROL, V11, P2351, DOI 10.1681/ASN.V11122351; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Krishnan M, 2002, SEMIN DIALYSIS, V15, P79, DOI 10.1046/j.1525-139X.2002.00028.x; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lewin J, 2005, EUR J HEART FAIL, V7, P953, DOI 10.1016/j.ejheart.2005.06.003; Martinez-Selles M, 2002, EUR J HEART FAIL, V4, P779, DOI 10.1016/S1388-9842(02)00116-2; Matsukawa T, 1998, AM J PHYSIOL-REG I, V275, pR1600, DOI 10.1152/ajpregu.1998.275.5.R1600; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Obrador GT, 1999, KIDNEY INT, V56, P2227, DOI 10.1046/j.1523-1755.1999.00779.x; Shahar DR, 2001, EUR J EPIDEMIOL, V17, P129, DOI 10.1023/A:1017542928978; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Sposito M, 2000, AM J KIDNEY DIS, V35, P812, DOI 10.1016/S0272-6386(00)70249-6; Stewart S, 2002, J AM COLL CARDIOL, V39, P760, DOI 10.1016/S0735-1097(02)01685-6; Usvyat LA, 2012, CLIN J AM SOC NEPHRO, V7, P108, DOI 10.2215/CJN.03880411; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178967	10.1371/journal.pone.0178967	http://dx.doi.org/10.1371/journal.pone.0178967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575124	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300136
J	Reulen, RC; de Vogel, S; Zhong, WD; Zhong, ZH; Xie, LP; Hu, ZQ; Deng, YL; Yang, K; Liang, YX; Zeng, X; Wong, YC; Tam, PC; Hemelt, M; Zeegers, MP				Reulen, Raoul C.; de Vogel, Stefan; Zhong, Weide; Zhong, Zhaohui; Xie, Li-Ping; Hu, Zhiquan; Deng, Yilan; Yang, Kai; Liang, Yuxiang; Zeng, Xing; Wong, Yong Chuan; Tam, Po-Chor; Hemelt, Marjolein; Zeegers, Maurice P.			Physical activity and risk of prostate and bladder cancer in China: The South and East China case-control study on prostate and bladder cancer	PLOS ONE			English	Article							LUNG-CANCER; VALIDITY; CARCINOMA; MEN	Background Recent meta-analyses have suggested a modest protective effect of high levels of physical activity on developing both prostate and bladder cancer, but significant heterogeneity between studies included in these meta-analyses existed. To our knowledge, few Chinese studies investigated the association between physical activity and prostate cancer and none between physical activity and bladder cancer. Given the inconsistencies between previous studies and because studies on the relation between physical activity and prostate and bladder cancer in China are scarce, it remains elusive whether there is a relationship between physical activity and prostate and bladder cancer within the Chinese population. Methods We investigated the association between physical activity and risk of developing prostate and bladder cancer within a hospital-based case-control study in the East and South of China among 260 and 438 incident prostate and bladder cancer cases, respectively, and 427 controls. A questionnaire was administered to measure physical activity as metabolic equivalents (METs). Random effects logistic regression was used to calculate odds ratios (ORs) of prostate and bladder cancer for different levels of physical activity and for the specific activities of walking and cycling. Results Increasing overall physical activity was associated with a significant reduction in prostate cancer risk (P-trend = 0.04) with the highest activity tertile level showing a nearly 50% reduction in prostate cancer risk (OR = 0.53, 95% CI: 0.28-0.98). Overall physical activity was not significantly associated with risk of bladder cancer (Ptrend = 0.61), neither were vigorous (P-trend = 0.60) or moderate levels of physical activity (P-trend = 0.21). Walking and cycling were not significantly associated with either prostate (P-trend > = 0.62) or bladder cancer risk (P-trend > = 0.25). Conclusions The findings of this largest ever case-control study in China investigating the relationship between physical activity and prostate and bladder cancer suggest that overall physical activity is associated with a decreased risk of prostate cancer, but not with bladder cancer.	[Reulen, Raoul C.; Hemelt, Marjolein] Univ Birmingham, Insititute Appl Hlth Res, Birmingham, W Midlands, England; [de Vogel, Stefan] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Zhong, Weide; Liang, Yuxiang] Guangzhou Med Univ, Municipal Hosp Guangzhou 1, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhong, Zhaohui; Deng, Yilan] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China; [Xie, Li-Ping; Yang, Kai] Zhejiang Univ, Sch Med, Dept Urol, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Hu, Zhiquan; Zeng, Xing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Urol, Wuhan, Peoples R China; [Wong, Yong Chuan] Univ Hong Kong, Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tam, Po-Chor] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Zeegers, Maurice P.] Maastricht Univ, Dept Complex Genet & Epidemiol, Nutr & Toxicol Res Inst, Maastricht, Netherlands	University of Birmingham; University of Bergen; Guangzhou Medical University; Central South University; Zhejiang University; Huazhong University of Science & Technology; University of Hong Kong; University of Hong Kong; Maastricht University	Reulen, RC (corresponding author), Univ Birmingham, Insititute Appl Hlth Res, Birmingham, W Midlands, England.	r.c.reulen@bham.ac.uk	Xie, li/HGE-6052-2022; Reulen, Raoul/AAO-1033-2020	Reulen, Raoul/0000-0002-7328-0467; Zeegers, Maurice/0000-0002-2387-083X	Medical Research Council (MRC); Royal Society; University of Birmingham; Hong Kong University	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); University of Birmingham; Hong Kong University(University of Hong Kong)	This study has been jointly funded by the Medical Research Council (MRC), the Royal Society, the University of Birmingham, and the Hong Kong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Buffart LM, 2014, J SCI MED SPORT, V17, P67, DOI 10.1016/j.jsams.2013.02.015; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chen YC, 2005, BRIT J CANCER, V93, P1057, DOI 10.1038/sj.bjc.6602809; Deng HB, 2008, MED SCI SPORT EXER, V40, P303, DOI 10.1249/mss.0b013e31815b0db5; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Ferlay J, 2013, GLOBOCAN 2012 V10 CA; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; Jian L, 2005, EUR J EPIDEMIOL, V20, P155, DOI 10.1007/s10654-004-3007-7; Keimling M, 2014, BRIT J CANCER, V110, P1862, DOI 10.1038/bjc.2014.77; Lacey JV, 2001, INT J EPIDEMIOL, V30, P341, DOI 10.1093/ije/30.2.341; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Liu YP, 2011, EUR UROL, V60, P1029, DOI 10.1016/j.eururo.2011.07.007; McTiernan A., 2006, CANC PREVENTION MANA; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Monninkhof EM, 2007, EPIDEMIOLOGY, V18, P137, DOI 10.1097/01.ede.0000251167.75581.98; Muntner P, 2005, AM J PUBLIC HEALTH, V95, P1631, DOI 10.2105/AJPH.2004.044743; Ng SW, 2009, SOC SCI MED, V68, P1305, DOI 10.1016/j.socscimed.2009.01.035; Rebillard A, 2013, FREE RADICAL BIO MED, V60, P115, DOI 10.1016/j.freeradbiomed.2013.02.009; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Sung JFC, 1999, CANCER, V86, P484, DOI 10.1002/(SICI)1097-0142(19990801)86:3&lt;484::AID-CNCR17&gt;3.0.CO;2-P; Tardon A, 2005, CANCER CAUSE CONTROL, V16, P389, DOI 10.1007/s10552-004-5026-9; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Yun YH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-366	27	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178613	10.1371/journal.pone.0178613	http://dx.doi.org/10.1371/journal.pone.0178613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575110	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300074
J	Liu, Y; Du, SY; Ding, M; Dou, X; Zhang, FF; Wu, ZY; Qian, SW; Zhang, W; Tang, QQ; Xu, CJ				Liu, Yang; Du, Shao-Yue; Ding, Meng; Dou, Xin; Zhang, Fei-Fei; Wu, Zhi-Yong; Qian, Shu-Wen; Zhang, Wei; Tang, Qi-Qun; Xu, Cong-Jian			The BMP4-Smad signaling pathway regulates hyperandrogenism development in a female mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; STAT 1 PIAS1; ANDROGEN RECEPTOR; PROTEIN INHIBITOR; CELLS; HORMONE; WOMEN; AND-7; BETA; PCOS	Polycystic ovary syndrome is a common endocrine disorder and a major cause of anovulatory sterility in women at reproductive age. Most patients with polycystic ovary syndrome have hyperandrogenism, caused by excess androgen synthesis. Bone morphogenetic protein 4 (BMP4) is an essential regulator of embryonic development and organ formation, and recent studies have also shown that BMP4 may be involved in female steroidogenesis process. However, the effect of BMP4 on hyperandrogenism remains unknown. Here, using a female mouse model of hyperandrogenism, we found that ovarian BMP4 levels were significantly decreased in hyperandrogenism. Elevated androgens inhibited BMP4 expression via activation of androgen receptors. Moreover, BMP4 treatment suppressed androgen synthesis in theca cells and promoted estrogen production in granulosa cells by regulating the expression of steroidogenic enzymes, including CYP11A, HSD3B2, CYP17A1, and CYP19A1. Consistently, knockdown of BMP4 augmented androgen levels and inhibited estrogen levels. Mechanistically, Smad signaling rather than the p38 MAPK pathway regulated androgen and estrogen formation, thereby mediating the effect of BMP4. Of note, BMP4-transgenic mice were protected against hyperandrogenism. Our observations clarify a vital role of BMP4 in controlling sex hormone levels and offer new insights into intervention for managing hyperandrogenism by targeting the BMP4-Smad signaling pathway.	[Liu, Yang; Du, Shao-Yue; Zhang, Fei-Fei; Wu, Zhi-Yong; Zhang, Wei; Xu, Cong-Jian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200090, Peoples R China; [Liu, Yang; Ding, Meng; Dou, Xin; Qian, Shu-Wen; Tang, Qi-Qun] Fudan Univ, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Tang, QQ (corresponding author), Fudan Univ, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med, Minist Educ,Shanghai Med Coll, Shanghai 200032, Peoples R China.; Xu, CJ (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, 419 Fangxie Rd, Shanghai 200011, Peoples R China.	qqtang@shmu.edu.cn; xucj@hotmail.com			National Key Basic Research Project [2011CB910201, 2013CB530601, 2016YFC1303100]; State Key Program of National Natural Science Foundation [31030048C120114, 81390350]; National Natural Science Foundation of China [81601251]; China Postdoctoral Science Foundation	National Key Basic Research Project(National Basic Research Program of China); State Key Program of National Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported partially by National Key Basic Research Project Grants 2011CB910201 and 2013CB530601 and The State Key Program of National Natural Science Foundation 31030048C120114 and 81390350 (to Q.-Q.T.); National Natural Science Foundation of China Grant 81601251 and Project funded by China Postdoctoral Science Foundation (to Y.L.); National Key Basic Research Project Grant 2016YFC1303100 (to C.-J.X.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2016, Nat Rev Dis Primers, V2, P16058, DOI 10.1038/nrdp.2016.58; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Davey Rachel A, 2016, Clin Biochem Rev, V37, P3; Deplewski D, 2000, ENDOCR REV, V21, P363, DOI 10.1210/er.21.4.363; Diaz Rosanne, 2011, Nat Rev Endocrinol, V7, P437, DOI 10.1038/nrendo.2011.98; Dooley CA, 2000, J CLIN ENDOCR METAB, V85, P3331, DOI 10.1210/jc.85.9.3331; Erickson Gregory F, 2003, Reprod Biol Endocrinol, V1, P9, DOI 10.1186/1477-7827-1-9; ESCOBARMORREALE H, 1994, FERTIL STERIL, V62, P521; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Li DH, 2007, MOL CELL BIOL, V27, P6669, DOI 10.1128/MCB.00355-07; Li H, 2013, ENDOCRINE, V43, P184, DOI 10.1007/s12020-012-9739-3; Liu Y, 2015, DIABETES, V64, P4061, DOI 10.2337/db15-0278; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Lizneva D, 2016, BEST PRACT RES CL OB, V37, P98, DOI 10.1016/j.bpobgyn.2016.05.003; Luque-Ramirez M, 2015, EXPERT OPIN THER TAR, V19, P1545, DOI 10.1517/14728222.2015.1075511; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moran LJ, 2015, TRENDS ENDOCRIN MET, V26, P136, DOI 10.1016/j.tem.2014.12.003; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Palomba S, 2016, HUM REPROD, V31, P223, DOI 10.1093/humrep/dev284; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Rosenfield RL, 2016, ENDOCR REV, V37, P467, DOI 10.1210/er.2015-1104; Shohat-Tal A, 2015, NAT REV ENDOCRINOL, V11, P429, DOI 10.1038/nrendo.2015.64; Sirmans SM, 2014, CLIN EPIDEMIOL, V6, P1, DOI 10.2147/CLEP.S37559; STEINKAMPF MP, 1987, MOL ENDOCRINOL, V1, P465, DOI 10.1210/mend-1-7-465; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; van de Wijngaart DJ, 2012, MOL CELL ENDOCRINOL, V352, P57, DOI 10.1016/j.mce.2011.08.007; Wickenheisser JK, 2004, MOL ENDOCRINOL, V18, P588, DOI 10.1210/me.2003-0090; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yu C, 2013, MOL ENDOCRINOL, V27, P966, DOI 10.1210/me.2012-1364	36	18	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11740	11750		10.1074/jbc.M117.781369	http://dx.doi.org/10.1074/jbc.M117.781369			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572510	hybrid, Green Published			2022-12-26	WOS:000405485600013
J	Jang, TY; Lin, PC; Huang, CI; Liao, YM; Yeh, ML; Zeng, YS; Liang, PC; Hsu, WY; Tsai, SP; Lin, ZY; Chen, SC; Huang, JF; Dai, CY; Huang, CF; Chiou, SS; Chuang, WL; Yu, ML				Jang, Tyng-Yuan; Lin, Pei-Chin; Huang, Ching-I; Liao, Yu-Mei; Yeh, Ming-Lun; Zeng, Yu-Sheng; Liang, Po-Cheng; Hsu, Wan-Yi; Tsai, Shih-Pien; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chiou, Shyh-Shin; Chuang, Wan-Long; Yu, Ming-Lung			Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients	PLOS ONE			English	Article							C-VIRUS-INFECTION; VOLUNTEER BLOOD-DONORS; B-VIRUS; FACTOR CONCENTRATE; SPONTANEOUS CLEARANCE; GENETIC-VARIANTS; LIVER-DISEASE; ENDEMIC AREA; TAIWAN; PREVALENCE	Background/Aims Transfusion dependent subjects are at a great risk of viral hepatitis infection. We aimed to evaluate the prevalence and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among transfusion-dependent patients in Taiwan. Methods A total of 140 patients (67 thalassemic patients, 70 hemophilic patients, two patients with hereditary spherocytosis and one patient with von Willebrand disease) were prospectively enrolled to evaluate the prevalence and factors associated with viral hepatitis and spontaneous HCV clearance. All patients were tested for HBV and HCV serology and virology. Two consecutive serum samples, at least 1 year apart, were collected to clarify HCV seroclearance. Results The seropositivity rate of hepatitis B surface antigen (HBsAg), HCV antibody (anti-HCV), and both HBsAg/anti-HCV were 6.4%, 45.7% and 5%, respectively. Logistic regression analysis of factors associated with anti-HCV seropositivity included age (odds ratio/95% confidence interval [OR/CI]: 1.12/1.07-1.18, P<0.001), serum alanine aminotransferase (ALT) (OR/CI: 1.04/1.02-1.06, P<0.001) and platelet counts (OR/CI: 0.995/0.991-0.998, P = 0.002). Age was the only factor independently associated with HBsAg seropositivity (OR/CI: 1.08/1.02-1.14.4, P = 0.007). Compared to patients born before 1992, the sero-prevalence of HCV among thalassemic patients decreased dramatically in those born after 1992 (46.0% vs. 11.8%, p = 0.012). The seroprevalence of HCV among hemophilic patients also decreased significantly when comparing patients born before 1987 to those born after 1987 (79.5% vs. 11.5%, p<0.001). Similarly, the seroprevalence of HBV decreased significantly in the post-vaccination cohort compared to its counterpart (13.1%, vs. 1.3%, p = 0.005). The spontaneous clearance of HCV was observed in 25.4% (15/59) of patients, and ALT was the only factor associated with it (OR/CI 0.98/0.96-1.00, P = 0.02). Conclusions Both HBV and HCV infections are prevalent among transfusion-dependent thalassemic and hemophilic patients in Taiwan. Nevertheless, seroprevalence decreased significantly and dramatically for HCV after universal blood screening and for HBV after implementation of a universal mass vaccination program.	[Jang, Tyng-Yuan; Huang, Ching-I; Yeh, Ming-Lun; Liang, Po-Cheng; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Lin, Pei-Chin; Liao, Yu-Mei; Zeng, Yu-Sheng; Hsu, Wan-Yi; Chiou, Shyh-Shin; Yu, Ming-Lung] Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Pediat, Kaohsiung, Taiwan; [Lin, Pei-Chin; Liao, Yu-Mei; Zeng, Yu-Sheng; Hsu, Wan-Yi; Tsai, Shih-Pien; Chiou, Shyh-Shin] Kaohsiung Med Univ Hosp, Special Hematol Dis Serv Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long] Kaohsiung Med Univ, Sch Med, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Liang, Po-Cheng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Shih-Pien] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Dai, Chia-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan; [Yu, Ming-Lung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Yu, Ming-Lung] Harvard Med Sch, Massachusetts Gen Hosp, Div Gastroenterol, Ctr Liver, Boston, MA USA	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Huang, CF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan.; Chiou, SS (corresponding author), Kaohsiung Med Univ Hosp, Div Hematol & Oncol, Dept Pediat, Kaohsiung, Taiwan.; Chiou, SS (corresponding author), Kaohsiung Med Univ Hosp, Special Hematol Dis Serv Ctr, Kaohsiung, Taiwan.; Huang, CF (corresponding author), Kaohsiung Med Univ, Sch Med, Fac Internal Med, Coll Med, Kaohsiung, Taiwan.; Huang, CF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan.	fengcheerup@gmail.com; chiouss@kmu.edu.tw	Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021; Yu, Ming-Lung/AAZ-4306-2020; Dai, Chia-Yen/V-6560-2019	Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X; Yu, Ming-Lung/0000-0001-8145-1900; Dai, Chia-Yen/0000-0003-2296-3054; Tyng Yuan, Jang/0000-0003-2961-130X; LIAO, YU MEI/0000-0001-9916-9356	 [MOST 103-2314-B-037-055-MY3];  [KMUH104-4R06]	; 	This study was supported by MOST 103-2314-B-037-055-MY3 and KMUH104-4R06.; We thank all of the patients and their parents for their participation in this study. This work was supported in part by a grant from 1. MOST 103-2314-B-037-055-MY3 2. KMUH104-4R06	Alter HJ, 2000, NAT MED, V6, P1082, DOI 10.1038/80394; Barbosa AP, 2002, MEM I OSWALDO CRUZ, V97, P643, DOI 10.1590/S0074-02762002000500009; Chang MH, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021493; CHANG WY, 1992, J GASTROEN HEPATOL, V7, P128, DOI 10.1111/j.1440-1746.1992.tb00948.x; CHANG WY, 1992, J GASTROEN HEPATOL, V7, P455, DOI 10.1111/j.1440-1746.1992.tb01019.x; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; CHEN DS, 1990, J INFECT DIS, V162, P817, DOI 10.1093/infdis/162.4.817; CHEN DS, 1991, GASTROENTEROL JPN, V26, P164; Chiavetta JA, 2003, CAN MED ASSOC J, V169, P767; Chiou SS, 2006, DIGESTION, V74, P208, DOI 10.1159/000100506; Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x; Dai CY, 2007, GUT, V56, P737, DOI 10.1136/gut.2006.116384; Dai CY, 2010, J HEPATOL, V52, P160, DOI 10.1016/j.jhep.2009.11.017; Dai CY, 2004, DIGEST DIS SCI, V49, P1181, DOI 10.1023/B:DDAS.0000037809.87654.73; Di Marco V, 2012, HAEMATOL-HEMATOL J, V97, P679, DOI 10.3324/haematol.2011.050351; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; HOROWITZ MS, 1988, LANCET, V2, P186; Hou JinLin, 2005, International Journal of Medical Sciences, V2, P50; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Huang CF, 2008, T ROY SOC TROP MED H, V102, P929, DOI 10.1016/j.trstmh.2008.05.018; Huang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058882; Huang CF, 2012, J HEPATOL, V56, P34, DOI 10.1016/j.jhep.2011.03.029; Huang CF, 2009, PREV MED, V48, P397, DOI 10.1016/j.ypmed.2009.02.002; Katsanos KH, 2005, ANN GASTROENTEROL, V18, P56; Lai ME, 2013, EUR J HAEMATOL, V90, P501, DOI 10.1111/ejh.12086; Laperche S, 2005, Euro Surveill, V10, P3; Lin YY, 2009, SCAND J INFECT DIS, V41, P614, DOI 10.1080/00365540902875073; MacDonald M, 1996, EPIDEMIOL REV, V18, P137, DOI 10.1093/oxfordjournals.epirev.a017921; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mannucci PM, 2008, HAEMOPHILIA, V14, P10, DOI 10.1111/j.1365-2516.2008.01708.x; Maor Y, 2013, HAEMOPHILIA, V19, P150, DOI 10.1111/j.1365-2516.2012.02932.x; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Nagel K, 2011, HAEMOPHILIA, V17, P872, DOI 10.1111/j.1365-2516.2011.02506.x; Ni YH, 2010, PATHOL BIOL, V58, P296, DOI 10.1016/j.patbio.2009.11.002; Ni YH, 1996, PEDIATR RES, V39, P323, DOI 10.1203/00006450-199602000-00022; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Posthouwer D, 2007, BLOOD, V109, P3667, DOI 10.1182/blood-2006-08-038349; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Tu TC, 2013, YONSEI MED J, V54, P71, DOI 10.3349/ymj.2013.54.1.71; Vermehren J, 2011, J CLIN VIROL, V52, P133, DOI 10.1016/j.jcv.2011.07.007; Wait S, 2012, KAOHSIUNG J MED SCI, V28, P1, DOI 10.1016/j.kjms.2011.10.027; Yu ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000690; Yu ML, 2014, J HEPATOL, V60, P253, DOI 10.1016/j.jhep.2013.09.023; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976; Yu ML, 2000, J GASTROEN HEPATOL, V15, P1404, DOI 10.1046/j.1440-1746.2000.02359.x; Zhang MD, 2006, BLOOD, V107, P892, DOI 10.1182/blood-2005-07-2781	46	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178883	10.1371/journal.pone.0178883	http://dx.doi.org/10.1371/journal.pone.0178883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598970	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000012
J	Fusco, R; Gugliandolo, E; Campolo, M; Evangelista, M; Di Paola, R; Cuzzocrea, S				Fusco, Roberta; Gugliandolo, Enrico; Campolo, Michela; Evangelista, Maurizio; Di Paola, Rosanna; Cuzzocrea, Salvatore			Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome	PLOS ONE			English	Article							NOCICEPTIVE SENSITIZATION; INFLAMMATORY PAIN; NEUROPATHIC PAIN; MAST-CELLS; REPAIR; SUSPENSIONS; MECHANISMS; BEHAVIORS; MEDIATORS; RECEPTOR	Complex regional pain syndrome type 1 (CRPS-I) is a disabling and frequently chronic condition. It involves the extremities and is a frequent consequence of distal tibia and radius fractures. The inflamed appearance of the affected CRPS-I limb suggests that local production of inflammatory mediators may be implicated in the ensuing etiology. A rodent tibia fracture model, characterized by inflammation, chronic unilateral hindlimb warmth, edema, protein extravasation, allodynia and hyperalgesia resembles the clinical features of patients with acute CRPS-I. N-palmitoylethanolamine (PEA), a member of the family of naturally-occurring N-acylethanolamines, is well-known for its ability to modulate inflammatory processes and regulate pain sensitivity. However, the large particle size and lipidic nature of PEA may limit its bioavailability and solubility when given orally. Micronized formulations are frequently used to enhance the dissolution rate of drug and reduce its variability of absorption when orally administered. The aim of this study was to assess the effects of a formulation of micronized and ultramicronized PEA (PEA-MPS), given orally in a mouse model of CRPS-I. CD-1 male mice were subjected to distal tibia fracture and divided into two groups: control and treated with PEA-MPS (PEA micronized 300 mg/kg and ultramicronized 600 mg/kg). Sensibility to pain was monitored in all mice throughout the course of the experiment. Twenty-eight days after tibia fracture induction animals were sacrificed and biochemical parameters evaluated. The PEA-MPS-treated group showed an improved healing process, fracture recovery and fibrosis score. PEA-MPS administration decreased mast cell density, nerve growth factor, matrix metalloproteinase 9 and cytokine expression. This treatment also reduced (poly-ADP) ribose polymerase activation, peroxynitrite formation and apoptosis. Our results suggest that PEA-MPS may be a new therapeutic strategy in the treatment of CRPS-1.	[Fusco, Roberta; Gugliandolo, Enrico; Campolo, Michela; Di Paola, Rosanna; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, Rome, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Saint Louis University	Di Paola, R; Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	dipaolar@unime.it; salvator@unime.it	Campolo, Michela/K-6432-2016; FUSCO, Roberta/AAC-1745-2019; evangelista, maurizio/G-6820-2012; Gugliandolo, Enrico/AAB-9972-2019; Cuzzocrea, Salvatore/K-4734-2016; di paola, rosanna/U-4356-2019	FUSCO, Roberta/0000-0003-0223-1403; Gugliandolo, Enrico/0000-0001-6840-3154; di paola, rosanna/0000-0001-6725-8581; Evangelista, Maurizio/0000-0001-8438-3480; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690				ATTAL N, 1990, PAIN, V41, P235, DOI 10.1016/0304-3959(90)90022-6; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Birklein F, 2008, NEUROSCI LETT, V437, P199, DOI 10.1016/j.neulet.2008.03.081; BISRAT M, 1988, INT J PHARM, V47, P223, DOI 10.1016/0378-5173(88)90235-9; Coderre TJ, 2011, J PAIN, V12, P2, DOI 10.1016/j.jpain.2010.06.001; Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559; Dan H, 2009, J ANIM SCI, V87, P3544, DOI 10.2527/jas.2009-2068; Di Paola R, SHOCK AUGUSTA GA; Di Paola R, 2016, PHARMACOL RES, V111, P405, DOI 10.1016/j.phrs.2016.07.010; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Gradl G, 2004, PAIN, V112, P121, DOI 10.1016/j.pain.2004.08.007; Gradl G, 2006, NEUROSCI LETT, V402, P267, DOI 10.1016/j.neulet.2006.04.007; Guida F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00342-1; Guida F, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0139-5; Huygen FJPM, 2004, IMMUNOL LETT, V91, P147, DOI 10.1016/j.imlet.2003.11.013; Impellizzeri D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0136-0; Joshi J.T., 2011, J PHARMA SCI TECHNOL, V3, P651; LEE KC, 1994, ANESTHESIOLOGY, V81, P1284, DOI 10.1097/00000542-199411000-00024; Li WW, 2012, ANESTHESIOLOGY, V116, P882, DOI 10.1097/ALN.0b013e31824bb303; Li WW, 2009, PAIN, V144, P303, DOI 10.1016/j.pain.2009.04.033; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Luongo L, 2017, PHARMACOL RES, V119, P272, DOI 10.1016/j.phrs.2017.02.019; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Mannelli LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128080; Moalem G, 2006, BRAIN RES REV, V51, P240, DOI 10.1016/j.brainresrev.2005.11.004; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Oh DM, 1995, ARCH PHARM RES, V18, P427, DOI 10.1007/BF02976347; Okine BN, 2016, PAIN, V157, P2687, DOI 10.1097/j.pain.0000000000000687; Olusanmi D, 2014, POWDER TECHNOL, V258, P222, DOI 10.1016/j.powtec.2014.03.032; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Petrosino S, 2010, BIOCHIMIE, V92, P724, DOI 10.1016/j.biochi.2010.01.006; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Sabsovich I, 2008, PAIN, V137, P507, DOI 10.1016/j.pain.2007.10.013; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; SUDECK P, 1900, ARCH KLIN CHIR, V62, P147; Varenna M, 2015, CLIN CASES MINER BON, V12, P27, DOI 10.11138/ccmbm/2015.12.1.027; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178553	10.1371/journal.pone.0178553	http://dx.doi.org/10.1371/journal.pone.0178553			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594885	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200039
J	Mahfouz, N; Tahtouh, R; Alaaeddine, N; El Hajj, J; Sarkis, R; Hachem, R; Raad, I; Hilal, G				Mahfouz, Nadine; Tahtouh, Roula; Alaaeddine, Nada; El Hajj, Joelle; Sarkis, Riad; Hachem, Ray; Raad, Issam; Hilal, George			Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1 alpha and VEGF receptors	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; RANDOMIZED PHASE-III; PLUS CAPECITABINE; MITOCHONDRIAL-DNA; BREAST-CARCINOMA; 1ST-LINE THERAPY; EXPRESSION; DAMAGE; RESISTANCE	Background Targeting angiogenesis has been considered a promising treatment of choice for a large number of malignancies, including gastrointestinal cancers. Bevacizumab is an anti-vascular endothelial growth factor (anti-VEGF) being used for this purpose. However, treatment efficacy is largely questioned. Telomerase activity, responsible for cancer cell immortality, is detected in 85-95% of human cancers and is considered a potential regulator of VEGF. The aim of our study was to investigate the interrelationship between VEGF and hTERT in gastrointestinal cancers and to explore cell response to a combined inhibition of telomerase and VEGF. Methods AGS (gastric cancer), Caco-2 (colorectal cancer) and HepG2/C3A (hepatocellular carcinoma), were treated with telomerase inhibitors BIBR-1232 (10 mu M) and costunolide (10 mu M), with bevacizumab (Avastin (R) at 5 ng/ml or 100 mu g/ml) or with a combination of both types of inhibitors. VEGF and hTERT mRNA levels, and telomerase activity were detected by RTPCR. VEGF levels were quantified by ELISA. Telomerase was knocked down using hTERT siRNA and hTERT was overexpressed in the telomerase negative cell line, Saos-2 (osteosarcoma), using constructs expressing either wild type hTERT (hTERT-WT) or dominant negative hTERT (hTERT-DN). Tube formation by HUVECs was assessed using ECMatrix (TM) (EMD Millipore). Results Our results showed that telomerase regulates VEGF expression and secretion through its catalytic subunit hTERT in AGS, Caco2, and HepG2/C3A, independent of its catalytic activity. Interestingly, VEGF inhibition with bevacizumab (100 mu g/ml) increased hTERT expression 42.3% in AGS, 94.1% in Caco2, and 52.5% in HepG2/C3A, and increased telomerase activity 30-fold in AGS, 10.3-fold in Caco2 and 8-fold in HepG2/C3A. A further investigation showed that VEGF upregulates hTERT expression in a mechanism that implicates the PI3K/AKT/mTOR pathway and HIF-1 alpha. Moreover, bevacizumab treatment increased VEGFR1 and VEGFR2 expression in cancer cells and human umbilical vein endothelial cells (HUVECs) through hTERT. Thus, the combination of bevacizumab with telomerase inhibitors decreased VEGF expression and secretion by cancer cells, inhibited VEGFR1 and VEGFR2 upregulation, and reduced tube formation by HUVECs. Conclusions Taken together, our results suggest that bevacizumab treatment activates a VEGF autoregulatory mechanism involving hTERT and VEGF receptors and that an inhibition of this pathway could improve tumor cell response to anti-VEGF treatment.	[Mahfouz, Nadine; Tahtouh, Roula; El Hajj, Joelle; Hilal, George] St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon; [Alaaeddine, Nada] St Joseph Univ, Regenerat Med Lab, Fac Med, Beirut, Lebanon; [Sarkis, Riad] St Joseph Univ, Fac Med, Beirut, Lebanon; [Sarkis, Riad] Hotel Dieu France, Surg Dept, Beirut, Lebanon; [Hachem, Ray; Raad, Issam] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Hilal, G (corresponding author), St Joseph Univ, Canc & Metab Lab, Fac Med, Beirut, Lebanon.	george.hilal@usj.edu.lb	Tahtouh, Roula/ABD-4322-2020; HAJJ, Joëlle EL/AAG-9136-2020	HAJJ, Joëlle EL/0000-0002-9637-102X; Mahfouz, Nadine/0000-0001-7592-1574; Hilal, George/0000-0001-7629-4090	Research Council of Saint-Joseph University; Lebanese National Council for Scientific Research (CNRS)	Research Council of Saint-Joseph University; Lebanese National Council for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Research Council of Saint-Joseph University and the Lebanese National Council for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcic U, 2012, NEOPLASIA, V14, P612, DOI 10.1593/neo.11948; Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Bachelder RE, 2001, CANCER RES, V61, P5736; Bagheri S, 2006, P NATL ACAD SCI USA, V103, P11306, DOI 10.1073/pnas.0510085103; Belair CD, 1997, P NATL ACAD SCI USA, V94, P13677, DOI 10.1073/pnas.94.25.13677; Bennudez Y, 2007, GYNECOL ONCOL, V106, P526, DOI 10.1016/j.ygyno.2007.05.005; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Geserick C, 2006, ONCOGENE, V25, P4310, DOI 10.1038/sj.onc.1209465; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; Santos JH, 2006, HUM MOL GENET, V15, P1757, DOI 10.1093/hmg/ddl098; Hsu CH, 2010, BRIT J CANCER, V102, P981, DOI 10.1038/sj.bjc.6605580; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Lanahan AA, 2010, DEV CELL, V18, P713, DOI 10.1016/j.devcel.2010.02.016; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Paiva TF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1648-4; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sullivan LA, 2010, MABS-AUSTIN, V2, P165, DOI 10.4161/mabs.2.2.11360; Vale P R, 2001, J Interv Cardiol, V14, P511, DOI 10.1111/j.1540-8183.2001.tb00367.x; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xiang H, 2002, ONCOGENE, V21, P3784, DOI 10.1038/sj.onc.1205455; Yanagisawa M, 2010, ANTI-CANCER DRUG, V21, P687, DOI 10.1097/CAD.0b013e32833b7598; Yatabe N, 2004, ONCOGENE, V23, P3708, DOI 10.1038/sj.onc.1207460; Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200; Zeng HY, 2001, J BIOL CHEM, V276, P32714, DOI 10.1074/jbc.M103130200; Zhou LL, 2009, BIOCHEM BIOPH RES CO, V386, P739, DOI 10.1016/j.bbrc.2009.06.116	50	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179202	10.1371/journal.pone.0179202	http://dx.doi.org/10.1371/journal.pone.0179202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594907	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200102
J	Norwood, MS; Lupo, PJ; Chow, EJ; Scheurer, ME; Plon, SE; Danysh, HE; Spector, LG; Carozza, SE; Doody, DR; Mueller, BA				Norwood, Marlena S.; Lupo, Philip J.; Chow, Eric J.; Scheurer, Michael E.; Plon, Sharon E.; Danysh, Heather E.; Spector, Logan G.; Carozza, Susan E.; Doody, David R.; Mueller, Beth A.			Childhood cancer risk in those with chromosomal and non-chromosomal congenital anomalies in Washington State: 1984-2013	PLOS ONE			English	Article							CHILDRENS ONCOLOGY GROUP; BIRTH-DEFECTS; INTERSTITIAL DELETION; RECORD-LINKAGE; ACUTE-LEUKEMIA; DOWN-SYNDROME; RETINOBLASTOMA; CLASSIFICATION; ABNORMALITIES; CERTIFICATES	Background The presence of a congenital anomaly is associated with increased childhood cancer risk, likely due to large effects of Down syndrome and chromosomal anomalies for leukemia. Less is known about associations with presence of non-chromosomal anomalies. Methods Records of children diagnosed with cancer at <20 years of age during 1984-2013 in Washington State cancer registries were linked to their birth certificates (N = 4,105). A comparison group of children born in the same years was identified. Congenital anomalies were assessed from birth records and diagnosis codes in linked hospital discharge data. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for cancer, and for specific cancer types in relation to the presence of any anomaly and specific anomalies. Results Having any congenital anomaly was associated with an increased risk of childhood cancer (OR: 1.46, 95% CI 1.28-1.65). Non-chromosomal anomalies were also associated with increased childhood cancer risk overall (OR: 1.35; 95% CI: 1.18-1.54), and with increased risk of several cancer types, including neuroblastoma, renal, hepatoblastoma, soft-tissue sarcoma, and germ cell tumors. Increasing number of non-chromosomal anomalies was associated with a stronger risk of childhood cancer (OR for 3+ anomalies: 3.11, 95% CI: 1.54-6.11). Although central nervous system (CNS) anomalies were associated with CNS tumors (OR: 6.05, 95% CI 2.75-13.27), there was no strong evidence of other non-chromosomal anomalies being specifically associated with cancer occurring in the same organ system or anatomic location. Conclusions Non-chromosomal anomalies increased risk of several cancer types. Additionally, we found that increasing number of non-chromosomal anomalies was associated with a stronger risk of cancer. Pooling similar data from many regions would increase power to identify specific associations in order to inform molecular studies examining possible common developmental pathways in the etiologies of birth defects and cancer.	[Norwood, Marlena S.; Chow, Eric J.; Mueller, Beth A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Norwood, Marlena S.; Doody, David R.; Mueller, Beth A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lupo, Philip J.; Scheurer, Michael E.; Plon, Sharon E.; Danysh, Heather E.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Chow, Eric J.] Seattle Childrens Hosp, Seattle, WA USA; [Spector, Logan G.] Univ Minnesota, Dept Pediat, Div Epidemiol Clin Res, Minneapolis, MN 55455 USA; [Carozza, Susan E.] Oregon State Univ, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Baylor College of Medicine; Seattle Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities; Oregon State University	Lupo, PJ (corresponding author), Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA.	Philip.Lupo@bcm.edu	Chow, Eric/GWV-1056-2022; Chow, Eric/AAU-8380-2021; Lupo, Philip/R-8314-2019	Chow, Eric/0000-0001-7712-961X; Chow, Eric/0000-0001-7712-961X; Lupo, Philip/0000-0003-0978-5863; Scheurer, Michael/0000-0002-8379-6088; Spector, Logan/0000-0003-2516-0222; Doody, David/0000-0003-2291-6493; Danysh, Heather/0000-0003-3014-7508	Alex's Lemonade Stand Foundation for childhood Cancer; Cancer Prevention & Research Institute of Texas [CPRIT RP140258]	Alex's Lemonade Stand Foundation for childhood Cancer; Cancer Prevention & Research Institute of Texas	This project was supported, in part,by research support from the Alex's Lemonade Stand Foundation for childhood Cancer (B. Mueller and P. Lupo), as well as the Cancer Prevention & Research Institute of Texas (CPRIT RP140258; P. Lupo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported, in part, by research support from the Alex's Lemonade Stand Foundation for Childhood Cancer (B. Mueller and P. Lupo), as well as the Cancer Prevention & Research Institute of Texas (CPRIT RP140258; P. Lupo). We also thank the Washington State Department of Health for Data Access and Mr. Bill O'Brien for programming and data management assistance.	Agha MM, 2005, CANCER-AM CANCER SOC, V103, P1939, DOI 10.1002/cncr.20985; Altmann AE, 1998, BRIT J CANCER, V78, P1244, DOI 10.1038/bjc.1998.662; Bjorge T, 2008, CANCER EPIDEM BIOMAR, V17, P500, DOI 10.1158/1055-9965.EPI-07-2630; Botto LD, 1997, AM J MED GENET, V71, P8, DOI 10.1002/(SICI)1096-8628(19970711)71:1<8::AID-AJMG2>3.0.CO;2-V; Botto LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069077; BUNIN GR, 1989, J NATL CANCER I, V81, P370, DOI 10.1093/jnci/81.5.370; Carozza SE, 2012, AM J EPIDEMIOL, V175, P1217, DOI 10.1093/aje/kwr470; Christianson A, 2006, GLOBAL REPORT BIRTH; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Fisher PG, 2012, J PEDIATR-US, V160, P978, DOI 10.1016/j.jpeds.2011.12.006; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Janitz AE, 2016, BIRTH DEFECTS RES A, V106, P633, DOI 10.1002/bdra.23494; Linabery AM, 2006, PEDIATRICS, V118, pE1499, DOI 10.1542/peds.2006-0644; Lydon-Rochelle MT, 2005, PAEDIATR PERINAT EP, V19, P460, DOI 10.1111/j.1365-3016.2005.00682.x; Lydon-Rochelle MT, 2005, AM J OBSTET GYNECOL, V193, P125, DOI 10.1016/j.ajog.2005.02.096; Madsen NL, 2013, CONGENIT HEART DIS, V8, P131, DOI 10.1111/j.1747-0803.2012.00714.x; MOTEGI T, 1983, HUM GENET, V64, P160, DOI 10.1007/BF00327116; Narod SA, 1997, AM J HUM GENET, V60, P474; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Ognjanovic S, 2009, PEDIATR BLOOD CANCER, V52, P602, DOI 10.1002/pbc.21914; PARRISH KM, 1993, AM J EPIDEMIOL, V138, P119, DOI 10.1093/oxfordjournals.aje.a116834; Rankin J, 2008, PEDIATR BLOOD CANCER, V51, P608, DOI 10.1002/pbc.21682; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910	25	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179006	10.1371/journal.pone.0179006	http://dx.doi.org/10.1371/journal.pone.0179006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594943	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200077
J	Pannacciulli, FG; Maltagliati, F; de Guttry, C; Achituv, Y				Pannacciulli, Federica G.; Maltagliati, Ferruccio; de Guttry, Christian; Achituv, Yair			Phylogeography on the rocks: The contribution of current and historical factors in shaping the genetic structure of Chthamalus montagui (Crustacea, Cirripedia)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; INTERTIDAL BARNACLES; NORTHEAST ATLANTIC; MEDITERRANEAN SEA; STELLATUS POLI; EXPANSION; BIODIVERSITY; CONNECTIVITY; EXISTENCE	The model marine broadcast-spawner barnacle Chthamalus montagui was investigated to understand its genetic structure and quantify levels of population divergence, and to make inference on historical demography in terms of time of divergence and changes in population size. We collected specimens from rocky shores of the north-east Atlantic Ocean (4 locations), Mediterranean Sea (8) and Black Sea (1). The 312 sequences 537 bp) of the mitochondrial cytochrome c oxidase I allowed to detect 130 haplotypes. High within-location genetic variability was recorded, with haplotype diversity ranging between h = 0.750 and 0.967. Parameters of genetic divergence, haplotype network and Bayesian assignment analysis were consistent in rejecting the hypothesis of panmixia. C. montagui is genetically structured in three geographically discrete populations, which corresponded to north-eastern Atlantic Ocean, western-central Mediterranean Sea, and Aegean Sea-Black Sea. These populations are separated by two main effective barriers to gene flow located at the Almeria-Oran Front and in correspondence of the Cyclades Islands. According to the ` isolation with migration' model, adjacent population pairs diverged during the early to middle Pleistocene transition, a period in which geological events provoked significant changes in the structure and composition of palaeocommunities. Mismatch distributions, neutrality tests and Bayesian skyline plots showed past population expansions, which started approximately in the Mindel-Riss interglacial, in which ecological conditions were favourable for temperate species and calcium-uptaking marine organisms.	[Pannacciulli, Federica G.; de Guttry, Christian] ENEA Marine Environm Res Ctr, La Spezia, Italy; [Maltagliati, Ferruccio; de Guttry, Christian] Univ Pisa, Dept Biol, Pisa, Italy; [Achituv, Yair] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Italian National Agency New Technical Energy & Sustainable Economics Development; University of Pisa; Bar Ilan University	Maltagliati, F (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	ferruccio.maltagliati@unipi.it	Maltagliati, Ferruccio/L-2617-2014	Maltagliati, Ferruccio/0000-0002-4683-8648	Israel Science Foundation (ISF) [574/14]	Israel Science Foundation (ISF)(Israel Science Foundation)	The research was supported by grant 574/14 of the Israel Science Foundation (ISF) to YA: "Following Darwin: The evolution of the acorn barnacles".	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARNES H, 1956, J MAR BIOL ASSOC UK, V35, P631, DOI 10.1017/S002531540001047X; Bertini A, 2010, QUATERN INT, V219, P95, DOI 10.1016/j.quaint.2009.10.026; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Burrows MT, 1999, J MAR BIOL ASSOC UK, V79, P93, DOI 10.1017/S0025315498000101; BURROWS MT, 1992, J EXP MAR BIOL ECOL, V160, P229, DOI 10.1016/0022-0981(92)90240-B; Burrows MT, 1988, COMP BIOL CHTHAMALUS; Cheang CC, 2012, J BIOGEOGR, V39, P1819, DOI 10.1111/j.1365-2699.2012.02742.x; Cita MB, 2006, EPISODES, V29, P107, DOI 10.18814/epiiugs/2006/v29i2/004; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crisp D., 1976, PERSPECTIVES EXPT BI, V1, P145; CRISP DJ, 1981, J MAR BIOL ASSOC UK, V61, P359, DOI 10.1017/S0025315400047007; Dando B.R., 1987, Crustacean Issues, V5, P73; DANDO PR, 1979, J MAR BIOL ASSOC UK, V59, P307, DOI 10.1017/S0025315400042612; DANDO PR, 1981, MAR BIOL LETT, V2, P239; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foglini F, 2015, GEOLOGY ARCHAEOLOGY; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Govindarajan AF, 2015, PEERJ, V3, DOI 10.7717/peerj.926; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Held C, 2011, CRUSTACEAN ISS, V19, P1; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Howard WR, 1997, NATURE, V388, P418, DOI 10.1038/41201; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; HUDSON RR, 1992, GENETICS, V132, P583; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MALANOTTERIZZOLI P, 1989, OCEANOL ACTA, V12, P335; Maltagliati F, 2004, BIOL J LINN SOC, V83, P101, DOI 10.1111/j.1095-8312.2004.00374.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Mieszkowska N, 2014, J MARINE SYST, V133, P70, DOI 10.1016/j.jmarsys.2012.11.008; Mudie PJ, 2002, MAR GEOL, V190, P203, DOI 10.1016/S0025-3227(02)00348-1; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; O'Riordan RM, 2004, J EXP MAR BIOL ECOL, V304, P243, DOI 10.1016/j.jembe.2003.12.005; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pannacciulli FG, 1997, MAR BIOL, V128, P73, DOI 10.1007/s002270050070; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Pektas H., 1958, RAPPORTS PROCES VERB, V14, P85; Perez-Losada M, 2007, MOL ECOL, V16, P2667, DOI 10.1111/j.1365-294X.2007.03333.x; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ryan WBF, 1999, NEW SCI DISCOVERIES; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Sayin E, 2011, J MARINE SYST, V88, P502, DOI 10.1016/j.jmarsys.2011.06.005; Schneider S, 1999, GENETICS, V152, P1079; Shemesh E, 2009, ZOOL SCR, V38, P365, DOI 10.1111/j.1463-6409.2008.00384.x; Slatkin Montgomery, 1994, P3; Sousa EB, 2000, HYDROBIOLOGIA, V440, P339, DOI 10.1023/A:1004160203187; SOUTHWARD AJ, 1991, J MAR BIOL ASSOC UK, V71, P495, DOI 10.1017/S002531540005311X; STRATHMANN R, 1974, AM NAT, V108, P29, DOI 10.1086/282883; Svitoch AA, 2000, OCEANOLOGY+, V40, P868; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; Fernandez MV, 2011, MAR ECOL PROG SER, V421, P163, DOI 10.3354/meps08881; Wares JP, 2001, MOL PHYLOGENET EVOL, V18, P104, DOI 10.1006/mpev.2000.0857; Wu TH, 2015, MAR ECOL-EVOL PERSP, V36, P368, DOI 10.1111/maec.12146	71	12	12	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178287	10.1371/journal.pone.0178287	http://dx.doi.org/10.1371/journal.pone.0178287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594840	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200024
J	Da, CJ; Shen, BL; Yan, PC; Ma, DS; Song, J				Da, ChaoJiu; Shen, BingLu; Yan, PengCheng; Ma, DeShan; Song, Jian			The shallow water equation and the vorticity equation for a change in height of the topography	PLOS ONE			English	Article								We consider the shallow water equation and the vorticity equations for a variable height of topography. On the assumptions that the atmosphere is incompressible and a constant density, we simplify the coupled dynamic equations. The change in topographic height is handled as the sum of the inherent and changing topography using the perturbation method, together with appropriate boundary conditions of the atmosphere, to obtain the relationship between the relative height of the flow, the inherent topography and the changing topography. We generalize the conservation of the function of relative position, and quantify the relationship between the height of the topography and the relative position of a fluid element. If the height of the topography increases (decreases), the relative position of a fluid element descends (ascends). On this basis, we also study the relationship between the vorticity and the topography to find the vorticity decreasing (increasing) for an increasing (decreasing) height of the topography.	[Da, ChaoJiu; Ma, DeShan] Northwest Univ Nationalities, Sch Math, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu; Ma, DeShan] Northwest Univ Nationalities, Comp Sci Inst, Lanzhou, Gansu, Peoples R China; [Da, ChaoJiu] Lanzhou Univ, Coll Atmospher Sci, Lanzhou, Gansu, Peoples R China; [Shen, BingLu] Chengdu Univ Informat Technol, Coll Atmospher Sci, Chengdu, Sichuan, Peoples R China; [Yan, PengCheng] CMA, Inst Arid Meteorol, Lanzhou, Gansu, Peoples R China; [Song, Jian] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China	Northwest Minzu University; Northwest Minzu University; Lanzhou University; Chengdu University of Information Technology; China Meteorological Administration; Inner Mongolia University of Technology	Song, J (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Inner Mongolia, Peoples R China.	dmwsj@163.com		Da, ChaoJiu/0000-0003-3171-704X	National Natural Science Foundation of China [41465002, 41530531, 41375038]; National Basic Research Program of China [2013CB430204]; key Special Scientific Research Fund of Meteorological Public Welfare Profession of China [GYHY201506001]; Science Research Project of the Inner Mongolian Autonomous Region high school [NJZY16006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); key Special Scientific Research Fund of Meteorological Public Welfare Profession of China; Science Research Project of the Inner Mongolian Autonomous Region high school	This project is supported by the National Natural Science Foundation of China (Grant Nos. 41465002, 41530531, 41375038), the National Basic Research Program of China (Grant No. 2013CB430204), the key Special Scientific Research Fund of Meteorological Public Welfare Profession of China (Grant No. GYHY201506001) and the Science Research Project of the Inner Mongolian Autonomous Region high school (Grant No.NJZY16006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[毕宝贵 BI Baogui], 2006, [高原气象, Plateau Meteorology], V25, P485; Chao JiPing, 1957, ACTA METEOROL SIN, V28, P59; Chao-Jiu D, 2008, ACTA PHYS SIN-CH ED, V57, P2595, DOI 10.7498/aps.57.2595; [陈斌 CHEN Bin], 2006, [高原气象, Plateau Meteorology], V25, P406; Da CJ, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.039202; Da Chaojiu, 2011, PLATEAU METEOR, V30, P349; Feng GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167387; Feng GL, 2013, SCI CHINA EARTH SCI, V56, P1576, DOI 10.1007/s11430-012-4527-8; Guo BingRong, 1990, INTRO LINEAR NONLINE, p30 ; HUANG JP, 1992, SCI CHINA SER B, V35, P207; Joseph Pedlosky, 1986, GEOPHYS FLUID DYN, P7; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; [廖菲 LIAO Fei], 2009, [高原气象, Plateau Meteorology], V28, P115; [穆穆 Mu Mu], 2011, [气象, Meteorological Monthly], V37, P1; Mu Mu, 1995, SCI ATMOSPHERICA SIN, V19, P494; Sun GQ, 2017, NONLINEAR DYNAM, V88, P1385, DOI 10.1007/s11071-016-3317-9; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Wang Bing, 1981, GEOPHYS FLUID DYN, P7; Wu YP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26470; Wu YP, 2015, APPL MATH COMPUT, V268, P478, DOI 10.1016/j.amc.2015.06.059; Wu YP, 2012, ECOL COMPLEX, V9, P63, DOI 10.1016/j.ecocom.2011.12.002; [徐辉 Xu Hui], 2010, [高原气象, Plateau Meteorology], V29, P957; Ye DuZhen, 1966, QINGHAI XIZANG PLATE, P1	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178184	10.1371/journal.pone.0178184	http://dx.doi.org/10.1371/journal.pone.0178184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591129	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700022
J	Kadoglou, NPE; Biddulph, JP; Rafnsson, SB; Trivella, M; Nihoyannopoulos, P; Demakakos, P				Kadoglou, Nikolaos P. E.; Biddulph, Jane P.; Rafnsson, Snorri B.; Trivella, Marialena; Nihoyannopoulos, Petros; Demakakos, Panayotes			The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing	PLOS ONE			English	Article							SERUM FERRITIN; IRON-METABOLISM; RISK-FACTORS; DISEASE; HEALTH; TRANSFUSION; POPULATION; SURVIVAL	Background Ferritin constitutes a sensitive iron-storage index and multi-functional protein. Evidence on its association with mortality in general population is scarce and conflicting. We investigated the sex-specific associations of ferritin levels with all-cause and cardiovascular mortality in a population-based cohort. Methods Data came from the English Longitudinal Study of Ageing and the national mortality registry. The sample comprised 5,471 participants aged >= 52 years. Blood concentration of ferritin was measured at baseline in 2004-05. Sex-specific Cox proportional hazards models were estimated with adjustment for age, major chronic diseases, marital status, educational attainment, total net household wealth, anemia, inflammatory markers, body mass index, smoking, and physical activity. Stratified analyses by chronic disease status were also performed. Results We categorized ferritin in sex-specific quartiles. In men, we used, the following categorization: lowest (2-69ng/ml), second lowest (70-118ng/ml), second highest (reference category) (119-193ng/ml) and highest (194-598ng/ml) ferritin quartiles. In women, ferritin was categorized as follows: lowest (2-44ng/ml), second lowest (45-73ng/ml), second highest (reference category) (74-115ng/ml) and highest (116-341ng/ml) ferritin quartiles. 841 deaths of which 262 cardiovascular disease-related were recorded over a mean follow-up time of 7.7 years. Risk for all-cause mortality was found increased in men with hyperferritinemia (194-598ng/ml) and no history of major chronic diseases compared with the reference group [fully-adjusted HR: 1.49 (95%CI 1.03-2.16)]. Among women, those in the lowest ferritin quartile (2-44ng/ml) had increased risk for all-cause mortality [fully-adjusted HR: 1.59 (95% CI 1.18-2.13)] compared with the reference group after adjustment for all covariates. Regarding cardiovascular mortality, we observed a positive association with ferritin levels in men, which was blunted after adjustment for inflammatory markers and lifestyle parameters. Men with no major chronic diseases who were in the highest ferritin quartile had a significantly increased risk of cardiovascular mortality. No association between ferritin levels and cardiovascular mortality was detected in women. Conclusion Circulating ferritin levels showed sex-specific prognostic patterns. High ferritin levels in men with no major chronic disease and low ferritin levels in all women were associated with increased all-cause mortality after adjusting for covariates. High ferritin levels in men with no major chronic diseases were also independently associated with an increased risk of cardiovascular mortality. Future research is needed to clarify the prognostic role of ferritin.	[Kadoglou, Nikolaos P. E.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Kadoglou, Nikolaos P. E.; Trivella, Marialena] Univ Oxford, BOTNAR Res Ctr, Ctr Stat Med, Oxford, England; [Biddulph, Jane P.; Rafnsson, Snorri B.; Demakakos, Panayotes] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Nihoyannopoulos, Petros] Imperial Coll, Hammersmith Hosp, London, England	Catharina Hospital; University of Oxford; University of London; University College London; Imperial College London	Trivella, M (corresponding author), Univ Oxford, BOTNAR Res Ctr, Ctr Stat Med, Oxford, England.	marialena.trivella@csm.ox.ac.uk	Rafnsson, Snorri/AAH-1371-2020; Kadoglou, Nikolaos/AAA-8639-2021	Rafnsson, Snorri/0000-0002-7985-912X; Trivella, Marialena/0000-0003-4492-1760; Kadoglou, Nikolaos/0000-0002-7830-3488; Demakakos, Panayotes/0000-0002-7663-2122	National Institute on Aging [2R01AG7644-01A1, 2R01AG017644]; consortium of UK government; Cancer Research UK [C5529/A16895]; Cancer Research UK [16895] Funding Source: researchfish	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of UK government; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The English Longitudinal Study of Ageing is funded by the National Institute on Aging (Grants 2R01AG7644-01A1 and 2R01AG017644) and by a consortium of UK government departments coordinated by the Office for National Statistics. Dr Nikolaos Kadoglou was granted as a clinical fellow by the European Heart Rhythm Association. Dr Marialena Trivella was supported by a Cancer Research UK grant (number: C5529/A16895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, VIT MIN NUTR INF SYS; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Das SK, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003456; Dominguez-Rodriguez A, 2011, INT J CARDIOL, V152, P129, DOI 10.1016/j.ijcard.2011.07.052; Eftekhari MH, 2013, INT J PREVENTIVE MED, V4, P911; Ellervik C, 2014, CLIN CHEM, V60, P1419, DOI 10.1373/clinchem.2014.229013; Fan YQ, 2011, INT J CARDIOL, V152, P49, DOI 10.1016/j.ijcard.2010.07.005; Fonseca-Nunes A, 2014, CANCER EPIDEM BIOMAR, V23, P12, DOI 10.1158/1055-9965.EPI-13-0733; Friedrich N, 2009, BRIT J NUTR, V102, P594, DOI 10.1017/S000711450922085X; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Grammer TB, 2014, ATHEROSCLEROSIS, V236, P292, DOI 10.1016/j.atherosclerosis.2014.07.002; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ji M, 2014, TUMOR BIOL, V35, P10195, DOI 10.1007/s13277-014-2317-y; Kim Ki-Su, 2012, J Prev Med Public Health, V45, P196, DOI 10.3961/jpmph.2012.45.3.196; Knovich MA, 2009, BLOOD REV, V23, P95, DOI 10.1016/j.blre.2008.08.001; Marniemi J, 1998, INT J EPIDEMIOL, V27, P799, DOI 10.1093/ije/27.5.799; Menke A, 2012, NUTR METAB CARDIOVAS, V22, P734, DOI 10.1016/j.numecd.2010.11.011; Milman N, 2000, ANN HEMATOL, V79, P612, DOI 10.1007/s002770000209; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Oliveira F, 2014, J CLIN LAB ANAL, V28, P210, DOI 10.1002/jcla.21668; Ponikowska B, 2013, DIABETES CARE, V36, P4147, DOI 10.2337/dc13-0528; Rushton DH, 2010, CRIT REV ONCOL HEMAT, V73, P1, DOI 10.1016/j.critrevonc.2009.03.010; Sempos CT, 2000, ANN EPIDEMIOL, V10, P441, DOI 10.1016/S1047-2797(00)00068-5; Shander A, 2014, TRANSFUS MED REV, V28, P156, DOI 10.1016/j.tmrv.2014.05.001; Stack AG, 2014, QJM-INT J MED, V107, P623, DOI 10.1093/qjmed/hcu045; Sun Q, 2008, J NUTR, V138, P2436, DOI 10.3945/jn.108.097766; Sung KC, 2007, ARCH MED RES, V38, P121, DOI 10.1016/j.arcmed.2006.08.008; Takatoku M, 2007, EUR J HAEMATOL, V78, P487, DOI 10.1111/j.1600-0609.2007.00842.x; Thulluri S, 2012, ANN CLIN LAB SCI, V42, P145; Tran TN, 1997, BLOOD, V90, P4979, DOI 10.1182/blood.V90.12.4979.4979_4979_4986; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8	32	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178994	10.1371/journal.pone.0178994	http://dx.doi.org/10.1371/journal.pone.0178994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591160	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700068
J	Zhu, YQ; Xiong, K; Shi, JC; Cui, QH; Xue, LX				Zhu, Yuequan; Xiong, Kai; Shi, Jiangcheng; Cui, Qinghua; Xue, Lixiang			A potential role of microRNAs in protein accumulation in cellular senescence analyzed by bioinformatics	PLOS ONE			English	Article							CANCER; CELLS	Cellular senescence is an important protective mechanism against cell proliferation and has critical roles in aging and aging-related disease. Recently, one interesting observation is that the protein abundance is higher in senescent cells than that in young cells. So far, some factors were presented to interpret this observation, such as active protein synthesis linked with autophagy, mTOR, and oxidative stress. Here, applying bioinformatic analysis of microRNA profiles in young cells and aging cells, we revealed that globally senescent cells show lower miRNA abundance than that in young cells, suggesting that the repression of protein synthesis by miRNA in senescent cells could be largely attenuated. This finding provides clues that protein accumulation in cellular senescence could be associated with lower miRNA abundance in aging cells.	[Zhu, Yuequan; Xiong, Kai; Xue, Lixiang] Peking Univ, Hosp 3, Dept Radiat Oncol, Med Res Ctr, Beijing, Peoples R China; [Shi, Jiangcheng; Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing, Peoples R China	Peking University; Peking University	Xue, LX (corresponding author), Peking Univ, Hosp 3, Dept Radiat Oncol, Med Res Ctr, Beijing, Peoples R China.; Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; lixiangxue@hsc.pku.edu.cn	Jiangcheng, Shi/ABF-7858-2021	xue, lixiang/0000-0003-1507-7193; Shi, Jiangcheng/0000-0001-9934-4556	National Natural Science Foundation of China [81541142, 81672091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	None of the authors in this manuscript are employed or contracted by the National Natural Science Foundation of China (NSFC No.81541142, No.81672091, http://www.nsfagov.cn). As the funder, NSFC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen X, 2016, ONCOTARGET, V7, P65257, DOI 10.18632/oncotarget.11251; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21106; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Li JQ, 2017, ONCOTARGET, V8, P21187, DOI 10.18632/oncotarget.15061; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Markowski DN, 2013, GENES NUTR, V8, P449, DOI 10.1007/s12263-013-0354-6; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Narita M, 2009, AUTOPHAGY, V5, P1046, DOI 10.4161/auto.5.7.9444; Narita M, 2010, AGING-US, V2, P311, DOI 10.18632/aging.100145; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Wu H, 2013, TRENDS CARDIOVASCULA; You ZH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005455	17	6	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179034	10.1371/journal.pone.0179034	http://dx.doi.org/10.1371/journal.pone.0179034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591170	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700074
J	Contreras, F; Albacete, A; Tebe, C; Benejam, B; Cano, A; Menchon, JM				Contreras, Fernando; Albacete, Auria; Tebe, Cristian; Benejam, Bessy; Cano, Agnes; Manuel Menchon, Jose			Patients with schizophrenia activate behavioural intentions facilitated by counterfactual reasoning	PLOS ONE			English	Article							NEUROCOGNITIVE DEFICITS; COGNITION; REMISSION; THINKING	Previous research has associated schizophrenia with an inability to activate behavioural intentions facilitated by counterfactual thinking (CFT) as a step to improving performance. Consequently, these findings suggest that rehabilitation strategies will be entirely ineffective. To extend previous research, we evaluated the influence of CFT in the activation of behavioural intentions using a novel sequential priming paradigm in the largest sample of subjects explored to date. Method The main variables assessed were: answer to complete a target task (wrong or correctly), and percentage gain in the reaction time (RT) to complete a target task correctly depending on whether the prime was a counterfactual or a neutral-control cue. These variables were assessed in 37 patients with schizophrenia and 37 healthy controls. Potential associations with clinical status and socio-demographic characteristics were also explored. Results When a counterfactual prime was presented, the probability of giving an incorrect answer was lower for the entire sample than when a neutral prime was presented (OR 0.58; CI 95% 0.42 to 0.79), but the schizophrenia patients showed a higher probability than the controls of giving an incorrect answer (OR 3.89; CI 95% 2.0 to 7.6). Both the schizophrenia patients and the controls showed a similar percentage gain in RT to a correct answer of 8%. Conclusions Challenging the results of previous research, our findings suggest a normal activation of behavioural intentions facilitated by CFT in schizophrenia. Nevertheless, the patients showed more difficulty than the controls with the task, adding support to the concept of CFT as a potential new target for consideration in future therapeutic approaches for this illness.	[Contreras, Fernando; Albacete, Auria; Benejam, Bessy; Manuel Menchon, Jose] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Lhospitalet De Llobregat, Spain; [Contreras, Fernando; Albacete, Auria; Manuel Menchon, Jose] Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Spain; [Contreras, Fernando; Albacete, Auria; Manuel Menchon, Jose] Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos Hlth Inst 3, Barcelona, Spain; [Tebe, Cristian] Bellvitge Biomed Inst IDIBELL, Stat Advisory Serv, Lhospitalet De Llobregat, Spain; [Tebe, Cristian] Univ Rovira & Virgili, Fac Med & Hlth Sci, Tarragona, Spain; [Cano, Agnes] Univ Girona, Dept Psychol, Girona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Rovira i Virgili; Universitat de Girona	Contreras, F (corresponding author), Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Lhospitalet De Llobregat, Spain.; Contreras, F (corresponding author), Univ Barcelona, Sch Med, Dept Clin Sci, Lhospitalet De Llobregat, Spain.; Contreras, F (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Carlos Hlth Inst 3, Barcelona, Spain.	fcontreras@bellvitgehospital.cat	Tebé, Cristian/K-1991-2019; Contreras, Fernando/S-5217-2017; Menchon, Jose/A-5242-2009	Tebé, Cristian/0000-0003-2320-1385; Contreras, Fernando/0000-0003-2929-2804; Menchon, Jose/0000-0002-6231-6524; Albacete Belzunces, Auria/0000-0003-4156-4972	Spanish Ministry of Science and Innovation; Carlos III Health Institute [PI08/1118]; University of Barcelona (APIF-UB grants)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute(Instituto de Salud Carlos III); University of Barcelona (APIF-UB grants)	Support was provided by Spanish Ministry of Science and Innovation, the Carlos III Health Institute (PI08/1118) [http://www.isciii.es/]; University of Barcelona (APIF-UB grants) [http://www.ub.edu/web/ub/ca/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacete A, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02048; Albacete A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00665; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; APA, 1987, DIAGN STAT MAN MENT, V3rd; APA, 2000, DIAGN STAT MAN MENT; Brandstatter V, 2001, J PERS SOC PSYCHOL, V81, P946, DOI 10.1037//0022-3514.81.5.946; Byrne RMJ, 2016, ANNU REV PSYCHOL, V67, P135, DOI 10.1146/annurev-psych-122414-033249; Censits DM, 1997, SCHIZOPHR RES, V24, P289, DOI 10.1016/S0920-9964(96)00091-6; Contreras F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148440; Crespo-Facorro B, 2011, PSYCHOL MED, V41, P1449, DOI 10.1017/S003329171000200X; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; First M. B., 1997, STRUCTURED CLIN INTE; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Galinsky AD., 2005, PSYCHOL COUNTERFACTU, P110; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Gollwitzer PM, 1996, SOCIAL PSYCHOL HDB B, P361; Green MF, 1996, AM J PSYCHIAT, V153, P321; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hooker C, 2000, PSYCHIATRY, V63, P326, DOI 10.1080/00332747.2000.11024925; Jackowski AP, 2012, REV BRAS PSIQUIATR, V34, P207, DOI 10.1590/S1516-44462012000200014; Kane J. M., 2003, J CLIN PSYCHIAT S12, V64, P21; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2006, NEUROPSYCHOPHARMACOL, V31, P2033, DOI 10.1038/sj.npp.1301072; Keefe RSE, 2006, SCHIZOPHR RES, V88, P26, DOI 10.1016/j.schres.2006.06.041; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kraus MS, 2007, BRIT J PSYCHIAT, V191, pS46, DOI 10.1192/bjp.191.50.s46; Markman KD, 2007, PERS SOC PSYCHOL B, V33, P312, DOI 10.1177/0146167206296106; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Moritz S, 2015, COGNITIVE THER RES, V39, P627, DOI 10.1007/s10608-015-9690-8; Moritz S, 2014, JAMA PSYCHIAT, V71, P1103, DOI 10.1001/jamapsychiatry.2014.1038; Peralta V, 1994, ACTAS LUSO-ESP NEUR, V4, P44; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Roese NJ, 2008, SCHIZOPHR RES, V103, P343, DOI 10.1016/j.schres.2007.05.006; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Roese NJ, 1997, ADV EXP SOC PSYCHOL, V29, P1, DOI 10.1016/S0065-2601(08)60015-5; Roese NJ, 1997, SOC COGNITION, V15, P274, DOI 10.1521/soco.1997.15.4.274; Ross K, 2011, SCHIZOPHRENIA BULL, V37, P324, DOI 10.1093/schbul/sbn165; Segarra N, 2011, EUR PSYCHIAT, V26, P69, DOI 10.1016/j.eurpsy.2009.11.001; Sergi MJ, 2007, SCHIZOPHR RES, V90, P316, DOI 10.1016/j.schres.2006.09.028; Smallman R, 2009, J EXP SOC PSYCHOL, V45, P845, DOI 10.1016/j.jesp.2009.03.002; SPITZER R. L., 1994, STRUCTURED CLIN INTE; Van Hoeck N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00420; Ventura J, 2013, SCHIZOPHRENIA BULL, V39, P102, DOI 10.1093/schbul/sbr067; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Wechsler D, 1999, WECHSL AD INT SCAL	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178860	10.1371/journal.pone.0178860	http://dx.doi.org/10.1371/journal.pone.0178860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586400	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700033
J	Mulberry, G; White, KA; Vaidya, M; Sugaya, K; Kim, BN				Mulberry, Geoffrey; White, Kevin A.; Vaidya, Manjusha; Sugaya, Kiminobu; Kim, Brian N.			3D printing and milling a real-time PCR device for infectious disease diagnostics	PLOS ONE			English	Article							AMPLIFICATION; MALARIA	Diagnosing infectious diseases using quantitative polymerase chain reaction (qPCR) offers a conclusive result in determining the infection, the strain or type of pathogen, and the level of infection. However, due to the high-cost instrumentation involved and the complexity in maintenance, it is rarely used in the field to make a quick turnaround diagnosis. In order to provide a higher level of accessibility than current qPCR devices, a set of 3D manufacturing methods is explored as a possible option to fabricate a low-cost and portable qPCR device. The key advantage of this approach is the ability to upload the digital format of the design files on the internet for wide distribution so that people at any location can simply download and feed into their 3D printers for quick manufacturing. The material and design are carefully selected to minimize the number of custom parts that depend on advanced manufacturing processes which lower accessibility. The presented 3D manufactured qPCR device is tested with 20-mu L samples that contain various concentrations of lentivirus, the same type as HIV. A reverse-transcription step is a part of the device's operation, which takes place prior to the qPCR step to reverse transcribe the target RNA from the lentivirus into complementary DNA (cDNA). This is immediately followed by qPCR which quantifies the target sequence molecules in the sample during the PCR amplification process. The entire process of thermal control and time-coordinated fluorescence reading is automated by closed-loop feedback and a microcontroller. The resulting device is portable and battery-operated, with a size of 12 x 7 x 6 cm(3) and mass of only 214 g. By uploading and sharing the design files online, the presented low-cost qPCR device may provide easier access to a robust diagnosis protocol for various infectious diseases, such as HIV and malaria.	[Mulberry, Geoffrey; White, Kevin A.; Kim, Brian N.] Univ Cent Florida, Dept Elect & Comp Engn, Coll Engn & Comp Sci, Orlando, FL 32816 USA; [Vaidya, Manjusha; Sugaya, Kiminobu; Kim, Brian N.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kim, BN (corresponding author), Univ Cent Florida, Dept Elect & Comp Engn, Coll Engn & Comp Sci, Orlando, FL 32816 USA.; Kim, BN (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	brian.kim@ucf.edu		Kim, Brian/0000-0002-5523-6091; Sugaya, Kiminobu/0000-0002-2788-5457				Agrawal N., 2007, ANGEW CHEM, V119, P4394, DOI DOI 10.1002/ANGE.200700306; Ahrberg CD, 2016, LAB CHIP, V16, P586, DOI 10.1039/c5lc01415h; Almassian DR, 2013, CHEM SOC REV, V42, P8769, DOI 10.1039/c3cs60144g; [Anonymous], 2001, DRUG RESISTANCE MALA; Bartlett JMS, PCR PROTOCOLS, P3; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chudobova D, 2015, ELECTROPHORESIS, V36, P457, DOI 10.1002/elps.201400321; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Dryden MDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140349; Ho CMB, 2015, LAB CHIP, V15, P3627, DOI 10.1039/c5lc00685f; Kojima T, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni143; Koo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082704; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Rosenegger DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110475; Rowe AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023783; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; Tan KR, 2016, MMWR-MORBID MORTAL W, V65, P27, DOI 10.15585/mmwr.mm6502a3; Troxler S, 2011, J CLIN MICROBIOL, V49, P1339, DOI 10.1128/JCM.01626-10; Waheed S, 2016, LAB CHIP, V16, P1993, DOI 10.1039/c6lc00284f; Watson JD, 2013, MOL BIOL GENE MASTER; WHO, 2016, REC SEL CRIT PROC MA, P16; Wittbrodt BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134989; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389	25	29	31	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179133	10.1371/journal.pone.0179133	http://dx.doi.org/10.1371/journal.pone.0179133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586401	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700047
J	Anders, C; Patenge, S; Sander, K; Layher, F; Biedermann, U; Kinne, RW				Anders, Christoph; Patenge, Steffen; Sander, Klaus; Layher, Frank; Biedermann, Uta; Kinne, Raimund W.			Detailed spatial characterization of superficial hip muscle activation during walking: A multi-electrode surface EMG investigation of the gluteal region in healthy older adults	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; HUMAN LOCOMOTION; DIFFERENT SPEEDS; MOTOR PATTERNS; GAIT; MEDIUS; ARTHROPLASTY; SEGMENTS; MINIMUS; PROFILES	Purpose A multi-electrode array was used to generate spatially resolved Surface electromyography (SEMG) data of the hip muscles in healthy older adults. The cohort was meant to serve as an age-matched, normal control population for future surgical and rehabilitative studies in patients undergoing total hip arthroplasty, in view of the large, continuously increasing number of hip joint replacements. Methods Bilateral hip muscle SEMG activity, including tensor fasciae latae (TFL), gluteus medius (Gmed), and gluteus maximus (Gmax), was measured during locomotion on a walkway at self-selected slow, normal, and fast walking speeds (age-matched cohort of 29 females and 25 males). Eight equally-spaced, vertically oriented bipolar channels were applied on a horizontal line at mid-distance between iliac crest and greater trochanter (length 17.5 cm; named P1 to P8). Time-independent parameters (e.g., mean amplitude) were derived from the amplitude curves expressed as root mean square. Results The acquired SEMG data were not significantly influenced by gender (p = 0.202) or side (p = 0.313) and were therefore pooled. The most ventral to central electrode positions P1 to P5, representing TFL and ventral to central Gmed, showed the highest mean amplitude levels (averaged over the whole stride; 0.001 < p < 0.027 against P6 to P8; Bonferroni-adjusted paired t-test) at all walking speeds. Also, the respective curves showed two distinct amplitude peaks (representing load acceptance and hip stabilization during mid-stance), with a continuous increase of the first peak from P1 to P4 (most pronounced at fast speed) and the second peak from P1 to P3. Independently of the underlying individual muscles, both peaks displayed a continuous time shift from the most dorsal P8 to the most ventral P1 position, with the peaks for the ventral positions occurring at later time points during the normalized stride. Conclusions The continuously changing activation patterns of the superficial muscles in the gluteal region during walking may reflect function-driven, finely tuned coordination patterns of neighboring muscles and muscle segments, rather than independent activation of anatomically defined muscles. This may be important for the definition of specific target parameters for the improvement and/ or normalization of muscle function during training and post- injury rehabilitation.	[Anders, Christoph] Jena Univ Hosp, Div Motor Res Pathophysiol & Biomech, Clin Trauma Hand & Reconstruct Surg, Jena, Germany; [Patenge, Steffen; Sander, Klaus; Layher, Frank] Jena Univ Hosp, Waldkrankenhaus Rudolf Elle, Dept Orthoped, Chair Orthoped, Eisenberg, Germany; [Biedermann, Uta] Jena Univ Hosp, Inst Anat 1, Jena, Germany; [Kinne, Raimund W.] Jena Univ Hosp, Waldkrankenhaus Rudolf Elle, Dept Orthoped, Expt Rheumatol Unit, Eisenberg, Germany; [Patenge, Steffen] HELIOS Klin Blankenhein, Blankenhain, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Helios Kliniken	Anders, C (corresponding author), Jena Univ Hosp, Div Motor Res Pathophysiol & Biomech, Clin Trauma Hand & Reconstruct Surg, Jena, Germany.	christoph.anders@med.uni-jena.de	Anders, Christoph/P-7403-2019	Anders, Christoph/0000-0002-5580-5338	German Federal Ministry of Education and Research (BMBF) [FKZ 035577D, 0316205B, 13N12601]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We gratefully acknowledge the financial support by the German Federal Ministry of Education and Research (BMBF FKZ 035577D, 0316205B, and 13N12601 to RWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Georg Matziolis, MD, Head of the Department of Orthopedics, Jena University Hospital and Andreas Roth, MD, Head of the Department of Joint Replacement/Orthopedics, University Hospital Leipzig, for expert clinical advice. The authors also wish to thank David R. Carrier, Department of Biology, University of Utah, for helpful discussions. We gratefully acknowledge the financial support by the German Federal Ministry of Education and Research (BMBF FKZ 035577D, 0316205B, and 13N12601 to RWK). The authors also gratefully acknowledge the linguistic and intellectual support by Ms. Marcie Matthews of Polished Words.	Al-Hayani A, 2009, FOLIA MORPHOL, V68, P98; Anton SD, 2015, AGEING RES REV, V24, P304, DOI 10.1016/j.arr.2015.09.005; Antonio S, 2013, J BODYW MOV THER, V17, P512, DOI 10.1016/j.jbmt.2013.04.004; ARENDTNIELSEN L, 1991, J ELECTROMYOGR KINES, V1, P89, DOI 10.1016/1050-6411(91)90002-M; Barker PJ, 2014, CLIN ANAT, V27, P234, DOI 10.1002/ca.22233; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Carrier DR, 2015, BIOL OPEN, V4, P1635, DOI 10.1242/bio.014381; Carrier DR, 2011, P NATL ACAD SCI USA, V108, P18631, DOI 10.1073/pnas.1105277108; Comerford MJ, 2001, MANUAL THER, V6, P15, DOI 10.1054/math.2000.0388; Falla D, 2007, J ELECTROMYOGR KINES, V17, P299, DOI 10.1016/j.jelekin.2006.03.005; Flack NAMS, 2014, CLIN ANAT, V27, P241, DOI 10.1002/ca.22248; Floren M, 2009, EUROHIP HLTH TECHNOL, P47; GOTTSCHALK F, 1989, J ANAT, V166, P179; Gottschall JS, 2012, J ELECTROMYOGR KINES, V22, P67, DOI 10.1016/j.jelekin.2011.10.003; Gremeaux V, 2012, MATURITAS, V73, P312, DOI 10.1016/j.maturitas.2012.09.012; Hemmelmann C, 2005, J NEUROSCI METH, V142, P209, DOI 10.1016/j.jneumeth.2004.08.008; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; HOF AL, 1996, GAIT POSTURE, V4, P222; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2006, J NEUROPHYSIOL, V95, P602, DOI 10.1152/jn.00767.2005; Kaneda K, 2009, J ELECTROMYOGR KINES, V19, P1064, DOI 10.1016/j.jelekin.2008.11.001; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kendall F.P., 2005, MUSCLES TESTING FUNC, Vfifth; Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441; Lacquaniti F, 1999, NEWS PHYSIOL SCI, V14, P168, DOI 10.1152/physiologyonline.1999.14.4.168; MARKMAN B, 1987, PLAST RECONSTR SURG, V80, P248, DOI 10.1097/00006534-198708000-00015; Merx H, 2003, ANN RHEUM DIS, V62, P222, DOI 10.1136/ard.62.3.222; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; Nordander C, 2003, EUR J APPL PHYSIOL, V89, P514, DOI 10.1007/s00421-003-0819-1; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; RYF C, 1995, INJURY, V26, pSA1; Samson MM, 2001, AGING CLIN EXP RES, V13, P16, DOI 10.1007/BF03351489; Sander K, 2012, ORTHOPADE, V41, P365, DOI 10.1007/s00132-011-1891-6; Schmolders J, 2014, Z ORTHOP UNFALLCHIR, V152, P120, DOI 10.1055/s-0033-1360350; SCHUMANN NP, 1994, ARCH ORAL BIOL, V39, P369, DOI 10.1016/0003-9969(94)90166-X; Sculco TP, 2004, ORTHOP CLIN N AM, V35, P137, DOI 10.1016/S0030-5898(03)00116-0; Semciw AI, 2013, CLIN ANAT, V26, P244, DOI 10.1002/ca.22055; Semciw AI, 2013, J ELECTROMYOGR KINES, V23, P858, DOI 10.1016/j.jelekin.2013.03.007; Semciw AI, 2013, GAIT POSTURE, V38, P157, DOI 10.1016/j.gaitpost.2012.10.010; SHARRARD W J, 1964, Ann R Coll Surg Engl, V35, P106; Staudenmann D, 2009, J ELECTROMYOGR KINES, V19, P882, DOI 10.1016/j.jelekin.2008.04.013; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; van Vugt JPP, 2001, CLIN NEUROPHYSIOL, V112, P583, DOI 10.1016/S1388-2457(01)00482-5; Wickham JB, 1998, EUR J APPL PHYSIOL, V78, P219, DOI 10.1007/s004210050410; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Yang BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037947	51	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178957	10.1371/journal.pone.0178957	http://dx.doi.org/10.1371/journal.pone.0178957			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582456	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600063
J	Li, TS; Huang, ML; Xiao, HR; Zhang, GQ; Ding, JH; Wu, P; Zhang, H; Sheng, JL; Chen, CF				Li, Tiansen; Huang, Meiling; Xiao, Hongran; Zhang, Guoqi; Ding, Jinhua; Wu, Peng; Zhang, Hui; Sheng, Jinliang; Chen, Chuangfu			Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein	PLOS ONE			English	Article							IMMUNE-RESPONSES; VACCINATION; BINDING; IMPACT	Bovine viral diarrhea-mucosal disease (BVD-MD) is caused by bovine viral diarrhea virus (BVDV), and results in abortion, stillbirth, and fetal malformation in cows. Here, we constructed the phage display vector pCANTAB 5E-VHH and then transformed it into Escherichia coli TG1-competent cells, to construct an initial anti-BVDV nanobody gene library. We obtained a BVDV-E2 antigen epitope bait protein by prokaryotic expression using the nucleotide sequence of the E2 gene of the BVDV-NADL strain published in GenBank. Phage display was used to screen the anti-BVDV nanobody gene library. We successfully constructed a high quality phage display nanobody library, with an initial library capacity of 4.32x10(5). After the rescue of helper phage, the titer of the phage display nanobody library was 1.3x10(11). The BVDV-E2 protein was then expressed in Escherichia coli (DE3), and a 49.5 kDa band was observed with SDS-PAGE analysis that was consistent with the expected nanobody size. Thus, we were able to isolate one nanobody that exhibits high affinity and specificity against BVDV using phage display techniques. This isolated nanobody was then used in Enzyme Linked Immunosorbent Assay and qRT-PCR, and ELISA analyses of BVDV infection of MDBK cells indicated that the nanobodies exhibited good antiviral effect.	[Li, Tiansen; Xiao, Hongran; Ding, Jinhua; Wu, Peng; Zhang, Hui; Sheng, Jinliang; Chen, Chuangfu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China; [Huang, Meiling] Shihezi Univ, Shihezi Univ Lib, Shihezi, Xinjiang, Peoples R China; [Zhang, Guoqi] Shihezi Univ, Coll Life Sci, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Sheng, JL; Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.	sjlshzdky@sina.com; chen_chuangfu@163.com			National Natural Science Foundation of China [U1303283, 31572491]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant nos. U1303283, 31572491).	Akazawa-Ogawa Y, 2016, J BIOCH, V159; Alves PA, 2016, COMP IMMUNOL MICROB, V49, P70, DOI 10.1016/j.cimid.2016.09.005; Braun MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep19211; Bruce VJ, 2016, PROTEIN SCI, V25, P1129, DOI 10.1002/pro.2926; Carta A, 2016, EUR J MED CHEM, V117, P321, DOI 10.1016/j.ejmech.2016.03.080; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; Ciulli S, 2008, VET RES COMMUN, V32, pS183, DOI 10.1007/s11259-008-9164-5; Crasson O, 2015, PROTEIN ENG DESIGN S, V28; De Meyer T, 2014, TRENDS BIOTECHNOL, V32, P263, DOI 10.1016/j.tibtech.2014.03.001; Desmyter A, 2015, CURR OPIN STRUC BIOL, V32, P1, DOI 10.1016/j.sbi.2015.01.001; Downey-Slinker ED, 2016, VACCINE, V34, P5053, DOI 10.1016/j.vaccine.2016.08.087; El-Attar LMR, 2015, VACCINE, V33, P4004, DOI 10.1016/j.vaccine.2015.06.017; Fu Q, 2016, ARCH VIROL; Gray MA, 2016, CHEMBIOCHEM, V17, P155, DOI 10.1002/cbic.201500591; Helma J, 2015, J CELL BIOL, V209, P633, DOI 10.1083/jcb.201409074; Ju SY, 2015, SCI REPORTS, V5; Kazemi-Lomedasht F, 2015, MOL IMMUNOL, V65, P58, DOI 10.1016/j.molimm.2015.01.010; Kingston HWF, 2015, CLIN VACCINE IMMUNOL, V22, P1130, DOI 10.1128/CVI.00390-15; Koch K, 2016, JAIDS J ACQUIRED IMM, V71; Konning D, 2017, CURR OPIN STRUC BIOL, V45, P10, DOI 10.1016/j.sbi.2016.10.019; Li T, 2016, BRUCELLA MELITENSIS, V11; Loy JD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-35; Maya L, 2016, ARCH VIROL, V161, P529, DOI 10.1007/s00705-015-2688-4; Mody KT, 2015, PLOS ONE, V10; Nakayama Hiroshi, 2016, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V35, P231, DOI 10.1089/mab.2016.0003; Negi P, 2015, CLIN BIOCH, V53; Pecora A, 2012, VET RES COMMUN, V36, P157, DOI 10.1007/s11259-012-9526-x; Platt R, 2017, VET IMMUNOL IMMUNOP, V187, P20, DOI 10.1016/j.vetimm.2017.03.003; Quinet C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164451; Ridpath JF, 2015, VIROLOGY, V485, P297, DOI 10.1016/j.virol.2015.07.022; Roovers RC, 2007, CURR OPIN MOL THER, V9, P327; Sayers RG, 2015, VET J, V205, P56, DOI 10.1016/j.tvjl.2015.03.025; Shkoporov AN, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv083; Valadan R, 2015, J MAZANDARAN U MED S, V24, P43; Van Engen NK, 2016, VET IMMUNOL IMMUNOP, V175, P42, DOI 10.1016/j.vetimm.2016.05.006; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Workman AM, 2016, J VET DIAGN INVEST, V28, P519, DOI 10.1177/1040638716654943; Yan JR, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0343-6; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zhao A, 2016, CRITICAL REV BIOTECH, V36, P1; Zhu LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165044	41	11	12	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178469	10.1371/journal.pone.0178469	http://dx.doi.org/10.1371/journal.pone.0178469			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582444	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600018
J	Zheng, HJ; Zhou, XY; Li, DK; Yang, F; Pan, HJ; Li, TQ; Miao, MH; Li, RS; Yuan, W				Zheng, Huajun; Zhou, Xiaoyu; Li, De-kun; Yang, Fen; Pan, Hongjie; Li, Tianqi; Miao, Maohua; Li, Runsheng; Yuan, Wei			Genome-wide alteration in DNA hydroxymethylation in the sperm from bisphenol A-exposed men	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; TRANSGENERATIONAL INHERITANCE; ENDOCRINE DISRUPTORS; BINDING PROTEIN-2; IMPRINTED GENES; SEMEN QUALITY; 5-HYDROXYMETHYLCYTOSINE; METHYLATION; SPERMATOZOA; DEMETHYLATION	Environmental BPA exposure has been shown to impact human sperm concentration and motility, as well as rodent spermatogenesis. However, it is unclear whether BPA exposure is associated with alteration in DNA hydroxymethylation, a marker for epigenetic modification, in human sperm. A genome-wide DNA hydroxymethylation study was performed using sperm samples of men who were occupationally exposed to BPA. Compared with controls who had no occupational BPA exposure, the total levels of 5-hydroxymethylcytosine (5hmc) increased significantly (19.37% increase) in BPA-exposed men, with 72.69% of genome regions harboring 5hmc. A total of 9,610 differential 5hmc regions (DhMRs) were revealed in BPA-exposed men relative to controls, which were mainly located in intergenic and intron regions. These DhMRs were composed of 8,670 hyper-hMRs and 940 hypo-hMRs, affecting 2,008 genes and the repetitive elements. The hyper-hMRs affected genes were enriched in pathways associated with nervous system, development, cardiovascular diseases and signal transduction. Additionally, enrichment of 5hmc was observed in the promoters of eight maternally expressed imprinted genes in BPA-exposed sperm. Some of the BPA-affected genes, for example, MLH1, CHD2, SPATA12 and SPATA20 might participate in the response to DNA damage in germ cells caused by BPA. Our analysis showed that enrichment of 5hmc both in promoters and gene bodies is higher in the genes whose expression has been detected in human sperm than those whose expression is absent. Importantly, we observed that BPA exposure affected the 5hmc level in 11.4% of these genes expressed in sperm, and in 6.85% of the sperm genome. Finally, we also observed that BPA exposure tends to change the 5hmc enrichment in the genes which was previously reported to be distributed with the trimethylated Histone 3 (H3K27me3, H3K4me2 or H3K4me3) in sperm. Thus, these results suggest that BPA exposure likely interferes with gene expression via affecting DNA hydroxymethylation in a way partially dependent on trimethylation of H3 in human spermatogenesis. Our current study reveals a new mechanism by which BPA exposure reduces human sperm quality.	[Zheng, Huajun; Zhou, Xiaoyu; Yang, Fen; Pan, Hongjie; Li, Tianqi; Miao, Maohua; Li, Runsheng; Yuan, Wei] Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai, Peoples R China; [Zheng, Huajun; Zhou, Xiaoyu; Yang, Fen; Pan, Hongjie; Li, Tianqi; Miao, Maohua; Li, Runsheng; Yuan, Wei] WHO Collaborating Ctr Res Human Reprod, Shanghai, Peoples R China; [Li, De-kun] Kaiser Permanente Northern Calif, Kaiser Fdn Res Inst, Div Res, Oakland, CA USA; [Li, De-kun] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Fudan University; Kaiser Permanente; Stanford University	Miao, MH; Li, RS (corresponding author), Fudan Univ, Key Lab Reprod Regulat NPFPC, SIPPR, IRD, Shanghai, Peoples R China.; Miao, MH; Li, RS (corresponding author), WHO Collaborating Ctr Res Human Reprod, Shanghai, Peoples R China.	miaomaohua@163.com; runshengli2007@163.com	Zheng, Huajun/AAN-4973-2020		National Natural Science Foundation of China [81571495, 81501318, 81270760]; National Basic Research Program of China [2014CB943104]; Shanghai Municipal Committee of Science and Technology [15431902800]; Key Laboratory of Reproduction Regulation of NPFPC	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee); Key Laboratory of Reproduction Regulation of NPFPC	This work was supported by grants from the National Natural Science Foundation of China [Grant numbers. 81571495, 81501318 and 81270760], the National Basic Research Program of China [Grant numbers. 2014CB943104], Shanghai Municipal Committee of Science and Technology [Grant No. 15431902800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Natural Science Foundation of China [Grant numbers. 81571495, 81501318 and 81270760], the National Basic Research Program of China [Grant numbers. 2014CB943104], Shanghai Municipal Committee of Science and Technology [Grant No. 15431902800] and Key Laboratory of Reproduction Regulation of NPFPC.	Arama E, 2007, PLOS BIOL, V5, P2270, DOI 10.1371/journal.pbio.0050251; Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Berger SL, 2012, CELL METAB, V15, P6, DOI 10.1016/j.cmet.2011.12.012; Bhan A, 2014, J MOL BIOL, V426, P3426, DOI 10.1016/j.jmb.2014.07.025; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Calicchio R, 2014, CURR PHARM DESIGN, V20, P1726, DOI 10.2174/13816128113199990517; Cantonwine DE, 2013, EXPERT REV OBSTET GY, V8; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chen K, 2016, CELL RES, V26, P103, DOI 10.1038/cr.2015.150; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; De Flora S, 2011, TOXICOL SCI, V122, P45, DOI 10.1093/toxsci/kfr096; Di Giacomo M, 2013, MOL CELL, V50, P601, DOI 10.1016/j.molcel.2013.04.026; Docherty SJ, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-3; Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Doshi T, 2011, TOXICOLOGY, V289, P74, DOI 10.1016/j.tox.2011.07.011; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Gallego-Fabrega C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0097-x; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Haffner MC, 2013, CELL CYCLE, V12, P1835, DOI 10.4161/cc.25010; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hanaoka T, 2002, OCCUP ENVIRON MED, V59, P625, DOI 10.1136/oem.59.9.625; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; He ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096994; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XY, 2004, J ANDROL, V25, P363; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Jenkins TG, 2013, FERTIL STERIL, V100, P945, DOI 10.1016/j.fertnstert.2013.05.039; Jia GX, 2015, THERIOGENOLOGY, V83, P1000, DOI 10.1016/j.theriogenology.2014.11.036; Karaouzene T, 2013, BASIC CLIN ANDROL, V23, DOI 10.1186/2051-4190-23-7; Kim J, 2013, THESCIENTIFICWORLDJO, V2013; Knez J, 2014, FERTIL STERIL, V101, P215, DOI 10.1016/j.fertnstert.2013.09.030; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Kundu TK, 1999, J BIOCHEM, V125, P217, DOI 10.1093/oxfordjournals.jbchem.a022276; Kurotaki YK, 2015, HUM REPROD, V30, P1178, DOI 10.1093/humrep/dev039; Lambrot R, 2012, J ANDROL, V33, P1058, DOI 10.2164/jandrol.111.013870; Lassen TH, 2014, ENVIRON HEALTH PERSP, V122, P478, DOI 10.1289/ehp.1307309; Legendre C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0135-8; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lombo M, 2015, ENVIRON POLLUT, V206, P667, DOI 10.1016/j.envpol.2015.08.016; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Meeker JD, 2010, REPROD TOXICOL, V30, P532, DOI 10.1016/j.reprotox.2010.07.005; Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Miao M, 2014, ANDROLOGY-US, V2, P138, DOI 10.1111/j.2047-2927.2013.00166.x; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Montjean D, 2012, J ASSIST REPROD GEN, V29, P3, DOI 10.1007/s10815-011-9644-3; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Nagarajan P, 2009, ONCOGENE, V28, P1053, DOI 10.1038/onc.2008.440; Ni K, 2016, HUM REPROD; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Pacheco SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020280; Rahman MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09169; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Samans B, 2014, DEV CELL, V30, P23, DOI 10.1016/j.devcel.2014.05.023; Sendler E, 2013, NUCLEIC ACIDS RES, V41, P4104, DOI 10.1093/nar/gkt132; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; SUN L, 2014, BIOMED RES INT, V2014; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang HF, 2016, TOXICOLOGICAL SCI OF; Wang XX, 2015, ONCOTARGET, V6, P6535, DOI 10.18632/oncotarget.3163; Wang ZD, 2016, CELL REPROGRAM, V18, P78, DOI 10.1089/cell.2015.0060; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xie MN, 2016, ONCOTARGET, V7, P10606, DOI 10.18632/oncotarget.7218; Yaoi T, 2008, BIOCHEM BIOPH RES CO, V376, P563, DOI 10.1016/j.bbrc.2008.09.028; Yeo M, 2013, P NATL ACAD SCI USA, V110, P4315, DOI 10.1073/pnas.1300959110; Zhang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078201; Zhao YX, 2006, HUM REPROD, V21, P1583, DOI 10.1093/humrep/del027; Zhou Q, 2015, J CELL MOL MED, V19, P521, DOI 10.1111/jcmm.12407	78	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178535	10.1371/journal.pone.0178535	http://dx.doi.org/10.1371/journal.pone.0178535			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582417	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600023
J	Bak, LK				Bak, Lasse K.			Astrocytes take the stage in a tale of signaling-metabolism coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							GLYCOLYSIS	Astrocytes are crucial cells in the brain that are intimately coupled with neuronal metabolism. A new paper from San Martin et al. provides evidence that physiological levels of the gaseous signal molecule NO can rapidly and reversibly increase astrocyte metabolism of glucose and production of lactate. A proposed neurological coupling-from the potential source of NO, endothelial cells, to the potential beneficiary from the lactate, neurons-prompts new questions regarding the controversial role of lactate in the brain.	[Bak, Lasse K.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, 2 Univ Pk, DK-2100 Copenhagen, Denmark	University of Copenhagen	Bak, LK (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, 2 Univ Pk, DK-2100 Copenhagen, Denmark.	laba@sund.ku.dk		Bak, Lasse K./0000-0003-0784-7864				Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Bak LK, 2017, J NEUROSCI RES, V95, P2098, DOI 10.1002/jnr.23994; Dienel GA, 2017, J NEUROSCI RES, V95, P2103, DOI 10.1002/jnr.24015; Martin M, 2017, J BIOL CHEM, V292, P3433, DOI 10.1074/jbc.M116.740258; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Satrustegui J, 2015, NEUROCHEM RES, V40, P2425, DOI 10.1007/s11064-015-1652-8; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102	9	2	2	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9439	9440		10.1074/jbc.H117.777243	http://dx.doi.org/10.1074/jbc.H117.777243			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28576887	hybrid, Green Published			2022-12-26	WOS:000402538900037
J	Li, Z; Li, SA; Sun, Y; Liu, Y; Li, WL; Yang, L; Duan, Y; Li, JY; Guo, H; Zou, TN; Li, YL; Wang, KH				Li, Zhen; Li, Shu-an; Sun, Ya; Liu, Yu; Li, Wen-liang; Yang, Li; Duan, Yong; Li, Jingyu; Guo, Hao; Zou, Tian-ning; Li, Yunlong; Wang, Kun-hua			TNF-alpha-308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TNF-ALPHA; COLORECTAL-CANCER; GENE POLYMORPHISM; INDUCED APOPTOSIS; EXPRESSION; PROGNOSIS; PROMOTER; THERAPY; PATHWAY	Tumor necrosis factor-alpha (TNF-alpha), an important factor in systematic inflammation, is reportedly involved in several cancer types. The TNF-alpha-308 G>A (rs1800629) polymorphism in the promoter region influences TNF-alpha production. The association between TNF-alpha-308 G>A polymorphism and colorectal cancer (CRC) is not fully understood, especially the connections between TNF-alpha-308 G>A polymorphism and clinical features of CRC. In this study, TNF-alpha-308 G>A polymorphism was genotyped in 1140 individuals with or without CRC from Southwestern China. In case-control studies, we found no association between TNF-alpha-308 G>A polymorphism and CRC risk. Analysis of the correlations between TNF-alpha-308 G>A polymorphism and clinical features of CRC revealed that TNF-alpha-308 A allele was associated with higher body mass index (BMI) larger tumor size, and distant tumor metastasis in all CRC patients. Notably, rectal cancer (a subtype of CRC) patients with TNF-alpha-308 A allele had a very high risk of distant tumor metastasis [odds ratio (OR) = 4.481; 95% confidence interval (CI): 2.072-9.693; P = 0.00025]. The association between TNF-alpha-308 A allele and distant tumor metastasis remained even significant after adjusting all clinical characteristics (OR = 7.099; 95% CI: 2.482-20.301; P = 0.000256) in rectal cancer patients. Our results suggested that TNF-alpha-308 A allele was significantly associated with distant tumor metastasis in rectal cancer patients.	[Li, Zhen; Wang, Kun-hua] Kunming Med Univ, Affiliated Hosp 1, Inst Gastroenterol, Dept Gastrointestinal Surg, Kunming, Yunnan, Peoples R China; [Li, Zhen; Wang, Kun-hua] Kunming Digest Dis Treatment Engn Technol Ctr, Kunming, Yunnan, Peoples R China; [Li, Shu-an] Kunming Med Univ, Affiliated Hosp 1, Inst Gastroenterol, Dept Gastroenterol, Kunming, Yunnan, Peoples R China; [Sun, Ya; Liu, Yu; Zou, Tian-ning] Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Dept Breast Surg, Kunming, Yunnan, Peoples R China; [Li, Wen-liang] Kunming Med Univ, Affiliated Hosp 1, Dept Oncol Surg, Kunming, Yunnan, Peoples R China; [Yang, Li] Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Dept Clin Lab, Kunming, Yunnan, Peoples R China; [Duan, Yong] Kunming Med Univ, Affiliated Hosp 1, Dept Clin Lab, Kunming, Yunnan, Peoples R China; [Li, Jingyu; Li, Yunlong] Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China; [Guo, Hao] Kunming Med Univ, Affiliated Hosp 1, Dept Cardiol, Kunming, Yunnan, Peoples R China; [Li, Yunlong] Kunming Univ & Technol, Peoples Hosp Yunnan Prov 1, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming University of Science & Technology; Kunming Medical University; Kunming University of Science & Technology	Wang, KH (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Inst Gastroenterol, Dept Gastrointestinal Surg, Kunming, Yunnan, Peoples R China.; Wang, KH (corresponding author), Kunming Digest Dis Treatment Engn Technol Ctr, Kunming, Yunnan, Peoples R China.; Zou, TN (corresponding author), Kunming Med Univ, Affiliated Hosp 3, Yunnan Tumor Hosp, Dept Breast Surg, Kunming, Yunnan, Peoples R China.; Li, YL (corresponding author), Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China.; Li, YL (corresponding author), Kunming Univ & Technol, Peoples Hosp Yunnan Prov 1, Kunming, Yunnan, Peoples R China.	zoutn@aliyun.com; yunlongli.km@gamil.com; wkh1963@yeah.net	Li, Jingyu/GSD-1924-2022		Foundation of Leading Talent Program of Health and Family Planning Commission of Yunnan Province [L-201205]; National Natural Science Foundation of China [81460424]; Scholarship Award for Excellent Doctoral Student Grant of Yunnan Province; Foundation of Medical Discipline Leaders Program of Health and Family Planning Commission of Yunnan Province [D-201668]; Foundation of the Institute of Gastroenterology, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province [2014NS122]; Foundation of the Institute of Breast Surgery, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province [2014NS022]; Joint Special Research Funds of Kunming Medical University [2014FZ035]	Foundation of Leading Talent Program of Health and Family Planning Commission of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scholarship Award for Excellent Doctoral Student Grant of Yunnan Province; Foundation of Medical Discipline Leaders Program of Health and Family Planning Commission of Yunnan Province; Foundation of the Institute of Gastroenterology, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province; Foundation of the Institute of Breast Surgery, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province; Joint Special Research Funds of Kunming Medical University	This study was supported by the Foundation of Leading Talent Program of Health and Family Planning Commission of Yunnan Province (No. L-201205), National Natural Science Foundation of China (No. 81460424), the Scholarship Award for Excellent Doctoral Student Grant of Yunnan Province, the Foundation of Medical Discipline Leaders Program of Health and Family Planning Commission of Yunnan Province (No. D-201668), the Foundation of the Institute of Gastroenterology, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province (2014NS122), the Foundation of the Institute of Breast Surgery, Research Institutions attached to the Health and Family Planning Commission of Yunnan Province (2014NS022) and the Joint Special Research Funds of Kunming Medical University (2014FZ035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bredberg A, 2011, CANCER-AM CANCER SOC, V117, P440, DOI 10.1002/cncr.25440; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Cariaso M, 2012, NUCLEIC ACIDS RES, V40, pD1308, DOI 10.1093/nar/gkr798; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Favoriti P, 2016, UPDATES SURG, V68, P7, DOI 10.1007/s13304-016-0359-y; Garagnani P, 2013, CURR PHARM DESIGN, V19, P765, DOI 10.2174/138161213804581981; Garrity-Park M, 2012, INFLAMM BOWEL DIS, V18, P275, DOI 10.1002/ibd.21681; Grimm M, 2011, CELL ONCOL, V34, P315, DOI 10.1007/s13402-011-0027-7; Guo XF, 2013, WORLD J GASTROENTERO, V19, P9461, DOI 10.3748/wjg.v19.i48.9461; Hojilla CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026718; Hunter K, 2006, NAT REV CANCER, V6, P141, DOI 10.1038/nrc1803; Jeon YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11006; Jin YJ, 2015, J CLIN GASTROENTEROL, V49, pE76, DOI 10.1097/MCG.0000000000000261; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Li HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10244; Lim DSL, 2014, J IMMUNOL, V193, P5065, DOI 10.4049/jimmunol.1302240; Liu YM, 2015, LAB INVEST, V95, P504, DOI 10.1038/labinvest.2015.34; Loubaki L, 2015, CYTOKINE, V71, P181, DOI 10.1016/j.cyto.2014.10.016; Lu JF, 2016, FISH SHELLFISH IMMUN, V55, P559, DOI 10.1016/j.fsi.2016.06.033; Min L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085187; Nearchou A, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.54; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Ronnekleiv-Kelly SM, 2016, SURG ONCOL, V25, P190, DOI 10.1016/j.suronc.2016.05.018; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spriggs D R, 1992, Immunol Ser, V56, P3; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wang GH, 2013, CANCER RES, V73, P307, DOI 10.1158/0008-5472.CAN-12-2038; Wang N, 2014, HUM IMMUNOL, V75, P980, DOI 10.1016/j.humimm.2014.08.197; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu GS, 2008, J CANCER RES CLIN, V134, P1043, DOI 10.1007/s00432-008-0393-3; Zambon CF, 2004, GASTROENTEROLOGY, V126, P382, DOI 10.1053/j.gastro.2003.08.042; Zhang H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001955	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178218	10.1371/journal.pone.0178218	http://dx.doi.org/10.1371/journal.pone.0178218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575042	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300032
J	Zhang, C; Chen, ZQ; Meng, XY; Li, MT; Zhang, L; Huang, A				Zhang, Chi; Chen, Zhongqiang; Meng, Xiangyu; Li, Mengtao; Zhang, Li; Huang, Ann			The involvement and possible mechanism of pro-inflammatory tumor necrosis factor alpha (TNF-alpha) in thoracic ossification of the ligamentum flavum	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; BONE-FORMATION; CLINICAL-FEATURES; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; CELLS; POPULATION; MYELOPATHY; SPINE; SPONDYLOARTHRITIS	Thoracic ossification of the ligamentum flavum (TOLF) is characterized by ectopic bone formation in the ligamentum flavum and is considered to be a leading cause of thoracic spinal canal stenosis and myelopathy. However, the underlying etiology is not well understood. An iTRAQ proteomics was used to reveal the involvement of inflammation factors in TOLF. TNF-alpha is a pro-inflammatory cytokine implicated in the pathogenesis of many human diseases. Protein profiling analysis showed that the protein level of TNF-alpha increased in the ossified ligamentum flavum of TOLF, which was confirmed by western blot. The effects of TNF-alpha on primary ligamentum flavum cells was examined. Cell proliferation assay demonstrated that primary cells from the ossified ligamentum flavum of TOLF grew faster than the control. Flow cytometry assay indicated that the proportions of cells in S phase of cell cycle of primary cells increased after TNF-alpha stimulation. To address the effect of TNF-alpha on gene expression, primary cells were derived from ligamentum flavum of TOLF patients. Culture cells were stimulated by TNF-alpha. RNA was isolated and analyzed by quantitative RT-PCR. G1/S-specific proteins cyclin D1 and c-Myc were upregulated after TNF-alpha stimulation. On the other hand, osteoblast differentiation related genes such as Bmp2 and Osterix (Osx) were upregulated in the presence of TNF-alpha. TNF-alpha activated Osx expression in a dose dependent manner. Interestingly, a specific mitogen-activated protein kinase ERK inhibitor U0126, but not JNK kinase inhibitor SP600125, abrogated TNF-alpha activation of Osx expression. This suggests that TNF-alpha activates Osx expression through the mitogen-activated protein kinase ERK pathway. Taken together, we provide the evidence to support that TNF-alpha involves in TOLF probably through regulating cell proliferation via cyclin D1 and c-Myc, and promoting osteoblast differentiation via Osx.	[Zhang, Chi] Peking Univ, Int Hosp, Dept Orthoped, Beijing, Peoples R China; [Zhang, Chi; Meng, Xiangyu; Li, Mengtao] Peking Univ, Int Hosp, Cent Lab, Beijing, Peoples R China; [Zhang, Chi] Univ Texas Southwestern Med Ctr Dallas, Bone Res Lab, Dallas, TX 75390 USA; [Chen, Zhongqiang] Peking Univ, Hosp 3, Dept Orthoped, Beijing, Peoples R China; [Zhang, Li; Huang, Ann] Daobio Inc, Dept Res, Dallas, TX USA	Peking University; Peking University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Peking University	Zhang, C (corresponding author), Peking Univ, Int Hosp, Dept Orthoped, Beijing, Peoples R China.; Zhang, C (corresponding author), Peking Univ, Int Hosp, Cent Lab, Beijing, Peoples R China.; Zhang, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Bone Res Lab, Dallas, TX 75390 USA.; Chen, ZQ (corresponding author), Peking Univ, Hosp 3, Dept Orthoped, Beijing, Peoples R China.	chi.zhang@case.edu; puh3_czq@bjmu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [81272031, 81572101, 81460171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by National Natural Science Foundation of China, Grant Number: 81272031 (ZC), 81572101 (ZC) and 81460171 (CZ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aizawa T, 2006, J NEUROSURG-SPINE, V5, P514, DOI 10.3171/spi.2006.5.6.514; Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Cai HX, 2012, SPINE, V37, pE639, DOI 10.1097/BRS.0b013e318242a132; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Du C, 2014, J PROTEOME RES, V13, P720, DOI 10.1021/pr400803w; Edwards CK, 2006, ARTHRITIS RHEUM-US, V54, P2872, DOI 10.1002/art.22077; Fan DW, 2007, J BIOL CHEM, V282, P29958, DOI 10.1074/jbc.M611779200; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Feng FB, 2015, ORTHOP SURG, V7, P87, DOI 10.1111/os.12165; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Guo JJ, 2010, SPINE, V35, P51, DOI 10.1097/BRS.0b013e3181b3f779; Hou XF, 2016, CLIN SPINE SURG, V29, P86, DOI 10.1097/BSD.0000000000000081; Hreggvidsdottir HS, 2014, MOL IMMUNOL, V57, P28, DOI 10.1016/j.molimm.2013.07.016; Kang KC, 2011, J NEUROSURG-SPINE, V14, P513, DOI 10.3171/2010.11.SPINE10405; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong QQ, 2007, SPINE, V32, P2834, DOI 10.1097/BRS.0b013e31815b761c; KUDO S, 1983, AM J ROENTGENOL, V141, P117, DOI 10.2214/ajr.141.1.117; Lang N, 2013, EUR SPINE J, V22, P857, DOI 10.1007/s00586-012-2492-8; Li FC, 2006, J NEUROSURG-SPINE, V4, P191, DOI 10.3171/spi.2006.4.3.191; Limon-Camacho L, 2012, J RHEUMATOL, V39, P830, DOI 10.3899/jrheum.110862; Liu Y, 2010, CLIN ORTHOP RELAT R, V468, P3333, DOI 10.1007/s11999-010-1511-5; Lories RJU, 2012, RHEUM DIS CLIN N AM, V38, P555, DOI 10.1016/j.rdc.2012.08.003; Miyakoshi N, 2003, J NEUROSURG, V99, P251, DOI 10.3171/spi.2003.99.3.0251; Mobbs RJ, 2007, J CLIN NEUROSCI, V14, P703, DOI 10.1016/j.jocn.2006.01.010; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ning SL, 2017, INT J MOL MED, V39, P135, DOI 10.3892/ijmm.2016.2803; Ohtsuka K, 1986, Nihon Seikeigeka Gakkai Zasshi, V60, P1087; Qu XC, 2017, EUR J HUM GENET, V25, P565, DOI 10.1038/ejhg.2017.2; Sato T, 1998, TOHOKU J EXP MED, V184, P1, DOI 10.1620/tjem.184.1; Schmidt-Bleek K, 2014, EXPERT OPIN BIOL TH, V14, P247, DOI 10.1517/14712598.2014.857653; Shiokawa K, 2001, J NEUROSURG, V94, P221, DOI 10.3171/spi.2001.94.2.0221; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Wang WB, 2007, EUR SPINE J, V16, P1119, DOI 10.1007/s00586-006-0242-5; Wang Wenbao, 2006, J Orthop Surg Res, V1, P10, DOI 10.1186/1749-799X-1-10; Wang Z, 2008, J SPINAL CORD MED, V31, P279, DOI 10.1080/10790268.2008.11760723; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	42	24	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178986	10.1371/journal.pone.0178986	http://dx.doi.org/10.1371/journal.pone.0178986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575129	gold, Green Submitted, Green Published			2022-12-26	WOS:000402624300141
J	Liao, SY; Chiang, CW; Hsu, CH; Chen, YT; Jen, J; Juan, HF; Lai, WW; Wang, YC				Liao, S-Y; Chiang, C-W; Hsu, C-H; Chen, Y-T; Jen, J.; Juan, H-F; Lai, W-W; Wang, Y-C			CK1 delta/GSK3 beta/FBXW7 alpha axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; FBW7 UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; BETA-CATENIN; PHOSPHORYLATION; RECOGNITION; PROTEOLYSIS; MECHANISMS; GROWTH; MCL1	Overexpression of Cys2His2 zinc-finger 322A (ZNF322A) oncogenic transcription factor is associated with lung tumorigenesis. However, the mechanism of ZNF322A overexpression remains poorly understood. Here, we discover that protein stability of ZNF322A is regulated by coordinated phosphorylation and ubiquitination through the CK1 delta/GSK3 beta/FBXW7 alpha axis. CK1 delta and GSK3 beta kinases sequentially phosphorylate ZNF322A at serine-396 and then serine-391. Moreover, the doubly phosphorylated ZNF322A protein creates a destruction motif for the ubiquitin ligase FBXW7 alpha leading to ZNF322A protein destruction. Overexpression of FBXW7a induces ZNF322A protein degradation, thereby blocks ZNF322A transcription activity and suppresses ZNF322A-induced tumor growth and metastasis in vitro and in vivo. Clinically, overexpression of ZNF322A correlates with low FBXW7a or defective CK1 delta/GSK3 beta-mediated phosphorylation in lung cancer patients. Multivariate Cox regression analysis indicates that patients with ZNF322A high/FBXW7 low expression profile can be used as an independent factor to predict the clinical outcome in lung cancer patients. Our results reveal a new mechanism of ZNF322A oncoprotein destruction regulated by the CK1 delta/GSK3 beta/FBXW7 alpha axis. Deregulation of this signaling axis results in ZNF322A overexpression and promotes cancer progression.	[Liao, S-Y; Chiang, C-W; Wang, Y-C] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, 1 Univ Rd, Tainan 70101, Taiwan; [Chiang, C-W] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Hsu, C-H] Natl Taiwan Univ, Dept Agr Chem, Taipei, Taiwan; [Chen, Y-T; Jen, J.; Wang, Y-C] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, 1 Univ Rd, Tainan 70101, Taiwan; [Juan, H-F] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Inst Mol & Cellular Biol, Dept Life Sci, Taipei, Taiwan; [Lai, W-W] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Surg, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Cheng Kung University Hospital	Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, 1 Univ Rd, Tainan 70101, Taiwan.; Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, 1 Univ Rd, Tainan 70101, Taiwan.	ycw5798@mail.ncku.edu.tw	, 賴吾為/T-8615-2019; Wang, Yi-Ching/J-8702-2019; HSU, CHUN-HUA/W-4554-2019	, 賴吾為/0000-0001-9174-8310; Wang, Yi-Ching/0000-0002-7694-2067; HSU, CHUN-HUA/0000-0002-0008-7383	Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital; Taiwan Ministry of Science and Technology [104-2627-B-006-001, 104-2627-B-002-001]; Taiwan Ministry of Education [D105-35A07]	Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital; Taiwan Ministry of Science and Technology; Taiwan Ministry of Education(Ministry of Education, Taiwan)	We are grateful for the support from the Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital. We thank Mr Chien-Hsun Lin for providing technical support. We acknowledge Dr Ruey-Hwa Chen, Institute of Biological Chemistry, Academia Sinica for discussion and comments on the manuscript. This work was supported in part by the Taiwan Ministry of Science and Technology grants (104-2627-B-006-001; 104-2627-B-002-001) and the Aim for the Top University Project grant from the Taiwan Ministry of Education (D105-35A07).	Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gan WJ, 2015, MOL CELL, V59, P917, DOI 10.1016/j.molcel.2015.07.026; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jen J, 2016, ONCOGENE, V35, P2357, DOI 10.1038/onc.2015.296; Jia D, 2013, BLOOD, V121, P707, DOI 10.1182/blood-2012-05-433045; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kao SH, 2014, ONCOGENE, V33, P3172, DOI 10.1038/onc.2013.279; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Thollet A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-291; Vendrell JA, 2012, CANCER RES, V72, P3593, DOI 10.1158/0008-5472.CAN-11-3095; Wang R, 2013, CELL RES, V23, P803, DOI 10.1038/cr.2013.42; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu Y, 2010, ONCOGENE, V29, P3124, DOI 10.1038/onc.2010.77; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	28	10	11	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5722	5733		10.1038/onc.2017.168	http://dx.doi.org/10.1038/onc.2017.168			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28581525				2022-12-26	WOS:000412843900006
J	Hsu, JY; Chang, JY; Chang, KY; Chang, WC; Chen, BK				Hsu, Jinn-Yuan; Chang, Jang-Yang; Chang, Kwang-Yu; Chang, Wen-Chang; Chen, Ben-Kuen			Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin	FASEB JOURNAL			English	Article						EGF; PDK1; HNSCC; MMP	HIGH LACTATE LEVELS; CANCER-CELLS; GLUCOSE-METABOLISM; PATIENT SURVIVAL; HYPOXIA; ACTIVATION; GLYCOLYSIS; RECEPTOR; OVEREXPRESSION; TUMORIGENESIS	Epidermal growth factor receptor (EGFR) activation is a major cause of metastasis in such cancers as head and neck squamous cell carcinoma (HNSCC); however, whether the metabolic enzyme, pyruvate dehydrogenase kinase 1 (PDK1), mediates EGF-enhanced HNSCC metastasis remains unclear. Of interest, we found that EGF induced PDK1 expression in HNSCC. Tumor cell transformation induced by EGF was repressed by PDK1 knockdown, and the down-regulation of PDK1 expression or inhibition of its activity significantly blocked EGF-enhanced cell migration and invasion. In addition, depletion of PDK1 impeded EGF-enhanced binding of HNSCC cells to endothelial cells as well as the metastatic seeding of tumor cells in lungs. PDK1 depletion inhibited EGF-induced matrix metalloproteinase-1 (MMP-1), MMP-2, MMP-3, MMP-9, and fibronectin expression and Rac1/cdc42 activation. Furthermore, PDK1 overexpression induced MMP-1, MMP-2, MMP-3, MMP-9, and fibronectin expression and Rac1/cdc42 activation. Of interest, depletion of fibronectin inhibited PDK1-enhanced MMP-1-3 and MMP-9 expression as well as Rac1/cdc42 activation and tumor invasion. These results demonstrate that EGF-induced PDK1 expression enhances HNSCC metastasis via activation of the fibronectin signaling pathway. Inhibition of PDK1 may be a potential strategy for the treatment of EGFR-mediated HNSCC metastasis.-Hsu, J.-Y., Chang, J.-Y., Chang, K.-Y., Chang, W.-C., Chen B.-K. Epidermal growth factor-induced pyruvate dehydrogenase kinase 1 expression enhances head and neck squamous cell carcinoma metastasis via up-regulation of fibronectin.	[Hsu, Jinn-Yuan] Natl Cheng Kung Univ Hosp, Ctr Infect Dis & Signaling Res, Tainan, Taiwan; [Chang, Jang-Yang] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan, Taiwan; [Chang, Kwang-Yu] Natl Cheng Kung Univ, Div Hematol Oncol, Dept Internal Med, Tainan, Taiwan; [Chen, Ben-Kuen] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Coll Biosci & Biotechnol, Tainan, Taiwan; [Chang, Jang-Yang; Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, 1 Univ Rd, Tainan 701, Taiwan.	wcchang@tmu.edu.tw; bkchen58@mail.ncku.edu.tw		Chen, Ben-Kuen/0000-0002-4720-4364	Ministry of Science and Technology of Taiwan [NSC 102-2628-B-006-011-MY3, 102-2320-B-038-046-MY3]; Headquarters of University Advancement at National Cheng Kung University	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Headquarters of University Advancement at National Cheng Kung University	This work was supported by the Ministry of Science and Technology of Taiwan (Grants NSC 102-2628-B-006-011-MY3 and 102-2320-B-038-046-MY3), and the Headquarters of University Advancement at National Cheng Kung University. The authors declare no conflicts of interest.	Akakura N, 2001, CANCER RES, V61, P6548; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Blum R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.38; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Boussouar F, 1999, BIOL REPROD, V61, P1139, DOI 10.1095/biolreprod61.4.1139; Carneiro BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116001; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GRANDIS JR, 1993, CANCER RES, V53, P3579; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hsu JY, 2015, ONCOTARGET, V6, P1723, DOI 10.18632/oncotarget.2783; Huang M, 2012, ONCOGENE, V31, P2783, DOI 10.1038/onc.2011.450; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; ISHITOYA J, 1989, BRIT J CANCER, V59, P559, DOI 10.1038/bjc.1989.113; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kamarajan P, 2013, CANCER MED-US, V2, P793, DOI 10.1002/cam4.147; KAPLAN O, 1990, J BIOL CHEM, V265, P13641; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200; Mikuriya K, 2007, INT J ONCOL, V30, P849; Moore JD, 2014, ONCOTARGET, V5, P12862, DOI 10.18632/oncotarget.2656; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ota S, 2013, TARGET ONCOL, V8, P145, DOI 10.1007/s11523-013-0273-x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Robey RB, 2002, J BIOL CHEM, V277, P14370, DOI 10.1074/jbc.M111722200; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; STEINSVAG SK, 1991, LARYNGOSCOPE, V101, P1323, DOI 10.1002/lary.5541011212; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; van Houten VMM, 2000, RECENT RESULTS CANC, V157, P90; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Yang P, 2014, CELL SIGNAL, V26, P1853, DOI 10.1016/j.cellsig.2014.03.020; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeh TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055018; Zhou WD, 2011, J PROTEOME RES, V10, P1944, DOI 10.1021/pr101179t; Ziebart T, 2011, J CANCER RES CLIN, V137, P193, DOI 10.1007/s00432-010-0875-y	53	12	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4265	4276		10.1096/fj.201700156R	http://dx.doi.org/10.1096/fj.201700156R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28596235				2022-12-26	WOS:000413397400007
J	Murtaza, M; Khan, G; Aftab, MF; Afridi, SK; Ghaffar, S; Ahmed, A; Hafizur, RM; Waraich, RS				Murtaza, Munazza; Khan, Gulnaz; Aftab, Meha Fatima; Afridi, Shabbir Khan; Ghaffar, Safina; Ahmed, Ayaz; Hafizur, Rahman M.; Waraich, Rizwana Sanaullah			Cucurbitacin E reduces obesity and related metabolic dysfunction in mice by targeting JAK-STAT5 signaling pathway	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; 3T3-L1 CELLS; CANCER-CELLS; TNF-ALPHA; ADIPOCYTES; DIFFERENTIATION; TRANSCRIPTION; ADIPOGENESIS	Several members of cucurbitaceae family have been reported to regulate growth of cancer by interfering with STAT3 signaling. In the present study, we investigated the unique role and molecular mechanism of cucurbitacins (Cucs) in reducing symptoms of metabolic syndrome in mice. Cucurbitacin E (CuE) was found to reduce adipogenesis in murine adipocytes. CuE treatment diminished hypertrophy of adipocytes, visceral obesity and lipogenesis gene expression in diet induced mice model of metabolic syndrome (MetS). CuE also ameliorated adipose tissue dysfunction by reducing hyperleptinemia and TNF-alpha levels and enhancing hypoadiponectinemia. Results show that CuE mediated these effects by attenuating Jenus kinase-Signal transducer and activator of transcription 5 (JAK-STAT5) signaling in visceral fat tissue. As a result, CuE treatment also reduced PPAR gamma expression. Glucose uptake enhanced in adipocytes after stimulation with CuE and insulin resistance diminished in mice treated with CuE, as reflected by reduced glucose intolerance and glucose stimulated insulin secretion. CuE restored insulin sensitivity indirectly by inhibiting JAK phosphorylation and improving AMPK activity. Consequently, insulin signaling was up-regulated in mice muscle. As CuE positively regulated adipose tissue function and suppressed visceral obesity, dyslipedemia, hyperglycemia and insulin resistance in mice model of MetS, we suggest that CuE can be used as novel approach to treat metabolic diseases.	[Murtaza, Munazza; Khan, Gulnaz; Aftab, Meha Fatima; Afridi, Shabbir Khan; Ghaffar, Safina; Ahmed, Ayaz; Hafizur, Rahman M.; Waraich, Rizwana Sanaullah] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan	University of Karachi	Waraich, RS (corresponding author), Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan.	rizwanas.waraich@gmail.com	Ahmed, Ayaz/Q-7739-2019; Ahmed, Ayaz/M-7534-2016; Aftab, Meha F/A-1512-2019	Ahmed, Ayaz/0000-0001-8792-7850; 	International Federation for Science (IFS) [F/5774-1]	International Federation for Science (IFS)	This work was supported by a grant from the International Federation for Science (IFS grant no: F/5774-1) to RSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arel-Dubeau AM, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/425496; Balhoff JP, 1998, BIOCHEM BIOPH RES CO, V247, P894, DOI 10.1006/bbrc.1998.8890; Cai Y, 2015, AM J CHINESE MED, V43, P1331, DOI 10.1142/S0192415X15500755; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Chen Y, 2016, BIOCHEM BIOPH RES CO, V471, P391, DOI 10.1016/j.bbrc.2016.02.034; Fawcett J, 2010, BIOCHEM BIOPH RES CO, V402, P762, DOI 10.1016/j.bbrc.2010.10.104; Feng H, 2014, CANCER BIOTHER RADIO, V29, P210, DOI 10.1089/cbr.2014.1614; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Grundy SM, 2015, EUR J CLIN INVEST, V45, P1209, DOI 10.1111/eci.12519; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; International Diabetes Federation (IDF), IDF CONS WORLDW DEF; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Jia QY, 2015, INT IMMUNOPHARMACOL, V29, P884, DOI 10.1016/j.intimp.2015.08.026; Krisanapun C, 2009, NUTR RES, V29, P579, DOI 10.1016/j.nutres.2009.07.006; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lindsay Robert S, 2004, Curr Diab Rep, V4, P63, DOI 10.1007/s11892-004-0013-9; Liu TY, 2008, EUR ARCH OTO-RHINO-L, V265, P1225, DOI 10.1007/s00405-008-0625-9; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Sato T, 2014, NUTR RES, V34, P544, DOI 10.1016/j.nutres.2014.04.013; Seo CR, 2014, FOOD CHEM TOXICOL, V64, P217, DOI 10.1016/j.fct.2013.11.040; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Stewart WC, 1999, BBA-MOL CELL RES, V1452, P188, DOI 10.1016/S0167-4889(99)00129-9; Sung JH, 2011, NUTR RES PRACT, V5, P503, DOI 10.4162/nrp.2011.5.6.503; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Waraich RS, 2008, BIOCHEM BIOPH RES CO, V376, P26, DOI 10.1016/j.bbrc.2008.08.053; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Weigert C, 2005, J BIOL CHEM, V280, P37393, DOI 10.1074/jbc.M506134200; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yamamoto N, 2006, ANAL BIOCHEM, V351, P139, DOI 10.1016/j.ab.2005.12.011; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Yarwood SJ, 1999, J BIOL CHEM, V274, P8662, DOI 10.1074/jbc.274.13.8662; Zha QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124355; Zhang M, 2009, PHYTOTHER RES, V23, P713, DOI 10.1002/ptr.2724; Zhao Peng, 2013, JAKSTAT, V2, pe23092, DOI 10.4161/jkst.23092	41	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178910	10.1371/journal.pone.0178910	http://dx.doi.org/10.1371/journal.pone.0178910			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598969	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000015
J	Hariharan, P; D'Souza, GA; Horner, M; Morrison, TM; Malinauskas, RA; Myers, MR				Hariharan, Prasanna; D'Souza, Gavin A.; Horner, Marc; Morrison, Tina M.; Malinauskas, Richard A.; Myers, Matthew R.			Use of the FDA nozzle model to illustrate validation techniques in computational fluid dynamics (CFD) simulations	PLOS ONE			English	Article							IN-VITRO VALIDATION; BLOOD-FLOW; NUMERICAL PREDICTION; VIVO VALIDATION; SHEAR-STRESS	A "credible" computational fluid dynamics (CFD) model has the potential to provide a meaningful evaluation of safety in medical devices. One major challenge in establishing "model credibility" is to determine the required degree of similarity between the model and experimental results for the model to be considered sufficiently validated. This study proposes a "threshold-based" validation approach that provides a well-defined acceptance criteria, which is a function of how close the simulation and experimental results are to the safety threshold, for establishing the model validity. The validation criteria developed following the threshold approach is not only a function of Comparison Error, E (which is the difference between experiments and simulations) but also takes in to account the risk to patient safety because of E. The method is applicable for scenarios in which a safety threshold can be clearly defined (e.g., the viscous shear-stress threshold for hemolysis in blood contacting devices). The applicability of the new validation approach was tested on the FDA nozzle geometry. The context of use (COU) was to evaluate if the instantaneous viscous shear stress in the nozzle geometry at Reynolds numbers (Re) of 3500 and 6500 was below the commonly accepted threshold for hemolysis. The CFD results ("S") of velocity and viscous shear stress were compared with inter-laboratory experimental measurements ("D"). The uncertainties in the CFD and experimental results due to input parameter uncertainties were quantified following the ASME V&V 20 standard. The CFD models for both Re = 3500 and 6500 could not be sufficiently validated by performing a direct comparison between CFD and experimental results using the Student's t-test. However, following the threshold-based approach, a Student's t-test comparing |S-D| and |Threshold-S| showed that relative to the threshold, the CFD and experimental datasets for Re = 3500 were statistically similar and the model could be considered sufficiently validated for the COU. However, for Re = 6500, at certain locations where the shear stress is close the hemolysis threshold, the CFD model could not be considered sufficiently validated for the COU. Our analysis showed that the model could be sufficiently validated either by reducing the uncertainties in experiments, simulations, and the threshold or by increasing the sample size for the experiments and simulations. The threshold approach can be applied to all types of computational models and provides an objective way of determining model credibility and for evaluating medical devices.	[Hariharan, Prasanna; D'Souza, Gavin A.; Morrison, Tina M.; Malinauskas, Richard A.; Myers, Matthew R.] US FDA, Silver Spring, MD 20993 USA; [Horner, Marc] ANSYS Inc, Evanston, IL USA	US Food & Drug Administration (FDA); Ansys, Inc.	Hariharan, P (corresponding author), US FDA, Silver Spring, MD 20993 USA.	prasanna.hariharan@fda.hhs.gov			ANSYS, Inc.	ANSYS, Inc.(Ansys, Inc.)	ANSYS, Inc. provided support in the form of salaries for author MH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Mechanical Engineers, 2006, V V 10 2006 GUID VER; American Society of Mechanical Engineers, DRAFT STAND UND DEV; [Anonymous], SAND2010234P; [Anonymous], 2014, APPL GENETIC ALGORIT; [Anonymous], NASASTD7009A; Arzani A, 2012, ANN BIOMED ENG, V40, P860, DOI 10.1007/s10439-011-0447-6; ASME PTC Committee, 2009, AM SOC MECH ENG, V20, P1; Bhushan S., 2013, CARDIOVASC ENG TECHN, V4, P408, DOI [10.1007/s13239-013-0155-5, DOI 10.1007/S13239-013-0155-5]; Cheung SH, 2011, RELIAB ENG SYST SAFE, V96, P1137, DOI 10.1016/j.ress.2010.09.013; de Zelicourt DA, 2005, ANN THORAC SURG, V79, P2094, DOI 10.1016/j.athoracsur.2004.12.052; Delorme Y, 2013, CARDIOVASC ENG TECHN, V4, P4, DOI DOI 10.1007/S13239-013-0161-7; Department of Defense, 2008, MILSTD3022; Down LA, 2011, COMPUTATIONAL INVEST; Emory M, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4824659; FDA US, 2016, GUID IND FOOD DRUG A; Ferson S., 2007, EXPT UNCERTAINTY EST; Hariharan P, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003440; Janiga G, 2014, COMPUT BIOL MED, V47, P113, DOI 10.1016/j.compbiomed.2014.01.004; Ku JP, 2002, ANN BIOMED ENG, V30, P743, DOI 10.1114/1.1496086; Kung E, 2014, CARDIOVASC ENG TECHN, V5, P189, DOI 10.1007/s13239-014-0184-8; Kung EO, 2011, ANN BIOMED ENG, V39, P1947, DOI 10.1007/s10439-011-0284-7; Kung EO, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003526; LEVERETT LB, 1972, BIOPHYS J, V12, P257, DOI 10.1016/S0006-3495(72)86085-5; Malinauskas RA, 2016, FDA BENCHMARK MED DE; Morrison T., 2016, ROLE COMPUTATIONAL M; Morshed KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105357; Oakes JM, 2015, J BIOMECH, V48, P1147, DOI 10.1016/j.jbiomech.2015.01.004; Oberkampf WL, 2003, SAND20033769; Oberkampf WL., 2007, SAND20075948; Raghunathan R, 2016, SUMMER BIOMECHANICS; Rosner B., 2000, FUNDAMENTALS BIOSTAT; Salari K, 2000, SAND200014444; Sankaran S, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003259; Sarrami-Foroushani A, 2016, J BIOMECH, V49, P3815, DOI 10.1016/j.jbiomech.2016.10.005; Schiavazzi DE, 2016, INT J NUMER METH BIO, V32, DOI 10.1002/cnm.2737; Sotiropoulos F., 2012, CARDIOVASC ENG TECHN, V3, P137, DOI DOI 10.1007/S13239-012-0095-5; Steinman DA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023382; Stewart S., 2012, CARDIOVASCULAR ENG T, V3, P139, DOI [DOI 10.1007/S13239-012-0087-5, 10.1007/s13239-012-0087-5]; Thacker B.H., 2004, LA14167MS; Tran JS, 2017, COMPUT FLUIDS, V142, P128, DOI 10.1016/j.compfluid.2016.05.015; Trias M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092638; Troianowski G, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005377; Valen-Sendstad K, 2014, J BIOMECH, V47, P3210, DOI 10.1016/j.jbiomech.2014.04.018; Xie J, 2012, ANN ALLERTON CONF, P406, DOI 10.1109/Allerton.2012.6483247; Yang WG, 2015, J THORAC CARDIOV SUR, V149, P247, DOI 10.1016/j.jtcvs.2014.08.069	46	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178749	10.1371/journal.pone.0178749	http://dx.doi.org/10.1371/journal.pone.0178749			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594889	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200049
J	Kostner, N; Scharnreitner, L; Jurgens, K; Labrenz, M; Herndl, GJ; Winter, C				Koestner, Nicole; Scharnreitner, Lisa; Juergens, Klaus; Labrenz, Matthias; Herndl, Gerhard J.; Winter, Christian			High viral abundance as a consequence of low viral decay in the Baltic Sea redoxcline	PLOS ONE			English	Article							VIRUS-SIZED PARTICLES; FLOW-CYTOMETRY; VIRIOPLANKTON PRODUCTION; PELAGIC REDOXCLINES; LYSOGENIC BACTERIA; PROPHAGE INDUCTION; COASTAL WATERS; MARINE VIRUSES; BLACK SEAS; BACTERIOPLANKTON	Throughout the Baltic Sea redoxcline, virus production and the frequency of lytically-infected prokaryotic cells were estimated from parallel incubations of undiluted seawater and seawater that contained prokaryotes with substantially reduced numbers of viruses (virus dilution approach), effectively preventing viral reinfection during the incubation period. Undiluted seawater incubations resulted in much higher estimates of virus production (6-35x10(4) mL(-1) h(-1)) and the frequency of infected cells (5-84%) than the virus dilution approach (virus production: 1-3x10(4) mL(-1) h(-1); frequency of infected cells: 1-11%). Viral production and the frequency of infected cells from both approaches, however, cannot be directly compared, as data obtained from undiluted incubations were biased by viral reinfection and other uncontrollable processes during the incubation period. High in situ viral abundance (1-2x10(7) mL(-1)) together with low virus production rates based on the virus dilution approach resulted in some of the longest viral turnover times (24-84 d) ever reported for the epipelagial. Throughout a wide range of environmental conditions, viral turnover time and burst size were negatively correlated. Given that viral decay estimated in ultra-filtered water was below the detection limit and the burst size was low (1-17), we conclude that prokaryotic viruses in the Baltic Sea redoxcline are investing most of their resources into stress defense (strong capsids) rather than proliferation (high burst size). In summary, the Baltic Sea redoxcline constitutes an environment where low virus production is found in combination with low viral decay, resulting in high viral abundance.	[Koestner, Nicole; Scharnreitner, Lisa; Herndl, Gerhard J.; Winter, Christian] Univ Vienna, Dept Limnol & Biooceanog, Vienna, Austria; [Juergens, Klaus; Labrenz, Matthias] Leibniz Inst Balt Sea Res IOW, Dept Biol Oceanog, Rostock, Germany; [Herndl, Gerhard J.] Univ Utrecht, Dept Marine Microbiol & Biogeochem, Royal Netherlands Inst Sea Res, Ab Den Burg, Netherlands	University of Vienna; Leibniz Institut fur Ostseeforschung Warnemunde; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Kostner, N (corresponding author), Univ Vienna, Dept Limnol & Biooceanog, Vienna, Austria.	nicole.koestner@univie.ac.at	Herndl, Gerhard J./S-3011-2019; Herndl, Gerhard J./B-1513-2013	Herndl, Gerhard J./0000-0002-2223-2852; Herndl, Gerhard J./0000-0002-2223-2852; Winter, Christian/0000-0001-6327-0209; Jurgens, Klaus/0000-0002-7999-9368	Austrian Science Fund (FWF) [P24413-B21]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was funded by the Austrian Science Fund (FWF) through grant P24413-B21 to CW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anderson R, 2012, MAR ECOL PROG SER, V467, P1, DOI 10.3354/meps10001; Bettarel Y, 2005, AQUAT MICROB ECOL, V39, P205, DOI 10.3354/ame039205; Bettarel Y, 2009, J PLANKTON RES, V31, P909, DOI 10.1093/plankt/fbp041; Bongiorni L, 2005, APPL ENVIRON MICROB, V71, P6644, DOI 10.1128/AEM.71.11.6644-6650.2005; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Cochran PK, 1998, MAR ECOL PROG SER, V164, P125, DOI 10.3354/meps164125; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Deng L, 2014, ENV MICROBIOL REP, V6, P325, DOI 10.1111/1758-2229.12119; Evans C, 2009, ENVIRON MICROBIOL, V11, P2924, DOI 10.1111/j.1462-2920.2009.02050.x; Fox J, 2015, CAR COMPANION APPL R; Gelbart WM, 2009, SCIENCE, V323, P1682, DOI 10.1126/science.1170645; Glaubitz S, 2013, APPL ENVIRON MICROB, V79, P2767, DOI 10.1128/AEM.03777-12; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hammes F, 2010, APPL ENVIRON MICROB, V76, P1278, DOI 10.1128/AEM.01914-09; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; Hewson I, 2003, MICROB ECOL, V46, P337, DOI 10.1007/s00248-002-1041-0; Holmfeldt K, 2010, MICROB ECOL, V60, P572, DOI 10.1007/s00248-010-9668-8; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Liu W, 2011, J FOOD AGRIC ENVIRON, V9, P963; Malits A, 2014, BIOGEOSCIENCES, V11, P6841, DOI 10.5194/bg-11-6841-2014; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Matthaus W., 2008, STATE EVOLUTION BALT, P265, DOI [10.1002/9780470283134.ch10, DOI 10.1002/9780470283134.CH10]; Meyer KM, 2008, ANNU REV EARTH PL SC, V36, P251, DOI 10.1146/annurev.earth.36.031207.124256; Muck S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00264; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; Nausch G., 2015, WATER EXCHANGE BALTI; Noble RT, 1997, APPL ENVIRON MICROB, V63, P77, DOI 10.1128/AEM.63.1.77-83.1997; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Parada V, 2006, J MAR BIOL ASSOC UK, V86, P613, DOI 10.1017/S002531540601352X; Payet JP, 2013, LIMNOL OCEANOGR, V58, P465, DOI 10.4319/lo.2013.58.2.0465; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; R Development Core Team, 2014, R LANG ENV STAT COMP; Rocke E, 2014, MAR POLLUT BULL, V85, P410, DOI 10.1016/j.marpolbul.2014.04.050; Schlitzer R., 2017, OCEAN DATA VIEW VERS; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; SUZUKI H, 1967, J BACTERIOL, V93, P683, DOI 10.1128/JB.93.2.683-688.1967; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Teira E, 2004, APPL ENVIRON MICROB, V70, P4411, DOI 10.1128/AEM.70.7.4411-4414.2004; Thureborn P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074983; Tuomi P, 1999, J PLANKTON RES, V21, P923, DOI 10.1093/plankt/21.5.923; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weinbauer MG, 2003, AQUAT MICROB ECOL, V31, P137, DOI 10.3354/ame031137; Weinbauer MG, 2002, AQUAT MICROB ECOL, V27, P103, DOI 10.3354/ame027103; Wells LE, 2006, AQUAT MICROB ECOL, V45, P31, DOI 10.3354/ame045031; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Winget DM, 2011, P NATL ACAD SCI USA, V108, P11506, DOI 10.1073/pnas.1101907108; Winget DM, 2005, AQUAT MICROB ECOL, V41, P221, DOI 10.3354/ame041221; Winter C, 2004, AQUAT MICROB ECOL, V35, P207, DOI 10.3354/ame035207	54	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178467	10.1371/journal.pone.0178467	http://dx.doi.org/10.1371/journal.pone.0178467			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594863	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200033
J	Meinema, JG; Haafkens, JA; Jaarsma, DADC; van Weert, HCPM; van Dijk, N				Meinema, Jennita G.; Haafkens, Joke A.; Jaarsma, Debbie A. D. C.; van Weert, Henk C. P. M.; van Dijk, Nynke			Development and evaluation of a culturally appropriate hypertension education (CAHE) training program for health care providers	PLOS ONE			English	Article							INTERVENTIONS; DISPARITIES; SURINAMESE; GHANAIAN	Background In Western countries, hypertension and hypertension-related complication are more common in ethnic minority groups of African descent than in indigenous populations. Addressing ethnic minority patients' perceptions of hypertension and its treatment through the use of cultural appropriate hypertension education (CAHE) increases adherence to medication and lifestyle recommendations. Given these effects, it seems warranted to develop a training program on how to deliver this type of patient education for Primary Care Nurse Practitioners (PCNPs). Objective Development and evaluation of a training program for PCNPs aimed at providing culturally appropriate hypertension patient education. Design Prospective cohort study evaluating attitude and intended behavioral changes. Participants Both experienced PCNPs and PCNPs in training participated in this study. Main measures The effects of the CAHE-training were measured by 3 different questionnaires on 1) the satisfaction with the training program, 2) the attitude towards culturally appropriate care, and 3) the commitment to change. Results The CAHE-training program consists of 10 different components divided over two 4-hour sessions and was taught to 87 participating PCNPs. The program utilizes constructivistlearning principles and educational evidence on adult learning. The content of the program is based on the knowledge obtained from our previous studies on culturally appropriate care. The mean satisfaction-score was 7.5 (1-10 scale), with the role-play exercise with patient-actors scoring highest (8.2). We observed non-significant but positive changes in attitude. PCNPs who reported on the implementation of their intended behavior change showed significant attitude changes after three months. Conclusion We demonstrated that our evidence based training program for PCNPs resulted in a positive learning experience with adequate intended behavioral changes in practice. Unfortunately, response rates were too low to demonstrate persistent changes in attitude.	[Meinema, Jennita G.; van Weert, Henk C. P. M.; van Dijk, Nynke] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice Family Med, Amsterdam, Netherlands; [Haafkens, Joke A.] Univ Amsterdam, Amsterdam Inst Adv Labour Studies, Amsterdam, Netherlands; [Jaarsma, Debbie A. D. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Educ Dev & Res Hlth Pro, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Groningen	Meinema, JG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice Family Med, Amsterdam, Netherlands.	j.g.meinema@amc.uva.nl		Jaarsma, Debbie/0000-0003-1668-2002; Meinema, Jennita/0000-0003-3706-1360; van Dijk, Nynke/0000-0001-7959-5649	ZonMw [201X 12010095425]	ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by ZonMw (http://dx.doi.org/10.13039/501100001826) NOW grant 201X 12010095425 (Dr. Joke A. Haafkens).	Agyemang C, 2012, Ghana Med J, V46, P12; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2015, INT J CARDIOL, V183, P180, DOI 10.1016/j.ijcard.2015.01.061; Beune EJAJ, 2010, J HUM HYPERTENS, V24, P280, DOI 10.1038/jhh.2009.61; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Beune EJAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090103; Beune EJAJ, 2011, PATIENT EDUC COUNS, V82, P74, DOI 10.1016/j.pec.2010.02.015; Beune EJAJ, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-35; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper LA, 2002, J GEN INTERN MED, V17, P477, DOI 10.1046/j.1525-1497.2002.10633.x; Crotty, 1998, FDN SOCIAL RES MEANI; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; De Geest Sabina, 2003, Eur J Cardiovasc Nurs, V2, P323; Dolcourt J L, 2000, J Contin Educ Health Prof, V20, P156, DOI 10.1002/chp.1340200304; Domino FJ, 2011, MED TEACH, V33, pE495, DOI 10.3109/0142159X.2011.599452; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Haafkens JA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-193; Heiligers P., 2012, KENNISVRAAG PRAKTIJK; Khatib R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084238; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Klonoff EA, 2009, J BEHAV MED, V32, P48, DOI 10.1007/s10865-008-9192-1; Lie DA, 2011, J GEN INTERN MED, V26, P317, DOI 10.1007/s11606-010-1529-0; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Meinema JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133560; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Netto G, 2010, HEALTH PROMOT INT, V25, P248, DOI 10.1093/heapro/daq012; Prideaux D, 2003, BMJ-BRIT MED J, V326, P268, DOI 10.1136/bmj.326.7383.268; Reed S, 2014, CURR PROB PEDIATR AD, V44, P170, DOI 10.1016/j.cppeds.2014.01.008; Schoenthaler A, 2009, PATIENT EDUC COUNS, V75, P185, DOI 10.1016/j.pec.2008.09.018; Schon DA, 1983, REFLECTIVE PRACTITIO, P1983; Wakefield Jacqueline, 2003, J Contin Educ Health Prof, V23, P81, DOI 10.1002/chp.1340230205; Wakefield Jacqueline G, 2004, J Contin Educ Health Prof, V24, P197, DOI 10.1002/chp.1340240403; Whitlock EP, 2002, AM J PREV MED, V22, P267, DOI 10.1016/S0749-3797(02)00415-4	33	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178468	10.1371/journal.pone.0178468	http://dx.doi.org/10.1371/journal.pone.0178468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594878	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200034
J	Roche, K; Feltus, FA; Park, JP; Coissieux, MM; Chang, CY; Chan, VBS; Bentires-Alj, M; Booth, BW				Roche, Kimberly; Feltus, F. Alex; Park, Jang Pyo; Coissieux, Marie-May; Chang, Chenyan; Chan, Vera B. S.; Bentires-Alj, Mohamed; Booth, Brian W.			Cancer cell redirection biomarker discovery using a mutual information approach	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; AMPLIFICATION; PROGNOSIS; FRAMEWORK; ALTERS	Introducing tumor-derived cells into normal mammary stem cell niches at a sufficiently high ratio of normal to tumorous cells causes those tumor cells to undergo a change to normal mammary phenotype and yield normal mammary progeny. This phenomenon has been termed cancer cell redirection. We have developed an in vitro model that mimics in vivo redirection of cancer cells by the normal mammary microenvironment. Using the RNA profiling data from this cellular model, we examined high-level characteristics of the normal, redirected, and tumor transcriptomes and found the global expression profiles clearly distinguish the three expression states. To identify potential redirection biomarkers that cause the redirected state to shift toward the normal expression pattern, we used mutual information relationships between normal, redirected, and tumor cell groups. Mutual information relationship analysis reduced a dataset of over 35,000 gene expression measurements spread over 13,000 curated gene sets to a set of 20 significant molecular signatures totaling 906 unique loci. Several of these molecular signatures are hallmark drivers of the tumor state. Using differential expression as a guide, we further refined the gene set to 120 core redirection biomarker genes. The expression levels of these core biomarkers are sufficient to make the normal and redirected gene expression states indistinguishable from each other but radically different from the tumor state.	[Roche, Kimberly; Feltus, F. Alex; Chang, Chenyan] Clemson Univ, Dept Genet & Biochem, Clemson, SC USA; [Park, Jang Pyo; Booth, Brian W.] Clemson Univ, Inst Biol Interfaces Engn, Clemson, SC USA; [Coissieux, Marie-May; Bentires-Alj, Mohamed] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Coissieux, Marie-May; Bentires-Alj, Mohamed] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Chan, Vera B. S.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Booth, Brian W.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA	Clemson University; Clemson University; University of Basel; Friedrich Miescher Institute for Biomedical Research; Clemson University; Clemson University	Booth, BW (corresponding author), Clemson Univ, Inst Biol Interfaces Engn, Clemson, SC USA.; Booth, BW (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.	brbooth@clemson.edu	; Bentires-Alj, Mohamed/F-4484-2015	Coissieux, Marie-May/0000-0001-5017-5253; Feltus, Frank/0000-0002-2123-6114; Bentires-Alj, Mohamed/0000-0001-6344-1127	Novartis Research Foundation; European Research Council; Swiss National Science Foundation; Krebsliga Beider Basel; Swiss Cancer League; Department of Surgery of the University Hospital of Basel; Swiss Initiative for Systems Biology (SystemsX.ch)	Novartis Research Foundation; European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Krebsliga Beider Basel; Swiss Cancer League; Department of Surgery of the University Hospital of Basel; Swiss Initiative for Systems Biology (SystemsX.ch)	Funding was provided by the Institute for Biological Interfaces of Engineering of Clemson University. Research in the lab of MBA is supported by the Novartis Research Foundation, the European Research Council, the Swiss National Science Foundation, the Krebsliga Beider Basel, the Swiss Cancer League, the Department of Surgery of the University Hospital of Basel, and the Swiss Initiative for Systems Biology (SystemsX.ch). MMC is a Marie-Curie fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andrulis IL, 1998, J CLIN ONCOL, V16, P1340, DOI 10.1200/JCO.1998.16.4.1340; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062019; Boulanger CA, 2012, STEM CELLS DEV, V21, P948, DOI 10.1089/scd.2011.0148; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brown G, 2012, J MACH LEARN RES, V13, P27; Brucher BLDM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-331; Bruno RD, 2012, ONCOGENE, V31, P60, DOI 10.1038/onc.2011.215; Bussard KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049221; Bussard KM, 2010, CANC RES; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cover T.M., 1996, ELEMENTS INFORM THEO, V2nd; Felsher DW, 2003, NAT REV CANCER, V3, P375, DOI 10.1038/nrc1070; Fey D, 2016, SEMIN CELL DEV BIOL, V58, P96, DOI 10.1016/j.semcdb.2016.06.011; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lazennec G, 2016, BBA-REV CANCER, V1866, P290, DOI 10.1016/j.bbcan.2016.10.004; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; McGowan PM, 2011, MOL CANCER RES, V9, P834, DOI 10.1158/1541-7786.MCR-10-0457; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Park JP, 2015, IN VITRO CELL DEV-AN, V51, P776, DOI 10.1007/s11626-015-9889-8; Park JP, 2013, STEM CELLS DEV, V22, P1297, DOI 10.1089/scd.2012.0496; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schnitt SJ, 2010, MODERN PATHOL, V23, pS60, DOI 10.1038/modpathol.2010.33; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharma A, 2012, MOL CANCER THER, V11, P77, DOI 10.1158/1535-7163.MCT-11-0508; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Taneja P, 2009, EXPERT REV MOL DIAGN, V9, P423, DOI 10.1586/ERM.09.31; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weisstein EW., 2016, HYPOCYCLOID MATHWORL	37	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179265	10.1371/journal.pone.0179265	http://dx.doi.org/10.1371/journal.pone.0179265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594912	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200111
J	Calo-Blanco, A; Kovarik, J; Mengel, F; Romero, JG				Calo-Blanco, Aitor; Kovarik, Jaromir; Mengel, Friederike; Gabriel Romero, Jose			Natural disasters and indicators of social cohesion	PLOS ONE			English	Article							TRUST; RESILIENCE; CONFLICT; NETWORK; ENHANCE; RISK	Do adversarial environmental conditions create social cohesion? We provide new answers to this question by exploiting spatial and temporal variation in exposure to earthquakes across Chile. Using a variety of methods and controlling for a number of socio-economic variables, we find that exposure to earthquakes has a positive effect on several indicators of social cohesion. Social cohesion increases after a big earthquake and slowly erodes in periods where environmental conditions are less adverse. Our results contribute to the current debate on whether and how environmental conditions shape formal and informal institutions.	[Calo-Blanco, Aitor] Univ A Coruna, Dept Econ, Campus A Coruna, La Coruna 15071, Spain; [Kovarik, Jaromir] Univ Basque Country, Euskal Herriko Unibersitatea, Dept Fundamentos Anal Econ & Bridge 1, Av Lehendakari Aguirre 83, Bilbao 48015, Spain; [Kovarik, Jaromir] CERGE EI, Politickych Veznu 7, Prague 11121, Czech Republic; [Mengel, Friederike] Univ Essex, Dept Econ, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Gabriel Romero, Jose] Univ Santiago Chile, Dept Econ, Alameda 3363, Santiago, Chile	Universidade da Coruna; University of Basque Country; Charles University Prague; Czech Academy of Sciences; Economics Institute of the Czech Academy of Sciences; University of Essex; Universidad de Santiago de Chile	Kovarik, J (corresponding author), Univ Basque Country, Euskal Herriko Unibersitatea, Dept Fundamentos Anal Econ & Bridge 1, Av Lehendakari Aguirre 83, Bilbao 48015, Spain.	jaromir.kovarik@ehu.eus	Romero, José Gabriel/AAE-1999-2020; Kovarik, Jaromir/AAE-6921-2021; Kovarik, Jaromir/H-2938-2014; Calo-Blanco, Aitor/J-2784-2017	Romero, José Gabriel/0000-0002-4142-4331; Calo-Blanco, Aitor/0000-0003-3957-4741; KOVARIK, JAROMIR/0000-0002-0436-929X	Spanish Ministry of Economy and Competitiveness [ECO2011-22919, ECO2014-57413-P]; Xunta de Galicia [ED431C2016/007]; Dutch Science Foundation (NWO, VENI grant) [016.125.040]; Basque Government [IT-783-13]; Spanish Government [ECO2015-64467-R, ECO2015-66027-P]; GACR [14-22044S]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Dutch Science Foundation (NWO, VENI grant); Basque Government(Basque Government); Spanish Government(Spanish GovernmentEuropean Commission); GACR(Grant Agency of the Czech Republic)	Aitor Calo-Blanco thanks the Spanish Ministry of Economy and Competitiveness (ECO2011-22919 and ECO2014-57413-P) and Xunta de Galicia (ED431C2016/007), Friederike Mengel the Dutch Science Foundation (NWO, VENI grant 016.125.040), and Jaromir Kovarik the Basque Government (IT-783-13), the Spanish Government (ECO2015-64467-R, ECO2015-66027-P) and GACR (14-22044S) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Javier Gardeazabal, Xabier Gainza, Pablo Galaso, and Erik Strobl for helpful comments and Felipe Martin for assistance in constructing our data set. Aitor Calo-Blanco thanks the Spanish Ministry of Economy and Competitiveness (ECO2011-22919 and ECO2014-57413-P) and Xunta de Galicia (ED431C2016/007), Friederike Mengel the Dutch Science Foundation (NWO, VENI grant 016.125.040), and Jaromir Kovarik the Basque Government (IT-783-13), the Spanish Government (ECO2015-64467-R, ECO2015-66027-P) and GACR (14-22044S) for financial support.	Acemoglu D., 2012, FOREIGN POLICY, P85; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; Algermissen ST, 1985, DEP INTERIOR US GEOL; [Anonymous], [No title captured]; Belasen A, 2009, J HUM RESOUR, V44, P1; Bergholt D, 2012, J PEACE RES, V49, P147, DOI 10.1177/0022343311426167; Blaut JM, 1999, GEOGR REV, V89, P391, DOI 10.2307/216157; Bowles S, 2012, SCIENCE, V336, P876, DOI 10.1126/science.1217336; Brancati D, 2007, J CONFLICT RESOLUT, V51, P715, DOI 10.1177/0022002707305234; Bruneau M, 2003, EARTHQ SPECTRA, V19, P733, DOI 10.1193/1.1623497; Cassar A, 2017, WORLD DEV, V94, P90, DOI 10.1016/j.worlddev.2016.12.042; Coleman J., 1990, FDN SOCIAL THEORY; Diamond J., 2011, COLLAPSE SOC CHOOSE; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dussaillant F, 2014, DISASTERS, V38, P808, DOI 10.1111/disa.12077; Dzierma Y, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008914; Eckel CC, 2009, J ECON BEHAV ORGAN, V69, P110, DOI 10.1016/j.jebo.2007.08.012; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fleming DA, 2014, J DEV STUD, V50, P1482, DOI 10.1080/00220388.2014.936395; Friedkin NE, 2004, ANNU REV SOCIOL, V30, P409, DOI 10.1146/annurev.soc.30.012703.110625; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Gleditsch NP, 1998, J PEACE RES, V35, P381, DOI 10.1177/0022343398035003007; Guns Diamond J., 1997, GERMS STEEL FATES HU; Harris M, 1979, CULTURAL MAT STRUGGL; Helliwell J., 2015, WORLD HAPPINESS REPO, P12; Henrich J., 2007, WHY HUMANS COOPERATE; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Noy I, 2009, J DEV ECON, V88, P221, DOI 10.1016/j.jdeveco.2008.02.005; OECD, 2012, SOC GLANCE ASIA PAC; Ostrom E, 1994, GAMES COMMON POOL RE; Ostrom E., 1990, GOVERNING COMMONS D; Phan TQ, 2015, P NATL ACAD SCI USA, V112, P6595, DOI 10.1073/pnas.1404770112; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rothe JP, 1969, SEISMICITY EARTH 195, P91; Sachs JD, 2001, EUR ECON REV, V45, P827, DOI 10.1016/S0014-2921(01)00125-8; Scheffran J, 2012, SCIENCE, V336, P869, DOI 10.1126/science.1221339; Slettebak RT, 2012, J PEACE RES, V49, P163, DOI 10.1177/0022343311425693; Strobl E, 2011, REV ECON STAT, V93, P575, DOI 10.1162/REST_a_00082; Tomasello M, 2009, WHY WE COOPERATE, P1; Toya H, 2014, KYKLOS, V67, P255, DOI 10.1111/kykl.12053; Udias A, 2012, B SEISMOL SOC AM, V102, P1639, DOI 10.1785/0120110289; Veszteg RF, 2015, INT POLIT SCI REV, V36, P119, DOI 10.1177/0192512113509501; Whitt S, 2007, SOUTH ECON J, V74, P377, DOI 10.2307/20111973	49	54	54	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0176885	10.1371/journal.pone.0176885	http://dx.doi.org/10.1371/journal.pone.0176885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591148	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000402880700005
J	Lin, KT; Sun, SP; Wu, JI; Wang, LH				Lin, Kai-Ti; Sun, Shu-Pin; Wu, Jui-I; Wang, Lu-Hai			Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model	PLOS ONE			English	Article							CANCER-CELLS; KAPPA-B; PACLITAXEL; IL-18; MICROENVIRONMENT; TUMORIGENICITY; MICRORNA-708; RESISTANCE; PROTEIN-1; MIRNA-708	Ovarian cancer has the highest mortality rate among gynecologic malignancies. Despite chemotherapy and surgical debulking options, ovarian cancer recurs and disseminates frequently with a poor prognosis. We previously reported a novel role of glucocorticoids (GCs) in metastatic ovarian cancer by upregulating microRNA-708. In this study, we used an immunocompetent syngeneic mouse model and further evaluated the effect and optimal dosages of GCs in treating metastatic ovarian cancer. The treatment of C57BL/6-derived ovarian cancer ID-8 cells with a synthetic GC, dexamethasone (DEX), induced the expression of microRNA-708, leading to decreased cell migration and invasion through targeting Rap1B. Administration of DEX at a low dose, as low as 5 mu g/kg body weight, inhibited the primary tumor size and abdominal metastasis in mice bearing ID-8 cell-derived ovarian tumors. In the treated primary tumors, microRNA-708 was upregulated, whereas some proinflammatory cytokines, namely interleukin (IL)-1 beta and IL-18, were downregulated. The number of tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment were reduced. Overall, our study shows that low-dose GCs can suppress ovarian cancer progression and metastasis likely through not only the upregulation of the metastasis suppressor microRNA-708, but also the modulation of TAMs and MDSCs in the tumor microenvironment.	[Lin, Kai-Ti; Sun, Shu-Pin; Wu, Jui-I; Wang, Lu-Hai] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan; [Wu, Jui-I] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Wang, Lu-Hai] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Central University; China Medical University Taiwan	Wang, LH (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli County, Taiwan.; Wang, LH (corresponding author), China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan.	luhaiwang@mail.cmu.edu.tw	Lin, Kai-Ti/B-3840-2016	Lin, Kai-Ti/0000-0001-8656-5755	National Research Health Institutes [105A1-MGPP11-014]; Ministry of Science and Technology, Taiwan [MOST-104-2320-B-400-011-MY3, MOST-105-2321-B-400 -012 -MY3]	National Research Health Institutes; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by 105A1-MGPP11-014 from National Research Health Institutes, MOST-104-2320-B-400-011-MY3 and MOST-105-2321-B-400 -012 -MY3 from the Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Oliveira GS, 2014, ANESTH ANALG, V118, P1213, DOI 10.1213/ANE.0b013e3182a5d656; Gennari A, 1996, ANN ONCOL, V7, P978, DOI 10.1093/oxfordjournals.annonc.a010806; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Greenaway J, 2009, MOL CANCER THER, V8, P64, DOI 10.1158/1535-7163.MCT-08-0864; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hou WJ, 2013, EUR REV MED PHARMACO, V17, P2902; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Liberman AC, 2007, CYTOKINE GROWTH F R, V18, P45, DOI 10.1016/j.cytogfr.2007.01.005; Lim HX, 2014, J IMMUNOL, V193, P5453, DOI 10.4049/jimmunol.1401282; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Lin KT, 2016, STEROIDS; Luo ZY, 2016, CANCER LETT, V377, P174, DOI 10.1016/j.canlet.2016.04.038; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Matsuo K, 2010, GYNECOL ONCOL, V116, P61, DOI 10.1016/j.ygyno.2009.09.018; Munstedt K, 2004, CANCER, V101, P1696, DOI 10.1002/cncr.20534; Musrap N, 2012, MOL CANCER RES, V10, P1254, DOI 10.1158/1541-7786.MCR-12-0353; Orengo AM, 2011, INT J CANCER, V129, P1116, DOI 10.1002/ijc.25757; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roby KF, 2008, ADV EXP MED BIOL, V622, P169; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Ryu S, 2013, CANCER CELL, V23, P63, DOI 10.1016/j.ccr.2012.11.019; Sachdev P, 2002, J BIOL CHEM, V277, P17638, DOI 10.1074/jbc.M111575200; Saini S, 2012, CANCER RES, V72, P3618, DOI 10.1158/0008-5472.CAN-12-0540; Saini S, 2011, CANCER RES, V71, P6208, DOI 10.1158/0008-5472.CAN-11-0073; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sui MH, 2006, INT J CANCER, V119, P712, DOI 10.1002/ijc.21743; Terme M, 2011, CANCER RES, V71, P5393, DOI 10.1158/0008-5472.CAN-11-0993; WALSH D, 1992, CLEV CLIN J MED, V59, P505, DOI 10.3949/ccjm.59.5.505; Zhang CW, 2006, INT J ONCOL, V28, P551; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	41	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178937	10.1371/journal.pone.0178937	http://dx.doi.org/10.1371/journal.pone.0178937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591224	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700060
J	Randall, J; Chateau, D; Bolton, JM; Smith, M; Katz, L; Burland, E; Taylor, C; Nickel, NC; Enns, J; Katz, A; Brownell, M				Randall, Jason; Chateau, Dan; Bolton, James M.; Smith, Mark; Katz, Laurence; Burland, Elaine; Taylor, Carole; Nickel, Nathan C.; Enns, Jennifer; Katz, Alan; Brownell, Marni		PATHS Equity Team	Increasing medication adherence and income assistance access for first-episode psychosis patients	PLOS ONE			English	Article							EARLY INTERVENTION SERVICE; 1ST EPISODE; FOLLOW-UP; SCHIZOPHRENIA; HEALTH; CARE; PREDICTORS; DISORDERS; COHORT; COSTS	Background Assertive community treatment for first-episode psychosis programs have been shown to improve symptoms and reduce service use. There is little or no evidence on whether these programs can increase access to income assistance and improve medication adherence in first episode psychosis patients. This research examines the impact of the Early Psychosis Prevention and Intervention Service (EPPIS) on these outcomes. Methods We extracted data on EPPIS patients held in the Data Repository at the Manitoba Centre for Health Policy. The Repository is a comprehensive collection of person-level de-identified administrative records, including data from Manitoba's health services. We compared income assistance use and antipsychotic medication adherence in EPPIS patients to a historical cohort matched on pattern of diagnosis. Confounders were adjusted through propensity- score weighting with asymmetrical trimming. Odds ratios (OR), hazard ratios (HR) and 95% confidence intervals were calculated. Results We identified a matched sample of 244 patients and 449 controls. EPPIS patients had a higher rate of income assistance use during the program (67.4% vs. 38.7%; p< 0.0001). EPPIS patients were more likely to have been prescribed at least one antipsychotic medication than the control cohort, both during the program (OR = 15.05; 95% CI 10.81 to 20.94) and after the program ended (OR = 5.20; 95% CI: 4.50 to 6.02). Patients in EPPIS were also more likely to adhere to their medication during the program (OR = 4.71; 95% CI 3.75 to 5.92), and after the program (OR = 2.54; 95% CI 2.04 to 3.16). Conclusion Enrolment in the EPPIS program was associated with increased adherence to antipsychotic medication treatment and improved uptake of income assistance.	[Randall, Jason; Chateau, Dan; Bolton, James M.; Nickel, Nathan C.; Katz, Alan; Brownell, Marni] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Randall, Jason; Chateau, Dan; Bolton, James M.; Smith, Mark; Katz, Laurence; Burland, Elaine; Taylor, Carole; Nickel, Nathan C.; Enns, Jennifer; Katz, Alan; Brownell, Marni] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Manitoba Ctr Hlth Policy,Dept Community Hlth Sci, Winnipeg, MB, Canada; [Bolton, James M.; Katz, Laurence] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Psychiat, Winnipeg, MB, Canada; [Katz, Alan] Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Family Med, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Chateau, D (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Chateau, D (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Max Rady Coll Med, Manitoba Ctr Hlth Policy,Dept Community Hlth Sci, Winnipeg, MB, Canada.	Dan_Chateau@cpe.umanitoba.ca	Katz, Laurence/N-6698-2019; Metge, Colleen/G-7727-2016; Nickel, Nathan C./J-2537-2014	Metge, Colleen/0000-0001-9170-3294; Katz, Alan/0000-0001-8280-7024; Nickel, Nathan C./0000-0001-5836-5297; Roos, Leslie L./0000-0002-4215-8346; Brownell, Marni/0000-0001-7673-4404; chateau, Dan/0000-0002-2215-820X	Canadian Institutes of Health Research (CIHR) [FRN 115206]; Heart & Stroke Foundation of Canada [PG-12-0534]; University of Manitoba's Graduate Enhancement of Tri-Council Stipends program; Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award; Canadian Institutes of Health Research New Investigator Award [113589]; Brain & Behavior Research Foundation NARSAD Young Investigator Grant	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); University of Manitoba's Graduate Enhancement of Tri-Council Stipends program; Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award; Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Brain & Behavior Research Foundation NARSAD Young Investigator Grant	This work was supported by the Canadian Institutes of Health Research (CIHR; grant FRN 115206) and the Heart & Stroke Foundation of Canada (grant PG-12-0534), under the program of research entitled PATHS Equity for Children: A program of research into what works to reduce the gap for Manitobas children. Jason R Randall acknowledges funding from the University of Manitobas Graduate Enhancement of Tri-Council Stipends program. Dr Brownell acknowledges the financial support of the Government of Manitoba through the Manitoba Centre for Health Policy Population-Based Child Health Research Award. Dr Bolton is supported by a Canadian Institutes of Health Research New Investigator Award (113589) and a Brain & Behavior Research Foundation NARSAD Young Investigator Grant. None of the funders were involved in the conduct of this study. The corresponding author had full access to the data and responsibility for the decision to submit for publication. The funders of this study did not have any involvement in the design, analysis or interpretation of this study.; The authors acknowledge the Manitoba Centre for Health Policy (MCHP) for use of data contained in the Population Health Research Data Repository under project # 2012010 (HIPC #2013/201422). The results and conclusions are those of the authors and no official endorsement by MCHP, Manitoba Health, Seniors and Active Living (MHSAL), or other data providers is intended or should be inferred. Data used in this study were provided by MHSAL; Vital Statistics; Manitoba Jobs and the Economy; Family Services; and the Manitoba Adolescent Treatment Centre. Authors would also like to thank the PATHS Equity Team for its support. PATHS Equity Team members: James Bolton; Marni Brownell; Charles Burchill; Elaine Burland; Mariette Chartier; Dan Chateau; Malcolm Doupe; Jennifer Enns; Greg Finlayson; Randall Fransoo; Chun Yan Goh; Milton Hu; Doug Jutte; Alan Katz; Laurence Katz; Lisa Lix; Patricia J. Martens (deceased); Colleen Metge; Nathan C. Nickel; Farzana Qudus; Colette Raymond; Les Roos; Noralou Roos; Rob Santos; Joykrishna Sarkar; Mark Smith; Carole Taylor; Randy Walld. All members of the PATHS Equity team are affiliated with the Max Rady College of Medicine at the University of Manitoba. The principal investigator of the PATHs team is Marni Brownell (Marni_Brownell@cpe.umanitoba.ca).	Addington J, 2001, CAN PSYCHIAT ASS B, V33, P11; ARO S, 1995, BRIT J PSYCHIAT, V166, P759, DOI 10.1192/bjp.166.6.759; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bertelsen M, 2008, ARCH GEN PSYCHIAT, V65, P762, DOI 10.1001/archpsyc.65.7.762; Boden R, 2010, SOC PSYCH PSYCH EPID, V45, P665, DOI 10.1007/s00127-009-0108-3; BOND GR, 1991, AM J COMMUN PSYCHOL, V19, P41, DOI 10.1007/BF00942252; Chen EYH, 2011, EARLY INTERV PSYCHIA, V5, P315, DOI 10.1111/j.1751-7893.2011.00279.x; Craig TK, 2004, BMJ-BRIT MED J, V329, P1067, DOI 10.1136/bmj.38246.594873.7C; Cullberg J, 2002, ACTA PSYCHIAT SCAND, V106, P276, DOI 10.1034/j.1600-0447.2002.02376.x; Dodgson G, 2008, PSYCHIATR BULL, V32, P413, DOI 10.1192/pb.bp.107.017442; DOHRENWEND BP, 1990, SOC PSYCH PSYCH EPID, V25, P41; Fenton WS, 1997, SCHIZOPHRENIA BULL, V23, P637, DOI 10.1093/schbul/23.4.637; Fowler D, 2009, EARLY INTERV PSYCHIA, V3, P282, DOI 10.1111/j.1751-7893.2009.00146.x; Gilmer TP, 2004, AM J PSYCHIAT, V161, P692, DOI 10.1176/appi.ajp.161.4.692; Goldberg K, 2006, CAN J PSYCHIAT, V51, P895, DOI 10.1177/070674370605101405; Guo S. Y., 2009, PROPENSITY SCORE ANA; Malla A, 2006, PSYCHOL MED, V36, P649, DOI 10.1017/S0033291706007379; McGorry P, 1993, Australas Psychiatry, V1, P32, DOI 10.3109/10398569309081303; McGorry PD, 1996, SCHIZOPHRENIA BULL, V22, P305, DOI 10.1093/schbul/22.2.305; Nickel NC, 2014, INT J EPIDEMIOL, V43, P1438, DOI 10.1093/ije/dyu190; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Randall JR, 2016, SCHIZOPHR RES, V176, P307, DOI 10.1016/j.schres.2016.05.021; Randall JR, 2015, SCHIZOPHRENIA BULL, V41, P1379, DOI 10.1093/schbul/sbv016; Robinson D, 1999, ARCH GEN PSYCHIAT, V56, P241, DOI 10.1001/archpsyc.56.3.241; Sanbrook M, 2003, AEJAMH, V2; Schneeweiss S, 2009, EPIDEMIOLOGY, V20, P512, DOI 10.1097/EDE.0b013e3181a663cc; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198	28	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179089	10.1371/journal.pone.0179089	http://dx.doi.org/10.1371/journal.pone.0179089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591137	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700086
J	Zhang, SW; Wu, XW; You, ZH				Zhang, Shanwen; Wu, Xiaowei; You, Zhuhong			Jaccard distance based weighted sparse representation for coarse-to-fine plant species recognition	PLOS ONE			English	Article							DICTIONARY; ALGORITHM	Leaf based plant species recognition plays an important role in ecological protection, however its application to large and modern leaf databases has been a long-standing obstacle due to the computational cost and feasibility. Recognizing such limitations, we propose a Jaccard distance based sparse representation (JDSR) method which adopts a two-stage, coarse to fine strategy for plant species recognition. In the first stage, we use the Jaccard distance between the test sample and each training sample to coarsely determine the candidate classes of the test sample. The second stage includes a Jaccard distance based weighted sparse representation based classification(WSRC), which aims to approximately represent the test sample in the training space, and classify it by the approximation residuals. Since the training model of our JDSR method involves much fewer but more informative representatives, this method is expected to overcome the limitation of high computational and memory costs in traditional sparse representation based classification. Comparative experimental results on a public leaf image database demonstrate that the proposed method outperforms other existing feature extraction and SRC based plant recognition methods in terms of both accuracy and computational speed.	[Zhang, Shanwen; You, Zhuhong] Xijing Univ, Dept Informat Engn, Xian, Peoples R China; [Zhang, Shanwen; Wu, Xiaowei] Virginia Tech, Dept Stat, Blacksburg, VA USA	Xijing University; Virginia Polytechnic Institute & State University	You, ZH (corresponding author), Xijing Univ, Dept Informat Engn, Xian, Peoples R China.	zhuhongyou@163.com	You, Zhu-Hong/A-4056-2011; You, Zhu-Hong/AAI-6862-2020	You, Zhu-Hong/0000-0003-1266-2696; 				Chaki J, 2015, PATTERN RECOGN LETT, V58, P61, DOI 10.1016/j.patrec.2015.02.010; Du JX, 2007, APPL MATH COMPUT, V185, P883, DOI 10.1016/j.amc.2006.07.072; Du JX, 2016, NEUROCOMPUTING, V188, P131, DOI 10.1016/j.neucom.2014.10.113; Elhamifar E, 2013, IEEE T PATTERN ANAL, V35, P2765, DOI 10.1109/TPAMI.2013.57; Fan ZZ, 2015, NEUROCOMPUTING, V151, P304, DOI 10.1016/j.neucom.2014.09.035; Grinblat GL, 2016, COMPUT ELECTRON AGR, V127, P418, DOI 10.1016/j.compag.2016.07.003; Guo S, 2012, INT C PATT RECOG, P1241; Hati S., 2013, INT J COMPUTER APPL, V62, P15, DOI DOI 10.5120/10172-4897; Hu RX, 2012, IEEE T IMAGE PROCESS, V21, P4667, DOI 10.1109/TIP.2012.2207391; Jou-Ken Hsiao, 2014, 2014 IEEE International Conference on Consumer Electronics - Taiwan (ICCE-TW), P209, DOI 10.1109/ICCE-TW.2014.6904061; Kadir A, 2011, INT J COMPUTER TREND, V2231-2803, P224; Kumar S., 2012, INT J COMPUT SCI ENG, V3, P436; Li LY, 2014, IMAGE VISION COMPUT, V32, P814, DOI 10.1016/j.imavis.2014.02.007; Li S, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2155; Liu NA, 2016, NEUROCOMPUTING, V216, P460, DOI 10.1016/j.neucom.2016.08.005; Lu CY, 2013, J VIS COMMUN IMAGE R, V24, P111, DOI 10.1016/j.jvcir.2012.05.003; Mokrzycki W, 2012, LECT NOTES COMPUT SC, V7594, P533, DOI 10.1007/978-3-642-33564-8_64; Salleh SS, 2012, IJCSI INT J COMPUTER, V9, P124; Trishen M, 2015, PROCEDIA COMPUTER SC, V58, P740; Xu Y, 2013, INFORM SCIENCES, V238, P138, DOI 10.1016/j.ins.2013.02.051; Yang S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116500; Zhang SW, 2013, PATTERN RECOGN, V46, P1891, DOI 10.1016/j.patcog.2013.01.015; Zhang Z, 2017, IEEE T IND INFORM, V13, P644, DOI 10.1109/TII.2017.2653184; Zhao ZQ, 2016, PATTERN RECOGN, V56, P77, DOI 10.1016/j.patcog.2016.02.016; Zhao ZQ, 2015, NEUROCOMPUTING, V151, P1112, DOI 10.1016/j.neucom.2014.02.077; Zhao ZQ, 2012, IEEE T IMAGE PROCESS, V21, P4218, DOI 10.1109/TIP.2012.2197631	26	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178317	10.1371/journal.pone.0178317	http://dx.doi.org/10.1371/journal.pone.0178317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591147	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700029
J	Puig, L; Bragulat, MR; Castella, G; Cabanes, FJ				Puig, Laura; Rosa Bragulat, M.; Castella, Gemma; Javier Cabanes, F.			Characterization of the species Malassezia pachydermatis and re-evaluation of its lipid dependence using a synthetic agar medium	PLOS ONE			English	Article							IDENTIFICATION; DOGS; STRAINS	The genus Malassezia includes lipophilic yeasts, which are part of the skin microbiota of various mammals and birds. Unlike the rest of Malassezia species, M. pachydermatis is described as non-lipid-dependent, as it is able to grow on Sabouraud glucose agar (SGA) without lipid supplementation. In this study we have examined the phenotypic variability within M. pachydermatis and confirmed its lipid-dependent nature using a synthetic agar medium. We used a selection of representative non-lipid-dependent strains from different animal species and three atypical lipid-dependent strains of this species, which were not able to grow after multiple passages on SGA. More than 400 lipid-dependent Malassezia isolates from animals were studied in order to detect the three lipid-dependent strains of M. pachydermatis. The identity of the atypical strains was confirmed by DNA sequencing. On the other hand, we have modified the Tween diffusion test, which is widely used in the characterization of these yeasts, by using a synthetic agar-based medium instead of SGA. This modification has proved to be useful for differentiation of M. pachydermatis strains, providing reproducible results and a straightforward interpretation. The finding of these peculiar lipid-dependent strains exemplifies the large variability within the species M. pachydermatis, which involves rare atypical strains with particular growth requirements.	[Puig, Laura; Rosa Bragulat, M.; Castella, Gemma; Javier Cabanes, F.] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Catalonia, Spain	Autonomous University of Barcelona	Bragulat, MR (corresponding author), Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Vet Mycol Grp, Bellaterra, Catalonia, Spain.	rosa.bragulat@uab.cat	Castellá, Gemma/F-3622-2011; Cabanes, F. Javier/B-8255-2009; Bragulat, M. Rosa/L-1910-2014	Castellá, Gemma/0000-0002-8404-0688; Cabanes, F. Javier/0000-0002-2244-5778; Bragulat, M. Rosa/0000-0003-1853-1777	Veterinary Bacteriology and Mycology Service of the Universitat Autonoma de Barcelona	Veterinary Bacteriology and Mycology Service of the Universitat Autonoma de Barcelona	Financial support came from the Veterinary Bacteriology and Mycology Service of the Universitat Autonoma de Barcelona. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa T, 2001, MED MYCOL, V39, P329, DOI 10.1080/714031036; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, PLOS PATHOG, V10; [Anonymous], 2014, MED MYCOL, V52, P99; [Anonymous], 2016, MYCOPATHOLOGIA, V181, P681; BOND R, 1995, J APPL BACTERIOL, V78, P537, DOI 10.1111/j.1365-2672.1995.tb03096.x; Bond R, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P271, DOI 10.1007/978-3-642-03616-3_10; Cafarchia C, 2011, MED MYCOL, V49, P365, DOI 10.3109/13693786.2010.531487; Cafarchia C, 2008, FEMS YEAST RES, V8, P451, DOI 10.1111/j.1567-1364.2008.00358.x; Cafarchia C, 2007, MOL CELL PROBE, V21, P229, DOI 10.1016/j.mcp.2007.01.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Crespo MJ, 2000, J CLIN MICROBIOL, V38, P3872, DOI 10.1128/JCM.38.10.3872-3875.2000; Crespo MJ, 2000, J CLIN MICROBIOL, V38, P2383; Duarte ER, 2002, CAN J MICROBIOL, V48, P749, DOI 10.1139/W02-064; Gonzalez A, 2009, J CLIN MICROBIOL, V47, P48, DOI 10.1128/JCM.01422-08; Gueho E, 1996, ANTON LEEUW INT J G, V69, P337, DOI 10.1007/BF00399623; Gueho-Kellermann E, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1807, DOI 10.1016/B978-0-444-52149-1.00148-8; Gueho-Kellermann E, 2010, MALASSEZIA AND THE SKIN: SCIENCE AND CLINICAL PRACTICE, P17, DOI 10.1007/978-3-642-03616-3_2; Guillot I, 1999, MED MYCOL, V37, P295, DOI 10.1046/j.1365-280X.1999.00237.x; Guillot J, 1997, RES VET SCI, V62, P22, DOI 10.1016/S0034-5288(97)90174-0; Guillot J, 1996, J MYCOL MED, V6, P103; Honnavar P, 2016, J CLIN MICROBIOL, V54, P1826, DOI 10.1128/JCM.00683-16; Hossain H, 2007, MED MYCOL, V45, P41, DOI 10.1080/13693780601003827; HUANG HP, 1993, RES VET SCI, V55, P119, DOI 10.1016/0034-5288(93)90045-H; Cabanes FJ, 2016, REV IBEROAM MICOL, V33, P92, DOI 10.1016/j.riam.2016.03.003; Kaneko T, 2007, J CLIN MICROBIOL, V45, P3737, DOI 10.1128/JCM.01243-07; Kiss G, 1996, MYCOSES, V39, P313, DOI 10.1111/j.1439-0507.1996.tb00146.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; ODDS FC, 1991, J MED VET MYCOL, V29, P355; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triana S, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01197-15; Wu GX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005614	32	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0179148	10.1371/journal.pone.0179148	http://dx.doi.org/10.1371/journal.pone.0179148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586389	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700049
J	Kubli-Garfias, C; Vazquez-Ramirez, R; Trejo-Munoz, C; Berber, A				Kubli-Garfias, Carlos; Vazquez-Ramirez, Ricardo; Trejo-Munoz, Cynthia; Berber, Arturo			Insights on the mechanism of action of immunostimulants in relation to their pharmacological potency. The effects of imidazoquinolines on TLR8	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; IMIQUIMOD; RECOGNITION; INTERFERON; AGONISTS; LIGANDS; HERPES	Imidazoquinolines are powerful immunostimulants (IMMS) that function through Toll-like receptors, particularly TLR7 and TLR8. In addition to enhancing the immune response, IMMS also function as antineoplastic drugs and vaccine adjuvants. These small compounds display almost the same molecular structure, except in some cases in which atom in position 1 varies and changes the imidazole characteristics. A variable acyclic side chain is also always attached at atom in position 2, while another chain may be attached at atom in position 1. These structural differences alter immune responses, such as the production of interferon regulatory factor and nuclear factor-kappa B (IRF-NF kappa B). In this work, quantum mechanics theory and computational chemistry methods were applied to study the physicochemical properties of the crystal binding site of TLR8 complexed with the following six IMMS molecules: Hybrid-2, XG1-236, DS802, CL075, CL097 and R848 (resiquimod). The PDB IDs of the crystals were: 4R6A, 4QC0, 4QBZ, 3W3K, 3W3J, and 3W3N respectively. Thus, were calculated, the total energy, solvation energy, interaction energy (instead of free energy) of the system and interaction energy of the polar region of the IMMS. Additionally, the dipole moment, electrostatic potential, polar surface, atomic charges, hydrogen bonds, and polar and hydrophobic interactions, among others, were assessed. Together, these properties revealed important differences among the six TLR8-immunostimulant complexes, reflected as different interaction energies and therefore different electrostatic environments and binding energies. Remarkably, the interaction energy of a defined polar region composed of the highly polarized N3, N5 atoms and the N11 amino group, acted as a polar pharmacophore that correlates directly with the reported immunopharmacological potency of the six complexed molecules. Based on these results, it was concluded that accurate physicochemical analysis of the crystal binding site could reveal the binding energy (measured as interaction energy) and associated molecular mechanism of action between IMMS and TLR8. These findings may facilitate the development and design of improved small molecules with IMMS properties that are targeted to the TLR system and have enhanced pharmacological effectiveness and reduced toxicity.	[Kubli-Garfias, Carlos; Vazquez-Ramirez, Ricardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico; [Trejo-Munoz, Cynthia] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico; [Berber, Arturo] Fdn Avance Ciencia, Mexico City, DF, Mexico; [Berber, Arturo] Grunenthal Mexico, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Kubli-Garfias, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico.	kubli@unam.mx		VAZQUEZ-RAMIREZ, RICARDO/0000-0002-7002-0934				Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Dockrell DH, 2001, J ANTIMICROB CHEMOTH, V48, P751, DOI 10.1093/jac/48.6.751; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Ganapathi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134640; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Groom CR, 2016, ACTA CRYSTALLOGR B, V72, P171, DOI 10.1107/S2052520616003954; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEIDELBERGER C, 1962, J AM CHEM SOC, V84, P3597, DOI 10.1021/ja00877a046; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; HITCHINGS GH, 1945, SCIENCE, V102, P251, DOI 10.1126/science.102.2645.251; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; InvivoGen, IM COMP TLR7 8 LIG; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Majewski S, 2005, INT J DERMATOL, V44, P14, DOI 10.1111/j.1365-4632.2004.02318.x; Miller RL, 1999, ANTIVIR RES, V44, P31, DOI 10.1016/S0166-3542(99)00052-2; Miller RL, 2002, INT IMMUNOPHARMACOL, V2, P443, DOI 10.1016/S1567-5769(01)00184-9; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Musmuca I, 2009, J CHEM INF MODEL, V49, P1777, DOI 10.1021/ci900065a; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Privat-de-Garilhe M, 1964, CR HEBD ACAD SCI, V239, P2725; PRUSOFF WH, 1959, BIOCHIM BIOPHYS ACTA, V32, P295, DOI 10.1016/0006-3002(59)90597-9; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Schon MP, 2008, ONCOGENE, V27, P190, DOI 10.1038/sj.onc.1210913; Shi C, 2012, ACS MED CHEM LETT, V3, P501, DOI 10.1021/ml300079e; Shukla NM, 2009, BIOORG MED CHEM LETT, V19, P2211, DOI 10.1016/j.bmcl.2009.02.100; Smits ELJM, 2008, ONCOLOGIST, V13, P859, DOI 10.1634/theoncologist.2008-0097; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Wavefunction Inc, 2014, SPART 14; WEEKS CE, 1989, J INVEST DERMATOL, V93, P584; Wei TD, 2009, PROTEIN SCI, V18, P1684, DOI 10.1002/pro.186; Yoo E, 2014, J MED CHEM, V57, P7955, DOI 10.1021/jm500744f	35	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178846	10.1371/journal.pone.0178846	http://dx.doi.org/10.1371/journal.pone.0178846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582454	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600047
J	Rassu, M; Del Giudice, MG; Sanna, S; Taymans, JM; Morari, M; Brugnoli, A; Frassineti, M; Masala, A; Esposito, S; Galioto, M; Valle, C; Carri, MT; Biosa, A; Greggio, E; Crosio, C; Iaccarino, C				Rassu, Mauro; Del Giudice, Maria Grazia; Sanna, Simona; Taymans, Jean Marc; Morari, Michele; Brugnoli, Alberto; Frassineti, Martina; Masala, Alessandra; Esposito, Sonia; Galioto, Manuela; Valle, Cristiana; Carri, Maria Teresa; Biosa, Alice; Greggio, Elisa; Crosio, Claudia; Iaccarino, Ciro			Role of LRRK2 in the regulation of dopamine receptor trafficking	PLOS ONE			English	Article							REPEAT KINASE 2; PARKINSONS-DISEASE; ACTIVATION; MECHANISMS; PHOSPHORYLATION; STIMULATION; MUTATIONS; PHENOTYPE; NEURONS	Mutations in LRRK2 play a critical role in both familial and sporadic Parkinson's disease (PD). Up to date, the role of LRRK2 in PD onset and progression remains largely unknown. However, experimental evidence highlights a critical role of LRRK2 in the control of vesicle trafficking that in turn may regulate different aspects of neuronal physiology. We have analyzed the role of LRRK2 in regulating dopamine receptor D1 (DRD1) and D2 (DRD2) trafficking. DRD1 and DRD2 are the most abundant dopamine receptors in the brain. They differ in structural, pharmacological and biochemical properties, as well as in localization and internalization mechanisms. Our results indicate that disease-associated mutant G2019S LRRK2 impairs DRD1 internalization, leading to an alteration in signal transduction. Moreover, the mutant forms of LRRK2 affect receptor turnover by decreasing the rate of DRD2 trafficking from the Golgi complex to the cell membrane. Collectively, our findings are consistent with the conclusion that LRRK2 influences the motility of neuronal vesicles and the neuronal receptor trafficking. These findings have important implications for the complex role that LRRK2 plays in neuronal physiology and the possible pathological mechanisms that may lead to neuronal death in PD.	[Rassu, Mauro; Del Giudice, Maria Grazia; Sanna, Simona; Masala, Alessandra; Esposito, Sonia; Galioto, Manuela; Crosio, Claudia; Iaccarino, Ciro] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Taymans, Jean Marc] Univ Lille, CHRU Lille, INSERM, UMR S1172,Jean Pierre Aubert Res Ctr, Lille, France; [Morari, Michele; Brugnoli, Alberto; Frassineti, Martina] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Morari, Michele; Brugnoli, Alberto; Frassineti, Martina] Natl Inst Neurosci, Ferrara, Italy; [Valle, Cristiana; Carri, Maria Teresa] Fdn Santa Lucia, IRCCS, Rome, Italy; [Valle, Cristiana] CNR, IBCN, Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, Rome, Italy; [Biosa, Alice; Greggio, Elisa] Univ Padua, Dept Biol, Padua, Italy	University of Sassari; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Ferrara; IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Rome Tor Vergata; University of Padua	Iaccarino, C (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.	ciaccarino@uniss.it	Taymans, Jean-Marc/M-9175-2018; valle, cristiana/J-7302-2018; Biosa, Alice/AAC-2574-2022; Carri, Maria Teresa/K-5480-2016	Taymans, Jean-Marc/0000-0001-5503-5524; valle, cristiana/0000-0002-0914-6511; CROSIO, Claudia/0000-0003-2452-1145; Carri, Maria Teresa/0000-0002-1789-1546	Michael J. Fox Foundation (LRRK2 Challenge) [2014 ID9550]; Fondazione Banco di Sardegna [2014.0489]; Regione Sardegna [CRP-78083]; Italian Ministry of Health [RF-2011-02349806]; Post-doc fellowship of MJFF	Michael J. Fox Foundation (LRRK2 Challenge); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Regione Sardegna(Regione Sardegna); Italian Ministry of Health(Ministry of Health, Italy); Post-doc fellowship of MJFF	This research was supported by Michael J. Fox Foundation (LRRK2 Challenge 2014 ID9550), Fondazione Banco di Sardegna (grant number 2014.0489) and Regione Sardegna (grant number CRP-78083) to CI and by Italian Ministry of Health (grant number RF-2011-02349806) to MM. MGDG was supported by a Post-doc fellowship of MJFF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano MA, 1997, SYNAPSE, V27, P313, DOI 10.1002/(SICI)1098-2396(199712)27:4<313::AID-SYN5>3.3.CO;2-0; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Beccano-Kelly DA, 2015, HUM MOL GENET, V24, P1336, DOI 10.1093/hmg/ddu543; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Calo L, 2016, MOV DISORD; Chen J, 2004, J BIOL CHEM, V279, P39317, DOI 10.1074/jbc.M403891200; Cho HJ, 2014, EMBO J, V33, P2314, DOI 10.15252/embj.201487807; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Dumartin B, 1998, J NEUROSCI, V18, P1650; Esposito G, 2012, DEV NEUROBIOL, V72, P134, DOI 10.1002/dneu.20916; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; Godena VK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6245; Gomez-Suaga P, 2014, HUM MOL GENET, V23, P6779, DOI 10.1093/hmg/ddu395; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; JEZIORSKI M, 1989, SYNAPSE, V4, P267, DOI 10.1002/syn.890040403; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Law BMH, 2014, J BIOL CHEM, V289, P895, DOI 10.1074/jbc.M113.507913; Longo F, 2014, NEUROBIOL DIS, V71, P62, DOI 10.1016/j.nbd.2014.07.013; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Martin-Negrier ML, 2000, NEUROSCIENCE, V99, P257, DOI 10.1016/S0306-4522(00)00187-1; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; Migheli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077198; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou L, 2014, NAT NEUROSCI, V17, P367, DOI 10.1038/nn.3636; Sanna G, 2012, BIOCHEM SOC T, V40, P1117, DOI 10.1042/BST20120117; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Takeuchi Y, 2004, J NEUROCHEM, V89, P1498, DOI 10.1111/j.1471-4159.2004.02446.x; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yun HJ, 2015, J BIOCHEM, V157, P485, DOI 10.1093/jb/mvv005; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	43	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0179082	10.1371/journal.pone.0179082	http://dx.doi.org/10.1371/journal.pone.0179082			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582422	gold, Green Submitted, Green Published			2022-12-26	WOS:000402837600072
J	Suvarna, S; Das, U; Sunil, KC; Mishra, S; Sudarshan, M; Das Saha, K; Dey, S; Chakraborty, A; Narayana, Y				Suvarna, Saritha; Das, Ujjal; Sunil, K. C.; Mishra, Snehasis; Sudarshan, Mathummal; Das Saha, Krishna; Dey, Sanjit; Chakraborty, Anindita; Narayana, Y.			Synthesis of a novel glucose capped gold nanoparticle as a better theranostic candidate	PLOS ONE			English	Article							ENHANCED RAMAN-SCATTERING; BIOMEDICAL APPLICATIONS; PHOTOTHERMAL THERAPY; COMPUTED-TOMOGRAPHY; OXIDATIVE STRESS; CONTRAST AGENTS; DRUG-DELIVERY; CANCER-CELLS; IN-VIVO; 2-DEOXY-D-GLUCOSE	Gold nanoparticles are predominantly used in diagnostics, therapeutics and biomedical applications. The present study has been designed to synthesize differently capped gold nanoparticles (AuNps) by a simple, one-step, room temperature procedure and to evaluate the potential of these AuNps for biomedical applications. The AuNps are capped with glucose, 2-deoxy-D-glucose (2DG) and citrate using different reducing agents. This is the first report of synthesis of 2DG-AuNp by the simple room temperature method. The synthesized gold nanoparticles are characterized with UV-Visible Spectroscopy, Fourier transform infrared spectroscopy (FTIR), Transmission electron microscopy (TEM) and selected area electron diffraction (SAED), Dynamic light scattering (DLS), and Energy-dispersive X-ray spectroscopy (SEM-EDS). Surface-enhanced Raman scattering (SERS) study of the synthesized AuNps shows increase in Raman signals up to 50 times using 2DG. 3-(4, 5dimethylthiozol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay has been performed using all the three differently capped AuNps in different cell lines to assess cytotoxcity if any, of the nanoparticles. The study shows that 2DG-AuNps is a better candidate for theranostic application.	[Suvarna, Saritha; Sunil, K. C.; Narayana, Y.] Mangalore Univ, Dept Studies Phys, Mangalagangothri, Karnataka, India; [Das, Ujjal; Dey, Sanjit] Univ Calcutta, Ctr Nanosci & Nanotechnol, Dept Physiol, Kolkata, W Bengal, India; [Das, Ujjal; Dey, Sanjit] Univ Calcutta, Ctr Potential Excellence Particular Area, Kolkata, W Bengal, India; [Mishra, Snehasis; Das Saha, Krishna] IICB, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Sudarshan, Mathummal; Chakraborty, Anindita] UGC DAE Consortium Sci Res Ctr, Kolkata, W Bengal, India	Mangalore University; University of Calcutta; University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); UGC DAE Consortium for Scientific Research	Narayana, Y (corresponding author), Mangalore Univ, Dept Studies Phys, Mangalagangothri, Karnataka, India.	narayanay@yahoo.com	Mishra, Snehasis/AAW-1556-2021; Dey, Sanjit/AAM-6497-2020	Dey, Sanjit/0000-0001-6534-0522; K C, Sunil/0000-0001-9388-085X	 [41-877/2012/SR]		This work was supported by F. No. 41-877/2012/SR dated 26-07- 2012.	Anderson KM, 2006, ANTICANCER RES, V26, P4155; Aydogan B, 2010, MOL IMAGING BIOL, V12, P463, DOI 10.1007/s11307-010-0299-8; Bakr OM, 2006, CHEM MATER, V18, P3297, DOI 10.1021/cm060681i; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Cabuzu D, 2015, CURR TOP MED CHEM, V15, P1605; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; Chen F, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-220; Cole LE, 2015, NANOMEDICINE-UK, V10, P321, DOI [10.2217/NNM.14.171, 10.2217/nnm.14.171]; Curry T, 2014, CONTRAST MEDIA MOL I, V9, P53, DOI 10.1002/cmmi.1563; Dinh TV, 2015, NANOMEDICINE NANOBIO, V7, P17; Dwarakanath BS, 2009, J CANCER RES THER, V5, P27, DOI 10.4103/0973-1482.55137; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; Favi PM, 2015, J BIOMED MATER RES A, V103, P3449, DOI 10.1002/jbm.a.35491; Fei Zhaofu, 2009, EUROPEAN J, V12, P2131; Feng G, 2014, CLIN RADIOL, V69, P1105, DOI 10.1016/j.crad.2014.05.112; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Giasuddin A. S. M., 2012, BANGLADESH J MED BIO, V5, P56, DOI DOI 10.3329/BJMB.V5I2.13346; Gorin F, 2004, ACTA NEUROPATHOL, V107, P235, DOI 10.1007/s00401-003-0803-1; Hainfeld JF, 2013, NANOMEDICINE-UK, V8, P1601, DOI [10.2217/nnm.12.165, 10.2217/NNM.12.165]; Haynes CL, 2005, ANAL CHEM, V77, p338A, DOI 10.1021/ac053456d; Hong S, 2013, J NANOMATER, V2013, DOI [10.1155/2013/246328, 10.1155/2013/790323]; Hu CX, 2015, INT J NANOMED, V10, P2065, DOI 10.2147/IJN.S72144; Huang XH, 2010, J ADV RES, V1, P13, DOI 10.1016/j.jare.2010.02.002; Hwang S, 2014, NANOMEDICINE-UK, V9, P2003, DOI [10.2217/NNM.14.147, 10.2217/nnm.14.147]; Jackson JB, 2004, P NATL ACAD SCI USA, V101, P17930, DOI 10.1073/pnas.0408319102; Jiang XY, 2014, BIOMATERIALS, V35, P518, DOI 10.1016/j.biomaterials.2013.09.094; Kang HT, 2006, LIFE SCI, V78, P1392, DOI 10.1016/j.lfs.2005.07.001; Khan MS, 2013, ADV COLLOID INTERFAC, V199, P44, DOI 10.1016/j.cis.2013.06.003; Kneipp K., 2006, SURFACE ENHANCED RAM; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Li J, 2010, PHYS MED BIOL, V55, P4389, DOI 10.1088/0031-9155/55/15/013; Li M, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/11/115501; Liu J, 2009, EUROPEAN J, V12, P2131; Lu LH, 2008, LANGMUIR, V24, P1058, DOI 10.1021/la702886q; Maharramov AM, 2014, DIG J NANOMATER BIOS, V9, P1461; Maruyama T, 2015, J COLLOID INTERF SCI, V447, P254, DOI 10.1016/j.jcis.2014.12.046; Meir R, 2015, ACS NANO, V9, P6363, DOI 10.1021/acsnano.5b01939; Mieszawska AJ, 2013, MOL PHARMACEUT, V10, P831, DOI 10.1021/mp3005885; Mishra YK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838302; Mishra YK, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345606; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Nehl CL, 2008, J MATER CHEM, V18, P2415, DOI 10.1039/b714950f; Nicol JR, 2015, NANOMEDICINE-UK, V10, P1315, DOI 10.2217/nnm.14.219; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Paterson S, 2016, CHEM SCI, V7, P6232, DOI 10.1039/c6sc02465c; Pedrosa P, 2015, NANOMATERIALS-BASEL, V5, P1853, DOI 10.3390/nano5041853; Polavarapu L, 2015, CRYSTENGCOMM, V17, P3727, DOI 10.1039/c5ce00112a; Polavarapu L, 2013, NANOSCALE, V5, P4355, DOI 10.1039/c3nr01244a; Quester K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077486; Ramalingam M, 2012, INTEGRATED BIOMATERI, P440; Roa W, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/37/375101; Shilo M, 2012, NANOMEDICINE-UK, V7, P257, DOI [10.2217/nnm.11.190, 10.2217/NNM.11.190]; Shiohara A, 2014, NANOSCALE, V6, P9817, DOI 10.1039/c4nr02648a; Simons AL, 2007, CANCER RES, V67, P3364, DOI 10.1158/0008-5472.CAN-06-3717; Stiles PL, 2008, ANNU REV ANAL CHEM, V1, P601, DOI 10.1146/annurev.anchem.1.031207.112814; Tsao YC, 2014, J AM CHEM SOC, V136, P396, DOI 10.1021/ja410663g; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Vigderman L, 2013, ADV DRUG DELIVER REV, V65, P663, DOI 10.1016/j.addr.2012.05.004; Vijayakumar S, 2012, J NANOMATER, V2012, DOI 10.1155/2012/734398; Wahab R, 2014, COLLOID SURFACE B, V123, P664, DOI 10.1016/j.colsurfb.2014.10.012; Wang L, 2015, ADV NANOTHERANOSTICS, V6, P3; WEN ZQ, 1993, J AM CHEM SOC, V115, P285, DOI 10.1021/ja00054a041; Xiong F, 2012, PHARM RES-DORDR, V29, P1087, DOI 10.1007/s11095-011-0653-9; Yuan HK, 2013, J RAMAN SPECTROSC, V44, P234, DOI 10.1002/jrs.4172; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhang J. Z., 2009, OPTICAL PROPERTIES S, P205; Zhang Q, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395102; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P771, DOI 10.1007/s12013-015-0529-4; Zhao PX, 2013, COORDIN CHEM REV, V257, P638, DOI 10.1016/j.ccr.2012.09.002; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559; Zou XQ, 2006, NANOTECHNOLOGY, V17, P4758, DOI 10.1088/0957-4484/17/18/038	73	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178202	10.1371/journal.pone.0178202	http://dx.doi.org/10.1371/journal.pone.0178202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582426	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600015
J	Jensen, D; Kierulf-Lassen, C; Kristensen, MLV; Norregaard, R; Weyer, K; Nielsen, R; Christensen, EI; Birn, H				Jensen, Danny; Kierulf-Lassen, Casper; Kristensen, Marie Louise Vindvad; Norregaard, Rikke; Weyer, Kathrin; Nielsen, Rikke; Christensen, Erik Ilso; Birn, Henrik			Megalin dependent urinary cystatin C excretion in ischemic kidney injury in rats	PLOS ONE			English	Article							PROXIMAL TUBULE; ALBUMIN REABSORPTION; MEDIATED ENDOCYTOSIS; CUBILIN; RECEPTOR; BINDING; PROTEIN; LOCALIZATION; IMPAIRMENT; DISEASE	Background Cystatin C, a marker of kidney injury, is freely filtered in the glomeruli and reabsorbed by the proximal tubules. Megalin and cubilin are endocytic receptors essential for reabsorption of most filtered proteins. This study examines the role of these receptors for the uptake and excretion of cystatin C and explores the effect of renal ischemia/reperfusion injury on renal cystatin C uptake and excretion in a rat model. Methods Binding of cystatin C to megalin and cubilin was analyzed by surface plasmon resonance analysis. ELISA and/or immunoblotting and immunohistochemistry were used to study the urinary excretion and tubular uptake of endogenous cystatin C in mice. Furthermore, renal uptake and urinary excretion of cystatin C was investigated in rats exposed to ischemia/ reperfusion injury. Results A high affinity binding of cystatin C to megalin and cubilin was identified. Megalin deficient mice revealed an increased urinary excretion of cystatin C associated with defective uptake by endocytosis. In rats exposed to ischemia/reperfusion injury urinary cystatin C excretion was increased and associated with a focal decrease in proximal tubule endocytosis with no apparent change in megalin expression. Conclusions Megalin is essential for the normal tubular recovery of endogenous cystatin C. The increase in urinary cystatin C excretion after ischemia/reperfusion injury is associated with decreased tubular uptake but not with reduced megalin expression.	[Jensen, Danny; Weyer, Kathrin; Nielsen, Rikke; Christensen, Erik Ilso; Birn, Henrik] Aarhus Univ, Inst Hlth, Dept Biomed, Aarhus, Denmark; [Jensen, Danny; Birn, Henrik] Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark; [Kierulf-Lassen, Casper; Kristensen, Marie Louise Vindvad; Norregaard, Rikke] Aarhus Univ, Inst Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Jensen, D (corresponding author), Aarhus Univ, Inst Hlth, Dept Biomed, Aarhus, Denmark.; Jensen, D (corresponding author), Aarhus Univ Hosp, Dept Renal Med, Aarhus, Denmark.	doktordanny@gmail.com	Birn, Henrik/C-3931-2009	Birn, Henrik/0000-0003-3715-7266; Norregaard, Rikke/0000-0002-1287-4181; Nielsen, Rikke/0000-0003-3105-3474; Weyer, Kathrin/0000-0002-8473-7987; Norregaard, Rikke/0000-0002-0580-373X	Danish Medical Research Council; Novo-Nordisk Foundation; Lundbeck Foundation; Fonden til Laegevidenskabens Fremme	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo-Nordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme	The Danish Medical Research Council, The Novo-Nordisk Foundation, The Lundbeck Foundation, and Fonden til L ae gevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287; Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Birn H, 2000, J CLIN INVEST, V105, P1353, DOI 10.1172/JCI8862; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; CHRISTENSEN EI, 1992, J HISTOCHEM CYTOCHEM, V40, P1481, DOI 10.1177/40.10.1382088; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Donadio C, 2010, AM J PHYSIOL-RENAL, V299, pF1407, DOI 10.1152/ajprenal.00507.2009; Gburek J, 2002, J AM SOC NEPHROL, V13, P423, DOI 10.1681/ASN.V132423; Herget-Rosenthal S, 2007, CLIN BIOCHEM, V40, P946, DOI 10.1016/j.clinbiochem.2007.04.013; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Jaafar A, 2009, AIDS, V23, P257, DOI 10.1097/QAD.0b013e328314e382; Kaseda R, 2007, BIOCHEM BIOPH RES CO, V357, P1130, DOI 10.1016/j.bbrc.2007.04.072; Kim HJ, 2009, AM J PHYSIOL-RENAL, V296, pF1297, DOI 10.1152/ajprenal.90761.2008; Kim SS, 2013, DIABETES CARE, V36, P656, DOI 10.2337/dc12-0849; Konopska B, 2007, COMP BIOCHEM PHYS B, V146, P482, DOI 10.1016/j.cbpb.2006.11.004; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Kozyraki R, 2001, P NATL ACAD SCI USA, V98, P12491, DOI 10.1073/pnas.211291398; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; Moestrup SK, 1998, J BIOL CHEM, V273, P5235, DOI 10.1074/jbc.273.9.5235; Nakai Keiko, 2006, Nihon Jinzo Gakkai Shi, V48, P407; Nielsen R, 2016, KIDNEY INT, V89, P58, DOI 10.1016/j.kint.2015.11.007; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Schreiber A, 2012, KIDNEY INT, V82, P53, DOI 10.1038/ki.2012.62; SEETHARAM B, 1988, J BIOL CHEM, V263, P4443; SHANLEY PF, 1986, AM J PATHOL, V122, P462; Snoeijs MGJ, 2011, ANN SURG, V253, P598, DOI 10.1097/SLA.0b013e31820d9ae9; Storm T, 2011, NEW ENGL J MED, V364, P89, DOI 10.1056/NEJMc1009804; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; Thelle K, 2006, KIDNEY INT, V69, P1333, DOI 10.1038/sj.ki.5000272; Togashi Y, 2013, EXP TOXICOL PATHOL, V65, P615, DOI 10.1016/j.etp.2012.06.005; Togashi Y, 2012, EXP TOXICOL PATHOL, V64, P797, DOI 10.1016/j.etp.2011.01.018; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Uchida K, 2002, CLIN CHIM ACTA, V323, P121, DOI 10.1016/S0009-8981(02)00177-8; Weyer K, 2011, NEPHROL DIAL TRANSPL, V26, P3446, DOI 10.1093/ndt/gfr525; Zhang ZH, 2011, AM J KIDNEY DIS, V58, P356, DOI 10.1053/j.ajkd.2011.02.389	40	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178796	10.1371/journal.pone.0178796	http://dx.doi.org/10.1371/journal.pone.0178796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575050	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300118
J	Kim, YJ; Schroeder, M; Liang, NC; Moran, TH; Weller, A; Bi, S				Kim, Yonwook J.; Schroeder, Mariana; Liang, Nu-Chu; Moran, Timothy H.; Weller, Aron; Bi, Sheng			Effects of early postnatal environment on hypothalamic gene expression in OLETF rats	PLOS ONE			English	Article							TOKUSHIMA FATTY RAT; FOOD-INTAKE; DORSOMEDIAL HYPOTHALAMUS; NEUROPEPTIDE-Y; ENERGY-BALANCE; OBESITY; CHOLECYSTOKININ; HYPERPHAGIA; LEPTIN; GROWTH	Previous reports have shown that the early postnatal environment has the ability to modify the obesity phenotype of Otsuka Long-Evans Tokushima Fatty (OLETF) rats. To determine whether this early postnatal environment affects hypothalamic signaling systems involved in energy balance, OLETF pups and lean Long-Evans Tokushima Otsuka (LETO) pups were cross-fostered to same or opposite strain Dams (designated as LdLp: LETO pups with LETO dams; LdOp: OLETF pups with LETO dams; OdLp: LETO pups with OLETF dams; and OdOp: OLETF pups with OLETF dams). Hypothalamic gene expression was examined at postnatal day 23 (PND 23) and PND 90 as OdOp rats started to gain more body weight at PND 23 and developed obesity at PND 90 relative to lean control LdLp rats. On PND 23, neuropeptide Y (Npy) gene expression was significantly increased in the dorsomedial hypothalamus (DMH) in both LdOp and OdOp pups compared to LdLp pups. Maternal environment did not affect DMH Npy expression in LETO weanlings. On PND 90, maternal environment during the cross-fostering period had a major effect on DMH Npy expression. Levels were significantly increased in both OdOp and OdLp rats relative to those in LdOp rats and LdLp controls. Reduced expression of Npy in the DMH of LdOp rats was consistent with their reduction of body weight compared to OdOp rats. In contrast to DMH Npy, gene expression for Npy and proopiomelanocortin in the arcuate nucleus appeared to appropriately respond to alterations in body weight and plasma leptin levels. Levels of oxytocin gene expression in the paraventricular nucleus were lower in offspring raised by LETO dams apparently responding to the higher DMH NPY levels. Together, our results demonstrate effects of both genotype and early postnatal environment on obesity of OLETF rats and further suggest an important role of DMH NPY in the development of obesity of OLETF rats.	[Kim, Yonwook J.; Liang, Nu-Chu; Moran, Timothy H.; Bi, Sheng] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Schroeder, Mariana; Weller, Aron] Bar Ilan Univ, Psychol Dept, Ramat Gan, Israel; [Schroeder, Mariana; Weller, Aron] Bar Ilan Univ, Gonda Brain Res Ctr, Ramat Gan, Israel	Johns Hopkins University; Bar Ilan University; Bar Ilan University	Bi, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	sbi@jhmi.edu	Schroeder, Mariana/AAA-9216-2020; Weller, Aron/AAU-3074-2020	Schroeder, Mariana/0000-0002-9517-4243; Weller, Aron/0000-0002-0663-4384; bi, sheng/0000-0002-2441-0528	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK057609, R01DK074269, R01DK104867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104867, R01DK057609, R01DK074269] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/) R01DK057609 (THM), R01DK074269 (SB) and R01DK104867 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bi S, 2004, ENDOCRINOLOGY, V145, P3873, DOI 10.1210/en.2004-0284; Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; Bi S, 2003, AM J PHYSIOL-REG I, V285, pR1030, DOI 10.1152/ajpregu.00734.2002; Bi S, 2001, AM J PHYSIOL-REG I, V281, pR254, DOI 10.1152/ajpregu.2001.281.1.R254; Blevins JE, 2015, AM J PHYSIOL-REG I, V308, pR431, DOI 10.1152/ajpregu.00441.2014; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Gorski JN, 2006, AM J PHYSIOL-REG I, V291, pR768, DOI 10.1152/ajpregu.00138.2006; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Niimi M, 1999, J NEUROENDOCRINOL, V11, P605; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Schroeder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013825; Schroeder M, 2009, AM J PHYSIOL-REG I, V297, pR1749, DOI 10.1152/ajpregu.00461.2009; Schroeder M, 2009, DEV PSYCHOBIOL, V51, P358, DOI 10.1002/dev.20374; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Takiguchi S, 1997, GENE, V197, P169, DOI 10.1016/S0378-1119(97)00259-X; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Yang L, 2009, J NEUROSCI, V29, P179, DOI 10.1523/JNEUROSCI.4379-08.2009; Zheng FP, 2013, OBESITY, V21, P1086, DOI 10.1002/oby.20467	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178428	10.1371/journal.pone.0178428	http://dx.doi.org/10.1371/journal.pone.0178428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575002	gold, Green Published			2022-12-26	WOS:000402624300051
J	Li, SJ; Li, PL; Zhang, L; Hu, WL; Wang, M; Liu, Y; Tang, GP; Wang, DM; Zhou, BJ; Yan, J				Li, Shijun; Li, Peili; Zhang, Lei; Hu, Weilin; Wang, Ming; Liu, Ying; Tang, Guangpeng; Wang, Dingming; Zhou, Bijun; Yan, Jie			The role of reactive oxygen intermediates in the intracellular fate of Leptospira interrogans in the macrophages of different hosts	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; FRANCISELLA-TULARENSIS; APOPTOSIS; NITROGEN; LIPOPOLYSACCHARIDE; PHAGOSOME; SURVIVAL; CELLS; INHIBITION; EXPRESSION	Background Pathogenic species of Leptospira cause leptospirosis, a global zoonotic disease. Our previous work showed that leptospires survive and replicate in human macrophages but are killed in murine macrophages. However, the mechanism responsible for the different intracellular fates of leptospires within the macrophages of different hosts remains unclear. Results The present study demonstrates that infection with Leptospira interrogans caused significant up-regulation of reactive oxygen species (ROS) and superoxide in J774A. 1 cells but did so to a lesser extent in THP-1 cells. The up-regulation of ROS and superoxide was significantly inhibited by the NADPH oxidase inhibitor apocynin. The damaged leptospires and remnants of leptospires within membrane-bound vacuoles were significantly inhibited by apocynin in J774A. 1 cells but were less inhibited in THP-1 cells. In addition, apocynin significantly prevented damage to leptospires and the co-localization of L. interrogans with lyso-somes in J774A. 1 cells but did so to a lesser extent in THP-1 cells. Furthermore, the relative fluorescence intensity levels of intracellular leptospires and the viability of the intracellular leptospires increased in apocynin pretreated J774A. 1 and THP-1 cells after 2 h of infection. Conclusions The present study, based on our previous findings, further demonstrated that ROS contributed substantially to the bactericidal ability of mouse macrophages to kill intracellular leptospires. However, ROS did not contribute as much in human macrophages, which partially explains the different intracellular fates of L. interrogans in human and mouse macrophages.	[Li, Shijun; Liu, Ying; Tang, Guangpeng; Wang, Dingming] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Li, Peili; Wang, Ming; Zhou, Bijun] Guizhou Univ, Coll Anim Sci, Guiyang, Guizhou, Peoples R China; [Zhang, Lei] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Hu, Weilin; Yan, Jie] Zhejiang Univ, Dept Med Microbiol & Parasitol, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Li, Peili] Qiannan Agr Comm, Duyun, Guizhou, Peoples R China	Guizhou University; Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University	Li, SJ (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Guizhou, Peoples R China.; Yan, J (corresponding author), Zhejiang Univ, Dept Med Microbiol & Parasitol, Coll Med, Hangzhou, Zhejiang, Peoples R China.	zjumedjun@163.com; med_bp@zju.edu.cn			National Natural Science Foundation of China [81260250, 81401679]; China Scholarship Council [201408525061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (No. 81260250 and 81401679; URL: http://wtw.nsfc.gov.cn/), the Special Funds for the Cultivation of Outstanding Youth Talents of Science and Technology in Guizhou Province (No. Qian Ke He Ren Word [2015] 09; URL: http:/kjt.gzst.gov.cn/), the Special Funds for High-Level Creative Talents Cultivation Guizhou Province ((Nan Ke He (2016) 4021; URL: http://kftgzst.gov.cni), the Special Funds for Construction of Talent Base for Infectious Disease Control and Prevention (No. than Ren Ling Fa [2013] 15; URL: httpl/latozst own/) and State Scholarship Fund from China Scholarship Council (Grant No. 201408525061; URL: http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2; Bellaire BH, 2005, INFECT IMMUN, V73, P3702, DOI 10.1128/IAI.73.6.3702-3713.2005; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Cumley NJ, 2012, INFECT IMMUN, V80, P1650, DOI 10.1128/IAI.05443-11; Darrah PA, 2000, INFECT IMMUN, V68, P3587, DOI 10.1128/IAI.68.6.3587-3593.2000; Davis JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000463; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Ghigo E, 2002, J IMMUNOL, V169, P4488, DOI 10.4049/jimmunol.169.8.4488; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hu WL, 2013, CELL MICROBIOL, V15, P1624, DOI 10.1111/cmi.12141; Hwang YJ, 2016, DRUG DEVELOP RES, V77, P271, DOI 10.1002/ddr.21321; INOUE S, 1995, INFECT IMMUN, V63, P1876, DOI 10.1128/IAI.63.5.1876-1886.1995; Jin DD, 2009, INFECT IMMUN, V77, P799, DOI 10.1128/IAI.00914-08; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Li L, 2007, ARCH MICROBIOL, V188, P591, DOI 10.1007/s00203-007-0280-3; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Liu YY, 2007, MED MICROBIOL IMMUN, V196, P233, DOI 10.1007/s00430-007-0047-0; Lourdault K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005117; Luo BW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12177; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997; Monahan AM, 2009, VET PATHOL, V46, P792, DOI 10.1354/vp.08-VP-0265-N-REV; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Ogawa R, 2001, FREE RADICAL BIO MED, V30, P268, DOI 10.1016/S0891-5849(00)00470-6; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Qiu Q, 2014, APOPTOSIS, V19, P1113, DOI 10.1007/s10495-014-0993-0; Sano K, 2004, ANTIMICROB AGENTS CH, V48, P2132, DOI 10.1128/AAC.48.6.2132-2139.2004; Schwan WR, 2000, INFECT IMMUN, V68, P1005, DOI 10.1128/IAI.68.3.1005-1013.2000; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Tassinari WS, 2008, TROP MED INT HEALTH, V13, P503, DOI 10.1111/j.1365-3156.2008.02028.x; Tuominen-Gustafsson H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-92; Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006; WANG B, 1984, INFECT IMMUN, V46, P809, DOI 10.1128/IAI.46.3.809-813.1984; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687	40	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e017861	10.1371/journal.pone.0178618	http://dx.doi.org/10.1371/journal.pone.0178618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575082	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300077
J	Tomar, S; Sethi, R; Sundar, G; Quah, TC; Quah, BL; Lai, PS				Tomar, Swati; Sethi, Raman; Sundar, Gangadhara; Thuan Chong Quah; Boon Long Quah; Lai, Poh San			Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling	PLOS ONE			English	Article							ISOLATED UNILATERAL RETINOBLASTOMA; GENOTYPE-PHENOTYPE CORRELATIONS; GERM-LINE MUTATIONS; FAMILIAL RETINOBLASTOMA; INCOMPLETE PENETRANCE; HEREDITARY RETINOBLASTOMA; MOLECULAR DIAGNOSIS; DOSAGE ANALYSIS; PCR; EXPRESSION	Retinoblastoma (RB) is a rare childhood malignant disorder caused by the biallelic inactivation of RB1 gene. Early diagnosis and identification of carriers of heritable RB1 mutations can improve disease outcome and management. In this study, mutational analysis was conducted on fifty-nine matched tumor and peripheral blood samples from 18 bilateral and 41 unilateral unrelated RB cases by a combinatorial approach of Multiplex Ligation-dependent Probe Amplification (MLPA) assay, deletion screening, direct sequencing, copy number gene dosage analysis and methylation assays. Screening of both blood and tumor samples yielded a mutation detection rate of 94.9% (56/59) while only 42.4% (25/59) of mutations were detected if blood samples alone were analyzed. Biallelic mutations were observed in 43/59 (72.9%) of tumors screened. There were 3 cases (5.1%) in which no mutations could be detected and germline mutations were detected in 19.5% (8/41) of unilateral cases. A total of 61 point mutations were identified, of which 10 were novel. There was a high incidence of previously reported recurrent mutations, occurring at 38.98% (23/59) of all cases. Of interest were three cases of mosaic RB1 mutations detected in the blood from patients with unilateral retinoblastoma. Additionally, two germline mutations previously reported to be associated with low-penetrance phenotypes: missense-c. 1981C>T and splice variantc. 607+1G>T, were observed in a bilateral and a unilateral proband, respectively. These findings have implications for genetic counselling and risk prediction for the affected families. This is the first published report on the spectrum of mutations in RB patients from Singapore and shows that further improved mutation screening strategies are required in order to provide a definitive molecular diagnosis for every case of RB. Our findings also underscore the importance of genetic testing in supporting individualized disease management plans for patients and asymptomatic family members carrying low-penetrance, germline mosaicism or heritable unilateral mutational phenotypes.	[Tomar, Swati; Sethi, Raman; Thuan Chong Quah; Lai, Poh San] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Sundar, Gangadhara] Natl Univ Singapore Hosp, Dept Ophthalmol, Singapore, Singapore; [Boon Long Quah] Singapore Natl Eye Ctr, Singapore, Singapore	National University of Singapore; National University of Singapore; Singapore National Eye Center	Lai, PS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore.	paelaips@nus.edu.sg	Quah, Boon Long/GSD-9214-2022	Tomar, Swati/0000-0001-5543-6803; Sethi, Raman/0000-0003-1372-5652	National Medical Research Council of Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We acknowledge grant funding support from National Medical Research Council of Singapore.	Alonso J, 2001, HUM MUTAT, V17, P412, DOI 10.1002/humu.1117; Amitrano S, 2015, EUR J HUM GENET, V23, P1523, DOI 10.1038/ejhg.2015.6; Aung L, 2009, ANN ACAD MED SINGAP, V38, P693; Ayari-Jeridi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116615; Bamne MN, 2005, GENET TEST, V9, P200, DOI 10.1089/gte.2005.9.200; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; BOOKSTEIN R, 1990, NUCLEIC ACIDS RES, V18, P1666, DOI 10.1093/nar/18.6.1666; Bowles E, 2007, GENE CHROMOSOME CANC, V46, P118, DOI 10.1002/gcc.20383; Canzian F, 1996, CANCER RES, V56, P3331; Chen DN, 2001, CANCER GENET CYTOGEN, V129, P57, DOI 10.1016/S0165-4608(01)00427-7; Chen Z, 2014, HUM MUTAT, V35, P384, DOI 10.1002/humu.22488; Cheng GY, 2013, ASIA-PAC J OPHTHALMO, V2, P414, DOI 10.1097/APO.0000000000000016; Choy KW, 2005, NEOPLASIA, V7, P200, DOI 10.1593/neo.04565; Choy KW, 2002, INVEST OPHTH VIS SCI, V43, P1344; Choy Kwong Wai, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9077; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Devarajan B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1340-8; Dimaras H, 2015, NAT REV DIS PRIMERS, P15062; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Dimas AS, 2012, GENOME RES, V22, P2368, DOI 10.1101/gr.134981.111; Dommering CJ, 2014, J MED GENET, V51, P366, DOI 10.1136/jmedgenet-2014-102264; Eloy P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005888; Gallie B, 2009, CAN J OPHTHALMOL, V44, P639, DOI [10.3129/i09-229, 10.1139/i09-229]; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Harbour JW, 2001, ARCH OPHTHALMOL-CHIC, V119, P1699; He MY, 2014, MOL VIS, V20, P545; [何明燕 He Mingyan], 2013, [中华医学遗传学杂志, Chinese Journal of Medical Genetics], V30, P509; HOGG A, 1992, ONCOGENE, V7, P1445; HORSTHEMKE B, 1989, CANCER GENET CYTOGEN, V37, P95, DOI 10.1016/0165-4608(89)90079-4; Jeridi HA, 2014, EXP EYE RES, V124, P48, DOI 10.1016/j.exer.2014.04.013; Kanber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081502; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Klutz M, 2002, AM J HUM GENET, V71, P174, DOI 10.1086/341284; Kooi IE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153323; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Lim FPM, 2013, J PEDIAT OPHTH STRAB, V50, P106, DOI 10.3928/01913913-20121211-01; LOHMANN DR, 1994, HUM GENET, V94, P349; Lohmann DR, 1996, AM J HUM GENET, V58, P940; Lohmann DR, 2004, AM J MED GENET C, V129C, P23, DOI 10.1002/ajmg.c.30024; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; Lohmann DR, 1997, AM J HUM GENET, V61, P282, DOI 10.1086/514845; Marchong MN, 2004, MOL CANCER RES, V2, P495; McEvoy J, 2014, ONCOTARGET, V5, P438, DOI 10.18632/oncotarget.1686; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; MCGEE TL, 1990, NUCLEIC ACIDS RES, V18, P207, DOI 10.1093/nar/18.1.207-a; Mendoza PR, 2015, PROG MOL BIOL TRANSL, V134, P503, DOI 10.1016/bs.pmbts.2015.06.012; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mol BM, 2014, GENE CHROMOSOME CANC, V53, P1, DOI 10.1002/gcc.22111; Nichols KE, 2005, HUM MUTAT, V25, P566, DOI 10.1002/humu.20184; OHTANIFUJITA N, 1993, ONCOGENE, V8, P1063; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; Ottaviani D, 2013, OPHTHALMIC GENET, V34, P189, DOI 10.3109/13816810.2012.755553; Otterson GA, 1999, AM J HUM GENET, V65, P1040, DOI 10.1086/302581; Price EA, 2014, J MED GENET, V51, P208, DOI 10.1136/jmedgenet-2013-101821; Priya K, 2009, CANCER BIOL THER, V8, P714, DOI 10.4161/cbt.8.8.7921; Richter S, 2003, AM J HUM GENET, V72, P253, DOI 10.1086/345651; Rodriguez-Martin C, 2016, J HUM GENET, V61, P463, DOI 10.1038/jhg.2015.173; Rowland JS, 2001, J MED GENET, V38, P90, DOI 10.1136/jmg.38.2.90; Rushlow D, 2009, HUM MUTAT, V30, P842, DOI 10.1002/humu.20940; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Sagi M, 2015, FAM CANCER, V14, P471, DOI 10.1007/s10689-015-9794-z; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Saw SM, 2000, J PEDIAT OPHTH STRAB, V37, P87; Schuler A, 2005, EUR J CANCER, V41, P735, DOI 10.1016/j.ejca.2004.12.022; Sellner LN, 2006, PEDIATR DEVEL PATHOL, V9, P31, DOI 10.2350/07-05-0078.1; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Singh G, 2016, SEMIN OPHTHALMOL, V538, P1; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Stirzaker C, 1997, CANCER RES, V57, P2229; Taylor M, 2007, HUM MUTAT, V28, P284, DOI 10.1002/humu.20443; Temming P, 2015, PEDIATR BLOOD CANCER, V62, P1799, DOI 10.1002/pbc.25576; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; VAUGHN GL, 1990, NUCLEIC ACIDS RES, V18, P4965, DOI 10.1093/nar/18.16.4965; VOGEL F, 1979, HUM GENET, V52, P1; WADAYAMA B, 1994, CANCER RES, V54, P3042; Wang X, 2015, CELL MOL LIFE SCI, V72, P1931, DOI 10.1007/s00018-015-1843-0; Xin GH, 2012, INT J OPHTHALMOL-CHI, V5, P440, DOI 10.3980/j.issn.2222-3959.2012.04.07; Xu KP, 2004, AM J OPHTHALMOL, V137, P18, DOI 10.1016/S0002-9394(03)00872-9; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Zeschnigk M, 1999, J MED GENET, V36, P793, DOI 10.1136/jmg.36.10.793; Zhang LL, 2015, TUMOR BIOL, V36, P2409, DOI 10.1007/s13277-014-2851-7	84	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178776	10.1371/journal.pone.0178776	http://dx.doi.org/10.1371/journal.pone.0178776			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575107	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300113
J	Manent, J; Banerjee, S; de Matos Simoes, R; Zoranovic, T; Mitsiades, C; Penninger, JM; Simpson, KJ; Humbert, PO; Richardson, HE				Manent, J.; Banerjee, S.; de Matos Simoes, R.; Zoranovic, T.; Mitsiades, C.; Penninger, J. M.; Simpson, K. J.; Humbert, P. O.; Richardson, H. E.			Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species	ONCOGENE			English	Article							CELL-DEATH; DROSOPHILA-MELANOGASTER; TUMOR PROGRESSION; GENETIC SCREEN; ONCOGENIC RAS; CANCER; PROMOTES; EXPRESSION; GROWTH; TRANSFORMATION	Activation of Ras signalling occurs in similar to 30% of human cancers; however, activated Ras alone is not sufficient for tumourigenesis. In a screen for tumour suppressors that cooperate with oncogenic Ras (Ras(V12)) in Drosophila, we identified genes involved in the autophagy pathway. Bioinformatic analysis of human tumours revealed that several core autophagy genes, including GABARAP, correlate with oncogenic KRAS mutations and poor prognosis in human pancreatic cancer, supporting a potential tumour-suppressive effect of the pathway in Ras-driven human cancers. In Drosophila, we demonstrate that blocking autophagy at any step of the pathway enhances Ras(V12)-driven epithelial tissue overgrowth via the accumulation of reactive oxygen species and activation of the Jun kinase stress response pathway. Blocking autophagy in Ras(V12) clones also results in non-cell-autonomous effects with autophagy, cell proliferation and caspase activation induced in adjacent wild-type cells. Our study has implications for understanding the interplay between perturbations in Ras signalling and autophagy in tumourigenesis, which might inform the development of novel therapeutics targeting Ras-driven cancers.	[Manent, J.; Richardson, H. E.] La Trobe Univ, Sch Mol Sci, La Trobe Inst Mol Sci, Cell Polar & Signaling Lab,Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Manent, J.; Banerjee, S.; Richardson, H. E.] Peter MacCallum Canc Ctr, Cell Cycle & Dev Lab, Melbourne, Vic, Australia; [Manent, J.; Banerjee, S.; Humbert, P. O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Manent, J.; Banerjee, S.; Simpson, K. J.] Peter MacCallum Canc Ctr, Victorian Ctr Funct Gen, Melbourne, Vic, Australia; [Manent, J.; Banerjee, S.; Simpson, K. J.; Humbert, P. O.; Richardson, H. E.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [de Matos Simoes, R.; Mitsiades, C.] Harvard Med Sch, Dept Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Zoranovic, T.; Penninger, J. M.] Inst Mol Biotechnol, Vienna, Austria; [Humbert, P. O.; Richardson, H. E.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Humbert, P. O.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Humbert, P. O.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Canc Biol Cell Polar & Tissue Architecture Lab, Melbourne, Vic, Australia; [Richardson, H. E.] Univ Melbourne, Dept Anat & Neurobiol, Melbourne, Vic, Australia; [Manent, J.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Zoranovic, T.] Max Planck Inst Infect Biol, Berlin, Germany	La Trobe University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Melbourne; University of Melbourne; La Trobe University; University of Melbourne; Monash University; Max Planck Society	Richardson, HE (corresponding author), La Trobe Univ, Sch Mol Sci, La Trobe Inst Mol Sci, Cell Polar & Signaling Lab,Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	h.richardson@latrobe.edu.au	Pryjda, Tamara/O-5714-2019; Penninger, Josef M/I-6860-2013; Humbert, Patrick O/L-4264-2016; Richardson, Helena E/A-8080-2013	Penninger, Josef M/0000-0002-8194-3777; Humbert, Patrick O/0000-0002-1366-6691; Richardson, Helena E/0000-0003-3852-4953; zoranovic, tamara/0000-0002-5369-6385; de Matos Simoes, Ricardo/0000-0002-1700-5276; Simpson, Kaylene/0000-0001-9136-1781; Manent, Jan/0000-0001-9152-5459	National Health and Medical Research Council (NHMRC) [1020525]; PeterMac Foundation; LIMS; La Trobe University; NHMRC [1020525]; Australian Postgraduate Research Award; Marie Curie Excellence grant; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); PeterMac Foundation; LIMS; La Trobe University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Research Award; Marie Curie Excellence grant(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank Donna Denton, Sharad Kumar, Louise Cheng, Tor Erik Rusten, Lee Jun, Gabor Juhasz, Tom Neufeld, Stephen Gregory and Zeeshan Shaukat for reagents, and Tor Erik Rusten, Andreas Bergmann, Donna Denton, Sharad Kumar and Stephen Gregory for discussions. We thank Edwina McGlinn for critical reading of the manuscript. We are grateful to the Peter MacCallum Microscopy core and the LIMS Bioimaging facility for their help with imaging and analysis. We are grateful to OzDros and to Peter Burke for quarantine, shipment and maintenance of Drosophila stocks. The project was supported by grants from the National Health and Medical Research Council (NHMRC, no. 1020525) and from the PeterMac Foundation to HER, JMP, KJS and POH, and funds from LIMS and La Trobe University. JM was supported by an NHMRC grant (no. 1020525) and LIMS and La Trobe University, SB by a Australian Postgraduate Research Award and TZ by a Marie Curie Excellence grant. HER and POH are supported by fellowships of the (NHMRC) and funds from LIMS and La Trobe University.	Alves S, 2015, ONCOTARGET, V6, P30787, DOI 10.18632/oncotarget.5021; [Anonymous], MODELLING CANC DROSO; Avalos Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/603980; Belaid A, 2013, CANCER RES, V73, P4311, DOI 10.1158/0008-5472.CAN-12-4142; Bellot GL, 2013, MITOCHONDRION, V13, P155, DOI 10.1016/j.mito.2012.06.007; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Denton D, 2012, CELL DEATH DIFFER, V19, P1299, DOI 10.1038/cdd.2012.43; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; DiMauro T, 2010, CURR CANCER DRUG TAR, V10, P869, DOI 10.2174/156800910793357998; Doggett K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132987; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fogarty CE, 2016, CURR BIOL, V26, P575, DOI 10.1016/j.cub.2015.12.064; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Gargini R, 2016, ONCOL REP, V35, P3689, DOI 10.3892/or.2016.4699; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Halfar K, 2001, DEVELOPMENT, V128, P1687; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Karim FD, 1998, DEVELOPMENT, V125, P1; Karim FD, 1996, GENETICS, V143, P315; Katheder NS, 2017, NATURE, V541, P417, DOI 10.1038/nature20815; Khoo P, 2013, DIS MODEL MECH, V6, P661, DOI 10.1242/dmm.010066; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; Li ML, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0293-y; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Liu ZY, 2014, J NEURO-ONCOL, V116, P465, DOI 10.1007/s11060-013-1325-x; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Morelli E, 2014, AUTOPHAGY, V10, P2251, DOI 10.4161/15548627.2014.981913; Morgan MJ, 2014, AUTOPHAGY, V10, P1814, DOI 10.4161/auto.32135; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nakamura M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6264; O'Farrell F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001612; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez E, 2015, ONCOGENE, V34, P3369, DOI 10.1038/onc.2014.285; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Qin WJ, 2015, ONCOTARGET, V6, P39839, DOI 10.18632/oncotarget.5674; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Sacco E, 2012, EXPERT OPIN THER PAT, V22, P1263, DOI 10.1517/13543776.2012.728586; Santabarbara-Ruiz P, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005595; Schmukler E, 2014, ONCOTARGET, V5, P577, DOI 10.18632/oncotarget.1775; Shaukat Z, 2015, ONCOGENE, V34, P4044, DOI 10.1038/onc.2014.344; Su TT, 2015, AIMS GENET, V2, P54, DOI 10.3934/genet.2015.1.54; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tomiyama L, 2015, ONCOGENE, V34, P1141, DOI 10.1038/onc.2014.31; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2013, GENE DEV, V27, P2065, DOI 10.1101/gad.228122.113; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Willecke M, 2011, ONCOGENE, V30, P4067, DOI 10.1038/onc.2011.125; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Wu H, 2009, MECH DEVELOP, V126, P624, DOI 10.1016/j.mod.2009.06.1082; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zhou ZH, 2015, EXP CELL RES, V331, P399, DOI 10.1016/j.yexcr.2014.11.015	85	20	20	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5576	5592		10.1038/onc.2017.175	http://dx.doi.org/10.1038/onc.2017.175			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581519	Green Published, hybrid			2022-12-26	WOS:000412293600003
J	Sun, XJ; Kim, SP; Zhang, DM; Sun, H; Cao, Q; Lu, X; Ying, ZK; Li, LW; Henry, RR; Ciaraldi, TP; Taylor, SI; Quon, MJ				Sun, Xiao-Jian; Kim, Soohyun Park; Zhang, Dongming; Sun, Helen; Cao, Qi; Lu, Xin; Ying, Zhekang; Li, Liwu; Henry, Robert R.; Ciaraldi, Theodore P.; Taylor, Simeon I.; Quon, Michael J.			Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; PLECKSTRIN HOMOLOGY DOMAIN; NITRIC-OXIDE PRODUCTION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; ENDOTHELIAL DYSFUNCTION; SIGNALING PATHWAYS; IKK-BETA; RECIPROCAL RELATIONSHIPS; IMPAIRED REGULATION	Chronic inflammation may contribute to insulin resistance via molecular cross-talk between pathways for pro-inflammatory and insulin signaling. Interleukin 1 receptor-associated kinase 1 (IRAK-1) mediates pro-inflammatory signaling via IL-1 receptor/Toll-like receptors, which may contribute to insulin resistance, but this hypothesis is untested. Here, we used male Irak1 null (k/o) mice to investigate the metabolic role of IRAK-1. C57BL/6 wild-type (WT) and k/o mice had comparable body weights on low-fat and high-fat diets (LFD and HFD, respectively). After 12 weeks on LFD (but not HFD), k/o mice (versus WT) had substantially improved glucose tolerance (assessed by the intraperitoneal glucose tolerance test (IPGTT)). As assessed with the hyperinsulinemic euglycemic glucose clamp technique, insulin sensitivity was 30% higher in the Irak1 k/o mice on chow diet, but the Irak1 deletion did not affect IPGTT outcomes in mice on HFD, suggesting that the deletion did not overcome the impact of obesity on glucose tolerance. Moreover, insulin-stimulated glucose-disposal rates were higher in the k/o mice, but we detected no significant difference in hepatic glucose production rates (+/- insulin infusion). Positron emission/computed tomography scans indicated higher insulin-stimulated glucose uptake in muscle, but not liver, in Irak1 k/o mice in vivo. Moreover, insulin-stimulated phosphorylation of Akt was higher in muscle, but not in liver, from Irak1 k/o mice ex vivo. In conclusion, Irak1 deletion improved muscle insulin sensitivity, with the effect being most apparent in LFD mice.	[Sun, Xiao-Jian; Kim, Soohyun Park; Zhang, Dongming; Sun, Helen; Taylor, Simeon I.; Quon, Michael J.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Ying, Zhekang] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA; [Cao, Qi; Lu, Xin] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Sun, Xiao-Jian] Baltimore Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21201 USA; [Zhang, Dongming] Zhengzhou Univ, Affiliated Hosp 2, Zhengzhou 450014, Henan, Peoples R China; [Li, Liwu] Virginia Tech, Blacksburg, VA 24061 USA; [Henry, Robert R.; Ciaraldi, Theodore P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92166 USA; [Henry, Robert R.; Ciaraldi, Theodore P.] Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Zhengzhou University; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Sun, XJ (corresponding author), 660 W Redwood St,HH 594, Baltimore, MD 21201 USA.	xsun@som.umaryland.edu		QUON, MICHAEL/0000-0002-5289-3707	American Diabetes Association [1-13-BS-150, 1-14-BS-198]; NIEHS, National Institutes of Health [R01ES024516]; U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award [I01CX00635]; Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC); NIDDK, National Institutes of Health [5P30DK072488-12]; Ionis Pharmaceuticals; Aegerion Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024516] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000635] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award; Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ionis Pharmaceuticals; Aegerion Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Diabetes Association Grants 1-13-BS-150 (to M. J. Q.) and 1-14-BS-198 (to X. J. S.), NIEHS, National Institutes of Health Grant R01ES024516 (to Z. Y.), U. S. Department of Veterans Affairs Clinical Sciences Research and Development Service Merit Review Award I01CX00635, Baltimore Veterans Affairs Medical Center Geriatric Research Clinical Center (GRECC), and NIDDK, National Institutes of Health Grant 5P30DK072488-12 (to S. I. T.). S. I. T. has worked as a paid consultant for Ionis Pharmaceuticals and Aegerion Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Berglund M, 2008, SCAND J IMMUNOL, V67, P473, DOI 10.1111/j.1365-3083.2008.02096.x; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Chen H, 2003, AM J PHYSIOL-ENDOC M, V284, pE804, DOI 10.1152/ajpendo.00330.2002; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; Chen H, 2008, J BIOL CHEM, V283, P29228, DOI 10.1074/jbc.M802906200; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; COPPACK SW, 1994, J LIPID RES, V35, P177; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; DeFronzo RA, 2010, DIABETOLOGIA, V53, P1270, DOI 10.1007/s00125-010-1684-1; Dewberry R, 2000, ARTERIOSCL THROM VAS, V20, P2394, DOI 10.1161/01.ATV.20.11.2394; Eckardt K, 2011, REV ENDOCR METAB DIS, V12, P163, DOI 10.1007/s11154-011-9168-2; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; FOLLI F, 1992, J BIOL CHEM, V267, P22171; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Fujimoto Y, 2006, DIABETES, V55, P2479, DOI 10.2337/db05-1511; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Han SH, 2007, CURR OPIN LIPIDOL, V18, P58, DOI 10.1097/MOL.0b013e328012b627; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hommelberg PPH, 2010, CURR OPIN CLIN NUTR, V13, P647, DOI 10.1097/MCO.0b013e32833f1acd; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Hotamisligil GS, 2000, INT J OBESITY, V24, pS23, DOI 10.1038/sj.ijo.0801497; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Jang HJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1077, DOI 10.1152/ajpendo.00578.2012; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Jiang ZY, 1999, DIABETES, V48, P1120, DOI 10.2337/diabetes.48.5.1120; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kewalramani G, 2010, CURR OPIN CLIN NUTR, V13, P382, DOI 10.1097/MCO.0b013e32833aabd9; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kim JA, 2005, ARTERIOSCL THROM VAS, V25, P889, DOI 10.1161/01.ATV.0000164044.42910.6b; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim OK, 2015, ANN NUTR METAB, V67, P218, DOI 10.1159/000440905; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kim YB, 2003, DIABETES, V52, P1935, DOI 10.2337/diabetes.52.8.1935; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lakoski SG, 2007, EXP MOL PATHOL, V82, P280, DOI 10.1016/j.yexmp.2007.02.002; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Lee S, 2008, ENDOCRINOLOGY, V149, P2451, DOI 10.1210/en.2007-1595; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; McCarty MF, 2010, MED HYPOTHESES, V75, P276, DOI 10.1016/j.mehy.2009.12.027; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; Mishra AK, 2016, METABOLISM, V65, P48, DOI 10.1016/j.metabol.2015.10.008; Moller DE, 1996, ENDOCRINOLOGY, V137, P2397, DOI 10.1210/en.137.6.2397; Muniyappa R, 2008, ENDOCRIN METAB CLIN, V37, P685, DOI 10.1016/j.ecl.2008.06.001; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Nawaratne R, 2006, MOL ENDOCRINOL, V20, P1838, DOI 10.1210/me.2005-0536; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Quon MJ, 2002, J CLIN ENDOCR METAB, V87, P949, DOI 10.1210/jc.87.2.949; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; RIZZA RA, 1981, DIABETES, V30, P377, DOI 10.2337/diabetes.30.5.377; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sperry JL, 2014, ANN SURG, V260, P698, DOI 10.1097/SLA.0000000000000918; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	101	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12339	12350		10.1074/jbc.M117.779108	http://dx.doi.org/10.1074/jbc.M117.779108			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28572512	Green Published, hybrid			2022-12-26	WOS:000406053300028
J	Moreno, F; Indakoetxea, B; Barandiaran, M; Caballero, MC; Gorostidi, A; Calafell, F; Gabilondo, A; Tainta, M; Zulaica, M; Masso, JFM; de Munain, AL; Sanchez-Juan, P; Lee, SE				Moreno, Fermin; Indakoetxea, Begona; Barandiaran, Myriam; Cristina Caballero, Maria; Gorostidi, Ana; Calafell, Francesc; Gabilondo, Alazne; Tainta, Mikel; Zulaica, Miren; Marti Masso, Jose F.; Lopez de Munain, Adolfo; Sanchez-Juan, Pascual; Lee, Suzee E.			The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; C9ORF72 REPEAT EXPANSION; ALZHEIMERS-DISEASE; PROGRANULIN MUTATION; DEMENTIA; TAU; VARIANT; PHENOTYPES; HAPLOTYPE; SPECTRUM	Background The co-occurrence of the c.709-1G > A GRN mutation and the p.A152T MAPT variant has been identified in 18 Basque families affected by frontotemporal dementia (FTD). We aimed to investigate the influence of the p.A152T MAPT variant on the clinical and neuropathological features of these Basque GRN families. Methods and findings We compared clinical characteristics of 14 patients who carried the c.709-1G > A GRN mutation (GRN+/A152T-) with 21 patients who carried both the c.709-1G > A GRN mutation and the p.A152T MAPT variant (GRN+/A152T+). Neuropsychological data (n = 17) and plasma progranulin levels (n = 23) were compared between groups, and 7 subjects underwent neuropathological studies. We genotyped six short tandem repeat markers in the two largest families. By the analysis of linkage disequilibrium decay in the haplotype block we estimated the time when the first ancestor to carry both genetic variants emerged. GRN+/A152T+ and GRN+/A152T-patients shared similar clinical and neuropsychological features and plasma progranulin levels. All were diagnosed with an FTD disorder, including behavioral variant FTD or non fluent / agrammatic variant primary progressive aphasia, and shared a similar pattern of neuropsychological deficits, predominantly in executive function, memory, and language. All seven participants with available brain autopsies (6 GRN+/A152T+, 1 GRN+/A152T-) showed frontotemporal lobar degeneration with TDP-43 inclusions (type A classification), which is characteristic of GRN carriers. Additionally, all seven showed mild to moderate tau inclusion burden: five cases lacked beta-amyloid pathology and two cases had Alzheimer's pathology. The co-occurrence of both genes within one individual is recent, with the birth of the first GRN+/A152T+ individual estimated to be within the last 50 generations (95% probability). Conclusions In our sample, the p.A152T MAPT variant does not appear to show a discernible influence on the clinical phenotype of GRN carriers. Whether p.A152T confers a greater than expected propensity for tau pathology in these GRN carriers remains an open question.	[Moreno, Fermin; Indakoetxea, Begona; Barandiaran, Myriam; Tainta, Mikel; Marti Masso, Jose F.; Lopez de Munain, Adolfo] Hosp Univ Donostia, Dept Neurol, San Sebastian, Spain; [Moreno, Fermin; Indakoetxea, Begona; Barandiaran, Myriam; Gorostidi, Ana; Gabilondo, Alazne; Tainta, Mikel; Zulaica, Miren; Marti Masso, Jose F.; Lopez de Munain, Adolfo] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Moreno, Fermin; Indakoetxea, Begona; Barandiaran, Myriam; Gorostidi, Ana; Gabilondo, Alazne; Tainta, Mikel; Zulaica, Miren; Marti Masso, Jose F.; Lopez de Munain, Adolfo] Inst Biodonostia, Neurosci Area, San Sebastian, Spain; [Cristina Caballero, Maria] Hosp Univ Donostia, Dept Pathol, San Sebastian, Spain; [Cristina Caballero, Maria] Brain Bank Hosp Univ Donostia, Basque Biobank Res OEHUN, San Sebastian, Spain; [Calafell, Francesc] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Inst Evolutionary Biol, CSIC, Barcelona, Spain; [Gabilondo, Alazne] Hosp Bidasoa, Dept Neurol, Irun, Spain; [Marti Masso, Jose F.; Lopez de Munain, Adolfo] Univ Basque Country, UPV EHU, Dept Neurosci, San Sebastian, Spain; [Sanchez-Juan, Pascual] Univ Cantabria, Marques de Valdecilla Univ Hosp, Inst Res Marques de Valdecilla IDIVAL, Neurol Serv, Santander, Spain; [Sanchez-Juan, Pascual] Univ Cantabria, Marques de Valdecilla Univ Hosp, Inst Res Marques de Valdecilla IDIVAL, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Santander, Spain; [Lee, Suzee E.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA	CIBERNED; Instituto de Investigacion Sanitaria Biodonostia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Basque Country; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of California System; University of California San Francisco	Moreno, F (corresponding author), Hosp Univ Donostia, Dept Neurol, San Sebastian, Spain.; Moreno, F (corresponding author), Inst Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.; Moreno, F (corresponding author), Inst Biodonostia, Neurosci Area, San Sebastian, Spain.	FERMIN.MORENOIZCO@osakidetza.eus	Calafell, Francesc/C-8595-2014; Sanchez-Juan, Pascual/B-9282-2009; Lee, Suzee/AAG-2393-2019; Tainta, Mikel/AAX-7203-2020; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020	Calafell, Francesc/0000-0002-1083-9438; Sanchez-Juan, Pascual/0000-0002-6081-8037; Tainta, Mikel/0000-0003-0624-1211; GABILONDO, ALAZNE/0000-0001-5006-4481; /0000-0002-9509-4032; Gorostidi, Ana/0000-0002-5494-4512; Myriam, Barandiaran Amillano/0000-0002-8209-6530; Moreno, Fermin/0000-0001-5200-3164	Tau Consortium; Generalitat de Catalunya [2014 SGR 866]; ISCIII [PI12/02288]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)	Tau Consortium; Generalitat de Catalunya(Generalitat de Catalunya); ISCIII(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)	F.M., P.S.J. and S.E.L. receive funding from the Tau Consortium. F.C. receives funding from the Generalitat de Catalunya (grant 2014 SGR 866). P.S.J. receives funding from ISCIII (PI12/02288). This work was also supported by the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniek KF, 2013, ACTA NEUROPATHOL, V125, P289, DOI 10.1007/s00401-012-1048-7; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Chen-Plotkin AS, 2011, ARCH NEUROL-CHICAGO, V68, P488, DOI 10.1001/archneurol.2011.53; Chio A, 2012, J NEUROL NEUROSUR PS, V83, P730, DOI 10.1136/jnnp-2012-302219; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; de Munain AL, 2008, BIOL PSYCHIAT, V63, P946, DOI 10.1016/j.biopsych.2007.08.015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fong H, 2013, STEM CELL REP, V1, P226, DOI 10.1016/j.stemcr.2013.08.001; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Graff-Radford J, 2013, PARKINSONISM RELAT D, V19, P838, DOI 10.1016/j.parkreldis.2013.04.023; Kaivorinne AL, 2014, ALZ DIS ASSOC DIS, V28, P190, DOI 10.1097/WAD.0b013e318266fae5; Kara E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.006; King A, 2013, ACTA NEUROPATHOL, V125, P303, DOI 10.1007/s00401-012-1050-0; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kovacs GG, 2011, CLIN NEUROPATHOL, V30, P3, DOI 10.5414/NPP30003; Lashley T, 2014, NEUROPATH APPL NEURO, V40, P502, DOI 10.1111/nan.12100; Lee SE, 2013, ALZ DIS ASSOC DIS, V27, P302, DOI 10.1097/WAD.0b013e31828cc357; Mackenzie IRA, 2007, ACTA NEUROPATHOL, V114, P49, DOI 10.1007/s00401-007-0223-8; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Manubens JM, 2005, NEUROLOGIA, V20, P174; Masso JFM, 2015, ANN HUM GENET, V79, P57, DOI 10.1111/ahg.12088; Mignarri A, 2014, J NEUROL SCI, V341, P176, DOI 10.1016/j.jns.2014.03.030; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Moreno F, 2009, NEUROLOGY, V73, P1367, DOI 10.1212/WNL.0b013e3181bd82a7; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Papegaey A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0345-0; Pastor P, 2016, J ALZHEIMERS DIS, V49, P343, DOI 10.3233/JAD-150555; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S1474-4422(07)70221-1; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robinson AC, 2014, NEUROPATH APPL NEURO, V40, P844, DOI 10.1111/nan.12155; Silva MC, 2016, STEM CELL REP, V7, P325, DOI 10.1016/j.stemcr.2016.08.001; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; van Blitterswijk M, 2013, NEUROLOGY, V81, P1332, DOI 10.1212/WNL.0b013e3182a8250c; van Swieten JC, 2008, LANCET NEUROL, V7, P965, DOI 10.1016/S1474-4422(08)70194-7; Walsh B, 2001, GENETICS, V158, P897	37	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178093	10.1371/journal.pone.0178093	http://dx.doi.org/10.1371/journal.pone.0178093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594853	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200016
J	Taubert, R; Hardtke-Wolenski, M; Noyan, F; Lalanne, C; Jonigk, D; Schlue, J; Krech, T; Lichtinghagen, R; Falk, CS; Schlaphoff, V; Bantel, H; Muratori, L; Manns, MP; Jaeckel, E				Taubert, Richard; Hardtke-Wolenski, Matthias; Noyan, Fatih; Lalanne, Claudine; Jonigk, Danny; Schlue, Jerome; Krech, Till; Lichtinghagen, Ralf; Falk, Christine S.; Schlaphoff, Verena; Bantel, Heike; Muratori, Luigi; Manns, Michael P.; Jaeckel, Elmar			Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis	PLOS ONE			English	Article							SERUM FERRITIN CONCENTRATION; REGULATORY T-CELLS; LIVER-TRANSPLANTATION; CORTICOSTEROID-THERAPY; IRON HOMEOSTASIS; REMISSION; TYPE-1; HEPCIDIN; RELAPSE; ASSOCIATION	Autoimmune hepatitis (AIH) is a chronic hepatitis with an increasing incidence. The majority of patients require life-long immunosuppression and incomplete treatment response is associated with a disease progression. An abnormal iron homeostasis or hyperferritinemia is associated with worse outcome in other chronic liver diseases and after liver transplantation. We assessed the capacity of baseline parameters including the iron status to predict the treatment response upon standard therapy in 109 patients with untreated AIH type 1 (AIH-1) in a retrospective single center study. Thereby, a hyperferritinemia (> 2.09 times upper limit of normal; Odds ratio (OR) = 8.82; 95% confidence interval (CI): 2.25-34.52) and lower immunoglobulins (<1.89 times upper limit of normal; OR = 6.78; CI: 1.87-24.59) at baseline were independently associated with the achievement of complete biochemical remission upon standard therapy. The predictive value increased when both variables were combined to a single treatment response score, when the cohort was randomly split into a training (area under the curve (AUC) = 0.749; CI 0.635-0.863) and internal validation cohort (AUC = 0.741; CI 0.558-0.924). Patients with a low treatment response score (<1) had significantly higher cumulative remission rates in the training (p<0.001) and the validation cohort (p = 0.024). The baseline hyperferritinemia was accompanied by a high serum iron, elevated transferrin saturations and mild hepatic iron depositions in the majority of patients. However, the abnormal iron status was quickly reversible under therapy. Mechanistically, the iron parameters were not stringently related to a hepatocellular damage. Ferritin rather seems deregulated from the master regulator hepcidin, which was down regulated, potentially mediated by the elevated hepatocyte growth factor. In conclusion, baseline levels of serum ferritin and immunoglobulins, which are part of the diagnostic work-up of AIH, can be used to predict the treatment response upon standard therapy in AIH-1, although confirmation from larger multicenter studies is pending.	[Taubert, Richard; Hardtke-Wolenski, Matthias; Noyan, Fatih; Schlaphoff, Verena; Bantel, Heike; Manns, Michael P.; Jaeckel, Elmar] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Lalanne, Claudine; Muratori, Luigi] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Jonigk, Danny; Schlue, Jerome; Krech, Till] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Clin Chem, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Inst Transplantat Immunol, Hannover, Germany; [Falk, Christine S.] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Krech, Till] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany	Hannover Medical School; University of Bologna; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Taubert, R (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	Taubert.richard@mh-hannover.de	Hardtke-Wolenski, Matthias/I-2993-2019; Falk, Christine/Q-4143-2016; Noyan, Fatih/B-9449-2018	Hardtke-Wolenski, Matthias/0000-0002-2827-7787; Falk, Christine/0000-0003-1376-7318; 	German Research Foundation [KF0250, HA6880/2-1]; Hannover Medical School	German Research Foundation(German Research Foundation (DFG)); Hannover Medical School	This work was supported by grants from the German Research Foundation (KF0250 project 7; SFB TR 127 project A4; HA6880/2-1). RT was supported by the Young Faculty program from the Hannover Medical School.	Abdo Ayman A, 2006, Saudi J Gastroenterol, V12, P73; Al-Chalabi T, 2008, CLIN GASTROENTEROL H, V6, P1389, DOI 10.1016/j.cgh.2008.08.018; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Beland K, 2009, WORLD J GASTROENTERO, V15, P1025, DOI 10.3748/wjg.15.1025; Bhagat CI, 2000, CLIN CHEM, V46, P885; Bohne F, 2012, J CLIN INVEST, V122, P368, DOI 10.1172/JCI59411; Czaja AJ, 2002, HEPATOLOGY, V35, P890, DOI 10.1053/jhep.2002.32485; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Datz C, 2013, EUR J CLIN INVEST, V43, P215, DOI 10.1111/eci.12032; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; DEUGNIER YM, 1993, HEPATOLOGY, V18, P1363, DOI 10.1002/hep.1840180613; Dhaliwal HK, 2015, AM J GASTROENTEROL, V110, P993, DOI 10.1038/ajg.2015.139; Georgopoulou U, 2014, VIRULENCE, V5, P465, DOI 10.4161/viru.28508; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Gronbaek L, 2014, J HEPATOL, V60, P612, DOI DOI 10.1016/J.JHEP.2013.10.020; Hardtke-Wolenski M, 2015, HEPATOLOGY, V61, P1295, DOI 10.1002/hep.27639; Hardtke-Wolenski M, 2013, HEPATOLOGY, V58, P718, DOI 10.1002/hep.26380; Harrison-Findik DD, 2007, WORLD J GASTROENTERO, V13, P4925, DOI 10.3748/wjg.v13.i37.4925; Jonigk D, 2011, METHODS MOL BIOL, V755, P67, DOI 10.1007/978-1-61779-163-5_5; Kirstein MM, 2015, HEPATOLOGY; Koca SS, 2008, INFLAMMATION, V31, P146, DOI 10.1007/s10753-008-9060-8; Lyberopoulou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135486; Manns MP, 2010, GASTROENTEROLOGY, V139, P1198, DOI 10.1053/j.gastro.2010.06.046; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013; Montano-Loza AJ, 2007, AM J GASTROENTEROL, V102, P1005, DOI 10.1111/j.1572-0241.2007.01153.x; Muratori L, 2010, HEPATOLOGY, V52, P1857, DOI 10.1002/hep.23924; Muratori P, 2016, DIGESTIVE LIVER DIS; Muratori P, 2009, J HEPATOL, V50, P1210, DOI 10.1016/j.jhep.2009.01.020; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Puustinen L, 2016, SCAND J GASTROENTERO, P1; Taubert R, 2012, AM J TRANSPLANT, V12, P3425, DOI 10.1111/j.1600-6143.2012.04264.x; Taubert R, 2014, J HEPATOL, V61, P1106, DOI 10.1016/j.jhep.2014.05.034; van Gerven NMF, 2013, J HEPATOL, V58, P141, DOI 10.1016/j.jhep.2012.09.009; Verma S, 2004, AM J GASTROENTEROL, V99, P1510, DOI 10.1111/j.1572-0241.2004.30457.x; Walker NM, 2010, HEPATOLOGY, V51, P1683, DOI 10.1002/hep.23537; Weismuller TJ, 2011, HEPATOLOGY, V54, P2114, DOI 10.1002/hep.24635; Werner M, 2010, SCAND J GASTROENTERO, V45, P457, DOI 10.3109/00365520903555861; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016	39	19	20	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179074	10.1371/journal.pone.0179074	http://dx.doi.org/10.1371/journal.pone.0179074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594937	Green Published, gold			2022-12-26	WOS:000402923200083
J	Tiruveedula, GSS; Wangikar, PP				Tiruveedula, Gopi Siva Sai; Wangikar, Pramod P.			Gene essentiality, conservation index and co-evolution of genes in cyanobacteria	PLOS ONE			English	Article							UNICELLULAR CYANOBACTERIA; ESCHERICHIA-COLI; RESISTANCE PUMP; GENOME ANALYSIS; PHOTOSYSTEM-II; PROTEIN PHZF; BIOSYNTHESIS; LETHALITY; EVOLUTION; SEQUENCE	Cyanobacteria, a group of photosynthetic prokaryotes, dominate the earth with similar to 10(15) g wet biomass. Despite diversity in habitats and an ancient origin, cyanobacterial phylum has retained a significant core genome. Cyanobacteria are being explored for direct conversion of solar energy and carbon dioxide into biofuels. For this, efficient cyanobacterial strains will need to be designed via metabolic engineering. This will require identification of target knockouts to channelize the flow of carbon toward the product of interest while minimizing deletions of essential genes. We propose "Gene Conservation Index" (GCI) as a quick measure to predict gene essentiality in cyanobacteria. GCI is based on phylogenetic profile of a gene constructed with a reduced dataset of cyanobacterial genomes. GCI is the percentage of organism clusters in which the query gene is present in the reduced dataset. Of the 750 genes deemed to be essential in the experimental study on S. elongatus PCC 7942, we found 494 to be conserved across the phylum which largely comprise of the essential metabolic pathways. On the contrary, the conserved but non-essential genes broadly comprise of genes required under stress conditions. Exceptions to this rule include genes such as the glycogen synthesis and degradation enzymes, deoxyribose-phosphate aldolase (DERA), glucose-6-phosphate 1-dehydrogenase (zwf) and fructose-1,6-bisphosphatase class1, which are conserved but non-essential. While the essential genes are to be avoided during gene knockout studies as potentially lethal deletions, the non-essential but conserved set of genes could be interesting targets for metabolic engineering. Further, we identify clusters of co-evolving genes (CCG), which provide insights that may be useful in annotation. Principal component analysis (PCA) plots of the CCGs are demonstrated as data visualization tools that are complementary to the conventional heatmaps. Our dataset consists of phylogenetic profiles for 23,643 non-redundant cyanobacterial genes. We believe that the data and the analysis presented here will be a great resource to the scientific community interested in cyanobacteria.	[Tiruveedula, Gopi Siva Sai] Natl Inst Technol Karnataka, Dept Chem Engn, Mangalore, India; [Tiruveedula, Gopi Siva Sai; Wangikar, Pramod P.] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Mumbai, Maharashtra, India; [Wangikar, Pramod P.] Indian Inst Technol, Wadhwani Res Ctr Bioengn, Mumbai, Maharashtra, India	National Institute of Technology (NIT System); National Institute of Technology Karnataka; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; DBT-Pan IIT Centre for Bioenergy; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Wangikar, PP (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, DBT Pan IIT Ctr Bioenergy, Mumbai, Maharashtra, India.; Wangikar, PP (corresponding author), Indian Inst Technol, Wadhwani Res Ctr Bioengn, Mumbai, Maharashtra, India.	wangikar@iitb.ac.in		Wangikar, Pramod/0000-0003-0108-7585	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/EB/PAN IIT/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	Authors received funding from Department of Biotechnology, Ministry of Science and Technology, Government of India; Grant Number BT/EB/PAN IIT/2012.; The work was supported by a research grant provided by Department of Biotechnology, Government of India (Grant No: BT/EB/PAN IIT/2012).	Alagesan S, 2013, PHOTOSYNTH RES, V118, P191, DOI 10.1007/s11120-013-9911-5; Basler Georg, 2015, Methods Mol Biol, V1279, P183, DOI 10.1007/978-1-4939-2398-4_12; Beck C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-56; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; BROEDEL SE, 1990, J BACTERIOL, V172, P4023, DOI 10.1128/jb.172.7.4023-4031.1990; Burda K, 2003, FEBS LETT, V535, P159, DOI 10.1016/S0014-5793(02)03895-4; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Castillo R, 2010, INT J MICROBIOLOGY, V2010; Cohen SE, 2015, MICROBIOL MOL BIOL R, V79, P373, DOI 10.1128/MMBR.00036-15; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; Gaudana SB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00374; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hendry JI, 2016, BIORESOURCE TECHNOLO; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; JONES JG, 1991, GENE, V102, P117, DOI 10.1016/0378-1119(91)90549-Q; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Krishnakumar S, 2013, BIOTECHNOL BIOENG, V110, P2371, DOI 10.1002/bit.24882; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Larsson J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-187; LIU J, 1990, BIOCHEMISTRY-US, V29, P1417, DOI 10.1021/bi00458a012; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; MARCUS F, 1986, BIOCHEM BIOPH RES CO, V135, P374, DOI 10.1016/0006-291X(86)90005-7; Martin KA, 2003, PHOTOSYNTH RES, V75, P211, DOI 10.1023/A:1023990402346; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Nozzi Nicole E, 2013, Front Bioeng Biotechnol, V1, P7; Ohad I, 2004, BIOCHEMISTRY-US, V43, P2297, DOI 10.1021/bi0348260; Oliver JWK, 2013, P NATL ACAD SCI USA, V110, P1249, DOI 10.1073/pnas.1213024110; Parsons JF, 2004, BIOCHEMISTRY-US, V43, P12427, DOI 10.1021/bi049059z; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; ROSEN BP, 1990, RES MICROBIOL, V141, P336, DOI 10.1016/0923-2508(90)90008-E; Rubin BE, 2015, P NATL ACAD SCI USA, V112, pE6634, DOI 10.1073/pnas.1519220112; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Strauss E, 2001, J BIOL CHEM, V276, P13513, DOI 10.1074/jbc.C100033200; Suorsa M, 2004, EUR J BIOCHEM, V271, P96, DOI 10.1046/j.1432-1033.2003.03906.x; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; WALSBY AE, 1989, BIOCHEM J, V264, P313, DOI 10.1042/bj2640313; Whitton B., 2012, ECOLOGY CYANOBACTERI, DOI [DOI 10.1007/978-94-007-3855-3, DOI 10.1007/978-94-007-3855-3_24]; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	48	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178565	10.1371/journal.pone.0178565	http://dx.doi.org/10.1371/journal.pone.0178565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594867	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200040
J	Yang, YL; Xie, LX; Tao, X; Hu, KH; Huang, SB				Yang, Yunlong; Xie, Linxiang; Tao, Xin; Hu, Kaihui; Huang, Shaobin			Municipal wastewater treatment by the bioaugmentation of Bacillus sp. K5 within a sequencing batch reactor	PLOS ONE			English	Article							HETEROTROPHIC NITRIFICATION; AEROBIC DENITRIFICATION; DENITRIFYING BACTERIA; NITROGEN REMOVAL; NOSZ GENES; PCR PRIMERS; NIRK; DIVERSITY; ABUNDANCE; NITRITE	Artificial municipal wastewater was treated successfully by the bioaugmentation of Bacillus sp. K5 capable of simultaneous nitrification and denitrification (SND) within a sequencing batch reactor (SBR). During the long-term operation, the bioaugmentation system exhibited an excellent and steady COD and NH4+-N removal without nitrite and nitrate accumulation. The average removal efficiency for COD and NH4+-N achieved to 98% and 95%, respectively. PCR-DGGE, SEM and FISH revealed that the introduced Bacillus sp. K5 should be an important functional strain and exerted a critical influence on the structure of microbial community. qPCR analysis indicated that the strain K5 facilitated aerobic nutrients removal capabilities and SND might be the primary pathway for the nitrogen removal in the SBR. Overall, the SBR system used in our study should be very promising for the future wastewater treatment.	[Yang, Yunlong; Xie, Linxiang; Tao, Xin; Hu, Kaihui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Huang, Shaobin] Guangdong Regular Higher Educ Inst, Key Lab Environm Protect & Ecoremediat, Guangzhou, Guangdong, Peoples R China; [Huang, Shaobin] South China Univ Technol, Sch Environm & Energy, Guangzhou, Guangdong, Peoples R China	Fujian Agriculture & Forestry University; South China University of Technology	Huang, SB (corresponding author), Guangdong Regular Higher Educ Inst, Key Lab Environm Protect & Ecoremediat, Guangzhou, Guangdong, Peoples R China.; Huang, SB (corresponding author), South China Univ Technol, Sch Environm & Energy, Guangzhou, Guangdong, Peoples R China.	hshbyyl@126.com			National Natural Science Foundation of China [21407024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (no. 21407024).; This work was supported by National Natural Science Foundation of China (no. 21407024). We wish to thank the anonymous reviewers for their promote suggestions improving the work.	American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Boon N, 2002, ENVIRON SCI TECHNOL, V36, P4698, DOI 10.1021/es020076q; Bouchez T, 2009, BIORESOURCE TECHNOL, V100, P1031, DOI 10.1016/j.biortech.2008.07.028; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; Chen Q, 2015, BIORESOURCE TECHNOL, V183, P25, DOI 10.1016/j.biortech.2015.02.022; Dionisi HM, 2002, APPL ENVIRON MICROB, V68, P245, DOI 10.1128/AEM.68.1.245-253.2002; Ghehi TJ, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/s40201-014-0134-2; Guo Y, 2013, BIOTECHNOL LETT, V35, P2045, DOI 10.1007/s10529-013-1294-3; Gupta AB, 1997, ENZYME MICROB TECH, V21, P589, DOI 10.1016/S0141-0229(97)00070-7; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Lin Y, 2007, BIOMED ENVIRON SCI, V20, P450; Lopez-Gutierrez JC, 2004, J MICROBIOL METH, V57, P399, DOI 10.1016/j.mimet.2004.02.009; Mosier AC, 2010, ENV MICROBIOL REP, V2, P667, DOI 10.1111/j.1758-2229.2010.00156.x; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; Poly F, 2008, FEMS MICROBIOL ECOL, V63, P132, DOI 10.1111/j.1574-6941.2007.00404.x; Scala DJ, 1998, FEMS MICROBIOL LETT, V162, P61, DOI 10.1111/j.1574-6968.1998.tb12979.x; Song ZF, 2011, AQUACULTURE, V319, P188, DOI 10.1016/j.aquaculture.2011.06.018; Stres B, 2004, APPL ENVIRON MICROB, V70, P301, DOI 10.1128/AEM.70.1.301-309.2004; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Wang LA, 2011, APPL BIOCHEM BIOTECH, V163, P362, DOI 10.1007/s12010-010-9044-7; Yang YL, 2014, APPL BIOCHEM BIOTECH, V172, P829, DOI 10.1007/s12010-013-0590-7; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhao B, 2010, BIORESOURCE TECHNOL, V101, P5194, DOI 10.1016/j.biortech.2010.02.043; Zhi W, 2014, WATER RES, V64, P32, DOI 10.1016/j.watres.2014.06.035	24	11	13	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178837	10.1371/journal.pone.0178837	http://dx.doi.org/10.1371/journal.pone.0178837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594856	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200056
J	Yi, J; Lei, YJ; Xu, SY; Si, YY; Li, SY; Xia, ZY; Shi, YS; Gu, XP; Yu, JS; Xu, GH; Gu, EW; Yu, YH; Chen, YQ; Jia, HQ; Wang, YL; Wang, XL; Chai, XQ; Jin, XJ; Chen, JP; Xu, MY; Xiong, JY; Wang, GN; Lu, KZ; Yu, WL; Lei, WF; Qin, ZS; Xiang, JG; Li, LY; Xiang, ZY; Pan, S; Zhan, LJ; Qiu, K; Yao, M; Huang, YG				Yi, Jie; Lei, Yongjing; Xu, Shiyuan; Si, Yongyu; Li, Shiyang; Xia, Zhongyuan; Shi, Yisa; Gu, Xiaoping; Yu, Jianshe; Xu, Guohai; Gu, Erwei; Yu, Yonghao; Chen, Yanqing; Jia, Hequn; Wang, Yinglin; Wang, Xiuli; Chai, Xiaoqing; Jin, Xiaoju; Chen, Junping; Xu, Meiying; Xiong, Junyu; Wang, Guonian; Lu, Kaizhi; Yu, Wenli; Lei, Weifu; Qin, Zaisheng; Xiang, Jingguo; Li, Longyun; Xiang, Ziyong; Pan, Shuang; Zhan, Lujing; Qiu, Kai; Yao, Min; Huang, Yuguang			Intraoperative hypothermia and its clinical outcomes in patients undergoing general anesthesia: National study in China	PLOS ONE			English	Article							WOUND-INFECTION; BLOOD-LOSS; MILD; INCREASES; NORMOTHERMIA; DURATION	Background/Objective Inadvertent intraoperative hypothermia (core temperature <36 degrees C) is a frequently preventable complication with several adverse consequences. Our study aimed to determine the overall incidence of inadvertent intraoperative hypothermia and its risk factors associated with clinical outcomes in this national survey in China. Methods We conducted a national cross-sectional study with 30 days postoperative follow-up from November 2014 through August 2015. A total of 3132 eligible patients underwent general anesthesia were randomly selected from 28 hospitals in the nationwide of China. Results The overall incidence of intraoperative hypothermia was as high as 44.3%, in which cumulative incidence rates of hypothermia being 17.8%, 36.2%, 42.5% and 44.1% within 1 h, 2 h, 3 h and 4 h respectively following induction of anesthesia. All patients were warmed passively by covering of surgical draping, sheets or cotton blankets, whereas only 14.2% of patients received active warming with space heaters or electric heater or electronic blankets. Compared to normothermic patients, patients with hypothermia is associated with more postoperative ICU admit, longer PACU and more postoperative hospital days, but no difference in surgical site infection (SSI) rates or 30-day mortality. Several factors were shown to be associated with decreased risk of hypothermia. They are active warming (OR = 0.46, 95% CI 0.26-0.81), BMI >= 25 (OR = 0.54, 95% CI 0.45-0.65), higher baseline core temperature (OR = 0.04, 95% CI 0.03-0.06), and higher ambient temperature (OR = 0.83, 95% CI 0.78-0.88). Risk factors associated with an increased risk of hypothermia included major-plus surgery (OR = 1.49, 95% CI 1.23-1.79), and long anesthesia (>2 h) (OR = 2.60, 95% CI 2.09-3.24). Conclusions The incidence of intraoperative hypothermia in China is high, and the rate of active warming of patients during operation is low. Hypothermia is associated with more postoperative shivering, increased ICU admissions, and longer postoperative hospital days.	[Yi, Jie; Huang, Yuguang] Chinese Acad Med Sci, Dept Anesthesiol, Beijing, Peoples R China; [Yi, Jie; Huang, Yuguang] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Lei, Yongjing] Second Peoples Hosp Wuhu, Dept Anesthesiol, Wuhu, Anhui, Peoples R China; [Xu, Shiyuan] Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Si, Yongyu] Kunming Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Kunming, Yunnan, Peoples R China; [Li, Shiyang] Quanzhou Womens & Childrens Hosp, Dept Anesthesiol, Fujian, Peoples R China; [Xia, Zhongyuan] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Hubei, Peoples R China; [Shi, Yisa] Lanzhou Univ Second Hosp, Dept Anesthesiol, Lanzhou, Ganshu, Peoples R China; [Gu, Xiaoping] Nanjing Univ, Med Sch, Dept Anesthesiol, Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Yu, Jianshe] Inner Mongolia Med Univ, Affiliated Hosp, Dept Anesthesiol, Hohhot, Inner Mongolia, Peoples R China; [Xu, Guohai] Nanchang Univ, Affiliated Hosp 2, Dept Anesthesiol, Nanchang, Jiangxi, Peoples R China; [Gu, Erwei] Anhui Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Hefei, Anhui, Peoples R China; [Yu, Yonghao] Tianjin Med Univ Gen Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Chen, Yanqing] Fujian Prov Hosp, Dept Anesthesiol, Fuzhou, Fujian, Peoples R China; [Jia, Hequn] Fourth Hosp Hebei Med Univ, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China; [Wang, Yinglin] Haikou Peoples Hosp, Dept Anesthesiol, Haikou, Hainan, Peoples R China; [Wang, Xiuli] Third Hosp Hebei Med Univ, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China; [Chai, Xiaoqing] Anhui Prov Hosp, Dept Anesthesiol, Hefei, Anhui, Peoples R China; [Jin, Xiaoju] Wannan Med Coll, Affiliated Hosp 1, Dept Anesthesiol, Wuhu, Anhui, Peoples R China; [Chen, Junping] Ningbo 2 Hosp, Dept Anesthesiol, Ningbo, Zhejiang, Peoples R China; [Xu, Meiying] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Xiong, Junyu] Second Hosp Dalian Med Univ, Dept Anesthesiol, Dalian, Liaoning, Peoples R China; [Wang, Guonian] Harbin Med Univ, Canc Hosp, Dept Anesthesiol, Harbin, Heilongjiang, Peoples R China; [Lu, Kaizhi] Chongqing Third Mil Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Chongqing, Peoples R China; [Yu, Wenli] Tianjin First Cent Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Lei, Weifu] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan, Shandong, Peoples R China; [Qin, Zaisheng] Nanfang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Xiang, Jingguo] Peoples Hosp Sanya, Dept Anesthesiol, Sanya, Hainan, Peoples R China; [Li, Longyun] Jilin Univ, Sino Japanese Union Hosp, Dept Anesthesiol, Changchun, Jilin, Peoples R China; [Xiang, Ziyong; Pan, Shuang; Zhan, Lujing; Qiu, Kai; Yao, Min] 3M R&D Ctr, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Southern Medical University - China; Kunming Medical University; Wuhan University; Nanjing University; Inner Mongolia Medical University; Nanchang University; Anhui Medical University; Tianjin Medical University; Fujian Provincial Hospital; Hebei Medical University; Wannan Medical College; Shanghai Jiao Tong University; Dalian Medical University; Harbin Medical University; Tianjin Medical University; Shandong University; Southern Medical University - China; Jilin University	Huang, YG (corresponding author), Chinese Acad Med Sci, Dept Anesthesiol, Beijing, Peoples R China.; Huang, YG (corresponding author), Peking Union Med Coll Hosp, Beijing, Peoples R China.	huangyg@pumch.cn		xia, zhongyuan/0000-0002-5807-9554	China National Health and Planned Parenthood Committee Health Quality Improvement Award [201402017]; China National Nature Science Foundation [31070930]; unrestricted research grant from 3M China [MDI0091]	China National Health and Planned Parenthood Committee Health Quality Improvement Award; China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); unrestricted research grant from 3M China	This study was funded by three separate grants: China National Health and Planned Parenthood Committee Health Quality Improvement Award (ID# 201402017, principle investigator Yuguang Huang, MD), China National Nature Science Foundation (Grant # 31070930, principle investigator Yuguang Huang, MD), and an unrestricted research grant (MDI0091, principal investigator Yuguang Huang, MD) from 3M China. However, none of these grants provided salary support to any of the investigators. These grants were for IRB review, investigator meeting and CRO (study monitoring, data management, statistical analysis and report etc.), travel, national or international conference and publication.	Aasen Ansgar O, 2002, Surg Infect (Larchmt), V3 Suppl 1, pS1, DOI 10.1089/sur.2002.3.s1-1; Aasen Ansgar O, 2002, Surg Infect (Larchmt), V3 Suppl 1, pS99, DOI 10.1089/sur.2002.3.s1-99; Barie Philip S, 2002, Surg Infect (Larchmt), V3 Suppl 1, pS9, DOI 10.1089/sur.2002.3.s1-9; Bock M, 1998, BRIT J ANAESTH, V80, P159, DOI 10.1093/bja/80.2.159; Burger Leona, 2009, Br J Nurs, V18, P1116; Burns SM, 2010, J PERIANESTH NURS, V25, P286, DOI 10.1016/j.jopan.2010.07.001; Forbes SS, 2009, J AM COLL SURGEONS, V209, P492, DOI 10.1016/j.jamcollsurg.2009.07.002; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; FRANK SM, 1993, ANESTHESIOLOGY, V78, P468, DOI 10.1097/00000542-199303000-00010; Hedrick TL, 2007, J AM COLL SURGEONS, V205, P432, DOI 10.1016/j.jamcollsurg.2007.04.042; HEIER T, 1991, ANESTHESIOLOGY, V74, P815, DOI 10.1097/00000542-199105000-00003; Jeran L, 2001, J Perianesth Nurs, V16, P303, DOI 10.1053/jpan.2001.28452; Kongsayreepong S, 2003, ANESTH ANALG, V96, P826, DOI 10.1213/01.ANE.0000048822.27698.28; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Lenhardt R, 1997, ANESTHESIOLOGY, V87, P1318, DOI 10.1097/00000542-199712000-00009; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; Long KC, 2013, GYNECOL ONCOL, V131, P525, DOI 10.1016/j.ygyno.2013.08.034; Mahoney C B, 1999, AANA J, V67, P155; NICE, 2003, PREOP TESTS US PREOP; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Scott AV, 2015, ANESTHESIOLOGY, V123, P116, DOI 10.1097/ALN.0000000000000681; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; SLOTMAN GJ, 1985, AM J SURG, V149, P495, DOI 10.1016/S0002-9610(85)80046-5; Tappen R M, 1996, AORN J, V63, P639, DOI 10.1016/S0001-2092(06)63411-X; Wong PF, 2007, BRIT J SURG, V94, P421, DOI 10.1002/bjs.5631; Yi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136136	27	54	73	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177221	10.1371/journal.pone.0177221	http://dx.doi.org/10.1371/journal.pone.0177221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594825	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200009
J	Rivers, AM				Rivers, Andrew M.			The Weapons Identification Task: Recommendations for adequately powered research	PLOS ONE			English	Article							STATISTICAL POWER; COGNITIVE CONTROL; NEURAL SIGNALS; RACIAL BIAS; 1/F NOISE; RACE; PREJUDICE; STEREOTYPES; RESPONSES; EXPRESSION	This article synthesizes the extant literature on the Weapons Identification Task (WIT), a sequential priming paradigm developed to investigate the impact of racial priming on identification of stereotype-congruent and stereotype-irrelevant objects. Given recent controversy over the replicability of and statistical power required to detect priming effects, the aim of this synthesis is to systematically assess the literature in order to develop recommendations for statistical power in future research with the WIT paradigm. To develop these recommendations, the present article first quantitatively ascertains the magnitude of publication bias in the extant literature. Next, expected effect sizes and power recommendations are generated from the extant literature. Finally, a close conceptual replication of the WIT paradigm is conducted to prospectively test these recommendations. Racial priming effects are detected in this prospective test providing increased confidence in the WIT priming effect and credibility to the proposed recommendations for power.	[Rivers, Andrew M.] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Rivers, AM (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	amrivers@ucdavis.edu		Rivers, Andrew/0000-0002-6811-6275				Amodio DM, 2008, J PERS SOC PSYCHOL, V94, P60, DOI 10.1037/0022-3514.94.1.60; Amodio DM, 2006, SOC COGN AFFECT NEUR, V1, P26, DOI 10.1093/scan/nsl002; Amodio DM, 2009, J EXP SOC PSYCHOL, V45, P60, DOI 10.1016/j.jesp.2008.08.009; Amodio DM, 2004, PSYCHOL SCI, V15, P88, DOI 10.1111/j.0963-7214.2004.01502003.x; Amon MJ, 2008, ANN M COGN SCI SOC; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bartholow BD, 2012, J ABNORM PSYCHOL, V121, P173, DOI 10.1037/a0023664; Bradley KI, 2012, INT J INTERCULT REL, V36, P403, DOI 10.1016/j.ijintrel.2011.09.006; Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314; Correll J, 2008, J PERS SOC PSYCHOL, V94, P48, DOI 10.1037/0022-3514.94.1.48; Crandall CS, 2016, J EXP SOC PSYCHOL, V66, P93, DOI 10.1016/j.jesp.2015.10.002; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fazio R. H., 1990, REV PERSONALITY SOCI, V11, P74, DOI DOI 10.1037/031329; Fleming KK, 2010, SOC NEUROSCI-UK, V5, P201, DOI 10.1080/17470910903268931; Fraley RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109019; Gelman A., 2013, GARDEN FORKING PATHS; Gonzales J. E., 2015, PSYCHOL SCI AGENDA, V29; Govorun O, 2006, SOC COGNITION, V24, P111, DOI 10.1521/soco.2006.24.2.111; Huesmann LR, 2012, J RES ADOLESCENCE, V22, P556, DOI 10.1111/j.1532-7795.2012.00785.x; Huntsinger JR, 2009, J EXP SOC PSYCHOL, V45, P560, DOI 10.1016/j.jesp.2009.01.007; Ito TA, 2015, J PERS SOC PSYCHOL, V108, P187, DOI 10.1037/a0038557; Jones CR, 2010, PERS SOC PSYCHOL B, V36, P1073, DOI 10.1177/0146167210375817; Judd CM, 2004, J EXP SOC PSYCHOL, V40, P75, DOI 10.1016/S0022-1031(03)00063-5; Kenny DA, STAT SOCIAL BEHAV SC, P73; Klauer KC, 2008, PERS SOC PSYCHOL B, V34, P1124, DOI 10.1177/0146167208318603; Klauer KC, 2015, J EXP PSYCHOL GEN, V144, P198, DOI 10.1037/xge0000044; Kleiman T, 2014, J EXP PSYCHOL GEN, V143, P498, DOI 10.1037/a0033047; Krieglmeyer R, 2012, J PERS SOC PSYCHOL, V103, P205, DOI 10.1037/a0028764; Kubota JT, 2014, EMOTION, V14, P1115, DOI 10.1037/a0038214; Lakens D, 2014, PERSPECT PSYCHOL SCI, V9, P278, DOI 10.1177/1745691614528520; Lambert AJ, 2005, J EXP SOC PSYCHOL, V41, P114, DOI 10.1016/j.jesp.2004.06.006; Lambert AJ, 2003, J PERS SOC PSYCHOL, V84, P277, DOI 10.1037/0022-3514.84.2.277; Madurski C, 2015, PSYCHON B REV, V22, P1135, DOI 10.3758/s13423-014-0757-4; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; Payne BK, 2006, CURR DIR PSYCHOL SCI, V15, P287, DOI 10.1111/j.1467-8721.2006.00454.x; Payne BK, 2005, J EXP SOC PSYCHOL, V41, P36, DOI 10.1016/j.jesp.2004.05.001; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Payne BK, 2002, J EXP SOC PSYCHOL, V38, P384, DOI 10.1016/S0022-1031(02)00006-9; Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037/0022-3514.81.2.181; Phills CE, 2011, J PERS SOC PSYCHOL, V100, P197, DOI 10.1037/a0022159; Plant EA, 2005, PSYCHOL SCI, V16, P180, DOI 10.1111/j.0956-7976.2005.00800.x; Sawaoka Camp, 2015, DIRECT REPLICATION P; Schlauch RC, 2009, J STUD ALCOHOL DRUGS, V70, P328, DOI 10.15288/jsad.2009.70.328; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2015, PSYCHOL SCI, V26, P559, DOI 10.1177/0956797614567341; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Stepanova EV, 2012, J EXP SOC PSYCHOL, V48, P905, DOI 10.1016/j.jesp.2012.02.006; Stewart BD, 2008, PERS SOC PSYCHOL B, V34, P1332, DOI 10.1177/0146167208321269; Todd AR, 2016, PSYCHOL SCI, V27, P384, DOI 10.1177/0956797615624492; Todd AR, 2016, SOC COG, V34, P88; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177857	10.1371/journal.pone.0177857	http://dx.doi.org/10.1371/journal.pone.0177857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591143	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700014
J	Stafford, JL; Dyson, G; Levin, NK; Chaudhry, S; Rosati, R; Kalpage, H; Wernette, C; Petrucelli, N; Simon, MS; Tainsky, MA				Stafford, Jaime L.; Dyson, Gregory; Levin, Nancy K.; Chaudhry, Sophia; Rosati, Rita; Kalpage, Hasini; Wernette, Courtney; Petrucelli, Nancie; Simon, Michael S.; Tainsky, Michael A.			Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability	PLOS ONE			English	Article							FANCONI-ANEMIA; HOMOLOGOUS RECOMBINATION; SUSCEPTIBILITY LOCI; FALLOPIAN-TUBE; BREAST; MUTATIONS; VARIANTS; REPLICATION; GENES; RAD52	While up to 25% of ovarian cancer (OVCA) cases are thought to be due to inherited factors, the majority of genetic risk remains unexplained. To address this gap, we sought to identify previously undescribed OVCA risk variants through the whole exome sequencing (WES) and candidate gene analysis of 48 women with ovarian cancer and selected for high risk of genetic inheritance, yet negative for any known pathogenic variants in either BRCA1 or BRCA2. In silico SNP analysis was employed to identify suspect variants followed by validation using Sanger DNA sequencing. We identified five pathogenic variants in our sample, four of which are in two genes featured on current multi-gene panels; (RAD51D, ATM). In addition, we found a pathogenic FANCM variant (R1931*) which has been recently implicated in familial breast cancer risk. Numerous rare and predicted to be damaging variants of unknown significance were detected in genes on current commercial testing panels, most prominently in ATM (n = 6) and PALB2 (n = 5). The BRCA2 variant p. K3326*, resulting in a 93 amino acid truncation, was overrepresented in our sample (odds ratio = 4.95, p = 0.01) and coexisted in the germline of these women with other deleterious variants, suggesting a possible role as a modifier of genetic penetrance. Furthermore, we detected loss of function variants in non-panel genes involved in OVCA relevant pathways; DNA repair and cell cycle control, including CHEK1, TP53I3, REC8, HMMR, RAD52, RAD1, POLK, POLQ, and MCM4. In summary, our study implicates novel risk loci as well as highlights the clinical utility for retesting BRCA1/2 negative OVCA patients by genomic sequencing and analysis of genes in relevant pathways.	[Stafford, Jaime L.; Chaudhry, Sophia; Kalpage, Hasini; Wernette, Courtney; Tainsky, Michael A.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Dyson, Gregory; Levin, Nancy K.; Rosati, Rita; Petrucelli, Nancie; Simon, Michael S.; Tainsky, Michael A.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Tainsky, Michael A.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Tainsky, MA (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA.; Tainsky, MA (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.; Tainsky, MA (corresponding author), Wayne State Univ, Sch Med, Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI 48202 USA.	AF7502@wayne.edu	Kalpage, Hasini/AAG-1538-2019	Dresden, Courtney/0000-0002-8815-7226; Lopes, Jaime/0000-0002-9795-1093; Tainsky, Michael/0000-0002-0261-831X	Barbara and Fred Erb Endowed Chair in Cancer Genetics; Applied Genomics Technology Center at Wayne State University; Karmanos Cancer Institute [P30CA022453]; Interdisciplinary Biomedical Fellowship at Wayne State University	Barbara and Fred Erb Endowed Chair in Cancer Genetics; Applied Genomics Technology Center at Wayne State University; Karmanos Cancer Institute; Interdisciplinary Biomedical Fellowship at Wayne State University	This work was supported by Barbara and Fred Erb Endowed Chair in Cancer Genetics (MAT), the Karmanos Cancer Institute, Program in Molecular Therapeutic and the Applied Genomics Technology Center at Wayne State University and the Karmanos Cancer Institute, grant P30CA022453 (Whole Exome Sequencing of cohort) as well as the Interdisciplinary Biomedical Fellowship at Wayne State University (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2008, ONCOGENE, V27, P1290, DOI 10.1038/sj.onc.1210739; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bansidhar Brian J, 2012, Clin Colon Rectal Surg, V25, P103, DOI 10.1055/s-0032-1313781; Bogliolo M, 2015, CURR OPIN GENET DEV, V33, P32, DOI 10.1016/j.gde.2015.07.002; Broeks A, 2000, AM J HUM GENET, V66, P494, DOI 10.1086/302746; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Domchek S, 2008, J CLIN ONCOL, V26, P16, DOI 10.1200/JCO.2007.14.4154; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Fletcher O, 2010, CANCER EPIDEM BIOMAR, V19, P2143, DOI 10.1158/1055-9965.EPI-10-0374; Frank, 1999, Cancer Control, V6, P327; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Han JL, 2002, CANCER EPIDEM BIOMAR, V11, P1138; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Janatova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127711; Jensen RB, 2013, DNA REPAIR, V12, P306, DOI 10.1016/j.dnarep.2012.12.007; Johnson N, 2007, HUM MOL GENET, V16, P1051, DOI 10.1093/hmg/ddm050; Kelemen L, 2005, CANCER LETT, V218, P191, DOI 10.1016/j.canlet.2004.09.023; Kim TM, 2014, MUTAT RES-FUND MOL M, V766, P66, DOI 10.1016/j.mrfmmm.2014.06.003; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Kumar Pankaj, 2014, BMC Res Notes, V7, P747, DOI 10.1186/1756-0500-7-747; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrenson K, 2015, CARCINOGENESIS, V36, P1341, DOI 10.1093/carcin/bgv138; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu QH, 2000, GENE DEV, V14, P1448; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Martin ST, 2005, ONCOGENE, V24, P3652, DOI 10.1038/sj.onc.1208411; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Morak M, 2014, EUR J HUM GENET, V22, P1334, DOI 10.1038/ejhg.2014.15; Morimatsu M, 1998, CANCER RES, V58, P3441; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Norquist BM, 2016, JAMA ONCOL, V2, P482, DOI 10.1001/jamaoncol.2015.5495; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Peterlongo P, 2015, HUM MOL GENET; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Plevova P, 2009, Klin Onkol, V22 Suppl, pS8; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rahman N, 2010, CANCER, V39, P165; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sheu YJ, 2014, P NATL ACAD SCI USA, V111, pE1899, DOI 10.1073/pnas.1404063111; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; South CD, 2008, J NATL CANCER I, V100, P277, DOI 10.1093/jnci/djm291; Stancel JNK, 2009, DNA REPAIR, V8, P1355, DOI 10.1016/j.dnarep.2009.09.003; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Strafford J Craig, 2012, Rev Obstet Gynecol, V5, P42; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Thompson ER, 2015, SCI REP-UK, V5, DOI 10.1038/srep14800; Thompson ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054772; Thorstenson YR, 2003, CONTRIBUTIONS ATM MU, V1, P3325; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang Y, 2015, EUROPE PMC FUNDERS G, V46, P736; Wu KJ, 2005, CANCER RES, V65, P417; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Zhang W., 2015, ONCOTARGET, V6, P1, DOI 10.1109/TAC.2015.2498701	63	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178450	10.1371/journal.pone.0178450	http://dx.doi.org/10.1371/journal.pone.0178450			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591191	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700034
J	Sundby, OH; Hoiseth, LO; Mathiesen, I; Weedon-Fekjaer, H; Sundhagen, JO; Hisdal, J				Sundby, Oyvind Heiberg; Hoiseth, Lars Oivind; Mathiesen, Iacob; Weedon-Fekjaer, Harald; Sundhagen, Jon O.; Hisdal, Jonny			The acute effects of lower limb intermittent negative pressure on foot macro- and microcirculation in patients with peripheral arterial disease	PLOS ONE			English	Article							BLOOD-FLOW; WOUND THERAPY; NITRIC-OXIDE; CONSERVATIVE TREATMENT; ENDOTHELIAL-CELLS; SUCTION; RELEASE; INTERVENTION; TEMPERATURE; STATEMENT	Background Intermittent negative pressure (INP) applied to the lower leg and foot increases foot perfusion in healthy volunteers. The aim of the present study was to describe the effects of INP to the lower leg and foot on foot macro-and microcirculation in patients with lower extremity peripheral arterial disease (PAD). Methods In this experimental study, we analyzed foot circulation during INP in 20 patients [median (range): 75 (63-84yrs)] with PAD. One leg was placed inside an air-tight vacuum chamber connected to an INP-generator. During application of INP (alternating 10s of -40mmHg/7s of atmospheric pressure), we continuously recorded blood flow velocity in a distal foot artery (ultrasound Doppler), skin blood flow on the pulp of the first toes (laser Doppler), heart rate (ECG), and systemic blood pressure (Finometer). After a 5-min baseline sequence (no pressure), a 10-min INP sequence was applied, followed by 5-min post-INP (no pressure). To compare and quantify blood flow fluctuations between sequences, we calculated cumulative up-and-down fluctuations in arterial blood flow velocity per minute. Results Onset of INP induced an increase in arterial flow velocity and skin blood flow. Peak blood flow velocity was reached 3s after the onset of negative pressure, and increased 46% [(95% CI 36-57), P<0.001] above baseline. Peak skin blood flow was reached 2s after the onset of negative pressure, and increased 89% (95% CI 48-130), P<0.001) above baseline. Cumulative fluctuations per minute were significantly higher during INP-sequences compared to baseline [21 (95% CI 12-30) cm/s/min to 41 (95% CI 32-51) cm/s/min, P<0.001]. Mean INP blood flow velocity increased significantly similar to 12% above mean baseline blood flow velocity [(6.7 (95% CI 5.2-8.3) cm/s to 7.5 (95% CI 5.9-9.1) cm/s, P = 0.03)]. Conclusion INP increases foot macro- and microcirculatory flow pulsatility in patients with PAD. Additionally, application of INP resulted in increased mean arterial blood flow velocity.	[Sundby, Oyvind Heiberg; Hoiseth, Lars Oivind; Hisdal, Jonny] Oslo Univ Hosp, Dept Vasc Surg, Sect Vasc Invest, Oslo, Norway; [Sundby, Oyvind Heiberg] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Sundby, Oyvind Heiberg; Mathiesen, Iacob] Otivio AS, Oslo, Norway; [Hoiseth, Lars Oivind] Oslo Univ Hosp, Dept Anesthesiol, Oslo, Norway; [Weedon-Fekjaer, Harald] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Sundhagen, Jon O.] Oslo Univ Hosp, Dept Vasc Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Hisdal, J (corresponding author), Oslo Univ Hosp, Dept Vasc Surg, Sect Vasc Invest, Oslo, Norway.	jonny.hisdal@medisin.uio.no	Hisdal, Jonny/B-4112-2014	Mathiesen, Iacob/0000-0003-0397-0742	Research Council of Norway (NFR) [241589]	Research Council of Norway (NFR)(Research Council of Norway)	The Research Council of Norway has provided funding to Otivio (NFR grant no: 241589 for this study as part of an industrial PhD project to OHS). The Research Council of Norway's website: http://www.forskningsradet.no/en/Funding/ NAERINGSPHD/1235469221560. Other than providing support in the form of salaries for the authors IM & OHS, the funder (Otivio AS) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. OHS is a PhD student at the University of Oslo, Faculty of Clinical Medicine, employed by Otivio. The specific roles of IM & OHS are articulated in the 'author contributions' section.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Borgquist O, 2010, PLAST RECONSTR SURG, V125, P502, DOI 10.1097/PRS.0b013e3181c82e1f; Chaar CIO, 2012, J VASC SURG, V56, P703, DOI 10.1016/j.jvs.2012.01.073; COOKE JP, 1990, AM J PHYSIOL, V259, pH804, DOI 10.1152/ajpheart.1990.259.3.H804; de Takats G, 1934, J AMER MED ASSOC, V103, P1920, DOI 10.1001/jama.1934.02750510022006; ERIKSEN M, 1992, MED BIOL ENG COMPUT, V30, P46, DOI 10.1007/BF02446192; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402; GILL BS, 1974, BRIT J SURG, V61, P319; Gimbrone MA, 2013, CARDIOVASC PATHOL, V22, P9, DOI 10.1016/j.carpath.2012.06.006; Gray BH, 2014, CATHETER CARDIO INTE, V84, P539, DOI 10.1002/ccd.25395; Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547; HENRIKSEN O, 1976, ACTA PHYSIOL SCAND, V97, P447, DOI 10.1111/j.1748-1716.1976.tb10284.x; Herrmann LG, 1934, ANN SURG, V100, P750, DOI 10.1097/00000658-193410000-00016; HIMMELSTRUP H, 1991, CLIN PHYSIOL, V11, P263, DOI 10.1111/j.1475-097X.1991.tb00457.x; Hori N, 1998, HEPATOLOGY, V28, P1467, DOI 10.1002/hep.510280604; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kairinos N, 2009, PLAST RECONSTR SURG, V123, P601, DOI 10.1097/PRS.0b013e318196b97b; Kasapis C, 2009, CURR CARDIOL REV, V5, P296, DOI 10.2174/157340309789317823; Landis EM, 1933, J CLIN INVEST, V12, P925, DOI 10.1172/JCI100550; MEHLSEN J, 1993, ANGIOLOGY, V44, P16, DOI 10.1177/000331979304400103; Meyer W, 1909, BIERS HYPEREMIC TREA; Murray James, 1835, LANCET, V23, P909; Nakano T, 2000, AM J PHYSIOL-HEART C, V278, pH1098, DOI 10.1152/ajpheart.2000.278.4.H1098; NILSSON AL, 1987, J INVEST DERMATOL, V88, P586, DOI 10.1111/1523-1747.ep12470202; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; NORIS M, 1995, CIRC RES, V76, P536, DOI 10.1161/01.RES.76.4.536; Pinheiro J, R PACKAGE VERSION; Reid MR, 1933, J MED, V14, P200; RUBANYI GM, 1986, AM J PHYSIOL, V250, P1145, DOI 10.1152/ajpheart.1986.250.6.H1145; Sarnik Stanislav, 2007, Biomedical Papers (Olomouc), V151, P143; Shon YS, 2014, ARCH PLAST SURG-APS, V41, P668, DOI 10.5999/aps.2014.41.6.668; Sinkowitz SJ, 1917, J AMER MED ASSOC, V68, P961; SKAGEN K, 1983, ACTA PHYSIOL SCAND, V117, P411, DOI 10.1111/j.1748-1716.1983.tb00014.x; SMYTH CN, 1969, LANCET, V2, P657; Sundby OH, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12911; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; THORESEN M, 1980, ACTA PHYSIOL SCAND, V109, P333, DOI 10.1111/j.1748-1716.1980.tb06604.x; Vartanian SM, 2015, CIRC RES, V116, P1614, DOI 10.1161/CIRCRESAHA.116.303504; Vemulapalli S, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0611-y; Vikatmaa P, 2008, EUR J VASC ENDOVASC, V36, P438, DOI 10.1016/j.ejvs.2008.06.010; Wilson H, 1936, J AMER MED ASSOC, V106, P1885, DOI 10.1001/jama.1936.02770220021006; YAO ST, 1969, LANCET, V2, P902	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179001	10.1371/journal.pone.0179001	http://dx.doi.org/10.1371/journal.pone.0179001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591174	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700069
J	Clemente, AM; Castronovo, G; Antonelli, A; D'Andrea, MM; Tanturli, M; Perissi, E; Paccosi, S; Parenti, A; Cozzolino, F; Rossolini, GM; Torcia, MG				Clemente, Ann Maria; Castronovo, Giuseppe; Antonelli, Alberto; D'Andrea, Marco Maria; Tanturli, Michele; Perissi, Eloisa; Paccosi, Sara; Parenti, Astrid; Cozzolino, Federico; Rossolini, Gian Maria; Torcia, Maria Gabriella			Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; TGF-BETA; T-CELLS; VIRULENCE; ENTEROBACTERIACEAE; INTERLEUKIN-17; EPIDEMIOLOGY; INFECTIONS; EXPANSION; IMMUNE	The spread of KPC-type carbapenemases is mainly attributed to the global dissemination of Klebsiella pneumoniae (KP) strains belonging to the clonal group (CG) 258, including sequence type (ST) 258 and other related STs. Two distinct clades of CG258-KP have evolved, which differ mainly for the composition of their capsular polysaccharides, and recent studies indicate that clade 1 evolved from an ancestor of clade 2 by recombination of a genomic fragment carrying the capsular polysaccharide (cps) locus. In this paper, we investigated the ability of two ST258-KP strains, KKBO-1 and KK207-1, selected as representatives of ST258-KP clade 2 and clade 1, respectively, to activate an adaptive immune response using ex vivo-stimulation of PBMC from normal donors as an experimental model. Our data showed that KKBO-1 (clade 2) induces a Th17 response more efficiently than KK207-1 (clade 1): the percentage of CD4(+)IL17(+) cells and the production of IL-17A were significantly higher in cultures with KKBO-1 compared to cultures with KK207-1. While no differences in the rate of bacterial internalization or in the bacteria-induced expression of CD86 and HLA-DR by monocytes and myeloid dendritic cells were revealed, we found that the two strains significantly differ in inducing the production of cytokines involved in the adaptive immune response, as IL-1 beta, IL-23 and TNF-alpha, by antigen-presenting cells, with KKBO-1 being a more efficient inducer than KK207-1. The immune responses elicited by KK207-1 were comparable to those elicited by CIP 52.145, a highly virulent K. pneumoniae reference strain known to escape immune-inflammatory responses. Altogether, present results suggest that CG258-KP of the two clades are capable of inducing a different response of adaptive immunity in the human host.	[Clemente, Ann Maria; Castronovo, Giuseppe; Antonelli, Alberto; D'Andrea, Marco Maria; Perissi, Eloisa; Rossolini, Gian Maria; Torcia, Maria Gabriella] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [D'Andrea, Marco Maria] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Tanturli, Michele; Cozzolino, Federico] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Paccosi, Sara; Parenti, Astrid] Univ Florence, Dept Hlth Sci, Florence, Italy; [Rossolini, Gian Maria] Careggi Univ Hosp, Clin Microbiol & Virol Unit, Florence, Italy	University of Florence; University of Siena; University of Florence; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Torcia, MG (corresponding author), Univ Florence, Dept Expt & Clin Med, Florence, Italy.	torcia@unifi.it	Antonelli, Alberto/V-8418-2017; Torcia, Maria Gabriella G/K-1840-2018; D'Andrea, Marco Maria/H-6351-2019	Antonelli, Alberto/0000-0003-0295-6877; Torcia, Maria Gabriella G/0000-0003-4740-4646; D'Andrea, Marco Maria/0000-0003-3187-3210; Tanturli, Michele/0000-0002-2642-1706; Clemente, Ann Maria/0000-0003-0386-590X; CASTRONOVO, GIUSEPPE/0000-0003-2237-6765	European Commission [EvoTar-FP7-HEALTH-F3-2011-2011-282004]; Fondazione Ente Cassa di Risparmio di Firenze [2014.0740]; European Community projects EVOTAR [HEALTH-F3-2011-282004]; Italian Ministry of Education	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondazione Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); European Community projects EVOTAR; Italian Ministry of Education	This work was supported by grants from Italian Ministry of Education, from the European Commission [grant EvoTar-FP7-HEALTH-F3-2011-2011-282004] and from Fondazione Ente Cassa di Risparmio di Firenze [grant number 2014.0740]. Marco Maria D'Andrea was supported by a grant from European Community projects EVOTAR HEALTH-F3-2011-282004. Giuseppe Castronovo was supported by Fondazione Ente Cassa di Risparmio di Firenze [grant number 2014.0740]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2017, J INNATE IMMUN; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922; Cannatelli A, 2013, ANTIMICROB AGENTS CH, V57, P5521, DOI 10.1128/AAC.01480-13; Castronovo G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170125; Chen K, 2011, IMMUNITY, V35, P997, DOI 10.1016/j.immuni.2011.10.018; Chen L, 2014, MBIO, V5, DOI 10.1128/mBio.01355-14; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Clemente AM, 2013, INFECT IMMUN, V81, P1842, DOI 10.1128/IAI.01226-12; Clemente A, 2011, CELL MICROBIOL, V13, P1328, DOI 10.1111/j.1462-5822.2011.01622.x; Conte V, 2016, J ANTIMICROB CHEMOTH, V71, P3386, DOI 10.1093/jac/dkw337; Corpuz TM, 2016, J IMMUNOL, V196, P645, DOI 10.4049/jimmunol.1502082; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; D'Andrea MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096827; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Dembic Z., 2015, CYTOKINES IMMUNE SYS; Diago-Navarro E, 2014, J INFECT DIS, V210, P803, DOI 10.1093/infdis/jiu157; Franco-Colon M, 2013, BLOOD, P122; Frank CG, 2013, CELL MICROBIOL, V15, P1212, DOI 10.1111/cmi.12110; Geginat J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00527; Gitter AH, 2009, ANN NY ACAD SCI, V915, P193; Isailovic N, 2015, J AUTOIMMUN, V60, P1, DOI 10.1016/j.jaut.2015.04.006; Kobayashi SD, 2016, J INFECT DIS; Lee GC, 2012, ANN CLIN MICROB ANTI, P11; Lin YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054466, 10.1371/journal.pone.0069722]; Llobet E, 2015, P NATL ACAD SCI USA, V112, pE6369, DOI 10.1073/pnas.1508820112; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Parker D, 2016, PHYSIOL REV, V96, P19, DOI 10.1152/physrev.00009.2015; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Rathore JS, 2016, VACCINE, V34, P1504, DOI 10.1016/j.vaccine.2016.02.021; Snitkin E.S., 2012, SCI TRANSL MED, V4, DOI [10.1126/scitranslinect3004129148ra116-148ra116, DOI 10.1126/SCITRANSLMED.3004129148RA116]; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178847	10.1371/journal.pone.0178847	http://dx.doi.org/10.1371/journal.pone.0178847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586386	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700031
J	Lu, M; Ueno, S				Lu, Mai; Ueno, Shoogo			Comparison of the induced fields using different coil configurations during deep transcranial magnetic stimulation	PLOS ONE			English	Article							DOUBLE-CONE COIL; DIELECTRIC-PROPERTIES; PARKINSONS-DISEASE; BIOLOGICAL TISSUES; ELECTRIC-FIELD; HUMAN HEAD; H-COIL; ADD-ON; BRAIN; DEPRESSION	Stimulation of deeper brain structures by transcranial magnetic stimulation (TMS) plays a role in the study of reward and motivation mechanisms, which may be beneficial in the treatment of several neurological and psychiatric disorders. However, electric field distributions induced in the brain by deep transcranial magnetic stimulation (dTMS) are still unknown. In this paper, the double cone coil, H-coil and Halo-circular assembly (HCA) coil which have been proposed for dTMS have been numerically designed. The distributions of magnetic flux density, induced electric field in an anatomically based realistic head model by applying the dTMS coils were numerically calculated by the impedance method. Results were compared with that of standard figure-of-eight (Fo8) coil. Simulation results show that double cone, H-and HCA coils have significantly deep field penetration compared to the conventional Fo8 coil, at the expense of induced higher and wider spread electrical fields in superficial cortical regions. Double cone and HCA coils have better ability to stimulate deep brain subregions compared to that of the H-coil. In the mean time, both double cone and HCA coils increase risk for optical nerve excitation. Our results suggest although the dTMS coils offer new tool with potential for both research and clinical applications for psychiatric and neurological disorders associated with dysfunctions of deep brain regions, the selection of the most suitable coil settings for a specific clinical application should be based on a balanced evaluation between stimulation depth and focality.	[Lu, Mai] Lanzhou Jiaotong Univ, Minist Educ, Key Lab Optelect Technol & Intelligent Control, Lanzhou 730070, Gansu, Peoples R China; [Ueno, Shoogo] Kyushu Univ, Dept Appl Quantum Phys, Grad Sch Engn, Fukuoka 8128581, Japan	Lanzhou Jiaotong University; Kyushu University	Lu, M (corresponding author), Lanzhou Jiaotong Univ, Minist Educ, Key Lab Optelect Technol & Intelligent Control, Lanzhou 730070, Gansu, Peoples R China.	mai.lu@hotmail.com			National Nature Science Foundation of China [51267010, 51567015]; Gansu Science Fund for Distinguished Young Scholars [1308RJDA013]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Science Fund for Distinguished Young Scholars	This work is supported in part by the National Nature Science Foundation of China (No. 51267010, 51567015), and in part by the Gansu Science Fund for Distinguished Young Scholars (No. 1308RJDA013). There was no additional external funding received for this study.; This work is supported in part by the National Nature Science Foundation of China (No. 51267010, 51567015), and in part by the Gansu Science Fund for Distinguished Young Scholars (No. 1308RJDA013). There was no additional external funding received for this study.	BARKER AT, 1985, LANCET, V1, P1106; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Crowther LJ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3676623; Crowther LJ, 2011, J APPL PHYS, V109, DOI 10.1063/1.3563076; De Geeter N, 2011, IEEE T BIO-MED ENG, V58, P310, DOI 10.1109/TBME.2010.2087758; Deng ZD, 2014, CLIN NEUROPHYSIOL, V125, P1202, DOI 10.1016/j.clinph.2013.11.038; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gabriel C, 1996, PHYS MED BIOL, V41, P2231, DOI 10.1088/0031-9155/41/11/001; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Gabriel S, 1996, PHYS MED BIOL, V41, P2271, DOI 10.1088/0031-9155/41/11/003; George MS, 2007, TRANSCRANIAL MAGNETI; Harel EV, 2011, WORLD J BIOL PSYCHIA, V12, P119, DOI 10.3109/15622975.2010.510893; Holtzheimer PE., 2014, CLIN GUIDE TRANSCRAN; Huang YZ, 2009, BRAIN STIMUL, V2, P2, DOI 10.1016/j.brs.2008.09.007; Kakuda W, 2013, ACTA NEUROL SCAND, V128, P100, DOI 10.1111/ane.12085; Kreuzer PM, 2015, BRAIN STIMUL, V8, P240, DOI 10.1016/j.brs.2014.11.014; Li XB, 2013, BIOL PSYCHIAT, V73, P714, DOI 10.1016/j.biopsych.2013.01.003; Lontis ER, 2006, J CLIN NEUROPHYSIOL, V23, P462; Lu M, 2014, IFMBE P, V41, P1663; Lu M, 2015, IEEE T BIO-MED ENG, V62, P2911, DOI 10.1109/TBME.2015.2452261; Lu M, 2011, IEEE T MAGN, V47, P3841, DOI 10.1109/TMAG.2011.2157086; Lu M, 2009, IEEE T MAGN, V45, P1662, DOI 10.1109/TMAG.2009.2012770; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McNamara B, 2001, PSYCHOL MED, V31, P1141, DOI 10.1017/S0033291701004378; Meng Y, 2015, J APPL PHYS, V117, DOI 10.1063/1.4913937; Nadeem M, 2003, IEEE T BIO-MED ENG, V50, P900, DOI 10.1109/TBME.2003.813548; Nemeroff Charles B, 2002, Psychopharmacol Bull, V36 Suppl 2, P6; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; ORCUTT N, 1988, IEEE T BIO-MED ENG, V35, P577, DOI 10.1109/10.4590; Politi E, 2008, AM J ADDICTION, V17, P345, DOI 10.1080/10550490802139283; Prikryl R, 2013, SCHIZOPHR RES, V149, P167, DOI 10.1016/j.schres.2013.06.015; Roth Y, 2002, J CLIN NEUROPHYSIOL, V19, P361, DOI 10.1097/00004691-200208000-00008; Shen Y, 2017, BIOL PSYCHIAT, V81, pE49, DOI 10.1016/j.biopsych.2016.06.013; Shen Y, 2016, BIOL PSYCHIAT, V80, pE13, DOI 10.1016/j.biopsych.2016.02.006; Spagnolo F, 2014, BRAIN STIMUL, V7, P297, DOI 10.1016/j.brs.2013.10.007; Trebbastoni A, 2013, BRAIN STIMUL, V6, P545, DOI 10.1016/j.brs.2012.09.014; UENO S, 1988, J APPL PHYS, V64, P5862, DOI 10.1063/1.342181; Vanneste S, 2014, NEUROCASE, V20, P61, DOI 10.1080/13554794.2012.732086; Walsh V, 2003, BRADFORD BOOKS, P1; Yoth Y, 2007, J CLIN NEUROPHYSIOL, V24, P31	44	64	67	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178422	10.1371/journal.pone.0178422	http://dx.doi.org/10.1371/journal.pone.0178422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586349	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700011
J	Chami, M; Halmer, R; Schnoeder, L; Becker, KA; Meier, C; Fassbender, K; Gulbins, E; Walter, S				Chami, Marwan; Halmer, Ramona; Schnoeder, Laura; Becker, Katrin Anne; Meier, Carola; Fassbender, Klaus; Gulbins, Erich; Walter, Silke			Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; SPINAL-CORD; EXPRESSION; OLIGODENDROCYTES; ASTROCYTES; DISEASE; DEATH; CELLS	The cuprizone animal model, also known as the toxic demyelination model, is a well-reproducible model of demyelination-and remyelination in mice, and has been useful in studying important aspect of human demyelinating diseases, including multiple sclerosis. In this study, we investigated the role of acid sphingomyelinase in demyelination and myelin repair by inducing acute and chronic demyelination with 5-or 12-week cuprizone treatment, followed by a 2-week cuprizone withdrawal phase to allow myelin repair. Sphingolipids, in particular ceramide and the enzyme acid sphingomyelinase, which generates ceramide from sphingomyelin, seem to be involved in astrocyte activation and neuronal damage in multiple sclerosis. We used immunohistochemistry to study glial reaction and oligodendrocyte distribution in acid sphingomyelinase deficient mice and wild-type C57BL/6J littermates at various time intervals after demyelination and remyelination. Axonal injury was quantified using amyloid precursor protein and synaptophysin, and gene expression and protein levels were measured using gene analysis and Western blotting, respectively. Our results show that mice lacking acid sphingomyelinase had a significant increase in myelin recovery and a significantly higher oligodendrocyte cell count after 2 weeks remyelination compared to wildtype littermates. Detrimental astroglial distribution was also significantly reduced in acid sphingomyelinase deficient animals. We obtained similar results in experiments using amitriptyline to inhibit acid sphingomyelinase. These findings suggest that acid sphingomyelinase plays a significant role in myelin repair, and its inhibition by amitriptyline may constitute a novel therapeutic approach for multiple sclerosis patients.	[Chami, Marwan; Halmer, Ramona; Schnoeder, Laura; Fassbender, Klaus; Walter, Silke] Saarland Univ Hosp, Dept Neurol, Homburg, Germany; [Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany; [Meier, Carola] Saarland Univ, Inst Anat & Cell Biol, Homburg, Germany; [Gulbins, Erich] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA; [Walter, Silke] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Walter, Silke] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	Universitatsklinikum des Saarlandes; University of Duisburg Essen; Universitatsklinikum des Saarlandes; University System of Ohio; University of Cincinnati; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chami, M (corresponding author), Saarland Univ Hosp, Dept Neurol, Homburg, Germany.	Marwan.chami@uniklinikum-saarland.de		Fassbender, Klaus/0000-0003-3596-868X; Walter, Silke/0000-0002-1176-2911	Deutsche Forschungsgemeinschaft (DFG) German Research Foundation: Priority Program [1267]	Deutsche Forschungsgemeinschaft (DFG) German Research Foundation: Priority Program	Support was provided by Deutsche Forschungsgemeinschaft (DFG) German Research Foundation: Priority Program 1267 [http://www. dfg.de/foerderung/info_wissenschaft/2009/info_ wissenschaft_09_54/index.html] to EG and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our thanks to Andrea Schottek for excellent technical assistance.	Colton CA, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-27; Crawford AH, 2014, EXP NEUROL, V260, P50, DOI 10.1016/j.expneurol.2014.04.027; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Furusho M, 2012, J NEUROSCI, V32, P6631, DOI 10.1523/JNEUROSCI.6005-11.2012; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gulbins E, 2003, PHARMACOL RES, V47, P393, DOI 10.1016/S1043-6618(03)00052-5; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Jacobi J, 2016, CELLULAR SIGNALLING, V29, P52; Kim S, 2012, BRAIN PATHOL, V22, P41, DOI 10.1111/j.1750-3639.2011.00501.x; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Koch-Henriksen N, 2010, LANCET NEUROL, V9, P520, DOI 10.1016/S1474-4422(10)70064-8; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Kuhlmann T, 2008, ACTA NEUROPATHOL, V115, P275, DOI 10.1007/s00401-007-0320-8; Lassmann H, 2014, GLIA, V62, P1816, DOI 10.1002/glia.22597; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Messersmith DJ, 2000, J NEUROSCI RES, V62, P241, DOI 10.1002/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D; Mohan H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0168-9; Paxinos G., 2001, MOUSE BRAIN STEREOTA, V2; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Skripuletz T, 2013, BRAIN, V136, P147, DOI 10.1093/brain/aws262; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; van Doorn R, 2012, ACTA NEUROPATHOL, V124, P397, DOI 10.1007/s00401-012-1014-4; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zendedel A, 2016, METAB BRAIN DIS, V31, P425, DOI 10.1007/s11011-015-9781-y	29	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178622	10.1371/journal.pone.0178622	http://dx.doi.org/10.1371/journal.pone.0178622			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582448	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600028
J	Al-Idrus, A; Carpentier, SC; Ahmad, MT; Panis, B; Mohamed, Z				Al-Idrus, Aisyafaznim; Carpentier, Sebastien Christian; Ahmad, Mohamad Taufiq; Panis, Bart; Mohamed, Zulqarnain			Elucidation of the compatible interaction between banana and Meloidogyne incognita via high-throughput proteome profiling	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; PLANT-PARASITIC NEMATODES; CELL WALL LIGNIFICATION; LIGNIN BIOSYNTHESIS; ATP SYNTHASE; RESISTANCE; PROTEINS; DISEASE; GENE; DEFENSE	With a diverse host range, Meloidogyne incognita (root-knot nematode) is listed as one of the most economically important obligate parasites of agriculture. This nematode species establishes permanent feeding sites in plant root systems soon after infestation. A compatible host-nematode interaction triggers a cascade of morphological and physiological process disruptions of the host, leading to pathogenesis. Such disruption is reflected by altered gene expression in affected cells, detectable using molecular approaches. We employed a high-throughput proteomics approach to elucidate the events involved in a compatible banana- M. incognita interaction. This study serves as the first crucial step in developing natural banana resistance for the purpose of biological-based nematode management programme. We successfully profiled 114 Grand naive root proteins involved in the interaction with M. incognita at the 30th- and 60th- day after inoculation (dai). The abundance of proteins involved in fundamental biological processes, cellular component organisation and stress responses were significantly altered in inoculated root samples. In addition, the abundance of proteins in pathways associated with defence and giant cell maintenance in plants such as phenylpropanoid biosynthesis, glycolysis and citrate cycle were also implicated by the infestation.	[Al-Idrus, Aisyafaznim; Ahmad, Mohamad Taufiq; Mohamed, Zulqarnain] Univ Malaya, Inst Biol Sci, Genet & Mol Biol Div, Fac Sci, Kuala Lumpur, Malaysia; [Al-Idrus, Aisyafaznim; Mohamed, Zulqarnain] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia; [Carpentier, Sebastien Christian] Katholieke Univ Leuven, Fac Biosci Engn, Div Crop Biotech, Lab Trop Crop Improvement, Leuven, Belgium; [Carpentier, Sebastien Christian] SYBIOMA Facil Syst Biol Based MAss Spectrometry, Leuven, Belgium; [Panis, Bart] Katholieke Univ Leuven, Belgian Off, Biovers Int, Leuven, Belgium	Universiti Malaya; Universiti Malaya; KU Leuven; Alliance; Bioversity International; KU Leuven	Al-Idrus, A (corresponding author), Univ Malaya, Inst Biol Sci, Genet & Mol Biol Div, Fac Sci, Kuala Lumpur, Malaysia.; Al-Idrus, A (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	aisyafaznim@um.edu.my	carpentier, sebastien C.M./D-9482-2018; MOHAMED, ZULQARNAIN/C-1158-2010; al-Idrus, aisyafaznim/ABG-8477-2021; Rahman, Syarifah Aisyafaznim Sayed Abdul/AAV-5661-2021	carpentier, sebastien C.M./0000-0002-7389-6405; MOHAMED, ZULQARNAIN/0000-0001-7311-0356; Panis, Bart/0000-0001-6717-947X	Ministry of Science, Technology and Innovation Malaysia, under Top-down Grant [53-02-03-1069]; University of Malaya, Kuala Lumpur, Malaysia [PG194-2014B]; UMRG grant [RP005E-13BIO]; University of Malaya [FL002-2010]	Ministry of Science, Technology and Innovation Malaysia, under Top-down Grant; University of Malaya, Kuala Lumpur, Malaysia(Universiti Malaya); UMRG grant; University of Malaya(Universiti Malaya)	This work was supported by the Ministry of Science, Technology and Innovation Malaysia, under Top-down Grant [number 53-02-03-1069, 2010];University of Malaya, Kuala Lumpur, Malaysia under Postgraduate research Grant [number PG194-2014B, 2014], and UMRG grant [number RP005E-13BIO, 2013]. We would also like to acknowledge University of Malaya, for funding the first author's stay in the Laboratory of Tropical Crop Improvement, Leuven, Belgium through the Flagship programme [number FL002-2010, 2010].	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Backiyarani S, 2014, PHYSIOL MOL PLANT P, V86, P11, DOI 10.1016/j.pmpp.2014.02.002; Bird David McK., 2001, P139, DOI 10.1079/9780851994239.0139; Buts K, 2014, J PROTEOMICS, V105, P31, DOI 10.1016/j.jprot.2014.02.015; Cai DG, 1997, SCIENCE, V275, P832, DOI 10.1126/science.275.5301.832; Caillaud MC, 2008, J PLANT PHYSIOL, V165, P104, DOI 10.1016/j.jplph.2007.05.007; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Carpentier SC, 2007, PROTEOMICS, V7, P92, DOI 10.1002/pmic.200600533; Curtis Rosane H. C., 2007, Briefings in Functional Genomics & Proteomics, V6, P50, DOI 10.1093/bfgp/elm006; De Waele D, 2007, ANNU REV PHYTOPATHOL, V45, P457, DOI 10.1146/annurev.phyto.45.062806.094438; Engler JD, 2013, MOL PLANT MICROBE IN, V26, P17, DOI 10.1094/MPMI-05-12-0128-CR; Engler JD, 1999, PLANT CELL, V11, P793, DOI 10.1105/tpc.11.5.793; Engler JD, 2004, PLANT J, V38, P12, DOI 10.1111/j.1365-313X.2004.02019.x; Escobar C, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P157, DOI 10.1007/978-94-007-0434-3_9; Favery B, 1998, EMBO J, V17, P6799, DOI 10.1093/emboj/17.23.6799; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; GLAZER I, 1985, J NEMATOL, V17, P145; Gowen Simon R., 2005, P611, DOI 10.1079/9780851997278.0611; Guo L, 2012, PLANT CELL, V24, P2200, DOI 10.1105/tpc.111.094946; Hahlbrock K, 2003, P NATL ACAD SCI USA, V100, P14569, DOI 10.1073/pnas.0831246100; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Ibrahim HMM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-220; JaizmeVega MC, 1997, PLANT SOIL, V196, P27, DOI 10.1023/A:1004236310644; Jammes F, 2005, PLANT J, V44, P447, DOI 10.1111/j.1365-313X.2005.02532.x; Jaubert S, 2002, MOL BIOCHEM PARASIT, V121, P205, DOI 10.1016/S0166-6851(02)00034-8; Jepson S.B., 1987, IDENTIFICATION ROOT; Jonathan EI, 2000, BANANA IMPROVEMENT P; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karp G., 2010, CELL MOL BIOL; Konishi H, 2004, PLANT MOL BIOL, V56, P839, DOI 10.1007/s11103-004-5920-2; LEBHERZ HG, 1984, J BIOL CHEM, V259, P1011; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Li DS, 2013, MICROBIOL MOL BIOL R, V77, P253, DOI 10.1128/MMBR.00059-12; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Mehta A, 2008, CURR PROTEIN PEPT SC, V9, P108, DOI 10.2174/138920308783955225; Molinari S, 2010, CROP PROT, V29, P1354, DOI 10.1016/j.cropro.2010.07.012; Munoz-Bertomeu J, 2010, PLANT PHYSIOL, V152, P1830, DOI 10.1104/pp.109.150458; Castaneda NEN, 2017, ANN BOT-LONDON, V119, P915, DOI 10.1093/aob/mcw272; Niu JH, 2011, CROP PROT, V30, P1063, DOI 10.1016/j.cropro.2011.03.028; Palomares-Rius JE, 2011, J PROTEOMICS, V74, P2034, DOI 10.1016/j.jprot.2011.05.026; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Queneherve P, 2009, EUPHYTICA, V165, P137, DOI 10.1007/s10681-008-9774-6; Quirino BF, 2010, PHYTOCHEMISTRY, V71, P351, DOI 10.1016/j.phytochem.2009.11.005; Rahman SASA, 2014, SAINS MALAYS, V43, P175; Rahman SASA, 2010, EUR J PLANT PATHOL, V128, P343, DOI 10.1007/s10658-010-9656-3; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rutter WJ., 1964, FED P FED; SASSER JN, 1980, PLANT DIS, V64, P36, DOI 10.1094/PD-64-36; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Speijer PR, 1997, SCREENING MUSA GERMP, P1; Spoel SH, 2012, NATURE REV IMMUNOLOG, V12, P90; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Tobimatsu Y, 2013, PLANT J, V76, P357, DOI 10.1111/tpj.12299; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Tremblay A, 2010, PLANT SCI, V179, P183, DOI 10.1016/j.plantsci.2010.04.011; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Vanholme B, 2004, GENE, V332, P13, DOI [10.1016/j.gene.2004.02.024, 10.1016/j.gnee.2004.02.024]; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vanhove AC, 2015, J PROTEOMICS, V119, P10, DOI 10.1016/j.jprot.2015.01.014; Wang K. - H, 2009, SURVEY NEMATODES BAN; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Williamson VM, 1996, PLANT CELL, V8, P1735, DOI 10.1105/tpc.8.10.1735; Zhong RQ, 2000, PLANT PHYSIOL, V124, P563, DOI 10.1104/pp.124.2.563	69	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178438	10.1371/journal.pone.0178438	http://dx.doi.org/10.1371/journal.pone.0178438			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575037	Green Published, gold			2022-12-26	WOS:000402624300052
J	Niemeyer, C; Favero, CM; Shivaprasad, HL; Uhart, M; Musso, CM; Rago, MV; Silva, RP; Canabarro, PL; Craig, MI; Olivera, V; Pereda, A; Brandao, PE; Catao-Dias, JL				Niemeyer, Claudia; Favero, Cintia Maria; Shivaprasad, H. L.; Uhart, Marcela; Musso, Cesar Meyer; Virginia Rago, Maria; Silva-Filho, Rodolfo Pinho; Canabarro, Paula Lima; Isabel Craig, Maria; Olivera, Valeria; Pereda, Ariel; Brandao, Paulo Eduardo; Catao-Dias, Jose Luiz			Genetically diverse herpesviruses in South American Atlantic coast seabirds	PLOS ONE			English	Article							INFECTION; VIRUS	Different herpesviruses have been associated with respiratory and enteric disease and mortality among seabirds and waterfowl. In 2011, a respiratory disease outbreak affected 58.3% (98/168) of the Magellanic penguins undergoing rehabilitation due to an oil spill off the southern Brazilian coast. Etiology was attributed to a novel herpesvirus identified by histopathology, immunohistochemistry, electron microscopy and molecular studies with partial DNA sequencing. Since migration, rehabilitation and translocation may facilitate the spread of pathogens between populations and trigger the onset of clinical disease in animals with latent infections, investigation of herpesvirus occurrence in asymptomatic seabirds was performed. Samples from free-ranging seabirds were collected in Argentinian Patagonia (Magellanic penguins) and the Abrolhos Archipelago in Brazil (Brown boobies, Masked boobies, Red-billed tropicbirds, White-tailed tropicbirds and South American tern). Furthermore, asymptomatic seabirds housed at the facility where the outbreak occurred were also sampled. In total, 354 samples from eight seabird species were analyzed by PCR for herpesvirus. Four different sequences of herpesviruses were identified, one in Yellow-nosed Albatross, one in Boobies and Tropicbirds and two in Magellanic penguins. Magellanic penguin herpesvirus 1 was identified during the penguin outbreak at the rehabilitation facility in Brazil, while Magellanic penguin herpesvirus 2 was recovered from free-ranging penguins at four reproduction sites in Argentina. Phylogenic analysis of the herpesviruses sequences tentatively identified suggested that the one found in Suliformes and the one associated with the outbreak are related to sequences of viruses that have previously caused seabird die-offs. These findings reinforce the necessity for seabird disease surveillance programs overall, and particularly highlight the importance of quarantine, good hygiene, stress management and pre-release health exams in seabirds undergoing rehabilitation.	[Niemeyer, Claudia; Catao-Dias, Jose Luiz] Univ Sao Paulo, Sch Vet Med & Anim Sci, Wildlife Comparat Pathol Lab, Sao Paulo, Brazil; [Favero, Cintia Maria; Brandao, Paulo Eduardo] Univ Sao Paulo, Sch Vet Med & Anim Sci, Mol Biol & Appl Serol Lab, Sao Paulo, Brazil; [Shivaprasad, H. L.] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Tulare Branch, Davis, CA 95616 USA; [Uhart, Marcela] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Musso, Cesar Meyer] Avidepa Assoc Vila Velhense Protecao Ambiental, Vila Velha, ES, England; [Virginia Rago, Maria] Univ Buenos Aires, CONICET, Inst Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Silva-Filho, Rodolfo Pinho; Canabarro, Paula Lima] CRAM, Rio Grande, RS, Brazil; [Isabel Craig, Maria; Olivera, Valeria; Pereda, Ariel] INTA, Inst Virol, Hurlingham, Buenos Aires, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California Davis; University of California System; University of California Davis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Niemeyer, C (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Wildlife Comparat Pathol Lab, Sao Paulo, Brazil.	clauniemeyer@yahoo.com.br	Brandão, Paulo Eduardo/F-8155-2012; CATÃO-DIAS, JOSE LUIZ/C-4897-2012	Brandão, Paulo Eduardo/0000-0003-0213-7839; CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395	Fapesp; Conselho Nacional de Desenvolvimento Cientofico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientofico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support was provided by Fapesp; Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (BR); and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson KAS, 2006, J VIROL METHODS, V136, P261, DOI 10.1016/j.jviromet.2006.03.033; BirdLife International, 2012, IUCN RED LIST THREAT; Cardoso M, 2005, VIRUS GENES, V30, P371, DOI 10.1007/s11262-005-6781-8; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; de Thoisy B, 2009, J WILDLIFE DIS, V45, P802, DOI 10.7589/0090-3558-45.3.802; Doane F.W.A.N., 1987, ELECT MICROSCOPY DIA; Faria FA, 2014, WATERBIRDS, V37, P446, DOI 10.1675/063.037.0413; GOLDBERG DR, 1990, J WILDLIFE DIS, V26, P299, DOI 10.7589/0090-3558-26.3.299; GUY JS, 1992, AVIAN PATHOL, V21, P77, DOI 10.1080/03079459208418820; ICTV (International Committee on Taxonomy of Viruses), 2014, VIRUS TAXONOMY 2014; Kaleta Erhard F., 2007, P63, DOI 10.1002/9780470344668.ch3; KINCAID AL, 1988, J WILDLIFE DIS, V24, P173, DOI 10.7589/0090-3558-24.1.173; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Parsons NJ, 2015, DIS AQUAT ORGAN, V116, P149, DOI 10.3354/dao02907; Quesada RJ, 2011, J WILDLIFE DIS, V47, P233, DOI 10.7589/0090-3558-47.1.233; Ritchie BW, 1995, AVIAN VIRUSES FUNCTI, P171; Sick H, 2001, ORNITOLOGIA BRASILEI; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Wellehan JFX, 2003, J CLIN MICROBIOL, V41, P4054, DOI 10.1128/JCM.41.9.4054-4057.2003; WILLIAMS RA, 1992, J GEN VIROL, V73, P2415, DOI 10.1099/0022-1317-73-9-2415	21	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178811	10.1371/journal.pone.0178811	http://dx.doi.org/10.1371/journal.pone.0178811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575104	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300119
J	Older, CE; Diesel, A; Patterson, AP; Meason-Smith, C; Johnson, TJ; Mansell, J; Suchodolski, JS; Hoffmann, AR				Older, Caitlin E.; Diesel, Alison; Patterson, Adam P.; Meason-Smith, Courtney; Johnson, Timothy J.; Mansell, Joanne; Suchodolski, Jan S.; Hoffmann, Aline Rodrigues			The feline skin microbiota: The bacteria inhabiting the skin of healthy and allergic cats	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CANINE; DOGS; SEQUENCES; EXPOSURE; ANIMALS; CORNEOCYTES; PREVALENCE; MICROFLORA; GREENGENES	Background The skin is inhabited by a multitude of microorganisms. An imbalance of these microorganisms is associated with disease, however, the causal relationship between skin microbiota and disease remains unknown. To describe the cutaneous bacterial microbiota of cats and determine whether bacterial dysbiosis occurs on the skin of allergic cats, the skin surfaces on various regions of 11 healthy cats and 10 allergic cats were sampled. Methodology/Principal findings Genomic DNA was extracted from skin swabs and sequenced using primers that target the V4 region of the bacterial 16S rRNA. The bacterial sequences from healthy cats revealed that there are differences in species diversity and richness between body sites and different epithelial surfaces. Bacterial communities preferred body site niches in the healthy cats, however, the bacterial communities on allergic cat skin tended to be more unique to the individual cat. Overall, the number of bacterial species was not significantly different between the two health status groups, however, the abundances of these bacterial species were different between healthy and allergic skin. Staphylococcus, in addition to other taxa, was more abundant on allergic skin. Conclusions/Significance This study reveals that there are more bacterial species inhabiting the skin of cats than previously thought and provide some evidence of an association between dysbiosis and skin disease.	[Older, Caitlin E.; Meason-Smith, Courtney; Mansell, Joanne; Hoffmann, Aline Rodrigues] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Dermatopathol Specialty Serv, College Stn, TX 77843 USA; [Diesel, Alison; Patterson, Adam P.; Suchodolski, Jan S.] Texas A&M Univ, Dept Small Anim Clin Sci, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Johnson, Timothy J.] Univ Minnesota, Dept Vet & Biomed Sci, Coll Vet Med, St Paul, MN 55108 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Minnesota System; University of Minnesota Twin Cities	Hoffmann, AR (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Dermatopathol Specialty Serv, College Stn, TX 77843 USA.	arodrigues@cvm.tamu.edu	Older, Caitlin E./ABH-7775-2020; rodrigues hoffmann, aline/L-6859-2017	Older, Caitlin E./0000-0001-7007-5815; rodrigues hoffmann, aline/0000-0001-6148-2531; Johnson, Timothy/0000-0001-7556-9347; Smith, Courtney/0000-0002-5189-2702	Winn Feline Foundation [MT14-018]	Winn Feline Foundation	Funding was provided by the Winn Feline Foundation (http://www.winnfelinefoundation.org/) under grant ID MT14-018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Bradley CW, 2016, J INVEST DERMATOL; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Epstein TG, 2011, J PEDIATR-US, V158, P265, DOI 10.1016/j.jpeds.2010.07.026; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P74, DOI 10.1016/j.jaci.2004.10.030; Fazakerley J, 2009, VET DERMATOL, V20, P179, DOI 10.1111/j.1365-3164.2009.00745.x; Furiani N, 2011, VET DERMATOL, V22, P490, DOI 10.1111/j.1365-3164.2011.00979.x; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Havstad S, 2011, J ALLERGY CLIN IMMUN, V128, P880, DOI 10.1016/j.jaci.2011.06.039; Hoffmann AR, 2016, VET PATHOL, V53, P10, DOI 10.1177/0300985815595517; Hooda Seema, 2012, Animal Health Research Reviews, V13, P78, DOI 10.1017/S1466252312000059; KROGH HV, 1976, NORD VET MED, V28, P459; LAULIER M, 1995, J EVOLUTION BIOL, V8, P657, DOI 10.1046/j.1420-9101.1995.8050657.x; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Lu YF, 2007, VET DERMATOL, V18, P29, DOI 10.1111/j.1365-3164.2007.00567.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mandhane PJ, 2009, J ALLERGY CLIN IMMUN, V124, P745, DOI 10.1016/j.jaci.2009.06.038; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meason-Smith C, 2017, VET DERMATOL, V28, P71, DOI 10.1111/vde.12373; Meason-Smith C, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv139; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Middleton JR, 2005, J CLIN MICROBIOL, V43, P2916, DOI 10.1128/JCM.43.6.2916-2919.2005; Miller W.G.C., 2012, MULLER KIRKS SMALL A; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Oh C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131468; Ownby DR, 2011, J PEDIATR-US, V158, P184, DOI 10.1016/j.jpeds.2010.09.055; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Rich M, 2005, BRIT J BIOMED SCI, V62, P98, DOI 10.1080/09674845.2005.11732694; RODRIGUESHOFFMA.A, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.003197; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI 10.1016/j.smim.2013.09.005; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Sturgeon A, 2014, VET J, V201, P223, DOI 10.1016/j.tvjl.2014.01.024; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woolley KL, 2008, VET DERMATOL, V19, P1, DOI 10.1111/j.1365-3164.2007.00649.x; Yamasaki Y, 2012, ARCH ORAL BIOL, V57, P1183, DOI 10.1016/j.archoralbio.2012.02.015; Zeeuwen PLJM, 2017, J ALLERGY CLIN IMMUN, V139, P1368, DOI 10.1016/j.jaci.2016.09.017; Zeeuwen PL, 2016, J INVEST DERMATOL	53	23	23	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178555	10.1371/journal.pone.0178555	http://dx.doi.org/10.1371/journal.pone.0178555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575016	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300063
J	Smith, MA; Boyd, A; Chan, A; Clout, S; Brisay, PD; Dolson, S; Eagalle, T; Espinola, S; Fairweather, A; Frank, S; Fruetel, C; Cortes, CG; Hall, J; Ho, C; Matczak, E; McCubbin, S; McPhee, M; Pare, KA; Paris, K; Richard, E; Roblin, M; Russell, C; Snyder, R; Trombley, C; Schmitt, T; Vandermeer, C; Warne, C; Welch, N; Xavier-Blower, C				Smith, M. Alex; Boyd, Amanda; Chan, Amelia; Clout, Simonne; Brisay, Paulson des; Dolson, Sarah; Eagalle, Thanushi; Espinola, Sean; Fairweather, Aaron; Frank, Sydney; Fruetel, Christopher; Cortes, Cristina Garrido; Hall, James; Ho, Chris; Matczak, Eryk; McCubbin, Sandra; McPhee, Megan; Pare, Kate A.; Paris, Kelsie; Richard, Ellen; Roblin, Morgan; Russell, Cassandra; Snyder, Ryan; Trombley, Carolyn; Schmitt, Tyler; Vandermeer, Caitlin; Warne, Connor; Welch, Natasha; Xavier-Blower, Chelsie			Investigating the effect of forestry on leaf-litter arthropods (Algonquin Park, Ontario, Canada)	PLOS ONE			English	Article							PHYLOGENETIC COMMUNITY STRUCTURE; BEETLE ASSEMBLAGES COLEOPTERA; PARASITOID FLIES DIPTERA; SPECIES RICHNESS; DNA; DIVERSITY; CONSERVATION; HYMENOPTERA; ANTS; CARABIDAE	Arthropods are the most diverse taxonomic group of terrestrial eukaryotes and are sensitive to physical alterations in their environment such as those caused by forestry. With their enormous diversity and physical omnipresence, arthropods could be powerful indicators of the effects of disturbance following forestry. When arthropods have been used to measure the effects of disturbance, the total diversity of some groups is often found to increase following forestry. However, these findings are frequently derived using a coarse taxonomic grain (family or order) to accommodate for various taxonomic impediments (including cryptic diversity and poorly resourced taxonomists). Our intent with this work was to determine the diversity of arthropods in and around Algonquin Park, and how this diversity was influenced by disturbance (in this case, forestry within the past 25 years). We used DNA barcodederived diversity estimates (Barcode Index Number (BIN) richness) to avoid taxonomic impediments and as a source of genetic information with which we could conduct phylogenetic estimates of diversity (PD). Diversity patterns elucidated with PD are often, but not always congruent with taxonomic estimates and departures from these expectations can help clarify disturbance effects that are hidden from richness studies alone. We found that BIN richness and PD were greater in disturbed (forested) areas, however when we controlled for the expected relationship between PD and BIN richness, we found that cut sites contained less PD than expected and that this diversity was more phylogenetically clustered than would be predicted by taxonomic richness. While disturbance may cause an evident increase in diversity, this diversity may not reflect the full evolutionary history of the assemblage within that area and thus a subtle effect of disturbance can be found decades following forestry.	[Smith, M. Alex; Boyd, Amanda; Chan, Amelia; Clout, Simonne; Brisay, Paulson des; Dolson, Sarah; Eagalle, Thanushi; Espinola, Sean; Fairweather, Aaron; Frank, Sydney; Fruetel, Christopher; Cortes, Cristina Garrido; Hall, James; Ho, Chris; Matczak, Eryk; McCubbin, Sandra; McPhee, Megan; Pare, Kate A.; Paris, Kelsie; Richard, Ellen; Roblin, Morgan; Russell, Cassandra; Snyder, Ryan; Trombley, Carolyn; Schmitt, Tyler; Vandermeer, Caitlin; Warne, Connor; Welch, Natasha; Xavier-Blower, Chelsie] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada	University of Guelph	Smith, MA (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.	salex@uoguelph.ca	Smith, M Alex/B-4468-2013	Smith, M Alex/0000-0002-8650-2575; Dolson, Sarah/0000-0001-9312-2282	Ontario Ministry of Research and Innovation (OMRI) Early Research Award (ERA) [ER13-09-169]; Natural Sciences and Engineering Research Council (NSERCR) Discovery Grant (DG) [RGPIN-2016-05520]	Ontario Ministry of Research and Innovation (OMRI) Early Research Award (ERA); Natural Sciences and Engineering Research Council (NSERCR) Discovery Grant (DG)	We thank the Ontario Ministry of Research and Innovation (OMRI) Early Research Award (ERA; ER13-09-169; https://,www.ontario.ca/page/early-researcher-awards) and Natural Sciences and Engineering Research Council (NSERCR) Discovery Grant (DG; RGPIN-2016-05520; http //www.nserc-crsrg.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) for grants to MAS that enabled this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algonquin_ Forestry_ Authority, 2010, FOR MAN PLAN ALG PAR; Azevedo-Ramos C, 2006, FOREST ECOL MANAG, V232, P26, DOI 10.1016/j.foreco.2006.05.025; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Beaudry S, 1997, CAN J FOREST RES, V27, P2065, DOI 10.1139/cjfr-27-12-2065; Blagoev GA, 2016, MOL ECOL RESOUR, V16, P325, DOI 10.1111/1755-0998.12444; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Costion CM, 2015, DIVERS DISTRIB, V21, P279, DOI 10.1111/ddi.12266; Dainese M, 2016, GLOBAL CHANGE BIOL; Dunn RR, 2004, FOREST ECOL MANAG, V191, P215, DOI 10.1016/j.foreco.2003.12.008; Eagles P. F. J., 1997, Journal of Applied Recreation Research, V22, P79; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Francoeur A., 1966, Naturaliste Canadien, V93, P443; Haraguchi TF, 2015, ENVIRON ENTOMOL; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert P. D. N., 2016, PHILOS T ROYAL SOC B, V371, DOI 10. 1098/rstb. 2015. 0333; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jobes AP, 2004, J WILDLIFE MANAGE, V68, P51, DOI 10.2193/0022-541X(2004)068[0051:EOSCOB]2.0.CO;2; Jost Lou, 2011, P66; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Laity T, 2015, SCI TOTAL ENVIRON, V534, P131, DOI 10.1016/j.scitotenv.2015.04.113; Lindo Z, 2004, CAN J FOREST RES, V34, P998, DOI [10.1139/x03-284, 10.1139/X03-284]; Lovejoy T, 2010, CANADIAN TAXONOMY EX; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Maraun M, 2003, SOIL BIOL BIOCHEM, V35, P1387, DOI 10.1016/S0038-0717(03)00218-9; Marshall S, 1997, INSECTS ALGONQUIN PR; MCIVER JD, 1992, CAN J FOREST RES, V22, P984, DOI 10.1139/x92-132; MIDDLETON J, 1985, BIOL CONSERV, V33, P133, DOI 10.1016/0006-3207(85)90100-4; Moore JD, 2002, CAN J SOIL SCI, V82, P105, DOI 10.4141/S01-017; Nei M., 2000, MOL EVOLUTION PHYLOG; NIEMELA J, 1993, CONSERV BIOL, V7, P551, DOI 10.1046/j.1523-1739.1993.07030551.x; Niemela J, 2002, LANDSCAPE ECOL, V17, P387, DOI 10.1023/A:1021270121630; Niemela J, 1997, CONSERV BIOL, V11, P601, DOI 10.1046/j.1523-1739.1997.06008.x; Nol E, 2006, CAN FIELD NAT, V120, P15, DOI 10.22621/cfn.v120i1.239; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Porco D, 2014, MOL ECOL RESOUR, V14, P249, DOI 10.1111/1755-0998.12172; Proctor E, 2012, BIODIVERS CONSERV, V21, P1703, DOI 10.1007/s10531-012-0272-8; Quinn NWS, 2005, CAN FIELD NAT, V119, P330, DOI 10.22621/cfn.v119i3.142; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106940; Richards N, 1998, ALGONQUIN PROVINCIAL; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rutgers-Kelly AC, 2013, CAN ENTOMOL, V145, P655, DOI 10.4039/tce.2013.42; Schmuki C, 2006, MOL ECOL, V15, P1481, DOI 10.1111/j.1365-294X.2006.02849.x; Simard JR, 2003, CAN J ZOOL, V81, P1318, DOI [10.1139/z03-129, 10.1139/Z03-129]; Skillen EL, 2000, ENVIRON ENTOMOL, V29, P460, DOI 10.1603/0046-225X-29.3.460; Smith M.A., 2012, ENCY SUSTAINABILITY, P326; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2014, ECOGRAPHY, V37, P720, DOI 10.1111/j.1600-0587.2013.00631.x; Smith MA, 2013, MOL ECOL RESOUR, V13, P168, DOI 10.1111/1755-0998.12038; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2009, FRONT ZOOL, P6; Smith MA, 2010, P FIN INT C GIG IMAG; Smith MA, 2014, CAN ENTOMOL, V147, P611; Smith ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043319; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Sutherland IJ, 2016, FOREST ECOL MANAG, V374, P61, DOI 10.1016/j.foreco.2016.04.037; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TOWNES HENRY, 1962, PROC ENTOMOL SOC WASHINGTON, V64, P253; Tucker CM, 2013, DIVERS DISTRIB, V19, P845, DOI 10.1111/ddi.12087; VAISANEN R, 1993, BIODIVERS CONSERV, V2, P95, DOI 10.1007/BF00056127; Vance CC, 2003, ECOSCIENCE, V10, P49, DOI 10.1080/11956860.2003.11682750; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Zettler JA, 2004, ANN ENTOMOL SOC AM, V97, P513, DOI 10.1603/0013-8746(2004)097[0513:COFCFN]2.0.CO;2	71	4	4	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178568	10.1371/journal.pone.0178568	http://dx.doi.org/10.1371/journal.pone.0178568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575022	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300065
J	Wei, KC; Chen, CY; Feng, LY; Huang, WT; Chen, CH; Hsu, PW; Wang, K; Hood, LE; Chen, LY				Wei, Kuo-Chen; Chen, Chia-Yuan; Feng, Li-Ying; Huang, Wei-Tzu; Chen, Chia-Hua; Hsu, Peng-Wei; Wang, Kai; Hood, Leroy E.; Chen, Leslie Y.			The rs16906252:C > T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort	PLOS ONE			English	Article							MGMT PROMOTER METHYLATION; SINGLE-NUCLEOTIDE POLYMORPHISM; COLORECTAL-CANCER; MALIGNANT GLIOMAS; T ALLELE; GLIOBLASTOMA; RS16906252; BENEFIT; RADIOTHERAPY; EXPRESSION	The methylation status of O-6-methylguanine-DNA methyltransferase (MGMT) is associated with the prognosis in gliomas and in other cancers. Recent studies showed that rs16906252, an SNP in the MGMTpromoter, is associated with promoter methylation and is a predictor of the overall survival time (OST) and the response to temozolomide (TMZ) treatment. However, these findings haven't been systematically investigated in the Han-Chinese population. We analyzed the relevance between rs16906252 polymorphisms, the MGMTmethylation status, and the OST in 72 Han-Chinese gliomas patients. The MGMTpromoter methylation was measured by bisulfite conversion followed by pyro-sequencing, while rs16906252 was measured by restriction endonuclease digestion. Contrary to the previous findings, we found no association between rs16906252 genotypes and promoter methylation on MGMT. The lower-grade glioma (LGGs) patients carrying the C allele with rs16906252 showed a surprisingly better OST (P = 0.04). Furthermore, the LGG patients carrying hypo-methylated MGMT promoter and rs16906252 T allele showed significantly poorer prognosis. The prognostic benefit of MGMTpromoter methylation and genotypes on gliomas patients is marginal. A new molecular stratified patient grouping of LGGs is potentially associated with poorer OST. Active MGMT might have a protective role in LGG tumors, enabling evolution to severe malignancy.	[Wei, Kuo-Chen; Feng, Li-Ying; Chen, Chia-Hua; Hsu, Peng-Wei] Chang Gung Mem Hosp, Dept Neurosurg, Linkou Med Ctr, Taoyuan, Taiwan; [Wei, Kuo-Chen; Feng, Li-Ying] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chen, Chia-Yuan; Huang, Wei-Tzu; Chen, Leslie Y.] Chang Gung Mem Hosp, Dept Med Res & Dev, Linkou Med Ctr, Taoyuan, Taiwan; [Wang, Kai; Hood, Leroy E.; Chen, Leslie Y.] Inst Syst Biol, Seattle, WA USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Institute for Systems Biology (ISB)	Chen, LY (corresponding author), Chang Gung Mem Hosp, Dept Med Res & Dev, Linkou Med Ctr, Taoyuan, Taiwan.; Chen, LY (corresponding author), Inst Syst Biol, Seattle, WA USA.	chenyyl@gmail.com		Wei, Kuochen/0000-0003-3505-2196; Chen, Chia-Hua/0000-0003-0536-8085; Chen, Leslie/0000-0002-6257-8970	Ministry of Science and Technology, Republic of China [105-2314-B-182A-053-MY2]; Chang-Gung Memorial Hospital [CMRPG3F0621]	Ministry of Science and Technology, Republic of China; Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital)	LYC and the work was supported by the Ministry of Science and Technology, Republic of China (https://www.most.gov.tw) (105-2314-B-182A-053-MY2) and Chang-Gung Memorial Hospital (https://www.cgmh.org.tw) (CMRPG3F0621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kristensen LS, 2011, LUNG CANCER, V71, P130, DOI 10.1016/j.lungcan.2010.05.008; Kuroiwa-Trzmielina J, 2016, CLIN CANCER RES, V22, P6266, DOI 10.1158/1078-0432.CCR-15-2765; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Leng SG, 2011, CLIN CANCER RES, V17, P2014, DOI 10.1158/1078-0432.CCR-10-3026; McDonald KL, 2013, EUR J CANCER, V49, P360, DOI 10.1016/j.ejca.2012.08.012; Minniti G, 2009, ANTICANCER RES, V29, P5171; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Rapkins RW, 2015, NEURO-ONCOLOGY, V17, P1589, DOI 10.1093/neuonc/nov064; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Sadones J, 2009, EUR J CANCER, V45, P146, DOI 10.1016/j.ejca.2008.09.002; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Shen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107558; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Toffolatti L, 2014, VIRCHOWS ARCH, V465, P579, DOI 10.1007/s00428-014-1622-6; van den Bent MJ, 2011, CLIN CANCER RES, V17, P7148, DOI 10.1158/1078-0432.CCR-11-1274; Weller M, 2015, CLIN CANCER RES, V21, P2057, DOI 10.1158/1078-0432.CCR-14-2737; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wick W, 2014, NAT REV NEUROL, V10, P372, DOI 10.1038/nrneurol.2014.100; Yang LJ, 2014, CANCER INVEST, V32, P31, DOI 10.3109/07357907.2013.861474; Zhang Jihong, 2012, Curr Mol Pharmacol, V5, P102	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178842	10.1371/journal.pone.0178842	http://dx.doi.org/10.1371/journal.pone.0178842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575062	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300124
J	Song, Y; Li, S; Ray, A; Das, DS; Qi, J; Samur, MK; Tai, YT; Munshi, N; Carrasco, RD; Chauhan, D; Anderson, KC				Song, Y.; Li, S.; Ray, A.; Das, D. S.; Qi, J.; Samur, M. K.; Tai, Y-T; Munshi, N.; Carrasco, R. D.; Chauhan, D.; Anderson, K. C.			Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; 26S PROTEASOME; MITOCHONDRIAL MORPHOLOGY; DEUBIQUITINATING ENZYMES; PROTEIN-DEGRADATION; SUBUNIT RPN11; UBIQUITIN; CYCLE; DEXAMETHASONE; COMBINATION	Proteasome inhibition is an effective therapy for multiple myeloma (MM) patients; however, the emergence of drug resistance is common. Novel therapeutic strategies to overcome proteasome inhibitor resistance are needed. In this study, we examined whether targeting deubiquitylating (DUB) enzymes upstream of 20S proteasome overcomes proteasome inhibitor resistance. Gene expression analysis, immunohistochemical studies of MM patient bone marrow, reverse transcription-PCR and protein analysis show that Rpn11/POH1, a DUB enzyme upstream of 20S proteasome, is more highly expressed in patient MM cells than in normal plasma cells. Importantly, Rpn11 expression directly correlates with poor patient survival. Loss-of-function studies show that Rpn11-siRNA knockdown decreases MM cell viability. Pharmacological inhibition of Rpn11 with O-phenanthroline (OPA) blocks cellular proteasome function, induces apoptosis in MM cells and overcomes resistance to proteasome inhibitor bortezomib. Mechanistically, Rpn11 inhibition in MM cells activates caspase cascade and endoplasmic stress response signaling. Human MM xenograft model studies demonstrate that OPA treatment reduces progression of tumor growth and prolongs survival in mice. Finally, blockade of Rpn11 increases the cytotoxic activity of anti-MM agents lenalidomide, pomalidomide or dexamethasone. Overall, our preclinical data provide the rationale for targeting DUB enzyme Rpn11 upstream of 20S proteasome to enhance cytotoxicity and overcome proteasome inhibitor resistance in MM.	[Song, Y.; Ray, A.; Das, D. S.; Samur, M. K.; Tai, Y-T; Munshi, N.; Carrasco, R. D.; Chauhan, D.; Anderson, K. C.] Harvard Med Sch, LeBow Inst Myeloma Therapeut, 450 Brookline Ave,Mayer 553, Boston, MA 02115 USA; [Song, Y.; Ray, A.; Das, D. S.; Samur, M. K.; Tai, Y-T; Carrasco, R. D.; Chauhan, D.; Anderson, K. C.] Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr, Dept Med Oncol, 450 Brookline Ave,Mayer 553, Boston, MA 02115 USA; [Li, S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Qi, J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chauhan, D; Anderson, KC (corresponding author), Harvard Med Sch, LeBow Inst Myeloma Therapeut, 450 Brookline Ave,Mayer 553, Boston, MA 02115 USA.; Chauhan, D; Anderson, KC (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr, Dept Med Oncol, 450 Brookline Ave,Mayer 553, Boston, MA 02115 USA.	Dharminder_Chauhan@dfci.harvard.edu; Kenneth_Anderson@dfci.harvard.edu	Munshi, Nikhil/ABE-2338-2021	Samur, Mehmet/0000-0002-9978-5682	National Institutes of Health Specialized Programs of Research Excellence (SPORE) [P50100707, R01CA207237, RO1CA050947]; NATIONAL CANCER INSTITUTE [P01CA155258, R01CA207237, R01CA050947, P50CA100707] Funding Source: NIH RePORTER	National Institutes of Health Specialized Programs of Research Excellence (SPORE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by National Institutes of Health Specialized Programs of Research Excellence (SPORE) Grants P50100707, R01CA207237 and RO1CA050947. KCA is an American Cancer Society Clinical Research Professor.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 1996, P NATL ACAD SCI USA, V93, P13931, DOI 10.1073/pnas.93.24.13931; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chauhan D, 1996, BLOOD, V87, P1104, DOI 10.1182/blood.V87.3.1104.bloodjournal8731104; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Chauhan D, 2013, CLIN CANCER RES, V19, P3019, DOI 10.1158/1078-0432.CCR-12-3752; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chauhan D, 2009, CANCER CELL, V16, P309, DOI 10.1016/j.ccr.2009.08.019; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gallery M, 2007, MOL CANCER THER, V6, P262, DOI 10.1158/1535-7163.MCT-06-0542; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Hershko A, 2005, ANGEW CHEM INT EDIT, V44, P5932, DOI 10.1002/anie.200501724; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kuhn DJ, 2007, BLOOD, V110, P3281, DOI 10.1182/blood-2007-01-065888; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Lim KH, 2013, CURR PHARM DESIGN, V19, P4039, DOI 10.2174/1381612811319220013; Liu CW, 2013, TRENDS BIOCHEM SCI, V38, P103, DOI 10.1016/j.tibs.2012.11.009; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ray A, 2015, LEUKEMIA, V29, P1441, DOI 10.1038/leu.2015.11; Richardson PG, 2014, BLOOD, V123, P1461, DOI 10.1182/blood-2013-07-517276; Richardson PG, 2014, BLOOD, V123, P1826, DOI 10.1182/blood-2013-11-538835; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2009, J CLIN ONCOL, V27, P5713, DOI 10.1200/JCO.2009.22.2679; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Song Y, 2016, LEUKEMIA, V30, P1877, DOI 10.1038/leu.2016.97; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Spataro V, 2002, ANTICANCER RES, V22, P3905; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.13140/RG.2.1.1735.6249; Watson RA, 2002, CARCINOGENESIS, V23, P1791, DOI 10.1093/carcin/23.11.1791; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	47	56	57	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 5	2017	36	40					5631	5638		10.1038/onc.2017.172	http://dx.doi.org/10.1038/onc.2017.172			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI8ZW	28581522	Green Accepted			2022-12-26	WOS:000412293600007
J	Kemp, MG				Kemp, Michael G.			DNA damage-induced ATM- and Rad-3-related (ATR) kinase activation in non-replicating cells is regulated by the XPB subunit of transcription factor IIH (TFIIH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell cycle; cell signaling; DNA damage; DNA damage response; DNA repair; genomic instability; RNA polymerase; transcription; transcription factor	NUCLEOTIDE-EXCISION-REPAIR; CHECKPOINT ACTIVATION; TARGETING ATR; RNA-POLYMERASE; IN-VIVO; REPLICATION CHECKPOINT; HUMAN FIBROBLASTS; COUPLED REPAIR; UV-IRRADIATION; P53	The role of the DNA damage response protein kinase ataxia telangiectasia-mutated (ATM)- and Rad-3-related (ATR) in the cellular response to DNA damage during the replicative phase of the cell cycle has been extensively studied. However, little is known about ATR kinase function in cells that are not actively replicating DNA and that constitute most cells in the human body. Using small-molecule inhibitors of ATR kinase and overexpression of a kinase-inactive form of the enzyme, I show here that ATR promotes cell death in non-replicating/non-cycling cultured human cells exposed to N-acetoxy-2-acetylaminofluorene (NA-AAF), which generates bulky DNA adducts that block RNA polymerase movement. Immunoblot analyses of soluble protein extracts revealed that ATR and other cellular proteins containing SQ motifs become rapidly and robustly phosphorylated in non-cycling cells exposed to NA-AAF in a manner largely dependent on ATR kinase activity but independent of the essential nucleotide excision repair factor XPA. Although the topoisomerase I inhibitor camptothecin also activated ATR in non-cycling cells, other transcription inhibitors that do not directly damage DNA failed to do so. Interestingly, genetic and pharmacological inhibition of the XPB subunit of transcription factor IIH prevented the accumulation of the single-stranded DNA binding protein replication protein A (RPA) on damaged chromatin and severely abrogated ATR signaling in response to NA-AAF and camptothecin. Together, these results reveal a previously unknown role for transcription factor IIH in ATR kinase activation in non-replicating, non-cycling cells.	[Kemp, Michael G.] Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Kemp, MG (corresponding author), Wright State Univ, Dept Pharmacol & Toxicol, Boonshoft Sch Med, Dayton, OH 45435 USA.	mike.kemp@wright.edu	Kemp, Michael G./AAT-1545-2021	Kemp, Michael G./0000-0001-8203-0745	University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health) [P30ES010126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a pilot project award (to M. G. K.) from the University of North Carolina Center for Environmental Health and Susceptibility (National Institutes of Health Grant P30ES010126). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alekseev S, 2014, CHEM BIOL, V21, P398, DOI 10.1016/j.chembiol.2013.12.014; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; CHEN YH, 1993, J BIOL CHEM, V268, P5849; CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cleaver JE, 2011, PHOTOCHEM PHOTOBIOL, V87, P1230, DOI 10.1111/j.1751-1097.2011.00995.x; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Donahue BA, 1996, J BIOL CHEM, V271, P10588, DOI 10.1074/jbc.271.18.10588; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; He QL, 2015, ANGEW CHEM INT EDIT, V54, P1859, DOI 10.1002/anie.201408817; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang GC, 2006, MOL CELL BIOL, V26, P39, DOI 10.1128/MCB.26.1.39-49.2006; Karnitz LM, 2015, CLIN CANCER RES, V21, P4780, DOI 10.1158/1078-0432.CCR-15-0479; Kaufmann WK, 2003, MUTAT RES-FUND MOL M, V532, P85, DOI 10.1016/j.mrfmmm.2003.08.012; Kemp MG, 2017, PHOTOCHEM PHOTOBIOL, V93, P178, DOI 10.1111/php.12641; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Klibanov SA, 2001, J CELL SCI, V114, P1867; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Liu YY, 2010, J BIOL CHEM, V285, P5974, DOI 10.1074/jbc.M109.076109; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Llona-Minguez S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.10; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKay BC, 2000, MOL BIOL CELL, V11, P2543, DOI 10.1091/mbc.11.8.2543; Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517; Munoz MJ, 2017, CELL REP, V18, P2868, DOI 10.1016/j.celrep.2017.02.066; Nam EA, 2011, J BIOL CHEM, V286, P28707, DOI 10.1074/jbc.M111.248914; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; O'Hagan HM, 2004, ONCOGENE, V23, P5505, DOI 10.1038/sj.onc.1207709; Ray A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159344; Revet I, 2011, P NATL ACAD SCI USA, V108, P8663, DOI 10.1073/pnas.1105866108; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Song J, 2017, PHOTOCHEM PHOTOBIOL, V93, P192, DOI 10.1111/php.12638; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; van Gijssel HE, 2003, LIFE SCI, V73, P1759, DOI 10.1016/S0024-3205(03)00506-X; van Oosterwijk MF, 1998, J BIOL CHEM, V273, P13599, DOI 10.1074/jbc.273.22.13599; vanOosterwijk MF, 1996, NUCLEIC ACIDS RES, V24, P4653, DOI 10.1093/nar/24.23.4653; Vendetti FP, 2017, SCI REP-UK, V7, DOI 10.1038/srep41892; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Vrouwe MG, 2011, J CELL SCI, V124, P435, DOI 10.1242/jcs.075325; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12424	12435		10.1074/jbc.M117.788406	http://dx.doi.org/10.1074/jbc.M117.788406			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28592488	Green Published, hybrid			2022-12-26	WOS:000406636900008
J	Domingo-Fernandez, R; Coll, RC; Kearney, J; Breit, S; O'Neill, LAJ				Domingo-Fernandez, Raquel; Coll, Rebecca C.; Kearney, Jay; Breit, Samuel; O'Neill, Luke A. J.			The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1 beta transcription and activate the NLRP3 inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NUCLEAR TRANSLOCATION; ALZHEIMERS-DISEASE; NALP3 INFLAMMASOME; ATP BINDING; CELL-DEATH; URIC-ACID; INTERLEUKIN-1-BETA; RELEASE; SHOCK	The NLRP3 inflammasome is a multiprotein complex that regulates the activation of caspase-1 leading to the maturation of the proinflammatory cytokines IL-1 beta and IL-18 and promoting pyroptosis. Classically, the NLRP3 inflammasome in murine macrophages is activated by the recognition of pathogen-associated molecular patterns and by many structurally unrelated factors. Understanding the precise mechanism of NLRP3 activation by such a wide array of stimuli remains elusive, but several signaling events, including cytosolic efflux and influx of select ions, have been suggested. Accordingly, several studies have indicated a role of anion channels in NLRP3 inflammasome assembly, but their direct involvement has not been shown. Here, we report that the chloride intracellular channel proteins CLIC1 and CLIC4 participate in the regulation of the NLRP3 inflammasome. Confocal microscopy and cell fractionation experiments revealed that upon LPS stimulation of macrophages, CLIC1 and CLIC4 translocated into the nucleus and cellular membrane. In LPS/ATP-stimulated bone marrow-derived macrophages (BMDMs), CLIC1 or CLIC4 siRNA transfection impaired transcription of IL-1 beta, ASC speck formation, and secretion of mature IL-1 beta. Collectively, our results demonstrate that CLIC1 and CLIC4 participate both in the priming signal for IL-1 beta and in NLRP3 activation.	[Domingo-Fernandez, Raquel; Kearney, Jay; O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland; [Coll, Rebecca C.] Univ Queensland, IMB Ctr Inflammat & Dis Res, IMB, St Lucia, Qld 4072, Australia; [Breit, Samuel] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Breit, Samuel] Univ New South Wales, Sydney, NSW 2010, Australia	Trinity College Dublin; University of Queensland; St Vincents Hospital Sydney; University of New South Wales Sydney	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Pearse St, Dublin 2, Ireland.	laoneill@tcd.ie	Coll, Rebecca/J-2124-2014	Coll, Rebecca/0000-0002-7359-6023; O'Neill, Luke/0000-0002-4333-2748	European Research Council [268155_MicroInnate]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the European Research Council (268155_MicroInnate; to L.A.J.O.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Rawi PG, 2010, STROKE, V41, P122, DOI 10.1161/STROKEAHA.109.560698; Averaimo S, 2010, FEBS LETT, V584, P2076, DOI 10.1016/j.febslet.2010.02.073; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Cross M, 2015, MOL CELL BIOCHEM, V398, P83, DOI 10.1007/s11010-014-2207-z; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Denoble AE, 2011, P NATL ACAD SCI USA, V108, P2088, DOI 10.1073/pnas.1012743108; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Ip WKE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7931; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; LALIBERTE R, 1994, J IMMUNOL, V153, P2168; Laliberte RE, 2003, J BIOL CHEM, V278, P16567, DOI 10.1074/jbc.M211596200; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Legrand-Poels S, 2014, BIOCHEM PHARMACOL, V92, P131, DOI 10.1016/j.bcp.2014.08.013; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Malik M, 2012, P NATL ACAD SCI USA, V109, P6130, DOI 10.1073/pnas.1201351109; Malik M, 2010, J BIOL CHEM, V285, P23818, DOI 10.1074/jbc.M109.091611; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marty V, 2005, GLIA, V49, P511, DOI 10.1002/glia.20138; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meng DM, 2013, MOL MED REP, V7, P1761, DOI 10.3892/mmr.2013.1429; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Peeters PM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-3; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Perregaux DG, 1996, J BIOL CHEM, V271, P29830, DOI 10.1074/jbc.271.47.29830; Peter B, 2014, BIOCHEMISTRY-US, V53, P57, DOI 10.1021/bi401433f; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petroni RC, 2015, INFLAMMATION, V38, P2026, DOI 10.1007/s10753-015-0183-4; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Salminen A, 2008, J CELL MOL MED, V12, P2255, DOI 10.1111/j.1582-4934.2008.00496.x; Singh H, 2006, BIOPHYS J, V90, P1628, DOI 10.1529/biophysj.105.072678; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Wang YL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/201614; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200; Westwell-Roper C, 2014, IMMUNOL CELL BIOL, V92, P314, DOI 10.1038/icb.2014.4; Zeng WX, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0351-6	51	75	78	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12077	12087		10.1074/jbc.M117.797126	http://dx.doi.org/10.1074/jbc.M117.797126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28576828	Green Published, hybrid			2022-12-26	WOS:000406053300007
J	Castan, C; Munch, A; Mahling, M; Haffner, L; Griewatz, J; Hermann-Werner, A; Riessen, R; Reutershan, J; Celebi, N				Castan, Christoph; Munch, Alexander; Mahling, Moritz; Haffner, Leopold; Griewatz, Jan; Hermann-Werner, Anne; Riessen, Reimer; Reutershan, Jorg; Celebi, Nora			Factors associated with delayed defibrillation in cardiopulmonary resuscitation: A prospective simulation study	PLOS ONE			English	Article							COUNCIL GUIDELINES; CARDIAC ARRESTS; LIFE-SUPPORT; RETENTION; CARE	Introduction Early defibrillation is an important factor of survival in cardiac arrest. However, novice resuscitators often struggle with cardiac arrest patients. We investigated factors leading to delayed defibrillation performed by final-year medical students within a simulated bystander cardiac arrest situation. Methods Final-year medical students received a refresher lecture and basic life support training before being confronted with a simulated cardiac arrest situation in a simulation ambulance. The scenario was analyzed for factors leading to delayed defibrillation. We compared the time intervals the participants needed for various measures with a benchmark set by experienced resuscitators. After training, the participants were interviewed regarding challenges and thoughts during the scenario. Results The median time needed for defibrillation was 158 s (n = 49, interquartile range: 107-270 s), more than six-fold of the benchmark time. The major part of total defibrillation time (49%; median, n = 49) was between onset of ventricular fibrillation and beginning to prepare the defibrillator, more specifically the time between end of preparation of the defibrillator and actual delivery of the shock, with a mean proportion of 26% (n = 49, SD = 17%) of the overall time needed for defibrillation (maximum 67%). Self-reported reasons for this delay included uncertainty about the next step to take, as reported by 73% of the participants. A total of 35% were unsure about which algorithm to follow. Diagnosing the patient was subjectively difficult for 35% of the participants. Overall, 53% of the participants felt generally confused. Conclusions Our study shows that novice resuscitators rarely achieve guideline-recommended defibrillation times. The most relative delays were observed when participants had to choose what to do next or which algorithm to follow, and thus i.e. performed extensive airway management before a life-saving defibrillation. Our data provides a first insight in the process of defibrillation delay and can be used to generate new hypotheses on how to provide a timely defibrillation.	[Castan, Christoph; Haffner, Leopold] Univ Tubingen, Fac Med, Sch Med, Tubingen, Germany; [Munch, Alexander] Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Mahling, Moritz] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Griewatz, Jan] Univ Tubingen, Fac Med, Competence Ctr Univ Teaching Med, Tubingen, Germany; [Hermann-Werner, Anne] Univ Tubingen, Fac Med, DocLab, Tubingen, Germany; [Hermann-Werner, Anne] Univ Tubingen, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany; [Riessen, Reimer] Univ Tubingen, Med Intens Care Unit, Dept Internal Med, Tubingen, Germany; [Reutershan, Jorg] Bayreuth Hosp, Dept Anesthesiol & Intens Care Med, Preuschwitzer Str 101, Bayreuth, Germany; [Celebi, Nora] PHV Dialysezentrum Waiblingen, Beinsteiner Str 8-3, Waiblingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Klinikum Bayreuth	Mahling, M (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	moritz.mahling@med.uni-tuebingen.de	Riessen, Reimer/AFR-0686-2022	Griewatz, Jan/0000-0002-9731-3171	"PROFIL" program, Faculty of Medicine, University of Tubingen	"PROFIL" program, Faculty of Medicine, University of Tubingen	This study was funded by the "PROFIL" program, Faculty of Medicine, University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Dreyfus SE., 2004, B SCI TECHNOL SOC, V24, P177, DOI [DOI 10.1177/0270467604264992, 10.1177/0270467604264992]; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Hunt EA, 2009, RESUSCITATION, V80, P819, DOI 10.1016/j.resuscitation.2009.03.020; Marsch SCU, 2005, CRIT CARE MED, V33, P963, DOI 10.1097/01.CCM.0000157750.43459.07; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Soar J, 2015, ADULT ADV LIFE SUPPO; Spearpoint KG, 2000, RESUSCITATION, V44, P165, DOI 10.1016/S0300-9572(00)00158-1; Sullivan NJ, 2015, RESUSCITATION, V86, P6, DOI 10.1016/j.resuscitation.2014.10.021; Yang CW, 2012, RESUSCITATION, V83, P1055, DOI 10.1016/j.resuscitation.2012.02.027	13	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178794	10.1371/journal.pone.0178794	http://dx.doi.org/10.1371/journal.pone.0178794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594858	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200052
J	Florio, R; De Lellis, L; di Giacomo, V; Di Marcantonio, MC; Cristiano, L; Basile, M; Verginelli, F; Verzilli, D; Ammazzalorso, A; Prasad, SC; Cataldi, A; Sanna, M; Cimini, A; Mariani-Costantini, R; Mincione, G; Cama, A				Florio, Rosalba; De Lellis, Laura; di Giacomo, Viviana; Di Marcantonio, Maria Carmela; Cristiano, Loredana; Basile, Mariangela; Verginelli, Fabio; Verzilli, Delfina; Ammazzalorso, Alessandra; Prasad, Sampath Chandra; Cataldi, Amelia; Sanna, Mario; Cimini, Annamaria; Mariani-Costantini, Renato; Mincione, Gabriella; Cama, Alessandro			Effects of PPAR alpha inhibition in head and neck paraganglioma cells	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; SUCCINATE-DEHYDROGENASE; IN-VITRO; CANCER; ACID; EXPRESSION; MUTATIONS; GENE	Head and neck paragangliomas (HNPGLs) are rare tumors that may cause important morbidity, because of their tendency to infiltrate the skull base. At present, surgery is the only therapeutic option, but radical removal may be difficult or impossible. Thus, effective targets and molecules for HNPGL treatment need to be identified. However, the lack of cellular models for this rare tumor hampers this task. PPARa receptor activation was reported in several tumors and this receptor appears to be a promising therapeutic target in different malignancies. Considering that the role of PPARa in HNPGLs was never studied before, we analyzed the potential of modulating PPARa in a unique model of HNPGL cells. We observed an intense immunoreactivity for PPARa in HNPGL tumors, suggesting that this receptor has an important role in HNPGL. A pronounced nuclear expression of PPARa was also confirmed in HNPGL-derived cells. The specific PPARa agonist WY14643 had no effect on HNPGL cell viability, whereas the specific PPARa antagonist GW6471 reduced HNPGL cell viability and growth by inducing cell cycle arrest and caspase-dependent apoptosis. GW6471 treatment was associated with a marked decrease of CDK4, cyclin D3 and cyclin B1 protein expression, along with an increased expression of p21 in HNPGL cells. Moreover, GW6471 drastically impaired clonogenic activity of HNPGL cells, with a less marked effect on cell migration. Notably, the effects of GW6471 on HNPGL cells were associated with the inhibition of the PI3K/GSK3 beta/beta-catenin signaling pathway. In conclusion, the PPARa antagonist GW6471 reduces HNPGL cell viability, interfering with cell cycle and inducing apoptosis. The mechanisms affecting HNPGL cell viability involve repression of the PI3K/GSK3 beta/beta-catenin pathway. Therefore, PPARa could represent a novel therapeutic target for HNPGL.	[Florio, Rosalba; De Lellis, Laura; di Giacomo, Viviana; Basile, Mariangela; Verginelli, Fabio; Verzilli, Delfina; Ammazzalorso, Alessandra; Cataldi, Amelia; Cama, Alessandro] G dAnnunzio Univ Chieti Pescara, Dept Pharm, Chieti, Italy; [Florio, Rosalba; De Lellis, Laura; Verginelli, Fabio; Mariani-Costantini, Renato; Cama, Alessandro] Univ G dAnnunzio, Unit Gen Pathol, CeSI MeT, Chieti, Italy; [Di Marcantonio, Maria Carmela; Mariani-Costantini, Renato; Mincione, Gabriella] G dAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Cristiano, Loredana; Cimini, Annamaria] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Prasad, Sampath Chandra; Sanna, Mario] Grp Otol, Dept Otol & Skull Base Surg, Piacenza, Italy; [Cimini, Annamaria] Temple Univ, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA; [Cimini, Annamaria] Natl Inst Nucl Phys INFN, Gran Sasso Natl Lab LNGS, Assergi, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of L'Aquila; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN)	De Lellis, L; Cama, A (corresponding author), G dAnnunzio Univ Chieti Pescara, Dept Pharm, Chieti, Italy.; De Lellis, L; Cama, A (corresponding author), Univ G dAnnunzio, Unit Gen Pathol, CeSI MeT, Chieti, Italy.	laura.delellis@unich.it; alessandro.cama@unich.it	Mariani-Costantini, Renato/B-6637-2012; de lellis, laura/AAQ-8789-2020; CAMA, Alessandro/J-3964-2018; Di Marcantonio, Maria Carmela/AAB-9564-2022; Ammazzalorso, Alessandra/O-4415-2019; CIMINI, ANNAMARIA/C-3688-2011	Mariani-Costantini, Renato/0000-0002-4440-1848; CAMA, Alessandro/0000-0003-3647-1368; Ammazzalorso, Alessandra/0000-0003-4369-1772; CIMINI, ANNAMARIA/0000-0002-2737-7970; CATALDI, Amelia/0000-0002-4989-6210; VERGINELLI, Fabio/0000-0002-8636-2517; DI GIACOMO, Viviana/0000-0003-3332-993X	Ministry of Education, University and Research (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN) funds [2010NFEB9L_008, 2015B7M39T_006]; Associazione Italiana per la Ricerca sul Cancro (AIRC) funds [IG 16932]	Ministry of Education, University and Research (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN) funds(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC) funds(Fondazione AIRC per la ricerca sul cancro)	The study was supported by the Ministry of Education, University and Research (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN) funds (grant numbers 2010NFEB9L_008 and 2015B7M39T_006, http://prin.miur.it/) assigned to A. Cama and by the Associazione Italiana per la Ricerca sul Cancro (AIRC) funds (grant number IG 16932,http://www.airc.it/) assigned to RMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Aboud O, 2015, AM J PHYSIOL-CELL PH, V308, pC890, DOI 10.1152/ajpcell.00322.2014; Ammazzalorso A, 2016, EUR J MED CHEM, V114, P191, DOI 10.1016/j.ejmech.2016.02.064; Ammazzalorso A, 2013, CHEMMEDCHEM, V8, P1609, DOI 10.1002/cmdc.201300250; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Benedetti E, 2010, INT J IMMUNOPATH PH, V23, P235, DOI 10.1177/039463201002300121; Benedetti E, 2017, J CELL PHYSIOL, V232, P1458, DOI 10.1002/jcp.25648; Benedetti E, 2010, PPAR RES, V2010, DOI 10.1155/2010/427401; Bogino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079614; Cama A, 2013, ACTA NEUROPATHOL, V126, P575, DOI 10.1007/s00401-013-1165-y; Chang NW, 2013, J NUTR BIOCHEM, V24, P274, DOI 10.1016/j.jnutbio.2012.06.005; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Fliedner SMJ, 2010, SEMIN ONCOL, V37, P627, DOI 10.1053/j.seminoncol.2010.10.017; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Kaipainen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000260; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Lack EE, 2003, MODERN PATHOL, V16, P833, DOI 10.1097/01.MP.0000081050.89276.CA; Laurenti G, 2011, J CELL BIOCHEM, V112, P3891, DOI 10.1002/jcb.23323; Mincione G, 2014, EXP CELL RES, V327, P24, DOI 10.1016/j.yexcr.2014.06.012; Panigrahy D, 2008, P NATL ACAD SCI USA, V105, P985, DOI 10.1073/pnas.0711281105; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; Piccini V, 2012, ENDOCR-RELAT CANCER, V19, P149, DOI 10.1530/ERC-11-0369; Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Taieb D, 2014, ENDOCR REV, V35, P795, DOI 10.1210/er.2014-1026; Tung S, 2013, BLOOD, V122, P969, DOI 10.1182/blood-2013-03-489468; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	32	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178995	10.1371/journal.pone.0178995	http://dx.doi.org/10.1371/journal.pone.0178995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594934	Green Submitted, gold, Green Published			2022-12-26	WOS:000402923200075
J	Guu, SY; Lin, TH; Chang, SC; Wang, RJ; Hung, LY; Fang, PJ; Tang, WC; Yu, P; Chang, CF				Guu, Shih-Yun; Lin, Tsung-Hsien; Chang, Su-Chieh; Wang, Rei-Jing; Hung, Ling-Yi; Fang, Po-Jan; Tang, Wei-Chien; Yu, Peiwen; Chang, Chuan-Fa			Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients	PLOS ONE			English	Article							CONTAINING MEMBRANE-COMPONENTS; TRANSFORMED MOUSE FIBROBLASTS; CARBOHYDRATE-BASED VACCINES; GLOBO-H; PRECANCEROUS CONDITIONS; GLYCAN STRUCTURES; LUNG-CANCER; LEWIS-X; BREAST; OVARIAN	Glycosylation is a protein post translational modification which plays important role in protein function, stabilization, trafficking, and turnover. Alteration of protein glycosylation is a common phenomenon during tumor progression, migration, invasion, angiogenesis, as well as metastasis. Hence, aberrant glycan structures and the induced corresponding anti-carbohydrate antibodies are potential biomarkers for cancer diagnosis. In this study, serum N-glycomes and anti-carbohydrate antibodies from normal populations and oral squamous cell carcinoma (OSCC) patients were investigated. Total serum proteins were lyophilized and subjected to chemical reduction, alkylation and trypsin digestion. The N-glycans were released, purified, permethylated, and analyzed using MALDI-TOF-Mass spectrometry. In addition, the serum anti-carbohydrate antibody profiles were also investigated by carbohydrate microarray. We found that the relative abundances of seven N-glycans were decreased or increased in serum of OSCC with diagnostic accuracy greater than 75%. The relative abundances of total tri-antennary and tetra-antennary glycans with varying degrees of fucosylation and sialylation were also increased in serum N-glycomes of OSCC. In an independent validation group of forty-eight OCCC patients, most of the high-molecular weight serum N-glycans showed significantly high sensitivity and specificity according to the identified cutoff values. Furthermore, the serum levels of two IgM antibodies were elevated accompanied with the decreased levels of nine IgG antibodies in patient serum. Taken together, these serum N-glycans and antibodies identified in this study should be considered as the candidates of potential biomarkers for OSCC diagnosis.	[Guu, Shih-Yun; Lin, Tsung-Hsien; Chang, Su-Chieh; Wang, Rei-Jing; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Lin, Tsung-Hsien; Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Hung, Ling-Yi; Fang, Po-Jan; Tang, Wei-Chien; Yu, Peiwen] OBI Pharma Inc, Taipei, Taiwan; [Chang, Chuan-Fa] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan, Taiwan; [Chang, Chuan-Fa] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University	Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.; Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.; Chang, CF (corresponding author), Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan, Taiwan.; Chang, CF (corresponding author), Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.	affa@mail.ncku.edu.tw	Chang, Chuan-Fa/F-8660-2011	Chang, Chuan-Fa/0000-0003-2404-1248; Chang, Shu-Chieh/0000-0001-8716-8196	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan [MOST 106-2321-B-006-004-]; OBI Pharma, Inc	Center of Infectious Disease and Signaling Research of NCKU; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); OBI Pharma, Inc	This work was supported by the Center of Infectious Disease and Signaling Research of NCKU and the Ministry of Science and Technology of Taiwan (MOST 106-2321-B-006-004-, http://www.most.gov.tw/). OBI Pharma, Inc. provided support in the form of salaries for authors LYH, PJF, WCT and PY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abbott KL, 2008, PROTEOMICS, V8, P3210, DOI 10.1002/pmic.200800157; Adler G, 2001, LUNG CANCER-J IASLC, V34, P383, DOI 10.1016/S0169-5002(01)00264-1; Alicia M., 2009, FUNCTIONAL GLYCOMICS; Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Almogren Adel, 2012, Front Biosci (Schol Ed), V4, P840; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; BRYNE M, 1991, CANCER-AM CANCER SOC, V67, P613, DOI 10.1002/1097-0142(19910201)67:3<613::AID-CNCR2820670316>3.0.CO;2-I; Burford B, 2013, BRIT J CANCER, V108, P2045, DOI 10.1038/bjc.2013.214; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen YT, 2013, CLIN CHIM ACTA, V420, P45, DOI 10.1016/j.cca.2012.10.019; Chiang CJ, 2016, J FORMOS MED ASSOC, V115, P1076, DOI 10.1016/j.jfma.2015.10.011; Czerwinski MJ, 2013, OTOLARYNG HEAD NECK, V149, P97, DOI 10.1177/0194599813482879; Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951; Damerell D, 2012, BIOL CHEM, V393, P1357, DOI 10.1515/hsz-2012-0135; Danishefsky SJ, 2015, ACCOUNTS CHEM RES, V48, P643, DOI 10.1021/ar5004187; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; Desiderio V, 2015, ONCOTARGET, V6, P71, DOI 10.18632/oncotarget.2698; Eller CH, 2015, ACS CENTRAL SCI, V1, P181, DOI 10.1021/acscentsci.5b00164; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Hevey R, 2012, FUTURE MED CHEM, V4, P545, DOI [10.4155/FMC.11.193, 10.4155/fmc.11.193]; Hofmann BT, 2014, CLIN CANCER RES, V20, P6117, DOI 10.1158/1078-0432.CCR-14-0716; Huang YL, 2013, P NATL ACAD SCI USA, V110, P2517, DOI 10.1073/pnas.1222649110; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kaul A, 2012, INFLAMM BOWEL DIS, V18, P1872, DOI 10.1002/ibd.22862; KO YC, 1995, J ORAL PATHOL MED, V24, P450, DOI 10.1111/j.1600-0714.1995.tb01132.x; Koh YW, 2013, AM J CLIN PATHOL, V139, P746, DOI 10.1309/AJCP2E6QNDIDPTTC; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Kyselova Z, 2007, J PROTEOME RES, V6, P1822, DOI 10.1021/pr060664t; Lin WJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/525976; Manoharan S, 2004, CLIN CHIM ACTA, V339, P91, DOI 10.1016/j.cccn.2003.09.006; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Mechref Y, 2009, J PROTEOME RES, V8, P2656, DOI 10.1021/pr8008385; MEEZAN E, 1969, BIOCHEMISTRY-US, V8, P2518, DOI 10.1021/bi00834a039; Noto Z, 2013, ORAL ONCOL, V49, P787, DOI 10.1016/j.oraloncology.2013.04.012; O'Cearbhaill RE, 2016, CANCERS, V8, DOI 10.3390/cancers8040046; Pan S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003251; Pedersen JW, 2014, INT J CANCER, V134, P2180, DOI 10.1002/ijc.28538; Pochechueva T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164230; Price NPJ, 2008, APPL BIOCHEM BIOTECH, V148, P271, DOI 10.1007/s12010-007-8044-8; Rajpura KB, 2005, J ORAL PATHOL MED, V34, P263; Shah FD, 2011, INDIAN J CLIN BIOCHE, V26, P326, DOI 10.1007/s12291-011-0149-8; Shah M, 2008, CANCER-AM CANCER SOC, V113, P336, DOI 10.1002/cncr.23556; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Smorodin E, 2013, INT J MED SCI, V10, P1674, DOI 10.7150/ijms.6841; Smorodin EP, 2008, WORLD J GASTROENTERO, V14, P4352, DOI 10.3748/wjg.14.4352; Sterner E, 2016, ACS CHEM BIOL, V11, P1773, DOI 10.1021/acschembio.6b00244; Varki R. K. A., 2009, ESSENTIALS GLYCOBIOL; Vasseur JA, 2012, GLYCOBIOLOGY, V22, P1684, DOI 10.1093/glycob/cws108; Viet C T, 2007, J Calif Dent Assoc, V35, P844; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Wang SH, 2011, PROTEOMICS, V11, P2812, DOI 10.1002/pmic.201000794; WU HC, 1969, BIOCHEMISTRY-US, V8, P2509, DOI 10.1021/bi00834a038; Yoshihama N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124743; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	54	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178927	10.1371/journal.pone.0178927	http://dx.doi.org/10.1371/journal.pone.0178927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594851	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200067
J	Hardy, L; Jespers, V; De Baetselier, I; Buyze, J; Mwambarangwe, L; Musengamana, V; van de Wijgert, J; Crucitti, T				Hardy, Liselotte; Jespers, Vicky; De Baetselier, Irith; Buyze, Jozefien; Mwambarangwe, Lambert; Musengamana, Viateur; van de Wijgert, Janneke; Crucitti, Tania			Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women	PLOS ONE			English	Article							BACTERIAL VAGINOSIS; HORMONAL CONTRACEPTION; ORAL-CONTRACEPTIVES; FLORA; MICROBICIDES; PREVENTION	We investigated the presence, density and bacterial composition of contraceptive vaginal ring biomass and its association with the vaginal microbiome. Of 415 rings worn by 120 Rwandese women for three weeks, the biomass density was assessed with crystal violet and the bacterial composition of biomass eluates was assessed with quantitative polymerase chain reaction (qPCR). The biomass was visualised after fluorescence in situ hybridisation (FISH) and with scanning electron microscopy (SEM). The vaginal microbiome was assessed with Nugent scoring and vaginal biofilm was visualised after FISH. All vaginal rings were covered with biomass (mean optical density (OD) of 3.36; standard deviation (SD) 0.64). Lactobacilli were present on 93% of the rings, Gardnerella vaginalis on 57%, and Atopobium vaginae on 37%. The ring biomass density was associated with the concentration of A. vaginae (OD + 0.03; 95% confidence interval (CI) 0.01 - 0.05 for one log increase; p = 0.002) and of G. vaginalis (OD + 0.03; (95% CI 0.01 - 0.05; p = 0.013). The density also correlated with Nugent score: rings worn by women with a BV Nugent score (mean OD + 0.26), and intermediate score (mean OD + 0.09) had a denser biomass compared to rings worn by participants with a normal score (p = 0.002). Furthermore, presence of vaginal biofilm containing G. vaginalis (p = 0.001) and A. vaginae (p = 0.005) correlated with a denser ring biomass (mean OD + 0.24 and + 0.22 respectively). With SEM we observed either a loose network of elongated bacteria or a dense biofilm. We found a correlation between vaginal dysbiosis and the density and composition of the ring biomass, and further research is needed to determine if these relationships are causal. As multipurpose vaginal rings to prevent pregnancy, HIV, and other sexually transmitted diseases are being developed, the potential impact of ring biomass on the vaginal microbiota and the release of active pharmaceutical ingredients should be researched in depth.	[Hardy, Liselotte; Jespers, Vicky] Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Unit, Antwerp, Belgium; [Hardy, Liselotte; De Baetselier, Irith; Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium; [Buyze, Jozefien] Inst Trop Med, Dept Clin Sci, Clin Trials Unit, Antwerp, Belgium; [Mwambarangwe, Lambert; Musengamana, Viateur; van de Wijgert, Janneke] Rinda Ubuzima, Kigali, Rwanda; [van de Wijgert, Janneke] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of Liverpool	Hardy, L (corresponding author), Inst Trop Med, Dept Publ Hlth, HIV & Sexual Hlth Unit, Antwerp, Belgium.; Hardy, L (corresponding author), Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium.	liselotte.hardy@gmail.com	Buyze, Jozefien/B-8550-2014; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Crucitti, Tania/AAH-1902-2021; Hardy, Liselotte/AAF-3515-2019	Buyze, Jozefien/0000-0001-6780-380X; Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; van de Wijgert, Janneke H.H.M./0000-0003-2728-4560	European & Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy' [SP.2011.41304.043]; University of Liverpool; Institute of Tropical Medicine	European & Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy'; University of Liverpool; Institute of Tropical Medicine	This work has been funded by The European & Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled 'Preparing for clinical trials with vaginal rings that protect women from HIV and unintended pregnancy' (grant code SP.2011.41304.043); the University of Liverpool and the Institute of Tropical Medicine.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; DAVIES GC, 1992, CONTRACEPTION, V45, P511, DOI 10.1016/0010-7824(92)90163-N; De Seta F, 2012, CONTRACEPTION, V86, P526, DOI 10.1016/j.contraception.2012.02.012; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002; Gunawardana M, 2011, J MED MICROBIOL, V60, P828, DOI 10.1099/jmm.0.028225-0; Hardy L, 2013, EURO BIOFILMS; Hardy L, 2016, SEX TRANSM INFECT, V0, P1; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Jespers V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109670; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Jiang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115326; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Machado A, 2015, J INFECT DIS; Machado A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-82; Malcolm RK, 2012, INT J WOMENS HEALTH, V4, P595, DOI 10.2147/IJWH.S36282; Malcolm RK, 2004, J CONTROL RELEASE, V97, P313, DOI 10.1016/j.jconrel.2004.03.029; Miller L, 2005, CONTRACEPTION, V71, P65, DOI 10.1016/j.contraception.2004.07.015; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Rabe L, 2014, HIVR4P; RamaRao S, 2013, CONTRACEPTION, V88, P591, DOI 10.1016/j.contraception.2013.05.004; Rosenberg ZF, 2012, BEST PRACT RES CL OB, V26, P503, DOI 10.1016/j.bpobgyn.2012.02.001; ROY S, 1981, CONTRACEPTION, V24, P481, DOI 10.1016/0010-7824(81)90011-1; Schurmans C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1680-y; SCHWAN A, 1983, CONTRACEPTION, V28, P341, DOI 10.1016/0010-7824(83)90036-7; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Thurman AR, 2013, INT J WOMENS HEALTH, V5, P695, DOI 10.2147/IJWH.S34030; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13	32	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178324	10.1371/journal.pone.0178324	http://dx.doi.org/10.1371/journal.pone.0178324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594946	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200028
J	Peng, PH; Hsu, SY; Wang, WS; Ko, ML				Peng, Pai Huei; Hsu, Sheng Yao; Wang, Wei Shin; Ko, Mei Lan			Age and axial length on peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in nonglaucomatous Taiwanese participants	PLOS ONE			English	Article							DOMAIN OCT; MYOPIA; PREVALENCE; GLAUCOMA; LOCATION; COUNT; SIZE; HEAD; DISK; EYES	Purpose This study investigates the influence of age and axial length (AL) on the peripapillary retinal nerve fiber layer (RNFL) thickness, as measured by optical coherence tomography (OCT). Methods Healthy patients visiting an eye clinic at a county hospital were recruited. All participants underwent comprehensive ophthalmologic examinations, and their retinas were scanned using 3D OCT-1000. In total, 223 patients with 446 eyes were included. The mean age and AL were 42.07 +/- 13.16 (21 - 76) years and 25.38 +/- 1.73 (21.19 - 30.37) mm, respectively. Results The average RNFL thickness decreased by 2.71 mu m for every 10-year increase in age (P < 0.001). Age-related RNFL thinning was more significant in participants older than 41 years (-0.24 mu m/year; P = 0.015). The earliest sector showing a significant decline in RNFL thickness was after 35 years of age (-0.70 mu m/year; P = 0.011) at the superior quadrant and at the 1 - 2 o'clock hour (-1.42 mu m/year; P = 0.009). Meanwhile, the maximal rate of age-associated RNFL decay was observed in these two regions as well. The reduction of RNFL with age progression did not differ in eyes with long AL (> 27 mm; -0.16 mu m/year) or those with short AL (< 25 mm; -0.22 mu m/year). For every 1-mm-greater AL, RNFL was thinner by 1.78 mu m (P < 0.001). The inferior quadrant showed the greatest tendency of RNFL decline with longer AL (4.46 mu m/mm; P< 0.001). Conclusions The factors of age and AL should be considered when interpreting the results. Significantly age-associated RNFL thinning was found in participants older than 41 years. Reduction of RNFL thickness with increasing age was not affected by AL. Topographic variations in RNFL thinning were observed in that the maximal decline of RNFL thickness with advancing age at the superior quadrant whereas with elongation of AL at the inferior quadrant.	[Peng, Pai Huei] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hsu, Sheng Yao] China Med Univ Hosp, An Nan Branch, Dept Ophthalmol, Tainan, Taiwan; [Wang, Wei Shin] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Antibody Engn Technol Dept, Hsinchu, Taiwan; [Ko, Mei Lan] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Ophthalmol, Hsinchu, Taiwan; [Ko, Mei Lan] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Industrial Technology Research Institute - Taiwan; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University	Ko, ML (corresponding author), Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Ophthalmol, Hsinchu, Taiwan.; Ko, ML (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	aaddch@gmail.com		Ko, Mei Lan/0000-0001-9758-4249	National Taiwan University Hospital, Hsin Chu Branch [HcH -2-990001]	National Taiwan University Hospital, Hsin Chu Branch	This research (HcH -2-990001) was supported with the grant of National Taiwan University Hospital, Hsin Chu Branch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Cheung CYL, 2011, INVEST OPHTH VIS SCI, V52, P1314, DOI 10.1167/iovs.10-5427; Feuer WJ, 2011, J GLAUCOMA, V20, P133, DOI 10.1097/IJG.0b013e3181e079b2; FitzGibbon T, 2012, JPN J OPHTHALMOL, V56, P631, DOI 10.1007/s10384-012-0185-9; Gabriele ML, 2008, INVEST OPHTH VIS SCI, V49, P2315, DOI 10.1167/iovs.07-0873; Hsu SY, 2013, CLIN EXP OPTOM, V96, P373, DOI 10.1111/cxo.12052; Huang ML, 2005, INVEST OPHTH VIS SCI, V46, P4121, DOI 10.1167/iovs.05-0069; Hwang YH, 2012, J GLAUCOMA, V21, P394, DOI 10.1097/IJG.0b013e3182182567; JONAS JB, 1992, INVEST OPHTH VIS SCI, V33, P2012; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Kim MJ, 2010, BRIT J OPHTHALMOL, V94, P115, DOI 10.1136/bjo.2009.162206; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Lin LL, 2004, ANN ACAD MED SINGAP, V33, P27; Matsumura H, 1999, SURV OPHTHALMOL, V44, pS109, DOI 10.1016/S0039-6257(99)00094-6; Melo GB, 2006, AM J OPHTHALMOL, V142, P858, DOI 10.1016/j.ajo.2006.05.022; MIKELBERG FS, 1989, OPHTHALMOLOGY, V96, P1325; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Patel NB, 2014, INVEST OPHTH VIS SCI, V55, P5134, DOI 10.1167/iovs.14-14303; Qu S, 2014, INT J OPHTHALMOL-CHI, V7, P654, DOI 10.3980/j.issn.2222-3959.2014.04.12; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Rauscher FM, 2009, J GLAUCOMA, V18, P501, DOI 10.1097/IJG.0b013e318193c2be; Sung KR, 2009, BRIT J OPHTHALMOL, V93, P1580, DOI 10.1136/bjo.2008.152223; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Zhang X, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.1	25	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179320	10.1371/journal.pone.0179320	http://dx.doi.org/10.1371/journal.pone.0179320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594952	gold, Green Submitted, Green Published			2022-12-26	WOS:000402923200118
J	Gasperoni, F; Ieva, F; Barbati, G; Scagnetto, A; Iorio, A; Sinagra, G; Di Lenarda, A				Gasperoni, Francesca; Ieva, Francesca; Barbati, Giulia; Scagnetto, Arjuna; Iorio, Annamaria; Sinagra, Gianfranco; Di Lenarda, Andrea			Multi-state modelling of heart failure care path: A population-based investigation from Italy	PLOS ONE			English	Article							LONG-TERM MORTALITY; COMPETING RISKS; PREDICTING MORTALITY; HOSPITALIZATION; SURVIVAL; REGISTRIES; COMMUNITY; PACKAGE; TRENDS; COACH	Background How different risk profiles of heart failure (HF) patients can influence multiple readmissions and outpatient management is largely unknown. We propose the application of two multi-state models in real world setting to jointly evaluate the impact of different risk factors on multiple hospital admissions, Integrated Home Care (IHC) activations, Intermediate Care Unit (ICU) admissions and death. Methods and findings The first model (model 1) concerns only hospitalizations as possible events and aims at detecting the determinants of repeated hospitalizations. The second model (model 2) considers both hospitalizations and ICU/IHC events and aims at evaluating which profiles are associated with transitions in intermediate care with respect to repeated hospitalizations or death. Both are characterized by transition specific covariates, adjusting for risk factors. We identified 4,904 patients (4,129 de novo and 775 worsening heart failure, WHF) hospitalized for HF from 2009 to 2014. 2,714 (55%) patients died. Advanced age and higher morbidity load increased the rate of dying and of being rehospitalized (model 1), decreased the rate of being discharged from hospital (models 1 and 2) and increased the rate of inactivation of IHC (model 2). WHF was an important risk factor associated with hospital readmission. Conclusion Multi-state models enable a better identification of two patterns of HF patients. Once adjusted for age and comorbidity load, the WHF condition identifies patients who are more likely to be readmitted to hospital, but does not represent an increasing risk factor for activating ICU/IHC. This highlights different ways to manage specific patients' patterns of care. These results provide useful healthcare support to patients' management in real world context. Our study suggests that the epidemiology of the considered clinical characteristics is more nuanced than traditionally presented through a single event.	[Gasperoni, Francesca; Ieva, Francesca] Politecn Milan, Dept Math, MOX Modelling & Sci Comp, Milan, Italy; [Barbati, Giulia; Scagnetto, Arjuna] Univ Trieste, Dept Med Sci, Trieste, Italy; [Barbati, Giulia; Iorio, Annamaria; Di Lenarda, Andrea] Cardiovasc Ctr, Trieste, Italy; [Iorio, Annamaria] Papa Giovanni XXIII Hosp, Cardiol Unit, Bergamo, Italy; [Sinagra, Gianfranco] Azienda Sanitaria Univ Integrata Trieste ASUITS, Cardiovasc Dept, Trieste, Italy	Polytechnic University of Milan; University of Trieste; ASST Papa Giovanni XXIII; University of Trieste	Ieva, F (corresponding author), Politecn Milan, Dept Math, MOX Modelling & Sci Comp, Milan, Italy.	francesca.ieva@polimi.it	Scagnetto, Arjuna/AAC-2311-2022; Di Lenarda, Andrea/AAC-2377-2022; Sinagra, Gianfranco/AAE-3943-2020; Barbati, Giulia/N-8418-2014	Scagnetto, Arjuna/0000-0002-4571-3640; Di Lenarda, Andrea/0000-0001-8482-4872; Barbati, Giulia/0000-0001-8942-5686; Ieva, Francesca/0000-0003-0165-1983; Gasperoni, Francesca/0000-0002-1713-9477				Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bakal JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106494; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Butler J, 2008, J AM COLL CARDIOL, V52, P435, DOI 10.1016/j.jacc.2008.04.037; Corrao G, 2015, INT J CARDIOL, V181, P81, DOI 10.1016/j.ijcard.2014.12.004; Dahtstrom U, 2009, EUR J HEART FAIL, V11, P92, DOI 10.1093/eurjhf/hfn006; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Driscoll A, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0371-7; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; Gustafsson F, 2007, EUR J HEART FAIL, V9, P910, DOI 10.1016/j.ejheart.2007.05.008; Ieva F, 2015, STAT METHODS MED RES; Ieva F, 2014, EXPERT REV CARDIOVAS, V12, P1383, DOI 10.1586/14779072.2015.982096; Jaarsma T, 2004, EUR J HEART FAIL, V6, P227, DOI 10.1016/j.ejheart.2003.09.010; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Oliva F, 2012, EUR J HEART FAIL, V14, P1208, DOI 10.1093/eurjhf/hfs117; Postmus D, 2012, EUR J HEART FAIL, V14, P168, DOI 10.1093/eurjhf/hfr163; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; R Core Team, 2015, R LANGUAGE ENV STAT; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Schmoor C, 2013, CLIN CANCER RES, V19, P12, DOI 10.1158/1078-0432.CCR-12-1619; Senni M, 1999, ARCH INTERN MED, V159, P29, DOI 10.1001/archinte.159.1.29; Stewart S, 2001, EUR HEART J, V22; Tavazzi L, 2016, EUR J HEART FAIL, V18, P1093, DOI 10.1002/ejhf.615; Testa G, 2009, AGE AGEING, V38, P734, DOI 10.1093/ageing/afp165; Therneau T.M., 2000, MODELING SURVIVAL DA; Therneau TM, 2015, PACKAGE SURVIVAL ANA; Tribouilloy C, 2008, EUR HEART J, V29, P339, DOI 10.1093/eurheartj/ehm554; Tuppin P, 2014, ARCH CARDIOVASC DIS, V107, P158, DOI 10.1016/j.acvd.2014.01.012	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179176	10.1371/journal.pone.0179176	http://dx.doi.org/10.1371/journal.pone.0179176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591172	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700093
J	Lee, MY; Hsiao, PJ; Huang, YT; Huang, JC; Hsu, WH; Chen, SC; Shin, SJ				Lee, Mei-Yueh; Hsiao, Pi-Jung; Huang, Yu-Ting; Huang, Jiun-Chi; Hsu, Wei-Hao; Chen, Szu-Chia; Shin, Shyi-Jang			Greater HbA(1c) variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease	PLOS ONE			English	Article							GLYCEMIC VARIABILITY; OXIDATIVE STRESS; MICROVASCULAR COMPLICATIONS; ENDOTHELIAL FUNCTION; GLUCOSE; MELLITUS; RISK; HYPERGLYCEMIA; HYPOGLYCEMIA; ACTIVATION	Emerging evidence suggests that glycemic variability may be a more reliable measure of glycemic control than mean HbA(1c) in type 2 diabetes mellitus. This study aimed to determine if HbA(1c) variability is associated with cardiovascular events in type 2 diabetic patients and if different renal functions affect such association. This longitudinal study enrolled 8259 diabetic patients from the Kaohsiung Medical University Research Database in 2009 and were followed-up until 2015. Intra-individual HbA(1C) variability was defined as the standard deviation (SD) of HbA(1c) and cardiovascular events were defined as hospitalization for coronary artery disease, unstable angina, myocardial infarction, stroke, peripheral artery disease, and cardiovascular death. The patients were grouped into two based on their estimated glomerular filtration rate (eGFR) >= 60 or < 60 min/ml/1.73m(2). In a mean follow-up period of 6.3 years, cardiovascular events were recorded in 8.9% of the patients. In an adjusted Cox model, high HbA(1c) SD (hazard ratio, 1.290; 95% confidence interval, 1.008-1.650; p = 0.043), but not mean HbA(1c), was associated with significantly increased risk of cardiovascular events in patients with eGFR >= 60 min/ml/1.73m(2). This association was not seen in patients with eGFR < 60 min/ml/1.73m(2). In this study, greater HbA(1c) variability is associated with increased risk of cardiovascular among patients with preserved renal function, but not in those with moderate to advanced chronic kidney disease.	[Lee, Mei-Yueh; Huang, Jiun-Chi; Chen, Szu-Chia] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Hsu, Wei-Hao; Shin, Shyi-Jang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Huang, Jiun-Chi; Hsu, Wei-Hao; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Mei-Yueh; Hsiao, Pi-Jung; Huang, Jiun-Chi; Chen, Szu-Chia; Shin, Shyi-Jang] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Huang, Yu-Ting] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res, Div Med Stat & Bioinformat, Kaohsiung, Taiwan; [Huang, Jiun-Chi; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Shin, Shyi-Jang] Kaohsiung Med Univ, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, SC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan.; Chen, SC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	Huang, Jiun-Chi/AAI-2494-2021; 蘇, 河名/AAE-9843-2019	Huang, Jiun-Chi/0000-0002-5897-2860; HUANG, YUTING/0000-0002-7056-5686; Hsiao, Pi-Jung/0000-0001-5024-9371				Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Hanefeld M, 2002, NUTR METAB CARDIOVAS, V12, P98; Hanefeld M, 2002, INT J CLIN PRACT, P45; Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001; Horvath EM, 2009, DIABETOLOGIA, V52, P952, DOI 10.1007/s00125-009-1304-0; Hsu CR, 2015, J DIABETES COMPLICAT, V29, P302, DOI 10.1016/j.jdiacomp.2014.11.013; Jun JE, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0233-0; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Lin CC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.015; Ly J, 2004, AM J KIDNEY DIS, V44, P715, DOI 10.1053/j.ajkd.2004.06.018; Menon V, 2005, AM J KIDNEY DIS, V45, P223, DOI 10.1053/j.ajkd.2004.09.022; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Murata GH, 2004, ARCH INTERN MED, V164, P1445, DOI 10.1001/archinte.164.13.1445; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Saisho Y, 2014, INT J MOL SCI, V15, P18381, DOI 10.3390/ijms151018381; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sugawara A, 2012, DIABETOLOGIA, V55, P2128, DOI 10.1007/s00125-012-2572-7; Uzu T, 2009, THER APHER DIAL, V13, P89, DOI 10.1111/j.1744-9987.2009.00661.x; Wan EYF, 2016, J DIABETES COMPLICAT, V30, P1240, DOI 10.1016/j.jdiacomp.2016.05.024	26	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178319	10.1371/journal.pone.0178319	http://dx.doi.org/10.1371/journal.pone.0178319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591149	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700030
J	Reding-Bernal, A; Sanchez-Pedraza, V; Moreno-Macias, H; Sobrino-Cossio, S; Tejero-Barrera, ME; Burguete-Garcia, AI; Leon-Hernandez, M; Serratos-Canales, MF; Duggirala, R; Lopez-Alvarenga, JC				Reding-Bernal, Arturo; Sanchez-Pedraza, Valentin; Moreno-Macias, Hortensia; Sobrino-Cossio, Sergio; Elizabeth Tejero-Barrera, Maria; Isabel Burguete-Garcia, Ana; Leon-Hernandez, Mireya; Fabiola Serratos-Canales, Maria; Duggirala, Ravindranath; Lopez-Alvarenga, Juan Carlos			Heritability and genetic correlation between GERD symptoms severity, metabolic syndrome, and inflammation markers in families living in Mexico City	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; EROSIVE ESOPHAGITIS; PREVALENCE; COMPONENTS; PRESSURE; OBESITY	Objective The aim of this study was to estimate the heritability (h(2)) and genetic correlation (rho G) between GERD symptoms severity, metabolic syndrome components, and inflammation markers in Mexican families. Methods Cross-sectional study which included 32 extended families resident in Mexico City. GERD symptoms severity was assessed by the ReQuest in Practice questionnaire. Heritability and genetic correlation were determined using the Sequential Oligogenic Linkage Analysis Routines software. Results 585 subjects were included, the mean age was 42 (+/- 16.7) years, 57% were women. The heritability of the severity of some GERD symptoms was h2 = 0.27, 0.27, 0.37, and 0.34 (p-value < 1.0x10(-5)) for acidity complaints, lower abdominal complaints, sleep disturbances, and total ReQuest score, respectively. Heritability of metabolic syndrome components ranged from 0.40 for fasting plasma glucose to 0.61 for body mass index and diabetes mellitus. The heritability for fibrinogen and C-reactive protein was 0.64 and 0.38, respectively. Statistically significant genetic correlations were found between acidity complaints and fasting plasma glucose (rho G = 0.40); sleep disturbances and fasting plasma glucose (rho G = 0.36); acidity complaints and diabetes mellitus (rho G = 0.49) and between total ReQuest score and fasting plasma glucose (rho G = 0.43). The rest of metabolic syndrome components did not correlate with GERD symptoms. Conclusion Genetic factors substantially explain the phenotypic variance of the severity of some GERD symptoms, metabolic syndrome components and inflammation markers. Observed genetic correlations suggest that these phenotypes share common genes. These findings suggest conducting further investigation, as the determination of a linkage analysis in order to identify regions of susceptibility for developing of GERD and metabolic syndrome.	[Reding-Bernal, Arturo; Leon-Hernandez, Mireya; Fabiola Serratos-Canales, Maria] Hosp Gen Mexico Dr Eduardo Liceaga, Div Res, Mexico City, DF, Mexico; [Sanchez-Pedraza, Valentin] Hosp Gen Mexico Dr Eduardo Liceaga, Serv Endocrinol, Mexico City, DF, Mexico; [Moreno-Macias, Hortensia] Univ Autonoma Metropolitana, Dept Econ, Mexico City, DF, Mexico; [Sobrino-Cossio, Sergio] Hosp Angeles Pedregal, Endoscopy Serv, Mexico City, DF, Mexico; [Elizabeth Tejero-Barrera, Maria] Inst Nacl Med Genom, Nutrigen Lab, Mexico City, DF, Mexico; [Isabel Burguete-Garcia, Ana] Inst Nacl Salud Publ, Dept Genet Epidemiol, Cuernavaca, Morelos, Mexico; [Duggirala, Ravindranath; Lopez-Alvarenga, Juan Carlos] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Edinburg, TX 78539 USA	Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Salud Publica; University of Texas System; University of Texas Rio Grande Valley	Reding-Bernal, A (corresponding author), Hosp Gen Mexico Dr Eduardo Liceaga, Div Res, Mexico City, DF, Mexico.; Lopez-Alvarenga, JC (corresponding author), Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Edinburg, TX 78539 USA.	reding_79@yahoo.com; juan.lopezalvarenga@utrgv.edu		Lopez-Alvarenga, Juan/0000-0002-0966-8766	Federal resources	Federal resources	This study was funded in full by Federal resources allocated to the General Hospital of Mexico "Dr. Eduardo Liceaga". JCLA received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MA, 2004, DIABETES, V53, P1166, DOI 10.2337/diabetes.53.4.1166; Bardhan KD, 2004, DIGESTION, V69, P229, DOI 10.1159/000079707; Bellia A, 2009, NUTR METAB CARDIOVAS, V19, P455, DOI 10.1016/j.numecd.2008.11.002; Cameron AJ, 2002, GASTROENTEROLOGY, V122, P55, DOI 10.1053/gast.2002.30301; Lopez-Alvarenga JC, 2014, J NEUROGASTROENTEROL, V20, P64, DOI 10.5056/jnm.2014.20.1.64; Comuzzie AG, 2001, J MOL MED, V79, P57, DOI 10.1007/s001090100202; Delaney BC, 2004, ALIMENT PHARM THER, V20, P2, DOI 10.1111/j.1365-2036.2004.02219.x; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; El-Serag HB, 2006, SCAND J GASTROENTERO, V41, P887, DOI 10.1080/00365520500535402; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fass R, 2007, J CLIN GASTROENTEROL, V41, P131, DOI 10.1097/01.mcg.0000225631.07039.6d; Gutierrez JP, 2012, ENCUESTA NACL SALUDY; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Heading RC, 1999, SCAND J GASTROENTERO, V34, P3, DOI 10.1080/003655299750025200; Hsu CS, 2011, ALIMENT PHARM THER, V34, P994, DOI 10.1111/j.1365-2036.2011.04817.x; Huerta-Iga F, 2012, REV GASTROENTEROL ME, V77, P193, DOI 10.1016/j.rgmx.2012.10.002; Iwasaki E, 2008, J GASTROEN HEPATOL, V23, pS216, DOI 10.1111/j.1440-1746.2008.05441.x; Johanson John F., 2000, American Journal of Medicine, V108, p99S; Kallel L, 2011, DIS ESOPHAGUS, V24, P153, DOI 10.1111/j.1442-2050.2010.01118.x; Kraja AT, 2005, HYPERTENSION, V46, P751, DOI 10.1161/01.HYP.0000184249.20016.bb; Lin HF, 2005, DIABETOLOGIA, V48, P2006, DOI 10.1007/s00125-005-1892-2; Llunh I, 1999, AM J GASTROENTEROL, V94, P919; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lopez-Alvarenga Juan C., 2008, Metabolic Syndrome and Related Disorders, V6, P129, DOI 10.1089/met.2007.0039; Lopez-Alvarenga JC, 2011, J NEUROGASTROENTEROL, V17, P381, DOI 10.5056/jnm.2011.17.4.381; Matsuzaki J, 2010, NEUROGASTROENT MOTIL, V22, P965, DOI 10.1111/j.1365-2982.2010.01518.x; Mohammed I, 2003, GUT, V52, P1085, DOI 10.1136/gut.52.8.1085; Moki F, 2007, ALIMENT PHARM THER, V26, P1069, DOI 10.1111/j.1365-2036.2007.03454.x; Park JH, 2008, WORLD J GASTROENTERO, V14, P5442, DOI 10.3748/wjg.14.5442; Ramu B, 2011, INDIAN J GASTROENTER, V30, P144, DOI 10.1007/s12664-010-0067-3; Rubin G, 2008, ALIMENT PHARM THER, V27, P846, DOI 10.1111/j.1365-2036.2008.03641.x; SOLAR Manual, DISCR TRAITS; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Sung J, 2009, J CLIN ENDOCR METAB, V94, P4946, DOI 10.1210/jc.2009-1268; Uscanga Luis, 2002, Rev Gastroenterol Mex, V67, P216; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; WHO, 2011, NCD COUNTR PROF; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178815	10.1371/journal.pone.0178815	http://dx.doi.org/10.1371/journal.pone.0178815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582452	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600042
J	Sogabe, M; Okahisa, T; Nakasono, M; Fukuno, H; Miyamoto, Y; Okada, Y; Okazaki, J; Miyoshi, J; Tomonari, T; Taniguchi, T; Goji, T; Kitamura, S; Miyamoto, H; Muguruma, N; Takayama, T				Sogabe, Masahiro; Okahisa, Toshiya; Nakasono, Masahiko; Fukuno, Hiroshi; Miyamoto, Yoshihiko; Okada, Yasuyuki; Okazaki, Jun; Miyoshi, Jinsei; Tomonari, Tetsu; Taniguchi, Tatsuya; Goji, Takahiro; Kitamura, Shinji; Miyamoto, Hiroshi; Muguruma, Naoki; Takayama, Tetsuji			The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study	PLOS ONE			English	Article							VISCERAL FAT; INSULIN-RESISTANCE; ALCOHOL INTAKE; DISEASE; SMOKING; INFLAMMATION; OBESITY; STEATOHEPATITIS; PREVALENCE; SEVERITY	Background Nonalcoholic fatty liver disease (NAFLD) is known to be strongly associated with obesity, visceral fat, metabolic syndrome (MS), lifestyle, and lifestyle-related diseases in both males and females. However, the prevalence of NAFLD, MS, and clinical backgrounds is different between males and females. Objective We conducted a cross-sectional study to examine the differing influence of lifestyle-related factors and visceral fat on fatty liver (FL) with elevation of liver enzymes between males and females with MS. Methods We enrolled 42,134 persons who underwent a regular health check-up, and after excluding subjects who fulfilled excluding criteria, the remaining subjects were 2,110 persons with MS. We examined the differing influence of lifestyle-related factors and visceral fat on FL with elevation of alanine aminotransferase (ALT) (ALT elevation was defined as ALT level of >= 31 IU/1 in the present study). Results The odds rations for FL with ALT elevation were as follows: WC, 1.83 (95% confidence interval (CI) 1.36-2.46); dyslipidemia, 1.89 (95% CI 1.34-2.68); hemoglobin Al c, 1.36 (95% CI 1.00-1.85); visceral fat type MS (V-type MS), 5.78 (95% CI 4.29-7.80); and light drinker, 0.56 (95% CI 0.41-0.78) in males with MS and BMI, 2.18 (95% CI 1.43-3.33); WC, 1.85 (95% CI 1.27-2.70); diastolic blood pressure, 1.69 (95% CI 1.16-2.45); triglyceride, 2.22 (95% CI 1.56-3.17); impaired glucose tolerance, 1.66 (95% CI 1.11-2.47); and V-type MS, 3.83 (95% CI 2.57-5.70) in females with MS. The prevalence of FL with ALT elevation and ALT was significantly higher in V-type MS than in the subcutaneous fat type MS in both males and females with MS (P < 0.001). Conclusion Although V-type MS and WC is a common significant predictor of an increased prevalence of FL with ALT elevation in both males and females with MS, gender, lifestyle-related factors, and MS type in individuals with MS should be considered for the development of FL with ALT elevation.	[Sogabe, Masahiro; Okahisa, Toshiya; Miyamoto, Yoshihiko; Okada, Yasuyuki; Okazaki, Jun; Miyoshi, Jinsei; Tomonari, Tetsu; Taniguchi, Tatsuya; Goji, Takahiro; Kitamura, Shinji; Miyamoto, Hiroshi; Muguruma, Naoki; Takayama, Tetsuji] Tokushima Univ, Inst Biomed Sci, Grad Sch, Dept Gastroenterol & Oncol, Tokushima, Japan; [Sogabe, Masahiro] Kagawa Prefectural Canc Detect Ctr, Dept Gastroenterol, Takamatsu, Kagawa, Japan; [Nakasono, Masahiko] Tsurugi Municipal Handa Hosp, Dept Internal Med, Tokushima, Japan; [Fukuno, Hiroshi] Natl Hosp Org, Higashi Tokushima Med Ctr, Dept Internal Med, Tokushima, Japan	Tokushima University	Sogabe, M (corresponding author), Tokushima Univ, Inst Biomed Sci, Grad Sch, Dept Gastroenterol & Oncol, Tokushima, Japan.; Sogabe, M (corresponding author), Kagawa Prefectural Canc Detect Ctr, Dept Gastroenterol, Takamatsu, Kagawa, Japan.	tokushimakenananshi@yahoo.co.jp						Agarwal Rajiv, 2005, BMC Nephrol, V6, P13; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Clark JM, 2003, GASTROENTEROLOGY, V124, P248, DOI 10.1053/gast.2003.50032; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Eguchi Y, 2006, J GASTROENTEROL, V41, P462, DOI 10.1007/s00535-006-1790-5; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Koda M, 2007, J GASTROENTEROL, V42, P897, DOI 10.1007/s00535-007-2107-z; Lee PN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-385; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mudali S, 2004, MECH AGEING DEV, V125, P297, DOI 10.1016/j.mad.2004.01.004; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x; SCHEFFLER E, 1992, CLIN INVESTIGATOR, V70, P263; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Stranges S, 2004, HEPATOLOGY, V39, P754, DOI 10.1002/hep.20149; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V; Taniai M, 2012, HEPATOL RES, V42, P359, DOI 10.1111/j.1872-034X.2011.00935.x; Tilg H, 2010, GASTROENTEROLOGY, V139, P1823, DOI 10.1053/j.gastro.2010.10.038; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Williams CM, 2004, P NUTR SOC, V63, P153, DOI 10.1079/PNS2003314	38	0	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0177925	10.1371/journal.pone.0177925	http://dx.doi.org/10.1371/journal.pone.0177925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574988	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300023
J	Vieira, GC; Vieira, GF; Sinigaglia, M; Valente, VLD				Vieira, Gilberto Cavalheiro; Vieira, Gustavo Fioravanti; Sinigaglia, Marialva; da Silva Valente, Vera Lucia			Linking epigenetic function to electrostatics: The DNMT2 structural model example	PLOS ONE			English	Article							DNA METHYLATION; DROSOPHILA-MELANOGASTER; PROTEIN STRUCTURES; METHYLTRANSFERASE HOMOLOG; HAEIII METHYLTRANSFERASE; EVOLUTION; GENOMES; SEQUENCE; GENES; 5-METHYLCYTOSINE	The amino acid sequence of DNMT2 is very similar to the catalytic domains of bacterial and eukaryotic proteins. However, there is great variability in the region of recognition of the target sequence. While bacterial DNMT2 acts as a DNA methyltransferase, previous studies have indicated low DNA methylation activity in eukaryotic DNMT2, with preference by tRNA methylation. Drosophilids are known as DNMT2-only species and the DNA methylation phenomenon is a not elucidated case yet, as well as the ontogenetic and physiologic importance of DNMT2 for this species group. In addition, more recently study showed that methylation in the genome in Drosophila melanogaster is independent in relation to DNMT2. Despite these findings, Drosophilidae family has more than 4,200 species with great ecological diversity and historical evolution, thus we, therefore, aimed to examine the drosophilids DNMT2 in order to verify its conservation at the physicochemical and structural levels in a functional context. We examined the twenty-six DNMT2 models generated by molecular modelling and five crystallographic structures deposited in the Protein Data Bank (PDB) using different approaches. Our results showed that despite sequence and structural similarity between species close related, we found outstanding differences when they are analyzed in the context of surface distribution of electrostatic properties. The differences found in the electrostatic potentials may be linked with different affinities and processivity of DNMT2 for its different substrates (DNA, RNA or tRNA) and even for interactions with other proteins involved in the epigenetic mechanisms.	[Vieira, Gilberto Cavalheiro; Vieira, Gustavo Fioravanti; Sinigaglia, Marialva; da Silva Valente, Vera Lucia] Univ Fed Rio Grande do Sul, Programa Pos Grad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Vieira, Gilberto Cavalheiro; Sinigaglia, Marialva; da Silva Valente, Vera Lucia] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Porto Alegre, RS, Brazil; [Vieira, Gustavo Fioravanti] Univ Fed Rio Grande do Sul, Nucleo Bioinformat, Lab Imunogenet, Dept Genet, Porto Alegre, RS, Brazil; [Sinigaglia, Marialva] Inst Canc Infantil, Porto Alegre, RS, Brazil; [da Silva Valente, Vera Lucia] Univ Fed Rio Grande do Sul, Programa Pos Grad Biol Anim, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Vieira, GC (corresponding author), Univ Fed Rio Grande do Sul, Programa Pos Grad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Vieira, GC (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Inst Biociencias, Porto Alegre, RS, Brazil.	cavalheiro.rs@gmail.com	vieira, gustavo F/G-4846-2012; Cavalheiro, Gilberto/N-9928-2019; Sinigaglia, Marialva/AAG-3172-2020	vieira, gustavo F/0000-0002-2380-8059; Vieira, Gilberto/0000-0001-5972-6525; Valente, Vera/0000-0001-8661-6284; Sinigaglia, Marialva/0000-0002-8324-6860	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundagao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [10/0028-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD-CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD-CAPES)	This study was supported by grants and fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS no 10/0028-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD-CAPES).	AYALA FJ, 1972, P NATL ACAD SCI USA, V69, P1094, DOI 10.1073/pnas.69.5.1094; Bachli G., TAXODROS DATABASE TA; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bhabha G, 2013, NAT STRUCT MOL BIOL, V20, P1243, DOI 10.1038/nsmb.2676; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Branden C., 1999, INTRO PROTEIN STRUCT; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cohen HM, 2004, PROTEIN ENG DES SEL, V17, P3, DOI 10.1093/protein/gzh001; D'Avila MF, 2010, GENETICA, V138, P907, DOI 10.1007/s10709-010-9473-9; DACUNHA AB, 1950, EVOLUTION, V4, P212, DOI 10.2307/2405333; Damborsky J, 2014, CURR OPIN CHEM BIOL, V19, P8, DOI 10.1016/j.cbpa.2013.12.003; Deane C, 2003, THE PRACTICE OF MEDI; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3; Eastwood MP, 2001, IBM J RES DEV, V45, P475, DOI 10.1147/rd.453.0475; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fisher O, 2004, NUCLEIC ACIDS RES, V32, P287, DOI 10.1093/nar/gkh161; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Garcia RN, 2007, GENETICA, V131, P91, DOI 10.1007/s10709-006-9116-3; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Heger A, 2007, GENOME RES, V17, P1837, DOI 10.1101/gr.6249707; Hermann A, 2003, J BIOL CHEM, V278, P31717, DOI 10.1074/jbc.M305448200; Hildebrandt A, 2007, BIOINFORMATICS, V23, pE99, DOI 10.1093/bioinformatics/btl312; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeltsch A, 2006, TRENDS BIOCHEM SCI, V31, P306, DOI 10.1016/j.tibs.2006.04.005; Jurkowski TP, 2012, BIOCHEMISTRY-US, V51, P4438, DOI 10.1021/bi3002659; Kaiser S, 2017, RNA BIOL, V14, P1241, DOI 10.1080/15476286.2016.1236170; Katoh M, 2006, EUKARYOT CELL, V5, P18, DOI 10.1128/EC.5.1.18-25.2006; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Kuhlmann M, 2005, NUCLEIC ACIDS RES, V33, P6405, DOI 10.1093/nar/gki952; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerat E, 2011, GENE, V473, P100, DOI 10.1016/j.gene.2010.11.009; Li SS, 2013, J MOL CELL BIOL, V5, P64, DOI 10.1093/jmcb/mjs057; Lindstrom WM, 2000, J BIOL CHEM, V275, P4912, DOI 10.1074/jbc.275.7.4912; Lupas AN, 2001, J STRUCT BIOL, V134, P191, DOI 10.1006/jsbi.2001.4393; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; OGara M, 1996, J MOL BIOL, V263, P597, DOI 10.1006/jmbi.1996.0601; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; PATEL CV, 1987, ANAL BIOCHEM, V164, P164, DOI 10.1016/0003-2697(87)90381-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Ponger L, 2005, MOL BIOL EVOL, V22, P1119, DOI 10.1093/molbev/msi098; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Rohde C, 2012, GENET MOL BIOL, V35, P966, DOI 10.1590/S1415-47572012000600012; Schaefer M, 2010, NAT GENET, V42, P920, DOI 10.1038/ng1110-920; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schulz EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038728; Shanmugam R, 2014, NUCLEIC ACIDS RES, V42, P6487, DOI 10.1093/nar/gku256; Takayama S, 2014, GENOME RES, V24, P821, DOI 10.1101/gr.162412.113; Tang LY, 2003, J BIOL CHEM, V278, P33613, DOI 10.1074/jbc.C300255200; Thiagarajan D, 2011, EPIGENETICS-US, V6, P103, DOI 10.4161/epi.6.1.13418; Tweedie S, 1999, NAT GENET, V23, P389, DOI 10.1038/70490; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	63	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178643	10.1371/journal.pone.0178643	http://dx.doi.org/10.1371/journal.pone.0178643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575027	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300086
J	Weng, CC; Hawse, JR; Subramaniam, M; Chang, VHS; Yu, WCY; Hung, WC; Chen, LT; Cheng, KH				Weng, C-C; Hawse, J. R.; Subramaniam, M.; Chang, V. H. S.; Yu, W. C. Y.; Hung, W-C; Chen, L-T; Cheng, K-H			KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras(G12D) p53(flox/flox) model	ONCOGENE			English	Article							INDUCIBLE EARLY GENE; TGF-BETA; MESENCHYMAL TRANSITION; TUMOR SUPPRESSION; CELL-MIGRATION; CANCER; GROWTH; RECEPTOR; EXPRESSION; CXCR4	Kruppel-like transcription factor 10 (KLF10), also named as TIEG1, plays essential roles in mediating transforming growth factor beta (TGF beta) signaling and has been shown to function as a tumor suppressor in multiple cancer types. However, its roles in mediating cancer progression in vivo have yet to be fully characterized. Here, we have employed two well-characterized Pdx-1CreLSL-Kras(G12D) and Pdx-1CreLSL-Kras(G12D)p53(L/L) pancreatic cancer models to ablate KLF10 expression and determine the impact of KLF10 deletion on tumor development and progression. We show that loss of KLF10 cooperates with Kras(G12D) leading to an invasive and widely metastatic phenotype of pancreatic ductal adenocarcinoma (PDAC). Mechanistically, loss of KLF10 in PDAC is shown to increase distant metastases and cancer stemness through activation of SDF-1/CXCR4 and AP-1 pathways. Furthermore, we demonstrate that targeting the SDF-1/CXCR4 pathway in the context of KLF10 deletion substantially suppresses PDAC progression suggesting that inhibition of this pathway represents a novel therapeutic strategy for PDAC treatment.	[Weng, C-C; Cheng, K-H] Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan; [Hawse, J. R.; Subramaniam, M.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Chang, V. H. S.] Taipei Med Univ, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan; [Yu, W. C. Y.; Hung, W-C; Chen, L-T; Cheng, K-H] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hung, W-C] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Inst Basic Med Sci, Tainan, Taiwan; [Chen, L-T] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Cheng, K-H] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	National Sun Yat Sen University; Mayo Clinic; Taipei Medical University; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University	Chen, LT; Cheng, KH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 80424, Taiwan.	leochen@nhri.org.tw; khcheng@faculty.nsysu.edu.tw			Ministry of Science and Technology, Taiwan ROC [MOST 104-2320-B-110-003, 105-2320-B-110-004, MOST 101-2628-B-400-003-MY2, MOST 105-2321-B-400-010]; Kaohsiung Medical University, Kaohsiung, Taiwan [KMU-TP104G00, KMU-TP105G00]; National Institutes of Health, USA [R01 DE14036]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014036] Funding Source: NIH RePORTER	Ministry of Science and Technology, Taiwan ROC(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University, Kaohsiung, Taiwan; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants MOST 104-2320-B-110-003 and 105-2320-B-110-004 (to KH Cheng), MOST 101-2628-B-400-003-MY2 (to LT Chen) and MOST 105-2321-B-400-010 (to LT Chen and KH Cheng) from the Ministry of Science and Technology, Taiwan ROC, and grants KMU-TP104G00, KMU-TP105G00 (to KH Cheng) from Kaohsiung Medical University, Kaohsiung, Taiwan, and grant R01 DE14036 (to JRH and MS) from the National Institutes of Health, USA.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Chang VHS, 2012, AM J PATHOL, V181, P423, DOI 10.1016/j.ajpath.2012.04.025; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Cui K, 2011, J SURG RES, V171, P143, DOI 10.1016/j.jss.2010.03.001; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Dubrovsky L, 2014, BLOOD, V123, P3296, DOI 10.1182/blood-2014-01-549022; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gu HJ, 2008, CLIN CANCER RES, V14, P3627, DOI 10.1158/1078-0432.CCR-07-4808; Hawse JR, 2008, BONE, V42, P1025, DOI 10.1016/j.bone.2008.02.004; Hawse JR, 2008, MOL ENDOCRINOL, V22, P1579, DOI 10.1210/me.2007-0253; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Iacopetta BJ, 1998, J PATHOL, V184, P390; Im KS, 2017, VET COMP ONCOL, V15, P315, DOI 10.1111/vco.12165; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang L, 2009, CANCER LETT, V274, P101, DOI 10.1016/j.canlet.2008.09.017; Jin W, 2012, MOL CELL BIOL, V32, P50, DOI 10.1128/MCB.06152-11; Johnsen SA, 2002, ONCOGENE, V21, P5783, DOI 10.1038/sj.onc.1205681; Johnsen SA, 2002, J BIOL CHEM, V277, P30754, DOI 10.1074/jbc.M204812200; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1997, TRENDS CELL BIOL, V7, P187, DOI 10.1016/S0962-8924(97)01036-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Papadakis KA, 2015, AM J PHYSIOL-CELL PH, V308, pC362, DOI 10.1152/ajpcell.00262.2014; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sioletic S, 2014, J PATHOL, V234, P190, DOI 10.1002/path.4379; Spittau B, 2012, CELL TISSUE RES, V347, P65, DOI 10.1007/s00441-011-1186-6; Spittau G, 2010, J NEUROSCI RES, V88, P2017, DOI 10.1002/jnr.22364; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Tachibana I, 1997, J CLIN INVEST, V99, P2365, DOI 10.1172/JCI119418; Tau KR, 1998, ENDOCRINOLOGY, V139, P1346, DOI 10.1210/en.139.3.1346; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	55	21	21	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 28	2017	36	39					5532	5543		10.1038/onc.2017.155	http://dx.doi.org/10.1038/onc.2017.155			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FI4RG	28581520				2022-12-26	WOS:000411960500009
J	Plante, S; Normant, V; Ramos-Torres, KM; Labbe, S				Plante, Samuel; Normant, Vincent; Ramos-Torres, Karla M.; Labbe, Simon			Cell-surface copper transporters and superoxide dismutase 1 are essential for outgrowth during fungal spore germination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; FORESPORE MEMBRANE; TRANSCRIPTION FACTORS; ASPERGILLUS-NIDULANS; ENVIRONMENTAL-STRESS; SPORULATING CELLS; METAL	During fungal spore germination, a resting spore returns to a conventional mode of cell division and resumes vegetative growth, but the requirements for spore germination are incompletely understood. Here, we show that copper is essential for spore germination in Schizosaccharomyces pombe. Germinating spores develop a single germ tube that emerges from the outer spore wall in a process called outgrowth. Under low-copper conditions, the copper transporters Ctr4 and Ctr5 are maximally expressed at the onset of outgrowth. In the case of Ctr6, its expression is broader, taking place before and during outgrowth. Spores lacking Ctr4, Ctr5, and the copper sensor Cuf1 exhibit complete germination arrest at outgrowth. In contrast, ctr6 deletion only partially interferes with formation of outgrowing spores. At outgrowth, Ctr4-GFP and Ctr5-Cherry first co-localize at the spore contour, followed by re-location to a middle peripheral spore region. Subsequently, they move away from the spore body to occupy the periphery of the nascent cell. After breaking of spore dormancy, Ctr6 localizes to the vacuole membranes that are enriched in the spore body relative to the germ tube. Using a copper-binding tracker, results showed that labile copper is preferentially localized to the spore body. Further analysis showed that Ctr4 and Ctr6 are required for copper-dependent activation of the superoxide dismutase 1 (SOD1) during spore germination. This activation is critical because the loss of SOD1 activity blocked spore germination at outgrowth. Taken together, these results indicate that cell-surface copper transporters and SOD1 are required for completion of the spore germination program.	[Plante, Samuel; Normant, Vincent; Labbe, Simon] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada; [Ramos-Torres, Karla M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of Sherbrooke; University of California System; University of California Berkeley	Labbe, S (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Pavillon Z-8,3201 Jean Mignault St, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca		Labbe, Simon/0000-0002-4947-523X; Ramos-Torres, Karla/0000-0002-4657-2237	Canadian Institutes of Health Research [MOP-CP-243929]; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health Chemical Biology Training Studentship T32 [GM066698]; NIGMS [GM79465]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health Chemical Biology Training Studentship T32; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant MOP-CP-243929 from the Canadian Institutes of Health Research (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. 1 Recipient of an Alexander Graham Bell Canada; Recipient of an Alexander Graham Bell Canada Graduate Doctoral student-ship from the Natural Sciences and Engineering Research Council of Canada.; Supported in part by National Institutes of Health Chemical Biology Training Studentship T32 GM066698 and NIGMS Grant GM79465.	Ackerman CM, 2017, ANAL CHEM, V89, P22, DOI 10.1021/acs.analchem.6b04631; Barhoom S, 2008, EUKARYOT CELL, V7, P1098, DOI 10.1128/EC.00109-07; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bonazzi D, 2014, DEV CELL, V28, P534, DOI 10.1016/j.devcel.2014.01.023; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; Das M, 2009, CURR BIOL, V19, P1314, DOI 10.1016/j.cub.2009.06.057; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Fukunishi K, 2014, MOL BIOL CELL, V25, P1549, DOI 10.1091/mbc.E13-12-0731; Garcia I, 2006, MOL MICROBIOL, V59, P836, DOI 10.1111/j.1365-2958.2005.04995.x; Geib E, 2016, CELL CHEM BIOL, V23, P587, DOI 10.1016/j.chembiol.2016.03.014; Geijer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-554; GRADEN JA, 1994, J AM CHEM SOC, V116, P9743, DOI 10.1021/ja00100a047; Hatanaka M, 2001, YEAST, V18, P207, DOI 10.1002/1097-0061(200102)18:3<207::AID-YEA661>3.0.CO;2-I; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Itadani A, 2010, EUKARYOT CELL, V9, P1925, DOI 10.1128/EC.00022-10; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; Joseph-Strauss D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r241; KEENEY JB, 1994, GENETICS, V136, P849; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kloimwieder A, 2011, G3-GENES GENOM GENET, V1, P143, DOI 10.1534/g3.111.000323; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Matsuyama A, 2000, GENETICS, V155, P539; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Oiartzabal-Arano E, 2016, CURR GENET, V62, P371, DOI 10.1007/s00294-015-0556-0; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Plante S, 2014, J BIOL CHEM, V289, P10168, DOI 10.1074/jbc.M113.543678; Portnoy ME, 2001, MOL GENET GENOMICS, V265, P873, DOI 10.1007/s004380100482; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; Shi LB, 2014, APPL ENVIRON MICROB, V80, P4502, DOI 10.1128/AEM.00153-14; SHIMODA C, 1980, CAN J MICROBIOL, V26, P741, DOI 10.1139/m80-129; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Taricani L, 2002, J BIOL CHEM, V277, P10562, DOI 10.1074/jbc.M110686200; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Yao SH, 2016, FUNGAL GENET BIOL, V91, P32, DOI 10.1016/j.fgb.2016.03.006; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	57	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	2017	292	28					11896	11914		10.1074/jbc.M117.794677	http://dx.doi.org/10.1074/jbc.M117.794677			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA5LU	28572514	Green Published, hybrid			2022-12-26	WOS:000405485600026
J	Hall, JA; Isaiah, A; Estill, CT; Pirelli, GJ; Suchodolski, JS				Hall, Jean A.; Isaiah, Anitha; Estill, Charles T.; Pirelli, Gene J.; Suchodolski, Jan S.			Weaned beef calves fed selenium-biofortified alfalfa hay have an enriched nasal microbiota compared with healthy controls	PLOS ONE			English	Article							NASOPHARYNGEAL MICROBIOTA; FEEDLOT CATTLE; PATHOLOGY; IMMUNITY	Selenium (Se) is an essential trace mineral important for immune function and overall health of cattle. The nasopharyngeal microbiota in cattle plays an important role in overall respiratory health, especially when stresses associated with weaning, transport, and adaptation to a feedlot affect the normal respiratory defenses. Recent evidence suggests that cattle diagnosed with bovine respiratory disease complex have significantly less bacterial diversity. The objective of this study was to determine whether feeding weaned beef calves Seen-riched alfalfa (Medicago sativa) hay for 9 weeks in a preconditioning program prior to entering the feedlot alters nasal microbiota. Recently weaned beef calves (n = 45) were blocked by sex and body weight, randomly assigned to 3 treatment groups with 3 pens of 5 calves per treatment group, and fed an alfalfa hay based diet for 9 weeks. Alfalfa hay was harvested from fields fertilized with sodium selenate at a rate of 0, 45.0 or 89.9 g Se/ha. Blood samples were collected biweekly and analyzed for whole-blood Se concentrations. Nasal swabs were collected during week 9 from one or two calves from each pen (total n = 16). Calculated Se intake from dietary sources was 3.0, 15.6, and 32.2 mg Se/head/day for calves consuming alfalfa hay with Se concentrations of 0.34 to 2.42 and 5.17 mg Se/kg dry matter, respectively. Whole-blood Se concentrations after 8 weeks of feeding Se-fertilized alfalfa hay were dependent upon Se-application rates (0, 45.0, or 89.9 g Se/ha) and were 155, 345, and 504 ng/mL (P-Linear < 0.0001). Microbial DNA was extracted from nasal swabs and amplified and sequenced. Alpha rarefaction curves comparing the species richness (observed OTUs) and overall diversity (Chao1, Observed OTU, and Shannon index) between calves fed selenium-biofortified alfalfa hay compared with control calves showed that Se-supplementation tended to be associated with an enriched nasal microbiota. ANO-SIM of unweighted UniFrac distances showed that calves fed high Se-biofortified alfalfa hay clustered separately when compared with control calves in the PCoA plot (R = 0.216, P = 0.04). The bacterial orders Lactobacillales and Flavobacteriales were increased in healthy control calves compared with Clostridiales and Bacteroidales being increased in calves fed Se-biofortified alfalfa hay. Although there were strong trends, no significant differences were noted for any of the bacterial taxa. Based upon these findings, we suggest that weaned beef calves fed Se-biofortified hay tend to have an enriched nasal microbiota. Feeding Se-biofortified alfalfa hay to weaned beef calves prior to entering the feedlot is a strategy for increasing nasopharyngeal microbial diversity.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Isaiah, Anitha; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med, Gastrointestinal Lab, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [Estill, Charles T.] Oregon State Univ, Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA; [Estill, Charles T.; Pirelli, Gene J.] Oregon State Univ, Coll Agr Sci, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA	Oregon State University; Texas A&M University System; Texas A&M University College Station; Oregon State University; Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu		Isaiah, Anitha/0000-0001-7118-4124	Agriculture Research Foundation; Oregon State University, Corvallis, OR, USA	Agriculture Research Foundation; Oregon State University, Corvallis, OR, USA	Funded in part by a grant from the Agriculture Research Foundation (J. A. Hall and G. J. Pirelli, Principal Investigators), Oregon State University, Corvallis, OR, USA, and by internal funds. There was no additional external funding received for this study.	AOAC, 2000, OFFICIAL METHODS ANA; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Catry B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146488; Davis TZ, 2012, J VET DIAGN INVEST, V24, P319, DOI 10.1177/1040638711435407; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Gunther C, 2016, INT J MED MICROBIOL, V306, P257, DOI 10.1016/j.ijmm.2016.03.003; Hall JA, 2012, J ANIM SCI, V90, P568, DOI 10.2527/jas.2011-4075; Hall JA, 2011, ANIM FEED SCI TECH, V164, P184, DOI 10.1016/j.anifeedsci.2011.01.009; Hall JA, 2013, BIOL TRACE ELEM RES, V156, P96, DOI 10.1007/s12011-013-9843-0; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058188; Hall JA, 2009, SMALL RUMINANT RES, V82, P40, DOI 10.1016/j.smallrumres.2009.01.010; Holman DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15557; Holman DB, 2015, VET MICROBIOL, V180, P90, DOI 10.1016/j.vetmic.2015.07.031; Hugejiletu H, 2013, BIOL TRACE ELEM RES, V154, P28, DOI 10.1007/s12011-013-9716-6; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217, DOI 10.3168/jds.S0022-0302(82)82180-2; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; MWPS-6, 1987, BEEF HOUS EQ HDB; NRC, 2000, UPD 2000; OTOOLE D, 1995, J VET DIAGN INVEST, V7, P364, DOI 10.1177/104063879500700312; Pelton SI, 2012, PAEDIATR RESPIR REV, V13, P150, DOI 10.1016/j.prrv.2012.04.001; Piters WAAD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0294; Ren WK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00503; SAS Institute, 2009, SAS US GUID STAT VER, V5th ed.; Timsit E, 2016, ANIM FRONT, V6, P44, DOI 10.2527/af.2016-0022; Timsit E, 2016, VET MICROBIOL, V187, P75, DOI 10.1016/j.vetmic.2016.03.020; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Whanger PD, 2002, J AM COLL NUTR, V21, P223, DOI 10.1080/07315724.2002.10719214; Wu MM, 2016, MOL NUTR FOOD RES, V60, P1637, DOI 10.1002/mnfr.201600026	29	29	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179215	10.1371/journal.pone.0179215	http://dx.doi.org/10.1371/journal.pone.0179215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594919	gold, Green Published, Green Submitted			2022-12-26	WOS:000402923200103
J	Vollmer, B; Lundequist, A; Martensson, G; Nagy, Z; Lagercrantz, H; Smedler, AC; Forssberg, H				Vollmer, Brigitte; Lundequist, Aiko; Martensson, Gustaf; Nagy, Zoltan; Lagercrantz, Hugo; Smedler, Ann-Charlotte; Forssberg, Hans			Correlation between white matter microstructure and executive functions suggests early developmental influence on long fibre tracts in preterm born adolescents	PLOS ONE			English	Article							SPATIAL STATISTICS; BRAIN-DEVELOPMENT; CHILDREN BORN; BIRTH; DIFFUSION; ABNORMALITIES; AGE; CHILDHOOD; PATHWAYS; OUTCOMES	Main objectives Executive functions are frequently a weakness in children born preterm. We examined associations of executive functions and general cognitive abilities with brain structure in preterm born adolescents who were born with appropriate weight for gestational age and who have no radiological signs of preterm brain injury on neuroimaging. Methods The Stockholm Neonatal Project (SNP) is a longitudinal, population-based study of children born preterm (<36 weeks of gestation) with very low birth weight (<1501g) between 1988-1993. At age 18 years (mean 18 years, SD 2 weeks) 134 preterm born and 94 full term participants underwent psychological assessment (general intelligence, executive function measures). Of these, 71 preterm and 63 full term participants underwent Magnetic Resonance Imaging (MRI) at mean 15.2 years (range 12-18 years), including 3D T1-weighted images for volumetric analyses and Diffusion Tensor Imaging (DTI) for assessment of white matter microstructure. Group comparisons of regional grey and white matter volumes and fractional anisotropy (FA, as a measure of white matter microstructure) and, within each group, correlation analyses of cognitive measures with MRI metrics were carried out. Results Significant differences in grey and white matter regional volumes and widespread differences in FA were seen between the two groups. No significant correlations were found between cognitive measures and brain volumes in any group after correction for multiple comparisons. However, there were significant correlations between FA in projection fibres and long association fibres, linking frontal, temporal, parietal, and occipital lobes, and measures of executive function and general cognitive abilities in the preterm born adolescents, but not in the term born adolescents. Overall significance of the study In persons born preterm, in the absence of perinatal brain injury on visual inspection of MRI, widespread alterations in regional brain tissue volumes and microstructure are present in adolescence/young adulthood. Importantly, these alterations in WM tracts are correlated with measures of executive function and general cognitive abilities. Our findings suggest that disturbance of neural pathways, rather than changes in regional brain volumes, are involved in the impaired cognitive functions.	[Vollmer, Brigitte; Lundequist, Aiko; Martensson, Gustaf; Forssberg, Hans] Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Womens & Childrens Hlth, Neuropaediat, Stockholm, Sweden; [Vollmer, Brigitte] Univ Southampton, Fac Med, Clin Neurosci, Clin & Expt Sci, Southampton, Hants, England; [Nagy, Zoltan] Univ Zurich, Dept Econ, Zurich, Switzerland; [Lagercrantz, Hugo] Karolinska Inst, Neonatal Res Unit, Dept Womens & Childrens Hlth, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Smedler, Ann-Charlotte] Univ Stockholm, Dept Psychol, Stockholm, Sweden	Karolinska Institutet; University of Southampton; University of Zurich; Karolinska Institutet; Stockholm University	Vollmer, B (corresponding author), Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Womens & Childrens Hlth, Neuropaediat, Stockholm, Sweden.; Vollmer, B (corresponding author), Univ Southampton, Fac Med, Clin Neurosci, Clin & Expt Sci, Southampton, Hants, England.	b.vollmer@soton.ac.uk	vollmer, brigitte/AAB-3132-2020; Forssberg, Hans/A-2944-2009; Nagy, Zoltan/AAI-2485-2019	vollmer, brigitte/0000-0003-4088-5336; Nagy, Zoltan/0000-0001-6611-6362; Forssberg, Hans/0000-0003-2069-6618	Foundation Olle Engkvist Byggmastare; Sallskapet Barnavard; Swedish Brain Foundation; Foundation Frimurarna Barnhuset; Swedish Research Council [5925]; Strategic Research Programme of Neuroscience at Karolinska Institutet; Swedish Research Council for Working Life and Social Sciences [2006-0946]	Foundation Olle Engkvist Byggmastare; Sallskapet Barnavard; Swedish Brain Foundation; Foundation Frimurarna Barnhuset; Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme of Neuroscience at Karolinska Institutet; Swedish Research Council for Working Life and Social Sciences(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by Foundation Olle Engkvist Byggmastare, Sallskapet Barnavard, Swedish Brain Foundation, Foundation Frimurarna Barnhuset, Swedish Research Council (5925), the Swedish Research Council for Working Life and Social Sciences (Grant 2006-0946), and Strategic Research Programme of Neuroscience at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Foundation Olle Engkvist Byggmastare, Sallskapet Barnavard, Swedish Brain Foundation, Foundation Frimurarna Barnhuset, Swedish Research Council (5925), the Swedish Research Council for Working Life and Social Sciences (Grant 2006-0946), and Strategic Research Programme of Neuroscience at Karolinska Institutet.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson PJ, 2014, SEMIN FETAL NEONAT M, V19, P90, DOI 10.1016/j.siny.2013.11.012; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Bohm B, 2004, ACTA PAEDIATR, V93, P1363, DOI 10.1080/08035250410021379; Breeman LD, 2016, J CHILD PSYCHOL PSYC, V57, P132, DOI 10.1111/jcpp.12456; Breeman LD, 2015, PEDIATRICS, V136, P415, DOI 10.1542/peds.2015-0608; Burnett AC, 2015, PEDIATRICS, V135, pE826, DOI 10.1542/peds.2014-3188; Burnett AC, 2013, EARLY HUM DEV, V89, P215, DOI 10.1016/j.earlhumdev.2013.01.013; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Duerden EG, 2013, DEV MED CHILD NEUROL, V55, P952, DOI 10.1111/dmcn.12198; Gerner EM, 1997, STOCKHOLM NEONATAL S, V419, P37; Groeschel S, 2010, INT J DEV NEUROSCI, V28, P481, DOI 10.1016/j.ijdevneu.2010.06.004; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Li K, 2015, DEV MED CHILD NEUROL, V57, P328, DOI 10.1111/dmcn.12618; Litt JS, 2012, ACTA PAEDIATR, V101, P1240, DOI 10.1111/j.1651-2227.2012.02790.x; Lundequist A, 2015, ACTA PAEDIATR, V104, P292, DOI 10.1111/apa.12864; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mori S., 2005, MRI ATLAS HUMAN WHIT; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2008, NEUROPSYCHOLOGIA, V46, P111, DOI 10.1016/j.neuropsychologia.2007.08.004; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Pyhala R, 2011, NEUROLOGY, V77, P2052, DOI 10.1212/WNL.0b013e31823b473e; Seghete KLM, 2013, BRAIN RES, V1527, P15, DOI 10.1016/j.brainres.2013.06.003; Skranes J, 2009, NEUROREPORT, V20, P263, DOI 10.1097/WNR.0b013e32832027fe; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stalnacke J, 2015, CHILD NEUROPSYCHOL, V21, P648, DOI 10.1080/09297049.2014.958071; Stevens MC, 2009, NEUROIMAGE, V48, P738, DOI 10.1016/j.neuroimage.2009.06.065; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Taylor G., 2008, EXECUTIVE FUNCTIONS; Thuy ML, 2011, PEDIATRICS, V127, pE639, DOI 10.1542/peds.2010-1421; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wechsler D, 2004, ADULT INTELLIGENCE S; Wechsler D., 1991, WISC 3 WECHSLER INTE; Yap QJ, 2013, J NEURAL TRANSM, V120, P1369, DOI 10.1007/s00702-013-0971-7	48	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178893	10.1371/journal.pone.0178893	http://dx.doi.org/10.1371/journal.pone.0178893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594884	Green Accepted, Green Published, gold			2022-12-26	WOS:000402923200063
J	Yan, Q; Ahn, SH; Medie, FM; Sharma-Kuinkel, BK; Park, LP; Scott, WK; Deshmukh, H; Tsalik, EL; Cyr, DD; Woods, CW; Yu, CHA; Adams, C; Qi, R; Hansen, B; Fowler, VG				Yan, Qin; Ahn, Sun Hee; Medie, Felix Mba; Sharma-Kuinkel, Batu K.; Park, Lawrence P.; Scott, William K.; Deshmukh, Hitesh; Tsalik, Ephraim L.; Cyr, Derek D.; Woods, Christopher W.; Yu, Chen-Hsin Albert; Adams, Carlton; Qi, Robert; Hansen, Brenda; Fowler, Vance G., Jr.			Candidate genes on murine chromosome 8 are associated with susceptibility to Staphylococcus aureus infection in mice and are involved with Staphylococcus aureus septicemia in humans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELL; CR6-INTERACTING FACTOR-1; ANTIVIRAL IMMUNITY; RNA INTERFERENCE; FAS LIGAND; APOPTOSIS; RECEPTOR; CRIF1; PKA	We previously showed that chromosome 8 of A/J mice was associated with susceptibility to S. aureus infection. However, the specific genes responsible for this susceptibility are unknown. Chromosome substitution strain 8 (CSS8) mice, which have chromosome 8 from A/J but an otherwise C57BL/6J genome, were used to identify the genetic determinants of susceptibility to S. aureus on chromosome 8. Quantitative trait loci (QTL) mapping of S. aureus-infected N2 backcross mice (F1 [C8A] x C57BL/6J) identified a locus 83180780-88103009 (GRCm38/mm10) on A/J chromosome 8 that was linked to S. aureus susceptibility. All genes on the QTL (n similar to 102) were further analyzed by three different strategies: 1) different expression in susceptible (A/J) and resistant (C57BL/6J) mice only in response to S. aureus, 2) consistently different expression in both uninfected and infected states between the two strains, and 3) damaging non-synonymous SNPs in either strain. Eleven candidate genes from the QTL region were significantly differently expressed in patients with S. aureus infection vs healthy human subjects. Four of these 11 genes also exhibited significantly different expression in S. aureus-challenged human neutrophils: Ier2, Crif1, Cd97 and Lyl1. CD97 ligand binding was evaluated within peritoneal neutrophils from A/J and C57BL/6J. CD97 from A/J had stronger CD55 but weaker integrin alpha 5 beta 1 ligand binding as compared with C57BL/6J. Because CD55/CD97 binding regulates immune cell activation and cytokine production, and integrin alpha 5 beta 1 is a membrane receptor for fibronectin, which is also bound by S. aureus, strain-specific differences could contribute to susceptibility to S. aureus. Down-regulation of Crif1 with siRNA was associated with increased host cell apoptosis among both naive and S. aureus-infected bone marrow-derived macrophages. Specific genes in A/J chromosome 8, including Cd97 and Crif1, may play important roles in host defense against S. aureus.	[Yan, Qin; Medie, Felix Mba; Sharma-Kuinkel, Batu K.; Tsalik, Ephraim L.; Woods, Christopher W.; Yu, Chen-Hsin Albert; Adams, Carlton; Qi, Robert; Hansen, Brenda; Fowler, Vance G., Jr.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27706 USA; [Ahn, Sun Hee] Chonnam Natl Univ, Sch Dent, Dept Biochem, Gwangju, South Korea; [Park, Lawrence P.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Scott, William K.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Scott, William K.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Deshmukh, Hitesh] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Tsalik, Ephraim L.] Durham Vet Affairs Med Ctr, Emergency Med Serv, Durham, NC USA; [Tsalik, Ephraim L.; Cyr, Derek D.; Woods, Christopher W.; Fowler, Vance G., Jr.] Duke Clin Res Inst, Durham, NC USA; [Woods, Christopher W.] Durham Vet Affairs Med Ctr, Infect Dis Sect, Durham, NC USA	Duke University; Chonnam National University; Duke University; University of Miami; University of Miami; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Fowler, VG (corresponding author), Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27706 USA.; Fowler, VG (corresponding author), Duke Clin Res Inst, Durham, NC USA.	vance.fowler@duke.edu	Fowler, Vance/AAW-2017-2021; Yu, Chen-Hsin Albert/ABG-2121-2021	Yu, Chen-Hsin Albert/0000-0002-5662-3026; Tsalik, Ephraim/0000-0002-6417-2042; Mba Medie, Felix/0000-0002-8265-4563; Scott, William/0000-0001-9336-6404	National Institutes of Health [R01-A1068804]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	d This research was supported by R01-A1068804 (to VGF) from National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJM, 2007, J BIOL CHEM, V282, P22023, DOI 10.1074/jbc.M702588200; Adriani KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037618; Ahn SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048979; Ahn SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001088; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Beug ST, 2012, TRENDS IMMUNOL, V33, P535, DOI 10.1016/j.it.2012.06.004; Byun J, 2015, CELL DEATH DIFFER, V22, P959, DOI 10.1038/cdd.2014.184; Cao A, 2004, MOL IMMUNOL, V41, P45, DOI 10.1016/j.molimm.2004.02.002; Capasso M, 2006, J IMMUNOL, V177, P1070, DOI 10.4049/jimmunol.177.2.1070; Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chen DY, 2015, DEV BIOL, V407, P195, DOI 10.1016/j.ydbio.2015.09.016; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Cyr DD, 2017, GENES IMMUN, V18, P95, DOI 10.1038/gene.2017.6; DeLorenze GN, 2016, J INFECT DIS, V213, P816, DOI 10.1093/infdis/jiv483; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fritz Jorg H, 2006, Sci STKE, V2006, ppe27; Glickman SW, 2010, ACAD EMERG MED, V17, P383, DOI 10.1111/j.1553-2712.2010.00664.x; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jin T, 2015, J CELL BIOCHEM, V116, P2804, DOI 10.1002/jcb.25225; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Johnson NV, 2012, G3-GENES GENOM GENET, V2, P693, DOI 10.1534/g3.112.002501; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kim Y.-H., 2015, IEEE T VERY LARGE SC, VPP, P1, DOI DOI 10.1007/S00125-015-3506-Y); Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Lim SJ, 2014, RNA BIOL, V11, P1171, DOI 10.4161/rna.34381; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Messina JA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005330; Mootha VK, NATURE GENETICS, V34, P267; Nakada T, 2011, CRIT CARE, V15, DOI 10.1186/cc10515; Neeb A, 2012, ONCOGENE, V31, P3796, DOI 10.1038/onc.2011.535; Nelson CL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-83; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Okoye I, 2015, SCIENCE, V348, P995, DOI 10.1126/science.aaa7516; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Pedersen J, 2014, TRENDS MOL MED, V20, P652, DOI 10.1016/j.molmed.2014.09.006; Rolig AS, 2011, P NATL ACAD SCI USA, V108, P19749, DOI 10.1073/pnas.1104598108; Ryu MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003356; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053577; Song ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046113; Song ZJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-166; Souroullas GP, 2011, GENESIS, V49, P441, DOI 10.1002/dvg.20743; Sowerwine KJ, 2012, ANN NY ACAD SCI, V1250, P25, DOI 10.1111/j.1749-6632.2011.06387.x; Stenqvist AC, 2013, J IMMUNOL, V191, P5515, DOI 10.4049/jimmunol.1301885; Sugi N, 2013, INFECT IMMUN, V81, P2217, DOI 10.1128/IAI.00405-12; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Tian HY, 2012, EMBO J, V31, P3885, DOI 10.1038/emboj.2012.246; Vahedi S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1520-6; Veninga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024431; von Kockritz-Blickwede M, 2008, AM J PATHOL, V173, P1657, DOI 10.2353/ajpath.2008.080337; Voora D, 2013, J AM COLL CARDIOL, V62, P1267, DOI 10.1016/j.jacc.2013.05.073; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wu WJ, 2015, INT J MOL MED, V36, P1104, DOI 10.3892/ijmm.2015.2310; Xu Z, 2016, ONCOL REP, V37, P259; Yan Q., 2015, BIOPROTOC, V5, DOI [10.21769/bioprotoc.1406, DOI 10.21769/BIOPROTOC.1406]; Yan Q, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004149; Ye Z, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00125; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu SH, 2004, J MOL MED, V82, P621, DOI 10.1007/s00109-004-0559-7; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; ZHANG XF, 2015, J INEQUAL APPL, V2015, P1, DOI DOI 10.1002/STEM.2019; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	77	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179033	10.1371/journal.pone.0179033	http://dx.doi.org/10.1371/journal.pone.0179033			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594911	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200081
J	Heads, SW; Miller, AN; Crane, JL; Thomas, MJ; Ruffatto, DM; Methven, AS; Raudabaugh, DB; Wang, YN				Heads, Sam W.; Miller, Andrew N.; Crane, J. Leland; Thomas, M. Jared; Ruffatto, Danielle M.; Methven, Andrew S.; Raudabaugh, Daniel B.; Wang, Yinan			The oldest fossil mushroom	PLOS ONE			English	Article							BALTIC AMBER; DOMINICAN AMBER; GILLED MUSHROOM; ASPERGILLUS; ASCOMYCOTA; FUNGI	A new fossil mushroom is described and illustrated from the Lower Cretaceous Crato Formation of northeast Brazil. Gondwanagaricites magnificus gen. et sp. nov. is remarkable for its exceptional preservation as a mineralized replacement in laminated limestone, as all other fossil mushrooms are known from amber inclusions. Gondwanagaricites represents the oldest fossil mushroom to date and the first fossil mushroom from Gondwana.	[Heads, Sam W.; Miller, Andrew N.; Crane, J. Leland; Thomas, M. Jared; Ruffatto, Danielle M.; Raudabaugh, Daniel B.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Methven, Andrew S.] Savannah State Univ, Dept Biol, Savannah, GA USA; [Raudabaugh, Daniel B.] Univ Illinois, Dept Plant Biol, Urbana, IL USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; Savannah State University; University of Illinois System; University of Illinois Urbana-Champaign	Heads, SW (corresponding author), Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA.	swheads@illinois.edu	Raudabaugh, Daniel/AAJ-8846-2020; Miller, Andrew/AAB-7815-2019	Miller, Andrew/0000-0001-7300-0069	US National Science Foundation [EF-1304622, EF-1205935, EF-1502735]; NSF [EF-1304622, EF-1502735, EF1205935]; Div Of Biological Infrastructure [1502735] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partly supported by US National Science Foundation grant EF-1304622 (to SWH) and EF-1205935 and EF-1502735 (to ANM).; We thank Dra. Leonor Costa Maia of the URM Herbarium for providing a URM accession number and for assistance repatriating the specimen to Brazil. SEM work was carried out in the Frederick Seitz Materials Research Laboratory Central Research Facilities at the University of Illinois. This work was partly supported by NSF grant EF-1304622 (to SWH) and EF1205935 and EF-1502735 (to ANM).	Barling N, 2015, CRETACEOUS RES, V52, P605, DOI 10.1016/j.cretres.2014.05.007; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Butterfield NJ, 2005, PALEOBIOLOGY, V31, P165, DOI 10.1666/0094-8373(2005)031<0165:PPF>2.0.CO;2; Cai C, 2017, NATURE COMMUNICATION, V8, P1, DOI DOI 10.1038/NC0MMS14894; Caspary R, 1906, FLORA BERNSTEINS AND; Doerfelt H, 2007, BOT J LINN SOC, V155, P449, DOI 10.1111/j.1095-8339.2007.00728.x; Dorfelt H, 2005, MYCOL RES, V109, P956, DOI 10.1017/S0953756205003497; HIBBETT DS, 1995, NATURE, V377, P487, DOI 10.1038/377487a0; Hibbett DS, 2003, MYCOLOGIA, V95, P685, DOI 10.2307/3761943; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Krings M, 2011, MYCOSCIENCE, V52, P18, DOI 10.1007/s10267-010-0065-4; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Martill D. M., 2007, CRATO FOSSIL BEDS BR; Martill DM., 1993, PALAEONTOLOGICAL ASS; Poinar G, 2016, FUNGAL BIOL-UK, V120, P1090, DOI 10.1016/j.funbio.2016.06.008; Poinar GO, 2007, MYCOL RES, V111, P503, DOI 10.1016/j.mycres.2007.02.004; POINAR GO, 1990, SCIENCE, V248, P1099, DOI 10.1126/science.248.4959.1099; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rikkinen J, 2003, MYCOL RES, V107, P251, DOI 10.1017/S0953756203007330; Rikkinen J, 2000, MYCOL RES, V104, P7, DOI 10.1017/S0953756299001884; Rossi W, 2005, MYCOL RES, V109, P271, DOI 10.1017/S0953756204001819; Sadowski EM, 2012, FUNGAL BIOL-UK, V116, P1099, DOI 10.1016/j.funbio.2012.08.003; Talyor T.N., 2015, FOSSIL FUNGI; Taylor T.N., 2008, PALEOBOTANY BIOL EVO; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; THOMAS GM, 1988, J PALEONTOL, V62, P141	26	13	16	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178327	10.1371/journal.pone.0178327	http://dx.doi.org/10.1371/journal.pone.0178327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591180	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700031
J	Brun, S; Abella, N; Berciano, MT; Tapia, O; Jaumot, M; Freire, R; Lafarga, M; Agell, N				Brun, Sonia; Abella, Neus; Berciano, Maria T.; Tapia, Olga; Jaumot, Montserrat; Freire, Raimundo; Lafarga, Miguel; Agell, Neus			SUMO regulates p21(Cip1) intracellular distribution and with p21(Cip1) facilitates multiprotein complex formation in the nucleolus upon DNA damage	PLOS ONE			English	Article							RNA-POLYMERASE-I; NUCLEAR EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; DE-SUMOYLATION; CANCER; UBIQUITIN; PATHWAY; P53; STRESS; P21	We previously showed that p21(Cip1) transits through the nucleolus on its way from the nucleus to the cytoplasm and that DNA damage inhibits this transit and induces the formation of p21(Cip1)-containing intranucleolar bodies (INoBs). Here, we demonstrate that these INoBs also contain SUMO-1 and UBC9, the E2 SUMO-conjugating enzyme. Furthermore, whereas wild type SUMO-1 localized in INoBs, a SUMO-1 mutant, which is unable to conjugate with proteins, does not, suggesting the presence of SUMOylated proteins at INoBs. Moreover, depletion of the SUMO-conjugating enzyme UBC9 or the sumo hydrolase SENP2 changed p21(Cip1) intracellular distribution. In addition to SUMO-1 and p21(Cip1), cell cycle regulators and DNA damage checkpoint proteins, including Cdk2, Cyclin E, PCNA, p53 and Mdm2, and PML were also detected in INoBs. Importantly, depletion of UBC9 or p21 impacted INoB biogenesis and the nucleolar accumulation of the cell cycle regulators and DNA damage checkpoint proteins following DNA damage. The impact of p21Cip1 and SUMO-1 on the accumulation of proteins in INoBs extends also to CRM1, a nuclear exportin that is also important for protein translocation from the cytoplasm to the nucleolus. Thus, SUMO and p21(Cip1) regulate the transit of proteins through the nucleolus, and that disruption of nucleolar export by DNA damage induces SUMO and p21(Cip1) to act as hub proteins to form a multiprotein complex in the nucleolus.	[Brun, Sonia; Abella, Neus; Jaumot, Montserrat; Agell, Neus] Univ Barcelona, IDIBAPS, Dept Biomed, Barcelona, Spain; [Berciano, Maria T.; Tapia, Olga; Lafarga, Miguel] Univ Cantabria IDIVAL, Dept Anat & Biol Celular, Santander, Spain; [Freire, Raimundo] Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed, Tenerife, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad de Cantabria; Universidad de la Laguna	Agell, N (corresponding author), Univ Barcelona, IDIBAPS, Dept Biomed, Barcelona, Spain.	neusagell@ub.edu	Tapia, Olga/AAN-2427-2020; Agell, Neus/E-9640-2016; Jaumot, Montserrat/F-2640-2016; Freire, Raimundo/Q-7660-2019; Tapia, Olga/AAH-8651-2020; Lafarga, Miguel/K-3733-2014; Brun, Sonia/AAA-4585-2019	Agell, Neus/0000-0002-1205-6074; Freire, Raimundo/0000-0003-4473-8894; Tapia, Olga/0000-0002-0802-7975; Brun, Sonia/0000-0002-2056-3180; Berciano, Maria T./0000-0002-8225-6995; Lafarga, Miguel/0000-0003-3402-1152; Jaumot, Montserrat/0000-0003-2864-357X	Ministerio de Economia y Competitividad [SAF2013-42742-R, SAF201676239-R, BFU2014-54754-P, SAF2016-80626-R, SAF2016-76239-R]; Red Tematica de investigacion cooperativa en cancer [RD 12/0036/0049]; Ministerio de Educacion y Ciencia (Spain); University of Barcelona contribution	Ministerio de Economia y Competitividad(Spanish Government); Red Tematica de investigacion cooperativa en cancer; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); University of Barcelona contribution	This work was supported by: Ministerio de Economia y Competitividad (www.mineco.gob.es) grants: SAF2013-42742-R and SAF201676239-R to NA, BFU2014-54754-P to ML and SAF2016-80626-R to RE; Red Tematica de investigacion cooperativa en cancer grant RD 12/0036/0049 to NA (www.rtics.org). NAb was recipient of a pre-doctoral fellowship from the Ministerio de Educacion y Ciencia (Spain). Funding for open access charge: Ministerio de Economia y Competitividad grant SAF2016-76239-R to NA and University of Barcelona contribution.	Abella N, 2010, TRAFFIC, V11, P743, DOI 10.1111/j.1600-0854.2010.01063.x; Agell N, 2006, CELL CYCLE, V5, P3, DOI 10.4161/cc.5.1.2270; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bhaskaran N, 2013, MOL CELL BIOL, V33, P85, DOI 10.1128/MCB.00288-12; Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Donati G, 2013, CELL REPORTS, V4, P8798; Dou H, 2011, FEBS LETT, V585, P2891, DOI 10.1016/j.febslet.2011.04.002; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Ernoult-Lange M, 2009, MOL BIOL CELL, V20, P176, DOI 10.1091/mbc.E08-09-0904; Esteve V, 2003, CHEMBIOCHEM, V4, P863, DOI 10.1002/cbic.200300649; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Garcia-Rodriguez N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00087; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Goudarzi KM, 2016, INT J ONCOL, V48, P1313, DOI 10.3892/ijo.2016.3387; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Guan YH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002555; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Heun P, 2007, CURR OPIN CELL BIOL, V19, P350, DOI 10.1016/j.ceb.2007.04.014; Hutten S, 2011, CHROMOSOMA, V120, P481, DOI 10.1007/s00412-011-0327-8; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; James A, 2014, NUCLEUS, V5, P1, DOI DOI 10.4161/NUCL.32235; Juan G, 2001, CANCER RES, V61, P1220; Kurki S, 2004, CELL CYCLE, V3, P976; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Latonen L, 2011, BIOESSAYS, V33, P386, DOI 10.1002/bies.201100008; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Martin SF, 2008, PROTEIN SCI, V17, P777, DOI 10.1110/ps.073369608; Melchior F, 2000, MDM2 SUMO1 BIGGER BE, V2, P161; Melchior F, 2002, CELL CYCLE GEORGETOW, P245; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nebbioso A, 2005, NAT MED, V11, P77, DOI 10.1038/nm1161; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Nishida T, 2011, BIOCHEM BIOPH RES CO, V406; Olausson KH, 2014, J BIOL CHEM, V289, P34601, DOI 10.1074/jbc.M114.569244; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Perez-Castro AJ, 2012, J CELL SCI, P125; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rodriguez-Vilarrupla A, 2005, MOL CELL BIOL, V25, P7364, DOI 10.1128/MCB.25.16.7364-7374.2005; Rodriguez-Vilarrupla A, 2002, FEBS LETT, V531, P319, DOI 10.1016/S0014-5793(02)03549-4; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Tembe V, 2007, CELL SIGNAL, V19, P1113, DOI 10.1016/j.cellsig.2007.03.001; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; WALDMAN T, 1995, CANCER RES, V55, P5187; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; White Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10647; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	75	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178925	10.1371/journal.pone.0178925	http://dx.doi.org/10.1371/journal.pone.0178925			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582471	Green Submitted, Green Published, gold			2022-12-26	WOS:000402837600056
J	Gonzalez, AL; Konieczny, P; Llamusi, B; Delgado-Pinar, E; Borrell, JAI; Teixido, J; Garcia-Espana, E; Perez-Alonso, M; Estrada-Tejedor, R; Artero, R				Gonzalez, Alex L.; Konieczny, Piotr; Llamusi, Beatriz; Delgado-Pinar, Estefania; Borrell, Jose A. I.; Teixido, Jordi; Garcia-Espana, Enrique; Perez-Alonso, Manuel; Estrada-Tejedor, Roger; Artero, Ruben			In silico discovery of substituted pyrido[2,3-d] pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models	PLOS ONE			English	Article							MOLECULES TARGETING RNA; CUG-BINDING PROTEIN; FINGERPRINT METHODS; SPLICING DEFECTS; TYPE-1 DM1; REPEATS; DYNAMICS; DESIGN; LIGAND; INHIBITOR	Myotonic dystrophy type 1 (DM1) is a rare multisystemic disorder associated with an expansion of CUG repeats in mutant DMPK (dystrophia myotonica protein kinase) transcripts; the main effect of these expansions is the induction of pre-mRNA splicing defects by sequestering muscleblind-like family proteins (e.g. MBNL1). Disruption of the CUG repeats and the MBNL1 protein complex has been established as the best therapeutic approach for DM1, hence two main strategies have been proposed: targeted degradation of mutant DMPK transcripts and the development of CUG-binding molecules that prevent MBNL1 sequestration. Herein, suitable CUG-binding small molecules were selected using in silico approaches such as scaffold analysis, similarity searching, and druggability analysis. We used polarization assays to confirm the CUG repeat binding in vitro for a number of candidate compounds, and went on to evaluate the biological activity of the two with the strongest affinity for CUG repeats (which we refer to as compounds 1-2 and 2-5) in DM1 mutant cells and Drosophila DM1 models with an impaired locomotion phenotype. In particular, 1-2 and 2-5 enhanced the levels of free MBNL1 in patient-derived myoblasts in vitro and greatly improved DM1 fly locomotion in climbing assays. This work provides new computational approaches for rational large-scale virtual screens of molecules that selectively recognize CUG structures. Moreover, it contributes valuable knowledge regarding two compounds with desirable biological activity in DM1 models.	[Gonzalez, Alex L.; Borrell, Jose A. I.; Teixido, Jordi; Estrada-Tejedor, Roger] URL, IQS, GEM, Barcelona, Catalonia, Spain; [Konieczny, Piotr; Llamusi, Beatriz; Perez-Alonso, Manuel; Artero, Ruben] Incliva Hlth Res Inst, Translat Genom Grp, Valencia, Spain; [Konieczny, Piotr; Llamusi, Beatriz; Perez-Alonso, Manuel; Artero, Ruben] Univ Valencia, Dept Genet & Interdisciplinary Res Struct Biotech, Valencia, Spain; [Konieczny, Piotr; Llamusi, Beatriz; Perez-Alonso, Manuel; Artero, Ruben] Incliva CIPF Joint Unit, Valencia, Spain; [Delgado-Pinar, Estefania; Garcia-Espana, Enrique] Univ Valencia, Inst Ciencia Mol, Valencia, Spain	Universitat Ramon Llull; Institut Quimic de Sarria; University of Valencia; University of Valencia	Estrada-Tejedor, R (corresponding author), URL, IQS, GEM, Barcelona, Catalonia, Spain.	roger.estrada@iqs.url.edu	García-España, Enrique V./F-5473-2016; Estrada-Tejedor, Roger/R-5326-2018; Artero, Ruben/K-6815-2014; Pérez-Alonso, Manuel/M-3333-2014; Delgado-Pinar, Estefania/K-5194-2017; González, Alex/GYU-3220-2022	García-España, Enrique V./0000-0002-4601-6505; Estrada-Tejedor, Roger/0000-0002-2983-0492; Artero, Ruben/0000-0003-1596-047X; Pérez-Alonso, Manuel/0000-0002-3266-0340; Delgado-Pinar, Estefania/0000-0002-7400-5715; Konieczny, Piotr/0000-0003-2644-5502	Fundacio La Marato de TV3 [100231]; Plan Estatal de I+D+i; Institute de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion (funds from FEDER) [FIS13-0386]	Fundacio La Marato de TV3; Plan Estatal de I+D+i; Institute de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion (funds from FEDER)	This work was supported by Fundacio La Marato de TV3 under Grant 100231, Plan Estatal de I+D+i 2013-2016 and Institute de Salud Carlos III - Subdireccion General de Evaluacion y Fomento de la Investigacion (FIS13-0386 including funds from FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Fundacio La Marato de TV3 (grant number 100231), the Plan Estatal de I+D+i 2013-2016, and the Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion (FIS13-0386, including funds from FEDER). The authors thankfully acknowledge the technical assistance received from IUCT (Institut Universitari de Ciencia i Tecnologia), the computer resources, technical expertise, and assistance provided by the Computing Centre at the University of Valencia (Centre de Calcul de la Universitat de Valencia) for our use of TIRANT, the Spanish supercomputer network (RES-BSC; Red de Supercomputacion Espanola), and the Drugs design service at the Consorci de Serveis Universitaris de Catalunya (SDF-CSUC; Servei de Disseny de Farmacs).	[Anonymous], 2010, FILTER 2 1 1; Arambula JF, 2009, P NATL ACAD SCI USA, V106, P16068, DOI 10.1073/pnas.0901824106; Bakan A, 2012, J CHEM THEORY COMPUT, V8, P2435, DOI 10.1021/ct300117j; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bargiela A, 2015, DIS MODEL MECH, V8, P679, DOI 10.1242/dmm.018127; Bostrom J, 2003, J MOL GRAPH MODEL, V21, P449, DOI 10.1016/S1093-3263(02)00204-8; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chemical Computing Group Inc, 2013, MOE MOL OP ENV; Chen CZ, 2012, ANAL BIOANAL CHEM, V402, P1889, DOI 10.1007/s00216-011-5604-0; Chen L, 2012, J CHEM INF MODEL, V52, P2741, DOI 10.1021/ci300320t; Childs-Disney JL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3044; Childs-Disney JL, 2012, ACS CHEM BIOL, V7, P856, DOI 10.1021/cb200408a; Coonrod LA, 2013, ACS CHEM BIOL, V8, P2528, DOI 10.1021/cb400431f; Coonrod LA, 2012, BIOCHEMISTRY-US, V51, P8330, DOI 10.1021/bi300829w; Disney MD, 2014, ORG BIOMOL CHEM, V12, P1029, DOI 10.1039/c3ob42023j; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3; Garcia-Lopez A, 2011, P NATL ACAD SCI USA, V108, P11866, DOI 10.1073/pnas.1018213108; Guan LR, 2012, ACS CHEM BIOL, V7, P73, DOI 10.1021/cb200447r; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Hoskins JW, 2014, NUCLEIC ACIDS RES, V42, P6591, DOI 10.1093/nar/gku275; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Jahromi AH, 2013, J MED CHEM, V56, P9471, DOI 10.1021/jm400794z; Jahromi AH, 2013, ACS CHEM BIOL, V8, P1037, DOI 10.1021/cb400046u; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; Ketley A, 2014, HUM MOL GENET, V23, P1551, DOI 10.1093/hmg/ddt542; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Konieczny P, 2014, NUCLEIC ACIDS RES, V42, P10873, DOI 10.1093/nar/gku767; Kumar A, 2011, BIOCHEMISTRY-US, V50, P9928, DOI 10.1021/bi2013068; Lee MM, 2009, J AM CHEM SOC, V131, P17464, DOI 10.1021/ja906877y; Lewell XQ, 1998, J CHEM INF COMP SCI, V38, P511, DOI 10.1021/ci970429i; McGaughey GB, 2007, J CHEM INF MODEL, V47, P1504, DOI 10.1021/ci700052x; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Mu YG, 2006, BIOPHYS J, V90, P391, DOI 10.1529/biophysj.105.069559; Muchmore SW, 2006, CHEM BIOL DRUG DES, V67, P174, DOI 10.1111/j.1747-0285.2006.00341.x; Mulders SAM, 2009, P NATL ACAD SCI USA, V106, P13915, DOI 10.1073/pnas.0905780106; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Noy A, 2004, J MOL BIOL, V343, P627, DOI 10.1016/j.jmb.2004.07.048; Parkesh R, 2012, J AM CHEM SOC, V134, P4731, DOI 10.1021/ja210088v; Pascual R, 2003, MOL DIVERS, V6, P121; Philips A, 2013, RNA, V19, P1605, DOI 10.1261/rna.039834.113; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pushechnikov A, 2009, J AM CHEM SOC, V131, P9767, DOI 10.1021/ja9020149; Romeo V, 2012, ADV EXP MED BIOL, V724, P239, DOI 10.1007/978-1-4614-0653-2_18; Rzuczek SG, 2015, ACS CHEM BIOL, V10, P2706, DOI 10.1021/acschembio.5b00430; Sastry M, 2010, J CHEM INF MODEL, V50, P771, DOI 10.1021/ci100062n; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Sklenovsky P, 2011, J CHEM THEORY COMPUT, V7, P2963, DOI 10.1021/ct200204t; SRIRAM M, 1992, EMBO J, V11, P225, DOI 10.1002/j.1460-2075.1992.tb05045.x; Tamjar J, 2012, J BIOMOL STRUCT DYN, V30, P505, DOI 10.1080/07391102.2012.687517; Teague SJ, 1999, ANGEW CHEM INT EDIT, V38, P3743, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U; Teixido A J, 2016, PLOS ONE, V11; Thornton CA, 2014, NEUROL CLIN, V32, P705, DOI 10.1016/j.ncl.2014.04.011; Tran T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2119; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Warf MB, 2009, P NATL ACAD SCI USA, V106, P18551, DOI 10.1073/pnas.0903234106; Wetzel S, 2009, NAT CHEM BIOL, V5, P581, DOI 10.1038/nchembio.187; Wong CH, 2014, J AM CHEM SOC, V136, P6355, DOI 10.1021/ja5012146; Wong CH, 2012, CHEMBIOCHEM, V13, P2505, DOI 10.1002/cbic.201200602; Wong CH, 2011, NUCLEIC ACIDS RES, V39, P8881, DOI 10.1093/nar/gkr415; Yildirim I, 2015, J CHEM THEORY COMPUT, V11, P4943, DOI 10.1021/acs.jctc.5b00728; Yu ZM, 2015, HUM MOL GENET, V24, P954, DOI 10.1093/hmg/ddu507	67	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178931	10.1371/journal.pone.0178931	http://dx.doi.org/10.1371/journal.pone.0178931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582438	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600057
J	Wang, JX; Chandrasekhar, V; Abbadessa, G; Yu, Y; Schwartz, B; Kontaridis, MI				Wang, Jianxun; Chandrasekhar, Vasanth; Abbadessa, Giovanni; Yu, Yi; Schwartz, Brian; Kontaridis, Maria I.			In vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; PROTEIN-SYNTHESIS; LEOPARD-SYNDROME; PTPN11 GENE; S6 KINASE; ACTIVATION; MICE; COSTELLO; MYOCYTES; GROWTH	Noonan Syndrome with Multiple Lentigines (NSML, formerly LEOPARD syndrome) is an autosomal dominant "RASopathy" disorder manifesting in congenital heart disease. Most cases of NSML are caused by catalytically inactivating mutations in the protein tyrosine phosphatase (PTP), non-receptor type 11 (PTPN11), encoding the SH2 domain-containing PTP-2 (SHP2) protein. We previously generated knock-in mice harboring the PTPN11 mutation Y279C, one of the most common NSML alleles; these now-termed SHP2(Y279C/+) mice recapitulate the human disorder and develop hypertrophic cardiomyopathy (HCM) by 12 weeks of age. Functionally, heart and/or cardiomyocyte lysates from SHP2(Y279C/+) mice exhibit increased basal and agonist-induced AKT and mTOR activities. Here, we sought to determine whether we could reverse the hypertrophy in SHP2(Y279C/+) mice using ARQ 092, an oral and selective allosteric AKT inhibitor currently in clinical trials for patients with PI3K/AKT-driven tumors or Proteus syndrome. We obtained echocardiographs of SHP2(Y279C/+) and wildtype (SHP2(+/+)) littermates, either in the presence or absence of ARQ 092 at 12, 14, and 16 weeks of age. While SHP2(Y279C/+) mice developed significant left ventricular hypertrophy by 12 weeks, as indicated by decreased chamber dimension and increased posterior wall thickness, treatment of SHP2(Y279C/+) mice with ARQ 092 normalized the hypertrophy in as early as 2 weeks following treatment, with hearts comparable in size to those in wildtype (SHP2(+/+)) mice. In addition, we observed an increase in fractional shortening (FS%) in SHP2(Y279C/+) mice, an effect of increased compensatory hypertrophy, which was not apparent in SHP2(Y279C/+) mice treated with ARQ 092, suggesting functional improvement of HCM upon treatment with the AKT inhibitor. Finally, we found that ARQ 092 specifically inhibited AKT activity, as well as its downstream effectors, PRAS and S6RP in NSML mice. Taken together, these data suggest ARQ 092 may be a promising novel therapy for treatment of hypertrophy in NSML patients.	[Wang, Jianxun; Chandrasekhar, Vasanth; Kontaridis, Maria I.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA; [Abbadessa, Giovanni; Yu, Yi; Schwartz, Brian] ArQule Inc, Burlington, MA USA; [Kontaridis, Maria I.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kontaridis, MI (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiol, Boston, MA 02215 USA.; Kontaridis, MI (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	mkontari@bidmc.harvard.edu	Kontaridis, Maria/AAN-9781-2021	Kontaridis, Maria/0000-0002-6121-0533; Schwartz, Brian/0000-0003-2632-6351	Beth Israel Deaconess Medical Center, Department of Medicine, Division of Cardiology; ArQule, Inc.; Beth Israel Deaconess Medical Center Division of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114775, T32HL007374] Funding Source: NIH RePORTER	Beth Israel Deaconess Medical Center, Department of Medicine, Division of Cardiology; ArQule, Inc.; Beth Israel Deaconess Medical Center Division of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors declare a financial interest to ArQule, Inc. The funder provided support in the form of salary (J.W.) and supplies for the project, but did not have a direct role in the study design, data collection or analysis. The decision to publish was jointly agreed upon between both parties (ArQule and M.I.K). M.I.K. prepared the manuscript and ArQule reviewed before submission. The specific roles of these authors are articulated in the 'author contributions' section. Funding support for this project was also provided, in part, to M.I.K. by Beth Israel Deaconess Medical Center, Department of Medicine, Division of Cardiology.; We would like to acknowledge and thank ArQule, Inc. for funding of this project to M.I.K. This work was also supported in part by the Beth Israel Deaconess Medical Center Division of Cardiology.	Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Digilio MC, 2006, AM J MED GENET A, V140A, P740, DOI 10.1002/ajmg.a.31156; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P110; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Lauriol J, 2016, J CLIN INVEST; Limongelli G, 2006, EUR J MED GENET, V49, P426, DOI 10.1016/j.ejmg.2006.01.003; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Ogata Tsutomu, 2005, Pediatr Endocrinol Rev, V2, P669; Oliver RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136514; Rauen KA, 2007, CLIN GENET, V71, P101, DOI 10.1111/j.1399-0004.2007.00743.x; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; Sarkozy A, 2003, J MED GENET, V40, P704, DOI 10.1136/jmg.40.9.704; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2005, ANN REV GENOMICS HUM; Tidyman William E., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000902; Wan M, 2012, MOL CELL BIOL, V32, P96, DOI 10.1128/MCB.05806-11; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Wu CJ, 2001, ONCOGENE, V20, P6018, DOI 10.1038/sj.onc.1204699; Zhang SQ, 2002, MOL CELL BIOL, V22, P4062, DOI 10.1128/MCB.22.12.4062-4072.2002	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178905	10.1371/journal.pone.0178905	http://dx.doi.org/10.1371/journal.pone.0178905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582432	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600054
J	Godlewska, M; Arczewska, KD; Rudzinska, M; Lyczkowska, A; Krasuska, W; Hanusek, K; Ruf, J; Kiedrowski, M; Czarnocka, B				Godlewska, Marlena; Arczewska, Katarzyna D.; Rudzinska, Magdalena; Lyczkowska, Anna; Krasuska, Wanda; Hanusek, Karolina; Ruf, Jean; Kiedrowski, Miroslaw; Czarnocka, Barbara			Thyroid peroxidase (TPO) expressed in thyroid and breast tissues shows similar antigenic properties	PLOS ONE			English	Article							CANCER-RISK; CONFORMATIONAL EPITOPES; IMMUNODOMINANT REGION; MONOCLONAL-ANTIBODIES; HASHIMOTOS-THYROIDITIS; POSTMENOPAUSAL WOMEN; HUMAN AUTOANTIBODIES; MOLECULAR-CLONING; MESSENGER-RNA; AUTOIMMUNITY	Background Thyroid peroxidase (TPO) is essential for physiological function of the thyroid gland. The high prevalence of thyroid peroxidase antibodies (TPOAbs) in patients with breast cancer and their protective role had previously been demonstrated, indicating a link between breast cancer and thyroid autoimmunity. Recently, TPO was shown to be present in breast cancer tissue samples but its antigenicity has not been analyzed. Methods In this study, we investigated TPO expression levels in a series of fifty-six breast cancer samples paired with normal (peri-tumoral) tissue and its antigenic activity using a panel of well-characterized murine anti-human TPOAbs. Results We have shown that TPO transcripts were present in both normal and cancer tissue samples, although the amounts in the latter were reduced. Additionally, we observed that TPO levels are lower in more advanced cancers. TPO protein expression was confirmed in all tissue samples, both normal and cancerous. We also found that the antigenicity of the immunodominant regions (IDRs) in breast TPO resembles that of thyroid TPO, which is crucial for effective interactions with human TPOAbs. Conclusions Expression of TPO in breast cancer together with its antigenic activity may have beneficial effects in TPOAb-positive breast cancer patients. However, further studies are needed to confirm the beneficial role of TPOAbs and to better understand the underlying mechanism.	[Godlewska, Marlena; Arczewska, Katarzyna D.; Rudzinska, Magdalena; Lyczkowska, Anna; Krasuska, Wanda; Hanusek, Karolina; Czarnocka, Barbara] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Ruf, Jean] Aix Marseille Univ, Marseille Med Sch, UMR MD2, Marseille, France; [Kiedrowski, Miroslaw] Minist Interior Warsaw, Cent Clin Hosp, Clin Dept Oncol & Hematol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; UDICE-French Research Universities; Aix-Marseille Universite	Czarnocka, B (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	barbarac@cmkp.edu.pl	Arczewska, Katarzyna D./B-2689-2019; Hanusek, Karolina/V-1017-2019; Krasuska, Wanda/U-8820-2019; Ruf, Jean/E-3963-2016; Godlewska, Marlena/J-9540-2019; Czarnocka, Barbara/V-1048-2019	Arczewska, Katarzyna D./0000-0001-9606-1585; Hanusek, Karolina/0000-0002-8052-0086; Krasuska, Wanda/0000-0002-4807-4864; Ruf, Jean/0000-0003-4300-8048; Godlewska, Marlena/0000-0003-2337-6724; Czarnocka, Barbara/0000-0001-7701-760X; Kiedrowski, Miroslaw/0000-0003-1361-9286	Center of Postgraduate Medical Education [501-1-25-01-16]	Center of Postgraduate Medical Education	This work was supported by the Center of Postgraduate Medical Education, grant number 501-1-25-01-16 (http://www.cmkp.edu.p1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelousi AG, 2012, EUR J ENDOCRINOL, V166, P373, DOI 10.1530/EJE-11-0838; BANGA JP, 1989, IMMUNOLOGY, V67, P197; Brandt J, 2016, BRIT J SURG, V103, P1649, DOI 10.1002/bjs.10284; Bresson D, 2004, J BIOL CHEM, V279, P39058, DOI 10.1074/jbc.M403897200; CHAZENBALK GD, 1993, J CLIN INVEST, V92, P62, DOI 10.1172/JCI116600; CHIOVATO L, 1993, J CLIN ENDOCR METAB, V77, P1700, DOI 10.1210/jc.77.6.1700; Cristofanilli M, 2005, CANCER-AM CANCER SOC, V103, P1122, DOI 10.1002/cncr.20881; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Czarnocka B, 1997, J CLIN ENDOCR METAB, V82, P2639, DOI 10.1210/jc.82.8.2639; CZARNOCKA B, 1985, FEBS LETT, V190, P147, DOI 10.1016/0014-5793(85)80446-4; Czarnocka B, 2001, BRIT J CANCER, V85, P875, DOI 10.1054/bjoc.2001.2015; Czarnocka B, 2011, FRONT BIOSCI-LANDMRK, V16, P783, DOI 10.2741/3720; Di Cristotaro J, 2006, ENDOCR-RELAT CANCER, V13, P485, DOI 10.1677/erc.1.01164; ELISEI R, 1991, J CLIN ENDOCR METAB, V72, P700, DOI 10.1210/jcem-72-3-700; EWINS DL, 1992, AUTOIMMUNITY, V11, P141, DOI 10.3109/08916939209035148; Farahati J, 2012, CLIN CHEM LAB MED, V50, P709, DOI 10.1515/CCLM.2011.819; Ferrand M, 2003, J BIOL CHEM, V278, P3793, DOI 10.1074/jbc.M209513200; FINKE R, 1990, J CLIN ENDOCR METAB, V71, P53, DOI 10.1210/jcem-71-1-53; Fiore E, 2007, J ENDOCRINOL INVEST, V30, P734, DOI 10.1007/BF03350810; Fragoso MA, 2009, ARCH BIOCHEM BIOPHYS, V482, P52, DOI 10.1016/j.abb.2008.11.015; GARDAS A, 1990, AUTOIMMUNITY, V7, P149, DOI 10.3109/08916939008993387; Gardas A, 2000, REDOX REP, V5, P237, DOI 10.1179/135100000101535681; Giani C, 1996, J CLIN ENDOCR METAB, V81, P990, DOI 10.1210/jc.81.3.990; Giustarini E, 2006, EUR J ENDOCRINOL, V154, P645, DOI 10.1530/eje.1.02108; Godlewska M, 2011, PROGR MED, V11, P917; Godlewska M, 2012, AUTOIMMUNITY, V45, P476, DOI 10.3109/08916934.2012.682667; Gogas J, 2001, EUR J SURG, V167, P715; Gora M, 2004, CLIN EXP IMMUNOL, V136, P137, DOI 10.1111/j.1365-2249.2004.02422.x; Guo J, 2000, CLIN EXP IMMUNOL, V119, P38, DOI 10.1046/j.1365-2249.2000.01087.x; Hall LC, 2008, J STEROID BIOCHEM, V109, P57, DOI 10.1016/j.jsbmb.2007.12.008; Hardefeldt PJ, 2012, BREAST CANCER RES TR, V133, P1169, DOI 10.1007/s10549-012-2019-3; Hellevik AI, 2009, CANCER EPIDEM BIOMAR, V18, P570, DOI 10.1158/1055-9965.EPI-08-0911; Hobby P, 2000, ENDOCRINOLOGY, V141, P2018, DOI 10.1210/en.141.6.2018; Jastrzebska-Bohaterewicz E, 2004, AUTOIMMUNITY, V37, P211, DOI 10.1080/0891693042000193339; Jiskra J, 2007, ONCOL REP, V18, P1603; Kuijpens JLP, 2005, THYROID, V15, P1253, DOI 10.1089/thy.2005.15.1253; Le Fourn V, 2004, BBA-MOL BASIS DIS, V1689, P134, DOI 10.1016/j.bbadis.2004.03.001; Le SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142615; McLachlan SM, 2007, THYROID, V17, P939, DOI 10.1089/thy.2007.0169; McLachlan SM, 2014, ENDOCR REV, V35, P59, DOI 10.1210/er.2013-1055; Muller I, 2014, INT J CANCER, V134, P1706, DOI 10.1002/ijc.28493; Rebuffat SA, 2008, J CLIN ENDOCR METAB, V93, P929, DOI 10.1210/jc.2007-2042; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; RUF J, 1989, ENDOCRINOLOGY, V125, P1211, DOI 10.1210/endo-125-3-1211; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; Simon MS, 2002, CANCER EPIDEM BIOMAR, V11, P1574; Smyth PPA, 1998, J CLIN ENDOCR METAB, V83, P2711, DOI 10.1210/jc.83.8.2711; Sogaard M, 2016, EUR J ENDOCRINOL, V174, P409, DOI 10.1530/EJE-15-0989; Tosovic A, 2012, INT J CANCER, V131, P2126, DOI 10.1002/ijc.27470; Tosovic A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2587; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609; Weiss HA, 1999, INT J EPIDEMIOL, V28, P816, DOI 10.1093/ije/28.5.816	53	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0179066	10.1371/journal.pone.0179066	http://dx.doi.org/10.1371/journal.pone.0179066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575127	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300146
J	Papillion, AM; Kenderes, KJ; Yates, JL; Winslow, GM				Papillion, Amber M.; Kenderes, Kevin J.; Yates, Jennifer L.; Winslow, Gary M.			Early derivation of IgM memory cells and bone marrow plasmablasts	PLOS ONE			English	Article							SWITCH DNA RECOMBINATION; B-CELLS; ANTIBODY-RESPONSES; HUMORAL IMMUNITY; CD11C EXPRESSION; HUMAN SPLEEN; T-BET; ACCUMULATION; LYMPHOCYTES; ACTIVATION	IgM memory cells are recognized as an important component of B cell memory in mice and humans. Our studies of B cells elicited in response to ehrlichial infection identified a population of CD11c-positive IgM memory cells, and an IgM bone marrow antibody-secreting cell population. The origin of these cells was unknown, although an early T-independent spleen CD11c- and T-bet-positive IgM plasmablast population precedes both, suggesting a linear relationship. A majority of the IgM memory cells detected after day 30 post-infection, also T bet -positive, had undergone somatic hypermutation, indicating they expressed activation induced cytidine deaminase (AID). Therefore, to identify early AID-expressing precursor B cells, we infected an AID-regulated tamoxifen-inducible Cre-recombinase-EYFP reporter strain. Tamoxifen administration led to the labeling of both IgM memory cells and bone marrow ASCs on day 30 and later post-infection. High frequencies of labeled cells were identified on day 30 post-infection, following tamoxifen administration on day 10 post-infection, although IgM memory cells were marked when tamoxifen was administered as early as day 4 post-infection. Transcription of Aicda in the early plasmablasts was not detected in the absence of CD4 T cells, but occurred independently of TLR signaling. Unlike the IgM memory cells, the bone marrow IgM ASCs were elicited independent of T cell help. Moreover, Aicda was constitutively expressed in IgM memory cells, but not in bone marrow ASCs. These studies demonstrate that two distinct long-term IgM-positive B cell populations are generated early in response to infection, but are maintained via separate mechanisms.	[Papillion, Amber M.; Kenderes, Kevin J.; Winslow, Gary M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Yates, Jennifer L.] Wadsworth Ctr, Albany, NY USA; [Yates, Jennifer L.] SUNY Albany, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Winslow, GM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	winslowg@upstate.edu		Yates, Jennifer/0000-0001-8841-9401	U.S. Public Health Service grant [R01A1114545]	U.S. Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by the U.S. Public Health Service grant R01A1114545 to GMW (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Bohannon C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11826; Bortnick A, 2013, J IMMUNOL, V190, P5913, DOI 10.4049/jimmunol.1300161; Bortnick A, 2012, J IMMUNOL, V188, P5389, DOI 10.4049/jimmunol.1102808; Della Valle L, 2014, J IMMUNOL, V193, P1071, DOI 10.4049/jimmunol.1400706; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; DUNNWALTERS DK, 1995, J EXP MED, V182, P559, DOI 10.1084/jem.182.2.559; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Good-Jacobson KL, 2012, INT IMMUNOL, V24, P403, DOI 10.1093/intimm/dxs050; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Jones DD, 2013, INFECT IMMUN, V81, P4490, DOI 10.1128/IAI.00998-13; Jones DD, 2012, J IMMUNOL, V189, P1440, DOI 10.4049/jimmunol.1200878; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kurosaki T, 2015, NAT REV IMMUNOL, V15, P149, DOI 10.1038/nri3802; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McHeyzer-Williams M, 2012, NAT REV IMMUNOL, V12, P24, DOI 10.1038/nri3128; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Perez-Shibayama C, 2014, J IMMUNOL, V192, P5192, DOI 10.4049/jimmunol.1302526; Pone EJ, 2015, AUTOIMMUNITY, V48, P1, DOI 10.3109/08916934.2014.993027; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Soenawan E, 2004, VACCINE, V22, P1553, DOI 10.1016/j.vaccine.2003.10.018; Takemori T, 2014, EUR J IMMUNOL, V44, P1258, DOI 10.1002/eji.201343716; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vasquez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139718; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Winter O, 2012, J IMMUNOL, V189, P5105, DOI 10.4049/jimmunol.1202317; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5382, DOI 10.1073/pnas.1121631109; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; YEFENOF E, 1985, J IMMUNOL, V135, P3777; ZANBAR I, 1979, J IMMUNOL, V123, P925; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	56	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178853	10.1371/journal.pone.0178853	http://dx.doi.org/10.1371/journal.pone.0178853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575114	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300125
J	Poli, CL; Harrison, AL; Vallarino, A; Gerard, PD; Jodice, PGR				Poli, Caroline L.; Harrison, Autumn-Lynn; Vallarino, Adriana; Gerard, Patrick D.; Jodice, Patrick G. R.			Dynamic oceanography determines fine scale foraging behavior of Masked Boobies in the Gulf of Mexico	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; TRACKING SEABIRDS; 1ST-PASSAGE TIME; MARINE PREDATOR; EL-NINO; STRATEGY; ALBATROSSES; HABITAT; MESOSCALE; FOOD	During breeding, foraging marine birds are under biological, geographic, and temporal constraints. These contraints require foraging birds to efficiently process environmental cues derived from physical habitat features that occur at nested spatial scales. Mesoscale oceanography in particular may change rapidly within and between breeding seasons, and findings from well-studied systems that relate oceanography to seabird foraging may transfer poorly to regions with substantially different oceanographic conditions. Our objective was to examine foraging behavior of a pan-tropical seabird, the Masked Booby (Sula dactylatra), in the understudied Caribbean province, a moderately productive region driven by highly dynamic currents and fronts. We tracked 135 individuals with GPS units during May 2013, November 2013, and December 2014 at a regionally important breeding colony in the southern Gulf of Mexico. We measured foraging behavior using characteristics of foraging trips and used area restricted search as a proxy for foraging events. Among individual attributes, nest stage contributed to differences in foraging behavior whereas sex did not. Birds searched for prey at nested hierarchical scales ranging from 200 m-35 km. Large-scale coastal and shelf-slope fronts shifted position between sampling periods and overlapped geographically with overall foraging locations. At small scales (at the prey patch level), the specific relationship between environmental variables and foraging behavior was highly variable among individuals but general patterns emerged. Sea surface height anomaly and velocity of water were the strongest predictors of area restricted search behavior in random forest models, a finding that is consistent with the characterization of the Gulf of Mexico as an energetic system strongly influenced by currents and eddies. Our data may be combined with tracking efforts in the Caribbean province and across tropical regions to advance understanding of seabird sensing of the environment and serve as a baseline for anthropogenic based threats such as development, pollution, and commercial fisheries.	[Poli, Caroline L.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA; [Poli, Caroline L.] Clemson Univ, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC 29634 USA; [Harrison, Autumn-Lynn] Clemson Univ, Inst Pk, Clemson, SC USA; [Vallarino, Adriana] Ctr Invest & Estudios Avanzados, Unidad Merida, Merida, Mexico; [Gerard, Patrick D.] Clemson Univ, Dept Math Sci, Clemson, SC USA; [Jodice, Patrick G. R.] Clemson Univ, South Carolina Cooperat Fish & Wildlife Res Unit, US Geol Survey, Clemson, SC USA; [Poli, Caroline L.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Harrison, Autumn-Lynn] Natl Zool Pk, Smithsonian Conservat Biol Inst, Migratory Bird Ctr, Washington, DC USA	Clemson University; Clemson University; Clemson University; Clemson University; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Poli, CL (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA.; Poli, CL (corresponding author), Clemson Univ, South Carolina Cooperat Fish & Wildlife Res Unit, Clemson, SC 29634 USA.; Poli, CL (corresponding author), Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA.	Cpoli@ufl.edu		Harrison, Autumn-Lynn/0000-0002-6213-1765	United States Fish and Wildlife Service [2008691]; Society for the Conservation and Study of Caribbean Birds; Sacramento Zoo Conservation Fund Small Grants Program; South Carolina Department of Natural Resources, Clemson University; U.S. Fish and Wildlife Service; U.S. Geological Survey	United States Fish and Wildlife Service(US Fish & Wildlife Service); Society for the Conservation and Study of Caribbean Birds; Sacramento Zoo Conservation Fund Small Grants Program; South Carolina Department of Natural Resources, Clemson University; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey)	This study was funded by the United States Fish and Wildlife Service, grant #2008691 (www.fws.gov, awarded to PGRJ), the Society for the Conservation and Study of Caribbean Birds (www.scscb.org, awarded to AV), and the Sacramento Zoo Conservation Fund Small Grants Program (www.saczoo.org, awarded to CLP). The South Carolina Cooperative Fish and Wildlife Research Unit is supported by the South Carolina Department of Natural Resources, Clemson University, the U.S. Fish and Wildlife Service, and the U.S. Geological Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvera-Azcarate A, 2009, J PHYS OCEANOGR, V39, P640, DOI 10.1175/2008JPO3765.1; Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Ancona S, 2012, MAR ECOL PROG SER, V462, P261, DOI 10.3354/meps09851; Anderson DJ., 2009, MASKED BOOBY; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Baduini CL, 2002, CONDOR, V104, P823, DOI 10.1650/0010-5422(2002)104[0823:PPPOWT]2.0.CO;2; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Borberg J. M., 2005, Marine Ornithology, V33, P173; BREAKER LC, 2005, MAPPING MONITORING L; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Calenge C, 2011, ANAL ANIMAL MOVEMENT; CHAURAND T, 1994, J ANIM ECOL, V63, P275, DOI 10.2307/5546; Chavez EA, 1988, ANALES I CIENCIAS MA, V15, P167; Cummings J.A., 2013, DATA ASSIMILATION FO, VII, P303, DOI [10.1007/978-3-642-35088-7_13, DOI 10.1007/978-3-642-35088-7, DOI 10.1007/978-3-642-35088-7_13]; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davoren GK, 1999, ANIM BEHAV, V58, P853, DOI 10.1006/anbe.1999.1209; Devney CA, 2009, ECOLOGY, V90, P1175, DOI 10.1890/08-0634.1; Dismukes DE., 2010, FACT BOOK OFFSHORE O; Erwin CA, 2007, MAR ECOL PROG SER, V331, P255, DOI 10.3354/meps331255; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; Govoni JJ, 2010, ICES J MAR SCI, V67, P403, DOI 10.1093/icesjms/fsp269; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Haney JC, 2014, MAR ECOL PROG SER, V513, P225, DOI 10.3354/meps10991; HANEY JC, 1986, J MAR RES, V44, P361, DOI 10.1357/002224086788405301; HANEY JC, 1992, ORNIS SCAND, V23, P49, DOI 10.2307/3676427; Hastad O, 2005, BIOL LETT-UK, V1, P306, DOI 10.1098/rsbl.2005.0320; Hastie T, 2005, MATH INTELL, V27, P758; Hunt G, 1999, P INT ORN C; Hunt G.L. Jr, 1987, P7; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; JERNELOV A, 1981, AMBIO, V10, P299; Jodice PGR, 2011, MAR BIOL, V158, P2289, DOI 10.1007/s00227-011-1733-4; Jodice PGR, 2002, CAN J ZOOL, V80, P214, DOI 10.1139/Z01-221; Kappes MA, 2011, MAR ECOL PROG SER, V441, P281, DOI 10.3354/meps09376; Kappes MA, 2010, PROG OCEANOGR, V86, P246, DOI 10.1016/j.pocean.2010.04.012; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Le Corre M, 2012, BIOL CONSERV, V156, P83, DOI 10.1016/j.biocon.2011.11.015; Lee D.S., 1983, Chat (Raleigh), V47, P1; LEIPPER DF, 1970, J GEOPHYS RES, V75, P637, DOI 10.1029/JC075i003p00637; Lewis S, 2004, BEHAV ECOL SOCIOBIOL, V56, P81, DOI 10.1007/s00265-004-0762-0; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Monroy C, 2010, N AM J FISH MANAGE, V30, P1187, DOI 10.1577/M09-101.1; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Moser ML, 2012, WILSON J ORNITHOL, V124, P66, DOI 10.1676/11-067.1; Muller-Karger FE, 2015, PROG OCEANOGR, V134, P54, DOI 10.1016/j.pocean.2014.12.007; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Oksanen J, 2020, R CRAN; Oppel S, 2009, J ANIM ECOL, V78, P524, DOI 10.1111/j.1365-2656.2008.01513.x; Orians G.H., 1979, P155; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Peron C, 2010, MAR ECOL PROG SER, V416, P267, DOI 10.3354/meps08785; Pichegru L, 2009, MAR ECOL PROG SER, V391, P199, DOI 10.3354/meps08283; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinet P, 2012, ANIM BEHAV, V83, P979, DOI 10.1016/j.anbehav.2012.01.019; Protegidas CNdAN, 2007, PROT CNDAN, P169; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; R Core Team, 2021, R LANGUAGE ENV STAT; REED JR, 1987, ETHOLOGY, V76, P33; Renner M, 2013, MAR ECOL PROG SER, V484, P259, DOI 10.3354/meps10347; Ribic CA, 1997, ICES J MAR SCI, V54, P545, DOI 10.1006/jmsc.1997.0251; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Robertson GS, 2014, MAR BIOL, V161, P1973, DOI 10.1007/s00227-014-2477-8; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Rothenbach CA, 2012, CONDOR, V114, P90, DOI 10.1525/cond.2012.110071; Scales KL, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0679; Schwemmer P, 2009, FISH OCEANOGR, V18, P161, DOI 10.1111/j.1365-2419.2009.00504.x; SILVER R, 1985, AM ZOOL, V25, P823; Sommerfeld J, 2015, J EXP MAR BIOL ECOL, V463, P79, DOI 10.1016/j.jembe.2014.11.005; Sommerfeld J, 2013, J AVIAN BIOL, V44, P531, DOI 10.1111/j.1600-048X.2013.00135.x; Sommerfeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063742; Spear LB, 2001, MAR ECOL PROG SER, V219, P275, DOI 10.3354/meps219275; Spear LB, 2007, STUD AVIAN BIOL, V35, P1, DOI DOI 10.1080/0301422320009517625; Stevens PW, 2003, ENVIRON BIOL FISH, V67, P71, DOI 10.1023/A:1024496801232; Sturges W, 2005, WASHINGTON DC AM GEO, V161; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Tew-Kai E, 2013, J APPL ECOL, V50, P659, DOI 10.1111/1365-2664.12086; Thorne LH, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0196; Tremblay Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088424; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; Van Buskirk RW, 2008, J EVOLUTION BIOL, V21, P67, DOI 10.1111/j.1420-9101.2007.01465.x; Wakefield ED, 2015, ECOLOGY, V96, P3058, DOI 10.1890/14-1300.1; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Weeks SJ, 2013, MAR ECOL PROG SER, V490, P247, DOI 10.3354/meps10398; Weimerskirch H, 2005, MAR ECOL PROG SER, V288, P251, DOI 10.3354/meps288251; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; Yen PPW, 2004, J MARINE SYST, V50, P79, DOI 10.1016/j.jmarsys.2003.09.015; Yoda K, 2014, PROG OCEANOGR, V122, P54, DOI 10.1016/j.pocean.2013.12.002; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Zetina-Moguel C, 1996, CIENC PESQ, V13, P27	106	14	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178318	10.1371/journal.pone.0178318	http://dx.doi.org/10.1371/journal.pone.0178318			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575078	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300039
J	Sample, SJ; Racette, MA; Hans, EC; Volstad, NJ; Holzman, G; Bleedorn, JA; Schaefer, SL; Waller, KR; Hao, ZL; Block, WF; Muir, P				Sample, Susannah J.; Racette, Molly A.; Hans, Eric C.; Volstad, Nicola J.; Holzman, Gerianne; Bleedorn, Jason A.; Schaefer, Susan L.; Waller, Kenneth R., III; Hao, Zhengling; Block, Walter F.; Muir, Peter			Radiographic and magnetic resonance imaging predicts severity of cruciate ligament fiber damage and synovitis in dogs with cranial cruciate ligament rupture	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PLATEAU LEVELING OSTEOTOMY; CONTRALATERAL STIFLE JOINT; RESISTANT ACID-PHOSPHATASE; LINING MACROPHAGES; CANINE STIFLE; RISK-FACTORS; CATHEPSIN-K; OSTEOARTHRITIS; PROGRESSION	Cruciate ligament rupture (CR) and associated osteoarthritis (OA) is a common condition in dogs. Dogs frequently develop a second contralateral CR. This study tested the hypothesis that the degree of stifle synovitis and cranial cruciate ligament (CrCL) matrix damage in dogs with CR is correlated with non-invasive diagnostic tests, including magnetic resonance (MR) imaging. We conducted a prospective cohort study of 29 client-owned dogs with an unstable stifle due to complete CR and stable contralateral stifle with partial CR. We evaluated correlation of stifle synovitis and CrCL fiber damage with diagnostic tests including bilateral stifle radiographs, 3.0 Tesla MR imaging, and bilateral stifle arthroscopy. Histologic grading and immunohistochemical staining for CD3(+) T lymphocytes, TRAP+ activated macrophages and Factor VIII+ blood vessels in bilateral stifle synovial biopsies were also performed. Serum and synovial fluid concentrations of C-reactive protein (CRP) and carboxyterminal telopeptide of type I collagen (ICTP), and synovial total nucleated cell count were determined. Synovitis was increased in complete CR stifles relative to partial CR stifles (P<0.0001), although total nucleated cell count in synovial fluid was increased in partial CR stifles (P<0.01). In partial CR stifles, we found that 3D Fast Spin Echo Cube CrCL signal intensity was correlated with histologic synovitis (SR = 0.50, P<0.01) and that radiographic OA was correlated with CrCL fiber damage assessed arthroscopically (SR = 0.61, P<0.001). Taken together, results of this study show that clinical diagnostic tests predict severity of stifle synovitis and cruciate ligament matrix damage in stable partial CR stifles. These data support use of client-owned dogs with unilateral complete CR and contralateral partial CR as a clinical trial model for investigation of disease-modifying therapy for partial CR.	[Sample, Susannah J.; Racette, Molly A.; Hans, Eric C.; Volstad, Nicola J.; Bleedorn, Jason A.; Schaefer, Susan L.; Waller, Kenneth R., III; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Holzman, Gerianne] Univ Wisconsin, Sch Vet Med, UW Vet Care Hosp, Madison, WI 53706 USA; [Block, Walter F.] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA.	peter.muir@wisc.edu	Muir, Peter/AAH-8057-2021; Bleedorn, Jason A/AAE-2115-2019; Fiumefreddo, Andrea/T-2977-2019; aubertin, rebeckah/O-9624-2015	Muir, Peter/0000-0003-0028-6005; Bleedorn, Jason A/0000-0003-2987-7722; Hans, Eric/0000-0001-7488-9728; aubertin, rebeckah/0000-0002-0558-7571	American Kennel Club Canine Health Foundation [01762]; National Institutes of Health [T32 OD 10999, K010D0197343]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019743] Funding Source: NIH RePORTER	American Kennel Club Canine Health Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the American Kennel Club Canine Health Foundation (01762), http//www.akcchf.org. Molly A. Racette also received funding from the National Institutes of Health (T32 OD 10999), https://www.nih.gov. Susannah J. Sample also received funding from the National Institutes of Health (K010D0197343), https.//www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh H, 2014, J MAGN RESON IMAGING, V40, P796, DOI 10.1002/jmri.24425; Barger B., 2016, Veterinary Record Case Reports, V4, pe000315, DOI 10.1136/vetreccr-2016-000315; Barrett E, 2009, J SMALL ANIM PRACT, V50, P448, DOI 10.1111/j.1748-5827.2009.00822.x; Bergh MS, 2014, J AM ANIM HOSP ASSOC, V50, P315, DOI 10.5326/JAAHA-MS-6356; Biercevicz AM, 2013, AM J SPORT MED, V41, P560, DOI 10.1177/0363546512472978; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003; Bottcher P, 2010, VET SURG, V39, P296, DOI 10.1111/j.1532-950X.2010.00650.x; Bresnihan B, 1998, BRIT J RHEUMATOL, V37, P636; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Chamberlain CS, 2011, CONNECT TISSUE RES, V52, P203, DOI 10.3109/03008207.2010.511355; Chuang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106389; Comerford EJ, 2004, AM J VET RES, V65, P1136, DOI 10.2460/ajvr.2004.65.1136; Conrozier T, 1998, REV RHUM, V65, P759; Crawford R, 2007, BRIT MED BULL, V84, P5, DOI 10.1093/bmb/ldm022; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Dusick A, 2014, VET J, V202, P550, DOI 10.1016/j.tvjl.2014.08.010; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Faldyna M, 2004, ACTA VET BRNO, V73, P79, DOI 10.2754/avb200473010079; Fleming BC, 2011, J BIOMECH, V44, P2843, DOI 10.1016/j.jbiomech.2011.09.004; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; Girling SL, 2006, J SMALL ANIM PRACT, V47, P708, DOI 10.1111/j.1748-5827.2006.00150.x; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Gordon-Evans WJ, 2013, JAVMA-J AM VET MED A, V243, P675, DOI 10.2460/javma.243.5.675; HAKALA M, 1995, ANN RHEUM DIS, V54, P886, DOI 10.1136/ard.54.11.886; Hayashi K, 2011, VET SURG, V40, P192, DOI 10.1111/j.1532-950X.2010.00777.x; Hulse D, 2010, VET SURG, V39, P350, DOI 10.1111/j.1532-950X.2010.00676.x; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Jones CJ, 2002, AM J VET RES, V63, P1527, DOI 10.2460/ajvr.2002.63.1527; Kent MS, 2002, AM J VET RES, V63, P363, DOI 10.2460/ajvr.2002.63.363; Kijowski R, 2009, RADIOLOGY, V252, P486, DOI 10.1148/radiol.2523090028; Kijowski R, 2009, RADIOLOGY, V251, P185, DOI 10.1148/radiol.2511081133; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; Kobayashi S, 2006, J ORTHOP RES, V24, P1509, DOI 10.1002/jor.20183; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; Little JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097329; Loeuille D, 2011, OSTEOARTHR CARTILAGE, V19, P1433, DOI 10.1016/j.joca.2011.08.010; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2005, VET SURG, V34, P239, DOI 10.1111/j.1532-950X.2005.00036.x; Muir P, 2002, AM J VET RES, V63, P1279, DOI 10.2460/ajvr.2002.63.1279; Muir P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159095; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Nelson SA, 2013, VET SURG, V42, P38, DOI 10.1111/j.1532-950X.2012.01052.x; Olive J, 2014, VET COMP ORTHOPAED, V27, P1, DOI 10.3415/VCOT-13-04-0054; Pearle AD, 2007, OSTEOARTHR CARTILAGE, V15, P516, DOI 10.1016/j.joca.2006.10.010; Provenzano PP, 2002, J APPL PHYSIOL, V92, P362, DOI 10.1152/jappl.2002.92.1.362; Racette M, 2016, VET J, V209, P150, DOI 10.1016/j.tvjl.2015.10.055; Sassi ML, 2003, CLIN CHEM LAB MED, V41, P1038, DOI 10.1515/CCLM.2003.160; SCAVELLI TD, 1990, J AM VET MED ASSOC, V196, P1135; Sharif M, 2000, ANN RHEUM DIS, V59, P71, DOI 10.1136/ard.59.1.71; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; TOWNLEY CO, 1985, CLIN ORTHOP RELAT R, P266; van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422; WHITEHAIR JG, 1993, J AM VET MED ASSOC, V203, P1016; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Winegardner KR, 2007, VET RADIOL ULTRASOUN, V48, P312, DOI 10.1111/j.1740-8261.2007.00248.x; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818	63	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178086	10.1371/journal.pone.0178086	http://dx.doi.org/10.1371/journal.pone.0178086			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575001	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300028
J	Barton, CM; Riding, CS; Loss, SR				Barton, Christine M.; Riding, Corey S.; Loss, Scott R.			Magnitude and correlates of bird collisions at glass bus shelters in an urban landscape	PLOS ONE			English	Article							WINDOW COLLISIONS; MORTALITY	Wildlife residing in urban landscapes face many human-related threats to their survival. For birds, collision with glass on manmade structures has been identified as a major hazard, causing hundreds of millions of avian fatalities in North America every year. Although research has investigated factors associated with bird-glass collision mortality at buildings, no prior studies have focused on bird fatalities at glass-walled bus shelters. Our objectives in this study were to describe the magnitude of bird-bus shelter collisions in the city of Stillwater, Oklahoma and assess potential predictors of collision risk, including characteristics of shelters (glass area) and surrounding land cover (e.g., vegetative features). We surveyed for bird carcasses and indirect collision evidence at 18 bus shelters over a five-month period. Linear regression and model selection results revealed that the amount of glass on shelters and the area of lawn within 50 m of shelters were both positively related to fatal bird collisions; glass area was also positively associated with observations of collision evidence on glass surfaces. After accounting for scavenger removal of carcasses, we estimate that a minimum of 34 birds are killed each year between May and September by collision with the 36 bus shelters in the city of Stillwater. While our study provides an initial look at bird fatalities at bus shelters, additional research is needed to generate a large-scale estimate of collision mortality and to assess species composition of fatalities at a national scale. Designing new bus shelters to include less glass and retrofitting existing shelters to increase visibility of glass to birds will likely reduce fatal bird collisions at bus shelters and thus reduce the cumulative magnitude of anthropogenic impacts to birds in cities.	[Barton, Christine M.; Riding, Corey S.; Loss, Scott R.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Barton, CM (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	affe54@vt.edu		Riding, Corey/0000-0002-2234-6884; Loss, Scott/0000-0002-8753-2995	National Institute of Food and Agriculture (United States Department of Agriculture) through the Oklahoma Agricultural Experiment Station [OKL-02915]	National Institute of Food and Agriculture (United States Department of Agriculture) through the Oklahoma Agricultural Experiment Station	Funding was provided by National Institute of Food and Agriculture (United States Department of Agriculture) Hatch Grant Funds through the Oklahoma Agricultural Experiment Station (OKL-02915). https://nifa.usda.gov/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Bird Conservancy and New York City Audubon, 2017, BIRD FRIENDL BUILD G; [Anonymous], 2013, NAIP IMP JUN 2013; [Anonymous], 2013, ARCGIS VERS 10 2 SOF; [Anonymous], 2015, ENV VIS IM VERS 5 3; Antworth RL, 2005, SOUTHEAST NAT, V4, P647, DOI 10.1656/1528-7092(2005)004[0647:HAREOS]2.0.CO;2; Arnold TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024708; Aronson MFJ, 2016, ECOLOGY, V97, P2952, DOI 10.1002/ecy.1535; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Banks RC (U. S. Dept. of the Interior Washington D. C.)., 1979, HUM REL MORT BIRDS U; Blancher P, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00557-080203; Borden W. Calvin, 2010, Ohio Journal of Science, V110, P44; Cusa M, 2015, URBAN ECOSYST, V18, P1427, DOI 10.1007/s11252-015-0459-3; Gelb Yigal, 2006, Kingbird, V56, P190; Gelb Y, 2009, NORTHEAST NAT, V16, P455, DOI 10.1656/045.016.n312; Hager SB, 2014, PREPRINT; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Hager SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053371; Hager SB, 2012, J FIELD ORNITHOL, V83, P203, DOI 10.1111/j.1557-9263.2012.00370.x; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Johnson R.E., 1976, Western Birds, V7, P99; Kahle LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144600; KLEM D, 1989, WILSON BULL, V101, P606; KLEM D, 1990, J FIELD ORNITHOL, V61, P120; Klem D, 2009, WILSON J ORNITHOL, V121, P314, DOI 10.1676/08-118.1; Korner-Nievergelt F, 2015, WILDLIFE BIOL, V21, P30, DOI 10.2981/wlb.00094; Ley Hans-Willy, 2006, Berichte zum Vogelschutz, V43, P87; Loss SR, 2015, ANNU REV ECOL EVOL S, V46, P99, DOI 10.1146/annurev-ecolsys-112414-054133; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; MacGregor-Fors I, 2011, BASIC APPL ECOL, V12, P372, DOI 10.1016/j.baae.2011.04.003; Martin GR, 2011, IBIS, V153, P239, DOI 10.1111/j.1474-919X.2011.01117.x; Metro Transit, 2017, SHELTER DESIGN; O'connell Timothy J., 2001, Raven, V72, P141; Ortega-Alvarez R, 2009, LANDSCAPE URBAN PLAN, V90, P189, DOI 10.1016/j.landurbplan.2008.11.003; R Core Team, 2016, R LANG ENV STAT COMP; RStudio Team, 2019, RSTUDIO INT DEV R; Sabo AM, 2016, PEERJ, V4, DOI 10.7717/peerj.2170; San Francisco Planning Department, 2011, STAND BIRD SAF BUILD; Schmid H, 2013, BIRD FRIENDLY BUILDI; Smallwood KS, 2007, J WILDLIFE MANAGE, V71, P2781, DOI 10.2193/2007-006; Somerlot K. E., 2003, J SERVICE LEANRING C, V1, P1; US Fish and Wildlife Service, 2016, RED BIRD COLL BUILD	42	8	8	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178667	10.1371/journal.pone.0178667	http://dx.doi.org/10.1371/journal.pone.0178667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570709	gold, Green Published, Green Submitted			2022-12-26	WOS:000402611800096
J	Chen, CC; Montalbano, AP; Hussain, I; Lee, WR; Mendelson, CR				Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.			The transcriptional repressor GATAD2B mediates progesterone receptor suppression of myometrial contractile gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; inflammation; nuclear receptor; progesterone; transcription corepressor	NF-KAPPA-B; DAVID BIOINFORMATICS RESOURCES; PROTEOMICS FACILITIES PIPELINE; BREAST-CANCER CELLS; HUMAN PARTURITION; MI-2/NURD COMPLEX; HUMAN-PREGNANCY; LABOR; TERM; WITHDRAWAL	The mechanisms whereby progesterone (P-4), acting via the progesterone receptor (PR), inhibits proinflammatory/contractile gene expression during pregnancy are incompletely defined. Using immortalized human myometrial (hTERT-HM) cells stably expressing wild-type PR-A or PR-B (PRWT), we found that P-4 significantly inhibited IL-1 induction of the NF-B target genes, COX-2 and IL-8. P-4-PRWT transrepression occurred at the level of transcription initiation and was mediated by decreased recruitment of NF-B p65 and RNA polymerase II to COX-2 and IL-8 promoters. However, in cells stably expressing a PR-A or PR-B DNA-binding domain mutant (PRmDBD), P-4-mediated transrepression was significantly reduced, suggesting a critical role of the PR DBD. ChIP analysis of hTERT-HM cells stably expressing PRWT or PRmDBD revealed that P-4 treatment caused equivalent recruitment of PRWT and PRmDBD to COX-2 and IL-8 promoters, suggesting that PR inhibitory effects were not mediated by its direct DNA binding. Using immunoprecipitation, followed by MS, we identified a transcriptional repressor, GATA zinc finger domain-containing 2B (GATAD2B), that interacted strongly with PRWT but poorly with PRmDBD. P-4 treatment of PRWT hTERT-HM cells caused enhanced recruitment of endogenous GATAD2B to COX-2 and IL-8 promoters. Further, siRNA knockdown of endogenous GATAD2B significantly reduced P-4-PRWT transrepression of COX-2 and IL-8. Notably, GATAD2B expression was significantly decreased in pregnant mouse and human myometrium during labor. Our findings suggest that GATAD2B serves as an important mediator of P-4-PR suppression of proinflammatory and contractile genes during pregnancy. Decreased GATAD2B expression near term may contribute to the decline in PR function, leading to labor.	[Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, North Texas March Dimes Birth Defects Ctr, Dallas, TX 75390 USA; [Chen, Chien-Cheng; Montalbano, Alina P.; Hussain, Imran; Lee, Wan-Ru; Mendelson, Carole R.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, North Texas March Dimes Birth Defects Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelson, CR (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carole.mendelson@utsouthwestern.edu		Hussain, Imran/0000-0003-1563-7656; Mendelson, Carole Ruth/0000-0003-1696-9791	Cancer Prevention Research Institute of Texas [RP120613]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD087150, P01HD011149] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Dr. Andrew Lemoff (University of Texas Southwestern Proteomics Core) for analysis of the mass spectrometry data as well as helpful discussion regarding this work. We also thank Dr. Linda Hynan (Division of Biostatistics, Department of Clinical Sciences) for help in statistical analysis of data from human myometrial samples. The UT Southwestern Proteomics Core is supported by the Cancer Prevention Research Institute of Texas (Grant RP120613).	Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Amini P, 2016, ENDOCRINOLOGY, V157, P4434, DOI 10.1210/en.2016-1654; Brackertz M, 2006, NUCLEIC ACIDS RES, V34, P397, DOI 10.1093/nar/gkj437; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; Chen CC, 2011, J BIOL CHEM, V286, P43091, DOI 10.1074/jbc.M111.295865; CHOW L, 1994, AM J OBSTET GYNECOL, V170, P788, DOI 10.1016/S0002-9378(94)70284-5; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; Cox SM, 1997, HUM REPROD UPDATE, V3, P517, DOI 10.1093/humupd/3.5.517; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; FUCHS AR, 1984, AM J OBSTET GYNECOL, V150, P734, DOI 10.1016/0002-9378(84)90677-X; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gong ZH, 2006, MOL CELL BIOL, V26, P4519, DOI 10.1128/MCB.00409-06; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; HARDY DB, 2006, FETAL MATERNAL MED R, V17, P281; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; Lee Y, 2012, J CELL MOL MED, V16, P2487, DOI 10.1111/j.1582-4934.2012.01567.x; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Li H, 2012, ONCOGENE, V31, P611, DOI 10.1038/onc.2011.253; Liu XY, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002373; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Nadeem L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11565; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Peters GA, 2017, ENDOCRINOLOGY, V158, P158, DOI 10.1210/en.2016-1537; POINTIS G, 1981, BIOL REPROD, V24, P801, DOI 10.1095/biolreprod24.4.801; Quiles I, 2009, MOL ENDOCRINOL, V23, P809, DOI 10.1210/me.2008-0454; Renthal NE, 2013, NAT REV ENDOCRINOL, V9, P391, DOI 10.1038/nrendo.2013.96; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Shynlova O, 2013, REPROD SCI, V20, P154, DOI 10.1177/1933719112446084; SIITERI PK, 1982, BIOL REPROD, V26, P1, DOI 10.1095/biolreprod26.1.1; Soloff MS, 2006, MOL HUM REPROD, V12, P619, DOI 10.1093/molehr/gal067; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Trudgian DC, 2012, J PROTEOME RES, V11, P6282, DOI 10.1021/pr300694b; Trudgian DC, 2011, PROTEOMICS, V11, P2790, DOI 10.1002/pmic.201000800; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Tseng L, 2003, DNA CELL BIOL, V22, P633, DOI 10.1089/104454903770238102; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; Williams KC, 2012, MOL ENDOCRINOL, V26, P1857, DOI 10.1210/me.2012-1199; Williams KC, 2012, P NATL ACAD SCI USA, V109, P7529, DOI 10.1073/pnas.1200650109; Xie N, 2012, MOL ENDOCRINOL, V26, P1370, DOI 10.1210/me.2012-1088	60	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12560	12576		10.1074/jbc.M117.791350	http://dx.doi.org/10.1074/jbc.M117.791350			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28576827	hybrid, Green Published			2022-12-26	WOS:000406636900021
J	Gavrila, AM; Hood, S; Robinson, B; Amir, S				Gavrila, Alex M.; Hood, Suzanne; Robinson, Barry; Amir, Shimon			Effects of bilateral anterior agranular insula lesions on food anticipatory activity in rats	PLOS ONE			English	Article							VENTROMEDIAL HYPOTHALAMIC-LESIONS; ENTRAINED CIRCADIAN-RHYTHMS; PARAVENTRICULAR NUCLEUS; SUPRACHIASMATIC NUCLEUS; LIMBIC CONNECTIONS; FEEDING SCHEDULES; PERIOD2 PROTEIN; EXPRESSION; MEAL; ABLATION	Food anticipatory activity (FAA) refers to a daily rhythm of locomotor activity that emerges under conditions of food restriction, whereby animals develop an intense, predictable period of activity in the few hours leading up to a predictable, daily delivery of food. The neural mechanisms by which FAA is regulated are not yet fully understood. Although a number of brain regions appear to be involved in regulating the development and expression of FAA, there is little evidence to date concerning the role of the anterior agranular insular cortex (AICa). The AICa plays a critical role in integrating the perception of visceral states with motivational behaviour such as feeding. We assessed the effect of bilateral electrolytic or ibotenic acid lesions of the AICa on FAA in male Wistar rats receiving food for varying lengths of time (2 h, 3 h, or 5 h) during the middle of the light phase (starting at either ZT4 or ZT6). Contrary to our initial expectations, we found that both electrolytic and ibotenic acid lesions significantly increased, rather than decreased, the amount of FAA expressed in lesioned rats. Despite increased FAA, lesioned rats did not eat significantly more during restricted feeding (RF) periods than control rats. Similar to controls, AlCa-lesioned rats showed negligible anticipatory activity to a restricted treat suggesting that the increased anticipatory activity in lesioned rats is associated with food restriction, rather than the appetitive value of the meal. Monitoring behaviour in an open field indicated that increased FAA in AlCa-lesioned rats was not explained by a general increase in locomotor activity. Together, these findings suggest that the AICa contributes to the network of brain regions involved in FAA.	[Gavrila, Alex M.; Robinson, Barry; Amir, Shimon] Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, FRSQ Grp Rech Neurobiol Comportementale, Montreal, PQ, Canada; [Hood, Suzanne] Bishops Univ, Dept Psychol, Sherbrooke, PQ, Canada	Concordia University - Canada; Bishops University	Amir, S (corresponding author), Concordia Univ, Dept Psychol, Ctr Studies Behav Neurobiol, FRSQ Grp Rech Neurobiol Comportementale, Montreal, PQ, Canada.	shimon.amir@concordia.ca	Hood, Suzanne/GOG-8970-2022; Amir, Shimon/AAE-4635-2022	Hood, Suzanne/0000-0001-6871-6230; Amir, Shimon/0000-0003-1919-5023	Canadian Institutes of Health Research [MOP142458]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (MOP142458) http://www.cihr-irsc.qc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; CRAWLEY JN, 1985, PEPTIDES, V6, P927, DOI 10.1016/0196-9781(85)90324-9; CRAWLEY JN, 1984, BRAIN RES, V295, P289, DOI 10.1016/0006-8993(84)90978-8; Davidson AJ, 2001, PHYSIOL BEHAV, V74, P349, DOI 10.1016/S0031-9384(01)00567-4; Davidson AJ, 2001, PHYSIOL BEHAV, V72, P231, DOI 10.1016/S0031-9384(00)00417-0; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; Frank S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00499; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; HONMA KI, 1983, PHYSIOL BEHAV, V30, P905, DOI 10.1016/0031-9384(83)90256-1; INOUYE SIT, 1982, BRAIN RES, V250, P183, DOI 10.1016/0006-8993(82)90967-2; JARRARD LE, 1989, J NEUROSCI METH, V29, P251, DOI 10.1016/0165-0270(89)90149-0; KRIEGER DT, 1980, ENDOCRINOLOGY, V106, P649, DOI 10.1210/endo-106-3-649; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Pomonis JD, 1997, J NEUROSCI, V17, P5175; Recabarren MP, 2005, NEUROSCIENCE, V134, P1413, DOI 10.1016/j.neuroscience.2005.05.022; Reynolds SM, 2005, J NEUROSCI, V25, P11757, DOI 10.1523/JNEUROSCI.3432-05.2005; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P731, DOI 10.1016/0031-9384(89)90359-4; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; STORLIEN LH, 1972, PHYSIOL BEHAV, V9, P191, DOI 10.1016/0031-9384(72)90234-X; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; YAMAMOTO T, 1980, J NEUROPHYSIOL, V44, P440, DOI 10.1152/jn.1980.44.3.440	41	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179370	10.1371/journal.pone.0179370	http://dx.doi.org/10.1371/journal.pone.0179370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594962	Green Published, Green Accepted, gold			2022-12-26	WOS:000402923200124
J	Pearson, LJ; Klaharn, IY; Thongsawang, B; Manuprasert, W; Saejew, T; Somparn, P; Chuengsaman, P; Kanjanabuch, T; Pisitkun, T				Pearson, Lachlan James; Klaharn, I-Yanut; Thongsawang, Bussakorn; Manuprasert, Wasin; Saejew, Thunvarat; Somparn, Poorichaya; Chuengsaman, Piyatida; Kanjanabuch, Talerngsak; Pisitkun, Trairak			Multiple extracellular vesicle types in peritoneal dialysis effluent are prominent and contain known biomarkers	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; APOPTOTIC BODIES; MESOTHELIAL CELL; EXOSOMES; MICROVESICLES; FLUID; MEMBRANE; IDENTIFICATION; TRANSITION; PROTEIN	Peritoneal dialysis inevitability results in activation of inflammatory processes and its efficiency is highly variable between patients. An improved method to isolate biomarkers and study pathophysiological mechanisms in peritoneal dialysis effluent (PDE) is expected to be of much benefit for the development of this treatment approach and help with patient management. Extracellular vesicles (EVs) are released as part of normal cellular processes. Their proteome is expected to reflect both type and health of their cell of origin. Although there is a significant interest in using EVs for "liquid biopsies", little is reported of their presence or composition in plentiful dialysis waste fluids, including peritoneal dialysis effluent (PDE). Here we determined the presence of EVs in PDE and subsequently characterized their proteome. EVs were first isolated from PDE using differential centrifugation, then a further enrichment using size exclusion chromatography (SEC) was performed. The presence of EVs was demonstrated using transmission electron microscopy, and their particle counts were investigated using nanoparticle tracking analysis and dynamic light scattering. Using tandem mass spectrometry, marker proteins from three types of EVs i.e. apoptotic bodies, ectosomes, and exosomes were identified. The proteomic results demonstrated that the isolation of EVs by differential centrifugation helped enrich for over 2,000 proteins normally masked by abundant proteins in PDE such as albumin and SEC markedly further improved the isolation of low abundant proteins. Gene ontology analysis of all identified proteins showed the marked enrichment of exosome and membrane-associated proteins. Over 3,700 proteins were identified in total, including many proteins with known roles in peritoneal pathophysiology. This study demonstrated the prominence of EVs in PDE and their potential value as a source of biomarkers for peritoneal dialysis patients.	[Pearson, Lachlan James; Klaharn, I-Yanut; Somparn, Poorichaya; Pisitkun, Trairak] Chulalongkorn Univ, Syst Biol Ctr, Res Affairs, Fac Med, Bangkok, Thailand; [Thongsawang, Bussakorn; Manuprasert, Wasin; Kanjanabuch, Talerngsak] Chulalongkorn Univ, Kidney & Metab Res Unit, Fac Med, Bangkok, Thailand; [Saejew, Thunvarat; Kanjanabuch, Talerngsak] King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellence Ctr, Bangkok, Thailand; [Chuengsaman, Piyatida] Bamphaeo Hosp, Prommitr Branch, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Pisitkun, T (corresponding author), Chulalongkorn Univ, Syst Biol Ctr, Res Affairs, Fac Med, Bangkok, Thailand.; Kanjanabuch, T (corresponding author), Chulalongkorn Univ, Kidney & Metab Res Unit, Fac Med, Bangkok, Thailand.; Kanjanabuch, T (corresponding author), King Chulalongkorn Mem Hosp, Peritoneal Dialysis Excellence Ctr, Bangkok, Thailand.	golfnephro@hotmail.com; Trairak.P@chula.ac.th		Kanjanabuch, Talerngsak/0000-0002-2996-8934	Rachadapisek Sompot Fund; Chulalongkorn University; National Research Council of Thailand [2558-113]; Grant for International Research Integration: Chula Research Scholar, and Rachadaphiseksompot Endowment Fund	Rachadapisek Sompot Fund; Chulalongkorn University(Chulalongkorn University); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Grant for International Research Integration: Chula Research Scholar, and Rachadaphiseksompot Endowment Fund	This research is supported by Rachadapisek Sompot Fund for Postdoctoral Fellowship, Chulalongkorn University, National Research Council of Thailand (2558-113), Grant for International Research Integration: Chula Research Scholar, and Rachadaphiseksompot Endowment Fund (GCURS_59_12_30_03 and Part of the "Research Grant for New Scholar CU Researcher's Project").	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Brewis IA, 2010, NEPHROL DIAL TRANSPL, V25, P1749, DOI 10.1093/ndt/gfq145; Cheema H, 2013, PERITON DIALYSIS INT, V33, P349, DOI 10.3747/pdi.2012.00320; Cuccurullo M, 2011, NEPHROL DIAL TRANSPL, V26, P1990, DOI 10.1093/ndt/gfq670; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Finkelstein FO, 2014, NAT REV NEPHROL, V10, P618, DOI 10.1038/nrneph.2014.176; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kawanishi H, 2005, NEPHROLOGY, V10, P249, DOI 10.1111/j.1440-1797.2005.00413.x; Keerthikumar S, 2015, ONCOTARGET, V6, P15375, DOI 10.18632/oncotarget.3801; Kim YL, 2009, PERITON DIALYSIS INT, V29, pS123; Korabecna M, 2013, J NEPHROL, V26, P1001, DOI 10.5301/jn.5000301; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu Y, 2015, PERITON DIALYSIS INT, V35, P14, DOI 10.3747/pdi.2014.00188; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Oh HJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001636; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raaijmakers R, 2008, NEPHROL DIAL TRANSPL, V23, P2402, DOI 10.1093/ndt/gfn212; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; Sole C, 2015, NEPHROL DIAL TRANSPL, V30, P1488, DOI 10.1093/ndt/gfv128; Sritippayawain S, 2007, J PROTEOME RES, V6, P4356, DOI 10.1021/pr0702969; Stanley M, 2010, NEPHROLOGY, V15, pS24, DOI 10.1111/j.1440-1797.2010.01228.x; Struijk DG, 2008, NDT PLUS, V1, piv29; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thomas CJ, 2002, FEBS LETT, V531, P184, DOI 10.1016/S0014-5793(02)03499-3; Torr EE, 2012, CELL DEATH DIFFER, V19, P671, DOI 10.1038/cdd.2011.167; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; Tyan YC, 2013, CLIN CHIM ACTA, V420, P34, DOI 10.1016/j.cca.2012.10.010; Vaksman O, 2014, CARCINOGENESIS, V35, P2113, DOI 10.1093/carcin/bgu130; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Wang HY, 2012, J PROTEOMICS, V75, P2053, DOI 10.1016/j.jprot.2012.01.011; Wang HY, 2010, NEPHROL DIAL TRANSPL, V25, P1955, DOI 10.1093/ndt/gfp696; Westman J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005319; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Windgassen EB, 2011, POSTGRAD MED, V123, P114, DOI 10.3810/pgm.2011.01.2252; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Yuana Y., 2014, J EXTRACELL VESICLES, V3	44	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178601	10.1371/journal.pone.0178601	http://dx.doi.org/10.1371/journal.pone.0178601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594924	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200041
J	Royall, DR; Al-Rubaye, S; Bishnoi, R; Palmer, RF				Royall, Donald R.; Al-Rubaye, Safa; Bishnoi, Ram; Palmer, Raymond F.			Serum proteins mediate depression's association with dementia	PLOS ONE			English	Article							DEFAULT MODE NETWORK; ALZHEIMER-DISEASE; SYMPTOMS; STATE; VALIDATION; PHENOTYPE; DIAGNOSIS; CORTISOL; SCALE; MILD	The latent variable "delta" (for "dementia") uniquely explains dementia severity. Depressive symptoms are independent predictors of delta. We explored 115 serum proteins as potential causal mediators of the effect of depressive symptoms on d in a large, ethnically diverse, longitudinal cohort. All models were adjusted for age, apolipoprotein E, education, ethnicity, gender, hemoglobin A1c, and homocysteine, and replicated in randomly selected 50% subsets. Alpha1-antitrypsin (A1AT), FAS, Heparin-binding EGF-like Growth Factor (HB-EGF), Insulin-like Growth Factor-1 (IGF-1), Luteinizing Hormone (LH), Macrophage Inflammatory Protein type 1 alpha (MIP-1 alpha), Resitin, S100b, Tissue Inhibitor of Metalloproteinase type 1 (TIMP-1), and Vascular Cell Adhesion Molecule type 1 (VCAM-1) each were partial mediators of depression's association with delta. These proteins may offer targets for the treatment of depression's specific effect on dementia severity and Alzheimer's Disease (AD) conversion risk.	[Royall, Donald R.; Al-Rubaye, Safa] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Royall, Donald R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Royall, Donald R.; Palmer, Raymond F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA; [Royall, Donald R.] South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA; [Bishnoi, Ram] Med Coll Georgia, Dept Psychiat, Augusta, GA 30912 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University System of Georgia; Augusta University	Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.; Royall, DR (corresponding author), South Texas Vet Hlth Syst, Audie L Murphy Div, Geriatr Res Educ & Clin Care Ctr, San Antonio, TX 78229 USA.	royall@uthscsa.edu	Bishnoi, Ram/P-4019-2014	Bishnoi, Ram/0000-0002-5202-5117; Royall, Donald/0000-0001-6475-0300	State of Texas; state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	State of Texas; state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders	Dr. Royall reports a grant from The State of Texas in support of TARCC data collection. However, the authors received no specific funding for this work, which includes data from all TARCC sites, not just Dr. Royall's funded site.; This study was made possible by the Julia and Van Buren Parr endowment for dementia related research and the Texas Alzheimer's Research and Care Consortium (TARCC) funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. The results have been presented as a poster at the 9th Edition of Clinical trials on Alzheimer's Disease (CtAD2016). San Diego, CA December 9, 2016.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arbuckle JL, 2006, ANAL MOMENT STRUCTUR; Bemelmans KJ, 2007, ACTA NEUROPSYCHIATR, V19, P231, DOI 10.1111/j.1601-5215.2006.00172.x; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Benton AL., 1983, MULTILINGUAL APHASIA; Bilello JA, 2015, J CLIN PSYCHIAT, V76, pE199, DOI 10.4088/JCP.14m09029; Bishnoi RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117282; Bishnoi RJ, 2015, J ALZHEIMERS DIS, V43, P37, DOI 10.3233/JAD-140042; Bollen K.A., 1993, TESTING STRUCTURAL E, DOI DOI 10.1093/SF/73.3.1161; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Czarees A, 1994, NIDA RES MONOGR, V139, P137; Degenhardt EK, 2016, PSYCHOSOMATICS, V57, P208, DOI 10.1016/j.psym.2015.12.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gabryelewicz T, 2007, INT J GERIATR PSYCH, V22, P563, DOI 10.1002/gps.1716; Gavett BE, 2015, NEUROPSYCHOLOGY, V29, P344, DOI 10.1037/neu0000128; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grice JW, 2001, PSYCHOL METHODS, V6, P430, DOI 10.1037//1082-989X.6.4.430; Hogervorst E, 2003, NEUROENDOCRINOL LETT, V24, P203; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jaeger J, 2006, PSYCHIAT RES, V145, P39, DOI 10.1016/j.psychres.2005.11.011; John SE, 2016, NEUROPSYCHOLOGY, V30, P946, DOI 10.1037/neu0000315; Kennedy N, 2007, BIPOLAR DISORD, V9, P25, DOI 10.1111/j.1399-5618.2007.00326.x; Kizilarslanoglu MC, 2015, TURK J MED SCI, V45, P1040, DOI 10.3906/sag-1403-55; Koch W, 2002, CLIN CHEM LAB MED, V40, P1123, DOI 10.1515/CCLM.2002.197; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Landau SM, 2016, NEUROLOGY, V86, P1377, DOI 10.1212/WNL.0000000000002576; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JG, 2009, PSYCHIAT INVEST, V6, P299, DOI 10.4306/pi.2009.6.4.299; Marinho PEM, 2012, ARCH GERONTOL GERIAT, V54, P453, DOI 10.1016/j.archger.2011.05.006; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P1066, DOI 10.1097/JGP.0b013e3181f60f81; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Palmer RF, 2016, J ALZHEIMERS DIS, V49, P521, DOI 10.3233/JAD-150254; Palmer RF, 2010, J AM GERIATR SOC, V58, pS343, DOI 10.1111/j.1532-5415.2010.03053.x; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; PASW Statistics 18, 2009, REL VERS 18 0 0; PlatenIk J, 2012, PROG NEUROPSYCHOPHAR, V50, P83; Royall DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172268; Royall DR, 2016, AGING-US, V8, P3241, DOI 10.18632/aging.101091; Royall Donald R, 2016, Alzheimers Dement (Amst), V3, P35, DOI 10.1016/j.dadm.2016.02.003; Royall DR, 2016, ONCOTARGET, V7, P13307, DOI 10.18632/oncotarget.7759; Royall DR, 2016, J ALZHEIMERS DIS, V49, P561, DOI 10.3233/JAD-150261; Royall DR, 2015, J ALZHEIMERS DIS, V43, P275, DOI 10.3233/JAD-140264; Royall DR, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00369; Royall DR, 2013, ALZHEIMERS DEMENT, V9, P318, DOI 10.1016/j.jalz.2011.11.009; Royall DR, 2013, J ALZHEIMERS DIS, V34, P547, DOI 10.3233/JAD-121639; Royall DR, 2012, J ALZHEIMERS DIS, V32, P467, DOI 10.3233/JAD-2012-120424; Royall DR, 2012, J ALZHEIMERS DIS, V30, P639, DOI 10.3233/JAD-2012-120055; Royall DR, 2016, J PREV ALZ DIS, V3, P283; Royall DR, 2017, J GERONT B IN PRESS; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Sheline YI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008169; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; T'Sjoen GG, 2005, J AM GERIATR SOC, V53, P636, DOI 10.1111/j.1532-5415.2005.53212.x; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Weber-Hamann B, 2007, J PSYCHIATR RES, V41, P344, DOI 10.1016/j.jpsychires.2006.01.002; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wheaton B., 1977, SOCIOL METHODOL, V8, P84, DOI [10.2307/270754, DOI 10.2307/270754]; YESAVAGE JA, 1981, J AM GERIATR SOC, V29, P164, DOI 10.1111/j.1532-5415.1981.tb01759.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	63	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0175790	10.1371/journal.pone.0175790	http://dx.doi.org/10.1371/journal.pone.0175790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594820	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200003
J	Schwartzbaum, J; Wang, M; Root, E; Pietrzak, M; Rempala, GA; Huang, RP; Johannesen, TB; Grimsrud, TK				Schwartzbaum, Judith; Wang, Min; Root, Elisabeth; Pietrzak, Maciej; Rempala, Grzegorz A.; Huang, Ruo-Pan; Johannesen, Tom Borge; Grimsrud, Tom K.			A nested case-control study of 277 prediagnostic serum cytokines and glioma	PLOS ONE			English	Article							GLIOBLASTOMA; STRATEGIES; IL-4; RISK	Recent research shows bidirectional communication between the normal brain and the peripheral immune system. Glioma is a primary brain tumor characterized by systemic immunosuppression. To better understand gliomagenesis, we evaluated associations between 277 prediagnostic serum cytokines and glioma. We used glioma (n = 487) and matched control (n = 487) specimens from the Janus Serum Bank Cohort in Oslo, Norway. Conditional logistic regression allowed us to identify those cytokines that were individually associated with glioma. Next, we used heat maps to compare case to control Pearson correlation matrices of 12 cytokines modeled in an in silico study of the interaction between the microenvironment and the tumor. We did the same for case-control correlation matrices of lasso-selected cytokines and all 277 cytokines in the data set. Cytokines related to glioma risk (P <= .05) more than 10 years before diagnosis are sIL10RB, VEGF, beta-Catenin and CCL22. LIF was associated with decreased glioma risk within five years before glioma diagnosis (odds ratio (OR) = 0.47, 95% confidence interval (CI) = 0.23, 0.94). After adjustment for cytokines above, the previously observed interaction between IL4 and sIL4RA persisted (> 20 years before diagnosis, OR = 1.72, 95% CI = 1.20, 2.47). In addition, during this period, case correlations among 12 cytokines were weaker than were those among controls. This pattern was also observed among 30 lasso-selected cytokines and all 277 cytokines. We identified four cytokines and one interaction term that were independently related to glioma risk. We have documented prediagnostic changes in serum cytokine levels that may reflect the presence of a preclinical tumor.	[Schwartzbaum, Judith] Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA; [Schwartzbaum, Judith] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wang, Min; Pietrzak, Maciej; Rempala, Grzegorz A.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Wang, Min; Pietrzak, Maciej; Rempala, Grzegorz A.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Wang, Min] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Root, Elisabeth] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Pietrzak, Maciej; Rempala, Grzegorz A.] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Huang, Ruo-Pan] RayBiotech Inc, Norcross, GA USA; [Huang, Ruo-Pan] RayBiotech Inc, Guangzhou, Guangdong, Peoples R China; [Johannesen, Tom Borge] Canc Registry Norway, Dept Registrat, Oslo, Norway; [Grimsrud, Tom K.] Canc Registry Norway, Dept Res, Oslo, Norway	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Oslo; University of Oslo	Schwartzbaum, J (corresponding author), Ohio State Univ, Coll Publ Hlth, Div Epidemiol, Columbus, OH 43210 USA.; Schwartzbaum, J (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	ja.schwartzbaum@gmail.com	Root, Elisabeth/A-7429-2016; Grimsrud, Tom K/M-6345-2015; Pietrzak, Maciej/GNH-5768-2022; Schwartzbaum, Judith/A-9022-2016	Root, Elisabeth/0000-0002-9566-4031; Grimsrud, Tom K/0000-0003-0425-043X; Pietrzak, Maciej/0000-0001-5768-7884; Schwartzbaum, Judith/0000-0002-1523-9941	National Cancer Institute, Natioinal Institutes of Health [R01CA122163]; RayBiotech, Inc.; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	National Cancer Institute, Natioinal Institutes of Health; RayBiotech, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the National Cancer Institute, Natioinal Institutes of Health (grant number (R01CA122163) to JS. RayBiotech, Inc. provided support in the form of salary for RPH.	Amirian ES, 2016, CANCER MED-US, V5, P1352, DOI 10.1002/cam4.682; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Cai JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126022; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Codrici E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5728438; Cohen JE, 2008, NEURON GLIA BIOL, V4, P43, DOI 10.1017/S1740925X09000076; Fan YY, 2013, ACTA NEUROBIOL EXP, V73, P485; Fine HA, 2015, CLIN CANCER RES, V21, P1984, DOI 10.1158/1078-0432.CCR-14-1328; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Hambardzumyan D, 2016, NAT NEUROSCI, V19, P20, DOI 10.1038/nn.4185; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Helgesson G, 2007, NAT BIOTECHNOL, V25, P973, DOI 10.1038/nbt0907-973b; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Kelly Patrick J, 2010, Surg Neurol Int, V1, P96, DOI 10.4103/2152-7806.74243; Kennedy BC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-11; Kindt TJ, 2006, KUBY IMMUNOLOGY; Koshy M, 2012, J NEURO-ONCOL, V107, P207, DOI 10.1007/s11060-011-0738-7; Langseth H, 2009, JANUS SERUM BANK FRO; Langseth H., 2016, INT J EPIDEMIOL, DOI 10.93/ije/dyw027.; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Lim Michael, 2016, Am Soc Clin Oncol Educ Book, V35, pe132, DOI 10.14694/EDBK_159084; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nager Mireia, 2012, Chemother Res Pract, V2012, P192362, DOI 10.1155/2012/192362; Nijaguna MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137524; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001; Razavi SM, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00011; Salazar-Onfray F, 2007, CYTOKINE GROWTH F R, V18, P171, DOI 10.1016/j.cytogfr.2007.01.015; Schmidt-Weber CB, 2012, CHEM IMMUNOL ALLERGY, V96, P120, DOI 10.1159/000332235; Schwartzbaum J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137503; Schwartzbaum J, 2012, J NATL CANCER I, V104, P1251, DOI 10.1093/jnci/djs315; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Walter MR, 2014, CURR TOP MICROBIOL, V380, P191, DOI 10.1007/978-3-662-43492-5_9; Wells E, 2016, ONCOTARGET; Wu Y, 2012, INTEGR BIOL-UK, V4, P1478, DOI 10.1039/c2ib20044a; Yamada Kazunari, 2011, Cancers (Basel), V3, P1975, DOI 10.3390/cancers3021975; Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001; Zisakis A, 2007, COMP ANAL PERIPHERAL	41	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178705	10.1371/journal.pone.0178705	http://dx.doi.org/10.1371/journal.pone.0178705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594935	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200045
J	Way, MJ; Ali, MA; McQuillin, A; Morgan, MY				Way, Michael J.; Ali, M. Adam; McQuillin, Andrew; Morgan, Marsha Y.			Genetic variants in ALDH1B1 and alcohol dependence risk in a British and Irish population: A bioinformatic and genetic study	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; PROTEIN-STRUCTURE; I-TASSER; ADH1B; ASSOCIATION; GENOTYPES; POLYMORPHISM; METABOLISM; ETHANOL; SIMULATION	Alcohol is metabolized in the liver via the enzymes alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Polymorphisms in the genes encoding these enzymes, which are common in East Asian populations, can alter enzyme kinetics and hence the risk of alcohol dependence and its sequelae. One of the most important genetic variants, in this regards, is the single nucleotide polymorphism (SNP) rs671 in ALDH2, the gene encoding the primary acetaldehyde metabolizing enzyme ALDH2. However, the protective allele of rs671 is absent in most Europeans although ALDH1B1, which shares significant sequence homology with ALDH2, contains several, potentially functional, missense SNPs that do occur in European populations. The aims of this study were: (i) to use bioinformatic techniques to characterize the possible effects of selected variants in ALDH1B1 on protein structure and function; and, (ii) to genotype three missense and one stop-gain, protein-altering, non-synonymous SNPs in 1478 alcohol dependent cases and 1254 controls of matched British and Irish ancestry. No significant allelic associations were observed between the three missense SNPs and alcohol dependence risk. The minor allele frequency of rs142427338 (Gln378Ter) was higher in alcohol dependent cases than in controls (allelic P = 0.19, OR = 2.98, [0.62-14.37]) but as this SNP is very rare the study was likely underpowered to detect an association with alcohol dependence risk. This potential association will needs to be further evaluated in other large, independent European populations.	[Way, Michael J.; Ali, M. Adam; McQuillin, Andrew] UCL, Mol Psychiat Lab, Div Psychiat, London, England; [Way, Michael J.; Ali, M. Adam; Morgan, Marsha Y.] UCL, UCL Inst Liver & Digest Hlth, Dept Med, Royal Free Campus, London, England	University of London; University College London; University of London; University College London	Morgan, MY (corresponding author), UCL, UCL Inst Liver & Digest Hlth, Dept Med, Royal Free Campus, London, England.	marsha.morgan@ucl.ac.uk	McQuillin, Andrew/C-1623-2008	McQuillin, Andrew/0000-0003-1567-2240	University College London; Hobson Charity Limited	University College London(General Electric); Hobson Charity Limited	The research was funded by a PhD studentship award jointly funded by University College London and the Hobson Charity Limited.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bierut LJ, 2012, MOL PSYCHIATR, V17, P445, DOI 10.1038/mp.2011.124; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Brocke KS, 2002, HUM MOL GENET, V11, P331, DOI 10.1093/hmg/11.3.331; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen YC, 2009, PHARMACOGENET GENOM, V19, P588, DOI 10.1097/FPC.0b013e32832ecf2e; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Edenberg HJ, 2012, ALCOHOL RES-CURR REV, V34, P336; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Eng MY, 2007, ALCOHOL RES HEALTH, V30, P22; Gelernter J, 2014, MOL PSYCHIATR, V19, P41, DOI 10.1038/mp.2013.145; GOEDDE HW, 1992, HUM GENET, V88, P344; GOEDDE HW, 1987, ENZYME, V37, P29, DOI 10.1159/000469239; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley TD, 1990, J BIOL CHEM; Hurley TD, 2012, ALCOHOL RES-CURR REV, V34, P339; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Jackson BC, 2013, CHEM-BIOL INTERACT, V202, P11, DOI 10.1016/j.cbi.2012.11.022; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KOPUN M, 1977, EUR J CLIN PHARMACOL, V11, P337, DOI 10.1007/BF00566530; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Li DW, 2011, BIOL PSYCHIAT, V70, P504, DOI 10.1016/j.biopsych.2011.02.024; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Linneberg A, 2010, CLIN EXP ALLERGY, V40, P123, DOI 10.1111/j.1365-2222.2009.03398.x; Liu MY, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/104614; Ni L, 1999, PROTEIN SCI, V8, P2784; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrook J., 2001, MOL CLONING LAB MANU; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; SHERMAN D, 1993, HUM GENET, V92, P477, DOI 10.1007/BF00216454; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; SMITH LJ, 1995, BIOCHEMISTRY-US, V34, P10918, DOI 10.1021/bi00034a026; Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Treutlein J, 2014, BIOL PSYCHIAT, V75, pE15, DOI 10.1016/j.biopsych.2013.05.042; Wang LX, 2016, QUATERN INT, V426, P187, DOI 10.1016/j.quaint.2016.03.008; Way M, 2015, ADDICT BIOL, V20, P594, DOI 10.1111/adb.12141; Way MJ, 2014, CHEM-BIOL INTERACT, V207, P23, DOI 10.1016/j.cbi.2013.10.019; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Wu YY, 2000, CLIN CHIM ACTA, V293, P213, DOI 10.1016/S0009-8981(99)00237-5; Xin YN, 2013, PROTEINS, V81, P406, DOI 10.1002/prot.24199; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; YIN SJ, 1984, BIOCHEMISTRY-US, V23, P5847, DOI 10.1021/bi00319a026; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0177009	10.1371/journal.pone.0177009	http://dx.doi.org/10.1371/journal.pone.0177009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594837	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200006
J	Hernandez-Pliego, J; Rodriguez, C; Dell'Omo, G; Bustamante, J				Hernandez-Pliego, Jesus; Rodriguez, Carlos; Dell'Omo, Giacomo; Bustamante, Javier			Combined use of tri-axial accelerometers and GPS reveals the flexible foraging strategy of a bird in relation to weather conditions	PLOS ONE			English	Article							KESTREL FALCO-NAUMANNI; HUNTING BEHAVIOR; ACCELERATION DATA; BREEDING-SEASON; BODY ACCELERATION; HOVERING FLIGHT; AERODYNAMICS; ANIMALS; MOVEMENT; AGE	Tri-axial accelerometry has proved to be a useful technique to study animal behavior with little direct observation, and also an effective way to measure energy expenditure, allowing a refreshing revisit to optimal foraging theory. This theory predicts that individuals should gain the most energy for the lowest cost in terms of time and energy when foraging, in order to maximize their fitness. However, during a foraging trip, central-place foragers could face different trade-offs during the commuting and searching parts of the trip, influencing behavioral decisions. Using the lesser kestrel (Falco naumanni) as an example we study the time and energy costs of different behaviors during the commuting and searching parts of a foraging trip. Lesser kestrels are small insectivorous falcons that behave as central-place foragers during the breeding season. They can commute by adopting either time-saving flapping flights or energy-saving soaring-gliding flights, and capture prey by using either time-saving active hovering flights or energy-saving perch-hunting. We tracked 6 lesser kestrels using GPS and tri-axial accelerometers during the breeding season. Our results indicate that males devoted more time and energy to flight behaviors than females in agreement with being the sex responsible for food provisioning to the nest. During the commuting flights, kestrels replaced flapping with soaring-gliding flights as solar radiation increased and thermal updrafts got stronger. In the searching part, they replaced perch-hunting with hovering as wind speed increased and they experienced a stronger lift. But also, they increased the use of hovering as air temperature increased, which has a positive influence on the activity level of the preferred prey (large grasshoppers). Kestrels maintained a constant energy expenditure per foraging trip, although flight and hunting strategies changed dramatically with weather conditions, suggesting a fixed energy budget per trip to which they adjusted their commuting and searching strategies in response to weather conditions.	[Hernandez-Pliego, Jesus; Bustamante, Javier] CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain; [Rodriguez, Carlos] CSIC, Dept Conservat Biol, Estn Biol Donana, Seville, Spain; [Dell'Omo, Giacomo] Ornis Italica, Rome, Italy	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hernandez-Pliego, J (corresponding author), CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain.	jhpliego@ebd.csic.es	Bustamante, Javier/AAA-7273-2019; Bustamante, Javier/C-2735-2008; Hernandez-Pliego, Jesus/M-4067-2015	Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677; Hernandez-Pliego, Jesus/0000-0002-7343-4518; Dell'Omo, Giacomo/0000-0002-9601-9675	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [P09-RNM-04588]; Ministerio de Economia y Competitividad, Spain [FICTS-2014/01 / AIC-A-2011-0706, CGL2016-79249-P]; NERC standard grants, United Kingdom; European Union; JAE-predoc fellowship; JAE-doc fellowship; Spanish National Research Council; European Social Fund	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad, Spain; NERC standard grants, United Kingdom; European Union(European Commission); JAE-predoc fellowship; JAE-doc fellowship; Spanish National Research Council; European Social Fund(European Social Fund (ESF))	This study was financed by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia, by "Adaptacion y mejora de la internacionalizacion de la e-infraestructura ICTS-RBD Para la ESFRI-Lifewatch" project (ref: FICTS-2014/01 / AIC-A-2011-0706) and "KESTREL-MOVE" project (ref: CGL2016-79249-P) financed by the Ministerio de Economia y Competitividad, Spain, by project "Migratory decisions in a changing world: mechanisms and drivers of changing migratory behaviour", NERC standard grants, United Kingdom, and by FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank I. Piudo and A. Quilez for their support during field work. We are especially grateful to M. Baena and J. Marin for the development of the technological design of the lesser kestrel nest-boxes installed at the breeding colonies that allowed us to capture kestrels and video record their behavior. We also thank L. Rubio for her illustrations. Sharon Swartz, Nir Sapir and an anonymous reviewer made useful comments on an early draft of this manuscript. This study was financed by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia, by "Adaptacion y mejora de la internacionalizacion de la e-infraestructura ICTS-RBD para la ESFRI-Lifewatch" project (ref: FICTS-2014/01 / AIC-A-2011-0706) and "KESTREL-MOVE" project (ref: CGL2016-79249-P) financed by the Ministerio de Economia y Competitividad, Spain, by "Migratory decisions in a changing world: mechanisms and drivers of changing migratory behaviour" project, NERC standard grants, United Kingdom, and by FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund.	ALES RF, 1992, LANDSCAPE ECOL, V7, P3, DOI 10.1007/BF02573953; Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; ANDERSON RA, 1981, OECOLOGIA, V49, P67, DOI 10.1007/BF00376899; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Aparicio Jose Miguel, 1990, Ardeola, V37, P163; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Berggren A, 2005, ECOL ENTOMOL, V30, P480, DOI 10.1111/j.0307-6946.2005.00709.x; Brown DD, 2014, J ZOOL, V293, P160, DOI 10.1111/jzo.12131; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; Chimienti M, 2016, ECOL EVOL, V6, P727, DOI 10.1002/ece3.1914; Chivers LS, 2012, MAR ECOL PROG SER, V456, P269, DOI 10.3354/meps09691; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cramp S., 1980, BIRDS W PALEARCTIC; Cushman-Roisin B., 2014, ATMOSPHERIC BOUNDARY; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DONAZAR JA, 1992, ORNIS SCAND, V23, P190, DOI 10.2307/3676448; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Larios DF, 2013, SENSORS-BASEL, V13, P2862, DOI 10.3390/s130302862; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Graf PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136751; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hernandez-Pliego J, 2015, MOVEBANK DATA REPOSI; Hernandez-Pliego J, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0100-6; Hernandez-Pliego J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145402; Hernandez-Pliego J, 2014, CURR ZOOL, V60, P604, DOI 10.1093/czoolo/60.5.604; IUCN, 2013, IUCN RED LIST THREAT; JAKSIC FM, 1985, ORNIS SCAND, V16, P165, DOI 10.2307/3676627; Jin MS, 2014, STUDY RELATIONS SOIL, P279; Le Vaillant M, 2012, J EXP BIOL, V215, P3685, DOI 10.1242/jeb.071175; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mills G. S., 1979, THESIS; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 2010, POPULATION ECOLOGY R; NORBERG UM, 1976, J EXP BIOL, V65, P459; Orians G.H., 1979, P155; Palatitz Peter, 2015, Ornis Hungarica, V23, P32; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Penteriani V, 2013, NATURWISSENSCHAFTEN, V100, P935, DOI 10.1007/s00114-013-1093-7; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050336; Rodriguez C, 2014, BIRD CONSERV INT, V24, P438, DOI 10.1017/S0959270913000129; Rodriguez C, 2010, J RAPTOR RES, V44, P120, DOI 10.3356/JRR-09-34.1; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; RUDOLPH SG, 1982, ECOLOGY, V63, P1268, DOI 10.2307/1938854; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; SALAMOLARD M, 1993, FUNCT ECOL, V7, P643, DOI 10.2307/2390184; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Spaar R, 1997, IBIS, V139, P523, DOI 10.1111/j.1474-919X.1997.tb04669.x; Spiegel O, 2013, AM NAT, V181, pE102, DOI 10.1086/670009; STIEDL O, 1991, BEHAV PROCESS, V23, P125, DOI 10.1016/0376-6357(91)90063-6; Tanida H, 2011, ANIM SCI J, V82, P792, DOI 10.1111/j.1740-0929.2011.00903.x; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Village A., 1990, THE KESTREL, P36; Vlachos C, 2003, ACTA ORNITHOL, V38, P129, DOI 10.3161/068.038.0210; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; WALKER TJ, 1975, ANN ENTOMOL SOC AM, V68, P607, DOI 10.1093/aesa/68.3.607; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Whitney NM, 2007, AQUAT LIVING RESOUR, V20, P299, DOI 10.1051/alr:2008006; Williams H.J., 2015, ANIM BIOTELEM, V3, P1, DOI [10.1186/s40317-015-0077-0, DOI 10.1186/S40317-015-0077-0]; Wilmers CC, 2015, ECOLOGY, V96, P1741, DOI 10.1890/14-1401.1; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2015, ELIFE, V4, DOI 10.7554/eLife.06487; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; WITHERS PC, 1979, J EXP BIOL, V80, P83; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yoda K, 1999, J EXP BIOL, V202, P3121; Zank CM, 1996, OSTRICH, V67, P63, DOI 10.1080/00306525.1996.9633785	82	18	18	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177892	10.1371/journal.pone.0177892	http://dx.doi.org/10.1371/journal.pone.0177892			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591181	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700016
J	Lee, FY; Chen, WK; Chiu, CH; Lin, CL; Kao, CH; Chen, CH; Yang, TY; Lai, CY				Lee, Feng-You; Chen, Wei-Kung; Chiu, Chun-Hsiang; Lin, Cheng-Li; Kao, Chia-Hung; Chen, Chao-Hsien; Yang, Tse-Yen; Lai, Ching-Yuan			Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; EPIDEMIOLOGY; POPULATION; EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; STRATIFICATION; VALIDATION	Studies on the association between aortic aneurysm (AA) and the subsequent risk of venous thromboembolism (VTE) are limited to a few case reports and investigations which only focused on surgical effects. Therefore, we used the National Health Insurance Research Database to clarify whether patients with AAs have a heightened risk of subsequent VTEs, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Our retrospective cohort study comprised patients aged >= 18 years who received a diagnosis of an AA and were hospitalized at any point during 2000-2010 (n = 16,630). Each AA patient was frequency-matched to 4 non-AA hospitalized patients based on age, sex, and index year (n = 66,453). The Cox proportional hazard regressions model was used to estimate the adjusted effect of AAs on VTE risk. The overall incidence of DVT and PE was higher in the patients with AA than in the non-AA group patients (23.5 versus 13.2 and 13.5 versus 7.98/1,000 person-years). After adjustment for age, sex, duration of hospitalization in the study period, and comorbidities, patients with AAs were associated with a 1.88-fold higher risk of DVT and 1.90-fold higher risk of PE compared to the non-AA cohort. Patients with abdominal AAs were more likely to develop DVT, whereas thoracic AA patients were more likely to develop PE. A diagnosis of a ruptured AA was associated with a substantially increased risk of DVT. Surgical treatment of AAs was associated with a heightened risk of VTE within 6-months post-operation. Our study demonstrates that AAs are associated with an increased risk of subsequent VTE. Future investigations are encouraged to delineate the mechanisms underlying this association and to evaluate the cost-effectiveness of screening for VTEs in patients with AAs.	[Lee, Feng-You] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Emergency Med, Taichung, Taiwan; [Chen, Wei-Kung; Lai, Ching-Yuan] China Med Univ Hosp, Trauma & Emergency Ctr, Dept Emergency Med, Taichung, Taiwan; [Chiu, Chun-Hsiang] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan; [Chen, Chao-Hsien; Yang, Tse-Yen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Yang, Tse-Yen] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Defense Medical Center; Tri-Service General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, TY (corresponding author), China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.; Yang, TY (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	yang_t_y@yahoo.com.tw	yang, zhe yan/C-4259-2015	yang, zhe yan/0000-0002-3165-132X	Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan; Management Office for Health Data of China Medical University Hospital, Taichung, Taiwan; China Medical University Hospital [DMR-106-162]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan; Management Office for Health Data of China Medical University Hospital, Taichung, Taiwan; China Medical University Hospital; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	We thank the Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan for providing the service of statistical analysis. Miss Cheng-Li Lin have received her salary from Management Office for Health Data of China Medical University Hospital, Taichung, Taiwan and the department was supported from the list of funding. Dr. Tse-Yen Yang received the grant from China Medical University Hospital (DMR-106-162). This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW106-TDU-B-212-113004); China Medical University Hospital (DMR-106-162); Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding has been received for this study.	Aggarwal S, 2011, EXP CLIN CARDIOL, V16, P11; AMELI FM, 1995, J VASC SURG, V21, P540, DOI 10.1016/S0741-5214(95)70301-2; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bath MF, 2015, BRIT J SURG, V102, P866, DOI 10.1002/bjs.9837; Belohlavek J, 2013, EXP CLIN CARDIOL, V18, P129; BRADBURY A, 1994, J VASC SURG, V20, P318, DOI 10.1016/0741-5214(94)90025-6; Brandao D, 2009, CASE REP MED, V2009, DOI 10.1155/2009/827954; Bulger Christopher M, 2004, Tech Vasc Interv Radiol, V7, P50, DOI 10.1053/j.tvir.2004.02.001; Burgazli KM, 2013, EUR REV MED PHARMACO, V17, P3123; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Coleman Dawn M, 2015, Curr Probl Surg, V52, P233, DOI 10.1067/j.cpsurg.2015.04.003; COON WW, 1973, CIRCULATION, V48, P839, DOI 10.1161/01.CIR.48.4.839; Davies JE, 2009, SEMIN THORAC CARDIOV, V21, P341, DOI 10.1053/j.semtcvs.2009.12.002; de Maistre E, 2009, J VASC SURG, V49, P596, DOI 10.1016/j.jvs.2008.10.005; DeFreitas MR, 2015, INT J CARDIOVASCULAR, P1; Dua A, 2014, J VASC SURG, V59, P1512, DOI 10.1016/j.jvs.2014.01.007; Eagleton MJ, 2002, J VASC SURG, V36, P912, DOI 10.1067/mva.2002.128640; Hansson PO, 1997, ARCH INTERN MED, V157, P1665, DOI 10.1001/archinte.157.15.1665; Heit JA, 2006, J THROMB THROMBOLYS, V21, P23, DOI 10.1007/s11239-006-5572-y; Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6; Huang W, 2014, AM J MED, V127, P829, DOI 10.1016/j.amjmed.2014.03.041; Kesieme E, 2011, J BLOOD MED, V2, P59, DOI 10.2147/JBM.S19009; Khashram M, 2015, EUR J VASC ENDOVASC; KNIFFIN WD, 1994, ARCH INTERN MED, V154, P861, DOI 10.1001/archinte.154.8.861; Kroegel C, 2003, RESPIRATION, V70, P7, DOI 10.1159/000068427; Kuivaniemi H, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/564734; Kurklinsky AK, 2011, VASC MED, V16, P409, DOI 10.1177/1358863X11424097; Lee MLT, 2006, STAT SCI, V21, P501, DOI 10.1214/088342306000000330; Martufi G, 2014, BIOMECH MODEL MECHAN, V13, P917, DOI 10.1007/s10237-014-0557-9; Mertens R, 1999, REV MED CHILE, V127, P459; Moore RD, 2013, AM J MED SCI, V346, P521, DOI 10.1097/MAJ.0b013e3182a55a96; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; Oger E., 2002, Annales de Cardiologie et d'Angeiologie, V51, P124, DOI 10.1016/S0003-3928(02)00083-5; OLIN JW, 1993, J VASC SURG, V18, P1037, DOI 10.1016/0741-5214(93)90559-5; Patel R, 2016, LANCET; Pawlaczyk K, 2016, EUR J VASC ENDOVASC, V51, P121, DOI 10.1016/j.ejvs.2015.08.021; Reimerink JJ, 2013, BRIT J SURG, V100, P1405, DOI 10.1002/bjs.9235; Sajjad J, 2015, J SURG CASE REP, DOI 10.1093/jscr/rjv092; Scarborough JE, 2012, J AM COLL SURGEONS, V214, P620, DOI 10.1016/j.jamcollsurg.2011.12.031; Sejersen Holger Marquard, 2007, Ugeskr Laeger, V169, P109; Siddiqui Juveria, 2011, BMJ Case Rep, V2011, DOI 10.1136/bcr.09.2011.4793; Sidloff D, 2014, CIRCULATION, V129, P747, DOI 10.1161/CIRCULATIONAHA.113.005457; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Skeik N, 2014, ANN VASC SURG, V28, DOI 10.1016/j.avsg.2013.12.020; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; Spencer FA, 2009, J THROMB THROMBOLYS, V28, P401, DOI 10.1007/s11239-009-0378-3; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; Tagalakis V, 2011, PHARMACOEPIDEM DR S, V20, P304, DOI 10.1002/pds.2061; Tudoran M, 2016, NIGER J CLIN PRACT, V19, P831, DOI 10.4103/1119-3077.181355; Wang SW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001716; White RH, 1998, ANN INTERN MED, V128, P737, DOI 10.7326/0003-4819-128-9-199805010-00006; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178587	10.1371/journal.pone.0178587	http://dx.doi.org/10.1371/journal.pone.0178587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591152	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700039
J	Park, JH; Kim, M; Oh, JH				Park, Joo-Hee; Kim, Moosang; Oh, Jong-Hyun			Effects of bevacizumab on endoplasmic reticulum stress in hypoxic retinal pigment epithelial cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; UNFOLDED PROTEIN RESPONSE; MACULAR DEGENERATION; SURVIVAL FACTOR; FACTOR-A; VEGF; DEATH; RANIBIZUMAB; TRANSCRIPTION; ANGIOGENESIS	Purpose To investigate the effects of bevacizumab on endoplasmic reticulum (ER) stress in human retinal pigment epithelial (RPE) cells cultured under hypoxic conditions. Methods RPE cells (ARPE-19) were cultured under hypoxic conditions (1% O-2) with or without bevacizumab (0.3125 mg/mL) for 24 and 48 h. Cell viability was measured by a PrestoBlue assay. The expression of vascular endothelial growth factor (VEGF), binding protein/glucose- regulated protein 78 (BiP/GRP78), and C/EBP homologous protein-10 (CHOP) mRNA was measured by quantitative real-time polymerase chain reaction (qRT-PCR). BiP/GRP78 and CHOP protein levels in the cells were assessed by western blot. VEGF protein in the media was quantified by enzyme-linked immunosorbent assay (ELISA). Results Under hypoxic conditions, cell viability decreased and mRNA and protein levels of VEGF, BiP/GRP78, and CHOP increased compared to those under normoxic conditions. Bevacizumab improved cell viability and reduced the expression of VEGF mRNA under hypoxic conditions. Bevacizumab also reduced the expression of both mRNA and protein of two ER stress indicators, BiP/GRP78 and CHOP, under hypoxic conditions. Conclusions Bevacizumab mitigated ER stress in human RPE cells cultured under hypoxic conditions. This effect may be involved in the improved cell viability and reduction of VEGF expression after bevacizumab treatment of hypoxic RPE cells in vitro. However, the effects of bevacizumab on RPE cells under experimental conditions are unlikely to be clinically equivalent to those in the human eye.	[Park, Joo-Hee; Oh, Jong-Hyun] Dongguk Univ, Ilsan Hosp, Dept Ophthalmol, Goyang, South Korea; [Kim, Moosang] Kangwon Natl Univ, Sch Med, Dept Ophthalmol, Chunchon, South Korea	Dongguk University; NHIS Ilsan Hospital; Kangwon National University	Oh, JH (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Ophthalmol, Goyang, South Korea.	blueretinaoh@gmail.com			Dongguk University (Dongguk University Research Fund)	Dongguk University (Dongguk University Research Fund)	This study was supported by a grant from the Dongguk University (www.dongguk.edu; Dongguk University Research Fund of 2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Arjamaa O, 2009, AGEING RES REV, V8, P349, DOI 10.1016/j.arr.2009.06.002; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Benavides A, 2005, GLIA, V52, P261, DOI 10.1002/glia.20242; Byeon SH, 2010, INVEST OPHTH VIS SCI, V51, P1190, DOI 10.1167/iovs.09-4144; Chen C, 2014, ANTIOXID REDOX SIGN, V20, P2091, DOI 10.1089/ars.2013.5240; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Ford KM, 2011, INVEST OPHTH VIS SCI, V52, P9478, DOI 10.1167/iovs.11-8353; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gorbatyuk M, 2013, MOL VIS, V19, P1985; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Hetz C, 2008, TRENDS CELL BIOL, V18, P38, DOI 10.1016/j.tcb.2007.10.003; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim M, 2016, INDIAN J OPHTHALMOL, V64, P427, DOI 10.4103/0301-4738.187659; Kim Sukjin, 2015, Korean J Ophthalmol, V29, P424, DOI 10.3341/kjo.2015.29.6.424; Malik D, 2014, BRIT J OPHTHALMOL, V98, P11, DOI 10.1136/bjophthalmol-2014-305302; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Metelitsina TI, 2008, INVEST OPHTH VIS SCI, V49, P358, DOI 10.1167/iovs.07-0526; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Roybal CN, 2005, J BIOL CHEM, V280, P20331, DOI 10.1074/jbc.M411275200; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; Ryan SJ, 2013, RETINA, P1145; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Sendoel A, 2014, PHYSIOLOGY, V29, P168, DOI 10.1152/physiol.00016.2013; Smith S. B., 2013, RETINA-J RET VIT DIS, V1, P529; Starita C, 1997, INVEST OPHTH VIS SCI, V38, P762; Steinbrook R, 2006, NEW ENGL J MED, V355, P1409, DOI 10.1056/NEJMp068185; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vavvas D. G., 2013, RETINA, V1, P562; Winkler BS, 1999, MOL VIS, V5; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Young M, 2014, RETINA-J RET VIT DIS, V34, P1308, DOI 10.1097/IAE.0000000000000081; Zhang SX, 2015, PROG RETIN EYE RES, V45, P111, DOI 10.1016/j.preteyeres.2014.12.001; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015; Zhu Q, 2008, OPHTHALMOLOGY, V115, P1750, DOI 10.1016/j.ophtha.2008.04.023	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179048	10.1371/journal.pone.0179048	http://dx.doi.org/10.1371/journal.pone.0179048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591217	gold, Green Submitted, Green Published			2022-12-26	WOS:000402880700081
J	Jaracz, M; Rosiak, I; Bertrand-Bucinska, A; Jaskulski, M; Niezurawska, J; Borkowska, A				Jaracz, Marcin; Rosiak, Izabela; Bertrand-Bucinska, Anna; Jaskulski, Maciej; Niezurawska, Joanna; Borkowska, Alina			Affective temperament, job stress and professional burnout in nurses and civil servants	PLOS ONE			English	Article							PATIENT SATISFACTION; DEPRESSIVE SYMPTOMS; OCCUPATIONAL STRESS; COMPASSION; MEMPHIS; FATIGUE; PARIS; TEMPS; RISK; PISA	Introduction The risk of professional burnout is constituted by job-related as well as individual factors. The latter involve affective temperament, which influences the perception of job-related stress. The aim of the present study was to assess the affective temperament, the level of job stress and professional burnout, as well as the relationships between these variables, in public servants and nurses. Material and methods 100 civil servants and 100 nurses were enrolled in the study. Affective temperament and burnout were assessed by means of TEMPS-A and MBI questionnaires, respectively. To measure the level of job-related stress, we have designed a 6-item self-reported questionnaire, which considered stressors common for both professions. Results Compared to the civil servants, nurses showed higher rate of anxious temperament and experienced greater intensity of job-related stress. The groups did not differ in the intensity of burnout symptoms. The rates of cyclothymic and anxious temperaments correlated with the intensity of stress, and burnout symptoms in the group of nurses. Within the civil servants group, the level of stress correlated with intensity of burnout, however no correlations with affective temperament were observed. The regression analysis performed in both groups revealed the significant effect of stress and cyclothymic temperament on burnout, while the effect of anxious temperament was not significant. Conclusions Cyclothymic and anxious temperaments are related to the level of experienced job stress and the risk of burnout. In professions like nursing, where employees show elevated rates of these temperaments, burnout prevention and stress management education is of particular importance.	[Jaracz, Marcin; Rosiak, Izabela; Borkowska, Alina] Nicolaus Copernicus Univ Torun, Fac Hlth Sci, Chair Clin Neuropsychol, Bydgoszcz, Poland; [Bertrand-Bucinska, Anna] Univ Warmia & Mazury, Dept Foreign Language Studies, Olsztyn, Poland; [Jaskulski, Maciej] Antoni Jurasz Univ Hosp 1, Bydgoszcz, Poland; [Niezurawska, Joanna] WSB Univ Torun, Management Dept, Torun, Poland	Nicolaus Copernicus University; University of Warmia & Mazury	Jaracz, M (corresponding author), Nicolaus Copernicus Univ Torun, Fac Hlth Sci, Chair Clin Neuropsychol, Bydgoszcz, Poland.	marcinjaracz@gmail.com		Niezurawska-Zajac, Joanna/0000-0001-6396-3363; Jaskulski, Maciej/0000-0002-4247-5114				Adriaenssens J, 2015, INT J NURS STUD, V52, P649, DOI 10.1016/j.ijnurstu.2014.11.004; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P1, DOI 10.1016/j.jad.2004.12.003; Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Akiskal KK, 2005, J AFFECT DISORDERS, V85, P231, DOI 10.1016/j.jad.2004.08.002; Akiskal KK, 2005, J AFFECT DISORDERS, V85, P201, DOI 10.1016/j.jad.2004.08.003; Alarcon G, 2009, WORK STRESS, V23, P244, DOI 10.1080/02678370903282600; Biagioli V, 2016, INT J PALLIAT NURS, V22, P292, DOI 10.12968/ijpn.2016.22.6.292; Borkowska A, 2010, J AFFECT DISORDERS, V123, P36, DOI 10.1016/j.jad.2009.09.024; Deighton RM, 2007, J TRAUMA STRESS, V20, P63, DOI 10.1002/jts.20180; Iliceto P, 2013, STRESS, V16, P143, DOI 10.3109/10253890.2012.689896; Rios-Risquez MI, 2016, INT J NURS STUD, V59, P60, DOI 10.1016/j.ijnurstu.2016.02.008; JACKSON SE, 1986, J APPL PSYCHOL, V71, P630, DOI 10.1037/0021-9010.71.4.630; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Kikuchi Y, 2014, INT J OCCUP MED ENV, V27, P426, DOI 10.2478/s13382-014-0270-z; Kurnatowska O, 2013, PSYCHIATR PSYCHOL KL, V13, P154; Langelaan S, 2006, PERS INDIV DIFFER, V40, P521, DOI 10.1016/j.paid.2005.07.009; Ledoux K, 2015, J ADV NURS, V71, P2041, DOI 10.1111/jan.12686; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; Leiter MP, 2003, EMERALD GROUP PUBLIS, V3, P91, DOI DOI 10.1016/S1479-3555(03)03003-8; Lin TC, 2016, J CLIN NURS, V25, P1120, DOI 10.1111/jocn.13119; Maremmani I, 2010, J AFFECT DISORDERS, V124, P314, DOI 10.1016/j.jad.2010.03.016; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Morita T, 2004, PALLIATIVE MED, V18, P550, DOI 10.1191/0269216304pm911oa; Nakai Y, 2015, J AFFECT DISORDERS, V187, P203, DOI 10.1016/j.jad.2015.08.011; Obholzer A., 1994, UNCONSCIOUS WORK IND; Pasikowski T., 2009, WYPALENIE ZAWODOWE, P135; Pompili M, 2006, ARCH PSYCHIAT NURS, V20, P135, DOI 10.1016/j.apnu.2005.12.002; Sakai Y, 2005, J AFFECT DISORDERS, V85, P101, DOI 10.1016/j.jad.2004.03.012; Sand A, 2003, J CLIN NURS, V12, P177, DOI 10.1046/j.1365-2702.2003.00729.x; Spector P. E., 1997, JOB SATISFACTION APP, V3; Swider BW, 2010, J VOCAT BEHAV, V76, P487, DOI 10.1016/j.jvb.2010.01.003; Tei-Tominaga M, 2012, DEPRESS RES TREAT, V2012, DOI [DOI 10.1155/2012/469384, 10.1155/2012/469384]; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; Varhama LM, 2004, PSYCHOL REP, V94, P1116, DOI 10.2466/pr0.94.3c.1116-1124; Wieclaw J, 2006, OCCUP ENVIRON MED, V63, P314, DOI 10.1136/oem.2004.019398; Wu SY, 2007, J ADV NURS, V59, P233, DOI 10.1111/j.1365-2648.2007.04301.x	37	27	29	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0176698	10.1371/journal.pone.0176698	http://dx.doi.org/10.1371/journal.pone.0176698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EW9YQ	28586391	Green Published, Green Submitted, gold			2022-12-26	WOS:000402875700003
J	Kopp, M; Rotan, O; Papadopoulos, C; Schulze, N; Meyer, H; Epple, M				Kopp, Mathis; Rotan, Olga; Papadopoulos, Chrisovalantis; Schulze, Nina; Meyer, Hemmo; Epple, Matthias			Delivery of the autofluorescent protein R-phycoerythrin by calcium phosphate nanoparticles into four different eukaryotic cell lines ( HeLa, HEK293T, MG-63, MC3T3): Highly efficient, but leading to endolysosomal proteolysis in HeLa and MC3T3 cells	PLOS ONE			English	Article							GENE DELIVERY; BIODEGRADABLE NANOPARTICLES; INORGANIC NANOPARTICLES; INTRACELLULAR DELIVERY; GOLD NANOPARTICLES; NONVIRAL VECTOR; DRUG-DELIVERY; NUCLEIC-ACIDS; PLASMID DNA; TRANSFECTION	Nanoparticles can be used as carriers to transport biomolecules like proteins and synthetic molecules across the cell membrane because many molecules are not able to cross the cell membrane on their own. The uptake of nanoparticles together with their cargo typically occurs via endocytosis, raising concerns about the possible degradation of the cargo in the endolysosomal system. As the tracking of a dye-labelled protein during cellular uptake and processing is not indicative of the presence of the protein itself but only for the fluorescent label, a label-free tracking was performed with the red-fluorescing model protein R-phycoerythrin (R-PE). Four different eukaryotic cell lines were investigated: HeLa, HEK293T, MG-63, and MC3T3. Alone, the protein was not taken up by any cell line; only with the help of calcium phosphate nanoparticles, an efficient uptake occurred. After the uptake into HeLa cells, the protein was found in early endosomes (shown by the marker EEA1) and lysosomes (shown by the marker Lamp1). There, it was still intact and functional (i.e. properly folded) as its red fluorescence was detected. However, a few hours after the uptake, proteolysis started as indicated by the decreasing red fluorescence intensity in the case of HeLa and MC3T3 cells. 12 h after the uptake, the protein was almost completely degraded in HeLa cells and MC3T3 cells. In HEK293T cells and MG-63 cells, no degradation of the protein was observed. In the presence of Bafilomycin A1, an inhibitor of acidification and protein degradation in lysosomes, the fluorescence of R-PE remained intact over the whole observation period in the four cell lines. These results indicate that despite an efficient nanoparticle-mediated uptake of proteins by cells, a rapid endolysosomal degradation may prevent the desired (e.g. therapeutic) effect of a protein inside a cell.	[Kopp, Mathis; Rotan, Olga; Epple, Matthias] Univ Duisburg Essen, Inorgan Chem, Essen, Germany; [Kopp, Mathis; Rotan, Olga; Epple, Matthias] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CeNIDE, Essen, Germany; [Papadopoulos, Chrisovalantis; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol, Fac Biol, Essen, Germany; [Schulze, Nina] Univ Duisburg Essen, ICCE, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Epple, M (corresponding author), Univ Duisburg Essen, Inorgan Chem, Essen, Germany.; Epple, M (corresponding author), Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CeNIDE, Essen, Germany.	matthias.epple@uni-due.de	Epple, Matthias/AAX-9694-2020; Meyer, Hemmo/GNH-5784-2022	Epple, Matthias/0000-0002-1641-7068; Meyer, Hemmo/0000-0003-1883-1796	Deutsche Forschungsgemeinschaft (DFG), within the collaborative research centre [SFB 1093]	Deutsche Forschungsgemeinschaft (DFG), within the collaborative research centre(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), within the collaborative research centre SFB 1093: Supramolecular chemistry on proteins to ME and HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft (DFG), within the collaborative research centre SFB 1093: Supramolecular chemistry on proteins to ME and HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Beddoes CM, 2015, ADV COLLOID INTERFAC, V218, P48, DOI 10.1016/j.cis.2015.01.007; Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j; Canton I, 2012, CHEM SOC REV, V41, P2718, DOI 10.1039/c2cs15309b; Cao X, 2011, INT J NANOMED, V6, P3335, DOI 10.2147/IJN.S27370; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chernousova S, 2017, GENE THER IN PRESS; Creusat G, 2010, BIOCONJUGATE CHEM, V21, P994, DOI 10.1021/bc100010k; CSATORDAY K, 1987, PHOTOCHEM PHOTOBIOL, V45, P845, DOI 10.1111/j.1751-1097.1987.tb07893.x; CSATORDAY K, 1988, PHOTOCHEM PHOTOBIOL, V47, P285, DOI 10.1111/j.1751-1097.1988.tb02728.x; Dautova Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097565; Domey J, 2016, NANOTOXICOLOGY, V10, P20, DOI 10.3109/17435390.2014.1000413; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Ewence AE, 2008, CIRC RES, V103, pE28, DOI 10.1161/CIRCRESAHA.108.181305; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; Fu AL, 2014, BIOCONJUGATE CHEM, V25, P1602, DOI 10.1021/bc500320j; Gemeinhart RA, 2005, BIOTECHNOL PROGR, V21, P532, DOI 10.1021/bp049648w; Ghosh P, 2010, J AM CHEM SOC, V132, P2642, DOI 10.1021/ja907887z; Giljohann DA, 2010, ANGEW CHEM INT EDIT, V49, P3280, DOI 10.1002/anie.200904359; Gilmore Ian R., 2006, Current Drug Delivery, V3, P147, DOI 10.2174/156720106776359159; Giner-Casares JJ, 2016, MATER TODAY, V19, P19, DOI 10.1016/j.mattod.2015.07.004; GLAZER AN, 1975, J BIOL CHEM, V250, P5487; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Gregory AE, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00013; Guo X, 2012, ACCOUNTS CHEM RES, V45, P971, DOI 10.1021/ar200151m; Habraken W, 2016, MATER TODAY, V19, P69, DOI 10.1016/j.mattod.2015.10.008; Hadjicharalambous C, 2015, J BIOMED MATER RES A, V103, P3834, DOI 10.1002/jbm.a.35527; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; HUANG C, 1987, BIOCHEMISTRY-US, V26, P243, DOI 10.1021/bi00375a033; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ito T, 2014, J PHARM SCI-US, V103, P179, DOI 10.1002/jps.23768; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Karim AA, 2016, CHEM-ASIAN J, V11, P1300, DOI 10.1002/asia.201501434; Kastl L, 2013, ACS NANO, V7, P6605, DOI 10.1021/nn306032k; Kesharwani P, 2012, BIOMATERIALS, V33, P7138, DOI 10.1016/j.biomaterials.2012.06.068; Knuschke T, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0258-9; Kozlova D, 2013, BIONANOMAT, V14, P161; Kuhn DA, 2014, BEILSTEIN J NANOTECH, V5, P1625, DOI 10.3762/bjnano.5.174; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Lee K, 2013, INT J PHARMACEUT, V445, P196, DOI 10.1016/j.ijpharm.2013.01.014; Lee MS, 2014, J CONTROL RELEASE, V192, P122, DOI 10.1016/j.jconrel.2014.06.049; Liu LN, 2009, BBA-BIOENERGETICS, V1787, P939, DOI 10.1016/j.bbabio.2009.02.018; Liu YC, 2011, INT J NANOMED, V6, P721, DOI 10.2147/IJN.S17096; MACCOLL R, 1990, BIOCHEMISTRY-US, V29, P430, DOI 10.1021/bi00454a018; Maitra A, 2005, EXPERT REV MOL DIAGN, V5, P893, DOI 10.1586/14737159.5.6.893; Mathaes R, 2015, EXPERT OPIN DRUG DEL, V12, P481, DOI 10.1517/17425247.2015.963055; Messerschmidt C, 2016, BEILSTEIN J NANOTECH, V7, P1296, DOI 10.3762/bjnano.7.121; Midoux P, 2009, BRIT J PHARMACOL, V157, P166, DOI 10.1111/j.1476-5381.2009.00288.x; Min KH, 2012, BIOMATERIALS, V33, P5788, DOI 10.1016/j.biomaterials.2012.04.057; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Moore NM, 2009, ACTA BIOMATER, V5, P854, DOI 10.1016/j.actbio.2008.09.009; Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041; Neuhaus B, 2016, RSC ADV, V6, P18102, DOI 10.1039/c5ra25333k; Neumann S, 2009, BIOMATERIALS, V30, P6794, DOI 10.1016/j.biomaterials.2009.08.043; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Pichon C, 2010, CURR OPIN BIOTECH, V21, P640, DOI 10.1016/j.copbio.2010.07.003; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; Rotan O, 2013, MATERIALWISS WERKST, V44, P176, DOI 10.1002/mawe.201300085; Rotan O, 2017, BEILSTEIN J NANOTECH, V8, P381, DOI 10.3762/bjnano.8.40; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sahdev P, 2013, J BIOMED NANOTECHNOL, V9, P132, DOI 10.1166/jbn.2013.1545; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shang L, 2014, BEILSTEIN J NANOTECH, V5, P2388, DOI 10.3762/bjnano.5.248; Silva JM, 2013, J CONTROL RELEASE, V168, P179, DOI 10.1016/j.jconrel.2013.03.010; Sokolova V, 2011, ACTA BIOMATER, V7, P4029, DOI 10.1016/j.actbio.2011.07.010; Sokolova V, 2008, ANGEW CHEM INT EDIT, V47, P1382, DOI 10.1002/anie.200703039; Sokolova V, 2015, J MATER CHEM B, V3, P4767, DOI 10.1039/c5tb00618j; Sokolova V, 2013, ACTA BIOMATER, V9, P7527, DOI 10.1016/j.actbio.2013.02.034; Sokolova V, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0910-9; Sokolova V, 2011, NANOSCALE, V3, P1957, DOI 10.1039/c1nr00002k; Sun TM, 2014, ANGEW CHEM INT EDIT, V53, P12320, DOI 10.1002/anie.201403036; Tabakovic A, 2012, WIRES NANOMED NANOBI, V4, P96, DOI 10.1002/wnan.163; Tan HX, 2016, MAR DRUGS, V14, DOI 10.3390/md14090166; Tang J, 2012, INT J PHARMACEUT, V431, P210, DOI 10.1016/j.ijpharm.2012.04.046; Tang R, 2013, ACS NANO, V7, P6667, DOI 10.1021/nn402753y; Tenkumo T, 2016, GENES CELLS, V21, P682, DOI 10.1111/gtc.12374; Urch H, 2009, J MATER CHEM, V19, P2166, DOI 10.1039/b810026h; Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Vercauteren D, 2012, J CONTROL RELEASE, V161, P566, DOI 10.1016/j.jconrel.2012.05.020; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Xiao L, 2011, ACS NANO, V5, P6315, DOI 10.1021/nn201348s; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	88	15	15	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178260	10.1371/journal.pone.0178260	http://dx.doi.org/10.1371/journal.pone.0178260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586345	Green Published, gold, Green Submitted			2022-12-26	WOS:000402875700010
J	Fantauzzo, KA; Soriano, P				Fantauzzo, Katherine A.; Soriano, Philippe			Generation of an immortalized mouse embryonic palatal mesenchyme cell line	PLOS ONE			English	Article							REGULATES CRANIOFACIAL DEVELOPMENT; SECONDARY PALATE; PDGFR-ALPHA; TUMOR SUPPRESSION; CLEFT-PALATE; MUTANT MICE; IN-VITRO; EXPRESSION; GROWTH; PROLIFERATION	Palatogenesis is a complex morphogenetic process, disruptions in which result in highly prevalent birth defects in humans. In recent decades, the use of model systems such as genetically-modified mice, mouse palatal organ cultures and primary mouse embryonic palatal mesenchyme (MEPM) cultures has provided significant insight into the molecular and cellular defects underlying cleft palate. However, drawbacks in each of these systems have prevented high-throughput, large-scale studies of palatogenesis in vitro. Here, we report the generation of an immortalized MEPM cell line that maintains the morphology, migration ability, transcript expression and responsiveness to exogenous growth factors of primary MEPM cells, with increased proliferative potential over primary cultures. The immortalization method described in this study will facilitate the generation of palatal mesenchyme cells with an unlimited capacity for expansion from a single genetically-modified mouse embryo and enable mechanistic studies of palatogenesis that have not been possible using primary culture.	[Fantauzzo, Katherine A.; Soriano, Philippe] Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA; [Fantauzzo, Katherine A.] Univ Colorado Anschutz Med Campus, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA	Icahn School of Medicine at Mount Sinai; University of Colorado System; University of Colorado Anschutz Medical Campus	Fantauzzo, KA (corresponding author), Icahn Sch Med Mt Sinai, Dept Cell Dev & Regenerat Biol, New York, NY 10029 USA.; Fantauzzo, KA (corresponding author), Univ Colorado Anschutz Med Campus, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA.	katherine.fantauzzo@ucdenver.edu	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X; Fantauzzo, Katherine/0000-0003-0365-4168	National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) [F32DE022719, R03DE025263, R01DE022363]; NIH/NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE022719, R01DE022363, R03DE025263] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) grants F32DE022719 and R03DE025263 (to KAF) and R01DE022363 (to PS). The FaceBase consortium and the FaceBase Coordinating Hub (1U01DE024449-01) are funded by the NIH/NIDCR. The NIH/NIDCR played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott B.D., 2003, CURR PROTOC TOXICOL; ABBOTT BD, 1992, TERATOLOGY, V45, P369, DOI 10.1002/tera.1420450408; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; Bush JO, 2012, DEVELOPMENT, V139, P828, DOI 10.1242/dev.079152; Bush JO, 2010, GENE DEV, V24, P2068, DOI 10.1101/gad.1963210; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Fantauzzo KA, 2016, GENE DEV, V30, P2443, DOI 10.1101/gad.288746.116; Fantauzzo KA, 2014, GENE DEV, V28, P1005, DOI 10.1101/gad.238709.114; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; He FL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003851; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Huang E, 2012, PLOS ONE, V7; Jin JZ, 2006, DEV DYNAM, V235, P539, DOI 10.1002/dvdy.20641; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Lan Y, 2001, MECH DEVELOP, V107, P175, DOI 10.1016/S0925-4773(01)00457-9; Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926; Li Q, 2007, INT J DEV BIOL, V51, P167, DOI 10.1387/ijdb.062212ql; Liu WJ, 2008, DEVELOPMENT, V135, P3959, DOI 10.1242/dev.025304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Parker SE, 2004, BIRTH DEFECTS RES A, V88, P1008, DOI DOI 10.1002/BDRA.20735; Pisano MM, 2000, METH MOL B, V137, P267; QUELLE DE, 1995, CELL, V83, P993; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2006, CELL BIOL LAB HDB, P223; Shi B, 2015, INT J ORAL SCI, V7, P14, DOI 10.1038/ijos.2014.59; TODARO GJ, 1966, VIROLOGY, V28, P756, DOI 10.1016/0042-6822(66)90261-3; VARGAS VI, 1967, ARCH ORAL BIOL, V12, P1283, DOI 10.1016/0003-9969(67)90130-6; Vasudevan HN, 2015, ELIFE, V4, DOI 10.7554/eLife.07186; Vasudevan HN, 2014, DEV CELL, V31, P332, DOI 10.1016/j.devcel.2014.10.005; Vlastos IM, 2009, INT J PEDIATR OTORHI, V73, P993, DOI 10.1016/j.ijporl.2009.03.027; Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971; Xu X, 2005, DEV DYNAM, V232, P75, DOI 10.1002/dvdy.20197; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0179078	10.1371/journal.pone.0179078	http://dx.doi.org/10.1371/journal.pone.0179078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582446	gold, Green Published, Green Submitted			2022-12-26	WOS:000402837600071
J	Rao, ZZ; Zhang, XW; Ding, YL; Yang, MY				Rao, Zhou-Zhou; Zhang, Xiao-Wen; Ding, Yi-Ling; Yang, Meng-Yuan			miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3	PLOS ONE			English	Article							NUCLEAR RECEPTOR PXR; X-RECEPTOR; MRP3; MIRNA; EXPRESSION; CELLS; LIVER; APOPTOSIS; TRANSPORT; MIR-148A	Intrahepatic cholestasis of pregnancy (ICP) is an idiopathic liver disease while the biochemical characteristic is the elevated level of total bile acid (TBA). The present study investigated whether miR-148a mediates the induced effect of estrogen on the development of ICP and the proper mechanism: PXR/MRP3 signal pathway. mRNA expression was detected by qPCR, protein expression was detected by western blotting, the concentration of estrogen and TBA were detected by reagent kit respectively. In the cinical research, it was found that miR-148a expression was positive related with the concentration of TBA in the serum of ICP patients. In in vitro research, estradiol (500 nmol/L, 12 h) significantly upregulated miR-148a expression and LV-148a-siRNA inhibited the function of estradiol (500 nmol/L, 48 h) on TBA secretion. In addition, gene silence of miR-148a upregulated PXR expression which was inhibited by estradiol in LO2 cells. Pretreatment of rifampin (10 mu mol/L), the agonist of PXR alleviated the TBA secretion induced by estradiol (500 nmol/L, 48 h). miR-148a-siRNA and PXR had a synergistic action on TBA secretion of LO2. Both of miR-148a-siRNA and rifampin (10 mu mol/L) inhibited the upregulated effect of estradiol on MRP3 expression. This research has demonstrated that miR-148a may be involved in the induction of estrogen on ICP via PXR signal pathway, and MRP3 may be involved.	[Rao, Zhou-Zhou; Zhang, Xiao-Wen; Ding, Yi-Ling; Yang, Meng-Yuan] Cent S Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China	Central South University	Ding, YL (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China.	erfyfe_06@163.com			National Natural Science Funds of China [81300502]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Funds of China (Grant No. 81300502) to Z-ZR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2012, TOXICOL SCI, V130, P257, DOI 10.1093/toxsci/kfs248; Baek S, 2015, HEPATOL RES, V45, P1331, DOI 10.1111/hepr.12510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cabrerizo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087697; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Ferraro L, 2012, HORM CANCER-US, V3, P65, DOI 10.1007/s12672-012-0102-1; Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Goedeke L, 2015, NAT MED, V21, P1280, DOI 10.1038/nm.3949; Gong HB, 2004, EXPERT OPIN THER TAR, V8, P49, DOI 10.1517/14728222.8.1.49; Gupta A, 2012, BIOCHEM SOC T, V40, P752, DOI 10.1042/BST20110763; Henderson CE, 2014, OBSTET GYNECOL, V124, P1210, DOI 10.1097/AOG.0000000000000571; Hirohashi T, 2000, J BIOL CHEM, V275, P2905, DOI 10.1074/jbc.275.4.2905; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Jansen C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116768; Keppler D, 2011, Z GASTROENTEROL, V49, P1553, DOI 10.1055/s-0031-1281755; Keppler D, 2014, DRUG METAB DISPOS, V42, P561, DOI 10.1124/dmd.113.055772; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Kron MW, 2011, MOL THER, V19, P1547, DOI 10.1038/mt.2011.83; Liu XY, 2015, AM J CANCER RES, V5, P2569; Ortiz DF, 1999, AM J PHYSIOL-GASTR L, V276, pG1493, DOI 10.1152/ajpgi.1999.276.6.G1493; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Takagi S, 2008, J BIOL CHEM, V283, P9674, DOI 10.1074/jbc.M709382200; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Williamson C, 2014, OBSTET GYNECOL, V124, P120, DOI 10.1097/AOG.0000000000000346; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zelcer N, 2006, J HEPATOL, V44, P768, DOI 10.1016/j.jhep.2005.07.022; Zhang XW, 2014, EXP THER MED, V8, P1701, DOI 10.3892/etm.2014.1986	30	19	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178702	10.1371/journal.pone.0178702	http://dx.doi.org/10.1371/journal.pone.0178702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575098	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300099
J	Soldevilla, B; Cuevas-Martin, C; Ibanez, C; Santacatterina, F; Alberti, MA; Simo, C; Casasnovas, C; Marquez-Infante, C; Sevilla, T; Pascual, SI; Sanchez-Arago, M; Espinos, C; Palau, F; Cuezva, JM				Soldevilla, Beatriz; Cuevas-Martin, Carmen; Ibanez, Clara; Santacatterina, Fulvio; Alberti, Maria A.; Simo, Carolina; Casasnovas, Carlos; Marquez-Infante, Celedonio; Sevilla, Teresa; Pascual, Samuel I.; Sanchez-Arago, Maria; Espinos, Carmen; Palau, Francesc; Cuezva, Jose M.			Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; CMT NEUROPATHY SCORE; ORAL FINGOLIMOD; FREE-TRYPTOPHAN; RELIABILITY; PHENOTYPE; BIOMARKER; EXERCISE; SUBTYPES; MODEL	Objective Charcot-Marie-Tooth 1A (CMT1A) disease is the most common inherited neuropathy that lacks of therapy and of molecular markers to assess disease severity. Herein, we have pursued the identification of potential biomarkers in plasma samples and skin biopsies that could define the phenotype of CMT1A patients at mild (Mi), moderate (Mo) and severe (Se) stages of disease as assessed by the CMT neuropathy score to contribute to the understanding of CMT pathophysiology and eventually inform of the severity of the disease. Methods We have used: (i) a high-throughput untargeted metabolomic approach of plasma samples in a cohort of 42 CMT1A patients and 15 healthy controls (CRL) using ultrahigh liquid chromatography coupled to mass spectrometry and (ii) reverse phase protein microarrays to quantitate the expression of some proteins of energy metabolism and of the antioxidant response in skin biopsies of a cohort of 70 CMT1A patients and 13 healthy controls. Results The metabolomic approach identified 194 metabolites with significant differences among the four groups (Mi, Mo, Se, CRL) of samples. A multivariate Linear Discriminant Analysis model using 12 metabolites afforded the correct classification of the samples. These metabolites indicate an increase in protein catabolism and the mobilization of membrane lipids involved in signaling inflammation with severity of CMT1 A. A concurrent depletion of leucine, which is required for the biogenesis of the muscle, is also observed in the patients. Protein expression in skin biopsies indicates early loss of mitochondrial and antioxidant proteins in patients' biopsies. Conclusion The findings indicate that CMT1 A disease is associated with a metabolic state resembling inflammation and sarcopenia suggesting that it might represent a potential target to prevent the nerve and muscle wasting phenotype in these patients. The observed changes in metabolites could be useful as potential biomarkers of CMT1 A disease after appropriate validation in future longitudinal studies.	[Soldevilla, Beatriz; Cuevas-Martin, Carmen; Santacatterina, Fulvio; Sanchez-Arago, Maria; Cuezva, Jose M.] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, Madrid, Spain; [Soldevilla, Beatriz; Cuevas-Martin, Carmen; Santacatterina, Fulvio; Sevilla, Teresa; Sanchez-Arago, Maria; Espinos, Carmen; Palau, Francesc; Cuezva, Jose M.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, ISCIII, Madrid, Spain; [Soldevilla, Beatriz; Cuevas-Martin, Carmen; Santacatterina, Fulvio; Sanchez-Arago, Maria; Cuezva, Jose M.] Univ Autonoma Madrid, Inst Invest Hosp Octubre 12, Madrid, Spain; [Ibanez, Clara; Simo, Carolina] CSIC, CIAL, Inst Invest Ciencias Alimentacio, Madrid, Spain; [Ibanez, Clara] IMDEA Food Inst, Nutr Genom & Food GENYAL Platform, Madrid, Spain; [Alberti, Maria A.; Casasnovas, Carlos] IIS Hosp Univ Bellvitge, Unidad Neuromuscular, IDIBELL, Lhospitalet De Llobregat, Spain; [Marquez-Infante, Celedonio] IIS Hosp Univ Virgen del Rocio, Serv Neurol & Neurofisiol, Seville, Spain; [Sevilla, Teresa] Univ Valencia, Dept Med, IIS Hosp Univ & Politecn La Fe, Valencia, Spain; [Pascual, Samuel I.] IDIPAZ, IIS Hosp Univ La Paz, Madrid, Spain; [Espinos, Carmen; Palau, Francesc] Ctr Invest Principe Felipe, Valencia, Spain; [Palau, Francesc] Inst Recerca St Joan Deu, Barcelona, Spain; [Palau, Francesc] Univ Barcelona, Fac Med & Ciencies Salut, Div Pediat, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitari i Politecnic La Fe; University of Valencia; Hospital Universitario La Paz; Prince Felipe Research Center; University of Barcelona	Cuezva, JM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Dept Biol Mol, Madrid, Spain.; Cuezva, JM (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, ISCIII, Madrid, Spain.; Cuezva, JM (corresponding author), Univ Autonoma Madrid, Inst Invest Hosp Octubre 12, Madrid, Spain.	jmcuezva@cbm.csic.es	Sevilla, Teresa/L-3292-2017; Ibañez, Clara/K-2946-2014; Cuezva, Jose M/AAR-5392-2020; Espinós, Carmen/A-9369-2014; Palau, Francesc/A-9391-2014; Simo, Carolina/H-4146-2012; Santacatterina, Fulvio/F-5722-2016	Ibañez, Clara/0000-0003-4427-2393; Espinós, Carmen/0000-0003-4435-1809; Marquez-Infante, Celedonio/0000-0001-7198-7736; Palau, Francesc/0000-0002-8635-5421; Pascual Pascual, Samuel Ignacio/0000-0002-5428-8121; Simo, Carolina/0000-0002-7140-0795; Sevilla, Teresa/0000-0003-4716-2667; Casasnovas Pons, Carlos/0000-0003-1170-2676; Santacatterina, Fulvio/0000-0002-4831-5402	IRDiRC; ISCIII grant [IR11/TREAT-CMT]; Institute de Salud Carlos III; Ministerio de Economia y Competitividad [SAF2013-41945-R, SAF2016-75916-R]; Comunidad de Madrid [S2011/BMD-2402]; Fundacion Ramon Areces (FRA), Spain; ISCIII; FRA	IRDiRC; ISCIII grant; Institute de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces (FRA), Spain; ISCIII(Instituto de Salud Carlos III); FRA	This work was supported by the Collaborative Joint Project awarded by IRDiRC and funded by ISCIII grant IR11/TREAT-CMT, Institute de Salud Carlos III (to CC, CM, TS, SIP, CE, FP and JMC) (http://www.isciii.es) and grants from Ministerio de Economia y Competitividad (SAF2013-41945-R and SAF2016-75916-R to JMC) (http://www.mineco.gob.es/portal/site/mineco), Comunidad de Madrid (S2011/BMD-2402 to JMC) (http://www.madrid.org) and Fundacion Ramon Areces (FRA to JMC) (http://www.fundacionareces.es), Spain. CE has a "Miguel Servet" contract funded by ISCIII. The CBMSO receives an institutional grant from FRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2009, TRANSL ONCOL, V2, P138, DOI 10.1593/tlo.09106; Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Barneo-Munoz M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005115; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; BLOMSTRAND E, 1988, ACTA PHYSIOL SCAND, V133, P115, DOI 10.1111/j.1748-1716.1988.tb08388.x; CANGIANO C, 1990, J NEURAL TRANSM-GEN, V81, P225, DOI 10.1007/BF01245044; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Correale J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00180; DAVIS JM, 1992, EUR J APPL PHYSIOL, V65, P513, DOI 10.1007/BF00602357; Dortch RD, 2014, NEUROLOGY, V83, P1545, DOI 10.1212/WNL.0000000000000919; Ebenezer GJ, 2007, J NEUROPATH EXP NEUR, V66, P1059, DOI 10.1097/nen.0b013e31815c8989; Fledrich R, 2014, NAT MED, V20, P1055, DOI 10.1038/nm.3664; Garcez-do-Carmo L, 2006, LIFE SCI, V79, P854, DOI 10.1016/j.lfs.2006.02.034; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lewis RA, 2013, JAMA NEUROL, V70, P981, DOI 10.1001/jamaneurol.2013.3178; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Mayers JR, 2014, NAT MED, V20, P1193, DOI 10.1038/nm.3686; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451; Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x; Newsholme EA, 1995, ADV EXP MED BIOL, V384, P315; Pareyson D, 2011, LANCET NEUROL, V10, P320, DOI 10.1016/S1474-4422(11)70025-4; Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; Pavelko KD, 1998, J NEUROSCI, V18, P2498; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Rieu I, 2006, J PHYSIOL-LONDON, V575, P305, DOI 10.1113/jphysiol.2006.110742; Sames L, 2014, F1000RES, V3, P83; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Santacatterina F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0424-1; Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Shy ME, 2005, NEUROLOGY, V64, P1209, DOI 10.1212/01.WNL.0000156517.00615.A3; Sivera R, 2013, NEUROLOGY, V81, P1617, DOI 10.1212/WNL.0b013e3182a9f56a; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zanker CL, 1997, EUR J APPL PHYSIOL O, V75, P543, DOI 10.1007/s004210050202	47	11	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178376	10.1371/journal.pone.0178376	http://dx.doi.org/10.1371/journal.pone.0178376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575008	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300044
J	Obermeier, J; Trefz, P; Happ, J; Schubert, JK; Staude, H; Fischer, DC; Miekisch, W				Obermeier, Juliane; Trefz, Phillip; Happ, Josephine; Schubert, Jochen K.; Staude, Hagen; Fischer, Dagmar-Christiane; Miekisch, Wolfram			Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BREATH AMMONIA; ORGANIC-COMPOUNDS; HEMODIALYSIS-PATIENTS; OXIDATIVE STRESS; CHILDREN; FGF23; UREA; METABOLISM; SPECTROMETRY	Monitoring metabolic adaptation to chronic kidney disease (CKD) early in the time course of the disease is challenging. As a non-invasive technique, analysis of exhaled breath profiles is especially attractive in children. Up to now, no reports on breath profiles in this patient cohort are available. 116 pediatric subjects suffering from mild-to-moderate CKD (n = 48) or having a functional renal transplant KTx (n = 8) and healthy controls (n = 60) matched for age and sex were investigated. Non-invasive quantitative analysis of exhaled breath profiles by means of a highly sensitive online mass spectrometric technique (PTR-ToF) was used. CKD stage, the underlying renal disease (HUS; glomerular diseases; abnormalities of kidney and urinary tract or polycystic kidney disease) and the presence of a functional renal transplant were considered as classifiers. Exhaled volatile organic compound (VOC) patterns differed between CKD/KTx patients and healthy children. Amounts of ammonia, ethanol, isoprene, pentanal and heptanal were higher in patients compared to healthy controls (556, 146, 70.5, 9.3, and 5.4 ppbV vs. 284, 82.4, 49.6, 5.30, and 2.78 ppbV). Methylamine concentrations were lower in the patient group (6.5 vs 10.1 ppbV). These concentration differences were most pronounced in HUS and kidney transplanted patients. When patients were grouped with respect to degree of renal failure these differences could still be detected. Ammonia accumulated already in CKD stage 1, whereas alterations of isoprene (linked to cholesterol metabolism), pentanal and heptanal (linked to oxidative stress) concentrations were detectable in the breath of patients with CKD stage 2 to 4. Only weak associations between serum creatinine and exhaled VOCs were noted. Non-invasive breath testing may help to understand basic mechanisms and metabolic adaptation accompanying progression of CKD. Our results support the current notion that metabolic adaptation occurs early during the time course of CKD.	[Obermeier, Juliane; Trefz, Phillip; Happ, Josephine; Schubert, Jochen K.; Miekisch, Wolfram] Univ Med Rostock, Rostock Med Breath Res Analyt & Technol ROMBAT, Dept Anesthesiol & Intens Care Med, Rostock, Germany; [Staude, Hagen; Fischer, Dagmar-Christiane] Univ Med Rostock, Dept Pediat, Rostock, Germany	University of Rostock; University of Rostock	Miekisch, W (corresponding author), Univ Med Rostock, Rostock Med Breath Res Analyt & Technol ROMBAT, Dept Anesthesiol & Intens Care Med, Rostock, Germany.	wolfram.miekisch@uni-rostock.de	Miekisch, Wolfram/I-1300-2019; Schubert, Jochen/F-4788-2016	Trefz, Phillip/0000-0001-6138-6515; Schubert, Jochen/0000-0002-0956-9506	Deutsche Forschungsgemeinschaft (DFG) [TR 1381/2-1]; European fund for regional development (EFRE); Marie Curie EU Grant [287382]; ROMBAT Group	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European fund for regional development (EFRE)(European Commission); Marie Curie EU Grant(European Commission); ROMBAT Group	We thank all the volunteers, U. Jacoby and the entire ROMBAT Group for participating and supporting this study. This study was supported by Deutsche Forschungsgemeinschaft (DFG; Grant no. TR 1381/2-1).; Authors have no relationships with companies or any financial interests to declare. The PTR-ToF-MS instrument used in this study was entirely funded by the European fund for regional development (EFRE). The study was supported by Marie Curie EU Grant (FP7-PEOPLE-ITN-PIMMS project, grant agreement no. 287382) and by Deutsche Forschungsgemeinschaft (DFG Grant no. TR 1381/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Anderson S, 2009, J AM SOC NEPHROL, V20, P1199, DOI 10.1681/ASN.2008080860; Bayrakli I, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.8.087004; Blanchet L, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa5cc5; Brannelly NT, 2016, CRIT REV ANAL CHEM, V46, P490, DOI 10.1080/10408347.2016.1153949; Brock B, 2017, J BREATH RES, V11, DOI 10.1088/1752-7163/aa53b2; Cappellin L, 2012, ENVIRON SCI TECHNOL, V46, P2283, DOI 10.1021/es203985t; Chen W, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/3/036011; Chen W, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/036003; Davies S, 1997, KIDNEY INT, V52, P223, DOI 10.1038/ki.1997.324; Davies S, 2001, NEPHROL DIAL TRANSPL, V16, P836, DOI 10.1093/ndt/16.4.836; Dogra GK, 2002, NEPHROL DIAL TRANSPL, V17, P2220, DOI 10.1093/ndt/17.12.2220; Eckel SP, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/012001; Eng K, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/2/026002; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Filser JG, 1996, TOXICOLOGY, V113, P278, DOI 10.1016/0300-483X(96)03457-9; Fornoni A, 2014, NAT REV NEPHROL, V10, P379, DOI 10.1038/nrneph.2014.87; Furth SL, 2006, CLIN J AM SOC NEPHRO, V1, P1006, DOI 10.2215/CJN.01941205; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Gulsahi A, 2014, J CLIN PERIODONTOL, V41, P814, DOI 10.1111/jcpe.12280; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; HERVEY GR, 1953, NATURE, V171, P1125, DOI 10.1038/1711125a0; Hibbard T, 2013, ANAL CHEM, V85, P12158, DOI 10.1021/ac403472d; Ketteler M, 2013, NEPHROL DIAL TRANSPL, V28, P821, DOI 10.1093/ndt/gfs557; King J, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027006; Kischkel S, 2010, CLIN CHIM ACTA, V411, P1637, DOI 10.1016/j.cca.2010.06.005; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurada S, 2015, ALIMENT PHARM THER, V41, P704, DOI 10.1111/apt.13127; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Lirk P, 2003, NEPHROL DIAL TRANSPL, V18, P937, DOI 10.1093/ndt/gfg049; Liu JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170246; Longoni B, 2001, FASEB J, V15, P731, DOI 10.1096/fj.00-0163com; Maranda B, 2007, CLIN BIOCHEM, V40, P531, DOI 10.1016/j.clinbiochem.2007.01.024; Mochalski P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-43; Morita M, 2001, J CLIN PERIODONTOL, V28, P813, DOI 10.1034/j.1600-051x.2001.028009813.x; Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598; Neri G, 2012, NEPHROL DIAL TRANSPL, V27, P2945, DOI 10.1093/ndt/gfr738; Pagonas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046258; Portale AA, 2014, CLIN J AM SOC NEPHRO, V9, P344, DOI 10.2215/CJN.05840513; Querfeld U, 2010, CLIN J AM SOC NEPHRO, V5, P1642, DOI 10.2215/CJN.08791209; Rahman S, 2015, PROG BIOPHYS MOL BIO, V119, P129, DOI 10.1016/j.pbiomolbio.2015.06.002; Reinheckel T, 1998, FREE RADICAL RES, V29, P297, DOI 10.1080/10715769800300331; Rosales A, 2012, CLIN INFECT DIS, V54, P1413, DOI 10.1093/cid/cis196; Schonermarck U, 2016, CLIN NEPHROL, V86, P132, DOI 10.5414/CN108614; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Schwarz K, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027003; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; SIMENHOFF ML, 1977, NEW ENGL J MED, V297, P132, DOI 10.1056/NEJM197707212970303; Smith D, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/017101; Spanel P, 2006, PHYSIOL MEAS, V27, pN7, DOI 10.1088/0967-3334/27/2/N01; Spinelli GA, 2011, TRANSPL P, V43, P3730, DOI 10.1016/j.transproceed.2011.08.074; Tangerman A, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/1/017003; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; Trefz P, 2013, ANAL CHEM, V85, P10321, DOI 10.1021/ac402298v; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; van Mastrigt E, 2015, CLIN EXP ALLERGY, V45, P1170, DOI 10.1111/cea.12454; Vaziri ND, 2016, HEMODIAL INT; Watts GF, 2001, KIDNEY INT, V60, P182, DOI 10.1046/j.1523-1755.2001.00785.x; Weinstein T, 2000, NEPHROL DIAL TRANSPL, V15, P883, DOI 10.1093/ndt/15.6.883	59	36	36	7	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2017	12	6							e0178745	10.1371/journal.pone.0178745	http://dx.doi.org/10.1371/journal.pone.0178745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6HZ	28570715	Green Published, gold, Green Submitted			2022-12-26	WOS:000402611800116
J	Wang, XXX; Luo, YH; Wang, D; Adorini, L; Pruzanski, M; Dobrinskikh, E; Levi, M				Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Adorini, Luciano; Pruzanski, Mark; Dobrinskikh, Evgenia; Levi, Moshe			A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL LIPID-METABOLISM; ELEMENT-BINDING PROTEINS; DIABETIC-NEPHROPATHY; AGING POPULATION; ACTIVATION; RESTRICTION; DECLINE; ASSOCIATION; EXPRESSION; AUTOPHAGY	Even in healthy individuals, renal function gradually declines during aging. However, an observed variation in the rate of this decline has raised the possibility of slowing or delaying age-related kidney disease. One of the most successful interventional measures that slows down and delays age-related kidney disease is caloric restriction. We undertook the present studies to search for potential factors that are regulated by caloric restriction and act as caloric restriction mimetics. Based on our prior studies with the bile acid-activated nuclear hormone receptor farnesoid X receptor (FXR) and G protein-coupled membrane receptor TGR5 that demonstrated beneficial effects of FXR and TGR5 activation in the kidney, we reasoned that FXR and TGR5 could be excellent candidates. We therefore determined the effects of aging and caloric restriction on the expression of FXR and TGR5 in the kidney. We found that FXR and TGR5 expression levels are decreased in the aging kidney and that caloric restriction prevents these age-related decreases. Interestingly, in long-lived Ames dwarf mice, renal FXR and TGR5 expression levels were also increased. A 2-month treatment of 22-monthold C57BL/6J mice with the FXR-TGR5 dual agonist INT-767 induced caloric restriction-like effects and reversed age-related increases in proteinuria, podocyte injury, fibronectin accumulation, TGF-beta expression, and, most notably, age-related impairments in mitochondrial biogenesis and mitochondrial function. Furthermore, in podocytes cultured in serum obtained from old mice, INT-767 prevented the increases in the proin-flammatory markers TNF-alpha, toll-like receptor 2 (TLR2), and TLR4. In summary, our results indicate that FXR and TGR5 may play an important role in modulation of age-related kidney disease.	[Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Dobrinskikh, Evgenia; Levi, Moshe] Denver Vet Affairs Med Ctr, Dept Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Wang, Dong; Dobrinskikh, Evgenia; Levi, Moshe] Univ Colorado Anschutz Med Campus, Aurora, CO 80045 USA; [Adorini, Luciano; Pruzanski, Mark] Intercept Pharmaceut, New York, NY 10001 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; Intercept Pharmaceuticals	Levi, M (corresponding author), Univ Colorado Denver, Dept Med, 12700 East 19th Ave,MC C281, Aurora, CO 80045 USA.; Levi, M (corresponding author), Vet Affairs Med Ctr, 12700 East 19th Ave,MC C281, Aurora, CO 80045 USA.	Moshe.Levi@ucdenver.edu	Wang, Dong/A-6518-2018; Adorini, Luciano/AAE-5149-2020		National Institutes of Health [NIA R01 AG049493, NIDDK R01 DK098336]; Intercept medical school Investigator Initiated Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG049493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intercept medical school Investigator Initiated Study; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants NIA R01 AG049493 and NIDDK R01 DK098336 and an Intercept medical school Investigator Initiated Study grant (to M.L.). Luciano Adorini and Mark Pruzanski are employees of Intercept. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelhafiz AH, 2010, NEPHRON CLIN PRACT, V116, pC19, DOI 10.1159/000314545; Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537; Berg UB, 2006, NEPHROL DIAL TRANSPL, V21, P2577, DOI 10.1093/ndt/gfl227; Bitzer M, 2016, ADV CHRONIC KIDNEY D, V23, P12, DOI 10.1053/j.ackd.2015.11.005; Choksi KB, 2011, AGING-US, V3, P754, DOI 10.18632/aging.100357; Choudhury D, 2011, NAT REV NEPHROL, V7, P706, DOI 10.1038/nrneph.2011.104; Fliser D, 1997, KIDNEY INT, V51, P1196, DOI 10.1038/ki.1997.163; Glassock RJ, 2012, KIDNEY INT, V82, P270, DOI 10.1038/ki.2012.65; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Jankauskas SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44430; Jiang T, 2005, KIDNEY INT, V68, P2608, DOI 10.1111/j.1523-1755.2005.00733.x; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Kanasaki K, 2012, HYPERTENS RES, V35, P1121, DOI 10.1038/hr.2012.159; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; LUFT FC, 1980, AM J MED SCI, V279, P15, DOI 10.1097/00000441-198001000-00002; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Miyazaki-Anzai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108270; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Musso CG, 2011, NEPHRON PHYSIOL, V119, P1, DOI 10.1159/000328010; Perico N, 2011, CURR OPIN NEPHROL HY, V20, P312, DOI 10.1097/MNH.0b013e328344c327; Ribstein J, 2001, J HYPERTENS, V19, P2257, DOI 10.1097/00004872-200112000-00020; Rizzo G, 2010, MOL PHARMACOL, V78, P617, DOI 10.1124/mol.110.064501; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Rule AD, 2010, ANN INTERN MED, V152, P561, DOI 10.7326/0003-4819-152-9-201005040-00006; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; TAUCHI H, 1971, GERONTOLOGY, V17, P87, DOI 10.1159/000211811; Tonelli M, 2014, AM J PHYSIOL-RENAL, V306, pF469, DOI 10.1152/ajprenal.00063.2014; Tonelli M, 2014, NEPHROL DIAL TRANSPL, V29, P221, DOI 10.1093/ndt/gft519; Tsaih SW, 2010, KIDNEY INT, V77, P201, DOI 10.1038/ki.2009.434; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; Wang XXX, 2010, DIABETES, V59, P2916, DOI 10.2337/db10-0019; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zha Y, 2008, AM J NEPHROL, V28, P755, DOI 10.1159/000128607	37	30	34	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12018	12024		10.1074/jbc.C117.794982	http://dx.doi.org/10.1074/jbc.C117.794982			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28596381	Green Published, hybrid			2022-12-26	WOS:000406053300002
J	Bennett, AS; Golub, A; Elliott, L				Bennett, Alex S.; Golub, Andrew; Elliott, Luther			A behavioral typology of opioid overdose risk behaviors among recent veterans in New York City	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; CENTERED MEDICAL HOME; HEROIN OVERDOSE; SUBSTANCE USE; HEALTH-CARE; DRUG-USE; NONFATAL OVERDOSE; PEER SUPPORT; ABUSE; VALIDATION	Objective To identify meaningful classes of opioid-using military veterans in terms of self-reported opioid overdose risk behaviors. Method The study recruited a sample of 218 military veterans in the NYC area who were discharged from active duty service after September 11, 2001 and reported past-month opioid use. Survey data including measures of mental health, social stressors, substance use, and opioid-related overdose risk behaviors were analyzed using Latent Class Analysis (LCA). Results A five group solution had excellent fit scores and interpretability. Factor analysis confirmed the existence of two major dimensions of variation: non-adherence and heroin use. The five groups included lower-risk prescription opioid users, non-adherent prescription opioid users and heroin users. The non-adherent prescription opioid users and heroin user classes were both further subdivided into "occasional" and "regular" use categories. In addition to endorsing a greater number of overdose risk behaviors, users in the regular use classes were more likely to screen positive for alcohol and substance use disorders, reported greater self-medicating opioid use to relieve anxiety, reported greater problems with physical pain, were more likely to have had mental health, alcohol and drug treatment, and were less likely to be employed or in school. Heroin users also were less likely to report stable housing. Conclusions Findings indicate that opioid overdose risk classes are grounded in contextual factors related to experiences of psychological, physiological, and social adjustment pain and distress which should be addressed in tailored interventions targeting opioid users' unique constellations of risk behaviors and comorbid conditions.	[Bennett, Alex S.; Golub, Andrew; Elliott, Luther] Natl Dev & Res Inst Inc, New York, NY 10013 USA; [Bennett, Alex S.; Elliott, Luther] NYU, Rory Meyers Coll Nursing, Ctr Drug Use & HIV HCV Res, New York, NY 10003 USA	National Development & Research Institutes, Inc; New York University	Bennett, AS (corresponding author), Natl Dev & Res Inst Inc, New York, NY 10013 USA.; Bennett, AS (corresponding author), NYU, Rory Meyers Coll Nursing, Ctr Drug Use & HIV HCV Res, New York, NY 10003 USA.	Bennett@ndri.org			National Institutes of Health, National Institute on Drug Abuse [NIH R01 DA 036754]	National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	Dr. Bennett's current project is a 4-year study of Opioid Use/Misuse and Overdose Risk among veterans (R01DA036754) that will help determine ecological, structural, and psychosocial aspects of opioid use and overdose risk. Funding for this project is provided by the National Institutes of Health, National Institute on Drug Abuse, awarded to Dr. Alex S. Bennett - (NIH R01 DA 036754). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, ADDICTION, V102, P94, DOI 10.1111/j.1360-0443.2006.01630.x; [Anonymous], 2002, ADDICT DISORD TREAT; Army US. Army, 2020, ARM 2020 GEN HLTH DI; Ashbury FD, 1998, PATIENT EDUC COUNS, V35, P89, DOI 10.1016/S0738-3991(98)00035-4; Barber JA, 2008, COMMUNITY MENT HLT J, V44, P433, DOI 10.1007/s10597-008-9146-7; Bennett AS, 2013, SUBST USE MISUSE, V48, P894, DOI 10.3109/10826084.2013.796991; Bergen-Cico DK., 2011, WAR DRUGS ROLE MILIT; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Bohnert ASB, 2012, AM J PSYCHIAT, V169, P64, DOI 10.1176/appi.ajp.2011.10101476; Britton PC, 2010, DRUG ALCOHOL DEPEN, V107, P51, DOI 10.1016/j.drugalcdep.2009.09.005; Butler SF, 2008, J PAIN, V9, P360, DOI 10.1016/j.jpain.2007.11.014; Butler SF, 2007, PAIN, V130, P144, DOI 10.1016/j.pain.2007.01.014; Butler SF, 2010, CLIN J PAIN, V26, P770, DOI 10.1097/AJP.0b013e3181f195ba; Carlson RG, 2005, DRUG ALCOHOL DEPEN, V79, P167, DOI 10.1016/j.drugalcdep.2005.01.011; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Connell CM, 2009, J STUD ALCOHOL DRUGS, V70, P943, DOI 10.15288/jsad.2009.70.943; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Darke S, 2005, DRUG ALCOHOL REV, V24, P425, DOI 10.1080/09595230500286005; Darke S, 2003, J URBAN HEALTH, V80, P189, DOI 10.1093/jurban/jtg022; Ferrante JM, 2010, ANN FAM MED, V8, P108, DOI 10.1370/afm.1080; Frank D, 2015, INT J DRUG POLICY, V26, P84, DOI 10.1016/j.drugpo.2014.07.013; Green TC, 2010, DRUG ALCOHOL DEPEN, V110, P208, DOI 10.1016/j.drugalcdep.2010.02.020; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Hakkinen M, 2012, EUR J CLIN PHARMACOL, V68, P301, DOI 10.1007/s00228-011-1122-4; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hamilton CM, 2011, AM J EPIDEMIOL, V174, P253, DOI 10.1093/aje/kwr193; Institute of Medicine, 2012, SUBST US DIS US ARM; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Jones JD, 2012, DRUG ALCOHOL DEPEN, V125, P8, DOI 10.1016/j.drugalcdep.2012.07.004; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Lanza S.T., 2015, LCA STATA PLUGIN USE; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Li-Hui Chen HH, 2015, QUICKSTATS RATES DEA, P1999; Meyer JP, 2011, J WOMENS HEALTH, V20, P991, DOI 10.1089/jwh.2010.2328; Monga N, 2007, DRUG ALCOHOL DEPEN, V88, P1, DOI 10.1016/j.drugalcdep.2006.08.029; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; New York City Department of Health and Mental Hygiene, 2015, UN DRUG POS OV DEATH, P2000; Norris SL, 2006, DIABETIC MED, V23, P544, DOI 10.1111/j.1464-5491.2006.01845.x; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; O'Toole TP, 2003, J GEN INTERN MED, V18, P929, DOI 10.1046/j.1525-1497.2003.21209.x; Oliva EM, REPORT OPIOID OVERDO; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pedersen W, 1999, ADDICTION, V94, P1695, DOI 10.1046/j.1360-0443.1999.941116957.x; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Pouget ER, 2015, ABSTRACTS DRUG ALCOH, V156, pe180; Pouget ER, 2016, UNDERSTANDING HIV AI, P195; Quinones S., 2015, HEALTH AFFAIR, V34, P9; Rivers JE, 1998, AM BEHAV SCI, V41, P1136, DOI 10.1177/0002764298041008009; Robins LN, 2010, AM J ADDICTION, V19, P203, DOI 10.1111/j.1521-0391.2010.00046.x; ROBINS LN, 1993, ADDICTION, V88, P1041, DOI 10.1111/j.1360-0443.1993.tb02123.x; Rosenblum A, 2008, EXP CLIN PSYCHOPHARM, V16, P405, DOI 10.1037/a0013628; Rosland A-M, 2013, AM J MANAGED CARE, V19; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Seal KH, 2001, AM J PUBLIC HEALTH, V91, P1842, DOI 10.2105/AJPH.91.11.1842; Shin SH, 2010, DRUG ALCOHOL DEPEN, V109, P226, DOI 10.1016/j.drugalcdep.2010.01.013; Singer, 2016, FREE INQUIRY CREATIV, V28, P13; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Substance Abuse and Mental Health Services Administration (SAMHSA), 2013, RES 2012 NAT SURV DR; U.S. Army, 2010, ARM HLTH PROM RISK R; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; Webster LR, 2011, PAIN MED, V12, pS26, DOI 10.1111/j.1526-4637.2011.01134.x	64	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e179054	10.1371/journal.pone.0179054	http://dx.doi.org/10.1371/journal.pone.0179054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0PL	28594892	Green Published, gold, Green Submitted			2022-12-26	WOS:000402923200082
J	Berkowitz, SA; Berkowitz, TSZ; Meigs, JB; Wexler, DJ				Berkowitz, Seth A.; Berkowitz, Theodore S. Z.; Meigs, James B.; Wexler, Deborah J.			Trends in food insecurity for adults with cardiometabolic disease in the United States: 2005-2012	PLOS ONE			English	Article							NUTRITION ASSISTANCE PROGRAM; GLYCEMIC CONTROL; DIETARY QUALITY; US ADULTS; PARTICIPATION; MANAGEMENT; OBESITY	Background Food insecurity, the uncertain ability to access adequate food, can limit adherence to dietary measures needed to prevent and manage cardiometabolic conditions. However, little is known about temporal trends in food insecurity among those with diet-sensitive cardiometabolic conditions. Methods We used data from the Continuous National Health and Nutrition Examination Survey (NHANES) 2005-2012, analyzed in 2015-2016, to calculate trends in age-standardized rates of food insecurity for those with and without the following diet-sensitive cardiometabolic conditions: diabetes mellitus, hypertension, coronary heart disease, congestive heart failure, and obesity. Results 21,196 NHANES participants were included from 4 waves (4,408 in 2005-2006, 5,607 in 2007-2008, 5,934 in 2009-2010, and 5,247 in 2011-2012). 56.2% had at least one cardiometabolic condition, 24.4% had 2 or more, and 8.5% had 3 or more. The overall age-standardized rate of food insecurity doubled during the study period, from 9.06% in 2005-2006 to 10.82% in 2007-2008 to 15.22% in 2009-2010 to 18.33% in 2011-2012 (p for trend <.001). The average annual percentage change in food insecurity for those with a cardiometabolic condition during the study period was 13.0% (95% CI 7.5% to 18.6%), compared with 5.8% (95% CI 1.8% to 10.0%) for those without a cardiometabolic condition, (parallelism test p =.13). Comparing those with and without the condition, age-standardized rates of food insecurity were greater in participants with diabetes (19.5% vs. 11.5%, p <.0001), hypertension (14.1% vs. 11.1%, p =.0003), coronary heart disease (20.5% vs. 11.9%, p <.001), congestive heart failure (18.4% vs. 12.1%, p =.004), and obesity (14.3% vs. 11.1%, p <.001). Conclusions Food insecurity doubled to historic highs from 2005-2012, particularly affecting those with diet-sensitive cardiometabolic conditions. Since adherence to specific dietary recommendations is a foundation of the prevention and treatment of cardiometabolic disease, these results have important implications for clinical management and public health.	[Berkowitz, Seth A.; Meigs, James B.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Berkowitz, Seth A.; Wexler, Deborah J.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Berkowitz, Seth A.; Meigs, James B.; Wexler, Deborah J.] Harvard Med Sch, Boston, MA 02115 USA; [Berkowitz, Theodore S. Z.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Berkowitz, SA (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Berkowitz, SA (corresponding author), Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.; Berkowitz, SA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	SABerkowitz@partners.org	Meigs, James/P-3927-2019; Wexler, Deborah/AAE-4205-2019	Meigs, James/0000-0002-2439-2657; Wexler, Deborah/0000-0001-6979-402X; Berkowitz, Seth/0000-0003-1030-4297	Division of General Internal Medicine and Diabetes Unit at Massachusetts General Hospital; National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health [K23DK109200];  [K24DK080140]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140, K23DK109200] Funding Source: NIH RePORTER	Division of General Internal Medicine and Diabetes Unit at Massachusetts General Hospital; National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Seth A. Berkowitz's role in the research reported in this publication was supported by the Division of General Internal Medicine and Diabetes Unit at Massachusetts General Hospital and the National Institute Of Diabetes And Digestive And Kidney Diseases of the National Institutes of Health under Award Number K23DK109200. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. James B. Meigs was supported in part by K24DK080140. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of data; or preparation, review, or approval of the manuscript.	Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Alley DE, 2016, NEW ENGL J MED, V374, P8, DOI 10.1056/NEJMp1512532; Andreyeva T, 2015, AM J PREV MED, V49, P594, DOI 10.1016/j.amepre.2015.04.035; [Anonymous], 2016, Diabetes Care, V39 Suppl 1, pS107, DOI 10.2337/dc16-S018; [Anonymous], 2010, ANN NBERS BUS CYCL D; Berkowitz SA, 2015, CAN MED ASSOC J, V187, P1031, DOI 10.1503/cmaj.150644; Berkowitz SA, 2015, JAMA INTERN MED, V175, P257, DOI 10.1001/jamainternmed.2014.6888; Berkowitz SA, 2014, DIABETES CARE, V37, P2587, DOI 10.2337/dc14-0753; Berkowitz SA, 2014, AM J MED, V127, P303, DOI 10.1016/j.amjmed.2014.01.002; Berkowitz SA, 2013, DIABETES CARE, V36, P3093, DOI 10.2337/dc13-0570; Castillo DC, 2012, CURR CARDIOVASC RISK, V6, P245, DOI 10.1007/s12170-012-0236-2; Coleman-Jensen A., 2015, HOUSEHOLD FOOD SECUR; Crews DC, 2014, AM J NEPHROL, V39, P27, DOI 10.1159/000357595; Davy BM, 2015, J NUTR EDUC BEHAV, V47, P196, DOI 10.1016/j.jneb.2015.01.001; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Ford ES, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130244, 10.5888/pcd10.120316e, 10.5888/pcd10.120316]; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Mayer VL, 2015, PUBLIC HEALTH NUTR, P1; Morales Mary E, 2016, Curr Nutr Rep, V5, P54, DOI 10.1007/s13668-016-0153-y; Moreno G, 2015, MED CARE, V53, P423, DOI 10.1097/MLR.0000000000000348; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murphy S, 2013, NATL VITAL STAT SYST, V64, P1; National Center for Health Statistics, 2016, NAT HLTH NUTR EX SUR; Nguyen BT, 2015, AM J PUBLIC HEALTH, V105, P1453, DOI 10.2105/AJPH.2015.302580; Nguyen BT, 2014, MAYO CLIN PROC, V89, P1211, DOI 10.1016/j.mayocp.2014.05.010; R Core Team, 2015, R LANG ENV STAT COMP; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2015, HEALTH AFFAIR, V34, P1956, DOI 10.1377/hlthaff.2015.0641; Seligman HK, 2012, DIABETES CARE, V35, P233, DOI 10.2337/dc11-1627; Seligman HK, 2010, J HEALTH CARE POOR U, V21, P1227, DOI 10.1353/hpu.2010.0921; Seligman HK, 2010, NEW ENGL J MED, V363, P6, DOI 10.1056/NEJMp1000072; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Service USDoAFaN, 2016, NUTR ASS PROGR SNA S; Service USDoAFaN, 2016, FOOD INS US TRENDS P; Skinner AC, 2015, NEW ENGL J MED, V373, P1307, DOI 10.1056/NEJMoa1502821; Statistics NCfH, 2016, AG STAND POP COUNTS; Statistics NCfH, 2007, DAT 2007 2008 DAT DO; Thow AM, 2016, FOOD NUTR BULL; United States Department of Agriculture Food and Nutrition Service, 2015, REACH THOS NEED EST; Wang EA, 2015, PUBLIC HEALTH REP, V130, P261, DOI 10.1177/003335491513000313; White House Council of Economic Advisors, 2016, LONG TERM BEN S NUTR; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405	47	78	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179172	10.1371/journal.pone.0179172	http://dx.doi.org/10.1371/journal.pone.0179172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX0AO	28591225	gold, Green Published, Green Submitted			2022-12-26	WOS:000402880700092
J	Denorme, F; Kraft, P; Pareyn, I; Drechsler, C; Deckmyn, H; Vanhoorelbeke, K; Kleinschnitz, C; De Meyer, SF				Denorme, Frederik; Kraft, Peter; Pareyn, Inge; Drechsler, Christiane; Deckmyn, Hans; Vanhoorelbeke, Karen; Kleinschnitz, Christoph; De Meyer, Simon F.			Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ISCHEMIC-STROKE; EARLY ATHEROSCLEROSIS; MICE; THROMBOLYSIS; DEFICIENCY; INFARCTION; BINDING; RISK; VWF	Von Willebrand Factor (VWF) plays a major role in thrombosis and hemostasis and its thrombogenicity is controlled by ADAMTS13. Whereas increasing evidence shows a clear association between VWF levels and acute ischemic stroke, little is known about a correlation with ADAMTS13. Therefore, the aim of this study was to compare plasma levels of ADAMTS13 between 85 healthy volunteers (HV), 104 patients with acute ischemic stroke and 112 patients with a chronic cerebrovascular disease (CCD). In this case-control study, plasma ADAMTS13 antigen levels were measured by ELISA and plasma VWF levels, measured previously, were next used to calculate VWF: ADAMTS13 ratios. ADAMTS13 levels and VWF: ADAMTS13 ratios were subsequently correlated with key demographic and clinical parameters. ADAMTS13 levels were significantly lower in acute ischemic stroke patients (82.6 +/- 21.0%) compared with HV (110.6 +/- 26.9%). Also, CCD patients (99.6 +/- 24.5%) had significantly lower ADAMTS13 levels compared with HV however these were still higher than in acute stroke patients. Furthermore, when assessing the VWF: ADAMTS13 ratios, an even greater difference was revealed between stroke patients (2.7 +/- 1.9), HV (1.1 +/- 0.5) and CCD patients (1.7 +/- 0.7). The VWF: ADAMTS13 ratio was significantly associated with stroke severity and modality. In conclusion, both in acute and chronic cerebrovascular disease patients, ADAMTS13 levels were significantly decreased, with the lowest ADAMTS13 levels found in acute stroke patients. This difference was even more distinct when the ratio of VWF: ADAMTS13 was considered. These results demonstrate the potentially important involvement of the VWF/ADAMTS13 axis in ischemic stroke.	[Denorme, Frederik; Pareyn, Inge; Deckmyn, Hans; Vanhoorelbeke, Karen; De Meyer, Simon F.] Katholieke Univ Leuven, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium; [Kraft, Peter] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Drechsler, Christiane] Univ Hosp Wurzburg, Dept Internal Med, Wurzburg, Germany; [Kleinschnitz, Christoph] Univ Hosp Essen, Dept Neurol, Essen, Germany	KU Leuven; University of Wurzburg; University of Wurzburg; University of Duisburg Essen	De Meyer, SF (corresponding author), Katholieke Univ Leuven, Lab Thrombosis Res, Campus Kulak Kortrijk, Kortrijk, Belgium.	Simon.Demeyer@kuleuven.be	Deckmyn, Hans/N-8932-2019; Deckmyn, Hans/L-9434-2015	Deckmyn, Hans/0000-0003-3952-5501; Deckmyn, Hans/0000-0003-3952-5501; De Meyer, Simon/0000-0002-1807-5882; Denorme, Frederik/0000-0003-1442-3568; Kleinschnitz, Christoph/0000-0002-1650-8875	Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0A86.13, 1509216N, G.0D66.15]; KU Leuven [0T/14/099]; Deutsche Forschungsgemeinschaft	Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); KU Leuven(KU Leuven); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0A86.13, 1509216N and G.0D66.15 to S.F. De Meyer, an Onderzoekstoelage grant from KU Leuven (0T/14/099 to S.F. De Meyer) and by the Deutsche Forschungsgemeinschaft (grant to C.K.).	Allie S, 2015, INT J STROKE, V10, P1294, DOI 10.1111/ijs.12550; Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Bongers TN, 2009, ATHEROSCLEROSIS, V207, P250, DOI 10.1016/j.atherosclerosis.2009.04.013; Bustamante A, 2015, STROKE, V46; Chauhan AK, 2006, J EXP MED, V203, P767, DOI 10.1084/jem.20051732; De Meyer SF, 2016, STROKE, V47, P1165, DOI 10.1161/STROKEAHA.115.011238; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; De Meyer SF, 2010, ARTERIOSCL THROM VAS, V30, P1949, DOI 10.1161/ATVBAHA.110.208918; Denorme F, 2016, BLOOD, V127, P2337, DOI 10.1182/blood-2015-08-662650; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Jin SY, 2012, ARTERIOSCL THROM VAS, V32, P1817, DOI 10.1161/ATVBAHA.112.247262; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Kraft P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099851; Lambers M, 2013, ANN NEUROL, V73, P58, DOI 10.1002/ana.23735; McCabe DJH, 2015, J NEUROL SCI, V348, P35, DOI 10.1016/j.jns.2014.10.035; Pedrazzini G, 2016, BLOOD, V127, P2934, DOI 10.1182/blood-2015-12-688010; Qu L, 2016, CLIN APPL THROMB-HEM, V22, P252, DOI 10.1177/1076029615583347; Sonneveld MAH, 2015, BLOOD, V126, P2739, DOI [10.1182/blood-2015-05643338, 10.1182/blood-2015-05-643338]; Sonneveld MAH, 2014, BLOOD REV, V28, P167, DOI 10.1016/j.blre.2014.04.003; Stoll M, 2016, CIRC-CARDIOVASC GENE, V9, P357, DOI 10.1161/CIRCGENETICS.115.001184; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Zhao BQ, 2009, BLOOD, V114, P3329, DOI 10.1182/blood-2009-03-213264	23	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179258	10.1371/journal.pone.0179258	http://dx.doi.org/10.1371/journal.pone.0179258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591212	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700096
J	Gholami, K; Loh, SY; Salleh, N; Lam, SK; Hoe, SZ				Gholami, Khadijeh; Loh, Su Yi; Salleh, Naguib; Lam, Sau Kuen; Hoe, See Ziau			Selection of suitable endogenous reference genes for qPCR in kidney and hypothalamus of rats under testosterone influence	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; RT-PCR; DEPENDENT EXPRESSION; NORMALIZATION; MEN; HYPERTENSION; VASOPRESSIN; METABOLISM; SECRETION	Real-time quantitative PCR (qPCR) is the most reliable and accurate technique for analyses of gene expression. Endogenous reference genes are being used to normalize qPCR data even though their expression may vary under different conditions and in different tissues. Nonetheless, verification of expression of reference genes in selected studied tissue is essential in order to accurately assess the level of expression of target genes of interest. Therefore, in this study, we attempted to examine six commonly used reference genes in order to identify the gene being expressed most constantly under the influence of testosterone in the kidneys and hypothalamus. The reference genes include glyceraldehyde- 3-phosphate dehydrogenase (GAPDH), actin beta (ACTB), beta-2 microglobulin (B2m), hypoxanthine phosphoribosyltransferase 1 (HPRT), peptidylprolylisomerase A (Ppia) and hydroxymethylbilane synthase (Hmbs). The cycle threshold (Ct) value for each gene was determined and data obtained were analyzed using the software programs NormFinder, geNorm, BestKeeper, and rank aggregation. Results showed that Hmbs and Ppia genes were the most stably expressed in the hypothalamus. Meanwhile, in kidneys, Hmbs and GAPDH appeared to be the most constant genes. In conclusion, variations in expression levels of reference genes occur in kidneys and hypothalamus under similar conditions; thus, it is important to verify reference gene levels in these tissues prior to commencing any studies.	[Gholami, Khadijeh; Loh, Su Yi] Int Med Univ, Sch Med, Div Human Biol, Kuala Lumpur, Malaysia; [Salleh, Naguib; Lam, Sau Kuen; Hoe, See Ziau] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia	International Medical University Malaysia; Universiti Malaya	Gholami, K (corresponding author), Int Med Univ, Sch Med, Div Human Biol, Kuala Lumpur, Malaysia.	shadigholami16@gmail.com	HOE, SEE ZIAU/B-8637-2010; Salleh, Naguib/ABG-6960-2021; Gholami, Shadi/A-5560-2013; Gholami, Shadi/ABD-5582-2020; SALLEH, NAGUIB/T-6426-2019	HOE, SEE ZIAU/0000-0001-6138-1271; Salleh, Naguib/0000-0002-4926-0490; Gholami, Shadi/0000-0003-1429-118X; Gholami, Shadi/0000-0003-1429-118X; 	University of Malaya [H-20001-E000086]	University of Malaya(Universiti Malaya)	This study has been funded by high impact research grant (H-20001-E000086), University of Malaya. The grant is awarded to SZH.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anstaett OL, 2010, VET IMMUNOL IMMUNOP, V137, P201, DOI 10.1016/j.vetimm.2010.05.006; Baddela VS, 2014, REPROD BIOL ENDOCRIN, V12, P1, DOI 10.1186/1477-7827-12-118; Budak H, 2014, COMP BIOCHEM PHYS C, V166, P44, DOI 10.1016/j.cbpc.2014.07.002; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; Cai ZW, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0014-5; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chueh WH, 2012, FOOD CHEM, V131, P1263, DOI 10.1016/j.foodchem.2011.09.116; CROFTON JT, 1986, J ENDOCRINOL, V108, P191, DOI 10.1677/joe.0.1080191; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; DAI WJ, 1995, BRAIN RES, V676, P178, DOI 10.1016/0006-8993(95)00112-4; Dart DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071694; Das RK, 2013, ENDOCR RES, V38, P105, DOI 10.3109/07435800.2012.723294; Dupasquier S, 2014, BMC MOL BIOL, V15, DOI 10.1186/1471-2199-15-9; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Gibbs PJ, 2003, TRANSPL IMMUNOL, V12, P89, DOI 10.1016/S0966-3274(03)00010-8; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Hu JP, 2011, AM J MED SCI, V342, P38, DOI 10.1097/MAJ.0b013e31820f835b; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hvid H, 2011, VET J, V190, P103, DOI 10.1016/j.tvjl.2010.09.002; Julian GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109902; Kim Insook, 2011, BMC Res Notes, V4, P440, DOI 10.1186/1756-0500-4-440; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Langnaese K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-53; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118821; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Liu B, 2011, ADV PHARM SCI, V2011, P8; Monteiro MB, 2016, METABOLISM, V65, P816, DOI 10.1016/j.metabol.2016.02.012; Mu XJ, 2015, GEN COMP ENDOCR, V215, P25, DOI 10.1016/j.ygcen.2014.09.017; Mullins LJ, 2006, PHYSIOL REV, V86, P709, DOI 10.1152/physrev.00016.2005; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Noriega NC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-47; Paillart C, 1997, J PHARMACOL EXP THER, V280, P521; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Petersson SJ, 2014, EUR J ENDOCRINOL, V171, P77, DOI 10.1530/EJE-14-0006; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reckelhoff JF, 1999, CLIN EXP PHARMACOL P, V26, P127, DOI 10.1046/j.1440-1681.1999.02996.x; Sajjad Y, 2007, ASIAN J ANDROL, V9, P751, DOI 10.1111/j.1745-7262.2007.00320.x; Santollo J, 2015, FRONT SYST NEUROSCI, V9, DOI [10.3369/fusys.2015.00025, 10.3389/fnsys.2015.00025]; SHARE L, 1988, AM J MED SCI, V295, P314, DOI 10.1097/00000441-198804000-00017; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sun JH, 2012, INT J LEGAL MED, V126, P113, DOI 10.1007/s00414-011-0604-3; Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Toot Jonathan, 2008, BMC Physiology, V8, P5, DOI 10.1186/1472-6793-8-5; Usui T, 2014, FEBS LETT, V588, P1935, DOI 10.1016/j.febslet.2014.03.051; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma AS, 2006, J GASTROEN HEPATOL, V21, P1004, DOI 10.1111/j.1440-1746.2005.03948.x; Wenner MM, 2012, J PHYSIOL-LONDON, V590, P5949, DOI 10.1113/jphysiol.2012.236752; Zhang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136355; Zhao J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/190945	56	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0176368	10.1371/journal.pone.0176368	http://dx.doi.org/10.1371/journal.pone.0176368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591185	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700002
J	Majka, J; Ksiazczyk, T; Kielbowicz-Matuk, A; Kopecky, D; Kosmala, A				Majka, Joanna; Ksiazczyk, Tomasz; Kielbowicz-Matuk, Agnieszka; Kopecky, David; Kosmala, Arkadiusz			Exploiting repetitive sequences and BAC clones in Festuca pratensis karyotyping	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; DNA-SEQUENCES; LOLIUM-MULTIFLORUM; CYTOGENETIC MAP; SECALE-CEREALE; WHEAT; GENES; CHROMOSOMES; EVOLUTION; REVEALS	The Festuca genus is thought to be the most numerous genus of the Poaceae family. One of the most agronomically important forage grasses, Festuca pratensis Huds. is treated as a model plant to study the molecular mechanisms associated with tolerance to winter stresses, including frost. However, the precise mapping of the genes governing stress tolerance in this species is difficult as its karyotype remains unrecognized. Only two F. pratensis chromosomes with 35S and 5S rDNA sequences can be easily identified, but its remaining chromosomes have not been distinguished to date. Here, two libraries derived from F. pratensis nuclear DNA with various contents of repetitive DNA sequences were used as sources of molecular probes for fluorescent in situ hybridisation (FISH), a BAC library and a library representing sequences most frequently present in the F. pratensis genome. Using FISH, six groups of DNA sequences were revealed in chromosomes on the basis of their signal position, including dispersed-like sequences, chromosome painting-like sequences, centromeric-like sequences, knob-like sequences, a group without hybridization signals, and single locus-like sequences. The last group was exploited to develop cytogenetic maps of diploid and tetraploid F. pratensis, which are presented here for the first time and provide a remarkable progress in karyotype characterization.	[Majka, Joanna; Ksiazczyk, Tomasz; Kielbowicz-Matuk, Agnieszka; Kosmala, Arkadiusz] Polish Acad Sci, Inst Plant Genet, Poznan, Poland; [Kopecky, David] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Majka, J (corresponding author), Polish Acad Sci, Inst Plant Genet, Poznan, Poland.	jcho@igr.poznan.pl	Kopecky, David/F-7284-2014; Kosmala, Arkadiusz/R-6737-2019	Kosmala, Arkadiusz/0000-0002-1760-1334; Majka, Joanna/0000-0001-9918-2980				Aliyeva-Schnorr L, 2016, CHROMOSOME RES, V24, P231, DOI 10.1007/s10577-016-9518-8; Banaei-Moghaddam AM, 2015, BBA-GENE REGUL MECH, V1849, P64, DOI 10.1016/j.bbagrm.2014.11.007; Bennett MD, 2012, PLANT DNA C VALUES D; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Catalan P, 2004, MOL PHYLOGENET EVOL, V31, P517, DOI 10.1016/j.ympev.2003.08.025; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Feldman M, 1997, GENETICS, V147, P1381; Fonseca A, 2013, GENOME, V56, P335, DOI 10.1139/gen-2013-0025; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Han YH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-18; Harper JA, 2004, PLANT SYST EVOL, V245, P163, DOI 10.1007/s00606-003-0110-2; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; He QY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0480-y; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; Idziak D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093503; Iovene M, 2011, CHROMOSOME RES, V19, P493, DOI 10.1007/s10577-011-9202-y; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jones ES, 2002, GENOME, V45, P282, DOI 10.1139/G01-144; Kopecky D, 2008, CHROMOSOME RES, V16, P987, DOI 10.1007/s10577-008-1256-0; Kopecky D, 2014, BIOTECHNOL ADV, V32, P190, DOI 10.1016/j.biotechadv.2013.11.010; Kopecky D, 2013, PLANT PHYSIOL, V163, P1323, DOI 10.1104/pp.113.224105; Kosmala A, 2007, J HERED, V98, P311, DOI 10.1093/jhered/esm047; Kosmala A, 2006, HEREDITY, V96, P243, DOI 10.1038/sj.hdy.6800787; Kosmala A, 2006, J APPL GENET, V47, P215, DOI 10.1007/BF03194626; Kosmala A, 2009, J EXP BOT, V60, P3595, DOI 10.1093/jxb/erp205; Ksiazczyk T, 2010, J APPL GENET, V51, P449, DOI 10.1007/BF03208874; Ksiazczyk T, 2011, J APPL GENET, V52, P305, DOI 10.1007/s13353-011-0048-y; Langdon T, 2000, GENETICS, V156, P313; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Loureiro J, 2007, PLANT SYST EVOL, V269, P89, DOI 10.1007/s00606-007-0564-8; Mandakova T, 2015, PLANT J, V82, P785, DOI 10.1111/tpj.12849; Murat F, 2014, GENOME BIOL EVOL, V6, P12, DOI 10.1093/gbe/evt200; Nunome T, 2006, PLANT MOL BIOL REP, V24, P305, DOI 10.1007/BF02913457; Pedrosa A, 2002, GENETICS, V161, P1661; Reheul D, 2010, HANDB PLANT BREED, V5, P1, DOI 10.1007/978-1-4419-0760-8_1; Renny-Byfield S, 2014, AM J BOT, V101, P1711, DOI 10.3732/ajb.1400119; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharma A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-142; Sun JY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-461; Thomas HM, 1997, GENOME, V40, P406, DOI 10.1139/g97-054; THOMAS HM, 1981, HEREDITY, V46, P263, DOI 10.1038/hdy.1981.33; Tsujimoto H, 1997, GENES GENET SYST, V72, P303, DOI 10.1266/ggs.72.303; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Weiss H, 2000, HEREDITAS, V133, P255, DOI 10.1111/j.1601-5223.2000.00255.x; Wolny E, 2013, GENOME, V56, P239, DOI 10.1139/gen-2013-0012; Yagi K, 2014, CYTOGENET GENOME RES, V144, P237, DOI 10.1159/000369183; Zhang P, 2004, GENOME, V47, P979, DOI [10.1139/g04-042, 10.1139/G04-042]; Zwierzykowski Z, 1999, GENOME, V42, P720, DOI 10.1139/gen-42-4-720	53	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179043	10.1371/journal.pone.0179043	http://dx.doi.org/10.1371/journal.pone.0179043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591168	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700078
J	Olsson, KH; Johansson, S; Blom, EL; Lindstrom, K; Svensson, O; Skold, HN; Kvarnemo, C				Olsson, Karin H.; Johansson, Sandra; Blom, Eva-Lotta; Lindstrom, Kai; Svensson, Ola; Skold, Helen Nilsson; Kvarnemo, Charlotta			Dark eyes in female sand gobies indicate readiness to spawn	PLOS ONE			English	Article							MINUTUS PALLAS PISCES; MALE MATE CHOICE; SEXUAL SELECTION; NATURAL-SELECTION; CONVICT CICHLIDS; MATING PATTERNS; COLOR PATTERNS; GOBY; COMPETITION; DIMORPHISM	In animals, colorful and conspicuous ornaments enhance individual attractiveness to potential mates, but are typically tempered by natural selection for crypsis and predator protection. In species where males compete for females, this can lead to highly ornamented males competing for mating opportunities with choosy females, and vice versa. However, even where males compete for mating opportunities, females may exhibit conspicuous displays. These female displays are often poorly understood and it may be unclear whether they declare mating intent, signal intrasexual aggression or form a target for male mate preference. We examined the function of the conspicuous dark eyes that female sand gobies temporarily display during courtship by experimentally testing if males preferred to associate with females with artificially darkened eyes and if dark eyes are displayed during female aggression. By observing interactions between a male and two females freely associating in an aquarium we also investigated in which context females naturally displayed dark eyes. We found that dark eyes were more likely to be displayed by more gravid females than less gravid females and possibly ahead of spawning, but that males did not respond behaviorally to dark eyes or prefer dark-eyed females. Females behaving aggressively did not display dark eyes. We suggest that dark eyes are not a signal per se but may be an aspect of female mate choice, possibly related to vision.	[Olsson, Karin H.; Johansson, Sandra; Blom, Eva-Lotta; Svensson, Ola; Kvarnemo, Charlotta] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Lindstrom, Kai] Abo Akad Univ, Environm & Marine Biol, Turku, Finland; [Svensson, Ola; Skold, Helen Nilsson; Kvarnemo, Charlotta] Univ Gothenburg, Ctr Marine Evolutionary Biol, Gothenburg, Sweden; [Skold, Helen Nilsson] Univ Gothenburg, Sven Loven Ctr Marine Infrastruct Kristineberg, Gothenburg, Sweden; [Olsson, Karin H.] Cefas Lab, Lowestoft, Suffolk, England; [Svensson, Ola] Sodertorn Univ, Sch Nat Sci Technol & Environm Studies, Huddinge, Sweden; [Skold, Helen Nilsson] Havets Hus Lysekil, Strandvagen 9, Lysekil, Sweden	University of Gothenburg; Abo Akademi University; University of Gothenburg; University of Gothenburg; Centre for Environment Fisheries & Aquaculture Science; Sodertorn University	Olsson, KH (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.; Olsson, KH (corresponding author), Cefas Lab, Lowestoft, Suffolk, England.	olsson.karin.h@gmail.com	Lindström, Kai/B-5479-2008; Lindström, Kai/ABG-4353-2020; Svensson, Ola/F-5232-2013	Lindström, Kai/0000-0002-8356-5538; Lindström, Kai/0000-0002-8356-5538; Svensson, Ola/0000-0003-3752-3131; Olsson, Karin/0000-0002-1695-0989	Graduate School in Marine Environmental Research at the Gothenburg Centre; Helge Ax:son Johnson Foundation; Linnaeus Center for Marine Evolutionary Biology [217-2008-1719]; Swedish Royal Society of Sciences; Swedish Research Council [621-2011-4004]; Wahistrom Foundation	Graduate School in Marine Environmental Research at the Gothenburg Centre; Helge Ax:son Johnson Foundation; Linnaeus Center for Marine Evolutionary Biology; Swedish Royal Society of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wahistrom Foundation	This work was supported by Graduate School in Marine Environmental Research at the Gothenburg Centre for Marine Research (E-LB), http://gmv.gu.se/english/collaborations-and-projects/collaboration-within-education/graduate-schools/graduate-school-in-marine-environmental-research, Grant is not numbered; Helge Ax:son Johnson Foundation (E-LB), http:http://haxsonj.se/www/, Grant is not numbered; Linnaeus Center for Marine Evolutionary Biology (OS, CK), http://cemeb.science.gu.se, Grant number: 217-2008-1719; Swedish Royal Society of Sciences (KL, KHO), http://www.kva.se/en/, Grant is not numbered; Swedish Research Council (CK), http://www.vr.se, Grant number: 621-2011-4004; Wahistrom Foundation (HNS), Wahistroms stiftelse, c/o Bengt Wedel, Spektrumsgatan 108,42163 Vastra Frolunda, Goteborg, Sweden, Email: bengt.wedel@gmail.com, phone: 46-31/28 44 41, No formal grant number, application date #20140922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Amundsen T, 1997, P ROY SOC B-BIOL SCI, V264, P1579, DOI 10.1098/rspb.1997.0220; Anderson C, 2016, BEHAV ECOL SOCIOBIOL, V70, P647, DOI 10.1007/s00265-016-2085-3; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Beeching SC, 1998, ANIM BEHAV, V56, P1021, DOI 10.1006/anbe.1998.0868; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; BERGLUND A, 1991, EVOLUTION, V45, P770, DOI 10.1111/j.1558-5646.1991.tb04346.x; Blom EL, 2016, ENVIRON BIOL FISH, V99, P999, DOI 10.1007/s10641-016-0550-5; Darwin C., 1871, THE DESCENT OF MAN A; DeBroff BM, 2003, ARCH OPHTHALMOL-CHIC, V121, P997, DOI 10.1001/archopht.121.7.997; Dijkstra PD, 2009, BEHAV ECOL, V20, P593, DOI 10.1093/beheco/arp036; du Gobius minutus, 1892, ARCH ZOOL EXPT GEN; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; FICKEN RW, 1971, SCIENCE, V173, P936, DOI 10.1126/science.173.4000.936; Forsgren E, 1997, ANIM BEHAV, V53, P267, DOI 10.1006/anbe.1996.0374; Forsgren E, 1999, BEHAV CONSERVATION L, P249; Fujii R., 1994, Advances in Comparative and Environmental Physiology, V20, P1; HEALEY MC, 1971, T AM FISH SOC, V100, P520, DOI 10.1577/1548-8659(1971)100<520:GDAFOT>2.0.CO;2; Heinsohn R, 2005, SCIENCE, V309, P617, DOI 10.1126/science.1112774; HESTHAGEN IH, 1977, SARSIA, V63, P17, DOI 10.1080/00364827.1977.10411316; HESTHAGEN IH, 1979, J FISH BIOL, V14, P225, DOI 10.1111/j.1095-8649.1979.tb03513.x; Jones AG, 2001, MOL ECOL, V10, P461, DOI 10.1046/j.1365-294x.2001.01193.x; Kelley JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2730; Kjernsmo K, 2016, ANIM BEHAV, V111, P189, DOI 10.1016/j.anbehav.2015.10.028; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Kvarnemo C, 2000, BEHAV ECOL SOCIOBIOL, V48, P378, DOI 10.1007/s002650000246; KVARNEMO C, 1994, P ROY SOC B-BIOL SCI, V256, P151, DOI 10.1098/rspb.1994.0063; Kvarnemo C, 1995, ANIM BEHAV, V50, P1455, DOI 10.1016/0003-3472(95)80002-6; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lande R., 1987, Life Sciences Research Report, V39, P83; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; LeBas NR, 2003, P ROY SOC B-BIOL SCI, V270, P2159, DOI 10.1098/rspb.2003.2482; Lehtonen TK, 2012, ANIM BEHAV, V83, P1153, DOI 10.1016/j.anbehav.2012.01.040; Lindstrom K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0983; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; MAGNHAGEN C, 1989, J FISH BIOL, V35, P755, DOI 10.1111/j.1095-8649.1989.tb03027.x; Massironi M, 2005, MAR BIOL, V147, P71, DOI 10.1007/s00227-004-1549-6; MOLLER AP, 1988, BEHAV ECOL SOCIOBIOL, V22, P373; Nilsson S. H., 2013, PIGM CELL MELANOMA R, V26, P29, DOI DOI 10.1111/PCMR.12040; Ord TJ, 2008, P NATL ACAD SCI USA, V105, P18830, DOI 10.1073/pnas.0807657105; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Rohde PA, 1999, CONDOR, V101, P96, DOI 10.2307/1370450; ROSENQVIST G, 1990, ANIM BEHAV, V39, P1110, DOI 10.1016/S0003-3472(05)80783-3; Rosenqvist G, 2011, J FISH BIOL, V78, P1647, DOI 10.1111/j.1095-8649.2011.02972.x; Rosvall KA, 2011, BEHAV ECOL, P1; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; Skold HN, 2015, BIOL OPEN, V4, P206, DOI 10.1242/bio.20149993; Smiseth PT, 2000, BEHAV ECOL SOCIOBIOL, V47, P205, DOI 10.1007/s002650050657; Stokkan KA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2451; Svensson PA, 2006, FUNCT ECOL, V20, P689, DOI 10.1111/j.1365-2435.2006.01151.x; Szamado S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135379; Weese DJ, 2010, EVOLUTION, V64, P1802, DOI 10.1111/j.1558-5646.2010.00945.x; WHITTINGHAM LA, 1992, AUK, V109, P928, DOI 10.2307/4088178	58	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177714	10.1371/journal.pone.0177714	http://dx.doi.org/10.1371/journal.pone.0177714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591156	Green Submitted, gold, Green Published			2022-12-26	WOS:000402880700012
J	Zhu, YC; Yao, JX; Adamczyk, J; Luttrell, R				Zhu, Yu Cheng; Yao, Jianxiu; Adamczyk, John; Luttrell, Randall			Feeding toxicity and impact of imidacloprid formulation and mixtures with six representative pesticides at residue concentrations on honey bee physiology (Apis mellifera)	PLOS ONE			English	Article							SEED-TREATED CANOLA; TARNISHED PLANT BUG; COLORIMETRIC DETERMINATION; PYRETHROID INSECTICIDE; RESISTANT STRAIN; HYMENOPTERA; ACETYLCHOLINESTERASE; NEONICOTINOIDS; MECHANISM; SYNERGISM	Imidacloprid is the most widely used insecticide in agriculture. In this study, we used feeding methods to simulate in-hive exposures of formulated imidacloprid (Advise (R) 2FL) alone and mixtures with six representative pesticides for different classes. Advise, fed at 4.3 mg/L (equal to maximal residue detection of 912 ppb active ingredient [a.i.] in pollen) induced 36% mortality and 56% feeding suppression after 2-week feeding. Treatments with individual Bracket (acephate), Karate (lambda-cyhalothrin), Vydate (oxamyl), Domark (tetraconazole), and Roundup (glyphosate) at residue level had a mortality range of 1.3-13.3%, statistically similar to that of control (P>0.05). The additive/synergistic toxicity was not detected from binary mixtures of Advise with different classes of pesticides at residue levels. The feeding of the mixture of all seven pesticides increased mortality to 53%, significantly higher than Advise only but still without synergism. Enzymatic data showed that activities of invertase, glutathione S-transferase, and acetylcholinesterase activities in imidacloprid-treated survivors were mostly similar to those found in control. Esterase activity mostly increased, but was significantly suppressed by Bracket (acephate). The immunity-related phenoloxidase activity in imidacloprid-treated survivors tended to be lower, but most treatments were statistically similar to the control. Increase of cytochrome P450 activity was correlated with Advise concentrations and reached significant difference at 56 mg/L (12 ppm a.i.). Our data demonstrated that residue levels of seven pesticide in pollens/hive may not adversely affect honey bees, but long term exclusive ingestion of the maximal residue levels of imidacloprid (912 ppb) and sulfoxaflor (3 ppm a.i.) may induce substantial bee mortality. Rotating with other insecticides is a necessary and practical way to reduce the residue level of any given pesticide.	[Zhu, Yu Cheng; Yao, Jianxiu; Luttrell, Randall] USDA ARS, Stoneville, MS 38776 USA; [Adamczyk, John] USDA ARS, Poplarville, MS USA; [Yao, Jianxiu] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University	Zhu, YC (corresponding author), USDA ARS, Stoneville, MS 38776 USA.	yc.zhu@ars.usda.gov		Adamczyk, John/0000-0002-6536-7255				Altmann R., 2003, Pflanzenschutz-Nachrichten Bayer, V56, P102; Anderson TD, 2004, PESTIC BIOCHEM PHYS, V80, P54, DOI 10.1016/j.pestbp.2004.06.003; Anelli CM, 2015, PLOS ONE, V10; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BECERRIL JM, 1989, PHYTOCHEMISTRY, V28, P695, DOI 10.1016/0031-9422(89)80095-0; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandon H, 2015, DELTA AGR DIGEST; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CAMP HB, 1969, J AGR FOOD CHEM, V17, P243, DOI 10.1021/jf60162a038; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Catchot A, 2016, MISSISSIPPI STATE U, V2471; Cedergreen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096580; Chauret N, 1999, ANAL BIOCHEM, V276, P215, DOI 10.1006/abio.1999.4348; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; DONER LW, 1977, J SCI FOOD AGR, V28, P443, DOI 10.1002/jsfa.2740280508; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Greene JK, 1999, J ECON ENTOMOL, V92, P941, DOI 10.1093/jee/92.4.941; Han P, 2010, ECOTOXICOLOGY, V19, P1612, DOI 10.1007/s10646-010-0546-4; IRAC, 2015, INS RES ACT COMM VER; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Khandekar DC, 2014, BIOPROC BIOSYST ENG, V37, P2529, DOI 10.1007/s00449-014-1230-5; Krupke CH, 2014, CORN INSECT CONTROL, VE- 219- W; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; LEVER M, 1972, ANAL BIOCHEM, V47, P273, DOI 10.1016/0003-2697(72)90301-6; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Marzaro M, 2011, B INSECTOL, V64, P119; Maus Christian, 2003, Bulletin of Insectology, V56, P51; MOFFETT JO, 1972, J ECON ENTOMOL, V65, P32, DOI 10.1093/jee/65.1.32; Mullin CA, 2015, PESTIC BIOCHEM PHYS, V120, P27, DOI 10.1016/j.pestbp.2014.12.026; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schmid MR, 2008, J INSECT PHYSIOL, V54, P439, DOI 10.1016/j.jinsphys.2007.11.002; Spurgeon D, EFSAQ201300424; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Stumpf N, 2001, J ECON ENTOMOL, V94, P1577, DOI 10.1603/0022-0493-94.6.1577; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Van Leeuwen T, 2006, PEST MANAG SCI, V62, P425, DOI 10.1002/ps.1183; VANDENBOSSCHE H, 1991, AM J OBSTET GYNECOL, V165, P1193, DOI 10.1016/S0002-9378(12)90726-7; Waxman DJ, 2006, CYTOCHROME P450 PROT, V320, P153; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Yamamoto Izuru, 1999, NICOTINOID INSECTICI, P3, DOI DOI 10.1007/978-4-431-67933-2_1; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; YU SJ, 1982, PESTIC BIOCHEM PHYS, V18, P101, DOI 10.1016/0048-3575(82)90092-X; Zhu KY, 1999, PESTIC SCI, V55, P11, DOI 10.1002/(SICI)1096-9063(199901)55:1<11::AID-PS850>3.0.CO;2-4; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2004, INSECT BIOCHEM MOLEC, V34, P1175, DOI 10.1016/j.ibmb.2004.07.008; Zhu YC, 2015, J ECON ENTOMOL, V108, P2640, DOI 10.1093/jee/tov269; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037586	73	51	55	6	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0178421	10.1371/journal.pone.0178421	http://dx.doi.org/10.1371/journal.pone.0178421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591204	Green Submitted, Green Published, gold			2022-12-26	WOS:000402880700033
J	Grandner, MA; Winkelman, JW				Grandner, Michael A.; Winkelman, John W.			Nocturnal leg cramps: Prevalence and associations with demographics, sleep disturbance symptoms, medical conditions, and cardiometabolic risk factors	PLOS ONE			English	Article							MUSCLE CRAMPS; GENERAL-POPULATION	Background Nocturnal leg cramps (NLC) are common and poorly understood. Objective To determine the prevalence of NLC and associations with cardiometabolic, sleep, and behavioral risk factors in the US population. Design Cross-sectional epidemiology. Participants National Health and Nutrition Examination Survey, 2005-2006 and 2007-2008 waves. Main outcome(s) and measure(s) NLC were assessed with, "In the past month, how often did you have leg cramps while trying to sleep?" Responses were categorized as None, Mild, or Moderate-Severe. Demographics, medical history, sleep disturbances, and cardiometabolic risk factors were evaluated using the 2005-2006 dataset. Variables that demonstrated significant relationships to NLC after adjusting for age, sex, education, and BMI were assessed in the 2007-2008 dataset. Variables that were still significant were entered into a forward stepwise regression model combining both waves, to determine which variables best explained the variance in NLC. Results Prevalence was 24-25% reporting mild and 6% reporting moderate-severe NLC. NLC increased with age, lower education, unemployment, shorter sleep duration, all assessed sleep symptoms (nocturnal "leg jerks", snoring, snorting/gasping, difficulty falling asleep, difficulty maintaining sleep, non-restorative sleep, sleepiness, use of sleep medications), higher BMI, smoking, medical history (hypertension, heart failure, angina, stroke, arthritis, respiratory disease, and cancer), depression symptoms, and biomarkers (CRP, HbA1c, calcium, cadmium, red blood cells). Stepwise analysis showed that moderate-severe nocturnal leg cramps were associated with (in decreasing order of partial R-2): leg jerks, poor overall health, arthritis, difficulty falling asleep, age, nonrestorative sleep, red blood cell count, lower education, angina, and difficulty maintaining sleep. Conclusions and relevance Based on this first large, representative study, NLC occurring >5x per month are reported by 6% of the adult US population. Sleep disturbance symptoms and health conditions are associated with higher frequency of NLC, suggesting that NLC is a marker, and possibly contributor, to poor sleep and general health.	[Grandner, Michael A.] Univ Arizona, Dept Psychiat, Tucson, AZ USA; [Winkelman, John W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA; [Winkelman, John W.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA	University of Arizona; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Winkelman, JW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA.; Winkelman, JW (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.	jwwinkelman@partners.org		Grandner, Michael/0000-0002-4626-754X	National Heart, Lung, and Blood Institute [K23HL110216]; Luitpold Pharmaceuticals; Xenoport; UCB Pharma; NeuroMetrix; NIMH	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Luitpold Pharmaceuticals; Xenoport; UCB Pharma(UCB Pharma SA); NeuroMetrix; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work received support from the National Heart, Lung, and Blood Institute, Grant number: K23HL110216, URL: https://www.nhlbi.nih.gov/. Author who received funding: MG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Susan Redline for her contributions to editing the manuscript, as well as Nicholas Jackson for input on statistical models. Dr. Winkelman is a consultant for Merck and Flex Pharma, has provided expert testimony for Cantor Colburn, receives royalties from UpToDate, and has received research grants from Luitpold Pharmaceuticals, Xenoport, UCB Pharma, NeuroMetrix, and NIMH. Dr. Grandner is a consultant for FitBit and is on the Scientific Advisory Board for CurAegis Technologies. He has provided expert testimony for Morrison Foerster. This abstract was presented at the 2016 APSS SLEEP meeting.	Abdulla AJJ, 1999, INT J CLIN PRACT, V53, P494; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Brown TM, 2015, SLEEP MED CLIN, V10, P385, DOI 10.1016/j.jsmc.2015.05.002; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Garrison SR, 2012, ARCH INTERN MED, V172, P120, DOI 10.1001/archinternmed.2011.1029; Gottlieb DJ, 2016, SLEEP MED; HALL AJ, 1947, LANCET, V253, P231; Hawke F, 2013, QUAL LIFE RES, V22, P1281, DOI 10.1007/s11136-012-0274-8; Hawke F, 2013, MUSCLE NERVE, V47, P339, DOI 10.1002/mus.23531; Hornyak M, 2006, SLEEP MED REV, V10, P169, DOI 10.1016/j.smrv.2005.12.003; JANSEN PHP, 1991, J NEUROL NEUROSUR PS, V54, P1124, DOI 10.1136/jnnp.54.12.1124; Jansen PHP, 1999, J EUR ACAD DERMATOL, V12, P222, DOI 10.1016/S0926-9959(99)00041-0; Katzberg H, 2014, DIABETES CARE, V37, pE17, DOI 10.2337/dc13-1163; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; NAYLOR JR, 1994, AGE AGEING, V23, P418, DOI 10.1093/ageing/23.5.418; OBOLER SK, 1991, WESTERN J MED, V155, P256; Rabbitt L, 2016, AGE AGEING, V45, P776, DOI 10.1093/ageing/afw139; Winkelman JW, 2011, UPTO DATE	19	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178465	10.1371/journal.pone.0178465	http://dx.doi.org/10.1371/journal.pone.0178465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586374	Green Submitted, gold, Green Published			2022-12-26	WOS:000402875700013
J	Nadadhur, AG; Melero, JE; Meijer, M; Schut, D; Jacobs, G; Li, KW; Hjorth, JJJ; Meredith, RM; Toonen, RF; Van Kesteren, RE; Smit, AB; Verhage, M; Heine, VM				Nadadhur, Aishwarya G.; Melero, Javier Emperador; Meijer, Marieke; Schut, Desiree; Jacobs, Gerbren; Li, Ka Wan; Hjorth, J. J. Johannes; Meredith, Rhiannon M.; Toonen, Ruud F.; Van Kesteren, Ronald E.; Smit, August B.; Verhage, Matthijs; Heine, Vivi M.			Multi-level characterization of balanced inhibitory-excitatory cortical neuron network derived from human pluripotent stem cells	PLOS ONE			English	Article							GANGLIONIC EMINENCE; DIFFERENTIATION; GABA; SPECIFICATION; GLUTAMATE; DISEASE; MOUSE; INTERNEURONS; MATURATION; REVEAL	Generation of neuronal cultures from induced pluripotent stem cells (hiPSCs) serve the studies of human brain disorders. However we lack neuronal networks with balanced excitatory-inhibitory activities, which are suitable for single cell analysis. We generated low-density networks of hPSC-derived GABAergic and glutamatergic cortical neurons. We used two different co-culture models with astrocytes. We show that these cultures have balanced excitatory-inhibitory synaptic identities using confocal microscopy, electrophysiological recordings, calcium imaging and mRNA analysis. These simple and robust protocols offer the opportunity for single-cell to multi-level analysis of patient hiPSC-derived cortical excitatory-inhibitory networks; thereby creating advanced tools to study disease mechanisms underlying neurodevelopmental disorders.	[Nadadhur, Aishwarya G.; Melero, Javier Emperador; Meijer, Marieke; Schut, Desiree; Toonen, Ruud F.; Verhage, Matthijs] Vrije Univ Amsterdam, Amsterdam Neurosci, Ctr Neurogen & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Jacobs, Gerbren; Heine, Vivi M.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Neurosci, Dept Pediat Child Neurol, Amsterdam, Netherlands; [Li, Ka Wan; Van Kesteren, Ronald E.; Smit, August B.] Vrije Univ Amsterdam, Amsterdam Neurosci, Dept Mol & Cellular Neurobiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Hjorth, J. J. Johannes; Meredith, Rhiannon M.] Vrije Univ Amsterdam, Amsterdam Neurosci, Dept Integrat Neurophysiol, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Verhage, Matthijs] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Heine, Vivi M.] Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Amsterdam, Netherlands; [Hjorth, J. J. Johannes] KTH Royal Inst Technol, Sci Life Lab, Sch Comp Sci & Commun, Solna, Sweden	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Royal Institute of Technology	Heine, VM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam Neurosci, Dept Pediat Child Neurol, Amsterdam, Netherlands.; Heine, VM (corresponding author), Vrije Univ Amsterdam, Dept Complex Trait Genet, Ctr Neurogen & Cognit Res, Amsterdam Neurosci, Amsterdam, Netherlands.	vm.heine@vumc.nl	van Kesteren, Ronald E/E-2505-2014; Heine, Vivi M/F-1741-2011; Meredith, Rhiannon/A-4657-2010	Heine, Vivi M/0000-0003-4416-3875; G Nadadhur, Aishwarya/0000-0003-0468-9135; li, ka wan/0000-0001-6983-5055; verhage, matthijs/0000-0002-6085-7503; Toonen, Ruud/0000-0002-9900-4233; Meredith, Rhiannon/0000-0003-0228-4169; van Kesteren, Ronald/0000-0002-9592-3777; EMPERADOR MELERO, JAVIER/0000-0002-1364-4935	Neuroscience Campus Amsterdam; EU MSCA-ITN CognitionNet [FP7-PEOPLE-2013-ITN 607508]	Neuroscience Campus Amsterdam; EU MSCA-ITN CognitionNet	This study was supported and funded by Neuroscience Campus Amsterdam and EU MSCA-ITN CognitionNet (FP7-PEOPLE-2013-ITN 607508).	Barker Alison J, 2008, Commun Integr Biol, V1, P207; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Elias LAB, 2008, NEURON, V59, P679, DOI 10.1016/j.neuron.2008.08.017; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Falk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029597; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hjorth J. J., 2015, DEV NEUROBIOL; Jaeger I, 2011, DEVELOPMENT, V138, P4363, DOI 10.1242/dev.066746; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kelsom C, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-19; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kuijlaars J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36529; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Lodato S, 2011, J NEUROSCI, V31, P4650, DOI 10.1523/JNEUROSCI.6580-10.2011; Lujan R, 2005, NEUROSCIENCE, V130, P567, DOI 10.1016/j.neuroscience.2004.09.042; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mahairaki V, 2014, STEM CELLS DEV, V23, P2996, DOI 10.1089/scd.2013.0511; Malchenko S, 2014, GENE, V534, P400, DOI 10.1016/j.gene.2013.07.101; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marin O, 2014, CURR OPIN NEUROBIOL, V26, P132, DOI 10.1016/j.conb.2014.01.015; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Miyoshi G, 2015, J NEUROSCI, V35, P12869, DOI 10.1523/JNEUROSCI.1164-15.2015; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Neves G, 2013, CEREB CORTEX, V23, P1811, DOI 10.1093/cercor/bhs159; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Pre D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103418; Schmitz SK, 2011, J NEUROSCI METH, V195, P185, DOI 10.1016/j.jneumeth.2010.12.011; Shcheglovitov A, 2013, NATURE, P503; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Skogh C, 2003, NEUROSCIENCE, V120, P379, DOI 10.1016/S0306-4522(03)00427-5; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Vasistha NA, 2015, CEREB CORTEX, V25, P3290, DOI 10.1093/cercor/bhu125; Vigneault E, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00023; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; WOOD JD, 1973, J PHARMACOL EXP THER, V184, P590; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xu JC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0623; Zhang DW, 2014, BIOMATERIALS, V35, P1420, DOI 10.1016/j.biomaterials.2013.11.028	54	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2017	12	6							e0178533	10.1371/journal.pone.0178533	http://dx.doi.org/10.1371/journal.pone.0178533			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9YQ	28586384	Green Published, gold			2022-12-26	WOS:000402875700018
J	Accattato, F; Greco, M; Pullano, SA; Care, I; Fiorillo, AS; Pujia, A; Montalcini, T; Foti, DP; Brunetti, A; Gulletta, E				Accattato, Francesca; Greco, Marta; Pullano, Salvatore A.; Care, Ilaria; Fiorillo, Antonino S.; Pujia, Arturo; Montalcini, Tiziana; Foti, Daniela P.; Brunetti, Antonio; Gulletta, Elio			Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ADIPOSE-TISSUE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; METABOLIC SYNDROME; GENE-EXPRESSION; HEART-FAILURE; OLDER-ADULTS; HYPOXIA; MEN	Circulating oxidative stress and pro-inflammatory markers change after regular physical exercise; however, how a short session of acute physical activity affects the inflammatory status and redox balance in sedentary individuals is still unclear. Aim of this study is to assess antioxidant and inflammatory parameters, both at rest and after acute exercise, in sedentary young men with or without obesity. Thirty sedentary male volunteers, aged 20-45 (mean age 32 +/- 7 years), were recruited, divided into 3 groups (normal weight: BMI < 25 kg/m(2); overweight to moderate obesity: 25-35 kg/m(2); severe obesity: 35-40 kg/m(2)), and their blood samples collected before and after a 20-min run at similar to 70% of their VO2max for the measurement of Glutathione Reductase, Glutathione Peroxidase, Superoxide Dismutase, Total Antioxidant Status (TAS) and cytokines (IL-2, IL-4, IL-6, IL-8, IL-10, IL-1 alpha, IL-1 beta, TNF alpha, MCP-1, VEGF, IFNY, EGF). Inter-group comparisons demonstrated significantly higher Glutathione Reductase activity in severely obese subjects in the post-exercise period (P = 0.036), and higher EGF levels in normal weight individuals, either before (P = 0.003) and after exercise (P = 0.05). Intra-group comparisons showed that the acute exercise stress induced a significant increase in Glutathione Reductase activity in severely obese subjects only (P = 0.007), a significant decrease in MCP-1 in the normal weight group (P = 0.02), and a decrease in EGF levels in all groups (normal weight: P = 0.025, overweight/moderate obesity: P = 0.04, severe obesity: P = 0.018). Altogether, these findings suggest that in sedentary individuals with different ranges of BMI, Glutathione Reductase and distinct cytokines are differentially involved into the adaptive metabolic changes and redox responses induced by physical exercise. Therefore, these biomarkers may have the potential to identify individuals at higher risk for developing diseases pathophysiologically linked to oxidative stress.	[Accattato, Francesca; Greco, Marta; Pullano, Salvatore A.; Fiorillo, Antonino S.; Foti, Daniela P.; Brunetti, Antonio; Gulletta, Elio] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Care, Ilaria; Pujia, Arturo; Montalcini, Tiziana] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Foti, DP (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy.	foti@unicz.it	Pullano, Salvatore Andrea/P-3098-2019; Pullano, Salvatore Andrea/H-1149-2016; Greco, Marta/K-8227-2016; Foti, Daniela P/K-8038-2016; Brunetti, Antonio/K-7756-2016	Pullano, Salvatore Andrea/0000-0003-3391-1698; Pullano, Salvatore Andrea/0000-0003-3391-1698; Greco, Marta/0000-0003-4192-3891; Brunetti, Antonio/0000-0003-1533-8779				Adamopoulos S, 2001, EUR HEART J, V22, P791, DOI 10.1053/euhj.2000.2285; Ashton T, 1998, EUR J APPL PHYSIOL O, V77, P498, DOI 10.1007/s004210050366; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barbieri E., 2012, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2012/982794; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beltowski J, 2000, J PHYSIOL PHARMACOL, V51, P883; Berzosa C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/540458; BLACK HR, 1994, HYPERTENSION, V23, P275; Buresh R, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-014-0003-7; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cases N, 2006, EUR J APPL PHYSIOL, V98, P263, DOI 10.1007/s00421-006-0273-y; Diaz K M, 2011, Int J Exerc Sci, V4, P247; Dimitrov S, 2017, BRAIN BEHAV IMMUN, V61, P60, DOI 10.1016/j.bbi.2016.12.017; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Elosua R, 2003, ATHEROSCLEROSIS, V167, P327, DOI 10.1016/S0021-9150(03)00018-2; Fatouros I, 2010, STRESS, V13, P461, DOI 10.3109/10253891003743432; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Franckowiak SC, 2011, J STRENGTH COND RES, V25, P1407, DOI 10.1519/JSC.0b013e3181d682d2; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gliemann L, 2014, FREE RADICAL RES, V48, P71, DOI 10.3109/10715762.2013.835045; Greco M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/750860; Heiss K, 2016, NEUROSCI LETT, V626, P142, DOI 10.1016/j.neulet.2016.05.025; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang CJ, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0031-y; Karner-Rezek K, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-328; La Gerche A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130031; La Gerche A, 2014, CIRCULATION, V130, P992, DOI 10.1161/CIRCULATIONAHA.114.008141; Laaksonen DE, 1996, DIABETES CARE, V19, P569, DOI 10.2337/diacare.19.6.569; Li PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22831; Margaritelis NV, 2014, REDOX BIOL, V2, P520, DOI 10.1016/j.redox.2014.02.003; Mercken EM, 2005, AM J RESP CRIT CARE, V172, P994, DOI 10.1164/rccm.200411-1580OC; Messineo S, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00073; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Miller JA, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-18; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nemet D, 2004, MED SCI SPORT EXER, V36, P794, DOI 10.1249/01.MSS.0000126804.30437.52; Nishiyama Y, 1998, AM HEART J, V135, P115, DOI 10.1016/S0002-8703(98)70351-5; Nosaka K, 1996, MED SCI SPORT EXER, V28, P953, DOI 10.1097/00005768-199608000-00003; Otocka-Kmiecik A., 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/230271; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Petridou A, 2002, J LIPID RES, V43, P1331, DOI 10.1194/jlr.C200003-JLR200; Pialoux V, 2009, INT J SPORTS MED, V30, P87, DOI 10.1055/s-0028-1103284; Powers SK, 2011, COMPR PHYSIOL, V1, P941, DOI 10.1002/cphy.c100054; Powers SK, 2011, FREE RADICAL BIO MED, V51, P942, DOI 10.1016/j.freeradbiomed.2010.12.009; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Prior Ronald L., 2004, Journal of Nutrition, V134, p3184S; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Rundqvist H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067579; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Serrano E, 2010, J SPORT SCI, V28, P1047, DOI 10.1080/02640414.2010.484067; SERRERO G, 1993, AM J PHYSIOL, V264, pE800, DOI 10.1152/ajpendo.1993.264.5.E800; SERRERO G, 1991, P NATL ACAD SCI USA, V88, P3912, DOI 10.1073/pnas.88.9.3912; SWAIN DP, 1994, MED SCI SPORT EXER, V26, P112; Tahan F, 2006, ANN ALLERG ASTHMA IM, V96, P819, DOI 10.1016/S1081-1206(10)61344-0; Takahashi M, 2013, J SPORT SCI MED, V12, P571; Terblanche SE, 1999, CELL BIOL INT, V23, P749, DOI 10.1006/cbir.1999.0442; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trayhurn P, 2008, BRIT J NUTR, V100, P227, DOI 10.1017/S0007114508971282; Vincent HK, 2006, OBESITY, V14, P1921, DOI 10.1038/oby.2006.224; Vincent HK, 2006, OBESITY, V14, P2224, DOI 10.1038/oby.2006.261; Vincent HK, 2005, MED SCI SPORT EXER, V37, P213, DOI 10.1249/01.MSS.0000152705.77073.B3; Vincent HK, 2004, MED SCI SPORT EXER, V36, P772, DOI 10.1249/01.MSS.0000126576.53038.E9; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	71	62	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178900	10.1371/journal.pone.0178900	http://dx.doi.org/10.1371/journal.pone.0178900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582461	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600053
J	Komisarczuk, AZ; Grotmol, S; Nilsen, F				Komisarczuk, Anna Z.; Grotmol, Sindre; Nilsen, Frank			Ionotropic receptors signal host recognition in the salmon louse (Lepeophtheirus salmonis, Copepoda)	PLOS ONE			English	Article							GLUTAMATE RECEPTORS; SEA LICE; MOLECULAR CHARACTERIZATION; ATLANTIC SALMON; DROSOPHILA; SEMIOCHEMICALS; ARCHITECTURE; AQUACULTURE; REPELLENTS; SETTLEMENT	A remarkable feature of many parasites is a high degree of host specificity but the mechanisms behind are poorly understood. A major challenge for parasites is to identify and infect a suitable host. Many species show a high degree of host specificity, being able to survive only on one or a few related host species. To facilitate transmission, parasite's behavior and reproduction has been fine tuned to maximize the likelihood of infection of a suitable host. For some species chemical cues that trigger or attract the parasite in question have been identified but how metazoan parasites themselves receive these signals remains unknown. In the present study we show that ionotropic receptors (IRs) in the salmon louse are likely responsible for identification of a specific host. By using RNAi to knock down the expression level of different co-receptors, a significant change of infectivity and settlement of lice larvae was achieved on Atlantic salmon. More remarkably, knock down of the IRs changed the host specificity of the salmon louse and lice larvae settled at a significant rate on host that the wild type lice rejected within minutes. To our knowledge, this has never before been demonstrated for any metazoan parasite. Our results show that the parasites are able to identify the host quickly upon settlement, settle and initiate the parasitic life style if they are on the right host. This novel discovery opens up for utilizing the host recognition system for future parasite control.	[Komisarczuk, Anna Z.; Grotmol, Sindre; Nilsen, Frank] Univ Bergen, Dept Biol, Sea Lice Res Ctr, Bergen, Norway	University of Bergen	Komisarczuk, AZ (corresponding author), Univ Bergen, Dept Biol, Sea Lice Res Ctr, Bergen, Norway.	Anna.Komisarczuk@uib.no	Grotmol, Sindre/AAB-8316-2020		Research Council of Norway [203513]	Research Council of Norway(Research Council of Norway)	This research has been funded by the Research Council of Norway, Grant Number 203513 (www.forskningsradet.no) to FN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ai MR, 2013, J NEUROSCI, V33, P10741, DOI 10.1523/JNEUROSCI.5419-12.2013; Andersson MN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-501; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Bailey RJE, 2006, CAN J FISH AQUAT SCI, V63, P448, DOI 10.1139/F05-231; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Benton R, 2008, CURR OPIN NEUROBIOL, V18, P357, DOI 10.1016/j.conb.2008.08.012; Browman HI, 2004, J FISH DIS, V27, P701, DOI 10.1111/j.1365-2761.2004.00592.x; Castelletto ML, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004305; Corey EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060551; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Devine GJ, 2000, J CHEM ECOL, V26, P1833, DOI 10.1023/A:1005592606682; Dweck HKM, 2013, CURR BIOL, V23, P2472, DOI 10.1016/j.cub.2013.10.047; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Genna RL, 2005, CAN J FISH AQUAT SCI, V62, P2675, DOI 10.1139/F05-163; Guo M, 2014, INT J BIOL SCI, V10, P1, DOI 10.7150/ijbs.7624; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hamre LA, 2011, DIS AQUAT ORGAN, V97, P47, DOI 10.3354/dao02397; Heuch PA, 1997, J PLANKTON RES, V19, P735, DOI 10.1093/plankt/19.6.735; Ingvarsdottir A, 2002, PEST MANAG SCI, V58, P537, DOI 10.1002/ps.510; JOHNSON SC, 1992, DIS AQUAT ORGAN, V14, P179, DOI 10.3354/dao014179; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Liang D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156380; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Mauritzen-Skern L, 2016, SALMONIS GENOME; Mordue AJ, 2009, J FISH DIS, V32, P3, DOI 10.1111/j.1365-2761.2008.01004.x; Nunez-Acuna G, 2014, EXP PARASITOL, V145, P99, DOI 10.1016/j.exppara.2014.08.003; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pert CC, 2009, AQUACULTURE, V288, P321, DOI 10.1016/j.aquaculture.2008.12.005; PIKE AW, 1989, PARASITOL TODAY, V5, P291, DOI 10.1016/0169-4758(89)90020-3; Pike AW, 2000, ADV PARASIT, V44, P233; Ray A, 2015, CURR OPIN NEUROBIOL, V34, P158, DOI 10.1016/j.conb.2015.06.014; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Spletter ML, 2009, CELL, V136, P23, DOI 10.1016/j.cell.2008.12.031; Tangtrakulwanich K, 2011, MED VET ENTOMOL, V25, P327, DOI 10.1111/j.1365-2915.2011.00946.x; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Walker WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23518; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715	48	20	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178812	10.1371/journal.pone.0178812	http://dx.doi.org/10.1371/journal.pone.0178812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582411	Green Published, Green Submitted, gold			2022-12-26	WOS:000402837600041
J	Oike, A; Kodama, M; Yasumasu, S; Yamamoto, T; Nakamura, Y; Ito, E; Nakamura, M				Oike, Akira; Kodama, Maho; Yasumasu, Shigeki; Yamamoto, Takashi; Nakamura, Yoriko; Ito, Etsuro; Nakamura, Masahisa			Participation of androgen and its receptor in sex determination of an amphibian species	PLOS ONE			English	Article							FROG RANA-RUGOSA; DM-DOMAIN GENE; EXPRESSION; MICE; CHROMOSOMES; KNOCKOUT; REVERSAL; P450C17; DMRT1; CYP17	Introduction In the Japanese frog Rana (R.) rugosa the androgen receptor (AR) gene on theWchromosome (W-AR) is barely expressed. Previously we showed that incomplete female-to-male sex-reversal occurred in Z-AR transgenic female frogs. To date, however, there is no report showing that AR with androgens can determine genetically programed male sex fate in any vertebrate species. Here, we examined whether AR together with androgens functions as a sex determinant in an amphibian species. Methods To examine whether complete female-to-male sex-reversal occurs in R. rugosa frogs, we produced AR-transgenic (Tg) and -knockdown (KD) female R. rugosa frogs by the I-SceI meganuclease-mediated gene trap and CRISPR/Cas9 system, respectively. AR-Tg and -KD tadpoles were reared in water containing testosterone (T) at 0 to 7.1 ng/ml. Frozen sections were prepared from the gonads of metamorphosed frogs and immunostained for laminin, Vasa, Pat1a, CYP17 and AR. We also employed PCR analysis to examine Dmrt1, Pat1a and CYP17 expression in the gonads of KD and placebo-KD female frogs. Results Complete female-to-male sex-reversal occurred in the AR-Tg ZW female frogs when a low dosage of T was supplied in the rearing water of tadpoles. However, no sex-reversal was observed in AR-KD ZW female frogs when the gonads were treated with dosages of T high enough to induce complete female-to-male sex-reversal even in wild type frogs. Discussion These results suggest that AR with its androgen ligand functions as a male sex-determinant in the ZW type R. rugosa frogs.	[Oike, Akira; Kodama, Maho; Ito, Etsuro; Nakamura, Masahisa] Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Yasumasu, Shigeki] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, Tokyo, Japan; [Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Higashihiroshima, Hiroshima, Japan; [Nakamura, Yoriko] Ehime Univ, Fac Educ, Dept Sci Educ, Matsuyama, Ehime, Japan	Waseda University; Sophia University; Hiroshima University; Ehime University	Nakamura, M (corresponding author), Waseda Univ, Fac Educ & Integrated Arts & Sci, Dept Biol, Shinjuku Ku, Tokyo, Japan.	nakamra@waseda.jp	Yamamoto, Takashi/U-4790-2017	Yamamoto, Takashi/0000-0002-6516-2903	Ministry of Education, Science, and Culture of Japan [15K07137]; Waseda University Grant for Special Research projects Category A [A-16]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University Grant for Special Research projects Category A	This work was supported by Grants-in-Aid to MN from the Ministry of Education, Science, and Culture of Japan (no. 15K07137) and FY2016 Waseda University Grant for Special Research projects Category A (no. A-16) to MN.	Fujii J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093655; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Iwade R, 2008, GEN COMP ENDOCR, V155, P79, DOI 10.1016/j.ygcen.2007.02.032; Kerkhofs S, 2009, J MOL ENDOCRINOL, V42, P11, DOI 10.1677/JME-08-0122; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Maruo K, 2008, GEN COMP ENDOCR, V158, P87, DOI 10.1016/j.ygcen.2008.04.019; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Nakamura Y, 2015, J EXP ZOOL PART A, V323, P516, DOI 10.1002/jez.1938; Nishioka Midori, 1994, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V13, P1; Ogata M, 2002, CYTOGENET GENOME RES, V99, P185, DOI 10.1159/000071592; Oike A, 2016, J EXP ZOOL PART A, V325, P532, DOI 10.1002/jez.2037; Sakurai N, 2008, J STEROID BIOCHEM, V112, P5, DOI 10.1016/j.jsbmb.2008.07.002; Saotome K, 2010, J EXP ZOOL PART A, V313A, P369, DOI 10.1002/jez.607; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Shen HC, 2012, MOL ENDOCRINOL, V26, P1836, DOI 10.1210/me.2012-1222; Shibata K, 2002, GEN COMP ENDOCR, V127, P232, DOI 10.1016/S0016-6480(02)00039-4; Shumway W, 1940, ANAT REC, V78, P139, DOI 10.1002/ar.1090780202; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Steinemann S, 2005, BIOESSAYS, V27, P1076, DOI 10.1002/bies.20288; Takehana Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5157; TAYLOR AC, 1946, ANAT REC, V94, P7, DOI 10.1002/ar.1090940103; Uno Y, 2008, CHROMOSOME RES, V16, P637, DOI 10.1007/s10577-008-1217-7; Wallace H, 1999, CELL MOL LIFE SCI, V55, P901, DOI 10.1007/s000180050343; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yokoyama S, 2009, J EXP ZOOL PART A, V311A, P1; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105	27	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178067	10.1371/journal.pone.0178067	http://dx.doi.org/10.1371/journal.pone.0178067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582396	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600009
J	Sim, MY; Huynh, H; Go, ML; Yuen, JSP				Sim, Mei Yi; Huynh, Hung; Go, Mei Lin; Yuen, John Shyi Peng			Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels	PLOS ONE			English	Article							NF-KAPPA-B; SMALL-MOLECULE SUPPRESSOR; APOPTOSIS PROTEINS IAPS; TARGETING SURVIVIN; PHASE-II; ANTITUMOR-ACTIVITY; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; PLUS DOCETAXEL	The dioxonapthoimidazolium YM155 is a survivin suppressant which has been investigated as an anticancer agent in clinical trials. Here, we investigated its growth inhibitory properties on a panel of immortalized and patient derived renal cell carcinoma (RCC) cell lines which were either deficient in the tumour suppressor von Hippel-Lindau (VHL) protein or possessed a functional copy. Neither the VHL status nor the survivin expression levels of these cell lines influenced their susceptibility to growth inhibition by YM155. Of the various RCC lines, the papillary subtype was more resistant to YM155, suggesting that the therapeutic efficacy of YM155 may be restricted to clear cell subtypes. YM155 was equally potent in cells (RCC786.0) in which survivin expression had been stably silenced or overexpressed, implicating a limited reliance on survivin in the mode of action of YM155. A follow-up in-vitro high throughput RNA microarray identified possible targets of YM155 apart from survivin. Selected genes (ID1, FOXO1, CYLD) that were differentially expressed in YM155-sensitive RCC cells and relevant to RCC pathology were validated with real-time PCR and western immunoblotting analyses. Thus, there is corroboratory evidence that the growth inhibitory activity of YM155 in RCC cell lines is not exclusively mediated by its suppression of survivin. In view of the growing importance of combination therapy in oncology, we showed that a combination of YM155 and sorafenib at 1/2 x IC50 concentrations was synergistic on RCC786.0 cells. However, when tested intraperitoneally on a murine xenograft model derived from a nephrectomised patient with clear cell RCC, a combination of suboptimal doses of both drugs failed to arrest tumour progression. The absence of synergy in vivo highlighted the need to further optimize the dosing schedules of YM155 and sorafenib, as well as their routes of administration. It also implied that the expression of other oncogenic proteins which YM155 may target is either low or absent in this clear cell RCC.	[Sim, Mei Yi; Yuen, John Shyi Peng] Singapore Gen Hosp, Dept Urol, Singapore, Singapore; [Huynh, Hung] Natl Canc Ctr, Div Mol & Cellular Res, Lab Mol Endocrinol, Singapore, Singapore; [Go, Mei Lin] Natl Univ Singapore, Dept Pharm, Singapore, Singapore	Singapore General Hospital; National Cancer Centre Singapore (NCCS); National University of Singapore	Sim, MY (corresponding author), Singapore Gen Hosp, Dept Urol, Singapore, Singapore.	sim.mei.yi@sgh.com.sg			Singhealth Foundation [SHF/FG462P/2011]; SGH Graduate Scholarship	Singhealth Foundation; SGH Graduate Scholarship	This work was supported by Singhealth Foundation (SHF/FG462P/2011) awarded to Shyi Peng John Yuen and SGH Graduate Scholarship awarded to Mei Yi Sim.; This work was supported by Singhealth Foundation (SHF/FG462P/2011) awarded to John Shyi Peng Yuen and SGH Graduate Scholarship awarded to Mei Yi Sim.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Byun SS, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.09.024; Carew JS, 2015, MOL CANCER THER, V14, P1404, DOI 10.1158/1535-7163.MCT-14-1036; Chakrabarty A, 2013, CANCER RES, V73, P1190, DOI 10.1158/0008-5472.CAN-12-2440; Cheng Qiuying, 2012, Int J Biochem Mol Biol, V3, P179; Cheson BD, 2012, CANCER-AM CANCER SOC, V118, P3128, DOI 10.1002/cncr.26510; Chiou SK, 2003, MED SCI MONITOR, V9, pP125; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chu L, 2006, CANCER BIOL THER, V5, P615, DOI 10.4161/cbt.5.6.2662; Clemens MR, 2015, BREAST CANCER RES TR, V149, P171, DOI 10.1007/s10549-014-3238-6; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fulda S, 2008, ANTI-CANCER AGENT ME, V8, P533, DOI 10.2174/187152008784533107; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Groner B, 2014, BIODRUGS, V28, P27, DOI 10.1007/s40259-013-0058-x; Huynh H, 2006, CLIN CANCER RES, V12, P4306, DOI 10.1158/1078-0432.CCR-05-2568; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Kaneko N, 2014, CLIN CANCER RES, V20, P1814, DOI 10.1158/1078-0432.CCR-13-2707; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim YS, 2011, BIOCHEM PHARMACOL, V82, P216, DOI 10.1016/j.bcp.2011.04.011; Knudson A G, 1995, Cancer J Sci Am, V1, P180; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kudchadkar R, 2015, CANCER MED-US, V4, P643, DOI 10.1002/cam4.363; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lai XL, 2014, ONCOL REP, V32, P79, DOI 10.3892/or.2014.3172; Lei Y, 2010, MOL CELL BIOCHEM, V344, P23, DOI 10.1007/s11010-010-0525-3; Li F, 2005, BRIT J CANCER, V92, P212, DOI 10.1038/sj.bjc.6602340; Li X, 2007, HISTOPATHOLOGY, V50, P484, DOI 10.1111/j.1365-2559.2007.02637.x; Lin J., 2010, SYNTHESIS LECT HUMAN, V3, P1, DOI [DOI 10.2200/S00274ED1V01Y201006HLT007, 10.2200/S00274ED1V01Y201006HLT007]; Linehan WM, 2012, GENOME RES, V22, P2089, DOI 10.1101/gr.131110.111; Ling MT, 2006, DIFFERENTIATION, V74, P481, DOI 10.1111/j.1432-0436.2006.00083.x; Marques I, 2013, MOL BIOL REP, V40, P4819, DOI 10.1007/s11033-013-2578-3; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Ni HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095846; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Papaspyridonos M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7840; Parker AS, 2006, CANCER-AM CANCER SOC, V107, P37, DOI 10.1002/cncr.21952; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Smolewski P, 2011, CURR MOL MED, V11, P633, DOI 10.2174/156652411797536723; Strobel P, 2002, AM J SURG PATHOL, V26, P119, DOI 10.1097/00000478-200201000-00016; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tao YF, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-619; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Vequaud E, 2015, ONCOTARGET, V6, P13476, DOI 10.18632/oncotarget.3638; Wilson JW, 2001, CANCER RES, V61, P8803; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Xiong C, 2016, EUR J INTERN MED; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Yuen JSP, 2011, BRIT J CANCER, V104, P941, DOI 10.1038/bjc.2011.55; Zamparese R, 2008, CANCER INVEST, V26, P929, DOI 10.1080/07357900802017553; Zbar B, 2003, ANNU REV MED, V54, P217, DOI 10.1146/annurev.med.54.101601.152514; Zhou LB, 2012, J SURG ONCOL, V105, P841, DOI 10.1002/jso.23013	67	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178168	10.1371/journal.pone.0178168	http://dx.doi.org/10.1371/journal.pone.0178168			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582447	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600013
J	Yasutaka, T; Naka, A; Sakanakura, H; Kurosawa, A; Inui, T; Takeo, M; Inoba, S; Watanabe, Y; Fujikawa, T; Miura, T; Miyaguchi, S; Nakajou, K; Sumikura, M; Ito, K; Tamoto, S; Tatsuhara, T; Chida, T; Hirata, K; Ohori, K; Someya, M; Katoh, M; Umino, M; Negishi, M; Ito, K; Kojima, J; Ogawa, S				Yasutaka, Tetsuo; Naka, Angelica; Sakanakura, Hirofumi; Kurosawa, Akihiko; Inui, Toru; Takeo, Miyuki; Inoba, Seiji; Watanabe, Yasutaka; Fujikawa, Takuro; Miura, Toshihiko; Miyaguchi, Shinji; Nakajou, Kunihide; Sumikura, Mitsuhiro; Ito, Kenichi; Tamoto, Shuichi; Tatsuhara, Takeshi; Chida, Tomoyuki; Hirata, Kei; Ohori, Ken; Someya, Masayuki; Katoh, Masahiko; Umino, Madoka; Negishi, Masanori; Ito, Keijiro; Kojima, Junichi; Ogawa, Shohei			Reproducibility of up-flow column percolation tests for contaminated soils	PLOS ONE			English	Article							SEQUENTIAL EXTRACTION PROCEDURE; HEAVY-METALS; WASTE	Up-flow column percolation tests are used at laboratory scale to assess the leaching behavior of hazardous substance from contaminated soils in a specific condition as a function of time. Monitoring the quality of these test results inter or within laboratory is crucial, especially if used for Environment-related legal policy or for routine testing purposes. We tested three different sandy loam type soils (Soils I, II and III) to determine the reproducibility (variability inter laboratory) of test results and to evaluate the difference in the test results within laboratory. Up-flow column percolation tests were performed following the procedure described in the ISO/TS 21268-3. This procedure consists of percolating solution (calcium chloride 1 mM) from bottom to top at a flow rate of 12 mL/h through softly compacted soil contained in a column of 5 cm diameter and 30 +/- 5 cm height. Eluate samples were collected at liquid-to-solid ratio of 0.1, 0.2, 0.5, 1, 2, 5 and 10 L/kg and analyzed for quantification of the target elements (Cu, As, Se, Cl, Ca, F, Mg, DOC and B in this research). For Soil I, 17 institutions in Japan joined this validation test. The up-flow column experiments were conducted in duplicate, after 48 h of equilibration time and at a flow rate of 12 mL/h. Column percolation test results from Soils II and III were used to evaluate the difference in test results from the experiments conducted in duplicate in a single laboratory, after 16 h of equilibration time and at a flow rate of 36 mL/h. Overall results showed good reproducibility (expressed in terms of the coefficient of variation, CV, calculated by dividing the standard deviation by the mean), as the CV was lower than 30% in more than 90% of the test results associated with Soil I. Moreover, low variability (expressed in terms of difference between the two test results divided by the mean) was observed in the test results related to Soils II and III, with a variability lower than 30% in more than 88% of the cases for Soil II and in more than 96% of the cases for Soil III. We also discussed the possible factors that affect the reproducibility and variability in the test results from the up-flow column percolation tests. The low variability inter and within laboratory obtained in this research indicates that the ISO/TS 21268-3 can be successfully upgraded to a fully validated ISO standard.	[Yasutaka, Tetsuo; Kurosawa, Akihiko] Natl Inst Adv Ind Sci & Technol, Res Inst Georesources & Environm, Tsukuba, Ibaraki, Japan; [Naka, Angelica; Sakanakura, Hirofumi] Natl Inst Environm Studies, Ctr Mat Cycles & Waste Management Res, Tsukuba, Ibaraki, Japan; [Inui, Toru; Takeo, Miyuki] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Inoba, Seiji] Cent Res Inst Elect Power Ind, Environm Sci Res Lab, Chiba, Japan; [Watanabe, Yasutaka] Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Chiba, Japan; [Fujikawa, Takuro] Fukuoka Univ, Dept Civil Engn, Fukuoka, Japan; [Miura, Toshihiko] Obayashi Corp, Tech Res Inst, Tokyo, Japan; [Miyaguchi, Shinji; Nakajou, Kunihide] OYO Corp, Core Lab Testing Inst, Saitama, Saitama, Japan; [Sumikura, Mitsuhiro] Shimizu Corp, Inst Technol, Koto Ku, Tokyo, Japan; [Ito, Kenichi] Univ Miyazaki, Ctr Int Relat, Miyazaki, Miyazaki, Japan; [Tamoto, Shuichi] Civil Engn Res Inst Cold Reg, Cold Reg Construct Engn Res Grp, Sapporo, Hokkaido, Japan; [Tatsuhara, Takeshi] Pacific Consultants Co Ltd, Chiyoda Ku, Tokyo, Japan; [Chida, Tomoyuki] Pacific Consultants Environm Res Co Ltd, Tsukuba, Ibaraki, Japan; [Hirata, Kei; Ohori, Ken] MC Evolve Technol Corp, Ami, Ibaraki, Japan; [Someya, Masayuki] Tokyo Environm Publ Serv Corp, Koto Ku, Tokyo, Japan; [Katoh, Masahiko] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan; [Umino, Madoka; Negishi, Masanori] Taisei Corp, Taisei Technol Ctr, Yokohama, Kanagawa, Japan; [Ito, Keijiro] Kajima Corp, Kajima Tech Res Inst, Tokyo, Japan; [Kojima, Junichi] Tokai Technol Ctr, Nagoya, Aichi, Japan; [Ogawa, Shohei] Gifu Univ, Grad Sch Engn, Gifu, Gifu, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute for Environmental Studies - Japan; Kyoto University; Central Research Institute of Electric Power Industry - Japan; Central Research Institute of Electric Power Industry - Japan; Fukuoka University; Obayashi Corporation; OYO Corporation; Shimizu Corporation; University of Miyazaki; Meiji University; Taisei Corporation; Kajima Corporation; Gifu University	Yasutaka, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Georesources & Environm, Tsukuba, Ibaraki, Japan.	t.yasutaka@aist.go.jp	Sakanakura, Hirofumi/AAW-5487-2021; Yasutaka, Tetsuo/N-6727-2016; ITO, KENICHI/AHC-2529-2022	Yasutaka, Tetsuo/0000-0001-6000-663X; Sakanakura, Hirofumi/0000-0001-8621-0743	JSPS KAKENHI [15H02264]; Grants-in-Aid for Scientific Research [15H02264] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI Grant Number 15H02264 (https.//ltaken.nii.ac.jp/ja/grant/KAKEHHI-PROJECT15H02264/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Obayashi Corporation, OYO Corporation, Shimizu Corporation, Pacific Consultants Co. Ltd, Pacific Consultants Environment Research Co., Ltd, MC Evolve Technologies Corporation, Tokyo Environmental Public Service Corporation and Taisei Technology Center, Taisei Corporation provided support in the form of salaries for authors [TM, SM, KN, MS, TT, TC, KH, KO, MU, MN, KI, JK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 212683 ISOTS; [Anonymous], 2002, 124572 EN CEN COMM E; [Anonymous], 2004, 14405 CENTS EUR COMM; [Anonymous], 2007, 212682 ISOTS; [Anonymous], 2004, 7373NL NEN; [Anonymous], 2009, A1202 JIS; [Anonymous], 2013, E45613AE3A ASTM; [Anonymous], 2016, E69116 ASTM; [Anonymous], 2007, 212681 ISOTS; [Anonymous], 2014, E17714 ASTM; [Anonymous], 2014, D487495 ASTM; [Anonymous], 2013, 1314 US EPA; [Anonymous], 2009, A1203 JIS; [Anonymous], 2000, A1226 JIS; [Anonymous], 1995, 002 NT ENVIR; [Anonymous], 2015, 19529 DIN GERM STAND; [Anonymous], 2002, 124571 EN CEN COMM E; Arain MB, 2008, J HAZARD MATER, V160, P235, DOI 10.1016/j.jhazmat.2008.02.092; Cappuyns V, 2008, TALANTA, V75, P1338, DOI 10.1016/j.talanta.2008.01.047; DIN, 2009, 19528 DIN GERM STAND; Fytianos K, 1998, ENVIRON INT, V24, P467, DOI 10.1016/S0160-4120(98)00026-9; Garrabrants A, 2012, 1314 US EPA OFF RES; Geurts R, 2016, WASTE MANAGE, V55, P31, DOI 10.1016/j.wasman.2016.06.010; Hartlen, 1997, STUDIES ENV SCI, V67, P483; HORWITZ W, 1980, J ASSOC OFF ANA CHEM, V63, P1344; Japanese Geotechnical Society, 2009, A1204 JIS; Kalbe U, 2008, WASTE MANAGE, V28, P1027, DOI 10.1016/j.wasman.2007.03.008; Kosson DS, 2002, ENVIRON ENG SCI, V19, P159, DOI 10.1089/109287502760079188; Meza SL, 2008, WASTE MANAGE, V28, P1853, DOI 10.1016/j.wasman.2007.11.009; Ministry of the Environment, 2012, METH SED SURV; Naka A, 2016, J HAZARD MATER, V320, P326, DOI 10.1016/j.jhazmat.2016.08.046; Nemati K, 2011, J HAZARD MATER, V192, P402, DOI 10.1016/j.jhazmat.2011.05.039; OECD/ OCDE ( Organisation for Economic Cooperation and Development), 2004, 312 OECDOCDE; Pueyo M, 2008, ENVIRON POLLUT, V152, P330, DOI 10.1016/j.envpol.2007.06.020; Quina MJ, 2009, WASTE MANAGE, V29, P2483, DOI 10.1016/j.wasman.2009.05.012; Thompson M, 2000, ANALYST, V125, P385, DOI 10.1039/b000282h; United States Environmental Protection Agency, 2013, 1316 US EPA; US EPA, 1992, SW846 US EPA; van der Sloot HA, 2006, J GEOCHEM EXPLOR, V88, P72, DOI 10.1016/j.gexplo.2005.08.092; vanderSloot HA, 1996, SCI TOTAL ENVIRON, V178, P111, DOI 10.1016/0048-9697(95)04803-0	40	12	12	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178979	10.1371/journal.pone.0178979	http://dx.doi.org/10.1371/journal.pone.0178979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582458	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600065
J	Zhao, WW; Zhang, CY; Yan, ZG; Zhou, YY; Li, JR; Xie, YB; Bai, LP; Jiang, L; Li, FS				Zhao, Weiwei; Zhang, Chaoyan; Yan, Zengguang; Zhou, Youya; Li, Jianrong; Xie, Yabo; Bai, Liping; Jiang, Lin; Li, Fasheng			Preparation, characterization, and performance evaluation of UiO-66 analogues as stationary phase in HPLC for the separation of substituted benzenes and polycyclic aromatic hydrocarbons	PLOS ONE			English	Article							METAL-ORGANIC FRAMEWORKS; LIQUID-CHROMATOGRAPHIC SEPARATION; SELECTIVE ADSORPTION; XYLENE ISOMERS; COATED CAPILLARY; METHANE STORAGE; ETHYLBENZENE; MOFS; CO2; PHOTOCATALYST	UiO-66 analogues are good candidates as stationary phase in HPLC because of their chemical/thermal stability, large surface area, and two cage structures. Here, two UiO-66 analogues, UiO-66-NH2 and UiO-67, were synthesized and used as stationary phase in HPLC to evaluate their performance in the separation of substituted benzenes (SBs) and polycyclic aromatic hydrocarbons (PAHs). The results showed that SBs could be well separated on UiO-66-NH2 column but not on UiO-67 column. Nonetheless, PAHs could be well separated on UiO-67 column. The separation mechanisms of SBs and PAHs on UiO-66 analogues may be involved in the pore size and functional group in the frameworks of UiO-66 analogues. Introduction of the-NH2 into UiO-66 significantly reduced its adsorption capacity for SB congeners, which resulted in less separation of SBs on UiO-66-NH2. As for the separation of PAHs on UiO-67 column, the Pi-Pi stacking effect was supposed to play a vital role.	[Zhao, Weiwei; Zhang, Chaoyan; Yan, Zengguang; Zhou, Youya; Bai, Liping; Li, Fasheng] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Zhao, Weiwei; Li, Jianrong; Xie, Yabo] Beijing Univ Technol, Beijing Key Lab Green Catalysis & Separat, Beijing, Peoples R China; [Zhao, Weiwei; Li, Jianrong; Xie, Yabo] Beijing Univ Technol, Coll Environm & Energy Engn, Beijing, Peoples R China; [Jiang, Lin] Beijing Municipal Res Inst Environm Protect, Beijing, Peoples R China	Chinese Research Academy of Environmental Sciences; Beijing University of Technology; Beijing University of Technology; Beijing Municipal Research Institute of Environment	Zhou, YY (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.; Li, JR (corresponding author), Beijing Univ Technol, Beijing Key Lab Green Catalysis & Separat, Beijing, Peoples R China.; Li, JR (corresponding author), Beijing Univ Technol, Coll Environm & Energy Engn, Beijing, Peoples R China.	zhouyy@craes.org.cn; jrli@bjut.edu.cn	Jiang, Lin/AHD-4254-2022; Li, Jian-Rong (Jeff)/G-2781-2010	Li, Jian-Rong (Jeff)/0000-0002-8101-8493; Jiang, Lin/0000-0002-6982-0758; Li, Fasheng/0000-0002-8318-6714	National Natural Science Foundation of China [21075114]; Special Environmental Protection Fund for Public Welfare Project of China - Ministry of Environmental Protection of the People's Republic of China [201509034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Environmental Protection Fund for Public Welfare Project of China - Ministry of Environmental Protection of the People's Republic of China	Y. Zhou received the funding of National Natural Science Foundation of China (No. 21075114, https://isisn.nsfc.gov.cn/) supported by the National Natural Science Foundation of China. L. Jiang received the funding of the Special Environmental Protection Fund for Public Welfare Project of China (No.201509034, http://kjs.mep.gov.cn/gyxhykyzx/) supported by the Ministry of Environmental Protection of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, LANGMUIR, V25, P11977, DOI 10.1021/la902276a; Ahmed I, 2015, J HAZARD MATER, V283, P544, DOI 10.1016/j.jhazmat.2014.10.002; Alaerts L, 2008, J AM CHEM SOC, V130, P14170, DOI 10.1021/ja802761z; Alaerts L, 2007, ANGEW CHEM INT EDIT, V46, P4293, DOI 10.1002/anie.200700056; Alaerts L, 2009, PHYS CHEM CHEM PHYS, V11, P2903, DOI 10.1039/b823233d; Paz FAA, 2012, CHEM SOC REV, V41, P1088, DOI 10.1039/c1cs15055c; Cavka JH, 2014, IND ENG CHEM RES, V53, P15500, DOI 10.1021/ie500421h; Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953; Chang N, 2012, J CHROMATOGR A, V1257, P116, DOI 10.1016/j.chroma.2012.07.097; Chang N, 2010, J AM CHEM SOC, V132, P13645, DOI 10.1021/ja1058229; Chavan S, 2012, PHYS CHEM CHEM PHYS, V14, P1614, DOI 10.1039/c1cp23434j; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Garibay SJ, 2010, CHEM COMMUN, V46, P7700, DOI 10.1039/c0cc02990d; Gu ZY, 2010, ANGEW CHEM INT EDIT, V49, P1477, DOI 10.1002/anie.200906560; Gu ZY, 2010, J PHYS CHEM C, V114, P311, DOI 10.1021/jp9063017; Hasan Z, 2014, J PHYS CHEM C, V118, P21049, DOI 10.1021/jp507074x; Kandiah M, 2010, CHEM MATER, V22, P6632, DOI 10.1021/cm102601v; Li JR, 2012, CHEM REV, V112, P869, DOI 10.1021/cr200190s; Li SL, 2013, ENERG ENVIRON SCI, V6, P1656, DOI 10.1039/c3ee40507a; Long JL, 2012, CHEM COMMUN, V48, P11656, DOI 10.1039/c2cc34620f; Maes M, 2010, J AM CHEM SOC, V132, P15277, DOI 10.1021/ja106142x; Makal TA, 2012, CHEM SOC REV, V41, P7761, DOI 10.1039/c2cs35251f; Murray LJ, 2009, CHEM SOC REV, V38, P1294, DOI 10.1039/b802256a; Peterson GW, 2014, IND ENG CHEM RES, V53, P701, DOI 10.1021/ie403366d; Schoenecker PM, 2012, IND ENG CHEM RES, V51, P6513, DOI 10.1021/ie202325p; Shen LJ, 2013, DALTON T, V42, P13649, DOI 10.1039/c3dt51479j; Sun DR, 2013, CHEM-EUR J, V19, P14279, DOI 10.1002/chem.201301728; Torres-Knoop A, 2015, LANGMUIR, V31, P3771, DOI 10.1021/acs.langmuir.5b00363; Vermoortele F, 2011, CHEM COMMUN, V47, P1521, DOI 10.1039/c0cc03038d; Wang B, 2014, INORG CHEM, V53, P9254, DOI 10.1021/ic5013473; Yang CX, 2012, ANALYST, V137, P133, DOI 10.1039/c1an15600d; Yang CX, 2011, ANAL CHEM, V83, P7144, DOI 10.1021/ac201517c; Yang QY, 2012, CHEM COMMUN, V48, P9831, DOI 10.1039/c2cc34714h; Zhang WP, 2012, CHEM SOC REV, V41, P192, DOI 10.1039/c1cs15009j; Zhao M, 2014, ACCOUNTS CHEM RES, V47, P1199, DOI 10.1021/ar400265x; Zhao WW, 2014, J CHROMATOGR A, V1370, P121, DOI 10.1016/j.chroma.2014.10.036	37	11	12	7	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178513	10.1371/journal.pone.0178513	http://dx.doi.org/10.1371/journal.pone.0178513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582453	Green Submitted, gold, Green Published			2022-12-26	WOS:000402837600020
J	Dillinger, S; Straub, T; Nemeth, A				Dillinger, Stefan; Straub, Tobias; Nemeth, Attila			Nucleolus association of chromosomal domains is largely maintained in cellular senescence despite massive nuclear reorganisation	PLOS ONE			English	Article							HETEROCHROMATIN FORMATION; GENE-EXPRESSION; CHROMATIN ORGANIZATION; LAMINA INTERACTIONS; GENOME STABILITY; SAHF FORMATION; INACTIVE-X; ARCHITECTURE; CELLS; MAINTENANCE	Mammalian chromosomes are organized in structural and functional domains of 0.1-10 Mb, which are characterized by high self-association frequencies in the nuclear space and different contact probabilities with nuclear sub-compartments. They exhibit distinct chromatin modification patterns, gene expression levels and replication timing. Recently, nucleolus-associated chromosomal domains (NADs) have been discovered, yet their precise genomic organization and dynamics are still largely unknown. Here, we use nucleolus genomics and single-cell experiments to address these questions in human embryonic fibroblasts during replicative senescence. Genome-wide mapping reveals 1,646 NADs in proliferating cells, which cover about 38% of the annotated human genome. They are mainly heterochromatic and correlate with late replicating loci. Using Hi-C data analysis, we show that interactions of NADs dominate interphase chromosome contacts in the 10-50 Mb distance range. Interestingly, only minute changes in nucleolar association are observed upon senescence. These spatial rearrangements in subdomains smaller than 100 kb are accompanied with local transcriptional changes. In contrast, large centromeric and pericentromeric satellite repeat clusters extensively dissociate from nucleoli in senescent cells. Accordingly, H3K9me3-marked heterochromatin gets remodelled at the perinucleolar space as revealed by immunofluorescence analyses. Collectively, this study identifies connections between the nucleolus, 3D genome structure, and cellular aging at the level of interphase chromosome organization.	[Dillinger, Stefan; Nemeth, Attila] Univ Regensburg, Biochem Ctr Regensburg, Regensburg, Germany; [Straub, Tobias] Ludwig Maximilians Univ Munchen, Biomed Ctr, Bioinformat, Munich, Germany; [Nemeth, Attila] Inst Mol Biol, Mainz, Germany	University of Regensburg; University of Munich; Institute of Molecular Biology (IMB)	Nemeth, A (corresponding author), Univ Regensburg, Biochem Ctr Regensburg, Regensburg, Germany.	attila.nemeth@ur.de	Straub, Tobias/B-2023-2009	Straub, Tobias/0000-0002-0547-0453	Deutsche Forschungsgemeinschaft [SFB960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB960 to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmont AS, 2014, CURR OPIN CELL BIOL, V26, P69, DOI 10.1016/j.ceb.2013.10.002; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bouwman BAM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0730-1; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Corpet A, 2014, CHROMOSOMA, V123, P423, DOI 10.1007/s00412-014-0469-6; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cremer T, 2015, FEBS LETT, V589, P2931, DOI 10.1016/j.febslet.2015.05.037; Cremer T, 2014, HUM GENET, V133, P403, DOI 10.1007/s00439-014-1425-5; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Criscione SW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500882; Cruickshanks HA, 2013, NAT CELL BIOL, V15, P1495, DOI 10.1038/ncb2879; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dillinger S, 2016, METHODS MOL BIOL, V1455, P59, DOI 10.1007/978-1-4939-3792-9_5; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Fedoriw AM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002468; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Floutsakou I, 2013, GENOME RES, V23, P2003, DOI 10.1101/gr.157941.113; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Hein N, 2011, SENESCENCE; Hutten S, 2011, NUCLEOLUS GENOME ORG, P279; Illner D, 2010, EXP CELL RES, V316, P1662, DOI 10.1016/j.yexcr.2010.03.008; JORDAN EG, 1984, J CELL SCI, V67, P217; Kind J, 2015, CELL, V163, P134, DOI 10.1016/j.cell.2015.08.040; Kind J, 2014, NUCLEUS-PHILA, V5, P124, DOI 10.4161/nucl.28825; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lackner DH, 2014, AGING CELL, V13, P946, DOI 10.1111/acel.12234; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Matheson TD, 2016, CHROMOSOMA, V125, P361, DOI 10.1007/s00412-015-0527-8; Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nemeth A, 2013, CHROMATIN ORG MAMMAL; Nemeth A, 2011, TRENDS GENET, V27, P149, DOI 10.1016/j.tig.2011.01.002; Nemeth A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000889; Nishimura K, 2015, CELL REP, V10, P1310, DOI 10.1016/j.celrep.2015.01.055; Padeken J, 2014, CURR OPIN CELL BIOL, V28, P54, DOI 10.1016/j.ceb.2014.03.001; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Politz JCR, 2016, CURR OPIN GENET DEV, V37, P1, DOI 10.1016/j.gde.2015.10.007; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Pope BD, 2015, NATURE NATURE PUBLIS, V515, P402; Postepska-Igielska A, 2013, EMBO REP, V14, P704, DOI 10.1038/embor.2013.87; Rai TS, 2012, BBA-GENE REGUL MECH, V1819, P322, DOI 10.1016/j.bbagrm.2011.07.014; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sadaie M, 2013, GENE DEV, V27, P1800, DOI 10.1101/gad.217281.113; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Saka K, 2016, NUCLEIC ACIDS RES, V44, P4211, DOI 10.1093/nar/gkw110; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Smith CL, 2014, MOL BIOL CELL, V25, P2866, DOI 10.1091/mbc.E14-05-1029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan GJ, 2001, EMBO J, V20, P2867, DOI 10.1093/emboj/20.11.2867; Swanson EC, 2013, J CELL BIOL, V203, P929, DOI 10.1083/jcb.201306073; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Wang RJ, 2015, CURR OPIN CELL BIOL, V34, P54, DOI 10.1016/j.ceb.2015.04.004; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807; Yang F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0618-0; Yang LX, 2015, CELL CYCLE, V14, P3613, DOI 10.1080/15384101.2015.1100777; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036; Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356; Zillner K, 2015, EPIGENOMICS-UK, V7, P363, DOI 10.2217/epi.14.93	77	58	58	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178821	10.1371/journal.pone.0178821	http://dx.doi.org/10.1371/journal.pone.0178821			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575119	Green Published, gold, Green Submitted			2022-12-26	WOS:000402624300121
J	Lendeckel, D; Kromrey, ML; Ittermann, T; Schafer, S; Mensel, B; Kuhn, JP				Lendeckel, Derik; Kromrey, Marie-Luise; Ittermann, Till; Schaefer, Sophia; Mensel, Birger; Kuehn, Jens-Peter			Pulmonary emphysema is a predictor of pneumothorax after CT-guided transthoracic pulmonary biopsies of pulmonary nodules	PLOS ONE			English	Article							CHEST TUBE PLACEMENT; NEEDLE ASPIRATION BIOPSY; LUNG-BIOPSY; MICROSCOPIC MORPHOMETRY; RISK-FACTORS; LESIONS; COMPLICATIONS; MANAGEMENT; VARIABLES; ACCURACY	Purpose Pneumothoraces are the most frequently occurring complications of CT-guided percutaneous transthoracic pulmonary biopsies (PTPB). The aim of this study was to evaluate the influence of pre-diagnostic lung emphysema on the incidence and extent of pneumothoraces and to establish a risk stratification for the evaluation of the pre-procedure complication probability. Material and methods CT-guided PTPB of 100 pre-selected patients (mean age 67.1 12.8 years) were retrospectively enrolled from a single center database of 235 PTPB performed between 2012-2014. Patients were grouped according to pneumothorax appearance directly after PTPB (group I: without pneumothorax, n = 50; group II: with pneumothorax, n = 50). Group II was further divided according to post-interventional treatment (group I la: chest tube placement, n = 24; group I lb: conservative therapy, n = 26). For each patient pre-diagnostic percentage of emphysema was quantified using CT density analysis. Emphysema stages were compared between groups using bivariate analyses and multinomial logistic regression analyses. Results Emphysema percentage was significantly associated with the occurrence of post-interventional pneumothorax (p = 0.006). Adjusted for potential confounders (age, gender, lesion size and length of interventional pathway) the study yielded an OR of 1.07 (p = 0.042). Absolute risk of pneumothorax increased from 43.4% at an emphysema rate of 5% to 73.8% at 25%. No differences could be seen in patients with pneumothorax between percentage of emphysema and mode of therapy (p = 0.721). Conclusion The rate of lung emphysema is proportionally related to the incidence of pneumothorax after CT-guided PTPB and allows pre-interventional risk stratification. There is no association between stage of emphysema and post-interventional requirement of chest tube placement.	[Lendeckel, Derik; Kromrey, Marie-Luise; Schaefer, Sophia; Mensel, Birger; Kuehn, Jens-Peter] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Ittermann, Till] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Kuehn, Jens-Peter] Carl Gustav Carus Univ Dresden, Univ Klinikum Dresden, Dept Radiol, Dresden, Germany	Greifswald Medical School; Greifswald Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Kromrey, ML (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.	marie-luise.kromrey@uni-greifswald.de						Anzidei M, 2015, EUR J CARDIO-THORAC, V48, pe1, DOI 10.1093/ejcts/ezv172; Boskovic T, 2014, J THORAC DIS, V6, pS99, DOI 10.3978/j.issn.2072-1439.2013.12.08; Chami HA, 2015, CLIN RADIOL, V70, P1382, DOI 10.1016/j.crad.2015.08.003; Connor S, 2000, EUR RADIOL, V10, P490, DOI 10.1007/s003300050082; Cox JE, 1999, RADIOLOGY, V212, P165, DOI 10.1148/radiology.212.1.r99jl33165; Diaz S., 2015, EUROPEAN RESPIRATORY, V46; Geraghty PR, 2003, RADIOLOGY, V229, P475, DOI 10.1148/radiol.2291020499; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Khan MF, 2008, EUR RADIOL, V18, P1356, DOI 10.1007/s00330-008-0893-1; Laurent F, 1999, AM J ROENTGENOL, V172, P1049, DOI 10.2214/ajr.172.4.10587145; Madani A, 2008, RADIOLOGY, V248, P1036, DOI 10.1148/radiol.2483071434; Mahnken AH, 2014, RADIOLOGE, V54, P478, DOI 10.1007/s00117-013-2603-5; Moore EH, 1998, RADIOLOGY, V208, P303, DOI 10.1148/radiology.208.2.9680552; Nakamura M, 2011, J MED IMAG RADIAT ON, V55, P474, DOI 10.1111/j.1754-9485.2011.02283.x; Otto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124947; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; Tavare AN, 2016, THORAX, V71, P190, DOI 10.1136/thoraxjnl-2015-207352; Tomiyama N, 2006, EUR J RADIOL, V59, P60, DOI 10.1016/j.ejrad.2006.02.001; Topal U, 2003, EUR J RADIOL, V48, P263, DOI 10.1016/S0720-048X(03)00058-5; Wang R, 2015, AM J ROENTGENOL, V204, P743, DOI 10.2214/AJR.14.13101; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659	21	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178078	10.1371/journal.pone.0178078	http://dx.doi.org/10.1371/journal.pone.0178078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574995	gold, Green Published, Green Submitted			2022-12-26	WOS:000402624300027
J	Qian, WL; Gang, XX; Zhang, TL; Wei, L; Yang, XX; Li, Z; Yang, Y; Song, L; Wang, P; Peng, J; Cheng, DJ; Xia, QY				Qian, Wenliang; Gang, Xiaoxu; Zhang, Tianlei; Wei, Ling; Yang, Xinxin; Li, Zheng; Yang, Yan; Song, Liang; Wang, Peng; Peng, Jian; Cheng, Daojun; Xia, Qingyou			Protein kinase A-mediated phosphorylation of the Broad-Complex transcription factor in silkworm suppresses its transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; phosphorylation; post-translational modification (PTM); protein kinase A (PKA); signal transduction; 20-hydroxyecdysone; Broad-Complex; suppression	OXIDE SYNTHASE PHOSPHORYLATION; KRUPPEL HOMOLOG 1; NUCLEAR IMPORT; JUVENILE-HORMONE; GENE-EXPRESSION; BOMBYX-MORI; DROSOPHILA; 20-HYDROXYECDYSONE; METAMORPHOSIS; LOCALIZATION	The insect-specific transcription factor Broad-Complex (BR-C) is transcriptionally activated by the steroid 20-hydroxyecdysone (20E) and regulates the expression of many target genes involved in insect growth and development. However, although the transcriptional regulation of BR-C proteins has been well studied, how BR-C is regulated at post-transcription and -translation levels is poorly understood. To this end, using liquid chromatography-tandem mass spectrometry analysis, we identified residue Ser-186 as a phosphorylation site of BR-C in silkworm. Site-directed mutagenesis and treatment with specific kinase activators and inhibitors indicated that the Ser-186 residue in silkworm BR-C is phosphorylated by protein kinase A (PKA). Immunostaining assays disclosed that PKA-mediated phosphorylation of silkworm BR-C has no effect on its nuclear import. However, luciferase reporter analysis, electrophoretic mobility shift assays, and chromatin immunoprecipitation revealed that the PKA phosphorylation event suppresses the transcriptional activation of silkworm BR-C target genes and that this inhibition was caused by repression of BR-C binding to its DNA targets. Of note, both in vitro and ex vivo experiments disclosed that a continuous 20E signal inhibits the PKA-mediated BR-C phosphorylation and also the cAMP/PKA pathway, indicating that 20E's inhibitory effect on PKA-mediated phosphorylation of silkworm BR-C contributes to maintaining BR-C transcriptional activity. In conclusion, our findings indicate that PKA-mediated phosphorylation inhibits silkworm BR-C activity by interfering with its binding to DNA and that 20E signaling relieves PKA-mediated phosphorylation of BR-C, thereby maintaining its transcriptional activity.	[Qian, Wenliang; Gang, Xiaoxu; Zhang, Tianlei; Yang, Xinxin; Li, Zheng; Yang, Yan; Song, Liang; Wang, Peng; Peng, Jian; Cheng, Daojun; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Wei, Ling] Southwest Univ, Sch Life Sci, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Cheng, DJ; Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	chengdj@swu.edu.cn; xiaqy@swu.edu.cn	Li, Zheng/HCH-4626-2022; yang, xin/HGU-9981-2022	Li, Zheng/0000-0002-7803-5401; Xia, Qingyou/0000-0002-9263-2886	National Natural Science Foundation of China [31272503, 31572464, 31172267]; municipal graduate student research innovation project of Chongqing [CYB14047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); municipal graduate student research innovation project of Chongqing	This work was supported by grants from the National Natural Science Foundation of China (31272503, 31572464, and 31172267) and the municipal graduate student research innovation project of Chongqing (CYB14047). The authors declare that they have no conflicts of interest with the contents of this article.	Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Blaker AL, 2009, ARTERIOSCL THROM VAS, V29, P2153, DOI 10.1161/ATVBAHA.109.197285; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Cakouros D, 2002, J CELL BIOL, V157, P985, DOI 10.1083/jcb.200201034; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Cheng DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109111; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Di Giacomo M, 2016, J BIOL CHEM, V291, P3821, DOI 10.1074/jbc.M115.680983; Diamond MI, 2015, J BIOL CHEM, V290, P9075, DOI 10.1074/jbc.M114.619874; DIBELLO PR, 1991, GENETICS, V129, P385; Ditlevsen DK, 2003, J NEUROCHEM, V84, P546, DOI 10.1046/j.1471-4159.2003.01538.x; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Fimia GM, 2001, J CELL SCI, V114, P1971; Gradin K, 2002, J BIOL CHEM, V277, P23508, DOI 10.1074/jbc.M201307200; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Horovitz-Fried M, 2007, CELL SIGNAL, V19, P556, DOI 10.1016/j.cellsig.2006.08.005; Ibanez IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044502; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jing YP, 2016, J BIOL CHEM, V291, P12771, DOI 10.1074/jbc.M115.706028; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Meng M, 2015, J BIOL CHEM, V290, P24438, DOI 10.1074/jbc.M115.651810; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Mizoguchi A, 2001, INSECT BIOCHEM MOLEC, V31, P349, DOI 10.1016/S0965-1748(00)00127-2; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Qian WL, 2015, INT J MOL SCI, V16, P3335, DOI 10.3390/ijms16023335; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song L, 2017, J PROTEOMICS, V154, P49, DOI 10.1016/j.jprot.2016.11.018; Sun XP, 2006, ARCH INSECT BIOCHEM, V62, P116, DOI 10.1002/arch.20130; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wagner L, 2007, ENDOTHELIUM-J ENDOTH, V14, P245, DOI 10.1080/10623320701606707; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Wang S, 2012, J PROTEOME RES, V11, P6187, DOI 10.1021/pr3008804; Wang W, 2005, J BIOL CHEM, V280, P16772, DOI 10.1074/jbc.M411537200; Ye LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08301; Zhang Z, 2016, NUCLEIC ACIDS RES, V44, pD1172, DOI 10.1093/nar/gkv1141; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	47	13	13	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12460	12470		10.1074/jbc.M117.775130	http://dx.doi.org/10.1074/jbc.M117.775130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584058	hybrid, Green Published			2022-12-26	WOS:000406636900011
J	Willems, AP; Gundogdu, M; Kempers, MJE; Giltay, JC; Pfundt, R; Elferink, M; Loza, BF; Fuijkschot, J; Ferenbach, AT; van Gassen, KLI; van Aalten, DMF; Lefeber, DJ				Willems, Anke P.; Gundogdu, Mehmet; Kempers, Marlies J. E.; Giltay, Jacques C.; Pfundt, Rolph; Elferink, Martin; Loza, Bettina F.; Fuijkschot, Joris; Ferenbach, Andrew T.; van Gassen, Koen L. I.; van Aalten, Daan M. F.; Lefeber, Dirk J.			Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; glycosyltransferase; metabolic disease; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); Congenital Disorders of Glycosylation; Host Cell Factor 1 (HCF-1); X-linked Intellectual Disability	TETRATRICOPEPTIDE REPEATS; HIPPOCAMPAL SYNAPSES; CYTOSOLIC PROTEINS; MISSENSE MUTATION; ACTIVE-SITE; GLYCOSYLATION; NUCLEAR; GLCNACYLATION; HCFC1; HCF-1	N-Acetylglucosamine (O-GlcNAc) transferase (OGT) regulates protein O-GlcNAcylation, an essential and dynamic post-translational modification. The O-GlcNAc modification is present on numerous nuclear and cytosolic proteins and has been implicated in essential cellular functions such as signaling and gene expression. Accordingly, altered levels of protein O-GlcNAcylation have been associated with developmental defects and neurodegeneration. However, mutations in the OGT gene have not yet been functionally confirmed in humans. Here, we report on two hemizygous mutations in OGT in individuals with X-linked intellectual disability (XLID) and dysmorphic features: one missense mutation (p.Arg284Pro) and one mutation leading to a splicing defect (c.463-6T>G). Both mutations reside in the tetratricopeptide repeats of OGT that are essential for substrate recognition. We observed slightly reduced levels of OGT protein and reduced levels of its opposing enzyme O-GlcNAcase in both patient-derived fibroblasts, but global O-GlcNAc levels appeared to be unaffected. Our data suggest that mutant cells attempt to maintain global O-GlcNAcylation by down-regulating O-GlcNAcase expression. We also found that the c.463-6T>G mutation leads to aberrant mRNA splicing, but no stable truncated protein was detected in the corresponding patient-derived fibroblasts. Recombinant OGT bearing the p.Arg284Pro mutation was prone to unfolding and exhibited reduced glycosylation activity against a complex array of glycosylation substrates and proteolytic processing of the transcription factor host cell factor 1, which is also encoded by an XLID-associated gene. We conclude that defects in O-GlcNAc homeostasis and host cell factor 1 proteolysis may play roles in mediation of XLID in individuals with OGT mutations.	[Willems, Anke P.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Kempers, Marlies J. E.; Pfundt, Rolph] Radboud Univ Nijmegen, Med Ctr, Dept Genet, NL-6500 HB Nijmegen, Netherlands; [Willems, Anke P.; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab,Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Gundogdu, Mehmet; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Giltay, Jacques C.; Elferink, Martin; van Gassen, Koen L. I.] Univ Med Ctr Utrecht, Dept Genet, NL-3508 AB Utrecht, Netherlands; [Loza, Bettina F.] VieCuri Hosp, Dept Paediat, NL-5900 BX Venlo, Netherlands; [Fuijkschot, Joris] Radboud Univ Nijmegen, Med Ctr, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; [Fuijkschot, Joris] Amalia Childrens Hosp, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Dundee; Utrecht University; Utrecht University Medical Center; VieCuri Medical Center; Radboud University Nijmegen	Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.; Lefeber, DJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab,Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.; van Aalten, DMF (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Lefeber, Dirk DJ/A-2146-2014; Willems, Anke/S-5105-2017; Pfundt, Rolph/L-4576-2015	van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; van Gassen, Koen/0000-0001-7934-0662; Gundogdu, Mehmet/0000-0003-0061-5243	Dutch Organization for Scientific Research VIDI Grant [91713359]; Wellcome Trust [110061]; University of Dundee Translational Medical Research Fund Ph.D. fellowship	Dutch Organization for Scientific Research VIDI Grant; Wellcome Trust(Wellcome TrustEuropean Commission); University of Dundee Translational Medical Research Fund Ph.D. fellowship	This work was supported by the Dutch Organization for Scientific Research VIDI Grant 91713359 (to D.J.L.), Wellcome Trust Investigator Award 110061 (to D.M. F.V.A.), and a University of Dundee Translational Medical Research Fund Ph.D. fellowship (to M.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; HANOVER JA, 1987, J BIOL CHEM, V262, P9887; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang LL, 2012, AM J HUM GENET, V91, P694, DOI 10.1016/j.ajhg.2012.08.011; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Janetzko J, 2016, NAT CHEM BIOL, V12, P899, DOI [10.1038/NCHEMBIO.2173, 10.1038/nchembio.2173]; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Jolly LA, 2015, HUM MOL GENET, V24, P3335, DOI 10.1093/hmg/ddv083; Kapuria V, 2016, GENE DEV, V30, P960, DOI 10.1101/gad.275925.115; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; Myers SA, 2013, PROTEOMICS, V13, P982, DOI 10.1002/pmic.201200332; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Niranjan TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116454; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ruan HB, 2013, TRENDS ENDOCRIN MET, V24, P301, DOI 10.1016/j.tem.2013.02.002; Sayat R, 2008, EXP CELL RES, V314, P2774, DOI 10.1016/j.yexcr.2008.05.017; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Su C, 2017, J NEUROSCI, V37, P2125, DOI 10.1523/JNEUROSCI.3384-16.2017; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206; Zheng BW, 2016, NEUROL RES, V38, P177, DOI 10.1080/01616412.2015.1133485	45	44	47	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12621	12631		10.1074/jbc.M117.790097	http://dx.doi.org/10.1074/jbc.M117.790097			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28584052	Green Published, hybrid			2022-12-26	WOS:000406636900026
J	Besson, M; Gache, C; Brooker, RM; Moussa, RM; Waqalevu, VP; LeRohellec, M; Jaouen, V; Peyrusse, K; Berthe, C; Bertucci, F; Jacob, H; Brie, C; Wan, B; Galzin, R; Lecchini, D				Besson, Marc; Gache, Camille; Brooker, Rohan M.; Moussa, Rakamaly Madi; Waqalevu, Viliame Pita; LeRohellec, Moana; Jaouen, Vincent; Peyrusse, Kevin; Berthe, Cecile; Bertucci, Frederic; Jacob, Hugo; Brie, Christophe; Wan, Bruno; Galzin, Rene; Lecchini, David			Consistency in the supply of larval fishes among coral reefs in French Polynesia	PLOS ONE			English	Article							GREAT-BARRIER-REEF; POPULATION CONNECTIVITY; PELAGIC LARVAE; MOOREA ISLAND; PATCH SIZE; RECRUITMENT; SETTLEMENT; DISPERSAL; MARINE; PATTERNS	For marine fishes with a bipartite life cycle, pelagic larval dispersal can shape the distribution, connectivity, composition and resilience of adult populations. Numerous studies of larval dispersal, and associated settlement and recruitment processes, have examined the relationship between population connectivity and oceanographic features. However, relatively little is known about spatial and temporal variation in the abundance of larvae settling among different reefs and the extent to which the species assemblage of larvae settling at one location is reflective of the assemblage in neighbouring areas. Here, using crest nets, which provide a non-selective measure of the total abundance and assemblage of larvae settling to a reef (i.e. larval supply), we collected larval coral reef fishes at five locations surrounding two spatially disparate French Polynesian islands: Moorea and Nengo-Nengo. Overall, larval settlement patterns were correlated with the lunar cycle, with larval abundance peaking during the new moon. Although there were some spatial differences in larval supply among the five monitored sites, settlement patterns were largely consistent, even at the species level, irrespective of factors such as coastline orientation or distance between sites. This study provides further insights into the mechanisms driving patterns of dispersal and settlement of larval fishes over large spatial scales.	[Besson, Marc; Gache, Camille; Moussa, Rakamaly Madi; LeRohellec, Moana; Jaouen, Vincent; Peyrusse, Kevin; Berthe, Cecile; Bertucci, Frederic; Jacob, Hugo; Brie, Christophe; Galzin, Rene; Lecchini, David] PSL Res Univ, UPVD, CNRS, USR 3278,CRIOBE,EPHE, Moorea, French Polynesi, France; [Besson, Marc] UPMC, CNRS, UMR 7232, Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France; [Brooker, Rohan M.] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Waqalevu, Viliame Pita] Univ South Pacific, Inst Marine Resources, Sch Marine Studies, Suva, Fiji; [Waqalevu, Viliame Pita] IRCP, Inst Pacific Coral Reefs, Moorea, French Polynesi, France; [Jacob, Hugo] IAEA, Environm Labs IAEA EL, Monaco, Monaco; [Wan, Bruno] Tahiti Perles, Tahiti, French Polynesi, France; [Galzin, Rene; Lecchini, David] Lab Excellence CORAIL, Moorea, French Polynesi, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; University of Delaware; University of the South Pacific	Besson, M (corresponding author), PSL Res Univ, UPVD, CNRS, USR 3278,CRIOBE,EPHE, Moorea, French Polynesi, France.; Besson, M (corresponding author), UPMC, CNRS, UMR 7232, Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France.	marc.besson@ens-lyon.org	Brooker, Rohan/AAB-6248-2021; Besson, Marc/GWQ-9517-2022; Besson, Marc/AAB-9030-2020	Brooker, Rohan/0000-0001-8739-6914; Besson, Marc/0000-0003-3381-322X; Besson, Marc/0000-0003-3381-322X; Bertucci, Frederic/0000-0002-2425-9362	CRISP program (Coral Reef Initiatives in the South Pacific); FFEM (Fond Francais pour l'Environnement Marin); IRCP grant	CRISP program (Coral Reef Initiatives in the South Pacific); FFEM (Fond Francais pour l'Environnement Marin); IRCP grant	This research was supported by grants from CRISP program (Coral Reef Initiatives in the South Pacific) and FFEM (Fond Francais pour l'Environnement Marin) to D. Lecchini and also by an IRCP grant to V. P. Waqalevu.	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Almany GR, 2013, CURR BIOL, V23, P626, DOI 10.1016/j.cub.2013.03.006; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Brooker RM, 2016, CHEM SIGNALS VERTEBR, P229; Burgess SC, 2007, MAR ECOL PROG SER, V341, P233, DOI 10.3354/meps341233; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; de L'ORSTOME A, 1993, ATLAS POLYNESIE FRAN; Dixson DL, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.53; Doherty P, 1996, MAR FRESHWATER RES, V47, P383, DOI 10.1071/MF9960383; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; DOHERTY PJ, 1987, B MAR SCI, V41, P411; Dufour S., 2012, METAMORPHOSIS FISH; Dufour V, 1996, MAR FRESHWATER RES, V47, P413, DOI 10.1071/MF9960413; DUFOUR V, 1993, MAR ECOL PROG SER, V102, P143, DOI 10.3354/meps102143; Dufour V., 1994, ATOLL RES B, P415; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; FOWLER AJ, 1992, MAR ECOL PROG SER, V82, P131, DOI 10.3354/meps082131; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Hjort J., 1914, CONS PERM INT EXPLOR, VXX; Irisson JO, 2008, J FISH BIOL, V72, P2707, DOI 10.1111/j.1095-8649.2008.01868.x; Irisson JO, 2010, LIMNOL OCEANOGR, V55, P909, DOI 10.4319/lo.2009.55.2.0909; Largier J, 2004, AM FISH S S, V42, P105; Leahy SM, 2015, CORAL REEFS, V34, P1283, DOI 10.1007/s00338-015-1330-y; Lecchini D, 2004, J FISH BIOL, V65, P1142, DOI 10.1111/j.0022-1112.2004.00493.x; Lecchini D, 2013, AQUAT BIOL, V19, P231, DOI 10.3354/ab00532; Leis J., 2000, LARVAE INDOPACIFIC C; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2006, MAR BIOL, V148, P655, DOI 10.1007/s00227-005-0108-0; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 1998, ENVIRON BIOL FISH, P259; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; McCormick MI, 1999, MAR ECOL PROG SER, V176, P25, DOI 10.3354/meps176025; Meekan MG, 2001, MAR BIOL, V139, P373; Ottmann D, 2016, P NATL ACAD SCI USA, P1; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; Pena M, 2015, DEEP-SEA RES PT I, V97, P92, DOI 10.1016/j.dsr.2014.11.017; Robertson DR, 1999, ECOL MONOGR, V69, P195, DOI 10.1890/0012-9615(1999)069[0195:SVEDIA]2.0.CO;2; Sih TL, 2016, CORAL REEFS, V35, P303, DOI 10.1007/s00338-015-1376-x; Sponaugle S, 1996, MAR FRESHWATER RES, V47, P433, DOI 10.1071/MF9960433; Teske PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep34205; THORROLD SR, 1994, MAR BIOL, V118, P555, DOI 10.1007/BF00347502; Thorrold SR, 1992, P 7 INT COR REEF S, V1, P629; VICTOR BC, 1984, LIMNOL OCEANOGR, V29, P1116, DOI 10.4319/lo.1984.29.5.1116; Vigliola L, 1998, MAR ECOL PROG SER, V168, P45, DOI 10.3354/meps168045; Wolanski E, 2014, J R SOC INTERFACE, P11; Wolanski E, 1984, J GEOPHYS RES, P89; Wormald CL, 2013, ECOL APPL, V23, P365, DOI 10.1890/12-0790.1	53	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178795	10.1371/journal.pone.0178795	http://dx.doi.org/10.1371/journal.pone.0178795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594864	Green Submitted, Green Published, gold			2022-12-26	WOS:000402923200053
J	Freake, MJ; DePerno, CS				Freake, Michael J.; DePerno, Christopher S.			Importance of demographic surveys and public lands for the conservation of eastern hellbenders Cryptobranchus alleganiensis alleganiensis in southeast USA	PLOS ONE			English	Article							POPULATION STATUS; SALAMANDER; RIVER; GROWTH; AGE	Comparisons of recent and historic population demographic studies of eastern hellbenders Cryptobranchus alleganiensis alleganiensis have identified significant population declines and extirpations associated with habitat degradation, poor water quality and disease, leading to nomination as a candidate for listing under the Endangered Species Act. However, populations in the southern Appalachian region of the range have received less attention despite relatively high levels of watershed protection due to the establishment of federally protected National Forest and National Park public lands. These watersheds likely represent some of the best remaining available habitat, yet the lack of published studies make assessment of population stability and viability very difficult. Our objectives were to (1) conduct a capture-mark-recapture (CMR) demographic study and a point transect survey on the Hiwassee River in Tennessee which is designated a National Scenic River, and is largely contained within the Cherokee National Forest, (2) quantify the size structure of the population, (3) compare abundance, survival and recruitment with historic and contemporary hellbender populations across the range, (4) assess the importance of this population and the significance of National Forest and National Park lands in the context of hellbender population conservation in the southeastern United States. We detected all age classes present, with larval hellbenders comprising 21.5% of captures. Using a combination of static life table and CMR methods, we determined that survival rates during the first year were low ( similar to 10%), but were high (68-94%) for taggable sized hellbenders. Density of hellbenders at the study site was very high (84 taggable sized hellbenders per 100m of river) compared to recent demographic studies conducted in other regions of the range. We detected hellbenders over similar to 28 km of river, with a mean density of 23 taggable sized hellbenders per 100m of river, and a total population estimate of 6440 taggable hellbenders. National Forest and National Park lands are likely to continue to play a particularly important role in providing suitable habitat for hellbenders in the southern Appalachians. In fact, only six of 21 known hellbender locations in Tennessee appear to show consistent larval recruitment, all of which are located within or adjacent to National Forest or National Park land.	[Freake, Michael J.] Lee Univ, Dept Nat Sci & Math, Cleveland, TN 37311 USA; [DePerno, Christopher S.] North Carolina State Univ, Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC USA	University of North Carolina; North Carolina State University	Freake, MJ (corresponding author), Lee Univ, Dept Nat Sci & Math, Cleveland, TN 37311 USA.	mfreake@leeuniversity.edu		Freake, Michael/0000-0002-5517-4898; PERNO, CARLO FEDERICO/0000-0002-0825-5388	United States Department of Agriculture National Forest Service [15-CS-11080400-012]; Tennessee Wildlife Resource Agency [28179]; Appalachian College Association; Declining Amphibian Population Taskforce; Lee University; Garden Club of America	United States Department of Agriculture National Forest Service; Tennessee Wildlife Resource Agency; Appalachian College Association; Declining Amphibian Population Taskforce; Lee University; Garden Club of America	This work was supported by the United States Department of Agriculture National Forest Service, Grant #15-CS-11080400-012 to MJF; Tennessee Wildlife Resource Agency (http://tennessee.gov/twra) # 28179 to MJF; Appalachian College Association (http://www.acaweb.org) to MJF; Declining Amphibian Population Taskforce (http://ice.ucdavis.edu/project/daptf) to MJF; Lee University (http://www.leeuniversity.edu) to MJF and the Garden Club of America (https://www. gcamerica.org/scholarships) to MJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P196; [Anonymous], 2010, SALAMANDERS US CANAD; Archer E., 2016, RFPERMUTE ESTIMATE P; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Bothner Richard C., 1991, Proceedings of the Rochester Academy of Science, V17, P41; Briggler J., 2007, HELLBENDER POPULATIO; Burgmeier NG, 2011, J HERPETOL, V45, P195, DOI 10.1670/10-094.1; Burgmeier NG, 2011, J WILDLIFE DIS, V47, P836, DOI 10.7589/0090-3558-47.4.836; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Dodd Jr CK, 2003, MONITORING AMPHIBIAN; Dolloff CA, 1995, P WILD TROUT 5 WILD, P121; Foster RL, 2009, J HERPETOL, V43, P579, DOI 10.1670/08-156.1; Gentry G., 1955, Journal of the Tennessee Academy of Science, V30, P168; Gilpin M.E., 1986, P19; Hecht-Kardasz KA, 2012, BULL FLA MUS NAT HIS, V51, P227; HILLIS R E, 1971, Journal of Herpetology, V5, P121, DOI 10.2307/1562734; Humphries WJ, 2005, AM MIDL NAT, V154, P135, DOI 10.1674/0003-0031(2005)154[0135:LHOTHC]2.0.CO;2; Huston MA, 2005, ECOL APPL, V15, P1864, DOI 10.1890/03-5281; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kern WH, 1984, CRYPTOBRANCHUS ALLEG; Kulp MA, 2015, NPSGRSMNRR2015930; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Luisi MP, 2005, 0113 TENN WILDL RES, P1; Mast MA, 1999, 1173A US GEOL SURV, P1963; McGregor AZ, 1986, HIWASSEE RIVER SURVE; McManamay RA, 2014, FISHERIES MANAG ECOL, V21, P96, DOI 10.1111/fme.12056; Miller BT, 2005, SOUTHEAST NAT, V4, P513, DOI 10.1656/1528-7092(2005)004[0513:POPAIE]2.0.CO;2; NatureServe and IUCN (International Union for Conservation of Nature), 2007, CRYPT ALL; Nickerson M.A., 1973, Publications Biol Geol Milwaukee publ Mus, VNo. 1,1973, P1; Nickerson MA, 2003, SOUTHEAST NAT, V2, P619, DOI 10.1656/1528-7092(2003)002[0619:HDAACD]2.0.CO;2; NICKERSON MA, 1973, ECOLOGY, V54, P1164, DOI 10.2307/1935586; Nickerson Max A., 2003, Applied Herpetology, V1, P37, DOI 10.1163/157075403766451216; Owen R. D., 2002, J N CAROLINA ACAD SC, V118, P27; PETERSON CL, 1987, J HERPETOL, V21, P197, DOI 10.2307/1564483; PETERSON CL, 1988, AM MIDL NAT, V119, P291, DOI 10.2307/2425812; PETERSON CL, 1983, COPEIA, P225, DOI 10.2307/1444718; Phillips, 2003, NAT RESOUR RES, V9, P1; Pollock KH, 2005, HDB CAPTURE RECAPTUR, P22; Pugh MW, 2013, SOUTHEAST NAT, V12, P137, DOI 10.1656/058.012.0111; Pugh MW, 2015, HYDROBIOLOGIA; Quinn SA, 2013, J HERPETOL, V47, P78, DOI 10.1670/11-127; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Spear S, 2015, BIOL CONSERV, V183; Swank WT, 2001, FOREST ECOL MANAG, V143, P163, DOI 10.1016/S0378-1127(00)00515-6; TABER CA, 1975, COPEIA, P633; Tennessee Wildlife Resource Agency, 2015, 2015 STAT WILDL ACT; Trauth Stanley E., 1992, Arkansas Academy of Science Proceedings, V46, P83; Unger SD, 2013, J NAT CONSERV, V21, P423, DOI 10.1016/j.jnc.2013.06.002; USFWS, 2011, FED REG, V76, P61978; USFWS (U.S. Fish and Wildlife Service), 2011, FED REGISTER, V76, P61956; Wheeler BA, 2003, BIOL CONSERV, V109, P151, DOI 10.1016/S0006-3207(02)00136-2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILLIAMS R D, 1981, Wildlife Society Bulletin, V9, P94; WILLIAMS RD, 1981, J HERPETOL, V15, P23, DOI 10.2307/1563642; WILSON KR, 1985, J MAMMAL, V66, P13, DOI 10.2307/1380951	57	12	12	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0179153	10.1371/journal.pone.0179153	http://dx.doi.org/10.1371/journal.pone.0179153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594881	Green Published, Green Submitted, gold			2022-12-26	WOS:000402923200091
J	Ng, BF; Xiong, JW; Wan, MP				Ng, Bing Feng; Xiong, Jin Wen; Wan, Man Pun			Application of acoustic agglomeration to enhance air filtration efficiency in air-conditioning and mechanical ventilation (ACMV) systems	PLOS ONE			English	Article							AEROSOL-PARTICLES; FINE PARTICLES; HYDRODYNAMIC INTERACTION; PRESSURE-DROP; ENERGY-CONSUMPTION; COAL COMBUSTION; SOUND FIELD; ULTRASONIC AGGLOMERATION; AERODYNAMIC DISPERSION; NUMERICAL-SIMULATION	The recent episodes of haze in Southeast Asia have caused some of the worst regional atmospheric pollution ever recorded in history. In order to control the levels of airborne fine particulate matters (PM) indoors, filtration systems providing high PM capturing efficiency are often sought, which inadvertently also results in high airflow resistance (or pressure drop) that increases the energy consumption for air distribution. A pre-conditioning mechanism promoting the formation of particle clusters to enhance PM capturing efficiency without adding flow resistance in the air distribution ductwork could provide an energy-efficient solution. This pre-conditioning mechanism can be fulfilled by acoustic agglomeration, which is a phenomenon that promotes the coagulation of suspended particles by acoustic waves propagating in the fluid medium. This paper discusses the basic mechanisms of acoustic agglomeration along with influencing factors that could affect the agglomeration efficiency. The feasibility to apply acoustic agglomeration to improve filtration in air-conditioning and mechanical ventilation (ACMV) systems is investigated experimentally in a small-scale wind tunnel. Experimental results indicate that this novel application of acoustic pre-conditioning improves the PM2.5 filtration efficiency of the test filters by up to 10% without introducing additional pressure drop. The fan energy savings from not having to switch to a high capturing efficiency filter largely outstrip the additional energy consumed by the acoustics system. This, as a whole, demonstrates potential energy savings from the combined acousticenhanced filtration system without compromising on PM capturing efficiency.	[Ng, Bing Feng; Xiong, Jin Wen; Wan, Man Pun] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wan, MP (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	mpwan@ntu.edu.sg	Ng, Bing Feng/D-5893-2019; Wan, Man Pun/C-3742-2008; COLE, Murukeshan/ABD-6157-2020	Ng, Bing Feng/0000-0001-8112-1151; COLE, Murukeshan/0000-0001-6661-7597; Wan, Man Pun/0000-0002-5326-6705	Republic of Singapore's Ministry of Education [RG190/14, MOE2016-T2-1-063]; National Research Foundation	Republic of Singapore's Ministry of Education(Ministry of Education, Singapore); National Research Foundation	This study is jointly supported by the Republic of Singapore's Ministry of Education through grant no. RG190/14 and MOE2016-T2-1-063 https://www.moe.gov.sg/ to MP, and the National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore-Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) Program http://sinberbest.berkeley. edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is jointly supported by the Republic of Singapore's Ministry of Education through grant no. RG190/14 and MOE2016-T2-1-063 as well as the National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore-Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) Program.	Aktas MK, 2004, J ACOUST SOC AM, V116, P2822, DOI 10.1121/1.1795332; An S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081377; Andrade END, 1936, T FARADAY SOC, V32, P1111; Balasubramanian R, 2006, J GEOPHYS RES-ATMOS, P111; Bearg D. W., 1993, INDOOR AIR QUALITY H; Beko G, 2008, BUILD ENVIRON, V43, P1647, DOI 10.1016/j.buildenv.2007.10.006; Bernstein JA, 2008, J ALLERGY CLIN IMMUN, V121, P585, DOI 10.1016/j.jaci.2007.10.045; Betha R, 2014, ENVIRON SCI TECHNOL, V48, P4327, DOI 10.1021/es405533d; BOULAUD D, 1984, J AEROSOL SCI, V15, P247, DOI 10.1016/0021-8502(84)90080-6; Brandt O, 1936, KOLLOID Z, V77, P103, DOI 10.1007/BF01422153; Burge H, 1993, INDOOR ALLERGENS ASS; Burge HA, 1995, BIOAEROSOLS; Burge HG., 1989; Byeon JH, 2008, BIORESOURCE TECHNOL, V99, P5150, DOI 10.1016/j.biortech.2007.09.014; Calvert G, 2013, CHEM ENG SCI, V86, P146, DOI 10.1016/j.ces.2012.06.035; Calvert G, 2009, ADV POWDER TECHNOL, V20, P4, DOI 10.1016/j.apt.2008.09.001; Camfil, 2014, PROD CAT 2014 AIR GR; CAPERAN P, 1995, J AEROSOL SCI, V26, P595, DOI 10.1016/0021-8502(94)00140-T; Caperan PH, 1993, J AEROSOL SCI, V24, P593; Chao CYH, 2003, ATMOS ENVIRON, V37, P4233, DOI 10.1016/S1352-2310(03)00560-0; Chen H, 2009, P CSEE, V2, P8; Cheng MT, 1983, J COLLOID INTERF SCI, P91; Chimack MJ, 2000, P 2000 ACEEE SUMM ST, P77; CHOU KH, 1981, J COLLOID INTERF SCI, V83, P335, DOI 10.1016/0021-9797(81)90329-5; CHOU KH, 1980, J ACOUST SOC AM, V68, P1780, DOI 10.1121/1.385222; Chou KH, 1980, AEROSOL AGGLOMERATIO; Chua KJ, 2013, APPL ENERG, V104, P87, DOI 10.1016/j.apenergy.2012.10.037; Clair HWS, 1949, IND ENG CHEM, V41, P2434; COLE R, 1993, AEROSOL SCI TECH, V19, P339, DOI 10.1080/02786829308959641; Collier L, 1998, TOPLEY WILSONS MICR, P33; Cowling BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108850; Cox C. S., 1995, BIOAEROSOLS HDB; Czyz H., 1987, Archives of Acoustics, V12, P199; DANILOV SD, 1984, SOV PHYS ACOUST+, V30, P280; de Sarabia ERF, 2003, ULTRASONICS, V41, P277, DOI 10.1016/S0041-624X(02)00452-3; de Sarabia ERF, 2000, ULTRASONICS, V38, P642, DOI 10.1016/S0041-624X(99)00129-8; DESARABIA ERF, 1986, J SOUND VIB, V110, P413, DOI 10.1016/S0022-460X(86)80144-4; DEWEY S, 1995, ZBL HYG UMWELTMED, V197, P504; DIANOV DB, 1968, SOV PHYS ACOUST+, V13, P314; Doinikov AA, 2003, RECENT RES DEV ACOUS, V661, P39; Doman L. E, 2013, INT ENERGY OUTLOOK 2; Dong SZ, 2006, J AEROSOL SCI, V37, P540, DOI 10.1016/j.jaerosci.2005.05.008; Douwes J, 1997, INT J OCCUP ENV HEAL; Edelman L, 2008, FILTR SEPARAT, V45, P24, DOI 10.1016/S0015-1882(08)70368-9; Emmanuel S C, 2000, Respirology, V5, P175, DOI 10.1046/j.1440-1843.2000.00247.x; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Fan F, 2008, STUDY GROWTH MECHANI; Faulkner WB, 2006, APPL ENG AGRIC, V22, P155; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385; Fisk WJ, 2002, INDOOR AIR, V12, P223, DOI 10.1034/j.1600-0668.2002.01136.x; Fu SC, 2015, CR MECANIQUE, V343, P589, DOI 10.1016/j.crme.2015.07.012; Fuchs N.A., 1989, MECH AEROSOLS; Funcke G, 1995, J AEROSOL SCI, V26, P147; Fung Frederick, 2003, Appl Occup Environ Hyg, V18, P535, DOI 10.1080/10473220301451; Gallego-Juarez J. A., 1996, HIGH TEMPERATURE GAS, P60; Gallego-Juarez JA, 1999, ENVIRON SCI TECHNOL, V33, P3843, DOI 10.1021/es990002n; Gallego-Juarez JA, 1979, P ULTR INT 1979, P227; GALLEGOJUAREZ JA, 1978, ULTRASONICS, V16, P267, DOI 10.1016/0041-624X(78)90053-7; Gonzalez I, 2000, J AEROSOL SCI, V31, P1461, DOI 10.1016/S0021-8502(00)00046-X; Gonzalez I, 2003, J AEROSOL SCI, V34, P1611, DOI 10.1016/S0021-8502(03)00190-3; Gonzalez I, 2002, ACTA ACUST UNITED AC, V88, P19; Gonzalez I, 2001, ACUSTICA, V87, P454; Gonzalez-Gomez I, 2000, ACUSTICA, V86, P784; GOTOH K, 1994, ADV POWDER TECHNOL, V5, P323, DOI 10.1016/S0921-8831(08)60750-5; Gougeon R, 1996, CHEM ENG COMMUN, V151, P19, DOI 10.1080/00986449608936539; GUCKER FT, 1956, J PHYS CHEM-US, V60, P989, DOI 10.1021/j150541a042; Guo QJ, 2012, POWDER TECHNOL, V227, P67, DOI 10.1016/j.powtec.2011.12.033; Haep S, 1997, J AEROSOL SCI, V28, P331; Hamilton MF, 2003, J ACOUST SOC AM, V113, P153, DOI 10.1121/1.1528928; He CR, 2004, ATMOS ENVIRON, V38, P3405, DOI 10.1016/j.atmosenv.2004.03.027; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Hoffmann TL, 1996, J ACOUST SOC AM, V99, P2130, DOI 10.1121/1.415400; Hoffmann TL, 2000, ULTRASONICS, V38, P353, DOI 10.1016/S0041-624X(99)00184-5; Hoffmann TL, 1997, J AEROSOL SCI, V28, P919, DOI 10.1016/S0021-8502(96)00489-2; Hoffmann TL, 1993, J VIB ACOUST, P115; HORTON KD, 1991, J AEROSOL SCI, V22, P347, DOI 10.1016/S0021-8502(05)80012-6; Huang R, 2008, INDOOR AIR, V18, P106, DOI 10.1111/j.1600-0668.2007.00512.x; Huffnagle GB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000549; JOVANOVICKOVACEVIC OZ, 1979, ISOTOPENPRAXIS, V15, P288, DOI 10.1080/10256017908544354; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Kuo SM, 1999, P IEEE, V87, P943, DOI 10.1109/5.763310; LAMB GER, 1995, AEROSOL SCI TECH, V23, P250, DOI 10.1080/02786829508965308; LEE PS, 1982, AEROSOL SCI TECH, V1, P47, DOI 10.1080/02786828208958578; Li QZ, 2013, POWDER TECHNOL, V233, P137, DOI 10.1016/j.powtec.2012.08.023; Liu JZ, 2011, J ENVIRON SCI, V23, P1845, DOI 10.1016/S1001-0742(10)60652-3; Liu JZ, 2009, POWDER TECHNOL, V193, P20, DOI 10.1016/j.powtec.2009.02.002; Maknickas A, 2016, PARTICUL SCI TECHNOL, P1; MALHERBE C, 1988, AEROSOL SCI TECH, V9, P93, DOI 10.1080/02786828808959198; Marsh SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103269; Martin KM, 1997, EXP FLUIDS, V23, P483, DOI 10.1007/s003480050138; Masuda H, 2009, ADV POWDER TECHNOL, V20, P113, DOI 10.1016/j.apt.2009.02.001; McMurry PH, 2000, ATMOS ENVIRON, V34, P1959, DOI 10.1016/S1352-2310(99)00455-0; Mednikov E.P., 1965, APPL MECH MAT, V34, P1087; Mikhailov EF, 2001, J AEROSOL SCI, V32, P697, DOI 10.1016/S0021-8502(00)00101-4; Miller SL, 2001, ATMOS ENVIRON, V35, P2053, DOI 10.1016/S1352-2310(00)00506-9; Moldavsky L, 2006, J AEROSOL SCI, V37, P528, DOI 10.1016/j.jaerosci.2005.05.004; Moldavsky L, 2013, J AEROSOL SCI, V57, P125, DOI 10.1016/j.jaerosci.2012.10.002; Nash DG, 2006, INT J MASS SPECTROM, V258, P2, DOI 10.1016/j.ijms.2006.09.017; Nelson AJ, 2013, AEROSOL SCI TECH, V47, P1285, DOI 10.1080/02786826.2013.835026; Ng BF, 2016, IND AIR 2016 14 INT; Noh KC, 2010, INDOOR BUILT ENVIRON, V19, P444, DOI 10.1177/1420326X10373213; Noorpoor AR, 2013, INT J ENVIRON RES, V7, P131; Obersteiner A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149545; Ostermann K., 2001, FOREST FIRES REGIONA, P41; Otto E, 1999, ADV POWDER TECHNOL, V10, P1, DOI 10.1016/S0921-8831(08)60453-7; Patterson HS, 1931, NATURE, P127; Perez-Lombard L, 2008, ENERG BUILDINGS, V40, P394, DOI 10.1016/j.enbuild.2007.03.007; Perez-Lombard L, 2011, APPL ENERG, V88, P5020, DOI 10.1016/j.apenergy.2011.07.003; PlattsMills TAE, 1997, NEW ENGL J MED, V336, P1382, DOI 10.1056/NEJM199705083361909; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; RAJENDRAN N, 1979, J AEROSOL SCI, V10, P329, DOI 10.1016/0021-8502(79)90048-X; Reethof G, 1987, J VIB ACOUST STRESS, V109, P185; Reethof G, 1988, NOISE CONTROL ACOUST, V110, P552; Reponen T, 2001, GRANA, V40, P119, DOI 10.1080/00173130152625851; Riera E, 2006, ULTRASON SONOCHEM, V13, P107, DOI 10.1016/j.ultsonch.2005.04.001; Riera E, 2015, WOODH PUB SER ELECT, V66, P1023, DOI 10.1016/B978-1-78242-028-6.00034-X; Riera-Franco de Sarabia E., 2000, J AEROSOL SCI, V31, P827, DOI DOI 10.1016/S0021-8502(00)90837-1; Riley WJ, 2002, ENVIRON SCI TECHNOL, V36, P200, DOI 10.1021/es010723y; Rodriguez-Maroto JJ, 1996, J AEROSOL SCI, V27, P621; Sagartzazu X, 2008, ARCH COMPUT METHOD E, V15, P311, DOI 10.1007/s11831-008-9022-1; Salinas SV, 2013, ATMOS RES, V122, P555, DOI 10.1016/j.atmosres.2012.05.021; SAMET JM, 1987, AM REV RESPIR DIS, V136, P1486, DOI 10.1164/ajrccm/136.6.1486; Sanchez-Monedero MA, 2008, WATER RES, V42, P3739, DOI 10.1016/j.watres.2008.06.028; Schild P.G., 2009, RECOMMENDATIONS SPEC; SCOTT DS, 1975, J SOUND VIB, V43, P607, DOI 10.1016/0022-460X(75)90223-0; Shaw D.T., 1978, RECENT DEV AEROSOL S; SHAW DT, 1979, J AEROSOL SCI, V10, P317, DOI 10.1016/0021-8502(79)90047-8; Sheng CD, 2006, J AEROSOL SCI, V37, P16, DOI 10.1016/j.jaerosci.2005.03.004; Sheng CD, 2007, AEROSOL SCI TECH, V41, P1, DOI 10.1080/02786820601009704; Shirokova NL, 1970, PHYS PRINC ULTRASON, V2, P477; Shuster K, 2002, PHYS FLUIDS, P14; SONG L, 1994, J VIB ACOUST, V116, P208, DOI 10.1115/1.2930414; Song L, 1989, MODELING ACOUSTIC AG; SS554, 1982, 5542009 SS; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Stephens B, 2010, ASHRAE T, P116; Stephens B, 2010, HVAC&R RES, V16, P273, DOI 10.1080/10789669.2010.10390905; Sun DS, 2013, J AEROSOL SCI, V66, P12, DOI 10.1016/j.jaerosci.2013.08.008; Tang P, 2008, POWDER TECHNOL, V187, P27, DOI 10.1016/j.powtec.2008.01.003; Teixeira R, 2007, J MECH SCI TECHNOL, V21, P1881, DOI 10.1007/BF03177444; TEMKIN S, 1976, J SOUND VIB, V49, P75, DOI 10.1016/0022-460X(76)90758-6; TEMKIN S, 1989, J FLUID MECH, V202, P467, DOI 10.1017/S0022112089001254; TEMKIN S, 1980, J FLUID MECH, V96, P133, DOI 10.1017/S0022112080002054; Temkin S, 1994, PHYS FLUIDS, P6; Temkin S., 1981, ELEMENTS ACOUSTICS; Thomas D, 1999, J AEROSOL SCI, V30, P235, DOI 10.1016/S0021-8502(98)00036-6; TIMOSHENKO V, 1976, ULTRASONICS, V14, P218, DOI 10.1016/0041-624X(76)90021-4; Tiwari AJ, 2013, AEROSOL SCI TECH, V47, P1267, DOI 10.1080/02786826.2013.834292; TIWARY R, 1986, J SOUND VIB, V108, P33, DOI 10.1016/S0022-460X(86)80309-1; TIWARY R, 1984, J ACOUST SOC AM, V76, P841, DOI 10.1121/1.391308; Tomaides M, 1971, J AEROSOL SCI, V2, P39; VOLK M, 1976, WATER AIR SOIL POLL, V5, P319; Walker IS, 2013, P ASHRAE ANN C DENV; Wallace L, 1996, J AIR WASTE MANAGE, V46, P98, DOI 10.1080/10473289.1996.10467451; Wang J, 2011, CIESC J, V2, P11; Wang J, 2011, POWDER TECHNOL, V210, P315, DOI 10.1016/j.powtec.2011.04.002; Weingartner E, 1997, ATMOS ENVIRON, V31, P2311, DOI 10.1016/S1352-2310(97)00023-X; WEISER MAH, 1984, ACUSTICA, V56, P114; Wiklund M, 2012, LAB CHIP, V12, P2438, DOI 10.1039/c2lc40203c; Wilby JF, 1996, J SOUND VIB, V190, P545, DOI 10.1006/jsvi.1996.0078; Wu CL, 2011, INDOOR BUILT ENVIRON; Wu X, 2014, P 21 INT C SOUND VIB; Xiong JW, 2016, IND AIR 2016 14 INT; Yan JP, 2016, CHEM ENG J, V290, P319, DOI 10.1016/j.cej.2016.01.075; Yan JP, 2016, FUEL, V165, P316, DOI 10.1016/j.fuel.2015.10.077; Yang L, 2007, INT J REFRIG, V30, P489, DOI 10.1016/j.ijrefrig.2006.08.006; Yang L, 2007, INT J REFRIG, V30, P506, DOI 10.1016/j.ijrefrig.2006.08.010; Yao G, 2006, ACOUSTIC AGGLOMERATI; Yao Y, 2007, ENERG BUILDINGS, V39, P558, DOI 10.1016/j.enbuild.2006.09.010; You SM, 2014, AEROSOL SCI TECH, V48, P1031, DOI 10.1080/02786826.2014.955908; You SM, 2014, J HAZARD MATER, V267, P183, DOI 10.1016/j.jhazmat.2013.12.058; Yuen WT, 2016, AEROSOL SCI TECH, V50, P52, DOI 10.1080/02786826.2015.1124986; Yuen WT, 2014, AEROSOL SCI TECH, V48, P907, DOI 10.1080/02786826.2014.938800; Yuen WT, 2016, J AEROSOL SCI; Zaatari M, 2014, BUILD ENVIRON, V73, P151, DOI 10.1016/j.buildenv.2013.12.010; Zhang GX, 2012, CHINESE SCI BULL, V57, P2404, DOI 10.1007/s11434-012-5212-1; Zhao B, 2007, J POWER ENG, V5, P30; ZHENG XY, 1995, J ACOUST SOC AM, V97, P2218, DOI 10.1121/1.411947; Zhou D, 2016, APPL ENERGY; Zhou D, 2015, PROCEDIA ENGINEER, V102, P1261, DOI 10.1016/j.proeng.2015.01.256; Zhou D, 2016, POWDER TECHNOL, V289, P52, DOI 10.1016/j.powtec.2015.11.009	181	23	25	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2017	12	6							e0178851	10.1371/journal.pone.0178851	http://dx.doi.org/10.1371/journal.pone.0178851			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0PL	28594862	Green Published, gold			2022-12-26	WOS:000402923200057
J	Baharom, F; Thomas, OS; Lepzien, R; Mellman, I; Chalouni, C; Smed-Sorensen, A				Baharom, Faezzah; Thomas, Oliver S.; Lepzien, Rico; Mellman, Ira; Chalouni, Cecile; Smed-Sorensen, Anna			Visualization of early influenza A virus trafficking in human dendritic cells using STED microscopy	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGEN PRESENTATION; MEMBRANE-FUSION; FLUORESCENCE MICROSCOPY; ENTRY; MACROPHAGES; REPLICATION; INFECTIONS; RESOLUTION; ENDOSOMES	Influenza A viruses (IAV) primarily target respiratory epithelial cells, but can also replicate in immune cells, including human dendritic cells (DCs). Super-resolution microscopy provides a novel method of visualizing viral trafficking by overcoming the resolution limit imposed by conventional light microscopy, without the laborious sample preparation of electron microscopy. Using three-color Stimulated Emission Depletion (STED) microscopy, we visualized input IAV nucleoprotein (NP), early and late endosomal compartments (EEA1 and LAMP1 respectively), and HLA-DR (DC membrane/cytosol) by immunofluorescence in human DCs. Surface bound IAV were internalized within 5 min of infection. The association of virus particles with early endosomes peaked at 5 min when 50% of NP+ signals were also EEA1(+). Peak association with late endosomes occurred at 15 min when 60% of NP+ signals were LAMP1(+). At 30 min of infection, the majority of NP signals were in the nucleus. Our findings illustrate that early IAV trafficking in human DCs proceeds via the classical endocytic pathway.	[Baharom, Faezzah; Thomas, Oliver S.; Lepzien, Rico; Smed-Sorensen, Anna] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden; [Mellman, Ira; Chalouni, Cecile] Genentech Inc, 1 DNA Way, San Francisco, CA USA	Karolinska Institutet; Roche Holding; Genentech	Smed-Sorensen, A (corresponding author), Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden.	anna.smed.sorensen@ki.se	Mellman, Ira/ABG-5896-2020; Baharom, Faezzah/AAC-4466-2019	Smed Sorensen, Anna/0000-0001-6966-7039; Baharom, Faezzah/0000-0003-4513-3600; Lepzien, Rico/0000-0001-8584-2917	Swedish Research Council; Swedish Heart-Lung Foundation; Karolinska Institutet; Genentech, Inc.	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); Genentech, Inc.(Roche HoldingGenentech)	This work was supported by grants to AS-S from the Swedish Research Council, the Swedish Heart-Lung Foundation, and Karolinska Institutet. Genentech, Inc. provided support in the form of salaries for CC and IM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Baharom F, 2015, J IMMUNOLOGY; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Blom H, 2014, J INTERN MED, V276, P560, DOI 10.1111/joim.12278; Chatterjee B, 2012, BLOOD, V120, P2011, DOI 10.1182/blood-2012-01-402370; Cohn L, 2013, J EXP MED, V210, P1049, DOI 10.1084/jem.20121251; Colberg-Poley AM, 2015, MED MICROBIOL IMMUN, V204, P449, DOI 10.1007/s00430-015-0395-0; de Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001329; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Edinger TO, 2015, MBIO, V6, DOI 10.1128/mBio.00297-15; Edinger TO, 2014, J GEN VIROL, V95, P263, DOI 10.1099/vir.0.059477-0; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Fontana J, 2015, ARCH BIOCHEM BIOPHYS, V581, P86, DOI 10.1016/j.abb.2015.04.011; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; GUJULUVA CN, 1994, VIROLOGY, V204, P491, DOI 10.1006/viro.1994.1563; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Herter S, 2005, J IMMUNOL, V175, P891, DOI 10.4049/jimmunol.175.2.891; HILLEMAN MR, 1958, NEW ENGL J MED, V258, P969, DOI 10.1056/NEJM195805152582001; Kramer B, 2005, BLOOD CELL MOL DIS, V35, P136, DOI 10.1016/j.bcmd.2005.06.006; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee BL, 2014, TRENDS CELL BIOL, V24, P360, DOI 10.1016/j.tcb.2013.12.002; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Mercer J, 2013, TRENDS MICROBIOL, V21, P380, DOI 10.1016/j.tim.2013.06.001; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; SCHMID S, 1989, J CELL BIOL, V108, P1291, DOI 10.1083/jcb.108.4.1291; Schoonderwoert V, 2013, MICROSC TODAY, V21, P38; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Short KR, 2012, J GEN VIROL, V93, P2315, DOI 10.1099/vir.0.045021-0; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Smed-Sorensen A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002572; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van de Sandt CE, 2012, VIRUSES-BASEL, V4, P1438, DOI 10.3390/v4091438; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Yewdell J, 2002, CURR OPIN MICROBIOL, V5, P414, DOI 10.1016/S1369-5274(02)00346-6; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; Zhou Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-384	49	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177920	10.1371/journal.pone.0177920	http://dx.doi.org/10.1371/journal.pone.0177920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591131	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700018
J	Hayes, DA; Kunde, DA; Taylor, RL; Pyecroft, SB; Sohal, SS; Snow, ET				Hayes, Dane A.; Kunde, Dale A.; Taylor, Robyn L.; Pyecroft, Stephen B.; Sohal, Sukhwinder Singh; Snow, Elizabeth T.			ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER CELLS; NERVE SHEATH TUMORS; BREAST-CANCER; MONOCLONAL-ANTIBODY; TASMANIAN DEVILS; DOWN-REGULATION; EXTRACELLULAR DOMAIN; NUCLEAR-LOCALIZATION; TRANSMISSIBLE CANCER	Devil Facial Tumour 1 (DFT1) is one of two transmissible neoplasms of Tasmanian devils (Sarcophilus harrisii) predominantly affecting their facial regions. DFT1's cellular origin is that of Schwann cell lineage where lesions are evident macroscopically late in the disease. Conversely, the pre-clinical timeframe from cellular transmission to appearance of DFT1 remains uncertain demonstrating the importance of an effective pre-clinical biomarker. We show that ERBB3, a marker expressed normally by the developing neural crest and Schwann cells, is immunohistohemically expressed by DFT1, therefore the potential of ERBB3 as a biomarker was explored. Under the hypothesis that serum ERBB3 levels may increase as DFT1 invades local and distant tissues our pilot study determined serum ERBB3 levels in normal Tasmanian devils and Tasmanian devils with DFT1. Compared to the baseline serum ERBB3 levels in unaffected Tasmanian devils, Tasmanian devils with DFT1 showed significant elevation of serum ERBB3 levels. Interestingly Tasmanian devils with cutaneous lymphoma (CL) also showed elevation of serum ERBB3 levels when compared to the baseline serum levels of Tasmanian devils without DFT1. Thus, elevated serum ERBB3 levels in otherwise healthy looking devils could predict possible DFT1 or CL in captive or wild devil populations and would have implications on the management, welfare and survival of Tasmanian devils. ERBB3 is also a therapeutic target and therefore the potential exists to consider modes of administration that may eradicate DFT1 from the wild.	[Hayes, Dane A.] Dept Primary Ind Pk Water & Environm, Anim Hlth Lab, Launceston, Tas, Australia; [Hayes, Dane A.; Taylor, Robyn L.] Univ Tasmania, Save Tasmanian Devil Program, Hobart, Tas, Australia; [Hayes, Dane A.; Kunde, Dale A.; Sohal, Sukhwinder Singh; Snow, Elizabeth T.] Univ Tasmania, Sch Hlth Sci, Fac Hlth, Launceston, Tas, Australia; [Taylor, Robyn L.] Dept Primary Ind Pk Water & Environm, Resource Management & Conservat, Hobart, Tas, Australia; [Pyecroft, Stephen B.] Univ Adelaide, Sch Anim & Vet Sci, Fac Sci, Roseworthy Campus, Roseworthy, SA, Australia	University of Tasmania; University of Tasmania; University of Adelaide	Hayes, DA (corresponding author), Dept Primary Ind Pk Water & Environm, Anim Hlth Lab, Launceston, Tas, Australia.; Hayes, DA (corresponding author), Univ Tasmania, Save Tasmanian Devil Program, Hobart, Tas, Australia.; Hayes, DA (corresponding author), Univ Tasmania, Sch Hlth Sci, Fac Hlth, Launceston, Tas, Australia.	dane.hayes@dpipwe.tas.gov.au	Snow, Elizabeth T/J-7394-2014; Kunde, Dale/J-7935-2014	Snow, Elizabeth T/0000-0002-9363-5130; Kunde, Dale/0000-0002-6513-032X	University of Tasmanian; Save the Tasmanian Devil Appeal (STDP); Department of Primary Industries water and Environment (DPIPWE); University of Adelaide; Dr Eric Guiler Save the Tasmanian Devil Research Grant	University of Tasmanian; Save the Tasmanian Devil Appeal (STDP); Department of Primary Industries water and Environment (DPIPWE); University of Adelaide; Dr Eric Guiler Save the Tasmanian Devil Research Grant	This research was funded by the Dr Eric Guiler Tasmanian Devil Research grant through the University of Tasmanian and the Save the Tasmanian Devil Appeal (STDP) to DH and SS [http://www.tassiedevil.com.au/tasdevil.nsf. The Department of Primary Industries water and Environment (DPIPWE) and the University of Adelaide provided financial and in kind support.; This research was funded by the Dr Eric Guiler Save the Tasmanian Devil Research Grant and we are extremely grateful to Save the Tasmanian Devil Program especially the program manager David Pemberton, University of Tasmania, Department of Primary Industries, Water and Environment and the University of Adelaide for their continued support. We are grateful to all STDP field staff including Colette Harmsen, DPIPWE staff including veterinary officer Sarah Peck and senior keeper David Schaap. Pathologists Jim Taylor, Graeme Knowles, Andrew Davis. Librarians Margaret Quill and Toni Venettacci. Molecular biologists Richard Morrison and Teresa Wilson. Histological Support from Alistair Townsend, Tony Van Galen and Dhirendra Prasad-Royal Hobart Hospital, Mike Burley-Hobart Pathology, Dr Terry Brain and Karen Wolfswinkel-Launceston General Hospital, Jann Brauer-Launceston Pathology and Catherine Marshall-Mt Pleasant laboratories.	Adilakshmi T, 2011, J NEUROSCI, V31, P5106, DOI 10.1523/JNEUROSCI.5635-10.2011; Akahane K, 2015, BREAST CANCER-TOKYO, V22, P317, DOI 10.1007/s12282-012-0362-1; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Allen SD, 2007, J IMMUNOL, V179, P472, DOI 10.4049/jimmunol.179.1.472; Amin DN, 2012, BIOCHEM J, V447, P417, DOI 10.1042/BJ20120724; Anderson Katie L, 2015, Vet Sci, V2, P363, DOI 10.3390/vetsci2040363; Aurisicchio L, 2012, ONCOTARGET, V3, P744, DOI 10.18632/oncotarget.550; Aurisicchio L, 2012, EXPERT OPIN BIOL TH, V12, P1043, DOI 10.1517/14712598.2012.689279; Baric M, 2015, PATHOL ONCOL RES, V21, P589, DOI 10.1007/s12253-014-9859-6; Baron AT, 2009, IDRUGS, V12, P302; Baron AT, 2003, CANCER EPIDEM BIOMAR, V12, P103; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Baulida J, 1996, J BIOL CHEM, V271, P5251; Beeton N, 2011, J APPL ECOL, V48, P1315, DOI 10.1111/j.1365-2664.2011.02060.x; Belleudi F, 2012, CELL CYCLE, V11, P1455, DOI 10.4161/cc.19861; Bergman PJ, 2014, VET CLIN N AM-SMALL, V44, P925, DOI 10.1016/j.cvsm.2014.05.002; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Blackburn E, 2012, BREAST CANCER RES TR, V134, P53, DOI 10.1007/s10549-011-1908-1; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourdeaut F, 2008, ONCOGENE, V27, P3066, DOI 10.1038/sj.onc.1210965; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Brand TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071518; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Brown GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024475; CANFIELD PJ, 1993, J ZOO WILDLIFE MED, V24, P158; CANFIELD PJ, 1990, J COMP PATHOL, V103, P147, DOI 10.1016/S0021-9975(08)80171-5; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carney WP, 2003, LAB MED, V34, P58, DOI 10.1309/TY6M-DWB0-G2BU-6D5F; Carroll SL, 2012, ACTA NEUROPATHOL, V123, P321, DOI 10.1007/s00401-011-0928-6; Cavallo F, 2014, EXPERT OPIN BIOL TH, V14, P1427, DOI 10.1517/14712598.2014.927433; Chadwick B., 2003, Journal of Wildlife Diseases, V39, P7; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Cheng CJ, 2007, MOL CANCER RES, V5, P675, DOI 10.1158/1541-7786.MCR-06-0306; Chijiwa K, 2004, VET PATHOL, V41, P307, DOI 10.1354/vp.41-4-307; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clarke N, 2014, EUR J CANCER, V50, P98, DOI 10.1016/S0959-8049(14)70426-5; Clifton GT, 2016, FUTURE ONCOL, V12, P1321, DOI 10.2217/fon-2015-0054; D'Souza JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112376; Deakin JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002483; Dey N, 2015, AM J TRANSL RES, V7, P733; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Doster AR, 2011, J COMP PATHOL, V145, P12, DOI 10.1016/j.jcpa.2010.11.007; Duke FD, 2015, VET PATHOL, V52, P181, DOI 10.1177/0300985814522811; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fazekas J, 2016, ONCOL LETT, V12, P2271, DOI 10.3892/ol.2016.5001; Feng SM, 2007, MOL ENDOCRINOL, V21, P1861, DOI 10.1210/me.2006-0101; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Ferreira RB, 2015, ONCOTARGET, V6, P10445, DOI 10.18632/oncotarget.3398; Fitzgerald JB, 2014, MOL CANCER THER, V13, P410, DOI 10.1158/1535-7163.MCT-13-0255; Flies A, 2016, EUR J IMMUNOL, V46, P1095; Foreman PK, 2012, MOL CANCER THER, V11, P1411, DOI 10.1158/1535-7163.MCT-12-0068; Foy KC, 2013, J IMMUNOL, V191, P217, DOI 10.4049/jimmunol.1300231; Francis D, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-4495; Fricker FR, 2013, BRAIN, V136, P2279, DOI 10.1093/brain/awt148; Fricker FR, 2011, J NEUROSCI, V31, P3225, DOI 10.1523/JNEUROSCI.2568-10.2011; Funayama T, 1998, ONCOLOGY-BASEL, V55, P161, DOI 10.1159/000011851; Gaborit N, 2015, P NATL ACAD SCI USA, V112, P839, DOI 10.1073/pnas.1423645112; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Garrett JT, 2013, CANCER RES, V73, P6013, DOI 10.1158/0008-5472.CAN-13-1191; Gil EY, 2014, BREAST CANCER RES TR, V147, P69, DOI 10.1007/s10549-014-3086-4; GRINER LA, 1979, J NATL CANCER I, V62, P589, DOI 10.1093/jnci/62.3.589; Gu JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124135; GUILER ER, 1970, TASMANIAN J AGR, V41, P134; Gullick WJ, 1996, CANCER SURV, V27, P339; Guo CQ, 2013, ADV CANCER RES, V119, P421, DOI 10.1016/B978-0-12-407190-2.00007-1; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Hamede RK, 2013, J ANIM ECOL, V82, P182, DOI 10.1111/j.1365-2656.2012.02025.x; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hickinson DM, 2010, CLIN CANCER RES, V16, P1159, DOI 10.1158/1078-0432.CCR-09-2353; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Hogg CJ, 2017, CONSERV LETT, V10, P133, DOI 10.1111/conl.12221; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Howson LJ, 2014, ANAT REC, V297, P925, DOI 10.1002/ar.22904; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hsieh SY, 2011, J PROTEOME RES, V10, P4715, DOI 10.1021/pr200519q; Huang JC, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-134; Huang S, 2013, CANCER RES, V73, P824, DOI 10.1158/0008-5472.CAN-12-1611; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Huang Z, 2015, ONCOGENE, V34, P1105, DOI 10.1038/onc.2014.56; Ito D, 2015, LEUKEMIA LYMPHOMA, V56, P219, DOI 10.3109/10428194.2014.914193; Izycka-Swieszewska E, 2011, CLIN EXP METASTAS, V28, P271, DOI 10.1007/s10585-010-9369-1; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jiang N, 2012, CHEMOTHER RES PRACT, V2012, DOI DOI 10.1155/2012/817304; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Kagawa Y, 2001, J COMP PATHOL, V124, P122, DOI 10.1053/jcpa.2000.0439; Karu N, 2016, J PROTEOME RES, V15, P3827, DOI 10.1021/acs.jproteome.6b00629; KATOH M, 1993, BIOCHEM BIOPH RES CO, V192, P1189, DOI 10.1006/bbrc.1993.1542; Kaumaya PTP, 2015, HUM VACC IMMUNOTHER, V11, P1368, DOI 10.1080/21645515.2015.1026495; Kazemi T, 2016, ARTIF CELL NANOMED B, V44, P769, DOI 10.3109/21691401.2015.1019669; Kim JH, 2011, VET J, V189, P318, DOI 10.1016/j.tvjl.2010.08.012; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Kol A, 2014, PHARMACOL THERAPEUT, V143, P1, DOI 10.1016/j.pharmthera.2014.01.005; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; Koumakpayi IH, 2011, MOL CARCINOGEN, V50, P901, DOI 10.1002/mc.20766; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Kreiss A, 2015, VACCINE, V33, P3016, DOI 10.1016/j.vaccine.2015.01.039; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lachish S, 2010, CONSERV BIOL, V24, P841, DOI 10.1111/j.1523-1739.2009.01429.x; Ladds P., 2009, PATHOLOGY AUSTR NATI; Lam L, 2012, BBA-REV CANCER, V1826, P199, DOI 10.1016/j.bbcan.2012.03.012; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee H, 1998, ONCOGENE, V16, P3243, DOI 10.1038/sj.onc.1201866; Lee H, 2001, CANC RES, V61; Lee PR, 2006, NEUROSCI LETT, V397, P126, DOI 10.1016/j.neulet.2005.12.027; Lee S, 2015, P NATL ACAD SCI USA, V112, P13225, DOI 10.1073/pnas.1518361112; Lee Y, 2014, ACTA BIOCH BIOPH SIN, V46, P190, DOI 10.1093/abbs/gmt150; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Li YW, 2001, MOL CELL NEUROSCI, V17, P761, DOI 10.1006/mcne.2000.0967; Lin SH, 2008, ONCOGENE, V27, P5195, DOI 10.1038/onc.2008.156; Lin SH, 2008, CLIN CANCER RES, V14, P3729, DOI 10.1158/1078-0432.CCR-08-0472; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Ly LV, 2013, J IMMUNOL, V190, P489, DOI 10.4049/jimmunol.1200135; Ma J, 2014, MOL CANC, V13, P105; Maihle NJ, 2010, Patent number, Patent No. [US 7,744,882, 7744882]; Maramotti S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040593; Matsuyama S, 2001, J VET MED SCI, V63, P949, DOI 10.1292/jvms.63.949; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; McCallum H, 2016, PARASITOLOGY, V143, P805, DOI 10.1017/S0031182015000980; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Meetze K, 2015, CLIN CANCER RES, V21, P1106, DOI 10.1158/1078-0432.CCR-14-2407; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Miller MJ, 2014, ONCOIMMUNOL, V3; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Muenst S, 2016, J INTERN MED, V279, P541, DOI 10.1111/joim.12470; Munday B. L., 1978, Proceedings No.36 of Course for Veterinarians - Fauna., P335; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Nahta Rita, 2012, Chemother Res Pract, V2012, P648965, DOI 10.1155/2012/648965; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; OMI K, 1994, J COMP PATHOL, V111, P1, DOI 10.1016/S0021-9975(05)80106-9; Overholser J, 2015, VACCINES-BASEL, V3, P519, DOI 10.3390/vaccines3030519; Papaioannou NE, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.04.01; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Peck S, 2015, VET CLIN PATH, V44, P519, DOI 10.1111/vcp.12304; Pinfold TL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00251; Pitteri SJ, 2010, CANCER RES, V70, P8598, DOI 10.1158/0008-5472.CAN-10-1676; Pye R, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0553; Pye RJ, 2016, P NATL ACAD SCI USA, V113, P374, DOI 10.1073/pnas.1519691113; Pyecroft SB, 2007, ECOHEALTH, V4, P346, DOI 10.1007/s10393-007-0126-0; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Raabe TD, 2004, GLIA, V45, P197, DOI 10.1002/glia.10311; RAJKUMAR T, 1994, BRIT J CANCER, V70, P459, DOI 10.1038/bjc.1994.328; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Regan D, 2016, VET J, V207, P20, DOI 10.1016/j.tvjl.2015.10.008; Reif R, 2016, J BIOL CHEM, V291, P3837, DOI 10.1074/jbc.M115.686782; Ren XR, 2015, BREAST CANCER RES, V17, P528; Reschke M, 2008, CLIN CANCER RES, V14, P5188, DOI 10.1158/1078-0432.CCR-08-0186; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Rodriguez FJ, 2012, ACTA NEUROPATHOL, V123, P295, DOI 10.1007/s00401-012-0954-z; Rodriguez FJ, 2012, ACTA NEUROPATHOL, V123, P349, DOI 10.1007/s00401-011-0935-7; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Ronchi G, 2016, EUR J NEUROSCI, V43, P351, DOI 10.1111/ejn.12974; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sak MM, 2012, CARCINOGENESIS, V33, P1031, DOI 10.1093/carcin/bgs128; Sala G, 2013, TRANSL ONCOL, V6, P676, DOI 10.1593/tlo.13475; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Scheelings TF, 2014, J ZOO WILDLIFE MED, V45, P367, DOI 10.1638/2013-0217R.1; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Schoniger S, 2011, VET PATHOL, V48, P433, DOI 10.1177/0300985810377072; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Siampanopoulou M, 2013, HIPPOKRATIA, V17, P108; Siddle HV, 2015, IMMUNOLOGY, V144, P11, DOI 10.1111/imm.12377; Siddle HV, 2013, P NATL ACAD SCI USA, V110, P5103, DOI 10.1073/pnas.1219920110; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Singer J, 2014, MOL CANCER THER, V13, P1777, DOI 10.1158/1535-7163.MCT-13-0288; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Slingluff CL, 2011, CANCER J, V17, P343, DOI 10.1097/PPO.0b013e318233e5b2; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Srinivasan R, 2001, CELL SIGNAL, V13, P321, DOI 10.1016/S0898-6568(01)00155-3; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Stonecypher MS, 2005, ONCOGENE, V24, P5589, DOI 10.1038/sj.onc.1208730; Takahashi M, 2013, J BIOL CHEM, V288, P32910, DOI 10.1074/jbc.M113.491902; Tinoco G, 2013, J CANCER, V4, P117, DOI 10.7150/jca.4925; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Treder M, 2008, EJC SUPPL, V6, P99, DOI 10.1016/S1359-6349(08)72243-2; Tzekova N, 2014, J CLIN IMMUNOL, V34, pS86, DOI 10.1007/s10875-014-0015-6; Vakar-Lopez F, 2004, J PATHOL, V203, P688, DOI 10.1002/path.1568; van der Burg SH, 2016, NAT REV CANCER, V16, P219, DOI 10.1038/nrc.2016.16; van der Horst EH, 2005, INT J CANCER, V115, P519, DOI 10.1002/ijc.20867; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Wang XC, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00002; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Wilzen A, 2013, MOL CANCER, P12; Woods GM, 2015, J IMMUNOL, V195, P23, DOI 10.4049/jimmunol.1500131; Wu YM, 2013, MOL CANCER THER, V12, P427, DOI 10.1158/1535-7163.MCT-12-0838; YARDEN Y, 1991, BIOCHEMISTRY-US, V30, P3543, DOI 10.1021/bi00228a027; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun C, 2015, MOL CARCINOGEN, V54, P1700, DOI 10.1002/mc.22241; Zhang L, 2014, MOL CANCER THER, V13, P1345, DOI 10.1158/1535-7163.MCT-13-1033; Zhang NY, 2016, ACTA BIOCH BIOPH SIN, V48, P39, DOI 10.1093/abbs/gmv103; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	217	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0177919	10.1371/journal.pone.0177919	http://dx.doi.org/10.1371/journal.pone.0177919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591206	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000402880700017
J	Saha, D; Pal, A; Sarkar, N; Das, D; Blackard, JT; Guha, SK; Saha, B; Chakravarty, R				Saha, Debraj; Pal, Ananya; Sarkar, Neelakshi; Das, Dipanwita; Blackard, Jason T.; Guha, Subhasish Kamal; Saha, Bibhuti; Chakravarty, Runu			Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India	PLOS ONE			English	Article							SURFACE-ANTIGEN; MOLECULAR CHARACTERIZATION; HEPATOCELLULAR-CARCINOMA; ANTIRETROVIRAL THERAPY; LAMIVUDINE-RESISTANCE; BLOOD-DONORS; HBV DNA; MUTATIONS; PREVALENCE; ANTIBODY	Occult HBV infection (OBI), defined by the presence of HBV DNA in absence of hepatitis B surface antigen (HBsAg), is a significant concern in the HIV-infected population. Of 441 HIV +/HBsAg- patients analyzed, the overall prevalence of OBI was 6.3% (28/441). OBI was identified in 21 anti-HBc positives (17.8%), as well as among those who lacked any HBV-specific serological markers (2.2%). Comparison with HIV/HBV co-infection revealed that the levels of CD4, ALT, and HBV DNA were significantly lower during occult infection. Discrete differences were also observed with respect to quasispecies divergence. Additionally, subgenotype D1 was most frequent in occult infection, while D2 was widespread during chronic infection. The majority (similar to 90%) of occult D1 sequences had the sQ129R mutation in the surface gene. This study highlights several distinct features of OBI in India and underscores the need for additional HBV DNA screening in HIV-positive individuals.	[Saha, Debraj; Pal, Ananya; Sarkar, Neelakshi; Das, Dipanwita; Chakravarty, Runu] ICMR Virus Unit, ID & BG Hosp Campus, Kolkata, W Bengal, India; [Blackard, Jason T.] Univ Cincinnati, Coll Med, Div Digest Dis, Cincinnati, OH USA; [Guha, Subhasish Kamal; Saha, Bibhuti] Calcutta Sch Trop Med, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); ICMR - Virus Unit, Kolkata; University System of Ohio; University of Cincinnati; Calcutta School of Tropical Medicine (CSTM)	Chakravarty, R (corresponding author), ICMR Virus Unit, ID & BG Hosp Campus, Kolkata, W Bengal, India.	runugc@gmail.com			Department of Biotechnology, government of India [BT/PR14485/Med/29/203/2010]; Department of Biotechnology, India; Council of Scientific and Industrial Research (CSIR), India [09/030/(0077)/2015-EMR-I]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Department of Biotechnology, government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported financially by the Department of Biotechnology, government of India (Grant No. BT/PR14485/Med/29/203/2010).; The authors take this opportunity to thank the medical officers of the Calcutta School of Tropical Medicine, Kolkata for their help in collecting the samples. We would also like to express our gratitude towards Mr. Chinmay Mondal, Mr.Pulok Adak and Mr. Rajes Periyasamy for their technical assistance. This work was supported financially by the Department of Biotechnology, India. Author DS received Direct SRF (Senior Research Fellow) fellowship from the Council of Scientific and Industrial Research (CSIR), India [Sanction No: 09/030/(0077)/2015-EMR-I].	Aghakhani A, 2010, THER APHER DIAL, V14, P349, DOI 10.1111/j.1744-9987.2009.00798.x; Azadmanesh K, 2008, INTERVIROLOGY, V51, P270, DOI 10.1159/000160217; Bae E, 2012, SCAND J INFECT DIS, V44, P788, DOI 10.3109/00365548.2012.680488; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Banerjee P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109425; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Bhattacharya P, 2007, WORLD J GASTROENTERO, V13, P3730; Biswas A, 2013, SCI WORLD J, DOI 10.1155/2013/212704; Blaich A, 2012, TRANSFUSION, V52, P1999, DOI 10.1111/j.1537-2995.2011.03537.x; Chandra PK, 2009, J VIRAL HEPATITIS, V16, P749, DOI 10.1111/j.1365-2893.2009.01129.x; Chandra PK, 2007, INTERVIROLOGY, V50, P173, DOI 10.1159/000098960; CHAZOUILLERES O, 1994, LANCET, V343, P142, DOI 10.1016/S0140-6736(94)90934-2; Chua PK, 2005, J VIROL, V79, P13483, DOI 10.1128/JVI.79.21.13483-13496.2005; Datta S, 2006, EMERG INFECT DIS, V12, P1954; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074; Ghosh S, 2013, J VIRAL HEPATITIS, V20, P209, DOI 10.1111/j.1365-2893.2012.01655.x; Gupta S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-53; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; HOOFNAGLE JH, 1978, NEW ENGL J MED, V298, P1379, DOI 10.1056/NEJM197806222982502; Hu LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138552; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Jaroszewicz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043143; Kalinina T, 2003, HEPATOLOGY, V38, P1274, DOI 10.1053/jhep.2003.50484; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kleinman SH, 2005, TRANSFUSION, V45, P1247, DOI 10.1111/j.1537-2995.2005.00198.x; Kondo Yasuteru, 2013, ISRN Gastroenterol, V2013, P935295, DOI 10.1155/2013/935295; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lazarevic I, 2010, J MED VIROL, V82, P1160, DOI 10.1002/jmv.21810; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Maldonado-Rodriguez A, 2015, WORLD J HEPATOL, V7, P253, DOI 10.4254/wjh.v7.i2.253; Martin CM, 2012, J VIRAL HEPATITIS, V19, P716, DOI 10.1111/j.1365-2893.2012.01595.x; Martin CM, 2010, J VIRAL HEPATITIS, V17, P588, DOI 10.1111/j.1365-2893.2009.01214.x; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nunez M, 2002, AIDS, V16, P2099, DOI 10.1097/00002030-200210180-00024; Pal A, 2015, ANTIVIR THER, V20, P545, DOI 10.3851/IMP2942; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Panigrahi R, 2012, ANN HEPATOL, V11, P870, DOI 10.1016/S1665-2681(19)31412-7; Panigrahi R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-204; Pollicino T, 2004, GASTROENTEROLOGY, V126, P102, DOI 10.1053/j.gastro.2003.10.048; Rai Ramesh Roop, 2007, Trop Gastroenterol, V28, P19; Raimondo G, 2010, PATHOL BIOL, V58, P254, DOI 10.1016/j.patbio.2010.02.003; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Ramia S, 2008, INT J STD AIDS, V19, P197, DOI 10.1258/ijsa.2007.007200; Saha D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090432; Saha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073613; Schories M, 2000, J HEPATOL, V33, P799, DOI 10.1016/S0168-8278(00)80313-X; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Sellier P, 2010, J CLIN VIROL, V47, P13, DOI 10.1016/j.jcv.2009.10.010; Shi Y, 2012, LIVER INT, V32, P231, DOI 10.1111/j.1478-3231.2011.02481.x; Shiota G, 2000, J MED VIROL, V62, P151, DOI 10.1002/1096-9071(200010)62:2&lt;151::AID-JMV5&gt;3.0.CO;2-N; Shire NJ, 2007, JAIDS-J ACQ IMM DEF, V44, P309, DOI 10.1097/QAI.0b013e31802e29a9; Stuart JWTC, 2009, J MED VIROL, V81, P441, DOI 10.1002/jmv.21422; Tallo T, 2008, J GEN VIROL, V89, P1829, DOI 10.1099/vir.0.83660-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Yao QQ, 2013, CLIN VACCINE IMMUNOL, V20, P269, DOI 10.1128/CVI.00539-12; Zahn A, 2008, J GEN VIROL, V89, P409, DOI 10.1099/vir.0.83347-0; Zhang JM, 2007, CLIN INFECT DIS, V44, P1161, DOI 10.1086/513200	64	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179035	10.1371/journal.pone.0179035	http://dx.doi.org/10.1371/journal.pone.0179035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591184	Green Published, gold, Green Submitted			2022-12-26	WOS:000402880700075
J	Zhang, CC; Tang, Y; Li, YM; Xie, L; Zhuang, W; Liu, J; Gong, JB				Zhang, Chengcheng; Tang, Yi; Li, Yanming; Xie, Liang; Zhuang, Wei; Liu, Jing; Gong, Jianbin			Unfolded protein response plays a critical role in heart damage after myocardial ischemia/reperfusion in rats	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; ISCHEMIA-REPERFUSION INJURY; MESSENGER-RNA; ER-STRESS; MEDIATED APOPTOSIS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; ACTIVATION; CASPASE-12; DEATH	The unfolded protein response (UPR) plays a critical role in cell death mediated by ischemia/reperfusion (I/R) injury. However, little is known about the exact mechanism of UPR signaling pathways after myocardial I/R injury in rats. An attempt was therefore made to assess whether the myocardial I/R induced UPR, and which branch of UPR (ATF6, IRE1 and PERK) signal pathway was activated. Sprague-Dawley rats were pretreated with UPR stimulator dithiothreitol (DTT) and UPR inhibitor 4-phenylbutyrate (4PBA) and then subjected to myocardial I/R surgery. Compared with sham-operated group, the expression of GRP78, ATF6, CHOP and sXBP1 in the I/R injured group is significantly increased at transcript and protein levels, which indicated that all the three signal pathways of UPR were activated in the myocardial I/R injury. Compared with the I/R injured group, treatment with 4PBA effectively decreased myocardium infarct size, reduced myocardial apoptosis, down-regulated caspase-12 expression, diminished serum creatine kinase and lactate dehydrogenase levels. In contrast, these effects were reversed in DTT treated group. In summary, these results demonstrated that myocardial I/R injury activates UPR and inhibiting cell UPR possesses a cardioprotective effect through the suppression of ER stress-induced apoptosis. Therefore, inhibition of UPR might be used as a therapeutic target during myocardial I/R injury.	[Zhang, Chengcheng; Tang, Yi; Li, Yanming; Xie, Liang; Zhuang, Wei; Liu, Jing; Gong, Jianbin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Liu, J; Gong, JB (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	lygljhit@163.com; jianbingong@163.com	li, yan/GTI-4638-2022					Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; DeGracia DJ, 2002, J CEREBR BLOOD F MET, V22, P127, DOI 10.1097/00004647-200202000-00001; Ding WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094545; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441; Elrod JW, 2006, ARTERIOSCL THROM VAS, V26, P1517, DOI 10.1161/01.ATV.0000224324.52466.e6; Gaddam D, 2013, MOL BIOL CELL, V24, P14, DOI 10.1091/mbc.E12-06-0491; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.2004090768; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vilatoba M, 2005, SURGERY, V138, P342, DOI 10.1016/j.surg.2005.04.019; Wang XB, 2011, BASIC RES CARDIOL, V106, P865, DOI 10.1007/s00395-011-0176-x; Wu CT, 2015, INT J MOL MED, V35, P893, DOI 10.3892/ijmm.2015.2105; Wu H, 2016, INT J CARDIOL, V208, P65, DOI 10.1016/j.ijcard.2016.01.119; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao GL, 2016, ACTA PHARMACOL SIN, V37, P354, DOI 10.1038/aps.2015.136; Zhao MM, 2013, ACTA PHARMACOL SIN, V34, P501, DOI 10.1038/aps.2012.204	44	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2017	12	6							e0179042	10.1371/journal.pone.0179042	http://dx.doi.org/10.1371/journal.pone.0179042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX0AO	28591178	Green Published, Green Submitted, gold			2022-12-26	WOS:000402880700077
J	Kazemifar, S; Manning, KY; Rajakumar, N; Gomez, FA; Soddu, A; Borrie, MJ; Menon, RS; Bartha, R				Kazemifar, Samaneh; Manning, Kathryn Y.; Rajakumar, Nagalingam; Gomez, Francisco A.; Soddu, Andrea; Borrie, Michael J.; Menon, Ravi S.; Bartha, Robert		Alzheimers Dis Neuroimaging Init	Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; GLUCOSE-METABOLISM; COGNITIVE DECLINE; BLIND SEPARATION; MRI; DEMENTIA; PET	Previous studies have demonstrated altered brain activity in Alzheimer's disease using task based functional MRI (fMRI), network based resting-state fMRI, and glucose metabolism from 18 F fluorodeoxyglucose-PET (FDG-PET). Our goal was to define a novel indicator of neuronal activity based on a first-order textural feature of the resting state functional MRI (RS-fMRI) signal. Furthermore, we examined the association between this neuronal activity metric and glucose metabolism from F-18 FDG-PET. We studied 15 normal elderly controls (NEC) and 15 probable Alzheimer disease (AD) subjects from the AD Neuroimaging Initiative. An independent component analysis was applied to the RS-fMRI, followed by template matching to identify neuronal components (NC). A regional brain activity measurement was constructed based on the variation of the RS-fMRI signal of these NC. The standardized glucose uptake values of several brain regions relative to the cerebellum (SUVR) were measured from partial volume corrected FDG-PET images. Comparing the AD and NEC groups, the mean brain activity metric was significantly lower in the accumbens, while the glucose SUVR was significantly lower in the amygdala and hippocampus. The RS-fMRI brain activity metric was positively correlated with cognitive measures and amyloid beta 1-42 cerebral spinal fluid levels; however, these did not remain significant following Bonferroni correction. There was a significant linear correlation between the brain activity metric and the glucose SUVR measurements. This proof of concept study demonstrates that this novel and easy to implement RS-fMRI brain activity metric can differentiate a group of healthy elderly controls from a group of people with AD.	[Kazemifar, Samaneh; Manning, Kathryn Y.; Menon, Ravi S.; Bartha, Robert] Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada; [Kazemifar, Samaneh; Manning, Kathryn Y.; Menon, Ravi S.; Bartha, Robert] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Rajakumar, Nagalingam] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; [Gomez, Francisco A.] Univ Nacl Colombia, Dept Math, Bogota, Colombia; [Soddu, Andrea] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Borrie, Michael J.] Univ Western Ontario, Dept Med, London, ON, Canada; [Borrie, Michael J.] Lawson Hlth Res Inst, Div Aging Rehabil & Geriatr Care, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Universidad Nacional de Colombia; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Bartha, R (corresponding author), Univ Western Ontario, Robarts Res Inst, Ctr Funct & Metab Mapping, London, ON, Canada.; Bartha, R (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.	rbartha@robarts.ca	Soddu, Andrea/K-7087-2014; Menon, Ravi S/K-5500-2013; Menon, Ravi/ABA-8654-2020; Bartha, Robert/K-3611-2013; Borrie, Michael/G-3280-2011	Soddu, Andrea/0000-0001-6833-745X; Menon, Ravi S/0000-0002-7916-0263; Menon, Ravi/0000-0002-7916-0263; Bartha, Robert/0000-0002-7118-9096; 	Canadian Institute of Health Research [CSE 133350]; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health) [U01 AG024904]; U01 AG024904) and DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; ADNI clinical sites in Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U01 AG024904) and DOD ADNI (Department of Defense award); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; ADNI clinical sites in Canada	This study was funded by the Canadian Institute of Health Research (www.cihr-irsc.gc.can with grant CSE 133350. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Aiello M, 2015, NEUROIMAGE, V113, P111, DOI 10.1016/j.neuroimage.2015.03.017; Alavi A, 1980, J NUCL MED, V21, pP21; Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Del Sole A, 2008, EUR J NUCL MED MOL I, V35, P1357, DOI 10.1007/s00259-008-0773-6; Demertzi A, 2014, CORTEX, V52, P35, DOI 10.1016/j.cortex.2013.11.005; Di X, 2012, BRAIN CONNECT, V2, P275, DOI DOI 10.1089/BRAIN.2012.0086; Dukart J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002987; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; Gottschalk A, 1988, Invest Radiol, V23, P879, DOI 10.1097/00004424-198811000-00019; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Iacoboni M, 1999, CLIN NEUROPHYSIOL, V110, P2, DOI 10.1016/S0013-4694(98)00097-2; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Jagust W, 2006, ANN NEUROL, V59, P673, DOI 10.1002/ana.20799; Jagust WJ, 2010, ALZHEIMERS DEMENT, V6, P221, DOI 10.1016/j.jalz.2010.03.003; Kazemifar S, 2014, J NEUROSCI METH, V227, P35, DOI 10.1016/j.jneumeth.2014.01.033; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mormino EC, 2011, CEREB CORTEX, V21, P2399, DOI 10.1093/cercor/bhr025; Mosconi L, 2005, NEUROLOGY, V64, P1860, DOI 10.1212/01.WNL.0000163856.13524.08; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Mosconi L, 2013, CLIN TRANSL IMAGING, V1, P217, DOI 10.1007/s40336-013-0026-y; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Niwa K, 2002, NEUROBIOL DIS, V9, P61, DOI 10.1006/nbdi.2001.0460; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Nugent AC, 2015, J CEREBR BLOOD F MET, V35, P583, DOI 10.1038/jcbfm.2014.228; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; RAICHLE ME, 1976, ARCH NEUROL-CHICAGO, V33, P523, DOI 10.1001/archneur.1976.00500080001001; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shidahara M, 2009, NEUROIMAGE, V44, P340, DOI 10.1016/j.neuroimage.2008.09.012; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Solhi H, 2014, CASP J INTERN MED, V5, P9; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wyman BT, 2013, ALZHEIMERS DEMENT, V9, P332, DOI 10.1016/j.jalz.2012.06.004; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	63	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2017	12	6							e0178529	10.1371/journal.pone.0178529	http://dx.doi.org/10.1371/journal.pone.0178529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW9KF	28582450	Green Published, gold, Green Submitted			2022-12-26	WOS:000402837600021
J	Bottger, R; Hoffmann, R; Knappe, D				Boettger, Roland; Hoffmann, Ralf; Knappe, Daniel			Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ESCHERICHIA-COLI; AMINO-ACIDS; HEMOSTASIS; INFECTIONS	Proteolytic degradation of peptide-based drugs is often considered as major weakness limiting systemic therapeutic applications. Therefore, huge efforts are typically devoted to stabilize sequences against proteases present in serum or plasma, obtained as supernatants after complete blood coagulation or centrifugation of blood supplemented with anticoagulants, respectively. Plasma and serum are reproducibly obtained from animals and humans allowing consistent for clinical analyses and research applications. However, the spectrum of active or activated proteases appears to vary depending on the activation of proteases and cofactors during coagulation (serum) or inhibition of such enzymes by anticoagulants (plasma), such as EDTA (metallo-and Ca2+-dependent proteases) and heparin (e.g. thrombin, factor Xa). Here, we studied the presumed effects on peptide degradation by taking blood via cardiac puncture of CD-1 mice using a syringe containing a peptide solution. Due to absence of coagulation activators (e.g. glass surfaces and damaged cells), visible blood clotting was prevented allowing to study peptide degradation for one hour. The remaining peptide was quantified and the degradation products were identified using mass spectrometry. When the degradation rates (half-life times) were compared to serum derived freshly from the same animal and commercial serum and plasma samples, peptides of three different families showed indeed considerably different stabilities. Generally, peptides were faster degraded in serum than in plasma, but surprisingly all peptides were more stable in fresh blood and the order of degradation rates among the peptides varied among the six different incubation experiments. This indicates, that proteolytic degradation of peptide-based therapeutics may often be misleading stimulating efforts to stabilize peptides at degradation sites relevant only in vitro, i.e., for serum or plasma stability assays, but of lower importance in vivo.	[Boettger, Roland; Hoffmann, Ralf; Knappe, Daniel] Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, Leipzig, Germany; [Boettger, Roland; Hoffmann, Ralf; Knappe, Daniel] Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany	Leipzig University; Leipzig University	Hoffmann, R; Knappe, D (corresponding author), Univ Leipzig, Fac Chem & Mineral, Inst Bioanalyt Chem, Leipzig, Germany.; Hoffmann, R; Knappe, D (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed, Leipzig, Germany.	bioanaly@bbz.uni-leipzig.de; daniel.knappe@bbz.uni-leipzig.de	Knappe, Daniel/AAT-4373-2021; Hoffmann, Ralf/ABD-8779-2020	Knappe, Daniel/0000-0002-4661-8979; Bottger, Roland/0000-0002-5764-6844	Federal Ministry of Education and Research (BMBF) [01GU1104A]; Universitat Leipzig; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Universitat Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	This work was supported by the Federal Ministry of Education and Research (BMBF, grant number 01GU1104A to RH) and a PhD-stipend provided by Universitat Leipzig to RB are gratefully acknowledged. We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.; Support by the Federal Ministry of Education and Research (BMBF, grant number 01GU1104A to R. H.) and a PhD-stipend provided by Universitat Leipzig to R. B. are gratefully acknowledged. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. We acknowledge support from the German Research Foundation (DFG) and Uniyersitat Leipzig within the program of Open Access Publishing.	Berthold N, 2013, ANTIMICROB AGENTS CH, V57, P402, DOI 10.1128/AAC.01923-12; Bottger R, 2016, J CONTROL RELEASE, P230; Bush LA, 2006, J BIOL CHEM, V281, P7183, DOI 10.1074/jbc.M512082200; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Czihal P, 2012, ACS CHEM BIOL, V7, P1281, DOI 10.1021/cb300063v; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; Gobbo M, 2009, J MED CHEM, V52, P5197, DOI 10.1021/jm900396a; Hansen A, 2012, ANTIMICROB AGENTS CH, V56, P5194, DOI 10.1128/AAC.00585-12; Herce HD, 2014, J AM CHEM SOC, V136, P17459, DOI 10.1021/ja507790z; Jambunathan K, 2014, PROTEOM CLIN APPL, V8, P299, DOI 10.1002/prca.201300037; Karstad R, 2012, J MED CHEM, V55, P6294, DOI 10.1021/jm3002058; Knappe D, 2016, PROTEIN PEPTIDE LETT, V23, P1061, DOI 10.2174/0929866523666160719124712; Knappe D, 2014, PROTEIN PEPTIDE LETT, V21, P321, DOI 10.2174/09298665113206660105; Knappe D, 2011, INT J ANTIMICROB AG, V37, P166, DOI 10.1016/j.ijantimicag.2010.10.028; Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10; Knappe D, 2010, J MED CHEM, V53, P5240, DOI 10.1021/jm100378b; Krizsan A, 2014, ANGEW CHEM INT EDIT, V53, P12236, DOI 10.1002/anie.201407145; Mojsoska B, 2015, ANTIMICROB AGENTS CH, V59, P4112, DOI 10.1128/AAC.00237-15; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; O'Mullan P, 2009, CLIN CHEM LAB MED, V47, P685, DOI 10.1515/CCLM.2009.003; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Schmidt R, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00015; Schmidt R, 2016, J ANTIMICROB CHEMOTH, V71, P1003, DOI 10.1093/jac/dkv454; Schneider M, 2001, J INVERTEBR PATHOL, V78, P135, DOI 10.1006/jipa.2001.5054; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stief TW, 2008, INT J LAB HEMATOL, V30, P269, DOI 10.1111/j.1751-553X.2007.00959.x; Tanaka KA, 2009, ANESTH ANALG, V108, P1433, DOI 10.1213/ane.0b013e31819bcc9c; Turgeon M.L., 1999, CLIN HEMATOLOGY THEO; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Vine AK, 2009, RETINA-J RET VIT DIS, V29, P1, DOI 10.1097/IAE.0b013e31819091dc; Watson DS, 2011, BIOTECHNIQUES, V51, P95, DOI 10.2144/000113717; Werle M, 2006, AMINO ACIDS, V30, P351, DOI 10.1007/s00726-005-0289-3; Yi JZ, 2007, J PROTEOME RES, V6, P1768, DOI 10.1021/pr060550h; Yu ZY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015843, 10.1371/journal.pone.0017951]	35	138	139	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178943	10.1371/journal.pone.0178943	http://dx.doi.org/10.1371/journal.pone.0178943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575099	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300133
J	Christensen, A; Pike, CJ				Christensen, Amy; Pike, Christian J.			Age-dependent regulation of obesity and Alzheimer-related outcomes by hormone therapy in female 3xTg-AD mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TRANSGENIC MOUSE MODEL; HIGH-FAT DIET; COGNITIVE IMPAIRMENT; INSULIN-RESISTANCE; ADIPOSE-TISSUE; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; AMYLOID DEPOSITION; KNOCKOUT MICE	Depletion of ovarian hormones at menopause is associated with increased Alzheimer's disease (AD) risk. Hormone loss also increases central adiposity, which promotes AD development. One strategy to improve health outcomes in postmenopausal women is estrogen based hormone therapy (HT), though its efficacy is controversial. The window of opportunity hypothesis posits that HT is beneficial only if initiated near the onset of menopause. Here, we tested this hypothesis by assessing the efficacy of HT against diet-induced obesity and AD-related pathology in female 3xTg-AD mice at early versus late middle-age. HT protected against obesity and reduced P-amyloid burden only at early middle-age. One mechanism that contributes to AD pathogenesis is microglial activation, which is increased by obesity and reduced by estrogens. In parallel to its effects on P-amyloid accumulation, we observed that HT reduced morphological evidence of microglial activation in early but not late middle age. These findings suggest that HT may be effective during human perimenopause in reducing indices of obesity and AD-related pathology, a conclusion consistent with the window of opportunity hypothesis.	[Christensen, Amy; Pike, Christian J.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA	University of Southern California	Pike, CJ (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90007 USA.	cjpike@usc.edu	Pike, Christian J/D-4013-2018	Christensen, Amy/0000-0002-3357-0523; Pike, Christian/0000-0003-4577-7668	National Institute on Aging [AG026572, T32 AG052374]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026572, R01AG034103, T32AG052374] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institute on Aging (https://www.nia.nih.gov/) grant AG026572 awarded to R. Brinton/CJP. AC was supported in part by National Institute on Aging (https://www.nia.nih.gov/) grant T32 AG052374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenlle KK, 2009, NEUROBIOL AGING, V30, P932, DOI 10.1016/j.neurobiolaging.2007.09.004; Arimoto JM, 2013, ENDOCRINOLOGY, V154, P2101, DOI 10.1210/en.2012-2046; Ayoub AE, 2003, J NEUROSCI, V23, P7759; Bagger YZ, 2005, MENOPAUSE, V12, P12, DOI 10.1097/00042192-200512010-00005; Barron AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078554; Barron AM, 2013, J NEUROSCI, V33, P8891, DOI 10.1523/JNEUROSCI.1350-13.2013; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Brossia LJ, 2009, J AM ASSOC LAB ANIM, V48, P517; Buckman LB, 2014, BRAIN BEHAV IMMUN, V35, P33, DOI 10.1016/j.bbi.2013.06.007; Cai M, 2014, NEUROSCI LETT, V558, P115, DOI 10.1016/j.neulet.2013.11.007; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Carroll JC, 2008, ENDOCRINOLOGY, V149, P2607, DOI 10.1210/en.2007-1346; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Carroll JC, 2010, ENDOCRINOLOGY, V151, P2713, DOI 10.1210/en.2009-1487; Christensen A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00130; Collins DE, 2017, COMPARATIVE MED, V67, P11; Daniel JM, 2006, ENDOCRINOLOGY, V147, P607, DOI 10.1210/en.2005-0998; Davis KE, 2013, MOL METAB, V2, P227, DOI 10.1016/j.molmet.2013.05.006; Davis SR, 2012, CLIMACTERIC, V15, P419, DOI 10.3109/13697137.2012.707385; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Finch CE, 2014, J STEROID BIOCHEM, V142, P132, DOI 10.1016/j.jsbmb.2013.03.010; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Frick KM, 2002, NEUROSCIENCE, V115, P547, DOI 10.1016/S0306-4522(02)00377-9; Fugger HN, 2000, BRAIN RES, V883, P258, DOI 10.1016/S0006-8993(00)02993-0; Gandy S, 2000, EXP GERONTOL, V35, P503, DOI 10.1016/S0531-5565(00)00116-9; Gao S, 2010, BIOCHEM BIOPH RES CO, V398, P619, DOI 10.1016/j.bbrc.2010.05.114; Gardner WU, 1937, ENDOCRINOLOGY, V21, P727, DOI 10.1210/endo-21-6-727; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Gimenez-Llort L, 2008, NEUROIMMUNOMODULAT, V15, P331, DOI 10.1159/000156475; Gold M, 2015, SEMIN IMMUNOPATHOL, V37, P607, DOI 10.1007/s00281-015-0518-0; Gonzalez C, 2000, J ENDOCRINOL, V166, P283, DOI 10.1677/joe.0.1660283; Guillemot-Legris O, 2017, TRENDS NEUROSCI, V40, P237, DOI 10.1016/j.tins.2017.02.005; Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Henderson VW, 2005, J NEUROL NEUROSUR PS, V76, P103, DOI 10.1136/jnnp.2003.024927; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hughes TF, 2009, NEUROLOGY, V72, P1741, DOI 10.1212/WNL.0b013e3181a60a58; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Jayaraman A, 2014, ENDOCRINOLOGY, V155, P1398, DOI 10.1210/en.2013-1725; Jayaraman A, 2012, ENDOCRINOLOGY, V153, P5467, DOI 10.1210/en.2012-1464; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kawas C, 1997, NEUROLOGY, V48, P1517, DOI 10.1212/WNL.48.6.1517; KIRK EA, 1995, J LIPID RES, V36, P1522; Knight EM, 2014, NEUROBIOL AGING, V35, P1821, DOI 10.1016/j.neurobiolaging.2014.02.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maesako M, 2012, J BIOL CHEM, V287, P23024, DOI 10.1074/jbc.M112.367011; Maki PM, 2013, MENOPAUSE, V20, P695, DOI [10.1097/gme.0b013e3182960cf8, 10.1097/GME.0b013e3182960cf8]; Manrique C, 2012, CARDIORENAL MED, V2, P200, DOI 10.1159/000339563; Markowska AL, 2002, J NEUROSCI, V22, P10985; Mela V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048915; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Ordonez P, 2007, EXP PHYSIOL, V92, P241, DOI 10.1113/expphysiol.2006.035006; Paganini-Hill A, 1998, Int J Pharm Compd, V2, P24; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; Palm R, 2014, J NEUROCHEM, V130, P115, DOI 10.1111/jnc.12706; Pan XD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-45; Parachikova A, 2010, J ALZHEIMERS DIS, V21, P527, DOI 10.3233/JAD-2010-100204; Petanceska SS, 2000, EXP GERONTOL, V35, P1317, DOI 10.1016/S0531-5565(00)00157-1; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Picard F, 2002, P NATL ACAD SCI USA, V99, P15644, DOI 10.1073/pnas.202612199; Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Puig KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030378; Rae EA, 2015, NEUROSCI BIOBEHAV R, V57, P238, DOI 10.1016/j.neubiorev.2015.09.002; Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rosario ER, 2006, J NEUROSCI, V26, P13384, DOI 10.1523/JNEUROSCI.2514-06.2006; Setti SE, 2015, PHYSIOL BEHAV, V141, P1, DOI 10.1016/j.physbeh.2014.12.036; Shao HB, 2012, NEUROLOGY, V79, P1846, DOI 10.1212/WNL.0b013e318271f823; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; SIITERI PK, 1987, AM J CLIN NUTR, V45, P277, DOI 10.1093/ajcn/45.1.277; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2008, NEUROLOGY; Whitmer RA, 2011, ANN NEUROL, V69, P163, DOI 10.1002/ana.22239; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xu WL, 2011, NEUROLOGY, V76, P1568, DOI 10.1212/WNL.0b013e3182190d09; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013; Yue X, 2005, P NATL ACAD SCI USA, V102, P19198, DOI 10.1073/pnas.0505203102; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019; Zhao LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031267; Zhao LQ, 2011, NEUROBIOL AGING, V32, P1949, DOI 10.1016/j.neurobiolaging.2009.12.010	98	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178490	10.1371/journal.pone.0178490	http://dx.doi.org/10.1371/journal.pone.0178490			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575011	Green Published, Green Submitted, gold			2022-12-26	WOS:000402624300056
J	Andreoli, MCC; de Souza, NKG; Ammirati, AL; Matsui, TN; Carneiro, FD; Ramos, ACMD; Iizuca, IJ; Coelho, MPV; Afonso, RC; Ferraz-Neto, BH; de Almeida, MD; Durao, M; Batista, MC; Monte, JC; Pereira, VG; dos Santos, OP; dos Santos, BC				Cruz Andreoli, Maria Claudia; Guimaraes de Souza, Nadia Karina; Ammirati, Adriano Luiz; Matsui, Thais Nemoto; Carneiro, Fabiana Dias; Mallet de Souza Ramos, Ana Claudia; Iizuca, Ilson Jorge; Vilela Coelho, Maria Paula; Afonso, Rogerio Carballo; Ferraz-Neto, Ben-Hur; de Almeida, Marcio Dias; Durao, Marcelino; Batista, Marcelo Costa; Monte, Julio Cesar; Pereira, Virgilio Goncalves; dos Santos, Oscar Pavao; dos Santos, Bento Cardoso			Predictors of renal function recovery among patients undergoing renal replacement therapy following orthotopic liver transplantation	PLOS ONE			English	Article							FULMINANT HEPATIC-FAILURE; ACUTE KIDNEY INJURY; CONSENSUS CONFERENCE; DIALYSIS; DISEASE; IMPACT; RISK; RECIPIENTS; SURVIVAL; ETIOLOGY	Renal dysfunction frequently occurs during the periods preceding and following orthotopic liver transplantation (OLT), and in many cases, renal replacement therapy (RRT) is required. Information regarding the duration of RRT and the rate of kidney function recovery after OLT is crucial for transplant program management. We evaluated a sample of 155 stable patients undergoing post-intensive care hemodialysis (HD) from a patient population of 908 adults who underwent OLT. We investigated the average time to renal function recovery (duration of RRT required) and determined the risk factors for remaining on dialysis > 90 days after OLT. Log-rank tests were used for univariate analysis, and Cox proportional hazards models were used to identify factors associated with the risk of remaining on HD. The results of our analysis showed that of the 155 patients, 28% had pre-OLT diabetes mellitus, 21% had pre-OLT hypertension, and 40% had viral hepatitis. Among the patients, the median MELD (Model for End-Stage Liver Disease) score was 27 (interquartile range [IQR] 22-35). When they were listed for liver transplantation, 32% of the patients had serum creatinine (Scr) levels > 1.5 mg/dL or were on HD, and 50% had serum creatinine (Scr) levels > 1.5 mg/dL or were on HD at the time of OLT. Of the transplanted patients, 25% underwent pre-OLT intermittent HD, and 14% and 41% underwent continuous renal replacement therapy (CRRT) pre-OLT and post-OLT, respectively. At 90 days post-OLT, 118 (76%) patients had been taken off dialysis, and 16 (10%) patients had died while undergoing HD. The median recovery time of these post-OLT patients was 33 (IQR 27-39) days. In the multivariate analysis, fulminant hepatic failure as the cause of liver disease (p<0.001), the absence of pre-OLT hypertension (p = 0.016), a lower intraoperative fresh-frozen plasma (FFP) transfusion volume (p = 0.019) and not undergoing pre-OLT intermittent HD (p = 0.032) were associated with performing RRT for less than 90 days. Therefore, a high proportion of OLT patients showed improved renal function after OLT, and those who were diagnosed with fulminant hepatic failure, had no pre-OLT hypertension, received a lower transfused volume of intraoperative FFP and did not undergo pre-OLT intermittent HD had a higher probability of recovery.	[Cruz Andreoli, Maria Claudia; Guimaraes de Souza, Nadia Karina; Ammirati, Adriano Luiz; Matsui, Thais Nemoto; Carneiro, Fabiana Dias; Mallet de Souza Ramos, Ana Claudia; Iizuca, Ilson Jorge; Durao, Marcelino; Batista, Marcelo Costa; Monte, Julio Cesar; Pereira, Virgilio Goncalves; dos Santos, Oscar Pavao; dos Santos, Bento Cardoso] Hosp Israelita Albert Einstein, Ctr Dialise Einstein, Sao Paulo, Brazil; [Vilela Coelho, Maria Paula; Afonso, Rogerio Carballo; Ferraz-Neto, Ben-Hur; de Almeida, Marcio Dias] Hosp Israelita Albert Einstein, Unidade Transplante Figado, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	dos Santos, BC (corresponding author), Hosp Israelita Albert Einstein, Ctr Dialise Einstein, Sao Paulo, Brazil.	bento@einstein.br	Ammirati, Adriano/AAS-7792-2021; Ferraz-Neto, Ben-Hur/AAH-3969-2020	Cruz Andreoli, Maria Claudia/0000-0002-4599-5481				Al Riyami D, 2008, TRANSPLANTATION, V85, P1277, DOI 10.1097/TP.0b013e31816c4e6b; Bahirwani R, 2008, LIVER TRANSPLANT, V14, P665, DOI 10.1002/lt.21367; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Campbell MS, 2005, LIVER TRANSPLANT, V11, P1048, DOI 10.1002/lt.20445; Chandrakantan A, 2006, CLIN J AM SOC NEPHRO, V1, P832, DOI 10.2215/CJN.01191005; Chen J, 2011, TRANSPLANTATION, V91, P348, DOI 10.1097/TP.0b013e31820437da; Davis CL, 2007, AM J TRANSPLANT, V7, P1702, DOI 10.1111/j.1600-6143.2007.01856.x; Eason JD, 2008, AM J TRANSPLANT, V8, P2243, DOI 10.1111/j.1600-6143.2008.02416.x; Gallardo ML, 2004, LIVER TRANSPLANT, V10, P1379, DOI 10.1002/lt.20215; Gines P, 2009, NEW ENGL J MED, V361, P1279, DOI 10.1056/NEJMra0809139; Gonwa TA, 2006, AM J TRANSPLANT, V6, P2651, DOI 10.1111/j.1600-6143.2006.01526.x; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; Gonwa TA, 2001, TRANSPLANTATION, V72, P1934, DOI 10.1097/00007890-200112270-00012; Gotthardt D, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm650; Kim TS, 2013, CLIN TRANSPLANT, V27, P297, DOI 10.1111/ctr.12055; Leithead JA, 2011, AM J TRANSPLANT, V11, P1905, DOI 10.1111/j.1600-6143.2011.03649.x; Mendoza A, 1997, TRANSPLANT INT, V10, P55, DOI 10.1111/j.1432-2277.1997.tb00537.x; Northup PG, 2010, LIVER TRANSPLANT, V16, P440, DOI 10.1002/lt.22008; Ojo AO, 2007, SEMIN NEPHROL, V27, P498, DOI 10.1016/j.semnephrol.2007.03.010; Parajuli S, 2015, TRANSPLANTATION, V99, P1756, DOI 10.1097/TP.0000000000000820; Pham PTT, 2009, ADV CHRONIC KIDNEY D, V16, P256, DOI 10.1053/j.ackd.2009.04.002; Rueggeberg A, 2008, ANAESTHESIA, V63, P1174, DOI 10.1111/j.1365-2044.2008.05604.x; Ruiz R, 2007, LIVER TRANSPLANT, V13, P838, DOI 10.1002/lt.21149; Sharma P, 2013, CLIN J AM SOC NEPHRO, V8, P1135, DOI 10.2215/CJN.09600912; Sirivatanauksorn Y, 2014, TRANSPL P, V46, P818, DOI 10.1016/j.transproceed.2013.11.124; Tujios SR, 2015, CLIN GASTROENTEROL H, V13, P352, DOI 10.1016/j.cgh.2014.07.011	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178229	10.1371/journal.pone.0178229	http://dx.doi.org/10.1371/journal.pone.0178229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28574999	Green Submitted, gold, Green Published			2022-12-26	WOS:000402624300034
J	Ferreira, FC; Rodrigues, RA; Ellis, VA; Leite, LO; Borges, MAZ; Braga, EM				Ferreira Junior, Francisco C.; Rodrigues, Raquel A.; Ellis, Vincenzo A.; Leite, Lemuel O.; Borges, Magno A. Z.; Braga, Erika M.			Habitat modification and seasonality influence avian haemosporidian parasite distributions in southeastern Brazil	PLOS ONE			English	Article							TROPICAL DRY FOREST; WEST-NILE-VIRUS; BLOOD PARASITES; SUCCESSIONAL GRADIENT; INFECTIOUS-DISEASE; MALARIA PARASITES; SPATIAL VARIATION; HOST-RANGE; BLUE TITS; PREVALENCE	Habitat modification may change vertebrate and vector-borne disease distributions. However, natural forest regeneration through secondary succession may mitigate these effects. Here we tested the hypothesis that secondary succession influences the distribution of birds and their haemosporidian parasites (genera Plasmodium and Haemoproteus) in a seasonally dry tropical forest, a globally threatened ecosystem, in Brazil. Moreover, we assessed seasonal fluctuations in parasite prevalence and distribution. We sampled birds in four different successional stages at the peak and end of the rainy season, as well as in the middle and at the end of the dry season. A non-metric multidimensional scaling analysis revealed that bird communities in the pasture (i.e., highly modified) areas were different from those in the early, intermediate, and late successional areas (secondary forests). Among 461 individual birds, haemosporidian prevalence was higher in pasture areas than in the more advanced successional stages, but parasite communities were homogeneous across these areas. Parasite prevalence was higher in pasture-specialists birds (resilient species) than in forest-specialists species, suggesting that pasture-specialists may increase infection risk for co-occurring hosts. We found an increase in prevalence between the middle and end of the dry season, a period associated with the beginning of the breeding season (early spring) in southeastern Brazil. We also found effects of seasonality in the relative prevalence of specific parasite lineages. Our results show that natural forest recovery through secondary succession in SDTFs is associated with compositional differences in avian communities, and that advanced successional stages are associated with lower prevalence of avian haemosporidian parasites.	[Ferreira Junior, Francisco C.; Rodrigues, Raquel A.; Braga, Erika M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Ellis, Vincenzo A.] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Leite, Lemuel O.; Borges, Magno A. Z.] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Campus Univ Prof Darcy Ribeiro, Montes Claros, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros	Ferreira, FC; Braga, EM (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	franciscocarlosfj@gmail.com; embraga@icb.ufmg.br	Braga, Erika Martins/A-6776-2008; Ferreira, Francisco C./G-4013-2017; Borges, Magno A/E-2405-2016	Braga, Erika Martins/0000-0001-5550-7157; Ferreira, Francisco C./0000-0002-2034-4121; Borges, Magno A/0000-0001-5126-1794	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Sisbiota-BRASIL; National Institute of Science and Technology; Genetic and Health Information of the Brazilian Livestock (INCT-IGSPB); Inter-American Institute for Global Change Research (IAI) [CRN3025]; CAPES	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Sisbiota-BRASIL(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Institute of Science and Technology; Genetic and Health Information of the Brazilian Livestock (INCT-IGSPB); Inter-American Institute for Global Change Research (IAI); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientofico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Sisbiota-BRASIL, National Institute of Science and Technology, Genetic and Health Information of the Brazilian Livestock (INCT-IGSPB) and Inter-American Institute for Global Change Research (IAI) (CRN3025). CAPES granted FCFJ a doctorate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Alvarez-Anorve MY, 2012, AM J BOT, V99, P816, DOI 10.3732/ajb.1100200; APPLEGATE J E, 1971, Journal of Wildlife Diseases, V7, P91; Arroyo-Rodriguez V, 2017, BIOL REV, V92, P326, DOI 10.1111/brv.12231; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2003, J PARASITOL, V89, P388, DOI 10.1645/0022-3395(2003)089[0388:TASVOH]2.0.CO;2; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bonneaud C, 2009, J TROP ECOL, V25, P439, DOI 10.1017/S0266467409006178; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Christe P, 2002, J AVIAN BIOL, V33, P321, DOI 10.1034/j.1600-048X.2002.330317.x; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013; Cornet S, 2014, J ANIM ECOL, V83, P256, DOI 10.1111/1365-2656.12113; Cosgrove CL, 2008, J ANIM ECOL, V77, P540, DOI 10.1111/j.1365-2656.2008.01370.x; Falcao LAD, 2014, J TROP ECOL, V30, P123, DOI 10.1017/S0266467413000862; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Ellis VA, 2017, PARASITOL RES, V116, P73, DOI 10.1007/s00436-016-5263-3; Ellisa VA, 2015, P NATL ACAD SCI USA, V112, P11294, DOI 10.1073/pnas.1515309112; Espirito-Santo MM, 2009, FOREST ECOL MANAG, V258, P922, DOI 10.1016/j.foreco.2009.01.022; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, J PARASITOL, V89, P1044, DOI 10.1645/GE-3157; Dornelas AAF, 2012, REV BRAS ORNITOL, V20, P378; Ferreira FC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1865-y; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Foster JT, 2007, MOL ECOL, V16, P4738, DOI 10.1111/j.1365-294X.2007.03550.x; Godoi MN, 2016, AN ACAD BRAS CIENC, V88, P211, DOI 10.1590/0001-3765201620140723; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kim KS, 2012, MOL ECOL, V21, P5374, DOI 10.1111/mec.12047; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; Lalubin F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-307; Lapointe DA, 2008, J MED ENTOMOL, V45, P600, DOI 10.1603/0022-2585(2008)45[600:DOCQDC]2.0.CO;2; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Laurance SGW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076227; Legendre P., 2012, NUMERICAL ECOLOGY; Levin II, 2012, J PARASITOL, V98, P924, DOI 10.1645/GE-3027.1; Levin II, 2012, J PARASITOL, V98, P847, DOI 10.1645/GE-3007.1; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Madeira B, 2009, PLANT ECOL, V201, P291, DOI [10.1007/978-90-481-2795-5_22, 10.1007/s11258-009-9580-9]; Marini MA, 2001, CONDOR, V103, P767, DOI 10.1650/0010-5422(2001)103[0767:APOMAR]2.0.CO;2; Marini Miguel Angelo, 2009, Neotropical Biology and Conservation, V4, P3, DOI 10.4013/nbc.2009.41.01; Mendenhall CD, 2013, CONSERV LETT, V6, P125, DOI 10.1111/j.1755-263X.2012.00302.x; Mendes L, 2013, PARASITOL RES, V112, P2037, DOI 10.1007/s00436-013-3362-y; Moens MAJ, 2016, INT J PARASITOL, V46, P41, DOI 10.1016/j.ijpara.2015.08.001; Moura NG, 2013, BIOL CONSERV, V167, P339, DOI 10.1016/j.biocon.2013.08.023; Nassar J, 2014, TROPICAL DRY FORESTS IN THE AMERICAS: ECOLOGY, CONSERVATION, AND MANAGEMENT, P173; Neves FS, 2014, BIOTROPICA, V46, P14, DOI 10.1111/btp.12068; Oksanen J, 2022, R PACKAGE VERSION; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Perez-Rodriguez A, 2015, INT J PARASITOL, V45, P605, DOI 10.1016/j.ijpara.2015.03.008; Pezzini FF, 2014, PLANT BIOSYST, V148, P965, DOI 10.1080/11263504.2013.877530; Pinheiro RBP, 2016, INT J PARASITOL, V46, P115, DOI 10.1016/j.ijpara.2015.10.002; Portillo-Quintero CA, 2010, BIOL CONSERV, V143, P144, DOI 10.1016/j.biocon.2009.09.020; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; R Development Core Team, 2016, R LANG ENV STAT COMP; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos FL, 2015, PARASITOL RES, V114, P3903, DOI 10.1007/s00436-015-4622-9; Sambrook J., 2001, MOL CLONING LAB MANU; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; Tubelis D.P., 2001, ORNITOL NEOTROP, V12, P57; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2004, J WILDLIFE DIS, V40, P555, DOI 10.7589/0090-3558-40.3.555; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Young HS, 2014, P NATL ACAD SCI USA, V111, P7036, DOI 10.1073/pnas.1404958111	84	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2017	12	6							e0178791	10.1371/journal.pone.0178791	http://dx.doi.org/10.1371/journal.pone.0178791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EW6MJ	28575046	Green Submitted, Green Published, gold			2022-12-26	WOS:000402624300117
